2004”N“x –k—¢‘åŠwˆãŠw•”E‘åŠw•a‰@Œ¤‹†‹ÆÑW(HTML”Å)

i’FŒ´–{‚ÅŒäŠm”F‰º‚³‚¢ take@bme.ahs.kitasato-u.ac.jpj



<<‰ð–UŠwiŽR‰È’PˆÊj>>

mŠwp˜_•¶n

110001. [Œ´’˜] Developmental delay and unstable state of the testes in the rdw rat with congenital hypothyroidism. ŽðˆäNO1, ŽR‰È³•½1, ŒÃŠÙêˆê2 (1‰ð–U. 2ŽÀ“®): Development Growth & Differentiation, 46: 327-334. 2004.

110002. [Œ´’˜] Co-expression of de novo DNA methyltransferases Dnmt3a2 and Dnmt3L in gonocytes of mouse embryos. ŽðˆäNO1, Isao Suetake2, Fuminori Shinozaki2, ŽR‰È³•½1 (1‰ð–U. 2‘åã‘åE’`”’Œ¤): Gene Expression Patterns, 5: 231-237, 2004.

520001. [‘à] lHŠî’ê–Œ‚Ì‘n»|ƒ‰ƒ~ƒjƒ“Šˆ«ƒyƒvƒ`ƒh‚ÌV‚½‚ȃ`ƒƒƒŒƒ“ƒW|. –]ŒŽ–ƒ—F”ü1,2, –å’J—Tˆê3, –ì…Šî‹`1 (1“Œ‹ž–ò‰È‘å. 2–kŠC“¹‘å‘åŠw‰@. 3‰ð–U): ’`”’Ž¿EŠjŽ_Ey‘f, 50: 374-382, 2005.

mŠw‰ïEŒ¤‹†‰ï“™n

712001. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Intercalated duct cells as a possible progenitor of endocrine cells in the rat pancreas. ŽR‰È³•½1, Ÿ–”@C2, Œ´@Žé”ü1, —é–Ø“N‘¾˜Y3, —Ñ@‹žŽq3, ‹Ê–؉p–¾1, –å’J—Tˆê1 (1‰ð–U. 2Œ`‘ÔŒn. 3ŠO): ‘æ7‰ñ“ú’†‘gD×–E‰»ŠwƒZƒ~ƒi|, ‘ÛƒVƒ“ƒ|ƒWƒEƒ€ (2004/10/21-24), ’†‘E•Š¿Žs. Chinese Journal of Histochemistry and Cytochemistry, 13 (3): 346, 2004.

713001. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) 3-Dimentional organization of the centroacinar cells in rat pancreas acini. Ÿ–”@C1, –å’J—Tˆê2, ŽR‰È³•½2 (1Œ`‘ÔŒn. 2‰ð–U): 8th Asia-Pacific Conference on Electron Microscopy (8APEM) (2004/6/8), ‹à‘ò. Program and Summaries 8th Asia-Pacific Conference on Electron Microscopy, p.92, 2004.

713002. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Multiple origin of endocrine cells of rat pancreatic islet. Œ´@Žé”ü, –å’J—Tˆê, ŽR‰È³•½ (‰ð–U): 16th International Congress of the IFAA (2004/8/22-27), ‹ž“s. Anatomical Science International, 79 (Suppl): 421, 2004.

713003. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Clevage-like cell division in mouse gonocytes. ŽðˆäNO, ŽR‰È³•½ (‰ð–U): 16th International Congress of the IFAA (2004/8/22-27), ‹ž“s. Anatimical Sciencs International, 79(Suppl): 259, 2004.

713004. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Dynamics of the Golgi apparatus during mitosis of rat parotid acinar cells. ‹Ê–؉p–¾, ŽR‰È³•½ (‰ð–U): 12th International Congress of Histochemistry and Cytochemistry (2004/7/27), San Diego. J Histochem Cytochem, 52 (Suppl.1): S54, 2004.

713005. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Three-dimensional structure of the Golgi apparatus in rat parotid acinar cells as revealed by electron tomography. ‹Ê–؉p–¾, ŽR‰È³•½ (‰ð–U): 16th International Congress of the IFAA (2004/8/26), ‹ž“s. Anatomical Science International, 79 (Suppl): 406, 2004.

713006. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Role of laminin-ƒ¿5 chain LG4 module in epithelial branching morphogenesis. –å’J—Tˆê1, –]ŒŽ–ƒ—F”ü2,3, –ì…Šî‹`3, L. Sorokin4, ŽR‰È³•½1 (1‰ð–U. 2–kŠC“¹‘å‘åŠw‰@. 3School of Pharmacy, Tokyo University of Pharmacy and Life Science. 4Department of Experimantal Pathology, Lund University): 16th international congress of the IFAA and 109th annual meeting of Japanese Association of Anatomists (2004/8/22-27), ‹ž“s. Anatomical Science International, 79 (Supple.): 401, 2004.

723001. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘Ù¶Šúƒ‰ƒbƒgäX“à•ª”å•”‚ÌŒ`‘ÔŒ`¬. Œ´@Žé”ü, –å’J—Tˆê, ŽR‰È³•½ (‰ð–U): ‘æ45‰ñ“ú–{‘gD×–E‰»Šw‰ï (2004/10/29-30), Ž­Ž™“‡. —\eW, p.74, 2004.

723002. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “dŽqüƒgƒ‚ƒOƒ‰ƒtƒB[‚É‚æ‚é—§‘Ì×–E‰»Šw‚ÌŽŽ‚Ý. ‹Ê–؉p–¾, ŽR‰È³•½ (‰ð–U): ‘æ45‰ñ“ú–{‘gD×–E‰»Šw‰ï‘S‘ŠwpW‰ï (2004/10/29), Ž­Ž™“‡. —\eW, p.47, 2004.

723003. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒ‰ƒbƒg‚É‚¨‚¯‚éäX“‡‘gD‚ÌŒ`‘ÔŒ`¬. Œ´@Žé”ü, –å’J—Tˆê, ŽR‰È³•½ (‰ð–U): ‘æ110‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï (2005/3/29-31), •xŽR. Acta Anatomica Nipponica, 80 (Suppl): 166, 2005.

723004. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) AG-73 peptide conjugated chitosan membrane‚Ì—L—p«‚ɂ‚¢‚Ä. ’r–{”ÉO1, –]ŒŽ–ƒ—F”ü2, ŽR“c^˜H2, –ì…Šî‹`2, •“c@Œ[3, “àÀ‰hŽ÷1, ŽR‰È³•½4, –å’J—Tˆê4 (1Œ`ŠO. 2–kŠC“¹‘å‘åŠw‰@. 3‰¡•lŽs`˜p•a‰@. 4‰ð–U): ‘æ47‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠwpW‰ï (2004/4/7-8), “Œ‹ž.

732001. [Œ¤‹†‰ï] (µ‘Ò‚³‚ꂽu‰‰) –Ɖu“dŒ°‚ÌŠî‘bƒeƒNƒjƒbƒN. Ÿ–”@C1, ‹Ê–؉p–¾2, ˆÀ’B‰hŽ¡˜Y3, ŽR‰È³•½2 (1Œ`‘ÔŒn. 2‰ð–U. 3ˆã—ÃŒn‘åŠw‰@•ªŽqŒ`‘ԉȊw): “ú–{Œ°”÷‹¾Šw‰ïŠÖ“ŒŽx•”u‰‰‰ï‘æ29‰ñu‰‰‰ï (2005/3/5), “Œ‹ž. —\eW, p.140-141, 2005.

733001. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒCƒ“ƒeƒOƒŠƒ“‚ƃVƒ“ƒfƒJƒ“‚Éì—p‚·‚éBifunctionalƒyƒvƒ`ƒh‚̶•¨Šˆ«. ‰¡ŽRŽj°1. –å’J—Tˆê2, —é–ØŠì°1, ‰F’JŒúŽu3, t–؉늰1, –ì…Šî‹`4 (1“Œ‹ž–ò‘å. 2‰ð–U. 3‹ž“s‘åˆã. 4–kŠC“¹‘å‘åŠw‰@): ‘æ52‰ñƒ}ƒgƒŠƒbƒNƒXŒ¤‹†‰ï (2005/3/19-20), ‘啪Œ§“’•z‰@’¬.

733002. [Œ¤‹†‰ï] (Œû“ª) o¶‘OŒã‚É‚¨‚¯‚éƒ}ƒEƒXƒSƒmƒTƒCƒg‚Ì‘B. ŽðˆäNO (‰ð–U): ¸ŽqŒ`¬E¸‘ƒ“Å«Œ¤‹†‰ï (2004/10/31), ‘åã.


<<‰ð–UŠwi‹T“c’PˆÊj>>

mŠwp˜_•¶n

110003. [Œ´’˜] The role of Hoxa3 gene in parathyroid gland organogenesis of the mouse. ‹T“c•‡Žq1, Vˆä—Y‘¾1, ¼ê r”V1, çâ@C2 (1‰ð–U. 2‹ž“s‘å‘åŠw‰@): J. Histochem. Cytochem, 52 (5): 641-651, 2004.

110004. [Œ´’˜] Diurnal rhythms of common ƒ¿-subunit mRNA expression in the pars tuberalis of hamsters and chickens. Vˆä—Y‘¾, ‹T“c•‡Žq (‰ð–U): Cell and Tissue Research, 317 (3): 279-288, 2004.

mŠw‰ïEŒ¤‹†‰ï“™n

713007. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Molecular mechanishms for the third arch artery development revealed by Hoxa3-deficient mice. ‹T“c•‡Žq1, Vˆä—Y‘¾1, çâ@C2 (1‰ð–U. 2‹ž“s‘å‘åŠw‰@j: 12th International Congress of Histochemistry and Cytochemistry (2004/7/26), San Diego La Jolla, California. J Histochem Cytochem, 52 (Suppl. 1): S47, 2004.

713008. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Mash1 is required for development of the carotid body glomus cells. ‹T“c•‡Žq1, ¼ê r”V1, ŽO‰Y³–¾1, SX. Jiang2 (1‰ð–U. 2•a—): 16th International Congress of the IFAA (2004/8/25), Anat. Sci. Intern., 79 (Suppl): 371, 2004.

713009. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Long-term survival and neuronal differentiation of cultured chick C cells after nicotinamide treatment. ŽO‰Y³–¾, ‹T“c•‡Žq (‰ð–U): ‘æ109‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï‚¨‚æ‚Ñ‘æ16‰ñ‘Û‰ð–UŠw‰ï‹c (‘Û‰ð–UŠw‰ï‡“¯ŠJÃ) (2004/8/26), ‹ž“s. ‰ð–UŠwŽGŽ‘æ109‰ñ‘‰ïE‘S‘ŠwpW‰ï´˜^†, p.425, 2004.

713010. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Decrease of VEGF and Endothelin-1 Expressions in the Third Arch Artery of Hoxa3 Null Mutant Mice. Vˆä—Y‘¾1, çâ@C2, ‹T“c•‡Žq1 (1‰ð–U. 2‹ž“s‘å‘åŠw‰@): ‘æ109‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï‚¨‚æ‚Ñ‘æ16‰ñ‘Û‰ð–UŠw‰ï‹c (‘Û‰ð–UŠw‰ï) (2004/8/25), ‹ž“s. ‰ð–UŠwŽGŽ‘æ109‰ñ‘‰ïE‘S‘ŠwpW‰ï´˜^†, p.370, 2004.

732002. [Œ¤‹†‰ï] (µ‘Ò‚³‚ꂽu‰‰) ˆô“ª”h¶‘Ì“à•ª”åŠíŠ¯‚ÌŒ`¬‚Æ•ª‰». ‹T“c•‡Žq (‰ð–U): ‘æ9‰ñɪ‘å‘åŠw‰@—HŠwŒ¤‹†‰ÈƒVƒ“ƒ|ƒWƒ…ƒEƒ€ (2005/3/11), ɪ. ¶–½‰ÈŠw‚ÌÅ‘Oü, p.3-4, 2005.


<<¶—Šwiìã’PˆÊj>>

mŠwp˜_•¶n

110005. [Œ´’˜] Morphological changes in the rat carotid body 1, 2, 4, and 8 weeks after the termination of chronically hypocapnic hypoxia. Kusakabe T1, Hirakawa H2, Oikawa S2, Matsuda H2, ìã@—Ï3, Takenaka T1, Hayashida Y4 (1‘ŽmŠÚ‘å. 2‰¡•lŽs‘å. 3¶—. 4ŽY‹Æˆã‘å): Histology and Histopathology 19: 1133-1140, 2004.

120001. [Œ´’˜] ü’Ž‚ªŽ¦‚·s“®‚ÌŠT“úƒŠƒYƒ€‚ÌŽžŠÔ¶•¨Šwã‚̈Ӌ`. ŽOŽ}@“O1, ŠâˆäžÄˆê1, ’·’J쌚Ž¡2 (1ˆã—ÃŒn‘åŠw‰@. 2¶—): –k—¢ˆãŠw, 35 (1): 2004.

520002. [‘à] —Õ°‚É•K—v‚È_Œo‰»Šw@A. ƒÀ‚É‚æ‚é_ŒoŽ²õ—A‘—‚Ì—}§. ”ä—¯ŠÔO”ü (¶—): Clinical Neuroscience, 22 (7): 748-749, 2004.

m’˜@‘n

620001. [Šwp‘] (•ª’SŽ·•M) ”]‚Ì”M—ÍŠw; ”]‚̃tƒBƒWƒbƒNƒX, p.51-101. ’·’J쌚Ž¡ (¶—), ŠÄC ’·’J쌚Ž¡, ‹¤—§o”Å, “Œ‹ž, 2004”­s.

620002. [Šwp‘] (’P’˜) ¶‘Ì‚ÌŽžŠÔ’˜”­Œ»‹@\, V•ª–ìŠJ‘ñ‹L. ‘‡Œ¤‹†‘åŠw‰@‘åŠwEƒOƒ‹[ƒvŒ¤‹†uV•ª–ì‚ÌŠJ‘ñv, ’·’J쌚Ž¡ (¶—), ŠÄC “’ì“N”V, 2004/6”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

713011. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Clonidine prevents neurotoxic effects of lidocaine in cultured DRG neurons. ´…@—v2, ìã@—Ï1, ŠO@{”ü•v2, ”ä—¯ŠÔO”ü1 (1¶—. 2–ƒŒj: Society for Neuroscience 34th Annual Meeting Abstract (2004/10/27), ƒTƒ“ƒfƒBƒGƒS, •Ä‘.

713012. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Membrane mechanisms of neurotoxicity of lidocaine in cultured mouse dorsal root ganglion neurons. ’|˜Q–¯]1, ”ä—¯ŠÔO”ü2, ŠO@{”ü•v1, ìã@—Ï2 (1–ƒŒ. 2¶—): Society for Neuroscience 34th Annual Meeting Abstract (2004/10/27), ƒTƒ“ƒfƒBƒGƒS, •Ä‘.

722001. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‚à‚¤ˆê‚‚̃T[ƒJƒfƒBƒAƒ“ƒNƒƒbƒN‚ð‹‚ß‚Ä. ’·’J쌚Ž¡ (¶—): ‘æ7‰ñŒõ¶•¨ƒVƒ“ƒ|ƒWƒEƒ€ƒvƒƒOƒ‰ƒ€ (2004/7/17-18), •l¼.

723005. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒŠƒhƒJƒCƒ“‚ÌŽ²õ—A‘——}§ì—p‚Ì×–E–ŒƒƒJƒjƒYƒ€. Vˆä–¯]1, ”ä—¯ŠÔO”ü2, ŠO@{”ü•v1, ìã@—Ï2 (1–ƒŒ. 2¶—): ‘æ81‰ñ“ú–{¶—Šw‰ï‘å‰ïƒvƒƒOƒ‰ƒ€ (2004/6/2), ŽD–y. The Japanese Journal of Physiology, 54 (Suppl): S70, p.77, 2004.

723006. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) 4-ƒAƒ~ƒmƒsƒŠƒWƒ“‚Í×–E“àƒIƒ‹ƒKƒlƒ‰‚̃uƒ‰ƒEƒ“‰^“®‚É‘±‚­‹ó–EŒ`¬‚ðˆø‚«‹N‚±‚·. ”ä—¯ŠÔO”ü1, •Ð‘q@—²1, “‡“cƒˆê, ‚‹´‘•c1, ìã@—Ï1 (1¶—): ‘æ81‰ñ“ú–{¶—Šw‰ï‘å‰ïƒvƒƒOƒ‰ƒ€ (2004/6/2), ŽD–y. The Japanese Journal of Physiology, 54 (Suppl): S78, p.82, 2004.

723007. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ü’Ž‚ÉŒ©‚éV‚µ‚¢ŠT“úŽžŒv‹@\. ŽOŽ}@“O1, “c’†ç‹M1, ŽR–{Šî‰h1, ’·’J쌚Ž¡2 (1ˆã—ÃŒn‘åŠw‰@. 2¶—): ‘æ42‰ñ“ú–{¶•¨•¨—Šw‰ï (2004/12), ‹ž“s.

723008. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒ]ƒEƒŠƒ€ƒV‚ÌŠjEƒ~ƒgƒRƒ“ƒhƒŠƒADNA‚É‚¨‚¯‚鑹C•œ‚ÌŠT“ú•Ï“®. “c’†ç‹M1, ŽOŽ}@“O1, ”Ž“c—³Žj1, ŽR–{Šî‰h1, ’·’J쌚Ž¡2 (1ˆã—ÃŒn‘åŠw‰@. 2¶—): ‘æ27‰ñ“ú–{_Œo‰ÈŠwŠw‰ï (2004/9/21-23), ‘åã.

723009. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ü’ŽCaenorhabditis elegans‚É‚æ‚éV‚½‚ÈŠT“úŽžŒv‹@\‚̉ðÍ. ŽOŽ}@“O1, “c’†ŠÚ–¾”Ž, ‰ª‘º@‹Ï, ’·’J쌚Ž¡2 (1ˆã—ÃŒn‘åŠw‰@. 2¶—): ‘æ27‰ñ“ú–{_Œo‰ÈŠwŠw‰ï (2004/9/21-23), ‘åã.

731001. [Œ¤‹†‰ï] (“Á•Êu‹`) ¶•¨‚É‚¨‚¯‚鎞ŠÔ‚̘b. ’·’J쌚Ž¡ (¶—): ‚Í‚±‚¾‚Ä–¢—ˆ‘åŠw•¡ŽGŒn‰ÈŠwŠw‰È (2004.10.14`15, ”ŸŠÙ.

732003. [Œ¤‹†‰ï] (µ‘Òu‰‰) ŽžŠÔŽ²ã‚𶂫‚é‚Æ‚¢‚¤‚±‚Æ. ’·’J쌚Ž¡ (¶—): –kŠC“¹‘åŠw, ã“cŒ¤ƒZƒ~ƒi[ (2005/3/2), ŽD–y.

732004. [Œ¤‹†‰ï] (µ‘Òu‰‰) ¶•¨‚É‚¨‚¯‚éd—Í‚ÆŽžŠÔ‚Ì–â‘è. ’·’J쌚Ž¡ (¶—): î•ñ¶•¨•¨—Šw§’k‰ï (2004), •Ù“V“‡.


<<¶—Šwi‰ÍŒ´’PˆÊj>>

mŠwp˜_•¶n

110006. [Œ´’˜] Mutational and functional analysis of SLC4A4 in a patient with proximal renal tubular acidosis. Jun Inatomi1, Shoko Horita1, Nancy Braverman2, Takashi Sekine1, Hideomi Yamada1, —é–ØŠì˜Y3, ‰ÍŒ´Ž‰ë3, Nobuo Moriyama1, Akihiko Kudo1, Hayato Kawakami1, Mitsunobu Shimadzu4, Hitoshi Endo5, Toshiro Fujita, George Seki1, Takashi Igarashi1 (1“Œ‹ž‘å. 2Mckusick-Nathans Institute for Genetic Medicine. 3¶—. 4ŽO•H–û‰». 5ˆÇ—Ñ‘å): Pfl ugers Archiv-European Journal of Physiology, 448: 438`444, 2004.

520003. [‘à] ƒAƒ‹ƒhƒXƒeƒƒ“@ƒGƒXƒP[ƒvŒ»Û. ‰ÍŒ´Ž‰ë, ˆÀ‰ª—L‹IŽq (¶—): t‚Æ“§Í, 57 (5): 583`586, 2004.

520004. [‘à] ‚j+ƒ`ƒƒƒlƒ‹. ‰ÍŒ´Ž‰ë, ˆÀ‰ª—L‹IŽq (¶—): t‚Æ“§Í, 57 (4): 474`477, 2004.

520005. [‘à] ƒJƒŠƒEƒ€‚̊댯«. ‰ÍŒ´Ž‰ë (¶—): t‘Ÿ, 27 (2): 120`121, 2004.

520006. [‘à] ‘ãŽÓ«ƒAƒVƒh[ƒVƒX. ‰ÍŒ´Ž‰ë (¶—): t‘Ÿ, 27 (1): 42`44, 2004.

520007. [‘à] •¡ŽGŒn‚Ì\‘¢‰üŠv. ‰ÍŒ´Ž‰ë (¶—): t‚Æ“§Í, 56 (5): 579`580, 2004.

520008. [‘à] ‘gDŠÔ‰t‚Ì—e—Ê’²ß‹@\. ‰ÍŒ´Ž‰ë, ˆÀ‰ª—L‹IŽq, ì“c‰p–¾ (¶—): “ú–{—Õ°, 63 (1): 31`36, 2005.

520009. [‘à] ’¹‚Ì‚³‚¦‚¸‚è ‰¹ºŠwKE’mŠo‚Ì”]“à_Œo‹@\. “¡Œ´GŽq1, ²“¡—º•½2, ‹{–{•“T1 (1“ú–{—Žq‘åE—. 2¶—): ”äŠr¶—¶‰»Šw 21: 80-89, 2004.

m’˜ ‘n@

620003. [Šwp‘] (•ÒW) ƒJƒ‰[}‰ðl‘̳̂í\‘¢‚Æ‹@”\‡[_ŒoŒn (1). ‰Í“cŒõ”Ž (‹ž“s•{—§ˆã‘å), ˆî£³•F (‹ß‹E‘å), •ÒW âˆäŒ’—Y (‡“V“°‘å), ‰ÍŒ´Ž‰ë (¶—), “ú–{ˆãŽ–V•ñŽÐ, 2004/11/25”­s.

620004. [Šwp‘] (•ÒW) ƒJƒ‰[}‰ðl‘̳̂í\‘¢‚Æ‹@”\IX_ŒoŒn (2). ‹v–ì‚Ý‚ä‚« (‘åãŽs‘å), ˆÀ“¡Œ[Ži (_ŒË‘å), ™Œ´@ò, H“cŒbˆê (“Œ‹žˆãŽ•‘å), •ÒW âˆäŒ’—Y (‡“V“°‘å), ‰ÍŒ´Ž‰ë (¶—), “ú–{ˆãŽ–V•ñŽÐ, 2005/3/16”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

713013. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Song-induced ZENK gene expression in the brain of female budgerigars. Yamazaki, S1, “¡Œ´GŽq2, ²“¡—º•½3, ‹{–{•“T2, Ohi, S1 (1Šò•Œ‘åE‹³ˆç. 2“ú–{—‘åE—. 3¶—): 28th International Congress of Psychology (2004/8/8-13), –k‹ž. Int. J. Psychology, 39 (5-6): 197, 2004.

713014. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Habituation to male song by female budgerigars. “¡Œ´GŽq1, Kobayashi, S1, ²“¡—º•½2, Kimura, T1, ‹{–{•“T1, Miyamoto, T1 (1“ú–{—‘åE—. 2¶—): Joint European Conference on Behavioural Biology (The meeting of The Association for the Study of Animal Behaviour) (2004/7/29), ƒIƒ‰ƒ“ƒ_. Abstract, p.206, 2004.

713015. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) TNF-ƒ¿down-regulates transient outward K+ current (Ito) by reducing the expression of Kv4.2 and KchiP2 in cultured neonatal rat cardiomyocytes. A possible cause of arrythmia in acute myocardial inflammation. ì“c‰p–¾1, ’ë–ìTˆê2, ’ë–ì—TŒb2, “’–{‰ÀG2, ‹|í@‘å2, ˜aò@“O2 (1¶—. 2“à‡U): Heart Rhythm 2004 (2004/5/17), ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR.

723010. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒqƒg‹C“¹ã”ç×–E‚É‚¨‚¯‚é’áZ“§ˆ³ŽhŒƒŠ´Žó«ATP•úo‹@\. ‰ÍŒ´Ž‰ë, ˆÀ‰ª—L‹IŽq (¶—): “ú–{t‘ŸŠw‰ï (2004/5/27), “È–ØŒ§. The Japanese Journal of Nephrology, 46 (3): 302, 2004.

723011. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Mechanical stress-induced ATP releasefrom human bronchial cells. ‰ÍŒ´Ž‰ë1, ’|‘º®Žu1, Yasuhiro Takamura2, ˆÀ‰ª—L‹IŽq1, ì“c‰p–¾1, Jun Tamaoki2,, Atsushi Nagai (1¶—. 2,“Œ‹ž—ˆã‘å): The Japanese Journal of Physiology (“ú–{¶—Šw‰ï) (2004/6/2), ŽD–y. The Japanese Journal of Physiology, 54 (Suppl): S87, 2004.

723012. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) tãk–§”Á×–E‚ÌŽ÷—§‚Æ‹@”\‰ðÍ. ˆÀ‰ª—L‹IŽq1, ì“c‰p–¾1, ²“¡³G2, ‰ÍŒ´Ž‰ë1 (1¶—. 2“ŒŠC‘呈㌤): ‘æ27‰ñ•ªŽq¶•¨Šw‰ï (2004/12/10), _ŒËŽs. ƒvƒƒOƒ‰ƒ€Eu‰‰—vŽ|W, p.228, 2004.

723013. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ž“ƒZƒLƒZƒCƒCƒ“ƒR‚Ì‚³‚¦‚¸‚è’mŠo—̈æ. ²“¡—º•½1, “¡Œ´GŽq2, ŠC•”@•‘2, ‹{–{•“T2 (1¶—. 2“ú–{—‘åE—): ‘æ75‰ñ“ú–{“®•¨Šw‘å‰ï (2004/9/10-12), _ŒËŽs. Zoological Sci., in press, 2004.

733003. [Œ¤‹†‰ï] (ˆê”Êu‰‰) t‚j+•ª”å”\‚Ì”­’B‚É‚¨‚¯‚é“àŒü‚«®—¬«‚j+ƒ`ƒƒƒlƒ‹ (ROMKAKir7.1) ‚Ì”­Œ». —é–ØŠì˜Y1, ˆÀ‰ª—L‹IŽq1, ’†‘ºM‘å2, L£–΋v2, ‰ÍŒ´Ž‰ë1 (1¶—. 2“Œ‹žH‘å): ”­’BtŒ¤‹†‰ï. ”­’BtŒ¤‹†‰ïŽ (Journal of Developmental Nephrology), 12 (1): 13-14, 2004.

733004. [Œ¤‹†‰ï] (ˆê”Êu‰‰) nNOS-GFP transgenicƒ}ƒEƒX‚Ì컂ɂæ‚étƒ}ƒNƒ‰ƒfƒ“ƒT×–E‹@”\‚ÌŒ¤‹†. ˆÀ‰ª—L‹IŽq, —é–ØŠì˜Y, ‰ÍŒ´Ž‰ë (¶—): ¶—ŠwŒ¤‹†ŠŒ¤‹†‰ï (2004/10/7), “Œ‰ªè.

733005. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Meniere's disease (“àƒŠƒ“ƒp…Žî) ‚Ì•a‘Ô¶—‚ÆV‚µ‚¢Ž¡—Ö@‚ÌŠJ”­. ‰ÍŒ´Ž‰ë1, ì“c‰p–¾1, ’·À‰p–¾2, ‰ª–{–ql2 (1¶—. 2Ž¨•@): ¶—ŠwŒ¤‹†ŠŒ¤‹†‰ï (2004/11/16), “Œ‰ªè.


<<‘ãŽÓE’`”’Šw>>

mŠwp˜_•¶n

110007. [Œ´’˜] Differential Localization of SHPS-1 and CD47 and Its Molecular Mechanism in Cultured Hippocampal Neurons. Hiroshi Ohnishi1, Yuka Kaneko1, Hideki Okazawa1, Motoaki Miyashita1, Ryuji Sato1, Akiko Hayashi1, Kazutoshi Tada2, Shigekazu Nagata2, ‚‹´³g3, Takashi Matozaki1 (1ŒQ”n‘å. 2‘åã‘å. 3‘ãŽÓE’`”’): J Neuroscience, 25: 2702-2711, 2005.

110008. [Œ´’˜] Quantal size of catecholamine release from rat chromaffin cells is regulated by tonic activity of protein kinase A. Koga T1, ‚‹´³g2 (1“Œ‹ž‘å. 2‘ãŽÓE’`”’): Neuroscience Letters, 360: 145-148, 2004.

110009. [Œ´’˜] Appearance of specific mucins recognized by monoclonal antibodies in the rat gastric mucosa healing from HCl-induced gastric mucosal damage. ’ràV’q–¾1, ŒÜäzsM2, Žs쑸•¶2, —Ñ“c_–¾1, ŒIŒ´@½3, ‰ªˆÀ@ŒM4, ¼Œ³Ž›ŽâX1, ÎŒ´˜a•F5 (1“à‡T. 2‘ãŽÓE’`”’. 3ŠÖ“Œ‰»Šw. 4•a—. 5ˆã‰q): J Gastroenterol, 39(2): 113-119, 2004.

110010. [Œ´’˜] Roles of lipid rafts in integrin-dependent adhesion and gp130 signalling pathway in mouse embryonic neural precursor cells. Makoto Yanagisawa1,2, ’†‘º˜a¶3, Tetsuya Taga1,2 (1The 21st Century COE program 'Cell Fate Regulation Research and Education Unit', 2ŒF–{‘å, 3‘ãŽÓE’`”’): Genes to Cells, 9 (9): 801-809, 2004.

110011. [Œ´’˜] Kinetic Study on Conformational Change in a Single Molecular Species, ƒÀ3, of ƒÀ-Conglycinin in an Acidic Ethanol Solution. Kazunobu Tsumura1, Wataru Kugimiya1, ŒK“c³L2, Yuki Shimura2, ˜@Œ©‰p¢2 (1New Ingredients Research Institute, Tsukuba R&D Center, Fuji Oil Co. Ltd. 2‘ãŽÓE’`”’): The Protein Journal, 23 (6): 361-369, 2004.

210001. [€Œ´’˜] IgA nephropathy and tonsils-An approach from the structure of IgA1 produced by tonsillar lymphocytes. ”äŠé”\”V1, Akeyo Horie2, Yoshinari Yasuda2, Šâ£m—E3, Satoshi Sugiyama1 (1“¡“c•ÛŒ’‰q¶‘å. 2–¼ŒÃ‰®‘å. 3‘ãŽÓE’`”’): Acta Otolaryngologica, 555: 28-31, 2004.

220001. [€Œ´’˜] Roxatidine 7“úŠÔ˜A‘±“Š—^‚É‚æ‚郉ƒbƒgˆÝ”S‰tŽY¶×–E‚Ì•Ï“®|Bƒ€ƒ`ƒ“ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚É‚æ‚é–Ɖu‘gD‰»Šw“IŒŸ“¢|. ’Øì‘åŒå1, ’ràV’q–¾2, ŒÜäzsM3, Žs쑸•¶3, ‹Ê’u@Œ«4, –x“c‹±Žq5, ÎŒ´˜a•F6 (1ˆã—ÃŒn‘åŠw‰@. 2“à‡T. 3‘ãŽÓE’`”’. 4’é‘‘ŸŠí»–ò. 5¶‰»Šw. 6ˆã‰q): Ulcer Res, 31 (2): 145-147, 2004.

220002. [€Œ´] ƒ‰ƒbƒgŒn“‚É‚æ‚é—H–å“´’×ᇔ­Ç‚Ì”äŠrŒŸ“¢. ¬Œ´@i (‘ãŽÓE’`”’): ŽÀŒ±’×á‡, 31 (1): 67-70, 2004.

520010. [‘à] IgAtÇ‚ÆIgA1ƒqƒ“ƒW•”ƒ€ƒ`ƒ“Œ^“œ½•s‘S. ”äŠé”\”V1, ™ŽR@•q1, Šâ£m—E2 (1“¡“c•ÛŒ’‰q¶‘å. 2‘ãŽÓE’`”’): t‚Æ“§Í, 58 (3): 331-338, 2005.

m’˜@‘n

620005. [Šwp‘] (•ª’SŽ·•M) ˆâ“`Žq§Œä‚É‚æ‚éu‘I‘ð“IƒVƒiƒvƒX‹­‰»Eœ‹Žv‹@\‚̉ð–¾; AMPAŒ^Žó—e‘Ì‚Ì”‚Ì’²ß‚É‚æ‚éƒVƒiƒvƒX‰Â‘Y«‹@\, p.177-202. ”‘q@½, ‚‹´³g (‘ãŽÓE’`”’), •ÒW Žë–ì•ûL (‹à‘ò‘å), ƒNƒoƒvƒ, 2005/3/10”­s.

620006. [Šwp‘] (‹¤’˜/6–¼) ˆÝ”S‰tƒoƒŠƒA[. ÎŒ´˜a•F1, Žs쑸•¶2, ŒÜäzsM2, ‘¾“c_—Ç3, ’†ŽR@~3 (1ˆã‰q. 2‘ãŽÓE’`”’. 3MB‘å), ŠÄC –x“c‹±Žq1, ÎŒ´˜a•F2 (1–¼—_‹³Žö. 2ˆã‰q), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/12/6”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

712002. [Šw‰ï (‘Û)] (µ‘Ò‚³‚ꂽu‰‰) Recent development in IgA nephropathy research. Šâ£m—E1, ˆÉ“¡º•F2, ‚’J@“O3, ”äŠé”\”V4 (1‘ãŽÓE’`”’. 2Ž¨•@. 3“à‡W. 4“¡“c•ÛŒ’‰q¶‘å): Human Disease Glycomics/Proteome Initiative (HGPI) 1st Workshop 2004: Functional Glycomics in Disease (2004/8/24), ‘åã. Abstract of Human Disease Glycomics/Proteome Initiative.

713016. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Continuous administration of human underglycosylated IgA1 causes its mesangial deposition in KM mouse having entire human Ig Loci. ”äŠé”\”V1, Makoto Tomita1, Isao Ishida2, Šâ£m—E3, Satoru Sugiyama1 (1“¡“c•ÛŒ’‰q¶‘å. 2ƒLƒŠƒ“ƒr[ƒ‹. 3‘ãŽÓE’`”’): ‘æ37‰ñƒAƒƒŠƒJt‘ŸŠw‰ï‘‰ï (2004/10/30), ƒZƒ“ƒgƒ‹ƒCƒX. J Am Soc Nephrol, 15: 224A, 2004. —\eW Abstract of Human Disease Glycomics/Proteome Initiative.

722002. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) AMPAŽó—e‘Ì‚ðŠÜ—L‚µ‚½‚³‚Ü‚´‚܂Ȭ–E‚̉ðÍ. ”‘q@½1, ŽRX‘D1, ˆî‘º”ü•äŽq2, ¼‹{¹ˆê˜N1, ‚‹´³g1 (1‘ãŽÓE’`”’. 2–ƒŒ): ‘æ27‰ñ“ú–{_Œo‰ÈŠw‘å‰ïE‘æ47‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ï‡“¯‘å‰ï (2004/9/22), ‘åã. _Œo‰»Šw, 43: p.345, 2004.

723014. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) _Œo“`’B•¨Ž¿•úo‚É‚¨‚¯‚éƒJƒ‹ƒ‚ƒWƒ…ƒŠƒ“‘jŠQ܂̉e‹¿. ˆÀ“¡Œö—S1, H“¡‰À‹v1, ‚‹´³g2 (1“Œ‹ž–ò‘å‘åŠw‰@. 2‘ãŽÓE’`”’): ‘æ27‰ñ“ú–{_Œo‰ÈŠw‘å‰ïE‘æ47‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ï‡“¯‘å‰ï (2004/9/21), ‘åã. _Œo‰»Šw, 43: 417, 2004.

723015. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) PI (4,5) P2ƒ}ƒCƒNƒƒhƒƒCƒ“‚ÆŠJŒû•úo•”ˆÊ. –ö‹¤‘¾1, ›’J’ËMŽq2, ”~“c^‹½3, ŽR–{´“ñ4, Ž›ì@i4, ‚‹´³g2 (1“Œ‹ž‘å‘åŠw‰@E‘‡•¶‰». 2‘ãŽÓE’`”’. 3‹ž“s‘å. 4•l¼ˆã‘å): ‘æ27‰ñ“ú–{_Œo‰ÈŠw‘å‰ïE‘æ47‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ï‡“¯‘å‰ï (2004/9/21), ‘åã. _Œo‰»Šw, 43: 418, 2004.

723016. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) VAMPƒtƒ@ƒ~ƒŠ[ŠÜ—L¬–E‚̉ðÍ. ¼‹{¹ˆê˜N1, ”‘q@½1, ¬Ž›‹`’j2, ‘O“c’‰Œv2, ‚‹´³g1 (1‘ãŽÓE’`”’. 2—Šw•”): ‘æ27‰ñ“ú–{_Œo‰ÈŠw‘å‰ïE‘æ47‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ï‡“¯‘å‰ï (2004/9/22), ‘åã. _Œo‰»Šw, 43: 469, 2004.

723017. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘å”]”玿‚Ì_Œo×–E‚É‚Ý‚ç‚ê‚éStargazin family‚̈قȂÁ‚½ƒtƒHƒXƒtƒ@ƒ^[ƒ[‚̧Œä. ˆî‘º”ü•äŽq1, ”‘q@½2, ‰ª‘º_Žk1, ŠO@{”ü•v1, ‚‹´³g2 (1–ƒŒ. 2‘ãŽÓE’`”’): ‘æ27‰ñ“ú–{_Œo‰ÈŠw‘å‰ïE‘æ47‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ï‡“¯‘å‰ï (2004/9/22), ‘åã. _Œo‰»Šw, 43: 474, 2004.

723018. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Characterization of mAb HIK1083-recognizing oligosaccharides obtained from porcine and rat gastric mucins. ŒÜäzsM1, ’Øì‘åŒå2, ŒIŒ´@½3, ÎŒ´˜a•F4 (1‘ãŽÓE’`”’. 2ˆã—ÃŒn‘åŠw‰@. 3ŠÖ“Œ‰»Šw. 4ˆã‰q): ‘æ77‰ñ“ú–{¶‰»Šw‰ï‘å‰ï(2004/10/1), ‰¡•l. ¶‰»Šw, 76 (8): 749, 2004.

723019. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Analysis of N-glycan glycoform of IgA1 in IgA1-binding protein prepared from human serum. Šâ£m—E1, ‚‹´âXŽq2, ‰Á“¡Wˆê2, ˆÉ“¡º•F3, ‚’J@“O4, ”äŠé”\”V5 (1‘ãŽÓE’`”’. 2–¼ŒÃ‰®Žs‘å, 3Ž¨•@. 4“àIV. 5“¡“c•ÛŒ’‰q¶‘å): ‘æ77‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (2004/10/14), ‰¡•l. ¶‰»Šw, 7: 749, 2004.

723020. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Detection of Mouse MUC6 (mMuc6) Apomucin Using Anti-Peptide Antibody. ¬Œ´@i1, ‹Ê–؉p–¾2, ”‘q@½1, ˜@Œ©‰p¢1, •lèG–¾3 (1‘ãŽÓE’`”’. 2‰ð–U. 3¶•¨): “ú–{¶‰»Šw‰ï (2004/10/16), ‰¡•l. ¶‰»Šw, 76 (8): 1033, 2004.

723021. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆÝ”S–ŒŠQEĶ‰ß’ö‚É‚¨‚¯‚é”S‰t×–E‚Ì“®‘Ô‚ÉŠÖ‚·‚錟“¢. Žs쑸•¶1, ’ràV’q–¾2, ÎŒ´˜a•F3 (1‘ãŽÓE’`”’. 2“à‡T. 3ˆã‰qj: ‘æ46‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (2004/10/21), •Ÿ‰ª. “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 101: A703, 2004.

731002. [Œ¤‹†‰ï] (“Á•Êu‰‰) î“®ˆÙí‚Ì•ªŽq“I—‰ð‚ð‚ß‚´‚µ‚Ä. ‚‹´³g (‘ãŽÓE’`”’): ‘æ34‰ñŽRŒûNeuroscienceŒ¤‹†‰ï (2005/2/10), ‰F•”.

732005. [Œ¤‹†‰ï] (µ‘Ò‚³‚ꂽu‰‰) _Œo“`’B•¨Ž¿•úo‚É‚¨‚¯‚éƒJƒ‹ƒVƒEƒ€EƒZƒ“ƒVƒ“ƒO‚Ì•ªŽq‹@\. ˆÀ“¡Œö—S1, H“¡‰À‹v1, ‚‹´³g2 (1“Œ‹ž–ò‘å‘åŠw‰@. 2‘ãŽÓE’`”’): ‘æ8‰ñŠˆ«ƒAƒ~ƒ“‚ÉŠÖ‚·‚éƒ[ƒNƒVƒ‡ƒbƒv (2004/8/27), “Œ‹ž. ‘æ8‰ñŠˆ«ƒAƒ~ƒ“‚ÉŠÖ‚·‚éƒ[ƒNƒVƒ‡ƒbƒv—\eW.

732006. [Œ¤‹†‰ï] (µ‘Ò‚³‚ꂽu‰‰) —lX‚È×–E“à•ª”嬖E‚Ì’P—£‚Æ\¬•ªŽqŒˆ’è‚©‚ç–¾‚ç‚©‚É‚·‚éŠJŒû•úo‚Ì‘½—l«. ”‘q@½1, ŽRX‘D1, ¼‹{¹ˆê˜N1, ˆî‘º”ü•äŽq2, ‚‹´³g1 (1‘ãŽÓE’`”’. 2–ƒŒ): ‘æ8‰ñŠˆ«ƒAƒ~ƒ“‚ÉŠÖ‚·‚éƒ[ƒNƒVƒ‡ƒbƒv (2004/8/27), “Œ‹ž. ‘æ8‰ñŠˆ«ƒAƒ~ƒ“‚ÉŠÖ‚·‚éƒ[ƒNƒVƒ‡ƒbƒv—\eW.

732007. [Œ¤‹†‰ï] (µ‘Ò‚³‚ꂽu‰‰) PI (4,5) P2ƒ}ƒCƒNƒƒhƒƒCƒ“Œ`¬‚É‚æ‚éŠJŒû•úo•”ˆÊ‚ÌŠˆ«‰». –ö‹¤‘¾1, ›’J’ËMŽq2, ”~“c^‹½3, ŽR–{´“ñ4, Ž›ì@i4, ‚‹´³g2 (1“Œ‹ž‘å‘åŠw‰@E‘‡•¶‰». 2‘ãŽÓE’`”’, 3‹ž“s‘å, 4•l¼ˆã‘åj: ‘æ8‰ñŠˆ«ƒAƒ~ƒ“‚ÉŠÖ‚·‚éƒ[ƒNƒVƒ‡ƒbƒv (2004/8/27), “Œ‹ž. ‘æ8‰ñŠˆ«ƒAƒ~ƒ“‚ÉŠÖ‚·‚éƒ[ƒNƒVƒ‡ƒbƒv—\eW.

733006. [Œ¤‹†‰ï] (ˆê”Êu‰‰) IgA1Œ‹‡’`”’Ž¿ iIgA1-BPj ‚Ì•ªÍ‹y‚Ñt’¾’…ŒŒ´’`”’Ž¿‚Æ‚Ì”äŠr. ‚’J@“O1, “ŒŒ´³–¾1, Šâ£m—E2, ˆÉ“¡º•F3, ’†‘ºˆèŽq4, ¬—Ñ@–L4, ”äŠé”\”V5 (1“àIV. 2‘ãŽÓE’`”’. 3Ž¨•@. 4‚ ‚¯‚Ú‚Ì•a‰@. 5“¡“c•ÛŒ’‰q¶‘åj: IgAtÇŒ¤‹†‰ï (2005/1/29), “Œ‹ž. ´˜^, p.5, 2005.

733007. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒqƒg–ƉuƒOƒƒuƒŠƒ“ŽY¶ƒ}ƒEƒX iKMƒ}ƒEƒXj ‚Ö‚ÌŽ‘±“I“Š—^‚É‚æ‚éƒqƒg“œ½•s‘SIgA1‚ÌŽ…‹…‘Ì’¾’…«. ”äŠé”\”V1, ˆÉ“¡”ü—R‹I1, ˆäã˜aŽq1, –x]–¾¢1, •x“c@—º1, ‘ºã˜a—²1, ’·’Jì‚Ý‚Ç‚è1, “瓇–M_1, ™ŽR@•q1, Šâ£m—E2, Γc@Œ÷2 (1“¡“c•ÛŒ’‰q¶‘å. 2‘ãŽÓE’`”’. 3ƒLƒŠƒ“ƒr[ƒ‹j: IgAtÇŒ¤‹†‰ï (2005/1/29), “Œ‹ž. ´˜^, p.2, 2005.


<<ˆâ“`ŽqŠw>>

mŠwp˜_•¶n

110012. [Œ´’˜] Characterization of new monoclonal antibodies against porcine lymphocytesFmolecular characterization of clone ‚VG3, an antibody reactive with the constant region of the T-cell receptor ƒÂ-chains. Tang WR, Shioya N, Eguchi T, Ebata T, Matsui J, Takenouchi H, Honma D, Yasue H, ‚Š_—m‘¾˜Y1, Enosawa S, Itagaki M, Taguchi T, Kiyokawa N, Amemiya H, Fujita J (1ˆâ“`Žq): Veterinary Immunology and Immunopathology, 103: 113-127, 2005.

mŠw‰ïEŒ¤‹†‰ï“™n

713017. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Cloning and comparative analysis of swinepre-T cell receptor a-chain gene. Yamamoto R, Sato E, ‚Š_—m‘¾˜Y1, Yasue H (1ˆâ“`Žq): 29th International Conference on Animal Genetics B023 (2004/9), “Œ‹ž.

713018. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Genomic organization and generation of diversity of the porcine TCRƒ¿/ƒÂ Chain gene. ã¼”Ž‰p1, Toki D, Morozumi T, Yamamoto R, Tanaka M, Shinkai H, Eguchi-Ogawa T, ‚Š_—m‘¾˜Y1, ˆ¾“c@’ (1ˆâ“`Žq): 29th International Conference on Animal Genetics B024 (2004/9), “Œ‹ž.

713019. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) The genomic structure of porcine T-cell receptor gamma locus: involvement of exon-shuffling in creating the ‚bƒÁ3 gene. ‹TŽRFŽO, ã¼”Ž‰p, ˆ¾“c@’, ‚Š_—m‘¾˜Y (ˆâ“`Žq): 29th International Conference on Animal Genetics B025(2004/9), “Œ‹ž.

713020. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Porcine T cell receptor genes: the genomic structure and expression in piglets. ‚Š_—m‘¾˜Y1, Hatsuse H, Watanabe M, Yamamoto R, ‹TŽRFŽO1, Akiyama M, Omori T, Yamada S, Shimizu M, ã¼”Ž‰p1, ˆ¾“c@’1, Yasue H (1ˆâ“`Žq): 29th International Conference on Animal Genetics B026 (2004/9), “Œ‹ž.

723022. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒGƒLƒ\ƒ“-ƒVƒƒƒtƒŠƒ“ƒO‚É‚æ‚è‚‚­‚ç‚ꂽƒuƒ^‚s×–EƒŒƒZƒvƒ^[CƒÁ3ˆâ“`Žq‚̉ðÍ. ‹TŽRFŽO, ã¼”Ž‰p, ŒI“c@’, ‚Š_—m‘¾˜Y (ˆâ“`Žq): ‘æ27‰ñ“ú–{•ªŽq¶•¨Šw‰ï”N‰ï (2004), _ŒË.


<<–ò—Šw>>

mŠwp˜_•¶n

110013. [Œ´’˜] Roles of thromboxane A (2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. Kobayashi T, Tahara Y, Matsumoto M, Iguchi M, Sano H, Murayama T, Arai H, Oida H, Yurugi-Kobayashi T, Yamashita JK, •Ð‹ËŠ°”V1, ”n“ˆ³—²2, Yokode M, Kita T, ¬‹{@Žü3 (1ŠO. 2–ò—. 3‹ž“s‘å‘åŠw‰@): J Clin Invest, 114 (6): 784-794, 2004.

110014. [Œ´’˜] Nitric oxide generated by iNOS reduces deformability of Lewis lung carcinoma cells. ˆäì@‘1, —Ñ@ò2, “c’†’¼•F1, ”n“ˆ³—²2, ìã‹M•q, ¬—ÑO—S1 (1“à‡X. 2–ò—): Cancer Sci, 95 (4): 342-347, 2004.

110015. [Œ´’˜] Role of thromboxane derived from COX-1 and -2 in hepatic microcirculatory dysfunction during endotoxemia in mice. •Ð‹ËŠ°”V1, ˆÉ“¡‹`–ç1, Έ䌒ˆê˜Y1, —Ñ@ò2, ––¼@½, ŽR‰È³•½3, ‘º“c—²•F, ¬‹{@Žü4, Š`“c@Í1, ”n“ˆ³—²2 (1ŠO. 2–ò—. 3‰ð–U. 4‹ž“s‘å‘åŠw‰@): Hepatology, 39 (1): 139-150, 2004.

110016. [Œ´’˜] Mild irritant prevents ethanol-induced gastric mucosal microcirculatory disturbances through actions of calcitonin gene-related peptide and PGI2 in rats. ²”ŒˆÐ’j1, ‘å–ì@—²1, Š™“cˆêŽõ1, VˆäŸt1, …ŒûŸl1, Ž­Žæ@M2, ¼Œ³Ž›ŽâX1, ”n“ˆ³—²2 (1“à‡T. 2–ò—): Am J Physiol Gastrointest Liver Physiol, 286 (1): G68-75, 2004.

110017. [Œ´’˜] Roles of the renal kallikrein-kinin system in salt-sensitive hypertension. Ž­Žæ@M, ”n“ˆ³—² (–ò—): Hypertension, 44 (6): e12, 2004.

110018. [Œ´’˜] Prevention of Ethanol-induced Gastric Mucosal Microcirculatory Disturbances by Mild Irritant Through the Actions of Calcitonin Gene-Related Peptide and Prpstaglandin I2 in Rats. ²”ŒˆÐ’j1, ‘å–ì@—²1, Š™“cˆêŽõ1, VˆäŸt1, …ŒûŸl1, •ž•”—fˆê˜Y1, ¼Œ³Ž›ŽâX1, ”n“ˆ³—²2 (1“à‡T. 2–ò—): Organ Microcircuration Springer-Verlag Tokyo, 13: 93-97, 2005.

110019. [Œ´’˜] Roles of Thromboxane in Lipopolysaccharide-Induced Hepatic Microcirculatory Dysfunction in Mice. •Ð‹ËŠ°”V1, ˆÉ“¡‹`–ç1, Έ䌒ˆê˜Y1, —Ñ@ò2, ––¼@½, ¬‹{@Žü3, Š`“c@Í1, ”n“ˆ³—²2 (1ŠO. 2–ò—. 3‹ž“s‘å‘åŠw‰@): Organ Microcircuration Springer-Verlag Tokyo, 13: 165-173, 2005.

110020. [Œ´’˜] Pharmacokinetics of the active metabolites of ethyl loflazepate in elderly patients who deied of asphyxia associated with benzodiazepine-related toxicity. 㞊‹gl1, —Ñ@ò2, Nishikawa T, Yoshimura K, ‘Š”nˆêˆå1 (1‹~–½. 2–ò—): J Anal Toxicol. 29(2):140-144, 2005.

110021. [Œ´’˜] Down-regulation of lipoxin A4 recepter by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo. ²“¡—DŽq1, –k—¢‰p˜Y1, ‘ºã—m‰î1, ‹´–{@“Ä2, ‰““¡•½m2, ‹ß“¡Œ[•¶2, ˆä㼋v1, —Ñ@ò3 (1”÷EŠñ. 2“à‡X. 3–ò—): Biomed Pharmacother, 58 (6-7): 381-387, 2004.

110022. [Œ´’˜] Effect of milk on intestinal fluid accumulation and renal injury following mercuric chloride ingestion in rats. 㞊‹gl1, —Ñ@ò2, Yoshimura K, ‘Š”nˆêˆå1 (1‹~–½. 2–ò—): J Appl Toxicol, 24 (2): 129-134, 2004.

110023. [Œ´’˜] The effects of cholesterol-3-sulfate(CH-3S) on the phosphorylation of human C3a (hC3a) in vitro and on the ability of hC3a to induce vascular permeability in rats. Kawakami F, Ito M, Matsuda Y, —Ñ@ò1, Ohtsuki K (1–ò—): Biol Pharm Bull, 27 (3): 282-287, 2004.

120002. [Œ´’˜] —Õ°–ò—ŽŽŒ±‚É‚¨‚¯‚éƒvƒ‰ƒZƒ{“Š—^Žž‚ÌŽ©ŠoÇó”­Œ»‚ÉŠÖ‚·‚錟“¢|‰ß‹Ž13”NŠÔ‚É‚¨‚¯‚éWŒv|. —L‘ò‹IŽq1, ˜@À’qŽq1, •Ÿ“ˆ–Mº1, ‚•^Ž÷Žq1, ´…’qŽq1, ”Ñ“‡@”£1, ‚–ö@”Ž2, ŠÔŸº–õ•v2, ••”‰ël2, ŽR“cD‘¥1, ’|“à³O3, ŒF’J—YŽ¡4 (1–k—¢Œ¤‹†Š. 2(Š”) ƒAƒCEƒfƒB[EƒfƒB[. 3ˆã—ÃŒn‘åŠw‰@. 4–ò—): —Õ°–ò—, 36 (1): 29-34, 2005.

210002. [€Œ´’˜] Chronoastrobiology: proposal, nine conferences, heliogemagne- ics, transyears, near-weeks, near-decades, phylogenetic and ontogenetic memories. Franz Halberg1, Germaine Cornelissen, Philip Regal, Kuniaki Otsuka, Zhengrong Wang, George S Katinas, Jarmila Siegelova, Pavel Homolka, Pavel Prikryl, Sergey M Chibisov, Daniel C Holley, Hans W Wendt, Chriatopher Bingham, Sally L Palm, Robert P Sonkowsky, Robert B Sothern, Emil Pales, Miroslav Mikulecky, Roberto Tarquini, Federico Perfetto, Roberto Salti, Cristina Maggioni, Rita Jozsa, Alexander A Konradov, Elena V Kharlitskaya, Miguel Revilla, Chaomin Wan, Manfred Herold, Elena V Syutkina, Anatoly V. Masalov, Piero Faraone, Ram B Singh, RK Singh, Adarsh Kumar, Ranjana Singh, Sakikumar Sundaram, Tina Sarabandi, Giancarlo Pantaleoni, Yoshihiko Watanabe, ŒF’J—YŽ¡2, Denis Gubin, Keiko Uezono, Andras Olah, Katarina Borer, Eugene A Kanabrocki, Srilakshmi Bathina, Erhard Haus, Dewayne Hillman, Othils Schwartzkopff, Earl E Bakken, Michal Zeman. (1ƒ~ƒlƒ\ƒ^‘å. 2–ò—): Biomedicine and Pharmacotherapy, 58 (Supl.1): S150-S187, 2004.

210003. [€Œ´’˜] Chronomic blood pressure (BP) and heart rat (HR) monitoring for lasting pain? George S Katinas1, Germaine Cornelissen, RB Singh, Kuniaki Otsuka, Jarmila Siegelova, Pavel Homolka, Boumil Fiser, ŒF’J—YŽ¡2, Othild Schwartzkopff, Franz Halberg (1ƒ~ƒlƒ\ƒ^‘å. 2–ò—): The 5th International Symposium Workshop on Chronoastro-biology and Chronotherapy Proceedings, 64-68, 2004.

210004. [€Œ´’˜] Chronomics:Circadian amplitude of blood pressure, ethanol, natureal history of mesor-hypertension and treatments. ŒF’J—YŽ¡1, Germaine Cornelissen, Othild Schwartzkopff, Franz Halberg (1–ò—): International Journal of Cardiology, 97(Supl.2): S14-S15, 2004.

520011. [‘à] ƒGƒrƒfƒ“ƒX‚ÉŠî‚­f—ÃKƒCƒhƒ‰ƒCƒ“‚ÆEssential Medicine. ŒF’J—YŽ¡ (–ò—): —Õ°ˆã–ò, 20 (4): 395-400, 2004.

520012. [‘à] —Õ°–ò—ŽŽŒ±‚ÌŒ»ó‚Æ¡Œã. ŒF’J—YŽ¡ (–ò—): ƒtƒ@ƒ‹ƒ}ƒVƒA, 40 (12): 1113-1117, 2004.

520013. [‘à] ƒLƒjƒmƒQƒ“‚̈â“`Žq, ¶‡¬, ‹@”\. “¡“c•üŒb, ”n“ˆ³—² (–ò—): “ú–{—Õ°, 63 (‘3): 357-362, 2005.

520014. [‘à] ƒƒCƒRƒgƒŠƒGƒ“‚ƃƒCƒRƒgƒŠƒGƒ“Žó—e‘Ì. ”n“ˆ³—² (–ò—): ƒAƒŒƒ‹ƒM[‰È, 17 (5): 414-421, 2004.

m’˜@‘n

620007. [Šwp‘] (•ª’SŽ·•M) ¸_‰È@•K{–ò‚ð’T‚é; A. •K{–ò‚Ìl‚¦•û, p.1-10. ŒF’J—YŽ¡ (–ò—), •ÒW ‹{‰ª@“™ (¸_), ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2004/11.20”­s.

620008. [Šwp‘] (•ª’SŽ·•M) ‚­‚·‚è‚ƃGƒrƒfƒ“ƒX; f—ÃKƒCƒhƒ‰ƒCƒ“‚Æ‚­‚·‚è, p.208-215. ŒF’J—YŽ¡1, “nç²—TŽi2 i1–ò—. 2•l¼ˆã‘åj, •ÒW ’Ã’JŠìˆê˜Y1, “à“c‰p“ñ2 i1“Œ‹ž‘å. 2º˜a‘åj, ’†ŽR‘“X, “Œ‹ž, 2005/3”­s.

620009. [Šwp‘] (•ª’SŽ·•M) 21¢‹I‚݂̈̉ŠÇŠw; ‰ŠÇ‚ÆŒŒŠÇ“à”ç×–E, p.103-118. ”n“ˆ³—² (–ò—), •ÒW 󳔎 (–kŠC“¹‘å), ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, “Œ‹ž, 2004/10/10”­s.

620010. [Šwp‘] (•ª’SŽ·•M) Ž_‰»ƒXƒgƒŒƒXƒiƒrƒQ[ƒ^[; COX-2 ‘jŠQ–ò. ”n“ˆ³—² (–ò—), •ÒW ŽRŠÝ¹ˆê (‹v—¯•Ä‘å), ŠÄC ‘q—ѳ•F (ŒQ”n‘å), ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, 2005/3/15”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

712003. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Chronomic blood pressure (BP) and heart rat (HR) monitoring for lasting pain? George S Katinas1, Germaine Cornelissen, RB Singh, Kuniaki Otsuka, Jarmila Siegelova, Pavel Homolka, Boumil Fiser, ŒF’J—YŽ¡2, Othild Schwartzkopff, Franz Halberg (1ƒ~ƒlƒ\ƒ^‘å. 2–ò—): The 5th International Symposium Workshop on Chronoastro- biology and Chronotherapy (2004/11/6), “Œ‹ž. The 5th International Symposium Workshop on Chronoastrobiology and Chronotherapy Proceedings, 64-68, 2004.

712004. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Chronomics: Circadian amplitude of blood pressure, ethanol, natureal history of mesor-hypertension and treatments. ŒF’J—YŽ¡1, Germaine Cornelissen, Othild Schwartzkopff, Franz Halberg (1–ò—): The Third International Congress on Cardiovascular Disease (2004/11/26-28), Taipei, Taiwan. The Third International Congress on Cardiovascular Disease Abstract Book, p.64, 2004.

712005. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Adverse event report Issues from Investigator (and IRB Member). ŒF’J—YŽ¡ (–ò—): 5th workshop in Japan for Progress in Clinical Trials (2005/2/18-19), “Œ‹ž.

713021. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) ECG QT interval variation by physiologyical load in healthy ale volunteer- Exploration for substitutional positive control, considering ICH-E14 guideline. ”öè^’qŽq1, “¡“c•üŒb2, ²‹´–M•F1, ‰¡“cTˆê3, àV“cŽÀ‰Ô3, •ŽR­ˆê3, Atsushi Sugiyama4, ‘å’J‹`•v1, ŒF’J—YŽ¡2 (1Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[. 2–ò—. 3–òÜ•”. 4ŽR—œ‘å): 2nd Japan-China Joint Meeting of Basic and Clinical Pharmacology (2004/9/19), ɪ. Jpn J Clin Pharmacol Ther, 35(Suppl): S262, 2004.

713022. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Pharmacokinetics of mosapride citrate in patients with gastrictomy. ŒF’J—YŽ¡1, “¡“c•üŒb1, ”öè^’qŽq2, ‘å’J‹`•v2, ”n“ˆ³—²1 (1–ò—. 2Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[): American Society for Clinical Pharmacology and Therapeutics (2005/3/2-6), Orland, Florida, USA. Clinical Pharmacology and Therapeutics, 77 (2): 51, 2005.

713023. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Pharmacokinetics of cefdinir in healthy subjects after high protein diet and L-phenylalanine load. “¡“c•üŒb1, ŽRè@W2, ”öè^’qŽq2, ”n“ˆ³—²1, ‘å’J‹`•v2, ŒF’J—YŽ¡1 (1–ò—. 2Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[): American Society for Clinical Pharmacology and Therapeutics (2005/3/2-6), Orland, Florida, USA. Clinical Pharmacology and Therapeutics, 77 (2): 81, 2005.

713024. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Pharmacokinetics of cefdinir in healthy subjects after high protein diet and l-phenylalanine load. “¡“c•üŒb1, Yamazaki M, ”öè^’qŽq2, ”n“ˆ³—²1, ‘å’J‹`•v2, ŒF’J—YŽ¡1 (1–ò—. 2Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[): 106th Annual Meeting of the American Society for Clinical Pharmacology (ASCPT)(2005/3/5), ƒI[ƒ‰ƒ“ƒh, •Ä‘. Clinical Pharmacology & Therapeutics, 77 (2): 81, 2005.

722003. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) TDMŒ¤‹†‚Ì–â‘è“_. ŒF’J—YŽ¡ (–ò—): ‘æ21‰ñ“ú–{TDMŠw‰ïEŠwp‘å‰ï(2004/6/5-6), ‘åã. ‘æ21‰ñTDMŠw‰ïEŠwp‘å‰ï|TDM‚ªŽx‚¦‚é‚à‚Ì|ƒvƒƒOƒ‰ƒ€—vŽ|W, p.39, 2004.

723023. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘æ1‘ŠŽŽŒ±‚É‚¨‚¯‚鉉ñ“Š—^—Êݒ誋’‚Æ‚µ‚Ä‚ÌÅ‘å–³“Å«—Ê‚Ì‘Ì•\–ÊϕⳂ̑Ó–«‚ÌŒŸ“¢. “¡“c•üŒb1 , ”öè^’qŽq2, ‰¡“cTˆê3, àV“cŽÀ‰Ô3, ’†‘º’q”ü2, “¡“c’‰˜a2, ’†Œ´‚¢‚¿‚Ý2, –쑺¡“úŽq2, ”n“ˆ³—²1, •ŽR­ˆê3, ‘å’J‹`•v2, ŒF’J—YŽ¡1 (1–ò—. 2Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[. 3–òÜ•”): ‘æ25‰ñ“ú–{—Õ°–ò—Šw‰ï”N‰ï(2004/9/17-18), ɪ. —Õ°–ò—, 35 iSuppl.j: S122, 2004.

723024. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –ò•¨‹zŽû‚Ì“ú“à•Ï“®‚ƈ݉^“®«. ‘å“à_Žq1, ŒF’J—YŽ¡2, “¡“c•üŒb2, ”öè^’qŽq3, ‰¡“cTˆê4, àV“cŽÀ‰Ô4, ‘å’J‹`•v3, ‹gŽR—F“ñ1, ›’J•áŽq1 i1‹¤—§–ò‘å. 2–ò—. 3Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[. 4–òÜ•”j: ‘æ25‰ñ“ú–{—Õ°–ò—Šw‰ï”N‰ï (2004/9/17-18), ɪ. —Õ°–ò—, 35iSuppl.j: S163, 2004.

723025. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) S“d}QTŠÔŠu‚̌‘̓àEŒÂ‘ÌŠÔ‹y‚Ñ“ú“à•Ï“®‚ÉŠÖ‚·‚錟“¢|Œ’N¬l’jŽq‚ð‘ÎÛ‚Æ‚µ‚½—\”õ“IŒŸ“¢|. àV“cŽÀ‰Ô1, ŒF’J—YŽ¡2, ²‹´–M•F3, –쑺¡“úŽq3, ’†‘º’q”ü3, ‰¡“cTˆê1, ‰i¼‹IŽq3, ”öè^’qŽq3, “¡“c•üŒb2, •ŽR­ˆê1, ‘å’J‹`•v1 i1–òÜ•”. 2–ò—. 3Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[j: ‘æ25‰ñ“ú–{—Õ°–ò—Šw‰ï”N‰ï(2004/9/17-18), ɪ. —Õ°–ò—, 35 iSuppl.j: S168, 2004.

723026. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰‰ñ“Š—^—ÊÝ’è‚ÉŠÖ‚·‚郌ƒgƒƒXƒyƒNƒeƒBƒu‚ÈŒŸ“¢. ”öè^’qŽq1, “¡“c•üŒb2, ‰¡“cTˆê3, àV“cŽÀ‰Ô3, ‰i¼‹IŽq1, ²‹´–M•F1, ¬—Ñ^”ü1, ŽµžŠ‹v”üŽq1, “üŒË–ì˜a‘ã3, •ŽR­ˆê3, ŒF’J—YŽ¡2, ‘å’J‹`•v1 i1Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[. 2–ò—. 3–òÜ•”j: ‘æ25‰ñ“ú–{—Õ°–ò—Šw‰ï”N‰ï (2004/9/17-18), ɪ. —Õ°–ò—, 35iSuppl.j: S171, 2004.

723027. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒŒ´ƒrƒŠƒ‹ƒrƒ“’l‚ɉe‹¿‚ð‹y‚Ú‚·UGT1A1ˆâ“`Žq‘½Œ^‚Ì—Õ°“IˆÓ‹`. “cç²’qŽq1, ‘å–ì‰ëŽq1, ¼–{‹žŽq1, ˆÀ‰iŽÀ¹1, ŒE“c—³“ñ1, ˜@À’qŽq2, ”Ñ“‡@”£2, —L‘ò‹IŽq2, ‚•^Ž÷Žq2, ••”‰ël3, ŒF’J—YŽ¡4, “Œ@ƒˆê1 i1‘åã‘å‘åŠw‰@. 2–k—¢Œ¤‹†Š. 3(Š”) ƒAƒCEƒfƒB[EƒfƒB[. 4–ò—): ‘æ25‰ñ“ú–{—Õ°–ò—Šw‰ï”N‰ï (2004/9/17-18), ɪ. —Õ°–ò—, 35 iSuppl.j: S181, 2004.

723028. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘æ1‘ŠŽŽŒ±‚É‚¨‚¯‚鉉ñ“Š—^—Êݒ誋’‚Æ‚µ‚Ä‚ÌÅ‘å–³“Å«—Ê‚Ì‘Ì•\–ÊϕⳂ̑Ó–«‚ÌŒŸ“¢. “¡“c•üŒb1, ”öè^’qŽq2, ‰¡“cTˆê3, àV“cŽÀ‰Ô3, ’†‘º’q”ü2, “¡“c’‰˜a2, ’†Œ´‚¢‚¿‚Ý2, –쑺¡“úŽq2, ”n“ˆ³—²1, •ŽR­ˆê3, ‘å’J‹`•v2, ŒF’J—YŽ¡1 (1–ò—. 2Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[. 3–òÜ•”): ‘æ25‰ñ“ú–{—Õ°–ò—Šw‰ï”N‰ï(2004/9/17), ɪ. —Õ°–ò—, 35 (Suppl.): S122, 2004.

723029. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œ’í¬l‚É‚¨‚¯‚é‚’`”’, L-ƒtƒFƒjƒ‹ƒAƒ‰ƒjƒ“•‰‰×Œã‚̬’°ƒyƒvƒ`ƒhƒgƒ‰ƒ“ƒXƒ|[ƒ^ŠîŽ¿–ò•¨ƒZƒtƒFƒ€ŒnR¶•¨Ž¿‚Ì‹zŽû‚ւ̉e‹¿‚ÌŒŸ“¢. “¡“c•üŒb1, ‰¬–ìŽO’qŽq2, ŽRè@W2, ”öè^’qŽq2, àV“cŽÀ‰Ô3, ’†‘º’q”ü2, ²‹´–M•F2, ŽµžŠ‹v”üŽq2, –쑺¡“úŽq2, ‰¡“cTˆê3, “¡“c’‰˜a2, •ŽR­ˆê3, ‘å’J‹`•v2, ”n“ˆ³—²1, ŒF’J—YŽ¡1 (1–ò—. 2Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[. 3–òÜ•”): ‘æ125‰ñ“ú–{–òŠw‰ï”N‰ï (2005/3/29), “Œ‹ž. Journal of Pharmacological Sciences, 97 (Suppl.): 281P, 2005.

723030. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Functional analysis of genetic variants of the human organic anion transporter, OAT1 (SLC22A6). “¡“c•üŒb1, Maya K Leabman, Chaline Brown, Kazumi Fujita, Kathleen M Giacomini, ”n“ˆ³—²1 (1–ò—): ‘æ78‰ñ“ú–{–ò—Šw‰ï”N‰ï (2005/3/24), ‰¡•l. ‘æ78‰ñ“ú–{–ò—Šw‰ï”N‰ïƒvƒƒOƒ‰ƒ€, p.179, 2005.

731003. [Œ¤‹†‰ï] (“Á•Êu‰‰) ˆã—Âɂ¨‚¯‚éu‚¤‚»v‚ÌŒø—p: ƒvƒ‰ƒZƒ{Œø‰Ê. ŒF’J—YŽ¡ (–ò—): ‘啪“Œv’k˜b‰ïE‘æ31‰ñ‹L”O‘å‰ï (2005/2/9-10), ‘啪.


<<”÷¶•¨EŠñ¶’ŽŠw>>

mŠwp˜_•¶n

110024. [Œ´’˜] PROTEKT 1999-2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan. ˆä㼋v1, Shigeru Kohno2, Mitsuo Kaku3, Keizo Yamaguchi4, Jun Igari5, Kiyoharu Yamanaka6 (1”÷EŠñ. 2’·è‘å. 3“Œ–k‘å. 4“Œ–M‘å. 5‡“V“°‘å. 6‘åŽè‘O•a‰@): International Journal of Infectious Diseases, 9: 27-36, 2005.

120003. [Œ´’˜] Molecular analytical evaluation of macrolide-and ketolide-resistant Streptococcus pneumoniae. ˆä㼋v, Œ“ŽqŒªˆê, ’†–ì—³ˆê, ²“¡—DŽq, Susumu Arai (”÷EŠñ): Jpn J Antibiot, 57: 425-437, 2004.

120004. [Œ´’˜] ‰·ò…‚É‚¨‚¯‚éLegionella‘®‹Û‰˜õ‚ÆòŽ¿‚ÉŠÖ‚·‚é’²¸Œ¤‹†. ùŒ´•Žu1, ‹e–ì—’ÃŽq2, ‰œ“cwŽ¡2, ŠÖŒû•üŽq1, ²“¡‹`‘¥1, ‚ŽR—zŽq3, ‘]‰ä‰p‹v2, –سl2, ˆä㼋v1 (1”÷EŠñ. 2–k—¢ŠÂ‹«‰ÈŠwƒZƒ“ƒ^[. 3—ÕŒŸŠw): Š´õÇŠwŽGŽ, 78 (7): 545-553, 2004.

120005. [Œ´’˜] V‹KŽE‹ÛƒZƒ‰ƒ~ƒbƒN‚É‚æ‚éLegionella pneumophilaŽE‹ÛŒø‰Ê‚É‹y‚Ú‚·‰·ò…òŽ¿‚̉e‹¿. ùŒ´•Žu1, ‰œ“cwŽ¡2, ‹e–ì—’ÃŽq2, ²“¡‹`‘¥1, ŠÖŒû•üŽq1, ‚ŽR—zŽq3, ˆä㼋v1 (1”÷EŠñ. 2–k—¢ŠÂ‹«‰ÈŠwƒZƒ“ƒ^[. 3—ÕŒŸŠw): Š´õÇŠwŽGŽ, 79 (3): 157-160, 2005.

210005. [€Œ´’˜] A Klebsiella pneumoniae producing three kinds of class A beta-lactamases encoded by one single plasmid isolated from a patient in Huashan Hospital, Shanghai, China. Xiong Z1, Zhu D1, Wang F1, Zhang Y1, ‰ª–{—¹ˆê2, ˆä㼋v2 (1Fudan Univ. 2”÷EŠñ): Int J Antimicrob Agents, 23 (3): 262-267, 2004.

210006. [€Œ´’˜] CFE-1, a Novel Plasmid-Encoded AmpCƒÀ-Lactamase with an ampR Gene Originating from Citrobacter freundii. ’†–ì—³ˆê1, ‰ª–{—¹ˆê2, ’†–ì•SŽÀŽq2, Œ“ŽqŒªˆê2, ‰«’îO2, •Ûâ”ü¶3, ˆä㼋v2 (1ˆã—ÃŒn‘åŠw‰@E”÷. 2”÷EŠñ. 3“à‡T): Antimicrobial Agents and Chemotherapy, 48 (4): 1151-1158, 2004.

210007. [€Œ´’˜] A comparison of the microbiological characteristcs of Neisseria gonorrhoeae isolated from male and femalepatienta with gonorrhea. Takeshi Saika1, Intetsu Kobayashi1, ˆä㼋v2 (1ŽO•H‰»ŠwBCL. 2”÷EŠñ): Chemotherapy, 50 (2): 92-97, 2004.

210008. [€Œ´’˜] Down-regulation of lipoxin A4 receptor by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo. ²“¡‹`‘¥1, –k—¢‰p˜Y2, ‘ºã—m‰î2, ‹´–{@“Ä3, ‰““¡•½m3, ‹ß“¡Œ[•¶3, ˆä㼋v2, —Ñ@ò4 (1ˆã—ÃŒn‘åŠw‰@E”÷. 2”÷EŠñ. 3“à‡X. 4–ò—): Biomedicine & Pharmacotherapy, 58: 381-387, 2004.

210009. [€Œ´’˜] Characterization of ermB Gene Transposition by Tn1545 and Tn917 in Macrolide-Resistant Streptococcus pneumoniae Isolates. ‰«’îO1,3, Satoru Kaieda2, Hisakazu Yano3, ’†–ì—³ˆê1, •Ûâ”ü¶4, ‰ª–{—¹ˆê1, Toshimitsu Kobayashi3, ˆä㼋v1 (1”÷EŠñ. 2’·è‘å. 3“Œ–k‘å. 4“à‡T): Journal of Clinical Microbiology, 43 (1): 168-173, 2005.

210010. [€Œ´’˜] Use of the Restriction Enzyme EcoRI for Pulsed-Field Gel Electrophoretic Analysis of Helicobacter pylori. •Ûâ”ü¶2, “ü–ì“cˆê•F1, ’†–ì—³ˆê1, “c•Ó@‘2, ¬ò˜aŽO˜Y2, ¼Œ³Ž›ŽâX2, ˆä㼋v1 (1”÷EŠñ. 2“à‡T): Journal of Clinical Microbiology, 43 (2): 931-932, 2005.

210011. [€Œ´’˜] Establishment of rat model of acute staphylococcal osteomyelitis: Relationship between inoculation dose and development of osteomyelitis. •Ÿ“‡é–¾1, ‰¡ŽRˆê•F1, ùŒ´•Žu2, Yoh Dobashi3, Ž…–ž·Œ›1 (1®ŠO. 2”÷EŠñ. 33ŽR—œ‘å): Arch. Orthop. Traum. Surg., 125 (3): 169-176, 2005.

210012. [€Œ´’˜] Macrofilaricidal and microfilaricidal effects of Neurolaena lobata, a Guatemalan medicinal plant, on Brugia pahanngi. Fujimaki Y1, KamachiT1, Yanagi T1, Caceres A2, –q@ƒ3, Aoki Y1 (1’·è‘å”M‘шيwŒ¤‹†Š. 2ƒOƒAƒeƒ}ƒ‰EƒTƒ“ƒJƒ‹ƒƒX‘å. 3”÷EŠñ): Journal of Helminthology, 79: 23-28, 2004.

210013. [€Œ´’˜] Inhibition of branching morphogenesis of mouse fetal submandibular gland by sodium fluoride-protection by epidermal growth factor. Naka T1, Maruyama S1, NagaoT1, Takayama F1, –q@ƒ2, Yasui T1, Sakagami H1, Ohkawa S1 (1–¾ŠC‘å. 2”÷EŠñ): In Vivo, 19: 327-334, 2004.

210014. [€Œ´’˜] The description and studies on parasitic endemic disease, gKatayama-byoh by traditional-herb and Westernized doctors in the 19-20th century in Japan. –q@ƒ1, ŒK“c³L2 (1”÷EŠñ. 2‘ãŽÓE’`”’): AKTEN des fuenfunddreissigsten Internationalen Kongresses fuer Geschite der Pharmazie, P1-P11 (pp.900), published in CD-ROM.

220003. [€Œ´’˜] ƒÀ-ƒ‰ƒNƒ^ƒ€ŒnR‹Û–ò‚̉ŠúŽE‹Û”\. ¼“ck“ñ1, ˆä㼋v2 (1–œ—L»–ò. 2”÷EŠñ): “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 53 (1): 2005.

220004. [€Œ´’˜] ƒAƒtƒŠƒJ‚Å‚Ì‘Ûˆã—˦—Í‚É‚¨‚¯‚éŽÐ‰ï–òŠw“IŒ¤‹†: “`“ˆã—ÂƋߑãˆã—Â̕¹‘¶‚Æ’²˜a‚ÉŠÖ‚·‚é—\”õ“IŒŸ“¢ i‚»‚Ì‚Pj. –q@ƒ1, ‘å’JˆÀŽq2, ŒK“c³L3 (1”÷EŠñ. 2‘Û•¶‰»Œ¤. 3‘ãŽÓE’`”’): ŽÐ‰ï–òŠw, 23 (1): 81`83, 2004.

m’˜ ‘n

620011. [‹³‰È‘] (•ª’SŽ·•M) V”Å@—Õ°–ƉuŠw; Š´õǂƖƉu, p.111-133. ùŒ´•Žu (”÷EŠñ), •ÒW ‹{âM”V1, ‰GŽR@ˆê1, óì‰p’j2, ŒË‘òGŽ÷3 (1“Œ‹žˆãŽ•‘å. 2‹ã’iâ•a‰@. 3–k—¢‘å–¼—_‹³Žö), u’kŽÐƒTƒCƒGƒ“ƒeƒBƒtƒBƒN, “Œ‹ž, 2004/2/10”­s.

620012. [Ž«‘] (•ª’SŽ·•M) ˆãŠw‰p˜a‘厫“T@‰ü’ù12”Å; –ƉuŠw—pŒê‚ÌZ‰{/V‹K—pŒê‘I’è (•ÒW‹¦—Í). ùŒ´•Žu (”÷EŠñ), •ÒW ¼Œ³Ž›ŽâX (“à‡T), ŠÄC ²“¡“oŽu˜Y (–k—¢‘å), “ìŽR“°, “Œ‹ž, 2005/3/10”­s.

620013. [Šwp‘] (•ª’SŽ·•M) Š´õ‚ÆR‹Û–ò, 7 (2) 2004; ¡ŒãŠëœœ‚³‚ê‚éV‚½‚È‘Ï«‹Û, p.216-221. ‰ª–{—¹ˆê (”÷EŠñ), ƒ”ƒ@ƒ“ƒƒfƒBƒJƒ‹, “Œ‹ž, 2004/6”­s.

620014. [Šwp‘] (•ª’SŽ·•M) BIO Clinica, 20 i3j 2005; Šî‘b‚Ì—§ê‚©‚ç‚Ý‚½‘½Ü‘Ï«ƒOƒ‰ƒ€—z«‹Û‚ÌŒ»ó‚Æ–â‘è“_, p.18-23. ‰ª–{—¹ˆê (”÷EŠñ), –k—²ŠÙ, “Œ‹ž, 2005/3”­s.

620015. [Šwp‘] (•ª’SŽ·•M) —Õ°–Ɖu; GATA3‚ÍT×–E‚Å‚ÍIFN-ƒÁ‚̶¬‚ð—}‚¦‚邪NK×–E‚Å‚Í‚»‚ê‚ð˜´i‚·‚é. ‹Ê“àGˆê (”÷EŠñ), •ÒW —Õ°–Ɖu•ÒWˆÏˆõ‰ï, ‰ÈŠw•]˜_ŽÐ, “Œ‹ž, 2004/10/25”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

721001. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) Cryptosporidium’°ŠÇŠ´õ‚ÌŽd‘g‚Ý‚Æ–{–M‰Íì‚̉˜õ󋵂ɂ‚¢‚Ä. ùŒ´•Žu (”÷EŠñ): ‘æ18‰ñ“ú–{Œ´’Ž•aŠw‰ïŠwpW‰ï (2004/4), “¡‘òŽs. u‰‰´˜^, p.1-2, 2004.

723031. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠL—Þ‚É‚Ý‚éCryptos-poridium parvumƒI[ƒVƒXƒg‚̉˜õó‹µ@‘æ‚Q•ñ. ùŒ´•Žu1, ’†‘º@Œ’1, ²“¡‹`‘¥1, ŠÖŒû•üŽq1, ‹e–ì—’ÃŽq2, –سl2, ‚ŽR—zŽq3, –k—¢‰p˜Y4, ˆä㼋v1 (1”÷EŠñ. 2–k—¢ŠÂ‹«‰ÈŠwƒZƒ“ƒ^[. 3—ÕŒŸŠw. 4ˆã‰qE”÷¶•¨): ‘æ78‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (2004/4/6), “Œ‹ž. Š´õÇŠwŽGŽ, 78(7): 653, 2004.

723032. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) GATA3ƒgƒ‰ƒ“ƒXƒWƒFƒjƒbƒNƒ}ƒEƒX‚ð—p‚¢‚½TNCBÚG”畆‰Š—U“±‚É‚¨‚¯‚éTh2Œ^–Ɖu”½‰ž‚ÌŠÖ—^‚ɂ‚¢‚Ä. ‹Ê“àGˆê1, “V‰HN”V2, ˆÉ“¡@Žç3, Ž›“‡³ƒ4, ‘àVŠ²’j2, Ÿ‰ªŒ›¶2, •äÏŸl5, Š_¶‰€Žq5 i1”÷EŠñ. 2”ç. 3ŽÀ’†Œ¤E–Ɖu. 4Z—F»–ò. 5“ŒŠC‘åˆãE–Ɖuj: ‘æ16‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ïtŠú—Õ°‘å‰ï(2004/5/13), ‘O‹´. ƒAƒŒƒ‹ƒM[, 53 (2,3): 360, 2004.

723033. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒƒJƒu—R—ˆƒtƒRƒCƒ_ƒ“‚ÌCryptosporidium parvumŠ´õ‚ɑ΂·‚é—\–hŒø‰Ê. ŠÛŽROŽq1, ùŒ´•Žu2, ²“¡^‹|2, ‹e–ì—’ÃŽq3, ‹´–{@ŽÀ4, ’‡–ì—²‹v4, ˆä㼋v2 (1ˆã‰qE•a—. 2”÷EŠñ. 3–k—¢ŠÂ‹«‰ÈŠwƒZƒ“ƒ^[. 4—Œ¤ƒrƒ^ƒ~ƒ“): ‘æ58‰ñ“ú–{‰h—{EH—ÆŠw‰ï‘å‰ï (2004/5/23), å‘ä. u‰‰—vŽ|W, p.311, 2004.

723034. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) AmpC‘½—ÊŽY¶‚É‚æ‚éƒZƒtƒFƒ€–ò‘Ï«‘å’°‹Û‚̉ðÍ. ‰ª–{—¹ˆê1, ²“¡—DŽq1, ’†–ì—³ˆê1, Œ“ŽqŒªˆê1, ’†–ì•SŽÀŽq1, {“c˜a”ü2, ˆä㼋v1 (1”÷EŠñ. 2ˆã—ÃŒn‘åŠw‰@): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï(2004/6/3), ‰«“ê. “ú–{‰»Šw—Ö@ŠwŽGŽ, 52 (Supple. A): 139, 2004.

723035. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) TEMŒ^, CTX-MŒ^‚¨‚æ‚Ñbla-IMPŒ^ƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[‚𓯎ž‚ÉŽY¶‚·‚éE. cloacae‚ɂ‚¢‚Ä. ²“¡—DŽq1, ’†–ì—³ˆê1, ’†–ì•SŽÀŽq1, Œ“ŽqŒªˆê1, {“c˜a”ü2, ˆä㼋v1, ‰ª–{—¹ˆê1 (1”÷EŠñ. 2ˆã—ÃŒn‘åŠw‰@): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3), ‰«“ê. “ú–{‰»Šw—Ö@ŠwŽGŽ, 52 (Supple. A): 139, 2004.

723036. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Enterobacter cloacae‚ÌAmpCƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[ˆâ“`Žq‚Ì‘½Œ^«. {“c˜a”ü1, ’†–ì—³ˆê2, ’†–ì•SŽÀŽq2, ²“¡—DŽq2, ‰ª–{—¹ˆê2, ˆä㼋v2 (1ˆã—ÃŒn‘åŠw‰@. 2”÷EŠñ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï(2004/6/3), ‰«“ê. “ú–{‰»Šw—Ö@ŠwŽGŽ, 52 (Supple. A): 138, 2004.

723037. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) BRO-1ƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[ŽY¶Moraxella lacunata‚É‚æ‚鬎™„’芴õ«S“à–Œ‰Š. Ä“¡—DŽq1, ’·–ì—R‹IŽq, ’·–ì‘¥”V2, Œ“ŽqŒªˆê3, ’†–ì—³ˆê3, ‰ª–{—¹ˆê3, ˆä㼋v3 (1‘D‹´Žs—§ˆã—ÃZƒ“ƒ^[. 2ˆã—ÃŒn‘åŠw‰@. 3”÷EŠñ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï(2004/6/3), ‰«“ê. “ú–{‰»Šw—Ö@ŠwŽGŽ, 52 (Supple. A): 152, 2004.

723038. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “¯ˆêŠ³ŽÒ—R—ˆ‚Ìgenotype‚̈قȂ銴«‹y‚ÑCTX-M-1, V‹Kmissense mutation•Û—LTEM-1ƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[. ’·–ì‘¥”V1, Ä“¡—DŽq2, ’·–ì—R‹IŽq, Œ“ŽqŒªˆê3, ’†–ì—³ˆê3, ‰ª–{—¹ˆê3, ˆä㼋v3 (1ˆã—ÃŒn‘åŠw‰@. 2‘D‹´Žs—§ˆã—ÃZƒ“ƒ^[. 3”÷EŠñ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3), ‰«“ê. “ú–{‰»Šw—Ö@ŠwŽGŽ, 52 (Supple. A): 167, 2004.

723039. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) PFGE‰ðÍ‚©‚猩‚½—‘……‚ÌLegionella‘®‹Û‚̉˜õ•ª•z. ùŒ´•Žu1, ‹e–ì—’ÃŽq2, ‰œ“cwŽ¡2, ‚ŽR—zŽq3, –k—¢‰p˜Y4, ‰ª–{—¹ˆê1, ˆä㼋v1 (1”÷EŠñ. 2–k—¢ŠÂ‹«‰ÈŠwƒZƒ“ƒ^[, 3—ÕŒŸŠw, 4ˆã‰qE”÷¶•¨): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3), ‰«“ê. “ú–{‰»Šw—Ö@Šw‰ïŽ, 52 (Supple. A): 148, 2004.

723040. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Legionella‘®‹Û‚ɑ΂·‚铺ƒCƒIƒ“‚ÌR‹ÛŒø‰Ê. ùŒ´•Žu1, ‹e–ì—’ÃŽq2, ‰œ“cwŽ¡2, ‚ŽR—zŽq3, –k—¢‰p˜Y4, ‰ª–{—¹ˆê1, ˆä㼋v1 (1”÷EŠñ. 2–k—¢ŠÂ‹«‰ÈŠwƒZƒ“ƒ^[. 3—ÕŒŸŠw. 4ˆã‰qE”÷¶•¨): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3), ‰«“ê. “ú–{‰»Šw—Ö@Šw‰ïŽ, 52 (Supple. A): 159, 2004.

723041. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “ºƒCƒIƒ“‚ÌCryptos-poridium parvumƒI[ƒVƒXƒgŠ´õ«‚ɑ΂·‚é•sŠˆ‰»Œø‰Ê. ‹e–ì—’ÃŽq1, ùŒ´•Žu2, ŠÖŒû•üŽq2, ‚‹´@W3, ‘]‰ä‰p‹v1, –سl1, ²“¡‹`‘¥2, ‚ŽR—zŽq4, –k—¢‰p˜Y5, ˆä㼋v2 (1–k—¢ŠÂ‹«‰ÈŠwƒZƒ“ƒ^[. 2”÷EŠñ. 3ŽÀŒ±“®•¨. 4—ÕŒŸŠw. 5ˆã‰qE”÷¶•¨): ‘æ55‰ñ‘S‘…“¹Œ¤‹†”­•\‰ï (2004/6/17), ‹ž“s. u‰‰W, p.344-345, 2004.

723042. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒAƒtƒŠƒJ‚Å‚Ì‘Ûˆã—˦—Í‚É‚¨‚¯‚éŽÐ‰ï–òŠw“IŒ¤‹† (1). –q@ƒ1, ‘å’JˆÀŽq2, ŒK“c³L3 (1”÷EŠñ. 2‘Û•¶‰»Œ¤. 3‘ãŽÓE’`”’): “ú–{ŽÐ‰ï–òŠw‰ï‘æ23”N‰ï (2004/9/19), –kŠC“¹‘åŠw iŽD–yj. u‰‰—vŽ|W, p.94, 2004.

723043. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) GATA3—U”­ƒAƒgƒs[«”畆‰Šƒ‚ƒfƒ‹‚É‚¨‚¯‚é–òÜŒø‰Ê‚ÌŒŸ“¢. ‹Ê“àGˆê1, “V‰HN”V2, ˆÉ“¡@Žç3, Ž›“‡³ƒ4, ‘àVŠ²’j2, Ÿ‰ªŒ›¶2, •äÏŸl5, Š_¶‰€Žq5 i1”÷EŠñ. 2”ç. 3ŽÀ’†Œ¤E–Ɖu. 4Z—F»–ò. 5“ŒŠC‘åˆãE–Ɖuj: ‘æ34‰ñ“ú–{–ƉuŠw‰ï‘‰ïEŠwpW‰ï (2004/12/1), ŽD–y. “ú–{–ƉuŠw‰ï‘‰ïEŠwpW‰ï‹L˜^ƒAƒŒƒ‹ƒM[, 34: 102, 2004.

731004. [Œ¤‹†‰ï] (“Á•Êu‰‰) –òÜ‘Ï«Œ¤‹†‚Ì“W–]. ˆä㼋v (”÷EŠñ): ‘æ33‰ñ–òÜ‘Ï«‹ÛƒVƒ“ƒ|ƒWƒEƒ€ (2004/7/30), •xŽR. u‰‰´˜^W.

732008. [Šw‰ï (’n•û)] (ƒVƒ“ƒ|ƒWƒEƒ€) –òÜ‘Ï«‹@\‚ÌV‚½‚È“WŠJ. ‰ª–{—¹ˆê, ’†–ì—³ˆê (”÷EŠñ): ‘æ87‰ñ“ú–{׋ۊw‰ïŠÖ“ŒŽx•”‘‰ï (2004/11/6), “Œ‹ž. u‰‰´˜^W.

733008. [Œ¤‹†‰ï] (ˆê”Êu‰‰) GATA-3—U”­ÚG”畆‰Š‚̓Aƒgƒs[«”畆‰Šƒ‚ƒfƒ‹‚Ƭ‚肤‚é‚©H ‹Ê“àGˆê1, “V‰HN”V2, ˆÉ“¡@Žç2, Ž›“‡³ƒ4, ŠÛŽROŽq5, ˆä㼋v1, ‘àVŠ²’j2, •äÏŸl6, Š_¶‰€Žq6, Ÿ‰ªŒ›¶2 (1”÷EŠñ. 2”ç. 3ŽÀ’†Œ¤E–Ɖu. 4Z—F»–ò. 5ˆã‰qE•a—. 6“ŒŠC‘åˆãE–Ɖu): ‘æ17‰ñuˆâ“`Žq‚Æ‚»‚ÌŽü•ÓvŒ¤‹†‰ï (2004/8/3), ‘Š–ÍŒ´. Œû‰‰—vŽ|W.

733009. [Šw‰ï (’n•û)] (ˆê”ʉ‰‘è) …Œn‰˜õLegionella‘®‹Û‚ɑ΂·‚銴õ–hŽ~‘Îô–@‚ÌŠm—§|zŠÂŽ®—‘…‚Ö‚ÌŽE‹ÛƒZƒ‰ƒ~ƒbƒN‚̉ž—p|. ùŒ´•Žu1, ‰œ“cwŽ¡2, ‹e–ì—’ÃŽq2, ŠÛŽROŽq3, ‚ŽR—zŽq4Aˆä㼋v1 (1”÷EŠñ. 2–k—¢ŠÂ‹«‰ÈŠwƒZƒ“ƒ^[, 3ˆã‰qE•a—. 4—ÕŒŸŠw): ‘æ53‰ñ“ú–{Š´õÇŠw‰ï“Œ“ú–{’n•û‰ï‘‰ïE‘æ51‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï‡“¯Šw‰ï (2004/10/22), VŠƒŽs. Š´õÇŠwŽGŽ, 79 (1): 94, 2005.

733010. [Šw‰ï (’n•û)] (ˆê”ʉ‰‘è) ƒƒJƒu—R—ˆƒtƒRƒCƒ_ƒ“‚ÌCryptosporidium parvumŠ´õ‚ɑ΂·‚é—\–hŒø‰Ê‚Æ‚»‚Ìì—p‹@˜ ‘æ2•ñ. ŠÛŽROŽq1, ùŒ´•Žu2, “ˆè“TŽq3, ’‡–ì—²‹v4, ˆä㼋v2 (1ˆã‰qE•a—. 2”÷EŠñ. 3–k—¢ŠÂ‹«‰ÈŠwƒZƒ“ƒ^[. 4—Œ¤ƒrƒ^ƒ~ƒ“): ‘æ53‰ñ“ú–{Š´õÇŠw‰ï“Œ“ú–{’n•û‰ï‘‰ïE‘æ51‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï‡“¯Šw‰ï (2004/10/22), VŠƒŽs. Š´õÇŠwŽGŽ, 79(1): 103-104, 2005.

733011. [Šw‰ï (’n•û)] (ˆê”ʉ‰‘è) ƒvƒ‰ƒXƒ~ƒh«AmpCƒÀ-lactamase CMY-4‚Ì”­Œ»‹@\‰ðÍ. ’†–ì—³ˆê1, ’·–ì‘¥”V2, ‘OŽR‰À•F2, Îì’¼l, ‰ª–{—¹ˆê1, ˆä㼋v1 (1”÷EŠñ. 2ˆã—ÃŒn‘åŠw‰@): ‘æ51‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï (2004/10), VŠƒŽs. ƒvƒƒOƒ‰ƒ€Eu‰‰´˜^W.

733012. [Šw‰ï (’n•û)] (ˆê”ʉ‰‘è) ”x‰Š‹…‹Û‚É‚¨‚¯‚é•ÏˆÙPBPsˆâ“`Žq‘Š“¯‘gŠ·‚¦‘Ì‚Ì‘I‘ðŒø—¦‚É‚¨‚æ‚Ú‚·ŠeŽíƒÀ-ƒ‰ƒNƒ^ƒ€Œn–ò‚̉e‹¿. •Ÿ“‡’Œb1, ‘O“c‹v”üŽq2, ˆä“cFŽu2, •Ä‘ò@ŽÀ2, ¶•ûŒöŽq2, ˆä㼋v3 (1–¾Ž¡»‰Ù. 2¶–½‰ÈŒ¤. 3”÷EŠñ): ‘æ87‰ñ“ú–{׋ۊw‰ïŠÖ“ŒŽx•”‘‰ï (2004/11/6), “Œ‹ž. u‰‰´˜^W.

733013. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒvƒ‰ƒXƒ~ƒh«AmpCƒÀ-lactamase‚Ì‘½—ÊŽY¶‹@\‚̉ðÍ. ’†–ì—³ˆê1, ’·–ì‘¥”V2, ‘OŽR‰À•F2, Îì’¼l, ‰ª–{—¹ˆê1, ˆä㼋v1 (1”÷EŠñ. 2ˆã—ÃŒn‘åŠw‰@): ‘æ2‰ñ–òÜ‘Ï«‹ÛŒ¤‹†‰ï (2004/11), ˆÉ•Û. u‰‰´˜^W.

733014. [Œ¤‹†‰ï] (Œ¤‹†•¬•ñ) Ž…‹…‘ÌIgA’¾’…‚É‚¨‚¯‚éGATA-3ˆË‘¶“I”S–Œ–Ɖu‚ÌŠÖ—^‚ɂ‚¢‚Ä. ŽR’†‹M”Ž1, ‹Ê“àGˆê2, —é@—T‰î1, —é–Ø@m1, Œ@‰z@“N1, Š_¶‰€Žq3, •x–ìN“úŒÈ1 i1‡“V“°‘åˆãEt“à. 2”÷EŠñ. 3“ŒŠC‘åˆãE–Ɖu): ‘æ28‰ñIgAtÇŒ¤‹†‰ï (2005/1/29), “Œ‹ž. ´˜^, 28: 14, 2005.


<<•a—Šw>>

mŠwp˜_•¶n

110025. [Œ´’˜] High microvascular density is correlated with high VEGF, iNOS and COX-2 expression in penetrating growth-type early gastric carcinomas. ˆêŒË¹–¾1, ŽOã“N•v1, Shiraishi H, ‰ªˆÀ@ŒM1 (1•a—): Histopathology, 45 (6): 612-618, 2004.

110026. [Œ´’˜] Multicenter evaluation of commercial frozen plates for microdijution broth antifungal susceptibility testing of yeasts and comparison of MIC limits recommended in NCCLS M27-A2. Koichi Makimura1, Toyoko Oguri2, Yuzuru Mikami3, ‹v•Ä@Œõ4, Ryo Hanazawa2, ˆ¢•””ü’mŽq5, Reiko Ikeda6, Takako Shinoda6 (1’é‹ž‘å. 2‡“V“°‘å. 3ç—t‘å. 4•a—. 5ˆã‰qE—Õ°ŒŸ¸. 6–¾Ž¡–ò‘å): Microbiology and Immunology, 49 (2): 97-106, 2005.

110027. [Œ´’˜] Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Œ´@“ÖŽq, ‰ªˆÀ@ŒM (•a—): Acta Neuropathologica, 108: 43-48, 2004.

110028. [Œ´’˜] ƒÀ-Catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells. ŽOŽ}@M1, ‹´‘º”ü‹I2, ŒK“c@Œ’2, •l–ì”üŒbŽq3, ‰ªˆÀ@ŒM1 (1•a—. 2ŠàŒ¤. 3‘gD”|—{ƒZƒ“ƒ^[j: Am J Pathol, 164: 1739-1749, 2004.

110029. [Œ´’˜] Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors. ŒÜ\—’@“O1, Ó@¢ˆ®1, ‹T’J@“O2, 󑺮¶3, ²“¡—Yˆê4, Kanji Nagai5, ‰ªˆÀ@ŒM1 (1•a—. 2ɪŒ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[E•a—. 3‘—§‚ª‚ñƒZƒ“ƒ^[’†‰›•a‰@E‹¹ŠO. 4ˆã‰qEˆâ“`ŽqŒŸ¸. 5‘—§‚ª‚ñƒZƒ“ƒ^[“Œ•a‰@E‹¹ŠO): Modern Pathology, 17(10): 1259-1267, 2004.

110030. [Œ´’˜] Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus. “n•Ó@ƒ1, Nishizaki R2, ã–V•qŽq3, Š™“c—TŽq2, `@GŽ÷3, ¼‘º—R—¢2, Fujisawa T2, ‰ªˆÀ@ŒM1, ‘ –{”Žs2 (1•a—. 2ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 3ŽY•w): Int J Gynecol Pathol, 23: 234-240, 2004.

110031. [Œ´’˜] Cyclin D1 Expression in Endometrioid-type Endometrial Adenocarcinoma is Correlated with Histological Grade and Proliferative Activity, but not with Prognosis. ¼‘º—R—¢1, “n•Ó@ƒ2, ã–V•qŽq3, Kato N1, Fujisawa T1, Š™“c—TŽq1, ‘ –{”Žs1 (1ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 2•a—. 3ŽY•w): Anticancer Res, 24: 2185-2192, 2004.

110032. [Œ´’˜] Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma. ‹{–{•üK1, “n•Ó@ƒ2, `@GŽ÷3, ã–V•qŽq3, ìŒû”ü˜a1, •ž•”@Šw1, Saito M1, ‘ –{”Žs1 (1ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 2•a—. 3ŽY•w): J Seroid Biochem Mol Biol, 92: 111-118, 2004.

110033. [Œ´’˜] Cytological scoring of endometrioid adenocarcinoma of the endometrium-correlation with histological grade and clinicopathological factors. ¼‘º—R—¢1, “n•Ó@ƒ2, ã–V•qŽq3, •ž•”@Šw1, Vˆä@“w1, ‘ –{”Žs1 (1ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 2•a—. 3ŽY•w): Cancer Cytopathol, 105: 8-12, 2004.

110034. [Œ´’˜] Upregulation of p16INK4A and Bax in p53 wild/p53 overexpressing crypts in ulcerative colitis-associated tumors. ‹g“c@Œ÷, Matsutomo N, ŽOã“N•v, ‰ªˆÀ@ŒM (•a—): British Journal of Cancer, 91: 1081-1088, 2004.

320001. [Ç—á•ñ] • …×–Ef‚Å“÷Žî¬•ª‚ÌÄ”­‚ªŽ¦´‚³‚ꂽ—‘‘ƒŠà“÷Žî‚Ì1—á. £”ö“T‹v1, •ž•”@Šw1, –L‰i^Ÿ2, “n•Ó@ƒ3, Vˆä@“w1, ìŒû”ü˜a1, ã–V•qŽq4, ‘ –{”Žs1 (1ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 2‘åŠw•a‰@×–Ef. 3•a—. 4ŽY•w): “ú–{—Õ°×–EŠw‰ïŽGŽ, 43 (1): 56-60, 2004.

320002. [Ç—á•ñ] —‘‘ƒbó‘BŽî«ƒJƒ‹ƒ`ƒmƒCƒh‚Ì1—á. ‹{–{•üK1, ¼‘º—R—¢1, •ž•”@Šw1, Š`ÀœA–M2, “n•Ó@ƒ3, Vˆä³G4, ã–V•qŽq4, ‘ –{”Žs1 (1ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 2‘åŠw•a‰@×–Ef. 3•a—. 4ŽY•w): “ú–{—Õ°×–EŠw‰ïŽGŽ, 43 (2): 130-134, 2004.

320003. [Ç—á•ñ] ‹¹•Ç‚É”­¶‚µ‚½‘½Œ`Œ^‰¡–ä‹Ø“÷Žî‚Ì1—á. ŽR“c”ü•Û1, •ž•”@Šw1, ‰¡ŽR@‘å2, Š`ÀœA–M2, “n•Ó@ƒ3, •i“c@ƒ4, ¬’†çŽç5, ‘ –{”Žs1 (1ˆã‰qE—Õ°×–E. 2‘åŠw•a‰@×–Ef. 3•a—. 4‹¹ŠO. 5“Œ‹žˆã‘åEŠO): “ú–{—Õ°×–EŠw‰ïŽGŽ, 43 (5): 321-326, 2004.

520015. [‘à] ^‹Ûǂ̖ƉuŠw“If’f–@ •aŒ´«^‹Û‚Ì¡“ú“IˆÓ–¡|^‹ÛŠ´õ‚ƶ‘Ì–hŒä|, ‰»Šw—Ö@‚̗̈æ. ‹v•Ä@Œõ (•a—): ‰»Šw—Ö@‚̗̈æ, 20 (1): 5-10, 2004.

520016. [‘à] Ž…ó‹Û‚Ì–òÜŠ´Žó«‘ª’è–@. ˆ¢•””ü’mŽq1, ¬ì‘PŽ‘1, ‹v•Ä@Œõ2 (1ˆã‰q. 2•a—): Medical Technology, 32 (12): 1285-1291, 2004.

m’˜@‘n

610001. [Šwp‘] (•ª’SŽ·•M) World Heath Organization Classification of Tumours. Pathology and Genetics of Tuomurs of the Lung, Pleura, Thymus and Heart; Large Cell carcinoma, p.45-50. E Brambilla1, B Pugatch2, K Geisinger3, A Gal4, MN Sheppard5, DG Guinee6, Ó@¢ˆ®7, S Lantuejoul8, YL Chang9, I Petersen10, M Meyerson11, SM Hanash12, –ìŒû‰ë”V13 (1Department of anatomy and cytologic patology, Centre Hospitalier Universitaire, France. 2Department of Diasgnostic Radiology, University of Maryland Medical System, USA. 3Department of Pathology, Wake Forest University School of Medicine, USA. 4Department of Pathology, Emory University Hospital, USA. 5Department of Histopathology, Royal Brompton National Heart and Lung Hospital, USA. 6Department of Pathology, Virginia Mason Clinic, USA. 7•a—. 8Department of Anatomy and Cytologic Pathology, Center Hospitalier Universitaire, France. 9Department of Pathology, National Taiwan University Hospital, Taiwan/China. 10Institute of Pathology, University Hospital Charite, Germany. 11Department of Adult Oncology, Harvard Medical School, USA. 12Department of Pediatrics, University of Michigan Medical Center, USA. 13’}”g‘åˆãŠwê–åŠwŒQE•a—). •ÒW WD Travis1, E Brambilla2, HK Muller-Hermelink3, CC Harris4 (1Department of Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology, USA. 2Department of anatomy and cytologic patology, Centre Hospitalier Universitaire, France. 3Department of Pathology, University of Wurzburg, Germany. 4Laboratory of Human Carcinogenesis, National Institute of Health, USA), ŠÄC World Heath Organization, IARC Press (France), 2004.

620016. [Šwp‘] (•ª’SŽ·•M) —Õ°ŒŸ¸–@’ñ—v; ^‹ÛŒŸ¸. ˆ¢•””ü’mŽq1, ‹v•Ä@Œõ2 (1ˆã‰q. 2•a—), •ÒW ‹àˆä³Œõ (MB‘åj, ‹àŒ´o”Å, 2005/2/20”­s.

620017. [Šwp‘] (•ª’SŽ·•M) ƒXƒ^ƒ“ƒ_[ƒh@”÷¶•¨Šw; Še˜_2@4. ^‹Û. ˆ¢•””ü’mŽq1, ‹v•Ä@Œõ2 (1ˆã‰q. 2•a—), •ÒW ŽR–{—e³ (‘åã‘å) ‘¼, •¶Œõ“°, 2005/3/31”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

713025. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Effect of estrogen on endometrial cancer cells stably-transfected with estrogen receptor gene. “n•Ó@ƒ1, Š™“c—TŽq2, ìŒû”ü˜a2, ¼‘º—R—¢2, Vˆä@“w2, ¬•Û•û@ˆ©2, ‰ªˆÀ@ŒM1, ‘ –{”Žs2 (1•a—. 2ˆã—ÃŒn‘åŠw‰@E—Õ°×–E): 10th biennial international gynecologic cancer society meeting (2004/10/5), Edinburgh, Scotland, UK. Int J Gynecol Cancer, 14 (Suppl.1): 120, 2004.

713026. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Expressions of cell cycle reguratory proteins and E-cadherin in clear cell adenocarcinoma of the endometrium. Vˆä@“w1, “n•Ó@ƒ2, ìŒû”ü˜a1, Š™“c—TŽq1, ¼‘º—R—¢1, ‹àˆä“”V3, ã–V•qŽq3, ‘ –{”Žs1 (1ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 2•a—. 3ŽY•w): 10th biennial international gynecologic cancer society meeting (2004/10/5), Edinburgh, Scotland, UK. Int J Gynecol Cancer, 14 (Suppl.1): 99, 2004.

713027. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Effect of medroxy-progesterone acetate on proteome expression of endometrial cancer cells. Š™“c—TŽq1, “n•Ó@ƒ2, •l–ì”üŒbŽq3, Satoh M4, ¬Ž›‹`’j4, ‘åΖΘY4, ‘O“c’‰Œv4, ìŒû”ü˜a1, ‘ –{”Žs1 (1ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 2•a—. 3‘gD”|—{ƒZƒ“ƒ^[. 4—Šw•”): 10th biennial international gynecologic cancer society meeting (2004/10/5), Edinburgh, Scotland, UK. Int J Gynecol Cancer, 14(Suppl.1): 137, 2004.

713028. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Stimulatory effect of medroxyprogesterone acetate on p21 and p27 expression in Ishikawa endometrial carcinoma cells transfected with PRBcDNA. ìŒû”ü˜a1, “n•Ó@ƒ2, •l–ì”üŒbŽq3, Vˆä@“w1, Š™“c—TŽq1, ¼‘º—R—¢1, “c‘ºr’j‚S, ‘ –{”Žs1 (1ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 2•a—. 3‘gD”|—{ƒZƒ“ƒ^[. ‚SŽY•w): 10th biennial international gynecologic cancer society meeting (2004/10/6), Edinburgh, Scotland, UK. Int J Gynecol Cancer, 14(Suppl.1): 140, 2004.

713029. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Immunohistochemical study on MMP-11 in the endometrium and endometrial carcinoma. ¬•Û•û@ˆ©1, “n•Ó@ƒ2, Š™“c—TŽq1, ¼‘º—R—¢1, Vˆä@“w1, ìŒû”ü˜a1, ‘ –{”Žs1 (1ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 2•a—): 10th biennial international gynecologic cancer society meeting (2004/10/7), Edinburgh, Scotland, UK. Int J Gynecol Cancer, 14 (Suppl.1): 215, 2004.

723044. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’×ᇫ‘å’°‰Š‰ŠÇ‘ƒ‚É‚¨‚¯‚ép53-p53R2Œn—U“±‚ÆŽîᇉ»‚ÌŠÖ˜A. ‹g“c@Œ÷, –F‰ê‚µ‚¨‚è, À“c‰êŽq, ‰ªˆÀ@ŒM (•a—): ‘æ93‰ñ“ú–{•a—Šw‰ï‘‰ï (2004/4), ŽD–y. “ú–{•a—Šw‰ïŽ.

723045. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’×ᇫ‘å’°‰Š iUCj ŠÖ˜A”­Šà‚ɑ΂·‚éŠÔŽ¿ƒQƒmƒ€•sˆÀ’è«‚ÌŠÖ—^. –ö‰ºOŽq, ‹g“c@Œ÷, À“c‰êŽq, Ε‘ã, ‰ªˆÀ@ŒM (•a—): ‘æ93‰ñ“ú–{•a—Šw‰ï‘‰ï (2004/4), ŽD–y. “ú–{•a—Šw‰ïŽ.

723046. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Žq‹{“à–ŒŠà×–E‚ւ̃vƒƒQƒXƒeƒƒ“Žó—e‘̈â“`Žq“±“ü‚ƃvƒƒQƒXƒeƒƒ“Œø‰Ê‚¨‚æ‚Ñ‚»‚Ìì—p‹@˜‚̉ðÍ. ìŒû”ü˜a1, “n•Ó@ƒ2, Š™“c—TŽq1, •l–ì”üŒbŽq3, ‘ –{”Žs1 (1ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 2•a—, 3‘gD”|—{ƒZƒ“ƒ^[): ‘æ77‰ñ“ú–{‘gD”|—{Šw‰ï (2004/5/27), –¼ŒÃ‰®. ‘gD”|—{Œ¤‹†, 23 (1): 17, 2004.

723047. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒGƒXƒgƒƒQƒ“Žó—e‘̈â“`Žq“±“üŽq‹{“à–ŒŠà×–EŠ”‚É‚¨‚¯‚éƒGƒXƒgƒƒQƒ“Œø‰Ê. “n•Ó@ƒ1, Š™“c—TŽq2, ‘ –{”Žs2, ‰ªˆÀ@ŒM1 (1•a—. 2ˆã—ÃŒn‘åŠw‰@E—Õ°×–E): ‘æ93‰ñ“ú–{•a—Šw‰ï‘‰ï (2004/6/9), ŽD–y. “ú–{•a—Šw‰ï‰ïŽ, 93 (1): 218, 2004.

723048. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’×ᇫ‘å’°‰ŠŠÖ˜AˆÙŒ`¬‚Å‚Íbottom upŒ^×–E‰ñ“]§Œä‚ðŽó‚¯‚é: ‘å’°‘BŽî‚Æ‚Ì”äŠr. ŽOã“N•v, ˆêŒË¹–¾, À“c‰êŽq, ‰ªˆÀ@ŒM (•a—): ‘æ93‰ñ“ú–{•a—Šw‰ï‘‰ï (2004/6/9), ŽD–y. “ú–{•a—Šw‰ï‰ïŽ, 93 (1): 215, 2004.

723049. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒÀ-ƒJƒeƒjƒ“‚É‚æ‚éŽq‹{“à–ŒŠà×–E•ª‰»—U“± iG•½ã”牻¶j ‹@˜‚̉ð–¾. ŽOŽ}@M1, ‹´‘º”ü‹I2, ŒK“c@Œ’2, •l–ì”üŒbŽq3, ‰ªˆÀ@ŒM1 (1•a—. 2ŠàŒ¤. 3‘gD”|—{ƒZƒ“ƒ^[): ‘æ93‰ñ“ú–{•a—Šw‰ï‘‰ï (2004/6/10), –kŠC“¹. “ú–{•a—Šw‰ïŽ, 93 (1): 233, 2004.

723050. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒOƒŠƒI[ƒ}‚ÌŒŒŠÇV¶‰ß’ö‚É‚¨‚¯‚éƒÀ-ƒJƒeƒjƒ“‚̉ʂ½‚·–ðŠ„. Œ´@“ÖŽq, ŽOŽ}@M, ‰ªˆÀ@ŒM (•a—): ‘æ93‰ñ“ú–{•a—Šw‰ï‘‰ï (2004/6/10), –kŠC“¹. ƒvƒƒOƒ‰ƒ€, p.347, 2004.

723051. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ”x‚Ì_Œo“à•ª”åŽîá‡|‘å×–E«_Œo“à•ª”åŠà‚Ì‘gDf’f‚Æ‚»‚ÌŠÓ•Êf’f‚ð’†S‚É|. Ó@¢ˆ®1, ‹T’J@“O2, 󑺮¶3, Îì—Yˆê4, ˆäã@Œ’5, ²“¡—Yˆê6, “y‰®g6, –ìŒû‰ë”V7, ¼–ì‹gG8, ‰¡£’q”V9, ‰ªˆÀ@ŒM1 (1•a—. 2ɪŒ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[E•a—. 3‘—§‚ª‚ñƒZƒ“ƒ^[’†‰›•a‰@E‹¹ŠO. 4ŠàŒ¤E•a—. 5‘åãŽs—§‘‡ˆã—ÃZƒ“ƒ^[E•a—. 6ˆã‰qEˆâ“`ŽqŒŸ¸. 7’}”g‘åˆãŠwê–åŠwŒQE•a—. 8‘—§‚ª‚ñƒZƒ“ƒ^[’†‰›•a‰@E•a—. 9ƒTƒ“ƒŠƒc•a—¶•¨î•ñ‰ð̓Zƒ“ƒ^[): ‘æ93‰ñ“ú–{•a—Šw‰ï (2004/6/11), ŽD–y. “ú–{•a—Šw‰ï‰ïŽ, 93 (1): 197, 2004.

723052. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ³íŽq‹{“à–Œ, Žq‹{“à–ŒŠà‚É‚¨‚¯‚éMatrix metalloproteinase-11‚̖Ɖu‘gD‰»Šw“IŒŸ“¢. ¬•Û•û@ˆ©1, “n•Ó@ƒ2, •ž•”@Šw1, ¼‘º—R—¢1, Vˆä@“w1, ìŒû”ü˜a1, ‘ –{”Žs1 (1ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 2•a—): ‘æ45‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (2004/7/10), “Œ‹ž. “ú–{—Õ°×–EŠw‰ïŽGŽ, 43 (Suppl.1): 242, 2004.

723053. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ’×ᇫ‘å’°‰Š‚Æ”­‚ª‚ñ. ‰ªˆÀ@ŒM (•a—): ‘æ63‰ñ“ú–{ŠàŠw‰ï‘‰ï (2004/10/1), •Ÿ‰ª. Cancer Sci, 95 (Suppl): 2004.

723054. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{“à–Œ×–EfThin layer–@‚É‚æ‚éŽq‹{“à–ŒŠà‚Ìf’f‚Æ—\Œã”»’è2004. ¼‘º—R—¢1, “n•Ó@ƒ2, •ž•”@Šw1, Š™“c—TŽq1, Vˆä@“w1, ìŒû”ü˜a1, ¬•Û•û@ˆ©1, ‹{–{•üK1, ã–V•qŽq3, ‘ –{”Žs1 (1ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 2•a—, 3ŽY•w): ‘æ43‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï (2004/11/12), “Œ‹ž. “ú–{—Õ°×–EŠw‰ïŽGŽ, 43 (Suppl.1): 488, 2004.

723055. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒûŠW¬‘Á‰t‘BŒ´”­‚Ì clear cell adenocarcinoma‚Ì1—á. ¬—Ñ”ü•Û1, •ž•”@Šw1, ‹{–{•üK1, ‰¡ŽR@‘å2, –L‰i^Ÿ2, Š`ÀœA–M2, “n•Ó@ƒ3, Šâ•£Œ[ˆê3, ¬’†çŽç4, ‘ –{”Žs1 (1ˆã‰qE—Õ°×–E. 2‘åŠw•a‰@×–Ef. 3•a—. 4“Œ‹žˆã‘åEŠO): ‘æ43‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï (2004/11/13), “Œ‹ž. “ú–{—Õ°×–EŠw‰ïŽGŽ, 43 (Suppl.1): 414, 2004.

733015. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Endometrial stromal nodule‚̈ê—á. Œ´@“ÖŽq (•a—): _“Þ쌧•a—ˆã‰ï‘æ80‰ñ—á‰ï (2005/1/8), _“Þì.


<<‰q¶ŠwEŒöO‰q¶Šw>>

mŠwp˜_•¶n

110035. [Œ´’˜] Altered metabolism of dopamine in the midbrain of mice treated with tributyltin chloride via subacute oral exposure. Šp“c³Žj1, ®–ìMO2, ’†–ì@Œ›3, Yang Liu4 (1‰q¶. 2ŒSŽR—Žq‘å. 3•Ÿ“‡‰q¶Œ¤‹†Š. 4’†‘ˆã‘å): Environ Sci, 11 (4): 209-219, 2004.

110036. [Œ´’˜] Glucose intolerance and coronary artery disease in individuals with long-term spinal cord injury. ¡ˆäD1, V’Ã’J^l2, ò@—BŽj3, ³•xçŒb3, ’r“c@•q3, ’†“‡º•v4, ‘ŠàVDŽ¡2, ‹g—Ç®•½3 i1ŒQ”n‘å. 2‰q¶. 3‰ªŽR‘å. 4˜JЃŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ˆ¤’mì‹ÆŠj: JJOMT, 52 (4): 219-223, 2004.

110037. [Œ´’˜] Factors associated with satisfaction among participants in a periodical worksite health check-up in Japan. H“¡ˆÀŽj, ²“¡•q•F, ׈ä@, ‘ŠàVDŽ¡ (‰q¶): J Occup Health, 46: 461-469, 2004.

110038. [Œ´’˜] Occupational class and exposure to job stressors among employed men and women in Japan. ì㌛l1, Œ´’J—²Žj2, ¬—ÑÍ—Y3, Î蹕v4, —Ñ@„5, “¡“c@’è6, ‘ŠàVDŽ¡7, ‹{貌á8, œA@®“T9, –‘Œ³@•10, ‹´–{C“ñ11, r‹Lrˆê2 i1‰ªŽR‘å. 2ŽY‹ÆˆãŠw‘‡Œ¤‹†Š. 3ˆ¤’mˆã‘å. 4‹à‘òˆã‘å. 5“ú—§. 6ˆ¤’m‹³ˆç‘å. 7‰q¶. 8–¾Ž¡‘å–@‰È‘åŠw‰@. 9‚±‚¤‚©‚ñ‰ï. 10ŽO•H‰»Šw. 11“¡“c•ÛŒ’‰q¶‘åj: J Epidemiol, 14 (6): 204-211, 2004.

110039. [Œ´’˜] Tributyltin(TBT) increases TNFƒ¿ mRNA expression and induces apoptosis in the murine macrophage cell line in vitro. ’†–ì@Œ›1, Šp“c³Žj2, ®–ìMO3 i1•Ÿ“‡‰q¶Œ¤‹†Š. 2‰q¶. 3ŒSŽR—Žq‘å): Environ Health Prev Med, 9 (6): 266-271, 2004.

110040. [Œ´’˜] Decreased membrane fluidity and hyperpolarization in aluminum-treated PC-12 cells correlates with increases production of cellular oxidants. Johnson VJ1, Šp“c³Žj2, Muray TF3, Sharma RP3 (1National Institute for Occupational Safety and Health. 2‰q¶. 3University of Georgia): Environ Toxicol Pharmacol, 19: 221-230, 2005.

110041. [Œ´’˜] The differences of the effects on serum cytokine levels among healthy men. Šp“c³Žj1, ²“¡•q•F1, ‘ŠàVDŽ¡1, Šp“c•¶’j2, Guevarra L3, Tollerud DJ4 (1‰q¶. 2ŠâŽèˆã‘å. 3Joseph Stokes Research Center of the Children's Hospital of Philadelphia. 4University of Louisville): Kitasato Med J, 34 (1): 13-20, 2004.

110042. [Œ´’˜] Relationship between chest X-ray findings and pulmonary function tests in dust workers. ‰“æ—zŽq1, V’Ã’J^l1, ²“¡•q•F1, ™‰Y—R”üŽq2, ŽO‘î@m3, ‘ŠàVDŽ¡1 (1‰q¶. 2—\–hˆãŠwŒn. 3•xŽm’Ê): Ind Health, 43 (1): 256-266, 2005.

110043. [Œ´’˜] The cytotoxicity of microglass fibers on alveolar macrophages of Fischer 344 rats evaluated by cell magnetometry, cytochemistry and morphology. iŽm‰iŽq1, “n粌õN1, H“¡—Yˆê˜N1, V’Ã’J^l1, Šp“c³Žj1, ²“¡•q•F1, ŽðˆäNO2, ¬’J@½3, ‘ŠàVDŽ¡1 (1‰q¶. 2‰ð–U. 3“Œ‹ž“d‹@‘å): Environ Health Prev Med, 10 (2): 111-119, 2005.

120006. [Œ´’˜] ‹³Eˆõ‚Ì‹i‰Œ‚ÉŠÖ‚·‚éˆÓŽ¯‚Æ‹i‰Œ–hŽ~‹³ˆçŒoŒ±|Ž¿–⎆•[‚É‚æ‚é’²¸‚©‚ç|. —é–Ø—çŽq1, —é–ØŒbŽq2, Žµ‹{‚Ђë‚Ý2, ª–{‰]3, ‘–ì‚‚¬4, ’·àVãùˆê5, ã–앶œ\6, Šp“c³Žj7 (1•Ÿ“‡Šw‰@‘å. 2•Ÿ“‡Œ§“ì•ÛŒ’•ŸŽƒŽ––±Š. 3•Ÿ“‡Œ§‘‡‰q¶Šw‰@. 4•Ÿ“‡Œ§‘Š‘o•ÛŒ’•ŸŽƒŽ––±Š. 5•Ÿ“‡Œ§–k•ÛŒ’•ŸŽƒŽ––±Š. 6•xŽm•a‰@. 7‰q¶): •Ÿ“‡Œ§•ÛŒ’‰q¶î•ñ, 14 (1): 8-12, 2004.

120007. [Œ´’˜] ¸_•ÛŒ’•ŸŽƒ–@‰ü³Ž{s’¼‘O‚ÌŽs‹æ•ÛŒ’Š‚É‚¨‚¯‚é¸_•ÛŒ’•ŸŽƒŠˆ“®‚ÌŽÀŽ{ó‹µ. ‘åˆä@Æ1, ²X–غŽq2, ’|“‡@³3, “ì@—´ˆê4, ‚‰ª“¹—Y5, Ήº‹±Žq6, Šp“c³Žj7, ã–앶œ\8 i1“Œ‹ž“sç‘ã“c•ÛŒ’Š. 2“Œ‹ž“s¸_•ÛŒ’•ŸŽƒƒZƒ“ƒ^[. 3‘—§¸__ŒoƒZƒ“ƒ^[. 4ŒF–{Œ§Œ’N•ŸŽƒ•”. 5•ºŒÉŒ§“òèŽs•ÛŒ’Š. 6•Ÿ“‡Œ§Œ§“ì•ÛŒ’Š. 7‰q¶. 8•xŽm•a‰@j: “ú–{ŒöO‰q¶ŽGŽ, 52 (1): 46-54, 2005.

220005. [€Œ´’˜] ŠÂ‹«‹ó‹C’†—±ŽqóE‘@ˆÛ󕨎¿‚ÌŒ’N‰e‹¿. ‘ŠàVDŽ¡, H“¡—Yˆê˜N, iŽm‰iŽq (‰q¶): —Õ°ŠÂ‹«ˆãŠw, 13 (1): 4-10, 2004.

520017. [‰ðà] “ÁŽêŒ’Nf’f‚ɂ‚¢‚ć@ŽÀŽ{‚̈Ӌ`‚Æ•û–@. ‘ŠàVDŽ¡ (‰q¶): ŽY‹Æ•ÛŒ’, 21 (36): 18-21, 2004.

520018. [‰ðà] ƒVƒbƒNƒnƒEƒXÇŒóŒQ‚Ì‘˜_. ‘ŠàVDŽ¡ (‰q¶): ¶Šˆ‚Ɗ‹«, 49 (6): 9-13, 2004.

520019. [‰ðà] ƒVƒbƒNƒnƒEƒXÇŒóŒQ‚ɂ‚¢‚Ä. ‘ŠàVDŽ¡ (‰q¶): ˆÀ‘S‰q¶ƒRƒ“ƒTƒ‹ƒ^ƒ“ƒg, 24 (72): 28-33, 2004.

520020. [‘à] “ÁŽêŒ’Nf’f. ‘ŠàVDŽ¡ (‰q¶): —\–hˆãŠw, 46: 77-79, 2004.

520021. [‘à] 3Ží—ނ̃ƒbƒNƒE[ƒ‹‚Ì”x“à“®‘Ô‚ÉŠÖ‚·‚錤‹†‚ÌŠT—v. H“¡—Yˆê˜N, ‘ŠàVDŽ¡ (‰q¶): ƒƒbƒNƒE[ƒ‹, 174: 8-13, 2005.

520022. [‘à] ƒVƒbƒNƒrƒ‹ÇŒóŒQ‚ÌŠT”O‚Æ—vˆö|ƒVƒbƒNƒnƒEƒXÇŒóŒQ‚Æ‚ÌŠÖ˜A‚ðl‚¦‚é|. ΋´”ü¶, ˜a“ckŽ¡, Šp“c³Žj, ‘ŠàVDŽ¡ (‰q¶): ŽY‹ÆˆãŠwƒWƒƒ[ƒiƒ‹, 28 (2):75-78, 2005.

521001. [Œ¤‹†•ñ‘ (ŠÂ‹«È)] –{‘Ô«‘½Ží‰»Šw•¨Ž¿‰ß•qó‘Ô‚Ì’²¸Œ¤‹†•ñ. ‘åˆä@Œº1, ‘ŠàVDŽ¡2, r‹Lrˆê3, ˆÀ“¡³“T4, ‰Y–ìh•½5, ‹v•Û–Ø•x–[6, ’|’†@—m7, “y‰®‰x‹P8, ¼‰ª@´9, ‹´–{M–ç10, “¡ŠªG˜a1, ‹g‘ºŒ’´11, —é–Ø’B•v12, â•”@v12,, ‰“æGŽ÷2 (1‘—§ŠÂ‹«Œ¤. 2‰q¶. 3ŽYˆãŒ¤. 4‘—§ˆã–ò•iH•i‰q¶Œ¤‹†Š. 5‰¡•l‘—§‘å. 6“Œ‹ž‘å. 7‘åãˆã‘å. 8HŠw‰@‘å. 9“Œ‹žˆã‰ÈŽ•‰È‘å. 10‘ÛŠw‰@é‹Ê’ZŠú‘å. 11ŽY‹Æˆã‘å. 12,–k—¢Œ¤‹†Š•a‰@—Õ°ŠÂ‹«‰ÈŠwƒZƒ“ƒ^[j: •½¬15”N“x@–{‘Ô«‘½Ží‰»Šw•¨Ž¿‰ß•qó‘Ô‚Ì’²¸Œ¤‹†•ñ‘, p.1-106, 2004.

521002. [Œ¤‹†•ñ‘ (ŠÂ‹«È)] “ñd–ÓŒŸ–@‚É‚æ‚é”÷—ʉ»Šw•¨Ž¿”˜˜IŽŽŒ±. â•”@v1, ‰“æGŽ÷2, ”ö“‡³K2, âV“¡–ƒ—¢Žq3, —é–ØK’j4, “c’†ŠÙ–¾”Ž5 (1–k—¢Œ¤‹†Š•a‰@—Õ°ŠÂ‹«‰ÈŠwƒZƒ“ƒ^[. 2‰q¶. 3“Œ‹ž‘å‘åŠw‰@. 4–k—¢Œ¤‹†Š•a‰@. 5ˆã‰qj: •½¬15”N“x@–{‘Ô«‘½Ží‰»Šw•¨Ž¿‰ß•qó‘Ô‚Ì’²¸Œ¤‹†•ñ‘, p.3-32, 2004.

521003. [Œ¤‹†•ñ‘] (Œú˜JÈ) ƒVƒbƒNƒnƒEƒXÇŒóŒQ‚Ì—Õ°•ª—Þ‚ÌŽŽ‚Ý. ‘ŠàVDŽ¡1, ”ö“‡³K1, ‰“æGŽ÷1, ΋´”ü¶1, ‰“æ—zŽq1, â•”@v2, ‹{“cŠ²¶2, Îì@“N2 (1‰q¶. 2–k—¢Œ¤‹†Š•a‰@): •½¬15”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à‚ª‚ñ—\–h“™Œ’N‰ÈŠw‘‡Œ¤‹†Ž–‹Æ@”÷—ʉ»Šw•¨Ž¿‚É‚æ‚éƒVƒbƒNƒnƒEƒXÇŒóŒQ‚Ì•a‘Ô‰ð–¾, f’fEŽ¡—ÑÎô‚ÉŠÖ‚·‚錤‹†•ñ‘, p.79-90, 2004.

521004. [Œ¤‹†•ñ‘] (ƒƒbƒNƒE[ƒ‹H‹Æ‰ï) ‚RŽí—ނ̃ƒbƒNƒE[ƒ‹‚Ì”x“à“®‘Ô‚ÉŠÖ‚·‚錤‹†. ‘ŠàVDŽ¡1, H“¡—Yˆê˜N1, V’Ã’J^l1, Šp“c³Žj1, ²“¡•q•F1, _ŽRé•F2, ¬¼il3, “cŒûŒPO4, ¬¼‰ëŽj4 i1‰q¶. 2ŽYˆãŒ¤. 3“ú‘ª‹¦. 4ŠÂ‹«‘ª’è‹ZpŒ¤‹†Šj: •½¬14”N“x, 15”N“xƒƒbƒNƒE[ƒ‹H‹Æ‰ïˆÏ‘õŒ¤‹†•ñ‘ 3Ží—ނ̃ƒbƒNƒE[ƒ‹‚Ì”x“à“®‘Ô‚ÉŠÖ‚·‚錤‹†, p.1-117, 2004.

521005. [Œ¤‹†•ñ‘] ’´‰¹”g‚É‚æ‚éœW’cŒŸf‚Ì—L—p« |œ‘eé ŒŸf10”NŒã‚Ì’ÇÕ’²¸|. ²“¡•q•F1, ׈ä@1, ‰€Œ´N‘ã2, ‹ß“¡“Œ˜Y3 i1‰q¶. 2’·–쌧ˆ¢’q‘º•ÛŒ’ƒZƒ“ƒ^[. 3Œc‰ž‘å): •½¬16”N“xˆ¢’q‘ºœŒŸf’²¸Œ‹‰Ê•ñ‘, p.1-15, 2004.

521006. [Œ¤‹†•ñ‘] (Œú˜JÈ) ¸_•ÛŒ’•ŸŽƒ‹Æ–±‚É‚¨‚¯‚éŠë‹@‰î“ü‚ÉŠÖ‚·‚é’²¸Œ¤‹†•ñ. ‚‰ª“¹—Y1, ŽRŒû–õ–¾2, ²X–غŽq3, ‘åˆä@º4, ”\“o—²Œ³5, Žðˆäƒ‹ƒ~1, Ζ{Š°Žq6, ’†“cžÄŽ¡7, ’|“‡@³8, Šp“c³Žj9, ‰vŽq@–Î10 i1•ºŒÉŒ§“òèŽs•ÛŒ’Š. 2•Ÿ“‡Œ§‘Š‘o•ÛŒ’Š. 3“Œ‹ž“s—§¸_•ÛŒ’•ŸŽƒƒZƒ“ƒ^[. 4“Œ‹ž“sç‘ã“c‹æ•ÛŒ’Š. 5Î쌧“ì‰Á‰ê•ÛŒ’Š. 6“¿“‡Œ§“¿“‡•ÛŒ’Š. 7ŒF–{Œ§“V‘•ÛŒ’Š. 8‘—§¸__ŒoƒZƒ“ƒ^[¸_•ÛŒ’Œ¤‹†Š. 9‰q¶. 10“Œ‹ž“s—§‘½–€‘‡¸_•ÛŒ’•ŸŽƒƒZƒ“ƒ^[): •½¬16”N“x’nˆæ•ÛŒ’‘‡„iŽ–‹Æu¸_•ÛŒ’‘Îô‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錤‹†v•ñ‘, p.1-46, 2004.

521007. [Œ¤‹†•ñ‘] (Œú˜JÈ) ‘Š‡Œ¤‹†•ñ‘@Žº“à‹ó‹CŽ¿‚ÌŒ’N‰e‹¿‚ÉŒW‚éˆãŠw“I’mŒ©‚Ì®—. ‘ŠàVDŽ¡ (‰q¶): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à@Œú¶˜J“­‰ÈŠw“Á•ÊŒ¤‹†Ž–‹Æ@Žº“à‹ó‹CŽ¿‚ÌŒ’N‰e‹¿‚ÉŒW‚éˆãŠw“I’mŒ©‚Ì®—@•½¬16”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.1-8, 2004.

521008. [Œ¤‹†•ñ‘] (Œú˜JÈ) Žº“à‹ó‹CŽ¿‚ÌŒ’N‰e‹¿‚ÉŒW‚éˆãŠw“I’mŒ©‚Ì®—@Œ’NáŠQ‚ÌŠT”O‚Ì®—. ‘ŠàVDŽ¡, ˜a“ckŽ¡ (‰q¶): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à@Œú¶˜J“­‰ÈŠw“Á•ÊŒ¤‹†Ž–‹Æ@Žº“à‹ó‹CŽ¿‚ÌŒ’N‰e‹¿‚ÉŒW‚éˆãŠw“I’mŒ©‚Ì®—@•½¬16”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.27-39, 2004.

521009. [Œ¤‹†•ñ‘] (Œú˜JÈ) ŽY‹Æˆã“™ŽY‹Æ•ÛŒ’ƒXƒ^ƒbƒt‚Ì‚½‚ß‚Ì“­‚­—«‚ÌŒ’NŠÇ—ƒnƒ“ƒhƒuƒbƒN. ⌳³ˆê1, ’†—ѳ—Y2, ‘ŠàVDŽ¡3, –ƒ¶•Žu4, “àŽRŠ°Žq5, –؉ºŸ”V6, ´ì@®7, ‹v•Û“cr˜Y4, ’F@‚ ‚³‚Ý8, ’·ˆä‘—¢9, –쌴—Žq10, •SŽ}Š²—Y11, X@WŽ¢9 i1“ú–{ŽY•wl‰Èˆã‰ï, •êŽqˆ¤ˆç‰ï‘‡•êŽq•ÛŒ’ƒZƒ“ƒ^[. 2•êŽqˆ¤ˆç‰ï‘‡•êŽq•ÛŒ’ƒZƒ“ƒ^[ˆ¤ˆç•a‰@. 3‰q¶. 4“Œ‹žˆãŽ•‘å. 5JR“Œ“ú–{Œ’N„iƒZƒ“ƒ^[. 6‡“V“°‘å. 7‘D‹´Žs—§ˆã—ÃZƒ“ƒ^[. 8•l¼ˆã‘å. 9ŽY‹Æˆã‘å. 10“Œ‹ž—Žqˆã‘å. 11“Œ‹ž‘åj: Œú¶˜J“­ÈˆÏ‘õŽ–‹Æ@ŽY‹Æˆã“™ŽY‹Æ•ÛŒ’ƒXƒ^ƒbƒt‚Ì‚½‚ß‚Ì“­‚­—«‚ÌŒ’NŠÇ—ƒnƒ“ƒhƒuƒbƒN, p.1-100, 2004.

521010. [Œ¤‹†•ñ‘] (‰F’ˆq‹óŒ¤‹†ŠJ”­‹@\) ‘Û‰F’ˆƒXƒe[ƒVƒ‡ƒ“‘D“àŠÂ‹«‹ó‹C’†‚Ì—LŠQ•¨Ž¿‹–—e”Z“xEŠî€’l’ñˆÄ——R‘. ‘ŠàVDŽ¡, Šp“c³Žj1, ˆäã—tŽq2, ŽO–Ø–Ò¶1, ¬—јa–ç1 (1‰q¶. 2—\–hˆãŠwŒn): •½¬16”N“xJAXAˆÏ‘õŒ¤‹†•ñ‘@‘Û‰F’ˆƒXƒe[ƒVƒ‡ƒ“‚É‚¨‚¯‚é‘D“àŠÂ‹«‹ó‹C’†‚Ì—LŠQ•¨Ž¿‹–—e”Z“xEŠî€’l‚ÌŒŸ“¢, p.1-50, 2004.

521011. [Œ¤‹†•ñ‘ (Œú˜JÈ)] ”M’†Ç‚Ì”­¶–hŽ~‚ÉŒW‚é’²¸Œ¤‹†. ‘ŠàVDŽ¡1, ‰Á•”@—E2, àV“cWˆê3, ‚‹´M—Y4, “ÈŒ´@—T5, –L“c•¶‰„6, ”\¨@”Ž7, –x]³’m8, ”óìO”V9 (1‰q¶. 2ŒÃ‰Í“d‹CH‹Æ. 3ŽY‹ÆˆãŠw‘‡Œ¤‹†Š. 4JFEƒXƒ`[ƒ‹. 5‹ãB‘å‘åŠw‰@. 6ŒÜ—mŒšÝ. 7MB‘å‘åŠw‰@. 8ŽY‹Æˆã‰È‘å. 9ŒšÝ‹Æ˜J“­ÐŠQ–hŽ~‹¦‰ïj: ”M’†Ç‚Ì”­¶–hŽ~‚ÉŒW‚é’²¸Œ¤‹†•ñ‘, p.1-60, 2004.

521012. [Œ¤‹†•ñ‘ (Œú˜JÈ)] ƒVƒbƒNƒnƒEƒXÇŒóŒQ‚Ì—Õ°•ª—Þ. ‘ŠàVDŽ¡1, ΋´”ü¶1, ‰“æGŽ÷1, Šp“c³Žj1, ˜a“ckŽ¡1, ŽO–Ø–Ò¶1, â•”@v2, ‹{“cŠ²¶3, Îì@“N3 (1‰q¶. 2–ò. 3–k—¢Œ¤‹†Š•a‰@—Õ°ŠÂ‹«ˆãŠwƒZƒ“ƒ^[): •½¬16”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹àŒ’N‰ÈŠw‘‡Œ¤‹†Ž–‹Æ@”÷—ʉ»Šw•¨Ž¿‚É‚æ‚éƒVƒbƒNƒnƒEƒXÇŒóŒQ‚Ì•a‘Ô‰ð–¾, f’fEŽ¡—ÑÎô‚ÉŠÖ‚·‚錤‹†•ñ‘, p.53-61, 2004.

521013. [Œ¤‹†•ñ‘ (Œú˜JÈ)] ƒVƒbƒNƒnƒEƒXÇŒóŒQ‚ÌŠ³ŽÒ‚É‚¨‚¯‚é”÷—ʃgƒ‹ƒGƒ“‹z“ü”˜˜I‚É‚æ‚éfMRI‚ð—p‚¢‚½”]ŒŒ—¬•Ï‰»‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‘ŠàVDŽ¡1, ˜a“ckŽ¡1, ŽO–Ø–Ò¶1, ΋´”ü¶1, ¬—јa–ç1, ˆäã—tŽq2, ™‰Y—R”üŽq2, Šp“c³Žj1, ›@Mˆê3, â•”@v4, ‹{“cŠ²¶5, Îì@“N5 (1‰q¶. 2—\–hˆãŠwŒn. 3•ú. 4–òŠw•”. 5–k—¢Œ¤‹†Š•a‰@—Õ°ŠÂ‹«ˆãŠwƒZƒ“ƒ^[): •½¬16”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹àŒ’N‰ÈŠw‘‡Œ¤‹†Ž–‹Æ@”÷—ʉ»Šw•¨Ž¿‚É‚æ‚éƒVƒbƒNƒnƒEƒXÇŒóŒQ‚Ì•a‘Ô‰ð–¾, f’fEŽ¡—ÑÎô‚ÉŠÖ‚·‚錤‹†•ñ‘, p.62-72, 2004.

521014. [Œ¤‹†•ñ‘ (Œú˜JÈ)] ƒGƒAƒƒ]ƒ‹‚ÌŒ’N‰e‹¿. ‘ŠàVDŽ¡ (‰q¶): •½¬16”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à (Œ’N‰ÈŠw‘‡Œ¤‹†Ž–‹Æ) Œš’z•¨‚É‚¨‚¯‚éŠÂ‹«‰q¶‚ÉŠÖ‚·‚錤‹†•ñ‘, p.12-24, 2004.

521015. [Œ¤‹†•ñ‘ (‘“yŒð’ÊÈq‹ó‹Ç/(à) q‹óŒð’ʊǧ‹¦‰ï) q‹óŠÇ§Š¯‚Ì“K³ŒŸ¸‚ÉŠÖ‚·‚é’²¸•ñ. ¼“c­’j1, Š_–{—R‹IŽq2, ΋´@–¾3, ‘ŠàVDŽ¡4, ’ç@–M•F5, ”Ñ“c—TN6, ã–ìMŒá7, ]Œ´M‘¾8, ŒÃì‹`‘¥8, ”ªàV–¾’j8, ÎX‰ë•¶9 (1q‹ó•ÛˆÀŒ¤‹†ƒZƒ“ƒ^[. 2q‹óE“S“¹Ž–ŒÌ’²¸ˆÏˆõ‰ï. 3“ú–{ƒqƒ…[ƒ}ƒ“ƒtƒ@ƒNƒ^[Œ¤‹†Š. 4‰q¶. 5¸. 6˜J“­‰ÈŠwŒ¤‹†Š. 7ŽO•H‘‡Œ¤‹†Š. 8‘“yŒð’ÊÈ. 9q‹ó•ÛˆÀ‘åŠwZ): q‹óŠÇ§Š¯‚Ì“K³ŒŸ¸‚ÉŠÖ‚·‚é’²¸•ñ, q‹óŠÇ§Š¯‚Ì“K³ŒŸ¸‚ÉŠÖ‚·‚é’²¸•ñ‘, p.1-129, 2004.

m’˜@‘n

620018. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•ME•ÒW) ¡“ú‚ÌŽ¡—ÃŽwj2005”N”Å|Ž„‚Í‚±‚¤Ž¡—µ‚Ä‚¢‚é|; ŠÂ‹«EE‹Æ«ˆöŽq‚É‚æ‚鎾Š³, p.709-717. ‘ŠàVDŽ¡ (‰q¶), •ÒW ‘ŠàVDŽ¡, ŠÄC ŽRŒû@“O1, –kŒ´Œõ•v2 (1ŒÕ‚Ì–å•a‰@. 2“Œ‹ž“s϶‰ïŒü“‡•a‰@), ˆãŠw‘‰@, “Œ‹ž, 2005/1/1”­s.

620019. [ŠTà‘] (•ª’SŽ·•M) ŽY‹Æ•ÛŒ’ƒnƒ“ƒhƒuƒbƒN@VDTì‹Æ‚ÆŒ’NáŠQ|—Õ°E—\–hŠÇ—E•âž‚Ì‚·‚ׂÄ|; VDTì‹Æ‚ÆŠÖ˜A‚·‚錒NáŠQ, p.22-30. ‘ŠàVDŽ¡ (‰q¶), ŠÄC ˜a“c@Œ÷ (“Œ‹ž‘å), ŽY‹ÆˆãŠwU‹»à’c, “Œ‹ž, 2005/3/11”­s.

620020. [‚»‚Ì‘¼‚Ì’˜‘] (‹¤’˜) ¸_•ÛŒ’•ŸŽƒ–@‘æ34ð‚ÉŠî‚­ˆÚ‘—‚É‚©‚©‚éƒ}ƒjƒ…ƒAƒ‹. ‚‰ª“¹—Y1, ŽRŒû–õ–¾2, ²X–غŽq3, ‘åˆä@º4, ’†“cžÄŽ¡5, ’|“‡@³6, Šp“c³Žj7, ã–앶œ\8, ŒKŒ´@Š°9 (1•ºŒÉŒ§“òèŽs•ÛŒ’Š. 2•Ÿ“‡Œ§‘Š‘o•ÛŒ’Š. 3“Œ‹ž“s—§¸_•ÛŒ’•ŸŽƒƒZƒ“ƒ^[. 4“Œ‹ž“sç‘ã“c‹æ•ÛŒ’Š. 5ŒF–{Œ§“V‘•ÛŒ’Š. 6‘—§¸__ŒoƒZƒ“ƒ^[¸_•ÛŒ’Œ¤‹†Š. 7‰q¶. 8•xŽm•a‰@. 9_“Þ쌧¸_•ÛŒ’•ŸŽƒƒZƒ“ƒ^[j: •ÒW ‘S‘•ÛŒ’Š’·‰ï¸_•ÛŒ’•ŸŽƒŒ¤‹†”Ç, “ú–{ŒöO‰q¶‹¦‰ï, “Œ‹ž, 2004/9”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

712006. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) High job demands, and its combination with low superviser support ato work predict acute myocardial infraction in Japanese men: A prospective cohort study. ¬—ÑÍ—Y1, ì㌛l2, Œ´’J—²Žj3, Î蹕v4, —Ñ@„5, “¡“c@’è6, ‘ŠàVDŽ¡7, ‹{貌á8, œA@®“T8, –‘Œ³@•9, ‹´–{C“ñ10, r‹Lrˆê3 i1ˆ¤’mˆã‘å. 2‰ªŽR‘å. 3ŽY‹ÆˆãŠw‘‡Œ¤‹†Š. 4‹à‘òˆã‘å. 5“ú—§. 6ˆ¤’m‹³ˆç‘å. 7‰q¶. 8‚±‚¤‚©‚ñ‰ï. 9ŽO•H‰»Šw. 10“¡“c•ÛŒ’‰q¶‘åj: Fourth international conference on work environment and cardiovascular diseases (2005/3/9), Los Angeles.

713030. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Fifteen year follow-up study of VC and FEV1 in dust-exposed workers. “cŒû–¾Žq1, ‰“æ—zŽq2, ™‰Y—R”üŽq3, ‰“æGŽ÷2, V’Ã’J^l2, ²“¡•q•F2, ‘ŠàVDŽ¡2 (1ˆã‰q. 2‰q¶. 3—\–hˆãŠwŒn): The 15th Japan-China-Korea Joint Conference on Occupational Health (2004/5/21), –k‹ãB. Abstracts, 178, 2004.

713031. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Cell magnetometry for an evaluation of toxicity of man-made mineral fibers. ‘ŠàVDŽ¡1, H“¡—Yˆê˜N1, iŽm‰iŽq1, ‰ª“c[Žj1, ™‰Y—R”üŽq2, ¬¼—T”ü2, ¬’J@½3 (1‰q¶. 2—\–hˆãŠwŒn. 3“Œ‹ž“d‹@‘å): BIOMAG 2004 (2004/8/8), Boston. Proceedings of the 14th International Conference on Biomagnetism, 248-249, 2004.

713032. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Development of a magnetic field measurement system for small animal lungs. ¬’J@½1, Zheng Y1, ‘ŠàVDŽ¡2, H“¡—Yˆê˜N2 (1“Œ‹ž“d‹@‘å. 2‰q¶): BIOMAG 2004 (2004/8/8), Boston. Proceedings of the 14th International Conference on Biomagnetism, 263-264, 2004.

713033. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Safety evaluation of new artificial dura mater (GM972) and its tin compounds constituents using ex vivo striatal slices. Filipov N1, Šp“c³Žj2 (1Mississippi State Univ. 2‰q¶): Society for Neuroscience 34th Annual Meeting (2004/10/23), San Diego. Abstract Viewer/Itinerary Planner, Program No. 345, 13, 2004, Online.

713034. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) The increase in total IgE in serum of female mice after intranasal exposure of carbon black particles with pollen. ¬—јa–ç1, ˆÉ“¡‹žŽq2, ˆäã—tŽq2, H“¡—Yˆê˜N1, Šp“c³Žj1, ²“¡•q•F1, ”ª‘ãçŒb3, ¬¼—ÇŽq3, ‘ŠàVDŽ¡1 (1‰q¶. 2—\–hˆãŠwŒn. 3‘—§ˆã–ò•iH•i‰q¶Œ¤‹†Š): Society of Toxicology 44th Annual Meeting (2005/3/7), New Orleans. Toxicol SCI (Suppl), 93, 2005.

713035. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) The effects of tributyltin (TBT) chloride on dopamine metabolism in brain tissues of female mice after subacute oral exposure. Šp“c³Žj1, H“¡—Yˆê˜N1, ’†–ì@Œ›2, ®–ìMO3, ¬¼—ÇŽq4, ‘ŠàVDŽ¡1 (1‰q¶. 2•Ÿ“‡Œ§Œ§–k•ÛŒ’•ŸŽƒŽ––±Š. 3ŒSŽR—Žq‘å. 4‘—§ˆã–ò•iH•i‰q¶Œ¤‹†Š): Society of Toxicology 44th Annual Meeting (2005/3/7), New Orleans. Toxicol SCI (Suppl), 124, 2005.

713036. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Effect of tributyltin chloride on natural immunodefences in the F1 generation in mice. ¬¼—ÇŽq1, –Ø‘ºŠóŽÀŽq2, ¬—шê•v1, Šp“c³Žj3, —é–؉ÕF2 (1‘—§ˆã–ò•iH•i‰q¶Œ¤‹†Š. 2–ƒ•z‘å. 3‰q¶): Society of Toxicology 44th Annual Meeting (2005/3/7), New Orleans. Toxicol SCI (Suppl), 181, 2005.

713037. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Biopersistence of rock wool (RW) in the rat lung after short-term inhalation via nose. H“¡—Yˆê˜N1, ™‰Y—R”üŽq2, Šp“c³Žj1, ²“¡•q•F1, ‘ŠàVDŽ¡1 (1‰q¶. 2—\–hˆãŠwŒn): Society of Toxicology 44th Annual Meeting (2005/3/7), New Orleans. Toxicol SCI (Suppl), 193, 2005.

722004. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) –{‘Ô«‘½Ží‰»Šw•¨Ž¿‰ß•qÇ (MCS) ‚ƃVƒbƒNƒnƒEƒXÇŒóŒQ‚ÌŠT”O‚Ì•Ï‘J. ‘ŠàVDŽ¡ (‰q¶): ‘æ34‰ñŒãŽÀѶŠU‹³ˆçƒVƒ“ƒ|ƒWƒEƒ€|ŠÂ‹«‚Ɣ畆: ˆßHZ‚ÉŠÖ‚í‚é”畆Ž¾Š³| (2004/8/29), “Œ‹ž. u‰‰W, 19, 2004.

722005. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”x–Eƒ}ƒNƒƒtƒ@[ƒW—R—ˆMH-S×–E‚ð—p‚¢‚½×–E“Å«ŽŽŒ±–@‚ɂ‚¢‚Ä. Šp“c³Žj1, ‘ŠàVDŽ¡1, ¬¼—ÇŽq2, ¬â’‰Ži3, ŽR–ì—DŽq4, Žs–ì’qŽq4, ’†ŠÙr•v4 i1‰q¶. 2‘—§ˆã–ò•iH•i‰q¶Œ¤‹†Š. 3Žc—¯”_–òŒ¤‹†Š. 4º˜a‘åj: 2004”N–Ɖu“Å«EƒAƒŒƒ‹ƒM[Šw‰ï (2004/9/11), •Ÿˆä. “ú–{E‹ÆEŠÂ‹«ƒAƒŒƒ‹ƒM[Šw‰ïŽGŽ, 12 (1): 37, 2004.

722006. [Šw‰ï (‘S‘)] (‰ï’·u‰‰) ŠÂ‹«ƒXƒgƒŒƒX—vˆö‚Æ‚»‚̉e‹¿. ‘ŠàVDŽ¡ (‰q¶): ‘æ20‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ï (2004/11/25), ‰¡•l. ƒXƒgƒŒƒX‰ÈŠw, 19 (2): 17, 2004.

722007. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) î“®‚ð‰î‚·‚éŠÂ‹«ƒXƒgƒŒƒX‚É‚æ‚錒N‰e‹¿‚Ì•]‰¿. ²“¡•q•F (‰q¶): ‘æ20‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ï (2004/11/25), ‰¡•l. ƒXƒgƒŒƒX‰ÈŠw, 19 (2): 18, 2004.

722008. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Žº“àŠÂ‹«…€‚̒ቺ‚ÆŒ’N‰e‹¿. ‘ŠàVDŽ¡ (‰q¶): ‘æ32‰ñŒš’z•¨ŠÂ‹«‰q¶ŠÇ—‘S‘‘å‰ïEƒVƒ“ƒ|ƒWƒEƒ€u‹Æ–±—pŒš’z•¨‚̉q¶ŠÇ—‚ÆȃGƒlƒ‹ƒM[‘Îô‚Ì—Z‡v (2005/1/21), “Œ‹ž. ´˜^W, 66-71, 2005.

723056. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’j«‹Î˜JŽÒ‚̃Rƒz[ƒg‚É‚¨‚¯‚錌´‘ƒRƒŒƒXƒeƒ[ƒ‹’l‚Æ‚ª‚ñœëŠ³. ì㌛l1, Œ´’J—²Žj2, ¬—ÑÍ—Y3, Î蹕v4, ‹´–{C“ñ5, r‹Lrˆê2, ‘ŠàVDŽ¡6 (1‰ªŽR‘å. 2ŽY‹ÆˆãŠw‘‡Œ¤‹†Š. 3ˆ¤’mˆã‘å. 4‹à‘òˆã‘å. 5“Œ‹ž‘å. 6‰q¶): ‘æ74‰ñ“ú–{‰q¶Šw‰ï‘‰ï (2004/3/25), “Œ‹ž. “ú–{‰q¶ŠwŽGŽ, 59 (—Õ‘): 181, 2004.

723057. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) •²‚¶‚ñì‹ÆŽÒ‚Ì‹¹•”ƒGƒbƒNƒXüŠŒ©‚Æ”x‹@”\ŒŸ¸Œ‹‰Ê‚ÌŠÖŒW. ‰“æ—zŽq1, V’Ã’J^l1, ²“¡•q•F1, ™‰Y—R”üŽq2, ŽO‘î@m3 i1‰q¶. 2—\–hˆãŠwŒn. 3•xŽm’Êj: ‘æ74‰ñ“ú–{‰q¶Šw‰ï‘‰ï (2004/3/25), “Œ‹ž. “ú–{‰q¶ŠwŽGŽ, 59 (—Õ‘): 198, 2004.

723058. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒƒbƒNƒE[ƒ‹‚Ì•@•””˜˜I‹z“üŽŽŒ±‚É‚¨‚¯‚é”x“à‘Ø—¯«‚ÌŒŸ“¢. H“¡—Yˆê˜N1, iŽm‰iŽq1, â–{‘×—1, ’†“‡Dl1, ¬¼—T”ü2, ¬ŽR”ü’q‘ã2, ™‰Y—R”üŽq2, ˆäã—tŽq2, V’Ã’J^l1, ²“¡•q•F1, “cŒûŒPO3, ¬¼il4, _ŽRé•F5, ‘ŠàVDŽ¡1 (1‰q¶. 2—\–hˆãŠwŒn. 3ŠÂ‹«‘ª’è‹ZpŒ¤‹†Š. 4“ú–{ì‹ÆŠÂ‹«‘ª’苦‰ï. 5ŽY‹ÆˆãŠw‘‡Œ¤‹†Š): ‘æ77‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2004/4/14), –¼ŒÃ‰®. ŽY‹Æ‰q¶ŠwŽGŽ, 46 (—Õ‘): 304, 2004.

723059. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) _“Þ쌧‚É‚¨‚¯‚éŽY‹Æ•ÛŒ’Šˆ“®’²¸ (1)|ÝEŽÒŽ€–S‚Ì’²¸|. ŒÃ‰Í@‘×1, ç—tGˆê2, V’Ã’J^l3, ’‡‘º@€4, œA@®“T5, ’JŒûŽu•ä6, —é–؉pF7, ‹{貌á5, ŽO‰ô•”@”£8 i1–¡‚Ì‘f. 2ƒrƒNƒ^[. 3‰q¶. 4ƒuƒŠƒWƒXƒgƒ“. 5‚±‚¤‚©‚ñ‰ï. 6‘Š–Í“S“¹. 7ƒGƒŠƒNƒ\ƒ“ƒ‚[ƒrƒ‹. 8“úŽYj: ‘æ77‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2004/4/14), –¼ŒÃ‰®. ŽY‹Æ‰q¶ŠwŽGŽ, 46 (—Õ‘): 351, 2004.

723060. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) _“Þ쌧‚É‚¨‚¯‚éŽY‹Æ•ÛŒ’Šˆ“®’²¸ (2)|ŽY‹ÆˆãŠˆ“®‚Ì’²¸|. ’‡‘º@€1, ç—tGˆê2, ‹{貌á3, œA@®“T3, —é–؉pF4, ’JŒûŽu•ä5, V’Ã’J^l6, ŒÃ‰Í@‘×7, ŽO‰ô•”@”£8 i1ƒuƒŠƒWƒXƒgƒ“. 2ƒrƒNƒ^[. 3‚±‚¤‚©‚ñ‰ï. 4ƒGƒŠƒNƒ\ƒ“ƒ‚[ƒrƒ‹. 5‘Š–Í“S“¹. 6‰q¶. 7–¡‚Ì‘f. 8“úŽYj: ‘æ77‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2004/4/14), –¼ŒÃ‰®. ŽY‹Æ‰q¶ŠwŽGŽ, 46 (—Õ‘): 351, 2004.

723061. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) _“Þ쌧‚É‚¨‚¯‚éŽY‹Æ•ÛŒ’Šˆ“®’²¸ (3)|Œ’NŠm•Û‘Îô‚Ì’²¸|. ’JŒûŽu•ä1, ç—tGˆê2, œA@®“T3, —é–؉pF4, ŽO‰ô•”@”£5, ’‡‘º@€6, V’Ã’J^l7, ŒÃ‰Í@‘×8, ‹{貌á3 i1‘Š–Í“S“¹. 2ƒrƒNƒ^[. 3‚±‚¤‚©‚ñ‰ï. 4ƒGƒŠƒNƒ\ƒ“ƒ‚[ƒrƒ‹. 5“úŽY. 6ƒuƒŠƒWƒXƒgƒ“. 7‰q¶. 8–¡‚Ì‘fj: ‘æ77‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2004/4/14), –¼ŒÃ‰®. ŽY‹Æ‰q¶ŠwŽGŽ, 46 (—Õ‘): 352, 2004.

723062. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) _“Þ쌧‚É‚¨‚¯‚é•a‹x‹Æ“Œv ‘æ6•ñ. V’Ã’J^l1, ²“¡Mˆê2, ‰“æ—zŽq1, ‰“æGŽ÷1, ™‰Y—R”üŽq3, ‘ŠàVDŽ¡1 (1‰q¶. 2_“Þì˜J–±ˆÀ‘S‰q¶‹¦‰ï. 3—\–hˆãŠwŒn): ‘æ77‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2004/4/14), –¼ŒÃ‰®. ŽY‹Æ‰q¶ŠwŽGŽ, 46 (—Õ‘): 367, 2004.

723063. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒ}ƒEƒXƒ}ƒNƒƒtƒ@[ƒWŒn×–E, J774.1×–E‚ð—p‚¢‚½–Ɖu“Å«‚ÌŒŸ“¢‚ɂ‚¢‚Ä. Šp“c³Žj1, ŽR–ì—DŽq2, ’†ŠÙr•v2, ²“¡•q•F1, ‘ŠàVDŽ¡1 (1‰q¶. 2º˜a‘å): ‘æ77‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2004/4/16), –¼ŒÃ‰®. ŽY‹Æ‰q¶ŠwŽGŽ, 46 (—Õ‘): 381, 2004.

723064. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) NIOSHE‹Æ«ƒXƒgƒŒƒX’²¸•[‚Ì‘ÎlŠ‹“¡ŽÚ“x’Zk”Å‚ÌŠJ”­. Œ´’J—²Žj1, ì㌛l2, ¬—ÑÍ—Y3, Î蹕v4, —Ñ@„5, “¡“c@’è6, ‘ŠàVDŽ¡7, ‹{貌á8, œA@®“T8, –‘Œ³@•9, r‹Lrˆê1 i1ŽY‹ÆˆãŠw‘‡Œ¤‹†Š. 2‰ªŽR‘å. 3ˆ¤’mˆã‘å. 4‹à‘òˆã‘å. 5“ú—§. 6ˆ¤’m‹³ˆç‘å. 7‰q¶. 8‚±‚¤‚©‚ñ‰ï. 9ŽO•H‰»Šwj: ‘æ77‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2004/4/16), –¼ŒÃ‰®. ŽY‹Æ‰q¶ŠwŽGŽ, 46 (—Õ‘): 417, 2004.

723065. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬“®•¨”xŽ¥ŠEŒv‘ªƒVƒXƒeƒ€‚ÌŠJ”­. ¬’J@½1, ‘“c—²—T1, ŽO–ØáÁ–ç1, ‚‹´Ž–¾1, “A@ˆÈ‹Î1, ‘ŠàVDŽ¡2, H“¡—Yˆê˜N2 (1“Œ‹ž“d‹@‘å. 2‰q¶): ‘æ19‰ñ“ú–{¶‘ÌŽ¥‹CŠw‰ï‘å‰ï (2004/6/5), “¿“‡. “ú–{¶‘ÌŽ¥‹CŠw‰ïŽ, 17 (“Á•Ê): 208-209, 2004.

723066. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ƒVƒbƒNƒnƒEƒXÇŒóŒQ‚Ì—Õ°•ª—Þ‚ÌŽŽ‚Ý. ΋´”ü¶1, ‰“æGŽ÷1, ”ö“‡³K1, ‰“æ—zŽq1, â•”@v2, ‹{“cŠ²•v2, Îì@“N2, Šp“c³Žj1, ‘ŠàVDŽ¡1 (1‰q¶. 2–k—¢Œ¤‹†Š•a‰@): ‘æ13‰ñ“ú–{—Õ°ŠÂ‹«ˆãŠw‰ï‘‰ï (2004/7/2), ˆ®ì. u‰‰W, p.34, 2004.

723067. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) —Õ°ŠÂ‹«ˆãŠwƒZƒ“ƒ^[ŽófŠ³ŽÒ‚É‚¨‚¯‚édS“®—hŒŸ¸‚Ì—LŒø«‚ɂ‚¢‚Ä. ¼ˆäFŽq1, ²X–ØŒbŽq1, ˆÀ‰ª—FŽq1, ”ö“‡³K2, ‰“æGŽ÷2, â•”@v1, ‘ŠàVDŽ¡2, ‹{“cŠ²•v1, Îì@“N1 i1–k—¢Œ¤‹†Š•a‰@. 2‰q¶j: ‘æ13‰ñ“ú–{—Õ°ŠÂ‹«ˆãŠw‰ï‘‰ï (2004/7/2), ˆ®ì. u‰‰W, p.38, 2004.

723068. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠÂ‹«‰»Šw•¨Ž¿‚Ì”jœ×–E‚ւ̉e‹¿|“à•ª”嘗‰»Šw•¨Ž¿‚ð’†S‚Æ‚µ‚Ä|. ìã’qŽj1, ’r“c^‹I1, –å˜e•”Ž1, ‘ŠàVDŽ¡2, â•”@v1 i1ˆã—ÃŒn‘åŠw‰@. 2‰q¶j: ‘æ13‰ñ“ú–{—Õ°ŠÂ‹«ˆãŠw‰ï‘‰ï (2004/7/3), ˆ®ì. ´˜^W 60, 2004.

723069. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¸_•ÛŒ’•ŸŽƒ–@‰ü³‚É”º‚¤–@34ðˆÚ‘—‚ɂ‚¢‚Ä ‘æ1•ñ|ˆÚ‘—ŽÀŽ{‘̧‚ɂ‚¢‚Ä|. Šp“c³Žj1, ‘åˆä@º2, ²X–غŽq3, ’|“‡@³4, ’†“cžÄŽ¡5, ŽRŒû–õ–¾6, ŒKŒ´@Š°7, ‚‰ª“¹—Y8, ã–앶œ\9 i1‰q¶. 2“Œ‹žç‘ã“c‹æ•ÛŒ’Š. 3“Œ‹ž“s¸_•ÛŒ’•ŸŽƒƒZƒ“ƒ^[. 4‘—§¸_•ÛŒ’•ŸŽƒƒZƒ“ƒ^[. 5ŒF–{Œ§“V‘•ÛŒ’Š. 6•Ÿ“‡Œ§‘Š‘o•ÛŒ’•ŸŽƒŽ––±Š. 7_“Þ쌧¸_•ÛŒ’•ŸŽƒƒZƒ“ƒ^[. 8•ºŒÉŒ§“òèŽs•ÛŒ’Š. 9•xŽm•a‰@j: ‘æ63‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2004/10/27), “‡ª. “ú–{ŒöO‰q¶ŽGŽ, 51 (10): 751, 2004.

723070. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¸_•ÛŒ’•ŸŽƒ–@‰ü³‚É”º‚¤–@34ðˆÚ‘—‚ɂ‚¢‚Ä ‘æ2•ñ|ˆÚ‘—ƒ}ƒjƒ…ƒAƒ‹‚ɂ‚¢‚Ä|. ‚‰ª“¹—Y1, ²X–غŽq2, ’|“‡@³3, ’†“cžÄŽ¡4, ‘åˆä@º5, Šp“c³Žj6, ŒKŒ´@Š°7, ã–앶œ\8 i1•ºŒÉŒ§“òèŽs•ÛŒ’Š. 2“Œ‹ž“s¸_•ÛŒ’•ŸŽƒƒZƒ“ƒ^[. 3‘—§¸_•ÛŒ’•ŸŽƒƒZƒ“ƒ^[. 4ŒF–{Œ§“V‘•ÛŒ’Š. 5“Œ‹žç‘ã“c‹æ•ÛŒ’Š. 6‰q¶. 7_“Þ쌧¸_•ÛŒ’•ŸŽƒƒZƒ“ƒ^[. 8•xŽm•a‰@j: ‘æ63‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2004/10/27), “‡ª. “ú–{ŒöO‰q¶ŽGŽ, 51 (10): 752, 2004.

723071. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘å•aŒoŒ±‚Ì—L–³‚ðl—¶‚µ‚½Eˆæ’èŠúŒ’Nf’fŽófŽÒ‚Ì–ž‘«“x‚ÉŠÖ‚·‚錤‹†. H“¡ˆÀŽj, ²“¡•q•F, ׈ä@, ‘ŠàVDŽ¡ (‰q¶): ‘æ63‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2004/10/27), “‡ª. “ú–{ŒöO‰q¶ŽGŽ, 51 (10): 912, 2004.

723072. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¢ŠEŒ’N’²¸ (WHS) ‚Å—p‚¢‚½ŽåŠÏ“I‰ñ“š‚ðŒÂl‚̉¿’lŠî€‚É‚æ‚è•â³‚·‚é•û–@. ²“¡•q•F1, ’r“c“Þ—R2, ׈ä@1, ’·’Jì•q•F2 i1‰q¶. 2‘—§•ÛŒ’ˆã—ÉȊw‰@j: ‘æ63‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2004/10/28), “‡ª. “ú–{ŒöO‰q¶ŽGŽ, 51 (10): 319, 2004.

723073. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –^•ÛŒ’•ŸŽƒŽ––±Š‚É‚¨‚¯‚éƒGƒCƒYŒŸ¸‚Ì—˜—pó‹µ ‘æ6•ñ. ‰ª“c[Žj, ‘ŠàVDŽ¡ (‰q¶): ‘æ63‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2004/10/28), “‡ª. “ú–{ŒöO‰q¶ŽGŽ, 51 (10): 839, 2004.

723074. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒVƒbƒNƒnƒEƒXÇŒóŒQ‚Ì—Õ°•ª—ނƉ»Šw•¨Ž¿‰ß•qÇ‚Æ‚ÌŠÖ˜A. ΋´”ü¶1, ˜a“ckŽ¡1, ¬—јa–ç1, ™‰Y—R”üŽq2, Šp“c³Žj1, ‘ŠàVDŽ¡1 (1‰q¶. 2—\–hˆãŠwŒn): ‘æ63‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2004/10/28), “‡ª. “ú–{ŒöO‰q¶ŽGŽ, 51 (10): 916, 2004.

723075. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) u‘²‰Œƒlƒbƒgv—˜—pŽÒ‚Ì‘®«‚¨‚æ‚Ñ‹Ö‰ŒŒXŒü‚Ì•ªÍ. ˆ¢•”áÁ‹|1,2, ”öè“N‘¥3, ㌴—T”üŽq3, ²“¡•q•F4 (1“Œ‹ž”_H‘å, 2“Œ‹ž—ˆã‘å. 3“ú–{‘å. 4‰q¶): ‘æ63‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2004/10/29), “‡ª. “ú–{ŒöO‰q¶ŽGŽ, 51 (10): 219, 2004.

723076. [‘S‘ (Šw‰ï)](ƒ|ƒXƒ^[) •’ÊH‚ƉF’ˆHێ掞‚Ì”A’†ƒtƒb‘f”rŸ•“®Œü. –x“àrF1, ”ˆäˆêD2, ’†‘º@—²3, “ß{ˆè•v1, Šp“c³Žj4, “n糎õŽq1 (1“ú–{‘å. 2ŠâŽèˆã‘å. 3“Œv”—Œ¤‹†Š. 4‰q¶): ‘æ63‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2004/10/29), “‡ª. “ú–{ŒöO‰q¶ŽGŽ, 51 (10): 909, 2004.

723077. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) _ŒoÇŒXŒü‚Æ—}‚¤‚ÂEE‹Æ«ƒXƒgƒŒƒX‚ÌŠÖ˜A«‚ɂ‚¢‚Ä ‘æ2•ñ. â–{‘×—1, ‰“æGŽ÷1, ‘ŠàVDŽ¡1, ì㌛l2, Œ´’J—²Žj3, ¬—ÑÍ—Y4, —Ñ@„5, ‹´–{C“ñ6, Î蹕v6, “¡“c@’è7, ‹{貌á8, œA@®“T8, r‹Lrˆê3, –‘Œ³@•9 i1‰q¶. 2‰ªŽR‘å. 3ŽY‹ÆˆãŠw‘‡Œ¤‹†Š. 4ˆ¤’mˆã‘å. 5“ú—§. 6‹à‘òˆã‘å. 7ˆ¤’m‹³ˆç‘å. 8‚±‚¤‚©‚ñ‰ï. 9ŽO•H‰»Šwj: ‘æ20‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ï (2004/11/25), ‰¡•l. ƒXƒgƒŒƒX‰ÈŠw, 19 (2): 40, 2004.

723078. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) —}‚¤‚ÂÇó‚ɑ΂·‚郉ƒCƒtƒXƒ^ƒCƒ‹‚ƉƑ°‚̃Tƒ|[ƒg‚̉e‹¿‚ɂ‚¢‚Ä. ˜a“ckŽ¡1, ²“¡•q•F1, “c’†Žr2, ‘ŠàVDŽ¡1 (1‰q¶. 2ˆã—ÃŒn‘åŠw‰@): ‘æ20‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ï (2004/11/25), ‰¡•l. ƒXƒgƒŒƒX‰ÈŠw, 19 (2): 43, 2004.

723079. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Ý“úƒuƒ‰ƒWƒ‹l˜J“­ŽÒ‚É‚¨‚¯‚éƒXƒgƒŒƒX, Œ’Nó‹µ, Œ’NŠÇ—. ’Â@‰àäŽ1, Šp“c³Žj2, ‘ŠàVDŽ¡2 (1‘Ûˆã—ÕŸŽƒ‘å. 2‰q¶): ‘æ20‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ï (2004/11/25), ‰¡•l. ƒXƒgƒŒƒX‰ÈŠw, 19 (2): 39, 2004.

723080. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’´‰¹”g–@‚É‚æ‚霌Ÿf‚Ì—L—p«|10”NŒã’ÇÕ’²¸|. ׈ä@1, ‰€Œ´N‘ã2, ‘ŠàVDŽ¡1, ‹ß“¡“Œ˜Y3, ²“¡•q•F1 (1‰q¶. 2’·–쌧ˆ¢’q‘º•ÛŒ’ƒZƒ“ƒ^[. 3Œc‰ž‘å): ‘æ15‰ñ“ú–{‰uŠw‰ïŠwp‘‰ï (2005/1/21), Ž ‰ê. u‰‰W, p.80, 2005.

723081. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ž“ƒ}ƒEƒX‚É‚¨‚¯‚é, ‰–‰»ƒgƒŠƒuƒ`ƒ‹ƒXƒYˆŸ‹}«ŒoŒû“Š—^‚É‚æ‚é–ƉuŒn‚ւ̉e‹¿. Šp“c³Žj1, ’†–ì@Œ›2, ®–ìMO3, ‘ŠàVDŽ¡1 (1‰q¶. 2•Ÿ“‡Œ§Œ§–k•ÛŒ’•ŸŽƒŽ––±Š. 3ŒSŽR—Žq‘å): ‘æ75‰ñ“ú–{‰q¶Šw‰ï‘‰ï (2005/3/29), VŠƒ. “ú–{‰q¶ŠwŽGŽ, 60 (2): 244, 2005.

723082. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) •@•”‹z“ü”˜˜IŽÀŒ±‚É‚æ‚郃bƒNƒE[ƒ‹‚Ì”x“à“®‘Ô‚ÉŠÖ‚·‚錤‹†. H“¡—Yˆê˜N1, â–{‘×—1, ’†“‡Dl1, V’Ã’J^l1, Šp“c³Žj1, ²“¡•q•F1, “cŒûŒPO2, ¬¼il3, _ŽRé•F4, ‘ŠàVDŽ¡1 (1‰q¶. 2ŠÂ‹«‘ª’è‹ZpŒ¤‹†Š. 3“ú–{ì‹ÆŠÂ‹«‘ª’苦‰ï. 4ŽY‹ÆˆãŠw‘‡Œ¤‹†Š): ‘æ75‰ñ“ú–{‰q¶Šw‰ï‘‰ï (2005/3/29), VŠƒ. “ú–{‰q¶ŠwŽGŽ, 60 (2): 253, 2005.

723083. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “àŽ‹‹¾ôòÁ“ÅŒã‚̃Iƒ‹ƒgƒtƒ^ƒ‹ƒAƒ‹ƒfƒqƒhŽc—¯‚ɂ‚¢‚Ä. •Ð‹Ë—TŽj1, …–ìˆèŠG1, ŽR–{“NŽm1, ‘ŠàVDŽ¡2, –å˜e•”Ž1 i1ˆã‰q. 2‰q¶j: ‘æ75‰ñ“ú–{‰q¶Šw‰ï‘‰ï (2005/3/29), VŠƒ. “ú–{‰q¶ŠwŽGŽ, 60 (2): 257, 2005.

723084. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “àŽ‹‹¾ŽèpôòÁ“Åì‹Æ‚É‚¨‚¯‚鎺“àƒOƒ‹ƒ^[ƒ‹ƒAƒ‹ƒfƒqƒh”Z“x. …–ìˆèŠG1, •Ð‹Ë—TŽj1, ŽR–{“NŽm1, ‘ŠàVDŽ¡2, –å˜e•”Ž1 i1ˆã‰q. 2‰q¶j: ‘æ75‰ñ“ú–{‰q¶Šw‰ï‘‰ï (2005/3/29), VŠƒ. “ú–{‰q¶ŠwŽGŽ, 60 (2): 257, 2005.

723085. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒOƒ‹ƒ^ƒ‹ƒAƒ‹ƒfƒqƒh, ƒIƒ‹ƒgƒtƒ^ƒ‹ƒAƒ‹ƒfƒqƒhŒo‹C“¹”˜˜I‚É‚æ‚郉ƒbƒg”]’†ƒh[ƒpƒ~ƒ“”Z“x‚ւ̉e‹¿. ŽR–{“NŽm1, •Ð‹Ë—TŽj1, Šp“c³Žj2, …–ìˆèŠG1, ‘ŠàVDŽ¡2, –å˜e•”Ž1 i1ˆã‰q. 2‰q¶j: ‘æ75‰ñ“ú–{‰q¶Šw‰ï‘‰ï (2005/3/29), VŠƒ. “ú–{‰q¶ŠwŽGŽ, 60 (2): 257, 2005.

723086. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒJ[ƒ{ƒ“ƒuƒ‰ƒbƒN•@o“à”˜˜I‚É‚æ‚éƒ}ƒEƒXŒŒ’†ƒqƒXƒ^ƒ~ƒ“”Z“x‚̕ω»‚ɂ‚¢‚Ä. ¬—јa–ç1, ˆÉ“¡‹žŽq2, ˆäã—tŽq2, H“¡—Yˆê˜N1, Šp“c³Žj1, ²“¡•q•F1, ¬¼—ÇŽq3, ‘ŠàVDŽ¡1 (1‰q¶. 2—\–hˆãŠwŒn. 3‘—§ˆã–ò•iH•i‰q¶Œ¤‹†Š): ‘æ75‰ñ“ú–{‰q¶Šw‰ï‘‰ï (2005/3/29), VŠƒ. “ú–{‰q¶ŠwŽGŽ, 60 (2): 297, 2005.


<<–@ˆãŠw>>

mŠwp˜_•¶n

110044. [Œ´’˜] Three cases of sudden death due to butane or propane gas inhalation: analysis of tissues for gas components. ™]G–¾1, ²X–ØçŽõŽq1, ‹´–{çŽq1, ’|‰º—TŽj1, ‰iˆä’q‹I1, ’†‘º–Ίî1, ŒÃì—F1, Nishikawa T2, ŒIŒ´Ž—R1 (1–@ˆã. 2Division of Medico-chemical Analysis, Kyoritsu College of Pharmacyj: Forensic Science International, 143: 211-214, 2004.

220006. [€Œ´’˜] Y-STR‚̃nƒvƒƒ^ƒCƒv‰ðÍ. ‹´–{çŽq, ’†‘º–Ίî, ²X–ØçŽõŽq, ’|‰º—TŽj, ‰iˆä’q‹I, ™]G–¾, ŒÃì—F (–@ˆã): DNA‘½Œ^, 12: 257-260, 2004.

320004. [Ç—á•ñ] ‹¹•”Ž©Œã, ‹´‚©‚çì‚É”ò‚Ñ~‚è“MŽ€‚µ‚½1–UŒŸ—á. ŽR茒‘¾˜Y1,2, ‰iˆä’q‹I2,3, ˆ¢•”LK2, “yˆäŠ²—Y4, ‘å‹´‹³—Ç2,5,–{“cŽ–ç2,6, ‹e’r˜a“¿3, •Ÿ‰i—´”É2 (1’}”g–UŒŸƒZƒ“ƒ^[. 2“Œ‹ž“sŠÄŽ@ˆã–±‰@. 3–@ˆã. 4ˆï錧‰q¶Œ¤‹†Š. 5’}”gƒƒfƒJƒ‹ƒZƒ“ƒ^[. 6’}”g‘åŠwŽÐ‰ïŠwŒn): –@ˆã•a—, 10: 64-68,2004.

mŠw‰ïEŒ¤‹†‰ï“™n

723087. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Y-STR‚̃nƒvƒƒ^ƒCƒv‰ðÍ‚Æ‚»‚Ì–@ˆãŠw“I‰ž—p. ‹´–{çŽq1, ’†‘º–Ίî1, ²X–ØçŽõŽq1, ’|‰º—TŽj1, ˆ¢•”–@Žq2, ‰iˆä’q‹I1, ™]G–¾1, ŒÃì—F1 (1–@ˆã. 2•ÛŒ’‰q¶ê–åŠw‰@): “ú–{–@ˆãŠw‰ï (2004/6/3), ˆ®ì. “ú–{–@ˆãŠwŽGŽ, 58 (1): 97, 2004.

723088. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) LPƒKƒX‹zˆø‚É‚æ‚é’†“ÅŽ€—á. ²X–ØçŽõŽq1, ™]G–¾1, ’|‰º—TŽj1, ‹´–{çŽq1, ˆ¢•”–@Žq2, ‰iˆä’q‹I1, ’†‘º–Ίî1, ŒÃì—F1, ŒIŒ´Ž—R1 (1–@ˆã. 2•ÛŒ’‰q¶ê–åŠw‰@): “ú–{–@ˆãŠw‰ï (2004/6/3), ˆ®ì. “ú–{–@ˆãŠwŽGŽ, 58 (1): 102, 2004.

723089. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Š¥“®–¬‘¢‰e‚Å‘S‚­•`o‚³‚ê‚È‚©‚Á‚½‚Ñ‚Ü‚ñ«‹·ó‚ª‰ð–UŽž‚É”»–¾‚µ, ŠŒ©‚ª‘å‚«‚­˜¨—£‚µ‚½S‘Ÿ“Ë‘RŽ€—á. ‹g“c@“O2, ¡ˆä@Š°1, ’¬ˆä³l1, ŽR–{Ms1, ó—˜@–õ1, ‘Š”nˆêˆå1, ˜aò@“O2, ‰iˆä’q‹I3, ŒIŒ´Ž—R3 (1‹~–½. 2“à‡U. 3–@ˆã): “ú–{—Õ°‹~‹}ˆãŠw‰ï (2004/5/15), ‰¡•l. “ú–{—Õ°‹~‹}ˆãŠw‰ïŽGŽ, 7 (2): 200, 2004.

723090. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) eŽqŠÓ’è‚ÅŒ©‚¢o‚³‚ꂽY-STR‚Ì“Ë‘R•ÏˆÙ. ‹´–{çŽq1, ’†‘º–Ίî1, –xØN‘ã1, ˆ¢•”–@Žq2, ‰iˆä’q‹I1, ™]G–¾1, ŒÃì—F1, ŒIŒ´Ž—R1 (1–@ˆã. 2•ÛŒ’‰q¶ê–åŠw‰@): “ú–{DNA‘½Œ^Šw‰ï(2004/12/2), ‰¡•l. “ú–{DNA‘½Œ^Šw‰ï‘æ13‰ñŠwpW‰ï—\eW, p.77, 2004.

733016. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ˆÙ󎀑̂ƖUŒŸƒVƒXƒeƒ€ i10j H“¹ú”j‚𗈂µ‚½‹¹•”‘å“®–¬áŽ‚̈ê—á. ‰iˆä’q‹I1, ‹´–{çŽq1. ŒÃì—F1, ™]G–¾1, ’†‘º–Ίî1, ˆ¢•”–@Žq2, –xØN‘ã1, ¡ˆä@Š°3, ŒIŒ´Ž—R1 (1–@ˆã. 2•ÛŒ’‰q¶ê–åŠw‰@. 3‹~–½): “ú–{–@ˆãŠw‰ï‹ãB’n•û‰ï (2004/10/9), ‹{è. —\eW, p.15, 2004.

733017. [Šw‰ï (’n•û‰ï)] (ˆê”Êu‰‰) DYS389‚É”F‚ß‚ç‚ꂽ“Ë‘R•ÏˆÙ‚Ì1—á. ‹´–{çŽq1, ’†‘º–Ίî1, ‰iˆä’q‹I1, –xØN‘ã1, ˆ¢•”–@Žq2, ™]G–¾1, ŒÃì—F1, ŒIŒ´Ž—R1 (1–@ˆã. 2•ÛŒ’‰q¶ê–åŠw‰@): “ú–{–@ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2004/11/20), “Œ‹ž. —\eW, p.45, 2004.


<<ŽÀŒ±“®•¨Šw>>

mŠwp˜_•¶n

110045. [Œ´’˜] Unfolded protein response is involved in the pathology of human congenital hypothyroid goiter and rat non-goitrous congenital hypothyroidism. M Baryshev1, E Sargsyan1, G Wallin2, A Lejniek3, ŒÃŠÚêˆê4, A Hishinuma5, S Mkrtchian1 (1ƒJƒƒŠƒ“ƒXƒJŒ¤‹†Š. 2ƒJƒƒŠƒ“ƒXƒJ•a‰@. 3ƒXƒgƒ‰ƒ“ƒWƒFƒWƒƒ‘å. 4ŽÀ“®. 5àÕ‹¦ˆã‘å): J Mol Endocrinol, 32 (3): 903-920, 2004.

110046. [Œ´’˜] Effect of thyroxine on abnormal pancreatic proteomes of the hypothyroid rdw rat. Satoh M1, Haruta-Satoh E1, Omori A2, Oh-Ishi M1, Kodera Y1, ŒÃŠÚêˆê3, Maeda T1 (1—Šw•”. 2ŽO•H‰»Šw¶–½Œ¤. 3ŽÀ“®): Proteomics, 5: 113-1124, 2005.

210015. [’Z•ñ] Delayed persistent estrus induced by continuous lighting after inadequate acclimation in rats. ŒÃŠÚêˆê1, Akira Takahashi1, Mamoru Takagi1, ŒK“c³L2 (1ŽÀ“®. 2‘ãŽÓE’`”’): Exp Anim, 54 (1): 93-95, 2005.

m’˜@‘n

620021. [ŠwpŽ] (•ª’SŽ·•M) ˆâ“`ŽqˆãŠwMOOK 2†uŽ¾Š³ƒvƒƒeƒIƒ~ƒNƒX‚ÌÅ‘Oü|ƒvƒƒeƒIƒ~ƒNƒX‚Å•a‹C‚ðŽ¡‚¹‚é‚©v; ‘æ6Í@“®•¨Ž¾Š³ƒ‚ƒfƒ‹@4. Ž¾Š³ƒ‚ƒfƒ‹“®•¨‚É‚æ‚éƒvƒƒeƒIƒ~ƒNƒX‚Ì—L—p«, p.70-75. ‘åγ“¹1, ¬Ž›‹`’j1, ‘O“c’‰Œv1, ŒÃŠÚêˆê2 (1—Šw•”. 2ŽÀ“®): •ÒW ŒË“c”N‘, r–Ø—ß], (Š”) ƒƒfƒBƒJƒ‹ƒhƒE, ‘åã, 2005/2”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

723091. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆâ“`«bó‘B‹@”\’ቺǃ‰ƒbƒgrdwäX‘Ÿ‚̃vƒƒeƒI[ƒ€‰ðÍ. ŒÃŠÚêˆê1, ²“¡@Žç2, ‘åγ“¹2 (1ŽÀ“®, 2—Šw•”): ‘æ51‰ñ“ú–{ŽÀŒ±“®•¨Šw‰ï‘‰ï (2004/5/21-22), ’·è. Exp. Anim., 53 (3): 272, 2004.

723092. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) bó‘B‹@”\•s‘Sƒ‚ƒfƒ‹ƒ‰ƒbƒgrdw‚Ì•›t‚É‚¨‚¯‚鎾Š³ƒvƒƒeƒI[ƒ€‰ðÍ. ‘åγ“¹1, ‘åâ^‹NŽq1, ²“¡@Žç1, ¬Ž›‹`’j1, ‘O“c’‰Œv1, ŽðˆäNO2, ŒÃŠÚêˆê3 (1—Šw•”, 2‰ð–U, 3ŽÀ“®): ‘æ2‰ñƒqƒgƒvƒƒeƒI[ƒ€Šw‰ï (2004/5/19), “Œ‹ž.

733018. [Œ¤‹†‰ï] (ƒ|ƒXƒ^[) bó‘B‹@”\’ቺ‚ÌäX‘Ÿ‚ւ̉e‹¿. ²“¡@Žç1, ²“¡ (t“c) Œb—¢1, ‘åX@•j2, ‘åγ“¹1, ¬Ž›‹`’j1, ŒÃŠÚêˆê3, ‘O“c’‰Œv1 (1—Šw•”. 2ŽO•H‰»Šw. 3ŽÀ“®j: ‘æ2‰ñŽ¾Š³ƒvƒƒeƒI[ƒ€Œ¤‹†‰ï (2004/8/2), –k—¢‘åŠw—Šw•”.

733019. [Œ¤‹†‰ï] (ƒ|ƒXƒ^[) bó‘B‹@”\•s‘Sƒ‚ƒfƒ‹ƒ‰ƒbƒgrdw•›t‚É‚¨‚¯‚鎾Š³ƒvƒƒeƒI[ƒ€‰ðÍ. ‘åγ“¹1, ‘åâ^‹NŽq1, ²“¡@Žç1, ¬Ž›‹`’j1, ‘O“c’‰Œv1, ŽðˆäNO2, ŒÃŠÚêˆê3 (1—Šw•”. 2‰ð–U. 3ŽÀ“®): ‘æ2‰ñŽ¾Š³ƒvƒƒeƒI[ƒ€Œ¤‹†‰ï (2004/8/2), –k—¢‘åŠw—Šw•”.

733020. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒvƒƒeƒI[ƒ€‚É‚æ‚é“œ”A•a‚Ì•a‘Ô‰ðÍ–@‚ÌŠJ”­. ‘O“c’‰Œv1, ‘åγ“¹1, ”nêŽu˜Y2, ŒÃŠÚêˆê3, ¼è›š—Y4, ‘åX@•j4, ‰Í–ìr”V4 (1—Šw•”. 2”å”A. 3ŽÀ“®. 4ŽO•H‰»Šw): •¶•”ȉȊwŒ¤‹†”ï•â•‹à, “Á’茤‹†‚buƒQƒmƒ€v4—̈懓¯”ljï‹c (2004/8/20), _ŒË.


<<–ƉuŠw>>

mŠwp˜_•¶n

110047. [Œ´’˜] Clonality analysis of Tcells mediating acute and chronic rejection in kidey allografts. Obata F, Yoshida K, Ikeda Y, Ohkubo M, Saito T, Takeuchi Y, ŽÂŒ´MŒ«1, Endo T, Baba S (1–Ɖu) : Transplant Immunol, 13: 233-237, 2004.

110048. [Œ´’˜] Prominent dominant negative effect of a mutant Fas molecule lacking death domain on cell-mediated induction of apoptosis. ‰¡“c@Ê1, Takeuchi E, Iizuka M, Ikegami Y, Takayama H, ŽÂŒ´MŒ«1 (1–Ɖu) : Mol Immunol, 42: 71-78, 2005.

110049. [Œ´’˜] Anti-Fas antibody-induced maturation of dendritic cell is mediated through FcƒÁreceptor. Oikawa A, ]“‡k“ñ1, ŽÂŒ´MŒ«1 (1–Ɖu): Kitasato Med J, 34: 21-26, 2005.

110050. [Œ´’˜] Contribution of ‚b‚c4+ and ‚b‚c8+ T cells and interferon-gamma to the progress of chronic rejection of kidney allografts: the Th1 response mediates both acute and chronic rejection. Obata F, Yoshida K, Ohkubo M, Ikeda Y, Taoka Y, Takeuchi Y, ŽÂŒ´MŒ«1, Endo T, Baba S (1–Ɖu): Transplant Immunmol, 14: 21-25, 2005.


<<¶•¨Šw>>

mŠw‰ï˜_•¶n

723093. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “ú–{‚É•ª•z‚µ‚Ä‚¢‚éƒcƒ`ƒKƒGƒ‹Rana rugosa‚ÌŠjŒ^E«õF‘̂ɂ‚¢‚Ä. —´è³Žm1, ‘ë‘ò’¼’è2 (1¶•¨. 2ˆê”Ê‹³ˆç•”): “ú–{—¼¶—ÞŒ¤‹†‰ï (2004/7/31), VŠƒŽs. —¼¶—ÞŽ, 13: 36, 2004.


ˆãŠwŒ´˜_Œ¤‹†•”–å

mŠwp˜_•¶n

520023. [‘à] ƒqƒgƒNƒ[ƒ“ãó‚Ìlˆ×“I쬂ƒ…°‘Of’f: l‚ªƒqƒg‚ð—˜—pEŽ¡—ÃE‘I•Ê‚·‚邱‚Æ. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): •ŽYŽGŽ, 58 (4): 6-7, 2004.

520024. [‘à] ¶Bˆã—Âð‚ß‚®‚é—Ï—–â‘è: •s”DŽ¡—ÂÆo¶‘Of’f‚ð‚ß‚®‚鉿’l‚Ì‘ŠŽ. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): ¬l•a‚ƶŠˆKŠµ•a, 34 (5): 706-707, 2004.

520025. [‘à] Š³ŽÒ‚Æ‚µ‚Ä‚ÌV¶Ž™E‚»‚Ì‚Q. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): •ŽYŽGŽ, 58 (6): 6-7, 2004.

520026. [‘à] Š³ŽÒ‚³‚Ü‚Æ‚¨ˆãŽÒ‚³‚Ü: ŒäŠ÷‰ºEŒäŽ˜Žj‚Æ‹L‚·•¶‰»‚Ì’†‚Å. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): •ŽYŽGŽ, 58(8): 6-7, 2004.

520027. [‘à] ’†â‘ÙŽ™”pŠü, ƒNƒ[ƒ“ãó—e”F, ’…°‘Of’f—e”F. 2004”N‰Ä‚Ì‚Í‚¶‚ß‚É. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): •ŽYŽGŽ, 58 (10): 6-7, 2004.

520028. [‘à] —‘Žq“€Œ‹, —‘‘ƒˆÚA, —‘Žq’ñ‹Ÿ: Ž©•ª‚Ì‚½‚ß‚É, ‘¼l‚Ì‚½‚ß‚É, ˆãŠw‚Ì‚½‚ß‚É. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): •ŽYŽGŽ, 58 (12): 6-7, 2004.

520029. [‘à] ˆãŠwŒ¤‹†‚Ìg•ïŠ‡“¯ˆÓh‚ɂ‚¢‚Äl‚¦‚é. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): ŒöO‰q¶, 69 (1): 55-58, 2005.

520030. [‘à] TDMŒ¤‹†‚Æ–ò•¨“®‘ÔŽŽŒ±‚É‚¨‚¯‚é‰ÈŠw‚Æ—Ï—«TDMŒ¤‹†‚ƶ–½—Ï—. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): TDMŒ¤‹†, 22 (2): 61-62, 2005.

521016. [Œ¤‹†•ñ] (Œú¶˜J“­È) ƒqƒgãó‚ÌŒ¤‹†‘̧‚ÉŠÖ‚·‚錤‹†: ”z‹ôŽqEãó‚Ì’ñ‹ŸŒó•âŽÒ‚ɑ΂·‚éƒqƒAƒŠƒ“ƒO’²¸. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): Œú¶˜J“­‰ÈŠw“Á•ÊŒ¤‹†Ž–‹Æ•ª’SŒ¤‹†•ñ‘, p.38-45, 2005.

mŠw‰ïEŒ¤‹†‰ï“™n

722009. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) TDMŒ¤‹†‚ƶ–½—Ï—. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): ‘æ21‰ñ“ú–{TDMŠw‰ïƒVƒ“ƒ|ƒWƒEƒ€ (2004), ç—¢.

722010. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) lH”DP’†â‚Æ–@F‘ÙŽ™Eƒqƒgãó‚ªgˆã—ÃŽ‘Œ¹h‚ƂȂ鎞‘ã‚É. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): ‘æ23‰ñ“ú–{ˆãŠw“NŠwE—Ï—Šw‰ïƒVƒ“ƒ|ƒWƒEƒ€ (2004), “Œ‹ž.

722011. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) —Ï—R¸ˆÏˆõ‰ï‚ÌŒ»ó, ‰¼‘è, –¢—ˆ. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): “ú–{¶–½—Ï—Šw‰ï‘æ16‰ñ”NŽŸ‘å‰ïƒ[ƒNƒVƒ‡ƒbƒv (2004), ’¹Žæ.

722012. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ˆãŠwŒ¤‹†—Ï—R¸‚ÌŽÀÛ. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï—Ï—ˆÏˆõ‰ïƒtƒH[ƒ‰ƒ€ (2004), ‹ž“s.

723094. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —Õ°ŽÀK‚É‚¨‚¯‚éˆã‚Ì—Ï—‹³ˆç. “ŒŒ´³–¾1, âV“¡—L‹IŽq2 (1“à‡W. 2ˆãŠwŒ´˜_): ‘æ63‰ñ“ú–{ŠàŠw‰ï (2004), •Ÿ‰ª.

731005. [Œ¤‹†‰ï] (“Á•Êu‰‰) —Õ°Œ¤‹†‚É‚¨‚¯‚éŒÂlî•ñ•ÛŒì‚Æ—Ï—. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): NPO–@l¼“ú–{‹¹•”Žîᇌ¤‹†‹@\ iWJTOGj (2005), ‘åã.

732009. [Œ¤‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€) ˆã—ÃEˆãŠwŒ¤‹†‚É‚¨‚¯‚é—Ï—Žwj‚ÆŒÂlî•ñ•ÛŒì. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): ŽœŒb‘åŠw•‘®4•a‰@‡“¯ƒŠƒXƒNƒ}ƒlƒWƒƒ“ƒgƒVƒ“ƒ|ƒWƒEƒ€ (2005), “Œ‹ž.

733021. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) lH”DP’†â‚ð‚ß‚®‚éˆã—ÃE—Ï—E§“x. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): “ú–{ˆãŠw“NŠwE—Ï—Šw‰ïŠÖ“ŒŽx•”—á‰ï (2004), “Œ‹ž.

733022. [Œ¤‹†‰ï] (ˆê”Êu‰‰) o¶‘OŒŸ¸‚Æ—«‚ÌŽ©ŒÈŒˆ’è. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): 21¢‹I“ú–{‚Ìd—v”‰Û‘è‚Ì‘‡“I”cˆ¬‚ð–ÚŽw‚·ŽÐ‰ï“NŠw“IŒ¤‹†‰ï (2004), ‹ž“s.

733023. [Œ¤‹†‰ï] (ˆê”Êu‰‰) —Õ°Œ¤‹†‚Ì—Ï—. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): “ú–{ŠwpU‹»‰ïƒvƒƒWƒFƒNƒgŒ¤‹†Ž–‹Æ(2005), å‘ä.

733024. [Œ¤‹†‰ï] (Šî’²u‰‰) l‚Ì”]‚Í, l‚Ì”]‚É, ‚Ç‚±‚Ü‚ÅŽ©ŒÈŒ¾‹y‚Å‚«‚é‚Ì‚©@”]‰ÈŠw‚Æ–@E—Ï—. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): JST‘æ1‰ñu”]_Œo‰ÈŠw‚Æ—Ï—vƒ[ƒNƒVƒ‡ƒbƒv (2005), “Œ‹ž.

733025. [Œ¤‹†‰ï] (ˆê”Êu‰‰) •wl‰È‚ð‚ß‚®‚鶖½—Ï—. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): •wl‰È•¶‰»˜_Œ¤‹†‰ï (2005), “Œ‹ž.

733026. [Œ¤‹†‰ï] (ˆê”Êu‰‰) —Õ°Œ¤‹†‚Ì—Ï—. âV“¡—L‹IŽq (ˆãŠwŒ´˜_): “ú–{ŠwpU‹»‰ïƒvƒƒWƒFƒNƒgŒ¤‹†Ž–‹Æ (2005), å‘ä.


<<“à‰ÈŠw‡TiÁ‰»Ší“à‰ÈŠwj

mŠwp˜_•¶n

110051. [Œ´’˜] Serum alanine transferase and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus-associated liver cirrhosis. Kazuo Tarao, Yasushi Rino, Shioji Takemiya, Shinichi Ohkawa, Kaoru Miyakawa, Setsuo Tamai, ‹g“c@‹I2, š •ª–ΔŽ1, Š`“c@Í2 (1“à‡T. 2ŠO): Cancer Sci, 94: 1083-1090, 2004.

110052. [Œ´’˜] Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. Miyachi K, Hankins RW, Matsushima H, Kikuchi F, Inomata T, Horigome T, Shibata M, Onozuka Y, Ueno Y, Hashimoto E, Hayashi N, a’J–¾—²1, Miyakawa H (1“à‡T): Journal of Autoimmunity, 20 (3): 247-254, 2004.

110053. [Œ´’˜] Randomized Phase II Study Comparing Mitomycin, Cisplatin Plus Doxifluridine with Cisplatin Plus Doxifluridine in Advanced Unresectable Gastric Cancer. ¬ò˜aŽO˜Y1, Fukuyama Y2, Fkuda T3, Akiya T3, Hasegawa K4, Kojima Y5, Ohno N6, Kurihara M7 (1“à‡T. 2Kimitsu Chuo Hospital. 3ŒQ”n‚ª‚ñƒZƒ“ƒ^[•a‰@. 4Tsuboi Hospital. 5“Œ–M‘åE‘åX•a‰@. 6’†ŠO»–ò. 7º˜a‘åE–LF•a‰@): Anticancer Reserch, 24: 2465-2470, 2004.

110054. [Œ´’˜] Melanodin, a Food protin-Derived Advanced Maillard Reaction Product, Suppresses Helicobacter pylori in vitro and in vivo. Hiromoto S, Itoh K, Shizuuchi Y, Morishita Y, Nagase M, Suzuki Y, Nobuta Y, Sudou Y, Nakamura O, Kagaya I, Gosima H, Kodama Y, Icatro FC, ¬ò˜aŽO˜Y1, ¼Œ³Ž›ŽâX1, Miura S, Sugiyama T, Kimura N. (1“à‡T): Helicobacter, 9 (5): 429-435, 2004.

110055. [Œ´’˜] Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer. ¬ò˜aŽO˜Y1, Minoru Kurihara2, Koichi Hasegawa3, Akimiti Chonan4, Yasuhiko Kubo5, Ryuichiro Maekawa6, Ryozo Iwasaki7, Tadashi Sasai8, Yoshio Fukuyama9, Kunitsugu Ishikawa10, Kazuo Miyoshi11, Koichi Yasutake12, Makoto Hayakawa13 (1“à‡T. 2º˜a‘åE–LF•a‰@. 3Tsuboi Hospital. 4Sendai open Hospital. 5‘å–´“cŽs—§•a‰@. 6Shakai-Hoken Tagawa Hospital. 7‡“V“°‘å. 8National Okayama Hospital. 9ŒN’Ã’†‰›•a‰@. 10“ŒŽD–y•a‰@. 11‚³‚¢‚½‚ÜÔ\Žš•a‰@. 12Hyogo Medical Center for Adults. 13Meitetsu Hospital); Oncology Reports, 12: 557-561, 2004.

110056. [Œ´’˜] Efficacy and Tolerability of Cancer Pain Management with Controlled-release Oxycodone Tablets in Opioid-naive Cancer Pain Patients, Starting with 5 mg Tablets. ¬ò˜aŽO˜Y1, Hiroshi Toma2, Ken-ichi Watanabe3, Kanji Katayama4, Masaaki Kawahara5, Kaoru Matsui6, Hiroya Takiuchi7, Kunitoshi Yoshino8, Nobuhito Araki9, Ken Kodama10, Hideyuki Kimura11, Ichiro Kono12, Hiroyasu Hasegawa13 , Kaoru Hatanaka14, Kazuaki Hiraga15, Fumikazu Takeda16 (1“à‡T. 2“Œ‹ž—ˆã‘å. 3“ú–{‘å. 4•Ÿˆäˆã‘å. 5National Kinki Central Hospital for Chest Diseases. 6Osaka Prefectural Habikkino Hospital. 7‘åãˆã‘å. 8Department of Otolaryngology, 9Department of Orthopedic Surgery and 10Department of Thoracic Surgery, Osaka Medical Center and Cardiovascular Diseases, Osaka, 11Okayama Saiseikai General Hospital. 12ìèˆã‘å. 13Tokuyama Central Hospital. 14‰––ì‹`»–ò. 15National Cancer Center Hospita. 16é‹Êˆã‘å): Jpn J Clin Oncol, 34 (10): 608-614, 2004.

110057. [Œ´’˜] Phase I/II Study of Bi-weekly Irinotecan plus Cisplatin in the Treatment of Advanced Gastric Cancer. ¬ò˜aŽO˜Y1, M Kurihara2, A Satoh3, H Takiuchi4, “c•Ó@‘1, K Shimada, R Iwasaki5, ¼Œ³Ž›ŽâX1 (1“à‡T. 2The Tokyo Cooperative Oncology Study Group, 3Northern Yokohama Hospital, 4‘åãˆã‘å. 5Iwasaki Internal Medicine Clinic): Anticancer Research, 25: 1257-1262, 2005.

110058. [Œ´’˜] A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors. T. Saeki1, S. Takashima1, M. Terashima2, A. Satoh3, M. Toi, A. Osaki4, T. Toge4, S. Ohno5, N. Nomura6, Y. Fukyama7, ¬ò˜aŽO˜Y8, T. Taguchi9 (1Department of Clinical Research and Surgery, National Hospital Organization Shikoku Cancer Center. 2•Ÿ“‡ˆã‘å. 3º˜a‘åE‰¡•l–k•”•a‰@. 4L“‡‘å. 5National Hospital Organization Kyusyu Cancer Center. 6–kL“‡•a‰@. 7Kimitsu Cancer Hospital. 8“à‡T. 9Japan Society for Cancer Chemotherapy): International Journal of Clinical oncology, 10 (1): 51-57, 2005/2.

110059. [Œ´’˜] Usefulness of EMR with an oblique aspiration mucosectomy device compared with strip biopsy in patients with superficial esophageal cancer. “c•Ó@‘1, ¬ò˜aŽO˜Y1, ŽO•xO”V2, –k‘º@‹§1, “cŒ´‹v”üŽq1, Žs쇎q1, ”óŒûŸ•F1, ²X–Ø@“O1, ’†ŽR¸“T1, –Ø“cŒõL1, ¼Œ³Ž›ŽâX1 (1“à‡T. 2‘—§‘Š–ÍŒ´•a‰@): Gastrointestinal Endoscopy, 59 (4): 558-563, 2004.

110060. [Œ´’˜] Indication of endoscopic polypectomy for rectal carcinoid tumors and clinical usefulness of endoscopic ultrasonography. ¬—Ñ´“T1, Ÿ–””º‰h1, ‹gàV@”É1, ²“c”ü˜a1, ŒÜ\—’³L1, ¼Œ³Ž›ŽâX1, ‘å’J„³2 i1“à‡T. 2ŠOj: Diseases of the Colon and Rectum, 48 (2): 285-291, 2005.

110061. [Œ´’˜] Clinical usefulness of colonoscopic insertion of a decompression tube for obstructive colorectal cancer. ¬—Ñ´“T, ŒÜ\—’³L, ‹gàV@”É, Ÿ–””º‰h, ¼Œ³Ž›ŽâX i“à‡Tj: Digestive Endoscopy, 16(Suppl.): S70-72, 2004.

110062. [Œ´’˜] Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit. ¡ò@O1, –Ø“cŒõL1, ¼Šª@”Ž2, ‰œ–쇎q1, •Ð‰ª—Sˆê2, ‘Š”nˆêˆå2, ¼Œ³Ž›ŽâX1 (1“à‡T. 2‹~–½j: Pancreas, 28 (4): 369-373, 2004.

110063. [Œ´’˜] Dye spraying and magnifying endoscopy for dysplasia and cancer surveillance in ulcerative colitis. ²“c”ü˜a1, ŒÜ\—’³L1, ‹gàV@”É1, ¬—Ñ´“T1, Ÿ–””º‰h1, ¼Œ³Ž›ŽâX1, ‘å’J„³2, ‰ªˆÀ@ŒM3, ŽO•xO”V4 (1“à‡T. 2ŠO. 3•a—. 4‘—§‘Š–ÍŒ´•a‰@): Diseases of the Colon & Rectum, 47 (11): 816-1823, 2004.

110064. [Œ´’˜] Chemotherapy is More Active against Proximal than Distal Gastric Carcinoma. ”óŒûŸ•F1, ¬ò˜aŽO˜Y1, “c•Ó@‘1, ¼Œ³Ž›ŽâX1, Ajani JA2 (1“à‡T. 2Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Tex., USA): Oncology, 66: 269-74, 2004.

110065. [Œ´’˜] ‚hnfluence of Endoscopic Papillary Balloon Dilation and Endoscopic Sphincterotomy on Sphincter of Oddi Function: A Randomized Controlled Trial. ’|àVŽO‘ãŽq, –Ø“c–FŽ÷, –Ø“cŒõL, ¼Œ³Ž›ŽâX (“à‡T): Endoscopy, 36 (7): 631-637, 2004.

110066. [Œ´’˜] Validity study of a new diagnostic scale for drug -induced liver injury in Japan-comparison with two Previous scales. “nç²^², a’J–¾—² (“à‡T): Hepatology Research, 30: 148-154, 2004.

110067. [Œ´’˜] Risk factors of delay in restoration of hepatic reserve capacity and local recurrence: after radiofrequency ablation therapy for hepatocellular carcinoma. ¬–ìO“ñ, š •ª–ΔŽ, “ú‚@‰›, “nç²^², ’†‘ò‹MG, ¼Œ³Ž›ŽâX (“à‡T): Hepatology Resarch, 31: 172-177, 2005.

110068. [Œ´’˜] Difference in Clinicopathological Findings, Cell Kinetics and p53 Expression between Early Gastric Cancers With and Without Helicobacter pylori infection. ŽO‹´@~1,2, ŽO•xO”V3, “c•Ó@‘1, ¬ò˜aŽO˜Y1, ‹e’rŽj˜Y4, T. Ojima3, ‰ªˆÀ@ŒM2, ¼Œ³Ž›ŽâX1 (1“à‡T. 2•a—. 3‘—§‘Š–ÍŒ´•a‰@. 4ŠO): Hepato-Gastroenterology, 51: 1636-1640, 2004.

110069. [Œ´’˜] Argon Plasma Coagulation for the Treatment of Early Gastric Cancer. ‘ºã‹§l1,2, K Nishino1, A Inoue1, Y Takaoka1, K Iwasaki1, B Murakami1, “c•Ó@‘2 (1Murakami Memorial Hospital. 2“à‡T): Hepato-Gastroenterology, 51: 1658-1661, 2004.

110070. [Œ´’˜] Measuring Tumor Volume with Three-Dimensional Endoscopic Ultrasonography: an Experrimental and Clinical Study. “n•Ó–€–ç, –Ø“c–FŽ÷, ŽR“cŽŠl, ¼Œ³Ž›ŽâX (“à‡T): Endoscopy, 36: 972-975, 2004.

110071. [Œ´’˜] Characterization of ermB gene transposition by TN1545 and TN917 in macrolide-resistant streptococcus pneumoniae isolates. ‰«’îO1, S Kaieda1, H Yano1, ’†–ì—³ˆê1, •Ûâ”ü¶2, ‰ª–{—¹ˆê1, T Kobayashi3, ˆä㼋v1 (1”÷EŠñ. 2“à‡T. 3“Œ–k‘å): Journal of clinical microbiology, 43 (1): 168-173, 2005.

110072. [Œ´’˜] Effect of argon plasma coagulation in patients with upper Gastrointestinal active hemorrhage. H Komatsu1, Y Hara1, Y Naito1, •Ûâ”ü¶2, S yamanaka1, H Masuda1, K Imamura1 (1Department of Gastroenterology and cancer Examnation Center, Yokohama Municipal Citizens Hospital, 2“à‡T): Digestive Endoscopy, 17 (1): 13-16, 2005.

120008. [Œ´’˜] ƒVƒhƒj[ƒVƒXƒeƒ€‚Ì•]‰¿‚É•K—v‚ȈݶŒŸÞ—¿‚Ì‘å‚«‚³‚ɂ‚¢‚Ä‚ÌŒŸ“¢. •½“ˆ–ƒ—¢1, “c•Ó@‘1, ŽO•xO”V2, ²“c”ü˜a1, Ÿ–””º‰h1, ¼Œ³Ž›ŽâX1 (1“à‡T. 2‘—§‘Š–ÍŒ´•a‰@): Gastroenterological Endoscopy, 46 (10): 2261-2266, 2004.

120009. [Œ´’˜] ‹Ù‹}‘å’°“àŽ‹‹¾‚É‚¨‚¯‚é’¼Ž‹‰º‘å—Êôò–@‚Ì—L—p«‚ÌŒŸ“¢. ‹gàV@”É, Ÿ–””º‰h, ²“c”ü˜a, ¬—Ñ´“T, ŒÜ\—’³L, ¼Œ³Ž›ŽâX (“à‡T): “ú–{‘å’°ŒŸ¸Šw‰ïŽGŽ, 21 (1): 40-44, 2004.

210016. [€Œ´’˜] Pulsed-Field gel electrophoretic analysis of helicobacter pylori using restricton enzyme ECOR‡T. •Ûâ”ü¶1, “ü–ì“cˆê•F2, ’†–ì—³ˆê2, “c•Ó@‘1, ¬ò˜aŽO˜Y1, ¼Œ³Ž›ŽâX1, ˆä㼋v2 (1“à‡T. 2”÷EŠñ): Journal of Clinical Microbiology, 43 (2): 931-932, 2005.

210017. [€Œ´’˜] What is the standard of EUS guided FNA in Japan? –Ø“cŒõL1, Y Saito2 (1“à‡T. 2ƒIƒŠƒ“ƒpƒX): Digestive Endoscopy, 16 (Suppl.): S100-S103, 2004.

210018. [€Œ´’˜] Stent therapy for malignant esophago-gastroestinal stricture. –Ø“cŒõL1, “ˆ”ö@m2, ¼Œ³Ž›ŽâX1 (1“à‡T. 2ŠO): Digestive Endoscopy, 16 (Suppl.): S22-S23, 2004.

210019. [’Z•ñ] Hepatocellular carcinoma associated with idiopathic portal hypertension: Review of large nodules in seven non-cirrhotic portal hypertensive livers. “ú‚@‰›1, ‘å•”@½2, š •ª–ΔŽ1, a’J–¾—²1, ¼Œ³Ž›ŽâX1, ‰ªˆÀ@ŒM3 (1“à‡T. 2ˆã‰q. 3•a—): Journal of Gastroenterology and Hepatology, 20: 493-495, 2005.

220007. [€Œ´’˜] Crohn•a’·ŠúŒo‰ß—á‚Å‚Ì’°ŠÇ•a•Ï‚ɑ΂·‚é‰h—{—Ö@‚ÌŽ¡—ÃŒø‰Ê|–ò•¨—Ö@‚Æ‚Ì”äŠr‚ð’†S‚É|. ¬—Ñ´“T, Ÿ–””º‰h, ŒÜ\—’³L, ‹gàV@”É, ²“c”ü˜a, ¼Œ³Ž›ŽâX (“à‡T): ˆÝ‚Æ’°, 39 (2•Êü): 145-154, 2004.

220008. [€Œ´’˜] “àŽ‹‹¾“I‘å’°ƒ|ƒŠ[ƒv“Eœp‚É‚¨‚¯‚éƒNƒŠƒjƒJƒ‹ƒpƒX‚ÌŽŽ‚݂ɂ‚¢‚Ä. ‰¡ŽR@ŒO1, ‚‹´—T”V2 (1“à‡T. 2‚‹´“à‰ÈƒNƒŠƒjƒbƒN): “ú–{‘å’°ŒŸ¸Šw‰ïŽGŽ, 21 (2): 140-145, 2004.

220009. [€Œ´’˜] “WŠJŒ^“d‹Éj‚É‚æ‚éRFA‚Ì’ˆÓ“_‚¨‚æ‚ÑH•v|‘åŒ^“WŠJjRITA model 90‚ÌŽg—pŒoŒ±|. ¬–ìO“ñ, š •ª–ΔŽ, “nç²^², “ú‚@‰›, “y‹´@Œ’, ’†‘ò‹MG, ¼Œ³Ž›ŽâX (“à‡T): ˆãŠw‚Æ–òŠw, 52 (2): 203-205, 2004.

310001. [Ç—á•ñ] An extensive metabolizer with recurrent ulcer responding to high dose of lansoprazole. ”óŒûŸ•F1, “c•Ó@‘1, ’†ŽR¸“T1, ²X–Ø@“O1, ’·êÃ1, ¬ò˜aŽO˜Y1, ¼Œ³Ž›ŽâX1, •Ð“c‰Ä–ç2 (1“à‡T. 2ŠO): Hepatogastroenterology, 51: 774-776, 2004.

310002. [Ç—á•ñ] Reply to Baiocchi et al. Žs쇎q, “c•Ó@‘ i“à‡T): Endoscopy, 5 i36j: 460-461, 2004.

320005. [Ç—á•ñ] ’°ŠÇ”XŽî—l‹CŽîÇ (pneumatosis cystoids intestinalis). ¬—Ñ´“T, Ÿ–””º‰h, ŒÜ\—’³L (“à‡T): Gastoroenterological Endoscopy, 46 (11): 2436-2437, 2004.

320006. [Ç—á•ñ] Second Line Chemotherapy‚É‚Ä’˜Œø‚ª“¾‚ç‚ꂽ‘½”­«ŠÌ“]ˆÚ‚𔺂¤Øœ•s”\isˆÝŠà‚Ì1—á. ”óŒûŸ•F, ¬ò˜aŽO˜Y, “c•Ó@‘, ²X–Ø@“O, ’†ŽR¸“T, ¼Œ³Ž›ŽâX (“à‡T): Á‰»Ší“àŽ‹‹¾, 16 (12): 1850-1853, 2004.

320007. [Ç—á•ñ] äXŠÇ‘’_ŠÇá‘‚ðŒ`¬‚µ, ’˜–¾‚È”S‰t•ª”å‚É‚æ‚è•ÂÇ«‰©át‚ð’悵‚½äXŠÇ“à“û“ªŽîᇂÌ1—á. Ž‰ÆKŽq1,4, ’†–ìŽj˜Y1,4, ‰œ˜e—T‰î1,4, ŒŠàVNŽu1,4, ˜@Œ©ŒjŽO1, X–앶•q1, ‘å–ì@—²1,4, ’†ˆÀ–M•v2, ŽÂ“c­K2, ŒF–ØLŽ}3 (1ˆÉ¨Œ´‹¦“¯•a‰@Á“à. 2“¯ŠO. 3“¯•a—. 4“à‡T): Progress of Digestive Endoscopy, 64 (2): 142-143, 2004.

320008. [Ç—á•ñ] Œo”çŒoŠÌ“I“û“ªŠ‡–ñ‹ØØŠJp‚Ì1—á. ‘å–ì@—²1,2, ‰œ˜e—T‰î1,2, ‘OàV@”J1,2, ŒŠàVNŽu1,2, ˜@Œ©ŒjŽO1, X–앶•q1, ’†–ìŽj˜Y1,2 (1ˆÉ¨Œ´‹¦“¯•a‰@Á“à. 2“à‡T): Progress of Digestive Endoscopy, 65 (2): 114-115, 2004.

320009. [Ç—á•ñ] “àŽ‹‹¾‰º‚É‘å–Ô[“Up‚ðŽ{s‚µ“¾‚½‚—îŽÒúE«ˆÝ’×ᇂÌ1—á. r쌒‘¾˜Y1, ¬¼Oˆê1, Œ´@—R—¢Žq1, “à“¡‹g—²2, ŽR’†@–Î1, •Ûâ”ü¶2, ‘“c‰p–¾1, ¡‘º´Žq1 (1‰¡•lŽs—§Žs–¯•a‰@. 2“à‡T): ˜V”NÁ‰»Ší•a, 16 (2): 123-126, 2004.

420001. [—Õ°Ž¡Œ±] ‘Šú‘å’°Šà‚Ì[’B“xf’f‚¨‚æ‚ÑŽ¡—Ö@‘I‘ð‚É‚¨‚¯‚é’´‰¹”g“àŽ‹‹¾f’f‚Ì—Õ°“IˆÓ‹`. ¬—Ñ´“T, –Ø“cŒõL, Ÿ–””º‰h, ‹gàV@”É, ‰¡ŽR@ŒO, ²“c”ü˜a, ŒÜ\—’³L, ¼Œ³Ž›ŽâX (“à‡T): Gastoroenterological Endoscopy, 46 (9): 2132-2140, 2004.

510001. [‘à] The state-of-the-art of endoscopic treatment of colorectal stenosis in Japan: survey of participating institutions in endoscopy forum Japan. Shinji Tanaka1, ŒÜ\—’³L2 (1L“‡‘å. 2“à‡T): Digestive Endoscopy, 16 (Suppl.): S64-S65, 2004.

510002. [‘à] Endoscopic treatment of lower gastrointestinal strictures. ŒÜ\—’³L (“à‡T): Digestive Endoscopy, 16 (Suppl.): S62-S63, 2004.

510003. [‘à] Available options in chemotherapy for advanced gastric cancer: the current developments in Japan. ¬ò˜aŽO˜Y (“à‡T): Ashley Publications Ltd ISSN, 1465-1566, 2005.

520031. [‘à] ‚±‚ê‚©‚ç‚̈݊à‚Ìf’f‚ÆŽ¡—Ã. ¼Œ³Ž›ŽâX1, “n•Ó‰pL, ‹”ö‹±•ã, ‹g“c–κ, ŒFˆä_ˆê˜Y, ˆ¤b@F, ŽRŒûr°, ‘OŒ´Šì•F, –k“‡­Ž÷ (1“à‡T): ˆÝ‚Æ’°, 40 (1): 119-138, 2004.

520032. [‘à] ˜à@‚È‚º, ‚¢‚Ü Colitic Cancer‚È‚Ì‚©. Ÿ–””º‰h (“à‡T): Á‰»Ší“àŽ‹‹¾, 16 (7): 1118-1119, 2004.

520033. [‘à] Š´õ«’°‰Š‹^‚¢Ç—á‚É‚¨‚¯‚éˆê”Êf’f–@‚Æ’ˆÓ“_. ŒÜ\—’³L, ²“c”ü˜a, ¬—Ñ´“T, ‹gàV@”É, Ÿ–””º‰h (“à‡T): —Õà¬Á‰»Ší“à‰È, 19 (8): 1101-1107, 2004.

520034. [‘à] Á‰»ŠÇ”S–Œ‰ºŽîᇂÌXüf’f. ŒÜ\—’³L, ¬—Ñ´“T, ²“c”ü˜a, ‰œ–쇎q, ‹gàV@”É, Ÿ–””º‰h, ¼Œ³Ž›ŽâX (“à‡T): ˆÝ‚Æ’°, 39 i4j: 429-445, 2004.

520035. [‘à] ‰ŠÇ«’°Ž¾Š³‚ɑ΂·‚éŠg‘å“àŽ‹‹¾‚̈Ӌ` (2) Dysplasia (DALM) ‚ɑ΂·‚éˆÓ‹`. ŒÜ\—’³L, ²“c”ü˜a, ¬—Ñ´“T, ‹gàV@”É, Ÿ–””º‰h (“à‡T): Early Colorectal Cancer, 9 (2): 175-180, 2005.

520036. [‘à] –å–¬ˆ³˜´iÇ@f—ÃEŒ¤‹†‚ÌV‚½‚È“WŠJ B-RTO‚Ì“K‰ž‚ÆŒø‰Ê. š •ª–ΔŽ, “ú‚@‰› (“à‡T): ŠÌ’_äX, 49 (1): 79-86, 2004.

520037. [‘à] H“¹Ã–¬áŽ (–å–¬ˆ³˜´iÇ). ‘ºã‹§l, š •ª–ΔŽ (“à‡T): ŠÌ’_äX, 49 (5): 791-795, 2004.

520038. [‘à] ‹i‰Œ‚ÍŠÌŠàÄ”­‚̊댯ˆöŽq‚Å‚ ‚é. a’J–¾—² i“à‡Tj: ˆãŠw‚Ì‚ ‚ä‚Ý, 210 (12): 1013, 2004.

520039. [‘à] 5f-ƒkƒNƒŒƒIƒ`ƒ_[ƒ[. ’|“à“ÖŽq, a’J–¾—² (“à‡T): “ú–{—Õ°, 62 (‘11) L”͈͌Œ‰tE”A‰»ŠwŒŸ¸ –ƉuŠw“IŒŸ¸|‚»‚Ì”’l‚ð‚Ç‚¤“Ç‚Þ‚©|‘æ6”Å, 2004.

520040. [‘à] ‡V. Ž¡—ÂƗ\–h‚̉”\« 6. ˆÝŠà‰È‰»Šw—Ö@‚Ìi•à. ¬ò˜aŽO˜Y, ¼Œ³Ž›ŽâX (“à‡T): “ú–{“à‰ÈŠw‰ïŽGŽ, 94 (1): 85-91, 2005/1.

520041. [‘à] Á‰»ì—p (Œû‚©‚çH“¹‚Ü‚Å). ¬ò˜aŽO˜Y (“à‡T): ‚©‚炾‚Ì•sŽv‹c 21¢‹I‚ÌŒ’Nƒ}ƒKƒWƒ“, 1 (7): 1-4, 2004.

520042. [‘à] Ä”­EisˆÝŠà‚ɑ΂·‚éV‚µ‚¢‘½Ü•¹—p—Ö@ TS-1‚ðŠÜ‚ވ݊à‚Ì‘½Ü•¹—p—Ö@@1) ˆÝŠà‚ɑ΂·‚éTS-1{CDDP—Ö@. ¬ò˜aŽO˜Y, “c•Ó@‘, ”óŒûŸ•F, ²X–Ø@“O, ’†ŽR¸“T, ’·êÃ, “Œ@’q, ‰º“c‘ñ–ç, ¼‘º@Œ«, ’†’JŒ¤“l, ¼Œ³Ž›ŽâX (“à‡T): Japan Journal of Cancer and Chemotherapy, 31 (12): 1957-1961, 2004.

520043. [‘à] EUS-FNA‚É‚æ‚é”S–Œ‰ºŽîᇂ̊ӕÊ. –Ø“cŒõL, r–س—Y, ‹{àVŽj˜N, ‰œ˜e—T‰î, ˆÀ“¡@‹, X–ØOŽq, ‘OàV@”J, ‹e’nG•F, ’|àVŽO‘ãŽq, “n•Ó–€–ç, ‹ß“¡ˆê‰p, –Ø“c–FŽ÷, ¡ò@O, ¬—Ñ´“T, ŽR“cŽŠl, âŒû“NÍ, ¼Œ³Ž›ŽâX (“à‡T): Á‰»Ší“àŽ‹‹¾, 16 (8): 1267-1273, 2004.

520044. [‘à] f’f“IERCP|ERCP‰º×–EfE¶ŒŸ|. –Ø“cŒõL, ¡ò@O, ‹e’nG•F, ’|àVŽO‘ãŽq, ‹{àVŽj˜N, Šâˆä’m‹v, ‰œ˜e—T‰î, ˆÀ“¡@‹, X–ØOŽq, ‘OàV@”J, r–س—Y, “n•Ó–€–ç, ‹ß“¡ˆê‰p, –Ø“c–FŽ÷, ŽR“cŽŠl, âŒû“NÍ, ¼Œ³Ž›ŽâX (“à‡T): Á‰»Ší“àŽ‹‹¾, 17 (2): 148-156, 2005.

520045. [‘à] ’´‰¹”g“àŽ‹‹¾f’f ¡Œã‚Ì“WŠJ. –Ø“cŒõL, ¬—Ñ´“T, r–س—Y, X–ØOŽq, ˆÀ“¡@‹, ‹e’nG•F, ’|àVŽO‘ãŽq, ‹ß“¡ˆê‰p, “n•Ó–€–ç, ‘ºã‹§l, –Ø“c–FŽ÷, ¡ò@O, ŽR“cŽŠl, âŒû“NÍ, ¼Œ³Ž›ŽâX (“à‡T): ˆÝ‚Æ’°, 39 (12): 1651-1660, 2004.

520046. [‘à] ƒAƒ‹ƒSƒ“ƒvƒ‰ƒYƒ}‹ÃŒÅ (APC) ‚É‚æ‚éÄŽÜŽ¡—Â̌»‹µ‚Æ“W–]. “c•Ó@‘, –k‘º@‹§, ¼Œ³Ž›ŽâX (“à‡T): Gastroenterrological Endoscopy, 46 (11): 2391-2398, 2004.

520047. [‘à] ¬’°“®Ã–¬ŠïŒ`. ¬—Ñ´“T, Ÿ–””º‰h, ‹gàV@”É, ²“c”ü˜a, ŒÜ\—’³L, ¼Œ³Ž›ŽâX (“à‡T): Á‰»ŠíŠO‰È, 28 (1): 75-81, 2005.

520048. [‘à] ‚æ‚­‚݂鎾Š³‚ÌŒø—¦“I‚È—Õ°ŒŸ¸|‘å’°Šà|. ¬—Ñ´“T, ŒÜ\—’³L, Ÿ–””º‰h (“à‡T): medicina, 41 (5): 818-820, 2004.

520049. [‘à] “ÁW: “àŽ‹‹¾‚±‚ꂪŠî–{‚¾@‘å’°•a•Ï‚Ì’´‰¹”g“àŽ‹‹¾f’f. ¬—Ñ´“T, Ÿ–””º‰h, –Ø“cŒõL (“à‡T): Á‰»Ší“àŽ‹‹¾, 16 (3): 482-484, 2004.

520050. [‘à] ‰ŠÇ«’°Ž¾Š³|f—Â̖â‘è“_ ’°Œ‹Šj|. ¬—Ñ´“T, ²“c”ü˜a, ŒÜ\—’³L, Ÿ–””º‰h, ¼Œ³Ž›ŽâX (“à‡T): ŒŽŠ§ —Õଂƌ¤‹†@•Êû, 81 (9): 45-50, 2004.

520051. [‘à] •a‘œ‚ð•Ï‚¦‚â‚·‚¢E•Ç‚ÌL“W“x‚ª•Û‚½‚ê‚éEŽ¨‰îóŽîᇂÍlymphoma. ¡ò@O1, “ú”䌪ˆê1, “c•Ó@‘1, Ÿ–””º‰h1, ¼Œ³Ž›ŽâX1, ”äŠé”\Ž÷2 (1“à‡T. 2ŠO): Á‰»Ší“àŽ‹‹¾, 16 (6): ‘‘å† 983-984, 2004.

520052. [‘à] ICU‚É‚¨‚¯‚édÇ‹}«äX‰Š‚ɑ΂·‚éäXy‘f‘jŠQÜER¶ÜŽ‘±“®’—Ö@. ¡ò@O1, –Ø“cŒõL1, X–ØOŽq1, ˆÀ“¡@‹1, ‘OàV@”J1, ‹e’nG•F1, ’|àVŽO‘ãŽq1, ¼Šª@”Ž2, ‘Š”nˆêˆå2, ¼Œ³Ž›ŽâX1 (1“à‡T. 2‹~–½j: Á‰»Ší‰È, 39 (3): 294-299, 2004.

520053. [‘à] ‘å’°Šà“àŽ‹‹¾“IŽ¡—ÃŒã‚̃T[ƒxƒCƒ‰ƒ“ƒX–@. ²“c”ü˜a, ŒÜ\—’³L, ‹gàV@”É, ¬—Ñ´“T, Ÿ–””º‰h (“à‡T): ‘Šú‘å’°Šà, 8 (2): 109-114, 2004.

520054. [‘à] ‘å’°‚ÌŒŒŠÇ‘œ‚ªÁ‚¦‚½‚çF‘f‚ð‚©‚¯‚æ. ²“c”ü˜a, Ÿ–””º‰h (“à‡T): Á‰»Ší“àŽ‹‹¾, 16 (6): 1083, 2004.

520055. [‘à] Colitic Cancer‚ÆDysplasia‚ÌŒø—¦“I‚ÈŒ©‚‚¯•û. ²“c”ü˜a, ŒÜ\—’³L, Ÿ–””º‰h, ‹gàV@”É, ¬—Ñ´“T, ¼Œ³Ž›ŽâX (“à‡T): Á‰»Ší“àŽ‹‹¾, 16 (7): 1171-1180, 2004.

520056. [‘à] H“¹ŠàEˆÝŠàE‘å’°Šà‚ɑ΂·‚é–ò‚Æ‚»‚ÌŽg‚¢•û. ”óŒûŸ•F, ¬ò˜aŽO˜Y (“à‡T): ƒNƒŠƒjƒJ, 31 (4•Êû): 262-265, 2004.

520057. [‘à] ˆÝŠà‚Ìis“xf’f Œ´”­‘ƒ‚Ìis“xf’f. ”óŒûŸ•F, –Ø“cŒõL, “c•Ó@‘, ²X–Ø@“O, ’†ŽR¸“T, ‹e’nG•F, ¡ò@O, ¬ò˜aŽO˜Y, ¼Œ³Ž›ŽâX (“à‡T): —Õ°Á‰»Ší“à‰È, 19 (7): 815-824, 2004.

520058. [‘à] ‚¢‚Ü, ˆê”ʉȂƸ_‰È‚ª‚Ƃ蓾‚é˜AŒg•û–@‚ð’ñˆÄ‚µ‚Ü‚·. “nç²^² (“à‡T): ¸_ŠÅŒì, 8 (1): 49-55, 2004.

m’˜@‘n

620022. [Šwp‘] (•ª’SŽ·•M) Á‰»«’×á‡|ÅV‚ÌŽ¡—Ã|; Á‰»«’×ᇎ¡—ÂɎc‚³‚ꂽ21¢‹I‚̉ۑè, p.236-243. ¼Œ³Ž›ŽâX, “c•Ó@‘ (“à‡T), •ÒW 󳔎, ‚Ö‚é‚·o”Å, “Œ‹ž, 2004/6/20”­s.

620023. [Šwp‘] (•ª’SŽ·•M) ˆãŠw‚Ì‚ ‚ä‚Ý|Á‰»«’×á‡UPDATE|; Á‰»«’×ᇂ̈ێ—Ö@|œ‹Û—Ö@‚Æ‚Ì”äŠr|, p.435-439. ¼Œ³Ž›ŽâX (“à‡T), •ÒW “¡“cŸŽ¡, ˆãŽ•–òo”Å (Š”), “Œ‹ž, 2004/7/31”­s.

620024. [Šwp‘] (•ª’SŽ·•M) Á‰»Ší“àŽ‹‹¾Ž~ŒŒp; ‹Ù‹}“àŽ‹‹¾ŒŸ¸‚ÆŽ¡—Ö@‚Ì‘I‘ð: ¬’°E‘å’°Eãè–å•”, p.36-39. Ÿ–””º‰h, ‹gàV@”É (“à‡T), •ÒW ó–Ø@–Î iå‘äŠÈˆÕ•ÛŒ¯‘‡Œ’fƒZƒ“ƒ^[), ƒƒfƒBƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/4/1”­s.

620025. [Šwp‘] (•ª’SŽ·•M) ŠÌŽ¾Š³ƒŒƒWƒfƒ“ƒgƒ}ƒjƒ…ƒAƒ‹; • o‹¾, p.161-165. a’J–¾—² (“à‡T), •ÒW ŽÄ“c@ŽÀ, ŠÖŽR˜a•F, ŽR“ct–Ø, ˆãŠw‘‰@, “Œ‹ž, 2004/5”­s.

620026. [Šwp‘] (•ª’SŽ·•M) ŠÌŽ¾Š³ƒŒƒWƒfƒ“ƒgƒ}ƒjƒ…ƒAƒ‹; –ò•¨«ŠÌáŠQ, p.313-319. a’J–¾—² (“à‡T), •ÒW ŽÄ“c@ŽÀ, ŠÖŽR˜a•F, ŽR“ct–Ø, ˆãŠw‘‰@, “Œ‹ž, 2004/5”­s.

620027. [Šwp‘] (•ª’SŽ·•M) ŠÌŽ¾Š³ƒŒƒWƒfƒ“ƒgƒ}ƒjƒ…ƒAƒ‹; ƒAƒ‹ƒR[ƒ‹«ŠÌáŠQ, p.307-312. a’J–¾—² (“à‡T), •ÒW ŽÄ“c@ŽÀ, ŠÖŽR˜a•F, ŽR“ct–Ø, ˆãŠw‘‰@, “Œ‹ž, 2004/5”­s.

620028. [Šwp‘] (•ª’SŽ·•M) Ž¾Š³•ÊÅVˆ•û; ˆÝŠà, p.288-289. ¬ò˜aŽO˜Y (“à‡T), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2005/3/30”­s.

620029. [Šwp‘] (•ª’SŽ·•M: 3•Åj Á‰»Ší•af—à —Ç‚«ƒCƒ“ƒtƒH[ƒ€ƒhEƒRƒ“ƒZƒ“ƒg‚ÉŒü‚¯‚Ä; Á‰»ŠíŠà‚̉»Šw—Ö@, p.386-388. ¬ò˜aŽO˜Y (“à‡T), •ÒW uÁ‰»Ší•af—Ãv•ÒWˆÏˆõ‰ï, ˆãŠw‘‰@, “Œ‹ž, 2004/5/1”­s.

620030. [‚»‚Ì‘¼‚Ì’˜‘] (Šª“ªŒ¾EŠÄC) ƒJƒ“ƒvƒg’@—LŒø—áW, ¬ò˜aŽO˜Y (“à‡T). ŠÄC ¬ò˜aŽO˜Y, (Š”) ƒ„ƒNƒ‹ƒg–{ŽÐ, “Œ‹ž, 2004/3”­s.

620031. [Šwp‘] (•ª’SŽ·•Mj Á‰»Ší“àŽ‹‹¾NOW; ‘æ‡UÍ ˆÝE\“ñŽw’° 2. ˆÝŽ¾Š³‚ɑ΂·‚é’´‰¹”g“àŽ‹‹¾, p.74-79. –Ø“cŒõL, ‹e’nG•F, ¼Œ³Ž›ŽâX (“à‡T), •ÒW “cK‹v—Y, ¼ˆä•qK, “¡“c’¼F, –k–쳄, “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2004/5/25”­s.

620032. [Šwp‘] (•ª’SŽ·•M) ’´‰¹”g“àŽ‹‹¾ UP TO NOW; 3D-IDUS (3D-ERUS), p.184-189. –Ø“cŒõL, “n•Ó–€–ç (“à‡T), •ÒW ‘º“c—mŽq1, •õ@“OÆ2 (1ƒ€ƒ‰ƒ^ƒNƒŠƒjƒbƒN. 2“ŒŠC‘åE“à‰ÈŠwŒn), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004”­s.

620033. [Šwp‘] (•ª’SŽ·•Mj Á‰»Ší“àŽ‹‹¾ NOW; ‘æ‡UÍ@ˆÝE\“ñŽw’° 5. “àŽ‹‹¾“IŽ~ŒŒp, p.91-95. “c•Ó@‘, ¼Œ³Ž›ŽâX (“à‡T), •ÒW “cK‹v—Y, ¼ˆä•qK, “¡“c’¼F, –k–쳄, “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2004/5/25”­s.

620034. [Šwp‘] (•ª’SŽ·•M) Á‰»ŠíŽ¡—Ã“àŽ‹‹¾‚ÌŠî–{Žè‹Z ‰ü’ù‘æ2”Å; ‰ŠúŽ¡—ÂƎ~ŒŒ–@‚Ì‘I‘ð, p.158-165. “c•Ó@‘, ¼Œ³Ž›ŽâX (“à‡T), •ÒW “¡“c—Í–ç, ‹àŒ´o”Å, “Œ‹ž, 2004/5/28”­s.

620035. [Šwp‘] (•ª’SŽ·•Mj GERDŽ¡—ÂÌV‚½‚ȃXƒgƒ‰ƒeƒW[; GERD‚É‚¨‚¯‚éˆÝŽ_•ª”å”\‚¨‚æ‚шݔro”\‚©‚ç‚Ý‚½ˆÝ‹@”\•]‰¿, p.36-41. “c•Ó@‘1, •Ð“c‰Ä–ç2, ¼Œ³Ž›ŽâX1 (1“à‡T. 2ŠO), •ÒW –{‹½“¹•v (“Œ–k‘å•a‰@), æ’[ˆãŠwŽÐ, “Œ‹ž, 2004”­s.

620036. [Šwp‘] (•ª’SŽ·•Mj ’´‰¹”g“àŽ‹‹¾ UP TO NOW; ‘å’°Šà‚Ì3D-EUSf’f, p.136-139. ¬—Ñ´“T, –Ø“cŒõL (“à‡T), •ÒW ‘º“c—mŽq1, •õ@“OÆ2 (1‘º“cƒNƒŠƒjƒbƒN. 2“ŒŠC‘åE“à‰ÈŠwŒn), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004”­s.

620037. [Šwp‘] (•ª’SŽ·•Mj ã•”Á‰»ŠÇŽ¾Š³‚ð’T‚é; ‘˜_‡C ã•”Á‰»ŠÇŽ¾Š³‚Ì–âf‚Æg‘ÌŠŒ©‚Ì‚Æ‚è•û, p.15-17. ¡ò@O, ¼Œ³Ž›ŽâX (“à‡T), •ÒW •õ@“OÆ i“ŒŠC‘åE“à‰ÈŠwŒnj, ‰iˆä‘“X, ‘åã, 2004/11/8”­s.

620038. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ƒƒ“ƒ|ƒCƒ“ƒgƒAƒhƒoƒCƒX Á‰»Ší“àŽ‹‹¾‚̃gƒ‰ƒuƒ‹–hŽ~ƒ}ƒjƒ…ƒAƒ‹; “àŽ‹‹¾“IH“¹Ã–¬áŽd‰»—Ö@Œã‚ÉcŠu‰Š‚ª”­Ç‚µ‚½, p.191. “ú‚@‰›, š •ª–ΔŽ (“à‡T), •ÒW –‹“à”ŽN, ŒFˆä_ˆê˜Y, àV“cr•v, •õ@“OÆ, “¡XF”Ž, ŠÄC —é–Ø”Žº, “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2004/10”­s.

620039. [Šwp‘] (•ª’SŽ·•Mj Á‰»Ší‚Ì—Õ° (1344-3070); H“¹Šà‚ɑ΂·‚éŽOŽŸŒ³’´‰¹”gƒvƒ[ƒu‚Ì‹ÇŠi“W“xf’f, 7 (3): p.297-303. ‹e’nG•F, –Ø“cŒõL, ¼Œ³Ž›ŽâX (“à‡T), ƒ”ƒ@ƒ“ƒƒfƒBƒJƒ‹, 2004/6”­s.

620040. [Šwp‘] (•ª’SŽ·•Mj Ž¾Š³•ÊÅVˆ•û; “]ˆÚ«ŠÌŠà, p.350-351. ”óŒûŸ•F (“à‡T), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2005/3/30”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

711001. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Chemotherapy for Advanced Gastric Cancer in Japan. ¬ò˜aŽO˜Y (“à‡T): 19th WC-ISDS (2004/12/9), ‰¡•l.

711002. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Present status and future prospects of EUS-FNA technique. –Ø“cŒõL (“à‡T): ‘æ4‰ñ‘ä˜p’´‰¹”g“àŽ‹‹¾ƒVƒ“ƒ|ƒWƒEƒ€ (2004/12/19), ‘ä“ì.

712007. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) What is the Second-line Therapy of MCRC? ¬ò˜aŽO˜Y (“à‡T): International Society of Gastrointestinal Oncology (2004/7/9), •Ä‘.

712008. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Should Gastric Cancer be Done in the Community? ¬ò˜aŽO˜Y (“à‡T): International Society of Gastrointestinal Oncology (2004/7/9), •Ä‘.

712009. [Šw‰ï (‘Û)] (ƒ‰ƒCƒuƒfƒ‚ƒ“ƒXƒgƒŒ[ƒVƒ‡ƒ“) EUS Live Demonstration for colorectal cancer. ¬—Ñ´“T (“à‡T): 14th International Symposium on Endoscopic Ultrasonography (2004/11/13), “Œ‹ž.

713038. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Prospective study of magnifying colonoscopy for the surveillance of ulcerative colitis. ŒÜ\—’³L, ²“c”ü˜a, ¬—Ñ´“T, ‹gàV@”É, Ÿ–””º‰h, ¼Œ³Ž›ŽâX (“à‡T): 12th United European Gastroenterology week (2004/9/28), Prague.

713039. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Habitual smoking as a risk factor for distant recurrence of hepatocellular carcinoma after Radiofrequency Ablation therapy. a’J–¾—², ’†‘ò‹MG, “nç²^² (“à‡T): The American Association for the Study of Liver Diseases 55th Annual Meeting and Postgraduate Corses(2004/10/30), Boston. Hepatology, 40 (4 S.1): 2004.

713040. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Randomized control trial of EST with either endocut mode or conventional pure cutting current. –Ø“cŒõL, ‹e’nG•F, r–س—Y, ’|àVŽO‘ãŽq, ŽRèDŠì, ”’{‹±Žq, ‘“ŒŠ²•v, “nç²^², –Ø“c–FŽ÷, ¡ò@O, ¼Œ³Ž›ŽâX (“à‡T): ƒAƒƒŠƒJÁ‰»Ší•aTŠÔ (2004/5/18), ƒjƒ…[ƒIƒŠƒ“ƒY.

713041. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Three-dimensional endoscopic ultrasonography for diagnosing the local staging of esophageal cancer. –Ø“cŒõL, ‹e’nG•F, r–س—Y, “nç²^², ‹ß“¡ˆê‰p, ¡ò@O, âŒû“NÍ, ŽR“cŽŠl, ¼Œ³Ž›ŽâX (“à‡T): ƒˆ[ƒƒbƒpÁ‰»Ší•aTŠÔ (2004/9/28), ƒvƒ‰ƒn.

713042. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Risk factors and the mode for recurrence after radiofrequency ablation against primary single hepatocellular carcinoma. ’†‘ò‹MG, š •ª–ΔŽ, a’J–¾—², ¬–ìO“ñ, “y‹´@Œ’, “nç²^², “ú‚@‰›, ¼Œ³Ž›ŽâX (“à‡T): 12th UEGW (2004/9/25-29), ƒ`ƒFƒR. Endscopy, 36 (S.1): A255, 2004.

713043. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Clinical usefulness of endoscopic ultrasonography for the diagnosis of intestinal endometriosis. ‰¡ŽR@ŒO, ¬—Ñ´“T, –Ø“cŒõL, ŒÜ\—’³L, Ÿ–””º‰h, ¼Œ³Ž›ŽâX (“à‡T): 14th International symposium on endoscopic ultrasonography (2004/11/13), “Œ‹ž. Digestive Endoscopy, 16 (S.2): 66, 2004.

713044. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Chemotherapy is More Active against Proximal than Distal Gastric Carcinoma. ”óŒûŸ•F, ¬ò˜aŽO˜Y, “c•Ó@‘, ¼Œ³Ž›ŽâX (“à‡T): 12th UEGW (2004/9/25-29), Prague. Gut, 53 (S.6): A277, 2004.

722013. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ¬’°Ž¾Š³‚Ìf’f‚ÆŽ¡—Âɂ¨‚¯‚鬒°“dŽq“àŽ‹‹¾‚Ì—Õ°“I—L—p«. ¬—Ñ´“T, ŒÜ\—’³L, Ÿ–””º‰h (“à‡T): ‘æ90‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2004/4/22), å‘ä. “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 101 (—Õ‘): A125, 2004.

722014. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) ’_EäX—̈æ‚Å‚Ì‹ô”­Ç‚Æ‚»‚Ì‘Îô. ¡ò@O (“à‡T): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/26), ‹ž“s.

722015. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[j ‰ñ“]Ž®j撲ߋ@\•túŽhj|ƒŠƒ{ƒ‹ƒo[‚ðŽg‚Á‚½“àŽ‹‹¾“Id‰»—Ö@|. š •ª–ΔŽ (“à‡T): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/26), ‹ž“s. Gastroenterological Endoscopy, 46 (S.1): 801, 2004.

722016. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“EŽw’è) ŠÌ×–EŠà‚ɑ΂·‚郉ƒWƒI”g”M‹ÃŒÅ—Ö@Œã‚ÌŠÌ—\”õ”\‰ñ•œ’x‰„ˆöŽq‚ÆŽîᇌa•ÊÄ”­—¦‚ÉŠÖ‚·‚錟“¢. š •ª–ΔŽ, ¬–ìO“ñ, “ú‚@‰›, “nç²^², ’†‘ò‹MG (“à‡T): ‘æ40‰ñ“ú–{ŠÌŠàŒ¤‹†‰ï (2004/6/25), ‚‚­‚Î. ´˜^W, p.55, 2004.

722017. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šˆ“®«’×ᇫ‘å’°‰Š‚ɑ΂·‚錌‹…¬•ª‹z’…œ‹Ž—Ö@‚ÌŽ¡—ÃŒø‰Ê. ‰¡ŽR@ŒO, ¬—Ñ´“T, Ÿ–””º‰h (“à‡T): ‘æ46‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï iDDW-Japan 2004j (2004/10/21), •Ÿ‰ª. “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 101 (—Õ‘ S.): A415, 2004.

722018. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŽOŽŸŒ³’´‰¹”g“àŽ‹‹¾‚É‚æ‚éH“¹Šà‚Ì[’B“xf’f. –Ø“cŒõL, ‹e’nG•F, ¼Œ³Ž›ŽâX (“à‡T): ‘æ68‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/10/22), •Ÿ‰ª.

722019. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ØŠJ”—£–@‚É‚¨‚¯‚éV‚µ‚¢‚Žü”g“dŒ¹‘•’uVIO‚Ì—L—p«. “c•Ó@‘, ”óŒûŸ•F, ²X–Ø@“O (“à‡T): ‘æ68‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/10/23), •Ÿ‰ª.

722020. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘ŠúˆÝŠà‚ɑ΂·‚é“àŽ‹‹¾“I”S–ŒØœp‚ÌŽ¡—Ãí—ª|]—ˆ–@‚ÆØŠJ”—£–@‚É‚æ‚éƒe[ƒ‰[ƒƒCƒhŽ¡—Ã|. “c•Ó@‘, ”óŒûŸ•F, ²X–Ø@“O (“à‡T): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/27), ‹ž“s.

722021. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ‹•ŒŒ«‘å’°‰Š”­•a‘Šú‚Ì•aŒ^f’f‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ¬—Ñ´“T, Ÿ–””º‰h, ²“c”ü˜a, ‹gàV@”É, ŒÜ\—’³L, ¼Œ³Ž›ŽâX (“à‡T): ‘æ59‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï (2004/11/6), ‹v—¯•Ä. “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ, 57 (9): 541, 2004.

722022. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ‘å’°ŒeŽºoŒŒ‚ɑ΂·‚é‹Ù‹}“àŽ‹‹¾‰ºŽ~ŒŒp‚Ì—L—p«‚Æ–â‘è“_. ‹gàV@”É, Ÿ–””º‰h, t–Ø‘”ü, ²“c”ü˜a, ¬—Ñ´“T, ŒÜ\—’³L, ¼Œ³Ž›ŽâX (“à‡T): ‘æ22‰ñ“ú–{‘å’°ŒŸ¸Šw‰ï‘‰ï (2004/11), “Œ‹ž. ƒvƒƒOƒ‰ƒ€E´˜^W, 87, 2004.

723095. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Øœ•s”\4ˆÝŠà‚ɑ΂·‚鉻Šw—Ö@. ”óŒûŸ•F, ¬ò˜aŽO˜Y, ²X–Ø@“O, ’†ŽR¸“T, ’·êÃ, –k‘º@‹§, “c•Ó@‘, ¼Œ³Ž›ŽâX (“à‡T): ‘æ76‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2004/3/5), •ÄŽq.

723096. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) è÷—±‹…œ‹Ž—Ö@‚ª—LŒø‚¾‚Á‚½”DPŽž”­Ç‚Ì’×ᇫ‘å’°‰Š‚Ì1—á. ‰¡ŽR@ŒO1, ’r“à@“N2, —é–ØŒ÷ˆê2, ‰LŠ@ŽÀ2, ¯–ì˜a•F2 (1“à‡T. 2¬“cŒ´Žs—§•a‰@j: ‘æ90‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2004/4/22), å‘ä. “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 101 (—Õ‘ S.): 120, 2004.

723097. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¢‚ĉ»Šw—Ö@‚ðs‚Á‚½ŠO‰È“IØœ•s”\‚Ȉ««äX“à•ª”åŽîᇂÌ4—á. ‹e’nG•F, –Ø“cŒõL, ˆÀ“¡@‹, ’†’JŒ¤“l, X–ØOŽq, ‘OàV@”J, ’|àVŽO‘ãŽq, r–س—Y, ”’{‹±Žq, ŽRèDŠì, Ž­ŠÔL–¾, ‘“ŒŠ²•v, “n•Ó–€–ç, –Ø“c–FŽ÷, ¡ò@O, ¼Œ³Ž›ŽâX (“à‡T): ‘æ90‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2004/4/22), å‘ä. “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 101 (S.): A333, 2004.

723098. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰»Šw—Ö@‚É‚¨‚¯‚éˆÝŠàŒ´”­‘ƒ‚ÌĶ”S–ŒoŒ»‚̈Ӌ`. ¬ò˜aŽO˜Y, ŽRè‚¢‚¸‚Ý, ‹ß“¡ˆê‰p (“à‡T): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/26), ‹ž“s.

723099. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) 3D-EUS‚ÆEUS-FNA‚Ì—Õ°“I—L—p«‚ƈʒu‚¯. –Ø“cŒõL, r–س—Y, ¼Œ³Ž›ŽâX (“à‡T): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/26), ‹ž“s.

723100. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘ŠúˆÝŠà‚ÌEMR‚É‚¨‚¯‚é“àŽ‹‹¾“I‹zˆø”S–ŒØœ–@ iEAM–@j ‚ÆITƒiƒCƒt–@‚̈ʒu‚¯. “c•Ó@‘1, ”óŒûŸ•F1, ŽO•xO”V2 (1“à‡T. 2‘—§‘Š–ÍŒ´•a‰@): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/26), ‹ž“s.

723101. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) colitic cancer/dysplasia”­Œ©‚Ì‚½‚ß‚ÌŠg‘å“àŽ‹‹¾‚Ì—L—p«‚ÌŒŸ“¢. ²“c”ü˜a, ŒÜ\—’³L, Ÿ–””º‰h (“à‡T): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/26), ‹ž“s. “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 46 (—Õ‘ S.1): 506, 2004.

723102. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) H“¹•\ÝŠà‚ɑ΂·‚éEMR“K‰žŠg‘å‚̉”\«|m3sm1H“¹Šà‚ɑ΂·‚é“àŽ‹‹¾“I”S–ŒØœp iEMRj ‚Ì“K‰žŠg‘å|. ”óŒûŸ•F1, “c•Ó@‘1, ¬—ÑLs2 (1“à‡T. 2ŠO): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/26), ‹ž“s. “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 46 (S.): 1526, 2004.

723103. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ˆÝ‚ÌSMT‚É‚¨‚¯‚éEUS-FNA‚Ì–ðŠ„. r–س—Y, –Ø“cŒõL, ’†’JŒ¤“l, X–ØOŽq, ˆÀ“¡@‹, ‘OàV@”J, ‹e’nG•F, ’|àVŽO‘ãŽq, ‰F’Ö؋±Žq, ŽRèDŠì, ‘“ŒŠ²•v, “n•Ó–€–ç, ‹ß“¡ˆê‰p, –Ø“c–FŽ÷, ¡ò@O, ŽR“cŽŠl, âŒû“NÍ, ¼Œ³Ž›ŽâX (“à‡T): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/26), ‹ž“s.

723104. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒKƒCƒhƒƒCƒ„[Ž®ŽOŽŸŒ³’´‰¹”gƒvƒ[ƒuXUM-DG20-35R‚ÌŽg—pŒoŒ±. “n•Ó–€–ç, –Ø“cŒõL, ¼Œ³Ž›ŽâX (“à‡T): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/26), ‹ž“s.

723105. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘å’°“àŽ‹‹¾‘}“ü¢“ï—á‚ÌŒ´ˆö‚Æ‘Îô‚ɂ‚¢‚Ä. ‹gàV@”É, ŒÜ\—’³L, Ÿ–””º‰h (“à‡T): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/27), ‹ž“s.

723106. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) 3DƒIƒvƒVƒ‡ƒ“ iMAJ-1330j “‹Ú’´‰¹”gŠÏ‘ª‘•’uEU-M60/2000‚ð—p‚¢‚½’ÊíŒ^’´‰¹”g“àŽ‹‹¾‚É‚æ‚éŽOŽŸŒ³’´‰¹”g“àŽ‹‹¾ i3D-EUSj ‚ÌŽg—pŒoŒ±. ‹e’nG•F, –Ø“cŒõL, ˆÀ“¡@‹, ’†’JŒ¤“l, X–ØOŽq, ‘OàV@”J, ’|àVŽO‘ãŽq, r–س—Y, ”’{‹±Žq, ŽRèDŠì, Ž­ŠÔL–¾, ‘“ŒŠ²•v, “n•Ó–€–ç, –Ø“c–FŽ÷, ¡ò@O, ¼Œ³Ž›ŽâX (“à‡T): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/27), ‹ž“s.

723107. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰È‚É‚¨‚¯‚éäX“à•ª”åŽîᇂ̌Ÿ“¢. ˆÀ“¡@‹, –Ø“cŒõL, ’†’JŒ¤“l, X–ØOŽq, ‘OàV@”J, ‹e’nG•F, ’|àVŽO‘ãŽq, r–س—Y, ”’{‹±Žq, ŽRèDŠì, ‘“ŒŠ²•v, “n•Ó–€–ç, –Ø“c–FŽ÷, ¡ò@O, ¼Œ³Ž›ŽâX (“à‡T): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/27), ‹ž“s.

723108. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “àŽ‹‹¾“I“û“ªŠ‡–ñ‹ØØŠJp iESTj ‚É‚¨‚¯‚éƒGƒ“ƒhƒJƒbƒg–@‚Æ‚Žü”g“d—¬ØŠJ–@‚É‚æ‚érandomized control study. ’†’JŒ¤“l, –Ø“cŒõL, X–ØOŽq, ˆÀ“¡@‹, ‘OàV@”J, ‹e’nG•F, ’|àVŽO‘ãŽq, r–س—Y, ”’{‹±Žq, Ž­ŠÔL–¾, ŽRèDŠì, “n•Ó–€–ç, ¡ò@O, –Ø“c–FŽ÷, ¼Œ³Ž›ŽâX (“à‡T): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/27), ‹ž“s.

723109. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚鈫«’_“¹‹·ó‚ɑ΂·‚é“àŽ‹‹¾“IƒhƒŒƒi[ƒWp‚ÌŒŸ“¢. ŽRèDŠì, –Ø“cŒõL, ¼Œ³Ž›ŽâX (“à‡T): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/27), ‹ž“s.

723110. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚éã•”Á‰»ŠÇoŒŒ‚ɑ΂·‚é“àŽ‹‹¾“IŽ~ŒŒ–@‚̬тƎ¡—Ö@‚ɂ‚¢‚Ä. –k‘º@‹§, “c•Ó@‘, ¼Œ³Ž›ŽâX (“à‡T): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/27), ‹ž“s.

723111. [Šw‰ï (‘S‘)] (ƒrƒfƒIƒVƒ“ƒ|ƒWƒEƒ€) ˆÝ’ꕔ֬ᎎ¡—Â̕W€‰»|B-RTO‚Ìp‘O•]‰¿‚É‚¨‚¯‚éMR-angiography‚Ì—L—p«|. “ú‚@‰›, š •ª–ΔŽ1, ˆé•”‹`Œ›2 (1“à‡T. 2•ú): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï (2004/5/28), ‹ž“s. “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 46 (2): 1854, 2004.

723112. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’°ŠÇŽq‹{“à–ŒÇ‚Ì‰æ‘œŠŒ©‚Ì“Á’¥‚ÆŠÓ•Êf’f‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‰¡ŽR@ŒO1, ¬—Ñ´“T1, ŒÜ\—’³L1, Ÿ–””º‰h1, ¼Œ³Ž›ŽâX1, ‰ªˆÀ@ŒM2 (1“à‡T. 2•a—): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/28), ‹ž“s. “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 46 (—Õ‘ S.1): 685, 2004.

723113. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) •ÂÇ«¶‘¤‘å’°Šà‚ɑ΂·‚éŒoãè–å“I–ň³ƒ`ƒ…[ƒu‘}“üp‚Ì—Õ°“I—L—p«. t–Ø‘”ü, ¬—Ñ´“T, ‹gàV@”É, ²“c”ü˜a, ŒÜ\—’³L, Ÿ–””º‰h, ¼Œ³Ž›ŽâX (“à‡T): ‘æ67‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/5/28), ‹ž“s.

723114. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) CŒ^ŠÌd•ÏÇ iChild Aj ‚Å‚ÍALT80’PˆÊ–¢–ž‚ðˆÓŽ¯‚µ‚½‘½Ü•¹—p—Ö@‚ð‚àŠÜ‚ÞR‰ŠÇ—Ö@‚Í–{“–‚ÉŠÌ”­Šà—\–h‚É—LŒø‚©@(1) Ü“Š—^—Ö@‚Æ‚Ì”äŠrŒŸ“¢. ‘½—…”ö˜a˜Y, a’J–¾—²1, —˜–ì@–õ, ‹{ì@ŒO, ­–Ø—²”Ž, ã–ì@½, “V–ì•àŠw (1“à‡T): ‘æ40‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2004/6/3), ‰YˆÀ. ŠÌ‘Ÿ, 45 (S.): A202, 2004.

723115. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠÌŠà‰“ŠuÄ”­‚ɑ΂·‚é‹i‰Œ‚̉e‹¿. a’J–¾—², ‹Ê^r•½, ŒŠàVNŽu, ¬–ìO“ñ, “nç²^², “ú‚@‰›, “y‹´@Œ’, ’†‘ò‹MG, š •ª–ΔŽ, ¼Œ³Ž›ŽâX (“à‡T): ‘æ40‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2004/6/3), ‰YˆÀ. ŠÌ‘Ÿ, 45 (S.): A49, 2004.

723116. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠÌ×–EŠà‚ɑ΂·‚郉ƒWƒI”g”M‹ÃŒÅ—Ö@Œã‚ÌŽîᇌa•ÊÄ”­‹y‚ÑŠÌ—\”õ”\‰ñ•œ’x‰„ˆöŽq‚ÉŠÖ‚·‚錟“¢. ¬–ìO“ñ, š •ª–ΔŽ, “nç²^², “y‹´@Œ’, ’†‘ò‹MG, a’J–¾—², “ú‚@‰›, ¼Œ³Ž›ŽâX (“à‡T): ‘æ40‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2004/6/3), ‰YˆÀ. ŠÌ‘Ÿ, 45 (S.1): A59, 2004.

723117. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘ãž«ŠÌd•Ï‚É‚¨‚¯‚éŠÌ”­Šà‚̊댯ˆöŽq. ŒŠàVNŽu, a’J–¾—², ‹Ê^r•½, ¬–ìO“ñ, “nç²^², “ú‚@‰›, “y‹´@Œ’, ’†‘ò‹MG, š •ª–ΔŽ, ¼Œ³Ž›ŽâX (“à‡T): ‘æ40‰ñ“ú–{ŠÌŠàŒ¤‹†‰ï (2004/6/24), ‚‚­‚Î. ´˜^W, p.121, 2004.

723118. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) m3sm1H“¹Šà‚ɑ΂·‚é“àŽ‹‹¾“I”S–ŒØœp (EMR) ‚ÌŒŸ“¢. ”óŒûŸ•F1, “c•Ó@‘1, ²X–Ø@“O1, ’†ŽR¸“T1, –k‘º@‹§1, ¬ò˜aŽO˜Y1, ¼Œ³Ž›ŽâX1, ¬—ÑLs2 (1“à‡T. 2ŠO): ‘æ58‰ñ“ú–{H“¹Šw‰ï (2004/6/24), “Œ‹ž. ƒvƒƒOƒ‰ƒ€E´˜^W, p.172, 2004.

723119. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚éŠÌ–å•”’_ŠÇŠà‚ɑ΂·‚é“àŽ‹‹¾“IƒhƒŒƒi[ƒWp‚Ì—Õ°“IŒŸ“¢. X–ØOŽq, –Ø“cŒõL, ¼Œ³Ž›ŽâX (“à‡T): ‘æ68‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/10/21), •Ÿ‰ª.

723120. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) PTCDƒ‹[ƒg‚©‚çEST‚ðs‚Á‚½2—á. ‘å–ì@—²1,2, ‰œ˜e—T‰î1,2, ‘OàV@”J1,2, ŒŠàVNŽu1,2, ˜@Œ©ŒjŽO2, X–앶•q2, ’†–ìŽj˜Y1,2 (1“à‡T. 2ˆÉ¨Œ´‹¦“¯•a‰@j: DDW Japan 2004 i‘æ46‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ïj (2004/10/21-24), ”Ž‘½. “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽG, 46 (S.2): 1995, 2004.

723121. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ªŽ¡Žèp•s”\—á‚ÌÁ‰»ŠÇŠÔ—tŒnŽîᇠiGISTj •ªŽq•W“IŽ¡—ÖòƒCƒ}ƒ`ƒjƒu‚Ì—Õ°“IŽ¡—ÃŒø‰Ê‚ÌŒŸ“¢. “à“¡‹g—²1, Œ´@—R—¢Žq2, ¬¼Oˆê2, ŽR’†@–Î2, •Ûâ”ü¶1, ‘“c‰p–¾2, ¡‘º´Žq2, ‹S“ª•¶•F2 (1“à‡T. 2‰¡•lŽs—§Žs–¯•a‰@): ‘æ46‰ñ“ú–{Á‰»Ší•aŠw‰ï (2004/10/21), •Ÿ‰ª.

723122. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬ŠÌ×–EŠà‚ɑ΂·‚郉ƒWƒI”g”M‹ÃŒÅ—Ö@Œã‚Ì‹ÇŠÄ”­ŠëŒ¯ˆöŽq, Ä”­—lŽ®‚ÌŒŸ“¢. ’†‘ò‹MG, š •ª–ΔŽ, a’J–¾—², ¬–ìO“ñ, “nç²^², “y‹´@Œ’, “ú‚@‰›, ¼Œ³Ž›ŽâX (“à‡T): ‘æ8‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï (2004/10/22), •Ÿ‰ª. ŠÌ‘Ÿ, 45 (S.2): A494, 2004.

723123. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –ò•¨«ŠÌáŠQ‚Ìf’fŠî€ì¬‚ÉŒü‚¯‚Ä‚Ì’ñˆÄ. “nç²^², a’J–¾—², ¼Œ³Ž›ŽâX (“à‡T): ‘æ8‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï (2004/10/22), •Ÿ‰ª. ŠÌ‘Ÿ, 45 (S.2): A416, 2004.

723124. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚éEUS-FNA‚ÌŒ»‹µ. r–س—Y, –Ø“cŒõL, ¼Œ³Ž›ŽâX (“à‡T): ‘æ68‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/10/22), •Ÿ‰ª.

723125. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) H“¹Ã–¬áŽŽ¡—Âɂ¨‚¯‚éEVL‚ÆEIS‚ÌŽg‚¢•ª‚¯|Vp3ŠÌ×–EŠàÇ—á‚ÌH“¹ˆÝ֬ᎂɑ΂·‚é“àŽ‹‹¾Ž¡—Â̌Ÿ“¢@EIS vs EVL|. “ú‚@‰›, š •ª–ΔŽ, ¼Œ³Ž›ŽâX (“à‡T): ‘æ68‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï (2004/10/23), •Ÿ‰ª. “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 46 (2): 1854, 2004.

723126. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒŸf‚Å”­Œ©‚³‚ꂽ‚O-‡TŒ^ˆÝŠà‚Ì3—á. •Ûâ”ü¶1, ¡‘º´Žq2, ‘“c‰p–¾2, ŽR’†@–Î2, ¬¼Oˆê2, “à“¡‹g—²1, Œ´@—R—¢Žq2, “°X‹»ˆê˜Y1 (1“à‡T. 2‰¡•lŽs—§Žs–¯•a‰@): ‘æ42‰ñ“ú–{Á‰»ŠíW’cŒŸfŠw‰ï‘å‰ï (2004/10/23), •Ÿ‰ª.

723127. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–Ž{Ý‚Ì’´‰¹”gŒŸf‚Å”­Œ©‚³‚ꂽ’_”X‚ª‚ñÇ—á‚ÌŒŸ“¢. ‘“c‰p–¾2, ŽR’†@–Î2, •Ûâ”ü¶1, ¡‘º´Žq2, “°X‹»ˆê˜Y1, Œ´@—R—¢Žq2, “à“¡‹g—²1 (1“à‡T. 2‰¡•lŽs—§Žs–¯•a‰@): ‘æ42‰ñ“ú–{Á‰»ŠíW’cŒŸfŠw‰ï‘å‰ï (2004/10/23), •Ÿ‰ª.

723128. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘å’°Œ‹ßWâÆ—l•a•Ï‚ɑ΂·‚鎡—Ö@‚Ì‘I‘ð‚Æ”S–ŒØœp‚Ì•]‰¿. ²“c”ü˜a, ŒÜ\—’³L, Ÿ–””º‰h (“à‡T): ‘æ68‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï iDDW-Japan 2004j (2004/10/24), •Ÿ‰ª. “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 46 (—Õ‘ S.2): 1764, 2004.

723129. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘’_ŠÇŒ‹Î‚Ì“àŽ‹‹¾Ž¡—Âɂ¨‚¯‚éEST‚ÆEPBD‚Ì’·Šú—\Œã. ‹e’nG•F, –Ø“cŒõL, ¼Œ³Ž›ŽâX (“à‡T): ‘æ68‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/10/24), •Ÿ‰ª.

723130. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) m3sm1H“¹Šà‚ɑ΂·‚é“àŽ‹‹¾“I”S–ŒØœp (EMR) ƒGƒrƒfƒ“ƒX‚ÌŠm—§‚ÉŒü‚¯‚Ä. ”óŒûŸ•F1, “c•Ó@‘1, ¬—ÑLs2 (1“à‡T. 2ŠO): ‘æ68‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/10/24), •Ÿ‰ª. “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 46 (S.2): 1954, 2004.

723131. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰È‚É‚¨‚¯‚éäXŠÇ“àƒXƒeƒ“ƒg‚ÌŒŸ“¢. ˆÀ“¡@‹, –Ø“cŒõL, X–ØOŽq, ‘OàV@”J, ‹e’nG•F, ’|àVŽO‘ãŽq, r–س—Y, ‰F’Ö؋±Žq, ŽRèDŽ÷, Ž­ŠÔL–¾, ‘“ŒŠ²•v, “n•Ó–€–ç, –Ø“c–FŽ÷, ¡ò@O, ¼Œ³Ž›ŽâX (“à‡T): ‘æ68‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/10/24), •Ÿ‰ª.

723132. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚é’†•”E‰º•”ˆ««’_“¹‹·ó‚ɑ΂·‚éEBD‚ÌŒŸ“¢. ŽRèDŠì, –Ø“cŒõL, ˆÀ“¡@‹, X–ØOŽq, ‘OàV@”J, ä݉®@Šî, ‹e’nG•F, ’|àVŽO‘ãŽq, r–س—Y, ‰F’Ö؋±Žq, Ž­ŠÔL–¾, ‘“ŒŠ²•v, “n•Ó–€–ç, –Ø“c–FŽ÷, ¡ò@O, ¼Œ³Ž›ŽâX (“à‡T): ‘æ68‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/10/24), •Ÿ‰ª.

723133. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’¼’°ƒJƒ‹ƒ`ƒmƒCƒhŽîᇂɑ΂·‚é“àŽ‹‹¾“I“Eœ‚Ì—L—p«‚Æ–â‘è“_. ¬—Ñ´“T1, ŒÜ\—’³L1, ‹gàV@”É1, ²“c”ü˜a1, Ÿ–””º‰h1, ¼Œ³Ž›ŽâX1, ‘å’J„³2, “nç²¹•F2, ‰ªˆÀ@ŒM3 (1“à‡T. 2ŠO. 3•a—): ‘æ62‰ñ‘å’°ŠàŒ¤‹†‰ï (2005/1/21), “Œ‹ž.

723134. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Crohn•a‚ÌÝ‘îŒo’°‰h—{—Ö@‚É‚¨‚¯‚éŒo”ç“àŽ‹‹¾“IˆÝá‘‘¢Ýp (PEG) ‚Ì—L—p«‚Æ–â‘è“_. ×’J‘Žq1, ¬—Ñ´“T1, t–Ø‘”ü1, ‹gàV@”É1, ²“c”ü˜a1, ŒÜ\—’³L1, Ÿ–””º‰h1, ¼Œ³Ž›ŽâX1, –ìŒû‹…Žq2 (1“à‡T. 2‰h—{•”): ‘æ20‰ñ“ú–{Ö¬Œo’°‰h—{Šw‰ï (2005/2/18), –¼ŒÃ‰®.

723135. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠÌŠà‚ɑ΂·‚éRVS (Real-time Virtual Sonography) ‚ÌŽ{sŒoŒ±. ¬–ìO“ñ, š •ª–ΔŽ, “nç²^², “y‹´@Œ’, ’†‘ò‹MG, –Ø“cŒõO, ¼Œ³Ž›ŽâX (“à‡T): “ú–{’´‰¹”gˆãŠw‰ï‘æ77‰ñŠwpW‰ï (2004), ‰F“s‹{. ’´‰¹”gˆãŠw, 31 (S.1): S338, 2004.

731006. [‚»‚Ì‘¼] (“Á•Êu‰‰) ˆÝŠà‰»Šw—Ö@‚ÌŒ»ó‚Æ«—ˆ. ¬ò˜aŽO˜Y (“à‡T): CPT-11Šwpu‰‰‰ï (2004/4/2), ‰¡•l.

731007. [‚»‚Ì‘¼] (“Á•Êu‰‰j ƒ‰ƒWƒI”g”M‹ÃŒÅ—Ö@‚ÌŒ»‹µ‚Æ“K‰žŠg‘å|Model90‚̉ʂ½‚·–ðŠ„|. š •ª–ΔŽ (“à‡T): ’†Žl‘ÅVƒ‰ƒWƒI”g”M‹ÃŒÅ—Ö@u‰‰‰ï (2004/4/10), ‰ªŽR.

731008. [‚»‚Ì‘¼] (“Á•Êu‰‰j RFA‚ÍŠÌŠà‚Ì—\Œã‚ÉvŒ£‚µ‚½‚©? š •ª–ΔŽ (“à‡T): –kŠC“¹D.D club (2004/5/8), ŽD–y.

731009. [‚»‚Ì‘¼] (“Á•Êu‰‰) ’m‚Á‚Ä‚Ä“¾‚·‚éˆÝ’°‚Ì•a‹C. ¼Œ³Ž›ŽâX (“à‡T): ‘å–´“cŽs–¯uÀ (2004/5), ‹ãB.

731010. [‚»‚Ì‘¼] (“Á•Êu‰‰) ’×ᇎ¡—Â̗¬‚ê‚ÆŽc‚³‚ꂽ‰Û‘è. ¼Œ³Ž›ŽâX (“à‡T): Á‰»«’×ᇧ˜b‰ï (2004/6/11), ŽD–y.

731011. [Œ¤‹†‰ï] (“Á•Êu‰‰) Á‰»«’×ᇂÌÄ”­‚ƃGƒJƒxƒg‚Ì—L—p«. ¬ò˜aŽO˜Y (“à‡T): “ú–{ˆãŽt‰ï¶ŠU‹³ˆçuÀŠwpu‰‰‰ï (2004/7/1), ˆ®ì.

731012. [Œ¤‹†‰ï] (“Á•Êu‰‰) isˆÝŠà‚ɑ΂·‚鉻Šw—Ö@‚ÌŒ»‹µ. ¬ò˜aŽO˜Y (“à‡T): ‘æ118‰ñç—tŽsˆãŽt‰ïˆÝ’°Ž¾Š³Œ¤C‰ï (2004/7/16), ç—t.

731013. [Œ¤‹†‰ï] (“Á•Êu‰‰j ŠÌŠà‚ɑ΂·‚éÅVƒ‰ƒWƒI”g”M‹ÃŒÅ—Ö@|“K‰žŠg‘å‚Æ”wŒiŠÌ‚ւ̉e‹¿|. š •ª–ΔŽ (“à‡T): ‡“V“°‘åÁ‰»Ší“à‰ÈƒZƒ~ƒi[ (2004/7/16), “Œ‹ž.

731014. [Œ¤‹†‰ï] (“Á•Êu‰‰j ŠÌd•ÏEŠÌŠà‚ÌŽ¡—ÂƉh—{. š •ª–ΔŽ (“à‡T): ‘æ3‰ñ‰h—{EŽ¡—ÃZƒ~ƒi[ (2004/9/14), ‰¡•l.

731015. [‚»‚Ì‘¼] (“Á•Êu‰‰) ‹•ŒŒ«‘å’°‰Š‚Ì—Õ°. ¬—Ñ´“T (“à‡T): ‘æ166‰ñå‘ä‚¢‚¿‚傤‰ï (2004/9/16), å‘ä.

731016. [Œ¤‹†‰ï] (“Á•Êu‰‰) ˆÝEH“¹‹t—¬Ç‚É‚¨‚¯‚é“à‰È“IŽ¡—Ã. ¡ò@O (“à‡T): ‘æ17‰ñ‘Š–ÍŒ´ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€ (2004/9/16), ‘Š–ÍŒ´.

731017. [Œ¤‹†‰ï] (“Á•Êu‰‰j ŠÌŠàŽ¡—Â̓W–]|RFA‚ð’†S‚Æ‚µ‚Ä|. š •ª–ΔŽ (“à‡T): ‘æ‚U‰ñ‹ãBŠÌŠàŒ¤‹†‰ï (2004/9/25), •Ÿ‰ª.

731018. [Œ¤‹†‰ï] (“Á•Êu‰‰) Á‰»«’×ᇂÌÄ”­—\–h|Å‹ß‚Ì’mŒ©|. ¬ò˜aŽO˜Y (“à‡T): ‰ªè“à‰ÈˆãŽt‰ï (2004/9/27), ‰ªè.

731019. [Œ¤‹†‰ï] (“Á•Êu‰‰) NSAID‚É‚æ‚é‘å’°•a•Ï‚ÌŽÀ‘Ô‚Æ‚»‚Ì‘Îô. ŒÜ\—’³L (“à‡T): Hokkaido GI Fronter (2004/10/8), ŽD–y.

731020. [Œ¤‹†‰ï] (“Á•Êu‰‰) ˆÝŠà‰»Šw—Ö@‚ÌŒ»‹µ‚Æ«—ˆ. ¬ò˜aŽO˜Y (“à‡T): ‘æ‚S‰ñˆÝŠà‰»Šw—Ö@Œ¤‹†‰ï (2004/11/2), ·‰ª.

731021. [Œ¤‹†‰ï] (“Á•Êu‰‰j RFA‚ð’†S‚Æ‚µ‚½ŠÌ×–EŠàŽ¡—Â̓W–]. š •ª–ΔŽ (“à‡T): ‘æ33‰ñ‹ž“sŠÌŠàƒZƒ~ƒi[ (2004/11/19), ‹ž“s.

731022. [Œ¤‹†‰ï] (“Á•Êu‰‰) —\Œã‚©‚猩‚½ˆÝŠàŽ¡—Ãí—ª. ¬ò˜aŽO˜Y (“à‡T): ‘æ9‰ñÁ‰»ŠíŠàƒtƒH[ƒ‰ƒ€ (2004/11/20), ‘åã.

731023. [Œ¤‹†‰ï] (“Á•Êu‰‰j RFA‚ð’†S‚Æ‚µ‚½ŠÌ×–EŠàŽ¡—Â̓W–]. š •ª–ΔŽ (“à‡T): ‘æ39‰ñ‘åãŠÌúŽh¶ŒŸŽ¡—ÃŒ¤‹†‰ï (2004/11/26), ‘åã.

731024. [Šw‰ï (’n•û)] (“Á•Êu‰‰) IBD‚Ì“àŽ‹‹¾f’f. ŒÜ\—’³L (“à‡T): ‘æ84‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï–k—¤’n•û‰ï (2004/11/28), ‹à‘ò.

731025. [Œ¤‹†‰ï] (“Á•Êu‰‰) Á‰»«’×ᇂÌÄ”­—\–h|Å‹ß‚Ì’mŒ©|. ¬ò˜aŽO˜Y (“à‡T): •½’ËŽsˆãŽt‰ï“à‰È•”‰ïu‰‰‰ï (2004/12/13), •½’Ë.

731026. [Œ¤‹†‰ï] (“Á•Êu‰‰) RFA‚ð’†S‚Æ‚µ‚½ŠÌŠàŽ¡—Â̓W–]. š •ª–ΔŽ (“à‡T): ‘æ31‰ñ–kÛŠÌŠàŒ¤‹†‰ï (2005/1/26), ‘åã.

731027. [‚»‚Ì‘¼] (“Á•Êu‰‰) ‘å’°Ž¾Š³‚ɑ΂·‚é’´‰¹”g“àŽ‹‹¾f’f‚̈Ӌ`. ¬—Ñ´“T (“à‡T): ‘æ15‰ñ’߉®’¬§˜b‰ï (2005/2/18), ‰¡•l.

732010. [Œ¤‹†‰ï] (ƒ‰ƒCƒuƒfƒ‚ƒ“ƒXƒgƒŒ[ƒVƒ‡ƒ“) ‘å’°Šà‚ɑ΂·‚é’´‰¹”g“àŽ‹‹¾f’f. ¬—Ñ´“T (“à‡T): ‘æ1‰ñ–k—¢EUSƒZƒ~ƒi[ (2004/6/19), _“Þì.

732011. [Œ¤‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€) TS-1{CDDP. ¬ò˜aŽO˜Y (“à‡T): DIF Meeting 2004 (2004/6/26), “Œ‹ž.

732012. [Šw‰ï (’n•û)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[j –å–¬ˆ³˜´iÇ‚ÌŽ¡—Ãí—ª2004`ˆÝH“¹Ã–¬áŽ‚ðŠÜ‚ß‚Ä. š •ª–ΔŽ (“à‡T): ‘æ133‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï“Œ–k’n•û‰ï (2004/7/10), ŽRŒ`.

732013. [Œ¤‹†‰ï] (µ‘Ò‚³‚ꂽu‰‰) Øœ•s”\isˆÝŠà‰»Šw—Ö@. ¬ò˜aŽO˜Y (“à‡T): ‘æ5‰ñ—Õ°ŽîᇉĊúW’†ƒZƒ~ƒi[ (2004/7/23), “Œ‹ž.

732014. [Œ¤‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€) Study on magnifying observation for dysplasia and colitic cancer. ¬—Ñ´“T, ²“c”ü˜a, ŒÜ\—’³L, Ÿ–””º‰h i“à‡T): Endoscopy Forum Japan 2004 (2004/8/9), ” ª.

732015. [Šw‰ï (’n•û)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[j RFA‚ð’†S‚Æ‚µ‚½ŠÌ×–EŠàŽ¡—Â̓W–]. š •ª–ΔŽ (“à‡T): ‘æ82‰ñ“ú–{Á‰»Ší•aŠw‰ïŽl‘Žx•”—á‰ï (2004/11/27), ¼ŽR.

732016. [Šw‰ï (’n•û)] (ƒVƒ“ƒ|ƒWƒEƒ€) “–‰@‚É‚¨‚¯‚éäXŠàTS1Ç—á‚ÌŒŸ“¢. ‹e’nG•F, –Ø“cŒõL, ¼Œ³Ž›ŽâX (“à‡T): ‘æ79‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (2004/12/3), “Œ‹ž. Progress of Digestive Endoscopy (Á‰»Ší“àŽ‹‹¾‚Ìi•à), 66 (1): 50, 2004.

732017. [Šw‰ï (’n•û)] (ƒrƒfƒIƒVƒ“ƒ|ƒWƒEƒ€) “àŽ‹‹¾“I•ªŠ„”S–ŒØœp iEPMRj ‚Ì“K‰ž‚Æ—\Œã. ²“c”ü˜a1, ŒÜ\—’³L1, ‹gàV@”É1, ¬—Ñ´“T1, Ÿ–””º‰h1, ¼Œ³Ž›ŽâX1, ‰ªˆÀ@ŒM2 (1“à‡T. 2•a—): ‘æ79‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (2004/12/4), “Œ‹ž. Prog Dig Endosc, 66 (1): 45, 2004.

732018. [Šw‰ï (’n•ûj] (µ‘Ò‚³‚ꂽu‰‰) ŠÌ×–EŠà‚ɑ΂·‚郉ƒWƒI”g”M‹ÃŒÅ—Ö@‚ÆŠÌ—\”õ”\. š •ª–ΔŽ (“à‡T): ‘æ35‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (2004/12/11), “Œ‹ž.

732019. [Œ¤‹†‰ï] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) “àŽ‹‹¾“I•ªŠ„”S–ŒØœp iEPMRj ‚̇•¹Ç‚Æ’·Šú—\Œã. ²“c”ü˜a1, ŒÜ\—’³L1, ‹gàV@”É1, ¬—Ñ´“T1, Ÿ–””º‰h1, ¼Œ³Ž›ŽâX1, ‰ªˆÀ@ŒM2 (1“à‡T. 2•a—): ‘æ35‰ñ_“Þì‘å’°Ž¾Š³Œ¤‹†‰ï (2005/2/3), ‰¡•l. ƒvƒƒOƒ‰ƒ€E´˜^W, 5, 2005.

733027. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ã•”Á‰»ŠíŠà‚É‚¨‚¯‚é“àŽ‹‹¾Ž¡—ÂÌÅ‘Oü|ƒe[ƒ‰[ƒƒCƒhŽ¡—Â̊m—§‚ð‚ß‚´‚µ‚Ä|. “c•Ó@‘ (“à‡T): ‘æ2‰ñÁ‰»Ší“àŽ‹‹¾•×‹­‰ï (2004/4/27), ¹ƒ}ƒŠƒAƒ“ƒiˆã‘å.

733028. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ”S–ŒŽY¶’_ŠÇŠà‚Ì1Øœ—á. ˆÀ“¡@‹1, –Ø“cŒõL1, X–ØOŽq1, ‘OàV@”J1, ‹e’nG•F1, ’|àVŽO‘ãŽq1, r–س—Y1, ”’{‹±Žq1, ŽRèDŠì1, Ž­ŠÔL–¾1, “n•Ó–€–ç1, –Ø“c–FŽ÷1, ¡ò@O1, ¼Œ³Ž›ŽâX1, ¯–ìOŽ÷2, “‡“c@Œª2, ‹g“c@‹I2, ˆêŒË¹–¾3, ‘å•”@½4 (1“à‡T. 2ŠO. 3•a—. 4ˆã‰qj: ‘æ78‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (2004/6/11), “Œ‹ž.

733029. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “àŽ‹‹¾‚ÅŽ¡—ÃŒø‰Ê‚ð•]‰¿‚µ“¾‚½Cronkhite-CanadaÇŒóŒQ‚Ì1—á. ‰º“c‘ñ–ç1, ¬—Ñ´“T1, ‹gàV@”É1, ²“c”ü˜a1, ŒÜ\—’³L1, Ÿ–””º‰h1, ¼Œ³Ž›ŽâX1, ‰ªˆÀ@ŒM2 (1“à‡T. 2•a—): ‘æ78‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (2004/6/11), “Œ‹ž.

733030. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) p‘O‚ɬ’°“àŽ‹‹¾‚ÅŠm”F‚µ“¾‚½¬’°GIST‚Ì2—á. ‹e’n³b1, ‹gàV@”É1, ²“c”ü˜a1, ¬—Ñ´“T1, ŒÜ\—’³L1, Ÿ–””º‰h1, ¼Œ³Ž›ŽâX1, “nç²¹•F2, ‰ªˆÀ@ŒM3 (1“à‡T. 2ŠO. 3•a—j: ‘æ78‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (2004/6/11), “Œ‹ž.

733031. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) äXŠÇƒXƒeƒ“ƒg‚ª—L—p‚Å‚ ‚Á‚½äX«‹¹• …‚𔺂Á‚½–«äX‰Š‚Ì1—á. X–ØOŽq, ¡ò@O, ˆÀ“¡@‹, ‘OàV@”J, ‹e’nG•F, ’|àVŽO‘ãŽq, r–س—Y, ”’{‹±Žq, ŽRèDŠì, Ž­ŠÔL–¾, ‘“ŒŠ²•v, “n•Ó–€–ç, –Ø“c–FŽ÷, –Ø“cŒõL, ¼Œ³Ž›ŽâX (“à‡T): ‘æ78‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (2004/6/11), “Œ‹ž.

733032. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ŠJŒûáŠQ‚ÅERCP¢“ï‚È‚½‚ßPTCDƒ‹[ƒg‚©‚çEST‚ðs‚Á‚½1—á. ‘å–ì@—²1,2, Ž‰ÆKŽq1,2, ‰œ˜e—T‰î1,2, ŒŠàVNŽu1,2, ˜@Œ©ŒjŽO2, X–앶•q2, ’†–ìŽj˜Y1,2 (1“à‡T. 2ˆÉ¨Œ´‹¦“¯•a‰@j: ‘æ78‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (2003/6/11-12), “Œ‹ž. Progress of Digestive Endoscopy, 65 (1): 89, 2004.

733033. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Ž¡—ÊJŽn’ZŽžŠÔ‚Å’¼’°‹·ó‚𶂶‚½ƒAƒ[ƒo«‘å’°‰Š‚̈ê—á. ’·‹v•ÛGˆê2, ¬¼Oˆê2, Œ´@—R—¢Žq2, “à“¡‹g—²1, •Ûâ”ü¶1, ŽR’†@–Î2, ‘“c‰p–¾2, ¡‘º´Žq2 (1“à‡T. 2‰¡•lŽs—§Žs–¯•a‰@): ‘æ78‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (2004/6/11), “Œ‹ž.

733034. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒCƒŒƒEƒXÇó‚É‚æ‚è”­Ç‚µ‚½Ã–¬d‰»Ç‚Ì2—á. t–Ø‘”ü, ŒÜ\—’³L, ‹gàV@”É, ²“c”ü˜a, ¬—Ñ´“T, Ÿ–””º‰h, ¼Œ³Ž›ŽâX (“à‡T): ‘æ78‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (2004/6/12), “Œ‹ž.

733035. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “àŽ‹‹¾“I”S–ŒØœp iEMRj Œã‚ɒljÁŽèp‚ðs‚Á‚½‘ŠúˆÝŠàÇ—á‚ÌŒŸ“¢. ²X–Ø@“O, “c•Ó@‘, ”óŒûŸ•F, ’†ŽR¸“T, ¬ò˜aŽO˜Y, ¼Œ³Ž›ŽâX (“à‡T): ‘æ78‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (2004/6/12), “Œ‹ž.

733036. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŠÌ•s‘S‚ð‚«‚½‚·‚à‹~–½‚µ‚¦‚½äBŒ´”­‚Æl‚¦‚ç‚ê‚鈫«ƒŠƒ“ƒpŽî‚Ì1—á. ŒŠàVNŽu1,2, ‰œ˜e—T‰î1,2, ‘OàV@”J1,2, ˜@Œ©ŒjŽO2, X–앶•q2, ’†–ìŽj˜Y1,2, ‘å–ì@—²1,2, ´…@“§2 (1“à‡T. 2ˆÉ¨Œ´‹¦“¯•a‰@j: ‘æ49‰ñ_“Þ쌧Á‰»Ší•aŒ¤‹†‰ï (2004/7/3), Š™‘qŽs.

733037. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‘ŠúˆÝŠà‚ɑ΂·‚éØŠJ”—£–@‚Ì—L—p«‚ÆPitfalls|]—ˆ–@‚Æ‚Ì”äŠr‚ðŠÜ‚ß‚Ä|. “c•Ó@‘, ”óŒûŸ•F, ²X–Ø@“O, ’†ŽR¸“T, –k‘º@‹§, –Ø“cŒõL, ¬ò˜aŽO˜Y, ¼Œ³Ž›ŽâX (“à‡T): –k—¢ŽîᇃtƒH[ƒ‰ƒ€ (2004/7/30), ‘Š–ÍŒ´Žs.

733038. [Œ¤‹†‰ï] (ˆê”Êu‰‰) p‘O‚É[’B“x‚ð‰ß‘å•]‰¿‚µ‚½S󌋒°Šà‚Ì1—á. ¬—Ñ´“T1, ²“c”ü˜a1, ¬ì‘åŽu1, ‹gàV@”É1, ŒÜ\—’³L1, Ÿ–””º‰h1, ¼Œ³Ž›ŽâX1, ‘å’J„³2, ‰ªˆÀ@ŒM3 (1“à‡T. 2ŠO. 3•a—): ‘æ14‰ñ‘å’°‡UcŒ¤‹†‰ï (2004/9/18), V‰¡•l.

733039. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ˆÉ¨Œ´‹¦“¯•a‰@‚É‚¨‚¯‚éRFA‚É‚æ‚éŠÌ×–EŠàŽ¡—Â̌»ó. ŒŠàVNŽu1,2, ‘OàV@”J1,2, ’†–ìŽj˜Y1,2, ‘å–ì@—²1,2 (1“à‡T. 2ˆÉ¨Œ´‹¦“¯•a‰@j: ‘æ4‰ñÓ켕”ŠÌŽ¾Š³•×‹­‰ï (2004/9/25), Œú–Ø.

733040. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Œ´ˆö•s–¾‚Ì”­”M‚É‚Ä”­Ç‚µ, ŠÌ“àŒŒŽî, • o“àoŒŒ‚ð’悵‚½Œ‹ß«‘½”­“®–¬‰Š‚Ì1—á. ˆäã@Œ«1, ’·‹v•ÛGˆê1, Œ´@—R—¢Žq1, ¬¼Oˆê1, •Ûâ”ü¶2, ŽR’†@–Î1, ‘“c‰p–¾1, ¡‘º´Žq1 (1‰¡•lŽs—§Žs–¯•a‰@. 2“à‡T): ‘æ78‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (2004/9/25), “Œ‹ž.

733041. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Œã• –Œo‚É”­¶‚µ‚½‹CŠÇŽxŒ´«”X–E‚̈êØœ—á. ’GŒŽ‡–ç1, ¬¼Oˆê1, •Ûâ”ü¶2, ‹g‘ò–ΗY1, Œ´@—R—¢Žq1, ŽR’†@–Î1, ’·‹v•ÛGˆê1, ŒF蔎ˆê1, ¡‘º´Žq1 (1‰¡•lŽs—§Žs–¯•a‰@. 2“à‡Tj: ‘æ19‰ñ‰¡•l•a‰@Á‰»ŠíƒtƒH[ƒ‰ƒ€ (2004/11/12), ‰¡•l.

733042. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒNƒ[ƒ“•a‚ɑ΂·‚é’ZŠú‰h—{•]‰¿. ‹gàV@”É, Ÿ–””º‰h, t–Ø‘”ü, ¬ì‘åŽu, ¬—Ñ´“T, ²“c”ü˜a, ŒÜ\—’³L, ¼Œ³Ž›ŽâX (“à‡T): ‘æ34‰ñ_“ÞìIBD (2004/11), ‰¡•l. ƒvƒƒOƒ‰ƒ€E´˜^W, 2, 2004.

733043. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ŠÌ×–EŠà‚©‚ç‚Ì‘’_ŠÇ“à—Ž‰ºŽîᇉò‚É‚æ‚é‹}«äX‰Š‚Ì1—á. ¯@Œ’‘¾1,2, ‘å–ì@—²1,2, ‘OàV@”J1,2, ŒŠàVNŽu1,2, ’†–ìŽj˜Y1,2 (1“à‡T. 2ˆÉ¨Œ´‹¦“¯•a‰@j: ‘æ79‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (2004/12/3-4), “Œ‹ž. Progress of Digestive Endoscopy, 66 (1): 93, 2004.

733044. [Šw‰ï (’n•û)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) “àŽ‹‹¾“I‘å’°ƒ|ƒŠ[ƒv“Eœp‚É‚¨‚¯‚é“ü‰@—pƒNƒŠƒjƒJƒ‹ƒpƒX‚ÌŽg—pŒoŒ±‚ɂ‚¢‚Ä. ‰¡ŽR@ŒO (“à‡T): ‘æ78‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (2004/12/4), “Œ‹ž. Prog Dig Endosc, 65 (1): 69, 2004.

733045. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŒŒ‹…¬•ªœ‹Ž—Ö@‚ÌŽ¡—ÑŠú‚É‚¨‚¯‚éŒø‰Ê”»’è‚ɂ‚¢‚Ä. ‰¡ŽR@ŒO, Ÿ–””º‰h, ¬—Ñ´“T, ‹gàV@”É, ²“c”ü˜a, ŒÜ\—’³L, ¼Œ³Ž›ŽâX (“à‡T): _“ÞìƒTƒCƒ^ƒtƒFƒŒ[ƒVƒXŒ¤‹†‰ï‘æ2‰ñŒ¤‹†•ñ‰ï (2004/12/9), ‰¡•l.

733046. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) HCV—z«ŠÌd•Ï‚É‚¨‚¯‚éOccult HBVŠ´õ‚Æ”­Šà. ˆÀ’B@Ž , a’J–¾—², ‹Ê^r•½, ŒŠàVNŽu, a’JŽ÷Žq, “nç²^², ’†‘ò‹MG, ’|“à“ÖŽq, ¼Œ³Ž›ŽâX (“à‡T): ‘æ35‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (2004/12/11), “Œ‹ž. ŠÌ‘Ÿ, 45 (S.3): A574, 2004.

733047. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ã•”ˆÝŠà‚͉º•”ˆÝŠà‚æ‚è‚à‰»Šw—Ö@‚É‘tŒ÷‚·‚é. ”óŒûŸ•F, ¬ò˜aŽO˜Y, “c•Ó@‘, ²X–Ø@“O, ’†ŽR¸“T, ¼Œ³Ž›ŽâX (“à‡T): ‘æ27‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï (2004/12/20), ‰¡•l. ƒvƒƒOƒ‰ƒ€E´˜^W, 26, 2004.

733048. [Œ¤‹†‰ï] (ˆê”Êu‰‰) H“¹Ã–¬áŽ‡•¹–å–¬ˆ³˜´iÇ‚É‚¨‚¯‚éˆêŽ_‰»’‚‘f (No) ‘ãŽÓŽY•¨‚ÌŒŸ“¢. “ú‚@‰› (“à‡T): ‘æ23‰ñƒTƒCƒgƒvƒƒeƒNƒVƒ‡ƒ“Œ¤‹†‰ï (2005/2/4), ‹ž“s.

733049. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) L”Í‚È“]ˆÚ‚ð‚«‚½‚µ‚½‘å’°G•½ã”çŠà‚Ì1—á. ΌˌªŽŸ1, ˆÀ’B@Ž 1, ˜a“c—R”üŽq1, ‹Ê^ r•½1, ›–ì@‘1, ŽO•x O”V2 i1“à‡T. 2‘—§‘Š–ÍŒ´•a‰@j: ‘æ283‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï (2005/2/19), “Œ‹ž.

733050. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‘å’°ŒeŽºoŒŒ‚ɑ΂·‚é‹Ù‹}“àŽ‹‹¾‰ºŽ~ŒŒp‚Ì—L—p«‚Æ–â‘è“_. ‹gàV@”É, ŒÜ\—’³L, t–Ø‘”ü, ²“c”ü˜a, ¬—Ñ´“T, Ÿ–””º‰h, ¼Œ³Ž›ŽâX (“à‡T): ‘æ13‰ñƒNƒŠƒjƒJƒ‹EƒrƒfƒIƒtƒH[ƒ‰ƒ€ (2005/2), “Œ‹ž. ƒvƒƒOƒ‰ƒ€E´˜^W, 53, 2005.

733051. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) • •”CTŒŸ¸‚É‚Ä“Á’¥“IŠŒ©‚ð’悵‚½Fitz-Hugh-Curtis syndrome‚Ì1—á. ˜a“c—R”üŽq1, ˆÀ’B@ Ž 1, ΌˌªŽŸ1, ‹Ê^r•½1, ›–ì@‘1, ‘åX’qŽq2, ‘ëì­˜a2, ŽO•x O”V3 i1“à‡T. 2•ú. 3•a—j: “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2005/3/12), “Œ‹ž.


<<“à‰ÈŠw‡Ti“à•ª”å‘ãŽÓ“à‰ÈŠwj>>

mŠwp˜_•¶n

110073. [Œ´’˜] Renal ultranstructural changes in normo-and microalbuminuric Japanese type 2 diabetic patients revealed by quick-freezing and deep-etching methods. Žç‰®’B”ü, “c’†Œ[Ži, “¡“c–F–M (“à‡T): 8th Asia-Pacific Conference on Electron Microscopy Proceeding, 1242-1243, 2004.

120010. [Œ´’˜] “œ”A•a‚ð‡•¹‚µ‚½‹•ŒŒ«SŽ¾Š³Š³ŽÒ‚ÌQOL“Á«. Šâ‘º‹M”ü1, ‚‹´—R”ü1, Šâ¼GŽ÷1, œA£^ƒ1, ‘“c¹D2, âV“¡³˜a3, _’JŒ’‘¾˜Y3, •ÄàV—²‰î3, â–{ƒŽq3, ¼‰i“Ä•F3, ‘“c@‘ì2,5, Žç‰®’B”ü4, “c’†Œ[Ži4, ’¬“cçŠGŽq4, ˜aò@“O5 (1S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Žº. 2ˆã‰q. 3ˆã—ÃŒn‘åŠw‰@. 4“à‡T. 5“à‡U): S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“, 98 (1): 96-100, 2004.

520059. [‘à] ¶ŠˆKŠµ•a‚ƃvƒƒeƒIƒ~ƒNƒX. ‚“c“NG1, ¼Œ´‚Ü‚Ç‚©, ¬Ž›‹`’j2, ‘åγ“¹2, ‘O“c’‰Œv2, “¡“c–F–M1 (1“à‡T. 2—Šw•”): ˆâ“`ˆãŠwMOOK (in press), 2004.

520060. [‘à] ׬ŒŒŠÇáŠQ‚Æ‚µ‚Ä‚Ì“œ”A•a«tǂƑ匌ŠÇáŠQ‚Æ‚µ‚Ä‚Ì“®–¬d‰»Ç. “c’†Œ[Ži, Žç‰®’B”ü (“à‡T): ŒŒŠÇŠO‰È, 23 (1): 23-26, 2004.

mŠw‰ïEŒ¤‹†‰ï“™n

712010. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Renal ultranstructural changes in normo-and microalbuminuric Japanese type 2 diabetic patients revealed by quick-freezing and deep-etching methods. Žç‰®’B”ü, “c’†Œ[Ži, “¡“c–F–M (“à‡T): 8th Asia-Pacific Conference on Electron Microscopy (2004/6/7-11), ‹à‘ò. 8th APEM Program and Summaries, 62, 2004.

723136. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) JDCS‚É‚¨‚¯‚郉ƒCƒtƒXƒ^ƒCƒ‹‰î“ü‚Ì“œ”A•atÇ‚Ì”­ÇEi“W‚É‹y‚Ú‚·Œø‰Ê|‚U”NŽŸ‰ðÍ‚æ‚è|. ‰¡“cç’ÃŽq, Žç‰®’B”ü1, ŽR“cŒ¤ˆê, …–ì²’qŽq, ‘å‹´–õ—Y, ŽR“cM”Ž, ÔÀˆÀ•v, –‹`’‰, •ÐŽR–ΗT (1“à‡T): ‘æ47‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2004/5/13-15), “Œ‹ž. “œ”A•a, 47: S-162, 2004.

723137. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) 2Œ^“œ”A•a‚É‚¨‚¯‚ét‘gD‘œ‚Æ—Õ°“I“Á’¥‚¨‚æ‚Ñ—\Œã‚Æ‚ÌŠÖ˜A. “c’†Œ[Ži1, Žç‰®’B”ü1, –öË•v, •ì’q•F1, _ŽR‘¾˜Y, •½àV—zŽq1, Š™“c—T“ñ1, ‚“c“NG1, “¡“c–F–M1 (1“à‡T): ‘æ47‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2004/5/13-15), “Œ‹ž. “œ”A•a, 47: S-206, 2004.

723138. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) 2Œ^“œ”A•a‚̳í`”÷—ʃAƒ‹ƒuƒ~ƒ“”AŠú‚Ìt¶Œ¤Œã3”NŠÔ‚ÌŒo‰ßŠÏŽ@. Žç‰®’B”ü1, “c’†Œ[Ži1, –öË•v, ‚“c“NG1, “¡“c–F–M1 (1“à‡T): ‘æ47‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2004/5/13-15), “Œ‹ž. “œ”A•a, 47: S-206, 2004.

723139. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠO—ˆ“œ”A•a«tÇ‹³ŽºŽQ‰Á‚É‚æ‚éHŽ–—Ö@‚¨‚æ‚ÑtÇi“W–hŽ~‚ÌŒø‰Ê. ‹g“c•üŽq, lŒ©–ƒ”üŽq, ²“¡ÆŽq, –öË•v, “c’†Œ[Ži1, Žç‰®’B”ü1, “¡“c–F–M1 (1“à‡T): ‘æ47‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2004/5/13-15), “Œ‹ž. “œ”A•a, 47: S-221, 2004.

723140. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠO—ˆ‚É‚¨‚¯‚é“œ”A•a«tÇ‚ÌŠ³ŽÒ‹³ˆç‚É–òÜŽt‚ÌŠÖ—^‚Í—LŒø‚Å‚ ‚é|–ò•¨—Ö@‚ɑ΂·‚銳ŽÒ‚̈ӎ¯‚ƃAƒhƒqƒAƒ‰ƒ“ƒX‚ÌŒüã‚ɂ‚¢‚Ä|. Ÿ˜C”ü, –Ø‘º—˜”ü, ¼Œ´@”£, ²ìŒ«ˆê1, –îŒã˜a•v1, –öË•v, “c’†Œ[Ži2, Žç‰®’B”ü2, “¡“c–F–M2 (1–òÜ•”. 2“à‡T): ‘æ47‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2004/5/13-15), “Œ‹ž. “œ”A•a, 47: S-162, 2004.

723141. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “œ”A•aƒ‰ƒbƒg‚̃vƒƒeƒI[ƒ€‰ðÍ. ‚“c“NG1, ¼Œ´‚Ü‚Ç‚©, •½àV—zŽq1, Š™“c—T“ñ1, ‘åγ“¹2, ‘O“c’‰Œv2, “¡“c–F–M1 (1“à‡T. 2—Šw•”): ‘æ47‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2004/5/13-15), “Œ‹ž.


<<“à‰ÈŠw‡UizŠÂŠí“à‰ÈŠwj>>

mŠwp˜_•¶n

110074. [Œ´’˜] Prediction of ClinicalRecurrence of Atrioventricular-Nodal Reentrant Tachycardia (AVNRT) After Succeessful Slow Pathway Ablation. Œ´@‰pK, ’ë–ìTˆê, ‹g“c@“O, ¼ŽRÄ‹v, ˜eâ—TŽq, ²X–Ø@‹B, –k–ì‹`˜a, ˜aò@“O (“à‡U): Circulation Journal, 686: 558-562, 2004.

110075. [Œ´’˜] Structual and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure. ˜eâ—TŽq, ’ë–ìTˆê, ’ë–ì—TŒb, Ä“¡~Žq, ‹g“c@“O, •½àV³ŽŸ, Hideaki Kawada, ˜aò@“O (“à‡U): Cardiovascular Reseach, 63: 689-699, 2004.

110076. [Œ´’˜] Serum Levels of Interleukin-10 on Admission as a Prognostic Predictor of Human Fulminant Myocarditis. ¼ˆäŠîŒp, ’––”FŒ³, ’|’[@‹Ï, ’|“àˆê˜Y, ’†–ì_¬, ¬”‹´r”ü, ’†”¨ˆê, ÂŽR’¼‘P, ˜aò@“O (“à‡U): Journal of the America College of Cardiology, 44 (6): 1297-1298, 2004.

110077. [Œ´’˜] Effects of the Endothelin Receptor Antagonist Bosentan on Hemodynamics, Symptoms and Functional Capacity in Japanese Patients With Severe Pulmonary Hypertention. ùŽRd•1, Takeyoshi Kuneida, Hitonobu Tomoike, Masunori Matsuzaki, Takayuki Kuriyama, ˜aò@“O1, Hideki Origasa, Paul LM van Giersbergen, Jasper Dingemanse, Satoshi Tanaka (1“à‡U): Circulation Journal, 69 (2): 131-137, 2005.

110078. [Œ´’˜] Clinical Characteristics of Heart Disease Patients With a Good Prognosis in Spite of Markedly Increased Plasma Levels of Type-B Natriuretic Peptide (BNP) -Anomalous Behavior of Plasma BNP in Hypertrophic Cardiomyopathy-. ’|“àˆê˜Y1, ’––”FŒ³1, ¼ˆäŠîŒp1, ¬”‹´r”ü1, ’†–ì_¬1, •iì–íl2, ’|’[@‹Ï1, ˜aò@“O1 (1“à‡U. 2“à‡V): Circulation Journal, 69 (3): 277-282, 2005.

310003. [Ç—á•ñ] Vasospams of the Radial Artery After the Transradial Approach for Coronary Angiography and Angioplasty. •Ÿ“c’¼l1, Shin-ichiro Iwahara, Atushi Harada, Shinya Yokoyama, Kouichi Akutsu, Masamichi Takano, Akiyoshi Kobayashi, •ìMŒå1, ˜aò@“O1 (1“à‡U): Japanese Heart Journal, 45 (5): 723-731, 2004.

320010. [Ç—á•ñ] ƒAƒ“ƒWƒIƒeƒ“ƒVƒ“‡UŽó—e‘ÌhR–ò‚̒ljÁ•¹—p“Š—^‚É‚æ‚茀“I‰ü‘P‚ð”F‚ß‚½“«S•s‘S‚Ì1—á. ’†–ì_¬, ’––”FŒ³, m–Ø@~, “ŒžŠ‘å‹P, ’|“àˆê˜Y, ¬”‹´r”ü, ¼ˆäŠîŒp, ’|’[@‹Ï, ’†”¨ˆê, •ìMŒå, ˜aò@“O (“à‡U): ŒÄ‹z‚ÆzŠÂ, 52 (7): 755`758, 2004.

520061. [‘à] ƒJƒeƒRƒ‰ƒ~ƒ“S‹ØÇES‹Ø‰Š. ¼ˆäŠîŒp, ˜aò@“O (“à‡U): Heart View, 8 (6): 74-78, 2004.

520062. [‘à] BNP‚É‚æ‚édÇ“xf’f. ¬”‹´r”ü, ˜aò@“O (“à‡U): Pharma Medica, 22 (6): 29-33, 2004.

520063. [‘à] –«S•s‘S‚ÌŽ¡—Ã. ¬”‹´r”ü, ˜aò@“O (“à‡U): ˆãŠw‚Æ–òŠw, 51 (6): 790-798, 2004.

m’˜@‘n

620041. [Šwp‘] (‹¤’˜) S‘ŸƒiƒrƒQ[ƒ^[; ‹}«S‹Ø‰ŠE‹}«SŠO–Œ‰Š. ’†–ì_¬, ˜aò@“O (“à‡U), •ÒW ó“c—SŽm˜Y1, ]“ªŒ’•ã2, b”ã‹vŽj3, ŒÃXŒö_4, ²“c­—²5, ŽºŒ´–L–¾4 i1‹{è‘å. 2‹ãB‘å. 3‹v—¯•Ä‘å. 4–¼ŒÃ‰®‘åŠw‘åŠw‰@. 5“Œ‹ž‘å‘åŠw‰@j, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, “Œ‹ž, 2004/4/1”­s.

620042. [Šwp‘] (•ª’SŽ·•M) S‘Ÿ‚ÌŠO—ˆf—Ã; S‹Ø‰Š, S192-193. ˜aò@“O (“à‡U), •ÒW –îè‹`—Y, ‘å—ÑŠ®“ñ, ¬—Ñ@‘, –x@³“ñ, ¼è‰v“¿, ‰iˆä—ÇŽO, “ú–{ˆãŽt‰ï, “Œ‹ž, 2004/10/15”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

713045. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) TNF-alfa down-regulates transient outward K+ current (Ito) by reducing the expressions of Kv4.2 and KChIP2 in cultured newborn rat cardiomyocytes. A Kawada H, ’ë–ìTˆê, ’ë–ì—TŒb, “’–{‰ÀG, ‹|í@‘å, ˜aò@“O (“à‡U): Heart & Rhythm Society Annual Sicentific Meeting (2004/5), San Francisco, USA. possible cause of arrhythmia in acute myocardial inflammation- Heart Rhythm, 1: S220-221, 2004.

713046. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Heterogenic process of the appearance of the atrial electrical remodeling in canine rapid stimulation model. ²“¡‘å•ã, ’ë–ìTˆê, ¬“‡Žžº, XŒû¹•F, ˜eâ—TŽq, ’r“c˜aŽq, Œ¢”öŒöŒú (“à‡U): The 31st International Congress on Electrocardiology (2004/7), Kyoto. The 31st International Congress on Electrocardiology, p.144, 2004.

713047. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Acute myocarditis causes structural and electrical ventricular remodeling -The role of reduction of Ito related molecules in experimental autoimmune myocarditis rat-. ˜eâ—TŽq, ’ë–ìTˆê, ’ë–ì—TŒb, Ä“¡~Žq, ‹g“c@“O, •½àV³ŽŸ, ˜aò@“O (“à‡U): The 31st International Congress on Electrocardiology (2004/7), Kyoto. The 31st International Congress on Electrocardiology, p.173, 2004.

713048. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Evaluation of the T-wave during exercise-testing in patients with idiopathic dilated cardiomyopathy (DCM) with and without beta-blockades. Œ´@‰pK, ’ë–ìTˆê, •½àV³ŽŸ, ²X–Ø@‹B, ’r“c˜aŽq, Miyahara H, ˜aò@“O (“à‡U): The 31st International Congress on Electrocardiology (2004/7), Kyoto. The 31st International Congress on Electrocardiology, p.187, 2004.

713049. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Exceptions of the diagnostic value for heart failure of plasma B-type natriuretic peptide levels-Disproportion between BNP and norepinephrine levels implies constrictive pericarditis. ’––”FŒ³, ˜aò@“O (“à‡U): European Society of Cardiology Congress 2004 (2004/8/28-9/1), Munich.

713050. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) B-type-natriuretic-peptide-guided management reduces the impact of atrial fibrillation on the prognosis of patients with heart failure. ¬”‹´r”ü, ’––”FŒ³ (“à‡U): European Society of Cardiology Congress 2004 (2004/8/28-9/1), Munich.

713051. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Evaluation of long-term prognosis of ventricular arrhythmias originating from right ventricular outflow tract (RVOT). ˜eâ—TŽq, ’ë–ìTˆê, ²X–Ø@‹B, •½àV³ŽŸ, ²“¡‘å•ã, ¡–Ø—²‘¾, ‹|í@‘å, XŒû¹•F, ’ë–ì—TŒb, ˜aò@“O (“à‡U): Scientific Sessions of American Heart Association (2004/11), New Orleans, USA. Circulation, 110: III-694-695, 2004.

713052. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Role of IQGAPI in Racl and reactive oxygen species-dependent VEGF signaling linked to angiogenesis. ŽR‰ª (“ŒžŠ) ”ü“ÞŽq1, “ŒžŠ‘å‹P1, Satoshi I, Hilenski L, Patrushev NA, Alexander RW, Ushio-Fukai M (1“à‡U): Scientific Sessions of American Heart Association (2004/11), New Orleans, USA. Circulation, abstrct, 110: IV, 2004.

713053. [Šw‰ï (‘Û)] (ˆê”Êu‰‰j Role of reactive oxygen species derived from NAD (P) H oxidase in postnatal angiogenesis in response to hindlimb ischemia. “ŒžŠ‘å‹P1, Ushio-Fukai M, ŽR‰ª (“ŒžŠ) ”ü“ÞŽq1, Satoshi I, Patrushev NA, Alexander RW (1“à‡U): Scientific Sessions of American Heart Association (2004/11), New Orleans, USA. Circulation, abstrct, 110: IV, 2004.

713054. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Immunomodulatory Effects of beta-Adrenergic Stimulation Through G-Protein Signaling Pathway on the Development of Myocarditis. ’†–ì_¬, ’––”FŒ³, ¼ˆäŠîŒp (“à‡U): American College of Cardiology Scientific Session 2005 (2005/3/6-9), J Am Coll Cardiol, 45 (Suppl A): 165A, 2005.

713055. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Dual role of antioxidant-1 in modulating the activity and expression of extracellular superoxide dismutase. Viktoria Jeney, Shinichi Ito, Zhenyu Qin, “ŒžŠ‘å‹P1, Francis J Miller Jr, Masuko Ushio-Fukai, Tohru Fukai (1“à‡U): AHA scientific essions (2004/11), New Orleans, USA.

713056. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) B type natriuretic peptide guided management reduces the impact of atrial fibrillation on the prognosis of patients with heart failure. ¬”‹´r”ü, ’––”FŒ³, ’|“àˆê˜Y, ’†–ì_¬, ¼ˆäŠîŒp, ’|’[@‹Ï, ’†”¨ˆê, •ìMŒå, ˜aò@“O (“à‡U): ESC congress (2004/8/28/-9/1), Munich, Germany.

713057. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Comparison of FDG-PET and Tc-99m-Flolate-spect to detect infiltration of inflammatory cells as a marker for atherosclerosis. “¼“c®Ž÷1, Pat Zanzonico2, Mark Dunphy2, Yuliya Jhanwar2, Gregor J. Forster2, Elmer B. Santos2, Peter M. Smith-Jones2, Steven M. Larson2, Harry W. Strauss2 (1Internal Medicine and Cardiology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan. 2Nuclear Medicine Laboratory, Memorial Sloan-Kettring Cancer Center, New York, NY): Society of Nuclear Medicine Annual Meeting (2004/6/19), Toronto, Canada

722023. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Effects of combined administration of angiotensin-II receptor blocker in patients with refractory heart failure treated with angiotensin-converting enzyme inhibitor. ’––”FŒ³, ˜aò@“O (“à‡U): ‘æ52‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2004/9/13-15j, ‹ž“s. J Cardiol, 44 (SupplI): 122, 2004.

722024. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Immunomodu-latory Effects of beta-Adrenergic Stimulation Through G-Protein Signaling Pathway on the Development of Myocarditis. ’––”FŒ³, ’†–ì_¬, ¼ˆäŠîŒp (“à‡U): ‘æ69‰ñ“ú–{zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï(2005/3/19-21), _“Þì. Circ J, 69 (Suppl I): 35, 2005.

722025. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Tailored B-Type-Natriuretic-Peptide-Guided Strategy for Heart Failure Management. ’––”FŒ³ (“à‡U): ‘æ69‰ñ“ú–{zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2005/3/19-21), _“Þì. Circ J, 69 (Suppl I): 48, 2005.

723142. [Šw‰ï (‘S‘)] (ƒRƒƒfƒBƒJƒ‹ƒZƒbƒVƒ‡ƒ“E‹³ˆçu‰‰j –«S•s‘SŽ¡—ÂÌÅ‘Oü|–ò•¨—Ö@. ’––”FŒ³ (“à‡U): ‘æ69‰ñ“ú–{zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2005/3/19-21), _“Þì. ƒvƒƒOƒ‰ƒ€, p.189, 2005.

723143. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) –«S•s‘SƒÀŽÕ’f–ò—Ö@‚É‚¨‚¯‚錌’†ƒ}[ƒJ[‘ª’è‚̈Ӌ`. ’––”FŒ³, ’|“àˆê˜Y, ’†–ì_¬ (“à‡U): ‘æ101‰ñ“ú–{“à‰ÈŠw‰ïu‰‰‰ï (2004/4/4j, “Œ‹ž. “ú–{“à‰ÈŠw‰ïŽGŽ, 93 (Suppl): 170, 2004.

723144. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) A‚¦ž‚ÝŒ^œ×“®Ší (ICD) A‚¦ž‚ÝÇ—á‚Ì—Õ°Œo‰ß‚É‚¨‚¯‚éì“®ó‹µ. ‹|í@‘å, ’ë–ìTˆê, ¡–Ø—²‘¾, •½àV³ŽŸ, ²“¡‘å•ã, ²X–Ø@‹B, ˜eâ—TŽq, Œ´@‰pK, XŒû¹•F, ’ë–ì—TŒb, ˜aò@“O (“à‡Uj: ‘æ19‰ñ“ú–{S‘Ÿƒy[ƒVƒ“ƒOE“d‹C¶—Šw‰ïŠwp‘å‰ï (2004/5/27-29), VŠƒ. •s®–¬, 20: 264, 2004.

723145. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) S•s‘SÇ—á‚É‚¨‚¯‚éS‹@”\•Ï‰»‚Æ•s®–¬”­¶‚Ì‘ŠŠÖ‚ÌŒŸ“¢. •½àV³ŽŸ, ’ë–ìTˆê, ’––”FŒ³, ‹|í@‘å, ¡–Ø—²‘¾, ²“¡‘å•ã, ²X–Ø@‹B, ˜eâ—TŽq, Œ´@‰pK, XŒû¹•F, ’ë–ì—TŒb, ˜aò@“O (“à‡U): ‘æ19‰ñ“ú–{S‘Ÿƒy[ƒVƒ“ƒOE“d‹C¶—Šw‰ïŠwp‘å‰ï (2004/5/27-29), VŠƒ. •s®–¬, 20: 224, 2004.

723146. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) ƒuƒ‹ƒKƒ_Œ^S“d}Ç—á‚É‚¨‚¯‚éVF—U”­«‚Æ—Õ°“IŠëŒ¯—\‘ªˆöŽq‚Ì”äŠrŒŸ“¢. ¡–Ø—²‘¾, ’ë–ìTˆê, ‹|í@‘å, •½àV³ŽŸ, ²“¡‘å•ã, ²X–Ø@‹B, ˜eâ—TŽq, “’–{‰ÀG, ’ë–ì—TŒb. Œ´@‰pK, XŒû¹•F, ˜aò@“O (“à‡Uj: ‘æ19‰ñ“ú–{S‘Ÿƒy[ƒVƒ“ƒOE“d‹C¶—Šw‰ïŠwp‘å‰ï (2004/5/27-29), VŠƒ. •s®–¬, 20: 196. 2004.

723147. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) Šg’£Œ^S‹ØÇŠ³ŽÒ‚É‚¨‚¯‚é‰^“®•‰‰×ŽžT”gŒ`‘ԕω»‚ÌŠÏŽ@. Œ´@‰pK, ’ë–ìTˆê, •½àV³ŽŸ, ˜aò@“O (“à‡U): ‘æ19‰ñ“ú–{S‘Ÿƒy[ƒVƒ“ƒOE“d‹C¶—Šw‰ïŠwp‘å‰ï (2004/5/27-29), VŠƒ. •s®–¬, 20: 212 2004.

723148. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) S–[ד®ŽüŠú’·‚Ì“ú“à•Ï“®‚ɉe‹¿‚·‚éˆöŽq‚ÌŒŸ“¢. ד®Žü”g”‰ðÍ‚É‚æ‚錟“¢. ²X–Ø@‹B1, ’ë–ìTˆê1, ¡–Ø—²‘¾1, ‹|í@‘å1, •½àV³ŽŸ1, ²“¡‘å•ã1, ˜eâ—TŽq1, Œ´@‰pK1, XŒû¹•F1, ’ë–ì—TŒb1, ˜aò@“O, “¡–Ø@–¾ (1“à): ‘æ19‰ñ“ú–{S‘Ÿƒy[ƒVƒ“ƒOE“d‹C¶—Šw‰ïŠwp‘å‰ï (2004/5/27-29), VŠƒ. •s®–¬, 20: 244, 2004.

723149. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) –«S•s‘S‚ɇ•¹‚·‚éS–[ד®‚Ì‘w•Ê‰»`S•s‘S—\Œã‹K’èˆöŽq‚Æ‚µ‚Ä‚Ì”­ì«S–[ד®‚̈Ӌ`. ¬”‹´r”ü, ’––”FŒ³, ’ë–ìTˆê (“à‡U): ‘æ52‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2004/9/13-15j, ‹ž“s. J Cardiol, 44 (Suppl I): 305, 2004.

723150. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) BNPƒKƒCƒh‚É‚æ‚éS•s‘SŠ³ŽÒ‚ÌŠÇ—. ’––”FŒ³ (“à‡U): ‘æ52‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2004/9/13-15j, ‹ž“s. J Cardio, 44 (Suppl I): 180, 2004.

723151. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) SŽº•p”‚Ì“ñŽŸ—\–h‚É‚¨‚¯‚éEPSƒKƒCƒhŽ¡—Â̈Ӌ`‚ÌŒŸ“¢. ‹|í@‘å, ’ë–ìTˆê, XŒû¹•F, •½àV³ŽŸ, ¡–Ø—²‘¾ ,²“¡‘å•ã ,²X–Ø@‹B, ˜aò@“O (“à‡U): ‘æ21‰ñS“dŠw‰ïŠwpW‰ï (2004/9/13-14), ‘åã. S“d}, 24: 334, 2004.

723152. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) S‹Ø‰Šƒ‰ƒbƒg‚É‚¨‚¯‚éƒjƒRƒ‰ƒ“ƒWƒ‹‚ƃƒLƒVƒŒƒ`ƒ“‚ÌS‹Ø•ÛŒìì—p‚ÌŒŸ“¢. •½àV³ŽŸ, ’ë–ìTˆê, ˜eâ—TŽq, ’ë–ì—TŒb, ˜aò@“O (“à‡U): ‘æ21‰ñS“dŠw‰ïŠwpW‰ï (2004/9/13-14), ‘åã. S“d}, 24: 356, 2004.

723153. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) “Á”­«Šg’£Œ^S‹ØÇ (DCM) Š³ŽÒ‚É‚¨‚¯‚é‰^“®•‰‰×ŽžT”gŒ`‘ԕω»‚ÌŠÏŽ@. Œ´@‰pK1, ’ë–ìTˆê1, Žç“cŒ›’, ‰ªŽR@’q, ’r“cŒ›º1, ˆÉ“¡_Žk, Œ¢”öŒöŒú1, ˜aò@“O1 (1“à‡U): ‘æ21‰ñS“dŠw‰ïŠwpW‰ï (2004/9/13-14), ‘åã. S“d}, 24: 329, 2004.

723154. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) S‹Ø‰Š‚É‚¨‚¯‚鶎º‚Ì\‘¢“IE“d‹C“IƒŠƒ‚ƒfƒŠƒ“ƒO‚ÌŒoŽž“I•]‰¿. ˜eâ—TŽq, ’ë–ìTˆê, ’ë–ì—TŒb, Ä“¡~Žq, ‹g“c@“O, •½àV³ŽŸ, ˜aò@“O (“à‡U): ‘æ21‰ñS“dŠw‰ïŠwpW‰ï (2004/9/13-14), ‘åã. S“d}, 24: 354, 2004.

723155. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) ƒqƒgS–[—˜”Aƒyƒvƒ^ƒCƒh (hANP) ‘ãŽÓ‘jŠQ–ò‚Í’ZŠú“I“d‹C“IƒŠƒ‚ƒfƒŠƒ“ƒO‚ð—}§‚·‚é. ¡–Ø—²‘¾, ’ë–ìTˆê, ²“¡‘å•ã, ‹g“c@“O, ’ë–ì—TŒb, ˜aò@“O (“à‡U): ‘æ21‰ñS“dŠw‰ïŠwpW‰ï (2004/9/13-14), ‘åã. S“d}, 24: 354, 2004.

723156. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) S–[ד®”gŽüŠú’·‚ɑ΂·‚鶎º‹@”\áŠQ‚̉e‹¿‚ɂ‚¢‚Ä‚ÌŒŸ“¢|ד®”gŽü”g”‰ðÍ‚É‚æ‚錟“¢|. ²X–Ø@‹B1, ’ë–ìTˆê1, ¡–Ø—²‘¾1, ‹|í@‘å1, •½àV³ŽŸ1, ²“¡‘å•ã1, ˜eâ—TŽq1, XŒû¹•F1, ’ë–ì—TŒb1, ˜aò@“O1, “¡–Ø@–¾ (1“à‡U): ‘æ21‰ñS“dŠw‰ïŠwpW‰ï (2004/9/13-14), ‘åã. S“d}, 24: 358, 2004.

723157. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) The Role of Phosphoinositie 3-kinase in Thyroid Hormone Induced Cardiac Hypertrophy in Mice. ¬™—Œb (“à‡U): ‘æ8‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2004/9/30-10/2), Šò•ŒD

723158. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) Clinical significance of serial measurements of cardiactroponin T level to predict fulmination of acute myocarditis. ’––”FŒ³, ’|’[@‹Ï, ’|“àˆê˜Y (“à‡U): ‘æ8‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2004/9/30-10/2j, Šò•Œ. ´˜^W, p.122, 2004.

723159. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) ¶Žºƒy[ƒVƒ“ƒO‚Ì•¹—p‚É‚æ‚è’˜–¾‚ÈS‹@”\‰ü‘P‚ª“¾‚ç‚ꂽ•Ù’uŠ·pŒã‚̈ê—á. •iì–íl, ’––”FŒ³1, XŒû¹•F1 (1“à‡U): ‘æ8‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2004/9/30-10/2j, Šò•Œ. ´˜^W, p.206, 2004.

723160. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) Conflicting Effects on Experimental Autoimmune Myocarditis by Disrupting of Gi Protein Signal. ’†–ì_¬, ’––”FŒ³, ¼ˆäŠîŒp (“à‡U): ‘æ8‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2004/9/30-10/2j, Šò•Œ. ´˜^W, p.149, 2004.

723161. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) Õs®–¬«S‹ØÇ—l‚Ì—Õ°Œo‰ß‚ð‚Æ‚èS‹Ø‚ÉŽ‰Ž¿’¾’…‚ð”F‚ß‘gDŠw“I‚ÉSFabry•a‚ª‹^‚í‚ꂽˆê–UŒŸ—á. ’|“àˆê˜Y, ’––”FŒ³, ŸÀ‰p‘¾ (“à‡U): ‘æ8‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2004/9/30-10/2j, Šò•Œ. ´˜^W, p.221, 2004.

723162. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) Angiotensin II Receptor Antagonist Suppressed The Expression of Aging Markers in Diabetic Mouse Heart. ¬™—Œb (“à‡U): ISHR The 21st Annual Meeting of the Japanese Section (2004/11/24-25j, ŽR—œ.

723163. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) Swan-GanzƒJƒe[ƒeƒ‹ˆê‰ñS”o—Ê‘ª’è‚É‚æ‚é‹}«S‹Ø[ÇÄŸó—¬’¼Œã‚Å‚Ì‹CâS‹Ø‚Ì•]‰¿. ‹g“c@“O1, ¡ˆä@Š°2, ’¬ˆä³l3, ˆä㕶Žq2, ¬—Ñ@ŒM3, ó—˜@–õ, ‘Š”nˆêˆå3, ˜aò@“O1 (1“à‡U. 2‹~–½. 3‹¹ŠOj: ‘æ31‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2004/3/4-6), •Ÿ‰ª. “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, 11 (Supplj: 142, 2004.

723164. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Š¥“®–¬‘¢‰e‚Å‘S‚­•`o‚³‚ê‚È‚©‚Á‚½‚Ñ‚Ü‚ñ«‹·ó‚ª–UŒŸŽž‚É”»–¾‚µ, ŠŒ©‚ª‘å‚«‚­˜¨—£‚µ‚½S‘Ÿ“Ë‘RŽ€—á. ‹g“c@“O1, ¡ˆä@Š°2, ’¬ˆä³l3, ŽR–{Ms2, ó—˜@–õ2, ‘Š”nˆêˆå2, ˜aò@“O1, ‰iˆä’q‹I4, ŒIŒ´Ž—R4 (1“à‡U. 2‹~–½. 3‹¹ŠO. 4–@ˆãj: ‘æ7‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï (2004/5/14-16), ‰¡•l. “ú–{—Õ°‹~‹}ˆãŠw‰ïŽGŽ, 7 (2): 200, 2004.

723165. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‹~–½‹~‹}ƒZƒ“ƒ^[‚É”À‘—‚³‚ꂽSŽ¾Š³Š³ŽÒ”‚Ì‹Gß•Ï“®|ƒXƒgƒŒƒX‚Æ‚ÌŠÖ˜A‚©‚ç|. ‹g“c@“O1, •Ð‰ª—Sˆê2, ¡ˆä@Š°2, ²“¡çŒb2, ¬—Ñ@ŒM2, –k–ì‹`˜a2, 㞊‹gl2, –kŒ´F—Y2, ‘Š”nˆêˆå2 (1“à‡U. 2‹~–½): ‘æ32‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2004/10/27-29), ç—t. “ú‹~‹}ˆã‰ïŽ, 15: 404, 2004.

723166. [Šw‰ï (‘S‘)] TNF-alfa induced Ion Channel (Ito) Down Regulation in Myocyte is not Mediated by Reactive Oxygen Species (ROS). ‹|í@‘å, ’ë–ìTˆê, ’ë–ì—TŒb, Kawada H, “’–{‰ÀG, ˜eâ—TŽq, Sasaki S, ˜aò@“O (“à‡U): ‘æ69‰ñ“ú–{zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2005/3/19-21), _“Þì. Circ J, 69 (1): 273, 2005.

723167. [Šw‰ï (‘S‘)] Neutralendopeptide Inihbitor (NEPI) Suppresses Early Phase of Atrial Electrical Remodeling in Canine Rapid Atrial Stimulation Model. ¡–Ø—²‘¾, ’ë–ìTˆê, ²“¡‘å•ã, ‹g“c@“O, ’ë–ì—TŒb, ˜aò@“O (“à‡U): ‘æ69‰ñ“ú–{zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2005/3/19-21), _“Þì. Circ J, 69 (1): 367, 2005.

723168. [Šw‰ï (‘S‘)] Bepridil Inhibits Sub-acute Phase of the Atrial Electrical Remodeling in Canine Rapid Atrial Stimulation Model. ²“¡‘å•ã, ’ë–ìTˆê, ’ë–ì—TŒb, ¡–Ø—²‘¾, ¬“‡Žžº, ˜aò@“O (“à‡U): ‘æ69‰ñ“ú–{zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2005/3/19-21), _“Þì. Circ J, 69 (1): 609, 2005.

723169. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘èEŒûq) Clinical Significance of Aggressive Intervension with Defibrillation and Pharmacological Maintenance of Sinus Rhythm for Persistent Atrial Fibrillation with Heart Failure. ¬”‹´r”ü1, ’––”FŒ³1, ’ë–ìTˆê1, ’†–ì_¬1, ’|“àˆê˜Y1, •iì–íl, ¼ˆäŠîŒp1, ’|’[@‹Ï1, •ìMŒå1, ˜aò@“O1 (1“à‡U): ‘æ69‰ñ“ú–{zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2005/3/19-21), _“Þì. Circ J, 69 (1): 189, 2005.

723170. [Šw‰ï (‘S‘)] (ŠwpˆÏˆõ‰ï•ñ) u‹}«‚¨‚æ‚Ñ–«S•s‘S‚Ìf’fEŽ¡—ÂɊւ·‚éƒKƒCƒhƒ‰ƒCƒ“v‰ðà|‘˜_E‹}«S‹Ø‰Š. ’––”FŒ³ (“à‡Uj: ‘æ69‰ñ“ú–{zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2005/3/19-21), _“Þì. ƒvƒƒOƒ‰ƒ€, p.680, 2005.

723171. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘èEŒûq) Clinical Characteristics of Heart Disease Patinets with a Good Prognosis in spite of Markedly Increased BNP. ’|“àˆê˜Y, ’––”FŒ³, ¼ˆäŠîŒp (“à‡Uj: ‘æ69‰ñ“ú–{zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2005/3/19-21), _“Þì. Circ J, 69 (Suppl): 233, 2005.

723172. [Šw‰ï (‘S‘)] (ˆê”Êu‘è) Cardiac Aging - Angiotensin II Receptor Antagonist Suppressed the Expression of Senescence Markers in Diabetic Mouse Hear. ¬™—Œb (“à‡Uj: ‘æ69‰ñ“ú–{zŠÂŠíŠw‰ï (2005/3/19`21j, _“Þì.

732020. [Šw‰ï (’n•û)] (‹³ˆçu‰‰) Ç—á’ñŽ¦E‰ðà|BNPƒKƒCƒh‚ÌS•s‘SŽ¡—Ã. ’––”FŒ³ (“à‡Uj: ‘æ13‰ñ“ú–{S‘Ÿ•aŠw‰ï‹³ˆçƒZƒ~ƒi[EƒAƒhƒoƒ“ƒXƒR[ƒX (2005/3/6j, ‘åã.

733052. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “ÁˆÙ‚È––½_ŒoáŠQ‚ð—L‚µ‹}«is«‚ÌS‹@”\áŠQ‚É‚æ‚莀–S‚µ‚½Žá”N—á. ¡–Ø—²‘¾, ’––”FŒ³ (“à‡Uj: ‘æ190‰ñŠÖ“ŒbM‰z’n•û‰ï (2004/6/18j, “Œ‹ž.

733053. [Šw‰ï (’n•û)] –«S•s‘S‚ɇ•¹‚·‚éS–[ד®‚Ì‘w•Ê‰»|S•s‘S—\Œã‹K’èˆöŽq‚Æ‚µ‚Ä‚Ì”­ì«S–[ד®‚̈Ӌ`. ¬”‹´r”ü1, ’––”FŒ³1, ’ë–ìTˆê1, ’†–ì_¬1, ’|“àˆê˜Y1, •iì–íl, ¼ˆäŠîŒp1, ˜aò@“O1 (1“à‡Uj: S•s‘S‚Æ•s®–¬ƒtƒH[ƒ‰ƒ€ (2004/11), “Œ‹ž. Jpn J Cardiol, 44: 305, 2004.

733054. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ŒŒŸ÷BNP‚ª’á’l‚É‚àŠÖ‚í‚炸ƒÀŽÕ’f–ò“±“ü‚ª¢“ï‚Å‚ ‚Á‚½dÇS•s‘S‚̈ê—á. •iì–íl, ’––”FŒ³1, “n•Ó¹•¶1 (1“à‡Uj: ‘æ194‰ñŠÖ“ŒbM‰z’n•û‰ï (2004/12/4j, “Œ‹ž. Circ J, 69 (Suppl II): 838, 2004.

733055. [Šw‰ï (’n•û)] (ˆê”ʉ‰‘èEŒûq) S•s‘S‘ˆ«Šú‚Ì—Õ°Žw•W‚ÉŠî‚­–«S•s‘S‚Ì—\Œã—\‘ª|‰ES•s‘S’¥Œó‚É’…–Ú‚µ‚Ä. •iì–íl, ’––”FŒ³1, ’†–ì_¬1 (1“à‡Uj: ‘æ17‰ñ_“ÞìS•s‘SŒ¤‹†‰ï (2005/2/19), ‰¡•l.

733056. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‹~‹}‘à‚É‚æ‚é’¼—¬œ×“®‚É‚Ä‹~–½‚ɬŒ÷‚µ‚½”ñ“ÁˆÙ“IS“d}‚ÌBrugadaÇŒóŒQ‚̈ê—á. ‘OìŒb”ü, XŒû¹•F1, •iì–íl, ‹|í@‘å1, ¼ˆäŠîŒp1, –k–ì‹`˜a2, ‹g“c@“O1, •Ÿ“c’¼l1, ’ë–ìTˆê1, ˜aò@“O1 (1“à‡U. 2‹~–½j: ‘æ194‰ñ“ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2004), “Œ‹ž. Circulation J, 69 (Suppl II): 844, 2004.

733057. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘m–X•Ù’uŠ·p‚ª‘tŒ÷‚µ‚½•ÂÇ«”ì‘åŒ^S‹ØÇ‚Ì‘m–X•Ù‹·óLJ•¹—á. ¬–Ñ@’, ŸÀ‰p‘¾, ’––”FŒ³ (“à‡Uj: ‘æ195‰ñŠÖ“ŒbM‰z’n•û‰ï (2005/2/5j, “Œ‹ž.

733058. [Šw‰ï (’n•û)] f’f‚É‹ê—¶‚µ‚½2ŽŸ«SƒAƒ~ƒƒCƒh[ƒVƒX‚Ì1—á. ŽR–{Œ›Žq, Œ´@‰pK1, ‰Á“¡L‘¾˜Y, ’¬’JŒö”üŒb, ˆÉ“¡_Žk, ‹´–{iŽq, Žá—Ñ—Ç‘¥, ]Œû³M (1“à‡U): ‘æ195‰ñ“ú–{“à‰ÈŠw‰ï“ŒŠC’n•û‰ï (2005/2), ŽOd.

733059. [Šw‰ï (’n•û)] (ˆê”Êu‰‰j Œ¸ˆ³Ç‚Æf’f‚³‚ꂽ‹}«‘å“®–¬‰ð—£‚̈ê—á. ‹g“c@“O1, •ž•”@, ¬—Ñ@ŒM2, “‡“c@Œª3, •Ð‰ª—Sˆê2, ¼Šª@”Ž4, ŽR–{aˆê˜Y2, ²“¡çŒb2, ˆø“crˆê2, ¡ˆä@Š°2, –kŒ´F—Y2, ‘Š”nˆêˆå2 (1“à‡U. 2‹~–½. 3ŠO. 4•új: ‘æ4‰ñ“ú–{‚‹Cˆ³ŠÂ‹«ˆãŠw‰ïŠÖ“Œ’n•û‰ïE‘æ6‰ñö…ˆãŠwuÀ¬“cŒ´ƒZƒ~ƒi[‡“¯ŠwpW‰ï (2005), ¬“cŒ´. “ú–{‚‹Cˆ³ŠÂ‹«ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽ, 3 (3): 35, 2005.

733060. [Šw‰ï (’n•û)] (ˆê”Êu‰‰j “–‰, Œ¸ˆ³Ç‚Æ‚Ì”»•Ê‚ª¢“ï‚Å‚ ‚Á‚½‹}«‘å“®–¬‰ð—£‚̈ê—á. •ž•”@, ‹g“c@“O1, ¬—Ñ@ŒM2, “‡“c@Œª3, •Ð‰ª—Sˆê2, ¼Šª@”Ž4, ŽR–{aˆê˜Y2, ²“¡çŒb2, ˆø“crˆê2, ¡ˆä@Š°2, –kŒ´F—Y2, ‘Š”nˆêˆå2 (1“à‡U. 2‹~–½. 3ŠO. 4•új: ‘æ55‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2005), ç—t.

733061. [Œ¤‹†‰ï] (ˆê”Êu‰‰) bó‘Bƒzƒ‹ƒ‚ƒ“‚É‚æ‚éS”ì‘å‚É‚¨‚¯‚éPI3KŒo˜H‚ÌŠÖ—^. ¬™—Œb (“à‡U): ‘æ8‰ñMolecular Cardiovascular Conference (2004), –kŠC“¹.

733062. [Œ¤‹†‰ï] (ˆê”Êu‰‰) “ÁˆÙ‚ÈŒŒ’†ƒoƒCƒIƒ}[ƒJ[ŠŒ©‚ªf’f‚ÌŒ_‹@‚Æ‚È‚è, S–ŒØŠJp‚É‚ÄŒy‰õ‚µ‚½Žûk«S–Œ‰Š‚̈ê—á. ’––”FŒ³, ŸÀ‰p‘¾ (“à‡Uj: ‘æ16‰ñ_“ÞìS•s‘SŒ¤‹†‰ï (2004/8/7), _“Þì.

733063. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‰ES•s‘SŠŒ©‚̉ü‘P‚É‚à‚©‚©‚í‚炸’˜–¾‚È• …’™—¯‚ªŽ‘±‚µ‚½Œ´”­«”x‚ŒŒˆ³Ç‚̈ꎀ–S—á. ¬”‹´r”ü, ’––”FŒ³ (“à‡Uj: ‘æ5‰ñ”x‚ŒŒˆ³ÇŽ¡—ÃŒ¤‹†‰ï (2004/5/29), “Œ‹ž.

733064. [Œ¤‹†‰ï] (ˆê”Êu‰‰) —}§«G’`”’ƒVƒOƒiƒ‹‘jŠQ‚É‚æ‚éŽÀŒ±“IŽ©ŒÈ–Ɖu«S‹Ø‰Š‚Ì—¼•ûŒü«CüŒø‰Ê‚Æ‚»‚Ì‹@˜‚̉ð–¾. ’––”FŒ³, ’†–ì_¬ (“à‡Uj: “Á”­«S‹ØÇ‚ÉŠÖ‚·‚é’²¸Œ¤‹†”Ç@•½¬16”N“x‘æ1‰ñ”ljï‹c (2004/6/12), –kŠC“¹.

733065. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŠŒF×–EŽî”j—ô‚É”º‚¢‹}«”­Ç‚µ‚½ƒJƒeƒRƒ‰ƒ~ƒ“S‹Øǂ̈ê–UŒŸ—á. •iì–íl, ’––”FŒ³1, ¼ŽRÄ‹v (1“à‡U): ‘æ26‰ñS‹Ø¶ŒŸŒ¤‹†‰ï (2004/11/26-27), ç—t. ´˜^W, p.49, 2004.

733066. [Œ¤‹†‰ï] (ˆê”Êu‰‰) —}§«G’`”’ƒVƒOƒiƒ‹‘jŠQ‚É‚æ‚éŽÀŒ±“IŽ©ŒÈ–Ɖu«S‹Ø‰Š‚Ì—¼•ûŒü«CüŒø‰Ê‚Æ‚»‚Ì‹@˜‚̉ð–¾. ’––”FŒ³, ’†–ì_¬, ¼ˆäŠîŒp (“à‡Uj: “Á”­«S‹ØÇ‚ÉŠÖ‚·‚é’²¸Œ¤‹†”Ç@•½¬16”N“x‘æ2‰ñ”ljï‹c (2005/2/4j, ŽD–y. ´˜^W, p.6, 2005.


<<“à‰ÈŠw‡Vi_Œo“à‰ÈŠwj>>

mŠwp˜_•¶n

110079. [Œ´’˜] Eletriptan for the treatment of migraine: results of bridging a Japanese study to Western clinical trials. âˆä•¶•F1, Diener HC, Ryan R, Poole P (1“à‡V): Current Medical Research and Opinion 2004.

110080. [Œ´’˜] MIDAS-assessment of migraine management including the use of triptans in Japan. ‘å’Ë‹IŽq, âˆä•¶•F, ”у–’J”ü•ô (“à‡V): Headache Care, 1 (2): 2004: in press.

110081. [Œ´’˜] Triptophan-immobilized Column-based Immunoadsorption as the Chpice Method for Plasmapheresis in Guillan-Barr Syndrome. ‰ª‹{@‘, ‰¬–ì”üŒbŽq, ‰¬–ì@—T, “ü]KŽq, ‹ààV’¼”ü, âV“¡–L˜a, âˆä•¶•F (“à‡V): Therapeutic Apheresis and Dialysis, 8 (3): 248-253, 2004.

110082. [Œ´’˜] Serotonin 2C receptor gene Cys23er polymorphism: a candidate genetic risk factor of migraine with aura in Japanese population. Kusumi M, Ijiri T, Kowa H, Adachi Y, Takeshima T, âˆä•¶•F1, Nakashima K (1“à‡V): Acta Neurologica Scandinavica, 109: 407-409, 2004.

110083. [Œ´’˜] Predicting Long-term Functional Outcome of Stroke Using Multivariate Analysis. Sugimoto S, Kanda T, âˆä•¶•F1 (1“à‡V): Journal of Physiological Therapuic Science, 16 (2): 129-135, 2004.

110084. [Œ´’˜] FK506 abrogates delayed neuronal death via suppression of nitric oxide production in rats. Sasaki T1, à_“cˆê1,2, Shibata M1, Gotoh J1, •Ÿ“à–õ’j1 (1Œc‰ž‘å. 2“à‡V): Brain Res, 1009: 34-39, 2004.

110085. [Œ´’˜] Current status of diagnosis and treatment of migraine headache in Japanese women. ŒÜ\—’‹v‰À1,2, âˆä•¶•F1 (1“à‡V. 2•xŽm’ʇŠ“쑽–€HꌒN„iƒZƒ“ƒ^[): Headache care, 1: 1-7, 2004.

110086. [Œ´’˜] SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. J Johnson, SM Hague, M Hanson, A Gibson, KE Wilson, EW Evans, AA Singleton, A McInerney-Leo, RL Nussbaum, DG Hernandez, M Gallardo, IG McKeith, DJ Burn, —À@³•£1, O Hellstrom, B Ravina, J Eerola, RH Perry, E Jaros, P Tienari, R Weiser, K Gwinn-Hardy, CM Morris, J Hardy, AB Singleton (1“à‡Vj: Neurology, 63 (3): 554`556, 2004.

120011. [Œ´’˜] “ú–{Œê”ŕГª’É—pquality of life’²¸‘‚ÌM—Š«‚ƑÓ–«‚ÌŒŸ“¢. âˆä•¶•F1, •Ÿ“à–õ’j, Šâ“c@½, ¼‘ºŽüŽO, à_“cˆê1, —é–Ø‘¥G1, ŒÜ\—’‹v‰À1, ´…—˜•F, ‹´–{‚µ‚¨‚è, –]ŒŽ‰·Žq (1“à‡V): _ŒoŽ¡—Êw, 21 (49): 449-458, 2004.

120012. [Œ´’˜] “ú–{Œê”ŕГª’É—pquality of life’²¸‘‚ÌŒ¾Œê“I‘Ó–«‚ÌŒŸ“¢. à_“cˆê1, ´…—˜•F, •Ÿ“à–õ’j, âˆä•¶•F1, Šâ“c@½, ¼‘ºŽüŽO (1“à‡V): _ŒoŽ¡—Ã, 21: 443-447, 2004.

120013. [Œ´’˜] “ú–{Œê”ÅHeadache Impact Test (HIT-6) ‚ÌM—Š«‚ÌŒŸ“¢. âˆä•¶•F1, •Ÿ“à–õ’j, Šâ“c@½, à_“cˆê1, ŒÜ\—’‹v‰À1 , ´…—˜•F, “©ŽR˜a–¾, ‰eŽR@‘, rìˆê˜Y, ˆäKÍŒå, A’n‘×”V, ‰i“c@™B (1“à‡V): —Õ°ˆã–ò, 20 (10): 1045-1054, 2004.

120014. [Œ´’˜] “–‰@Eˆõ‚É‚¨‚¯‚铪’É‚ÌŽÀ‘Ô’²¸‚ɂ‚¢‚Ä. HŽR‹v® (“à‡VEìèŽs—§ˆä“c•a‰@): “ú–{“ª’ÉŠw‰ïŽ, 31 (2): 89-91, 2004.

120015. [Œ´’˜] •Ð“ª’ÉÇó‚Ì‘i‚¦•û|Œ¨‚±‚è‚Æ“ª’É‚Ì•”ˆÊE«ó|. ’|“‡‘½‰ê•v1, ŒÜ\—’‹v‰À2,3, (1’¹Žæ‘å. 2“à‡V. 3•xŽm’Ê (Š”) “쑽–€HꌒN„iƒZƒ“ƒ^[): f’f‚ÆŽ¡—Ã, 92: 1075`1080, 2004.

120016. [Œ´’˜] 5-HTŽó—e‘ÌŽhŒƒ‚̃‰ƒbƒgcortical spreading depression‚¨‚æ‚Ñ”º‚·‚é”]ŒŒ—¬‘‰Á”½‰ž‚É—^‚¦‚é‰e‹¿. •Ÿ“c—Ï–ç1, —é–Ø‘¥G1, ¬òŒ’ŽO1, ’ËŒ´M–ç2, âˆä•¶•F1, ‘¾“cWˆê3 (1“à‡V. 2Žµ‘òƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•a‰@. 3…ŒËÔ\Žš•a‰@): ”]zŠÂ‘ãŽÓ, 16: 64-65, 2004.

210020. [’Z•ñ] The International Classification of Headache Disorders, 2nd Edition (ICHD-II)- revision of criteria for 8.2 Medication-overuse headache. SD Silberstein, J Olesen, M-G Bousser, H-C Diener, D Dodick, M First, PJ Goadsby, H Gobel, MJA Lainez, JW Lance, RB Lipton, G Nappi, âˆä•¶•F1, J Schoenen, TJ Steiner (1“à‡V): Cephalalgia, 25: 460-465, 2005.

220010. [’Z•ñ] sumatriptan‚̃‰ƒbƒgcortical spreading depression‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä. •Ÿ“c—Ï–ç1, —é–Ø‘¥G1, ¬òŒ’ŽO1, ’ËŒ´M–ç2, âˆä•¶•F1, ‘¾“cWˆê3 (1“à‡V. 2Žµ‘òƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•a‰@. 3…ŒËÔ\Žš•a‰@j: “ú–{“ª’ÉŠw‰ïŽ, 31 (2): 105-107, 2004.

220011. [’Z•ñ] ƒ‰ƒbƒgŽO³_Œo”]ŒŒŠÇŽ}“d‹CŽhŒƒ‚É‚¨‚¯‚é“àèòÖ¬ŒŒ’†Cysteinyl leukotrienes‚Ì•Ï“®. ’ËŒ´M–ç1, —é–Ø‘¥G2, •Ÿ“c—Ï–ç2, ¬òŒ’ŽO2, ŠÛŽR–ΑP3, âˆä•¶•F2 (1Žµ‘òƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•a‰@. 2“à‡V. 3ŽÀ“®j: “ú–{“ª’ÉŠw‰ïŽ, 31 (2): 44-46, 2004.

220012. [’Z•ñ] MIDASŽ¿–â•[‚É‚æ‚éƒgƒŠƒvƒ^ƒ“Œn–òÜ‚Ì‹qŠÏ“I•]‰¿. ‘å’Ë‹IŽq, ”у–’J”ü•ô, ŒÜ\—’‹v‰À, âˆä•¶•F (“à‡V): “ú–{“ª’ÉŠw‰ï‰ïŽ, 31 (2): 95-97, 2004.

310004. [Ç—á] Vasogenic leakage on the mechanism of migraine with prolonged aura in Sturge-Weber syndrome. ”Ñ’Ë‚_, âˆä•¶•F, ŽRì‹M‹vŽq, —é–ØN•ã, —é–Ø‘¥G (“à‡V): Cephalalgia, 24: 767-770, 2004.

320011. [Ç—á•ñ] d“x‚Ìš‹‰ºáŠQ‚Å”­Ç‚µ‘ÎÆ“I‚ÈŒo‰ß‚ð’H‚Á‚½‰„‘ŠO‘¤ÇŒóŒQ‚Ì2—á. Š}Œ´@—²1, ¬ŽR—SŽi1, o]aˆê1, HŽR‹v®2,3, ŒÃìr–¾1, ŒIŒ´—R‰À1, Šp’J’¼•F1, Γc@ô1 (1“ŒŠC‘å. 2“à‡V. 3ìèŽs—§ˆä“c•a‰@): “ú–{ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ˆãŠw, 41 (8): 555-560, 2004.

320012. [Ç—á•ñ] Žã“¢˜_gƒŠƒXƒNƒtƒ@ƒNƒ^[‚𔺂킸Ĕ­«‘½”­«”][Ç‚ð’悵‚½‚—îŽÒ—áh. HŽR‹v® (“à‡VEìèŽs—§ˆä“c•a‰@): “à‰Èê–åˆã‰ïŽ, 16 (2): 263-273, 2004.

320013. [Ç—á•ñ] Žã“¢˜_g• ’ÉE‚ŒŒˆ³‚Å”­Ç‚µ• •”CT‚Å—¼‘¤t[Ç, ¶•›tŽî‘å, —¼‘¤t“®–¬‹·ó‚ð”F‚ß‚½44Η«h. HŽR‹v® (“à‡VEìèŽs—§ˆä“c•a‰@): “à‰Èê–åˆã‰ïŽ, 16 (3): 502-513, 2004.

320014. [Ç—á•ñ] Žã“¢˜_g‹}«t•s‘S‚ð’悵‚½60΂̒j«h. HŽR‹v® (“à‡VEìèŽs—§ˆä“c•a‰@): “à‰Èê–åˆã‰ïŽ, 16 (4): 697-703, 2004.

320015. [Ç—á•ñ] Progressing stroke‚Å”­Ç‚µ, ŽåŠ²“®–¬‚“x‹ ó‚ª’ZŠúŠÔ‚µÁŽ¸‚µ‚½•Ð‘¤«‹«ŠE—̈æ[ǂ̈ê—á. —é–ØN•ã, ‹{ì¹D, ”Ñ’Ë‚_, –å‘O’BÆ, —é–Ø‘¥G, âˆä•¶•F (“à‡V): •ªŽq”]ŒŒŠÇ•a, 3 (2): 236-239, 2004.

320016. [Ç—á•ñ] ”x‰Š‹…‹Û‚ƃAƒXƒyƒ‹ƒMƒ‹ƒX‚̬‡Š´õ‚É‚æ‚é‘–Œ”]‰Š‚̈ê—á. –å‘O’BÆ1, ”Ñ’Ë”ü1, ã–{”ü“ÞŽq1, —Rˆäi‘¾˜Y1, —é–ØN•ã1, ”Ñ’Ë‚_1, âˆä•¶•F1, ‘Š”nˆêˆå2 (1“à‡V. 2‹~–½): •ªŽq”]ŒŒŠÇ•a, 3 (2): 2004.

320017. [Ç—á•ñ] Zolmitriptan iZomigj “à•ž‚É‚Ä—U”­‚³‚ꂽŠ¥¹k«‹·SÇ‚Ì1—á. HŽR‹v®1,2, _ŽR”ü2 (1“à‡V. 2ìèŽs—§ˆä“c•a‰@): “ú–{“ª’ÉŠw‰ïŽ, 31 (2): 114-116, 2004.

510004. [‘à] Pathogenesis of stroke-like episodes in MELAS: Analysis of neurovascular cellular mechanisms. ”Ñ’Ë‚_, âˆä•¶•F (“à‡V): Current Neurovascular Research, 2: 29-45, 2005.

520064. [‘à] ƒvƒ‰ƒCƒ}ƒŠƒPƒA‚É‚¨‚¯‚é•Ð“ª’É‚ÌŒ©•ª‚¯•û. âˆä•¶•F (“à‡V): Pharma Medica, 22 (1): 75-85, 2004.

520065. [‘à] ˆãŠw‚ƈã—ÂÌÅ‘Oü. •Ð“ª’É‚ÌŽ¡—Ã. Å‹ß‚Ìi•à. ”Ñ’Ë‚_, âˆä•¶•F (“à‡V): “ú–{“à‰ÈŠw‰ïŽGŽ, 93 (2): 198-205, 2004.

520066. [‘à] ‹@”\«Ž¾Š³‚ÌŽ¡—ÂÌi•à. ”Ñ’Ë‚_, âˆä•¶•F (“à‡V): _ŒoŽ¡—Êw, 21 (4): 427-436, 2004.

520067. [‘à] “ª’É‚ÉŠÖ‚·‚é‘Û“I“®Œü. âˆä•¶•F (“à‡V): ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 22 (10): 85, 2004.

520068. [‘à] Migraine-QUEST‚Ì—L—p«‚ÆŠˆ—p–@. âˆä•¶•F (“à‡V): Medical Tribute, 55, 2004.

520069. [‘à] ”]ŒŒŠÇáŠQ‚Æ“ª’É. à_“cˆê (Œc‰ž‘åE“à‡V): Ž¡—Ã, 86 (4): 1541-1547, 2004.

520070. [‘à] “à‰ÈƒRƒ‚ƒ“ƒvƒƒuƒŒƒ€@“ª’É. à_“cˆê (Œc‰ž‘åE“à‡V): Medicina, 41 (4): 592-596, 2004.

520071. [‘à] ’É‚Ý‚Ì•ªŽqƒƒJƒjƒYƒ€‚Æ—Õ°@•Ð“ª’É. à_“cˆê (Œcœä‘åE“à‡V): Molecular Medicine, 41 (6): 729-735, 2004.

520072. [‘à] ”DP’† iŽžj ‚É‚¨‚¯‚é•Ð“ª’É. à_“cˆê (Œc‰ž‘åE‡V): _Œo“à‰È, 61 (1): 34-39, 2004.

520073. [‘à] “ÁW@_ŒoŽ¾Š³Ž¡—ÂÌi•à i2003”Nj ‹@”\«Ž¾Š³‚ÌŽ¡—ÂÌi•à. ”Ñ’Ë‚_, âˆä•¶•F (“à‡V): _ŒoŽ¡—Êw, 21 (4): 427-436, 2004.

520074. [‘à] ˜J“­ŽÒ‚Ì‘Ì‚ÌÇó‚Ì‘i‚¦‚ւ̑Ήž@“ª’É. ŒÜ\—’‹v‰À (“à‡VE•xŽm’ʇŠ“쑽–€HꌒN„iƒZƒ“ƒ^[): Ž¡—Ã, 86 (3): 507-509, 2004.

520075. [‘à] ƒvƒ‰ƒCƒ}ƒŠ[ƒPƒA‚ÌŽÀÛ|—Õ°Œ¤Cƒ}ƒjƒ…ƒAƒ‹|u“ª’Év. ŒÜ\—’‹v‰À (“à‡VE•xŽm’Ê (Š”) “쑽–€HꌒN„iƒZƒ“ƒ^[): —Õ°ˆã, 30 (‘): 827-828, 2004.

520076. [‘à] ‚ŒŒˆ³‚Ì‹}«‘ˆ«. ˆ¢‹v’Óñ•v (“à‡V): ‹~‹}ˆãŠw, 26 (9): 1019-1022, 2004.

520077. [‘à] ”DP‚É”º‚¤‚ŒŒˆ³«”]Ç, ”]oŒŒ. ˆ¢‹v’Óñ•v (“à‡V): _Œo“à‰È, 61 (1): 30-33, 2004.

520078. [‘à] ƒ¿-ƒVƒkƒNƒŒƒCƒ“ˆâ“`Žqd•¡‚ƃŒƒ”ƒB|¬‘Ì•a. —À@³•£ (“à‡VEˆÉ¨Œ´‹¦“¯•a‰@): Dementia Japan, 18 (3): 235-244, 2004.

520079. [‘à] •Ð“ª’É‚Ìf’fƒ|ƒCƒ“ƒg. ‘å’Ë‹IŽq1, —é–Ø‘¥G1,2 (1“à‡V. 2Œc‰ž‘å): Ž¡—Ã, 31 (4): 1471-1476, 2004.

520080. [uÀ] ‹Ù‹}‚ð—v‚·‚邵‚Ñ‚ê‚Æ’É‚Ý. •Ÿ“c—Ï–ç (“à‡V): Medicina 8. “à‰Èˆã‚ªf‚邵‚Ñ‚ê‚Æ’É‚Ý, p.1287-1289, 2004.

520081. [uÀ] –«“ª’É‚ÌÅV–ò•¨—Ö@. •Ÿ“c—Ï–ç, âˆä•¶•F (“à‡V): ŒŽŠ§ƒi[ƒVƒ“ƒO, 11: Nursing Lecture 6-14, 2004.

520082. [‰ðà] V‚µ‚¢‘Û“ª’É•ª—Þ. “ª’É‚ð‚ß‚®‚éŋ߂̘b‘è, “ÁW. âˆä•¶•F (“à‡V): ”]‚Æ_Œo, 56 (8): 639-643, 2004.

520083. [‰ðà] —Õ°ƒNƒCƒYgŒŒ‰t“§Í—Ö@“±“üŒã‚É’˜–¾‚ÈŒŒ¬”ÂŒ¸­‚𗈂½‚µ‚½–«t•s‘S‚Ì1—áh. HŽR‹v® (“à‡VEìèŽs—§ˆä“c•a‰@): “à‰Èê–åˆã‰ïŽ, 16 (2): 277-287, 2004.

520084. [‰ðà] —Õ°ƒNƒCƒYg¶ã• •”’É‚ð”F‚ß‚½ˆê—áh. HŽR‹v® (“à‡VEìèŽs—§ˆä“c•a‰@): “à‰Èê–åˆã‰ïŽ, 16 (3): 516-524, 2004.

520085. [‰ðà] —Õ°ƒNƒCƒYg”ç]CŠÖß’É‚Å—ˆ‰@‚µ‚½28΂̗«h. HŽR‹v® (“à‡VEìèŽs—§ˆä“c•a‰@): “à‰Èê–åˆã‰ïŽ, 16 (4): 704-710, 2004.

520086. [‰ðà] ”]ŒŒŠÇ«’s•ð‚Ì“ÁŽêŒ^|‰Æ‘°«•Ð–ƒáƒ«•Ð“ª’É|. ”у–’J”ü•ô1, —é–Ø‘¥G1,2 (1“à‡V. 2Œc‰ž‘å): “ú–{—Õ°, 3 (‘): 186-191, 2004.

520087. [‰ðà] —Õ°ƒNƒCƒYg3ƒJŒŽ‚ÌŒo‰ß‚ňŸ‹}«‚É’s•ð‚ª”­Œ»Eis‚µ‚½48Î’j«—áh. HŽR‹v® (“à‡VEìèŽs—§ˆä“c•a‰@): “à‰Èê–åˆã‰ïŽ, 17 (1): 100-107, 2005.

m’˜@‘n

620043. [Šwp‘] (•ª’SŽ·•M) V‚µ‚¢f’f‚ÆŽ¡—ÂÌABC (21) _Œo2u“ª’Év; ‘æ4Í@ƒZƒƒgƒjƒ“‚Ì–ðŠ„, p.119-126. à_“cˆê (Œc‰ž‘åE“à‡V), •ÒW âˆä•¶•F (“à‡V), ÅVˆãŠwŽÐ, ‘åã, 2004/5/31”­s.

620044. [Šwp‘] (•ª’SŽ·•M) •ÊûÅVˆãŠw@V‚µ‚¢f’f‚ÆŽ¡—ÂÌABC (21) _Œo2u“ª’Év; –âfƒAƒVƒXƒgƒpƒbƒP[ƒW, p.81-92. ”у–’J”ü•ô (“à‡V), •ÒW âˆä•¶•F (_Œo“à), ÅVˆãŠwŽÐ, ‘åã, 2004/5/31”­s.

620045. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) •ªŽq”]ŒŒŠÇ•a7; ŠCŠO˜_•¶Ð‰î@•ÂŒoŒã—«‚É‚¨‚¯‚éƒGƒXƒgƒƒQƒ“{ƒvƒƒQƒXƒeƒƒ“•¹—p—Ö@‚Ì”]‘²’†”­Ç‚É‹y‚Ú‚·‰e‹¿, p.344-346. •Ÿ“c—Ï–ç, —é–Ø‘¥G (“à‡V), æ’[ˆãŠwŽÐ, “Œ‹ž, 2004/7/1”­s.

620046. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) Clinical neuroscience 22 (8); “ªˆÊ•ÏŠ·Šá‹…”½ŽË, “ªˆÊŠá”½ŽËŒf, p.940-942. ”Ñ’Ë‚_1. —é–Ø‘¥G2 (1“à‡V. 2Œc‰ž‘å), •ÒW –؎Oç—Y, ’†ŠOˆãŠwŽÐ, 2004/8/1”­s.

620047. [‰ðà‘] (•ª’SŽ·•M) V•Ò@•S‰È@‰Æ’ë‚̈ãŠw; –«“ª’É. âˆä•¶•F (“à‡V), ŠÄC •û‰x˜Y, ¬—Ñ@“o, Žå•w‚ƶŠˆŽÐ, “Œ‹ž, 2004/9/17”­s.

620048. [‰ðà‘] (•ª’SŽ·•M) ƒJƒŒƒ“ƒgƒeƒ‰ƒs[•Êû, “ÁWu“ª’Éf—ÃÅ‘Oüv|‚æ‚è‚æ‚«“ª’Éf—Âð–ÚŽw‚µ‚Ä| 22 (10); “ª’É‚Ì–âf•[EŽxá“x•[, “ª’É“ú‹L, p.22-28. ”у–’J”ü•ô (“à‡V), •ÒW ŠÔ’†M–ç (‰·’m‰ïŠÔ’†•a‰@), ƒ‰ƒCƒtƒƒfƒBƒRƒ€, “Œ‹ž, 2004/9/25”­s.

620049. [‰ðà‘] (•ª’SŽ·•M) Œ’N•S‰È; “ª’É, p.4-15. âˆä•¶•F (“à‡V), W‰pŽÐ, “Œ‹ž, 2004/11/18”­s.

620050. [Šwp‘] (•ª’SŽ·•M) ƒtƒ@ƒuƒŠ[•a@Šî‘b‚©‚ç—Õ°‚Ü‚Å‚ÌÅ‹ß‚Ì’mŒ©; 3. ƒtƒ@ƒuƒŠ[•a‚Ì—Õ°Çó@6) ¸_E_ŒoÇó, p.58-62. ²“¡GŽ÷1, à_“cˆê1,2 (1Œc‰ž‘å. 2“à‡V), ŠÄC ‰q“¡‹`Ÿ (“Œ‹žŽœŒb‰ïˆã‘å), ƒuƒŒ[ƒ“o”Å, “Œ‹ž, 2004/11/30”­s.

620051. [Šwp‘] (‰ü’ù) ƒxƒbƒhƒTƒCƒh‚Ì_Œo‚Ìf‚©‚½@‰ü’ù16”Å. “cè‹`º, Ä“¡‰À—Y, âˆä•¶•F1 (1“à‡V), “ìŽR“°, “Œ‹ž, 2004”­s.

620052. [Šwp‘] (•ª’SŽ·•M) V‚µ‚¢f’fEŽ¡—ÂÌABC (21) _Œo2u“ª’Év; Eê, ŠwZ‚Å‚Ì“ª’É‘Îô, p.51-55. ŒÜ\—’‹v‰À (“à‡VE•xŽm’Ê (Š”) “쑽–€HꌒN„iƒZƒ“ƒ^[), •ÒW âˆä•¶•F (_Œo“à), ÅVˆãŠwŽÐ, ‘åã, 2004/5/31”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

713058. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) New Insight in the Mechanism of Prolonged Migraine Aura - Augmented Vasogenic Leakage Associated with Trigemionovascular Activation? ”Ñ’Ë‚_, âˆä•¶•F, ŽRì‹M‹vŽq, —é–ØN•ã, ŒÜ\—’‹v‰À, —é–Ø‘¥G (“à‡V): The 56th Annual Meeting of the American Academy of Neurology (2004/4/27), San Francisco, USA. Neurology Supplement 5, 62 (7): A81, 2004.

713059. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Impact of migraine among company workers in Japan. ŒÜ\—’‹v‰À1,2, âˆä•¶•F1 (1“à‡V. 2•xŽm’Ê (Š”) “쑽–€HꌒN„iƒZƒ“ƒ^[): ‘æ15‰ñMigraine Trust International Symposium (2004/9), London.

713060. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Assessment of regional cerebral blood flow with Three-Dimensional Stereotactic Surface Projection (3D-SSP) analysis in Migraine with Aura. ˆäorŒõ1, ”Ñ’Ë‚_1, âˆä•¶•F1, ŒÜ\—’‹v‰À1,2 (1“à‡V. 2•xŽm’Ê (Š”) “쑽–€HꌒN„iƒZƒ“ƒ^[): 15th Migraine Trust international symposium (2004/9/21), ƒƒ“ƒhƒ“. Cephalalgia, 24: 778, 2004.

713061. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Neuroprotective effect of D-ƒÀ-hydroxybutyrate against hypoxia in serum free hippocampal primary culture. ‘“c@—ã1, Monahan JW2, Fukuhara Y3, Leonard PJ2, Takeshima T3, âˆä•¶•F1, Veech RL4, Kashiwaya Y (1“à‡V. 2Cell and Molecular Biology Laboratory, Department of Natural Science, DeSales University. 3’¹Žæ‘å. 4Laboratory of Metabolic Control/National Institute on Alcohol Abuse and Alcoholism/National Institutes of Health): Neuroscience 2004 (2004/10/25), San Diego, CA, USA. J Neurosci Res, 15; 80 (4): 501-509, 2005.

721002. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) “ª’Éf—ẪRƒc‚Æ—Ž‚Æ‚µŒŠ. âˆä•¶•F (“à‡V): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/7), –¼ŒÃ‰®.

721003. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) “úŠØ‚Ì“ª’Éf—Â̋ï‘Ì“I‚È–â‘è“_. âˆä•¶•F1, Chin-Sang Chung (1“à‡V): ‘æ32‰ñ“ú–{“ª’ÉŠw‰ï (2004/11/13), Ž­Ž™“‡.

722026. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) Eê‚Ì“ª’ÉŽÀ‘Ô’²¸|ŽY‹Æˆã‚Æ‚µ‚Ä‚ÌŽæ‚è‘g‚Ý|. ŒÜ\—’‹v‰À (“à‡VE•xŽm’Ê (Š”) “쑽–€HꌒN„iƒZƒ“ƒ^[): ‘æ77‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï‘‰ï (2004/4/16), –¼ŒÃ‰®.

722027. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) •Ð“ª’ɈȊO‚Ì“ª’É. ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“2@“úí‚æ‚­‘˜‹ö‚·‚铪’É@ŠÓ•Ê‚Æ‚Æ‚Á‚Ä‚¨‚«‚̈•û. à_“cˆê (Œc‰ž‘åE“à‡V): ‘æ45‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2004/5/12), “Œ‹ž.

722028. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) “ª’Éf—Âɂ¨‚¯‚é–òÜŽt‚Ì–ðŠ„. ŒÜ\—’‹v‰À (“à‡VE•xŽm’Ê (Š”) “쑽–€HꌒN„iƒZƒ“ƒ^[): ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2004 (2004/‚V/17), ŽD–y.

722029. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) Ž©ŒÈ–ƉuŽ¾Š³ŠÖ˜A«•Ó‰Œn”]‰Š‚ɂ‚¢‚Ä. ˆäorŒõ (“à‡V): ‘æ9‰ñ“ú–{_ŒoŠ´õÇŠw‰ï (2004/10/8), O‘O. Neuroinfection, 9: 102, 2004.

722030. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘Û“ª’É•ª—Þ‘æ2”Å‚Ì“Á’¥‚Æ’ˆÓ“_|–ò•¨——p“ª’É|. ŒÜ\—’‹v‰À (“à‡VE•xŽm’Ê (Š”) “쑽–€HꌒN„iƒZƒ“ƒ^[): ‘æ32‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2004/11/12), Ž­Ž™“‡.

722031. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒ[ƒNƒVƒ‡ƒbƒv‰‰‘è) “ú–{‚É‚¨‚¯‚é•Ð“ª’Éf’f‚ÌŽÀ‘Ô‚¨‚æ‚ѕГª’Ɉã—ÂɊւ·‚éƒAƒ“ƒP[ƒg’²¸. ŒÜ\—’‹v‰À (“à‡VE•xŽm’Ê (Š”) “쑽–€HꌒN„iƒZƒ“ƒ^[): ‘æ32‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2004/11/13), Ž­Ž™“‡.

723173. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) •Ð“ª’ÉŠ³ŽÒ‚̃Šƒ“ƒp‹…‚É‚¨‚¯‚éƒZƒƒgƒjƒ“•úo‹@\‚ɂ‚¢‚Ä. ‰i“c‰hˆê˜Y1, ´…—˜•F1, Œã“¡‹žŽq1, ‰Á“o—L‹I1, à_“cˆê1,2, ’I‹´‹I•v1, —é–Ø‘¥G1,2 (1Œc‰ž‘å. 2“à‡V): ‘æ101‰ñ“ú–{“à‰ÈŠw‰ï‘‰ï (2004/4/8), “Œ‹ž.

723174. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) MIDASŽ¿–â•[‚É‚¨‚¯‚éƒgƒŠƒvƒ^ƒ“Œn–òÜ‚Ì‹qŠÏ“I•]‰¿. ‘å’Ë‹IŽq, ”у–’J”ü•ô, ŒÜ\—’‹v‰À, âˆä•¶•F (“à‡V): ‘æ102‰ñ“ú–{“à‰ÈŠw‰ï‘‰ï (2004/4/8), “Œ‹ž. “ú–{“à‰ÈŠw‰ïŽGŽ, 93: 145, 2004.

723175. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘½”­«d‰»Ç‚Ì—Õ°“I‰ðÍ|Ä”­Š°‰ðŒ^‚ƈꎟisŒ^‚Ì”äŠr‚ð’†S‚É|. “c’†k‘¾˜Y1, ’I‹´‹I•v1, à_“cˆê1,2, –ìì@–Î1, •“c‰pF1, —é–Ød–¾1, ‹vZ˜C—F‹I1, —é–Ø‘¥G1,2 (1Œc‰ž‘å. 2“à‡V): ‘æ45‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2004/5/12), “Œ‹ž.

723176. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) •Ð“ª’ÉŠ³ŽÒƒŠƒ“ƒp‹…‚Ì5-HT1B/1DŽó—e‘̃AƒSƒjƒXƒg‚ɑ΂·‚锽‰ž. ‰i“c‰hˆê˜Y1, à_“cˆê1,2, ´…—˜•F1, Œã“¡‹žŽq1, ‰Á“o—L‹I1, ’I‹´‹I•v1, —é–Ø‘¥G1,2 (1Œc‰ž‘å. 2“à‡V): ‘æ45‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2004/5/13), “Œ‹ž.

723177. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”­ìŠÔŒ‡Šú‚̕Гª’ÉŠ³ŽÒ‚É‚¨‚¯‚鎩—¥_Œo‹@”\‚ÌŒŸ“¢. ´…—˜•F1, Œã“¡‹žŽq1, ‰Á“o—L‹I1, ‰i“c‰hˆê˜Y1, à_“cˆê1,2, ’I‹´‹I•v1, —é–Ø‘¥G1 (1Œc‰ž‘å. 2“à‡V): ‘æ45‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2004/5/13), “Œ‹ž.

723178. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¸_Çó‚Å”­Ç‚µˆÓŽ¯áŠQ‚ƈÙí‰^“®‚ª‘J‰„‚µ‚½“«”]‰Š‚Ì—Õ°“IŒŸ“¢. ”Ñ’Ë‚_1, ˆäorŒõ1, —Rˆäi‘¾˜Y1, —é–ØN•ã1, —é–Ø‘¥G2, âˆä•¶•F1 (1“à‡V. 2Œc‰ž‘å): ‘æ45‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2004/5/14), “Œ‹ž.

723179. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Eê‚É‚¨‚¯‚é•Ð“ª’É‚ÌŽÀ‘Ô’²¸. ŒÜ\—’‹v‰À1,2, âˆä•¶•F2 (1•xŽm’Ê (Š”) “쑽–€HꌒN„iƒZƒ“ƒ^[. 2“à‡V): ‘æ45‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2004/5/14), “Œ‹ž.

723180. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘½Œn“ˆÞkÇ‚É‚¨‚¯‚éMRIã‚̉„‘‚̕ω». ˆ¢‹v’Óñ•v1, •Ä‘qƒŽq2 (1“à‡V. 2¬“cŒ´Žs—§•a‰@): ‘æ45‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2004/5/14), “Œ‹ž.

723181. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Brachial amyotrophic diplegia‚ÆŒz’ÅÇ‚ÌŠÖ˜A«‚ɂ‚¢‚Ä. ‘êŽR—eŽq, ‰¬–ì”üŒbŽq, ‰¬–ì@—T, •y“cˆ¤”ü, •Ÿ“c—Ï–ç, âˆä•¶•F (“à‡V): ‘æ45‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2004/5/14), “Œ‹ž. ƒvƒƒOƒ‰ƒ€, p.146, 2004.

723182. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) •Ð“ª’É”­ìŽ¡—Âɑ΂·‚ésumatriptan, zolmitriptan‚¨‚æ‚Ñeletriptan‚ÌŒø‰Ê‚Ì”äŠrŒŸ“¢. à_“cˆê1,2, ‰i“c‰hˆê˜Y1, ´…—˜•F1, Œã“¡‹žŽq1, ‰Á“o—L‹I1, ’I‹´‹I•v1, —é–Ø‘¥G1 (1Œc‰ž‘å. 2“à‡V): ‘æ22‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2004/6/24), ŽD–y.

723183. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘½”­«d‰»ÇŠ³ŽÒ‚É‚¨‚¯‚éinterferon-ƒÀ-1b‚ÌŽ¡—ÃŒø‰Ê. “c’†k‘¾˜Y1, ’I‹´‹I•v1, à_“cˆê1,2, –ìì@–Î1, •“c‰pF1, —é–Ød–¾1, ‹vZ˜C—F‹I1, —é–Ø‘¥G1 (1Œc‰ž‘å. 2“à‡V): ‘æ22‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2004/6/25), ŽD–y.

723184. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒƒCƒRƒgƒŠƒGƒ“Žó—e‘Ì‘jŠQ‚ÍŽO³_Œo”]ŒŒŠÇŽ} (•@–Ñ—l‘Ì_Œo) “d‹CŽhŒƒ‚É‚æ‚é”]ŒŒ—¬‘‰Á‚ɉe‹¿‚ð‹y‚Ú‚·‚©. •Ÿ“c—Ï–ç1, ’ËŒ´M–ç2, —é–Ø‘¥G3, ¬òŒ’ŽO1, âˆä•¶•F1 (1“à‡V. 2Žµ‘òƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•a‰@. 3Œc‰ž‘å): ‘æ16‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï‘‰ï (2004/9/24), ‚³‚¢‚½‚ÜŽs. ƒvƒƒOƒ‰ƒ€E´˜^W, p.68, 2004.

723185. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¸_Çó‚Å”­Ç‚µ, ˆÓŽ¯áŠQ, ˆÙí‰^“®‚ª‘J‰„‚µ‚½“«”]‰Š‚̈ê—á (‚»‚Ì1). –å‘O’BÆ1, ”Ñ’Ë‚_1, ˆäorŒõ1, ›@Mˆê2, âˆä•¶•F1 (1“à‡V. 2•új: ‘æ9‰ñ“ú–{_ŒoŠ´õÇŠw‰ï (2004/10/8), O‘O. _ŒoŠ´õÇ, 9 (2): 49, 2004.

723186. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¸_Çó‚Å”­Ç‚µ, ˆÓŽ¯áŠQ, ˆÙí‰^“®‚ª‘J‰„‚µ‚½“«”]‰Š‚̈ê—á (‚»‚Ì2) |PET‹y‚ÑIMP-SPECT‚É‚æ‚錟“¢|. ”Ñ’Ë‚_, ˆäorŒõ, —Rˆäi‘¾˜Y, —é–ØN•ã, âˆä•¶•F (“à‡V): ‘æ9‰ñ“ú–{_ŒoŠ´õÇŠw‰ï (2004/10/8), O‘O. _ŒoŠ´õÇ, 9 (2): 50, 2004.

723187. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒWƒFƒbƒgƒR[ƒXƒ^[æŽÔŒã‚ɒᑉtˆ³ÇŒóŒQ‚ð’悵‚½ˆê—á. ”у–’J”ü•ô, ‰¬–ì”üŒbŽq, ‰¬–ì@—T, âˆä•¶•F (“à‡V): ‘æ32‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2004/11/11), Ž­Ž™“‡.

723188. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) •Ð“ª’ÉŠ³ŽÒ––½ŒŒƒŠƒ“ƒp‹…‚É‚¨‚¯‚é”­Œ»ˆâ“`Žqƒvƒƒtƒ@ƒCƒŠƒ“ƒO. •ž•”‰p“T1, ‰i“c‰hˆê˜Y1, ‰Á“¡@Œì1, ¬Š}Œ´ÊŽq1, —é–Ød–¾1, ´…—˜•F1, à_“cˆê1,2, Šp“c’B•F1, ‘Šˆé’å˜a1, —é–Ø‘¥G1 (1Œc‰ž‘å. 2“à‡V): ‘æ32‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2004/11/12), Ž­Ž™“‡.

723189. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Eê‚É‚¨‚¯‚éˆêŽŸ«“ª’É’²¸. ŒÜ\—’‹v‰À (“à‡VE•xŽm’Ê (Š”) “쑽–€HꌒN„iƒZƒ“ƒ^[): ‘æ32‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2004/11/12), Ž­Ž™“‡.

723190. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒ‰ƒbƒgŽO³_Œo”]ŒŒŠÇŽ}“d‹CŽhŒƒ‚É‚æ‚é”]ŒŒ—¬‘‰ÁŒ»Û‚É‹y‚Ú‚·Pranlukast ‚̉e‹¿. ’ËŒ´M–ç1, •Ÿ“c—Ï–ç2, —é–Ø‘¥G3, ¬òŒ’ŽO2, âˆä•¶•F2 (1Žµ‘òƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•a‰@. 2“à‡V. 3Œc‰ž‘å): ‘æ32‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2004/11/12), Ž­Ž™“‡. ƒvƒƒOƒ‰ƒ€E´˜^W, p.53, 2004.

723191. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒ‰ƒbƒg’†”]…“¹ŽüˆÍŠD”’Ž¿‚É•ª•z‚·‚éƒjƒ…[ƒƒgƒ‰ƒ“ƒXƒ~ƒbƒ^[‚ɂ‚¢‚Ä. ¬òŒ’ŽO1, —é–Ø‘¥G2, âˆä•¶•F1, •Ÿ“c—Ï–ç1 (1“à‡V. 2Œc‰ž‘å): ‘æ32‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2004/11/12). Ž­Ž™“‡. ƒvƒƒOƒ‰ƒ€E´˜^W, p.53, 2004.

723192. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) AŒ^ƒ{ƒcƒŠƒkƒX“Å‘f‹ÇŠ’ŽË‚É‚æ‚é•Ð“ª’É—\–hŒø‰Ê‚ƈÀ‘S«‚ÉŠÖ‚·‚錟“¢. —é–ØN•ã, ”Ñ’Ë‚_, Ž‰ÆKŽq, ŒÜ\—’‹v‰À, âˆä•¶•F (“à‡V): ‘æ32‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2004/11/12-13), Ž­Ž™“‡.

723193. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘½”­«d‰»Ç‚̉”­Çó‚Æ‚µ‚Ä‚Ì“ª’É. ‹vZ˜C—F‹I1, “c’†k‘¾˜Y1, —é–Ød–¾1, à_“cˆê1,2, —é–Ø‘¥G1 (1Œc‰ž‘å. 2“à‡V): ‘æ32‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2004/11/13), Ž­Ž™“‡.
@
723194. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¶Œã“ª•”’É‚ÌŒ´ˆö‚Æ‚µ‚ĶŒã“ª‰º‹ØŒQ‚̉ŠÇ‚ª‹^‚í‚ꂽ1Ç—á. HŽR‹v® (“à‡VEìèŽs—§ˆä“c•a‰@): ‘æ32‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2004/11/13), Ž­Ž™“‡. “ú–{“ª’ÉŠw‰ïŽ, 31 (3): 112, 2004.

723195. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[‹y‚ÑŒû‰‰) _ŒoSweet•a‚̈ê–UŒŸ—á. ‘êŽR—eŽq, ‰¬–ì”üŒbŽq, ‰¬–ì@—T, ”’ÎœAÆ, –ö‰ºŽO˜Y, âV“¡–L˜a, âˆä•¶•F (“à‡V): ‘æ17‰ñ“ú–{_Œo–ƉuŠw‰ïŠwpW‰ï (2005/3/4), •Ÿ‰ª. Official Journal of Japanese Society for Neuroimmunology, 13 (1): 2005.

731028. [Œ¤‹†‰ï] (“Á•Êu‰‰) “ª’É‚Ìf’f‚ÆŽ¡—Ã|V‘Û“ª’É•ª—Þ‚ðŽg‚Á‚Ä|. âˆä•¶•F (“à‡V): ‘æ85‰ñL“‡_ŒoŽ¾Š³Œ¤‹†‰ï (2004/4/2), L“‡.

731029. [Œ¤‹†‰ï] (“Á•Êu‰‰) wƒp[ƒLƒ“ƒ\ƒ“•ax|f’f‚ÆŽ¡—Ã|. HŽR‹v® (“à‡VEìèŽs—§ˆä“c•a‰@): ˆä“c•a‰@EZ‹gŽx•”•af˜AŒg•×‹­‰ï (2004/4/22), ìèŽs.

731030. [Œ¤‹†‰ï] (“Á•Êu‰‰) •Ð“ª’É‚Ì•a‘Ô‚ÆŽ¡—Ã|Å‹ß‚Ìl‚¦•û|. âˆä•¶•F (“à‡V): ‘æ7‰ñ’É‚Ý‚ÌŒ¤‹†‰ï (2004/6/18), ˆ¤’mˆã‘å.

731031. [Œ¤‹†‰ï] (“Á•Êu‰‰) V‘Û“ª’É•ª—Þ|•Ð“ª’É‚ÆŒQ”­“ª’É‚ð‚ß‚®‚Á‚Ä|. âˆä•¶•F (_Œo“à): ‘æ3‰ñŠwpu‰‰‰ï‹{铪’ÉŒ¤‹†‰ï (2004/7/2), å‘ä.

731032. [Œ¤‹†‰ï] (“Á•Êu‰‰) •Ð“ª’É‚Ì•a‘Ô‚ÆV‚µ‚¢Ž¡—Ã. âˆä•¶•F (“à‡V): ‘æ20‰ñŽ ‰ê_ŒoŽ¾Š³Œ¤‹†‰ïŠwpŒ¤C‰ï (2004/7/12), Ž ‰ê.

731033. [Œ¤‹†‰ï] (“Á•Êu‰‰) •Ð“ª’É‚Ì•a‘Ô‚ÆŽ¡—Ã|Å‹ß‚Ìl‚¦•û|. âˆä•¶•F (“à‡V): ‘æ4‰ñL“‡“ª’ÉŒ¤‹†‰ï (2004/7/15), L“‡.

731034. [‚»‚Ì‘¼] (“Á•Êu‰‰) •Ð“ª’É‚ÌV‚µ‚¢Ž¡—Ã. âˆä•¶•F (“à‡V): “ú“cŒQŽsˆãŽt‰ïŠwpu‰‰‰ï (2004/7/22), ‘啪Œ§“ú“cŽs.

731035. [‚»‚Ì‘¼] (“Á•Êu‰‰) “ª’É‚Ìf’f‚ÆŽ¡—Ã|V‘Û“ª’É•ª—Þ‚ðŽg‚Á‚Ä|. âˆä•¶•F (“à‡V): Šwpu‰‰‰ïu•Ð“ª’É‚ðl‚¦‚év”ªŒËu‰‰‰ï (2004/7/30), ÂXŒ§”ªŒËŽs.

731036. [Œ¤‹†‰ï] (“Á•Êu‰‰) •Ð“ª’É‚Ì—Õ°|Å‹ß‚Ìi•à|. âˆä•¶•F (“à‡V): ‚È‚É‚í”]_Œo“à‰È§˜b‰ï (2004/10/16), ‘åã.

731037. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‘å‹K–Í—Õ°ŽŽŒ±‚ÌŒ‹‰Ê‚ð‚Ó‚Ü‚¦‚Ä”]‘²’†‚̊댯ˆöŽqŽ¡—Âɂǂ¤Œ‹‚т‚¯‚é‚©. HŽR‹v® (“à‡VEìèŽs—§ˆä“c•a‰@): Z‹g’n‹æ•×‹­‰ï@¶ŠˆKŠµ•aƒVƒŠ[ƒY‡J (2004/11/25), ìèŽs.

731038. [‚»‚Ì‘¼] (“Á•Êu‰‰) _Œo“à‰È‚æ‚茩‚½“ª’É|•Ð“ª’ÉE‹Ù’£Œ^“ª’É‚ð’†S‚É|. à_“cˆê (Œc‰ž‘åE“à‡V): ‘æ12‰ñŒc‰žˆãŽt‰ïEŽs–¯ŒöŠJuÀ (2005/2/8), “Œ‹ž.

732021. [‚»‚Ì‘¼] (µ‘Ò‚³‚ꂽu‰‰) ¡‚©‚ço—ˆ‚é”][Ç‚Ì—\–h. ˆ¢‹v’Óñ•v (“à‡V): Žs–¯Œ’N‚­‚èu‰‰‰ï ’¬“cˆãŽt‰ï (2004/7/31), ’¬“c.

732022. [Œ¤‹†‰ï] (µ‘Ò‚³‚ꂽu‰‰) ƒnƒCƒŠƒXƒN‚ŒŒˆ³Š³ŽÒ‚ÌŽ¡—Ãí—ª|”]ŒŒŠÇáŠQê–åˆã‚Ì—§ê‚©‚ç|. HŽR‹v® (“à‡VEìèŽs—§ˆä“c•a‰@): VALUE Expert Meeting in Oiso (2004/11/5), ‘åˆé’¬.

733067. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ’W‘“‹…•Ž¿ƒ‹ƒC‘̈Þkǂ̈ê–UŒŸ—á. ”у–’J”ü•ô1, ‰¬–ì”üŒbŽq1, ì˜Q@•¶1, âˆä•¶•F1, –ö‰ºŽO˜Y2 (1“à‡V. 2_“Þ샊ƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[•a‰@): ‘æ169‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï (2004/6), “Œ‹ž.

733068. [Œ¤‹†‰ï] (ˆê”Êu‰‰) –ƉuƒOƒƒuƒŠƒ“ŠÔŒ‡“Š—^‚ª—LŒø‚Å‚ ‚Á‚½CIDP‚Ì1—á. HŽR‹v® i“à‡VEìèŽs—§ˆä“c•a‰@j: ‘æ1‰ñ’†Œ´‹æ_ŒoƒŠƒnƒrƒŠ§˜b‰ï (2004/7/20), ìèŽs.

733069. [Œ¤‹†‰ï] (ƒ|ƒXƒ^[) Žñ‰º‚ª‚è‚ɑ΂µ‚Ä cabergoline iCabaserj “Š—^‚ª—LŒø‚Å‚ ‚Á‚½ƒp[ƒLƒ“ƒ\ƒ“•a‚Ì1—á. HŽR‹v® (“à‡VEìèŽs—§ˆä“c•a‰@): Parkinson's Disease Forum 2004 ‘æ4‰ñƒp[ƒLƒ“ƒ\ƒ“•aƒtƒH[ƒ‰ƒ€ (2004/8/28), ‰YˆÀŽs.

733070. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “Á”­«“ªŠW“àˆ³˜´iÇ‚Å”­Ç‚µ‚½ƒwƒ‚ƒOƒƒrƒ“ˆÙí‚̈ê—á. —Rˆäi‘¾˜Y, ”Ñ’Ë‚_, –î–ì‹M‹vŽq, —é–ØN•ã, âˆä•¶•F (“à‡V): ‘æ170‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï (2004/9/4), “Œ‹ž.

733071. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) AIDS‚Ì1–UŒŸ—á. HŽR‹v®1,2, •y“cˆ¤”ü1,2, •ûŒª‘¾˜Y2, ‚”ö¹Ž÷2 i1“à‡V. 2ìèŽs—§ˆä“c•a‰@j: ‘æ170‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û (2004/9/4), “Œ‹ž. —Õ°_ŒoŠw, 45 (2): 143, 2005.

733072. [Œ¤‹†‰ï] (ˆê”Êu‰‰) •úŽËüÆŽË16”NŒã‚É”­Ç‚µ‚½’x”­«—¼‘¤‘å‘Ú_ŒoáŠQ‚Ì1—á. •y“cˆ¤”ü, HŽR‹v® (“à‡VEìèŽs—§ˆä“c•a‰@): ‘æ316‰ñ_“Þì_Œo’k˜b‰ï (2004/9/9), ‰¡•lŽs.

733073. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘½”­«”]_Œo–ƒáƒ‚ÌŒo‰ß’†‚É”]Š²oŒŒ‚ð‚«‚½‚µ“]ˆÚ«‘O—§‘BŠà‚ª‹^‚í‚ꂽˆêÇ—á. •Ä“c•Žj1, ‘å’Ë–M”V1, Œã“¡@~1, à_“cˆê2,3 (1‘—§é‹Ê•a‰@. 2“à‡V. 3Œc‰ž‘å): ‘æ170‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï (2004/9/4), “Œ‹ž.

733074. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) 65΂ʼn‚ß‚Äf’f‚³‚ꂽæ“V«E”]ǂ̈ê—á. •y“cˆ¤”ü, HŽR‹v® i“à‡VEìèŽs—§ˆä“c•a‰@j: ‘æ40‰ñ“ú–{˜V”NˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2004/10/2), ‚³‚¢‚½‚ÜŽs.

733075. [Œ¤‹†‰ï] (ˆê”Êu‰‰) D-ƒÀ-ƒqƒhƒƒLƒV—Ž_‚̃~ƒgƒRƒ“ƒhƒŠƒA‚ð‰î‚·‚é’áŽ_‘fáŠQ‚ɑ΂·‚é•ÛŒìì—p|–³ŒŒ´”|—{‰‘ãŠC”n×–E‚ðƒ‚ƒfƒ‹‚ð—p‚¢‚½Œ¤‹†|. ‘“c@—ã (“à‡V): ‘æ31‰ñŠÖ“Œ”]ŒŒŠÇáŠQ§˜b‰ï (2004/10/12), “Œ‹ž.

733076. [Œ¤‹†‰ï] (ˆê”Êu‰‰) –ñ20”N‘O‚Ì—«‰»“û–[‚ª‰”­Çó‚Æl‚¦‚ç‚ꂽKennedy-Alter-Sung disease‚Ì1—á. HŽR‹v®1,2, —³è’˜a2, ŠÖ“c_“ñ˜Y2 i1“à‡V. 2ìèŽs—§ˆä“c•a‰@j: •½¬16”N“x_“Þì“à‰ÈW’k‰ï (2004/11/20), ‰¡•lŽs.

733077. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) èò‘Žî’¯‚ð’悵, ˆŸ‹}«ƒ~ƒGƒƒpƒ`[‚Å”­Ç‚µ‚½HAM‹^‚¢‚̈ê—á. –î–ì‹M‹vŽq, •Ÿ“c—Ï–ç, ‰¬–ì”üŒbŽq, ‰¬–ì@—T, âˆä•¶•F (“à‡V): ‘æ171‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï (2004/11/27), “Œ‹ž.

733078. [Œ¤‹†‰ï] (ˆê”Êu‰‰) MELAS‚Ì”]‘²’†—l”­ì‚Ì”­Ç‹@˜‚ÉŠÖ‚·‚élŽ@|Neurovascular Cellular Mechanisms|. ”Ñ’Ë‚_, ˆäorŒõ, ‘êŽR—eŽq, âˆä•¶•F (“à‡V): ‘æ4‰ñ“ú–{ƒ~ƒgƒRƒ“ƒhƒŠƒAŒ¤‹†‰ï (2004/12/18), “Œ‹ž.

733079. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Šç–Ê㎈‚É‘e‘å‚È‚Ò‚­‚‚«‚ªoŒ»‚µ‚½—«. Ž‰ÆKŽq, ”Ñ’Ë‚_, —é–ØN•ã, —Rˆäi‘¾˜Y, ˆ¢‹v’Óñ•v, âˆä•¶•F (“à‡V): ‘æ23‰ñKanagawa Visual Neurology (2005/2/18), ‰¡•l.

733080. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ¶•Ð–ƒáƒ‚Å”­Ç‚µ, “ª•”‰æ‘œã, ‘½Ê‚È•a‘œ•Ï‰»‚ð”F‚ß‚½39Î’j«–UŒŸ—á. HŽR‹v® i“à‡VEìèŽs—§ˆä“c•a‰@j: ‘æ4‰ñNeuro CPC (2005/2/25), “Œ‹ž.

733081. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ”]ŽåŠ²“®–¬‹·ó‚ð‡•¹‚µReversible posterior leukoencephalopathy syndrome‚ð’悵‚½‚ŒŒˆ³«”]Ç‚Ì51Î’j«. ‘å’Ë–M”V1, •Ä“c•Žj1, Î’Ã’¨—²1, Œã“¡@~1, à_“cˆê2,3 (1‘—§é‹Ê•a‰@. 2Œc‰ž‘å. 3“à‡V): ‘æ172‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï(2005/3/5), “Œ‹ž.

733082. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) t×–EŠà‚É‚æ‚éŽîᇔº«‰^“®ƒjƒ…[ƒƒ“Ž¾Š³‚Æl‚¦‚ç‚ꂽˆê—á. •ž•”‰p“T1, ‘½“cŒh“T1, ‰ª–ì James —m®1, à_“cˆê1,2, —é–Ø‘¥G1 (1Œc‰ž‘å. 2“à‡V): ‘æ172‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï (2005/3/5), “Œ‹ž.

733083. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ”]Š²Œ´”­ãó×–EŽî‚̈ê—á. ‹{ì¹D, ”Ñ’Ë‚_, —Rˆäi‘¾˜Y, ˆ¢‹v’Óñ•v, âˆä•¶•F (“à‡V): ‘æ172‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï (2005/3/5), “Œ‹ž.

733084. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ’†”]Œ´”­ãó×–EŽî‚̈ê—á. ‹{ì¹D, ”Ñ’Ë‚_, —Rˆäi‘¾˜Y, ˆ¢‹v’Óñ•v, âˆä•¶•F (“à‡V): ‘æ172‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï (2005/3/5), “Œ‹ž.

733085. [Œ¤‹†‰ï] (ˆê”Êu‰‰) “àèò“®–¬•ÂÇÇ‚ð”­Ç‚µ‚½ƒ~ƒgƒRƒ“ƒhƒŠƒA”]‹Øǂ̈ê—á|MELAS‚É‚¨‚¯‚é”]‘²’†—l”­ì‚Ƃ̈Ⴂ|. ŽO£–ƒ‹|, ”Ñ’Ë‚_, ‹{ì¹D, —Rˆäi‘¾˜Y, —é–ØN•ã, ˆ¢‹v’Óñ•v, ‰¬–ì”üŒbŽq, âˆä•¶•F (“à‡V): ‘æ16‰ñStroke Forum (2005/3/18), ‰¡•l.

733086. [Œ¤‹†‰ï] (ˆê”Êu‰‰) “àŒz“®–¬•ÂÇÇ‚ð”­Ç‚µ‚½ƒ~ƒgƒRƒ“ƒhƒŠƒA”]‹Øǂ̈ê—á. ŽO£–ƒ‹|, ”Ñ’Ë‚_, ‹{ì¹D, —Rˆäi‘¾˜Y, —é–ØN•ã, ˆ¢‹v’Óñ•v, ‰¬–ì”üŒbŽq, âˆä•¶•F (“à‡V): ‘æ16‰ñ_“ÞìStroke Forum (2005/3/18), ‰¡•l.


<<“à‰ÈŠw‡WiŒŒ‰t“à‰ÈŠwj>>

mŠwp˜_•¶n

110087. [Œ´’˜] Protein kinase C ƒÃ and the antiadrenergic action of adenosine in rat ventricular myocytes. ‹{è_“ñ1, Satoshi Komatsu2, Mitsuo Ikebe2, Richard A Fenton2, James G Dobson Jr2 (1“à‡W. 2Department Physiology, University of Massachusetts Medical Shcool): Am J Physiol Heart Circ Physiol, 287 (4): H1721-1729, 2004.

110088. [Œ´’˜] Clinical Significance of Intracytoplasmic nm23-H1 Expression in Diffuse Large B-Cell Lymphoma. V’Ã@–]1, ’†•õŠ°˜a2, ‰ª–{¹—²3, Ô¼—TŽq2, “ŒŒ´³–¾1, Honma Y2, Okabe-Kado J4, Hirano M3 (1“à‡W. 2˜a‰ÌŽRŒ§—§ˆã‘å. 3“¡“c•ÛŒ’‰q¶‘å. 4é‹Ê‚ª‚ñƒZƒ“ƒ^[): Clin Cancer Res, 10: 2482-2490, 2004.

110089. [Œ´’˜] Phase I study of rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphoma - effects on ADCC activity and FcƒÁRI (CD64) expression on neutrophils. V’Ã@–]1, ‰HŽR–í’à1, ‰ª–{¹—²2, ŒS@”ü‰À1, “ŒŒ´³–¾1, Tamaru J3, Hirano M2 (1“à‡W. 2“¡“c•ÛŒ’‰q¶‘å. 3é‹Êˆã‘å): Clin Cancer Res, 10: 4077-4082, 2004.

110090. [Œ´’˜] Development of hepatosplenic gammadelta T-cell lymphoma with pancytopenia during early pregnancy: a case report and review of the literature. V’Ã@–]1, ŒS@”ü‰À1, ’Ì–ì•x‹P1, ’†•õŠ°˜a2, ’†‘º‰h’j3, Šâ•£Œ[ˆê4, “ŒŒ´³–¾1 (1“à‡W. 2˜a‰ÌŽRŒ§—§ˆã‘å. 3ˆ¤’m‚ª‚ñƒZƒ“ƒ^[. 4•a—): Eur J Haematol, 73: 367-371, 2004.

110091. [Œ´’˜] Phase I/II Study of the Rituximab-EPOCT Regimen in Combination with Granulocyte Colony-Stimulating Factor in Patients with Relapsed or Refractory Follicular Lymphoma Including Evaluation of Its Cardiotoxicity Using B-Type Natriuretic Peptide and Troponin T Levels. V’Ã@–]1, ŒS@”ü‰À1, ‰HŽR–í’à1, ŠŒ´kˆê1, “ŒŒ´³–¾1, Tamaru J2 (1“à‡W. 2é‹Êˆã‘å): Clin Cancer Res, 11: 697-702, 2005.

110092. [Œ´’˜] Granulocytic differentiation of leukemic cells with t (9; 11) (p22; q23) induced by all-trans-retinoic acid. ”Ñ“‡Šì”üŽq1, Honma Y2, V’Ã@–]3 (1“Œ–M‘å. 2˜a‰ÌŽRŒ§—§ˆã‘å. 3“à‡W): Leuk Lymphoma, 45: 1017-1024, 2004.

110093. [Œ´’˜] Rabid tumor death model for evaluation of new therapeutic agents for adult T-cell leukemia. Takeo Ohsugi1, Kazunari Yamaguchi2, Toshio Kumasaka3, Takaomi Ishida4, –x]—Ljê4,5, “nç²rŽ÷4, Noboru Sako1, Toshio Fujimoto1, Noriyuki Sakamoto1, Toru Urano1 (1Division of Microbiology and Genetics, Center for Animal Resources and Development, Institute of Resource Development and Analysis. 2ŒF–{‘å. 3‡“V“°‘å. 4“Œ‹ž‘åˆã‰ÈŒ¤. 5“à‡W): Laboratory Investigation, 54: 263-266, 2004.

110094. [Œ´’˜] Prompt tumor formation and maintenance of constitutive NF-ƒÈB activity of multiple myeloma cells in NOD/SCID/ƒÁcnull mice. Zahidunabi Dewan1, “n•Ó^—Žq2, Kazuo Terashima1, Mizuho Aoki1, Tetsutaro Sata3, Mitsuo Honda4, Mamoru Ito5, Shoji Yamaoka1, “nç²rŽ÷6, –x]—Ljê2, Naoki Yamamoto1,4 (1“Œ‹žˆãŽ•‘å. 2“à‡W. 3Department of Pathology and 4AIDS Research Center, National Institute of Infectious Disease, 5Central Institute for Experimental Animals. 6“Œ‹ž‘åˆã‰ÈŒ¤): Cancer Sci, 95 (7): 561-568, 2004.

110095. [Œ´’˜] The NPM-AML oncoprotein abrogates CD30 signaling and constitutive NF-ƒÈB activation in anaplastic large cell lymphoma. –x]—Ljê1,2, “n•Ó^—Žq2, Takamori Ishida1, Tsukasa Koiwa1, Shigemi Aizawa1, Kinji Itoh1, “ŒŒ´³–¾2, Marshall E Kadin3, “nç²rŽ÷1,4 (1“Œ‹ž‘åˆã‰ÈŒ¤. 2“à‡W. 3Department of Pathology, Harvard Medical School and 4Beth Israel Deaconess Medical Center): Cancer Cell, 5: 353-364, 2004.

110096. [Œ´’˜] A novel NF-ƒÈB inhibitor DHMEQ selectively targets constitutive NF-ƒÈB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo. “n•Ó^—Žq1, Md. Zahidunnabi2, Takamitu Okamura2, Masataka Sasaki2, Kinji Itoh5,7, “ŒŒ´³–¾1, aŒûGº4, Mitsuo Honda3, Testutaro Sata6, “nç²rŽ÷7, Naoki Yamamoto2,3, ”~àVˆê•v7, –x]—Ljê1,7 (1“à‡W. 2“Œ‹žˆãŽ•‘å. 3AIDS Research Center, National Institute of Infectious Disease. 4“Œ‹ž—ˆã‘å. 5“Œ–M‘å. 6Department of Pathology National Institute of Infectious Diseases. 7“Œ‹ž‘åˆã‰ÈŒ¤): Int J Cancer, 114: 32-38, 2005.

320018. [Ç—á•ñ] ‹´–{•a, ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚ÌŒo‰ß’†‚ÉŒŒ¬”ÂŒ¸­Ç‚ð‚«‚½‚µ‚½1Ç—á|–ÔŒŒ¬”‘ª’è‚É‚æ‚錌¬”ÂŒ¸­Ç‚Ì•a‘Ô‰ð͂̈Ӌ`|. Έ䗲Ži, ‘åâ@Šw, ŒS@”ü‰À, •½@”ü–çŽq, ‹{è_“ñ, “ŒŒ´³–¾ (“à‡W): _“Þ쌌‰tŒ¤‹†‰ïŽ, 24: 125-126, 2004.

320019. [Ç—á•ñ] “_“Ë‘R•ÏˆÙ iThr359Metj ‚𔺂¤‘æVIIˆöŽqŒ‡–RÇ‚ÌŒyÇ—á. ‹{è_“ñ1, ŠŒ´kˆê1, “n•Ó^—Žq1, ‘åâ@Šw1, –Ñ—˜@”Ž2, “ŒŒ´³–¾1 (1“à‡W. 2“¡Ž}Žs—§‘‡•a‰@): “ú–{ŒŒðŽ~ŒŒŠw‰ïŽ, 16: 98-103, 2005.

320020. [Ç—á•ñ] ‹´–{•a, ‘ŸŠíŒ‡‘¹‚â–ƉuŠw“I‹@”\ˆÙí‚ð”F‚ß‚È‚¢“Á”­«äB‘Ÿ’áŒ`¬‚ÌÇ—á. ‘åâ@Šw, ‚ΉëÍ, –x]—Ljê, “ŒŒ´³–¾ (“à‡W): _“Þ쌌‰tŒ¤‹†‰ïŽ, 24: 9-11, 2004.

520088. [‘à] oŒŒŽžŠÔ. ‹{è_“ñ, “ŒŒ´³–¾ (“à‡W): “à‰È, 93 (6): 1180, 2004.

520089. [‘à] ‘S‹ÃŒÅŽžŠÔ. ‹{è_“ñ, “ŒŒ´³–¾ (“à‡W): “à‰È, 93 (6): 1181, 2004.

520090. [‘à] –Ñ׌ŒŠÇ’ïRŽŽŒ±. ‹{è_“ñ, “ŒŒ´³–¾ (“à‡W): “à‰È, 93 (6): 1182, 2004.

520091. [‘à] ƒzƒWƒLƒ“ƒŠƒ“ƒpŽî‚Ì•ªŽq•a‘Ô. –x]—Ljê (“à‡W): ŒŒ‰tƒtƒƒ“ƒeƒBƒA, 14: 17-26, 2004.

520092. [‘à] V‹KNF-ƒÈB‘jŠQÜ‚É‚æ‚éATL•ªŽq•W“I—Ö@‚̉”\«. –x]—Ljê (“à‡W): ŒŒ‰tŽîᇉÈ, 49: 257-265, 2004.

520093. [‘à] HodgkinƒŠƒ“ƒpŽî. –x]—Ljê (“à‡W): ŒŒ‰tŽîᇉÈ, 49: 141-148, 2004.

520094. [‘à] ƒvƒŠƒ“—U“±‘Ì‚É‚æ‚霑’P‹…«”’ŒŒ•aŽ¡—Ẩ”\«|Šî‘b“IŒŸ“¢‚ð’†S|. V’Ã@–] (“à‡W): ŒŒ‰tŽîᇉÈ, 49: 383-390, 2004.

520095. [‘à] nm23-H1”­Œ»‚Æ––½T×–EƒŠƒ“ƒpŽîŠ³ŽÒ‚Ì—\Œã. V’Ã@–] (“à‡W): ŒŒ‰tŽîᇉÈ, 49: 221-228, 2004.

mŠw‰ïEŒ¤‹†‰ï“™n

712011. [Šw‰ï (‘Û)] (µ‘Òu‰‰) Ligand-independent signaling by overexpressed CD30 drives NF-ƒÈB activation in Hodgkin-Reed Sternberg cells. –x]—Ljê (“à‡W): ‘æ6‰ñHodgkinƒŠƒ“ƒpŽî‘ÛŠw‰ï (2004), ƒhƒCƒc, ƒPƒ‹ƒ“. Eur J Haematol, 73 (S.): 65, (B11), 2004.

712012. [Šw‰ï (‘Û)] (µ‘Òu‰‰) Interactions between AP-1, NF-ƒÈB and CD30 signaling. –x]—Ljê (“à‡W): ‘æ6‰ñHodgkinƒŠƒ“ƒpŽî‘ÛŠw‰ï (2004), ƒhƒCƒc, ƒPƒ‹ƒ“. Eur J Haematol, 73 (S.): 65, (WH04), 2004.

713062. [Šw‰ï (‘Û)] (ˆê”ʉ‰‘è) The E1841K Mutation in MYH-9 of a Patient With May-Hegglin Anomaly Inhibits the Disassembly of Non-Muscle Myosin IIA (MYH-9) Responsible for the Phenotype of the Disease. ‹{è_“ñ1, Komatsu S2, “n•Ó^—Žq1, Nakadate H2, Ikebe M2, “ŒŒ´³–¾1 (1“à‡W. 2ƒ}ƒTƒ`ƒ…[ƒZƒbƒcˆã‘å): 46th Annual Meeting of the American Society of Hematology (2004/12/4-7), San Diego, CA, USA. Blood, 104 (11), Pt1 of 2, 210a-211a, #736, 2004.

722032. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ˆ««ƒŠƒ“ƒpŽî‚©‚çŠw‚ñ‚¾‚±‚Æ|”­Ç‹@˜‚©‚番Žq•W“IŽ¡—Â܂Å|•ªŽqŠî”Õ‚ÉŠî‚­ˆ««ƒŠƒ“ƒpŽî‚Ì—‰ð‚ÆŽ¡—Ã@HodgkinƒŠƒ“ƒpŽî‚Æ–¢•ª‰»‘å×–E«ƒŠƒ“ƒpŽî‚ÆHF-ƒÈB‚ð’†S‚Æ‚µ‚Ä. –x]—Ljê (“à‡W): ‘æ63‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2004/9/29-10/1), •Ÿ‰ª. Jpn J Cancer Res, 95 (S.): 61, 2004.

723196. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ”ñƒzƒWƒLƒ“ƒŠƒ“ƒpŽî‚É‚¨‚¯‚é×–EŽ¿“ànm23-H1”­Œ»‚ÌŒŸ“¢. V’Ã@–]1, ’†•õŠ°˜a2, ‰ª–{¹—²3, Ô¼—TŽq2, “ŒŒ´³–¾1, •½–ì³”ü3 (1“à‡W. 2˜a‰ÌŽRŒ§—§ˆã‘å. 3“¡“c•ÛŒ’‰q¶‘å): ‘æ101‰ñ“ú–{“à‰ÈŠw‰ï‘‰ï (2004/4/7-10), “Œ‹ž.

723197. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) V‹KNF-ƒÈB‘jŠQÜDHMEQ‚ð—p‚¢‚½ATLŽ¡—ÂƔ­Ç—\–h‚̉”\«. “nç²rŽ÷1, “n•Ó^—Žq2, ³“c“Žq1, ‘ŠàV”É”ü, Γc®b, ‰F“s‹{@äo, ŽRŒûˆê¬, ”~àVˆê•v, –x]—Ljê2 (1“Œ‹ž‘åˆã‰ÈŒ¤, 2“à‡W): ‘æ8‰ñ‚ª‚ñ•ªŽq•W“IŽ¡—ÃŒ¤‹†‰ï‘‰ï (2004/5/13-14), Ž­Ž™“‡. ƒvƒƒOƒ‰ƒ€E´˜^W, p.52, 2004.

723198. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ‘½”­«œ‘Žî (MM) ‚ɑ΂·‚éV‹KNF-ƒÈB‘jŠQÜ‚É‚æ‚镪Žq•W“I—Ö@‚ÌŠî‘b“IŒŸ“¢. –x]—Ljê1, “n•Ó^—Žq1, Zaidunabi Dewan2, ‰ª‘º—²Œõ3, aŒûGº3, “ŒŒ´³º1, ŽR–{’¼–Ø4, ”~àVˆê•v4, “nç²rŽ÷4 (1“à‡W. 2“Œ‹žˆãŽ•‘å. 3“Œ‹ž—ˆã‘å. 4“Œ‹ž‘åˆã‰ÈŒ¤): ‘æ8‰ñ‚ª‚ñ•ªŽq•W“IŽ¡—ÃŒ¤‹†‰ï‘‰ï (2004/5/13-14), Ž­Ž™“‡. ƒvƒƒOƒ‰ƒ€E´˜^W, p.52, 2004.

723199. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) IgAŒ^Ž©ŒÈ–Ɖu«—nŒŒ«•nŒŒ‚ÌŒo‰ß’†‚ɬ’°Œ´”­‚ÆŽv‚í‚ê‚éàh–E«ƒŠƒ“ƒpŽî‚ð”­Ç‚µ‚½1—á. ‰HŽR–í‹œ, V’Ã@–], “c•c@Œ’, •½@”ü–çŽq, ‘åâ@Šw, ŠŒ´kˆê, ŒS@”ü‰À, ‹{è_“ñ, –x]—Ljê, “ŒŒ´³–¾ (“à‡W): ‘æ150‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï—á‰ï (2004/5/22), “Œ‹ž.

723200. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ƒƒ\ƒgƒŒƒLƒZ[ƒg’á—p—Ê’·Šú“Š—^’†‚Ì–«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‚É”­Ç‚µ‚½ào–Ÿ«‘å×–E«B×–EƒŠƒ“ƒpŽî‚Ì2—á. ŒS@”ü‰À1, V’Ã@–]1, ŠŒ´kˆê1, ‘åâ@Šw1, ‰HŽR–í‹œ1, ‹{è_“ñ1, –x]—Ljê1, “ŒŒ´³–¾1, Šâ•£Œ[ˆê2, ‰““¡•½m3, ‹ß“¡Œ[•¶3 (1“à‡W. 2•a—. 3“à‡X): ‘æ150‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï—á‰ï (2004/5/22), “Œ‹ž.

723201. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) May-HegglinˆÙíÇ‚Æ”ñ‹Øƒ~ƒIƒVƒ“•ÏˆÙ. ‹{è_“ñ1, ’r•ÓŒõ’j2, “n•Ó^—Žq1, ’†ŠÚ®–ç3, •½@”ü–çŽq1, “ŒŒ´³–¾1 (1“à‡W. 2ƒ}ƒTƒ`ƒ…[ƒZƒbƒc‘åŠw. 3Ž™): ‘æ46‰ñ“ú–{•½ŠŠ‹ØŠw‰ï‘‰ï (2004/7/8), “Œ‹ž.

723202. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) NPM-ALK‚É‚æ‚éCD30-NFƒÈBŒo˜H‘jŠQ‚ÉŠî‚­H-RS×–E‚ÆALCL×–E‚Ì•ªŽqŠî”Ղ̉ðÍ. –x]—Ljê1, “n•Ó^—Žq1, Γc®b, ¬Šâ@Ži, ‘ŠàV”É”ü, ˆÉ“¡‹àŽŸ, “ŒŒ´³–¾1, Marshall E Kadin, “nç²rŽ÷2 (1“à‡W. 2“Œ‹ž‘åˆã‰ÈŒ¤): ‘æ44‰ñ“ú–{ƒŠƒ“ƒp–Ô“àŒnŠw‰ï (2004/7/14-16), ‹ž“s. ‘æ44‰ñ“ú–{ƒŠƒ“ƒp–Ô“àŒnŠw‰ïŽ, 44: 118, 2004.

723203. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ’˜–¾‚È‚IgGŒŒÇ‚𔺂Á‚½”xŒ´”­gŒ`Ž¿×–EŽîh‚Ì1—á. V’Ã@–]1, ‰HŽR–í‹œ1, ŒS@”ü‰À1, ’†‘º’¼Æ2, ’†•õŠ°˜a2, “ŒŒ´³–¾1 (1“à‡W. 2˜a‰ÌŽRŒ§—§ˆã‘å): ‘æ44‰ñ“ú–{ƒŠƒ“ƒp–Ô“àŒnŠw‰ï (2004/7/14`16), ‹ž“s.

723204. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ‘½Ž{Ý‹¤“¯Œ¤‹†‚É‚¨‚¯‚鎡—Â̗L—p«•]‰¿‚Ì‚½‚ß‚Ì‘SÇ—á“o˜^‚Æ•a—’†‰›f’f. ‰ª–{¹—²1, ‹g–ì@³, V’Ã@–]2, ŽO‰YˆÌ‹v’j3, •½–ì³”ü (1˜a‰ÌŽRŒ§—§ˆã‘å. 2“à‡W. 3H“c‘å): ‘æ44‰ñ“ú–{ƒŠƒ“ƒp–Ô“àŒnŠw‰ï (2004/7/14-16), ‹ž“s.

723205. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ˆâ“`«‘ȉ~ÔŒŒ‹…Ç‚ð‡•¹‚µ‚½CD5+CD10+‚Ñ‚Ü‚ñ«‘å×–EŒ^B×–EƒŠƒ“ƒpŽî iDLBCLj ‚̈ê—á. ‰HŽR–í‹œ1, V’Ã@–]1, •½@”ü–çŽq1, ‘åâ@Šw1, ŠŒ´kˆê1, ŒS@”ü‰À1, ‹{è_“ñ1, –x]—Ljê1, “ŒŒ´³–¾1, ’†•õŠ°˜a2, ŽO‰YˆÌ‹v’j3 (1“à‡W. 2˜a‰ÌŽRŒ§—§ˆã‰È‘å. 3H“c‘å): ‘æ66‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïE‘æ46‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï (2004/9/17-19), ‹ž“s.

723206. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) CD30‚É‚æ‚éICAMIˆâ“`Žq”­Œ»—U“±‹@\. “àŒ´”V‰î, ¼“c’|O, –x]—Ljê1, “nç²rŽ÷2, X@’¼Ž÷ (1“à‡W. 2“Œ‹ž‘åˆã‰ÈŒ¤): ‘æ66‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïE‘æ46‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï (2004/9/17-19), ‹ž“s.

723207. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ƒp[ƒLƒ“ƒ\ƒ“•a‚ÌŽ¡—Âɂæ‚茌¬””‚ª³í‰»‚µ‚½ITP‚̈ê—á. ‘åâ@Šw, •½@”ü–çŽq, ŠŒ´kˆê, ‹{è_“ñ, “ŒŒ´³–¾ (“à‡W): ‘æ66‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïE‘æ46‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï (2004/9/17-19), ‹ž“s.

723208. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ”DP‰Šú‚ɔČŒ‹…Œ¸­Ç‚Å”­Ç‚µ‚½ŠÌäBŒ^ƒÁƒÐT×–EƒŠƒ“ƒpŽî‚̈ê—á. ŒS@”ü‰À1, V’Ã@–]1, ’Ì–ì•x‹P1, ‘åâ@Šw1, ‰HŽR–í‹œ1, ŠŒ´kˆê1, ‹{è_“ñ1, –x]—Ljê1, “ŒŒ´³–¾1, ’†•õŠ°˜a2, ’†‘º‰h’j3 (1“à‡W. 2˜a‰ÌŽRŒ§—§ˆã‘å. 3ˆ¤’mŒ§‚ª‚ñƒZƒ“ƒ^[•a‰@): ‘æ66‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïE‘æ46‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï (2004/9/17-19), ‹ž“s.

723209. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) IgEŒ^M’`”’ŒŒÇ‚̈ê—á‚Æ•¶Œ£“IlŽ@. ‹{è_“ñ, ‘åâ@Šw, ‰HŽR–í‹œ, –x]—Ljê, “ŒŒ´³–¾ (“à‡W): ‘æ66‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïE‘æ46‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï (2004/9/17-19), ‹ž“s.

723210. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) –¢Ž¡—ÃisŠúàh–E«G-CSF, ƒLƒ“ƒŠƒ“ƒpŽî‚ɑ΂·‚éR-CHOP-G—Ö@‚Ì‘æ‡U‘ŠŽŽŒ±|FcƒÁRI iCD64j ‚¨‚æ‚ÑADCCŠˆ«‚ÌŒŸ“¢|. V’Ã@–]1, ‰HŽR–í‹œ1, ‰ª–{¹—²2, ŒS@”ü‰À1, ŠŒ´kˆê1, “ŒŒ´³–¾1, •½–ì³”ü (1“à‡W. 2˜a‰ÌŽRŒ§—§ˆã‘å): ‘æ66‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïE‘æ46‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï (2004/9/17-19), ‹ž“s.

723211. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) —Õ°ŽÀK‚É‚¨‚¯‚éˆã‚Ì—Ï—‹³ˆç. “ŒŒ´³–¾ (“à‡W): ‘æ63‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2004/9/29-10/1), •Ÿ‰ª.

723212. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) IFNŽ¡—Ã’†‚É”ñƒzƒWƒLƒ“ƒŠƒ“ƒpŽî‚ð”­Ç‚µ‚½–«œ‘«”’ŒŒ•a‚Ì1—á. –k‘º‰p“ñ, ’Ì–ì•x‹P, ‰HŽR–í‹œ, ‘åâ@Šw, ŒS@”ü‰À, ‹{è_“ñ, V’Ã@–], –x]—Ljê, “ŒŒ´³–¾ (“à‡W): ‘æ151‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï—á‰ï (2004/10/16), “Œ‹ž.

723213. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) EBƒEƒCƒ‹ƒXŠ´õ‚ðŒ_‹@‚Æ‚µ‚ÄäB[ǂ𗈂µ‚½æ“V«—nŒŒ«•nŒŒ. “n‰ï@W, Šp“c—TŽq1, •½@”ü–çŽq1, ’Ì–ì•x‹P1, ‘åâ@Šw1, ‰HŽR–í‹œ1, ŒS@”ü‰À1, ‹{è_“ñ1, V’Ã@–]1, –x]—Ljê1, “ŒŒ´³–¾1, ’†¼G˜a2 (1“à‡W. 2ìèˆã‘å): ‘æ152‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï—á‰ï (2005/2/26), “Œ‹ž.

731039. [Œ¤‹†‰ï] (“Á•Êu‰‰) Ž~ŒŒŒŒð—̈æ‚ÌÅV‚̘b‘è. “ŒŒ´³–¾ (“à‡W): ‘æ13‰ñì茌ðŽ~ŒŒ§˜b‰ï (2004/6/10), ìè.

731040. [Œ¤‹†‰ï] (“Á•Êu‰‰) –¢Ž¡—ÃisŠú’†‚ˆ««“xƒŠƒ“ƒpŽî‚ɑ΂·‚éCyclOBEAP—Ö@; ‘æ‡U‘ŠŽŽŒ±. V’Ã@–] (“à‡W): Lymphoma meeting in Shinagawa (2004/4), •iì.

731041. [Œ¤‹†‰ï] (“Á•Êu‰‰) –¢Ž¡—ÃisŠú’ራ«“xƒŠƒ“ƒpŽî‚ɑ΂·‚éR-CHOP-G—Ö@‚Ì‘æ‡T‘ŠŽŽŒ±|FcƒÁRI(CD64) ‚¨‚æ‚ÑADCCŠˆ«‚ÌŒŸ“¢|. V’Ã@–] (“à‡W): Lymphoma meeting in Shinagawa (2004/5), •iì.

733087. [Œ¤‹†‰ï] (ˆê”ʉ‰‘è) Ä”­EŽ¡—Ã’ïR«’ራ«“xB×–E«ˆ««ƒŠƒ“ƒpŽî‚ɑ΂·‚éR-EPOCT—Ö@ Rituximab, VP-16, PDN, VCR, CPA, THP‚Ì—Õ°‘æ‡U‘ŠŽŽŒ±. V’Ã@–] (“à‡W): ‘æ19‰ñˆ««ƒŠƒ“ƒpŽîŽ¡—ÃŒ¤‹†‰ï (2004/4), ‰¡•l.

733088. [Šw‰ï (’n•û)] (ˆê”ʉ‰‘è) œ‘Žî×–E‚ɃAƒEƒGƒ‹¬‘Ì—l\‘¢•¨‚ð”F‚ß‚½‘½”­«œ‘Žî‚Ì1—á. ‘º“c@“Œ, ŠŒ´kˆê1, ‘åâ@Šw1, ‹{è_“ñ1, “ŒŒ´³–¾1 (1“à‡W): ‘æ518‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2004/6/12), “Œ‹ž. ƒvƒƒOƒ‰ƒ€, p.16, 2004.

733089. [Œ¤‹†‰ï] (ˆê”ʉ‰‘è) May-HegglinˆÙíÇ‚Ì2‰ÆŒn‚Æ‚»‚Ì•ªŽq‹@\‚ÌŒŸ“¢. ‹{è_“ñ (“à‡W): ‘æ9‰ñÓ쌌‰tƒZƒ~ƒi[ (2004/6/17), ìè.

733090. [Šw‰ï (’n•û)] (ˆê”ʉ‰‘è) t (7; 9; 22)‚ª‚Ý‚ç‚ꂽ‰”­Žž‹}«“]‰»CML ilymphoid crisisj ‚Ì1—á. âŠÔ—æŽq, ‹{è_“ñ, ’Ì–ì•x‹P, ‘åâ@Šw, ŠŒ´kˆê, ŒS@”ü‰À, ‰HŽR–í‹œ, V’Ã@–], –x]—Ljê, “ŒŒ´³–¾ (“à‡W): ‘æ520‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2004/9/11), “Œ‹ž. ƒvƒƒOƒ‰ƒ€, p.8, 2004.

733091. [Šw‰ï (’n•û)] (ˆê”ʉ‰‘è) ƒuƒhƒE–Œ‰Š‚ð‡•¹‚µ‹}Œƒ‚È“]‹A‚ð‚Æ‚Á‚½NK/TƒŠƒ“ƒpŽî‚Ì1—á. “Œ–ìr—m, ’Ì–ì•x‹P1, ‘åâ@Šw1, ‹{è_“ñ1, ŒS@”ü‰À1, ‰HŽR–í‹œ1, V’Ã@–]1, –x]—Ljê1, “ŒŒ´³–¾1 (1“à‡W): ‘æ523‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2004/12/12), “Œ‹ž. ƒvƒƒOƒ‰ƒ€, p.13, 2004.

733092. [Œ¤‹†‰ï] (ˆê”ʉ‰‘è) ƒpƒ‹ƒ|ƒEƒCƒ‹ƒXB19Š´õ‚É‚æ‚èˆê‰ß«‚̔ČŒ‹…Œ¸­‚ð‚«‚½‚µ‚½ˆêÇ—á. ’†–Ú“N•½, ‹{è_“ñ1, “n‰ï@W, “ü]@Â, ’Ì–ì•x‹P1, ‘åâ@Šw1, Šp“c—TŽq1, “ŒŒ´³–¾1 (1“à‡W): ‘æ51‰ñ_“Þ쌌‰tŒ¤‹†‰ï (2005/2/5), ‰¡•l.


<<“à‰ÈŠw‡Wit‘Ÿ“à‰ÈŠwj>>

mŠwp˜_•¶n

110097. [Œ´’˜] Compositional similarity between immunoglobulins binding to asialo-,agalacto-IgA1-Sepharose and those deposited in glomeruli in IgA nephropathy. ‚’J@“O1, Šâ£m—E2, ˆÉ“¡º•F3, Ikuko Nakamura4, —Ñ@‚Ý‚ä‚«2, â–{®“o1, Š™“cvšæ1, ¬—Ñ@–L4, Yoshiyuki Hiki5, ‰ª–{–ql3, “ŒŒ´³–¾1 i1“à‡W. 2‘ãŽÓE’`”’. 3Ž¨•@. 4‚ ‚¯‚Ú‚Ì•a‰@. 5“¡“c•ÛŒ’‰q¶‘åj: Journal of Nephrology, 17 (5): 679-686, 2004.

110098. [Œ´’˜] Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). “¡“c•üŒb1, Chaline Brown4, Elaine J Carlson2, Travis Taylor2, Melanie de la Cruz2, Susan J Johns3, Doug Stryke3, Michiko Kawamoto3, “¡“c˜aŒÈ7, Richard Castro4, Chung-Wen Chen4, Emil T Lin4, Claire M Brett5, Esteban Gonzalez Burchard6, Thomas E Ferrin3, Conrad C Huang4, Maya K Leabman4, Katheleen M Giacomini4 (1–ò—. 2Genomics Core Facility, Program in Human Genetics, University of California, Departments of 3Pharmaceutical Chemistry, 4Biophamaceutical Sciences, 5Anesthesia, University of California, 6Lung Biology Center,University of California. 7“à‡W): Pharmacogenetics and Genomics, 15 (4): 201-209, 2005.

110099. [Œ´’˜] Local irradiation enhances congenic donor pluripotent hematopoietic stem cell engraftment similarity in irradiated and nonirradiated sites. Hiroshi Ito1, ’|“àN—Y2, Shaffer Juanita3, Sykes Megan3 (1ŽRŒû‘åŠO‰È. 2“à‡W. 3Massachusetts General Hospital): Blood, 103 (5): 1949-1954, 2004.

110100. [Œ´’˜] Clonality analysis of T cells mediating acute and chronic rejection in kidney allografts. Obata Fumiya1, ‹g“cˆê¬2, ‘å‹v•Û[l3, ’|“àN—Y4, ŽÂŒ´MŒ«5, Endo Tadao6, ”nêŽu˜Y2 (1Department of Immunology, School of Allied Health Sciences. 2”å. 3²–ìN¶‘‡•a‰@. 4“à‡W. 5–Ɖu. 6Saitama Keno Hospital): Transpl Immunol, 13 (3): 233-237, 2004.

110101. [Œ´’˜] Contribution of CD4 and CD8 T cells and interferon-gamma to the progress of chronic rejectiion of kidney allografts; the Th1 response mediates both acute and chronic rejection. Obata Fumiya1, ‹g“cˆê¬2, ‘å‹v•Û[l3, “c‰ª‰ÀŒ›2, ’|“àN—Y4, ŽÂŒ´MŒ«5, Endo Tadao6, ”nêŽu˜Y2 (1Department of Immunology, School of Allied Health Sciences. 2”å. 3Sano Kosei Hospital. 4“à‡W. 5–Ɖu. 6Saitama Keno Hospital): Transpl Immunol, 14 (1): 21-25, 2005.

110102. [Œ´’˜] Cooperative Induction of Histidine Decarboxylase (HDC) and Histamine H2 Receptor in the Infiltrating Cells Participates in the Regulation of Inflammation Induced by Unilateral Ureteral Obstruction (UUO). ´…Œ’Žj, â–{®“o, ¼”öFr, “ŒŒ´³–¾ (“à‡W): The Kitasato Medical Journal, 34 (2): 2004.

110103. [Œ´’˜] Juxtaglomerular Apparatus T cell infiltration affects glomerular structure in Type 1 diabetic patients. Žç‰®—˜‰À1, Manivil C, Mauer M (1“à‡W): Diabetologia Jan, 47 (1): 82-88, 2004.

110104. [Œ´’˜] Regular hemodialysis reverses gastric mucosal atrophy of patients with chronic renal failure. Ohara T, Suzuki H, Žë–ì—Lì1, Žç‰®—˜‰À2, ‰ªˆÀ@ŒM3, Morishita T, Ishii H (1—ÕŒŸŠw. 2“à‡W. 3•a—): Hepatogastroenterology, 51 (57): 679-683, 2004.

110105. [Œ´’˜] Diversity in the Sorting Disorder Induced by the Mutant ClC-5 Chloride Channels Responsible for Dent's Disease. ¼”öFr1, â–{®“o1, Satoko Inoue2, Ichiro Naito2, ¬—Ñ@–L1, “ŒŒ´³–¾1 (1“à‡W. 2Shigei Medical Research Institute): Kitasato Med, 33: 233`244, 2003.

310005. [Ç—á•ñ] Spontaneous rupture of a left gastroepiploic artery aneurysm in a patient with autosomal-dominant polycystic kidney disease. ’·ê@‘×1, ¼Šª@”Ž2, ˆêŒË¹–¾3, ‰œ˜e—T‰î2, ‰H‘º‘fŽq1, –q–ì•Žu1, ²–ì@—²1, “ŒŒ´³–¾1, Š™“cvšæ1, ‘Š”nˆêˆå2 (1“à‡W. 2‹~–½. 3•a—): Clinical Nephrology, 63 (2): 163-166, 2005.

320021. [Ç—á•ñ] Candida parapsilosis‚É‚æ‚éd“Ä‚ÈCAPDŠÖ˜A• –Œ‰Š‚Ƀ~ƒJƒtƒ@ƒ“ƒMƒ“‚Ì“Š—^‚ª‘tŒ÷‚µ‚½“§ÍŠ³ŽÒ‚Ì1—á. ‹´–{ƒqƒƒR1, Žç‰®—˜‰À1, Š™“cvšæ1, “ŒŒ´³–¾1, ‹g“cˆê¬2, ‹v•Ä@Œõ3 (1“à‡W. 2”å. 3•a—): Š´õÇŠwŽGŽ (J. J. A. Inf. D.), 79 (3): 195-200, 2005.

520096. [‘à] “ÁW: t‰ŠŽä‹NŠÖ˜A•ªŽq@–Œ«Ž…‹…‘Ìt‰Š‚Ì•aˆö•ªŽq. Š™“cvšæ (“à‡W): t‚Æ“§Í, 57 (6): 777`780, 2004.

520097. [uÀ] “ÁW: Ç—á‚ÆQ & A‚Å…E“d‰ðŽ¿,—A‰t‚ª‚í‚©‚éI@Q • A ‘ãŽÓ«ƒAƒVƒh[ƒVƒX‚ÌŠÓ•Êf’f‚Æ’YŽ_…‘fƒiƒgƒŠƒEƒ€‚ÌŽg‚¢•û‚ð‹³‚¦‚ĉº‚³‚¢. ’·ê@‘×, Š™“cvšæ (“à‡W): ¡ŒŽ‚ÌŽ¡—Ã, 13 (2): 79`83, 2005.

m’˜@‘n

620053. [‰ðà‘] (•ª’SŽ·•M) ª‹’‚ª‚í‚©‚é@ƒi[ƒX‚Ì‚½‚ß‚Ì“§ÍƒPƒAQ•A; 3. ŒŒ‰t“§Í‚ÌŽÀÛ, p.52-54. ‚±‚¤‚¢‚¤Š³ŽÒ‚³‚ñ‚É‚Í‚±‚¤‘Ήž‚µ‚悤, p.110. Š™“cvšæ (“à‡W), “ì]“°, “Œ‹ž, 2004/7/1”­s.

620054. [‹³‰È‘] (•ª’SŽ·•M) u‹`˜^@t‘ŸŠw; ‘SgŽ¾Š³‚É”º‚¤Ž…‹…‘ÌŽ¾Š³, p.200`219. Š™“cvšæ (“à‡W), MEDICAL VIEWŽÐ, “Œ‹ž, 2004/11/20”­s.

620055. [Šwp‘] (•ª’SŽ·•M) ŒŒ‰tò‰»—Ö@|Šî‘b—˜_‚ÆÅV—Õ°‰ž—p|; ”A“ÅÇ‚Ì•a‘Ô˜_@”÷—ÊŒ³‘f (Disturbances of trace elements), p.101-107. â–{®“o, ´…Œ’Žj (“à‡W), “ú–{—Õ°, ‘åã, 2004/6/28”­s.

620056. [Šwp‘] (•ª’SŽ·•M) Medical Practice 22 (1); ‚—îŽÒ‚Ì’áƒiƒgƒŠƒEƒ€ŒŒÇ|SIADH‚ÆMRHE‚Ì•a‘Ԃ̈Ⴂ|, p.151. â–{®“o (“à‡W), •¶Œõ“°, “Œ‹ž, 2005/1/1”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

713063. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Analysis of cytokines and anti-HLA antibodies in kidney transplantation: Transforming growth factor-beta1 exhibited a protective effect on choronic rejection. Obata Fumiya1, ‹g“cˆê¬2, Ohkubo Michihito3, ’|“àN—Y4, “c‰ª‰ÀŒ›2, ŽÂŒ´MŒ«5, Endo Tadao6, ”nêŽu˜Y2 (1Department of Immunology, School of Allied Health Sciences. 2”å. 3Sano Kosei Hospital. 4“à‡W. 5–Ɖu. 6Saitama Keno Hospital): ‘æ20‰ñ‘ÛˆÚAŠw‰ï (2004/9/8), ƒEƒC[ƒ“.

713064. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) T cell-depleted allogeneic bone marrow transplantation induces mixed chimerism and donor-specific tolerance and prevents diabetes in NOD mice receiving low-dose (4 Gy) total body irradiation, CD8 T cell depletion, and anti-CD40L mAb. ’|“àN—Y1, Nikolic Bolis2, Sykes Megan2 (1“à‡W. 2Massachusetts General Hospital): ‘æ20‰ñ‘ÛˆÚAŠw‰ï (2004/9/8), ƒEƒC[ƒ“.

713065. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) CD8 T cell tolerance after bone marrow transplantation using non-myeloablative conditioning with TBI and anti-CD154 mAb: importance of signal 1, CD4 T cells and CTLA4, but no evidence for long-term regulation. Fehr Thomas1, ’|“àN—Y2, Kurtz Josef1, Sykes Megan1 (1Massachusetts General Hospital. 2“à‡Wj: ‘æ20‰ñ‘ÛˆÚAŠw‰ï (2004/9/8), ƒEƒC[ƒ“.

713066. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Cooperative Induction of Histidine Decarboxylase (HDC) and Histamine H2 Receptor in the Infiltrating Cells Participate in the Regulation of Inflammation Induced by Unilateral Ureteral Obstruction (UUO) in Autocrine/Paracrine Manner. ´…Œ’Žj, â–{®“o, ¼”öFr, “ŒŒ´³–¾ (“à‡W): ‘æ37‰ñƒAƒƒŠƒJt‘ŸŠw‰ïŠwpW‰ï (2004/10/30), ƒZƒ“ƒgƒ‹ƒCƒX, USA. Journal of the American Society of Nephrolgy, 15: Abstracts Issue, 478A, 2004.

713067. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Prediction of Hypotension during a Hemodialysis Session by the Entropy of the Heart Rate Variability. ŽR’†@–]1, Š™“cvšæ1, ÂŽR“ŒŒÜ1, ’r“cŒ›º2, â–{®“o1, “ŒŒ´³–¾1 i1“à‡W. 2ˆã‰qj: 37th Annual Meeting of American Society of Nephrology (2004/10/31), St. Louis, Missouri, USA. Journal of the American Society of Nephrology, 15: 611A, 2004.

713068. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Proteomic Analysis Reveals Alteration in Galectin-1 in a Novel Mutant in C-Terminus of ClC-5 Channel-Induced Sorting Disorder from Endoplasmic Reticulum. â–{®“o, ¼”öFr, ´…Œ’Žj, “ŒŒ´³–¾ i“à‡Wj: Annual Meeting of American Society of Nephrology (2004/10/31), St. Louis, MO, USA. J Am Soc Nephrol, 15: 542A, 2004.

723214. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ANCAŠÖ˜At‰Š‚ɑ΂·‚éƒvƒŒƒhƒjƒ“’†“™—Ê“Š—^‚ÌŽ¡—ìÑ. Š™“cvšæ1, –q–ì•Žu1, ‰H‘º‘fŽq1, ‹´–{ƒqƒƒR1, ²–ì@—²1, ’·ê@‘×1, ’|“àN—Y1, Žç‰®—˜‰À1, â–{®“o1, ¬—Ñ@–L2 (1“à‡W. 2‚ ‚¯‚Ú‚Ì•a‰@): ‘æ47‰ñ“ú–{t‘ŸŠw‰ïŠwpW‰ï (2004/5/27), ‰F“s‹{. “ú–{t‘ŸŠw‰ïŽ, 46 (3): 196, 2004.

723215. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒqƒgƒlƒtƒŠƒ“‚ƒDNA“Š—^‚É‚æ‚è—U“±‚³‚ê‚éRƒqƒgƒlƒtƒŠƒ“R‘̂̉ðÍ. ÂŽR“ŒŒÜ1, ŽR’†@–]1, ’|“àŒb”üŽq1, ’|“àN—Y2, “ŒŒ´³–¾2, Š™“cvšæ2 (1ˆã—ÃŒn‘åŠw‰@. 2“à‡W): ‘æ47‰ñ“ú–{t‘ŸŠw‰ïŠwpW‰ï (2004/5/27), ‰F“s‹{. “ú–{t‘ŸŠw‰ïŽ, 46 (3): 251, 2004.

723216. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆâ“`Žq–Ɖu‚É‚æ‚éƒlƒtƒŠƒ“R‘Ì‚Ì쬂ƒ`”’”A‚Ì—U“±. ŽR’†@–]1, ÂŽR“ŒŒÜ1, ’|“àŒb”üŽq1, ’|“àN—Y2, “ŒŒ´³–¾2, Š™“cvšæ2 (1ˆã—ÃŒn‘åŠw‰@. 2“à‡W): ‘æ47‰ñ“ú–{t‘ŸŠw‰ïŠwpW‰ï (2004/5/27), ‰F“s‹{. “ú–{t‘ŸŠw‰ïŽ, 46 (3): 251, 2004.

723217. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒŒƒNƒ`ƒ“ƒtƒ@ƒ~ƒŠ[’`”’‚É‚æ‚éCIC-5ƒNƒƒ‰ƒCƒhƒ`ƒƒƒlƒ‹‚̃\[ƒeƒBƒ“ƒO§Œä. ¼”öFr1, â–{®“o1, ´…Œ’Žj1, ˆäã‘Žq2, “à“¡ˆê˜Y2, “ŒŒ´³–¾1 (1“à‡W. 2dˆäˆãŠwŒ¤‹†Š): ‘æ47‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2004/5/28), ‰F“s‹{. “ú–{t‘ŸŠw‰ïŽ, 46 (3): 215, 2004.

723218. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) tŠÔŽ¿üˆÛ‰»‚É”º‚¤Z«’P‹…^ƒ}ƒNƒƒtƒ@[ƒW‚ւ̃qƒXƒ^ƒ~ƒ“‚g2Žó—e‘Ì‚Ì—U“±Œ^”­Œ». ´…Œ’Žj, â–{®“o, ¼”öFr, ²–ì@—², “ŒŒ´³–¾ (“à‡W): ‘æ47‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2004/5/28), ‰F“s‹{. “ú–{t‘ŸŠw‰ïŽ, 46 (3): 272, 2004.

723219. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒIƒ“ƒ‰ƒCƒ“ iO|j HDFŽ{sŒã1”NŠÔ‚É‚¨‚¯‚éƒZƒbƒVƒ‡ƒ“‘OŒã‚̃yƒ“ƒgƒVƒWƒ“ iPentj ‚Ì•Ï“®‚ɂ‚¢‚Ä. ’|“àN—Y1, ¬—Ñ’¼”V2, “c‘º‰ël1, â–{®“o1, Š™“cvšæ1, ÎŒ´˜a•F3, Žðˆä@‹Š4, ‘å‹v•Û[l5, “ŒŒ´³–¾1 (1“à‡W. 2‘Š•‘äƒj[ƒŒƒ“ƒNƒŠƒjƒbƒN. 3ˆã‰q. 4¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š. 5²–ìŒú¶‘‡•a‰@): ‘æ47‰ñ“ú–{t‘ŸŠw‰ïŠwpW‰ï (2004/5/28), ‰F“s‹{. “ú–{t‘ŸŠw‰ïŽ, 46 (3): 267, 2004.

723220. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) RŠî’ê–ŒR‘ÌŒ^t‰Š10—á‚Ì—Õ°“IŒŸ“¢. ’·ê@‘×1, ²–ì@—²1, ’|“àN—Y1, Žç‰®—˜‰À1, ‹´’ÜŒ’ŽŸ˜Y, –q–ì•Žu1, ‰H‘º‘fŽq1, ‹´–{ƒqƒƒR1, â–{®“o1, ¬—Ñ@–L1, Š™“cvšæ1, “ŒŒ´³–¾1 (1“à‡W): ‘æ47‰ñ“ú–{t‘ŸŠw‰ïŠwpW‰ï (2004/5/29), ‰F“s‹{. “ú–{t‘ŸŠw‰ïŽ, 46 (3): 285, 2004.

723221. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “à•”àh‰ß‚Í“§Íœ…’†‚É‹N‚«‚é‚Ì‚¾‚낤‚©? “ì•”³l1, “Œ@Œ«ˆê1, “¡Œ´Nì1, –ìì—²ˆê˜Y1, ¬ŽR@½1, ‘Š Cˆê1, ¼àV­•F3, â–{®“o2, Š™“cvšæ2 (1tƒZƒ“ƒ^[. 2“à‡W. 3‚ ‚¯‚Ú‚Ì•a‰@): ‘æ49‰ñ iŽÐj “ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2004/6/18), _ŒË. “ú–{“§ÍŠw‰ïŽ, 37 (S.1): 767, 2004.

723222. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒŒ‰t“§Í‚ª”DPoŽY‚É‹y‚Ú‚·‰e‹¿. ÂŽR“ŒŒÜ1, ‰E“‡•xŽm’j3, –q–ì•Žu2, ŽR’†^—Žq2, ’·ê@‘×2, Žç‰®—˜‰À2, ²–ì@—²2, ’|“àN—Y2, â–{®“o2, “V–ì@Š®3, Š™“cvšæ2 (1ˆã—ÃŒn‘åŠw‰@. 2“à‡W. 3ŽY•wj: ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2004/6/18), _ŒË. “ú–{“§ÍŠw‰ïŽ, 37 (S.1): 799, 2004.

723223 [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “œ”A•a«‚Æ”ñ“œ”A•a«t•s‘S‚Æ‚Ì“§Í“±“üŠú‘Šˆá“_`‘æ2•ñ. “c‘º_ŽO1, –ìX‘º–í¶2, Š™“cvšæ3 (1’¬“cŽs–¯•a‰@. 2‘å˜aŽs—§•a‰@. 3“à‡W): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2004/6/18), _ŒË. “ú–{“§ÍŠw‰ïŽ, 37 (S.1): 998, 2004.

723224. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰–Ž_ƒZƒxƒ‰ƒ}[“Š—^‚É‚æ‚éintact PTH‚¨‚æ‚Ñwhole PTH‚ւ̉e‹¿. ’·ê@‘×1, ¼”öFr1, ²–ì@—²1, ’|“àN—Y1, Žç‰®—˜‰À1, â–{®“o1, “ŒŒ´³–¾1, Š™“cvšæ1, ‚–Ø@—T2, ‹g“c@àˆ2, ‰i‰ª@—²3, ŸNˆäŒ’Ž¡4, âV“¡@‹B4 (1“à‡W. 2‚³‚ª‚ÝzŠÂŠí. 3‘Š–ÍŒ´ƒNƒŠƒjƒbƒN. 4‹´–{ƒNƒŠƒjƒbƒNj: ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ï (2004/6/18), _ŒË. “ú–{“§ÍˆãŠw‰ïŽGŽ, 37 (S.1): 1016, 2004.

723225. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “§Í’†‚ÌŒŒˆ³’²ßˆöŽq‚Ìentropy‰ðÍ. ù–ì—F”ü1, ŽR’†@–]3, ²“¡‰hŽ¡1, œA£@–«1, ¬—ÑO—S1, ‰i‰ª@—²2, Š™“cvšæ4 (1ˆã‰q. 2‘Š–ÍŒ´ƒNƒŠƒjƒbƒN. 3ˆã—ÃŒn‘åŠw‰@. 4“à‡W): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2004/6/19), _ŒË. “ú–{“§ÍŠw‰ïŽ, 37 (S.1): 869, 2004.

723226. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒ\ƒmƒNƒƒbƒgACT‘ª’è–@‚É‚¨‚¯‚é‹ÃŒÅŠˆ«Ü‚ÌŒŸ“¢. “Œ@Œ«ˆê1, “ì•”³l1, “¡Œ´Nì1, –ìì—²ˆê˜Y1, ¬ŽR@ ½1, ‘Š Cˆê1, â–{®“o2, Š™“cvšæ2 (1tƒZƒ“ƒ^[. 2“à‡W): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2004/6/19), _ŒË. “ú–{“§ÍŠw‰ïŽ, 37(S.1): 855, 2004.

723227. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “§ÍŠ³ŽÒ‚É‚¨‚¯‚é”]ŒŒŠÇáŠQ‚Ì”­Ç“Á«. ‰H‘º‘fŽq, â–{®“o, ‹´–{ƒqƒƒR, –q–ì•Žu, ²–ì@—², ’·ê@‘×, ’|“àN—Y, Žç‰®—˜‰À, Š™“cvšæ, “ŒŒ´³–¾ (“à‡W): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2004/6/19), _ŒË. “ú–{“§ÍŠw‰ïŽ, 37 iS.1j: 1047, 2004.

723228. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒGƒ“ƒhƒgƒLƒVƒ“‹z’…, Ž‘±ŒŒ‰tàh‰ß“§Í‚É‚Ä‹~–½‚³‚ꂽƒtƒ‹ƒjƒGÇŒóŒQ‚Ì1—á. ÂŽR‰ë‘¥1, ’F@—m2, Š™“cvšæ1, “ŒŒ´³–¾1 (1“à‡W. 2‚ ‚¯‚Ú‚Ì•a‰@j: ‘æ49‰ñ iŽÐj “ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2004/6/20), _ŒË. “ú–{“§ÍŠw‰ïŽ, 37 (S.1): 925, 2004.

723229. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) CAPD‚©‚çHD‚ÖˆÚs‚µ6”NŒã‚É”­Ç‚µ‚½’×ᇫ‘å’°‰ŠŽèpŒã‚É”í”X«d‰»«• –ŒÇ iEPS) ‚ð”­Ç‚µ‚½ˆê—á. Žç‰®—˜‰À1, ‰H‘º‘fŽq1, ‹´–{ƒqƒƒR1, –q–ì•Žu1, ²–ì@—²1, ’·ê@‘×1, ’|“àN—Y1, â–{®“o1, Š™“cvšæ1, “y“c–š”ü2, ‹g“cˆê¬2, ˆäŒ´@Œú3, ã@‘4 (1“à‡W. 2”å. 3ŠO. 4ãƒNƒŠƒjƒbƒN): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ï (2004/6/20), _ŒË. “ú–{“§ÍˆãŠw‰ïŽGŽ, 37 (S.1): 977, 2004.

723230. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’´‰¹”g‚‘¬3ŽŸŒ³•\Ž¦‚Ì—LŒø«‚ÌŒŸ“¢. ’F@—m1, Š™“cvšæ2, ÂŽR“ŒŒÜ2, “¡XˆŸŠó1, ’†‘ºˆèŽq1, ŠÚ–샶1, “싽‰p–¾1 (1‚ ‚¯‚Ú‚Ì•a‰@. 2“à‡W): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2004/6/20), _ŒË. “ú–{“§ÍŠw‰ïŽ, 37 (S.1): 1121, 2004.

723231. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒŒ‰t“§ÍŠ³ŽÒ‚É‚¨‚¯‚éƒZƒ‹ƒtEƒGƒtƒBƒJƒV[‚Æg‘Ì‹@”\‚ÌŠÖ˜A. Ô–x”ü’qŽq1, ‚–Ø@—T1, ‹g“c@àˆ1, ’|“àN—Y2, “ŒŒ´³–¾2, Š™“cvšæ2, â–{ƒŽq3, ꎓ¡³˜a3, ¼‰i“Ä•F3, ‘“c@‘ì4 (1‚³‚ª‚ÝzŠÂŠíƒNƒŠƒjƒbƒN. 2“à‡W. 3ˆã—ÃŒn‘åŠw‰@. 4ˆã‰q): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2004/6/20), _ŒË. “ú–{“§ÍŠw‰ïŽ, 37 (S.1): 1141, 2004.

723232. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Š´õÇ‚ª‹^‚í‚ê, ‘½Ê‚È—Õ°ŠŒ©‚ðŽ¦‚µ‚½late onset acute rejection‚Ì1—á. ’|“àN—Y1, “à“¡³‹g1, ‹àŒõ•ôŽq1, ÂŽR‰ë‘¥1, ‰H‘º‘fŽq1, “y“c–š”ü2, ‹g“cˆê¬2, Š™“cvšæ1, “ŒŒ´³–¾1, ”nêŽu˜Y2 (1“à‡W. 2”å): ‘æ38‰ñ“ú–{tˆÚA—Õ°Šw‰ï (2005/1/26), “Œ‹ž.

731042. [Œ¤‹†‰ï] (“Á•Êu‰‰) t‹@”\áŠQ‚Æ–òÜ‚Ì•›ì—p. Š™“cvšæ (“à‡W): ‘å˜a–òÜŽt‰ï (2004/7/8), ‘å˜aŽs.

732023. [Œ¤‹†‰ï] (µ‘Òu‰‰) tŽ¾Š³‚Æ‚ŒŒˆ³|~ˆ³—Ö@‚ÌŒ»ó‚Æ–â‘è“_|. â–{®“o (“à‡W): ‘Š–ÍŒ´ŽsˆãŽt‰ï“à‰Èˆã‰ï Four Season's Conference (2004/5/12), ‘Š–ÍŒ´.

732024. [Šw‰ï (’n•û)] (‹³ˆçu‰‰) Šw¶EŒ¤Cˆã‚Ì‚½‚ß‚Ìt‘ŸƒZƒ~ƒi[ i”AˆÙí‚ł̃Aƒvƒ[ƒ`j. Š™“cvšæ (“à‡W): “ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2004/11/6), “Œ‹ž. “ú–{t‘ŸŠw‰ïŽ, 46 (6): 558, 2004.

732025. [Œ¤‹†‰ï] (µ‘Òu‰‰) ”A‚̈Ù튌©‚ÆŽæ‚舵‚¢‚ɂ‚¢‚Ä. â–{®“o (“à‡W): _“Þì•ÛŒ¯ˆã‹¦‰ïŒŽ—ጤ‹†‰ï (2005/3/17), ‰¡•l.

732026. [Œ¤‹†‰ï] (µ‘Òu‰‰) ŒŒ‰tò‰»Ž¡—Âɂ¨‚¯‚éÅ‹ß‚Ì’mŒ©. â–{®“o (“à‡W): ‘ŠB“§Í‹ZŽt§˜b‰ï (2005/3/27), ’¬“cŽs.

733093. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ANCAŠÖ˜At‰Š‚ɑ΂·‚éƒvƒŒƒhƒjƒ“’†“™—Ê“Š—^‚ÌŽ¡—ìÑ. Š™“cvšæ1, –q–ì•Žu1, ‰H‘º‘fŽq1, ‹´–{ƒqƒƒR1, ²–ì@—²1, ’·ê@‘×1, ’|“àN—Y1, Žç‰®—˜‰À1, â–{®“o1, ¬—Ñ@–L2 (1“à‡W. 2‚ ‚¯‚Ú‚Ì•a‰@j: ‘æ5‰ñ“Œ‹žt‰ŠEƒlƒtƒ[ƒ[Œ¤‹†‰ï (2004/7/17), “Œ‹ž.

733094. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‹ßˆÊ”A׊ǂ̃Gƒ“ƒhƒTƒCƒg[ƒVƒXáŠQ‚𔺂Á‚½‹U«•›bó‘B‹@”\’ቺǂÌ1—á. ’|“àN—Y1, â–{®“o1, âŠÔ—æŽq, ‰H‘º‘fŽq1, ²–ì@—²1, ’·ê@‘×1, Žç‰®—˜‰À1, Š™“cvšæ1, “ŒŒ´³–¾1 (1“à‡W): ‘æ36‰ñ—Õ°‘̉tŒ¤‹†‰ï (2004/10/16), “Œ‹ž.

733095. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) RŽ…‹…‘ÌŠî’ê–Œ iGBMj R‘Ì‚ÆMPO-ANCA‚ª—z«‚ðŽ¦‚µ‚½‹}‘¬is«Ž…‹…‘Ìt‰Š‚̈ê—á. ‹àŒõ•ôŽq, ²–ì@ —², ‰H‘º‘fŽq, ÂŽR‰ë‘¥, “à“¡³‹g, ’·ê@‘×, ’|“àN—Y, Žç‰®—˜‰À, â–{®“o, “ŒŒ´³–¾, Š™“cvšæ (“à‡W): ‘æ34‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2004/11/5), “Œ‹ž. “ú–{t‘ŸŠw‰ïŽ, 46 (6): 599, 2004.

733096. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒlƒtƒ[ƒ[ÇŒóŒQ‰Á—Ã’†‚ÉŒ´ˆö•s–¾‚ÌŽlŽˆ, ŒÄ‹z–ƒáƒ‚ðŽ¦‚µ‚½1—á. “c‘º_ŽO1, “c‘º‰ël2, Š™“cvšæ3 (1’¬“cŽs–¯•a‰@. 2‘å˜aŽs—§•a‰@. 3“à‡W): ‘æ34‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2004/11/5), “Œ‹ž. “ú–{t‘ŸŠw‰ïŽ, 46 (6): 602, 2004.

733097. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘I‘ð“IƒZƒƒgƒjƒ“ÄŽæž‚Ý‘jŠQ–ò iSSRIj ‚É‚æ‚è’áKŒŒÇ‚𔺂¤SIADH‚ð‚«‚½‚µ‚½ˆê—á. ‰H‘º‘fŽq, â–{®“o, ²–ì@—², ÂŽR‰ë‘¥, ‹àŒõ•ôŽq, “à“¡³‹g, ’·ê@‘×, ’|“àN—Y, Žç‰®—˜‰À, Š™“cvšæ, “ŒŒ´³–¾ (“à‡W): ‘æ34‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2004/11/5), “Œ‹ž. “ú–{t‘ŸŠw‰ïŽ, 46 (6): 613, 2004.

733098. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‰^“®Œã‹}«t•s‘S‚𔽕œ‚µ‚½t«’á”AŽ_ŒŒÇ‚̈ê—á. ’·ê@‘×. ²–ì@—², ’|“àN—Y, Žç‰®—˜‰À, ‰Ž“c‹M”V, ‰H‘º‘fŽq, â–{®“o, “ŒŒ´³–¾, Š™“cvšæ (“à‡W): ‘æ34‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2004/ 11/5), “Œ‹ž. “ú–{t‘ŸŠw‰ïŽ, 46 (6): 609, 2004.

733099. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) —¼‘¤…tÇ‚ÌŒo‰ß’†‚É”­Œ©‚³‚ꂽRŽ…‹…‘ÌŠî’ê–ŒR‘ÌŒ^”¼ŒŽ‘ÌŒ`¬«Ž…‹…‘Ìt‰Š‚̈ê—á. “à“¡³‹g, ’|“àN—Y, –q–ì•Žu, ‰H‘º‘fŽq, ²–ì@—², ’·ê@‘×, Žç‰®—˜‰À, â–{®“o, “ŒŒ´³–¾, Š™“cvšæ (“à‡W): ‘æ34‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2004/11/6), “Œ‹ž. “ú–{t‘ŸŠw‰ïŽ, 46 (6): 626, 2004.

733100. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) MRSAŠ´õÇ‚ÆPR3-ANCA—z«‚ð‡•¹‚µ‚½‹}‘¬is«Ž…‹…‘Ìt‰Š‚̈ê—á. ÂŽR‰ë‘¥, Žç‰®—˜‰À, “à“¡³‹g, ‹àŒõ•ôŽq, ‰H‘º‘fŽq, ²–ì@—², ’·ê@‘×, ’|“àN—Y, â–{®“o, “ŒŒ´³–¾, Š™“cvšæ (“à‡W): ‘æ34‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2004/11/6), “Œ‹ž. “ú–{t‘ŸŠw‰ïŽ, 46 (6): 62, 2004.

733101. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) PR3-ANCA—z«, ‚Ô‚Ç‚¤–Œ‰Š‚𔺂¤MRSAŠÖ˜At‰Š‚Ì1—á. ÂŽR‰ë‘¥, Žç‰®—˜‰À, “à“¡³‹g, ‹àŒõ•ôŽq, ‰H‘º‘fŽq, ²–ì@—², ’·ê@‘×, ’|“àN—Y, â–{®“o, “ŒŒ´³–¾, Š™“cvšæ (“à‡W): ‘æ34‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2004/11/6), “Œ‹ž. “ú–{t‘ŸŠw‰ïŽ, 46 (6): 628, 2004.

733102. [Œ¤‹†‰ï] (ˆê”Êu‰‰) MRSAŠ´õǂ𔺂¤ANCAŠÖ˜AŒŒŠÇ‰Š‚̈ê—á. ÂŽR‰ë‘¥, Žç‰®—˜‰À, “à“¡³‹g, ‹àŒõ•ôŽq, ‰H‘º‘fŽq, ²–ì@—², ’·ê@‘×, ’|“àN—Y, â–{®“o, “ŒŒ´³–¾, Š™“cvšæ (“à‡W): ‘æ68‰ñ_“ÞìtŒ¤‹†‰ï (2004/11/28), ‰¡•l.

733103. [Œ¤‹†‰ï] (ˆê”Êu‰‰) –Œ«tÇ‚Ì’·ŠúŒo‰ßŒã‚ÉCrow-FukaseÇŒóŒQ‚ð”­Ç‚µ, V‚½‚ÈŽ…‹…‘Ì•a•Ï‚ð”F‚ß‚½ˆê—á. ‹àŒõ•ôŽq1, ’·ê@‘×1, ²–ì@—²1, ‰H‘º‘fŽq1, “à“¡³‹g1, ÂŽR‰ë‘¥1, ’|“àN—Y1, Žç‰®—˜‰À1, â–{®“o1, ¬—Ñ@–L2, Š™“cvšæ1 (1“à‡W. 2‚ ‚¯‚Ú‚Ì•a‰@): ‘æ43‰ñ_“Þìt‰ŠŒ¤‹†‰ï (2005/2/12), ‰¡•l.

733104. [Œ¤‹†‰ï] (ˆê”Êu‰‰) dÇS‹@”\’ቺ‚𔺂¤––Šút•s‘SŠ³ŽÒ‚̈ێ“§Í—Ö@. ‰H‘º‘fŽq, ‹´–{ƒqƒƒR, Žç‰®—˜‰À, ‹àŒõ•ôŽq, “à“¡³‹g, ÂŽR‰ë‘¥, ²–ì@—², ’·ê@‘×, â–{®“o, Š™“cvšæ (“à‡W): ‘æ19‰ñ_“Þ쌧CAPDŒ¤‹†‰ï (2005/3/19), ‰¡•l.


<<“à‰ÈŠw‡XiŒÄ‹zŠí“à‰ÈŠwj>>

mŠwp˜_•¶n

120017. [Œ´’˜] ‚Ñ‚Ü‚ñ«”xŽ¾Š³‚É‚¨‚¯‚é‹CŠÇŽx”x–Eôò‰t’†‚̈ŸÉŽ_^ÉŽ_”Z“x‚ÌŒŸ“¢. ‘Ÿº—²”V1, ‹v•Û“c@Ÿ2, ˆäì@‘2, “c’†’¼•F2, ‰v“c“TK2, ¬—ÑO—S2,3 (1‘Š–ÍŒ´‹¦“¯•a‰@. 2“à‡X. 3ˆã‰q): –k—¢ˆãŠw, 34 (1): 1-6, 2004.

120018. [Œ´’˜] ÔŠOü“dŽq“µEŒv‚É‚æ‚é–«”x‹CŽîŠ³ŽÒ‚ÌŽ©—¥_Œo‹@”\•]‰¿. {“¡“N—Y1, “c’†’¼•F1, Îì@‹Ï2, ´…Œö–ç2, ‰v“c“TK1, ¬—ÑO—S1,3 (1“à‡X. 2Šá. 3ˆã‰q): –k—¢ˆãŠw, 34 (1): 7-12, 2004.

320022. [Ç—á•ñ] Ò’Å‘¤œ]ǂɑ΂·‚éÒ’Å‘O•ûŒÅ’èpŒã‚É”­Ç‚µ‚½‹CŠÇŽx‹·ó‚Ì1—á. ˆäì@‘1, ‚“cM˜a1, ‰¡ê³“T1, –î“àŒ´’qŽq1, ¡è‹M¶1, ŽO“¡@‹v1, ‹v•Û“c@Ÿ1, •Ð‹Ë^l1,2, ¬—ÑO—S1,2, –î“ߣM—Y1,2, ‰v“c“TK1 (1“à‡X. 2ˆã‰q): ‹CŠÇŽxŠw, 26 (7): 654-658, 2004.

320023. [Ç—á•ñ] ’†‚—îŽÒ i40ΈÈãj ‚Ì‹C‹¹Žèp—á‚ÌŒŸ“¢. ’J‘º”É—Y1, ¶ˆä¢—Y2, ‰¡ê³“T2, –{ŠÔ˜a•v2 (1‘Š–ÍŒ´‹¦“¯•a‰@. 2“à‡X): “ú‹C”XŽ¾‰ïŽ 6: 40`43, 2004.

320024. [Ç—á•ñ] RHTLV-IR‘Ì—z«‚Å—¼‘¤”x–ì‚ÉŒ‹ß‰e‚Æ‚Ñ‚Ü‚ñ«‰A‰e‚ª¬Ý‚µ‚½B×–EŒ^ˆ««ƒŠƒ“ƒpŽî‚Ì1—á. {“¡“N—Y1, ŽO“¡@‹v1, ‚“cM˜a1,2, ²“¡˜aŒÈ1, Ó@¢ˆ®3, •Ð‹Ë^l1,2, –î“ߣM—Y1,2, ‰v“c“TK1 (1“à‡X. 2ˆã‰q. 3•a—): ŒÄ‹z (0286-9314), 23 (11): 910-915, 2004.

320025. [Ç—á•ñ] “§ÍŠ³ŽÒ‚É”­Ç‚µ‚½‰ÄŒ^‰ß•q«”x‘Ÿ‰Š‚Ì1—á. ‘Ÿº—²”V1, ŽR–{”Ž”V2, {“¡“N—Y1, “c’†’¼•F1, ’J‘º”É—Y2, –{ŠÔ˜a•v1 (1“à‡X. 2‘Š–ÍŒ´‹¦“¯•a‰@): –k—¢ˆãŠw, 34 (1): 29-32, 2004.

520098. [‘à] NPPV‚̇•¹Ç, –â‘è“_. ‹v•Û“c@Ÿ1, ‘Š”nˆêˆå2 (1“à‡X. 2‹~–½j: ICU‚ÆCCU, 29 (3): 215-220, 2005.

520099, [‰ðà] ”xŠà‚ÌŽ¡—Ã|‰»Šw—Ö@‚ð’†S‚Æ‚µ‚Ä|. ŽO“¡@‹v, ‰v“c“TK (“à‡X): ŒÄ‹z‚ÆzŠÂ (0452-3458), 52 (8): 847-852, 2004.

520100. [uÀ] ‰–Ž_ƒmƒMƒeƒJƒ“ (topotecan: INN). –î“ߣM—Y1,2, ŽO“¡@‹v1, ‰v“c“TK1 (1“à‡X. 2ˆã‰q): ŒÄ‹z, 23 (11): 896-901, 2004.

520101. [‘à] “Á•ÊŠé‰æ: •ªŽq•W“IŽ¡—Öò|”ñ¬×–E”xŠà‚ɑ΂·‚éã”笒·ˆöŽqŽó—e‘̃`ƒƒVƒ“ƒLƒi|ƒ[‘jŠQÜ, ƒQƒtƒBƒ`ƒjƒu iƒCƒŒƒbƒTj ‚ɂ‚¢‚Ä|. –î“ߣM—Y1,2, ‰v“c“TK1 (1“à‡X. 2ˆã‰q): –k—¢ˆãŠw, 33 (3): 189-194, 2003.@

m’˜@‘n

620057. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ˆãŠw¶‚Ì‚½‚ß‚ÌŠî‘b—Õ°‹Z”\ iICMj ƒVƒŠ[ƒY ‘æ4Šª —Õ°„˜_|EBM‚Æ•a‘Ô¶—|; ‡[. ÇŒóE•a‘Ô‚©‚ç‚̃Aƒvƒ[ƒ` 18. ŒÄ‹z¢“ï, p.230-237. ‰¡ê³“T1, ˆ¢•”@’¼2 (1“à‡X. 2ˆãŠw‹³ˆç•”–å), •ÒW Œã“¡‰pŽi, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/8”­s.

620058. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ˆãŠw¶‚Ì‚½‚ß‚ÌŠî‘b—Õ°‹Z”\ iICMj ƒVƒŠ[ƒY ‘æ4Šª —Õ°„˜_|EBM‚Æ•a‘Ô¶—|: ‡[. ÇŒóE•a‘Ô‚©‚ç‚̃Aƒvƒ[ƒ` 19. ŠP, á‚, p.238-244. ¬—Ñç—¢1, ˆ¢•”@’¼2 (1“à‡X. 2ˆãŠw‹³ˆç•”–å), •ÒW Œã“¡‰pŽi, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/8”­s.

620059. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) “à‰ÈŠwƒŒƒrƒ… 2005 |ÅVŽå—v•¶Œ£‚Ɖðà|; ”xŽîá‡. ŽO“¡@‹v1, –î“ߣM—Y1,2, ‰v“c“TK1 (1“à‡X. 2ˆã‰q), ŠÄC Žðˆä@‹I, ‘ìOˆê, ¼è@“, ¬—ÑË‘×, •ŸˆäŽŸ–î. ‘‡ˆãŠwŽÐ, “Œ‹ž, 2005/3/19”­s.

620060. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ‹~‹}EW’†Ž¡—à 16(11) 2004; COPD‹}«‘ˆ«‚̑Ήž|ŒÄ‹z‹@”\ŒŸ¸|, p.1277`1281. ¼ˆäNl1, ‰¡ê³“T1, ˆ¢•”@’¼2 (1“à‡X. 2ˆãŠw‹³ˆçŒ¤‹†•”–å), •ÒW ‘Š”nˆêˆå (‹~–½j, ‘‡ˆãŠwŽÐ, “Œ‹ž, 2004/10/10”­s.

620061. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ”xŠàŽ¡—ÃÇ—áW; Ç—á24 ƒQƒtƒBƒ`ƒjƒuÄ“Š—^—á. –î“àŒ´’qŽq1, ‰v“c“TK1, •Ð‹Ë^l1,2 (1“à‡X. 2ˆã‰q), ŠÄC “c‘º—FG(‘—§‚ª‚ñƒZƒ“ƒ^[), ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, “Œ‹ž, 2004/7/1”­s.

620062. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) MOOK ”xŠà‚Ì—Õ° Annual Review 2003; Ä”­–³Œø¬×–EŠà‚ÌŽ¡—Ã, p.171-177. –î“ߣM—Y1,2, ‰v“c“TK1 (1“à‡X. 2ˆã‰q), ŠÄC ‰Á“¡Ž¡•¶1, ¼žŠ’·G2, •Ÿ‰ª³”Ž3, ¬—Ñhˆê4, V•”‰p’j5, ŠC˜VŒ´‘P˜Y1 i1“Œ‹žˆã‘å. 2‘—§‚ª‚ñƒZƒ“ƒ^[’†‰›•a‰@. 3‹ß‹E‘å. 4Œc‰ž‘å. 5ŒQ”n‘å), ŽÂŒ´o”ÅVŽÐ, “Œ‹ž, 2003/10/31”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

723233. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Nitric oxide generated by iNOS reduces deformability of Lewis lung carcinoma cells. ˆäì@‘ (“à‡X): ‘æ3‰ñ‘ÛNOŠw‰ï (2004/5/24-28), “Þ—Ç.

723234. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Salbutamol“Š—^‚É‚æ‚éÅ‘åsniff•@o“àˆ³‚Æ–T‹¹œ˜]ŠÔ‹Ø‚Ì‹ØŠˆ“®‚̕ω». ‰¡ê³“T1, •Ð‹Ë^l1,2, ¬—Ñç—¢1, ŽR–{—ÏŽq1, ˆäì@‘1, –î“àŒ´’qŽq1, ¡è‹M¶1, ‚“cM˜a1,2, –î“ߣM—Y1,2, ˆ¢•”@’¼3, ‰v“c“TK1 (1“à‡X. 2ˆã‰q. 3ˆãŠw‹³ˆç•”–å): ‘æ44‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠwpu‰‰‰ï (2004/4/1), “Œ‹ž. “ú–{ŒÄ‹zŠíŠw‰ïŽGŽ, 42: 227, 2004.

723235. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ƒ[ƒNƒVƒ‡ƒbƒv3u‚Ñ‚Ü‚ñ«”xŽ¾Š³‚ÌŠm’èf’fvDŽ_‹…«”x‰Š‚É‚¨‚¯‚é‹CŠÇŽx”x–Eôò‰t–ƉuƒOƒƒuƒŠƒ“‚ÌŒŸ“¢. ŽR–{—ÏŽq1, ‹v•Û“c@Ÿ1, ¬–ì“c´1, –î“àŒ´’qŽq1, ¡è‹M¶1, “c’†’¼•F1, ‚“cM˜a1,2, •Ð‹Ë^l1,2, ¬—ÑO—S1,2, –î“ߣM—Y1,2, ‰v“c“TK1, ‘Š”nˆêˆå3 (1“à‡X. 2ˆã‰q. 3‹~–½): ‘æ27‰ñ“ú–{ŒÄ‹zŠí“àŽ‹‹¾Šw‰ï‘‰ï (2004/6/2), ‘åã. ‹CŠÇŽxŠw, 26 (3): 223, 2004.

723236. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) Œ’f‚É‚¨‚¯‚é”~“ÅŒŒ´”½‰ž‚Ì—Õ°“IˆÓ‹`‚ÉŠÖ‚·‚錟“¢. ”óìŽuD1, “¡“cŒbŽq, ¼“c—BŽj, ŽR•Ó‚³‚¨‚è3, –î“ߣM—Y1,2, ‰ª“c@ƒ3 (1“à‡X. 2ˆã‰q. 3Œ’NŠÇ—ƒZƒ“ƒ^[): “ú–{‘‡Œ’fˆãŠw‰ï‘æ33‰ñ‘å‰ï (2005/1/28-29), ‘åã.

723237. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –k—¢‘åŠw•a‰@‚É‚¨‚¯‚錋ŠjÚGŽÒŒŸf‚ÉŠÖ‚·‚錟“¢. –î“ߣM—Y1,3, ”óìŽuD1, ‰ª“c@ƒ2, •Ð‹Ë^l1,3 (1“à‡X. 2Œ’NŠÇ—ƒZƒ“ƒ^[. 3ˆã‰q): ‘æ78‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (2004/4/7), “Œ‹ž. Š´õÇŠwŽGŽ, 78 (8): 749, 2004.

733105. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ŒãcŠu‚ÉŽîᎂðŒ`¬‚µ‚½intravascular large B-cell lymphoma‚Ì1—á. ‰HØT‘¾˜Y1, ŽO“¡@‹v1, ¼ˆäNl1, ˜a“c^—RŽq1, ŽR–{—ÏŽq1, ˆäì@‘1, ‰¡ê³“T1, ‚“cM˜a1,2, ¬—ÑO—S1,2, –î“ߣM—Y1,2, ‰v“c“TK1 (1“à‡X. 2ˆã‰q): ‘æ140‰ñ“ú–{”xŠàŠw‰ïŠÖ“Œ•”‰ï (2004/7/3), ‘Š–ÍŒ´. ”xŠà, 44 (4): 280-281, 2004.

733106. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) —¼‘¤”x–僊ƒ“ƒpߎ‚𔺂Á‚½–«DŽ_‹…«”x‰Š‚Ì1—á. ‰Á“¡Œb”ü1, ‹v•Û“c@Ÿ1, –î“àŒ´’qŽq1, ¼ˆäNl1, —´‰ØTˆê˜Y1, ‰HØT‘¾˜Y1, ¬–ì“c´1, ŽO“¡@‹v1, “c’†’¼•F1, ‚“cM˜a1,2, –î“ߣM—Y1,2, ˆ¢•”@’¼3, ‰v“c“TK1 (1“à‡X. 2ˆã‰q. 3ˆãŠw‹³ˆç•”–å): 161‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠÖ“Œ’n•û‰ï (2004/9/11), “Œ‹ž.

733107. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ’P”­«”xÉŽq‰»“÷‰èŽî‚Ì1—á. Έä‰À—¢1, –î“àŒ´’qŽq1, ‰Á“¡Œb”ü1, —´‰ØTˆê˜Y1, ¬–ì“c´1, “c’†’¼•F1, ‹v•Û“c@Ÿ1, •Ð‹Ë^l1,2, ˆ¢•”@’¼3, ‰v“c“TK1, •i“c@ƒ4, ‹g‘º”Ž–M4 (1“à‡X. 2ˆã‰q. 3ˆãŠw‹³ˆç•”–å. 4‹¹ŠO): ‘æ160‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠÖ“Œ’n•û‰ï (2004/7/10), “Œ‹ž.

733108. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Gefitinib“à•ž‚É‚æ‚èwarfarin“Š—^—Ê‚Ì•ÏX‚ð—v‚µ‚½”ñ¬×–E”xŠàŠ³ŽÒ‚Ì2—á. —´‰ØTˆê˜Y1, ¬–ì“c´1, ‰HØT‘¾˜Y1, ‰¡ê³“T1, ŽO“¡@‹v1, ‹v•Û“c@Ÿ1, ‚“cM˜a1,2, •Ð‹Ë^l1,2, –î“ߣM—Y1,2, ¬—ÑO—S1,2, ˆ¢•”@’¼3, ‰v“c“TK1 (1“à‡X. 2ˆã‰q. 3ˆãŠw‹³ˆç•”–å): ‘æ141‰ñ“ú–{”xŠàŠw‰ïŠÖ“Œ•”‰ï (2004/12/18), “Œ‹ž. ”xŠà, 45 (1): 85, 2005.

733109. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Œ´”­«’_`«ŠÌd•Ï‚ɇ•¹‚µ‚½ŒÀ‹Ç«‹CŠÇŽxƒAƒ~ƒƒCƒh[ƒVƒX‚Ì1—á. ˜a“c^—RŽq1, ‹v•Û“c@Ÿ1, –î“àŒ´’qŽq1, Έä‰À—¢1, ŽR–{—ÏŽq1, ˆäì@‘1, ‰¡ê³“T1, •Ð‹Ë^l1,2, ¬—ÑO—S1,2, ‰v“c“TK1 (1“à‡X. 2ˆã‰q): ‘æ521‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2004/10/9), “Œ‹ž.


<<“à‰ÈŠw‡XiäPŒ´•aEŠ´õ“à‰ÈŠwj>>

mŠwp˜_•¶n

110106. [Œ´’˜] Efficacy and safety of Facrolimus (FK506) in treatment of rheumatoid arthritis : a randomizcd, double blind , placebo controlled dose-finding study. ‹ß“¡Œ[•¶1, Abe T, Hashimoto H, Uchida S, Irimajiri S, Hara M, Sugawara S i1“à‡X): J Rheumatol, 31: 243-251, 2004.

110107. [Œ´’˜] Immunogenetic features in 120 Japanese patients with idispathic inflammatory nuyopathy. Furuya ‚s, Hakoda M, Tsuchiya ‚m, Kotake S, Ichikawa N, Nanke ‚x, Nakajima A, Takeuchi M, Nishinarita M, ‹ß“¡Œ[•¶1, Kawasaki A, Kobayashi S, Mimori ‚s, Tokunaga K, Kamatani N i1“à‡X): J Rheumatol, 31: 1768-1774, 2004.

110108. [Œ´’˜] Host Stromal Bradykinin B2 receptor Signaling facilitates Tumor- Associated angiogenesis and Tumor growth. Ikeda Y, —Ñ@ò1, Kamoshita E, ‰““¡•½m2, Ishihara K, ŽR‰È³•½3, Tsutsumi Y, Matsubara H, ”n“ˆ³—²1 (1•a—. 2“à‡X. 3‰ð–U): Cancer Res, 64: 5178-5185, 2004.

120019. [Œ´’˜] ‘ŠúŠÖ߃ŠƒEƒ}ƒ`‚Ìf—ẪRƒc. ‹ß“¡Œ[•¶1, “c’†Z–¾1, Îì@Í1, ‰ª“c@ƒ1,2 (1“à‡X. 2Œ’NŠÇ—ƒZƒ“ƒ^[): —Õ°ƒŠƒEƒ}ƒ`, 16: 68`73, 2004.

120020. [Œ´’˜] …Œn‰˜õLegionella‘®‹Û‚ɑ΂·‚銴õ–hŽ~‘Îô–@‚ÌŠm—§|ƒZƒ‰ƒ~ƒbƒNG”}‚ÌŽE‹Ûì—p‚ÉŠÖ‚·‚é•]‰¿|. ùŒ´•Žu1, ‹e–ì—’ÃŽq2, ‘]‰ä‰p‹v2, ŠÖŒû•üŽq1, ²“¡‹`‘¥1, ‚ŽR—zŽq3, ‚‹´@W4, –سl2, –k—¢‰p˜Y5, ˆä㼋v1 (1”÷EŠñ. 2–k—¢ŠÂ‹«‰ÈŠwƒZƒ“ƒ^[. 3“à‡X. 4ŽÀŒ±“®•¨. 5ˆã‰q): Š´õÇŠwŽGŽ, 78 (1): 22-31, 2004.

120021. [Œ´’˜] RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ‚Ìf’f‚É‚¨‚¯‚éRƒzƒXƒtƒ@ƒ`ƒWƒ‹ƒZƒŠƒ“Eƒvƒƒgƒƒ“ƒrƒ“•¡‡‘ÌR‘Ì‘ª’è‚Ì—Õ°“IˆÓ‹`|‘½Ž{ÝŠÔ¬Ñ|. “L–Ø~ˆê, ŒK–¼³—², ‹T“cGl, ’|“à@‹Î, ‰ª“c@ƒ1, •ÐŽR‰ë•v, ‹g“crŽ¡, ’r“cN•v (1“à‡X): “ú–{—Õ°ŒŒ‰tŠw‰ïŽ, 46: 19-21, 2005.

220013. [€Œ´’˜] äPŒ´•a‚̓«•a‘Ô, ”x‚ŒŒˆ³Ç. ‰““¡•½m, “c’†Z–¾, âˆä”ü•Û, ‹ß“¡Œ[•¶ (“à‡X): “ú–{—Õ°–ƉuŠw‰ïŽ, 27: 127-135, 2004.

220014. [€Œ´’˜] SLEESLE‹^f—á‚É‚¨‚¯‚郋[ƒvƒXƒAƒ“ƒ`ƒRƒAƒOƒ‰ƒ“ƒg‘ª’è‚Ì—Õ°“IˆÓ‹`. “L–Ø~ˆê, ŒK–¼³—², ‹T“cGl, ’|“à@‹Î, ‰ª“c@ƒ1, •ÐŽR‰ë•v, ‹g“crŽ¡, ’r“cN•v (1“à‡X): “ú–{çΘ­V•ñ, 4208: 25-28, 2004.

320026. [Ç—á•ñ] SAPHOÇŒóŒQ‚ð‡•¹‚µ‚½SLE-RAd•¡ÇŒóŒQ‚̈ê—á. ‹´–{@“Ä, Îì@Í, ‹ß“¡Œ[•¶ (“à‡X): —Õ°ƒŠƒEƒ}ƒ`, 16: 61`67, 2004.

320027. [Ç—á•ñ] ‰Æ’ë—p24ŽžŠÔ•—˜C‚ªŠ´õŒ¹‚Æ“Á’è‚Å‚«‚½ƒŒƒWƒIƒlƒ‰”x‰Š‚Ì1—á. Îì@Í1, ‰ª“c@ƒ1, ‹ß“¡Œ[•¶1, ‚ŽR—zŽq1, »ìŒc‰î2, ]¬—BŽq, Î@—ǘa (1“à‡X. 2Š´õÇ): Š´õÇŽ, 78: 898`904, 2004.

520102. [‘à] f’f‚̃|ƒCƒ“ƒg‚ƃxƒXƒg‚ÌŽ¡—ÃKƒCƒhƒ‰ƒCƒ“: ¬‡«Œ‹‡‘gD•a. ‹ß“¡Œ[•¶, ‰ª“c@ƒ (“à‡X): “à‰È, 93: 272`276, 2004.

520103. [‘à] V‚µ‚¢RƒŠƒEƒ}ƒ`–ò‚ÌŒø‰Ê‚Æ–â‘è“_ 1j–Ɖu—}§–ò-‚e‚j506, ƒVƒNƒƒXƒ|ƒŠƒ“. ‹ß“¡Œ[•¶, Îì@Í (“à‡X): ƒŠƒEƒ}ƒ`‰È, 31: 4`39, 2004.

520104. [‘à] ŠÖ߃ŠƒEƒ}ƒ`‚Ì–ò•¨—Ö@. ‹ß“¡Œ[•¶, Îì@Í (“à‡X): —Õ°‚ÆŒ¤‹†, 81: 212`216, 2004.

520105. [‘à] ‘ŠúŠÖ߃ŠƒEƒ}ƒ`‚Ìl‚¦•û. ‹ß“¡Œ[•¶, ‰Í–ì@à (“à‡X): Œ»‘ãˆã—Ã, 36: 713`717, 2004.

520106. [‘à] ¬‡«Œ‹‡‘gD•a‚Ì”x•a•Ï. ‰ª“c@ƒ, ‹ß“¡Œ[•¶ (“à‡X): ŒÄ‹zŠí‰È, 5: 228`235, 2004.

520107. [‘à] äPŒ´•a‚É‚Ý‚ç‚ê‚ét•a•Ï‚Ì•a‘Ô‚ÆŽ¡—Ã: ‹­”çÇ. ‰““¡•½m, ‹g“c@G, ”Ñ’ËiŽq, ‹ß“¡Œ[•¶ (“à‡X): ƒŠƒEƒ}ƒ`‰È, 31: 248`252, 2004.

520108. [‘à] ‹­”çÇ, ‹}‘¬‚Ét‹@”\’ቺ‚ð‚«‚½‚·Ž¾Š³‚Ìf‚©‚½. ‰““¡•½m, ‹g“c@G, ”Ñ’ËiŽq, ‹ß“¡Œ[•¶ (“à‡X): t‚Æ“§Í, 56: 353`356, 2004.

520109. [‘à] ŒŒŠÇ•a•Ï‚ɑ΂·‚éƒ{ƒZƒ“ƒ^ƒ“‚Ì“K‰ž‚ÆŽg—pã‚Ì’ˆÓ. ‹ß“¡Œ[•¶, “c’†Z–¾ (“à‡X): ƒŠƒEƒ}ƒ`‰È, 31: 542`547, 2004.

520110. [‘à] ¬‡«Œ‹‡‘gD•a‚ÉŠÖ‚·‚éÅV‚Ì’mŒ©. ‹ß“¡Œ[•¶ (“à‡X): ‰ŠÇ‚ƖƉu, 12: 504`508, 2004.

520111. [‘à] ‘Šúf’f‚Ìi•à. ‹ß“¡Œ[•¶, âˆä”ü•Û (“à‡X): “ú–{—Õ°, (S.): 289`292, 2004.

520112. [‘à] äPŒ´•a«”x‚ŒŒˆ³ÇŽ¡—Â̓WŠJ|PGI2ƒ|ƒ“ƒvŽ¡—ÂðŠÜ‚Þ|. “c’†Z–¾, ‹ß“¡Œ[•¶ (“à‡X): Ther Res, 25: 2013-2015, 2004.

520113. [‘à] ƒŠƒEƒ}ƒ`EäPŒ´•a‚É‚Ý‚ç‚ê‚ét•a•Ï‚Ì•a‘Ô‚ÆŽ¡—Ã. ‰““¡•½m, ‹g“c@G, ”Ñ’ËiŽq. ‹ß“¡Œ[•¶ (“à‡X): ƒŠƒEƒ}ƒ`‰È, 31: 248-252, 2004.

520114. [‘à] ¬‡«Œ‹‡‘gD•a‚Ìf’f. ‰ª“c@ƒ, ‹ß“¡Œ[•¶ (“à‡X): f’f‚ÆŽ¡—Ã, 92: 282-287, 2004.

520115. [‘à] D-ƒyƒjƒVƒ‰ƒ~ƒ“‚É‚æ‚éŠÔŽ¿«”x‰Š. ‰ª“c@ƒ, ”óìŽuD, –î“ߣM—Y (“à‡X): ƒŠƒEƒ}ƒ`‰È, 33: 30-34, 2005.

520116. [‘à] Ž©ŒÈ–ƉuŽ¾Š³‚ÌŽ¡—ÊT—ª. ‰ª“c@ƒ (“à‡X): —Õ°ŠÅŒì, (—Õ‘): 786-790, 2004.

520117. [‘à] äPŒ´•a‚É‚¨‚¯‚é”x‚ŒŒˆ³Ç‚ÌŽÀ‘Ô‚Æ‚»‚Ì‘Îô. ‰ª“c@ƒ (“à‡X): “à‰È, 95: 43-48, 2005.

520118. [‘à] äPŒ´•a”x‚ŒŒˆ³Ç‚ÌŽ¡—Ã: ƒGƒ|ƒvƒŒƒXƒeƒm[ƒ‹ ƒ{ƒZƒ“ƒ^ƒ“, ƒVƒfƒ‹ƒiƒtƒBƒ‹. ‰ª“c@ƒ, ‹ß“¡Œ[•¶ (“à‡X): Mebio, 22: 45-51, 2005.

520119. [‘à] ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‚É‚¨‚¯‚éCOX-2‘I‘ð“I‘jŠQ܃ƒƒLƒVƒJƒ€‚Ìt‹@”\‚ɑ΂·‚é‰e‹¿. ‰ª“c@ƒ, —é–؉€Žq, ”óìŽuD, Îì@Í (“à‡X): Pharma Medica, 157-160, 2005.

520120. [‘à] ƒŠƒEƒ}ƒ`—Þ‰Ž¾Š³@DŽ_‹…«‹Ø–Œ‰Š. ‰ª“c@ƒ, ‹ß“¡Œ[•¶ (“à‡X): NEW MOOK ®Œ`ŠO‰È, 147-152, 2004.

520121. [uÀ] MCTD‚ƃI[ƒo[ƒ‰ƒbƒvÇŒóŒQ. ‰ª“c@ƒ (“à‡X): “à‰Èf—ÃQ•A, 124-127, 2004.

521017. [Œ¤‹†•ñ‘] (Œú˜JÈ) ‘Sg«Ž©ŒÈ–ƉuŽ¾Š³‚É‚¨‚¯‚é“«•a‘Ô‚Ìf—ÃKƒCƒhƒ‰ƒCƒ“@‘Sg«Ž©ŒÈ–ƉuŽ¾Š³‚É‚¨‚¯‚é“«•a‘Ô‚Ìf’f‚ÆŽ¡—Ö@‚ÉŠÖ‚·‚錤‹†. ‰““¡•½m (“à‡X): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à–ƉuƒAƒŒƒ‹ƒM[Ž¾Š³—\–hEŽ¡—ÃŒ¤‹†Ž–‹Æ•½¬16”N“x쬎¡—ÃKƒCƒhƒ‰ƒCƒ“ 2004.

521018. [Œ¤‹†•ñ‘] (Œú˜JÈ) 3C•WŽ¯Ž‰–bŽ_‹zŽûŒÄ‹CŽŽŒ±‚ð—p‚¢‚½‹­”çÇ‚ÌdÇ’°ŠÇ•a•Ï‚Ì’è—Ê“I‰ðÍ. ‰““¡•½m, ‹´–{@“Ä, ‰Í–ì@Ã, ‹g“c@G, ”Ñ’ËiŽq, âˆä”ü•Û, ‹ß“¡Œ[•¶ (“à‡X): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à–ƉuƒAƒŒƒ‹ƒM[Ž¾Š³—\–hEŽ¡—ÃŒ¤‹†Ž–‹Æ•½¬16”N“x•ñ‘, p.46-48, 2004.

521019. [Œ¤‹†•ñ‘] (Œú˜JÈ) ¬‡«Œ‹‡‘gD•a‚Ì•a‘Ô, Ž¡—ÂƊ֘A‚·‚éˆâ“`“IˆöŽq, Ž©ŒÈR‘Ì‚ÌŒ¤‹†. ‹ß“¡Œ[•¶ (“à‡X): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ¬‡«Œ‹‡‘gD•a‚ÉŠÖ‚·‚錤‹†”Ç•½¬16”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.1-6, 2005/3/31.

521020. [Œ¤‹†•ñ‘] (Œú˜JÈ) RU1RNPR‘Ì—z«Ç—á‚̃vƒƒXƒyƒNƒeƒBƒu‘½Ž{Ý‹¤“¯Œ¤‹†|MCTDf’f‚ÌŽèˆø‚«‚ÌŒŸØ|. ‰ª“c@ƒ1, ‹ß“¡Œ[•¶1, ²“¡•q•F, ‰ª–ì“N˜Y (1“à‡X): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ¬‡«Œ‹‡‘gD•a‚ÉŠÖ‚·‚錤‹†”Ç•½¬16”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.7-10, 2005/3/31.

521021. [Œ¤‹†•ñ‘] (Œú˜JÈ) U1-snRNPEAˆâ“`Žq‚ÌSingle Nucleotide Polymorphism (SNP) ‰ðÍ i3”NŠÔ‚Ì‚Ü‚Æ‚ßj. ‘å‹v•ÛŒõ•v, ¡ˆäŒúŽq, ŠÖ@‚³‚¨‚è, •½“c—–Žq, ‘O“c•½¶, ‰ª“c@ƒ1, ‹ß“¡Œ[•¶1 (1“à‡X): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ¬‡«Œ‹‡‘gD•a‚ÉŠÖ‚·‚錤‹†”Ç•½¬16”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.22-25, 2005/3/31.

521022. [Œ¤‹†•ñ‘] (Œú˜JÈ) Prostaglandin E2‚É‚æ‚éTriggering receptor expressed on myeloid cells-1 (TREM) ‚Ì”­Œ»§Œä‚ÉŠÖ‚·‚錤‹†. –k—¢‰p˜Y1, ‘ºã—m‰î2, ‰““¡•½m3, ‹ß“¡Œ[•¶3, —Ñ@ò4 (1ˆã‰q. 2”÷EŠñ. 3“à‡X. 4–ò—): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ¬‡«Œ‹‡‘gD•a‚ÉŠÖ‚·‚錤‹†”Ç•½¬16”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.51-54, 2005/3/31.

521023. [Œ¤‹†•ñ‘] (Œú˜JÈ) ¬‡«Œ‹‡‘gD•a‡•¹”x‚ŒŒˆ³Ç‚ÌŽ©‘RŒo‰ß‚ÉŠÖ‚·‚錤‹†. ‹g“crŽ¡, [ìCì, ‰ª“c@ƒ1, ‹ß“¡Œ[•¶1 (1“à‡X): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ¬‡«Œ‹‡‘gD•a‚ÉŠÖ‚·‚錤‹†”Ç•½¬16”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.55-58, 2005/3/31.

521024. [Œ¤‹†•ñ‘] (Œú˜JÈ) ”x‚ŒŒˆ³Ç‡•¹¬‡«Œ‹‡‘gD•a iMCTD) ‚É‚¨‚¯‚éNOS2ˆâ“`Žq‘½Œ^‚ÌŠÖ—^. Œ´@‚Ü‚³Žq, ìŒû’ÁŽi, ‰ª“c@ƒ1, ‹ß“¡Œ[•¶1, ‘å‹v•ÛŒõ•v (1“à‡X): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ¬‡«Œ‹‡‘gD•a‚ÉŠÖ‚·‚錤‹†”Ç•½¬16”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.59-63, 2005/3/31.

521025. [Œ¤‹†•ñ‘] (Œú˜JÈ) äPŒ´•a‡•¹”x‚ŒŒˆ³ÇŽ¡—ÃKƒCƒhƒ‰ƒCƒ“ iˆÄj. ‹ß“¡Œ[•¶1, ‰ª“c@ƒ1, ‹g“crŽ¡ (1“à‡X): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ¬‡«Œ‹‡‘gD•a‚ÉŠÖ‚·‚錤‹†”Ç•½¬16”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.75-77, 2005/3/31.

521026. [Œ¤‹†•ñ‘] ¬‡«Œ‹‡‘gD•a‚ÌŽ¡—ÃKƒCƒhƒ‰ƒCƒ“@MCTD‚ÌŽ¾Š³ŠT—v. ‹ß“¡Œ[•¶ (“à‡X): ¬‡«Œ‹‡‘gD•a‚ÌŽ¡—ÃKƒCƒhƒ‰ƒCƒ“, p.1-6, 2005/3/31.

521027. [Œ¤‹†•ñ‘] ¬‡«Œ‹‡‘gD•a‚ÌŽ¡—ÃKƒCƒhƒ‰ƒCƒ“@MCTD‚ÌŽ©‘RŒo‰ß. ‰ª“c@ƒ (“à‡X): ¬‡«Œ‹‡‘gD•a‚ÌŽ¡—ÃKƒCƒhƒ‰ƒCƒ“, p.7, 2005/3/31.

521028. [Œ¤‹†•ñ‘] ‘Sg«Ž©ŒÈ–ƉuŽ¾Š³‚É‚¨‚¯‚é“«•a‘Ô‚Ìf—ÃKƒCƒhƒ‰ƒCƒ“@“«Á‰»ŠÇÇó. ‰““¡•½m (“à‡X): ‘Sg«Ž©ŒÈ–ƉuŽ¾Š³‚É‚¨‚¯‚é“«•a‘Ô‚Ìf—ÃKƒCƒhƒ‰ƒCƒ“, p.44-49, 2005/3/31.

521029. [Œ¤‹†•ñ‘] (Œú˜JÈ) ”x•a•Ï‚ÉŠÖ‚·‚鬈ψõ‰ï•ñ. ‹ß“¡Œ[•¶1, ’–ŒF–ÎŽq, ‹T“cGl, ‹àˆä”ü‹I, ŒE“c“N˜N, Œ´@‚Ü‚³Žq, ꠖ씎Žj (1“à‡X): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à–ƉuƒAƒŒƒ‹ƒM[Ž¾Š³—\–hEŒ¤‹†Ž–‹Æ–ƉuŽ¾Š³‚̇•¹Ç‚Æ‚»‚ÌŽ¡—Ö@‚ÉŠÖ‚·‚錤‹†”Ç•½¬16”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.9-11, 2005/3/31.

521030. [Œ¤‹†•ñ‘] (Œú˜JÈ) äPŒ´•a«”x“®–¬«”x‚ŒŒˆ³Ç‚É‚¨‚¯‚é”xzŠÂ“®‘Ô‚ÆuƒXƒeƒƒCƒhŽ¡—Â̗LŒø«v‚ÉŠÖ‚·‚錤‹†. ‹ß“¡Œ[•¶, “c’†Z–¾, ‰ª“c@ƒ (“à‡X): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à–ƉuƒAƒŒƒ‹ƒM[Ž¾Š³—\–hEŒ¤‹†Ž–‹Æ–ƉuŽ¾Š³‚̇•¹Ç‚Æ‚»‚ÌŽ¡—Ö@‚ÉŠÖ‚·‚錤‹†”Ç•½¬16”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.39-41, 2005/3/31.

m’˜@‘n

620063. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ‚æ‚­‚í‚©‚é‹­”çÇ‚Ì‚·‚ׂÄ; –ƒáƒ«ƒCƒŒƒEƒX, p.199-203. ‹ß“¡Œ[•¶ (“à‡X), •ÒW ’|Œ´˜a•F, ‰iˆä‘“X, “Œ‹ž, 2004”­s.

620064. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ‚æ‚­‚í‚©‚é‹­”çÇ‚Ì‚·‚ׂÄ; Á‰»ŠÇ, p.117-121. ‹ß“¡Œ[•¶ (“à‡X), •ÒW ’|Œ´˜a•F, ‰iˆä‘“X, “Œ‹ž, 2004”­s.

620065. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) New Mook ®Œ`ŠO‰È14; ‘½”­«‹Ø‰ŠE”畆‹Ø‰Š, p.143-147. ‰ª“c@ƒ, ‹ß“¡Œ[•¶ (“à‡X), •ÒW ‰z’q—²O, ‹e’nbˆê, ‹àŒ´o”Å, “Œ‹ž, 2004/4”­s.

620066. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) New Mook ®Œ`ŠO‰È14; DŽ_‹…«‹Ø–Œ‰Š, p.148-152. ‰ª“c@ƒ, ‹ß“¡Œ[•¶ (“à‡X), •ÒW ‰z’q—²O, ‹e’nbˆê, ‹àŒ´o”Å, “Œ‹ž, 2004/4”­s.

620067. [‚»‚Ì‘¼‚Ì’˜‘] (•ÒW) ƒCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg‚Ì‚½‚ß‚Ì}àƒVƒŠ[ƒY; äPŒ´•a,1`3. •ÒW ’|Œ´˜a•F, ‹ß“¡Œ[•¶1 (1“à‡X), ˆã–òƒWƒƒ[ƒiƒ‹, “Œ‹ž, 2004/9”­s.

620068. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ƒCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg‚Ì‚½‚ß‚Ì}àƒVƒŠ[ƒY; 2. ‘Sg«‹­”çÇ 6. Á‰»ŠÇÇó, p.30`33. ‹ß“¡Œ[•¶ (“à‡X), ˆã–òƒWƒƒ[ƒiƒ‹, “Œ‹ž, 2004/9”­s.

620069. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ƒCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg‚Ì‚½‚ß‚Ì}àƒVƒŠ[ƒY; 1. ¬‡«Œ‹‡‘gD•a‚»‚Ì‘¼‚ÌäPŒ´•a 1j •a‘ÔE•aˆö, p.6-9. ‹ß“¡Œ[•¶ (“à‡X), ˆã–òƒWƒƒ[ƒiƒ‹, “Œ‹ž, 2004/9”­s.

620070. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ƒCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg‚Ì‚½‚ß‚Ì}àƒVƒŠ[ƒY; 1. ¬‡«Œ‹‡‘gD•a‚»‚Ì‘¼‚ÌäPŒ´•a 1j •aóEf’f, p.10-15. ‰ª“c@ƒ (“à‡X), ˆã–òƒWƒƒ[ƒiƒ‹, “Œ‹ž, 2004/9”­s.

620071. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ƒCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg‚Ì‚½‚ß‚Ì}àƒVƒŠ[ƒY; ‘Sg«‹­”çÇ@‚»‚Ì‘¼‚ÌÇó, p.34-37. ‰““¡•½m (“à‡X), ˆã–òƒWƒƒ[ƒiƒ‹, “Œ‹ž, 2004/9”­s.

620072. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ¬‡«Œ‹‡‘gD•a@‹­”çÇ‚É‚¨‚¯‚éƒXƒeƒƒCƒh‚ÌŽg‚¢•û; ŽÀ’nˆã‰Æ‚Ì‚½‚߂̃XƒeƒƒCƒh‚ÌãŽè‚ÈŽg‚¢•û, p.91-98. ‰““¡•½m (“à‡X), ‰iˆä‘“X, “Œ‹ž, 2004”­s.

620073. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ¬‡«Œ‹‡‘gD•a; Guideline@äPŒ´•aEƒŠƒEƒ}ƒ`|Ž¡—ÃKƒCƒhƒ‰ƒCƒ“‚ð‚Ç‚¤“Ç‚Þ‚©|, p.58-69. ‹ß“¡Œ[•¶ (“à‡X), •ÒW ¬’r—²•v, Z“cF”V, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2005”­s.

620074. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ƒCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg‚Ì‚½‚ß‚Ì}àƒVƒŠ[ƒY; äPŒ´•a, ‹­”çÇ, p.36-38. ‰““¡•½m (“à‡X), ˆãŽ•–òƒWƒƒ|ƒiƒ‹, “Œ‹ž, 2004”­s.

620075. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) Ž¾Š³•ÊÅVˆ•û‰ü’è‘æ4”Å; ‹­”çÇ, p.500-501. ‰““¡•½m (“à‡X), •ÒW –îè‹`—Y, ›–쌒‘¾˜Y, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2005”­s.

620076. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) Ž¾Š³•ÊÅVˆ•û‰ü’è‘æ4”Å; DŽ_‹…«‹Ø–Œ‰Š, p.501-502. ‰““¡•½m (“à‡X), •ÒW –îè‹`—Y, ›–쌒‘¾˜Y, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2005”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

713069. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Differential expression of Leukotoviene B4 receptor subtypes in human synovial tissues and synovial fluid leukocytes patients with rheumatoid arthritis. ‹´–{@“Ä, ¼ˆär“¹1, ‰““¡•½m1, ‹ß“¡Œ[•¶1 (1“à‡X): American college of Rheumatology 68th annual seientific meeting (2004/10/6-21), San Antonio.

713070. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Novel auto antibodies agoinst 7SL RNA in patients with polymyositisl dermatomyositis (PM/DM). Satoh T, Okano T, ¼ˆär“¹1, Watabe H, Ogasawara T, Kubo K, Kuwana M, Fertig N Dddis CV, ‹ß“¡Œ[•¶1, Ô¯@“§2 (1“à‡X. 2—ÕŒŸŠw): American college of Rheumatology 68th annual seientific meeting (2004/10/6-21), San Antonio.

713071. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Inhibition of skin Sclerosis by 15deoxy ƒ¢12,14-prostaglaudin J2 and retro Virally transfected prostaglaudin D synthase in a mouse model bleonycininduced scleroderma. ‰Í–ì@Ã1, ‹´–{@“Ä, ¼ˆär“¹1, —Ñ@ò2, –k—¢‰p˜Y3, ‹ß“¡Œ[•¶1 (1“à‡X. 2–ò—. 3ˆã‰q): American college of Rheumatology 68th annual seientific meeting (2004/10/6-21), San Antonio.

722033. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) RƒŠƒEƒ}ƒ`–ò‚̃Vƒ“ƒ|: –Ɖu—}§–òE–Ɖu’²ß–ò‚Ì—Õ°ŠJ”­. ‹ß“¡Œ[•¶ (“à‡X): ‘æ48‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/4/16), ‰ªŽR.

723238. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”xŒŒÇ‚É‚¨‚¯‚év‘¬f’f–@‚̉ž—p. ‚ŽR—zŽq1, “c’†Z–¾1, Îì@Í1, ‰““¡•½m1, –k—¢‰p˜Y2, Ô¯@“§3, »ìŒc‰î4, ‹ß“¡Œ[•¶1 (1“à‡X. 2ˆã‰q. 3—ÕŒŸŠw. 4Š´õÇ): ‘æ78‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (2004/4/6-7), “Œ‹ž.

723239. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) DŽ_‹…‘‘½ÇŒóŒQ‚ɇ•¹‚µ‚½Stregtococcus a galactiaeŠ´õ«S“à–Œ‰Š‚Ì1—á. ˜a“c’B•F, ¼@³‘å, ”Ñ’ËiŽq, âˆä”ü•Û, “n•”—ms, “c’†Z–¾, Îì@Í, ‰““¡•½m, ‰ª“c@ƒ, ‹ß“¡Œ[•¶ (“à‡X): ‘æ78‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (2004/4/6-7), “Œ‹ž.

723240. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) äPŒ´•a‚É”º‚¤ŠÔŽ¿«”x•a•Ï iInterstitial Lung Disease: ILDj ‚Ì”x‚ŒŒˆ³ iPulmonary Hypertension: PHj ‚É‹y‚Ú‚·‰e‹¿. âˆä”ü•Û, “c’†Z–¾, ¼@³‘å, Îì@Í, ‰““¡•½m, ‰ª“c@ƒ, ‹ß“¡Œ[•¶ (“à‡X): ‘æ48‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/4/15), ‰ªŽR.

723241. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) RSRPR‘Ì—z«‹Ø‰ŠŠ³ŽÒ‚É‚¨‚¯‚éR7SL-RNAR‘Ì‚ÆlŽí“I”wŒi‚Æ‚ÌŠÖ˜A. ²“¡—²Ži, ‰ª–ì“N˜Y, “n•”—ms1, ‹ß“¡Œ[•¶1, Ô¯@“§2 (1“à‡X. 2—ÕŒŸŠw): ‘æ48‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/4/15), ‰ªŽR.

723242. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) RƒŠƒ“Ž‰Ž¿R‘Ì—z«—á‚ÌŽ¡—ÂɊւ·‚錟“¢. ‰ª“c@ƒ, âˆä”ü•Û, —é–؉€Žq, Îì@Í, ‹ß“¡Œ[•¶ (“à‡X): ‘æ48‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/4/15), ‰ªŽR.

723243. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) Churg-Strauss Syndrome (CSS) ‚É‚¨‚¯‚éDŽ_‹…è÷—±’`”’Ž¿eosinophil derived neurotoxin (EDN) ‚¨‚æ‚Ñeosinophil cationic protein (ECP) ‚ÌŒŸ“¢. “c’†Z–¾, ”Ñ’ËiŽq, Îì@Í, ‰““¡•½m, ‹ß“¡Œ[•¶ (“à‡X): ‘æ48‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/4/15), ‰ªŽR.

723244. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ŠÖ߃ŠƒEƒ}ƒ`ŠÖß•a•Ï‚̃Šƒ|ƒLƒVƒQƒi[ƒ[Œn§Œä‹@˜‚̉ðÍ. ‰““¡•½m1, ‹´–{@“Ä, “c’†Z–¾1, ‘ºã—m‰î2, –k—¢‰p˜Y3, ¼‘º–¾l, è•”@Œ›, ‹ß“¡Œ[•¶1 (1“à‡X. 2”÷EŠñ. 3ˆã‰q): ‘æ48‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/4/15), ‰ªŽR.

723245. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) üˆÛ‰», ‰ŠÇ•a•Ï‚É‚¨‚¯‚éƒvƒƒXƒ^ƒmƒCƒh‚É‚æ‚é”ì–ž×–E§Œä‹@˜‚̉ðÍ. ‰Í–ì@Ã1, ‰““¡•½m1, ‹´–{@“Ä, ‘ºã—m‰î2, –k—¢‰p˜Y3, ¼‘º–¾l, ‹ß“¡Œ[•¶1 (1“à‡X. 2”÷EŠñ. 3ˆã‰q): ‘æ48‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/4/15), ‰ªŽR.

723246. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ‘ŠúŠÖ߃ŠƒEƒ}ƒ`‚ɑ΂·‚郃gƒgƒŒƒLƒT[ƒg (MTX) ‹y‚уuƒVƒ‰ƒ~ƒ“ (BUC) •¹—p—Ö@‚Ì“ñd–ÓŒŸ”äŠrŽŽŒ±‚É‚æ‚錟“¢ iŒú˜JÈ: ŠÖ߃ŠƒEƒ}ƒ`‘ŠúŽ¡—ÃŽwj‚ÌŠm—§‚ÉŠÖ‚·‚錤‹†”Çj. Žsì—zˆê, Ä“¡‹PM, HŒŽ³Žj, ‹ß“¡Œ[•¶1, ¬—Ñ–Îl, ‘哇‹v“ñ, ì‡ áÁˆê (1“à‡X): ‘æ48‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/4/16), ‰ªŽR.

723247. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ¬lStill•a‚É‚¨‚¯‚錌´IL-18’l’˜‘—á‚Ì—Õ°‘œ. Îì@Í1, ŒF‘q—çŽq, “c’†~ˆê, ”Ñ’ËiŽq1, âˆä”ü•Û1, “n•”—ms1, “c’†Z–¾1, ‰““¡•½m1, ‰ª“c@ƒ1, ‹ß“¡Œ[•¶1 (1“à‡X): ‘æ48‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/4/16), ‰ªŽR.

723248. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) –ƉuŽ¾Š³Ž¡—Âɔº‚¤ƒXƒeƒƒCƒhœ‘eé Ç‚ÌŽÀ‘Ô’²¸•ñ iŒú˜JÈ: –ƉuŽ¾Š³‚̇•¹Ç‚Æ‚»‚ÌŽ¡—Ö@‚ÉŠÖ‚·‚錤‹†”Çj. ‰Í–콎i, ŒF’Jrˆê, ˆ­”ü’B–ç, ’–ŒF–ÎŽq, ‰ª“c—m‰E, ‹àˆä”ü‹I, “L–Ø~ˆê, ‹T“cGl, ‹ß“¡Œ[•¶1, z–K@º, ”‹ŽR—T”V, Œ´@‚Ü‚³Žq, L”¨r¬, –Š–씎Žj, ‹g“c‰ëŽ¡, ‹´–{”ŽŽj (1“à‡X): ‘æ48‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/4/16), ‰ªŽR.

723249. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) MTX‚ÌPPARƒÁ, LXRƒ¿”­Œ»—U“±‚ð‰ð‚µ‚½R“®–¬d‰»R‰ŠÇì—p. “n•”—ms1, Ô¯@“§2, ‹ß“¡Œ[•¶1 (1“à‡X. 2—ÕŒŸŠw): ‘æ48‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/4/16), ‰ªŽR.

723250. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) Ä”­«‘½”­“Š (Relapsing Polychondritis: RP) Ç—á‚Ì—Õ°‘œ‚ÌŒŸ“¢. ”Ñ’ËiŽq1, ¼@˜a•v, ¯@Œ’‘¾, ˜a“c’B•F1, Îì@Í1, âˆä”ü•Û1, “c’†Z–¾1, ‰““¡•½m1, ‰ª“c@ƒ1, ‹ß“¡Œ[•¶1 (1“à‡X): ‘æ48‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/4/17), ‰ªŽR.

723251. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ‘Sg«‹­”çÇ‚ÌdÇ’°ŠÇ•a•Ï‚Ì•a‘Ô‚ÆŠÇ—‚ÉŠÖ‚·‚錟“¢. ‹g“c@G, ‰““¡•½m, âˆä”ü•Û, ”Ñ’ËiŽq, “c’†Z–¾, Îì@Í, ‹ß“¡Œ[•¶ (“à‡X): ‘æ48‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2004/4/17), ‰ªŽR.

723252. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒLƒmƒƒ“‘Ï«”x‰Š—l‹Û‚Ì–òÜŠ´õ«‚ƈâ“`Žq•ÏˆÙ‚ÌŠÖ˜A. ‚ŽR—zŽq1, –k—¢‰p˜Y2, ùŒ´•Žu3, »ìŒc‰î4, ‰«’îO, ‹ß“¡Œ[•¶1 (1“à‡X. 2ˆã‰q. 3”÷EŠñ. 4Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï (2004/6/3-4), ‰«“ê.

723253. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒeƒCƒRƒvƒ‰ƒjƒ“‚Ì“§ÍŽž‚Ì“Š—^•û–@. ¬—ѹG, –Ø‘º—˜”ü1, ‘•ªG–ç1, ‘º£¨’ÃŽq1, ²ìŒ«ˆê1, “‡“cŽœ•F1, ‚ŽR—zŽq2, –ìXŽRŸl3, »ìŒc‰î3 (1–òÜ•”. 2“à‡X. 3Š´õÇ): ‘æ21‰ñ“ú–{TDMŠw‰ï (2004/6), ‘åã.

723254. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”x‚ŒŒˆ³Ç‚É‚¨‚¯‚éƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“ iPG) ‚Ì–ðŠ„. –k—¢‰p˜Y1, —Ñ@ò2, ‰““¡•½m3, ‘ºã—m‰î4, ‹´–{@“Ä, ‰Í–ì@Ã3, ‚ŽR—zŽq3, ”n“ˆ³—²2, ¬“‡ŽjÍ, ì‡áÁˆê, ‹ß“¡Œ[•¶3 (1ˆã‰q. 2•a—. 3“à‡X. 4”÷EŠñ): ‘æ25‰ñ“ú–{‰ŠÇEĶˆãŠw‰ï (2004/7/13-14), “Œ‹ž.

723255. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰ŠÇ•a•Ï‚É‚¨‚¯‚éLXA4Žó—e‘̧Œä‹@˜. ‰““¡•½m1, ‹´–{@“Ä, —Ñ@ò2, ‘ºã—m‰î3, –k—¢‰p˜Y4, ‹ß“¡Œ[•¶1 (1“à‡X. 2–ò—. 3”÷EŠñ. 4ˆã‰q): ‘æ25‰ñ“ú–{‰ŠÇEĶˆãŠw‰ï (2004/7/13-14), “Œ‹ž.

723256. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) RƒzƒXƒtƒ@ƒ`ƒWƒ‹ƒZƒŠƒ“Eƒvƒƒgƒƒ“ƒsƒ“•¡‡‘Ì iPS-PT) R‘Ì‚ÌRƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ iAPS) ‚ɑ΂·‚é—Õ°“IˆÓ‹`. “L–Ø~ˆê, ŒK–¼³—², ‹T“cGl, ’|“à@‹Î, ‰ª“c@ƒ1, •ÐŽR‰ëŽj, ‹g“crŽ¡, ’r“cN•v (1“à‡X): ‘æ32‰ñ“ú–{—Õ°ƒŠƒEƒ}ƒ`Šw‰ï (2004/10/8-9), “Œ‹ž.

723257. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) Bone morphogenetic proten-II iBMP-E) ‚ÆäPŒ´•a‚Ì”x‚ŒŒˆ³Ç‚Æ‚ÌŠÖ˜A. ‰ª“c@ƒ, Îì@Í, ‹ß“¡Œ[•¶ (“à‡X): ‘æ32‰ñ“ú–{—Õ°ƒŠƒEƒ}ƒ`Šw‰ï (2004/10/8-9), “Œ‹ž.

723258. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰¡’f«Ò‘‰Š‚ð‡•¹‚µ‚½‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX3Ç—á‚Ì—Õ°“I‰ðÍ. ‹g“c@G, ‰““¡•½m, ”Ñ’ËiŽq, ¼@³‘å, “c’†Z–¾, Îì@Í, ‰ª“c@ƒ, ‹ß“¡Œ[•¶ (“à‡X): ‘æ32‰ñ“ú–{—Õ°ƒŠƒEƒ}ƒ`Šw‰ï (2004/10/8-9), “Œ‹ž.

723259. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) äPŒ´•a‚ɇ•¹‚·‚é”x‚ŒŒˆ³Ç‚ɑ΂·‚鎡—Ãí—ª. “c’†Z–¾, âˆä”ü•Û, ‹ß“¡Œ[•¶ (“à‡X): ‘æ19‰ñ“ú–{—Õ°ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/11), “Œ‹ž.

723260. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ‹­”çÇ‚ÌS‹ØáŠQ‚Ìf’f‚É, S‹Ø99mTc•WŽ¯ƒsƒƒŠƒ“Ž_ (PYP) ƒVƒ“ƒ`‚ª—L—p‚Å‚ ‚Á‚½ˆê—á. ¼@³‘å, ”Ñ’ËiŽq, ‰““¡•½m, “c’†Z–¾, ‹ß“¡Œ[•¶ (“à‡X): ‘æ19‰ñ“ú–{—Õ°ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/11), “Œ‹ž.

723261. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ iAPSj ‚ɇ•¹‚µ‚½”x‚ŒŒˆ³Ç (PH). —é–؉€Žq, ‰ª“c@ƒ, âˆä”ü•Û, “c’†Z–¾, Îì@Í, ‹ß“¡Œ[•¶ (“à‡X): ‘æ19‰ñ“ú–{—Õ°ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (2004/11), “Œ‹ž.

731043. [Šw‰ï (’n•û)] (‹³ˆçu‰‰Eƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ‹­”çÇŽ¡—ÂÌÅ‘Oü‹­”çÇ‚É‚¨‚¯‚é‘ŸŠí•ÊŽ¡—ÃŽwj. ‹ß“¡Œ[•¶ (“à‡X): ‘æ55‰ñ“ú–{”畆‰ÈŠw‰ï’†•”Žx•”Šwp‘å‰ï (2004/9/11-12), ‹à‘ò.

731044. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‘Sg«‹­”çÇ‚Ì—Õ°. ‹ß“¡Œ[•¶ (“à‡X): H“c’n‹æƒŠƒEƒ}ƒ`‹³ˆçŒ¤C‰ï (2004/11/28), H“cŽs.

731045. [Œ¤‹†‰ï] (“Á•Êu‰‰) ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚éRTNF-ƒ¿R‘̂̈ʒu•t‚¯. ‹ß“¡Œ[•¶ (“à‡X): ŽO‰Y”¼“‡ƒŠƒEƒ}ƒ`§’k‰ï (2004/12/8), ‰¡{‰êŽs.

731046. [Œ¤‹†‰ï] (“Á•Êu‰‰) ŠÖ߃ŠƒEƒ}ƒ`‚Ì–ò•¨—Ö@‚Ìi•à. ‹ß“¡Œ[•¶ (“à‡X): ‘æ6‰ñ_“Þ샊ƒEƒ}ƒ`‚̃ŠƒoƒPƒAŒ¤‹†‰ï (2005/1/22), ‘Š–ÍŒ´.

732027. [Œ¤‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€) u”x‚ŒŒˆ³ÇŽ¡—ÂÌV‚µ‚¢“WŠJväPŒ´•a«”x‚ŒŒˆ³ÇŽ¡—Â̓WŠJ|PGI2ƒ|ƒ“ƒvŽ¡—ÂðŠÜ‚Þ|. “c’†Z–¾ (“à‡X): ‘æ5‰ñ”x‚ŒŒˆ³ÇŽ¡—ÃŒ¤‹†‰ï (2004/5/29), “Œ‹ž.

732028. [Šw‰ï (’n•û)] (ƒVƒ“ƒ|ƒWƒEƒ€) äPŒ´•a‚ÌŠˆ“®«‚Ì•]‰¿5: MCTD. ‹ß“¡Œ[•¶ (“à‡X): ‘æ55‰ñ“ú–{”畆‰ÈŠw‰ï’†•”Žx•”Šwp‘å‰ï (2004/9/11-12), ‹à‘ò.

732029. [Œ¤‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€) u13CŒÄ‹CŽŽŒ±‚ÌÁ‰»ŠÇ‚ւ̉ž—pv13CŽ‰–bŽ_‹zŽûŒÄ‹CŽŽŒ±‚ð—p‚¢‚½‹­”çÇ‚ÌdÇ’°ŠÇ•a•ÏdÇ’°ŠÇ‚Ì•]‰¿. ‰““¡•½m (“à‡X): 3CˆãŠw‰ž—pŒ¤‹†‰ï (2004), ç—t.

732030. [Œ¤‹†‰ï] (‹³ˆçu‰‰) “à‰Èˆã‚ªf‚éŠÖ߉Š@RA, NonRA. ‰““¡•½m (“à‡X): ‘Š–ÍŒ´ƒŠƒEƒ}ƒ`Œ¤‹†‰ï (2005/1/18), ‘Š–ÍŒ´.

732031. [Œ¤‹†‰ï] (µ‘Òu‰‰) ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚̗×{‚ÆŽ¡—Ã. ‰““¡•½m (“à‡X): ‘½–€•ÛŒ’ŠŒ’NuÀ (2005/2/7), ‘½–€Žs.

733110. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‘å—ʃVƒNƒƒzƒXƒtƒ@ƒ~ƒhŠÔŒ‡Ã’—Ö@ i1VCYj ‚ª—LŒø‚Å‚ ‚Á‚½äPŒ´•a‡•¹”x‚ŒŒˆ³Ç iPHj ‚Ì1—á. ”Ñ’ËiŽq, âˆä”ü•Û, “c’†Z–¾, ‰““¡•½m, ‰ª“c@ƒ, ‹ß“¡Œ[•¶ (“à‡X): ‘æ5‰ñ”x‚ŒŒˆ³ÇŽ¡—ÃŒ¤‹†‰ï (2004/5/29), “Œ‹ž.

733111. [Œ¤‹†‰ï] (ˆê”Êu‰‰) cŠu‹CŽî, lˆ×«’°•ÂÇ‚ð‡•¹‚µ‚½”畆‹Ø‰Š‚Ì1—á. ¼@³‘å, Îì@Í, ”Ñ’ËiŽq, âˆä”ü•Û, ‹g“c@G, “n•”—ms, “c’†Z–¾, ‰““¡•½m, ‰ª“c@ƒ, ‹ß“¡Œ[•¶ (“à‡X): ‘æ45‰ñŠÖ“ŒƒŠƒEƒ}ƒ`Œ¤‹†‰ï (2004/6/26), “Œ‹ž.

733112. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒI[ƒo[ƒ‰ƒbƒvÇŒóŒQ‚Ì1—á. ‹g“c@G, ‹ß“¡Œ[•¶ (“à‡X): ‘Š–ÍŒ´ƒŠƒEƒ}ƒ`Œ¤‹†‰ï (2004/7/6), ‘Š–ÍŒ´.

733113. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ”xüˆÛÇŽ¡—Âɂæ‚Á‚Ä‹}«‘žˆ«‚µ‚½RA‚Ì1—á. ¼@³‘å1, ŒIŒ´—[Žq, Îì@Í1, ”Ñ’ËiŽq1, âˆä”ü•Û1, ‰Í–ì@Ã1, ‹g“c@G1, “n•”—ms1, “c’†Z–¾1, ‰““¡•½m1, ‰ª“c@ƒ1, ‹ß“¡Œ[•¶1 (1“à‡X): ‘æ50‰ñ_“Þ샊ƒEƒ}ƒ`ˆã‰ï (2004/7/17), ‰¡•l.

733114. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Šáâ|‹Ø‰Š‚ªæs‚µ, ’°˜‹Ø¶ŒŸ‚ÅŠm’èf’f‚ÉŽŠ‚Á‚½‘½”­«‹Ø‰Š‚Ì1—á. ¼@³‘å1, ”Ñ’ËiŽq1, âˆä”ü•Û1, ‰Í–ì@Ã1, ‹g“c@G1, —é–؉€Žq1, ‚ŽR—zŽq2, “n•” —ms1, “c’†Z–¾1, Îì@Í1, ‰““¡•½m1, ‰ª“c@ƒ1, ‹ß“¡Œ[•¶1 (1“à‡X. 2—ÕŒŸŠw): ‘æ15‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ïŠÖ“ŒŽx•”ŠwpW‰ï (2004/12/4), “Œ‹ž.

733115. [Œ¤‹†‰ï] (ˆê”Êu‰‰) 13CŒÄ‹CŽŽŒ±‚ð—p‚¢‚½‹­”çÇ’°ŠÇ•a•Ï‚ÌdÇ“x•]‰¿. ‰““¡•½m (“à‡X): ”çÇŒ¤‹†‰ï(2005/1/15), “Œ‹ž.

733116. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‹­”çÇ‚ÌS‹ØáŠQ‚Ìf’f‚ÉS‹Ø99mTC•WŽ¯ƒsƒƒŠƒ“Ž_ iPYPj ƒVƒ“ƒ`‚ª—L—p‚Å‚ ‚Á‚½ˆê—á. ¼@³‘å, “c’†Z–¾, ‰““¡•½m, ‹ß“¡Œ[•¶ (“à‡X): ‹­”çÇŒ¤‹†‰ï (2005/1/15), “Œ‹ž.

733117. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ”­«‹Ø‰Š@”畆‹Ø‰Š‚Ì‚Æ‚Ì•t‚«‡‚¢•û@Ž¡—Õû–@‚ƶŠˆ‚ÌH•v. ‰““¡•½m (“à‡X): “Á’莾Š³u‰‰‰ï (2005/3/29), ‰¡•l.


<<ŠO‰ÈŠw>>

mŠwp˜_•¶n

110109. [Œ´’˜] Spraying of phenol red dye as a screening test for Helicobacter pylori infection in surgically resected stomach specimens. ŽO‹´@~1, ŽO•xO”V1, ¬ò˜aŽO˜Y2, ‹e’rŽj˜Y3, ‰ªˆÀ@ŒM4, ¼Œ³Ž›ŽâX2 (1‘—§‘Š–ÍŒ´•a‰@ŒŸ¸‰È. 2“à‡T. 3ŠO. 4•a—): J Gastroenterol, 38: 1049-1052, 2003.

110110. [Œ´’˜] Paired-like homeodomain protein ESXR1 possesses a leavable C-terminal region that inhibits cyclin degradation. ¬àV•½‘¾1, ˆ°àV@•q1, Masanori@Naito, Masatomo Yanagihara, Naomi Ohnishi, Tatsuya Maeda, Yoichi Matsuda (1ŠO): Oncogene, 23: 6590-6602, 2004.

110111. [Œ´’˜] Role of Endoscopic Clipping for Determining the Resection Line for Tumors Located in the Middle or Upper Corpus of the Stomach: Experience with 100 Gastrectomies for Early Gastric Cancer. ‹e’rŽj˜Y, •½ˆä˜a–í, •ŽRMˆê, •Ð“c‰Ä–ç, ÷–{Mˆê, ¬—ÑLs (ŠO): Anticancer Research, 24: 4163-4168, 2004.

110112. [Œ´’˜] Survival after surgical treatmemt of early gastric cancer: surgical techniques and long term survival. ‹e’rŽj˜Y1, •Ð“c‰Ä–ç1, ÷–{Mˆê1, ¬—ÑLs1, “ˆ”ö@m1, “nç²¹•F1, Y Hiki (1ŠO): Langenbecks Arch Surg, 38: 69-74, 2004.

110113. [Œ´’˜] Aberrant left hepatic artery in laparoscopic antireflux procedures. PJ. Klingler, MH. Seeling, NR. Floch, SA. Branton, MC. Freund, •Ð“c‰Ä–ç1, RA. Hinder (1ŠO): Surg Endsc, 18: 807-811, 2004.

110114. [Œ´’˜] Thermostability Gradient in the Collagen Triple Helix Reveals its Mult-domain Structure. Andrzei Steplewski, Lreneusz Majsterek, Erin McAdams, Eileen Rucker, Raymond J Brittingham, Hidetoshi Ito, •½ˆä˜a–í1, ˆÀ’B‰hŽ¡˜Y2, Sergio A Jimenez, Andrzei Fertala. (1ŠO. 2ˆã—ÃŒn‘åŠw‰@): JMB, 33: 989-998, 2004.

110115. [Œ´’˜] Ethanol binging exacerbates sinusoidal endothelial and parenchymal injury elicited by acetaminophen. RS. McCuskey, NW. Bethea, J Wong, MK. McCuskey, ER. Abril, X. Wang, ˆÉ“¡‹`–ç1, LD. Deleve (1ŠOE—¯Šw’†): ‚i Hepatol, 42: 371-377, 2005.

110116. [Œ´’˜] Inhibition of matrix metalloproteinases minimizes hepatic microvascular injury in response to acetaminophen in mice. ˆÉ“¡‹`–ç1, ER. Abril, NW. Bethea, RS. McCuskey (1ŠOE—¯Šw’†): Toxicol Sci, 83:190-196, 2005.

110117. [Œ´’˜] Ethanol binging enhances hepati microvascular responses to acetaminophen in mice. ˆÉ“¡‹`–ç1, ER. Abril, NW. Bethea, RS. McCuskey (1ŠOE—¯Šw’†): Microcirculation, 11: 625-632, 2004.

110118. [Œ´’˜] Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. RS. McCuskey, ˆÉ“¡‹`–ç1, GR. Robertson, MK. McCuskey, M. Perry, GC. Farrell (1ŠOE—¯Šw’†): Hepatology, 40: 386-393, 2004.

110119. [Œ´’˜] Randomized controlled trial of the efficacy of adjuvantimmunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation Ok-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur. “nç²¹•F1, Osamu Nishida, Yasuko Kunii, Susumu Kodaira,Takashi Takahashi, Takeshi Tominaga, Keiichi Hojo, Tomoyuki Kato, Minoru Niimoto, Kazufumi Kunitomo, Hiroyasu Isomoto, Yasuo Ohashi, Masayuki Yasutomi (1ŠO): International Journal of Clinical Oncology, 9 (2): 98-106, 2004.

120022. [Œ´’˜] DukesC‘å’°Šà‚É‚¨‚¯‚郊ƒ“ƒpß“]ˆÚ•ª—Þ‚ÌŒŸ“¢: “ú–{‘å’°ŠàŽæˆµ‚¢‹K–ñ‚Æ TNM •ª—Þ‚Ì”äŠr. ’†‘º—²r1, ŽO•xO”V2, ‹e’rŽj˜Y1, ²“¡•˜Y1, ¬àV•½‘¾1, š êK‹Ï1, ˆäŒ´@Œú1, ‘å’J„³1, “nç²¹•F1 (1ŠO. 2‘—§‘Š–ÍŒ´•a‰@): “ú–{‘å’°ãè–å•aŠw‰ïŽ, 58 (2): 2004.

120023. [Œ´’˜] DNA‚̃ƒ`ƒ‹‰». ¬àV•½‘¾, “nç²¹•F (ŠO): ƒRƒ“ƒZƒ“ƒTƒXŠàŽ¡—Ã, 11: 226, 2004.

210021. [€Œ´’˜] Functional evaluation of laparoscopic fundoplication for GERD. •Ð“c‰Ä–ç, ÷–{Mˆê, ¬—ÑLs, “ñ“nM], •ŽRMˆê, ‹e’rŽj˜Y, “nç²¹•F (ŠO): J gastrointest Surg, 2004.

210022. [€Œ´’˜] Effect of acetaminophen on hepatic microcirculation in mice. ˆÉ“¡‹`–ç1, Nancy W Machen, Edward R Abril, Robert S McCuskey (1ŠOE—¯Šw’†): Comparative Hepatology, 3 (S.1): S33, 2004.

220015. [€Œ´’˜] ’°ŠÇ‹•ŒŒ. ²“¡•˜Y, ‘å’J„³, ¬àV•½‘¾, ’†‘º—²r, š êK‹Ï, ˆäŒ´@Œú, “nç²¹•F (ŠO): Surgery Frontier, 11 (3): 54-60, 2004.

220016. [€Œ´’˜] ãè–å‘~áyÇ. ‘å’J„³, “nç²¹•F (ŠO): —Õ°ŠO‰È, 59 (11): 219-221, 2004.

220017. [€Œ´’˜] ‰h—{•â‹‹‚Ü‚½‚Í’°ŠÇŒ¸ˆ³‚ð–Ú“I‚Æ‚µ‚½“àŽ‹‹¾“IŽ¡—Ã. “ˆ”ö@m, X£¹Ž÷, •ŽRMˆê, “nç²¹•F (ŠO): —Õ°Á‰»Ší“à‰È, 19 (10): 1407-1412, 2004.

220018. [€Œ´’˜] ‹}‘¬‚É‘‘債‚½Žá”NŽÒ‚Ì”ñ‹@”\«äX“à•ª”åŠà‚Ì1—á. ¯–ìOŽ÷, ‹g“c@‹I, ”‹´_ˆê, ‚‹´’õl, “‡“c@Œª, ŒÃ“cˆê“¿, ‚‹´@‹B, ²“¡ŒõŽj, Š`“c@Í (ŠO): äX‘Ÿ, 19 (5): 529-534, 2004.

220019. [€Œ´’˜] Žîᇫ‘å’°E’¼’°Ž¾Š³. ‘å’J„³, “nç²¹•F (ŠO): —Õ°ŽGŽuŠO‰Èv, 66 (12): 1489-1496, 2004.

220020. [€Œ´’˜] –Ñ‘ƒ“´iá‘j. ‘å’J„³, “nç²¹•F (ŠO): —Õ°ŠO‰È, 59 (11): 222-224, 2004.

220021. [€Œ´’˜] • o‹¾•â•‰º‘å’°ˆŸ‘S“EE‰ñ’°”Xãè–åŠÇ•«‡p‚̃Rƒc. ‘å’J„³, ’†‘º—²r, ª–{ˆê•F, ²“¡•˜Y, š êK‹Ï, ˆäŒ´@Œú, Š`“c@Í (ŠO): —Õ°ŠO‰È, 58 (4): 513-518, 2004.

220022. [€Œ´’˜] ’°Ž¾Š³‚ÌŠO‰È“IŽ¡—Ã. ‘å’J„³, “nç²¹•F (ŠO): Annual Review Á‰»Ší, 2005.

220023. [€Œ´’˜] ‘å’°. š êK‹Ï, “nç²¹•F (ŠO): • o‹¾‰ºŽèp, 2004.

220024. [€Œ´’˜] ƒRƒ“ƒrƒl[ƒVƒ‡ƒ“ƒAƒvƒ[ƒ`‚É‚æ‚é• o‹¾‰º‘å’°Žèp. š êK‹Ï, ‘å’J„³, ’†‘º—²r, ª–{ˆê•F, ²“¡•˜Y, ²“¡ŒõŽj (ŠO): Žèp, 58 (3): 395-402, 2004.

220025. [€Œ´’˜] ‘å’°Šà‚É‚¨‚¯‚é• o‹¾‰ºŽèp‚̈À‘S‚ÈŠs´EŽö“®‚ÌH•v. š êK‹Ï, ²“¡•˜Y, ’†‘º—²r, ˆäŒ´@Œú, ‘å’J„³, “nç²¹•F (ŠO): Žèp, 58 (11): 1883-1890, 2004.

220026. [€Œ´’˜] • o‹¾‰ºŽèp‚ðˆÀ‘S‚És‚¤‚½‚ß‚É. š êK‹Ï, “nç²¹•F, ’†‘º—²r, ²“¡•˜Y, ª–{ˆê•F, ˆäŒ´@Œú, ‘å’J„³ (ŠO): —Õ°ŠO‰È, 59 (6): 687-692, 2004.

220027. [€Œ´’˜] • o‹¾‰º‘å’°Øœp‚É‚¨‚¯‚éÄŒš. š êK‹Ï, ²“¡•˜Y, ¬àV•½‘¾, ’†‘º—²r, ª–{ˆê•F, ˆäŒ´@Œú, ‘å’J„³, “nç²¹•F (ŠO): Á‰»ŠíŠO‰È, 27 (10): 1575-1582, 2004.

220028. [€Œ´’˜] ãè–å•”ˆ««ŽîᇂÌf’fEŽ¡—Ã. ‘å’J„³, ˆäŒ´@Œú, š êK‹Ï, ²“¡•˜Y, ª–{ˆê•F, ¬àV•½‘¾, ’†‘º—²r, “nç²¹•F (ŠO): —Õ°ŠO‰È, 59 (8): 1021`1027, 2004.

220029. [€Œ´’˜] Ž©“®•«‡Ší‚É‚æ‚éÄŒš|• o‹¾‰º‘å’°Øœp‚É‚¨‚¯‚éÄŒš|. š êK‹Ï, ²“¡•˜Y, ¬àV•½‘¾, ’†‘º—²r, ª–{ˆê•F, ˆäŒ´@Œú, ‘å’J„³, “nç²¹•F (ŠO): Á‰»ŠíŠO‰È9ŒŽ†, 27 (10): 1575`1582, 2004.

320028. [Ç—á•ñ] ‘å—ÊoŒŒ‚ð‚«‚½‚µ‹Ù‹}• o‹¾‰ºŽèp‚Å‹~–½‚µ“¾‚½‹ó’°pyogenic granuloma‚Ì1—á. ’†‘º—²r1, ŽO•xO”V2, ‘å’J„³1, ²X–Ø^‹|3, ˆé•”‹`Œ›3, ²“c”ü˜a4, ²“¡•˜Y1, ª–{ˆê•F1, š êK‹Ï1, ˆäŒ´@Œú1, ²“¡ŒõŽj1 (1ŠO. 2‘—§‘Š–ÍŒ´•a‰@. 3•ú. 4“à‡T) : “ú–{‘å’°ãè–å•aŠw‰ïŽ, 57 (1): 39-42, 2004.

510005. [‘à] Review article: surgical and endoscopic therapy of gastro-oesophageal reflux disease in Japan. •Ð“c‰Ä–ç (ŠO): Aliment Pharmacol Ther, 20: 28-31, 2004.

510006. [‘à] Analysis of the role of negative Tcell costimulatory pathways in CD4 and CD8 mediated alloimmune responses in vivo. ã–ì‘ôÆ1, Ito T, Yuan X, Clarkson NR, Yagita H, Azuma M, Auchincloss H Jr, Sayegh MH, Najafian N (Transplantation Unit, Surgical Services, Massachusetts General Hospital, Harvard Medical School) (1ŠOE—¯Šw’†): The Journal of Immunology, 174 (11): 6648-6656, 2005.

510007. [‘à] Effect over time of endotoxin adsorption therapy (PMX-DHP) in sepsis. ã–ì‘ôÆ1, Sugino M, ª–{—S‘¾1, Shoji H, Š`“c@Í1, “nç²¹•F1 (1ŠO): Therapeutic Apheresis and Dialysis, 9: 128-136, 2005.

510008. [‘à] Heme oxygenase system in ischemia and reperfusion injury W Kupiec-Wglinski. “y‹´½ˆê˜Y1, Constantion Fondevila, Jerzy W Kupiec-Weglinski (The Dumont-UCLA Transplant Center, Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at University of California, LosAngeles, CA.) (1ŠOE—¯Šw’†): Ann Transplant, 9 (1): 84-87, 2004.

510009. [‘à] Heme oxygenase-1 and heat shock proteins in ischemia/reperfusion injury. “y‹´½ˆê˜Y1, Constantion Fondevila, Jerzy W Kupiec-Weglinski (The Dumont-UCLA Transplant Center, Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at University of California, LosAngeles, CA.) (1ŠOE—¯Šw’†): Curr Opin Organ Transplant, 9: 145-152, 2004.

510010. [‘à] Biliverdin Therapy Protects Rat Livers From Ischemia and Reperfusion Injury. Constantion Fondevila, Xiu-Da Shen, “y‹´½ˆê˜Y1, Kenichiro Yamashita, Eva Csizmadia, Charles Lassman, Ronald W Busuttil, Jerzy W Kupiec-Weglinski, Fritz Bach (The Dumont-UCLA Transplant Center, Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at University of California, LosAngeles, CA.) (1ŠOE—¯Šw’†): Hepatology, 40: 133-134, 2004.

520122. [‘à] ãè–å•”ˆ««ŽîᇂÌf’fEŽ¡—Ã. ‘å’J„³, ˆäŒ´@Œú, š êK‹Ï, ²“¡•˜Y, ¬àV•½‘¾, ’†‘º—²r, “nç²¹•F (ŠO): —Õ°ŠO‰È, 59 (8): 1021-1027, 2004.

520123. [‘à] ˆÝŠà‚ɑ΂·‚é• o‹¾•â•‰º—H–呤ˆÝØœ D1+ƒÀ‚¨‚æ‚Ñ D2ƒŠƒ“ƒpߊs´. ÷–{Mˆê, ‹e’rŽj˜Y, •ŽRMˆê, “ñ“nM], •Ð“c‰Ä–ç, ¬—ÑLs, “nç²¹•F (ŠO): Šà‚Ì—Õ°, 50 (12): 999-1005, 2004.

520124. [‘à] ˆÝØœ—á‚ÌGERD. •Ð“c‰Ä–ç, a’JŽ ˜Y, “nç²¹•F (ŠO): ƒƒfƒBƒ`[ƒi, 42: 114-116, 2004.

520125. [‘à] ’°Ž¾Š³‚ɑ΂·‚é’áNPŽ¡—Ã. ˆäŒ´@Œú, š êK‹Ï, ‘å’J„³, “nç²¹•F (ŠO): G I Research, 12 (3): 21-29, 2004.

520126. [‘à] ŠÌüŽî—l‰ßŒ`¬ (Adenomatous Hyperplasia). Ž­Žæ³“¹1, š •ª–ΔŽ2 (1ŠO. 2“à‡T): ŠÌ’_äX, 49 (5): 791-795, 2004.

520127. ‘à] SSS (septic severity score) ‚É‚æ‚é‹}«• Ç‚𔺂¤‰º•”Á‰»ŠÇŽ¾Š³‚ÌdÇ“x•]‰¿. ã–ì‘ôÆ1 (—¯Šw’†), ™–ìŽOç’j1, ª–{@“ú•2, Š`“c@Í1, “nç²¹•F1 (1ŠO. 2‚ ‚»‚©•a‰@): –k—¢ˆãŠw, 34: 59-66, 2004.

520128. [‘à] ‘Šú‘å’°Šà‚ɑ΂·‚é• o‹¾‰º‘å’°Øœ‚Ìi•à. “nç²¹•F (ŠO): “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 101 (5): 495-501, 2004.

520129. [‘à] ’°Ž¾Š³‚ɑ΂·‚é“àŽ‹‹¾ŠO‰È‚Ìi•à. “nç²¹•F (ŠO): ŒcœäˆãŠw, 81 (2): 85-91, 2004.

520130. [‘à] ‰ŠÇ«’°Ž¾Š³‚Ì• o‹¾‰ºŽèp‚Ì“K‰ž‚ÆŒÀŠE. “nç²¹•F (ŠO): ŠO‰È, 66 (7): 806-811, 2004.

520131. [‘à] ‘å’°smŠà‚ÌŽ¡—Ã, • o‹¾‰ºŽèp‚ÌÅæ’[. “nç²¹•F (ŠO): ƒ‚ƒ_ƒ“ƒtƒBƒWƒVƒƒƒ“, 24 (7): 1169-1173, 2004.

520132. [‘à] Ú’…ŠîŽ¿‚Æ‚µ‚Ä‚Ì×–EŠOƒ}ƒgƒŠƒNƒX‚ÌFŽO‚Æ‘gDĶ‚ւ̉ž—p. ˆÀ’B‰hŽ¡˜Y1, ‘å‹´‚µ‚Ù‰Ô, •½ˆä˜a–í2, ’|‘ºK•q (1ˆã—ÃŒn‘åŠw‰@. 2ŠO): ˆâ“`ŽqˆãŠw, mook1:75-81, 2004.

m’˜@‘n

610002. [Šwp‘] (•ª’SŽ·•M) Role of thromboxane in lipopolysaccharide-induced hepatic microcirculatory dysfunction in mice; Organ Microcirculation, Agateway to diagnostic and therapeutic interventions. Katagiri H, ˆÉ“¡‹`–ç1 (—¯Šw’†), Έ䌒ˆê˜Y1, —Ñ@ò2, Suematsu M, ¬‹{@Žü3, Š`“c@Í1, ”n“ˆ³—²2 (1ŠO. 2–ò—. 3‹ž“s‘å), •ÒW Ishii H, Suematsu M, Tanishita K, Suzuki H, Springer-Verlag Tokyo, 2004”­s.

620077. [Šwp‘] (•ª’SŽ·•M) ‘å’°Šà‰ŠÇ«’°Ž¾Š³; ’°Ž¾Š³‚ɑ΂·‚é“àŽ‹‹¾ŠO‰È, p.108-109. “nç²¹•F (ŠO), •ÒW —Ž‡•“¿ (ç—t‘å), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004”­s.

620078. [Šwp‘] (•ª’SŽ·•M) ‘å’°Eãè–åŠO‰È‚Ì—v“_‚Æ–Ó“_; ‘å’°Ž¾Š³‚ɑ΂·‚é• o‹¾‰ºŽèp‚Ì“K‰ž, p.212-215. “nç²¹•F (ŠO), •ÒW ™Œ´Œ’ˆê (“Œ‹žˆãŽ•‘å), ŠÄC –‹“à‰ë•q(“Œ‹ž‘å), •¶Œõ“°, “Œ‹ž, 2004”­s.

620079. [Šwp‘] (•ª’SŽ·•M) ‘å’°Eãè–åŠO‰È‚Ì—v“_‚Æ–Ó“_; • o‹¾‰º’°Øœ‚ÌŠî–{‘€ì, p.216-220. “nç²¹•F (ŠO), •ÒW ™Œ´Œ’ˆê (“Œ‹žˆãŽ•‘å), ŠÄC –‹“à‰ë•q (“Œ‹ž‘å), •¶Œõ“°, “Œ‹ž, 2004”­s.

620080. [Šwp‘] (•ª’SŽ·•M) ‘å’°Eãè–åŠO‰È‚Ì—v“_‚Æ–Ó“_; ‰ñ–Ó•”ØœE‰EŒ‹’°Øœ, p.221-225. “nç²¹•F (ŠO), •ÒW ™Œ´Œ’ˆê (“Œ‹žˆãŽ•‘å), ŠÄC –‹“à‰ë•q (“Œ‹ž‘å), •¶Œõ“°, “Œ‹ž, 2004”­s.

620081. [Šwp‘] (•ª’SŽ·•M) ‘å’°Eãè–åŠO‰È‚Ì—v“_‚Æ–Ó“_; ‰¡sŒ‹’°Øœ, p.226-228. “nç²¹•F (ŠO), •ÒW ™Œ´Œ’ˆê (“Œ‹žˆãŽ•‘å), ŠÄC –‹“à‰ë•q (“Œ‹ž‘å), •¶Œõ“°, “Œ‹ž, 2004”­s.

620082. [Šwp‘] (•ª’SŽ·•M) ‘å’°Eãè–åŠO‰È‚Ì—v“_‚Æ–Ó“_; S󌋒°Øœ, p.229-232. “nç²¹•F (ŠO), •ÒW ™Œ´Œ’ˆê (“Œ‹žˆãŽ•‘å), ŠÄC –‹“à‰ë•q (“Œ‹ž‘å), •¶Œõ“°, “Œ‹ž, 2004”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

712013. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Inhibition of matrix metaloproteonase attenuates liver injury elicited by acetaminophen in mice. ˆÉ“¡‹`–ç1, E Abril, NW Bethea, RS McCuskey (1ŠOE—¯Šw’†): Experimental Biology (2004/4/17-21), Washington DC.

712014. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Attenuation of hepatic microvascular injury in response to acetaminophen by matrix metalloproteinases inhibition. ˆÉ“¡‹`–ç1, E Abril, NW Bethea, RS McCuskey (1ŠOE—¯Šw): 55th Annual meeting of the American association for the study of liver diseases (2004/10/29-11/2), Boston, Massachusetts, USA. Hepatology, 40 (S.): 698A, 2004.

712015. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Laparoscopic Surgery for Colorectal Cancer. “nç²¹•F (ŠO): 2004 Annual Surgical Leaders' Summit (2004/10), Soul.

712016. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Laparoscois Rectal Surgery: The status of the art. “nç²¹•F (ŠO): VI International Symposium on Rectal Cancer Milan (2004/11), Milan.

712017. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Laoaroscopic Surgery for Colorectal Cancer in Japan. “nç²¹•F (ŠO): Masterclass Advanced Trainng Course (2004/12), Paris.

712018. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Landmark in laparoscopic Colectomy. “nç²¹•F (ŠO): Adyanced Course in Laparoscopic Colorectal Surgery (2005/3/18), Strasbourg.

712019. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Clip-less laparoscopic total colectomy. “nç²¹•F (ŠO): Adyanced Course in Laroscopic Colorectal Surgery (2005/3/18), Strasbourg.

712020. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) How to perform laparoscopic TME. “nç²¹•F (ŠO): Advanced Course in Laparoscopic Colorectal Surgery (2005/3/19), Strasbourg.

712021. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) General Principles in laparoscopic colectomy-Lateral approach. “nç²¹•F (ŠO): Advanced Course in Laparoscopic Colorectal Surgery (2005/3/19), Strasbourg.

712022. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Techniques-Landmarks of surgical for a safe left and right colectomy. “nç²¹•F (ŠO): Advanced Course in Laparoscopic Colorectal Surgery (2005/3/19), Strasbourg.

713072. [‘Û (Šw‰ï)] (ƒ|ƒXƒ^[) The Laporascopic Combination Approach for Colon Cancer. š êK‹Ï, ‘å’J„³, ’†‘º—²r, ²“¡•˜Y, ª–{ˆê•F, ²“¡ŒõŽj (ŠO): 2004 Scientific Session & Postgraduate Courses SAGES (2004/4/3), Denver, Colo.

713073. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) HO-1 cytoprotective and anti-inflammatory effects in hepatic ischemia/reperfusion injury are toll-like receptor-4 independent. ischemia/reperfusion injury. “y‹´½ˆê˜Y1, Constantion Fondevila, Bibo Ke, Yuan Zhai, Busuttil RW, Jerzy W Kupiec-Weglinski (The Dumont-UCLA Traansplant Center, Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at University of California, LosAngeles, CA) (1ŠOE—¯Šw’†): American Society of Transplantation (2004/5/15-19), Boston, MA, USA. Am J Transplantation, (Suppl): 436, 2004.

713074. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) A new mouse model of prolonged hepatic cold ischemia followed by orthotopic liver transplantation (OLT). Xiu-Da Shen, Bibo Ke, Yuan Zhai, “y‹´½ˆê˜Y1, Lassman Charls, Douglas G Farmer, Busuttil RW, Jerzy W kupiec-Weglinski (The Dumont-UCLA Transplant Center, Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles, CA) (1ŠOE—¯Šw’†): American Society of Transplantation (2004/5/15-19), Boston, MA, USA. Am J Transplantation, (Suppl): 437, 2004.

713075. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Activation of TLR4 is critical in the mechanism of extended cold ischemia/reperfusion injury after liver transplantation. Xiu-Da Shen, Bibo Ke, Yuan Zhai, “y‹´½ˆê˜Y1, Lassman Charls, Douglas G Farmer, Busuttil RW, Jerzy W kupiec-Weglinski (The Dumont-UCLA Transplant Center, Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles, CA) (1ŠOE—¯Šw’†): American Society of Transplantation (2004/5/15-19), Boston, MA, USA. Am J Transplantation, (Suppl): 539, 2004.

713076. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Strategy of the treatment for hepatocellular carcinoma. ²“¡ŒõŽj1. â–{—FŒ©Žq1, ¯–ìOŽ÷1, Ž­Žæ³“¹1, ŒÃ“cˆê“¿1, ‚‹´@‹B1, “nç²¹•F1, S Kokubo1, a’JŽ ˜Y1, ˆé•”‹`Œ›2, ‹g“c@‹I1 (1ŠO. 2•ú) The 21th PPSA-JC‘¾•½—mŠO‰ÈŒnŠw‰ï“ú–{Žx•”‰ï (2004/11/7), ƒI[ƒXƒgƒ‰ƒŠƒA.

713077. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Ho-1 upregulation suppresses Type-1 IFN pathway in hepatic schemia/reperfusion injury. “y‹´½ˆê˜Y1, Yuan Zhai, Constantion Fondevila, Busuttil RW, Jerzy W Kupiec-Weglinski (The Dumont-UCLA Transplant Center, Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at University of California, LosAngeles, CA) (1ŠOE—¯Šw’†): The 3rd International Congress on Immunosuppression (2004/12/8-11), San Diego, California. USA. Program and Abstract, p.104, 2004.

713078. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Functional evaluation of laparoscopic fundoplication for GERD. •Ð“c‰Ä–ç, ÷–{Mˆê (ŠO): 19th World Congress of International society for Digestive Surgery (2004/12/9), ‰¡•l.

713079. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Methods and esults of Laparoscopic Surgery for GIST of the Stomach. ÷–{Mˆê, ‹e’rŽj˜Y, •ŽRMˆê, “ñ“nM], •Ð“c‰Ä–ç, “nç²¹•F (ŠO): 19th World Congress of International society for Digestive Surgery (2004/12/10), ‰¡•l.

713080. [Šw‰ï (‘Û)] (Oral) Role of nfat transcription factors in skin and@vascularized cardiac allograft rejection. ã–ì‘ôÆ1, Nader Najafian, Akira Yamada, Laurie H Glimcher, Mohamed H Sayegy, Hugh Auchincloss Jr (Transplantation Unit, Surgical Services, Massachusetts General Hospital, Harvard Medical School) (1ŠOE—¯Šw’†): 2004 American Transplant Congress (2004), Boston, MA, U.S.A.

713081. [Šw‰ï (‘Û)] (Oral) Generation of regulatory CD8+ T cells by icos-B7‚g signal blockade in vivo. Atushi Izawa, Michael R. Clarkson, Alan D. Salama, ã–ì‘ôÆ1 Hideo Yagita, Arlene H Sharpe, Gordon J Freeman, Mohamed H Sayegh, Nader Najafian(Transplantation research center, righam and Women's Hospital & Chidren's Hospital, Harvard Medical School) (1ŠOE—¯Šw’†): 2004 American Transplant Congress (2004), Boston, MA, U.S.A.

721004. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) Œ‹’°EŒ‹’°‚Ì• o‹¾‰ºŠO‰È‰ð–U. “nç²¹•F (ŠO): ‘æ104‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2004/4/7), ‘åã.

721005. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) Technique of Laparoscopic Surgery for Rectal Cancer. “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï’èŠúŠwp‘‰ï (2004/7/21-23), Ž­Ž™“‡.

721006. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ’¼’°ŠàŽèp‚©‚ç‚Ý‚½œ”Õ“àŽ‹‹¾ŠO‰È‰È‚Ì“WŠJ. “nç²¹•F (ŠO): ‘æ44‰ñ“ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ïŠwpu‰‰‰ï (2004/8/5), “Œ‹ž.

721007. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‘å’°Ž¾Š³‚É‚¨‚¯‚é“àŽ‹‹¾ŠO‰È‚ÌŒ»ó‚Æ“W–]. “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{ŠO‰ÈŠw‰ï‘²Œã‹³ˆçƒZƒ~ƒi[ (2004.10.14), ·‰ª.

721008. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) “àŽ‹‹¾ŠO‰È‚Ì’·Š‚ÆŒ‡“_. “nç²¹•F (ŠO): ‘æ17‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï (2004/11), ‰¡•l.

721009. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‘å’°Šà‚ɑ΂·‚é•â•‰»Šw—Ö@‚Ìi•à. “nç²¹•F (ŠO): 2004”N“xŒãŠú@“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‹³ˆçW‰ï (2004/12/12), ‰¡•l.

722034. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘å’°’áZPŽèp‚ÌH•v: • o‹¾‰º• ‰ï‰AŽ®’¼’°Ø’fp (Lac-APR) ‚ÌH•v. ²“¡•˜Y, š êK‹Ï, ‘å’J„³, ¬àV•½‘¾, ’†‘º—²r, ˆäŒ´@Œú, “nç²¹•F (ŠO): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10), ‹ž“s. “ú–{ŠàŽ¡—Êw‰ïŽ ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ïƒvƒƒOƒ‰ƒ€†, p.123, 2004.

722035. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‹¾Ž‹‰ºŽèp (‰º•”Á‰»ŠÇ)|‰E‘¤Œ‹’°Šà‚ɑ΂·‚é• o‹¾•â•‰ºŽèp‚ÌH•v|. š êK‹Ï, ²“¡•˜Y, ’†‘º—²r, ˆäŒ´@Œú, ‘å’J„³, “nç²¹•F (ŠO): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10), ‹ž“s. “ú–{ŠàŽ¡—Êw‰ïŽ ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ïƒvƒƒOƒ‰ƒ€†, p.82, 2004.

722036. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’×ᇫ‘å’°‰Š‚ɑ΂·‚é• o‹¾‰ºŽèp. ‘å’J„³, ª–{ˆê•F, ’†‘º—²r, ²“¡•˜Y (oŒü’†), ¬àV•½‘¾, š êK‹Ï, ˆäŒ´@Œú, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï (2004/10), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65 (‘): 231, 2003.

722037. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “àŽ‹‹¾ŠO‰ÈŽèp‚Ìpitfall (Á‰»ŠÇ)|ˆÀ‘S‚È• o‹¾‰º‘å’°Øœ‚̃Rƒc|. š êK‹Ï, “nç²¹•F, ’†‘º—²r, ²“¡•˜Y, ª–{ˆê•F, ˆäŒ´@Œú, ‘å’J„³ (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï’èŠúŠwp‘‰ï (2004/7/21-23), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 37 (7): 34 (760), 2004.

722038. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) äX’_ŠÇ‡—¬ˆÙíÇ‚É‚¨‚¯‚鋤’ÊŠÇ‚ÆŠà‡•¹‚ɂ‚¢‚Ä. ŒÃ“cˆê“¿, Ž­Žæ³“¹, ¯–ìOŽ÷, â–{—FŒ©Žq, ‚‹´@‹B, ‹g“c@‹I, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï (2004/10/13), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65: 285, 2004.

722039. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”牺–Ôü’Ý‚èã‚°–@‚É‚æ‚é• o‹¾‰º’_”X“Eop‚Æ‚»‚Ì–â‘è“_. ¯–ìOŽ÷, ŒÃ“cˆê“¿, â–{—FŒ©Žq, Ž­Žæ³“¹, ‚‹´@‹B, ‹g“c@‹I, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï (2004/10/13), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65: 232, 2004.

722040. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’×ᇫ‘å’°‰Š‚ɑ΂·‚é• o‹¾‰ºŽèp. ‘å’J„³, ª–{ˆê•F, ’†‘º—²r, ²“¡•˜Y, ¬àV•½‘¾, š êK‹Ï, ˆäŒ´@Œú, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï (2004/10/13), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65: 231, 2004.

723262. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) dÇSgáŠQŽ™‚̈ÝH“¹‹t—¬Ç‚ɑ΂·‚é‹t—¬–hŽ~Žèp|Žèp¬Ñ‚©‚ç‚Ý‚½“K‰ž‚ÌlˆÄ|. •Ð“c‰Ä–ç, ’†Œ´‚³‚¨‚è, Γc˜a•v, ÷–{Mˆê, ¬—ÑLs, •ŽRMˆê, ª–{—S‘¾, ‹e’rŽj˜Y, “ˆ”ö@m (ŠO): ‘æ104‰ñ“ú–{ŠO‰ÈŠw‰ï (2004/5/12), ‘åã. “ú–{ŠO‰ÈŠw‰ïŽGŽ, 105: 187, 2004.

723263. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠÌ×–E, “Á‚É‘å‚«‚³3 cmˆÈ‰º, Žîᇌ”2ŒÂ‚Ü‚Å‚ÌØœ—á‚ÌŒŸ“¢. ŒÃ“cˆê“¿, ¯–ìOŽ÷, Ž­Žæ³“¹, ”‹´_ˆê, “‡“c@Œª, ‚‹´@‹B, ‹g“c@‹I, ²“¡ŒõŽj (ŠO): ‘æ104‰ñ“ú–{ŠO‰ÈŠw‰ï (2004/5/12), ‘åã. “ú–{ŠO‰ÈŠw‰ïŽGŽ, 105: 429, 2004.

723264. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) y‘f‰»ŠwõF–@‚É‚æ‚éŽîá‡“àƒŠƒ“ƒpŠÇV¶‚ɂ‚¢‚Ä‚ÌŒŸ“¢. •ŽRMˆê1, ¬—ÑLs1, ‘å•”@½2, ‘å’J„³1, ª–{—S‘¾1, •Ð“c‰Ä–ç1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “ˆ”ö@m1, ‰ªˆÀ@ŒM3, ²“¡ŒõŽj1 (1ŠO. 2ˆã‰q. 3•a—): ‘æ104‰ñ“ú–{ŠO‰ÈŠw‰ï (2004/5/12), ‘åã. “ú–{ŠO‰ÈŠw‰ïŽGŽ, 105: 236, 2004.

723265. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”ñØœäXŠà‚ɑ΂·‚駊àÜŽ‘±‘–¬’“ü—Ö@‚Ì—Õ°¬Ñ‚ƈӋ`. ‹g“c@‹I, ¯–ìOŽ÷, Ž­Žæ³“¹, “‡“c@Œª, ŒÃ“cˆê“¿, ‚‹´@‹B, ²“¡ŒõŽj, Š`“c@Í (ŠO): ‘æ104‰ñ“ú–{ŠO‰ÈŠw‰ï (2004/5/12), ‘åã. “ú–{ŠO‰ÈŠw‰ïŽGŽ, 105: 213, 2004.

723266. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚錴”­«\“ñŽw’°Šà‚ÌŽ¡—Õûj‚ÌŒŸ“¢. ¯–ìOŽ÷, ‹g“c@‹I, Ž­Žæ³“¹, “‡“c@Œª, ŒÃ“cˆê“¿, ‚‹´@‹B, ²“¡ŒõŽj (ŠO): ‘æ104‰ñ“ú–{ŠO‰ÈŠw‰ï (2004/5/13), ‘åã. “ú–{ŠO‰ÈŠw‰ïŽGŽ, 105: 553, 2004.

723267. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹¹•”‘å“®–¬•a•Ï‚ð‡•¹‚·‚é• •”‘å“®–¬áŽ‚ɑ΂·‚铯ŽžŽèp. Ä“¡Œöˆê˜Y1, •½“cŒõ”Ž1, ¼Šª@”Ž2, “c‘ºK•ä1, ’¬ˆä³l3, ¬Œ´–M‹`3, “nç²¹•F1 (1ŠO. 2‹~–½. 3‹¹ŠO): ‘æ32‰ñ“ú–{ŒŒŠÇŠO‰ÈŠw‰ï‘‰ï (2004/5/14), “Œ‹ž.

723268. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰ºŽˆ[•”Ö¬ŒŒðǂɑ΂·‚éR‹ÃŒÅü—n—Ö@‚ÌŒŸ“¢. “c‘ºK•ä1, •½“cŒõ”Ž1, ¼Šª@”Ž2, Ä“¡Œöˆê˜Y1, ‹à鳉À3, “‡“c@Œª2, “nç²¹•F1 (1ŠO. 2‹~–½. 3Ó쓌•”‘‡•a‰@): ‘æ24‰ñ“ú–{Ö¬Šw‰ï (2004/6/3), ŽOdŒ§.

723269. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠÌ×–EŠà‚É‚¨‚¯‚éŠO‰È“IØœŒãÄ”­—á‚ɑ΂·‚鎡—Õû–@‚ÌŒŸ“¢. ŒÃ“cˆê“¿, ‚‹´@‹B, ”‹´_ˆê, ¯–ìOŽ÷, Ž­Žæ³“¹, “‡“c@Œª, ‹g“c@‹I, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ40‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2004/6/3), “Œ‹ž.

723270. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “«• …‚ɑ΂·‚é• o|Ö¬ƒVƒƒƒ“ƒgpÇ—á‚ÌŒŸ“¢. â–{—FŒ©Žq, ŒÃ“cˆê“¿, ‚‹´@‹B, ¯–ìOŽ÷, Ž­Žæ³“¹, ‹g“c@‹I, ²“¡ŒõŽj, “nç²¹•F, ‘呺FŽu (ŠO): ‘æ40‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2004/6/3), “Œ‹ž.

723271. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”DP, •ª•Ø‚ðŒoŒ±‚µ‚½’_“¹•Â½Ç6—á‚ÌŒŸ“¢. “c’†@Œ‰1, –{–¼•q˜Y2, •“c’B•v2, XìMs2, –k–ì—Ç”Ž2, Ÿº–{NŽj2, “c’†Œ\ˆê˜N2, 쓇Œ›Žq2, ’¬“ª¬˜Y2 (1ŠO. 2‘—§¬ˆçˆã—ÃZƒ“ƒ^[EŠO): ‘æ41‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï (2004/6/4), ‘åãŽs. “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ, 40 (3): 2004.

723272. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’_“¹•Â½Ç’·ŠúŒo‰ß—á‚Ì”DPEoŽY‚Ɗ̈ÚA‚Ì–ðŠ„. Ÿº–{NŽj1, –{–¼•q˜Y1, •“c’B•v1, “c’†@Œ‰2, XìMs1, –k–ì—Ç”Ž1, “c’†Œ\ˆê˜N1, 쓇Œ›Žq1, ’¬“ª¬˜Y1 (1‘—§¬ˆçˆã—ÃZƒ“ƒ^[EŠO. 2ŠO): ‘æ41‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï (2004/6/4), ‘åãŽs. “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ, 40 (3): 346, 2004.

723273. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Cholestasis may contribute to a high mortality of congenital diaphragmatic hernia. XìMs1, –{–¼•q˜Y1, •“c’B•v1, “c’†@Œ‰2, –k–ì—Ç”Ž1, Ÿº–{NŽj1, Satoshi Nakagawa1, Yasuyuki Suzuki1, Kenntaro Matsuoka1, Jun Miyachi1 (1‘—§¬ˆçˆã—ÃZƒ“ƒ^[. 2ŠO): ‘æ41‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï (2004/6/4), ‘åãŽs. “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ, 40 (3): 316, 2004.

723274. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) o¶‘Of’f‚É‚¨‚¯‚鬎™ŠO‰Èˆã‚Ì–ðŠ„: ‘—§¬ˆçˆã—ÃZƒ“ƒ^[‚ÌŒ»ó. –k–ì—Ç”Ž1, –{–¼•q˜Y1, •“c’B•v1, “c’†@Œ‰2, XìMs1, Ÿº–{NŽj1, “c’†Œ\ˆê˜N1, 쓇Œ›Žq1, ’¬“ª¬˜Y1, ¶‡Ž¡•F1 (1‘—§¬ˆçˆã—ÃZƒ“ƒ^[. 2ŠO): ‘æ41‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï (2004/6/5), ‘åãŽs.

723275. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) dÇSgáŠQŽ™‚ɑ΂·‚éˆÝH“°‹t—¬–hŽ~Žèp‚Ì“K‰ž, “Á‚É”N’·Ž™‚Ì‘Ïp«‚ɂ‚¢‚Ä‚ÌlŽ@. ’†Œ´‚³‚¨‚è1, Γc˜a•v1, •Ð“c‰Ä–ç1, Šâèr”V2, “nç²¹•F1 (1ŠO. 2Ž™): ‘æ41‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï (2004/6/5), ‘åãŽs. “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ, 40 (3): 506, 2004.

723276. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Cine MRI‚ð—p‚¢‚½Á‰»ŠÇ‰^“®‹@”\•]‰¿‚ÌŽŽ‚Ý. “c’†@Œ‰1, –{–¼•q˜Y2, •“c’B•v2, XìMs2, –k–ì—Ç”Ž2, Ÿº–{NŽj2, “c’†Œ\ˆê˜N2, 쓇Œ›Žq2, ’¬“ª¬˜Y2, ³–؉pˆê2 (1ŠO. 2‘—§¬ˆçˆã—ÃZƒ“ƒ^[), ‘æ41‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï (2004/6/5), ‘åãŽs. “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ, 40 (3): 465, 2004.

723277. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬ˆçˆã—Âɂ¨‚¯‚éƒLƒƒƒŠ[ƒI[ƒo[Š³ŽÒ‚ÌŠO‰È“If—Â̎À‘Ô. 쓇Œ›Žq1, –{–¼•q˜Y1, •“c’B•v1, “c’†@Œ‰2, XìMs1, –k–ì—Ç”Ž1, Ÿº–{NŽj1, “c’†Œ\ˆê˜N1, ’¬“ª¬˜Y1 (1‘—§¬ˆçˆã—ÃZƒ“ƒ^[. 2ŠO): ‘æ41‰ñ“ú–{¬Ž™‰ÈŠO‰ÈŠw‰ï (2004/6/5), ‘åãŽs. “ú–{¬Ž™‰ÈŠO‰ÈŠw‰ïŽGŽ, 40 (3): 448, 2004.

723278. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚éÁ‰»ŠÇˆÙ•¨‚ɑ΂·‚éf’f‚ÆŠO‰È“IŽ¡—Ã. ’¬“ª¬˜Y1, –{–¼•q˜Y1, •“c’B•v1, “c’†@Œ‰2, XìMs1, –k–ì—Ç”Ž1, Ÿº–{NŽj1, “c’†Œ\ˆê˜N1, 쓇Œ›Žq1 (1‘—§¬ˆçˆã—ÃZƒ“ƒ^[. 2ŠO): ‘æ41‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï (2004/6/5), ‘åãŽs. “ú–{ŠO‰ÈŠw‰ïŽGŽ, 40 (3): 451, 2004.

723279. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™ŠO‰È“I• •”Ž¾Š³‚Ìo¶‘OŒo‰ß‚ÆŽ¡—Ẩ”\«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. •“c’B•v1, –k–ì—Ç”Ž1, ¶‡Ž¡•F1, –{–¼•q˜Y1, “c’†@Œ‰2, XìMs1, Ÿº–{NŽj1, “c’†Œ\ˆê˜N1, 쓇Œ›Žq1, ’¬“ª¬˜Y1 (1‘—§¬ˆçˆã—ÃZƒ“ƒ^[. 2ŠO): “ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï (2004/6/5), ‘åãŽs. “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ, 40 (3): 469, 2004.

723280. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒpƒbƒ`–Dk‚µ‚½CDH6—á‚Æ’¼Ú–D‡‚µ‚½CDH4—á‚Æ‚Ì”äŠr. “c’†Œ\ˆê˜N1, –{–¼•q˜Y1, –k–ì—Ç”Ž1, •“c’B•v1, “c’†@Œ‰2, XìMs1, Ÿº–{NŽj1, 쓇Œ›Žq1, ’¬“ª¬˜Y1 (1‘—§¬ˆçˆã—ÃZƒ“ƒ^[. 2ŠO): “ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï (2004/6/5), ‘åãŽs. “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ, 40 (3): 476, 2004.

723281. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “ûŠà‰»Šw—Ö@Ž{sŠ³ŽÒ‚ɑ΂·‚éMulti-disciplinary care‚ÌŽŽ‚Ý. ‘ •À@Ÿ, ‰z“c‰À•ü, å΋I•F, —Ñ@‹žŽq, Γc˜a•v, ‰|–{‘ñ–Î (ŠO): ‘æ12‰ñ“ú–{“ûŠàŠw‰ï‘‰ï (2004/6/11), –k‹ãBŽs. ŒŸØ‚ÉŠî‚¢‚½ŽŸ‘ã‚Ö‚Ì“WŠJ, p.301, 2004.

723282. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚éRIEF‘f•¹—pƒZƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒp߶ŒŸ‚ÌŒŸ“¢. å΋I•F, ‰z“c‰À•ü, ‰|–{‘ñ–Î, Γc˜a•v, ‘ •À@Ÿ (ŠO): ‘æ12‰ñ“ú–{“ûŠàŠw‰ï‘‰ï (2004/6/11), –k‹ãBŽs. ŒŸØ‚ÉŠî‚¢‚½ŽŸ‘ã‚Ö‚Ì“WŠJ, p.217, 2004.

723283. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) WŠw“IŽ¡—Âɂæ‚èQOL‰ü‘P‚ª‚Í‚©‚ç‚ꂽstagelv—¼‘¤“ûŠà‚Ì1Ç—á. ”Ñ’Ë”ü, å΋I•F, ‰z“c‰À•ü, ‰|–{‘ñ–Î, Γc˜a•v, ‘ •À@Ÿ (ŠO): ‘æ12‰ñ“ú–{“ûŠàŠw‰ï‘‰ï (2004/6/12), –k‹ãBŽs. ŒŸØ‚ÉŠî‚¢‚½ŽŸ‘ã‚Ö‚Ì“WŠJ, p.299, 2004.

723284. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) H“¹ƒAƒJƒ‰ƒVƒA‚ɑ΂·‚éŠg’£p‚¨‚æ‚Ñ• o‹¾‰ºŽèp‚Ì’ZŠúŽ¡—ìт̔äŠrŒŸ“¢. •Ð“c‰Ä–ç, ÷–{Mˆê, ¬—ÑLs, “ñ“nM], •ŽRMˆê, ª–{—S‘¾, ‹e’rŽj˜Y, “ˆ”ö@m, “nç²¹•F (ŠO): ‘æ58‰ñ“ú–{H“¹Šw‰ï (2004/6/25), “Œ‹ž.

723285. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) •Gâ|“®–¬‰¼«áŽ‚ɑ΂µ‚ăoƒ‹[ƒ“•ÂljºŒo”ç“Iƒgƒƒ“ƒrƒ“’“üp‚ª—LŒø‚Å‚ ‚Á‚½ˆê—á. “c‘ºK•ä1, ¼Šª@”Ž2, •½“cŒõ”Ž1, Ä“¡Œöˆê˜Y1, “nç²¹•F1 (1ŠO. 2•ú): ‘æ10‰ñ“ú–{ŒŒŠÇ“àŽ¡—Êw‰ï (2004/6/29), ‘åãŽs.

723286. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ˆÝH“¹‹t—¬Ç‚ÌŽ¡—ÕûjŒˆ’è‚É‚¨‚¯‚éH“¹‹@”\ŒŸ¸‚Ìd—v«. •Ð“c‰Ä–ç1, ÷–{Mˆê1, ¬—ÑLs1, “ñ“nM]1, •ŽRMˆê1, ‹e’rŽj˜Y1, ²“¡•˜Y1, “nç²¹•F1, Hinder Ronald2 (1ŠO. 2Creighton University): ‘æ29‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ï (2004/7/2), “Œ‹ž. “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽGŽ, 29 (3): 484, 2004.

723287. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ‹~‹}ˆã—Â̕W€‰» i• •”j|’×ᇫ‘å’°‰Š‚ɑ΂·‚é‹Ù‹}Žèp‚ÌŽÀÛ. ²“¡•˜Y, š êK‹Ï, ‘å’J„³, ’†‘º—²r, ª–{ˆê•F, ˆäŒ´@Œú, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ29‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ï (2004/7/2), “Œ‹ž. “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽGŽ, 29 (3): 443, 2004.

723288. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) p‘O‚ÉŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚½ˆÝ‘Ìã•”Œã•ÇŒ´”­‚Ì‹‘åGIST‚̈êØœ—á. ’†‘º˜a“¿, ¯–ìOŽ÷, â–{—FŒ©Žq, Ž­Žæ³“¹, “‡“c@Œª, ŒÃ“cˆê“¿, ‚‹´@‹B, ‹g“c@‹I, ²“¡ŒõŽj (ŠO): ‘æ29‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ï (2004/7/2), “Œ‹ž. “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽGŽ, 29 (3): 562, 2004.

723289. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) stage 2‘å’°Šà‚É‚¨‚¯‚étumor budding‚Ì—\Œã‹K’èˆöŽq‚Æ‚µ‚Ä‚Ì—L—p«. ’†‘º—²r1, “nç²¹•F1, ŽO•xO”V2, ‘å’J„³1, ²“¡•˜Y1, ¬àV•½‘¾1, š êK‹Ï1, ª–{ˆê•F1, ˆäŒ´@Œú1 (1ŠO. 2‘—§‘Š–ÍŒ´•a‰@): ‘æ29‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ï (2004/7/2), “Œ‹ž. “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽGŽ, 29 (3): 563, 2004.

723290. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) “àŽ‹‹¾‰ºŽèp: What's proven, What's not: • o‹¾‰º‘å’°Žèp‚É‚¨‚¯‚éÅV‚Ì’mŒ©. š êK‹Ï, “nç²¹•F, ‘å’J„³, ²“¡•˜Y, ’†‘º—²r, ª–{ˆê•F, ˆäŒ´@Œú, ²“¡ŒõŽj (ŠO): ‘æ29‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ï (2004/7/2), “Œ‹ž. “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽGŽ, 29 (3): 495, 2004.

723291. [Šw‰ï (‘S‘)] (ƒrƒfƒI) Œoãè–å“I“àŽ‹‹¾‰ºƒ}ƒCƒNƒƒT[ƒWƒFƒŠ[ (TEM) ‚ÌŒoŒ±‚Æ‹Ø‘w‘¹‚ÌC•œ. ‘å’J„³, ²“¡•˜Y, ¬àV•½‘¾, ’†‘º—²r, ª–{ˆê•F, š êK‹Ï, ˆäŒ´@Œú, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ29‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ï (2004/7/3), “Œ‹ž. “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽGŽ, 29 (3): 546, 2004.

723292. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ˆÝŠàpŒã• –Œ”dŽíÇ—á‚ɑ΂·‚éŠO‰È“IŽ¡—Â̓K‰ž‚ÆŒÀŠE. •ŽRMˆê, ‹e’rŽj˜Y, ÷–{Mˆê, “ñ“nM], •Ð“c‰Ä–ç, ¬—ÑLs, “nç²¹•F (ŠO): ‘æ29‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ï (2004/7/3), “Œ‹ž. “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽGŽ, 29 (3): 528, 2004.

723293. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰æ‘œf’fupdate: ƒRƒ“ƒsƒ…[ƒ^[‰æ‘œ‰ðÍ‚ð—p‚¢‚½V‚µ‚¢Á‰»ŠÇŽîᇂÌf’f‚Æ‚»‚̈Ӌ`. ‹e’rŽj˜Y, –î–ì„Ži, •ŽRMˆê, •Ð“c‰Ä–ç, ÷–{Mˆê, ¬—ÑLs, “ˆ”ö@m, “nç²¹•F (ŠO): ‘æ29‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ï (2004/7/3), “Œ‹ž. “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽGŽ, 29 (3): 462, 2004.

723294. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒRƒ‰[ƒQƒ“‡¬“ÁˆÙ“IƒVƒƒƒyƒƒ“’`”’ (HSP47) ‚É‚æ‚éƒLƒ‹ƒXˆÝŠà•aó”cˆ¬‚̉”\«. •½ˆä˜a–í1, ‹e’rŽj˜Y1, ŒI“c@~1, “ñ“nM]1, •ŽRMˆê1, ª–{—S‘¾1, •Ð“c‰Ä–ç1, ÷–{Mˆê1, ¬—ÑLs1, “ˆ”ö@m1, ¼‰ª‘×O2, ‰i“c˜aG2 (1ŠO. 2‹ž“s‘å): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï (2004/7/21), Ž­Ž™“‡.

723295. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) pN1ˆÝŠàÇ—á‚É‚¨‚¯‚郊ƒ“ƒpß“]ˆÚŒ`Ž®‚ÌŒŸ“¢. •ŽRMˆê, ‹e’rŽj˜Y, •Ð“c‰Ä–ç, ÷–{Mˆê, ¬—ÑLs, “ˆ”ö@m, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï (2004/7/21), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 137 (7): 1081, 2004.

723296. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒXƒLƒ‹ƒXˆÝŠà”|—{ƒ‚ƒfƒ‹E‘gD‚É‚¨‚¯‚éƒRƒ‰[ƒQƒ“‡¬“ÁˆÙ“IƒVƒƒƒxƒƒ“ (HSP47) ‚Ì”­Œ». •½ˆä˜a–í, ‹e’rŽj˜Y, ŒI“c@~, •ŽRMˆê, ª–{—S‘¾, •Ð“c‰Ä–ç, ÷–{Mˆê, ¬—ÑLs, “ˆ”ö@m, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï (2004/7/21), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 137 (7): 1111, 2004.

723297. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) • o‹¾•â•‰ºˆÝØœp‚É‚¨‚¯‚éD1+ƒÀƒŠƒ“ƒpߊs´‚ÌŽ‹–ì“WŠJ‚ÌH•v. ÷–{Mˆê, ‹e’rŽj˜Y, •Ð“c‰Ä–ç, ª–{—S‘¾, •ŽRMˆê, ¬—ÑLs, “ˆ”ö@m, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï (2004/7/21), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 137 (7): 1134, 2004.

723298. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) —Õ°•a—Šw“IŒŸ“¢‚©‚ç‚Ý‚½äXIPMT‚ÌŽ¡—Õûj. Ž­Žæ³“¹, â–{—FŒ©Žq, ¯–ìOŽ÷, “‡“c@Œª, ŒÃ“cˆê“¿, ‚‹´@‹B, ‹g“c@‹I, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï (2004/7/21), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 137 (7): 1188, 2004.

723299. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚ɉ—‚¯‚é’_“¹ƒXƒeƒ“ƒg‚Ì“K‰ž‚ÆŽ¾Š³•Ê‚̃Xƒeƒ“ƒg‘I‘ð•ûj. ¯–ìOŽ÷, â–{—FŒ©Žq, Ž­Žæ³“¹, “‡“c@Œª, ŒÃ“cˆê“¿, ‚‹´@‹B, ‹g“c@‹I, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï (2004/7/21), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 137 (7): 1041, 2004.

723300. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) äX“ª\“ñŽw’°Øœ‚É‚¨‚¯‚éŠÈ’P‚ňÀ‘S‚ÈäXÁ‰»ŠÇ•«‡‚ÌH•v|äX‹ó’°–§’…•«‡p‚ÌŽè‹Z‚ƃRƒc|. â–{—FŒ©Žq, ¯–ìOŽ÷, Ž­Žæ³“¹, “‡“c@Œª, ŒÃ“cˆê“¿, ‚‹´@‹B, ‹g“c@‹I, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï (2004/7/22), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 137 (7): 1052, 2004.

723301. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠÌ×–EŠà‚ÌŠO‰È“IØœŒãÄ”­‚ÌŽ¡—Ö@‚ÌŒŸ“¢|’·Šú—\Œã‚ÌŒüã‚ð‚ß‚´‚µ‚Ä|. ŒÃ“cˆê“¿, ‚‹´@‹B, ”‹´_ˆê, ¯–ìOŽ÷, Ž­Žæ³“¹, ‚‹´’õl, “‡“c@Œª, ‹g“c@‹I, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï (2004/7/22), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 137 (7): 1272, 2004.

723302. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒƒ`ƒ‹Ž_ƒCƒ}ƒ`ƒjƒu‚ª‘tŒ÷‚µ‚½”dŽí«¬’°GIST‚Ì1—á. Žl‹{—mŽj, ŒÃ“cˆê“¿, ª–{—S‘¾, ‚‹´@‹B, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï (2004/7/22), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 137 (7): 1099, 2004.

723303. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ˆÀ‘S‚È• o‰º‘å’°Øœ‚̃Rƒc. š êK‹Ï, “nç²¹•F, ’†‘º—²r, ²“¡•˜Y, ª–{ˆê•F, ˆäŒ´@Œú, ‘å’J„³ (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï (2004/7/22), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 137 (7): 953, 2004.

723304. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘å’°Šà• –Œ”dŽíÇ—á‚É‚½‚¢‚·‚épŽ®‚ÌŒŸ“¢. ˆäŒ´@Œú, ‘å’J„³, ¬àV•½‘¾, ²“¡•˜Y, ’†‘º—²r, ª–{ˆê•F, š êK‹Ï, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï’èŠúŠwp‘‰ï (2004/7/22), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 37 (7): 505, 2004.

723305. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) • o‹¾‰º’¼’°’EŽèp‚ÌŒoŒ±. ª–{ˆê•F, š êK‹Ï, ’†‘º—²r, ²“¡•˜Y (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï’èŠúŠwp‘‰ï (2004/7/23), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 37 (7): 589, 2004.

723306. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) H“°ƒAƒJƒ‰ƒVƒA‚ɑ΂·‚é• o‹¾‰ºŽèp‚Ì’·ŠúŽ¡—ìÑ. •Ð“c‰Ä–ç, ÷–{Mˆê, ¬—ÑLs, ª–{—S‘¾, •ŽRMˆê, ‹e’rŽj˜Y, “ˆ”ö@m, ’†Œ´‚³‚¨‚è, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï’èŠúŠwp‘‰ï (2004/7/23), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 37 (7): 385, 2004.

723307. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚Ì‘å’°ŠàŠÌ“]ˆÚØœ—á‚ÌŒŸ“¢. ’†‘º—²r, ‘å’J„³, ²“¡•˜Y, ª–{ˆê•F, š êK‹Ï, ˆäŒ´@Œú, ¬àV•½‘¾, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï’èŠúŠwp‘‰ï (2004/7/23), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 37 (7): 389, 2004.

723308. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”S‰tŽY¶«äXŠÇ“à“û“ªŽîᇂɑ΂·‚é\“ñŽw’°‰·‘¶äX“ªØœp. ²“¡ŒõŽj, â–{—FŒ©Žq, ¯–ìOŽ÷, Ž­Žæ³“¹, ”‹´_ˆê, “‡“c@Œª, ŒÃ“cˆê“¿, ‚‹´@‹B, ‹g“c@‹I, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï’èŠúŠwp‘‰ï (2004/7/23), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 37 (7): 405, 2004.

723309 [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ’×ᇫ‘å’°‰Š‚ÌŽèp“K‰ž‚ÆŽèpƒ^ƒCƒ~ƒ“ƒO‚¨‚æ‚ÑpŽ®‚ÌŒŸ“¢. ‘å’J„³, ²“¡•˜Y, ¬àV•½‘¾, ’†‘º—²r, ª–{ˆê•F, š êK‹Ï, ˆäŒ´@Œú, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï (2004/7/23), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 137 (7): 965, 2004.

723310. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’_ŠÇ‰Š‚𕹔­‚µp‘O‚Éf’f¢“ï‚Å‚ ‚Á‚½ŠÌ“à’_ŠÇ‚Ì’˜–¾‚È”ŽìóŠg’£‚ð’悵‚½ Caroli •a‚̈ê—á. ‘å‹v•Û”Ž¢, ¯–ìOŽ÷, â–{—FŒ©Žq, Ž­Žæ³“¹, “‡“c@Œª, ŒÃ“cˆê“¿, ‚‹´@‹B, ‹g“c@‹I, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï (2004/7/23), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 137 (7): 1351, 2004.

723311. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) \“ñŽw’°“û“ª•”Šà‚ÌŠO‰ÈŽ¡—ìт©‚ç‚Ý‚½–â‘è“_‚ÆŽ¡—Â̂ ‚è•û. ‹g“c@‹I, â–{—FŒ©Žq, ¯–ìOŽ÷, Ž­Žæ³“¹, “‡“c@Œª, ŒÃ“cˆê“¿, ‚‹´@‹B, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï (2004/7/23), Ž­Ž™“‡. “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 137 (7): 1350, 2004.

723312. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒNƒ[ƒ“•apŒã•«‡•”Ä”­‚É‚¨‚¯‚錟“¢: Functional end to end anastmosis (FEE) ‚ÆŽè–D‚¢•«‡‚Ì”äŠr. ¬àV•½‘¾, ²“¡•˜Y, ’†‘º—²r, š êK‹Ï, ˆäŒ´@Œú, ‘å’J„³, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï (2004/10/13), ·‰ª.

723313. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’¼’°Šà‚ɑ΂·‚é• o‹¾‰º‘å’°Žèp‚Ì’mŒ©. š êK‹Ï, “nç²¹•F, ²“¡•˜Y, ¬àV•½‘¾, ’†‘º—²r, ª–{ˆê•F, ˆäŒ´@Œú, ‘å’J„³ (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï (2004/10/13), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65: 382, 2004.

723314. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –k—¢Ž®Needle Cap‚ð—p‚¢‚½H“¹|‹ó’°•«‡p‚É‚¨‚¯‚éV‚µ‚¢Á‰»ŠÇ•«‡–@|. ‹e’rŽj˜Y, •ŽRMˆê, ª–{—S‘¾, •Ð“c‰Ä–ç, ÷–{Mˆê, ¬—ÑLs, “ˆ”ö@m, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï (2004/10/13), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65: 357, 2004.

723315. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Ž¡—ìьüã‚ð–ÚŽw‚µ‚½i“W‚Æ—\Œã‚©‚ç‚Ý‚½is’_”XŠà‚ɑ΂·‚é“K³‚ÈpŽ®. ‹g“c@‹I, â–{—FŒ©Žq, ¯–ìOŽ÷, Ž­Žæ³“¹, ŒÃ“cˆê“¿, ‚‹´@‹B, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï (2004/10/13), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65: 343, 2004.

723316. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚éƒNƒŠƒjƒJƒ‹ƒpƒX‚ÌŒ»‹µ. ²“¡•˜Y, ‘å’J„³, ’†‘º—²r, š êK‹Ï, ˆäŒ´@Œú, ¬àV•½‘¾, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï (2004/10/13), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65: 326, 2004.

723317. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’_”XŠàpŒãÄ”­‚ɑ΂µWŠw“IŽ¡—Âðs‚¢’·Šú¶‘¶‚ª“¾‚ç‚ꂽ3Ç—á‚ÌŒŸ“¢. â–{—FŒ©Žq, ‹g“c@‹I, ¯–ìOŽ÷, Ž­Žæ³“¹, ŒÃ“cˆê“¿, ‚‹´@‹B, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï (2004/10/13), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65: 617, 2004.

723318. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚ÅŒoŒ±‚µ‚½¶ãüŒðâ|•›“ûŠà‚̈ê—á. –k‘º^Ž÷, å΋I•F, ”¼“cŠì”ü–ç, —Ñ@‹žŽq, ‰|–{‘ñ–Î, ‘ •À@Ÿ, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï (2004/10/14), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65: 756, 2004.

723319. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) • o‹¾‰º‚ÉØœ‚µ“¾‚½‰¡sŒ‹’°“®Ã–¬ŠïŒ`‚̈ê—á. “›ˆä“ÖŽq, ’†‘º—²r, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï (2004/10/14), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65: 501, 2004.

723320. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) H“¹Šà‚Æ‘¼‘ŸŠíd•¡ŠàÇ—á‚ÌŒŸ“¢. “ñ“nM], ¬—ÑLs, •Ð“c‰Ä–ç, •ŽRMˆê, ÷–{Mˆê, ‹e’rŽj˜Y, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï (2004/10/14), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65: 476, 2004.

723321. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Žîᇫ‘å’°‰Š‚ɑ΂·‚é• o‹¾‰ºŽèp. ‘å’J„³, ª–{ˆê•F, ’†‘º—²r, ²“¡•˜Y, ¬àV•½‘¾, š êK‹Ï, ˆäŒ´@Œú, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï (2004/10/14), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65: 231, 2004.

723322. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Crohn•apŒã•«‡•”Ä”­‚É‚¨‚¯‚錟“¢: Functional end-to-end anastmosis (FEE) ‚ÆŽè–D‚¢•«‡‚Æ‚Ì”äŠr. ¬àV•½‘¾, ²“¡•˜Y, ’†‘º—²r, š êK‹Ï, ˆäŒ´@Œú, ‘å’J„³, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï (2004/10/14), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65: 497, 2004.

723323. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) H“¹Šà‚Æ‘¼‘ŸŠíd•¡ŠàÇ—á‚ÌŒŸ“¢. “ñ“nM], ¬—ÑLs, •Ð“c‰Ä–ç, •ŽRMˆê, ÷–{Mˆê, ‹e’rŽj˜Y, “nç²¹•F (ŠO): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï (2004/10/14), ·‰ª. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65: 476, 2004.

723324. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘¥•ÐƒŠƒ“ƒpߊs´‚̈Ӌ`‚Æ‚»‚Ì–â‘è“_. ˆäŒ´@Œú, ’†‘º—²r, ¬àV•½‘¾, ²“¡•˜Y, ª–{ˆê•F, š êK‹Ï, ‘å’J„³, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï (2004/10/14), •Ÿ‰ª. “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ, 57 (9): 566, 2004.

723325. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) p‘Of’f‚É“ïa‚µ‚½ŠÇŠO”­ˆçŒ^\“ñŽw’°GIST‚Ì2Øœ—á. ¯–ìOŽ÷, â–{—FŒ©Žq, Ž­Žæ³“¹, “‡“c@Œª, ŒÃ“cˆê“¿, ‚‹´@‹B, ‹g“c@‹I, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ46‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (2004/10/22), •Ÿ‰ª.

723326. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’_ŠÇ‰Š‚𕹔­‚µp‘O‚Éf’f¢“ï‚Å‚ ‚Á‚½ŠÌ“à’_ŠÇ‚Ì’˜–¾‚È”ŽìóŠg’£‚ð’悵‚½ Caroli•a‚̈ê—á. â–{—FŒ©Žq, ¯–ìOŽ÷, Ž­Žæ³“¹, “‡“c@Œª, ŒÃ“cˆê“¿, ‚‹´@‹B, ‹g“c@‹I, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ46‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (2004/10/22), •Ÿ‰ª.

723327. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) DukesaB‘å’°Šà‚É‚¨‚¯‚é—\Œã‹K’èˆöŽq‚Æ‚µ‚Ä‚Ìtumor budding‚Ì—L—p«. ’†‘º—²r1, “nç²¹•F1, ŽO•yO”V2, ‘å’J„³1, š êK‹Ï1, ²“¡•˜Y1, ¬àV•½‘¾1, ª–{ˆê•F1, ˆäŒ´@Œú1 (1ŠO. 2‘—§‘Š–ÍŒ´•a‰@): ‘æ68‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (2004/10/22), •Ÿ‰ª.

723328. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒRƒ“ƒsƒ…[ƒ^[ƒOƒ‰ƒtƒBƒbƒNƒX‚ð—p‚¢‚½isˆÝŠà‚ÉŽOŽŸŒ³—§‘Ì\’z‚ÆŽîᇑÌÏ’lŒv‘ª‚̈Ӌ`. ‹e’rŽj˜Y, –î–ì„Ži, •ŽRMˆê, •Ð“c‰Ä–ç, ÷–{Mˆê, ¬—ÑLs, “nç²¹•F (ŠO): ‘æ46‰ñ“ú–{Á‰»Ší•aŠw‰ï (2004/10/22), •Ÿ‰ª. “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 101: 724, 2004.

723329. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒRƒ‰[ƒQƒ“ƒQƒ‹”|—{–@‚ð—p‚¢‚½ƒXƒLƒ‹ƒXˆÝŠàˆÚAƒ‚ƒfƒ‹‚ÌŠJ”­‚ɂ‚¢‚Ä. •½ˆä˜a–í1, ‹e’rŽj˜Y1, ŒI“c@~1, ˆÀ’B‰hŽ¡˜Y2, “nç²¹•F1 (1ŠO. 2ˆã—ÃŒnŒ¤‹†‰È): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/27), ‹ž“s.

723330. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒRƒ‰[ƒQƒ“‡¬“ÁˆÙ“IƒVƒƒƒyƒƒ“’`”’ (HSP47) ‚É‚æ‚éƒXƒLƒ‹ƒXˆÝŠà•aó”cˆ¬‚̉”\«. •½ˆä˜a–í, ‹e’rŽj˜Y, ŒI“c@~, “ñ“nM], •ŽRMˆê, •Ð“c‰Ä–ç, ÷–{Mˆê, ¬—ÑLs, “nç²¹•F (ŠO): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/28), ‹ž“s.

723331. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰E‘¤Œ‹’°Šà‚ɑ΂·‚é• o‹¾•â•‰ºŽèp‚ÌH•v. š êK‹Ï, ²“¡•˜Y, ¬àV•½‘¾, ’†‘º—²r, ˆäŒ´@Œú, ‘å’J„³, “nç²¹•F (ŠO): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/28), ‹ž“s.

723332. [Šw‰ï (‘S‘] (ƒ|ƒXƒ^[) • o‹¾‰º• ‰ï‰AŽ®’¼’°Øœp (Lac-APR) ‚ÌH•v. ²“¡•˜Y, š êK‹Ï, ‘å’J„³, ¬àV•½‘¾, ’†‘º—²r, ˆäŒ´@Œú, “nç²¹•F (ŠO): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/29), ‹ž“s.

723333. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ŠÉ˜aƒPƒAƒ`[ƒ€‚ÌŒ»ó‚Æ¡Œã‚Ì•ûŒü«: Z‘îƒzƒXƒsƒXŽÀŽ{‚ÉŒü‚¯‚½“–‰@‚ÌŒ»‹µ. ‘å’J„³, ²“¡•˜Y, ¬àV•½‘¾, ’†‘º—²r, š êK‹Ï, ˆäŒ´@Œú, “nç²¹•F (ŠO): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/29), ‹ž“s.

723334. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) DukesC‘å’°ŠàŠ³ŽÒ‚É‚¨‚¯‚郊ƒ“ƒpß“]ˆÚŒ`Ž®‚Æ—\Œã‚Æ‚ÌŠÖŒW. ’†‘º—²r, “nç²¹•F, ‘å’J„³, ˆäŒ´@Œú, š êK‹Ï, ²“¡•˜Y, ¬àV•½‘¾ (ŠO): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/29), ‹ž“s.

723335. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) is‘å’°ŠàStage4Ç—á‚Ì—\ŒãˆöŽq‚ÆŽ¡—Ã. ²“¡•˜Y, ¬àV•½‘¾, ’†‘º—²r, š êK‹Ï, ˆäŒ´@Œú, ‘å’J„³, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï (2004/11/5), •Ÿ‰ª. “ú–{‘å’°ãè–å•aŠw‰ïŽ, 57 (9): 619, 2004.

723336. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘¤•ûƒŠƒ“ƒpߊs´‚̈Ӌ`‚Æ‚»‚Ì–â‘è“_. ˆäŒ´@Œú, ’†‘º—²r, ¬àV•½‘¾, ²“¡•˜Y, ª–{ˆê•F, š êK‹Ï, ‘å’J„³, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï (2004/11/5), •Ÿ‰ª. “ú–{‘å’°ãè–å•aŠw‰ïŽ, 57 (9): 566, 2004.

723337. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Crohn•apŒã•«‡•”Ä”­‚É‚¨‚¯‚錟“¢: Functional end to end anastmosis (FEE) ‚ÆŽè–D‚¢•«‡‚Æ‚Ì”äŠr. ¬àV•½‘¾, ²“¡•˜Y, ’†‘º—²r, š êK‹Ï, ˆäŒ´@Œú, ‘å’J„³, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï (2004/11/5), •Ÿ‰ª. “ú–{‘å’°ãè–å•aŠw‰ïŽ, 57 (9): 556, 2004.

723338. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’×ᇫ‘å’°‰Š‚ɑ΂·‚é• o‹¾‰ºŽèp‚Ì“K‰ž‚ÆpŽ®. ‘å’J„³, ²“¡•˜Y, ¬àV•½‘¾, “›ˆä“ÖŽq, ’†‘º—²r, ª–{ˆê•F, š êK‹Ï, ˆäŒ´@Œú, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï (2004/11/5), •Ÿ‰ª. “ú–{‘å’°ãè–å•aŠw‰ïŽ, 57 (9): 715, 2004.

723339. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) • o‹¾‰º‘å’°Øœ‚ðˆÀ‘S‚ÉŽ{s‚·‚邽‚ß‚ÌH•v. š êK‹Ï, “nç²¹•F, ²“¡•˜Y, ¬àV•½‘¾, ’†‘º—²r, ª–{ˆê•F, ˆäŒ´@Œú, ‘å’J„³ (ŠO): ‘æ59‰ñ“ú–{‘å’°ãè–å•aŠw‰ï (2004/11/5), •Ÿ‰ª. “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ, 57 (9): 532, 2004.

723340. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œo‰ß’†‰¡sŒ‹’°‹·ó‚ð‚«‚½‚µ‚½’×ᇫ‘å’°‰Š‚Ì1—á. “›ˆä“ÖŽq, ²“¡•˜Y, ˆÀ•””üŠ°, ¬àV•½‘¾, ’†‘º—²r, š êK‹Ï, ˆäŒ´@Œú, ‘å’J„³, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{‘å’°ãè–å•aŠw‰ï (2004/11/6), •Ÿ‰ª. “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ, 57 (9): 796, 2004.

723341. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒNƒ[ƒ“•a‚É‚æ‚é—H–å—ÖE‘½”­“«‹·ó‚ɑ΂µ‚Ä• o‹¾‰ºŽèp‚ðŽ{s‚µ“¾‚½1—á. ¬‘q’¼l, ²“¡•˜Y, ¬àV•½‘¾, ’†‘º—²r, ª–{ˆê•F, š êK‹Ï, ˆäŒ´@Œú, ‘å’J„³, “nç²¹•F (ŠO): ‘æ59‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï (2004/11/6), •Ÿ‰ª. “ú–{‘å’°ãè–å•aŠw‰ïŽ, 57 (9): 792, 2004.

723342. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ‘å’°Šà‚ɑ΂·‚é• o‹¾Žèp‚Ì“K‰ž‚ƃsƒbƒgƒz[ƒ‹°: • o‹¾‰º‘å’°Øœ‚ðˆÀ‘S‚ÉŽ{s‚·‚邽‚ß‚ÌH•v. š êK‹Ï, “nç²¹•F, ²“¡•˜Y, ¬àV•½‘¾, ’†‘º—²r, ª–{ˆê•F, ˆäŒ´@Œú, ‘å’J„³ (ŠO): ‘æ58‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï (2004/11/6), •Ÿ‰ª. “ú–{‘å’°ãè–å•aŠw‰ïŽ, 57 (9): 715, 2004.

723343. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹}«’_”X‰Š‚ɑ΂·‚éŒo”çŒoŠÌ’_”XúŽh‹zˆø–@‚Ì—L—p«. ‰HœAŒ’m1, ²“¡ˆêŠì, ”Ñ–ì‘Pˆê˜N (1ŠOE’†ð’†‰›•a‰@ŠO‰ÈoŒü’†): ‘æ17‰ñ“ú–{ŠO‰ÈŠ´õÇŠw‰ï (2004/11/18), VŠƒ.

723344. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒ‰ƒbƒg‹t—¬«H“¹‰Šƒ‚ƒfƒ‹‚É‚¨‚¯‚éH“¹ã”ç‚ÌŒ`‘ÔŠw“I•Ï‰»|ˆÝ‰t‹y‚Ñ\“ñŽw’°‰t‹t—¬‚Ì”äŠr|. a’JŽ ˜Y1, •Ð“c‰Ä–ç1, “nç²¹•F1, ‰ªˆÀ@ŒM2 (1ŠO. 2•a—): ‘æ32‰ñ“ú–{ŽÀŒ±’×ᇊw‰ï (2004/11/20), ‘å’Ã.

723345. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) _Œo‰èŽíStagelV-AŽ¡—ÃŒã‚É”­•a˜Ro«ˆÝ’°Ç‚̈ê—á. “c’†@Œ‰1,2, ’†–ì”ü˜aŽq3, •“c’B•v2, –{–¼•q˜Y2, XìMs2, –k–ì—Ç”Ž2, Ÿº–{NŽj2, Ž›˜e@Š²2, “c’†Œ\ˆê˜N2, 쓇Œ›Žq2, ’¬“ª¬˜Y2 (1ŠO. 2‘—§¬ˆçˆã—ÃZƒ“ƒ^[ŠO‰È. 3‚³‚¢‚½‚ÜŽs—§•a‰@¬Ž™ŠO‰È): ‘æ20‰ñ“ú–{¬Ž™‚ª‚ñŠw‰ï (2004/11/22), ‹ž“s. ¬Ž™‚ª‚ñ, 41 (3): 684, 2004.

723346. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ˆÝŠà‚ɑ΂·‚é• o‹¾•â•‰ºˆÝ‘S“Ep‚̬Ñ. ÷–{Mˆê, ‹e’rŽj˜Y, •ŽRMˆê, “ñ“nM], •Ð“c‰Ä–ç, ¬—ÑLs, “ˆ”ö@m, “nç²¹•F (ŠO): ‘æ17‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï (2004/11/24), ‰¡•l. “ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ïŽGŽ, 9 (7): 225, 2004.

723347. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) • o‹¾•â•‰º’¼’°Ø’fp‚ÌŒ»‹µ. ²“¡•˜Y, š êK‹Ï, ‘å’J„³, ’†‘º—²r, ¬àV•½‘¾, ˆäŒ´@Œú, “nç²¹•F (ŠO): ‘æ17‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï (2004/11/26), ‰¡•l. “ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ïŽGŽ, 9 (7): 351, 2004.

723348. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œoãè–å“I“àŽ‹‹¾‰ºƒ}ƒCƒNƒƒT[ƒWƒFƒŠ[ (TEM) ‚ÌŒoŒ±. ‘å’J„³, ²“¡•˜Y, ¬àV•½‘¾, ’†‘º—²r, ª–{ˆê•F, š êK‹Ï, ˆäŒ´@Œú, “nç²¹•F (ŠO): ‘æ17‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï (2004/11/26), ‰¡•l. “ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ïŽGŽ, 9 (7): 352, 2004.

723349. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™‚̈ÝH“¹‹t—¬Ç‚ɑ΂·‚é‹t—¬–hŽ~Žèp‚ÌŽèp¬Ñ‚Æ–â‘è“_. •Ð“c‰Ä–ç, ’†Œ´‚³‚¨‚è, “c’†@Œ‰, ÷–{Mˆê, ¬—ÑLs, “ñ“nM], •ŽRMˆê, ‹e’rŽj˜Y, “nç²¹•F (ŠO): ‘æ17‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï (2004/11/26), ‰¡•l. “ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ïŽGŽ, 9 (7): 361, 2004.

723350. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) • o‹¾‚ª—L—p‚Å‚ ‚Á‚½¬’°oŒŒ‚Ì1—á. ’†‘º—²r1, š êK‹Ï1, ŽO•xO”V2, ²“¡•˜Y1, ¬àV•½‘¾1, ˆäŒ´@Œú1, ‘å’J„³1, “nç²¹•F1 (1ŠO. 2‘—§‘Š–ÍŒ´•a‰@): ‘æ17‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï (2004/11/26), ‰¡•l. “ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ïŽGŽ, 9 (7): 374, 2004.

723351. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒCƒ“ƒXƒŠƒm[ƒ}‚ɑ΂·‚é• o‹¾‰ºäX”ö•”Øœp‚Ì1—á. ¯–ìOŽ÷, ŒÃ“cˆê“¿, â–{—FŒ©Žq, Ž­Žæ³“¹, ‚‹´@‹B, ‹g“c@‹I, “nç²¹•F (ŠO): ‘æ17‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï (2004/11/26), ‰¡•l. “ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ïŽGŽ, 9 (7): 394, 2004.

723352. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒNƒ[ƒ“•a‚ɑ΂·‚é• o‹¾Žèp‚ÌŒŸ“¢. ¬àV•½‘¾, ²“¡•˜Y, ’†‘º—²r, ª–{ˆê•F, š êK‹Ï, ˆäŒ´ Œú, ‘å’J„³, “nç²¹•F (ŠO): ‘æ17‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï (2004/11/26), ‰¡•l. “ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ïŽGŽ, 9 (7): 347, 2004.

723353. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) • o‹¾‰º• ‰ï‰AŽ®’¼’°Ø’fp (Lac-APR) ‚ÌŒ»‹µ. ²“¡•˜Y, š êK‹Ï, ‘å’J„³, ’†‘º—²r, ¬àV•½‘¾, ˆäŒ´@Œú (ŠO): ‘æ17‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï (2004/11/26), ‰¡•l. “ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ïŽGŽ, 9 (7): 114, 2004.

723354. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰¡sŒ‹’°úE‚ð‚«‚½‚µ‚½¬lMorgagniEƒwƒ‹ƒjƒA‚Ì1—á. ã–쑈ê˜Y1, ‹{“à–MG, ’†ŒF‘¸Žm1, •½–ì@i1, ŒI“c@~1, ‰Y“‡‘¾˜Y, ‘O“cƒˆê (1ŠO): ‘æ41‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2005/3/11), –¼ŒÃ‰®.

731047. [Œ¤‹†‰ï] (“Á•Êu‰‰) CPT-11 (Irinotecan hydrochloride); Development and current status. “nç²¹•F (ŠO): Update on Colorectal Cancer Surgery (2004/4/16), “Œ‹ž.

731048. [Œ¤‹†‰ï] (“Á•Êu‰‰) ’°Ž¾Š³‚ɑ΂·‚é“àŽ‹‹¾ŠO‰È‚Ìi•à. “nç²¹•F (ŠO): ‰¡{‰êŠO‰Èˆã‰ïu‰‰‰ï (2004/5/19), ‰¡{‰ê.

731049. [Šw‰ï (’n•û)] (“Á•Êu‰‰) • o‹¾‰º‘å’°Øœ‚ÌŽÀÛ. “nç²¹•F (ŠO): ‘æ175‰ñ‹ß‹EŠO‰ÈŠw‰ï (‘æ12‰ñ“ú–{ŠO‰ÈŠw‰ï¶ŠU‹³ˆçƒZƒ~ƒi[) (2004/5/22), ‘åã.

731050. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‘å’°ŠàŽ¡—ÂÌÅ‘Oü. “nç²¹•F (ŠO): ‘Š–ÍŒ´ˆÝ‚Æ’°Œ¤‹†‰ï (2004/7/28), ‘Š–ÍŒ´.

731051. [Œ¤‹†‰ï] (“Á•Êu‰‰) ˆÝH“¹‹t—¬Ç‚Ì•a‘Ô‚ÆŽ¡—Ã. •Ð“c‰Ä–ç (ŠO): ‘æ81‰ñ‘Š–ÍŒ´ˆÝ‚Æ’°Œ¤‹†‰ï, ƒ~ƒjƒŒƒNƒ`ƒƒ[ (2004/11/24), ‘Š–ÍŒ´.

731052. [Œ¤‹†‰ï] (“Á•Êu‰‰) ƒqƒg‚É—D‚µ‚¢‘å’°Šà‚ÌV‚µ‚¢ŠO‰ÈŽ¡—Ã|“àŽ‹‹¾ŠO‰È‚Ìi•à|. “nç²¹•F (ŠO): Žs–¯ŒöŠJuÀE“àŽ‹‹¾Žèp‹îƒ–ªƒTƒ}[ƒZƒ~ƒi[ (2004/8), ’·–ì.

731053. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‘å’°ŠàŽ¡—ÂÌÅ‘Oü. “nç²¹•F (ŠO): ‘æ24‰ñL“‡ŽîᇊO‰ÈŒ¤‹†‰ï (2004/9/18), L“‡.

731054. [‚»‚Ì‘¼] (“Á•Êu‰‰) CPT-11 (ƒJƒ“ƒvƒg’) ‚Ì•Ï‘J‚Æ“W–]: ‘å’°Šà‰ÈŠw—Ö@‚Ìi•à‚ÆCPT-11. “nç²¹•F (ŠO): CPT-11”­”„10Žü”N‹L”Ou‰‰‰ï (2004/10/2), “Œ‹ž.

731055. [Œ¤‹†‰ï] (“Á•Êu‰‰) ’°Ž¾Š³‚ɑ΂·‚é“àŽ‹‹¾ŠO‰È‚Ìi•à. “nç²¹•F (ŠO): ‘æ6‰ñ–k‹ãB‚ª‚ñƒZƒ~ƒi[ (2004/11/2), ¬‘q.

731056. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‚ª‚ñŽ¡—Â̬ьüã‚Ì‚½‚ß‚É: ‘å’°Šà‚ÌV‚µ‚¢Ž¡—ÑI‘ð. “nç²¹•F (ŠO): ‘æ5‰ñTochigi Surgical Oncology Meeting (2004/11/16), ‰F“s‹{.

731057. [Œ¤‹†‰ï] (“Á•Êu‰‰) Š³ŽÒ‚É—D‚µ‚¢‘å’°Šà‚ÌŠO‰ÈŽ¡—Ã|“àŽ‹‹¾ŠO‰È‚Ìi•à|. “nç²¹•F (ŠO): ’¬“cˆãŽt‰ï (2004/12/7), ‰¡•l.

731058. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‘å’°Šà‚ɑ΂·‚éV‚µ‚¢Ž¡—à |“àŽ‹‹¾ŠO‰È‚Ìi•à|. “nç²¹•F (ŠO): ’†‰›‹æˆãŽt‰ïu‰‰‰ï (2005/1/14), “Œ‹ž.

731059. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‘å’°Šà‚ɑ΂·‚éV‚µ‚¢Ž¡—à |“àŽ‹‹¾ŠO‰È‚Ìi•à|. “nç²¹•F (ŠO): ‘½–€‚ª‚ñŒ¤‹†‰ï (2005/2/18), “Œ‹ž.

731060. [Œ¤‹†‰ï] (“Á•Êu‰‰) ’°Ž¾Š³‚ɑ΂·‚é“àŽ‹‹¾ŠO‰È‚Ìi•à. “nç²¹•F (ŠO): ç—t‘å’°Ž¾Š³Œ¤‹†‰ï‘æ1‰ñŠwpu‰‰‰ï (ç—tŒ§ˆãŽt‰ï¶ŠU‹³ˆç”F’èuÀ) (2005/3/26), ç—t.

732032. [Œ¤‹†‰ï] (µ‘Òu‰‰) ‘å’°ŠàŽ¡—Â̑I‘ð|¡, ‰½‚ð‚È‚·‚ׂ«‚©|. “nç²¹•F (ŠO): ‘æ61‰ñ‘å’°ŠàŒ¤‹†‰ï (2004/7/9), VŠƒ.

733118. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Œo”ç“Iƒ‰ƒWƒI”g”M‹ÃŒÅ—Ö@‚ÌŒ»‹µ‚Æ“K‰žŠg‘å|Žîᇌa•Ê‹ÇŠÄ”­—¦‚ÆReal-time Virtual Sonography‚̉ž—p|. š •ª–ΔŽ1, ¬–ìO“ñ1, ’†‘ò‹MG1, “ú‚@‰›1, ‹g“c@‹I2, ”‹´_ˆê2, Ž­Žæ³“¹2, ¯–ìOŽ÷2, ŒÃ“cˆê“¿2, “nç²¹•F2 (1“à‡T. 2ŠO): ‘æ33‰ñ_“Þ쌧Á‰»ŠíŠO‰ÈŒ¤‹†‰ï (2004/4/17), ‰¡•l.

733119. [Œ¤‹†‰ï] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚éŠÌ×–EŠà‚ÌŠO‰ÈŽ¡—Â̌»ó‚Æ“WŠJ. ŒÃ“cˆê“¿, ‹g“c@‹I, ¯–ìOŽ÷, Ž­Žæ³“¹, ‚‹´@‹B, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ33‰ñ_“Þ쌧Á‰»ŠíŠO‰ÈŒ¤‹†‰ï (2004/4/17), ‰¡•l.

733120. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŠÌŽîᇂɑ΂·‚é• o‹¾‰ºƒ‰ƒWƒI”g”M‹ÃŒÅ—Ö@ (RFA) ‚ÌŽè‹Z‚Æ–â‘è“_. ”‹´_ˆê1, š •ª–ΔŽ2, ¬–ìO“ñ2, “ú‚@‰›2, ¼Œ³Ž›ŽâX2, ‹g“c@‹I1, “nç²¹•F1 (1ŠO. 2“à‡T): ‘æ33‰ñ_“Þ쌧Á‰»ŠíŠO‰ÈŒ¤‹†‰ï (2004/4/17), ‰¡•l.

733121. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Œoãè–å“G“àŽ‹‹¾‰ºƒ}ƒCƒNƒƒT[ƒWƒFƒŠ[ (TEM) ‚ÌŒoŒ±‚Æ‹Ø‘w‘¹‚ÌC•œ. ‘å’J„³, ²“¡•˜Y, ¬àV•½‘¾, ’†‘º—²r, ª–{ˆê•F, š êK‹Ï, ˆäŒ´@Œú, ²“¡ŒõŽj, “nç²¹•F (ŠO): ‘æ10‰ñ_“Þì‘å’°ãè–åŽèpŽè‹ZŒ¤‹†‰ï (2004/5), _“Þì.

733122. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‹t—¬«H“¹‰Š‚ɑ΂·‚é• o‹¾‰ºŽèp|H“¹‹@”\ŒŸ¸‚É‚æ‚é•]‰¿|. •Ð“c‰Ä–ç, ÷–{Mˆê, ¬—ÑLs, “ñ“nM], •ŽRMˆê, ‹e’rŽj˜Y, “ˆ”ö@m, “nç²¹•F (ŠO): ‘æ78‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (2004/6/11), “Œ‹ž.

733123. [Œ¤‹†‰ï] (ˆê”Êu‰‰) H“¹”S–Œ‰ºŽîᇂÆf’f‚³‚ꂽ“ûŠà‹¹–Œ”dŽí‚Ì1—á. “ñ“nM]1, ¬—ÑLs1, •Ð“c‰Ä–ç1, “›ˆä“ÖŽq1, Œ´@‰p‘¥2, å΋I•F1, “nç²¹•F1 (1ŠO. 2‹¹ŠO): ‘æ793‰ñŠO‰ÈW’k‰ï (2004/6/12), ‰¡•l. “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65 (10): 252, 2004.

733124. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ’´’áˆÊ‘O•ûØœ‚Ì“K‰ž‚Ì–â‘è“_. ²“¡•˜Y, ‘å’J„³, ’†‘º—²r, ¬àV•½‘¾, š êK‹Ï, ˆäŒ´ Œú, “nç²¹•F (ŠO): ‘æ61‰ñ‘å’°ŠàŒ¤‹†‰ï (2004/7/9), VŠƒ.

733125. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ã•”ˆÝŠà‚ÌÄŒšp: •¬–呤؜, H“¹ŽcˆÝ•«‡p. “ñ“nM], ‹e’rŽj˜Y, •ŽRMˆê, •Ð“c‰Ä–ç, ÷–{Mˆê, ¬—ÑLs, “nç²¹•F (ŠO): ‘æ26‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï (2004/7/10), ‰¡•l.

733126. [Œ¤‹†‰ï] (ˆê”Êu‰‰) • o‹¾‰ºŽèp‚ðs‚Á‚½ MirizziÇŒóŒQ‚ƈÝGIST‚Ì1—á. Šâ–{Š°l, ÷–{Mˆê, •ŽRMˆê, ×’J@’q, ¬ì‹±Žj, “ñ“nM], •Ð“c‰Ä–ç, ‹e’rŽj˜Y, ¬—ÑLs, “nç²¹•F (ŠO): “ú–{—Õ°ŠO‰ÈˆãŠw‰ïW’k‰ï (2004/9/4), ‰¡•l.

733127. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Œ‹’°E’¼’°Žèp‚ÌŒoŒûÛŽæ‚ƃNƒŠƒjƒJƒ‹ƒpƒX (CP) ‚Ì“±“ü. ¬àV•½‘¾, ²“¡•˜Y, ’†‘º—²r, š êK‹Ï, ˆäŒ´@Œú, ‘å’J„³, “nç²¹•F (ŠO): _“Þì—Õ°ŠO‰È‘ãŽÓ‰h—{Œ¤‹†‰ï (2004/9/22), ‰¡•l.

733128. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒXƒLƒ‹ƒXˆÝŠàƒ‚ƒfƒ‹‚¨‚æ‚ÑŠ³ŽÒ‘gD‚É‚¨‚¯‚éƒRƒ‰[ƒQƒ““ÁˆÙ“I•ªŽqƒVƒƒƒyƒƒ“ HSP47‚Ì”­Œ». •½ˆä˜a–í1, ‹e’rŽj˜Y1, ŒI“c@~1, ˆÀ’B‰hŽ¡˜Y2, ¼‰ª‘×O3, ‰i“c˜aG3, “nç²¹•F1 (1ŠO. 2ˆã—ÃŒnŒ¤‹†‰È. 3‹ž“s‘å): ‘æ24‰ñ“ú–{•ªŽqŽîᇃ}[ƒJ[Œ¤‹†‰ï (2004/9/27), •Ÿ‰ª.

733129. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‘ŠúˆÝŠà‚ɑ΂·‚é• o‹¾•â•‰ºˆÝ‘S“Ep‚ÌŒoŒ±. ÷–{Mˆê, ‹e’rŽj˜Y, •ŽRMˆê, “ñ“nM], •Ð“c‰Ä–ç, ¬—ÑLs, “ˆ”ö@m, “nç²¹•F (ŠO): DDW-JAPAN (2004/10/23), •Ÿ‰ª.

733130. [Œ¤‹†‰ï] (ˆê”Êu‰‰) –À‘–_Œo‰·‘¶• o‹¾•â•‰º—H–呤ˆÝØœp‚ÌŽè‹Z‚ƬÑ. ÷–{Mˆê, ‹e’rŽj˜Y, •ŽRMˆê, “ñ“nM], •Ð“c‰Ä–ç, ¬—ÑLs, “ˆ”ö@m, “nç²¹•F (ŠO): ‘æ6‰ñŠÖ“Œ• o‹¾‰ºˆÝØœŒ¤‹†‰ï (2004/11/6), “Œ‹ž.

733131. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Ý‘î’†SÖ¬‰h—{ŠÇ—’†‚ɃJƒe[ƒeƒ‹Ž‘±Š´õ‚É‹Nˆö‚·‚é‚ÆŽv‚í‚ê‚ét‰Š‚ð”­Ç‚µ‚½1—á. “c’†@Œ‰1,2, –{–¼r˜Y2, •“c’B•v2, XìMs2, –k–ì—Ç”Ž2, Ÿº–{NŽj2, Ž›˜e@Š²2, “c’†Œ\ˆê˜N2, 쓇Œ›Žq2, ’¬“ª¬˜Y, ”Ñ“‡ˆê½2 (1ŠO. 2‘—§¬ˆçˆã—ÃZƒ“ƒ^[): ‘æ20‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïH‹GƒVƒ“ƒ|ƒWƒEƒ€ (2004/11/26), _ŒË.

733132. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ’_“¹Šg’£Ç‚Æ‚ÌŠÓ•Ê‚ª¢“ï‚ÈI cyctŒ^’_“¹•Â½Ç‚Ì1—á. ’†Œ´‚³‚¨‚è (ŠO): ‘æ31‰ñ“ú–{’_“¹•Â½ÇŒ¤‹†‰ï (2004/12/4), Ž­Ž™“‡.

733133. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‹}«äX‰Š‚Å”­•a‚µ, •›“û“ªŒ`¬p‚ÅŒy‰õ‚µ‚½äX–ü‡•s‘S‚Ì1—á. ’†Œ´‚³‚¨‚è, Γc˜a•v, ŒÃ“cˆê“¿, “c’†@Œ‰ (ŠO): ‘æ95‰ñ“Œ‹ž¬Ž™ŠO‰ÈŒ¤‹†‰ï (2004/12/7), “Œ‹ž.

733134. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‘¼‘ŸŠíZˆÝŠà‚ɑ΂·‚釕¹Øœ‚ÌŽ¡—ìт̌Ÿ“¢. •ŽRMˆê, ‹e’rŽj˜Y, “ñ“nM], •Ð“c‰Ä–ç, ÷–{Mˆê, ¬—ÑLs, “nç²¹•F (ŠO): ‘æ27‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï (2004/12/8), ‰¡•l.

733135. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‚ˆÊisˆÝŠà‚ɑ΂·‚éäB“®–¬, äB–å•”ƒŠƒ“ƒpߊs´‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‹e’rŽj˜Y, •ŽRMˆê, “ñ“nM], •Ð“c‰Ä–ç, ÷–{Mˆê, ¬—ÑLs, “nç²¹•F (ŠO): ‘æ27‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï (2004/12/8), ‰¡•l.

733136. [Œ¤‹†‰ï] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚é’¼’°Eãè–å•a•Ï‚ɑ΂·‚é• o‹¾‰º• ‰ï‰AŽ®’¼’°Ø’fp (Lac-APR). ¬àV•½‘¾, ²“¡•˜Y, ’†‘º—²r, š êK‹Ï, ˆäŒ´@Œú, ‘å’J„³, “nç²¹•F (ŠO): ‘æ13‰ñƒNƒŠƒjƒJƒ‹EƒrƒfƒIƒtƒH[ƒ‰ƒ€ (CVF) (2005/2/5), “Œ‹ž.

733137. [Œ¤‹†‰ï] (ˆê”Êu‰‰) –À‘–_Œo‰·‘¶• o‹¾‰ºˆÝØœp‚ÌŽèpŽè‹Z. ÷–{Mˆê, ‹e’rŽj˜Y, •ŽRMˆê, “ñ“nM], •Ð“c‰Ä–ç, ¬—ÑLs, “ˆ”ö@m, “nç²¹•F (ŠO): ‘æ13‰ñƒNƒŠƒjƒJƒ‹EƒrƒfƒIƒtƒH[ƒ‰ƒ€ (CVF) (2005/2/5), “Œ‹ž.

733138. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚éŠàI––ŠúŽ¡—Â̌Ÿ“¢. ã–쑈ê˜Y1, ‹{“à–MG, ’†ŒF‘¸Žm1, •½–ì@i1, ŒI“c ~1, ‰Y“‡‘¾˜Y, ‘O“cƒˆê (1ŠO): ‘æ42‰ñé‹ÊŒ§ˆãŠw‰ï‘‰ï (2005/2/27), ‰Y˜a.

733139. [Œ¤‹†‰ï] (ˆê”Êu‰‰) œ‚É”g‹y‚µ‚½ƒŠƒ“ƒpŠÇŽîÇ‚Ì1—á. “c’†@Œ‰1, ’†Œ´‚³‚¨‚è1, –¼ŠÙ®–ç2, ŒÃì^—S2 (1ŠO. 2Ž™): ‘æ42‰ñ_“Þ쬎™Žîᇌ¤‹†‰ï (2005/3/12), ‰¡•l.


<<‹¹•”ŠO‰ÈŠw>>

mŠwp˜_•¶n

110120. [Œ´’˜] Modified Dor's operation of left ventricular inferior wall aneurysm following old myocardial infarction. ŽOD@–L, ¬Œ´–M‹`, æÑ@³Šî, {“¡‹±ˆê, ’¹ˆäWŽO, ‹g‘º”Ž–M (‹¹ŠO): –k—¢ˆãŠw, 33 (5): 321-326, 2003.

110121. [Œ´’˜] One-lung Ventilation for Video-Assisted Thoracoscopic Interruuption of Patent ductus Arteriosus. ‹{’n@ŠÓ1, ‰ª–{_Žk2, ‚è‘׈ê1, ¬Œ´–M‹`1, ‹g‘º”Ž–M1 (1‹¹ŠO. 2–ƒŒ): Surgery Today, 34 (12): 1006-1009, 2004.

110122. [Œ´’˜] Arch Reconstruction without Circulatory Arrest in Neonates. •“c—TŽq1, –ƒ¶r‰p1, ŽµŠC”ü˜a1, ŽR–{Ms2, ¬Œ´–M‹`2, ‹g‘º”Ž–M2, ‰ª–{_Žk3 (1Department of Cardiac Surgery, Kanagawa Children's Hospital. 2‹¹ŠO. 3–ƒŒ).

110123. [Œ´’˜] The Limiting Factors for the Transxiphiod Approach in Congenital Cardiac Surgery. ‹{’n@ŠÓ1, Arata Murakami2, Hajime Sato2, Shinichi Takamoto2 (1‹¹ŠO. 2“Œ‹ž‘å): The Heart Surgery Forum, 7 (3) #2003-3013, E250-253, 2004.

120024. [Œ´’˜] Trehalose-albumin–”‚ÍNystose‚Ì“Y‰Á‚µ‚½Euro-Collins‰t‚Ìt, S, ”x‚Ì•Û‘¶Œø‰Ê. ^è‹`•F, Œã“¡®”ü, æÑ ³Šî, ‹g‘º”Ž–M (‹¹ŠO): ’ቷˆãŠw, 30 (2): 41-45, 2004/6.

310006. [Ç—á•ñ] Bioprosthetic Dysfunction Caused by Preserved Native Valve in Tricuspid Position. ¬—Ñ^—Žq1, –ƒ¶r‰p2, Zong-Bo Lin1, •“c—TŽq2, ¬Œ´–M‹`1, ‹g‘º”Ž–M1 (1‹¹ŠO. 2Department of Cardiac Surgery, Kanagawa Children's Hospital): Asian Cardiovascular & Thoracic Annals, 13 (1): 72-73, 2005.

310007. [Ç—á•ñ] Single-stage Repair of complete Arterioventricular Septal Defect and Coarctation of the Aorta in Neonate. ¬—Ñ^—Žq1,2, Yukihiro Takahashi2, Makoto Ando2, et al. (1‹¹ŠO. 2Sakakibara Heart Institute): The Japanes Journal of Thoracic and Cardiovascular Surgery, 52: 383-385, 2004.

320029. [Ç—á•ñ] Oversensing‚ÌŒ´ˆö“Á’肪¢“ï‚Å‚ ‚Á‚½Ç—á‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ¬ìŽj—m, ¬Œ´–M‹`, {“¡‹±ˆê, ’¹ˆäWŽO, æÑ ³Šî, ŽOD –L, ‹g‘º”Ž–M (‹¹ŠO): Therapeutic Research, 25 (3): 558-561, 2004.

510011. [‘à] Prostanoid receptor in tumor-associated angiogenesis and tumor growth. “V–ì‰pŽ÷1, —Ñ@ò2, ‹g‘º”Ž–M1, ”n“ˆ³—²2 (1‹¹ŠO. 2–ò—): Inflammation and Regeneration, 25 (1): 26-31, 2005.

520133. [‰ðà] Ž¡—Â̑I‘ðŽˆ‚ðŠ³ŽÒ‚Æ‚Æ‚à‚É–Íõ‚·‚é|Å‹ß‚Ì”xŠàŽèp—Ö@‚̬Ñ|. ‹g‘º”Ž–M (‹¹ŠO): Ž¡—Êw, 38 (6): 623-628, 2004.

520134. [‰ðà] ŒŒŠÇ—̈æ‚É‚¨‚¯‚éƒXƒeƒ“ƒgŽ¡—ÂÌi•à|ƒXƒeƒ“ƒg‚ÌŠî‘b‚ÆÅV‹Zp –òÜ—no«ƒXƒeƒ“ƒg‚ÉŠÖ‚·‚éŠî‘bEÅV‹Zp|. ’·’J•”Œõò1, “‡“c Œú, —é–Ø“N–ç, ”’_L”V, ”óŒû@–r, ΋´—¹’m, ¼‰ª‹`–¾, Ä“¡rÆ, é`•½–¼’qŽm, ‹g‘º”Ž–M2, ŒI—ÑK•v (1—§ì•a‰@. 2‹¹ŠO): —Õ°•úŽËü, 49 (13): 1771-1781, 2004.

520135. [‘à] ŠO«S‘¹. ŽOD –L, ¬Œ´–M‹` (‹¹ŠO): ‹¹•”ŠO‰È, 57 (8): 742-750, 2004.

520136. [‘à] ‹¹o‹¾‰º“®–¬ŠÇ•Â½p. ‹{’n@ŠÓ (‹¹ŠO): zŠÂŠí‰È, 55 (6): 574-578, 2004.

520137. [‘à] ŠO«”x‘¹. Œ´@‰p‘¥, ‹g‘º–M”Ž (‹¹ŠO): ‹¹•”ŠO‰È, 57 (8): 762-769, 2004.

m’˜@‘n

620083. [Šwp‘] (•ª’SŽ·•M) Annual ReviewzŠÂŠí 2004; “®–¬ŠÇŠJ‘¶Ç‚Ì‹¹o‹¾Žèp, p.234-237. ‹{’n@ŠÓ (‹¹ŠO), ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2004/4/20”­s.

620084. [‰ðà] (•ª’SŽ·•M) ”xŠàf—Óñ•Å‚Ì”éŒ; ”xŠàf—Â̔éŒ, p.270-271. ‹g‘º”Ž–M (‹¹ŠO), •ÒW “¡‘ºd•¶ (“Œ–kŒú¶”N‹à•a‰@), ‹àŒ´o”Å, “Œ‹ž, 2004/10/25”­s.

620085. [Šwp‘] (•ª’SŽ·•M) Š¥“®–¬ŠO‰È‚Ì—v“_‚Æ–Ó“_•ª’S•\‘è; SŽºáŽ, p.224-228. ¬Œ´–M‹` (‹¹ŠO), •ÒW ’|“à–õ•v (“Œ‹ž—ˆã‘å‘æ“ñ•a‰@), ŠÄC ‚–ØáÁˆê (“Œ‹ž‘å), •¶Œõ“°, “Œ‹ž, 2005/3/9”­s.

620086. [Šwp‘] (•ª’SŽ·•M) Š¥“®–¬ŠO‰È‚Ì—v“_‚Æ–Ó“_; ìè•aŠ¥“®–¬•a•Ï‚ÆŽèp“K‰ž. ’¹ˆäWŽO (‹¹ŠO), •ÒW ’|“à–õ•v (“Œ‹ž—ˆã‘å‘æ“ñ•a‰@), ŠÄC ‚–ØáÁˆê (“Œ‹ž‘å), •¶Œõ“°, “Œ‹ž, 2005/3/9”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

711003. [Šw‰ï (‘Û)] (“Á•Êu‰‰) WAB: The philosophy of one world society bronchology. ‹g‘º”Ž–M (‹¹ŠO): 13th World Congress for Bronchology (2004/6/23), ƒoƒ‹ƒZƒƒiEƒXƒyƒCƒ“.

711004. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Cost effectiveness in intrabronchial Palliative Therapy. ‹g‘º”Ž–M (‹¹ŠO): 10th Indian Congress on Bronchology (2005/2/12), ƒCƒ“ƒhEƒjƒ…[ƒfƒŠ[.

711005. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Tracheobronchial reconstruction. ‹g‘º”Ž–M (‹¹ŠO): 10th Indian Congress on Bronchology (2005/2/12), ƒCƒ“ƒhEƒjƒ…[ƒfƒŠ[.

712023. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Thoracoscopic surgery for lung cancer staginng (Smposium: Thoracoscopy: Old and New. ‹g‘º”Ž–M (‹¹ŠO): 13th World Congress for Bronchology (2004/6/21), ƒoƒ‹ƒZƒƒiEƒXƒyƒCƒ“.

712024. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) The world bronchoscopyAssociation (Special Session: Bronchoscopy around the world). ‹g‘º”Ž–M (‹¹ŠO): 13th World Congress for Bronchology (2004/6/23), ƒoƒ‹ƒZƒƒiEƒXƒyƒCƒ“.

713082. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Surgical Repair of Complete AVSD. ¬—Ñ^—Žq1,2, Yukihiro Takahashi2, Makoto Ando2, et al. (1‹¹ŠO. 2Sakakibara Heart Institute): The 13th Annual Meeting of the Asian Society for Cardiovascular Surgery (2005/2/6), Thailand.

721010. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ŒÄ‹zŠíŠO‰È‚ÌŒ»ó‚Æ«—ˆ. ‹g‘º”Ž–M (‹¹ŠO): ‘æ21‰ñ“ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï‘‰ï (2004/5/28), ‰¡•l.

722041. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “®–¬ŠÇŠJ‘¶Ç (PDA) ‚ɑ΂·‚éƒJƒe[ƒeƒ‹Ž¡—Ã‚Æ“àŽ‹‹¾Žèp‚Ì•¹—p—Ö@. ‹{’n@ŠÓ1, ‚è‘׈ê1, ¬ìŽj—m1, ’†”¨–í¶2, Έä³_2 (1‹¹ŠO. 2Ž™): ‘æ16‰ñ“ú–{Pediatric Interventional CardiologyŒ¤‹†‰ïŠwpW‰ï (2005/1/15), –¼ŒÃ‰®. ƒvƒƒOƒ‰ƒ€´˜^W, p.92, 2005.

723355. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žá”NŽÒ (40Ζ¢–ž) Š´õ«S“à–Œ‰Š‚ɑ΂·‚éŠO‰ÈŽ¡—Â̌Ÿ“¢. ’¹ˆäWŽO1, ¬Œ´–M‹`1, æÑ ³Šî1,2, {“¡‹±ˆê1, ŽOD@–L1,2, —F•Û‹M”Ž1, ’†“‡—TN1, ‹{’n@ŠÓ1, ‚è‘׈ê, ŽR–{Ms1,2, ‹g‘º”Ž–M1 (1‹¹ŠO. 2ŠC˜V–¼‘‡•a‰@): ‘æ104‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwp‘‰ï (2004/4/9), ‘åã. “ú–{ŠO‰ÈŠw‰ïŽGŽ, 105 (—Õ‘): 694, 2004.

723356. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¶ã—t“à‘½”­«‚Ì”x“à“]ˆÚ‚𔺂¤”x‘BŠà‚̈êŽèp—á. Œ´@‰p‘¥1, •i“c@ƒ1, Œã“¡@‹B1, ŽR‰º˜a–ç2, Šâ•£Œ[ˆê2, •Ð‹Ë^l3, ‘ì˜ad4, ‰ªˆÀ@ŒM3, ‹g‘º”Ž–M1 (1‹¹ŠO. 2•a—. 3“à‡X. 4•ú): ‘æ21‰ñ“ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï‘‰ï (2004/5/27), ‰¡•l.

723357. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Aortic connector system‚ÌŽg—pŒoŒ±‚Æpotfall. ’¹ˆäWŽO1, ¬Œ´–M‹`1, ’¬ˆä³l1, {“¡‹±ˆê1, ’†“ˆŒõ‹M1, —F•Û‹M”Ž1, ‹{’n@ŠÓ1, ‚è‘׈ê1, ]ŠÔ@—æ1, ‹g‘º”Ž–M1, æÑ ³Šî1,2, ŽOD@–L1,2, ŽR–{Ms1,2 (1‹¹ŠO. 2ŠC˜V–¼‘‡•a‰@): ‘æ9‰ñ“ú–{Š¥“®–¬ŠO‰ÈŠw‰ïŠwp‘å‰ï (2004/7/8), ŽD–y. u‰‰´˜^W, p.93, 2004.

723358. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) MDCT‚É‚æ‚éCABG‰“ŠuŠúƒOƒ‰ƒtƒgŠJ‘¶«‚ÌŒŸ“¢|pŒã10”NˆÈãŒo‰ß‚µ‚½ƒOƒ‰ƒtƒg‚Í‚Ç‚±‚Ü‚Å•]‰¿‰Â”\‚©|. ’¹ˆäWŽO1, ¬Œ´–M‹`1, ’¬ˆä³l1, {“¡‹±ˆê1, ’†“‡Œõ‹M1, —F•Û‹M”Ž1, ‹{’n@ŠÓ1, ‚è‘׈ê, ]ŠÔ@—æ1, ¬ìŽj—m1, ‹g‘º”Ž–M1, æÑ ³Šî1,2, ŽOD@–L1,2, ŽR–{Ms1,2 (1‹¹ŠO. 2ŠC˜V–¼‘‡•a‰@): ‘æ57‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2004/10/20), ŽD–y. “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 52 (S.): 397, 2004.

723359. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŽèpŽx‰‡—pƒƒ{ƒbƒg•â•‚É‚æ‚é“àŽ‹‹¾‰º“®–¬ŠÇ•Â½pSolo-VATSPDA. ‹{’n@ŠÓ, ‚è‘׈ê, ¬Œ´–M‹`, ‹g‘º”Ž–M (‹¹ŠO): ‘æ17‰ñ“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‘‰ï (2004/11/26), ‰¡•l. “ú–{“àŽ‹‹¾ŠO‰ÈŠw, 9 (7): 198, 2004.

723360. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) pŒã26”N–ڂɃOƒ‰ƒtƒg‚Ì—ÇD‚ÈŠJ‘¶‚É‚à‚©‚©‚í‚炸ICDA‚¦ž‚Ý‚ð—v‚µ‚½ìè•aŠ³ŽÒ‚Ì1—á. ’¹ˆäWŽO1, ¬Œ´–M‹`1, ’¬ˆä³l1, {“¡‹±ˆê1, ’†“‡Œõ‹M1, ˆäãMK, ]ŠÔ@—æ1, ‹{’n@ŠÓ1, ‚è‘׈ê, ¬ìŽj—m1, ‹g‘º”Ž–M1, ’|“à–õ•v2 (1‹¹ŠO. 2“Œ‹ž—ˆã‘åŠw‘æ“ñ•a‰@S‘ŸŒŒŠÇŠO‰È): ‘æ18‰ñ“ú–{Š¥Ž¾Š³Šw‰ïŠwpW‰ï (2004/12/11), ŒF–{. “ú–{Š¥Ž¾Š³Šw‰ïŠw, 10 (4): 294, 2004.

723361. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŽèpŽx‰‡—pƒƒ{ƒbƒg•â•‚É‚æ‚é“àŽ‹‹¾‰º“®–¬ŠÇ•Â½p. ‹{’n@ŠÓ1, ‰ª–{_Žk2, ‚è‘׈ê1, ¬ìŽj—m1, ¬Œ´–M‹`1, ’¹ˆäWŽO1, ’¬ˆä³l1, ‹g‘º”Ž–M1 (1‹¹ŠO. 2–ƒŒ): ‘æ35‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ï‘‰ï (2005/2/23), •l¼. “ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŽ, 34 (S.): 370, 2005.

723362. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹¹œ³’†ØŠJƒAƒvƒ[ƒ`‚É‚æ‚éModifid Blalock-Taussig shuntp‚ÌŒŸ“¢. ‹{’n@ŠÓ, ‚è‘׈ê, ¬ìŽj—m, ¬Œ´–M‹`, ’¹ˆäWŽO, ’¬ˆä³l, ‹g‘º”Ž–M (‹¹ŠO): ‘æ35‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ï‘‰ï (2005/2/24), •l¼. “ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŽ, 34 (S.): 283, 2005.

731061. [Œ¤‹†‰ï] (“Á•Êu‰‰) Š¥“®–¬ŠO‰ÈŽèp|ŋ߂̘b‘è‚ð’†S‚É|. ¬Œ´–M‹` (‹¹ŠO): ƒn[ƒgƒZƒ~ƒi[ (’†‰›‹æE“ú–{‹´ˆãŽt‰ïŽåà (2004/6/9), “Œ‹ž.

731062. [Œ¤‹†‰ï] (“Á•Êu‰‰) Š¥“®–¬Ž¾Š³|ŠO‰ÈŽ¡—Â̌»ó|. ¬Œ´–M‹` (‹¹ŠO): Œ§‰›SŒŒŠÇŽ¡—ÃŒ¤‹†‰ï (2004/7/28), ŠC˜V–¼Žs.

731063. [Œ¤‹†‰ï] (“Á•Êu‰‰) S‘Ÿ‚Ì‚¨˜b|ŠO‰Èˆã‚Ì—§ê‚©‚ç|. ¬Œ´–M‹` (‹¹ŠO): ˆã—ÃE•ŸŽƒŽÐ‰ïŒoÏŒ¤‹†‰ï (2004/7/2), “Œ‹ž.

733140. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Ž©‘R‹C‹¹‚ðŒ_‹@‚É”­Œ©‚³‚ꂽ‰Eã—t”xŠà‚̈êØœ—á. ¬ìŽj—m1, ]ŠÔ@—æ1, Œã“¡@‹B1, Œ´@‰p‘¥1, ˆä㔹l1, •i“c@ƒ1, ‹g‘º”Ž–M1, ‰¡ê³“T2, ‰v“c“TK2, Ó@¢ˆ®3, Šâ•£Œ[ˆê3 (1‹¹ŠO. 2“à‡X. 3•a—): ‘æ111‰ñ“ú–{ŒÄ‹zŠí“àŽ‹‹¾Šw‰ïŠÖ“Œ•”‰ï (2004/12/18), “Œ‹ž.

733141. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‹¹o“à‚É”dŽí«“]ˆÚ‚ð‚«‚½‚µ‚½d‰»«ŒŒŠÇŽî‚̈ê—á. ]ŠÔ@—æ1, Œ´@‰p‘¥1, Œã“¡@‹B1, ˆä㔹l1, Ó@¢ˆ®2, Šâ•£Œ[ˆê2, ‰v“c“TK3, ‘ì˜ad4, ‹g‘º”Ž–M1 (1‹¹ŠO. 2•a—. 3“à‡X. 4•ú): ‘æ142‰ñ“ú–{”xŠàŠw‰ïŠÖ“Œ•”‰ï (2005/3/12), “Œ‹ž.

733142. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) LITA, RITAŠJ‘¶‰º‚Å‚ÌÄŠ¥“®–¬ƒoƒCƒpƒXp|’´’á‘̉·, HeartstringRŽg—p‚É‚æ‚éˆê—á|. ¬—Ñ^—Žq1,2, ¬–örÆ1, ‘¼ (1匴‹L”O•a‰@. 2‹¹ŠO): ‘æ131‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2004/9/11), “Œ‹ž.


<<”]_ŒoŠO‰ÈŠw>>

mŠwp˜_•¶n

110124. [Œ´’˜] Microsurgical anatomy of he insula and sylvian fissure. Tanriover N, Rhoton AL, ‰Í“‡‰ë“ž, Ulm AJ, Yasuda A (ƒtƒƒŠƒ_‘å): J Neurosurg, 100: 891-922, 2004.

110125. [Œ´’˜] Microsurgical approaches to the permesencephalic and related segments of the posterior cerebral artery: comparison using a naval appkication of image guidance. Ulm AJ, Tanriover N, ‰Í“‡‰ë“ž, Campero A, Bova FJ, Rhoton AL (ƒtƒƒŠƒ_‘å): Neurosurg, 54: 1313-1328, 2004.

110126. [Œ´’˜] E, N-Cadherins and beta-catenin expression in medulloblastoma and atypical teratoid/rhabdoid tumor. ‰F’ÖØ@‘1, ‰ª@GG1, ²“¡—Yˆê2, “y‰®g2, ‹ß“¡GŽ¡1, ’Jè‹`“¿1, “c’†@‘1, “¡ˆä´F1 (1”]ŠO. 2ˆã‰q): Neurol Med Chir, 44 (8): 402-407, 2004.

110127. [Œ´’˜] Intracranail vertebral artery dissection with subarachnoid hemorrage: clinical characteristics and outcomes in conservatively treated patients. ŽR“c@Ÿ1, –kŒ´F—Y2, ‘q“c@²1, “¡ˆä´F1, ‹{â‰À’j1 (1”]ŠO. 2‹~–½): J Neurosurg, 101: 25-30, 2004.

110128. [Œ´’˜] Manual occipital ventricular puncture for cerebrospinal fluid shunt surgery: Can aiming be standardized? ´…@‹Å, “c’†–ö…, ”Ñ“cG•v, “¡ˆä´F (”]ŠO): Neurol Med Chir (Tokyo), 44 (7): 353-358. 2004.

110129. [Œ´’˜] The So-Called Anterior Meningeal Artery: an Anatomic Study for Treatment Modalities. ´…@‹Å1, AS Garcia2, N Tanriove2, “¡ˆä´F1 (1”]ŠO. 2ƒtƒƒŠƒ_‘åŠwE”]ŠO): Intervent Neuroradiol, 10: 293-299, 2004.

110130. [Œ´’˜] Light microscopic demonstratiom of the microlumen of ependymoma: a study of the usefulness of antigen retrieval for epithelial membrane antigen (EMA) immunostaining. ì–ìM”V1, ˆÀˆä”ü]1, ‰F’ÖØ@‘1, ‰ª@GG1, “¡ˆä´F1, ŽR‰È³•½2 (1”]ŠO. 2‰ð–U): Brain Tumor Pathol, 21: 17-21, 2004.

110131. [Œ´’˜] Efficacy of endovascular surgery for the treatment of acute epidural hematomas. —é–Ø˶1, ‰““¡¹F1, ‘q“c@²1, ‘å“ä’m1, ‰ª@GG1, –kŒ´F—Y2, ‘å˜a“c@—²2, ‰F’ÖØ@‘1, “¡ˆä´F1 (1”]ŠO. 2‹~–½): Am J Neuroradiol, 25: 1177-1180, 2004.

110132. [Œ´’˜] Experimental determination of minimal stimulation current and period for electrical thrombosis in dogs. —é–Ø˶1, ‘q“c@²1, ‘å“ä’m1, ‰ª@GG1, ’†ŽR–ÎM2, •½ŽR@Žõ1, ˆÀˆä”ü]1, “¡ˆä´F1 (1”]ŠO, 2ŽÀ“®ƒZƒ“ƒ^[): Intervent Neuroradiol, 10: 225-230, 2004.

110133. [Œ´’˜] Invasive meningioma is associated with a low expression of E-cadherin and ƒÀ-catenin. ‰F’ÖØ@‘1, ‰ª@GG1, ²“¡—Yˆê2, ì–ìM”V1, “y‰®g2, ¬—шè•v1, “¡ˆä´F1 (1”]ŠO. 2ˆã‰q): Clin Neuropathol, 24 (1): 8-12, 2005.

110134. [Œ´’˜] Gamma knife thalamotomy for movement disorders: evaluation of the thalamic lesion and clinical results. ‘å]çœA, ŽÄè@“O1, ²“¡Ÿl2 (1“ú‚•a‰@E‹@”\”]ŠO‰È. 2”]ŠO): J Neurosurg (Suppl), 102: 234-240, 2005.

120025. [Œ´’˜] “ñŽŸ‹~‹}•a‰@‚É‚¨‚¯‚éˆÓŽ¯áŠQŠ³ŽÒ‚ÌŒ»ó‚ɂ‚¢‚Ä. ‚–ì@½1, ‘å‚O–«1, ‰ª“c‘ì˜Y1, •½ŽR@Žõ1 (1”]ŠO): “ú–{_Œo‹~‹}Šw‰ïŽGŽ, 17: 50-53, 2004.

120026. [Œ´’˜] ’áˆÊèò’Å‚É‚¨‚¯‚é’Åœ“®–¬ŽüˆÍ‚̉ð–U|èò’ʼn¡“Ë‹N‚ð’†S‚É|. ‰Í“‡‰ë“ž1, Albert L Rhoton Jr2, “¡ˆä´F1 (1”]ŠO. 2ƒtƒƒŠƒ_‘åE”]ŠO): Ò’ÅÒ‘ƒWƒƒ[ƒiƒ‹, 17 (5): 438-445, 2004.

120027. [Œ´’˜] ”j—ô”]“®–¬áŽ‹}«Šúmanagement‚ÉŠÖ‚·‚é‘S‘ƒAƒ“ƒP[ƒg’²¸. ŽR“c@Ÿ1, “c’†–ö…1, ‘q“c@²1, “¡ˆä´F1, –kŒ´F—Y2, ‰““¡¹F1, ‘å˜a“c@—²2 (1”]ŠO. 2‹~–½): Journal of Japanese Congress on Neurological Emergencies, 17: 19-22, 2004.

120028. [Œ´’˜] ”j—ô‰ð—£«’Åœ“®–¬áŽ‚Ì—Õ°‘œ‚¨‚æ‚уRƒCƒ‹Çðp‚Ì—L—p«‚ɂ‚¢‚Ä. ‘q“c@²1, ”‹Œ´G”V1, “’àV@ò1, ¬àV@m2, “¡ˆä´F1, ‰““¡¹F1, –kŒ´F—Y3, ›@Mˆê4, —é–Ø˶1, ‘å“ä’m1 (1”]ŠO. 2Ž¬“c‘‡•a‰@. 3‹~–½. 4•ú): Neurosurg Emerg, 9: 24-34, 2004.

120029. [Œ´’˜] •sˆÓ‰^“®‚ɑ΂·‚鎋°Žèp|”÷¬“d‹É–@‚ƃKƒ“ƒ}ƒiƒCƒt‚É‚æ‚éŽèp‘ƒ‚̈ٓ¯|. ‘å]çœA1, ŽÄè@“O1, ²“¡Ÿl2, äï@ú“Œ1 (1“ú‚•a‰@E‹@”\”]ŠO‰È. 2”]ŠO): ‹@”\“I”]_ŒoŠO‰È, 43 (2): 86-87, 2004.

120030. [Œ´’˜] ƒOƒŠƒI[ƒ}‚ɑ΂·‚éŒÂ•Ê‰»•â•—Ö@‚Æevidence based medicine. “c’†@‘1, ¬—шè•v1, ‰ª@GG1, ‰F’ÖØ@‘1, ˆÀˆä”ü]1, “¡ˆä´F1, “n•Ó‚Žu2, –x@’qŸ3, ’|“à³O4 (1”]ŠO. 2’¹Žæ‘å. 3“Œ‹ž—ˆã‘å. 4–òŠw•”): ”]ŠOŽ, 13 (10): 694-700, 2004.

120031. [Œ´’˜] ”]ŒŒŠÇáŠQ‚É‚¨‚¯‚ép’†Œo“ªŠWMEPƒ‚ƒjƒ^ƒŠƒ“ƒO‚Ì—L—p«. “c’†@‘1, Šâ–{˜a‹v1, ë“à—²—Y1, ¬—шè•v1, ‚—œ~Žq2, “¡ˆä´F1, Ž‰Æ@O3 (1”]ŠO. 2–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@. 3“Œ‹ž—ˆã‘å): ”]‘²’†‚ÌŠO‰È, 32: 431-436, 2004.

120032. [Œ´’˜] ‹}«d–Œ‰ºŒŒŽî‚ɑ΂·‚錌ŠÇ“àŽèp‚ɂ‚¢‚Ä. —é–Ø˶1, ‘å“ä’m1, ‰““¡¹F1, ‘q“c@²1, “¡ˆä´F1, ™è“ß”üŽq2 (1”]ŠO. 2’²•z•a‰@): “Œ‹ž“sˆãŽt‰ïŽGŽ, 57 (4): 44-49, 2004.

120033. [Œ´’˜] ˆ««Žîᇂɑ΂·‚ép’†”]ŽîᇌuŒõf’f‚Ì—L—p«. ‰F’ÖØ@‘1, “c’†@‘1, Šâ–{˜a‹v1, œA£—²ˆê2, ’·’Jì‚ЂƂÝ2, ’Ò@rˆê2, –{@‹§2 (1”]ŠO. 2–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@): é‹ÊŒ§ˆãŠw‰ïŽGŽ, 39 (5): 545-547, 2005.

120034. [Œ´’˜] ”Xó”]“®–¬áŽ‚ɑ΂·‚é”]ŒŒŠÇ“àŽèpŽè‹Z‚É‚æ‚釕¹Ç‚ɂ‚¢‚Ä‚ÌŒŸ“¢. —é–Ø˶1, ‘q“c@²1, ›@Mˆê2, ‘å“ä’m1, –kŒ´F—Y3, ŽR“c@Ÿ1, “c’†–ö…1, ‰ª@GG1, “¡ˆä´F1 (1”]ŠO. 2•ú. 3‹~–½): ”]‘²’†‚ÌŠO‰È, 33:115-121, 2005.

120035. [Œ´’˜] Ò‘‘“ài“ü–@|‘O•û–@|. ´…@‹Å, ŽOˆäŒö•F, “¡ˆä´F (”]ŠO): Ò’ÅÒ‘ƒWƒƒ[ƒiƒ‹, 17 (5): 566-568, 2004.

220030. [€Œ´’˜] _Œo“àŽ‹‹¾•¹—p‚É‚æ‚éŠÔ”]‰º‚‘ÌŽîᇎèp‚Ì”÷¬‰ð–U‚ÆŽÀÛ. ‰ª@GG, “¡ˆä´F (”]ŠO): “ú–{“à•ª”åŠw‰ïŽGŽ, 80 (Suppl): 22-23, 2004.

220031. [€Œ´’˜] ’áˆÊèò’Å‚É‚¨‚¯‚é’Åœ“®–¬ŽüˆÍ‚̉ð–U: èò’ʼn¡“Ë‹N‚ð’†S‚É. ‰Í“‡‰ë“ž1, Albert L Rhoton Jr2, “¡ˆä´F1 (1”]ŠO. 2ƒtƒƒŠƒ_‘å): Œ°”÷‹¾‰ºŽèp‚Ì‚½‚ß‚Ì”]_ŒoŠO‰È‰ð–UXVI|—Õ°‚Ì‚½‚ß‚Ì“ª•”E“ªŠW’êEÒ‘ŠO‰È”÷¬ŠO‰È‰ð–U|, XVI: 18-25, 2004.

220032. [€Œ´’˜] •ïŠ‡ˆã—Ó±“ü‚É‚æ‚é•Ï‰»|”]_ŒoŠO‰È‚Ì—§ê‚æ‚è|. ŽR“c@Ÿ, “¡ˆä´F (”]ŠO): ”]‚ÆzŠÂ, 9(3): 29-33, 2004.

220033. [€Œ´’˜] ’ŜÖ¬‚¨‚æ‚Ñ•«‡Ž}‚ÌŠO‰È‰ð–U. ´…@‹Å, “c’†–ö…, ŽOˆäŒö•F, “¡ˆä´F (”]ŠO): Œ°”÷‹¾‰ºŽèp‚Ì‚½‚ß‚Ì”]_ŒoŠO‰È‰ð–UXVI|—Õ°‚Ì‚½‚ß‚Ì“ª•”E“ªŠW’êEÒ‘ŠO‰È”÷¬ŠO‰È‰ð–U|, XVI: 26-30, 2004.

220034. [’Z•ñ] Œo‘Ì–@‚ÉŠÖ˜A‚µ‚½Šç–Ê_Œo‚Ì‘–s. “c’†–ö…1, “¡ˆä´F1, Albert L Rhoton Jr2 (1”]ŠO. 2ƒtƒƒŠƒ_‘å): ”]_ŒoŠO‰È‘¬•ñ, 14 (6): 537-539, 2004.

220035. [’Z•ñ] ŽO³_Œo‚Ì”÷¬ŠO‰È‰ð–U. “c’†–ö…1, “¡ˆä´F1, Albert L Rhoton Jr2 (1”]ŠO. 2ƒtƒƒŠƒ_‘å): ”]_ŒoŠO‰È‘¬•ñ, 14 (12): 1173-1175, 2004.

310008. [Ç—á•ñ] Cerebral Infarction and Fluid Collection Due to an Enlarged Dissecting Aneurysm of the Middle Cerebral Artery. ”Ñ“cG•v1, ‹v{”ü^—1, ë“à—²—Y, ŽO•x“N•v2 (1”]ŠO. 2‘Ûe‘P‘‡•a‰@“à‰È): Neurol Med Chir, 44: 535-539, 2004.

310009. [Ç—á•ñ] Nevoid basal cell carcinoma syndrome with medulloblastoma and meningioma. •Ÿ“‡@_1, ‰ª@GG1, ‰F’ÖØ@‘1, Šâ–{˜a‹v1, “¡ˆä´F1 (1”]ŠO): Neurol Med Chir (Tokyo), 44: 665-668, 2004.

310010. [Ç—á•ñ] Biopsy of brain stem glioma using motor-evoked potential mapping by direct peduncular stimulation and individual adjuvant therapy. “c’†@‘1, ¬—шè•v1, ‰F’ÖØ@‘1, Šâ–{˜a‹v1, ‚—œ~Žq2 (1”]ŠO. 2–k–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): Neurol Med Chir (Tokyo), 45: 49-55, 2005.

320030. [€Œ´’˜] bFGF»Ü iƒtƒBƒuƒ‰ƒXRƒgƒXƒvƒŒ[j ‚ª—LŒø‚Å‚ ‚Á‚½“ª•”ŽèpŒã‚Ì‘n•””畆’×ᇂÌ1—á. —é–Ø˶, ‘‘ŽiŒõ•F, •Ÿ“‡@_, ‘åàV¬”V, ŽRè—F–ç, ‰ª@GG, ‰F’ÖØ@‘, “’àV@ò, ‘q“c@², “¡ˆä´F (”]ŠO): Prog Med, 24 (9): 2369-2372, 2004.

320031. [€Œ´’˜] reversible encephalopathy‚Ì‘œ‚ð’悵‚½SheehanÇŒóŒQ‚̈ê—á. ‰F’ÖØ@‘1, œA£—²ˆê2, ‰ª@GG1, “c’†@‘1, Šâ–{˜a‹v1, ’·’Jì‚ЂƂÝ2, “¡ˆä´F1 (1”]ŠO. 2–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@): “ú–{“à•ª”åŠw‰ïŽGŽ, 80 (Suppl): 143-145, 2004.

320032. [€Œ´’˜] ³’†_Œo¶‘¤Ž}‚ÌiN«áŠQ‚Ì2—á|ŽèªŠÇÇŒóŒQ‚Æ‚ÌŠÓ•Ê‚ð—v‚·‚é•a‘Ô|. ²“¡Œör, ‹k@Ž ‘, ´…@‹Å, Γn‰ë’j, “¡ˆä´F (”]ŠO): Ò‘ŠO‰È, 18 (3): 215-218, 2004.

320033. [€Œ´’˜] “ñŠú“IVim-Vo thalamotomy‚É‚æ‚è‰ü‘P‚µ‚½ƒWƒXƒgƒjƒA‚Ì1—á. ²“¡Ÿl1, ‘å]çœA2, ŽÄè@“O2, äï@ú“Œ2 (1”]ŠO. 2“ú‚•a‰@E‹@”\”]ŠO): ‰^“®áŠQ, 14 (1): 7-13, 2004.

320034. [€Œ´’˜] Pilomyxoid astrocytoma‚Ì1—á. ”‹Œ´G”V, ‰ª@GG, ‰F’ÖØ@‘1, “¡ˆä´F1 (”]ŠO): “ú–{“à•ª”åŠw‰ïŽGŽ, 80 (Suppl): 141-142, 2004.

520138. [uÀ] ”]‰º‚‘ÌŽîᇂƃXƒeƒƒCƒhƒzƒ‹ƒ‚ƒ“. ‰ª@GG (”]ŠO): ‚­‚·‚è‚ÆŒ’N, 287: 3, 2004.

520139. [‘à] ‘ÙŽ™«”]Žîá‡. ‰ª@GG, “¡ˆä´F (”]ŠO): •a—‚Æ—Õ°, 22 (10): 994-1000, 2004.

521031. [Œ¤‹†•ñ] iŒú˜J‰ÈŠwŒ¤‹†”ïj ƒ‚ƒ„ƒ‚ƒ„•a‚Ì“ŒvŠw“I”]ŒŒ—¬SPECT‰æ‘œ‰ðÍ‚É‚æ‚é•a‘Ô•]‰¿. ŽR“c@Ÿ, “’àV@ò, “¡ˆä´F (”]ŠO): ƒ‚ƒ„ƒ‚ƒ„•a iƒEƒBƒŠƒX“®–¬—Ö•ÂÇÇj‚ÉŠÖ‚·‚é’²¸Œ¤‹†, p.23-26, 2004.

m’˜@‘n

620087. [Šwp‘] (•ª’SŽ·•M) ”]_ŒoŠO‰ÈŠw‘ÌŒn9@•ÂÇ«”]ŒŒŠÇáŠQ; ”]“®–¬‰ð—£, p.358-366. ŽR“c@Ÿ, “¡ˆä´F (”]ŠO), ’†ŽR‘“X, “Œ‹ž, 2004”­s.

620088. [Šwp‘] (•ª’SŽ·•M) ”]_ŒoŠO‰ÈŽèpƒAƒgƒ‰ƒX㊪; ‘¤”]Žº“àŽîá‡, p.240-248. “¡ˆä´F (”]ŠO), •ÒW ŽR‰Y@», ˆãŠw‘‰@, “Œ‹ž, 2004”­s.

620089. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ŠwZ‹~‹}ˆ’uu‰‰EŽÀ‹ZuK‰ï‹L˜^W; “ª•”‘Å–o‚ÉŠÖ‚·‚éŠwZ‹~‹}ˆ’u, p.30-44. “¡ˆä´F (”]ŠO), ‚Ý‚·‚¸ˆóü, “Œ‹ž, 2004”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

711006. [Šw‰ï (‘Û)] (‹³ˆçu‰‰) Atypical Teratoid/Rhabdoid Tumors: A malignant pediatric brain tumor to be distinguished from medulloblastoma (PNET). ‰ª@GG, “¡ˆä´F (”]ŠO): 2004 AANS Annual Meeting (2004/5/1), Orland.

712025. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Microsurgical instrumentation. “¡ˆä´F (”]ŠO): 6th International Congrress on Minimally Invasive Neurosurgery (2005/3/8), –¼ŒÃ‰®.

713083. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) The ideal position of the MacCarty keyhole: An anatomic study. ´…@‹Å1, Necmettin Tanriover2, Albert L Rhoton Jr2 (1”]ŠO. 2ƒtƒƒŠƒ_‘å): 2004 AANS Annual Meeting (2004/5/2), Orland.

713084. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Thrombosed giant MCA aneurysm: Case report. ²“¡Œör, ŽR“c@Ÿ, ‘q“c@², “¡ˆä´F (”]ŠO): 7th Japanese and Korean Friendship Conference on Surgery for Cerebral Stroke (2004/6/5), ŠØ‘.

713085. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) A questionnaire survey of Moyamoya disease in Kanagawa prefecture in Japan in 2003. ŽR“c@Ÿ, ‘åàV¬”V, ²“¡Œör, ”‹Œ´G”V, “¡ˆä´F (”]ŠO): 7th Japanese and Korean Friendship Conference on Surgery for Cerebral Stroke (2004/6/5), ŠØ‘.

713086. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Effect of direct amd indirect combined bypass surgery for Moyamoya disease with ischemic presentation- comparioson with indirect bypass surgery. ŽR“c@Ÿ, ‘q“c@², —é–Ø˶, ”‹Œ´G”V, ²“¡Œör, “¡ˆä´F (”]ŠO): 7th Japanese and Korean Friendship Conference on Surgery for Cerebral Stroke (2004/6/5), ŠØ‘.

713087. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Intracerebral hematoma (ICH) due to ruptured cerebral aneurysm without SAH. ‘åàV¬”V, ŽR“c@Ÿ, “c’†–ö…, “¡ˆä´F, ”Ñ“cG•v (”]ŠO): 7th Japanese and Korean Friendship Conference on Surgery for Cerebral Stroke (2004/6/5), ŠØ‘.

713088. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) PCA (P2P) dissecting aneurysm presenting with SAH treated by endovascular occlusion of PCA and aneurysm. ”‹Œ´G”V, ‘q“c@², ŽR“c@Ÿ, “¡ˆä´F (”]ŠO): 7th Japanese and Korean Friendship Conference on Surgery for Cerebral Stroke (2004/6/5), ŠØ‘.

713089. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Bilateral somatosensory response of pallidal neurons studied with microrecording in humans. ‘å]çœA2, ŽÄè@“O2, ²“¡Ÿl1 (1”]ŠO. 2“ú‚•a‰@E‹@”\”]ŠO‰È): International Basal Ganglia Society 8th Triennial Meeting (2004/9/5), Scotland.

713090. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) The Microsurgical Anatomy of the Choroidal Arteries. “¡ˆä´F1, “c’†–ö…1, ŽR“c@Ÿ1, ´…@‹Å1, Rhoton A L Jr2 (1”]ŠO. 2ƒtƒƒŠƒ_‘å): 2nd International Symposium on Microsurgical Anatomy (2004/10/2), ƒgƒ‹ƒR.

713091. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Craniopharyngioma of the 3rd ventricle: Clinico-radiological study by long term follow up. ‹ß“¡GŽ¡, ‰ª@GG, “c’†@‘, ‰F’ÖØ@‘, ’Jè‹`“¿, “¡ˆä´F (”]ŠO): 3rd Meeting of the Asian Society for Neuro-Oncology (2004/11/18), ãŠC.

713092. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Ciliated cranio-pharyngioma: a case report. ²“¡Œör, ‰ª@GG, ‰F’ÖØ@‘, “¡ˆä´F (”]ŠO): 3rd Meeting of the Asian Society for Neuro-Oncology (2004/11/18), ãŠC.

713093. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Pathology features of intracranial germinoma with regard to fibrous tissue granulomatous change. ‰F’ÖØ@‘, ‰ª@GG, ’Jè‹`“¿, ‹ß“¡GŽ¡, ì–ìM”V, “¡ˆä´F (”]ŠO): The 3rd meeting of the Asian society for Neuro-oncology (2004/11/19), ãŠC.

713094. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) A questionnaire survey of moyamoya disease in Kanagawaprefecture 2003 -Comparison with Korean data-. ŽR“c@Ÿ (”]ŠO): The 2nd Korean Japanese joint-Stroke conference (2004/11/27), ‰¡•l.

713095. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Treatment of ruptured intracranaial samll aneurysn with endovascular coil embolization. Patient selection and technical key points for successful coiling. —é–Ø˶, ŽR“c@Ÿ, “¡ˆä´F (”]ŠO): The 2nd Korean-Japaneses Joint Stroke Conference (2004/11/28), “Œ‹ž.

722042. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “ªŠW“àgerminoma‚É‚¨‚¯‚é•a—‘gD‘œ‚ÆŽîᇂ̎¡—Ô½‰ž«‚Æ‚ÌŠÖŒW. ‰F’ÖØ@‘, ‰ª@GG, ‹ß“¡GŽ¡, ’Jè‹`“¿, ¬—шè•v, “c’†@‘, ˆÀˆä”ü], “¡ˆä´F (”]ŠO): ‘æ32‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï (2004/5/29), é‹Ê.

722043. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒOƒŠƒI[ƒ}‚ɑ΂·‚鉻Šw—Ö@‚Ì“W–]|ŒÂ•Ê‰»•â•—Ö@100‰ñ‚̉ðÍ‚©‚ç|. “c’†@‘1, ‰ª@GG1, ¬—шè•v1, ‰F’ÖØ@‘1, ë“à—²—Y1, ˆÀˆä”ü]1, “¡ˆä´F1, “n•Ó‚Žu2, –x@’qŸ3 (1”]ŠO. 2’¹Žæ‘å. 3“Œ‹ž—ˆã‘å): ‘æ22‰ñ“ú–{”]Žîᇊw‰ï (2004/10/17-19), ¼“‡.

722044. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) •a‰@‚Æ‚µ‚Ä‹‚ß‚é‚à‚Ì. ‘å‚O–« (”]ŠO): “ú–{ˆã—ÃKƒXŠw‰ï‘æ8‰ñŠwp‘å‰ïE‘‰ï (2004/11/6), “Œ‹ž.

722045. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”]Žîᇎèp‚É‚¨‚¯‚ép’†MEPƒ‚ƒjƒ^ƒŠƒ“ƒO. “c’†@‘1, ¬—шè•v1, ë“à—²—Y1, ‚—œ~Žq2, Šâ–{˜a‹v1, ²“¡Ÿl1, ‰ª@GG1, “¡ˆä´F1 (1”]ŠO. 2–k–{ƒƒfƒBƒJƒ‹): ‘æ9‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2004/11/11), ‹à‘ò.

722046. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘Α¤Žˆ‚̃^ƒbƒv‚É”½‰ž‚·‚鎋°‚̃jƒ…[ƒƒ“. ‘å]çœA1, ŽÄè@“O1, ¿ŠÔ@˜N1, ²“¡Ÿl2 (1“ú‚•a‰@E”]ŠO. 2”]ŠO): ‘æ44‰ñ“ú–{’èˆÊE‹@”\_ŒoŠO‰ÈŠw‰ï (2005/1/22), ‘åã.

722047. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Cyst‚ðŒ`¬‚·‚égloiblastoma‚Ì•a—‘gD‘œ. ‰F’ÖØ@‘, ‰ª@GG, —é–Ø˶, ´…@‹Å, ‹ß“¡GŽ¡, ’Jè‹`“¿, “c’†@‘, “¡ˆä´F (”]ŠO): ‘æ23‰ñ“ú–{”]Žîᇕa—Šw‰ï (2005/4/21), “Œ‹ž.

723363. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”][Ç‚Å”­Ç‚µŽ©‘RÁŽ¸‚µ‚½”]“®Ã–¬ŠïŒ`‚̈ê—á. ‰F’ÖØ@‘1, “c’†@‘1, Šâ–{˜a‹v1, œA£—²ˆê2, ’·’Jì‚ЂƂÝ2, ’Ò@rˆê2, “¡ˆä´F1 (1”]ŠO. 2–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@): ‘æ27‰ñ“ú–{”]_ŒoCIŠw‰ï‘‰ï (2004/4/2), –¼ŒÃ‰®.

723364. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ґÖ¬Šg’£‚𔺂Á‚½“Á”­«’ᑉtˆ³ÇŒóŒQ‚ÌŒŸ“¢. ’†Œ´–M»1, ”Ñ“cG•v1, ‘åàV¬”V1, ‰F’ÖØ@‘1, ŽO•x“N˜Y2, “¡ˆä´F1 (1”]ŠO. 2‘Ûe‘P‘‡•a‰@): ‘æ27‰ñ“ú–{”]_ŒoCIŠw‰ï‘‰ï (2004/4/2), –¼ŒÃ‰®.

723365. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒŒðœ‹Žp‚ð‰Á‚¦‚½’´‘I‘ð“IŒŒð—n‰ð—Ö@‚Ì—LŒø«‚ɂ‚¢‚Ä: “®•¨ŽÀŒ±“IŒŸ“¢. •½ŽR@Žõ1, ‘q“c@²2, —é–Ø˶2, “’àV@ò2, “¡ˆä´F2, ‘å“ä’m3 (1’·’ÓcŒú¶•a‰@. 2”]ŠO. 3’²•z•a‰@): ‘æ20‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï (2004/4/10), ŽD–y.

723366. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “àŽ¨“¹Œã•Ç휂ɂ¨‚¯‚é“àƒŠƒ“ƒp”XE“àƒŠƒ“ƒpŠÇ‘¹‚̃ŠƒXƒN: ‰ð–UŠw“IŒŸ“¢. ´…@‹Å1, “c’†–ö…1, Albert Rhoton Jr2, ‰ª@GG1, “¡ˆä´F1 (1”]ŠO. 2ƒtƒƒŠƒ_‘å): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/4/16), –¼ŒÃ‰®.

723367. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Mayo Clinic—¯Šw‹L|‹^–â‚ÉŠ´‚¶‚½Ç—á‚©‚çL‚ª‚Á‚½¢ŠE‚Ì—Ö|. ‰ª@GG (”]ŠO): ‘æ22‰ñ“ú–{”]Žîᇕa—Šw‰ï (2004/5/20), VŠƒ.

723368. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “ªŠW“àgerminoma‚É‚¨‚¯‚é•a—‘gD‘œ. ‰F’ÖØ@‘, ‰ª@GG, ‹ß“¡GŽ¡, ’Jè‹`“¿, ¬—шè•v, “c’†@‘, ˆÀˆä”ü], “¡ˆä´F (”]ŠO): ‘æ22‰ñ“ú–{”]Žîᇕa—Šw‰ï (2004/5/20), VŠƒ.

723369. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”]Žîᇂɂ¨‚¯‚é“æˆóEˆ³Á×–Ef‚Ìf’fŠw“I—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢E‘æ2•ñ. Š`ÀœA–M1. Šâ•£Œ[ˆê2. ì–ìM”V3. •ž•”@Šw1. ‰F’ÖØ@‘3. ‰ª@GG3. “¡ˆä´F3 ‰ªˆÀ@ŒM2 (1•a‰@•a—•”. 2•a—. 3”]ŠO): ‘æ22‰ñ“ú–{”]Žîᇕa—Šw‰ï (2004/5/20), VŠƒ.

723370. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Ž²’łւ̉“Šu“]ˆÚ‚ð‚«‚½‚µ‚½glioblastoma‚̈ê—á. ‰F’ÖØ@‘1, “c’†@‘1,2, ¬—шè•v2, Šâ–{˜a‹v1, ‰ª@GG1, ˆÀˆä”ü]1, “¡ˆä´F1, –{@‹§2 (1”]ŠO. 2–k–{ƒƒfƒBƒJƒ‹): ‘æ22‰ñ“ú–{”]Žîᇕa—Šw‰ï (2004/5/21), VŠƒ.

723371. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ä”­Žžpolar spongio-blastic pattern‚ð’悵‚½low grade astrocytoma‚Ì2—á. ²“¡Œör1, ‰ª@GG1, ‰F’ÖØ@‘1, ’Jè‹`“¿1, ‹ß“¡GŽ¡1, ¬—шè•v1, ˆÀˆä”ü]1, “¡ˆä´F1, ì–ìM”V2 (1”]ŠO. 2ˆé•”ƒNƒŠƒjƒbƒN): ‘æ22‰ñ“ú–{”]Žîᇕa—Šw‰ï (2004/5/21), VŠƒ.

723372. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘o“à”dŽí‚ª”F‚ß‚ç‚ꂽpilocytic astrocytoma‚̈ê–UŒŸ—á. ¬—шè•v1, ‰ª@GG1, ‰F’ÖØ@‘1, ’Jè‹`“¿1, ‹ß“¡GŽ¡1, Œ´@“ÖŽq2, “¡ˆä´F1, ì–ìM”V3, –ö‰ºŽO˜Y4 (1”]ŠO, 2•a—. 3ˆé•”ƒNƒŠƒjƒbƒN. 4_“Þ샊ƒnƒrƒŠƒe[ƒVƒ‡ƒ“): ‘æ22‰ñ“ú–{”]Žîᇕa—Šw‰ï (2004/5/21), VŠƒ.

723373. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Multicentric glioma ‚̈ê—á. m–Ø@~1, ‰ª@GG1, ‰F’ÖØ@‘1, ’Jè‹`“¿1, ‹ß“¡GŽ¡1, ¬—шè•v2, “c’†@‘2, “¡ˆä´F1 (1”]ŠO. 2–k–{ƒƒfƒBƒJƒ‹): ‘æ22‰ñ“ú–{”]Žîᇕa—Šw‰ï (2004/5/21), VŠƒ.

723374. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Astrocytoma‚ɑ΂·‚é•úŽËüŽ¡—ÃŒã‚É”­¶‚µ‚½•úŽËü—U”­«“÷Žî‚̈ê—á. –]ŒŽ’O, ‰ª@GG, ‰F’ÖØ@‘, ’Jè‹`“¿, ‹ß“¡GŽ¡, ˆÀˆä”ü], “¡ˆä´F (”]ŠO): ‘æ22‰ñ“ú–{”]Žîᇕa—Šw‰ï (2004/5/21), VŠƒ.

723375. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¬”]Œ´”­clear cell ependymoma‚̈ê—á. ‘‘ŽiŒõ•F1, ‰ª@GG1, ‰F’ÖØ@‘1, ’Jè‹`“¿1, ‹ß“¡GŽ¡1, ˆÀˆä”ü]1, “¡ˆä´F1, ì–ìM”V2 (1”]ŠO. 2ˆé•”ƒNƒŠƒjƒbƒN): ‘æ22‰ñ“ú–{”]Žîᇕa—Šw‰ï (2004/5/21), VŠƒ.

723376. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) pilomyxoid astrocytoma‚Æf’f‚µ‚½¬Ž™‚Ì1Ç—á. ”‹Œ´G”V, ‰ª@GG, “¡ˆä´F (”]ŠO): ‘æ22‰ñ“ú–{”]Žîᇕa—Šw‰ï (2004/5/21), VŠƒ.

723377. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Šáâ|“àadenoid cystic carcinoma‚Ì1–UŒŸ—á. ‹ß“¡GŽ¡1, ‰ª@GG2, ‰F’ÖØ@‘2, ’Jè‹`“¿2, ˆÀˆä”ü]2, “¡ˆä´F2, Œ´@“ÖŽq3 (1Šƒ–èŽs—§•a‰@. 2”]ŠO. 3•a—): ‘æ22‰ñ“ú–{”]Žîᇕa—Šw‰ï (2004/5/21), VŠƒ.

723378. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Ò‘Œ´”­‚ÌAtipycal teratoid/rhabdoid tumor‚̈ê—á. ’Jè‹`“¿, ‰ª@GG, ‰F’ÖØ@‘, ‹ß“¡GŽ¡, ˆÀˆä”ü], “¡ˆä´F (”]ŠO): ‘æ22‰ñ“ú–{”]Žîᇕa—Šw‰ï (2004/5/21), VŠƒ.

723379. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒOƒŠƒI[ƒ}‚É‚¨‚¯‚éMGMTˆâ“`Žq‚Ì”­Œ»‚ÆIndividual adjuvant therapy (IAT). “c’†@‘1, ¬—шè•v1, ‰F’ÖØ@‘1, ˆÀˆä”ü]1, ‰ª@GG1, “¡ˆä´F1, “n•Ó‚Žu2, –x@’qŸ3 (1”]ŠO. 2’¹Žæ‘å. 3“Œ‹ž—ˆã‘å): ‘æ22‰ñ“ú–{”]Žîᇕa—Šw‰ï (2004/5/21), VŠƒ.

723380. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”]Žîᇂɑ΂·‚é•úŽËüÆŽËŒã‚Ì“ªŠW“à•a•Ï. ‰F’ÖØ@‘, ‰ª@GG, ‹ß“¡GŽ¡, ’Jè‹`“¿, ¬—шè•v, “c’†@‘, ˆÀˆä”ü], “¡ˆä´F (”]ŠO): ‘æ32‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï (2004/5/27), é‹Ê.

723381. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘o“à”dŽí‚ª”F‚ß‚ç‚ꂽpiocytic astrocytoma‚̈ê–UŒŸ—á. ¬—шè•v, ‰ª@GG, ‰F’ÖØ@‘, “c’†@‘, “¡ˆä´F (”]ŠO): ‘æ32‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï (2004/5/27), é‹Ê.

723382. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Spinal atypical eratoid/rhabdoid tumor‚̈ê—á. ’Jè‹`“¿1, ‰ª@GG1, ‰F’ÖØ@‘1, ‹ß“¡GŽ¡1, ˆÀˆä”ü]1, “¡ˆä´F1, ì–ìM”V2 (1”]ŠO. 2ˆé•”ƒNƒŠƒjƒbƒN): ‘æ32‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï (2004/5/27), é‹Ê.

723383. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ªŠWœœÜ‚©œ–D‡‚©‚ÌŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚½1Ç—á. ’†Œ´–M»1, ‹{â‰À’j1, ”Ñ“cG•v1, ›@Mˆê2, ‚–Ø@G1, ‰F’ÖØ@‘1, “¡ˆä´F1 (1”]ŠO. 2•ú): ‘æ32‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï (2004/5/27), é‹Ê.

723384. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —c¬Ž™‚ÉŽ‹Œð³”­¶‚µ‚½pilomyxoid astrocytoma‚̈ê—á. ”‹Œ´G”V, ‰ª@GG, ‰F’ÖØ@‘, “¡ˆä´F (”]ŠO): ‘æ32‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï (2004/5/27), é‹Ê.

723385. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™‚à‚â‚à‚â•a‚ɑ΂·‚é’¼ÚŠÔÚ•¡‡ŒŒsÄŒšp‚ÌŒø‰Ê|ŠÔÚŒŒsÄŒšp‚Æ‚Ì”äŠr|. ŽR“c@Ÿ, “’àV@ò, “c’†–ö…, ë“à—²—Y, ”‹Œ´G”V, ‰ª@GG, “¡ˆä´F (”]ŠO): ‘æ32‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï (2004/5/28), é‹Ê.

723386. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Nueofibromatosis type 1‚ɇ•¹‚µ‚½trabecular cell hyperplasia|‰æ‘œã‚­‚à–Œ”X–E‚ÆŠÓ•Ê‚ª¢“ï‚ÈVŽ¾Š³ŠT”O|. ‰ª@GG, ‰F’ÖØ@‘, ’†Œ´–M», “¡ˆä´F (”]ŠO): ‘æ32‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï (2004/5/28), é‹Ê.

723387. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) _“Þ쌧‚É‚¨‚¯‚郂ƒ„ƒ‚ƒ„•a‚̃Aƒ“ƒP[ƒg’²¸|“Á‚ɬŽ™—á‚ɂ‚¢‚Ä|. ŽR“c@Ÿ, “’àV@ò, “¡ˆä´F (”]ŠO): ‘æ32‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï (2004/5/28), é‹Ê.

723388. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘“àŽîᇓEo‚É‚¨‚¯‚é’†SŒŒŠÇ‚̉·‘¶. ŽOˆäŒö•F, z–K’m–ç, ŽO“‡‘å“¿, ´…@@‹Å (”]ŠO): ‘æ19‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2004/6/17), •Ÿˆä.

723389. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) æ“V«ŠÂ’ÅŒã‹|Œ‡‘¹‚Ì1—á. ë“à—²—Y, ‹k@Ž ‘, ¬—шè•v, ²“¡Œör, ŽRè—F–ç, –]ŒŽ’O, ‰ª@GG, “¡ˆä´F (”]ŠO): ‘æ19‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2004/6/18), •Ÿˆä.

723390. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œo“ªŠWŽhŒƒ‰^“®—U”­“dˆÊ‚Ì’è—Ê“I•]‰¿|‘“àŽîᇓEop‚Å‚ÌŒŸ“¢|. ŽO“‡‘å“¿, z–K’m–ç, ŽOˆäŒö•F (”]ŠO): ‘æ19‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2004/6/18), •Ÿˆä.

723391. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘å“®–¬‚É‚¨‚¯‚镪ߓ®–¬‹NŽn•”‚̉ð–U. ´…@‹Å1, “c’†–ö…1, ›@Mˆê2, —é–Ø˶1, ‘q“c@²1, “¡ˆä´F1 (1”]ŠO. 2•ú): ‘æ19‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2004/6/18), •Ÿˆä.

723392. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ґÖ¬Šg’£‚𔺂Á‚½“Á”­«’ᑉtˆ³ÇŒóŒQ‚ÌŒŸ“¢. ’†Œ´–M»1, ”Ñ“cG•v1, ŽO•x“N˜Y2, ‘åàV¬”V1, “¡ˆä´F1 (1”]ŠO. 2‘Ûe‘P‘‡•a‰@): ‘æ19‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2004/6/18), •Ÿˆä.

723393. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “àŽ¨“¹Œã•Ç휂ɂ¨‚¯‚é“àƒŠƒ“ƒp”XE“àƒŠƒ“ƒpŠÇ‘¹‚̃ŠƒXƒN: ‰ð–UŠw“IŒŸ“¢. ´…@‹Å1, “c’†–ö…1, Albert L Rhoton Jr2, ‰ª@GG1, “¡ˆä´F1 (1”]ŠO. 2ƒtƒƒŠƒ_‘å): ‘æ16‰ñ“ú–{“ªŠW’êŠO‰ÈŠw‰ï (2004/7/1), ‰¡•l.

723394. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –TÒ’Œi“W‚µ‚½ã‰º_ŒoâŽî‚ɑ΂·‚éTranscervical approach. ²“¡Œör, ´…@@‹Å, ‰ª@GG, ’†Œ´–M», ‰F’ÖØ@‘, “¡ˆä´F (”]ŠO): ‘æ16‰ñ“ú–{“ªŠW’êŠO‰ÈŠw‰ï (2004/7/2), ‰¡•l.

723395. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Hemifacial spasm (HFS) ‚Ìp’†Abnormal muscle response (AMR) ƒ‚ƒjƒ^ƒŠƒ“ƒO‚É‚¨‚¯‚é–â‘è“_. ²“¡Ÿl1, ŽR“c@Ÿ1, ‘q“c@²1, “¡ˆä´F1, ‰Í“‡]”ü2, ¬–ì‘ò—T–ç2 (1”]ŠO. 2—ÕŒŸŠw): ‘æ34‰ñ“ú–{—Õ°_Œo¶—Šw‰ïŠwp‘å‰ï (2004/7/3), “Œ‹ž.

723396. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a‚ɑ΂·‚éƒKƒ“ƒ}ƒiƒCƒt‚É‚æ‚鎋°ÆŽË|Ž‹°ÆŽË‘ƒ‚Ì”½‰ž|. ‘å]çœA1, ŽÄè@“O1, ²“¡Ÿl2 (1“ú‚•a‰@E‹@”\”]ŠO‰È. 2”]ŠO): ‘æ13‰ñ“ú–{’èˆÊ•úŽËüŽ¡—Êw‰ï (2004/7/10), “Œ‹ž.

723397. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”]—ÀoŒŒ‚Å”­Ç‚µ‚½‚—îŽÒ|‘¤«“àèò“®–¬’áŒ`¬‚Ì1—á. ²“¡Œör, ŽR“c@Ÿ, ë“à—²—Y, “¡ˆä´F (”]ŠO): ‘æ17‰ñ“ú–{˜V”N”]_ŒoŠO‰ÈŠw‰ï (2004/7/17), ì.

723398. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒNƒ‚–Œ‰ºoŒŒ”­Ç‚Ì’Åœ“®–¬‰ð—£|•Û‘¶“IŽ¡—×á‚Ì—Õ°“I“Á’¥‚Æ“]‹A|. ŽR“c@Ÿ1, —é–Ø˶1, “’àV@ò1, ‘q“c@²1, ‰Í“‡‰ë“ž2, “¡ˆä´F1, –kŒ´F—Y3 (1”]ŠO. 2ƒtƒƒŠƒ_‘å. 3‹~–½): ‘æ23‰ñThe Mt. Fuji Workshop on CVD (2004/8/29), “Œ‹ž.

723399. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”ñoŒŒ«“ªŠW“à‰ð—£«’Åœ“®–¬áŽ|‰æ‘œŠŒ©‚Æ’·Šú“]‹A|. ŽR“c@Ÿ1, —é–Ø˶1, ‘q“c@²1, ‰Í“‡‰ë“ž2, “’àV@ò1, “¡ˆä´F1, –kŒ´F—Y3 (1”]ŠO. 2ƒtƒƒŠƒ_‘å. 3‹~–½): ‘æ23‰ñThe Mt. Fuji Workshop on CVD (2004/8/29), “Œ‹ž.

723400. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) MRI‚É‚Äf’f‚É“ïa‚µ‚½Ò‘‘“àŽîᇂÌ3—á. Γn‰ë’j, ‹k@Ž ‘, “¡ˆä´F (”]ŠO): ‘æ19‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2004/9/16), •Ÿˆä.

723401. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Ò‘¶ŒŸ‚ðs‚Á‚½4—á. ŽOˆäŒö•F, ŽO“‡‘å“¿, z–K’m–ç (”]ŠO): ‘æ11‰ñ“ú–{Ò’ÅEÒ‘_ŒoŽèpŽè‹ZŠw‰ï (2004/9/19), ‘å‹{.

723402. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘å“®–¬‚É‚¨‚¯‚镪ߓ®–¬‹NŽn•”‚̉ð–U|‘I‘ð“IÒ‘“®–¬‘¢‰e‚Ì‚½‚ß‚É|. ´…@‹Å1, “c’†–ö…1, ›@Mˆê2, —é–Ø˶1, ‘q“c@²1, “¡ˆä´F1 (1”]ŠO. 2•ú): ‘æ11‰ñ“ú–{Ò’ÅEÒ‘_ŒoŽèpŽè‹ZŠw‰ï (2004/9/19), ‘å‹{.

723403. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒ‰ƒbƒgˆê‰ß«’†‘å”]“®–¬•Âǃ‚ƒfƒ‹‚É‚¨‚¯‚éƒVƒƒXƒ^ƒ][ƒ‹‘O“Š—^‚ƃIƒUƒOƒŒƒ‹ƒiƒgƒŠƒEƒ€•¹—p‚Ì”]•ÛŒìŒø‰Ê. “’àV@ò, ŽR“c@Ÿ, “¡ˆä´F (”]ŠO): ‘æ16‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï‘‰ï (2004/9/25), é‹Ê.

723404. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Chiasmal apoplexy ‚Å”­Ç‚µ‚½chiasmal pilocytic astrocytoma‚Ì1—á. ‹ß“¡GŽ¡1, “c’†@—m2, ‰F’ÖØ@‘1, ‰ª@GG1, “¡ˆä´F1 (1”]ŠO. 2Šƒ–èŽs—§•a‰@): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/6), –¼ŒÃ‰®.

723405. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “àèò“®–¬Œ`¬•s‘SEŒ‡‘¹Ç‚Ì3—á. ²“¡Œör, ŽR“c@Ÿ, ë“à—²—Y, “¡ˆä´F (”]ŠO): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/6), –¼ŒÃ‰®.

723406. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘åŠw•a‰@”]_ŒoŠO‰Èf—Âɂ¨‚¯‚é•ïŠ‡ˆã—à (DPC) “±“üŒã‚̕ω». ŽR“c@Ÿ, “’àV@ò, ‘q“c@², “¡ˆä´F (”]ŠO): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/6), –¼ŒÃ‰®.

723407. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ˆ««ƒOƒŠƒI[ƒ}‚ɑ΂·‚é’è—Ê“IRT-PCR‚ÉŠî‚¢‚½Individual adjuvant therapy‚ÌRandomized clinical trial. “c’†@‘1, ¬—шè•v1, ë“à—²—Y1, ’|“à³O2, ‰ª@GG1, ‰F’ÖØ@‘1, ˆÀˆä”ü]1, “¡ˆä´F1 (1”]ŠO. 2–k—¢Œ¤‹†Š): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/6), –¼ŒÃ‰®.

723408. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŽÀŒ±“Iˆê‰ß«”]‹•ŒŒ‚É‚¨‚¯‚éƒVƒƒXƒ^ƒ][ƒ‹‘O“Š—^‚ƃIƒUƒOƒŒƒ‹ƒiƒgƒŠƒEƒ€•¹—p‚Ì”]•ÛŒìŒø‰Ê. “’àV@ò, ŽR“c@Ÿ, “¡ˆä´F (”]ŠO): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/6), –¼ŒÃ‰®.

723409. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹CŠÇØŠJ‚̇•¹Ç. ”Ñ“cG•v, ’†Œ´–M», ‹v{”ü^— (”]ŠO): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/6), –¼ŒÃ‰®.

723410. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ªŠWœŒ´”­‚ÌMalignant Lymphoma‚̈ê—á. •Ÿ“‡@_, ‰ª@GG, ‰F’ÖØ@‘, ’†Œ´–M», “¡ˆä´F (”]ŠO): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/7), –¼ŒÃ‰®.

723411. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “ªŠW’ê•”Žîᇎèp‚ɃA[ƒXƒƒPƒAƒ}ƒ‹ƒ`ƒGƒŒƒNƒgƒ[ƒhƒVƒXƒeƒ€2000‚Í—LŒø‚©? ‰ª@GG, ´…@‹Å, ‰F’ÖØ@‘, —é–Ø˶, “¡ˆä´F (”]ŠO): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/7), –¼ŒÃ‰®.

723412. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”]“®–¬áŽ•]‰¿‚É‚¨‚¯‚éŽOŽŸŒ³DSA‚Ì—L—p«: 86”]“®–¬áŽ‚ÌŒŸ“¢. ‰Í“‡‰ë“ž1, ‹{“‡—Ç‹P2, ¬òŠ°”V2, m–Ø@~2, –]ŒŽ’O2, ‰““¡¹F2, –kŒ´F—Y3, “¡ˆä´F2 (1ƒtƒƒŠƒ_‘å. 2”]ŠO. 3‹~–½): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/7), –¼ŒÃ‰®.

723413. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒWƒXƒgƒjƒA‚ɑ΂·‚éThalamotomy. ²“¡Ÿl1, ‘å]çœA2, ŽÄè@“O2 (1”]ŠO. 2“ú‚•a‰@E‹@”\”]ŠO‰È): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/7), –¼ŒÃ‰®.

723414. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) æ“V«ŠÂ’ÅŒã‹|‘¹‚Ì_ŒoÇó”­Œ»‚É‚¨‚¯‚é_Œo•úŽËüŠw“IŒŸ“¢. ë“à—²—Y, ‹k@Ž ‘, ²“¡Œör, ´…@‹Å, “¡ˆä´F (”]ŠO): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/7), –¼ŒÃ‰®.

723415. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”]Žº• o“àƒVƒƒƒ“ƒg‚Ì“ªŠW“à–À“ü: 2—á•ñ‚Æ•¶Œ£“IlŽ@. ŽRè—F–ç, ´…@‹Å, ë“à—²—Y, ‰F’ÖØ@‘, “¡ˆä´F (”]ŠO): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/7), –¼ŒÃ‰®.

723416. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) oŒŒ«‚à‚â‚à‚â•a‚Ì—Õ°“I“Á’¥. ”‹Œ´G”V1, ŽR“c@Ÿ1, —é–Ø˶1, ‘q“c@²1, ‹{“‡—Ç‹P1, ‰Í“‡‰ë“ž2, “¡ˆä´F1, ‘å“ä’m1 (1”]ŠO. 2ƒtƒƒŠƒ_‘å): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/7), –¼ŒÃ‰®.

723417. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘å“®–¬‚É‚¨‚¯‚镪ߓ®–¬‹NŽn•”: Ò‘“®–¬‘¢‰e‚Ì‘I‘ð“IƒJƒjƒ…ƒŒ[ƒVƒ‡ƒ“‚Ì‚½‚߂̉ð–U. ´…@‹Å1, “c’†–ö…1, ›@Mˆê2, —é–Ø˶1, ‘q“c@²1, “¡ˆä´F1 (1”]ŠO. 2•ú): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/7), –¼ŒÃ‰®.

723418. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠC–È‘wÖ¬“´•”d–Œ“®Ã–¬á‘‚Ì—Õ°‘œ‚¨‚æ‚Ñ•úŽËüŠw“IŒŸ“¢‚𓥂܂¦‚½‚»‚ÌŽ¡—Ãí—ª. ‘q“c@²1, —é–Ø˶1, “’àV@ò1, ¬àV@m2, “¡ˆä´F1, ›@Mˆê3, ”‹Œ´G”V1, ‘å“ä’m1 (1”]ŠO. 2Ž¬“c‘‡•a‰@. 3•ú): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/7), –¼ŒÃ‰®.

723419. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’·ŠúŒo‰ßŠÏŽ@‚©‚ç‚Ý‚½Ò‘¯×–EŽî‚Ì—\Œã. ’Jè‹`“¿, ‰ª@GG, ‰F’ÖØ@‘, ´…@‹Å, —é–Ø˶, “¡ˆä´F, ‹k@Ž ‘ (”]ŠO): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/7), –¼ŒÃ‰®.

723420. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹}«‘ˆ«‚µ‚½MELAS‚̈ê—á. ’†Œ´–M»1, ”Ñ“cG•v1, ŽO•x“N•v2, ë“à—²—Y1, ‹v{”ü^—1, “¡ˆä´F1 (1”]ŠO, 2‘Ûe‘P‘‡•a‰@): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/7), –¼ŒÃ‰®.

723421. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) spectrometer‚ð—p‚¢‚½p’†”]ŽîᇌuŒõf’f. ‰F’ÖØ@‘1, ‰ª@GG1, —é–Ø˶1, ´…@‹Å1, •Ÿ“‡@_1, ’Jè‹`“¿1, “c’†@‘1,2, “¡ˆä´F1 (1”]ŠO. 2–k–{ƒƒfƒBƒJƒ‹): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/8), –¼ŒÃ‰®.

723422. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”]Š²Œ´”­‚ÌRhabdomyosarcoma‚̈ê–UŒŸ—á. ‹{“‡—Ç‹P, ‰ª@GG, ‰F’ÖØ@‘, •Ÿ“‡@_, ’Jè‹`“¿, “¡ˆä´F (”]ŠO): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/8), –¼ŒÃ‰®.

723423. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘“àŽîᇓEop, Å‹ß‚Ìi•à. ŽOˆäŒö•F, ŽO“‡‘å“¿, z–K’m–ç, ´…@‹Å (”]ŠO): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/8), –¼ŒÃ‰®.

723424. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘“àŽîᇓEop, Å‹ß‚Ìi•à. ¬àV’B–ç1, “¿‰¤@G2, “’”Vãr“ñ2, ég@—§•½2, ƒpƒgƒ‰ƒLƒbƒgƒRƒ€ƒWƒ‡ƒ‹ƒ“EƒVƒŠƒ|ƒ“2, Œ´@•q_2, “¡ˆä´F1, r–Ø—ß]2, ²’JGs2 (1”]ŠO. 2ŒF–{‘å): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/8), –¼ŒÃ‰®.

723425. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”j—ô”÷¬”]“®–¬áŽ‚ɑ΂·‚é”]ŒŒŠÇ“àŽèp. —é–Ø˶1, ‘q“c@²1, –kŒ´F—Y2, ›@Mˆê3, ‘å“ä’m1, ¬àV@m4, “’àV@ò1, •Ÿ“‡@_1, ë“à—²—Y1, ŽR“c@Ÿ1, ‰ª@GG1, “¡ˆä´F1 (1”]ŠO. 2‹~–½. 3•ú. 4Ž¬“c‘‡•a‰@): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/8), –¼ŒÃ‰®.

723426. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) V‚µ‚¢Ç𕨎¿: ƒvƒ‰ƒ`ƒiƒ{[ƒ‹. ¬àV@m1, ‘q“c@²2, —é–Ø˶2, “¡ˆä´F2, ›@Mˆê3 (1Ž¬“c‘‡•a‰@. 2”]ŠO. 3•ú): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/8), –¼ŒÃ‰®.

723427. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Š´õ‚𔺂Á‚½“]ˆÚ«”]Žîᇂ̈ê—á. ‘åàV¬”V, ‰F’ÖØ@‘, ‰ª@GG, •Ÿ“‡@_, —é–Ø˶, ´…@‹Å, “¡ˆä´F (”]ŠO): ‘æ63‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (2004/10/8), –¼ŒÃ‰®.

723428. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Malignant Glioma‚ɑ΂·‚鉻Šw—Ö@Ž{s—á‚É‚¨‚¯‚éLenograstimŽŠ“K“Š—^—Ê‚ÌŒŸ“¢. ‰F’ÖØ@‘1, ‰ª@GG1, “c’†@‘1,2, •Ÿ“‡@_1, ’Jè‹`“¿1, ‹ß“¡GŽ¡1 (1”]ŠO. 2–k–{ƒƒfƒBƒJƒ‹): ‘æ22‰ñ“ú–{”]Žîᇊw‰ï (2004/10/18), ¼“‡.

723429. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ˆ««ƒOƒŠƒI[ƒ}Ž¡—Âɂ¨‚¯‚éŠO—ˆ‰»Šw—Ö@ƒZƒ“ƒ^[‚Æê”Cˆã—Î҂̈ç¬. ‰ª@GG1, ‰F’ÖØ@‘1, ’Jè‹`“¿1, —é–Ø˶1, “c’†@‘1,2, “¡ˆä´F1, ‘ì˜ad3 (1”]ŠO. 2–k–{ƒƒfƒBƒJƒ‹. 3•ú): ‘æ22‰ñ“ú–{”]Žîᇊw‰ï (2004/10/18), ¼“‡.

723430. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘æŽO”]Žº‚ÉŒÀ‹Ç‚µ‚½Œ´”­«“ªŠW“àˆ««ƒŠƒ“ƒpŽî‚Ì1—á. ‹{“‡—Ç‹P, ‰ª@GG, ‰F’ÖØ@‘, ’Jè‹`“¿, “¡ˆä´F (”]ŠO): ‘æ22‰ñ“ú–{”]Žîᇊw‰ï (2004/10/18), ¼“‡.

723431. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ciliated craniopharyngioma‚Ì1—á. ²“¡Œör1, ‰ª@GG2, ‰F’ÖØ@‘2, ’Jè‹`“¿2, ‹ß“¡GŽ¡2, “¡ˆä´F2 (1•½’Ë϶‰ï•a‰@. 2”]ŠO): ‘æ22‰ñ“ú–{”]Žîᇊw‰ï (2004/10/18), ¼“‡.

723432. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŽîᇓàoŒŒ‚É‚Ä”­Ç‚µ‚½“ªŠW“àŒ´”­ˆ««ƒŠƒ“ƒpŽî‚Ì1—á. ¬—шè•v1, “c’†@‘1, ë“à—²—Y1, –{@‹§2 (1”]ŠO. 2–k–{ƒƒfƒBƒJƒ‹): ‘æ22‰ñ“ú–{”]Žîᇊw‰ï (2004/10/18), ¼“‡.

723433. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Lipomatous meningioma‚É‚¨‚¯‚鎉Ž¿’è«•ªÍ. ’Jè‹`“¿1, ‰ª@GG1, ‰F’ÖØ@‘1, ²“¡Œör2, •Ÿ“‡@_1, “¡ˆä´F1, ’†‘º˜a¶3, ‚‹´³g3 (1”]ŠO. 2•½’Ë϶‰ï•a‰@. 3‘ãŽÓ’`”’): ‘æ22‰ñ“ú–{”]Žîᇊw‰ï (2004/10/18), ¼“‡.

723434. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ªŠWœŒ´”­‚ÌMalignant Lymphoma‚Ì1—á. •Ÿ“‡@_, ‰ª@GG, ‰F’ÖØ@‘, “¡ˆä´F (”]ŠO): ‘æ22‰ñ“ú–{”]Žîᇊw‰ï (2004/10/18), ¼“‡.

723435. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ú’Ê«“ª•”ŠO‚Ì•úŽËüŠw“I“Á’¥‚¨‚æ‚ÑŽ¡—Ãí—ª. ‹v{”ü^—1, ”Ñ“cG•v1, ’†Œ´–M»1, –kŒ´F—Y2, ‰““¡¹F1, “¡ˆä´F1 (1”]ŠO. 2‹~–½): ‘æ32‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïŠwpW‰ï (2004/10/29), ç—t.

723436. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”j—ô”]“®–¬áŽ‚É‚æ‚éƒNƒ‚–Œ‰ºoŒŒ‚ɑ΂·‚éƒNƒŠƒeƒBƒJƒ‹ƒpƒX‚Ì“±“ü. ”Ñ“cG•v1, ’†Œ´–M»1, ‹v{”ü^—1, –kŒ´F—Y2, “¡ˆä´F1 (1”]ŠO. 2‹~–½): ‘æ32‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïŠwpW‰ï (2004/10/29), ç—t.

723437. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Eloquent area‚Ì”]Žîᇫ•a•Ï‚ɑ΂·‚é”]ƒ‚ƒjƒ^ƒŠƒ“ƒOEŠoÁ‰º‚ÌŽèp¬Ñ. ‰ª@GG1, ²“¡Ÿl1. ‰F’ÖØ@‘1, ´…@‹Å1, —é–Ø˶1, “¡ˆä´F1, ‰ª–{_Žk2 (1”]ŠO. 2•ú): ‘æ9‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2004/11/11), ‹à‘ò.

723438. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “àèò“®–¬Œn‚©‚ç‚à‰h—{‚³‚ê‚é‘–ŒŽî‚Ìp‘O‘I‘ð“IÇðp‚ÌŒŸ“¢. —é–Ø˶1, ‘q“c@²1, ‰ª@GG1, ‰F’ÖØ@‘1, ›@Mˆê2, ‘å“ä’m1, ë“à—²—Y1, ´…@‹Å1, ’Jè‹`“¿1, “¡ˆä´F1 (1”]ŠO. 2•ú): ‘æ9‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2004/11/11), ‹à‘ò.

723439. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŽîᇊOoŒŒ‚ð‚«‚½‚µ‚½’®_ŒoâŽî‚Ì1—á. ‘åàV¬”V, ‰ª@GG, ‰F’ÖØ@‘, ´…@‹Å, —é–Ø˶, •Ÿ“‡@_, ‘‘ŽiŒõ•F, ŽRè—F–ç, “¡ˆä´F (”]ŠO): ‘æ9‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2004/11/11), ‹à‘ò.

723440. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “÷Šá“I‚ÉŒuŒõ”­F‚ðŽ¦‚³‚È‚¢Žîᇂɑ΂·‚éspectromenter‚ð—p‚¢‚½f’f. ‰F’ÖØ@‘1, ‰ª@GG1, —é–Ø˶1, ´…@‹Å1, •Ÿ“‡@_1, ’Jè‹`“¿1, “c’†@‘1,2, “¡ˆä´F1 (1”]ŠO. 2–k–{ƒƒfƒBƒJƒ‹): ‘æ9‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2004/11/12), ‹à‘ò.

723441. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Žr‘Ì“ª•”‚ð—p‚¢‚½ŠO‰È‰ð–U‚ÌŠwK–@EŒŸ‘Ì€”õEdissectionE3‚cŽÊ^ŽB‰e. ´…@‹Å1, “c’†–ö…1, ‘åàV¬”V1, ‰Í“‡‰ë“ž2, ‰ª@GG1, “¡ˆä´F1, A Rhoton2 (1”]ŠO. 2ƒtƒƒŠƒ_‘å): ‘æ9‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2004/11/12), ‹à‘ò.

723442. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) McaCarty keyhole‚ÌÅ“K‚ȈʒuE‰ð–UŠw“IŒŸ“¢. ´…@‹Å1, A Rhoton2, “¡ˆä´F1 (1”]ŠO. 2ƒtƒƒŠƒ_‘å): ‘æ9‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2004/11/12), ‹à‘ò.

723443. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”]_ŒoŠO‰Èp’†Œo“ªŠWMEPƒ‚ƒjƒ^ƒŠƒ“ƒO‚Ì•]‰¿. ‚—œ~Žq1, “c’†@‘2 (1–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@. 2”]ŠO): ‘æ34‰ñ“ú–{—Õ°_Œo¶—Šw‰ïŠwp‘å‰ï (2004/11/17), “Œ‹ž.

723444. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰¡E‚róÖ¬“´•”isolated type dural AVF‚ɑ΂·‚鎡—Ãí—ª. ë“à—²—Y1, ‘q“c@²1, —é–Ø˶1, “’àV@ò1, ´…@‹Å1, “¡ˆä´F1, ›@Mˆê2, ‘å“ä’m3, ”‹Œ´G”V3 (1”]ŠO. 2•ú. 3’²•z•a‰@): ‘æ20‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï (2004/11/18), ŽD–y.

723445. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”j—ô”÷¬”]“®–¬áŽ‚ɑ΂·‚錌ŠÇ“àŽèp‚ɂ‚¢‚Ä. —é–Ø˶1, ‘q“c@²1, “’àV@ò1, •Ÿ“‡@_1, ë“à—²—Y1, ¬àV@m1, “¡ˆä´F1, –kŒ´F—Y2, ›@Mˆê3, ‘å“ä’m4 (1”]ŠO. 2‹~–½. 3•ú. 4’²•z•a‰@): ‘æ20‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï (2004/11/18), ŽD–y.

723446. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) V‚µ‚¢Ç𕨎¿: ƒvƒ‰ƒ`ƒiƒ{[ƒ‹. ¬àV@m1, ‘q“c@²2, —é–Ø˶2, “¡ˆä´F2 (1Ž¬“c‘‡•a‰@. 2”]ŠO): ‘æ20‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï (2004/11/18), ŽD–y.

723447. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘å“®–¬‚É‚¨‚¯‚镪ߓ®–¬‹NŽn•”: Ò‘“®–¬‘¢‰e‚Ì‘I‘ð“IƒJƒjƒ…ƒŒ[ƒVƒ‡ƒ“‚Ì‚½‚߂̉ð–U. ´…@‹Å1, “c’†–ö…1, ›@Mˆê2, —é–Ø˶1, ‘q“c@²1, “¡ˆä´F1 (1”]ŠO. 2•ú): ‘æ20‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï (2004/11/18), ŽD–y.

723448. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚—îŽÒ”]“®–¬áŽŒŒŠÇ“àŽ¡—Âɂ¨‚¯‚é‘Œz“®–¬’¼ÚúŽh—pƒKƒCƒfƒBƒOƒJƒe[ƒeƒ‹‚Ì—L—p«. “’àV@ò1, ‘q“c@²1, —é–Ø˶1, ›@Mˆê2, “¡ˆä´F1 (1”]ŠO. 2•ú): ‘æ20‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï (2004/11/18), ŽD–y.

723449. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”j—ô‰ð—£«’Åœ“®–¬áŽ‚ɑ΂·‚éƒRƒCƒ‹Çðp‚Ì—LŒø«. X“ˆŒ[”V1, ÷ˆä@F1, ‘q“c@²2, ‹´–{‘ì—Y1, “¡ˆä´F2, –kŒ´F—Y3, ›@Mˆê4, X“ˆŒ[”V1 (1¹ƒ}ƒŠƒAƒ“ƒiˆã‘å. 2”]ŠO. 3‹~–½. 4•ú): ‘æ20‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï (2004/11.19), ŽD–y.

723450. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ªŠW“à“®–¬‚ªŽå‚½‚éŽîᇉh—{ŒŒŠÇ‚Ì”]Žîᇂɑ΂·‚鎡—Ãí—ª|ŒŒŠÇ“àŽèp‚Ì•¹—p|. ‘å“ä’m1, ‘q“c@²2, —é–Ø˶2, ”‹Œ´G”V1, ‰ª@GG2, “¡ˆä´F2 (1’²•z•a‰@. 2”]ŠO): ‘æ20‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï (2004/11/19), ŽD–y.

723451. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠOŒzÖ¬’¼ÚúŽh‰º, èò“®–¬Œo—RÇðp‚ªŒð‚ð‘t‚µ‚½lsolted sinus dural AVF‚Ì1—á. ‘q“c@²1, —é–Ø˶1, “’àV@ò1, ´…@‹Å1, “¡ˆä´F1, ›@Mˆê2, ‘å“ä’m3, ¬àV@m4 (1”]ŠO. 2•ú. 3’²•z•a‰@. 4Ž¬“c‘‡•a‰@): ‘æ20‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï (2004/11/19), ŽD–y.

723452. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) AVM‚ɑ΂·‚é, ƒŠƒLƒbƒhƒRƒCƒ‹Çðp‚Ì—L—p«. ‘q“c@²1, —é–Ø˶1, “’àV@ò1, ŽR“c@Ÿ1, “¡ˆä´F1, ›@Mˆê2, –kŒ´F—Y3, ‘å“ä’m4, ¬àV@m5 (1”]ŠO. 2•ú. 3‹~–½. 4’²•z•a‰@. 5Ž¬“c‘‡•a‰@): ‘æ20‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ï (2004/11/19), ŽD–y.

723453. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Chiasmal apoplexy‚Ì1Ç—á. ‹ß“¡GŽ¡1,2, “c’†@—m1, ‰F’ÖØ@‘2, ‰ª@GG2, “¡ˆä´F2 (1Šƒ–èŽs—§•a‰@. 2”]ŠO): ‘æ15‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2005/2/11), “Œ‹ž.

723454. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “ªŠWˆô“ªŽî‚ÌŽ¡—Ãí—ª |ŠeŽîᇂɑI‘ð‚·‚éŽèpƒAƒvƒ[ƒ`‚ÆŒ°”÷‹¾E“àŽ‹‹¾Žèp|surgical strategy for carnioharyngiomas. ‰ª@GG, “¡ˆä´F (”]ŠO): ‘æ15‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2005/2/11), “Œ‹ž.

723455. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹•ŒŒ«‰º‚‘Ì‘²’†‚Ž—Õ°•a—Šw“IŒŸ“¢|Clinico-pathological study for ischemic pituitary apoplexy|. ‰ª@GG, —é–Ø˶, ‰F’ÖØ@‘, ‹ß“¡GŽ¡, ’Jè‹`“¿, “¡ˆä´F (”]ŠO): ‘æ15‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2005/2/11), “Œ‹ž.

723456. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒ‰ƒPƒg”X–E‚̉摜f’f‚ÆŽ¡—ìÑ. ‰ª@GG, ‰F’ÖØ@‘, ‹ß“¡GŽ¡, ’Jè‹`“¿, ²“¡Œör, “¡ˆä´F (”]ŠO): ‘æ15‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2005/2/11), “Œ‹ž.

723457. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “®‘Ômultislice-detector low CT (MDCT) ‚ª•a‘Ô”cˆ¬‚É—L—p‚Å‚ ‚Á‚½æ“V«ŠÂ’ÅŒã‹|Œ‡‘¹Ç‚Ì1—á. ë“à—²—Y1, ›@Mˆê2, ‹k@Ž ‘1, ¬—шè•v1, “¡ˆä´F1 (1”]ŠO. 2•ú): ‘æ34‰ñ“ú–{_Œo•úŽËüŠw‰ï (2005/2/11), –¼ŒÃ‰®.

723458. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) èò•”ˆÀÂŎ©‘RÁŽ¸‚µ‚½retro-odontoid pseudotumor‚Ì•úŽËüŠw“IŒŸ“¢. ë“à—²—Y1, ›@Mˆê2, ‹k@Ž ‘1, “c’†–ö…1, ´…@‹Å1, ¬—шè•v1, “¡ˆä´F1 (1”]ŠO. 2•ú): ‘æ34‰ñ“ú–{_Œo•úŽËüŠw‰ï (2005/2/11), –¼ŒÃ‰®.

723459. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰º‚‘Ì‘BŽî‚ð‡•¹‚µ‚½–TˆÆ•”“î‚Ì1—á. ¬—шè•v1, “c’†@‘1, ë“à—²—Y1, –{@‹§2, Ž‰Æ@O3, –x@@’qŸ3 (1”]ŠO. 2–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@. 3“Œ‹ž—ˆã‘å): ‘æ15‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2005/2/11), “Œ‹ž.

723460. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŽîᇓàoŒŒ‚𗈂µ‚½Ž‹°‰º•”¯×–EŽî‚Ì1—á. ’Jè‹`“¿1, ‰ª@GG1, ‰F’ÖØ@‘1, —é–Ø˶1, ´…@‹Å1, ‹ß“¡GŽ¡2, “¡ˆä´F1 (1”]ŠO. 2Šƒ–èŽs—§•a‰@): ‘æ15‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2005/2/11), “Œ‹ž.

723461. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Hypothalamic/chiasmatic glioma‚ÌŽ¡—ìт̌Ÿ“¢. ‰F’ÖØ@‘1, ‰ª@GG1, ’Jè‹`“¿1, ‹ß“¡GŽ¡1, “c’†@‘2, ˆÀˆä”ü]1, “¡ˆä´F1 (1”]ŠO. 2–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@): ‘æ15‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2005/2/12), “Œ‹ž.

723462. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰º‚‘Ì‚¨‚æ‚Ñ–TˆÆ•”Žîᇂɑ΂·‚ép’†VEPƒ‚ƒjƒ^ƒŠƒ“ƒO. “c’†@‘1, ¬—шè•v1, ‚—œ~Žq1, ‰ª@GG2, ‰F’ÖØ@‘2, “¡ˆä´F2, Ž‰Æ@O3, –x@’qŸ3 (1–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@. 2”]ŠO. 3“Œ‹ž—ˆã‘å): ‘æ15‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2005/2/12), “Œ‹ž.

723463. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) germinoma MRI‰æ‘œ‚Æ•a—‘gD. ‰F’ÖØ@‘, ‰ª@GG, ë“à—²—Y, ’Jè‹`“¿, ‹ß“¡GŽ¡, “¡ˆä´F (”]ŠO): ‘æ28‰ñ“ú–{”]_ŒoCIŠw‰ï‘‰ï (2005/3/18), ì.

723464. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œã“ªŠWâ|‚É”­¶‚µ‚½fibrous tumor‚Ì•úŽËüŠw“IŒŸ“¢. ’†Œ´–M»1, ”Ñ“cG•v1, ‰F’ÖØ@‘1, ŽO•x“N˜Y2, “¡ˆä´F1 (1”]ŠO. 2‘Ûe‘P‘‡•a‰@): ‘æ28‰ñ“ú–{”]_ŒoCIŠw‰ï‘‰ï (2005/3/18), ì.

723465. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ú’Ê«“ª•”ŠO10—á‚É‚¨‚¯‚é•úŽËüŠw“If’f‚ÆŽ¡—Ãí—ª‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‹v{”ü^—1, ”Ñ“cG•v1, ’†Œ´–M»1, –kŒ´F—Y2, ‰““¡¹F1, “¡ˆä´F1 (1”]ŠO. 2‹~–½): ‘æ28‰ñ“ú–{_ŒoŠOŠw‰ï (2005/3/26), ‘å‹{.

731064. [Œ¤‹†‰ï] (‹³ˆçu‰‰) ‚ŒŒˆ³Šwpu‰‰@“ú–{l‚É‘½‚¢”]‘²’†‚ðŒ¸‚ç‚·‚É‚ÍH|Šë‚È‚¢”]‘²’†‚ðŒ©“¦‚³‚È‚¢|. ‘q“c@² (”]ŠO): –k—¢zŠÂŠíƒZƒ~ƒi[ (2004/5/13), ‘Š–Í‘å–ì.

731065. [Œ¤‹†‰ï] (“Á•Êu‰‰) •a‰@‚É‚¨‚¯‚郊ƒXƒNƒ}ƒlƒWƒƒ“ƒg. “¡ˆä´F (”]ŠO): ”]Œ¤ƒZƒ~ƒi[ (2004/6/4), ŽD–y.

731066. [u‰‰‰ï] (“Á•Êu‰‰) ”]‘²’†ƒKƒCƒhƒ‰ƒCƒ“‚Æ”]‘²’†f’f‚ɂ‚¢‚Ä. “¡ˆä´F (”]ŠO): ‘Š–ÍŒ´ŽsˆãŽt‰ï“à‰Èˆã‰ïŠwpu‰‰‰ï (2004/9/15), ‘Š–ÍŒ´.

731067. [u‰‰‰ï] (‹³ˆçu‰‰) ”]‘²’†Å‘Oü‚Æ~ˆ³—Ö@. ‘q“c@² (”]ŠO): ‘Š–Í–k•”Šwpu‰‰‰ï (2004/9/28), ‘Š–ÍŒ´.

731068. [u‰‰‰ï] (“Á•Êu‰‰) ‚à‚â‚à‚â•a‚̈ã—ÂƓúí¶Šˆ‚Ì—¯ˆÓ“_. “¡ˆä´F (”]ŠO): ‚à‚â‚à‚â•au‰‰‰ï i‰¡•lŽsˆéŽq•ŸŽƒ•ÛŒ’ƒZƒ“ƒ^[j (2004/10/16), ‰¡•lŽs.

731069. [Œ¤‹†‰ï] (‹³ˆçu‰‰) ”]_ŒoŠO‰ÈŽ¾Š³‚ÌÅV‚ÌŽ¡—Âƃvƒ‰ƒCƒ}ƒŠƒPƒA‚Ì–ðŠ„. ‘q“c@² (”]ŠO): ‘æ43‰ñŠw‚Ú‚¤‰ï (`–ìE’ËvˆäˆãŽt‰ï) (2004/10/24), `–ì.

731070. [‚»‚Ì‘¼] (“Á•Êu‰‰) ‚à‚â‚à‚â•a‚Á‚Ä‚Ç‚ñ‚È•a‹C?|¬Ž™‚âŽá‚¢l‚É‹N‚±‚é”]‘²’†|. “¡ˆä´F (”]ŠO): ‚à‚â‚à‚â•a‚Ì–¾“ú‚ðl‚¦‚é|Š³ŽÒ‰Æ‘°‚ÌŠè‚¢‚ɉž‚¦‚邽‚ß‚É| (2004/11/3), “Œ‹ž.

731071. [u‰‰‰ï] (“Á•Êu‰‰) ‚à‚â‚à‚â•a. “¡ˆä´F (”]ŠO): ‘Š–ÍŒ´Žs•ÛŒ’ŠŽåÓï•au‰‰‰ï (2004/12/7), ‘Š–ÍŒ´.

731072. [Œ¤‹†‰ï] (“Á•Êu‰‰) ”]“®–¬áŽ‚É•K—v‚ÈŠO‰È‰ð–U. “¡ˆä´F (”]ŠO): ‘æ221‰ñŽR—œ”]_ŒoŠO‰ÈƒZƒ~ƒi[ (2004/12/9), ŽD–y.

731073. [Œ¤‹†‰ï] (“Á•Êu‰‰) ˆã—Âɂ¨‚¯‚郊ƒXƒNƒ}ƒlƒWƒƒ“ƒg. “¡ˆä´F (”]ŠO): ƒjƒ…[ƒƒoƒXƒLƒ…ƒ‰[ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/2/15), ‘Š–ÍŒ´.

732033. [‚»‚Ì‘¼] (ƒVƒ“ƒ|ƒWƒEƒ€) ‚à‚â‚à‚â•a|”]zŠÂ—\”õ”\‚ƶŠˆŽwj|. “¡ˆä´F (”]ŠO): ƒ‚ƒ„ƒ‚ƒ„•a‚Ì–¾“ú‚ðl‚¦‚é|Š³ŽÒ‰Æ‘°‚ÌŠè‚¢‚ɉž‚¦‚邽‚ß‚É ‚à‚â‚à‚â•a‚ÌŠ³ŽÒ‚ƉƑ°‚̉ï20Žü”N‹L”OƒVƒ“ƒ|ƒWƒEƒ€ (2004/11/3), “Œ‹ž.

732034. [Œ¤‹†‰ï] (‹³ˆçu‰‰) VALUE‚ÌŒ‹‰Ê‚©‚çŠw‚Ô‚±‚Æ. ‘q“c@² (”]ŠO): ”]St“œ”A•aƒGƒLƒXƒp[ƒgƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/11/29), ‘Š–Í‘å–ì.

733143. [Œ¤‹†‰ï] (ˆê”Êu‰‰) 3‚‚±‚Ô‚ç‚­‚¾ó‚ÌIC anterior wall aneurysm‚ðƒRƒCƒ‹Çðp‚É‚ÄŽ¡—µ‚½1—á. •Ÿ“‡@_, ‹{â‰À’j, ‚–Ø@G (”]ŠO): ‘æ93‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2004/4/10), “Œ‹ž.

733144. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) pŒã‘Šú‚ÉΊD‰»‚𗈂µ‚½glioblastoma‚Ì1—á. Γn‰ë’j, ‹{â‰À’j, ‚–Ø@G, •Ÿ“‡@_ (”]ŠO): ‘æ95‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2004/4/20), “Œ‹ž.

733145. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒeƒ“ƒgã•\Ý«”]“®Ã–¬ŠïŒ`‚̉ð–U‚ÆŽèp. ‹{â‰À’j, ‚–Ø@G, ŽR“c@Ÿ, “c’†–ö…, ‘q“c@², “¡ˆä´F (”]ŠO): ‘æ18‰ñ”÷¬”]_ŒoŠO‰È‰ð–UƒZƒ~ƒi[ (2004/5/16), “¿“‡.

733146. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‰ð–U‚ÉŠî‚¢‚½‚à‚â‚à‚â•a‚ɑ΂·‚éŠO‰ÈŽ¡—Ã. “c’†–ö…, ´…@‹Å, ‘åàV¬”V, ŽR“c@@Ÿ, “¡ˆä´F (”]ŠO): ‘æ18‰ñ”÷¬”]_ŒoŠO‰È‰ð–UƒZƒ~ƒi[ (2004/5/17), “¿“‡.

733147. [§˜b‰ï] (ˆê”Êu‰‰) ”]Š²ƒOƒŠƒI[ƒ}‚ɑ΂·‚éPresigmoid transmastoideal approach. “c’†@‘1, ‚—œ~Žq2, Šâ–{˜a‹v1, ‰ª@GG1, Ž‰Æ@O3 (1”]ŠO. 2–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@. 3“Œ‹ž—ˆã‘å): ‘æ8‰ñ“Œ‹žŽáŽè”]Žîᇎ¡—ç˜b‰ï (2004/6/4), “Œ‹ž.

733148. [Œ¤C‰ï] (ˆê”Êu‰‰) ‚­‚à–Œ‰ºoŒŒ. “¡ˆä´F (”]ŠO): ‘æ21‰ñ”]_ŒoŠO‰Èê–åˆã‹³ˆçŒ¤C‰ï (2004/6/6), “Œ‹ž.

733149. [§˜b‰ï] (ˆê”Êu‰‰) ”]Žº“àŠC–È󌌊ǎî‚Ì1—á. ²“¡Œör, ‰F’ÖØ@‘, ‰ª@GG, ’Jè‹`“¿, ‹ß“¡GŽ¡, “¡ˆä´F (”]ŠO): ‘æ46‰ñŠÖ“Œ”]_ŒoŠO‰È§˜b‰ï (2004/6/26), “Œ‹ž.

733150. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒWƒXƒgƒjƒA‚ɑ΂·‚éThakamotomy. ²“¡Ÿl1, ‘å]çœA2, ŽÄè@“O2 (1”]ŠO. 2“ú‚•a‰@E‹@”\”]ŠO‰È): ‘æ19‰ñ“ú–{‘å”]Šî’êŠjŒ¤‹†‰ï (2004/7/3), ˆ¤•Q.

733151. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Œ´”­‘ƒ•s–¾‚̃Jƒ‹ƒ`ƒmƒCƒh‚ɑ΂·‚éƒIƒNƒgƒŒƒIƒ^ƒCƒhŽ¡—Ã. ‰ª@GG1, ‰F’ÖØ@‘1, ´…@‹Å1, —é–Ø˶1, “¡ˆä´F1, “c’†Œ[Ži2 (1”]ŠO. 2“à‡T): ‘æ3‰ñ‚©‚È‚ª‚íŠÔ”]‰º‚‘ÌŽ¾Š³ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/7/9), ‰¡•l.

733152. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‘§Žq‚Ì‹s‘Ò‚É‚æ‚èŽó‚µ, ‹»–¡‚ ‚é‰æ‘œ‚ð’悵‚½“ª•”ŠO‚Ì1—á. Šâ–{˜a‹v, ‚–ì@@½, ‰ª“c‘ì˜Y, ‘å‚O–« (”]ŠO): ‘æ10‰ñ‘½–€_ŒoŠOƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/7/9), “Œ‹ž.

733153. [§˜b‰ï] (ˆê”Êu‰‰) Isolated type T-S dural AVF‚ɑ΂·‚鎡—Ãí—ª. ”‹Œ´G”V1, ‘q“c@²1, —é–Ø˶1, ¬àV@m1,2, ‘å“ä’m1, “¡ˆä´F1 (1”]ŠO. 2Ž¬“c‘‡•a‰@): ‘æ26‰ñ_“Þì”]ŒŒŠÇ“àŽèp§˜b‰ï (2004/7/12), ‰¡•l.

733154. [§˜b‰ï] (ˆê”Êu‰‰) Isolated type T-S dural AVF. ”‹Œ´G”V, ‘q“c@², —é–Ø˶, ¬àV@m, ‘å“ä’m, “¡ˆä´F (”]ŠO): ‘æ26‰ñ_“Þì”]ŒŒŠÇ“àŽèp§˜b‰ï (2004/7/12), ‰¡•l.

733155. [Œ¤‹†‰ï] (ˆê”Êu‰‰) _Œo“àŽ‹‹¾‚ð—p‚¢‚½”]ŽîᇓEoŽèp. ‰ª@GG, ‰F’ÖØ@‘, “¡ˆä´F (”]ŠO) ‘æ7‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€ (2004.7.13), ‘Š–ÍŒ´.

733156. [§˜b‰ï] (ˆê”Êu‰‰) Pilomyxoid astrocytoma ‚̈ê—á. ŽRè—F–ç, ‰ª@GG, ‰F’ÖØ@‘, ”‹Œ´G”V, “¡ˆä´F (”]ŠO): ‘æ13‰ñ‘Š–ÍŽáŽè”]_ŒoŠO‰È§˜b‰ï (2004/7/13), ‘Š–ÍŒ´.

733157. [Œ¤‹†‰ï] (ˆê”Êu‰‰) 5-ALA‚ð—p‚¢‚½”]ŽîᇌuŒõf’f‚Ì”¼’è—Ê“IŒŸ“¢. ‰F’ÖØ@‘, ‰ª@GG, —é–Ø˶, ´…@‹Å, ’Jè‹`“¿, •Ÿ“‡@_, “¡ˆä´F (”]ŠO): ‘æ8‰ñWaterfront Neurosurgical Conference (2004/7/17), ‰YˆÀ.

733158. [Œ¤‹†‰ï] (ˆê”Êu‰‰) MRI, FLAIR‚ªf’f‚É—L—p‚Å‚ ‚Á‚½Šá“®–¬áŽ‚Ì1—á. Γn‰ë’j, ‹{â‰À’j, ‚–Ø@G (”]ŠO): ‘æ12‰ñ‚³‚ª‚Ý_ŒoŒ¤‹†‰ï (2004/7/20), ‘Š–ÍŒ´.

733159. [Œ¤‹†‰ï] (ˆê”Êu‰‰) spectrometer‚ð—p‚¢‚½—Ç«”]Žîá‡p’†f’f. ‰F’ÖØ@‘, ‰ª@GG, —é–Ø˶, ´…@‹Å, “¡ˆä´F (”]ŠO): ‘æ5‰ñ5-ALAŒ¤‹†‰ï (2004/8/7), ŽD–y.

733160. [Œ¤‹†‰ï] (ƒ|ƒXƒ^[) ”j—ô”÷¬”]“®–¬áŽ‚ɑ΂·‚é”]ŒŒŠÇ“àŽèp. —é–Ø˶1, ‘q“c@²1, ›@Mˆê2, ‘å“ä’m1, ¬àV@m3, “’àV@ò1, •Ÿ“‡@_1, ŽR“c@Ÿ1, –kŒ´F—Y4, “¡ˆä´F1 (1”]ŠO. 2•ú. 3Ž¬“c‘‡•a‰@. 4‹~–½): ‘æ23‰ñThe Mt. Fuji Workshop on CVD (2004/8/29), “Œ‹ž.

733161. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ”]Žº• oƒVƒƒƒ“ƒg‚Ì“ªŠW“à–À“ü: 2Ç—á•ñ‚Æ•¶Œ£“IlŽ@. ŽRè—F–ç, ´…@‹Å, ‰ª@GG (”]ŠO): ‘æ2‰ñ_“Þì”]_ŒoŠO‰ÈŽèpŽè‹ZŒ¤‹†‰ï (2004/9/11), ‰¡•l.

733162. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ”]oŒŒŒã‚Ɉٕ¨«“÷‰èŽî‚É‚æ‚èL”Í‚È”]•‚Žî‚ð‚«‚½‚µ‚½¶‘¤“ª—tAVM‚̈ê—á. ¬—шè•v1, “c’†@‘1, ë“à—²—Y1, –{‘@‹§2 (1”]ŠO. 2–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@): ‘æ94‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2004/9/16), “Œ‹ž.

733163. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ŽîᇊOoŒŒ‚ð‚«‚½‚µ‚½’®_ŒoâŽî‚̈ê—á. ‘åàV¬”V, ‰ª@GG, ‰F’ÖØ@‘, ´…@‹Å, —é–Ø˶, •Ÿ“‡@_, ‘‘ŽiŒõ•F, ŽRè—F–ç, “¡ˆä´F (”]ŠO): ‘æ94‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2004/9/16), “Œ‹ž.

733164. [Œ¤‹†‰ï] (ˆê”Êu‰‰) “ªŠWœŒ´”­‚ÌMalignant lymphoma‚̈ê—á. ’Jè‹`“¿, ‰ª@GG, •Ÿ“‡@_, ‰F’ÖØ@‘, “¡ˆä´F (”]ŠO): _“Þì”]ŽîᇃtƒH[ƒ‰ƒ€‘æ8‰ñŠwpW‰ï (2004/9/24), ‰¡•l.

733165. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Hemifacial spasm‚Ìp’† Abnormal muscle responseƒ‚ƒjƒ^ƒŠƒ“ƒO‚É‚¨‚¯‚é–â‘è“_. ²“¡Ÿl, ŽR“c@Ÿ, ‘q“c@², “¡ˆä´F (”]ŠO): ‘æ7‰ñ”]_ŒoŒ¸ˆ³pŒ¤‹†‰ï (2004/10/5), –¼ŒÃ‰®.

733166. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ¬”]ƒeƒ“ƒg‚æ‚è”­¶‚µ‚½f’f‚É‹ê—¶‚µ‚½ˆ««¬”]ŽîᇂÌ1—á. ’Jè‹`“¿1, ‰ª@GG1, ‰F’ÖØ@‘1, “¡ˆä´F1, ì–ìM”V1, –ö‰ºŽO˜Y2 (1”]ŠO. 2_“Þ쌧—§ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“): ‘æ87‰ñ“Œ‹ž”]Žîᇌ¤‹†‰ïEÇ—áƒvƒƒgƒR[ƒ‹ (2004/10/16), “Œ‹ž.

733167. [Œ¤‹†‰ï] (ˆê”Êu‰‰) AIDS‚É”º‚¤, “ªŠW“à‘½”­«•a•Ï. Γn‰ë’j, ‹{â‰À’j, ‚–Ø@G (”]ŠO): ‘æ13‰ñ‚³‚ª‚Ý_ŒoŒ¤‹†‰ï (2004/10/19), ‘Š–ÍŒ´.

733168. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ”][Ç‚Å”­Ç‚µŒo‰ß’†‚É”]oŒŒ‚ð‚«‚½‚µ‚½×‹Û«”]“®–¬áŽ‚̈ê—á. ë“à—²—Y1, “c’†@‘1, ¬—шè•v1, ’Ò@rˆê2, ’·’Jì‚ЂƂÝ2, œA£@—²2, –{@‹§2 (1”]ŠO. 2–k–{ƒƒfƒBƒJƒ‹): ‘æ16‰ñ–k‘«—§ŒSˆãŽt‰ïˆãŠw‰ï (2004/10/23), é‹Ê.

733169. [§˜b‰ï] (ˆê”Êu‰‰) ‹‘哪ŠWˆô“ªŽî‚ɑ΂·‚éŽèpƒAƒvƒ[ƒ`. ‰ª@GG, “¡ˆä´F (”]ŠO): ‘æ48‰ñŠÖ“Œ”]_ŒoŠO‰È§˜b‰ï (2004/11/6), “Œ‹ž.@

733170. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‹»–¡‚ ‚銌©‚ð’悵‚½––½«’†‘å”]“®–¬áŽ‚̈ê—á. Šâ–{˜a‹v1, ‚–ì@½1, ‰ª“c‘ì˜Y1, ‘å‚O–«1, ‰i“c˜aÆ2 (1”]ŠO. 2NTT“Œ“ú–{ŠÖ“Œ•a‰@): ‘æ25‰ñ‘½–€’n‹æ”]‘²’†Œ¤‹†‰ï (2004/11/6), “Œ‹ž.

733171. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Awake surgerypŒã, ’´”玿«Š´ŠoŽ¸Œê‚ð‚«‚½‚µ‚½¶‘O“ª—t low grade glioma ‚Ì1—á. ²“¡Ÿl1, ‰ª@GG1, ‰F’ÖØ@‘1, “¡ˆä´F1, ‰ª–{_Žk2 (1”]ŠO. 2–ƒŒ): ‘æ2‰ñ“ú–{Awake surgeryŒ¤‹†‰ï (2004/11/10), ‹à‘ò.

733172. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Œo‰ß’†‚É’˜–¾‚ÈΊD‰»‚ðŽ¦‚µ‚½_ŒoäP‰èŽî‚Ì1—á. Γn‰ë’j, ‹{â‰À’j, ‚–Ø@G (”]ŠO): ‘æ14‰ñ‚³‚ª‚Ý_ŒoŒ¤‹†‰ï (2004/11/19), ‘Š–ÍŒ´.

733173. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ˆ««glioma‚ÌŽ¡—ìÑ: ‰ß‹Ž‚ÌŽ¡—ìтƂ̔äŠr. ‰F’ÖØ@‘, ‰ª@GG, ‹ß“¡GŽ¡, ’Jè‹`“¿, “c’†@‘, “¡ˆä´F (”]ŠO): ‘æ28‰ñƒjƒ…[ƒEƒIƒ“ƒRƒƒW[‚̉ï (2004/12/4), “Œ‹ž.

733174. [Œ¤‹†‰ï] (ˆê”Êu‰‰) f’f‚Ü‚Å‚É’·ŠúŠÔ‚ð—L‚µ‚½’†”]Œ´”­germinoma‚Ì1—á. ¬òŠ°”V, ‰ª@GG, ‰F’ÖØ@‘, ²“¡Ÿl, –]ŒŽ’O, ’Jè‹`“¿, “¡ˆä´F (”]ŠO): ‘æ28‰ñƒjƒ…[ƒEƒIƒ“ƒRƒƒW[‚̉ï (2004/12/4), “Œ‹ž.

733175. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ŠO«•@oŒŒ‚ɑ΂·‚錌ŠÇ“àÇðp‚Ì—L—p«. m–Ø@~1, —é–Ø˶1, ‘q“c@²1, ´…@‹Å1, –]ŒŽ’O1, ‹{“‡—Ç‹P1, ¬òŠ°”V1, ¬àV@m2, “¡ˆä´F1 (1”]ŠO. 2Ž¬“c‘‡•a‰@): ‘æ95‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2004/12/11), “Œ‹ž.

733176. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) MRI (FLAIR–@) ‚ª—L—p‚Å‚ ‚Á‚½‚­‚à–Œ‰ºoŒŒ‚Ì2—á. Γn‰ë’j, ‹{â‰À’j, ‚–Ø@G, ‘q“c@², “¡ˆä´F (”]ŠO): ‘æ94‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2004/12/11), “Œ‹ž.

733177. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‰¡-SóÖ¬“´•”isolated type dural AVF‚ɑ΂·‚鎡—Ãí—ª. ”‹Œ´G”V, ‘å“ä’m, ‘q“c@², —é–Ø˶, ŽR“c@Ÿ, ë“à—²—Y, “’àV@ò, “¡ˆä´F (”]ŠO): ‘æ1‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠÖ“Œ’n•û‰ï (2004/12/11), “Œ‹ž.

733178. [Œ¤‹†‰ï] (ˆê”Êu‰‰) [Ç«‰º‚‘Ì‘²’†‚ð’悵‚½‰º‚‘Ì‘BŽî‚̈ê—á. ‹{“‡—Ç‹P, ‰ª@GG, ‰F’ÖØ@‘, •Ÿ“‡@_, “¡ˆä´F (”]ŠO): ‘æ3‰ñ‚©‚È‚ª‚íŠÔ”]‰º‚‘ÌŽ¾Š³ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/12/15), ‰¡•l.

733179. [§˜b‰ï] (ˆê”Êu‰‰) ’·ŠúŠÔŒo‰ß’†“ªŠW“à‚ÉÄ”­‚𗈂µ‚½adenoid cystic carcoma‚̈ê—á. ’Jè‹`“¿, ‰ª@GG, ‰F’ÖØ@‘, m–Ø@~, “¡ˆä´F (”]ŠO): ‘æ9‰ñ“Œ‹žŽáŽè”]Žîᇎ¡—ç˜b‰ï (2004/12/17), “Œ‹ž.

733180. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) 123I-IMP‚¨‚æ‚Ñ67Ga-citrate SPECT‚Å”ñ“ÁˆÙ“I‚ÈŠŒ©‚ð’悵‚½‘½”­«d‰»Ç‚̈ê—á. ë“à—²—Y1, ‰ª@GG1, ‰F’ÖØ@‘1, ¬—шè•v1, “c’†@‘1, Έ䟌È2, ó–ì—Y“ñ2, ‘ì˜ad2, “¡ˆä´F1 (1”]ŠO. 2•ú): ‘æ62‰ñ“ú–{ŠjˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï(2005/1/22), “Œ‹ž.

733181. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Awake surgery‚ðŽ{s‚µ‚½¶‘O“ª—tŒ¾Œê—Ì–ì‹ß–T‚É”­¶‚µ‚½glioma‚̈ê—á. ²“¡Ÿl1, ‰ª@GG1, ‰F’ÖØ@‘1, •Ÿ“‡@_1, “¡ˆä´F1, ‰ª–{_Žk2, ŠO@{”ü•v2, ¬•Û“àˆ»Žq3 (1”]ŠO. 2–ƒŒ. 3Ž¨•@): _“Þì”]ŽîᇃtƒH[ƒ‰ƒ€‘æ9‰ñŠwpW‰ï (2005/2/4), ‰¡•l.

733182. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒNƒ[ƒ“•a‚Æ‘å‹…«•nŒŒ‚𔺂Á‚½ã–îóÖ¬“´ŒŒðǂ̈ê—á. —é–Ø˶, ‘åàV¬”V, ŽR“c@Ÿ, •Ÿ“‡@_, ‘‘ŽiŒõ•F, ŽRè—F–ç, “¡ˆä´F (”]ŠO): ‘æ15‰ñ_“Þì”]‘²’†ƒtƒH[ƒ‰ƒ€ (2005/2/4), ‰¡•l.

733183. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŒŒŠÇ•«‡‚Ì—ûK–@@’¹‚ÌŽè‰Hæ‚ƃ‰ƒbƒg‚ð—p‚¢‚Ä. ŽR“c@Ÿ (”]ŠO): ‘æ10‰ñ–k—¢”]_ŒoŠO‰È”÷¬‰ð–UƒZƒ~ƒi[ (2005/2/6), ‘Š–ÍŒ´.

733184. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒNƒ[ƒ“•a‚Æ‘å‹…«•nŒŒ‚𔺂Á‚½ã–îóÖ¬“´ŒŒðǂ̈ê—á. ‘åàV¬”V, —é–Ø˶, •Ÿ“‡@_, ‘‘ŽiŒõ•F, ŽRè—F–ç, ŽR“c@Ÿ, “¡ˆä´F (”]ŠO): ‘æ15‰ñ_“Þì”]‘²’†ƒtƒH[ƒ‰ƒ€ (2004/2/6), ‰¡•l.
733185. [§˜b‰ï] (ˆê”Êu‰‰) ‰»Šw—Ö@’ïR«‚Ì•úŽËü—U“±«“÷Žî‚ð‚Ç‚¤Ž¡—·‚é‚©? ’Jè‹`“¿, ‰ª@GG, ‰F’ÖØ@‘, –]ŒŽ’O, •Ÿ“‡@_, ‘‘ŽiŒõ•F, ¬—шè•v, “c’†@‘, “¡ˆä´F (”]ŠO): ‘æ8‰ñ“Œ‹žŽáŽè”]Žîᇎ¡—ç˜b‰ï (2004/2/11), “Œ‹ž.

733186. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Œo“ªŠWŽhŒƒ‰^“®—U”­“dˆÊ‚Ì’è—Ê“I•]‰¿. ŽO“‡‘å“¿, z–K’m–ç, ŽOˆäŒö•F (”]ŠO): ‘æ26‰ñÒ‘‹@”\f’fŒ¤‹†‰ï (2004/2/14), “Œ‹ž.

733187. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Žîá‡“àŠ´õ‚ð‹N‚±‚µ‚½glioblastoma‚Ì1—á. ‹{“‡—Ç‹P, ‰ª@GG, ‰F’ÖØ@‘, ’Jè‹`“¿, –]ŒŽ’O, “¡ˆä´F (”]ŠO): ‘æ8‰ñ”]_ŒoŠO‰ÈŽ¾Š³‚Ì—Õ°‚Æ•a—‚ÌJoint Conference (2005/2/26), “Œ‹ž.

733188. [§˜b‰ï] (ˆê”Êu‰‰) Šç–Êáz¹‚ɑ΂·‚éƒX[ƒp|ƒLƒ“ƒ\ƒ“ƒJƒe[ƒeƒŠƒ[[ƒVƒ‡ƒ“@—L—p«. —é–Ø˶, ‘q“c@², ²“¡Ÿl, “’àV@ò, m–Ø@~, ŽR“c@Ÿ, “¡ˆä´F (”]ŠO): ‘æ28‰ñ_“Þì”]ŒŒŠÇ“àŽèp§˜b‰ï (2005/3/7), ‰¡•l.

733189. [§˜b‰ï] (ˆê”Êu‰‰) Acute multiple screlosis ‚̈ê—á. ²“¡Œör, ‰ª@GG, ¬—шè•v, ë“à—²—Y, “¡ˆä´F (”]ŠO): ‘æ12‰ñ‘Š–ÍŽáŽè”]_ŒoŠO‰È§˜b‰ï (2004/3/9), ‘Š–ÍŒ´.

733190. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŠJ“ªpƒhƒŒ[ƒsƒ“ƒO‚É‚¨‚¯‚é‰t˜R‚ê–hŽ~‚ÌH•v. –]ŒŽ’O, ´…@‹Å, ‰F’ÖØ@‘, —é–Ø˶, ‰ª@GG, “¡ˆä´F (”]ŠO): ‘æ3‰ñ_“Þì”]_ŒoŠO‰ÈŽèpŽè‹ZŒ¤‹†‰ï (2005/3/12), ‰¡•l.


<<¬Ž™‰ÈŠw>>

mŠwp˜_•¶n

110135. [Œ´’˜] Older Age Is a Risk Factor for the Development of Cardiovascular Sequelae in Kawasaki Disease. –´“cLŽÀ1, Έä³_1,2, ã㑸•F1, ]ãŒöN1, ŒÃˆä@1, ›Œ´—mŽq1, Ô–Ø’õŽ¡1, ’†‘ºDˆê3, –öì@—m4, ¼Î–LŽŸ˜Y1 (1‹v—¯•Ä‘å. 2Ž™. 3Ž©Ž¡ˆã‘å. 4é‹ÊŒ§—§‘å): Pediatrics, 114 (3): 751-754, 2004.

110136. [Œ´’˜] Early intravenous gamma-globulin treatment for Kawasaki Disease: The nationwide surveys in Japan. –´“cLŽÀ1, Έä³_1,2, ]ãŒöN1, ŒÃˆä@1, ›Œ´—mŽq1, Ô–Ø’õŽ¡1, ’†‘ºDˆê3, –öì@—m4, ¼Î–LŽŸ˜Y1 (1‹v—¯•Ä‘å. 2Ž™. 3Ž©Ž¡ˆã‘å. 3é‹ÊŒ§—§‘å): J Pediatr, 144: 496-499, 2004.

110137. [Œ´’˜] Screening for diabetes by urine glucose testing at school in Japan. ‰¡“csŽj1, ‹e’rMs2, ¼‰YM•v3 (1Ž™. 2‰¡•lŽs‘å. 3¹“¿‘å): Pediatric Diabetes, 5: 212-218, 2004.

110138. [Œ´’˜] Dermatophagoides-induced interleukin-10 production by peripheral blood lymphocytes from patients with asthma in remission. –ìŠÔ@„1, ›Œ´—zŽq1, ¬ì—ÏŽj1, ²”Œ•q—º1, ŽRŒûŒöˆê2, ì–ì@–L1 (1Ž™. 2“¯ˆ¤‹L”O•a‰@): Pediatr Allergy Immunol, 15 (5): 459-68, 2004.

110139. [Œ´’˜] Somatropin promotes dermato-phagoides farinae-specific IgE generation independently of IL-4 and IL-10. –ìŠÔ@„1, ‹g‘ò‚¢‚ÂÝ1, Sugano S2, ¬ì—ÏŽj1, ì–ì@–L1 (1Ž™. 2“Œ‹ž‘å): Asian Pac J Allergy Immunol, 22 (2-3): 133-142, 2004.

110140. [Œ´’˜] High frequency of QPY allel and linkage disequilibrium of granzyme-B in Epstein-Barr-virus-associated hemophagocytic lymphohistio-cytosis. Zaitsu M1, Yamamoto K2, Ishii E1, Teranuma T3, ’†ŠÚ®–ç4, Sako M5, Sakata N6, Wakiguchi H7, Hirose M8, Imayoshi M1, Ogawa Y1, Imashuku S3, Hamasaki Y1, Yasukawa M9 (1²‰ê‘å. 2‹ãB‘å. 3‹ž“sŽs‰q¶ŒöŠQŒ¤‹†Š. 4Ž™. 5‘åãŽs—§‘‡ˆã—ÃZƒ“ƒ^[. 6‘åã•{—§•êŽqˆã—ÃZƒ“ƒ^[. 7‚’m‘å. 8L£‚±‚Ç‚àƒNƒŠƒjƒbƒN. 9ˆ¤•Q‘å): Tissue Antigens, 64 (5): 611-615, 2004.

110141. [Œ´’˜] Characterization of VHepsilon gene expressed in PBL from children with atopic diseases: detection of homologous VH1-69 derived transcripts from three unrelated patients. â“Œ—R‹I1,2, Shimizu A3, Ra C4 (1Ž™. 2‡“V“°‘å. 3‹ž“s‘å. 4“ú–{‘å): Immunology Letters, 94: 99-106, 2004.

110142. [Œ´’˜] Hypocomplementemia and membranoproliferative glomeruloneophritis in children. ”Ñ‚Šì‹v—Y1,2, ’†‘ºM–ç2, Žç‰®r‰î2, ‰z–ì_]2, Šâ”g’¼”ü2, Žðˆä@Œª3, –{ŽR@Ž¡3 (1‘å˜aŽs—§•a‰@. 2Ž™. 3“Œ–M‘å): Clinical and Experimental Nephrology, 9(1): 31-33, 2005.

120036. [Œ´’˜] ìè•a”N’·—á‚ÌŒŸ“¢|‘æ16‰ñ‘S‘’²¸‚æ‚è|. ã㑸•F1, –´“cLŽÀ1, Έä³_1,2, ]ãŒöN1, ŒÃˆä@1, ›Œ´—mŽq1, Ô–Ø’õŽ¡1, ’†‘ºDˆê3, –öì@—m4, ¼Î–LŽŸ˜Y1 (1‹v—¯•Ä‘å. 2Ž™. 3Ž©Ž¡ˆã‘å): “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 108 (8): 1043-1046, 2004.

120037. [Œ´’˜] ƒˆƒEƒŒƒ`ƒ“ (Lecithin-bound iodine; LBI) Ž¡—Âɂæ‚é‹CŠÇŽxšb‘§Š³Ž™ƒŠƒ“ƒp‹…‚̃TƒCƒgƒJƒCƒ“ŽY¶ƒpƒ^[ƒ“‚̕ω». ì–ì@–L1, ²”Œ•q—º2, –ìŠÔ@„2 (1‰¡•lÔ\Žš•a‰@. 2Ž™): “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽ, 18(5): 560-565, 2004.

120038. [Œ´’˜] ¬Ž™Ž¡—ÃŒ»ê‚ÌŽÀ‘Ô‚Æ–â‘è“_|VGCPŽ{s‘OŒã‚Ì”äŠr‚ð’Ê‚µ‚Ä|. »‰Ÿ@Â1, ‰¡“csŽj1, Šâèr”V1, “‡ŠÑ@ˆè1, ‹´‘º—TŽq2, H“¡‚µ‚Æ‚Ý2 i1Ž™. 2Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[j: “ú–{¬Ž™—Õ°–ò—Šw‰ïŽGŽ, 17 (1): 110-113, 2004.

120039. [Œ´’˜] ¬Ž™–R”A—á‚ɑ΂·‚é—˜”A–ò“Š—^‚É‚¨‚¯‚鎡—Ãí—ª. ‰iŸºO”V1, _‘O‘׊ó1, “à“c—SŽi1, ”~Œ´@ŽÀ1,2 (1_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 2Ž™): “ú–{¬Ž™‹~‹}ˆãŠw‰ïŽGŽ, 3 (1): 134-136, 2004.

120040. [Œ´’˜] ¬Ž™‹}«S•s‘S—á‚É‚¨‚¯‚é–ò•¨Ž¡—ÂɊւ·‚élŽ@. ‰iŸºO”V1, _‘O‘׊ó1, “à“c—SŽi1, ”~Œ´@ŽÀ1,2 (1_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 2Ž™): “ú–{¬Ž™‹~‹}ˆãŠw‰ïŽGŽ, 3 (1): 137-140, 2004.

120041. [Œ´’˜] æ“V«bó‘B‹@”\’ቺǃ‰ƒbƒgrdw‚É‚¨‚¯‚錌’†bó‘Bƒzƒ‹ƒ‚ƒ“”Z“x‚ÌŒŸ“¢. ŽÄŽRŒ[Žq, ‰¡“csŽj, ¼‰YM•v (Ž™): ¬’·‰ÈŠw‹¦‰ïŒ¤‹†”N•ñ, 27: 155-161, 2003.

310011. [Ç—á•ñ] A male patient with steroid-dependent nephrotic syndrome for 25 years and obesity-associated focal segmental glomerulosclerosis. Motoyama O1, Muto A1, Ogiwara H1, Mizuiri S1, Kawamura S1, ”Ñ‚Šì‹v—Y2,3 (1“Œ–M‘å. 2‘å˜aŽs—§•a‰@. 3Ž™): Clinical and Experimental Nephrology, 8 (3): 263-265, 2004.

310012. [Ç—á•ñ] Acute glomerulonephritis in three siblings and suspected emm49-type Streptococcus pyogenes infection. –{ŽR@Ž¡1, ’·’Jì@Œc1, Okamatsu C1, Tamaki K1, ”Ñ‚Šì‹v—Y2,3 (1“Œ–M‘å. 2‘å˜aŽs—§•a‰@. 3Ž™j: Clinical and Experimental Nephrology, 8 (4): 356-358, 2004.

310013. [Ç—á•ñ] Subclinical hypothyroidism caused by a mutation of the thyrotropin receptor gene. ŽÄŽRŒ[Žq1, ‘åŽR‹XG1, •HÀ@º2, ‰¡“csŽj1, •—’£KŽi1, •—’£^—R”ü1, ‰Æ“ü‘“¶•v2, ¼‰YM•v1 (1Ž™. 2àÕ‹¦ˆã‘å): Pediatrics International, 47 (1): 105-108, 2005.

310014. [Ç—á•ñ] Two cases of congenital nephrotic syndrome. ”Ñ‚Šì‹v—Y1,3, –{ŽR@Ž¡2, –kžŠ‚Ý‚Ç‚è3, Šâ”g’¼”ü3, ‰z–ì_]3, ’†‘ºM–ç3, Žç‰®r‰î3 (1‘å˜aŽs—§•a‰@. 2“Œ–M‘å. 3Ž™): Clinical and Experimental Nephrology, 8 (2): 146-149, 2004.

320035. [Ç—á•ñ] Ž©ŠoÇ󂨂æ‚уs[ƒNƒtƒ[‚É‚æ‚éšb‘§•]‰¿‚ª‰ß¬‚Å‚ ‚Á‚½ŽvtŠúšb‘§‚̈ê’jŽ™—á. –ؑ‹P1, ŽRŒûŒöˆê1, ŒüŽR“¿Žq1, –ìŠÔ@„2 (1“¯ˆ¤‹L”O•a‰@. 2Ž™): “ú–{¬Ž™“šb‘§EƒAƒŒƒ‹ƒM[Ž¾Š³Šw‰ïŽ, 2 (1): 58-60, 2004.

520140. [‘à] “ÁW/Ç—á‚©‚çŠw‚ÔŽ©ŒÈ–ƉuŽ¾Š³@V¶Ž™ƒ‹[ƒvƒX. ²”Œ•q—º, –ìŠÔ@„ (Ž™): ¬Ž™“à‰È, 36 (10): 596-1599, 2004.

520141. [‘à] “ÁW/t”A˜HŒnˆ««Žîá‡|“à‰Èˆã‚É•K—v‚È’mŽ¯@¬Ž™‚ÌtŽîá‡|. ’†ŠÚ®–ç (Ž™): t‚Æ“§Í, 57(2): 187-192, 2004.

520142. [‘à] u•ê“û‚ð‰ÈŠw‚·‚év‰óŽ€«’°‰Š‚Æ•ê“ûˆçŽ™. –ì“n³•F (Ž™): ŽüŽYŠúˆãŠw, 34 (9): 1399-1402, 2004.

520143. [‘à] “ÁW/‹}Š³ƒZƒ“ƒ^[!!@¬Ž™ˆã—Â͂±‚ê‚ð‰Ÿ‚³‚¦‚Ä@¬Ž™‚Ì–ò•¨—Ö@ šb‘§Ž¡—Öò‚Ì펯. ã“cN‹v (Ž™): Ž¡—Ã, 86 (8): 2379-2385, 2004.

520144. [‘à] “ÁW/‚±‚Ç‚à‚̌ċzŠÇ—. ŒÄ‹zƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ƒ`[ƒ€ˆã—ÂƂµ‚Ă̌ċzƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ¬Ž™‰Èˆã‚Í‚Ç‚¤‚©‚©‚í‚é‚ׂ«‚©. ã“cN‹v (Ž™): ¬Ž™‰Èf—Ã, 67 (12): 2247-2252, 2004.

520145. [‘à] u‹CŠÇŽxšb‘§‚ÌŽ¡—Ã@Å‹ß‚Ìi•àv¬Ž™šb‘§‚Ì“Á’¥‚ÆŽ¡—Ö@ (¬l‚Æ‚Ì·ˆÙ‚àŠÜ‚ß‚Ä). ”~Œ´@ŽÀ (_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[, Ž™): ‹~‹}ˆãŠw, 29 (2): 209-216, 2005.

521032. [Œ¤‹†•ñ] (Œú˜JÈ) “œ”A•a‚¨‚æ‚ѶŠˆKŠµ•a‚ð‚à‚ÂŽq‚Ç‚à‚ÌQOL‰ü‘P‚Ì‚½‚ß‚ÌŒ¤‹† (•½¬15”N“xŽå”CŒ¤‹†•ñ). ¼‰YM•v (Ž™): Œú¶˜J“­‰ÈŠwŒ¤‹† (“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ) “œ”A•a‚¨‚æ‚ѶŠˆKŠµ•a‚ð‚à‚ÂŽq‚Ç‚à‚ÌQOL‰ü‘P‚Ì‚½‚ß‚ÌŒ¤‹†. •½¬15”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.3-5, 2004.

521033. [Œ¤‹†•ñ] (Œú˜JÈ) ¬Ž™1Œ^“œ”A•aŽ™‚ÌŠwZ, ŽÐ‰ï¶Šˆ‚ÌŽÀ‘Ô‚Æ‚»‚ÌQOL‚̉ü‘P‚ÉŠÖ‚·‚錤‹† (•½¬15”N“x•ª’SŒ¤‹†•ñ). ¼‰YM•v (Ž™): Œú¶˜J“­‰ÈŠwŒ¤‹† (“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ) “œ”A•a‚¨‚æ‚ѶŠˆKŠµ•a‚ð‚à‚ÂŽq‚Ç‚à‚ÌQOL‰ü‘P‚Ì‚½‚ß‚ÌŒ¤‹†. •½¬15”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.9-11, 2004.

521034. [Œ¤‹†•ñ] (Œú˜JÈ) ¬Ž™1Œ^“œ”A•aŽ™‚̃Cƒ“ƒXƒŠƒ“—Ö@‚Æ•½‹ÏHbA1c’l‚̉䂪‘Œ»ó‚ÉŠÖ‚·‚錤‹† (‘æ2•ñ) (•ª’SŒ¤‹†: ¬Ž™1Œ^“œ”A•aŽ™‚ÌŠwZ, ŽÐ‰ï¶Šˆ‚ÌŽÀ‘Ô‚Æ‚»‚ÌQOL‚̉ü‘P‚ÉŠÖ‚·‚錤‹†). ¼‰YM•v1, ‰¡“csŽj1, ŽO‘î@ò1, ²X–Ø@–]2, ‰J‹{@L3 (1Ž™. 2é‹Êˆã‘å. 3ŽR—œ‘åj: Œú¶˜J“­‰ÈŠwŒ¤‹† (“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ)“œ”A•a‚¨‚æ‚ѶŠˆKŠµ•a‚ð‚à‚ÂŽq‚Ç‚à‚ÌQOL‰ü‘P‚Ì‚½‚ß‚ÌŒ¤‹†. •½¬15”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.35-37, 2004.

521035. [Œ¤‹†•ñ] (Œú˜JÈ) “œ”A•a‚¨‚æ‚ѶŠˆKŠµ•a‚ð‚à‚ÂŽq‚Ç‚à‚ÌQOL‰ü‘P‚Ì‚½‚ß‚ÌŒ¤‹† (•½¬13-15”N“x‘Š‡Žå”CŒ¤‹†•ñ). ¼‰YM•v (Ž™): Œú¶˜J“­‰ÈŠwŒ¤‹† (“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ) “œ”A•a‚¨‚æ‚ѶŠˆKŠµ•a‚ð‚à‚ÂŽq‚Ç‚à‚ÌQOL‰ü‘P‚Ì‚½‚ß‚ÌŒ¤‹†. •½¬15”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.115-117, 2004.

521036. [Œ¤‹†•ñ] (Œú˜JÈ) ¬Ž™1Œ^“œ”A•aŽ™‚ÌŠwZ, ŽÐ‰ï¶Šˆ‚ÌŽÀ‘Ô‚Æ‚»‚ÌQOL‚̉ü‘P‚ÉŠÖ‚·‚錤‹† (•½¬13-15”N“x‘Š‡•ª’SŒ¤‹†•ñ). ¼‰YM•v (Ž™): Œú¶˜J“­‰ÈŠwŒ¤‹† (“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ) “œ”A•a‚¨‚æ‚ѶŠˆKŠµ•a‚ð‚à‚ÂŽq‚Ç‚à‚ÌQOL‰ü‘P‚Ì‚½‚ß‚ÌŒ¤‹†. •½¬15”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.118-121, 2004.

521037. [Œ¤‹†•ñ] (Œú˜JÈ) ‘“à, ‘Û‹¤“¯Œ¤‹†‚©‚猩‚½¬Ž™1Œ^“œ”A•aŽ™‚̃Cƒ“ƒXƒŠƒ“—Ö@‚ÆQOL‚ÌŒ¤‹† (•ª’SŒ¤‹†: ¬Ž™1Œ^“œ”A•aŽ™‚ÌŠwZ, ŽÐ‰ï¶Šˆ‚ÌŽÀ‘Ô‚Æ‚»‚ÌQOL‚̉ü‘P‚ÉŠÖ‚·‚錤‹†). ¼‰YM•v1, ‰¡“csŽj1, ŽO‘î@ò1, ²X–Ø@–]2, ‰J‹{@L3, ’†‘ºLŽ}4 (1Ž™. 2é‹Êˆã‘å. 3ŽR—œ‘å. 4ç—t‘åj: Œú¶˜J“­‰ÈŠwŒ¤‹† (“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ) “œ”A•a‚¨‚æ‚ѶŠˆKŠµ•a‚ð‚à‚ÂŽq‚Ç‚à‚ÌQOL‰ü‘P‚Ì‚½‚ß‚ÌŒ¤‹†. •½¬15”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.143-145, 2004.

521038. [Œ¤‹†•ñ] (Œú˜JÈ) ¬Ž™‚QŒ^“œ”A•a‚ɑ΂·‚éŒoŒûŒŒ“œ~‰º–òŽ¡—ẪGƒrƒfƒ“ƒX‚ÌŠm—§: “Á‚ɃƒgƒtƒHƒ‹ƒ~ƒ“‚ÌŽŠ“K“Š—^—Ê, —LŒø«‚ƈÀ‘S«‚ÌŒ¤‹† (•½¬15”N“xŽå”CŒ¤‹†•ñ). ¼‰YM•v (Ž™): Œú¶˜J“­‰ÈŠwŒ¤‹† (Œø‰Ê“Iˆã—ËZp‚ÌŠm—§„i—Õ°Œ¤‹†Ž–‹Æ: ¬Ž™Ž¾Š³‚ÉŠÖ‚·‚é—Õ°Œ¤‹†•ª–ì). ¬Ž™2Œ^“œ”A•a‚ɑ΂·‚éŒoŒûŒŒ“œ~‰º–òŽ¡—ẪGƒrƒfƒ“ƒX‚ÌŠm—§: “Á‚ɃƒgƒtƒHƒ‹ƒ~ƒ“‚ÌŽŠ“K“Š—^—Ê, —LŒø«‚ƈÀ‘S«‚ÌŒ¤‹†. •½¬15”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.3-7, 2004.

521039. [Œ¤‹†•ñ] (Œú˜JÈ) ¬Ž™2Œ^“œ”A•aŠ³Ž™‚̎Љï“I–â‘è‚ÉŠÖ‚·‚錟“¢ (•ª’SŒ¤‹†: 2Œ^“œ”A•a‚Ì•a‘Ô‰ðÍ‚Æ—LŒø«‚ÉŠÖ‚·‚錟“¢). ‰¡“csŽj, ‘å’ì”V, “c‹v•ÛŒ›s(Ž™): Œú¶˜J“­‰ÈŠwŒ¤‹† (Œø‰Ê“Iˆã—ËZp‚ÌŠm—§„i—Õ°Œ¤‹†Ž–‹Æ: ¬Ž™Ž¾Š³‚ÉŠÖ‚·‚é—Õ°Œ¤‹†•ª–ì). ¬Ž™2Œ^“œ”A•a‚ɑ΂·‚éŒoŒûŒŒ“œ~‰º–òŽ¡—ẪGƒrƒfƒ“ƒX‚ÌŠm—§: “Á‚ɃƒgƒtƒHƒ‹ƒ~ƒ“‚ÌŽŠ“K“Š—^—Ê, —LŒø«‚ƈÀ‘S«‚ÌŒ¤‹†. •½¬15”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.26-27, 2004.

521040. [Œ¤‹†•ñ] (Œú˜JÈ) ƒ~ƒgƒRƒ“ƒhƒŠƒA”]‹ØÇ‚¨‚æ‚Ñìè•a‚É‚¨‚¯‚錌ŠÇ“à”ç‹@”\‚ÌŒŸ“¢ (•ª’SŒ¤‹†•ñ). Έä³_ (Ž™): Œú¶˜J“­‰ÈŠwŒ¤‹† (¬Ž™Ž¾Š³—Õ°Œ¤‹†Ž–‹Æ) ¬Ž™Šú”­Ç‚̃~ƒgƒRƒ“ƒhƒŠƒA”]‹Øǂɑ΂·‚éL-ƒAƒ‹ƒMƒjƒ“‚¨‚æ‚уWƒNƒƒ|Ž_—Ö@‚ÌŒø‰Ê”»’è‚Æ•ªŽq•a‘Ԃ𓥂܂¦‚½V‚µ‚¢Ž¡—ÊJ”­‚ÉŠÖ‚·‚é—Õ°Œ¤‹†. •½¬16”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.46-47, 2005.

521041. [Œ¤‹†•ñ] (Œú˜JÈ) 2Œ^“œ”A•a•aˆöˆâ“`Žq‚Ì—LŒø«‚Ö‚ÌŠÖ—^‚ÉŠÖ‚·‚錤‹† (•ª’SŒ¤‹†•ñ‘). ‰¡“csŽj1, –xì—æŽq2, “àŽR@ ¹3 (1Ž™. 2‘—§¬ˆçˆã—ÃZƒ“ƒ^[. 3VŠƒ‘å): Œú¶˜J“­‰ÈŠwŒ¤‹† (¬Ž™Ž¾Š³—Õ°Œ¤‹†Ž–‹Æ). ¬Ž™2Œ^“œ”A•a‚ɑ΂·‚éŒoŒûŒŒ“œ~‰º–òŽ¡—ẪGƒrƒfƒ“ƒX‚ÌŠm—§: “Á‚ɃƒgƒtƒHƒ‹ƒ~ƒ“‚ÌŽŠ“K“Š—^—Ê, —LŒø«‚ƈÀ‘S«‚ÌŒ¤‹†. •½¬16”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.53-55, 2005.

521042. [Œ¤‹†•ñ] (Œú˜JÈ) ¬Ž™“œ”A•aŠ³ŽÒ‚É‚¨‚¯‚錌’†ƒAƒfƒBƒ|ƒlƒNƒ`ƒ“’l‚ÌŒŸ“¢ (•ª’SŒ¤‹†: 2Œ^“œ”A•a•aˆöˆâ“`Žq‚Ì—LŒø«‚Ö‚ÌŠÖ—^‚ÉŠÖ‚·‚錤‹†). ‰¡“csŽj (Ž™): Œú¶˜J“­‰ÈŠwŒ¤‹† (¬Ž™Ž¾Š³—Õ°Œ¤‹†Ž–‹Æ). ¬Ž™2Œ^“œ”A•a‚ɑ΂·‚éŒoŒûŒŒ“œ~‰º–òŽ¡—ẪGƒrƒfƒ“ƒX‚ÌŠm—§: “Á‚ɃƒgƒtƒHƒ‹ƒ~ƒ“‚ÌŽŠ“K“Š—^—Ê, —LŒø«‚ƈÀ‘S«‚ÌŒ¤‹†. •½¬16”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.56-60, 2005.

521043. [Œ¤‹†•ñ] (Œú˜JÈ) •Ÿ‰ªŽs“à‚̬ŠwZŽ™“¶‚ɑ΂·‚éƒAƒŒƒ‹ƒM[Ž¾Š³’²¸Œ‹‰Ê‚ɂ‚¢‚Ä‚ÌŒŸ“¢ (•ª’SŒ¤‹†•ñ‘). ¬“c“ˆ@”Ž1, ’ÓcŒbŽŸ˜Y2, ²“¡@O3, –ìŠÔ@„4, ‰ª“cŒ«Ži1, –Ø‘º’m‰ØŽq1, Žè’˃ˆê˜Y1, ‹v•Û“c“TŽq1, ˆäŽèN“ñ1, ¬—Ñ@”Ž1 (1•Ÿ‰ª•a‰@. 2‚‚¾‚±‚Ç‚à. 3ŽY‹Æˆã‘å. 4Ž™): Œú¶˜J“­‰ÈŠwŒ¤‹† (–ƉuƒAƒŒƒ‹ƒM[Ž¾Š³—\–hEŽ¡—ÃŒ¤‹†Ž–‹Æ) ‹CŠÇŽxšb‘§‚Ì—L•a—¦EœëŠ³—¦‹y‚ÑQOL‚ÉŠÖ‚·‚é‘S”N—îŠK‹‰•Ê‘S‘’²¸‚ÉŠÖ‚·‚錤‹†. •½¬16”N“xŒ¤‹†•ñ‘, p.16-19, 2005.

521044. [Œ¤‹†•ñ] (Œú˜JÈ) ŒÄ‹zŠíŽ¾Š³‚ÌŠù‰‚ƃAƒgƒs[«”畆‰Š”­Ç‚ÉŠÖ‚·‚éƒRƒz[ƒgÝ’èEƒAƒgƒs[«”畆‰Š‘žˆ«ˆöŽq‚̉ðÍ‚ÉŠÖ‚·‚錟“¢ (•ª’SŒ¤‹†•ñ‘). ¬“c“ˆ@”Ž1, –ìŠÔ@„2, ‘åŽÄW—m3, Xì‚Ý‚«4, –Ø‘º’m‰ØŽq5, ì–ì@–L6, Žè’˃ˆê˜Y5, “n•Ó”ü»7, ²”Œ•q—º2, ¼”ö@Œ’8 (1•Ÿ‰ª•a‰@. 2Ž™. 3“Œ‹žˆãŽ•‘å. 4JRå‘ä•a‰@. 5“ì•Ÿ‰ª•a‰@. 6‰¡•lÔ\Žš. 7“Œ–M‘å. 8•Ÿ‰ª‘å): Œú¶˜J“­‰ÈŠwŒ¤‹† (–ƉuƒAƒŒƒ‹ƒM[Ž¾Š³—\–hEŽ¡—ÃŒ¤‹†Ž–‹Æ) ƒAƒgƒs[«”畆‰Š‚Ì—LÇ—¦’²¸–@‚ÌŠm—§‚¨‚æ‚Ñ—LÇ—¦ (”­Ç—¦) ’ቺEÇ󈫉»–hŽ~‘Îô‚É‚¨‚¯‚鶊ˆŠÂ‹«®”õ‚ÉŠÖ‚·‚錤‹†. •½¬16”N“xŒ¤‹†•ñ‘, p.19-21, 2005.

521045. [Œ¤‹†•ñ] (•¶‰ÈÈ) ¬Ž™1Œ^“œ”A•a‚É‚¨‚¯‚éƒCƒ“ƒvƒŠƒ“ƒgˆâ“`Žq‚̈Ӌ`‚ÉŠÖ‚·‚錤‹†. ‰¡“csŽj, ¼‰YM•v, •—’£KŽi (Ž™): •½¬12”N“x`•½¬14”N“x‰ÈŠwŒ¤‹†•â•‹à Šî”ÕŒ¤‹† (C) Œ¤‹†¬‰Ê•ñ‘, p.1-47, 2004.

m’˜@‘n

620090. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ’áƒAƒŒƒ‹ƒM[H•i‚ÌŠJ”­ (•‹y”Å); H•¨ƒAƒŒƒ‹ƒM[ in vitrof’f–@‚ÌŒ»ó‚Æ‚»‚Ì“W–], p.73-81. –ìŠÔ@„1, ‰© (–Ø) ‘‹P2 (1Ž™. 2“¯ˆ¤‹L”O•a‰@), •ÒW ’ràV‘P˜Y (‰¡•lŽs‘å), ƒV[ƒGƒ€ƒV[o”Å, “Œ‹ž, 2004/3/26”­s.

620091. [ŠTà‘] (‹¤’˜) 2005 ¡“ú‚ÌŽ¡—ÃŽwj; ŠwZ‚É‚¨‚¯‚ét‘ŸŽ¾Š³Šw“¶¶“k‚ÌŠÇ—, p.968-969. ”Ñ‚Šì‹v—Y (‘å˜aŽs—§•a‰@, Ž™), •ÒW ŽRŒû@“O, –kŒ´Œõ•v, ˆãŠw‘‰@, “Œ‹ž, 2005/1/1”­s.

mŠw‰ï”­•\n

712026. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Kawasaki Disease: Cardiac Problem and Management. Έä³_ (Ž™): The Third International Congress on Cardiovascular Disease (2004/11/28), Taiwan.

713096. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Endothelial Dysfunction and Therapeutic Strategy for the Long Term after Kasawaki Disease: Assessment of Invasive and Noninvasive Study. Έä³_1, ŒÃˆä@2, ›Œ´—mŽq2, –´“cLŽÀ2, ]ãŒöN2, ¼Î–LŽŸ˜Y2 (1Ž™. 2‹v—¯•Ä‘å): Scientific sessions 2004 (2004/11/7-10), New Orleans. Circulation, 110 (17): III-387, 2004.

713097. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Long-term Follow-up Results of the Percutaneous Transluminal Coronary Revascularization (PTCR) in Kawasaki Disease. Koizumi H1, Έä³_2, ›Œ´—mŽq3, Kato H3 (1‹{é‘å. 2Ž™. 3‹v—¯•Ä‘å): Scientific sessions 2004 (2004/11/7-10), New Orleans. Circulation, 110 (17): III-III-389, 2004.

713098. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) The revised Japanese diagnostic criteria for Kawasaki disease are more sensitive than the American heart association criteria. –´“cLŽÀ1, Έä³_2, ]ãŒöN1, ›Œ´—mŽq1, ‰Æ‘º‘fŽj1, ‘O–ì‘׎÷1, ’†‘ºDˆê3, ¼Î–LŽŸ˜Y1 (1‹v—¯•Ä‘å. 2Ž™. 3Ž©Ž¡ˆã‘å): 8th International Kawasaki Disease Symposium (2005/2/18), San Diego. 8th International Kawasaki Disease Symposium Final Program, p.17, 2005.

713099. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Pathogenesis of Kawasaki disease: Chlamydia pneumoniae infection may be associated with Kawasaki disease. Kishimoto S1, Έä³_2, ]ãŒöN3, –´“cLŽÀ3, ›Œ´—mŽq3, ‰Æ‘º‘fŽj3, ‘O–ì‘׎÷3, Suda K3, ¼Î–LŽŸ˜Y3 (1¹ƒ}ƒŠƒA•a‰@. 2Ž™. 3‹v—¯•Ä‘å): 8th International Kawasaki Disease Symposium (2005/2/18), San Diego. 8th International Kawasaki Disease Symposium Final Program, p.18, 2005.

713100. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Pathogenesis of Kawasaki disease by microarray study: relationship of genetic factors and cardiovascular lesions. ]ãŒöN1, Έä³_2, –´“cLŽÀ1, ›Œ´—mŽq1, ‰Æ‘º‘fŽj1, ‘O–ì‘׎÷1, Suda K1, ¼Î–LŽŸ˜Y1 (1‹v—¯•Ä‘å. 2Ž™): 8th International Kawasaki Disease Symposium (2005/2/18), San Diego. 8th International Kawasaki Disease Symposium Final Program, p.18, 2005.

713101. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Risk factors associated with treatment failures with initial intravenous gamma globulin therapy for Kawasaki disease. ŒÃˆä@1, –´“cLŽÀ2, Έä³_3, ›Œ´—mŽq2, ‘O–ì‘׎÷2, Shimozono S1, Waki C1, ’†‘ºDˆê4, ¼Î–LŽŸ˜Y2 (1“y’J‘‡•a‰@. 2‹v—¯•Ä‘å. 3Ž™. 4Ž©Ž¡ˆã‘å): 8th International Kawasaki Disease Symposium (2005/2/19), San Diego. 8th International Kawasaki Disease Symposium Final Program, p.19, 2005.

713102. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Risk factors for atherosclerosis in the long term after Kawasaki disease: serum lipid profiles and body mass index study. ›Œ´—mŽq1, Έä³_2, ]ãŒöN1, –´“cLŽÀ1, ‰Æ‘º‘fŽj1, ‘O–ì‘׎÷1, Suda K1, ¼Î–LŽŸ˜Y1 (1‹v—¯•Ä‘å. 2Ž™): 8th International Kawasaki Disease Symposium (2005/2/19), San Diego. 8th International Kawasaki Disease Symposium Final Program, p.22, 2005.

713103. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) How do we manege pregnancy in women with coronary artery lesions due to Kawasaki disease. Ô–Ø’õŽ¡1, Himeno W2, Έä³_3, ›Œ´—mŽq2, Toyoda O2, Kato H2 (1‰ªŽR‘å. 2‹v—¯•Ä‘å. 3Ž™): 8th International Kawasaki Disease Symposium (2005/2/19), San Diego. 8th International Kawasaki Disease Symposium Final Program, p.23, 2005.

713104. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Artery bypass grafts as a conduit for coronary artery lesions in Kawasaki disease. ]ãŒöN1, –´“cLŽÀ1, ›Œ´—mŽq1, ‰Æ‘º‘fŽj1, ¼Î–LŽŸ˜Y1, Tashiro T2, Έä³_3 (1‹v—¯•Ä‘å. 2•Ÿ‰ª‘å. 3Ž™): 8th International Kawasaki Disease Symposium (2005/2/19), San Diego. 8th International Kawasaki Disease Symposium Final Program, p.23, 2005.

713105. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Prediction of intravenous immunoglobulin-resistant patients in Kawasaki disease: single-center study. ]ãŒöN1, –´“cLŽÀ1, ›Œ´—mŽq1, ‰Æ‘º‘fŽj1, ‘O–ì‘׎÷1, Suda K1, ¼Î–LŽŸ˜Y1, Έä³_2 (1‹v—¯•Ä‘å. 2Ž™): 8th International Kawasaki Disease Symposium (2005/2/19), San Diego. 8th International Kawasaki Disease Symposium Final Program, p.11, 2005.

713106. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Percutaneous transluminal coronary revascularization for Kawasaki disease: long-term follow-up study. Έä³_1, Koizumi H2, ‰Æ‘º‘fŽj3, –´“cLŽÀ3, ›Œ´—mŽq3, Kato H3 (1Ž™. 2‹{è‘å. 3‹v—¯•Ä‘å): 8th International Kawasaki Disease Symposium (2005/2/19), San Diego. 8th International Kawasaki Disease Symposium Final Program, p.11, 2005.

713107. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Warfarin therapy improves clinical outcome of Kawasaki disease patients with giant coronary aneurysms. ›Œ´—mŽq1, Έä³_2, ]ãŒöN1, –´“cLŽÀ1, ‰Æ‘º‘fŽj1, ‘O–ì‘׎÷1, Suda K1, ¼Î–LŽŸ˜Y1 (1‹v—¯•Ä‘å. 2Ž™): 8th International Kawasaki Disease Symposium (2005/2/19), San Diego. 8th International Kawasaki Disease Symposium Final Program, p.12, 2005.

713108. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Endothelial dysfunction and therapeutic new strategy in the long term after Kawasaki disease. Έä³_1, ŒÃˆä@2, ‰Æ‘º‘fŽj3, ’†”¨–í¶1, –´“cLŽÀ3, ›Œ´—mŽq3 (1Ž™. 2L“‡‘å. 3‹v—¯•Ä‘å): 8th International Kawasaki Disease Symposium (2005/2/20), San Diego. 8th International Kawasaki Disease Symposium Final Program, p.13, 2005.

713109. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Health-related quality of life in adolescents with a history of Kawasaki disease: assessment using the medical outcome study short form 36. –´“cLŽÀ1, Έä³_2, ]ãŒöN1, ›Œ´—mŽq1, ‰Æ‘º‘fŽj1, ‘O–ì‘׎÷1, ¼Î–LŽŸ˜Y1 (1‹v—¯•Ä‘å. 2Ž™): 8th International Kawasaki Disease Symposium (2005/2/20), San Diego. 8th International Kawasaki Disease Symposium Final Program, p.13, 2005.

713110. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Long-term follow-up study of percutaneous catheter intervention for Kawasaki disease: 10 years of observation. ‰Æ‘º‘fŽj1, Έä³_2, Ueno T3, –´“cLŽÀ1, ]ãŒöN1, ›Œ´—mŽq1, Himeno W1, ‘O–ì‘׎÷1, Suda K1, Kato H1, ¼Î–LŽŸ˜Y1 (1‹v—¯•Ä‘å. 2Ž™. 3•Ÿ‰ªŽsˆãŽt‰ï¬l•aƒZƒ“ƒ^[): 8th International Kawasaki Disease Symposium(2005/2/20), San Diego. 8th International Kawasaki Disease Symposium Final Program, p.14, 2005.

722048. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŠwZŒŸ”A‚ðŒŸØ‚·‚é@Ž¡—Öʂ©‚ç@–Œ«‘B«t‰Š iMPGNj. ”Ñ‚Šì‹v—Y (‘å˜aŽs—§•a‰@, Ž™j: ‘æ39‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ïŠwpW‰ï (2004/7/2), ŒF–{Žs. “ú–{¬Ž™t‘Ÿ•aŠw‰ïŽGŽ, 17(1 S.): 76, 2004.

722049. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Dialysis for extremely low birth weight infants in NICU at Kitasato Univ. Hospital. ’†‘ºM–ç1, Šâ”g’¼”ü1, ‰z–ì_]1, Žç‰®r‰î1, ‘Š”nˆêˆå2 i1Ž™. 2‹~–½j: ‘æ15‰ñ“ú–{‹}«ŒŒ‰tò‰»Šw‰ï (2004/9/17-18), –¼ŒÃ‰®.

722050. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ¬Ž™ŒÅŒ`Žîᇂ̕a‘Ô‰ð–¾@12ƒgƒŠƒ\ƒ~[‚𔺂¤‚2”{«ƒEƒCƒ‹ƒ€ƒXŽîᇂ̶•¨Šw“I“Á’¥. “n•Ó’¼Ž÷1, ’†ŠÚ®–ç2, ”Ñ’Ë@i3, ‹î“c”üO4, ²X–Ø•¶Í5, ‰““¡Š²–ç6, ‹e“c@“Ö7, P¼—R‹LŽq8, ‹C‰ê‘òŽõl9, –x‰z‘×—Y10, Γc–ç¡Žu11, …“cË‘ã12, ’ß@’mŒõ13, `@‡ˆê8, •ŸàV³—m14, ‹àŽqˆÀ”äŒÃ1 (1é‹ÊŒ§—§‚ª‚ñƒZƒ“ƒ^[. 2Ž™. 3–kŠC“¹‚ª‚ñƒZƒ“ƒ^[. 4ŽOd‘å. 5–kŠC“¹‘å. 6ŠâŽèˆã‘å. 7•Ÿ“‡Œ§—§ˆã‘å. 8‘—§¬ˆçˆã—Ã. 9_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 10ɪŒ§—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 11ˆ¤•Q‘å. 12‹ãB‘å. 13‹v—¯•Ä‘å. 14“ú–{‘å): ‘æ20‰ñ¬Ž™‚ª‚ñŠw‰ïE‘æ46‰ñ“ú–{¬Ž™ŒŒ‰tŠw‰ï (2004/11/21), ‹ž“s. “ú–{¬Ž™ŒŒ‰tŠw‰ïŽGŽ, 18 (4): 240, 2004 : ¬Ž™‚ª‚ñ, 41(3): 487, 2004.

722051. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) Toll-like receptor‚ð‰î‚·‚é–Ɖu§Œä. –ìŠÔ@„ (Ž™): ‘æ41‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ï (2004/11/27), “Œ‹ž. “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽ, 18 (4): 403, 2004.

722052. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) W’†Ž¡—ÂÆzŠÂŠÇ—@ƒGƒR[‚ð—p‚¢‚½¬Ž™dÇŠ³ŽÒ‚É‚¨‚¯‚ézŠÂŠÇ—–@. ‰iŸºO”V1, ¼–{‘½ŠG1, —Ñ@‰1,2, ”~Œ´@ŽÀ1,2, L–ØŒöˆê1 (1_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 2Ž™): ‘æ32‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2005/2/24), “Œ‹ž. “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, 12 (S.): 131, 2005.

723466. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “Ë‘R‚Ì•s‹@Œ™, šq“f‚ð‚­‚è•Ô‚µ4ƒ•ŒŽ‚ÅŽ€–S‚µ‚½1—á|Š¥“®–¬’áŒ`¬‚É‚æ‚éS‹Ø‹•ŒŒ|. “¡•‹`l1, –xŒû‘דT1, •½Î@ãà2, L“c•l•v1, ’†”¨–í¶1, “¡–ìé”V1, •“cM—T1, ¬ì‰ÄŽq1 (1Ž™. 2•½Î‚±‚Ç‚àƒNƒŠƒjƒbƒNj: ‘æ107‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2004/4/9), ‰ªŽRŽs. “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 108 (2): 234, 2004.

723467. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) –k—¢‘åŠw•a‰@¬Ž™‰È‚É‚¨‚¯‚ég¬Ž™ŒÄ‹z—Ö@ƒ`[ƒ€h‚ÌŽŽ‚Ý. ã“cN‹v1, ”~Œ´@ŽÀ2, –¥‰YŽ‘¥1, Œ´@^l1, ‰¡ŽR”ü²Žq3, ¬’r•üF3, ‰““¡^ˆê3 (1Ž™. 2_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 3ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[•”): ‘æ107‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2004/4/9), ‰ªŽRŽs. “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 108 (2): 160, 2004.

723468. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “ñŽŸˆÏ‘õ—\–hÚŽíŽw’è•a‰@‚É‚¨‚¯‚é7”NŠÔ‚ÌŒoŒ±. ‘º¼GŽ÷1, ª–{•¶Žq2, –ìXŽRŸl3, â“Œ—R‹I2, »‰Ÿ@Â2, ŒÜ\—’@—Y2 (1˜Z–{–؃qƒ‹ƒYƒNƒŠƒjƒbƒN. 2Ž™. 3Š´õÇ): ‘æ107‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2004/4/9), ‰ªŽRŽs. “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 108(2): 243, 2004.

723469. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) H•¨ƒAƒŒƒ‹ƒM[Š³ŽÒ‚ÌH•¨RŒ´‚Ìf’f. ¬ì—ÏŽj, ì–ì@–L, ²”Œ•q—º, –ìŠÔ@„ (Ž™): ‘æ107‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2004/4/9), ‰ªŽRŽs. “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 108 (2): 244, 2004.

723470. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒÄ‹zŠíŠjˆãŠwŒŸ¸‚ð—p‚¢‚½V¶Ž™–«”xŽ¾Š³‚Ì’·Šú—\Œã‚ÌŒŸ“¢. Œ´@^l1, ”~Œ´@ŽÀ2, –¥‰YŽ‘¥3, ŠÖª@“O3, ã“cN‹v3, •Ÿ“‡’‹`3 (1–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@. 2_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 3Ž™): ‘æ107‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2004/4/9), ‰ªŽRŽs. “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 108 (2): 255, 2004.

723471. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒŒŠÇ«Ž‡”Á•a‚Ì—Õ°“IŒ¤‹†. –{ŽR@Ž¡1, ”Ñ‚Šì‹v—Y2,3 (1“Œ–M‘å. 2‘å˜aŽs—§•a‰@. 3Ž™j: ‘æ107‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2004/4/9), ‰ªŽRŽs. “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 108 (2): 322, 2004.

723472. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”­Ç‚ÉCoxsackie Virus‚ÌŠÖ—^‚ª„‘ª‚³‚ꂽSLE’jŽ™—á. •û¹•½, –ìX“c@–L, ˆ¢•”‘׎q, ‰z–ì_], ’†‘ºM–ç, â“Œ—R‹I (Ž™): ‘æ107‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2004/4/10), ‰ªŽRŽs. “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 108 (2): 333, 2004.

723473. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒŒð«ŒŒ¬”ÂŒ¸­«Ž‡”Á•a‚Ì”­Ç (TTP) ‚ª‹^‚í‚ꂽ‘Sg«ƒGƒŠƒgƒ}ƒg[ƒfƒX‚̈ê—á. ¬ì—ÏŽj, •û¹•½, —Ñ@‰, ‰z–ì_], ’†‘ºM–ç, ì–ì@–L, ²”Œ•q—º, –ìŠÔ@„ (Ž™): ‘æ107‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2004/4/10), ‰ªŽRŽs. “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 108 (2): 334, 2004.

723474. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬‡«Œ‹‡‘gD•a‚Ì1—Ž™—á|—Õ°Œo‰ß‹y‚ÑŒŸ¸¬Ñ‚ÌŒŸ“¢|. ²”Œ•q—º, ¬ì—ÏŽj, ì–ì@–L, –ìŠÔ@„ (Ž™): ‘æ107‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2004/4/10), ‰ªŽRŽs. “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 108 (2): 335, 2004.

723475. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰”­Žž‚É‘½Ê‚ÈŒŒŠÇ‰ŠÇŒóŒQ‚ð’悵‚½systemic JIA‚Ì1—Ž™—á. ª–{•¶Žq, â“Œ—R‹I, –Ø‘ºƒl, ‘å’ì”V, •“cM—T, “à“¡„•F, –¥‰YŽ‘¥, ‹k“cˆê‹P, ˆÀ“¡@Žõ, “¡•‹`l (Ž™, ŠC˜V–¼‘‡•a‰@): ‘æ107‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2004/4/10), ‰ªŽRŽs. “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 108 (2): 336, 2004.

723476. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰ß‹Ž2”NŠÔ‚ÉŽOŽŸ‹~‹}ˆã—Â̓K‰ž‚Æ‚µ‚Ä, “–‰@‚É“ü‰@‚µ‚½¬Ž™Š³ŽÒ‚Ì’·Šú—\Œã‚ɂ‚¢‚Ä. Šâèr”V, Žç‰®r‰î, »‰Ÿ@ (Ž™): ‘æ107‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2004/4/10), ‰ªŽRŽs. “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 108 (2): 340, 2004.

723477. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™ƒAƒŒƒ‹ƒM[Ž¾Š³‚Ì”­Ç‚Ì—\’m‚ÉŠÖ‚·‚錟“¢ (‘æ5•ñ)|ƒAƒgƒs[«”畆‰Š‹y‚Ñšb‘§‚Ì”­Ç—vˆö‚Ì”äŠr|. ì–ì@–L1, Xì‚Ý‚«2, “nç²”ü»3, ‘åŽÄW—m4, –ìŠÔ@„5, ¬“c“ˆ@”Ž6 (1‰¡•lÔ\Žš•a‰@. 2JRå‘ä•a‰@. 3“Œ–M‘å. 4“Œ‹žˆãŽ•‘å. 5Ž™. 6‘—§—×{Š“ì•Ÿ‰ª•a‰@): ‘æ16‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Õ°‘å‰ï (2004/5/12), ‘O‹´Žs. ƒAƒŒƒ‹ƒM[, 53 (2-3): 315, 2004.

723478. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œ{—‘ƒAƒŒƒ‹ƒM[Š³Ž™ƒŠƒ“ƒp‹…‚É‚¨‚¯‚éCD47ì—p. ¬ì—ÏŽj, ì–ì@–L, ²”Œ•q—º, –ìŠÔ@„ (Ž™): ‘æ16‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Õ°‘å‰ï (2004/5/13), ‘O‹´Žs. ƒAƒŒƒ‹ƒM[, 53 (2-3): 339, 2004.

723479. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’áŽ_‘f”]Ç‚ð‚«‚½‚µ‚½‹C“¹ˆÙ•¨‚Ì1“ûŽ™—á. •û¹•½1, —Ñ@‰1, “¡•‹`l1, ã“cN‹v1, Œ´@^l2, ”~Œ´@ŽÀ3 i1Ž™. 2–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@. 3_“Þ쌧—§‚±‚Ç‚àˆã—Ãj: ‘æ18‰ñ“ú–{¬Ž™‹~‹}ˆãŠw‰ï (2004/6/18), ‹à‘òŽs. “ú–{¬Ž™‹~‹}ˆãŠw‰ïŽGŽ, 3 (1): 96, 2004.

723480. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) æ“V«ƒlƒtƒ[ƒ[ÇŒóŒQ‚Ì1—Ž™‚É‚¨‚¯‚鬒·”­’B‚ÉŠÖ‚µ‚Ä‚ÌŒŸ“¢. ¼‰Y—RŠóŽq1, Žç‰®r‰î1, Šâ”g’¼”ü1, ‰z–ì_]1, ’†‘ºM–ç1, ‰¡“csŽj1, ‰Í¼‹Iº2, ”Ñ‚Šì‹v—Y3 (1Ž™. 2‘å˜aŽs—§•a‰@. 3‘Š–Í–ì•a‰@): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2004/6/18-20), _ŒËŽs. “ú–{“§ÍˆãŠw‰ïŽGŽ, 37 (Sl.1): 1028, 2004.

723481. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@NICU‚É‚¨‚¯‚éæ“V«SŽ¾Š³‚É”º‚¤‡•¹ŠïŒ`‚ɂ‚¢‚Ä‚ÌŒŸ“¢. —Ñ@‰1, L“c•l•v1, ’†”¨–í¶1, –xŒû‘דT1, •½Î@ãà2, “¡–ìé”V1, •“cM—T1, ¬ì‰ÄŽq1, ‹{’n@ŠÓ3, –ƒ¶r‰p4 (1Ž™. 2•½Î‚±‚Ç‚àƒNƒŠƒjƒbƒN. 3‹¹ŠO. 4_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[j: ‘æ40‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï (2004/6/30), “Œ‹ž. “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 20 (3): 336, 2004.

723482. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Chaotic atrial rhythm ‚ð’悵‚½CostelloÇŒóŒQ‚Ì1—á. –Ø‘ºƒl, L“c•l•v, ’†”¨–í¶, –xŒû‘דT, •½Î@ãà2, •“cM—T1, ¬ì‰ÄŽq1, “¡–ìé”V1 (1Ž™. 2•½Î‚±‚Ç‚àƒNƒŠƒjƒbƒN): ‘æ40‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï (2004/6/30), “Œ‹ž. “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 20 (3): 341, 2004.

723483. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Modified BTƒVƒƒƒ“ƒg‚ɑ΂·‚éƒRƒCƒ‹Çðp|ƒŒ^”x“®–¬•Ù•Â½‚Ì1—á‚Å‚ÌŒoŒ±|. ”Ñ“‡^‹IŽq1, –xŒû‘דT1, ‰Hª“c‹IK2, L“c•l•v1, ’†”¨–í¶1, “¡–ìé”V1, •“cM—T1, ¬ì‰ÄŽq1, ‹{’n@ŠÍ3, ‚è‘׈ê2 (1Ž™. 2‚Ç‚ê‚݃NƒŠƒjƒbƒN. 3‹¹ŠOj: ‘æ40‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï (2004/6/30), “Œ‹ž. “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 20 (3): 346, 2004.

723484. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒtƒHƒ“ƒ^ƒ“Œ^ŽèppŒã‚ÌŒŒs“®‘Ô|ƒvƒƒ^ƒm[ƒ‹•‰‰×‚É‚æ‚錟“¢ (‘æ2•ñ)|. –xŒû‘דT1, L“c•l•v1, ’†”¨–í¶1, •½Î@ãà2, “¡–ìé”V1, •“cM—T1, ¬ì‰ÄŽq1 (1Ž™. 2•½Î‚±‚Ç‚àƒNƒŠƒjƒbƒN): ‘æ40‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï (2004/7/1), “Œ‹ž. “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 20 (3): 410, 2004.

723485. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰EŽº—¬o˜HÄŒšpŒãŠ³ŽÒ‚ÌŒðŠ´_ŒoáŠQ (‘æ2•ñ)|MIBGS‹ØƒVƒ“ƒ`ƒOƒ‰ƒ€‚Å‚ÌŒŸ“¢|. ’†”¨–í¶1,2, ‘å“àG—Y2, ‰ª“c—zŽq2, ‚™®Žu2, ˆä”W°‹`2, ¬–ìˆÀ¶2, ‰zŒã–ΔV2 i1Ž™. 2‘—§zŠÂŠí•aƒZƒ“ƒ^[): ‘æ40‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï (2004/7/1), “Œ‹ž. “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 20 (3): 292, 2004.

723486. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ˆ««ƒŠƒ“ƒpŽî‚É‘å“®–¬‰ŠÇŒóŒQ‚ð‡•¹‚µ‚½ˆê’jŽ™—á. ‹k“cˆê‹P1, ’†‘ºM–ç1, Šâ”g’¼”ü1, ‰z–ì_]1, Žç‰®r‰î1, ŽO‘î@ò1, ’†ŠÙ®–ç1, ”Ñ‚Šì‹v—Y1,2, ‰Í¼‹Iº3 (1Ž™. 2‘å˜aŽs—§•a‰@. 3‘Š–Í–ì•a‰@j: ‘æ39‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ïŠwpW‰ï (2004/7/2), ŒF–{Žs. “ú–{¬Ž™t‘Ÿ•aŠw‰ïŽGŽ, 17 (1 S.): 114, 2004.

723487. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) V¶Ž™’®Šoscreening ‚ÌŒŸ“¢ (‘æ2•ñ)|‹É’áo¶‘ÌdŽ™‚ɑ΂·‚é2 step screening‚ÌŽŽ‚Ý|. –ì“n³•F1, çÝŽ@ Šw1, ‰ª–{–ql2 (1Ž™. 2Ž¨•@): ‘æ40‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2004/7/12), “Œ‹ž. “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ, 40 (2): 297, 2004.

723488. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘ŽYŽ™‚ɑ΂·‚éƒpƒŠƒrƒYƒ}ƒu“Š—^‚ÉŠÖ‚·‚錟“¢ (‘æ2•ñ). çÝŽ@Šw, “n•Ó’qŽq, ŽO{—zŽq, –ì“n³•F (Ž™): ‘æ40‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2004/7/12), “Œ‹ž. “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ, 40 (2): 288, 2004.

723489. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) _“Þ쌧—§Žˆ‘Ì•sŽ©—R—{ŒìŠwZ‚ł̈ã—ÓIƒPƒA‚ÌŽæ‚è‘g‚Ý‚Æ‚»‚̉ۑè. דc‚Ì‚¼‚Ý1, ŽO‰YŽõ’j1, Šâèr”V2, •ˆäŒ¤“ñ1, •ÐŽR•¶•F2, “‡ŠÑ@ˆè2, »‰Ÿ@Â2, ”’ˆäGK2 (1‘Š–ÍŒ´—È牀. 2Ž™), ‘æ46‰ñ“ú–{¬Ž™_ŒoŠw‰ï (2004/7/17), “Œ‹ž. ”]‚Æ”­’B, 36(S.): S225, 2004.

723490. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™‚Ì’á2”{‘Ì‹}«ƒŠƒ“ƒp«”’ŒŒ•a (ALL) 68—á‚ÌŒŸ“¢. •Ÿ“‡@Œh1, N@ŸD2, ‚‹´_”V3, ^•”@~2, ¬Œ´@–¾4, —Ñ@‘×G5, ŠO¼@Šw6, ‹àŽq@—²7, 㞊Šx•F8, ˆéŽRŒbˆê9, –؉º–¾r10, Œã“¡—T–¾3, –L“c‹±“¿11, ‘O“c”ü•ä12, “ˆ“c”Ž”V13, ™“cŒ›ˆê14, âV“¡³”Ž15, ™“cŠ®Ž¢16, ŠŒ´“¹Žq17, –î•”W³18, ‹e’n@—z19, ’†ŠÚ®–ç20, –ìŒû@–õ21, –q–{@“Ö22, –ö‘ò—²º23, ¶“cFˆê˜Y24, ‰Ô“c—Ç“ñ19, “y“c¹G25 (1’}”g‘å. 2“Œ‹ž‘å. 3,‰¡•lŽs‘å. 4“Œ–M‘å. 5ŒQ”nŒ§—§¬Ž™ˆã—Ã. 6‘O‹´Ô\Žš. 7“s—§´£¬Ž™. 8MB‘å. 9º˜a‘å. 10¹ƒ}ƒŠƒAƒ“ƒiˆã‘å. 11_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 12“ú–{ˆã‘å. 13Œc‰ž‘å. 14àÕ‹¦ˆã‘å. 15‡“V“°‘å. 16ŽR—œ‘å. 17“Œ‹žˆãŽ•‘å. 18“ŒŠC‘å. 19é‹ÊŒ§—§¬Ž™ˆã—Ã. 20Ž™. 21¬“cÔ\Žš. 22‘—§‚ª‚ñƒZƒ“ƒ^[. 23ŽœŒbˆã‘å. 24‰¡•lŽs‘å. 25ˆï錧—§‚±‚Ç‚àj, “Œ‹ž¬Ž™‚ª‚ñŒ¤‹†ƒOƒ‹[ƒv: ‘æ66‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïE‘æ46‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï (2004/9/17-19), ‹ž“sŽs. ƒvƒƒOƒ‰ƒ€E´˜^W, p.752, 2004.

723491. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰fŽž‚ÉJHÄ\¬‚ð”F‚ß‚½¬Ž™‹}«œ‘«”’ŒŒ•a‚ÌŒŸ“¢. ¼‰Y—RŠóŽq, ŠJ“c”ü•Û, ˆÀ“¡@Žõ, ŽO‘î@ò, ’†ŠÚ®–ç (Ž™): ‘æ66‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ïE‘æ46‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï (2004/9/17-19), ‹ž“sŽs. ƒvƒƒOƒ‰ƒ€E´˜^W, p.903, 2004.

723492. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™2Œ^“œ”A•a‚Ì–ò•¨Ž¡—Â̌»ó|“ú–{¬Ž™“à•ª”åŠw‰ï¬Ž™2Œ^“œ”A•aŽ¡—Èψõ‰ï•ñ|. ™Œ´–ÎF1, ²X–Ø@–]2, ‰Í–ì@Ä3, ‰J‹{@L4, “c’†•qÍ5, ¼‰YM•v6 (1—Žqˆã‘å. 2é‹Êˆã‘å. 3•Ÿ‰ªŽs—§‚±‚Ç‚à•a‰@. 4ŽR—œ‘å. 5¬ˆçˆã—Ã. 6Ž™): ‘æ38‰ñ“ú–{¬Ž™“à•ª”åŠw‰ï (2004/9/23), _ŒË. ´˜^W, p.78, 2004.

723493. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒƒ‹ƒJƒ][ƒ‹¿Ü‚ŃRƒ“ƒgƒ[ƒ‹‚µ“¾‚½Basedow•a‚Ì1—Ž™—á. •û¹•½1, ‰¡“csŽj1, “c‹v•ÛŒ›s1, ‰º•l^—¢Žq1, ‘å’ì”V1, •—’£áÁ—R”ü1, ¼‰YM•v2 (1Ž™. 2¹“¿‘å): ‘æ38‰ñ“ú–{¬Ž™“à•ª”åŠw‰ï (2004/9/22-23), _ŒË. ‘æ38‰ñ“ú–{¬Ž™“à•ª”åŠw‰ï´˜^W, p.96, 2004.

723494. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) •›t”玿‹@”\’ቺǂ̬Ž™‚ɑ΂·‚éhydrocortisone¿Ü‚Ì—L—p«‚ÉŠÖ‚·‚é—Õ°–ò—Šw“IŒŸ“¢. ‘å’ì”V1, ‰¡“csŽj1, ‰º•l^—¢Žq1, “c‹v•ÛŒ›s1, •—’£áÁ—R”ü1, ¼‰YM•v2 (1Ž™. 2¹“¿‘åj: ‘æ38‰ñ“ú–{¬Ž™“à•ª”åŠw‰ï (2004/9/22-23), _ŒË. ´˜^W, p.110, 2004.

723495. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) WT1ˆÙí‚ðŽ¦‚³‚¸12ƒgƒŠƒ\ƒ~[‚𔺂¤‚2”{«ŒQ‚̓EƒCƒ‹ƒ€ƒXŽîᇂÌV‚µ‚¢ƒTƒuƒOƒ‹[ƒv‚©. “n•Ó’¼Ž÷1, ¬—ёו¶1, ’†ŠÚ®–ç2, ²X–Ø•¶Í3, P¼—R‹LŽq4, …“cË‘ã5, •ŸàV³—m6, ‹àŽqˆÀ”äŒÃ1 (1é‹ÊŒ§—§‚ª‚ñƒZƒ“ƒ^[. 2Ž™. 3–kŠC“¹‘å. 4‘—§¬ˆçˆã—Ã. 5‹ãB‘å. 6“ú–{‘åj: ‘æ63‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2004/9/29), •Ÿ‰ªŽs. Cancer Science, 95 (S.): 160, 2004.

723496. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) tˆÚAŒã3ƒ–ŒŽ–Ú, äNã÷”AŠÇ•«‡•”‚ÉŒ‹Î‚𶂶Œo”A“¹“I”AŠÇ”jÓp iTULj‚ðŽ{s‚µ‚½ˆê’jŽ™—á. Šâ”g’¼”ü1, ’†‘ºM–ç1, ‰z–ì_]1, Žç‰®r‰î1, “y“c–š”ü2, “c‰ª‰ÀŒ›2, rì@F2, ‹g“cˆê¬2, ‰““¡’‰—Y, ”nêŽu˜Y2 (1Ž™. 2”åj: ‘æ26‰ñ¬Ž™t•s‘SŠw‰ï(2004/10/7), Œyˆä‘òŽs. ƒvƒƒOƒ‰ƒ€E´˜^W, p.41, 2004.

723497. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚é’®ŠoƒXƒNƒŠ[ƒjƒ“ƒO‚ÉŠÖ‚·‚錟“¢. “n•Ó’qŽq1,2, ‰º•l^—¢Žq1,2, ’·’Jì@‹1,2, ²”Œ•q—º1,2, –ìXŽRŸl3, “¡–ìé”V1,2 (1Ž™. 2‘Š–ÍŒ´‹¦“¯•a‰@. 3Š´õÇ): ‘æ53‰ñ“ú–{”_‘ºˆãŠw‰ï (2004/10/7-8), H“cŽs. “ú–{”_‘ºˆãŠw‰ïŽGŽ, 53 (3): 545, 2004.

723498. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) àhŽ†ŒŒTSH, fT4“¯Žž‘ª’è‚É‚æ‚éƒNƒŒƒ`ƒ“ǃ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO|“–‰@‚É‚¨‚¯‚é5”NŠÔ‚ÌŒ‹‰Ê|. ˆÉ“¡®Žu1, ‰¡“csŽj1, “c‹v•ÛŒ›s1, ‰º•l^—¢Žq1, çÝŽ@Šw1, –ì“n³•F1, ¼‰YM•v2, ŽRã—SŽŸ3 (1Ž™. 2¹“¿‘å. 3_“Þ쌧—\–hˆãŠw‹¦‰ïj: ‘æ32‰ñ“ú–{ƒ}ƒX¥ƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ï (2004/10/8), å‘äŽs. “ú–{ƒ}ƒX¥ƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ïŽ, 14 (2): 71, 2004.

723499. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) æ“V«ƒlƒtƒ[ƒ[ÇŒóŒQ‚ÆDenys-DrashÇŒóŒQ‚Ì’·Šú—\Œã‚ÌŒŸ“¢. –{ŽR@Ž¡1, VˆäŒªŽi1, ‰Í‘º@‹B1, Žðˆä@Œª1, ‘Šì@Œú1, …“ü‰‘¶1, ¬Œ´•”Ž1, ’·’Jì@º1, ˆÉ“¡—S‰À1, ”Ñ‚Šì‹v—Y2,3 (1“Œ–M‘å. 2‘å˜aŽs—§•a‰@. 3Ž™j: ‘æ26‰ñ¬Ž™t•s‘SŠw‰ï (2004/10/8), Œyˆä‘òŽs. ƒvƒƒOƒ‰ƒ€E´˜^W, p.83, 2004.

723500. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Žá”N«ŠÖ߃ŠƒEƒ}ƒ`‚ð‹^‚í‚ê‹Ø‰Š—lÇó‚Å”­Ç‚µ‚½‹ØƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á. ²”Œ•q—º1, ì–ì@–L1, ¬ì—ÏŽj1, –ìŠÔ@„1, •ô“c‹ªb2, Ž¬è@—S3, –]ŒŽmŽu3, ŠC“cŒ«ˆê3, Š™‘qŒbŽq3 i1Ž™. 2”Ñ”\’†‰›•a‰@. 3–h‰qˆã‘åj: ‘æ14‰ñ“ú–{¬Ž™ƒŠƒEƒ}ƒ`Šw‰ï (2004/10/9), “Œ‹ž. ƒvƒƒOƒ‰ƒ€E´˜^W, p.48, 2004.

723501. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒŒð«ŒŒ¬”ÂŒ¸­«Ž‡”Á•a (TTP) ‚ª‹^‚í‚ꂽ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚Ì1—Ž™—á. •û¹•½, ‰z–ì_], ’†‘ºM–ç, ¬ì—ÏŽj, ì–ì@–L, ²”Œ•q—º, –ìŠÔ@„ (Ž™): ‘æ14‰ñ“ú–{¬Ž™ƒŠƒEƒ}ƒ`Šw‰ï (2004/10/9), “Œ‹ž. ƒvƒƒOƒ‰ƒ€E´˜^W, p.61, 2004.

723502. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) DŽ_‹…‘‘½ÇŒóŒQ‚É”º‚¢—Ü‘BŽî’¯‚ð‚«‚½‚µ‚½ˆê’jŽ™—á. ª–{•¶Žq, â“Œ—R‹I, ¡ˆäƒD (Ž™): ‘æ54‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ï‘‰ï (2004/11/4), ‰¡•l. ƒAƒŒƒ‹ƒM[, 53 (8-9): 919, 2004.

723503. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œ{—‘ƒAƒŒƒ‹ƒM[Š³Ž™ƒŠƒ“ƒp‹…‚É‚¨‚¯‚éCD47‚Ìì—p‚Æ—Õ°“IˆÓ‹`. ¬ì—ÏŽj, ì–ì@–L, ²”Œ•q—º, –ìŠÔ@„ (Ž™): ‘æ54‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ï‘‰ï (2004/11/5), ‰¡•l. ƒAƒŒƒ‹ƒM[, 53 (8-9): 972, 2004.

723504. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) —n˜A‹ÛŠ´õŒã‹}«Ž…‹…‘Ìt‰Š‚̉Ƒ°“à”­Ç—á. –{ŽR@Ž¡1, ’·’Jì@Œc1, ”Ñ‚Šì‹v—Y2,3 (1“Œ–M‘å. 2‘å˜aŽs—§•a‰@. 3Ž™j: ‘æ34‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2004/11/5), “Œ‹ž. “útŽ, 46 (6): 596, 2004.

723505. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™ƒAƒŒƒ‹ƒM[Ž¾Š³‚Ì”­Ç‚Ì—\’m‚ÉŠÖ‚·‚錟“¢ (‘æ6•ñ)|ŒoŽž“I‚È’²¸Œ‹‰Ê‚ɂ‚¢‚Ä|. ²”Œ•q—º1, ì–ì@–L2, Xì‚Ý‚«3, “nç²”ü»4, ‘åŽÄW—m5, –ìŠÔ@„1, ¬“c“ˆ@”Ž6 (1Ž™. 2‰¡•lÔ\Žš•a‰@. 3JRå‘ä•a‰@. 4“Œ–M‘å. 5“Œ‹žˆãŽ•‘å. 6‘—§—×{Š“ì•Ÿ‰ª•a‰@j: ‘æ54‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ï‘‰ï (2004/11/6), ‰¡•l. ƒAƒŒƒ‹ƒM[, 53 (8-9): 994, 2004.

723506. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ¬Ž™‚̌ċzƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“|“K؂ȌċzƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚ð‘I‘ð‚·‚é‚½‚ß‚É|. ã“cN‹v1, ”~Œ´@ŽÀ2 (1Ž™. 2_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[): ‘æ37‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï (2004/11/19), “Œ‹ž. ƒvƒƒOƒ‰ƒ€E´˜^W p.73, 2004.

723507. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒÄ‹zŠíŠjˆãŠwŒŸ¸‚ð—p‚¢‚½–ƒ]”x‰Š‚Ì—\Œã‚ÌŒŸ“¢. Œ´@^l1, ”~Œ´@ŽÀ2, –¥‰YŽ‘¥3, ŠÖª@“O3,, ã“cN‹v3,, •Ÿ“‡’‹`3, (1–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@. 2_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 3,Ž™): ‘æ37‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï (2004/11/19), “Œ‹ž. ƒvƒƒOƒ‰ƒ€E´˜^W, p.118, 2004.

723508. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¶PA sling‚𔺂¤CTS‚Ì1“ûŽ™—á‚̌ċzŠíŠÇ—‚É‚¨‚¯‚éˆêlŽ@. —Ñ@‰1, ã“cN‹v1, “¡•‹`l1, ‹k“cˆê‹P1, –¥‰YŽ‘¥2, Œ´@^l3, ”~Œ´@ŽÀ4, •i“c@ƒ5, ’Ãì@—Í6 (1Ž™. 2ŠC˜V–¼‘‡•a‰@. 3–k—¢Œ¤‹†Š. 4_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 5“à‡W. 6•ºŒÉŒ§—§‚±‚Ç‚à•a‰@j: ‘æ37‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï(2004/11/19), “Œ‹ž. ƒvƒƒOƒ‰ƒ€E´˜^W, p.126, 2004.

723509. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠJ• ¶ŒŸ’¼Œã‚©‚猌¬”—A’•s‰ž«‚ÌŒŒ¬”ÂŒ¸­‚𗈂µ‚½ŠÌ‰èŽî. ’†ŠÚ®–ç1, ŽO‘î@ò1, ’†Œ´‚³‚¨‚è2, “c’†@Œ‰2, Šâ•£Œ[ˆê3 (1Ž™. 2ŠO. 3•a—): ‘æ20‰ñ¬Ž™‚ª‚ñŠw‰ïE‘æ46‰ñ“ú–{¬Ž™ŒŒ‰tŠw‰ï(2004/11/22), ‹ž“s. “ú–{¬Ž™ŒŒ‰tŠw‰ïŽGŽ, 18 (4): 404, 2004. : ¬Ž™‚ª‚ñ, 41 (3): 665, 2004.

723510. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “Á”­«ŒŒ¬”ÂŒ¸­«Ž‡”Á•a‚Æf’f‚³‚ꂽMay-Hegglin Anomaly 1‰ÆŒn‚̈â“`Žq‰ðÍ. ’†ŠÚ®–ç1, ŒÃì^—S1, ˆÀ“¡@Žõ1, •û¹•½1, ŠJ“c”ü•Û1, ¼‰Y—RŠóŽq1, ‹{è_“ñ2, “n•Ó^—Žq2, “ŒŒ´³–¾2 (1Ž™. 2“à‡Wj: ‘æ20‰ñ¬Ž™‚ª‚ñŠw‰ïE‘æ46‰ñ“ú–{¬Ž™ŒŒ‰tŠw‰ï (2004/11/22), ‹ž“s. “ú–{¬Ž™ŒŒ‰tŠw‰ïŽGŽ, 18 (4): 460, 2004. : ¬Ž™‚ª‚ñ, 41 (3): 721, 2004.

723511. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Ž¡—ÃŒo‰ß’†‚ÉJH PCRƒNƒƒiƒŠƒeƒB‚ð”F‚ß‚½¬Ž™‹}«œ‘«”’ŒŒ•a. ŠJ“c”ü•Û, ŒÃì^—S, ¼‰Y—RŠóŽq, ˆÀ“¡@Žõ, •û¹•½, ŽO‘î@ò, ’†ŠÚ®–ç (Ž™): ‘æ20‰ñ¬Ž™‚ª‚ñŠw‰ïE‘æ46‰ñ“ú–{¬Ž™ŒŒ‰tŠw‰ï (2004/11/23), ‹ž“s. “ú–{¬Ž™ŒŒ‰tŠw‰ïŽGŽ, 18(4): 488, 2004. : ¬Ž™‚ª‚ñ, 41 (3): 749, 2004.

723512. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “ú–{¬Ž™MDSŒ¤‹†‰ïƒvƒƒgƒR[ƒ‹‚É‚ÄŽ¡—µ‚½RAEB II‚Ì—Ž™—á. ŒÃì^—S1, ŠJ“c”ü•Û1, ¼‰Y—RŠóŽq1, ˆÀ“¡@Žõ1, •û¹•½1, ŽO‘î@ò1, ’†ŠÚ®–ç1, Œã“¡—T–¾2, ‚‹´_”V2 i1Ž™. 2‰¡•lŽs‘åj: ‘æ20‰ñ¬Ž™‚ª‚ñŠw‰ïE‘æ46‰ñ“ú–{¬Ž™ŒŒ‰tŠw‰ï (2004/11/23), ‹ž“s. “ú–{¬Ž™ŒŒ‰tŠw‰ïŽGŽ, 18 (4): 507, 2004. : ¬Ž™‚ª‚ñ, 41 (3): 768, 2004.

723513. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) CFSEõFƒŠƒ“ƒp‹…‚ð—p‚¢‚½Œ{—‘ƒAƒŒƒ‹ƒM[Ž¾Š³‚Ì•aˆöRŒ´‚Ìf’f|RŒ´œ‹Ž‚É‚æ‚éÇó‰ü‘PŒQ‚ÌÇ—áŒo‰ß|. ¬ì—ÏŽj, ²”Œ•q—º, ì–ì@–L, –ìŠÔ@„ (Ž™): ‘æ41‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ï (2004/11/27), “Œ‹ž. “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽ, 18 (4): 508, 2004.

723514. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “ûŽ™Šú‘Šú‚É”­Ç‚µ‚½dÇV¶Ž™‰¼Ž€‚É”º‚¤H“¹—ôEƒwƒ‹ƒjƒA‚Ì1—á. ˆÀ“¡@Žõ, ˆÉ“¡®Žu, çÝŽ@Šw, –ì“n³•F, Έä³_ (Ž™): ‘æ49‰ñ“ú–{–¢nŽ™V¶Ž™Šw‰ï (2004/12/6), ‰¡•l. “ú–{–¢nŽ™V¶Ž™Šw‰ïŽGŽ, 16 (3): 479, 2004.

723515. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹}«Šú—£’EŒã‚É“Ë‘RzŠÂ•s‘S‚ð‹N‚±‚µ‚½’´’áo¶‘ÌdŽ™3—á‚ÌŒŸ“¢. ˆÉ“¡®Žu, ŒÏè‰ëŽq, çÝŽ@Šw, –ì“n³•F, “c‹v•ÛŒ›s, ‰¡“csŽj, Έä³_ (Ž™): ‘æ49‰ñ“ú–{–¢nŽ™V¶Ž™Šw‰ï (2004/12/6), ‰¡•l. “ú–{–¢nŽ™V¶Ž™Šw‰ïŽGŽ, 16 (3): 484, 2004.

723516. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚é’®ŠoƒXƒNƒŠ[ƒjƒ“ƒO‚ÉŠÖ‚·‚錟“¢. ’·’Jì@‹1,2, “¡–ìé”V1,2, –ìXŽRŸl3C²”Œ•q—º1,2, “n•Ó’qŽq1,2 (1Ž™. 2‘Š–ÍŒ´‹¦“¯•a‰@. 3Š´õÇ): ‘æ49‰ñ“ú–{–¢nŽ™V¶Ž™Šw‰ï (2004/12/7), ‰¡•l. “ú–{–¢nŽ™V¶Ž™Šw‰ïŽGŽ, 16 (3): 513, 2004.

723517. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Neuron specific enolase (NSE) ‚Í”]‰ŠE”]Ç‚Ìf’f‚̈ꕂƂȂ肤‚é‚©. ¼–{‘½ŠG1, —Ñ@‰1,2, ‰iŸºO”V1, ”~Œ´@ŽÀ1,2, ¬â@m1, ŽR‰ºƒ³1 (1_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 2Ž™): ‘æ32‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2005/2/24), “Œ‹ž. “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, 12 (S.): 165, 2005.

723518. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™‘½‘ŸŠí•s‘S‚ɑ΂·‚鎡—Ãí—ª (CRRT‚ð’†S‚Æ‚µ‚Ä). ‰iŸºO”V1, ¼–{‘½ŠG1, —Ñ@‰1,2, ”~Œ´@ŽÀ1,2, L–ØŒöˆê1 (1_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 2Ž™): ‘æ32‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2005/2/24), “Œ‹ž. “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, 12(S.): 183, 2005.

723519. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œëš‹«”x‰Š‚ƉŠúf’f‚³‚ꂽ‘m–X•ÙäFõ’f—ô‚É‚æ‚é‹}«‘m–X•Ù•Â½•s‘S‚Ì1“ûŽ™—á. —Ñ@‰1,2, “¹˜a•S‡1, ¼àV˜aŽq1, ¼–{‘½ŠG1, ‰iŸºO”V1, ”~Œ´@ŽÀ1,2, —Ñ@Œ›ˆê1, –ƒ¶r‰p1 (1_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 2Ž™): ‘æ32‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2005/2/24), “Œ‹ž. “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, 12(S.): 184, 2005.

723520. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “fŒŒ‚Å”­Ç‚µ‚½æ“V«ŠÌŠO–å–¬•ÂÇÇ‚Ì1—á. “¹˜a•S‡1, ²“¡O”V1, ¼–{‘½ŠG1, ‰iŸºO”V1, ”~Œ´@ŽÀ1,2, –k‰Í“¿•F1, •@_Žu1 (1_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 2Ž™): ‘æ32‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2005/2/25), “Œ‹ž. “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, 12 (S.): 224, 2005.

723521. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Ž‘±• oôò‚ª’˜Œø‚µ‚½¬Ž™dÇ‹}«äX‰Š‚̈ê—á. ¼àV˜aŽq1, “¹˜a•S‡1, —Ñ@‰1,2, ¼–{‘½ŠG1, ‰iŸºO”V1, ”~Œ´@ŽÀ1,2, ‘å–î’m¸1 (1_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[. 2Ž™): ‘æ32‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2005/2/25), “Œ‹ž. “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, 12 (S.): 224, 2005.

723522. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒqƒgƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX6Œ^E7Œ^‚̈â“`Žq•Û—L󋵂̌Ÿ“¢. “¡•‹`l1, ª–{•¶Žq1, â“Œ—R‹I1, ¼‰YM•v1, –ìXŽRŸl1, »ìŒc‰î2 i1Ž™. 2Š´õÇj: ‘æ35‰ñ“ú–{¬Ž™Š´õÇŠw‰ïŠwpW‰ï (2003/11/7), •xŽR, ¬Ž™Š´õ–Ɖu, 16(2): 226-227, 2004.

723523. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘ŽYŽ™‚ɑ΂·‚éƒpƒŠƒrƒYƒ}ƒu“Š—^‚ÉŠÖ‚·‚錟“¢ (‘æ2•ñ). çÝŽ@Šw, “n•Ó’qŽq, ŽO{—zŽq, –ì“n³•F (Ž™): ‘æ40‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2004/7/12), “Œ‹ž. “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ, 40 (2): 288, 2004.

731074. [u‰‰‰ï] (“Á•Êu‰‰) ìè•aÅV‚Ì’mŒ©|‹}«ŠúE‰“ŠuŠú‚ÌŠÇ—‚¨‚æ‚Ñ•aˆö‹†–¾‚Ö‚Ì•ªŽqˆâ“`Šw“IƒAƒvƒ[ƒ`|. Έä³_ (Ž™): ’¬“cˆãŽt‰ïŠwpu‰‰‰ï (2004/10/15), “Œ‹ž.

731075. [Šw‰ï (’n•û)] (“Á•Êu‰‰) ìè•a|ÅV‚Ì•aˆö˜_‚ð’†S‚Æ‚µ‚Ä|. Έä³_ (Ž™): ‘æ87‰ñ“ú–{׋ۊw‰ïŠÖ“ŒŽx•”‘‰ï (2004/11/5), “Œ‹ž.

731076. [u‰‰‰ï] (“Á•Êu‰‰) ìè•aÅV‚Ì’mŒ©: •aˆö, ‹}«ŠúŽ¡—¨‚æ‚щ“ŠuŠú‚Ì”–â‘è. Έä³_ (Ž™): ‘å˜aŽsˆãŽt‰ï¬Ž™‰Èˆã‰ïu‰‰‰ï (2004/11/18), _“Þì.

731077. [Šw‰ï (’n•û)] (“Á•Êu‰‰) ìè•aÅV‚Ì’mŒ©: •aˆö, ‹}«ŠúŽ¡—¨‚æ‚ÑSŒŒŠÇ•a•Ï‚ÌŽ©‘R—ð‚Æ’·ŠúŠÇ—. Έä³_ (Ž™): ‘æ46‰ñ_“ÞìˆãŠw‰ï¬Ž™‰È•ª‰È‰ïE‘æ271‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï (2004/11/20), _“Þì.

731078. [Œ¤‹†‰ï] (“Á•Êu‰‰) ìè•aSŒŒŠÇáŠQ‚̉“ŠuŠú‚Ì”–â‘è: ¬l“®–¬d‰»•a•Ï‚̃ŠƒXƒNƒtƒ@ƒNƒ^[‚Æ‚È‚é‚Ì‚©? Έä³_ (Ž™): ‘æ43‰ñ–k—¢zŠÂŠíƒZƒ~ƒi[ (2004/11/25), _“Þì.

731079. [Œ¤‹†‰ï] (“Á•Êu‰‰) ìè•aŋ߂̘b‘è|‹}«Šú, ‰“ŠuŠú‚ÌŽ¡—Ãí—ª‚¨‚æ‚Ñ•aˆö‰ð–¾‚Ö‚Ì•ªŽqˆâ“`Šw“IƒAƒvƒ[ƒ`|. Έä³_ (Ž™): ‘æ1‰ñ‚’m¬Ž™zŠÂŠíEìè•aŒ¤‹†‰ï (2004/12/9), ‚’m.

731080. [Œ¤‹†‰ï] (“Á•Êu‰‰) ìè•a‚ÌSŒŒŠÇ•a•Ï: ‹}«ŠúŽ¡—¨‚æ‚щ“ŠuŠú‚ÌŠÇ—. Έä³_ (Ž™): ‘æ11‰ñ‰«“êƒLƒbƒYƒn[ƒg (2005/1/24), ‰«“ê.

731081. [u‰‰‰ï] (“Á•Êu‰‰) ìè•aÅV‚Ì’mŒ©: SŒŒŠÇ•a•Ï‚Ì‹}«ŠúE‰“ŠuŠú‚ÌŠÇ—‚¨‚æ‚Ñ•aˆö‹†–¾. Έä³_ (Ž™): ÀŠÔEˆ»£ˆãŽt‰ï¬Ž™‰Èˆã‰ïŠwpu‰‰‰ï (2005/3/11), _“Þì.

732035. [Œ¤‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€) uŒŒŠÇ“à”çáŠQ‚̃Gƒrƒfƒ“ƒX‚Æ‚»‚Ì’·Šú—\Œãvìè•a‚̉“ŠuŠú‚ÌŒŒŠÇ“à”ç‹@”\‚¨‚æ‚ÑŽ¡—Ãí—ª. Έä³_ (Ž™): ‘æ24‰ñ“ú–{ìè•aŒ¤‹†‰ï (2004/11/12), ‹ž“s. Progress in Medicine, 25 (1): 192, 2005.

732036. [Œ¤‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€) u‰“ŠuŠú‚É‚¨‚¯‚錌ŠÇ‹@”\‚Ì•]‰¿v—Õ°Šw“I•]‰¿ (ŠÏŒŒ“I•]‰¿)E¬Ž™‰È. Έä³_ (Ž™): ‘æ8‰ñìè•aŽ¡—ç˜b‰ï (2004/9/5), “Œ‹ž.

733191. [Œ¤‹†‰ï] (ˆê”Êu‰‰) CLD‚ɑ΂·‚é“–‰@‚Å‚ÌV‚½‚ÈŽŽ‚Ý|æ’[…•½ƒJƒbƒg‹CŠÇ“àƒ`ƒ…[ƒu‚ÆEDƒ`ƒ…[ƒu‚Ì“±“ü|. çÝŽ@Šw, ˆÉ“¡®Žu, ŒÏè‰ëŽq, –ì“n³•F (Ž™): ‘æ12‰ñƒT[ƒtƒ@ƒNƒ^ƒ“ƒgŒ¤‹†‰ï (2004/6/19), ‰¡•l.

733192. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) f’f‚É“ïa‚µ‚½‹¹•”ˆÙí‰A‰e‚ð”F‚ß‚½1—á. ˆÀ“¡@Žõ1, ˆÉ“¡®Žu1, —Ñ@‰1, “¡•‹`l1, ã“cN‹v1, Έä³_1, Œ´@^l2, –¥‰YŽ‘¥3, ”~Œ´@ŽÀ4 i1Ž™. 2–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@. 3ŠC˜V–¼‘‡•a‰@. 4_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[j: ‘æ270‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï (2004/9/18), _“Þì. _“ÞìˆãŠw‰ïŽGŽ, 32 (1): 47, 2005.

733193. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ìè•a‚É‚æ‚鑽Ž}•a•Ï‚ɑ΂µ‚ănƒCƒuƒŠƒbƒhŽ¡—ÂðŽ{s‚µ‚½1—á. ›Œ´—mŽq1, ]ãŒöN1, ‰Æ‘º‘fŽj1, ‘O–ì‘׎÷1, ¼Î–LŽŸ˜Y1, Έä³_2, ã–ì‚Žj3, “c‘ã@’‰4 i1‹v—¯•Ä‘å. 2Ž™. 3•Ÿ‰ª¬l•aƒZƒ“ƒ^[. 4•Ÿ‰ª‘åj: ‘æ24‰ñ“ú–{ìè•aŒ¤‹†‰ï (2004/11/12), ‹ž“s. Progress in Medicine, 25 (1): 190, 2005.

733194. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ìè•a‚Ì‚“xΊD‰»‚𔺂¤Š¥“®–¬‹·ó‚ð”F‚ß‚½2Ç—á‚ɑ΂·‚éPTCRA. –Ø‘ºƒl, L“c•l•v, –xŒû‘דT, ’†”¨–í¶, “¡–ìé”V, •“cM—T, ¬ì‰ÄŽq, Έä³_ (Ž™): ‘æ24‰ñ“ú–{ìè•aŒ¤‹†‰ï (2004/11/12), ‹ž“s. Progress in Medicine, 25 (1): 191, 2005.

733195. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ìè•aŽ¡—Âɂ¨‚¯‚éƒKƒ“ƒ}ƒOƒƒuƒŠƒ“•s‰ž—á: —Õ°‘œ‹y‚Ñ—\‘ªˆöŽq‚ÌŒŸ“¢. ]ãŒöN1, –´“cLŽÀ1, ›Œ´—mŽq1, ‰Æ‘º‘fŽj1, ‘O–ì‘׎÷1, ¼Î–LŽŸ˜Y1, Έä³_2 (1‹v—¯•Ä‘å. 2Ž™): ‘æ24‰ñ“ú–{ìè•aŒ¤‹†‰ï (2004/11/13), ‹ž“s. Progress in Medicine, 25 (1): 195, 2005.

733196. [Œ¤‹†‰ï] (ˆê”Êu‰‰) “ú•Ä‚Ììè•af’fŠî€‚Ì”äŠr|‘æ17‰ñ‘S‘’²¸¬Ñ‚ð—p‚¢‚Ä|. –´“cLŽÀ1, ]ãŒöN1, ›Œ´—mŽq1, ‰Æ‘º‘fŽj1, ¼Î–LŽŸ˜Y1, Έä³_2, ’†‘ºDˆê3 i1‹v—¯•Ä‘å. 2Ž™. 3Ž©Ž¡ˆã‘åj: ‘æ24‰ñ“ú–{ìè•aŒ¤‹†‰ï (2004/11/13), ‹ž“s. Progress in Medicine, 25(1): 203, 2005.

733197. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ”NŠú‚É’B‚µ‚½ìè•aŠù‰ŽÒ‚ÌŒ’NŠÖ˜AQOL|SF-36‚ð—p‚¢‚Ä|. –´“cLŽÀ1, ]ãŒöN1, ›Œ´—mŽq1, ‰Æ‘º‘fŽj1, ¼Î–LŽŸ˜Y1, Έä³_2 (1‹v—¯•Ä‘å. 2Ž™): ‘æ24‰ñ“ú–{ìè•aŒ¤‹†‰ï (2004/11/13), ‹ž“s. Progress in Medicine, 25 (1): 207, 2005.

733198. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ìè•a—lÇó‚ð’悵‚½EB-VAHS‚̈ê—á. ˆÉ“¡®Žu1, L“c•l•v1, ‰º•l^—Žq1, â“Œ—R‹I1, –ìXŽRŸl2, ’†”¨–í¶1, –xŒû‘דT1, âÙ–ì‘×”V1, •“cM—T, ¬ì‰ÄŽq1, Έä³_1 (1Ž™. 2Š´õÇ): ‘æ15‰ñ“Œ‹žìè•aŒ¤‹†‰ï (2004/11/27), “Œ‹ž.

733199. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‚ ‚¹‚Á‚Ĉø‚­‚È!@PDAƒRƒCƒ‹”²‹Ž¢“ï‚Ì1—á. –xŒû‘דT1, •½Î@ãà2, L“c•l•v1, ’†”¨–í¶1, “¡–ìé”V1, •“cM—T1, ¬ì‰ÄŽq1 (1Ž™. 2•½Î‚±‚Ç‚àƒNƒŠƒjƒbƒN): ‘æ16‰ñ“ú–{Pediatric interventional cardiologyŒ¤‹†‰ï (2005/1/13-15), –¼ŒÃ‰®Žs. “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 20 (5): 584-585, 2005.

733200. [Œ¤‹†‰ï] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚éPDAƒRƒCƒ‹•Â½p. –xŒû‘דT1, L“c•l•v1, ’†”¨–í¶1, “¡–ìé”V1, •“cM—T1, ¬ì‰ÄŽq1, •½Î@ãà2 (1Ž™. 2•½Î‚±‚Ç‚àƒNƒŠƒjƒbƒN): ‘æ16‰ñ“ú–{Pediatric interventional cardiologyŒ¤‹†‰ï (2005/1/13-15), –¼ŒÃ‰®Žs. “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 20 (5): 586, 2005.

733201. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) BCGÚŽíŒã‚ÉŒ‹Šj]‚ð’悵‚½2—á. ‚–Ø—DŽ÷1, ‰º•l^—¢Žq2, ‘å˜a“c‰ÄŽq2, ”Ñ‚Šì‹v—Y1,2, Žµ”öŒªŽ¡1 i1‘å˜aŽs—§•a‰@. 2Ž™j: ‘æ272‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï (2005/3/19), ‰¡•l.

733202. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‰fŽž‚ÉJHÄ\¬‚ð”F‚ß‚½¬Ž™‹}«œ‘«”’ŒŒ•a‚ÌŒŸ“¢. ŠJ“c”ü•Û, •û¹•½, ¼‰Y—RŠóŽq, ˆÀ“¡@Žõ, ŽO‘î@ò, ’†ŠÚ®–ç (Ž™): ‘æ269‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï (2004/6/19), ‰¡•l. _“ÞìˆãŠw‰ïŽGŽ, 32 (1): 45, 2005.

733203. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‘J‰„«‰©át‚ÆŠÌ‹@”\áŠQ‚𕹔­‚µ‚½V¶Ž™ƒ~ƒ‹ƒNƒAƒŒƒ‹ƒM[«’°‰Š‚̈ê—á. “¡•‹`l, â“Œ—R‹I, ‹k“cˆê‹P, ˆÉ“¡®Žu (Ž™): ‘æ9‰ñ_“Þ쌧¬Ž™ŠÌŽ¾Š³Œ¤‹†‰ï (2004), ‰¡•l.

733204. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “ûŽ™Šú‘Šú‚É”­Ç‚µ‚½dÇV¶Ž™‰¼Ž€‚É”º‚¤H“¹—ôEƒwƒ‹ƒjƒA‚Ì1—á. ˆÀ“¡@Žõ, ˆÉ“¡®Žu, ŒÃì^—S, çÝŽ@Šw, Šâèr”V, ŽO{—zŽq, –ì“n³•F, ¼‰YM•v (Ž™): ‘æ266‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï (2004/4/17), ‰¡•l. _“ÞìˆãŠw‰ïŽGŽ, 31 (2): 215-216, 2004.


<<ŽY•wl‰ÈŠw>>

mŠwp˜_•¶n

110143. [Œ´’˜] PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus. –Ø‘º•¶ˆê, “n•Ó@ƒ1, `@GŽ÷2, “¡àV•Žu2, Š™“c—TŽq2, ¼‘º—R—¢2, ã–V•qŽq2, ‘ –{”Žs2,3 (1•a—. 2ŽY•w. 3ˆã‰q): Journal of Cancer Research Clinical Oncology, 130: 161`168, 2004.

110144. [Œ´’˜] Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis. ¼‘º—R—¢1, “n•Ó@ƒ2, ã–V•qŽq1, ‰ÁŒËL–¾, “¡àV•Žu1, Š™“c—TŽq1, ‘ –{”Žs1,3 (1ŽY•w. 2•a—. 3ˆã‰q): Anticancer Research, 24: 2185-2192, 2004.

110145. [Œ´’˜] Significance of progesterone receptor-A and -B expression in endometrial adenocarcinoma. ‹{–{•üK1, “n•Ó@ƒ2, `@GŽ÷1, ã–V•qŽq1, ìŒû”ü˜a1, •ž•”@Šw3, Ä“¡‚Ü‚ä‚Ý1, ‘ –{”Žs1,4 (1ŽY•w. 2•a—. 3ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 4ˆã‰q): Journal of Steroid Biochemistry and Molecular Biology, 92: 111-118, 2004.

110146. [Œ´’˜] Cytologic scoring of endometrioid adenocarcinoma of the endometrium. ¼‘º—R—¢1, “n•Ó@ƒ2, ã–V•qŽq1, •ž•”@Šw3, Vˆä@“w1, ‘ –{”Žs1,4 (1ŽY•w. 2•a—. 3ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 4ˆã‰q): Cancer, 105: 8-12, 2004.

110147. [Œ´’˜] Lymph node pathway in the spread of endometrial carcinoma. ã–V•qŽq1, ²“¡—Ï–ç1, Vˆä@“w1, “c‘ºr’j1, “n•Ó@ƒ2, ‘ –{”Žs1,3 (1ŽY•w. 2•a—. 3ˆã‰q): European Journal of Gynaecol Oncology, 26(2): 167-169, 2004.

110148. [Œ´’˜] Expression of SRC-1 and p/CIP in the mouse testis. “¡“cˆê”Ž1, ŽR‰ºC“ñ2, ŽðˆäNO3 i1ŽY•w. 2Œc‰ž‘å. 3‰ð–U): Acta Histochemica et Cytochemica, 2004.

110149. [Œ´’˜] Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth. ’r“c‘×—T1, —Ñ@ò2, Š›‰º‰r”ü1, Akira Yamazaki3, Keiko Ishihara3, Hirahito Endo3, ŽR‰È³•½4, Yoshiaki Tsutsumi5, Hiroaki Matsubara5, ”n“ˆ³—²2 (1ŽY•w. 2–ò—. 3Department of Molecular Pharmacology, 4‰ð–U. 5ŠÖ¼ˆã‘å): Cancer Res, 64: 5178-5185, 2004.

120042. [Œ´’˜] Preterm‚Ìg‘ÙŽ™ƒWƒXƒgƒŒƒXhf’f‚ƑΉž. –]ŒŽƒŽq, “V–ì@Š® (ŽY•w): ŽüŽYŠúƒVƒ“ƒ|ƒWƒEƒ€, 22: 101-107, 2004.

120043. [Œ´’˜] •ŽYŠ‚©‚ç‚Ì”À‘——á‚ÌŽÀó‚ÆŽüŽYŠú—\Œã. ’r“c‘×—T1, Š›‰º‰r”ü1, –]ŒŽƒŽq1, ‹àˆä—Y“ñ1, ‰E“‡•xŽm’j1, ’J@º”Ž1, “V–ì@Š®1, –ì“n³•F2 (1ŽY•w. 2Ž™): “ú–{ŽüŽYŠú¥V¶Ž™ˆãŠw‰ïŽGŽ, 40 (3): 553-556, 2004.

310015. [Ç—á•ñ] Aspiration cytology of malignant fibrous histiocytoma after radiation therapy for carcinoma of the uterine cervix-a case report. Vˆä@“w1, ã–V•qŽq1, ìŒû”ü˜a1, ‘ –{”Žs1,2 (1ŽY•w. 2ˆã‰q): Acta Cytologica, 48: 860-863, 2004.

320036. [Ç—á•ñ] ‘ÙŽ™‹¾‰ºä`‘ÑŒŒ—¬ŽÕ’f‚ðs‚Á‚½ˆêŽ™–³S‘Ì‘o‘Ù‚Ì1—á. ì“à”Žl, Š›‰º‰r”ü, “V–ì@Š®, ŠC–ìM–ç (ŽY•w): “ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ïŽGŽ, 10 (1): 97-100, 2005.

320037. [Ç—á•ñ] —‘‘ƒŒ´”­àh–E«ƒŠƒ“ƒpŽî‚Ì1—á. ’¬“c‘å•ã1, ‰¡ŽR@‘å1, Š`ÀœA–M2, •ž•”@Šw3, ‘ –{”Žs2,4, ã–V•qŽq2, Šâ•£Œ[ˆê5, ‰ªˆÀ@ŒM5 (1•a—•”. 2ŽY•w. 3ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 4ˆã‰q. 5•a—): “ú–{—Õ°×–EŠw‰ï_“Þ쌧Žx•”‰ïŽ, 9 (1): 16-20, 2004.

320038. [Ç—á•ñ] Žq‹{“à–Œ×–Ef‚Åf’f‚³‚ꂽt×–EŠàŽq‹{“]ˆÚ‚Ì1—á. Š›‰º‰r”ü1, Vˆä “w1, ‹àˆä“”V1, “n•Ó ƒ2, ‰¡ŽR@‘å3, ã–V•qŽq1, ‘ –{”Žs1,4 (1ŽY•w. 2•a—. 3•a—•”. 4ˆã‰q): “ú–{—Õ°×–EŠw‰ïŽGŽ, 43 (6): 397-402, 2004.

320039. [Ç—á•ñ] t“®Ã–¬ŠïŒ`”j—ô‚É‚æ‚é‹}«• Ç‚Ì1—á. ¡‘º—fŽq, ’r“c‘×—T, “¡“cˆê”Ž, ‹àˆä—Y“ñ, –]ŒŽƒŽq, ’J@º”Ž, “V–ì@Š® (ŽY•w): “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 41 (1): 3-7, 2004.

420002. [—Õ°Ž¡Œ±] ”DP’†‚És‚¤Žèp‚Ì“K‰ž‚Æ–â‘è“_|Žq‹{èò•”‰~Øœp|. ‘ –{”Žs1,2, Šp“cV•½1, ‹àˆä“”V1, ã–V•qŽq1, ¡ˆä@ˆ¤1, “c‘ºr’j1 (1ŽY•w. 2ˆã‰q): ŽY‰È‚Æ•wl‰È, 71 (7): 885-891, 2,004.

520146. [uÀ] Non-stress test (NST). ŠC–ìM–ç (ŽY•w): ŽY‰È‚Æ•wl‰È, 71 (12): 1816-1820, 2004.

520147. [uÀ] ‹ß–¢—ˆ i20”NŒãj ‚ÌŽY‰Èˆã—Ã. ŠC–ìM–ç (ŽY•w): ŽüŽYŠúˆãŠw, 35 (1): 129-133, 2005.

520148. [‘à] Žq‹{“à–Œ‘Bǂ̉uŠw‚Æ×–Ef‚̈Ӌ`. ã–V•qŽq1, ²“¡—Ï–ç1, ‘ –{”Žs1,2 (1ŽY•w. 2ˆã‰q): •a—‚Æ—Õ°, 22 (4): 377`380, 2004.

520149. [‘à] Žq‹{‘ÌŠà‚̉uŠw. ã–V•qŽq1, ‹àˆä“”V1, ‘ –{”Žs1,2 (1ŽY•w. 2ˆã‰q): “ú–{—Õ°, 62 (‘) 10: 243-247, 2004.

520150. [‘à] Žq‹{‘Ì•”‚Ì‹«ŠE•a•Ï. ‘ –{”Žs1,2, ìŒû”ü˜a1, ã–V•qŽq1, Vˆä@“w1 (1ŽY•w. 2ˆã‰q): “ú–{—Õ°, 62 (‘) 10: 279-284, 2004.

520151. [‘à] Žq‹{‘ÌŠà‚̃gƒsƒbƒNƒX|“à–Œ×–Ef‚ð’†S‚É|. ã–V•qŽq (ŽY•w): “ú–{—Õ°×–EŠw‰ï쌧Žx•”‰ï•ñ, (17): 1-5, 2004.

520152. [uÀ] ŒãŠúØ”—‘ŽY‚Ìf’f‚Æ‘Îô. Š›‰º‰r”ü, “V–ì@Š® (ŽY•w): ŽY•wl‰È‚Ì¢ŠE, 56 (7): 45`50, 2004.

520153. [uÀ] ”ì–ž”D•w‚Ì”DP•ª•ØŽžƒŠƒXƒN‚Í‚‚¢‚©? –]ŒŽƒŽq, “V–ì@Š® (ŽY•w): ŽüŽYŠúˆãŠw, 34 (‘): 317-319, 2004.

520154. [‘à] ‘ŽY‚Æ׋۫äSÇ. ‰E“‡•xŽm’j, ˆÀ“¡G”ü, ’r“c‘×—T, ‹àˆä—Y“ñ, –]ŒŽƒŽq, ’J@º”Ž, “V–ì@Š®(ŽY•w): “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 41 (1): 48-51, 2004.

520155. [‘à] ŽüŽYŠúˆã—ÃŒ»ê‚Ì–â‘è“_. ŽY‰È‚ÌŒ»ó‚Æ’ñŒ¾, “V–ì@Š® (ŽY•w): ŽüŽYŠúˆãŠw, 34: 1565-1568, 2004.

520156. [uÀ] ŽY‰ÈŠO—ˆ‚Ì‘Š’kƒiƒr@”DP‰Šú‚̃vƒ‰ƒCƒ}ƒŠ|”DP‰Šú‚̑щº, oŒŒ, ‰º• ’É, —¬ŽY. “V–ì@Š® (ŽY•w): ŽüŽYŠúˆãŠw, 34: 1653-1657, 2004.

520157. [uÀ] ‘ÙŽ™ well-being ‚Ì•]‰¿@4. ‘ÙŽ™ŒŒ‰tƒKƒX•ªÍ. “V–ì@Š® (ŽY•w): ŽY‰È‚Æ•wl‰È, 71: 1845-1850, 2004.

520158. [uÀ] ”x’áŒ`¬‚ÌŽ¡—Ã|o¶‘O. “V–ì@Š® (ŽY•w): ŽüŽYŠúˆãŠw, 35: 263-268, 2004.

520159. [‘à] ‘OŠú”j…‚Æ—r…’“ü. “V–ì@Š® (ŽY•w): ŽüŽYŠúˆãŠw, 35: 393-396, 2004.

520160. [uÀ] –ò•¨ˆ•û‚ÌŽÀÛ@–³’É•ª•Ø. “V–ì@Š® (ŽY•w): ŽY‰È‚Æ•wl‰È, 72: 120-122, 2004.

520161. [uÀ] ŽYåñ ‚—î”DP, Žá”N”DP‚Ì•ª•ØŽžƒŠƒXƒN‚͉½‚©? ’r“c‘×—T, “V–ì@Š® (ŽY•w): ŽüŽYŠúˆãŠw, 34 (‘): 311-313, 2004.

520162. [uÀ] ‘O’u‘ٔՂ̒鉤؊J‚̃ŠƒXƒN‚Í‚‚¢‚©? ‹àˆä—Y“ñ, “V–ì@Š® (ŽY•w): ŽüŽYŠúˆãŠw, 34 (‘): 314-316, 2004.

520163. [uÀ] Žq‹{‹ØŽî‡•¹”DP‚Ì•ª•ØŠÇ—‚Í‚Ç‚¤‚·‚é‚©? ‰E“‡•xŽm’j, “V–ì@Š® (ŽY•w): ŽüŽYŠúˆãŠw, 34 (‘): 320-322, 2004.

m’˜@‘n

620092. [‰ðà‘] (•ª’SŽ·•M) Ladies Medicine Today ŽY‰È—Õ°ƒxƒXƒgƒvƒ‰ƒNƒeƒBƒX@’N‚à‚ª–À‚¤93—á‚Ìf—ÃŽwj; •ª•ØŒo‰ß‚̈Ùí@62. •ª•Ø‘æ1ŠúoŒŒ@63. –³’É•ª•Ø@64. ‘o‘Ù•ª•Ø@65. ’éØŒãŒoäS•ª•Ø@66. •ª•ØŽž‚ŒŒˆ³. “V–ì@Š® (ŽY•w), •ÒW ‰ªˆä@’, ˆãŠw‘‰@, “Œ‹ž, 2004”­s.

620093. [‰ðà‘] (•ª’SŽ·•M) —Õ°•wl‰ÈŽY‰È; d–ŒŠO–ƒŒ•ª•Ø‚ðs‚¤‚½‚ß‚ÌÝ”õ‚Ƒ̧|d–ŒŠO–ƒŒ‚ÌŠÇ—. ƒoƒ‰ƒ“ƒX–ƒŒ, Ö¬–ƒŒ|. –k—¢‘åŠwˆãŠw•”ŽY•wl‰È‚Å‚ÌH•v. “V–ì@Š® (ŽY•w), ˆãŠw‘‰@, “Œ‹ž, 2004”­s.

620094. [‰ðà‘] (•ª’SŽ·•M) NEWƒGƒbƒZƒ“ƒVƒƒƒ‹@ŽY‰ÈŠwE•wl‰ÈŠw; ŽY•w‚ÌfŽ@. “V–ì@Š® (ŽY•w), •ÒW ’rƒmãŽ, —é–ØH‰x, ‚ŽR‰ëb, –L“c’·N, Lˆä³•F, ”ªdŠ~L¶, ˆãŽ•–òo”Å (Š”), “Œ‹ž, 2004”­s.

620095. [‰ðà‘] (•ª’SŽ·•M) ŽüŽYŠú‹~‹}‚̃Rƒc‚Æ—Ž‚Æ‚µŒŠ; •ª•ØŽž‚Ì‘ÙŽ™‹~‹}. “V–ì@Š® (ŽY•w), •ÒW ‰ª‘ºB”Ž, ’†ŽR‘“X, “Œ‹ž, 2004”­s.

mŠw‰ïEŒ¤‹†‰ïn

713111. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Stimulatory effect of medroxyprogesterone acetate on p21 and p27 expression in Ishikawa endometrial carcinoma cells transfected with PRB and cDNA. ìŒû”ü˜a1, “n•Ó@ƒ2, ã–V•qŽq1, Mieko Hamano, Š™“c—TŽq1, ¡ˆä@ˆ¤1, ‘ –{”Žs1,3 (1ŽY•w. 2•a—. 3ˆã‰q): XV International Congress of Cytology (2004/4/13), ƒTƒ“ƒ`ƒƒƒS. —\eW, p.117, 2004.

713112. [Šw‰ï (‘Û)] (ƒpƒlƒ‹u‰‰) Endometrial adenocarcinoma: prevention and early diagnosis|Cytological findings of early stage of endometrial adenocarcinoma. ã–V•qŽq (ŽY•w): XV International Congress of Cytology (2004/4/13), ƒTƒ“ƒ`ƒƒƒS. —\eW, p.18, 2004.

713113. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Medroxyprogesterone acetate therapy for patients with endometrial adenocarcinoma and its effect on cytological findings. ¡ˆä@ˆ¤1, ã–V•qŽq1, ìŒû”ü˜a1, ‘ –{”Žs1,2 (1ŽY•w. 2ˆã‰q): XV International Congress of Cytology (2004/4/14), ƒTƒ“ƒ`ƒƒƒS. —\eW, p.178, 2004.

713114. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Expression of cell cycle regulatory proteins and E-cadherin in clear cell adenocarcinoma of the endometrium. Vˆä@“w1, “n•Ó@ƒ2, ìŒû”ü˜a1, Š™“c—TŽq1, ¼‘º—R—¢1, ‹àˆä“”V1, ã–V•qŽq1, ‘ –{”Žs1,3 (1ŽY•w. 2•a—. 3ˆã‰q): 10th Biennial International Gynecologic Cancer Society Meeting (2004/10/6), ƒGƒWƒ“ƒoƒ‰. —\eW, p.99, 2004.

713115. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Cytologic scoring of endometrioid adenocarcinoma of the endometrium. ¼‘º—R—¢1, “n•Ó@ƒ2, ã–V•qŽq1, •ž•”@Šw3, ‰¡ŽR@‘å4, Vˆä@“w1, ìŒû”ü˜a1, ‹{–{•üK1, ‘ –{”Žs1,5 (1ŽY•w. 2•a—. 3ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 4•a—•”. 5ˆã‰q): 10th Biennial International Gynecologic Cancer Society Meeting (2004/10/6), ƒGƒWƒ“ƒoƒ‰. —\eW, p.155, 2004.

713116. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Increase of IUFD in pregnant mice immunized with massive cytokine producer TSST-1. •ˆä‰p—Žq1, ‹Ê“àGˆê2, ŠÛŽROŽq3, Îì‰ëˆê1, Š_¶‰€Žq4 (1ŽY•w. 2”÷EŠñ. 3ˆã‰qE•a—. 4“ŒŠC‘å): ‘æ9‰ñ‘Û¶B–ƉuŠw‰ï (2004/10/11-15), _“Þì.

713117. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Differential regulation of cord plasma concentrations of interleukin (IL)-8 and erythropoietin (EPO) in preterm deliveries complicated by preeclampsia (PE) and/or intrauterine growth restriction (IUGR). ŠC–ìM–ç1, K Takagi2, A Kikuchi2, S Saito3 i1ŽY•w. 2’·–쌧—§‚±‚Ç‚à•a‰@. 3•xŽRˆã‰È–ò‰È‘åj: 52th Annual Meeting of Society for Gynecologic Investigation (2005/3/25), Los Angeles.

722053. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Žq‹{èò•”¬×–EŠà‚Ì×–EŠŒ©. Šp“cV•½1, ã–V•qŽq1, Vˆä³G1, Vˆä@“w1, À”ö²Žq1, “n•Ó@ƒ2, ¬•Û•ûˆŸŒõ1, ‘ –{”Žs1,3 (1ŽY•w. 2•a—. 3ˆã‰q): ‘æ45‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (2004/7/9), “Œ‹ž. “ú–{—Õ°×–EŠw‰ïŽGŽ, 43 (•â1): 134, 2004.

722054. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) u•ŽYŠ‚É‚¨‚¯‚éˆÀ‘S‚ʼnõ“K‚ÈoŽYŠÂ‹«‚ð‚¢‚©‚ÉŠm•Û‚·‚é‚©v •ŽYŠ‚©‚ç‚Ì”À‘——á‚ÌŽÀó‚ÆŽüŽYŠú—\Œã: “V–ì@Š® (ŽY•w): ‘æ45‰ñ“ú–{•ê«‰q¶Šw‰ï‘‰ï (2004/9/17), “Œ‹ž.

722055. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Žq‹{èòŠà‚ɑ΂·‚é‹@”\‰·‘¶Žèp‚ÌŒ»ó‚Æ“W–]|Žq‹{èò•”Žîᇂɑ΂·‚éŽq‹{‰·‘¶Žèp‚ÌŒ»ó‚Æ“W–]|. ‹àˆä“”V1, ã–V•qŽq1, Šp“cV•½1, Vˆä@“w1, ìŒû”ü˜a1, ‘ –{”Žs1,2 (1ŽY•w. 2ˆã‰q): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/27), ‹ž“s. “ú–{ŠàŽ¡—Êw‰ïŽ, 39 (2): 309, 2004.

722056. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Žq‹{èò•”‘Šú‘B‚ª‚ñ×–Ef‚̉ۑè: ‘ŠúŽq‹{èò•”‘BŠà‚Ìf’f‚ÆŽ¡—Ã|×–Ef‚ð’†S‚É|. Šp“cV•½1, ‹àˆä“”V1, ¡ˆä@ˆ¤1, “c‘ºr’j1, Vˆä@“w1, ìŒû”ü˜a1, ã–V•qŽq1, ‘ –{”Žs1,2, “n•Ó@ƒ3 (1ŽY•w. 2ˆã‰q. 3•a—): ‘æ43‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï (2004/11/13), “Œ‹ž. “ú–{—Õ°×–EŠw‰ïŽGŽ, 43 (•â2): 372, 2004.

723524. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ä`‘ÑŒŒ’†—LŠjÔŒŒ‹…”‚Æ‘ÙŽ™’áŽ_‘fÇ‚Æ‚ÌŠÖŒW. –]ŒŽƒŽq, “V–ì@Š®, ˆÀ“¡G”ü, ’r“c‘×—T, ‹àˆä—Y“ñ, ‰E“‡•xŽm’j, ’J@º”Ž (ŽY•w): ‘æ56‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (2004/4/10), “Œ‹ž. “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 56 (2): 492, 2004.

723525. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Combined spinal epidural analgesia‚É‚æ‚镪•ØŽž–ƒŒ‚Ì—L—p«. ‹e’nMŽO1, ‰œ•xr”V2, Ö“¡”ü’mŽq2, “V–ì@Š®1 (1ŽY•w. 2–ƒ): ‘æ24‰ñ“ú–{—Õ°–ƒŒŠw‰ï (2004/10/14-16), ‘åã.

723526. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) dÇŽq‹{“à–ŒÇ‚É‘Î‚·‚éGnRHa, ”X–EúŽh, • o‹¾‰ºŽèp•¹—p—Ö@‚ÌŒø‰Ê. •ˆä‰p—Žq, ì“à”Žl, Îì‰ëˆê, “¡“cˆê”Ž, –{‹´Œb”üŽq (ŽY•w): ‘æ56‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (2004/4/10-13), “Œ‹ž.

723527. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Žq‹{‘Ì•”–¾×–E‘BŠà‚É‚¨‚¯‚é×–EŽüŠú‹y‚Ñ×–EÚ’…ˆöŽq‚Ì”­Œ». Vˆä@“w1, “n•Ó@ƒ2, ‹àˆä“”V1, ¡ˆä@ˆ¤1, ìŒû”ü˜a1, ã–V•qŽq1, ‘ –{”Žs1,3 (1ŽY•w. 2•a—. 3ˆã‰q): ‘æ56‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2004/4/12), “Œ‹ž. —\eW, p.365, 2004.

723528. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒ}ƒEƒX¸‘ƒ‚É‚¨‚¯‚é“]ŽÊƒRƒAƒNƒ`ƒx[ƒ^[‚ÌŠÖ—^. “¡“cˆê”Ž1, ŽðˆäNO2, ŽR‰ºC“ñ3, ŽR‰È³•½2 (1ŽY•w. 2‰ð–U. 3Œc‰ž‘å): ‘æ56‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (2004/4/12), “Œ‹ž.

723529. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{ŠO”DP‚ɑ΂·‚é”ñŠÏŒŒ“IŽ¡—Â̬Ñ. ì“à”Žl, “¡“cˆê”Ž, –{‹´Œb”üŽq, •ˆä‰p—Žq, Îì‰ëˆê (ŽY•wj: ‘æ56‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (2004/4/12), “Œ‹ž.

723530. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) •ØoŽžŠú‚É‹ê—¶‚µ‚½”ÄŒŒ‹…Œ¸­Ç‚Ì1—á. À”ö²Žq, ’r“c‘×—T, ‹e’nMŽO, ‰E“‡•xŽm’j, ˆÀ“¡G”ü, –]ŒŽƒŽq, ‹àˆä—Y“ñ, ’J@º”Ž, “V–ì@Š® (ŽY•w): ‘æ56‰ñ“ú–{ŽY•wl‰ÈŠw‰ï (2004/4/12), “Œ‹ž. “úŽY•wŽ, 56: 680 (S-550), 2004.

723531. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) õF‘̈Ùí—á‚Ì‘ÙŽ™S”ƒpƒ^[ƒ“‚ÆŽüŽYŠú—\Œã. ¡‘º—fŽq, –]ŒŽƒŽq, ‹àˆä—Y“ñ, ’J@º”Ž, “V–ì@Š® (ŽY•w): ‘æ56‰ñ“ú–{ŽY•wl‰ÈŠw‰ï (2004/4/12), “Œ‹ž. “úŽY•wŽ, 56: 680 (S-550), 2004.

723532. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆêãO–Ñ–Œ‘o‘Ù‚ÆŽüŽYŠú—\Œã. ’r“c‘×—T, ‹àˆä—Y“ñ, –]ŒŽƒŽq, ˆÀ“¡G”ü, ‰E“‡•yŽm’j, ’J@º”Ž, “V–ì@Š® (ŽY•w): ‘æ56‰ñ“ú–{ŽY•wl‰ÈŠw‰ï‘‰ï (2004/4/12), “Œ‹ž. “úŽY•wŽ, 56: 654 (S-524), 2004.

723533. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘ÙŽ™–ƒŒ‰º‚É•ª•Ø‚ðŽŽ‚Ý‚½2—á. ‹e’nMŽO, ‹àˆä—Y“ñ, “V–ì@Š® (ŽY•w): ‘æ56‰ñ“ú–{ŽY•wl‰ÈŠw‰ï‘‰ï (2004/4/13), “Œ‹ž. “úŽY•wŽ, 56: 678 (5-548), 2004.

723534. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Combined spinal epidural analgesia‚É‚æ‚镪•ØŽž–ƒŒ‚Ì—L—p«. ‹e’nMŽO, –]ŒŽƒŽq, ‹àˆä—Y“ñ, ’J@º”Ž, “V–ì@Š® (ŽY•w): “ú–{—Õ°–ƒŒŠw‰ï (2004/4/13), •Ÿ‰ª. “ú–{—Õ°×–EŠw‰ïŽGŽ, 23 (8): 273, 2004.

723535. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “à–Œ×–Ef‚ňٌ^×–E‚ð”F‚ß‚½—Þã”畽ŠŠ‹Ø“÷Žî‚Ì1—á. ¡‘º—fŽq1, Šp“cV•½1, ˜’ˉÁ“ÞŽq1, ‰¡ŽR@‘å2, “n•Ó@ƒ3, ã–V•qŽq1, ‘ –{”Žs1,4 (1ŽY•w. 2•a—•”. 3•a—. 4ˆã‰q): ‘æ45‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (2004/7/9), “Œ‹ž. “ú–{—Õ°×–EŠw‰ïŽGŽ, 43 (•â1): 148, 2004.

723536. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠO”A“¹Œû‚Ö“]ˆÚ‚µ‚½Žq‹{‘Ì•”‘BG•½ã”çŠà‚Ì1—á. À”ö²Žq1, Vˆä@“w1, “ñˆä”ü’Õä1, ¡‘º—fŽq1, ã–V•qŽq1, ‘ –{”Žs1,2 (1ŽY•w. 2ˆã‰q): ‘æ45‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (2004/7/9), “Œ‹ž. “ú–{—Õ°×–EŠw‰ïŽGŽ, 43 (•â1): 246, 2004.

723537. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒjƒgƒƒOƒŠƒZƒŠƒ“‚𕹗p‚µ‚½d–ŒŠO–ƒŒ‚Ì—L—p«. –]ŒŽƒŽq, ‹àˆä—Y“ñ, ’r“c‘×—T, ‰E“‡•xŽm’j, ’J@º”Ž, “V–ì@Š® (ŽY•w): ‘æ40‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2004/7/13), “Œ‹ž. “ú–{ŽüŽYŠúV¶Ž™Šw‰ïŽGŽ, 40 (2): 471, 2004.

723538. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{èò•”‘BŠà‚ɑ΂·‚ék¬Žèp‚ÌŒŸ“¢. ‹àˆä“”V1, Šp“cV•½1, Vˆä@“w1, ìŒû”ü˜a1, ã–V•qŽq1, ‘ –{”Žs1,2 (1ŽY•w. 2ˆã‰q): ‘æ36‰ñ“ú–{•wl‰ÈŽîᇊw‰ïEŠwpW‰ï (2004/7/16), L“‡. “ú–{•wl‰ÈŽîᇊw‰ïŽGŽ, 22 (3): 218, 2004.

723539. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —‘ŠÇŠà‚Ì—Õ°ŠŒ©‚Æp‘Of’f|—‘‘ƒŠà‚Æ‚Ì”äŠr‚Å|. Vˆä³G1, ã–V•qŽq1, Šp“cV•½1, ¡ˆä@ˆ¤1, ‹àˆä“”V1, ‘ –{”Žs1,2 (1ŽY•w. 2ˆã‰q): ‘æ36‰ñ“ú–{•wl‰ÈŽîᇊw‰ïEŠwpW‰ï (2004/7/16), L“‡. “ú–{•wl‰ÈŽîᇊw‰ïŽGŽ, 22 (3): 242, 2004.

723540. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —‘‘ƒŠàEŽq‹{‘ÌŠàE’_”XŠàES󌋒°Šà‚ªd•¡‚µ‚½ŽldŠà‚Ì1—á. ¡‘º—fŽq1, ¡ˆä@ˆ¤1, Vˆä@“w1, “n•Ó@ƒ2, ã–V•qŽq1, ‘ –{”Žs1,3 (1ŽY•w. 2•a—. 3ˆã‰q): ‘æ36‰ñ“ú–{•wl‰ÈŽîᇊw‰ïEŠwpW‰ï (2004/7/16), L“‡. “ú–{•wl‰ÈŽîᇊw‰ïŽGŽ, 22 (3): 243, 2004.

723541. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘å—ʃX[ƒp[RŒ´TSST-1‚ŖƉu‚³‚ꂽ”DPƒ}ƒEƒX‚Å‚ÍIUFD‚ª˜´i‚·‚é. •ˆä‰p—Žq1, ‹T’J”üŒb2, ‹Ê“àGˆê3, ŠÛŽROŽq4, Îì‰ëˆê1, Š_¶‰€Žq2 (1ŽY•w. 2“ŒŠC‘å. 3”÷EŠñ. 4ˆã‰qE•a—): ‘æ19‰ñ“ú–{¶B–ƉuŠw‰ï‘‰ï (2004/10/11-12), _“Þì.

723542. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ŠO—ˆ‰»Šw—Ö@ƒZƒ“ƒ^[‚̉^—p‚ƃŠƒXƒNƒ}ƒl[ƒWƒƒ“ƒg. ‘ •À@Ÿ1, å΋I•F1, ”¼“cŠì”ü–ç1, —Ñ@‹žŽq1, ‰|–{‘ñ–Î1, “nç²¹•F1, ‹àˆä“”V2, ã–V•qŽq2 (1ŠO. 2ŽY•w): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/27), ‹ž“s. “ú–{ŠàŽ¡—Êw‰ïŽGŽ, 39 (2): 333, 2004.

723543. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{èò•”G•½ã”çŠà Neoadjuvant Chemotherapy‚É‚¨‚¯‚éSIP—Ö@‚ÌŒø‰Ê‚ÌŒŸ“¢. Šp“cV•½1, ã–V•qŽq1, ‹àˆä“”V1, ¡ˆä@ˆ¤1, “c‘ºr’j1, Vˆä@“w1, ìŒû”ü˜a1, ‘ –{”Žs1,2 (1ŽY•w. 2ˆã‰q): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/27), ‹ž“s. “ú–{ŠàŽ¡—Êw‰ïŽGŽ, 39 (2): 796, 2004.

723544. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{“à–Œ×–EfThin layer–@‚É‚æ‚éŽq‹{“à–ŒŠà‚Ìf’f‚Æ—\Œã”»’è. ¼‘º—R—¢1, “n•Ó@ƒ2, •ž•”@Šw3, Š™“c—TŽq1, Vˆä@“w1, ìŒû”ü˜a1, ¬•Û•ûˆŸŒõ1, ‹{–{•üK1, ã–V•qŽq1, ‘ –{”Žs1,4 (1ŽY•w. 2•a—. 3ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 4ˆã‰q): ‘æ43‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï (2004/11/13), “Œ‹ž. “ú–{—Õ°×–EŠw‰ïŽGŽ, 43(•â2): 488, 2004.

723545. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{‘Ì•”—Þ“à–Œ‘BŠà‚É‚¨‚¯‚鉉ñŽq‹{“à–Œ×–EfŒ‹‰Ê‚ÌŒŸ“¢. –L‰i^Ÿ1, ‰¡ŽR@‘å2, Š`ÀœA–M1, ŽRŒû—D”üŽq2, ’¬“c‘å•ã2, •ž•”@Šw3, ã–V•qŽq1, ‘ –{”Žs1,4, Šâ•£Œ[ˆê5, ‰ªˆÀ@ŒM5 (1ŽY•w. 2•a—•”. 3ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 4ˆã‰q. 5•a—): ‘æ43‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï (2004/11/13), “Œ‹ž. “ú–{—Õ°×–EŠw‰ïŽGŽ, 43(•â2): 489, 2004.

723546. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) p‘O‚É×–Ef’f‰Â”\‚Å‚ ‚Á‚½Žq‹{‘Ì•”Ÿ÷‰t«‘BŠà‚Ì1—á. “ñˆä”ü’Õä1, ¡ˆä@ˆ¤1, Šp“cV•½1, ‹àˆä“”V1, “c‘ºr’j1, Vˆä@“w1, Š`ÀœA–M1, ã–V•qŽq1, ‘ –{”Žs1,2 (1ŽY•w. 2ˆã‰q): ‘æ43‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï (2004/11/13), “Œ‹ž. “ú–{—Õ°×–EŠw‰ïŽGŽ, 43 (•â2): 492, 2004.

723547. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ä”­‚Ìf’f‚ÉFNA‚ª—L—p‚Å‚ ‚Á‚½ŠO‰APaget•a‚Ì1—á. ‹{–{•üK1, Vˆä@“w1, “ñˆä”ü’Õä1, Šp“cV•½1, –L‰i^Ÿ1, •ž•”@Šw2, “n•Ó@ƒ3, ã–V•qŽq1, ‘ –{”Žs1,4 (1ŽY•w. 2ˆã—ÃŒn‘åŠw‰@E—Õ°×–E. 3•a—. 4ˆã‰q): ‘æ43‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï (2004/11/13), “Œ‹ž. “ú–{—Õ°×–EŠw‰ïŽGŽ, 43 (•â2): 509, 2004.

731082. [Œ¤‹†‰ï] (“Á•Êu‰‰) ŽüŽYŠúˆã—ÃVƒXƒeƒ€|’·–쌧‚ÌŒ»ó|. ŠC–ìM–ç (ŽY•w): ‘Š–ÍŒ´ŽsŽY•wl‰Èˆã‰ï(2004/12/6), ‘Š–ÍŒ´.

731083. [Šw‰ï (’n•û)] (“Á•Êu‰‰) Žq‹{‘ÌŠà‚̃gƒsƒbƒNƒX |“à–Œ×–Ef‚ð’†S‚É|. ã–V•qŽq (ŽY•w): ‘æ19‰ñ“ú–{—Õ°×–EŠw‰ï’¹ŽæŒ§Žx•”ŠwpW‰ï (2004/12/11), •ÄŽq. —\eW, p.4, 2004.

733205. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) Šg’£Œ^S‹ØLJ•¹”DP‚̈ê—á. À”ö²Žq, ‹e’nMŽO, ’r“c‘×—T, “V–ì@Š® (ŽY•w): ‘æ107‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (2004/6/29), “Œ‹ž.

733206. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Fetal brain death‚ª‹^‚í‚ꂽˆê—á. ¡‘º—fŽq, Š›‰º‰r”ü, À”ö²Žq, ‹e’nMŽO, ’r“c‘×—T, ‹àˆä—Y“ñ, –]ŒŽƒŽq, “V–ì@Š® (ŽY•w): ‘æ368‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (2004/7/3), ìè.

733207. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Intrauterine fetal brain death. Š›‰º‰r”ü, ¡‘º—fŽq, À”ö²Žq, ’J@º”Ž, “V–ì@Š® (ŽY•w): ‘æ108‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ïEŠwpW‰ï (2004/10/10), –‹’£. “¯•”‰ï‰ï•ñ, 41 (3): 286, 2004.

733208. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Combined spinal epidural analgesia‚É‚æ‚镪•ØŽž–ƒŒ. ‹e’nMŽO, –]ŒŽƒŽq, ‹àˆä—Y“ñ, ’J@º”Ž, “V–ì@Š® (ŽY•w): ‘æ108‰ñ“ú–{ŽY•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (2004/10/10), ç—t. “¯‰ïŽ, 41 (3): 272, 2004.

733209. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘nŽ¡–ü‚É‚¨‚¯‚éƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“EP3Žó—e‘Ì‚Ì–ðŠ„. Š›‰º‰r”ü1, ’r“c‘×—T1, ¬‹{@Žü2, ”n“ˆ³—²3 (1ŽY•w. 2‹ž“s‘å. 3–ò—): ‘æ111‰ñ“ú–{–ò—Šw‰ïŠÖ“Œ•”‰ï (2004/10/24), ˆïé‚‚­‚Î. “ú–{–ò—Šw‰ïŽGŽ, 125 (1): 14, 2004.

733210. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒXƒeƒƒCƒh‚ÍCCAM‚Ì‘ÙŽ™Ž¡—ÂɗLŒø‚©? ˜’ˉÁ“ÞŽq, ¡‘º—fŽq, ‹àˆä—Y“ñ, “V–ì@Š® (ŽY•w): ‘æ369‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (2004/10/30), ‰¡{‰ê.

733211. [Œ¤‹†‰ï] (ˆê”Êu‰‰) •ª•Ø‚Æ–ƒŒ|Œ¤‹†‰ï‰ïˆõŽ{Ý‚É‚¨‚¯‚é–ƒŒ•ª•Ø‚ÌŒ»ó. –]ŒŽƒŽq (ŽY•w): ‘æ108‰ñ•ª•Ø‚Æ–ƒŒŒ¤‹†‰ï (2004/12/18), ‰¡•l.

733212. [Œ¤‹†‰ï] (ˆê”Êu‰‰) “–‰È‚É‚¨‚¯‚é• o‹¾‰ºŽèp‚̇•¹Ç‚Æ‚»‚Ì‘Îô. “ñˆä”ü’Õä1, ì“à”Žl1, Îì‰ëˆê1, çÝŽ@Šw2, “¡“cˆê”Ž1, ‘å—ÞŒb”üŽq1 (1ŽY•w. 2Ž™): Žl…‰ï (2005/3/2), “Œ‹ž.

733213. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) •p‰ñ‚ÌäNã÷|—r–ŒoƒVƒƒƒ“ƒgp‚ðs‚È‚Á‚½ˆê—á. ˜’ˉÁ“ÞŽq, “V–ì@Š®, ‹àˆä—Y“ñ, ŠC–ìM–ç (ŽY•w): ‘æ370‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (2005/3/6), ‰¡•l.


<<®Œ`ŠO‰ÈŠw>>

mŠwp˜_•¶n

110150. [Œ´’˜] Spontaneous differentiation of mesenchymal stem cells obtained from fetal rat circulation. ¬£NŽ¡1Cè•”@Œ›1CŒüˆä“c’q”V1, T Ueno, ‰E“‡•xŽm’j2, A Oikawa, Y Takagaki3, Ž…–ž·Œ›1 (1®ŠO. 2ŽY•w. 3_“Þ쎕‘å): Bone, 35: 850-858, 2004.

110151. [Œ´’˜] Development of heating method by microwave for sterilization of bone allografts. “àŽRŸ•¶1, Ž•½­L2, ”nŸº´Ž‘2, ‚•½®L1, ¬‹{Gˆê˜Y1, Ž…–ž·Œ›1 (1®ŠO. 2ˆã‰q): Journal of Orthopaedic Science, 10: 77-83, 2005.

110152. [Œ´’˜] Angiotensin type 1a Receptor Signaling-dependent Induction of Vascular Endothelial Growth Factor in Stroma is Relevant to Tumor-associated Angiogenesis and Tumor Growth. “¡“c@Œì1, —Ñ@ò2, ŽR‰È³•½3, A Fukamizu4, Ž…–ž·Œ›1, ”n“ˆ³—²2 (1®ŠO. 2–ò—. 3‰ð–U. 4’}”g‘å): Carcinogenesis, 26: 271-279, 2005.

110153. [Œ´’˜] Tibial fractures associated with crush injuries to the soft tissues of the dorsal foot in children. “¡“c@Œì, ‰¡ŽRˆê•F, ’†‘ºŒõL, “à–ì³—², ˜e“c—²Ži, Ž…–ž·Œ› (®ŠO): Injury, 35: 272-277, 2004.

110154. [Œ´’˜] Validation of estimated muscle fiber conduction velocity with the normalized peak-averaging technique. Ken Nishihara, “ñŒ©r˜Y1, Kasuho Hosoda, Toshiaki Gomi (1®ŠO): Journal of Electromyography and Kinesiology, 15: 93-101, 2005.

120044. [Œ´’˜] ’e”­ŽwœëŠ³Žè‚É‚¨‚¯‚éŽèªŠÇ•”‚ł̳’†_Œo“`“±‘¬“x‚ÌŒŸ“¢. ¬—Ñ–¾³, ‘ü–ì@Œ÷, ’†àVr”V, ˆä‘º‹M”V, âZ@‰ë—_, “ñŒ©r˜Y (®ŠO): “Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 16 (2): 177-181, 2004.

120045. [Œ´’˜] Gustilo ‡VBŒ^‰º‘ÚœŠJ•úœÜ‚ɑ΂·‚鎡—Ã|‘Šú“î•”‘gDC•œ‚Ìd—v«‚ɂ‚¢‚Ä|. “à–ì³—²1, ‰¡ŽRˆê•F1, ’†‘ºŒõL1, Ž…–ž·Œ›1, V“¡³‹P2 (1®ŠO. 2º˜a‘åE‹~‹}): “ú–{E‹Æ¥ÐŠQˆãŠw‰ï‰ïŽ, 52 (2): 105-111, 2004.

120046. [Œ´’˜] ‘åŠw•a‰@‚É‚¨‚¯‚éŽè‚ÌŠO‰È‚̃ŠƒXƒNƒ}ƒlƒWƒƒ“ƒg. ¬—Ñ–¾³, “ñŒ©r˜Y, ‘ü–ì@Œ÷, ˆä‘º‹M”V, ˜e“c—²Ži (®ŠO): “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 21 (2): 7-9, 2004.

120047. [Œ´’˜] —«‚É”­Ç‚µ‚½Kienbock•a‚ÌŒŸ“¢|—Õ°‘œ‚ÆŽ¡—Ö@‚ð’†S‚É|. ‘ü–ì@Œ÷, ¬—Ñ–¾³, “¡“c@Œì, âZ@‰ë—_, “n•Ó“NÆ, “ñŒ©r˜Y (®ŠO): “Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 16 (4): 554-559, 2004.

120048. [Œ´’˜] V‚µ‚¢•\–Ê“d‹É‹Ø“d}ˆ—–@‚É‚æ‚é“™ŽÚ«ˆÓŽûkŽž‚Ì‹ØüˆÛ“`“±‘¬“x‚Ì„’è‚ÆŒŸØ. ¼Œ´@Œ«1, “ñŒ©r˜Y2, ‹v•Û“cÍm1 (1ˆã‰q. 2®ŠO): —Šw—Ö@Šw, 19 (4): 275-279, 2004.

220036. [€Œ´’˜] œÜŒã‚Ì”xŒŒðÇðÇ”­Ç󋵂̌»ó |2001`02”N‚É‚¨‚¯‚é“ú–{Ž¡—Êw‰ï‰ïˆõ‚¨‚æ‚ÑŠ‘®Ž{Ý‚ð‘ÎÛ‚Æ‚µ‚½ƒAƒ“ƒP[ƒgWŒvŒ‹‰Ê|. ‚•½®L1, V“¡³‹P2, ‰–“c’¼Žj3, ‹´–{W•½4, Ž…–ž·Œ›1, ’†–ì“N—Y5, ²“¡@“O6, ˆ¢•”–õ”V7 (1®ŠO. 2º˜a‘å. 3‹ßX•a‰@. 4ˆ¤’mˆã‘å. 5‹Ê–¼’†‰›•a‰@. 6‰ªŽR‘å. 7ŒF–{’†‰›•a‰@): œÜ, 26 (1): 39-43, 2004.

220037. [€Œ´’˜] ¬Ž™‘å‘Úœèò•”œÜ‚ÌŽ¡—ìÑ. ¬‹{Gˆê˜Y, ‰¡ŽRˆê•F, “àŽRŸ•¶, ŽR–{‹–¾, ‚•½®L, Ž…–ž·Œ› (®ŠO): œÜ, 26 (2): 538-541, 2004.

220038. [€Œ´’˜] žôœ‰“ˆÊ’[œÜ‚ɑ΂·‚éLocking Compression Plate‚ÌŽg—pŒoŒ±. ’†‘ºŒõL1, ‰¡ŽRˆê•F1, Ž…–ž·Œ›1, “c’†@³2, ‰Á“¡‘å‰î2, àVŒû@‹B3, –ÎZéO3, ‹g“cŒ’Ž¡4, ¯Žq@‹v4, ´d‰À˜Y5 (1®ŠO. 2ŒN’Ã’†‰›•a‰@. 3•xŽRŽs–¯•a‰@. 4¹ƒ}ƒŠƒAƒ“ƒi•a‰@. 5ŽRŒ`϶•a‰@): œÜ, 26 (2): 423-425, 2004.

220039. [€Œ´’˜] ƒŠƒ“Ž_ƒJƒ‹ƒVƒEƒ€œƒy[ƒXƒg‚ð[“U‚µ‚½ƒZƒƒ“ƒgƒŒƒXƒXƒeƒ€‚Ì’†Šú¬Ñ. “àŽRŸ•¶1, ‚•½®L1, ’Ë–{’B˜Y1, ¬‹{Gˆê˜Y1, Ž…–ž·Œ›1, ŠÖŒû¹˜a2, •àVˆê–ç3 (1®ŠO. 2‚¹‚«‚®‚¿®Œ`ŠO‰È. 3‚­‚낳‚í•a‰@): ‘æ4‰ñƒoƒCƒIƒAƒNƒeƒBƒuŒ¤‹†‰ï‹L˜^W, 93-96, 2004.

220040. [€Œ´’˜] •ÏŒ`«ŒÒŠÖßǂɑ΂·‚éŠO”½œØ‚èp‚¨‚æ‚ÑChiariœ”՜؂臕¹Žèp‚̬Ñ. “àŽRŸ•¶, ‚•½®L, ¬‹{Gˆê˜Y, ‚èƒF, ‘åì@F, Ž…–ž·Œ› (®ŠO): Hip Joint, 30: 364-369, 2004.

220041. [€Œ´’˜] ®Œ`ŠO‰ÈŽüpŠú‚̃ŠƒXƒNƒ}ƒlƒWƒƒ“ƒg. XŒû®¶1, ¬—Ñ–¾³1, “n•Ó“NÆ1, ’†àVr”V1, âZ@‰ë—_1, ‘ü–ì@Œ÷1, ˆä‘º‹M”V1, “ñŒ©r˜Y1, ‰Í“c‘½‰Á2 (1®ŠO. 2“Œ•a‰@ˆã—ÈÀ‘SŠÇ—Žº): _“Þ쮌`ЊQŠO‰ÈŒ¤‹†‰ïŽGŽ, 17 (3): 77-80, 2004/11.

220042. [€Œ´’˜] ƒ}ƒCƒNƒ”gÆŽË‚É‚æ‚铯ŽíœˆÚAœ‰Á‰·ˆ—–@|ŽE‹ÛŒø‰Ê‚¨‚æ‚Ñ—ÍŠw“I‹­“x‚ÌŒŸ“¢|. “àŽRŸ•¶1, ‚•½®L1, Ž…–ž·Œ›1 , Ž•½­L2, ”nŸº´Ž‘2 (1®ŠO. 2ˆã‰q): “ú–{—Õ°ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ïŽ, 25: 43`48, 2004.

220043. [€Œ´’˜] ƒZƒƒ“ƒgƒŒƒX‘SlHŒÒŠÖß’uŠ·p‚Ì‚—îŽÒ‚ɑ΂·‚é’ZŠú¬Ñ|Duetto SI stem‚ð—p‚¢‚Ä|. •Ÿ“‡Œ’‰î, ‚•½®L, “àŽRŸ•¶, ‚èƒF, ‹{•”@Šî, Ž…–ž·Œ› (®ŠO): “ú–{lHŠÖߊw‰ïŽGŽ, 34: 105-106, 2004.

220044. [€Œ´’˜] lHŒÒŠÖß’uŠ·p‚É‚¨‚¯‚é¬ØŠJ‚Æ]—ˆØŠJ‚Å‚Ìáu’É‚ÉŠÖ‚·‚錌‰tƒf[ƒ^‚Ì”äŠr. ‚•½®L1, “àŽRŸ•¶1, ‚èƒF1, –p@ W³1, V“c_Žj1, ‘P•½“N•v1, •Ÿ“‡Œ’‰î1, X’JŒõr1, Šâ£@‘å1, ‰Í‘º@’¼1, è•”@Œ›1, Ž…–ž·Œ›1, Ž…–žD2 (1®ŠO. 2–ƒ): “ú–{lHŠÖߊw‰ïŽGŽ, 34: 161-162, 2004.

220045. [€Œ´’˜] IMCƒXƒeƒ€‚Ì’ZŠú¬Ñ|‚wüŠw“I•]‰¿|. “àŽRŸ•¶1, ‚•½®L1, ‚èƒF1, ŽR–{‹–¾1, •Ÿ“‡Œ’‰î1, Šâ£@‘å1, Ž…–ž·Œ›1, Žðˆä—˜“Þ2, ”nŸº´Ž‘3 (1®ŠO. 2ˆã—ÃŒn‘åŠw‰@. 3ˆã‰q): lHŠÖߊw‰ïŽGŽ, 34: 217-218, 2004.

220046. [€Œ´’˜] •I•”ŠÇÇŒóŒQ‚ɑ΂·‚éf’f–@‚Æ‚µ‚Ä‚Ì Elbow flexion test‚ÌŽŽ‚Ý. ‘ü–ì@Œ÷, ¬—Ñ–¾³, XŒû®¶, ¬ÀŒ«Ž¡, “ñŒ©r˜Y (®ŠO): “ú–{•IŠÖߊw‰ïŽGŽ, 11(1): 159-160, 2004.

220047. [€Œ´’˜] ‰º‘ÚœŠJ•úœÜ‚É‚¨‚¯‚é‹UŠÖß”­¶‚ÉŠÖ—^‚·‚éŠëŒ¯ˆöŽq‚ÌŒŸ“¢. “à–ì³—²1, Ž…–ž·Œ›1, ‰¡ŽRˆê•F1, ‹e’r‹±‘¾1, ’†‘ºŒõL1, V“¡³‹P2 (1®ŠO. 2º˜a‘åE‹~‹}j: “Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ïŠw‰ïŽGŽ, 16 (1): 133-136, 2004.

220048. [€Œ´’˜] •I•”ŠÇÇŒóŒQ‚Æ‚µ‚Ä‚ÌElbow flexion test. ‘ü–ì@Œ÷, ¬—Ñ–¾³, ‹î“c•üG, âZ@‰ë—_, “ñŒ©r˜Y (®ŠO): “Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 16 (1): 42-46, 2004.

320040. [Ç—á•ñ] Temporary shunt tube‚ð—p‚¢‚Ä—ÇD‚È‹@”\¬Ñ‚ª“¾‚ç‚ꂽGustilo‡VCŒ^ŠJ•ú«floating elbow‚Ì1—á. ”\”ü@®, ‰¡ŽRˆê•F, ²“¡r”Ž, ‘å’Ë@G, ’†‘ºŒõL, Ž…–ž·Œ› (®ŠO): _“Þ쮌`ЊQŠO‰ÈŒ¤‹†‰ïŽGŽ, 16 (5): 157-161, 2004.

320041. [Ç—á•ñ] èò‹¹’ňÚs•”‚̉©Fx‘Ñœ‰», Œãcx‘Ñœ‰»‚¨‚æ‚ђŊԔƒwƒ‹ƒjƒA‚É‚æ‚èÒ‘Ç‚ð’悵‚½1—á. ‹e’r‹±‘¾1, ˆÀ’B@Œö1, ’†àVr”V1, ˆä‘º‹M”V1, ‹î“c•üG1, “ú–쟗˜, “¡“c@Œì1, •Ð–ì‘fº, “ñŒ©r˜Y1 (1®ŠO): _“Þ쮌`ЊQŠO‰ÈŒ¤‹†‰ïŽGŽ, 16 (5): 163-167, 2004.

320042. [Ç—á•ñ] ŽèªŠÇÇŒóŒQ‚𔺂Á‚½Mycobacterium nonchromogenicum‚É‚æ‚é’†Žw‹ü‹ØäFŠŠ–Œ‰Š‚Ì1—á. XŒû®¶, ¬—Ñ–¾³, ‘ü–ì@Œ÷, ’Ë–{’B˜Y, ˆä‘º‹M”V, “ñŒ©r˜Y (®ŠO): ®Œ`ŠO‰È, 55 (6): 673-677, 2004.

320043. [Ç—á•ñ] æ“V«žôŽÚœ–ü‡Ç‚Ì“à”½•I‚ɑ΂·‚éŽÚœ_Œo‘O•ûˆÚ“®pŒãƒKƒ“ƒOƒŠƒIƒ“‚É‚æ‚Á‚ÄÄ”­‚µ‚½’x”­«ŽÚœ_Œo–ƒáƒ‚Ì1—á. ŽR–{‹–¾, ¬—Ñ–¾³, “¡“c@Œì, ‘ü–ì@Œ÷, “ñŒ©r˜Y (®ŠO): ®Œ`ŠO‰È, 55 (10): 1330-1333, 2004.

320044. [Ç—á•ñ] Š°œ‰PœÜ‚É”º‚Á‚½’vŽ€«”xŒŒðÇðÇ‚Ì‹~–½‚µ“¾‚½1—á. ¬ÀŒ«Ž¡1, ‚•½®L1, “àŽRŸ•¶1, –p@W³1, Ž…–ž·Œ›1, “à–ì³—²2, ˜e“c—²Ži2 (1®ŠO. 2‹~–½): œÜ, 26 (1): 54-58, 2004.

320045. [Ç—á•ñ] ‘å‘Úœ“]Žq‰ºœÜ‚É‚¨‚¯‚éproximal femoral nail‚ÌÜ‘¹‚Ì1—á. –p@W³, ‚•½®L, ‰¡ŽRˆê•F, “à–ì³—², ‘åì@F, Ž…–ž·Œ› (®ŠO): œÜ, 26 (2): 596-598, 2004.

320046. [Ç—á•ñ] ––’[”ì‘åÇ iacromegalyj ‚É•¹”­‚µ‚½—¼‘¤•ÏŒ`«ŒÒŠÖßÇ‚Ì1—á. •Ÿ“‡Œ’‰î, “àŽRŸ•¶, ‚•½®L, Œüˆä“c’q”V, ‘åì@F, ‚èƒF, Ž…–ž·Œ› (®ŠO): ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 36 (1): 20-23, 2005.

320047. [Ç—á•ñ] ˆêŠú“I‚É‘S“Eo‚ðs‚Á‚½‹¹’ŋזEŽî‚Ì1—á. ã–쳊ì, ˆÀ’B@Œö, ’†àVr”V, ˆä‘º‹M”V, âZ@‰ë—_, “ñŒ©r˜Y (®ŠO): ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 35 (6): 389-394, 2004.

520164. [‘à] ‘å‘Úœèò•”œÜ|f—ÃKƒCƒhƒ‰ƒCƒ“쬂̌»ó|. ‰¬–ì@_1, “n•”‹Ó”E2, ’†–ì“N—Y3, Ž…–ž·Œ›4, ¼‰º@—²2 (1’¹Žæ‘å. 2’é‹ž‘å. 3‹Ê–¼’†‰›•a‰@. 4®ŠO): —Õ°®Œ`ŠO‰È, 39 (8): 1063-1067, 2004.

520165. [‘à] œÜ“àŒÅ’èÞ—¿‚Í”²‹Ž‚·‚ׂ«‚©? ’†‘ºŒõL, Ž…–ž·Œ› (®ŠO): œEŠÖßEx‘Ñ, 17 (5): 549-551, 2004.

520166. [‘à] žôœ‰“ˆÊ’[œÜ. ’†‘ºŒõL, ‰¡ŽRˆê•F, “à–ì³—², —é–Ø@‘ì, “¡“c@Œì, Ž…–ž·Œ› (®ŠO): ®Œ`ЊQŠO‰È, 47 (11): 1299-1304, 2004.

520167. [‘à] AO/ASIF Foundation (AOœÜŽ¡—ÃŒ¤‹†à’c). Ž…–ž·Œ› (®ŠO): ®Œ`ЊQŠO‰È, 47 (11): 1361-1372, 2004.

520168. [‘à] ã˜rœœŠ²•”‚ɑ΂·‚éƒAƒvƒ[ƒ`. ‘å’Ë@G, ‰¡ŽRˆê•F, Ž…–ž·Œ› (®ŠO): Monthly Book Orthopaedics, 17 (10): 55-62, 2004.

520169. [‘à] ŠO”½œØ‚èp‚ƃLƒAƒŠ[œØ‚èp‚Ì•¹—p |“K‰ž‚ÆÅ’Z10”NˆÈã‚Ì’·Šú¬Ñ|. ‚•½®L, “àŽRŸ•¶, ‚èƒF, Ž…–ž·Œ› (®ŠO): œEŠÖßEx‘Ñ, 17 (10): 1121-1126, 2004.

520170. [‘à] ¬ØŠJlHŒÒŠÖß’uŠ·p‚Íáu’É‚ð—}§‚Å‚«‚½‚©?|lHŒÒŠÖß’uŠ·p‚É‚¨‚¯‚é¬ØŠJ‚Æ]—ˆØŠJ‚Å‚Ìáu’É‚ÉŠÖ‚·‚錌‰tƒf[ƒ^‚Ì”äŠr|. ‚•½®L, “àŽRŸ•¶, ˆø“crˆê, ‚èƒF, –p@W³, ‘P•½“N•v, •Ÿ“‡Œ’‰î, Ž…–žD, Ž…–ž·Œ› (®ŠO): œEŠÖßEx‘Ñ, 17 (12): 1353-1357, 2004.

520171. [‘à] “¯ŽíœˆÚA‚ð—p‚¢‚½‘å‘Úœ‘¤lHŒÒŠÖßÄ’uŠ·p. ‚•½®L1, “àŽRŸ•¶1, ¬£NŽ¡1, ‚èƒF1, ¬‹{Gˆê˜Y1, Ž…–ž·Œ›1, ¬—Ñ (“à“c) ؉›2 (1®ŠO. 2œƒoƒ“ƒN): •Êû®Œ`ŠO‰È, 47: 75-82, 2005.

520172. [‘à] ¬Ž™‘å‘ÚœŒz•”œÜ‚É‚¨‚¯‚霉󎀔­ÇˆöŽq. ¬‹{Gˆê˜Y, ‰¡ŽRˆê•F, “àŽRŸ•¶, ŽR–{‹–¾, •ôŒ´G¹, ‚•½®L, Ž…–ž·Œ› (®ŠO): —Õ°®Œ`ŠO‰È, 39 (12): 1513-1518, 2004.

520173. [‘à] u‰õ“Kˆã—ÃVƒXƒeƒ€‚Ì‘n¬v: ŠÖß‹@”\ÄŒš‚Ö‚Ì’§í. Ž…–ž·Œ› (®ŠO): –k—¢ˆãŠw, 33 (6): 346-351, 2003.

520174. [‘à] ŠO|‚—îŽÒ‚É‚¨‚¯‚éŽlŽˆEÒ’Å‚ÌœÜ|. è•”@Œ›, Ž…–ž·Œ› (®ŠO): –ò‚Ì’mŽ¯, 55 (6): 16-20, 2004.

520175. [‘à] ŠO—ˆˆ’u@ŽlŽˆŠÖß’E‰P‚ɑ΂·‚鎡—Ã. ’†‘ºŒõL, Ž…–ž·Œ› (®ŠO): VOS NOW, 25: 71-80, 2005.

520176. [‘à] ƒAƒLƒŒƒXäF’f—ô‚Ì‹­ŒÅ‚È–D‡‚Æ‘Šú‰^“®—Ö@. è•”@Œ› (®ŠO): “ú–{ˆãŽ–V•ñ, 4168: 105, 2004.

520177. [‘à] ŽèªŠÇÇŒóŒQ. “ñŒ©r˜Y (®ŠO): •é‚炵‚ÆŒ’N, 2005”N3ŒŽ†, p.85.

m’˜@‘n

620096. [Šwp‘] (•ª’SŽ·•M) “§Íƒtƒƒ“ƒeƒBƒA; ŽèªŠÇÇŒóŒQ‚Ì‹qŠÏ“If’f–@, p.14-16. “ñŒ©r˜Y (®ŠO), ŠÄC ‘O“c’å—º‚Ù‚©, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/4”­s.

620097. [Šwp‘] (•ª’SŽ·•M) _’†®Œ`ŠO‰È ㊪ i‰ü’ù22”Åj; ã˜r‚ÌáŠQEŠO, p.817-818. “ñŒ©r˜Y (®ŠO), •ÒW ™‰ª—mˆê (‹ãB‘å–¼—_‹³Žö), ŠÄC Šâ–{K‰p (‹ãB‘å), “ìŽR“°, “Œ‹ž, 2004/5”­s.

620098. [Šwp‘] (•ª’SŽ·•M) _’†®Œ`ŠO‰È ‰ºŠª i‰ü’ù22”Åj; ‘æ5Íã˜r‚Æ•I, p.405-447, “ñŒ©r˜Y (®ŠO), •ÒW ™‰ª—mˆê (‹ãB‘å–¼—_‹³Žö), ŠÄC Šâ–{K‰p (‹ãB‘å), “ìŽR“°, “Œ‹ž, 2004/5”­s.

620099. [Šwp‘] (•ª’SŽ·•M) _’†®Œ`ŠO‰È ‰ºŠª i‰ü’ù22”Åj; ‘å‘ÚœœŠ²•”œÜ@‘å‘Ú•”‚ÌiN«_ŒoáŠQ, p.889-906. è•”@Œ› (®ŠO), •ÒW ™‰ª—mˆê (‹ãB‘å–¼—_‹³Žö), ŠÄC Šâ–{K‰p (‹ãB‘å), “ìŽR“°, “Œ‹ž, 2004/5”­s.

620100. [Šwp‘] (•ª’SŽ·•M) }àŒÒŠÖß‚Ì—Õ°; ŒÒŠÖ߂̉ð–UE‹@”\‰ð–U, p.6-11. Ž…–ž·Œ› (®ŠO), •ÒW Ž…–ž·Œ›, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/4/1”­s.

620101. [Šwp‘] (•ª’SŽ·•M) }àŒÒŠÖß‚Ì—Õ°; ŒÒŠÖß‚Ìf’f–@, p.32-45. ‚•½®L (®ŠO), •ÒW Ž…–ž·Œ› (®ŠO), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/4/1”­s.

620102. [Šwp‘] (•ª’SŽ·•M) }àŒÒŠÖß‚Ì—Õ°; ‰æ‘œf’f‚¨‚æ‚Ñ•â•f’f, p.46`67. è•”@Œ› (®ŠO), •ÒW Ž…–ž·Œ› (®ŠO), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/4/1”­s.

620103. [Šwp‘] (•ª’SŽ·•M) }àŒÒŠÖß‚Ì—Õ°; ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“, p.76`81. ‰¡ŽRˆê•F (®ŠO), •ÒW Ž…–ž·Œ› (®ŠO), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/4/1”­s.

620104. [Šwp‘] (•ª’SŽ·•M) }àŒÒŠÖß‚Ì—Õ°; ŒÒŠÖß‚Ìi“ü–@, p.82`90. Ž…–ž·Œ› (®ŠO), •ÒW Ž…–ž·Œ›, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/4/1”­s.

620105. [Šwp‘] (•ª’SŽ·•M) }àŒÒŠÖß‚Ì—Õ°; ŒÒŠÖ߂̜؂èp|‘å‘Úœ‘¤‚̜؂èp, p.106`115. Ž…–ž·Œ› (®ŠO). •ÒW Ž…–ž·Œ›, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/4/1”­s.

620106. [Šwp‘] (•ª’SŽ·•M) }àŒÒŠÖß‚Ì—Õ°; Š´õ«ŠÖ߉Š, p.200`206. ‚•½®L (®ŠO), •ÒW Ž…–ž·Œ› (®ŠO), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/4/1”­s.

620107. [Šwp‘] (•ª’SŽ·•M) }àŒÒŠÖß‚Ì—Õ°; ŒÒŠÖß‚¨‚æ‚Ñ‚»‚ÌŽü•Ó‚ÌŽîá‡, p.212`219. “ß{–ìG“ñ (®ŠO), •ÒW Ž…–ž·Œ› (®ŠO), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/4/1”­s.

620108. [Šwp‘] (•ª’SŽ·•M) }àŒÒŠÖß‚Ì—Õ°; ŒÒŠÖߎèp‚̇•¹Ç, p.226`238. ‚•½®L (®ŠO), •ÒW Ž…–ž·Œ› (®ŠO), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/4/1”­s.

620109. [Šwp‘] (•ª’SŽ·•M) }àŒÒŠÖß‚Ì—Õ°; Šª––Ž‘—¿, p.240`249. ‚•½®L (®ŠO), •ÒW Ž…–ž·Œ› (®ŠO), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/4/1”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

711007. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Metacarpal osteotomy. “ñŒ©r˜Y (®ŠO): 5th Asian Pacific Federation of Sociality for Surgery of the Hand (2004/11/14-16), ‘åã.

711008. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Cementless revision total hip arthroplasty on femoral side using allograft bones. ‚•½®L (®ŠO): Chang Gung Universityu‰‰‰ï (2005/3/10), ‘ä˜p iChang Gung Universityj

712027. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) The treatment outcome of revision total hip arthroplasty on femoral side. ‚•½®L, “àŽRŸ•¶, –p@W³, Ž…–ž·Œ› (®ŠO): APOA 2004 14th Triennial Congress (2004/9/5-10), Malaysia (Kuala Lumpur). Abstract book, p.102, 2004.

712028. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Repair of articular cartilage defect by implant of type ‡Ucollagen sponge with and without chondrocytes. è•”@Œ›1, Œüˆä“c’q”V1, ¬£NŽ¡1, S Gen2, Ž…–ž·Œ›1 (1®ŠO. 2‹ž“s‘å): 10th APASTB International Conference iThe Asia-Pacific Association of Surgical Tissue Bankingj(2004/11/6-8), `. ´˜^W, p.14, 2004.

712029. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Treatment outcome of cementless revision total hip arthroplasty on femoral side using allograft bones. ‚•½®L, “àŽRŸ•¶, –p@W³, Ž…–ž·Œ› (®ŠO): 10th APASTB International Conference (The Asia-Pacific Association of Surgical Tissue Banking) (2004/11/6-8), `. ´˜^W, p.29, 2004.

713118. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Spontaneous differentiation of mesenchymal stem cells obtained from fetal rat circulation. ¬£NŽ¡1, è•”@Œ›1, Yuko Mikuni-Takagaki2, Œüˆä“c’q”V1, ‘Šì@~1, Ž…–ž·Œ›1 (1®ŠO. 2_“Þ쎕‘å): The 5th International Cartilage Repair Society (2004/5/26), ƒxƒ‹ƒM[.

713119. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Three dimensional culture in the type II collagen sponge maintains chondrocyte phenotype and redifferentiates the dedifferentiated chondrocytes. Œüˆä“c’q”V, è•”@Œ›, ¬£NŽ¡, ‘Šì@~, Ž…–ž·Œ› (®ŠO): The 5th International Cartilage Repair Society (2004/5/26), ƒxƒ‹ƒM[.

713120. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) The biologic character of fetal circulating blood derived mesenchymal stem cells. ‘Šì@~1, è•”@Œ›1, ¬£NŽ¡1, Œüˆä“c’q”V1, Yuko Mikuni-Takagaki2, ‚•½®L1, Ž…–ž·Œ›1 (1®ŠO. 2_“Þ쎕‘å): The 5th International Cartilage Repair Society (2004/5/26), ƒxƒ‹ƒM[.

713121. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) The long-term results of osteotomy for advanced and terminal osteoarthritis of the hip before age 40 years. ‚•½®L, Ž…–ž·Œ›, “àŽRŸ•¶, ‚èƒF (®ŠO): SICOT/SIROT 2004 Third Annual International Conference (2004/9/26-29), Cuba (Havana). Abstract book, p.286, 2004.

713122. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Clinical outcome of the humeral shaft fracture treated with unreamed compression humeral rods (UCHR). ’†‘ºŒõL, Ž…–ž·Œ›, ‰¡ŽRˆê•F, •Ÿ“‡Œ’‰î (®ŠO): SICOT/SIROT 2004 Third Annual International Conference (2004/9/26-29), Cuba (Havana). Abstract book, p.91, 2004.

713123. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. “¡“c@Œì1, ”n“ˆ³—²2, A Fukamizu3, Ž…–ž·Œ›1 (1®ŠO. 2–ò—. 3’}”g‘å): 5th combined meeting of the orthopaedic research societies of Canada, U.S.A. Japan and Europe, 2004 (2004/10/10-13), Canada (Banff). Abstract book, p.11, 2004.

713124. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Development of a thermal disinfection method of bone allografts using a microwave apparatus -Microbiological and biomechanical studies-. “àŽRŸ•¶1, Ž•½­L2, ”nŸº´Ž‘2, ‚•½®L1, Ž…–ž·Œ›1 (1®ŠO. 2ˆã‰q): 10th APASTB International Conference iThe Asia-Pacific Association of Surgical Tissue Bankingj (2004/11/6-8), `. ´˜^W, p.31, 2004.

713125. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Evaluation of functional outcome of the floating knee injuries using multivariate analysis. ‰¡ŽRˆê•F, –ØMˆê, ’†‘ºŒõL, Ž…–ž·Œ› (®ŠO): 9th Intenatinal Society for Fracture Repair (2004/11/2-6), Bologna, Italia. J Orthop Trauma, 18 (S.): S36, 2004.

713126. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Functional outcome and QOL of Gustilo IIIB open tibial fractures requiring frss tissue transfers. –p@W³, ‰¡ŽRˆê•F, ’†‘ºŒõL, “à–ì³—², Ž…–ž·Œ› (®ŠO): 9th Intenatinal Society for Fracture Repair (2004/11/2-6), Bologna, Italia. J Orthop Trauma, 18 (S.): S35, 2004.

713127. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Treatment for Gustilo IIIB open tibial fractures -The significance of early soft-tissue coverage-. “à–ì³—², ‰¡ŽRˆê•F, ’†‘ºŒõL, ¬‹{Gˆê˜Y, Ž…–ž·Œ› (®ŠO): 9th Intenatinal Society for Fracture Repair (2004/11/2-6), Bologna, Italia. J Orthop Trauma, 18 (S.): S35, 2004.

713128. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Long-term results of excision of the hook in the treatment of fractures of the hook of hamates. “ñŒ©r˜Y, ¬—Ñ–¾³, ‘ü–ì@Œ÷ (®ŠO): 1st Japan-Italian Hand Conference (2004/11/14), ‘åã.

713129. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Trigger finger following carpal tunnel release. ¬—Ñ–¾³, “ñŒ©r˜Y, ‘ü–ì@Œ÷, XŒû®¶, ˆä‘º‹M”V (®ŠO): ‘æ4‰ñ“ú•Ä‡“¯Žè‚ÌŠO‰È‰ï‹c (2005/3/19-22), ƒnƒƒC.

713130. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Treatment of distal radius fractures with minimally invasive plate osteosynthyesis. ’†‘ºŒõL, ‰¡ŽRˆê•F, “à–ì³—², Ž…–ž·Œ› (®ŠO): ‘æ4‰ñ“ú•Ä‡“¯Žè‚ÌŠO‰È‰ï‹c (2005/3/19-22), ƒnƒƒC.

721011. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) Fracture treatment in Japan. Ž…–ž·Œ› (®ŠO): 8th AO Principles Course -Principles of Fracture Management- (2004/8/19-21), •xŽR.

722057. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘nŠOŒÅ’èŒã‘“à“B‚É‚æ‚Á‚ÄŽ¡—³‚ꂽGustilo ‡VBŒ^ãøœŠJ•úœÜ‚É‚¨‚¯‚鎡—ÃŒoŒ±: ‘Šú”ç•Ù‚Æ“¯Žž‚És‚í‚ꂽearly nailing‚Ì4—á‚ɂ‚¢‚Ä. ã–쳊ì1, ‰¡ŽRˆê•F1, ’†‘ºŒõL1, “à–ì³—²1, —é–Ø@‘ì2, ‘å’Ë@G1, –p@W³1, Ž…–ž·Œ›1 (1®ŠO. 2‹~–½): ‘æ30‰ñ“ú–{œÜŽ¡—Êw‰ï (2004/7/2-3), “Œ‹ž. ´˜^W, p.73, 2004.

722058. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Gustilo ‡VBŒ^ãøœŠJ•úœÜ‚ɑ΂·‚鑦Žž‘“à“BŒQ‚Æ‘nŠOŒÅ’èŒã‘“à“BŒQ‚Ì”äŠr. –p@W³1, ‰¡ŽRˆê•F1, ’†‘ºŒõL1, —é–Ø@‘ì2, ‘å’Ë@G1, Ž…–ž·Œ›1 (1®ŠO. 2‹~–½j: ‘æ30‰ñ“ú–{œÜŽ¡—Êw‰ï (2004/7/2-3), “Œ‹ž. ´˜^W, p.76, 2004.

722059. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ãøœœŠ²•”ŠJ•úœÜ‚Ì‘J‰„–ü‡, ‹UŠÖ߂ɑ΂·‚é’´‰¹”gŽ¡—Â̌oŒ±. V“c_Žj, ‰¡ŽRˆê•F, ’†‘ºŒõL, “à–ì³—², Ž…–ž·Œ› (®ŠO): ‘æ30‰ñ“ú–{œÜŽ¡—Êw‰ï (2004/7/2-3), “Œ‹ž. ´˜^W, p.82, 2004.

722060. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Hannover Fracture scale '98‚ÍŠ´õ”­Ç‚ÌŽw•W‚Æ‚È‚é‚Ì‚©? : ãøœŠJ•úœÜ‚É‚¨‚¯‚錟“¢. ‰¡ŽRˆê•F1, “à–ì³—²1, ’†‘ºŒõL1, ‘å’Ë@G1, —é–Ø@‘ì2, Ž…–ž·Œ›1 (1®ŠO. 2‹~–½j: ‘æ30‰ñ“ú–{œÜŽ¡—Êw‰ï (2004/7/2-3), “Œ‹ž. ´˜^W, p.91, 2004.

722061. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘½”­ŠO‚É”º‚¤ floating knee‘¹‚Ì‹@”\¬Ñ‚ɂ‚¢‚Ä. •Ÿ“‡Œ’‰î1, ‰¡ŽRˆê•F1, “à–ì³—²1, –ØMˆê1, ’†‘ºŒõL1, —é–Ø@‘ì2, ‘Š”nˆêˆå2, Ž…–ž·Œ›1 (1®ŠO. 2‹~–½j: ‘æ30‰ñ“ú–{œÜŽ¡—Êw‰ï (2004/7/2-3), “Œ‹ž. ´˜^W, p.156, 2004.

722062. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’áo—Í’´‰¹”gƒpƒ‹ƒX‚̜܎¡–ü‰ß’ö‚É‹y‚Ú‚·ì—pƒƒJƒjƒYƒ€. ¬£NŽ¡1, ‚Š_—TŽq2, è•”@Œ›1, Ž…–ž·Œ›2 (1®ŠO. 2_“Þ쎕‘åj: ‘æ19‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2004/10/21-22), •iì. “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ´˜^†, 78 (8): 768, 2004.

722063. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘O, ‰ŠúŒÒŠÖßǂɑ΂·‚éChiariœ”՜؂èp‚Ì’·Šú¬Ñ. “àŽRŸ•¶1, ‚•½®L1, ŽR–{‹–¾1, —é–Ø@‘ì2, –p@W³1, ‘P•½“N•v1, Ž…–ž·Œ›1 (1®ŠO. 2‹~–½): ‘æ31‰ñ“ú–{ŒÒŠÖߊw‰ï (2004/10/15-16), ’·è. ´˜^W, p.97, 2004.

722064. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒW‚©‚ç‚Ý‚½lH•GŠÖ߂̃Lƒlƒ}ƒeƒBƒNƒX. ”nŸº´Ž‘1, Žðˆä—˜“Þ1, Ž…–ž·Œ›2 (1ˆã‰q. 2®ŠO): ‘æ31‰ñ“ú–{—Õ°ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ï (2004/11/12-13), •Ÿ‰ª. ´˜^W, p.63, 2004.

722065. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) lH•GŠÖß‘S’uŠ·p‚É‚¨‚¯‚éposterior offset‚Æ•G‹ü‹È‰Â“®ˆæ‚ÌŒŸ“¢. “¡“c@Œì, è•”@Œ›, ‘Šì@~, Ž…–ž·Œ› (®ŠO): ‘æ35‰ñ“ú–{lHŠÖߊw‰ï (2005/2/3-4), ‰«“ê. ´˜^W, p.175, 2005.

722066. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ¬ØŠJTHA‚Ì]—ˆØŠJTHA‚Æ‚Ì—Õ°¬Ñ‚Ì”äŠr‚ÆŽèp‘€ìŽž‚ÌH•v. ‚•½®L, “àŽRŸ•¶, ‚èƒF, –p@W³, ‘P•½“N•v, Ž…–žD, •Ÿ“‡Œ’‰î, ŽR–{‹–¾, Ž…–ž·Œ› (®ŠO): ‘æ35‰ñ“ú–{lHŠÖߊw‰ï (2005/2/3-4), ‰«“ê. ´˜^W, p.193, 2005.

722067. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘å‘ÚœŠO”½œØ‚èpŒã‚ÌlHŒÒŠÖß‘S’uŠ·pŽž‚ÌH•v‚Æ–â‘è“_. “àŽRŸ•¶1, ‚•½®L1, —é–Ø@‘ì2, –p@W³1, ŽR–{‹–¾1, •Ÿ“‡Œ’‰î1, Ž…–ž·Œ›1 (1®ŠO. 2‹~–½): ‘æ35‰ñ“ú–{lHŠÖߊw‰ï (2005/2/3-4), ‰«“ê. ´˜^W, p.352, 2005.

722068. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘ÙŽ™ŒŒ—R—ˆ–¢•ª‰»ŠÔ—tŒn×–E‚Ìœ“îœÄ¶‚ւ̉ž—p. è•”@Œ›1, ¬£NŽ¡1, ‰E“‡•yŽm’j2, Œüˆä“c’q”V1, ‘Šì@~1, •Ð–ì‘fº1, jìTˆê˜Y1, Ž…–ž·Œ›1 (1®ŠO. 2ŽY•wj: ‘æ30‰ñ“ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ïŠwpW‰ï (2004/7/2-3), “Œ‹ž. “ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ïŽGŽ, 24 (1): 80, 2004.

723548. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ŠÖ߉t«ó‚Ì“€Œ‹•Û‘¶‘OŒã‚Å‚Ì”äŠr. ¬—Ñ–¾³1, ‘ü–ì@Œ÷1, “ñŒ©r˜Y1, ‘O“c˜aÍ2, ŽODÆŽO2 i1®ŠO. 2“d‹C‰»ŠwH‹Æj: ‘æ48‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2004/4/15-17), ‰ªŽR. ´˜^W, p.228, 2004.

723549. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ‘åŠw•a‰@‚É‚¨‚¯‚éŽè‚ÌŠO‰È‚̃ŠƒXƒNƒ}ƒl[ƒWƒƒ“ƒg. ¬—Ñ–¾³, “ñŒ©r˜Y, ‘ü–ì@Œ÷, ˆä‘º‹M”V, “¡“c@Œì (®ŠO): ‘æ47‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ïŠwpW‰ï (2004/4/22-23), ‘åã. “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ´˜^W, 21 (1): 114, 2004.

723550. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —Lç꜊œÜ‚ɑ΂·‚éçê“Eop‚Ì—L—p«‚ÌŒŸ“¢. ‘ü–ì@Œ÷, ¬—Ñ–¾³, ˆä‘º‹M”V, “¡“c@Œì, “ñŒ©r˜Y (®ŠO): ‘æ47‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ïŠwpW‰ï (2004/4/22-23), ‘åã. “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ´˜^W, 21 (1): 196, 2004.

723551. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘å‘Úœ‘¤lHŒÒŠÖßÄ’uŠ·p‚̬Ñ. ‚•½®L, “àŽRŸ•¶, ¬‹{Gˆê˜Y, ‚èƒF, –p@W³, V“c_Žj, Ž…–ž·Œ› (®ŠO): ‘æ77‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2004/5/20-23), _ŒË. “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ´˜^†, 78 (3S.): 169, 2004.

723552. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘nŠOŒÅ’èŒã“ñŠú“I‘“à“B‰¡Ž~‚ß–@‚É‚ÄŽ¡—³‚ꂽãøœŠJ•úœÜ‚É‚¨‚¯‚é[•”Š´õ‚ɉe‹¿‚·‚锈öŽq‚ÌŒŸ“¢. ‰¡ŽRˆê•F1, ’†‘ºŒõL1, “à–ì³—²1, ‘å’Ë@G1, —é–Ø@‘ì2, Ž…–ž·Œ›1 (1®ŠO. 2‹~–½j: ‘æ77‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2004/5/20-23), _ŒË. “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ´˜^†, 78 (3S.): 215, 2004.

723553. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Fraser‡UŒ^floating KneeœÜ‚ÌŽ¡—ÃŒoŒ±. –ØMˆê, ‰¡ŽRˆê•F, ’Ë–{’B˜Y, Ž…–ž·Œ› (®ŠO): ‘æ77‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2004/5/20-23), _ŒË. “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ´˜^†, 78 (4S.): 431, 2004.

723554. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘¦Žž‘“à“B‰¡Ž~‚ß–@‚É‚ÄŽ¡—³‚ꂽ‘å‘ÚœŠJ•úœÜ‚É‚¨‚¯‚é[•”Š´õ‚ɉe‹¿‚·‚锈öŽq‚ÌŒŸ“¢: ‘½•Ï—ʉðÍ‚ð—p‚¢‚Ä. ‘å’Ë@G1, ‰¡ŽRˆê•F1, ’†‘ºŒõL1, “à–ì³—²1, —é–Ø@‘ì2, Ž…–ž·Œ›1 (1®ŠO. 2‹~–½j: ‘æ77‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2004/5/20-23), _ŒË. “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ´˜^†, 78 (4S.) : 480, 2004.

723555. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Gustilo ‡VBŒ^‰º‘ÚœŠJ•úœÜ‚ÌŽ¡—Ã|‘Šú“î•”‘gDC•œ‚Ìd—v«‚ɂ‚¢‚Ä. “à–ì³—²1, ‰¡ŽRˆê•F1, ’†‘ºŒõL1, —é–Ø@‘ì2, V“¡³‹P3, Ž…–ž·Œ›1 (1®ŠO. 2‹~–½. 3º˜a‘åE‹~‹}j: ‘æ77‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2004/5/20-23), _ŒË. “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ´˜^†, 78 (4S.): 481, 2004.

723556. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —V—£•¡‡‘gDˆÚA‚ð—v‚µ‚½Gustilo ‡VBŒ^ãøœŠJ•úœÜ‚ÌQOL‚ɂ‚¢‚Ä: Short-Form 36‚ð—p‚¢‚Ä. –p@W³1, ‰¡ŽRˆê•F1, ’†‘ºŒõL1, “à–ì³—²1, ‘å’Ë@G1, —é–Ø@‘ì2, ‚èƒF1, Ž…–ž·Œ›1 (1®ŠO. 2‹~–½j: ‘æ77‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2004/5/20-23), _ŒË. “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ´˜^†, 78 (4S.): 481, 2004.

723557. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚¯‚鬎™ Gustilo IIIŒ^ãøœŠJ•úœÜ‚ÌŽ¡—ìÑ. “¡“c@Œì, ‰¡ŽRˆê•F, “à–ì³—², ’Ë–{’B˜Y, Ž…–ž·Œ› (®ŠO): ‘æ77‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2004/5/20-23), _ŒË. “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ´˜^†, 78 (4S.): 482, 2004.

723558. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ‘å‘ÚœŒz•”œÜf—ÃKƒCƒhƒ‰ƒCƒ“. ”‹–ì@_1, “n•”‹Ó”E2, ’†–ì“N•v3, Ž…–ž·Œ›4, ¼‰º@—²5 (1’¹Žæ‘å. 2¼‰º‹L”O•a‰@. 3‹Ê–¼’†‰›•a‰@. 4®ŠO. 5’é‹ž‘åj: ‘æ77‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2004/5/20-23), _ŒË. “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ´˜^†, 78 (4S.): 292, 2004.

723559. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒeƒjƒX‚ÆŽ‹Šo. ‘º¼GŽ÷1, •Ê•{”ŒZ1, •ì‘ìs1, ‹y”\–Γ¹1, ‚•½®L2, ’Ë–{’B˜Y2 (1“ú–{ƒeƒjƒX‹¦‰ïˆãŽ–ˆÏˆõ‰ï. 2®ŠO): ‘æ30‰ñ“ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ïŠwpW‰ï (2004/7/2-3), “Œ‹ž. “ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ïŽGŽ, 24 (1): 40, 2004.

723560. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) •às‚̧ŒÀ‚̓GƒXƒgƒƒQƒ“Œ‡–Rƒ‰ƒbƒg‚ɑ΂·‚霑ãŽÓEŒ`‘Ԃɉe‹¿‚ð‹y‚Ú‚·. ‹{ì˜aW1, ˆÉ“¡—R”ü1, ŠÖ’JGŽ÷1, ¬£NŽ¡2, ‚Š_—TŽq1 (1_“Þ쎕‘å. 2®ŠO): ‘æ22‰ñ“ú–{œ‘ãŽÓŠw‰ï (2004/7/6), ‘åã.

723561. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒAƒ“ƒMƒIƒeƒ“ƒVƒ“II AT1aŽó—e‘ÌŽÕ’f‚É‚æ‚éŽîᇌŒŠÇV¶‚¨‚æ‚ÑŽîᇑB‚Ì—}§. “¡“c@Œì1, —Ñ@ò2, […º‹g3, Ž…–ž·Œ›1, ”n“ˆ³—²2 (1®ŠO. 2–ò—. 3’}”g‘åj: ‘æ25‰ñ“ú–{‰ŠÇEĶˆãŠw‰ï (2004/7/13), “Œ‹ž. ‰ŠÇEĶ, 24: 435, 2004.

723562. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “¯Žíœbanking‚Ì–â‘è“_ iœƒoƒ“ƒN‰^‰c”ï—p‚¨‚æ‚Ñ׋Û, ƒEƒBƒ‹ƒXŒŸ¸‚ÌŒ‹‰Ê‚ɂ‚¢‚Äj. “àŽRŸ•¶, ¬‹{Gˆê˜Y, ˆø“crˆê, ¬£NŽ¡, ‚•½®L, Ž…–ž·Œ› (®ŠO): ‘æ3‰ñ“ú–{‘gDˆÚAŠw‰ï (2004/8/28), ‰¡•l. ´˜^W, p.36, 2004.

723563. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘ÙŽ™ŒŒˆÚA‚É‚æ‚霑Ä\’z‚ÌŒŸ“¢. ¬£NŽ¡1, è•”@Œ›1, Œüˆä“c’q”V1, Ž…–ž·Œ›1, ‰E“‡•xŽm’j2 (1®ŠO. 2ŽY•wj: ‘æ3‰ñ“ú–{‘gDˆÚAŠw‰ï (2004/8/28), ‰¡•l. ´˜^W, p.47, 2004.

723564. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) lH•GŠÖß‘å‘ÚœƒRƒ“ƒ|[ƒlƒ“ƒg‚̃Xƒeƒ€ˆÊ’u‚Æ‘å‘ÚœŽ²‚Æ‚Ì”äŠr|ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‚É‚¨‚¯‚錟“¢|. ã–쳊ì, è•”@Œ›, •ôŒ´G¹, “¡“c@Œì, ‘Šì@~, Ž…–ž·Œ› (®ŠO): ‘æ32‰ñ“ú–{ƒŠƒEƒ}ƒ`EŠÖߊO‰ÈŠw‰ï (2004/10/1-2), “Þ—Ç. “ú–{ƒŠƒEƒ}ƒ`EŠÖߊO‰ÈŠw‰ïŽGŽ, 23 i´˜^†j: 106, 2004.

723565. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ®Œ`ŠO‰ÈpŒã–D‡‘n‚ɑ΂·‚é”–Œ^ƒnƒCƒhƒƒRƒƒCƒhƒhƒŒƒbƒVƒ“ƒOÞ‚ÌŽg—pŒø‰Ê. ŒE“cLŒb1, ‹à“cKi1, ‘å’Ë‹žŽq1, ‹g“c‹±Žq1, ‚•½®L2, “àŽRŸ•¶2, ‚èƒF2, –p@W³2, Ž…–ž·Œ›2 (1ŠÅŒì•”. 2®ŠO): ‘æ31‰ñ“ú–{ŒÒŠÖߊw‰ï (2004/10/15-16), ’·è. ´˜^W, p.287, 2004.

723566. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒAƒ“ƒWƒIƒeƒ“ƒVƒ“‡UAT1aŽó—e‘Ì—}§‚É‚æ‚éŽîᇑB‚¨‚æ‚ÑŽîᇌŒŠÇV¶‚Ì—}§. “¡“c@Œì1, ”n“ˆ³—²2, Ž…–ž·Œ›1 (1®ŠO. 2–ò—j: ‘æ19‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2004/10/21-22), •iì. “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ´˜^†, 78 (8): 805, 2004.

723567. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) •úŽËü–Å‹ÛŽžŒÀ•ª‰ð‚Ì‹zŽû«ƒ|ƒŠ-“ûŽ_-ƒnƒCƒhƒƒLƒVƒAƒpƒ^ƒCƒg‚Ìin vivo‚Ì•]‰¿. ‘åì@F1, ’†‘ºŒõL1, Ž…–ž·Œ›1, ‹à@•ò“N2, Œº@åà}2, ’ç@’è”ü2 i1®ŠO. 2‹ž“s‘åĶˆã‰ÈŠwŒ¤‹†Šj: ‘æ19‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2004/10/21-22), •iì. “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ´˜^†, 78 (8): 1032, 2004.

723568. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) lHŒÒŠÖߊeŽíƒXƒeƒ€‚É‚¨‚¯‚鈳—Í•ª•z‘ª’è‚Æ—˜_‰ðÍ. Žðˆä—˜“Þ1, ‹àˆäLŽ}1, ”nŸº´Ž‘1, Ž…–ž·Œ›2 (1ˆã‰q. 2®ŠO): ‘æ31‰ñ“ú–{—Õ°ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ï (2004/11/12-13), •Ÿ‰ª. ´˜^W, p.88, 2004.

723569. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’áo—Í’´‰¹”gƒpƒ‹ƒX‚É‚æ‚霌`¬ì—pƒƒJƒjƒYƒ€‚̉ð–¾. ¬£NŽ¡1, è•”@Œ›1, ‘Šì@~1, Ž…–ž·Œ›1, ‚Š_—TŽq2 (1®ŠO. 2_“Þ쎕‘åj: ‘æ31‰ñ“ú–{—Õ°ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ï (2004/11/12-13), •Ÿ‰ª. ´˜^W, p.112, 2004.

723570. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) lHŒÒŠÖߊeŽíƒXƒeƒ€‚É‚¨‚¯‚駓®”\‚Ì”äŠr. ‹àˆäLŽ}1, Ž…–ž·Œ›2, Žðˆä—˜“Þ1, ”nŸº´Ž‘1 i1ˆã‰q. 2®ŠOj: ‘æ31‰ñ“ú–{—Õ°ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ï (2004/11/12-13), •Ÿ‰ª. ´˜^W, p.87, 2004.

723571. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒŒ‰t“§ÍŠ³ŽÒ‚ɑ΂·‚élHœ“ª’uŠ·p‚¨‚æ‚Ñ‘SlHŒÒŠÖß’uŠ·p‚ÌŽ¡—ìÑ. –p@W³, ‚•½®L, “àŽRŸ•¶, ‘P•½“N•v, Ž…–ž·Œ› (®ŠO): ‘æ35‰ñ“ú–{lHŠÖߊw‰ï (2005/2/3-4), ‰«“ê. ´˜^W, p.208, 2005.

723572. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) lH•GŠÖß‘S’uŠ·pŒã‚Ì—Šw—Ö@|Œ©‚©‚¯ã‚Ì‹r’··‚𶂶‚½Ç—á‚ɑ΂·‚é“–‰@‚ÌŽæ‚è‘g‚Ý|. Œ©ˆä“c˜a³1, ‰““¡^ˆê1, ¬’r•üF1, •Ó“y–¼@—²1, “n•Ó—T”V2, ‰¡ŽRˆê•F3, ‘Šì@~3, “¡“c@Œì3, è•”@Œ›3, Ž…–ž·Œ›3 (1ƒŠƒnƒrƒŠ•”. 2ˆã‰q. 3®ŠO): ‘æ35‰ñ“ú–{lHŠÖߊw‰ï (2005/2/3-4), ‰«“ê. ´˜^W, p.260, 2005.

723573. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰È‚É‚¨‚¯‚éDuetto SI stem‚ð—p‚¢‚½ƒZƒƒ“ƒgƒŒƒX‘SlHŒÒŠÖß’uŠ·p‚Ì’ZŠú¬Ñ|75ΈÈã‚Æ60Έȉº‚Ì”äŠr|. •Ÿ“‡Œ’‰î, ‚•½®L, “àŽRŸ•¶, –p@W³, ‰Í‘º@’¼, Ž…–ž·Œ› (®ŠO): ‘æ35‰ñ“ú–{lHŠÖߊw‰ï (2005/2/3-4), ‰«“ê. ´˜^W, p.282, 2005.

723574. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) lHœ“ª’uŠ·p‚¨‚æ‚Ñ‘SlHŒÒŠÖß’uŠ·pŒã‚ɶ‚¶‚½ƒXƒeƒ€ŽüˆÍ‚Ì‘å‘ÚœœÜ‚ÌŽ¡—Ã. V“c_Žj, ‚•½®L, “àŽRŸ•¶, ‚èƒF, •Ÿ“‡Œ’‰î, Ž…–ž·Œ›, “ñŒ©r˜Y (®ŠO): ‘æ35‰ñ“ú–{lHŠÖߊw‰ï (2005/2/3-4), ‰«“ê. ´˜^W, p.305, 2005.

723575. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘SlHŒÒŠÖß’uŠ·pŒã‚̉ºŽˆ‹Ø—Í‚Æ‹r’··‚ª•àsŽž‘ÌŠ²“®—h‚É—^‚¦‚é‰e‹¿. “n•Ó—T”V1, Œ©ˆä“c˜a³2, •Ó“y–¼@—²2, ‰¡ŽRˆê•F3, ‚•½®L3, “àŽRŸ•¶3, è•”@Œ›3, Ž…–ž·Œ›3 (1ˆã‰q. 2ƒŠƒnƒrƒŠ•”. 3®ŠO): ‘æ35‰ñ“ú–{lHŠÖߊw‰ï (2005/2/3-4), ‰«“ê. ´˜^W, p.331, 2005.

723576. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “Á’¥“I‚ÈŠOŒ`‚ðŽ‚ŠeŽíƒXƒeƒ€‚̌Œ…—Í‚Ì”äŠr. Žðˆä—˜“Þ1, Ž…–ž·Œ›2, ‹àˆäLŽ}1, ”nŸº´Ž‘1 i1ˆã‰q. 2®ŠOj: ‘æ35‰ñ“ú–{lHŠÖߊw‰ï (2005/2/3-4), ‰«“ê. ´˜^W, p.380, 2005.

723577. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) V‚µ‚¢R‹ÛƒLƒƒƒŠƒA‚Æ‚µ‚ẴqƒAƒ‹ƒƒ“Ž_»Ü‚Ì—L—p«. ¼–씎–¾1, ‘å¼@‘¾1, —V“¹˜a—Y2, Œã“¡@áÁ1, ‰Í茫ŽO1, –kŒ©Œ\Ži3, ‹{•”@Šî3, —é–Ø@r3, ‘åì@F3, Žë–쯌á1 i1‰¡•l‘‡•a‰@. 2¹ƒ}ƒŠƒAƒ“ƒi•a‰@. 3®ŠOj: ‘æ35‰ñ“ú–{lHŠÖߊw‰ï (2005/2/3-4), ‰«“ê. ´˜^W, p.246, 2005.

723578. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) lH•GŠÖß‘S’uŠ·pŒã‚Ì”xÇðf’f‚É‚¨‚¯‚é“®–¬ŒŒƒKƒX•ªÍ‚Ì—L—p«. “n•Ó“NÆ, âZ@‰ë—_, ¬—Ñ–¾³, “ñŒ©r˜Y (®ŠO): ‘æ35‰ñ“ú–{lHŠÖߊw‰ï (2005/2/3-4), ‰«“ê. ´˜^W, p.259, 2005.

723579. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) PDGF-bb, BMP-2, FGF-2‚Ìcommitted, uncommitted mesenchymal stem cell‚ɑ΂·‚é×–E—V‘–ì—p. “à“cŒ’‘¾˜Y1, è•”@Œ›2, ¬£NŽ¡2, ’¹‰z—TŽq1, Ž•½­L1, ”nŸº´Ž‘1, Ž…–ž·Œ›2 (1ˆã‰q. 2®ŠO): ‘æ4‰ñ“ú–{Ķˆã—Êw‰ï (2005/3/1), ‘åã.

723580. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’áo—Í’´‰¹”gƒpƒ‹ƒX‚ª“à“œ‰»‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ¬£NŽ¡1, è•”@Œ›1, ‚Š_—TŽq2, ‘Šì@~1, ‹{•”@Šî1, Ž…–ž·Œ›1 (1®ŠO. 2_“Þ쎕‘åj: ‘æ18‰ñ“ú–{“ãŽÓŠw‰ï (2005/3/18), ‘åã.

731084. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‘“à“BœÚ‡p‚ÆPitfall. Ž…–ž·Œ› (®ŠO): ‘æ73‰ñ“Œ‹žˆã‰ÈŽ•‰È‘åŠw®Œ`ŠO‰ÈW’k‰ï (2004/6/27), “Œ‹ž.

731085. [Œ¤C‰ï] (“Á•Êu‰‰) lHŒÒŠÖßÄ’uŠ·p‚É‚¨‚¯‚铯Žíœ‚Ì—˜—p. Ž…–ž·Œ› (®ŠO): ‘æ19‰ñ’†‘EŽl‘’n‹æ®Œ`ŠO‰È‹³ˆçŒ¤C‰ï (2004/7/25), ‰ªŽR.

731086. [Œ¤‹†‰ï] (“Á•Êu‰‰) “ú–{l‚ÌœŒ`‘Ô‚ðl—¶‚µ‚½lH•GŠÖß’uŠ·p. è•”@Œ› (®ŠO): ‘æ26‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWŒ¤‹†‰ï(2004/8/7), ɪ.

731087. [Œ¤C‰ï] (“Á•Êu‰‰) ‘“à“BœÚ‡p|ŋ߂̘b‘è‚Æ–â‘è“_|. Ž…–ž·Œ› (®ŠO): ŒF–{Œ§—Õ°®Œ`ŠO‰Èˆã‰ï‹³ˆçŒ¤Cu‰‰‰ï (2004/9/25), ŒF–{.

731088. [Œ¤‹†‰ï] (“Á•Êu‰‰) •IŠOŽ¡—ÂÌÅ‹ß‚Ì’mŒ©. “ñŒ©r˜Y (®ŠO): ‘æ4‰ñˆï錧œŠÖ߃tƒH[ƒ‰ƒ€ (2004/10/29), ‚‚­‚ÎŽs.

732037. [Œ¤‹†‰ï] (ƒfƒBƒx[ƒgŒ`Ž®‚Ì“¢˜_) lHŠÖß’uŠ·p‚É”º‚¤œŒ‡‘¹‚ÌŽ¡—Ã. ‚•½®L (®ŠO): ‘æ2‰ñ_“ÞìœÄŒšEĶƒtƒH[ƒ‰ƒ€ (2004/9/3), ‰¡•l.

732038. [Šw‰ï (’n•û)] (ƒVƒ“ƒ|ƒWƒEƒ€) “–‰@‚É‚¨‚¯‚鉺ŽˆŽèp‚ÌŽüpŠú‚̃ŠƒXƒNƒ}ƒl[ƒWƒƒ“ƒg. âZ@‰ë—_, “ñŒ©r˜Y, ¬—Ñ–¾³, “n•Ó“NÆ, ‘ü–ì@Œ÷, XŒû®¶ (®ŠO): ‘æ53‰ñ“Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ï(2004/9/24-25), ŽRŒ`. “Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ïŽGŽƒvƒƒOƒ‰ƒ€†, 16 (3): 440, 2004.

732039. [Šw‰ï (’n•û)] (ƒVƒ“ƒ|ƒWƒEƒ€) ®Œ`ŠO‰È•a“‚É‚¨‚¯‚é–òÜŠÇ—Žw“±‹Æ–±‚ÌŒ»ó|“ü‰@ŽžŠ³ŽÒŽŽQ–ò‚ÉŠÖ‚·‚郊ƒXƒNƒ}ƒlƒWƒƒ“ƒg|. Ä“¡—R”üŽq1, ‰¡ˆäMŽq1, •½ŽR•Ži1, •ŽR­ˆê1, ¬—Ñ–¾³2, “ñŒ©r˜Y2 (1–òÜ•”. 2®ŠO): ‘æ53‰ñ“Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ï (2004/9/24-25), ŽRŒ`. “Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ïŽGŽƒvƒƒOƒ‰ƒ€†, 16 (3): 488, 2004.

732040. [Œ¤‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€) ã˜rœŠOãè÷‰Š‚Ì—\Œã. “ñŒ©r˜Y (®ŠO): ‘æ17‰ñ“ú–{•IŠÖߊO‰ÈŒ¤‹†‰ï (2005/2/12), “Œ‹ž. “ú–{•IŠÖߌ¤‹†‰ïŽGŽ (ŠwpW‰ï†), 12 (1): S31, 2005.

732041. [Œ¤‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€) •I“à‘¤‘¤•›x‘Ñ‚Ì‹@”\‰ð–U. ¬—Ñ–¾³1, “ñŒ©r˜Y1, –ذ•F2, ‘ü–ì@Œ÷1 (1®ŠO. 2–خŒ`ŠO‰Èj: ‘æ17‰ñ“ú–{•IŠÖߊO‰ÈŒ¤‹†‰ï (2005/2/12), “Œ‹ž. “ú–{•IŠÖߌ¤‹†‰ïŽGŽ (ŠwpW‰ï†), 12 (1): S2, 2005.

732042. [Œ¤‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€) Œ’í•I‚¨‚æ‚Ñ•I•”ŠÇÇŒóŒQ‚É‚¨‚¯‚éElbow flexion test. ‘ü–ì@Œ÷1, ¬—Ñ–¾³1, “ñŒ©r˜Y1, ‹î“c•üG2 (1®ŠO. 2¬—Ñ•a‰@j: ‘æ17‰ñ“ú–{•IŠÖߊO‰ÈŒ¤‹†‰ï (2005/2/12), “Œ‹ž. “ú–{•IŠÖߌ¤‹†‰ïŽGŽ (ŠwpW‰ï†), 12 (1): S19, 2005.

733214. [Œ¤‹†‰ï] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚éŽüpŠú‚̃ŠƒXƒNƒ}ƒlƒWƒƒ“ƒg. XŒû®¶, ¬—Ñ–¾³, “n•Ó“NÆ, ’†àVr”V, ‘ü–ì@Œ÷, âZ@‰ë—_, ˆä‘º‹M”V, “ñŒ©r˜Y (®ŠO): ‘æ121‰ñ_“Þ쮌`ЊQŠO‰ÈŒ¤‹†‰ï (2004/6/5), ‰¡•l. _“Þ쮌`ЊQŠO‰ÈŒ¤‹†‰ïŽGŽ´˜^W, 17 (1): 7, 2004.

733215. [Œ¤‹†‰ï] (ˆê”ʉ‰u) BipolarŒ^lHœ“ª’uŠ·pŒã‚É’E“]‚ð‚«‚½‚µ‚½2—á. ŽR–{‹–¾, “àŽRŸ•¶, –p@W³, Ž…–ž·Œ› (®ŠO): ‘æ121‰ñ_“Þ쮌`ЊQŠO‰ÈŒ¤‹†‰ï (2004/6/5), ‰¡•l. _“Þ쮌`ЊQŠO‰ÈŒ¤‹†‰ïŽGŽ´˜^W, 17 (1): 12, 2004.

733216. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŠŠ–Œ«œ“îÇ. Ä“¡Ÿ‹`, “àŽRŸ•¶, ‚•½®L, Ž…–ž·Œ› (®ŠO): ‘æ23‰ñ–kE‘Š®Œ`ŠO‰Èˆã‰ïǗጟ“¢‰ï (2004/6/10), ‘Š–ÍŒ´.

733217. [Œ¤‹†‰ï] (ˆê”Êu‰‰) œ‘ãŽÓƒ}[ƒJ[‚É‚æ‚霑eé ÇŽ¡—Â̕]‰¿. “n•Ó“NÆ, ¬—Ñ–¾³, âZ@‰ë—_, ã–쳊ì, “ñŒ©r˜Y (®ŠO): ‘æ1‰ñSAGAMI OSTEOPOROSIS Œ¤‹†‰ï (2004/6/24), ’¬“cŽs.

733218. [Œ¤‹†‰ï] (ˆê”Êu‰‰) —V—£”ç•Ù‚ð—v‚µ‚½d“x‘«•”ŠO‚Ì1—á. ‰Í‘º ’¼1, ‰¡ŽRˆê•F1, ’†‘ºŒõL1, “à–ì³—²1, –p W³1, Ž…–ž·Œ›1, “‡‘qNl2 (1®ŠO. 2Œ`¬j: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï@‘æ624‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï (2004/6/26), “Œ‹ž.

733219. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ]—ˆØŠJTHA‚Ƭ؊JTHA‚É‚¨‚¯‚é—Õ°¬Ñ‚Ì”äŠr. ‚•½®L, “àŽRŸ•¶, ‚èƒF, ˆø“crˆê, Ž…–ž·Œ› (®ŠO): ‘æ12‰ñHip Forum 2004 (2004/7/31), ”ŸŠÙ. ´˜^W, p.5, 2004.

733220. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‘å‘ÚœŠO”½œØ‚èpŒã‚ÌlHŒÒŠÖß‘S’uŠ·p‚ÌH•v. “àŽRŸ•¶, ‚•½®L, ‚èƒF, –p@W³, ŽR–{‹–¾, ˆø“crˆê, Ž…–ž·Œ› (®ŠO): ‘æ12‰ñHip Forum 2004 (2004/7/31), ”ŸŠÙ. ´˜^W, p.16, 2004.

733221. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Ž¡—Âɓïa‚µ‚Ä‚¢‚銰œ‰PœÜŒã‚ÌMRSAŠ´õ«‹UŠÖß. Ž…–ž·Œ›, “àŽRŸ•¶, ‚•½®L, ‚èƒF, –p@W³, ŽR–{‹–¾, Ž…–žD (®ŠO): ‘æ12‰ñHip Forum 2004 (2004/7/31), ”ŸŠÙ. ´˜^W, p.20, 2004.

733222. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ABSƒ‰ƒCƒi[‚Ì’E“]‚𗈂½‚µ‚½THA‚Ì1—á. ˆø“crˆê, ‚•½®L, “àŽRŸ•¶, –p@W³, ‘P•½“N•v, •Ÿ“‡Œ’‰î, Ž…–ž·Œ› (®ŠO): ‘æ12‰ñHip Forum 2004 (2004/7/31), ”ŸŠÙ. ´˜^W, p.24, 2004.

733223. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‘½”‰ñ‚ÌŽèp‚ª•K—v‚Å‚ ‚Á‚½‚ˆÊˆŸ’E‰P«ŒÒŠÖßÇ‚Ì1—á. ŽR–{‹–¾, –p@W³, “àŽRŸ•¶, ‚•½®L, Ž…–ž·Œ› (®ŠO): ‘æ12‰ñHip Forum 2004 (2004/7/31), ”ŸŠÙ. ´˜^W, p.23, 2004.

733224. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Engelmann•a‚Ì1—á. “¡“c@Œì, è•”@Œ›, Ž…–ž·Œ› (®ŠO): ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï@‘æ625‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï (2004/9/11), “Œ‹ž.

733225. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‘ÙŽ™ŒŒˆÚA‚É‚æ‚霑Ä\’z‚ÌŒŸ“¢. ¬£NŽ¡1, è•”@Œ›1, Œüˆä“c’q”V1, ‰E“‡•yŽm’j2, Ž…–ž·Œ›1 (1®ŠO. 2ŽY•wj: ‘æ23‰ñ“ú–{‰^“®ŠíˆÚAEĶˆãŠwŒ¤‹†‰ï (2004/9/18), ‰ªŽR. ´˜^W, p.19, 2004.

733226. [Œ¤‹†‰ï] (ˆê”Êu‰‰) “¯Žíœbanking‚Ì–â‘è“_|œƒoƒ“ƒN‰^‰c”ï—p‚¨‚æ‚Ñ׋Û, ƒEƒBƒ‹ƒXŒŸ¸‚ÌŒ‹‰Ê‚ɂ‚¢‚Ä|. “àŽRŸ•¶1, ¬‹{Gˆê˜Y1, ¬£NŽ¡1, è•”@Œ›1, ‚•½®L1, ˆø“crˆê1, Ž…–ž·Œ›1, ¬—Ñ؉›2 (1®ŠO. 2œƒoƒ“ƒNj: ‘æ23‰ñ“ú–{‰^“®ŠíˆÚAEĶˆãŠwŒ¤‹†‰ï(2004/9/18), ‰ªŽR. ´˜^W, p.24, 2004.

733227. [Šw‰ï (’n•û)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) Gustilo ‡VŒ^‰º‘ÚœŠÖß•”ŠJ•úœÜ‚ÌŽ¡—Õûj. “à–ì³—²1, ¬‹{Gˆê˜Y1, ‰¡ŽRˆê•F1, ’†‘ºŒõL1, V“¡³‹P2, Ž…–ž·Œ›1 (1®ŠO. 2º˜a‘åj: ‘æ53‰ñ“Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ï (2004/9/24-25), ŽRŒ`. “Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ïŽGŽƒvƒƒOƒ‰ƒ€†, 16 (3): 358, 2004.

733228. [Šw‰ï (’n•û)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“j ‰º‘ÚŠJ•úœÜ‚ÌŽ¡—ÕϑJ‚ÆÅV‚ÌŽ¡—Ã. V“¡³‹P1, “c’†Œ[Ži1, ‰Œ©r–¾1, •Ûâ‘Pº1, Ž…–ž·Œ›2 (1º˜a‘å. 2®ŠO): ‘æ53‰ñ“Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ï (2004/9/24-25), ŽRŒ`. “Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ïŽGŽƒvƒƒOƒ‰ƒ€†, 16 (3): 361, 2004.

733229. [Šw‰ï (’n•û)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“j 50Έȉº‚ÌisŠú‚©‚ç––Šú•ÏŒ`«ŒÒŠÖßǂɑ΂·‚é‘å‘ÚœŠO”½œØ‚èp‚ƃLƒAƒŠ[œ”՜؂èp•¹—pŽèp‚Ì’·Šú¬Ñ. ‚•½®L, “àŽRŸ•¶, ‚èƒF, –p@W³, ‘P•½“N•v, Ž…–ž·Œ› (®ŠO): ‘æ53‰ñ“Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ï (2004/9/24-25), ŽRŒ`. “Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ïŽGŽƒvƒƒOƒ‰ƒ€†, 16 (3): 465, 2004.

733230. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ”ç•ÙÄŒš‚ð—v‚µ‚½d“x‘«•”ŠO‚ÌŒŸ“¢; Ø’f“K‰ž‚ÆQOL‚Ì•]‰¿‚ɂ‚¢‚Ä. ‰Í‘º@’¼1, ‰¡ŽRˆê•F1, –ØMˆê1, –p@W³1, “‡‘qNl2, Ž…–ž·Œ›1 (1®ŠO. 2Œ`¬j: ‘æ53‰ñ“Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ï (2004/9/24-25), ŽRŒ`. “Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ïŽGŽƒvƒƒOƒ‰ƒ€†, 16 (3): 371, 2004.

733231. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Œ¨ÎŠD’¾’…«äF‰Š‚ɑ΂·‚éƒVƒƒ`ƒWƒ““à•žŽ¡—Â̗L—p«. XŒû®¶, ¬—Ñ–¾³, ‘ü–ì@Œ÷, ¬ÀŒ«Ž¡, ŽR–{‹–¾, “ñŒ©r˜Y (®ŠO): ‘æ53‰ñ“Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ï (2004/9/24-25), ŽRŒ`. “Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ïŽGŽƒvƒƒOƒ‰ƒ€†, 16 (3): 377, 2004.

733232. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘SlH•GŠÖß’uŠ·ppŒã‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚ªpŒã‚̉ŠÇ‚¨‚æ‚Ñ‹@”\‚É—^‚¦‚é‰e‹¿‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‘P•½“N•v, è•”@Œ›, ‘Šì@~, “¡“c@Œì, –p@W³, Ž…–ž·Œ› (®ŠO): ‘æ53‰ñ“Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ï (2004/9/24-25), ŽRŒ`. “Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ïŽGŽƒvƒƒOƒ‰ƒ€†, 16 (3): 393, 2004.

733233. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Žè‚Ì‚ˆ³’“ü‘¹‚Ì3—á. ‹e’r‹±‘¾, ‘ü–ì@Œ÷, ¬—Ñ–¾³, âZ@‰ë—_, ˆä‘º‹M”V, “ñŒ©r˜Y (®ŠO): ‘æ53‰ñ“Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ï (2004/9/24-25), ŽRŒ`. “Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ïŽGŽƒvƒƒOƒ‰ƒ€†, 16 (3): 398, 2004.

733234. [Œ¤‹†‰ï] (ˆê”Êu‰‰) •I•”ŠÇÇŒóŒQpŒã‚ÉCRPS—lÇ󂪌°’˜‰»‚µ‚½1—á. “ñŒ©r˜Y (®ŠO): ‘æ2‰ñ_Œoˆö«áu’ÉŒ¤‹†‰ï (2004/9/24), é‹Ê.

733235. [Œ¤‹†‰ï] (ˆê”Êu‰‰) “Á”­«‘å‘Úœ“ª‰óŽ€Ç‚É“]ŽqŠÔ‰ñ“]œØ‚èp‚ðŽ{s‚µ‚½1—á. ‚•½®L, “àŽRŸ•¶, ‘P•½“N•v, ŽR–{‹–¾, Ž…–ž·Œ› (®ŠO): ‘æ2‰ñŒÒOsteotomy‚ðŒê‚é‰ï (2004/10/16), ’·è.

733236. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ˜ržôŠÖß“à‚Ö‚Ì—Öóx‘Ñ‚Ì•”•ªŠ×“ü‚É‚æ‚èƒeƒjƒX•IÇó‚ð’悵‚½1—á. Šâ£@‘å, ¬—Ñ–¾³, ‘ü–ì@Œ÷, XŒû®¶, ‹e’r‹±‘¾, “ñŒ©r˜Y (®ŠO): ‘æ10‰ñ_“ÞìŽèE•I‚ÌŠO‰ÈŒ¤‹†‰ï (2004/10/23), ‰¡•l.

733237. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒŠƒ“Ž_ƒJƒ‹ƒVƒEƒ€œƒy[ƒXƒg‚ð[“U‚µ‚½lHŠÖß’uŠ·p‚̃Zƒƒ“ƒgƒŒƒX‚̬Ñ. ’†‘ºŒõL, “àŽRŸ•¶, ’Ë–{’B˜Y, ‚•½®L, ŠÖŒû¹˜a, Ž…–ž·Œ› (®ŠO): ‘æ5‰ñƒoƒCƒIƒAƒNƒeƒBƒuƒy[ƒXƒgŒ¤‹†‰ï (2004/10/30), ‘åã.

733238. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ½œ‰“ˆÊ’[Øœp‚ðŽ{s‚µ‚½, —¼‘¤—L’É«•ÏŒ`«Œ¨½ŠÖßÇ‚Ì1—á. ¬ÀŒ«Ž¡, ¬—Ñ–¾³, ‘ü–ì@Œ÷, ’†àVr”V, ˆä‘º‹M”V, “ñŒ©r˜Y (®ŠO): ‘æ122‰ñ_“Þ쮌`ЊQŠO‰ÈŒ¤‹†‰ï (2004/11/6), ‰¡•l. ´˜^W, p.30, 2004.

733239. [Œ¤‹†‰ï] (ˆê”Êu‰‰) •ÏŒ`«•GŠÖßǂɑ΂·‚élHŠÖß’uŠ·p‘Šú‚ÌSF-36‚É‚æ‚éQOL•]‰¿. ‘Šì@~, è•”@Œ›, “¡“c@Œì, ‹{•”@Šî, Ž…–ž·Œ› (®ŠO): ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï@‘æ626‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï (2004/11/27), “Œ‹ž.

733240. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŋߌoŒ±‚µ‚½•Gœ“îÇ2—á‚ÌŽ¡—ÃŒoŒ±. âZ@‰ë—_, “n•Ó“NÆ, ¬ÀŒ«Ž¡, XŒû®¶, ¬—Ñ–¾³, “ñŒ©r˜Y (®ŠO): ‘æ31‰ñŠÖ“Œ•G‚ðŒê‚é‰ï (2004/11/27), “Œ‹ž.

733241. [Œ¤‹†‰ï] (ˆê”Êu‰‰) LCP (Locking compression plate) ‚É‚æ‚齜œÜ‚ÌŽ¡—ÃŒoŒ±. Ž…–žD, ’†‘ºŒõL, ‰¡ŽRˆê•F, “à–ì³—², –p@W³, Ž…–ž·Œ› (®ŠO): ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï@‘æ627‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï (2004/12/18), “Œ‹ž.

733242. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ’áo—Í’´‰¹”gƒpƒ‹ƒX‚ª“à“œ‰»‚É‹y‚Ú‚·‰e‹¿‚ÌŒŸ“¢. ¬£NŽ¡1, è•”@Œ›1, ‘Šì@~1, ‹{•”@Šî1, Ž…–ž·Œ›1, ‚Š_—TŽq2 (1®ŠO. 2_“Þ쎕‘åj: ‘æ8‰ñ’´‰¹”gœÜŽ¡—ÃŒ¤‹†‰ï (2005/1/22), ‘åã. ´˜^W, p.16, 2005.

733243. [Œ¤‹†‰ï] (ˆê”Êu‰‰) “Á”­«•Gœ‰óŽ€‚ɑ΂µ’áo—Í’´‰¹”gƒpƒ‹ƒX‚ð—p‚¢‚½3—á‚ÌŒŸ“¢. ã–쳊ì, è•”@Œ›, ¬£NŽ¡, ‹{•”@Šî, ‘Šì@~, “¡“c@Œì, Ž…–ž·Œ› (®ŠO): ‘æ8‰ñ’´‰¹”gœÜŽ¡—ÃŒ¤‹†‰ï (2005/1/22), ‘åã. ´˜^W, p.32, 2005.

733244. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‚T—ƒbƒg‘å‘Úœ•Â½«œÜƒ‚ƒfƒ‹‚ð—p‚¢‚½’áo—Í’´‰¹”gƒpƒ‹ƒX‚̜܎¡–ü‘£iŒø‰Ê‚ÌŒŸ“¢|’áo—Í’´‰¹”gƒpƒ‹ƒX‚ª“à“œ‰»‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä‚ÌŒŸ“¢|. ŽOD‘åŒá1, è•”@Œ›2, ¬£NŽ¡2, “à“cŒ’‘¾˜Y1, ”nŸº´Ž‘1, Ž…–ž·Œ›2 (1ˆã‰q. 2®ŠO): ‘æ8‰ñ“ú–{’´‰¹”gœÜŽ¡—ÃŒ¤‹†‰ï (2005/1/22), ‘åã. ´˜^W, p.32, 2005.

733245. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŠÖ߃ŠƒEƒ}ƒ`‚ɑ΂·‚é Sauve-Kapandji–@‚¨‚æ‚ÑDarrach –@‚ɑ΂·‚éŽÚœ’f’[‚ÌXüŠw“I•Ï‰»‚ÌŒŸ“¢. “¡“c@Œì, ¬—Ñ–¾³, ‘ü–ì@Œ÷, “ñŒ©r˜Y (®ŠO): ‘æ19‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŒ¤‹†‰ï (2005/2/11), “Œ‹ž. ´˜^W, p.54, 2005.

733246. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒeƒjƒX•IÇó‚ð’悵‚½—Öóx‘Ñ‚ªŠÖß“à‚Ö•”•ªŠ×“ü‚µ‚½1—á. Šâ£@‘å, ‘ü–ì@Œ÷, ¬—Ñ–¾³, XŒû®¶, ‹e’r‹±‘¾, “ñŒ©r˜Y (®ŠO): ‘æ19‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŒ¤‹†‰ï (2005/2/11), “Œ‹ž. ´˜^W, p.116, 2005.

733247. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŒÒŠÖß‚É”­Ç‚µ‚½ŠŠ–Œ«œ“îÇ‚Ì1—á. Ä“¡Ÿ‹`, ‚•½®L, “àŽRŸ•¶, •ôŒ´G¹, –p@W³, ã–쳊ì, ŽR–{‹–¾, Ž…–ž·Œ› (®ŠO): ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï@‘æ628‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï (2005/2/26), “Œ‹ž.

733248. [Œ¤‹†‰ï] (ˆê”Êu‰‰) lH•GŠÖß‘S’uŠ·pŽž‚Ì•GŠW‰ºŽ‰–b‘Ì•”•ªØœ‚ª•GŠWäF‚Ì’·‚³‚É—^‚¦‚é‰e‹¿‚ÌŒŸ“¢. ‘P•½“N•v, è•”@Œ›, ‘Šì@~, “¡“c@Œì, Ž…–ž·Œ› (®ŠO): ‘æ123‰ñ_“Þ쮌`ЊQŠO‰ÈŒ¤‹†‰ï (2005/3/12), ‰¡•l. _“Þ쮌`ЊQŠO‰ÈŠw‰ïŽGŽ, 17 (4): 125, 2005.

733249. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “–‰È‚É‚¨‚¯‚éDuetto SIƒXƒeƒ€‚ð—p‚¢‚½ƒZƒƒ“ƒgƒŒƒX‘SlHŒÒŠÖß’uŠ·p‚Ì’†Šú¬Ñ. •Ÿ“‡Œ’‰î, ‚•½®L, “àŽRŸ•¶, –p@W³, Ž…–ž·Œ› (®ŠO): ‘æ45‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (2005/3/26), “Œ‹ž. ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 36 (—Õ‘): 54, 2005.

733250. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) lH•GŠÖß‘S’uŠ·pŽž‚Ì•GŠW‰ºŽ‰–b‘ÌØœ‚ª•GŠWäF‚Ì’·‚³‚É—^‚¦‚é‰e‹¿‚ÌŒŸ“¢. ‘P•½“N•v, è•”@Œ›, “¡“c@Œì, ‘Šì@~, –p@W³, Ž…–ž·Œ› (®ŠO): ‘æ45‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (2005/3/26), “Œ‹ž. ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 36 (—Õ‘): 61, 2005.

733251. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “–‰@‚ÌlHŒÒŠÖß’uŠ·pŽüpŠú‚É‚¨‚¯‚é[•”Ö¬ŒŒðǂɑ΂·‚éMR Venography‚ÌŽg—pŒoŒ±. ŽR–{‹–¾1, ‚•½®L1, “àŽRŸ•¶1, –p@W³1, ‰Í‘º ’¼1, Ž…–ž·Œ›1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, `@”Ž•¶3 (1®ŠO. 2•ú. 3•úŽËü•”j: ‘æ45‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (2005/3/26), “Œ‹ž. ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 36(—Õ‘): 85, 2005.

733252. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚éÒ’ÅŽèp‚Ìp’†EpŒã‡•¹Ç. ˆä‘º‹M”V, ’†àVr”V, V“c_Žj, ¬—Ñ–¾³, “n•Ó“NÆ, âZ@‰ë—_, ‘ü–ì@Œ÷, ˆÀ’B@Œö, “ñŒ©r˜Y (®ŠO): ‘æ45‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (2005/3/26), “Œ‹ž. ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 36 (—Õ‘): 120, 2005.


<<Œ`¬ŠO‰ÈŠw>>

mŠwp˜_•¶n

120049. [Œ´’˜] lHŒûŠW°‚ÆpŒã\‰¹. —é–ØŒbŽq1, ŽRŽRšòˆÀ°2, £ŽRšòWˆê˜Y2, “àÀ‰hŽ÷2 (1ˆã‰q. 2Œ`ŠO): Œ`¬ŠO‰È, 48 (3): 247-254, 2005.

120050. [Œ´’˜] ”_ì‹ÆЊQ—\–hŒ¤‹†. ²X–ØáÁŽ¢1, ‰P“c@½1, LàVŽO˜aŽq1, ‰ÄìŽü‰î1, ‘å’J’˱”V2, –x@–¾—m3, •ŽR’¼Ž¡3, Γ˳•¶4 (1“ú–{”_‘ºˆãŠwŒ¤‹†Š. 2Œ`ŠO. 3‹v”üˆ¤•a‰@. 4“y‰Y‹¦“¯•a‰@): “ú–{”_‘ºˆãŠw‰ïŽGŽ, 53 (5): 796-804, 2005.

120051. [Œ´’˜] åñጎ¡—Õ]‰¿‚Ì‚½‚ß‚ÌVF i[ˆäj ƒXƒP[ƒ‹“±“üŒã1”NŠÔ‚Ì“ŒvŠw“IŒŸ“¢. [ˆäF˜Y (Œ`ŠO): é‹ÊŒ§ˆãŠw‰ïŽGŽ, 39 (5): 585-590, 2005.

120052. [Œ´’˜] VF i[ˆäj ƒXƒP[ƒ‹|ƒxƒbƒhƒTƒCƒh‚É‚¨‚¯‚év‘¬‚Èåñጎ¡—Õ]‰¿. [ˆäF˜Y, •“c@Œ[ (Œ`ŠO): “ú–{åñጊw‰ïŽ, 7 (1): 99-106, 2005.

120053. [Œ´’˜] Šç–Ê‚µ‚íŽæ‚è‚ɑ΂·‚éÅV”ü—eˆã—Ã. ‰F’Öؗ´ˆê, ²“¡‰p–¾ (Œ`ŠO): “ú–{”ü—eŠO‰ÈŠw‰ï•ñ, 26 (4): 11-21, 2004.

120054. [Œ´’˜] “–‰@‚É‚¨‚¯‚éskin dock‚ÌŽ¡—Ñ̌n‚ɂ‚¢‚Ä. —Ñ@Œ\Žq1, ‹{“cƒGƒŠ[1, ㌴@´1, ŒÃŽR“o—²1, ²“¡‰p–¾2 (1Ž©—R‚ª‹uƒNƒŠƒjƒbƒN. 2Œ`ŠO): Skin Surgery, 13 (2): 18-22, 2004.

210023. [€Œ´’˜] Subcutaneous emphysema of the hand caused by hydrogen peroxide. ª–{@[1, ’†–ì‘ãŽq1, ”nêŽq1, ”–ØT–ç1, “àÀ‰hŽ÷1, ‘Š”nˆêˆå2 (1Œ`ŠO. 2‹~–½): Proceedings of the 5th congress of the asian pacific federation of societies for surgery of the hand, p.111-115, Monduzzi Editore, Bologna, Italy, 2004.

220049. [€Œ´’˜] ŒûoŠO‰È‚¨‚æ‚ÑŒ`¬ŠO‰È“I—§ê‚©‚ç‚Ý‚½Š{‹¸³Žèp. ŽRŽRšòˆÀ° (Œ`ŠO): ‘æ8‰ñŠ{Šç–ÊŽèpŽè‹ZŒ¤‹†‰ï, 8: 26-32, 2004.

320048. [Ç—á•ñ] æ“V«ŠO•@EŽîᎂÌ3—á. ‘“c—³Ž™, £ŽRšòWˆê˜Y, Ε‹§Žj, “àÀ‰hŽ÷ (Œ`ŠO): “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 24 (5): 305-311, 2004.

320049. [Ç—á•ñ] Ä”­C“]ˆÚ‚ð‚«‚½‚µ‚½•@—ƒ•” Basosquamous Cell Carcinoma‚Ì1—á. ‘“c—³Ž™1, Ε‹§Žj1, “¿“c^‹IŽq, “àÀ‰hŽ÷1 (1Œ`ŠO): “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 24 (11): 706-712, 2004.

320050. [Ç—á•ñ] ãŠ{‘OŽ••”Ž•‘…œØ‚è‚ɃIƒgƒKƒCŒ`¬p‚𕹗p‚µ‚ÄŽ¡—Âðs‚Á‚½œŠi«ãŠ{‘O“Ë‚Ì1—á. Š}ˆä‹v”üŽq1, •{ìr•F1, ŽRŽRšòˆÀ°2 (1‚Ó‚©‚틸³Ž•‰È. 2Œ`ŠO): “Œ‹ž‹¸³Ž•‰ÈŠw‰ïŽGŽ, 14 (1): 36-44, 2004.

320051. [Ç—á•ñ] ”xŠà‚ð‡•¹‚µ‚½¬’°Œ´”­Ki-1ƒŠƒ“ƒpŽî‚ÌØœ—á. H–{•ôŽ1, •Ÿ“‡’‰’j2, –Ί_‰ër2, ’·–x@ŒO2, ׈ä‰p—Y2, ‘å‰Í“à@–«2 (1Œ`ŠO. 2‰¡{‰ê‹¤Ï•a‰@): “ú–{—Õ°ŠO‰ÈŠw‰ïŽGŽ, 65 (10): 2687-2691, 2004.

320052. [Ç—á•ñ] ƒwƒ‹ƒjƒAä`iNÇ‚Ì1—á. H“¡rÆ, ŽÄ“c—T’B, –Ñ—˜–ƒ—¢, “àÀ‰hŽ÷ (Œ`ŠO): “ú–{E‹ÆEЊQˆãŠw‰ïŽ, 52 (6): 375-377, 2004.

320053. [Ç—á•ñ] dÇ”M‚É•¹”­‚µ‚½‹}«”xáŠQ‚ɑ΂·‚éD’†‹…ƒGƒ‰ƒXƒ^[ƒ[‘jŠQ–ò‚ÌŽg—pŒoŒ±‚¨‚æ‚Ñ“Š—^ŽžŠú‚ÉŠÖ‚·‚élŽ@. ŽÄ“c’m‹`1, ‘å’J’˱”V1, ’†‘º@Œ’1, —L”n—TŽq1, ‰ª“c–M•F2 (1Œ`ŠO. 2JA’·–ìŒú¶˜A²‹v‘‡•a‰@): Progress in Medicine, 24: 2929-2932, 2004.

320054. [Ç—á•ñ] ‹ts«žô‘¤‘O˜r”ç•Ù‚É‚æ‚èÄŒš‚µ‚½‰EŽè”w•”“î•”‘gDŒ‡‘¹‚Ì1—á. ª–{@[1, V‘ò”ŽŽq2, “잊º—Y1, “àÀ‰hŽ÷1 (1Œ`ŠO. 2‘Š–ÍŒ´‹¦“¯•a‰@): “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 24 (4): 243-246, 2004.

520178. [‘à] “úíf—Âɖ𗧂Œ`¬ŠO‰ÈŠî–{Žè‹Z‚̃Rƒc. Žðˆä’¼•F, “àÀ‰hŽ÷ (Œ`ŠO): Œ`¬ŠO‰È, 47 (‘): 330-333, 2004.

520179. [‘à] ƒVƒ~‚Í‚Ç‚±‚Ü‚Å‚«‚ê‚¢‚É‚Å‚«‚é‚©?|ÂF•ê”Á|. ŽR‰º—ŠG (Ó슙‘q‘‡•a‰@, Œ`¬): Visual Dermatology, 3 (10): 1052-1053, 2004.

520180. [‘à] Š×“ü’ÜŽèp (•¡ŽG‚È‚à‚Ì). ˆêŽr¢ (Œ`ŠO): Visual Dermatology, 3 (10): 1264-1267, 2004.

520181. [‘à] ƒGƒXƒeƒeƒBƒbƒNƒT[ƒrƒX‚É‚¨‚¯‚éŠëŠQ‚ÌŒ»ó‚ƈÀ‘S‘ÎôŠm•Û. ŽR‰º—ŠG (Ó슙‘q‘‡•a‰@, Œ`¬): ‘–¯¶Šˆ, 10: 10-13, 2004.

520182. [‘à] Œõ˜V‰»‚ɑ΂·‚郌[ƒU[EŒõŽ¡—Ã: ƒVƒ~E‚µ‚í‚ÌŽ¡—à iƒXƒ|[ƒcŒ»ê‚Å‚Ì—\–h‚àŠÜ‚ß‚Ä, Œõ˜V‰»‚Ì–â‘è’ñ‘ij. ŽR‰º—ŠG (Ó슙‘q‘‡•a‰@, Œ`¬): —Õ°ƒXƒ|[ƒcˆãŠw, 22 (1): 47-52, 2005.

520183. [‘à] “ÁW/Šç–Ê‚ÌŽá•Ô‚莡—Ã, ”ñŽèp“IŽ¡—Ã|Laser rejuvenation‚ÌŒ»‹µ|. ŽR‰º—ŠG (Ó슙‘q‘‡•a‰@, Œ`¬): Œ`¬ŠO‰È, 47 (12): 1311-1318, 2005.

520184. [‘à] “dŒ‚. “‡‘qNl1, ‘Š”nˆêˆå2 (1Œ`ŠO. 2‹~–½): —Õ°ˆã, 30 (‘): 785-786, 2004.

520185. [‘à] ‘n. “‡‘qNl1, ‘Š”nˆêˆå2 (1Œ`ŠO. 2‹~–½): —Õ°ˆã, 30 (‘): 790-791, 2004.

520186. [‘à] ‘¤’ÜŠsE’Üa‚ð‘å‚«‚­Øœ‚µ‚È‚¢Š×“ü’ÜŽèp. “‡‘qNl (Œ`ŠO): Visual Dermatology, 3 (12): 1260-1263, 2004.

520187. [‘à] “ú푘‹ö‚·‚鬊O‰È“IŽ¾Š³‚Æåñጎ¡—ÃÅ‹ß‚Ì’mŒ©. [ˆäF˜Y (Œ`ŠO): –k‘«—§ŒSˆãŽt‰ï‰ï•ñ, 219: 38-43, 2005.

520188. [‘à] –Ñ•ïŒ`¬‚É‚¨‚¯‚éŠî’ê–Œƒ‰ƒ~ƒjƒ“‚Ì–ðŠ„: ’P—£ƒqƒQŒ´Šî‚̊튯”|—{Œn‚ƃ‰ƒ~ƒjƒ“ƒyƒvƒ`ƒh‚ð—p‚¢‚½ƒAƒvƒ[ƒ`. —Ñ@˜aO1, –å’J—Tˆê2 (1Œ`ŠO. 2‰ð–U): –k—¢ˆãŠw, 33: 293`298, 2003.

m’˜@‘n

620110. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) Œ`¬ŠO‰ÈADVANCEƒVƒŠ[ƒY@”ü—eŠO‰È@Å‹ß‚Ìi•à@‘æ2”Å; ”ü—eŠO‰È‚Ƹ_Ž¾Š³, p.9-13. —Ñ@˜aO, “àÀ‰hŽ÷ (Œ`ŠO), •ÒW ‘åXŠì‘¾˜Y (“Œ‹žŒxŽ@•a‰@), ŠÄC ”g—˜ˆä´‹I (ˆÇ—Ñ‘å), Ž½“°, “Œ‹ž, 2005/1/5”­s.

620111. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ƒŒ[ƒU[Ž¡—ÃÅ‹ß‚Ìi•à@Œ`¬ŠO‰ÈƒAƒhƒoƒ“ƒXƒVƒŠ[ƒY; ƒŒ[ƒU[Ž¡—Âɂ¨‚¯‚é‘nŽ¡–ü‚ƈ’u, p.202-209. ŽR‰º—ŠG (Ó슙‘q‘‡•a‰@, Œ`ŠO), •ÒW ’J–ì—²ŽO˜Y (“ŒŠC‘å), ŠÄC ”g—˜ˆä´‹I (“Œ‹ž‘å), Ž½“°, “Œ‹ž, 2004/4/1”­s.

620112. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ”畆‰Èƒvƒ‰ƒNƒeƒBƒX, 17. Rejuvenation‚ÌŽÀÛ i”畆‚ÌŽá•Ô‚èj; ‚mon-ablative laser‚Æ‚»‚Ì—ÞŽ—Ž¡—à i1j ƒIƒŠƒGƒ“ƒe[ƒVƒ‡ƒ“/‚È‚ºrejuvenationƒŒ[ƒU[‚É‚Í‘½‚­‚ÌŽí—Þ‚ª‚ ‚é‚Ì‚©? p.128-131. ŽR‰º—ŠG (Ó슙‘q‘‡•a‰@, Œ`ŠO), •ÒW ‹{’n—ÇŽ÷ (‹ž“s‘åj, ‘ëì‰ë_ (•l¼ˆã‘å), Š‹¼Œ’ˆê˜Y (Š‹¼Œ`¬ŠO‰È), •¶Œõ“°, “Œ‹ž, 2004/4/5”­s.

620113. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ”畆‰Èƒvƒ‰ƒNƒeƒBƒX, 17. Rejuvenation‚ÌŽÀÛ i”畆‚ÌŽá•Ô‚èj; Ž„‚Ìrejuvenationí—ª, Ž„‚Í‘½Ží‘½—l‚ÈŠ³ŽÒ‚Ìó‘Ô‚ð‚Ç‚¤f’f‚µ, Ž¡—Âð‘g‚Ý—§‚Ä‚Ä‚¢‚­‚©? p.249-254. ŽR‰º—ŠG (Ó슙‘q‘‡•a‰@, Œ`ŠO), •ÒW ‹{’n—ÇŽ÷ (‹ž“s‘åj, ‘ëì‰ë_ (•l¼ˆã‘å), Š‹¼Œ’ˆê˜Y (Š‹¼Œ`¬ŠO‰È), •¶Œõ“°, “Œ‹ž, 2004/4/5”­s.

620114. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ƒAƒ“ƒ`ƒGƒCƒWƒ“ƒOˆãŠw‚ÌŠî‘b‚Æ—Õ°; ”ü—e‚Ɖ»Ï, p.229-232. ŽR‰º—ŠG (Ó슙‘q‘‡•a‰@, Œ`ŠO): •ÒW “ú–{R‰Á—îˆãŠw‰ïê–åˆã; Žw“±Žm”F’èˆÏˆõ‰ï, ƒƒfƒBƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/6/1”­s.

620115. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ŠO—ˆ‚Å—eˆÕ‚É‚Å‚«‚éŽá•Ô‚è”ü—eˆã—Â̎ÀÛ|ƒAƒ“ƒ`ƒGƒCƒWƒ“ƒOˆã—ÂƃXƒLƒ“ƒPƒA; 4. Facial rejuvenation: Ablative skin rejuvenation: Er YAG, ‚bO2, p.75-83. ŽR‰º—ŠG (Ó슙‘q‘‡•a‰@, Œ`ŠO), •ÒW ‹v•Û“cˆê˜Y (’r‘܃g[ƒ^ƒ‹ƒrƒ…[ƒeƒB[ƒNƒŠƒjƒbƒN), ‰iˆä‘“X, ‘åã, 2004/10/1”­s.

620116. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ŠO—ˆ‚Å—eˆÕ‚É‚Å‚«‚éŽá•Ô‚è”ü—eˆã—Â̎ÀÛ|ƒAƒ“ƒ`ƒGƒCƒWƒ“ƒOˆã—ÂƃXƒLƒ“ƒPƒA; 4. Facial rejuvenation: Non-ablative rejuvenation: Cool Touch, p.84-91. ŽR‰º—ŠG (Ó슙‘q‘‡•a‰@, Œ`ŠO), •ÒW ‹v•Û“cˆê˜Y (’r‘܃g[ƒ^ƒ‹ƒrƒ…[ƒeƒB[ƒNƒŠƒjƒbƒN), ‰iˆä‘“X, ‘åã, 2004/10/1”­s.

620117. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) Visual Dermatology, VOL3- NO.12“ÁWƒtƒbƒgƒPƒAŠT”O‚¨‚æ‚ÑŽ¡—Ö@‚ɂ‚¢‚Ä; ‘à07: Š×“ü’ÜŽèp iˆÚsŒ^Š×“ü’Ü‚Æ‚¢‚¤ŠT”O‚¨‚æ‚ÑŽ¡—Ö@‚ɂ‚¢‚Ä), p.1268-1270. “잊º—Y (Œ`ŠO), •ÒW ‘q•û’·–å (‘q•û”畆‰È), ŠÄC ‘q•û’·–å, GŽÐ, “Œ‹ž, 2004/11/25”­s.

620118. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ¡“ú‚ÌŒ’N2ŒŽ†; ‚¨K‚É‚µ‚±‚肪‚Å‚«‚Ü‚µ‚½. ŽÄ“c—T’B (‰¡•lŽs–¯•a‰@, Œ`ŠO), •ÒW “ú–{•ú‘—‹¦‰ï, “ú–{•ú‘—o”Å‹¦‰ï, “Œ‹ž, 2005/2/1”­s.

620119. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ”畆‰Èf—Ãvƒ‰ƒNƒeƒBƒXERejuvenation‚ÌŽÀÛ (”畆‚ÌŽá•Ô‚è); Ž„‚̃gƒŒƒ`ƒmƒCƒ“Ž¡—Ã, p.90-99. —é–Ø•q•F (‰¡•l“실ϕa‰@, Œ`ŠO), •ÒW ‹{’n—ÇŽ÷ (‹ž“s‘å), ‘ëì‰ë_ (•l¼ˆã‘å), •¶Œõ“°, “Œ‹ž, 2004/4/5”­s.

620120. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ŠO—ˆ‚Å—eˆÕ‚É‚Å‚«‚éŽá•Ô‚è”ü—eˆã—Â̎ÀÛ|ƒAƒ“ƒ`ƒGƒCƒWƒ“ƒOˆã—ÂƃXƒLƒ“ƒPƒA|; ㉺ŠááÙœá°p@–jEèò•”ƒŠƒtƒg, p.204-212. ‰F’Öؗ´ˆê (Œ`ŠO), •ÒW ‹v•Û“cˆê˜Y (’r‘܃g[ƒ^ƒ‹ƒrƒ…[ƒeƒB[ƒNƒŠƒjƒbƒN), ‰iˆä‘“X, ‘åã, 2004/10/1”­s.

620121. [‚»‚Ì‘¼‚Ì’˜‘] (’P’˜) ”ül‰„–½@–k—¢Œ¤‹†Š•a‰@”ü—eˆãŠwƒZƒ“ƒ^[‚Ì’§í. ‰F’Öؗ´ˆê (Œ`ŠO), Žå•w‚Ì—FŽÐ, “Œ‹ž, 2004/8”­s.

620122. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) Œ`¬ŠO‰ÈADVANCEƒVƒŠ[ƒY@”ü—eŠO‰È@Å‹ß‚Ìi•à@‘æ2”Å; Face lift operationEComposite rhytidectomy‚ð’†S‚Æ‚µ‚Ä, p.67. ‰F’Öؗ´ˆê (Œ`ŠO), •ÒW ‘åXŠì‘¾˜Y (“Œ‹žŒxŽ@•a‰@), ŠÄC ”g—˜ˆä´‹I (ˆÇ—Ñ‘å), Ž½“°, “Œ‹ž, 2005/1/5”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

712030. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Non-ablative laser rejuvenaion. ŽR‰º—ŠG1,2, ˆêŽr¢1, ™–{F”V1, ™–{‰À2, ¼––•—Y2, “àÀ‰hŽ÷1 i1Œ`ŠO. 2Ó슙‘q‘‡•a‰@j: Japan-korean plastic surgery meeting (2004/6/12), ŽD–y.

713131. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Comparative study of solvents to expedite removal of asphalt. Iuchi M1, Sugiyama M1, ‘å’J’˱”V2, [ˆäF˜Y2 (1JA’·–ìŒú¶˜A²‹v‘‡•a‰@. 2Œ`ŠO): ‘Û”MŠw‰ï (2004/8/22-26), ‰¡•l.

713132. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Management of remained malocclusion after maxillofacial facture. ’†‹v–ØNˆê1, ŽRŽRšòˆÀ°1, ’†–kMº1, •{ìr•F2, Γn–õ•v3, ”öŠÖ‰ë•F4, “àÀ‰hŽ÷1 (1Œ`ŠO. 2‚Ó‚©‚틸³Ž•‰È. 3‚¢‚µ‚킽‹¸³Ž•‰È. 4º˜a‘åEŽ•j: 6th Asian congress on oral and maxillofacial surgery, 49th Annual meeting of Japanese society of oral and maxillofacial surgeons(2004/10/21), “Œ‹ž. 6th Asian congress on oral and maxillofacial surgery, p.130, 2004.

713133. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Subcutaneous emphysema of the hand caused by hydrogen peroxide. ª–{@[1, ”nêŽq1, ”–ØT–ç1, “àÀ‰hŽ÷1, ‘Š”nˆêˆå2 (1Œ`ŠO. 2‹~–½): The 5th congress of the asian pacific federation of societies for surgery of the hand (2004/11/13), ‘åã. Abstract, p.297, 2004.

713134. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Non-ablative laser rejuvenaion. ŽR‰º—ŠG (Ó슙‘q‘‡•a‰@, Œ`¬): anti-aging meeting 2005 (2005/1/6), ƒpƒŠ.

722069. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “–‰È‚É‚¨‚¯‚éŒûŠW°‚Ì–Ú“I‚ÆŒ»ó. ŽRŽRšòˆÀ°1, £ŽRšòWˆê˜Y1, ’†–kMº1, “àÀ‰hŽ÷1, —é–ØŒbŽq2, Γn–õ•v3 (1Œ`ŠO. 2ˆã‰q. 3‚¢‚µ‚킽‹¸³Ž•‰Èj: ‘æ28‰ñ“ú–{ŒûŠW—ôŠw‰ï‘‰ïEŠwpW‰ï (2004/5/28), Ž­Ž™“‡. “ú–{ŒûŠW—ôŠw‰ïŽGŽ, 29 (2): 101, 2004.

722070. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒ‰ƒ~ƒjƒ“ƒyƒvƒ`ƒhŒ‹‡ƒLƒgƒTƒ“–Œ‚Ì•\”ç×–EƒLƒƒƒŠƒA‚Æ‚µ‚Ä‚Ì—L—p«‚ɂ‚¢‚Ä. ’r–{”ÉO1, –]ŒŽ–ƒ—F”ü2, ŽR“c³˜H2, –ì…Šî‹`2, •“c@Œ[1, “àÀ‰hŽ÷1, ŽR‰È³•½3, –å’J—Tˆê3 (1Œ`ŠO. 2–kŠC“¹‘å. 3‰ð–Uj: ‘æ36‰ñ“ú–{Œ‹‡‘gDŠw‰ïŠwp‘å‰ï (2004/6/3), •Ÿ‰ª.

722071. [Šw‰ï (‘S‘)] (:ƒVƒ“ƒ|ƒWƒEƒ€) :‚É‚«‚Ñ, ‚É‚«‚Ñ­‚ɑ΂·‚郌[ƒU[Ž¡—Ã. ŽR‰º—ŠG1, ™–{‰À1, ™–{F”V1, ˆêŽr¢1, ¼––•—Y1, “àÀ‰hŽ÷2 (1Ó슙‘q‘‡•a‰@. 2Œ`ŠO): ‘æ16‰ñƒŒ[ƒU[Ž¡—Êw‰ï (2004/7/7), ’r‘Ü.

722072. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŒûO—ôEŒûŠW—ô‚ÆœˆÚA. ŽRŽRšòˆÀ° (Œ`ŠO): ’ߌ©‘åŠwŽ•Šw•”ƒoƒCƒIEƒxƒ“ƒ`ƒƒ[ƒvƒƒWƒFƒNƒg (2005/2/26), _“Þì.

723581. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒŒ[ƒU[•ƒtƒHƒgŽ¡—Âɂæ‚écombination facial rejuvenation. ŽR‰º—ŠG1, 2, “c’†‘•c1, ™–{F”V1, “àÀ‰hŽ÷1 (1Œ`ŠO. 2Ó슙‘q‘‡•a‰@): ‘æ47‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2004/4/7), “Œ‹ž.

723582. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) äF–Œ«ŠááÙ‰º‚Ç‚É”º‚¤SUNKEN-EYELID‚ÌC³–@‚ÌŒŸ“¢. “잊º—Y1, ‰F’Öؗ´ˆê1, ‚ŽR“ÖŽq1, Šâ‰®¹Žq2 (1Œ`ŠO. 2–k—¢Œ¤‹†Š•a‰@”ü—eˆãŠwƒZƒ“ƒ^[j: ‘æ47‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2004/4/7), “Œ‹ž. ƒvƒƒOƒ‰ƒ€¥´˜^W, p.148, 2004.

723583. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¶‰E—ôŒ^‚̈Ⴄ—¼‘¤OŠ{ŒûŠW—ô‚ɑ΂·‚éŒûOŒûŠW“¯ŽžŒ`¬p. £ŽRšòWˆê˜Y, ’†–kMº, ŽRŽRšòˆÀ°, ”nêŽq, “¿“c^‹IŽq, ‹ž’JŽ÷Žq, “àÀ‰hŽ÷ (Œ`ŠO): ‘æ47‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2004/4/7), “Œ‹ž.

723584. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “û–[‚Ì”ö‘¤•”•ªÄŒš‚ðs‚Á‚½3Ç—á. ”nêŽq, Žðˆä’¼•F, ‰““¡‚ ‚©‚Ë, ‚‹´—m•ã, “àÀ‰hŽ÷ (Œ`ŠO): ‘æ47‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2004/4/7), “Œ‹ž.

723585. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) “–‰È‚É‚¨‚¯‚éŠ{—ô•”œˆÚAŽžŠú‚Ì‘I‘ðŠî€. ŽRŽRšòˆÀ°1, Γn–õ•v2, £ŽRšòWˆê˜Y1, ’†–kMº1, “àÀ‰hŽ÷1 (1Œ`ŠO. 2‚¢‚µ‚킽‹¸³Ž•‰È): ‘æ47‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2004/4/7), “Œ‹ž. ƒvƒƒOƒ‰ƒ€E´˜^W, 47: 132, 2004.

723586. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Davidson–@‚ð—p‚¢‚½—«‰»“û–[‚ÌŽ¡—ÃŒoŒ±. “¿“c^‹IŽq, —Ñ@˜aO, ”nêŽq, –ö˜a–ç, ‹ž’JŽ÷Žq, “àÀ‰hŽ÷ (Œ`ŠO): ‘æ47‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2004/4/9), “Œ‹ž. ƒvƒƒOƒ‰ƒ€¥´˜^W, p.234, 2004.

723587. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “«’×ᇂɑ΂·‚铯Ží”|—{^”ç‚ÌŽg—pŒoŒ±. ŽR“c’¼l1, “àÀ‰hŽ÷1, ”–ØT–ç1, ”nêŽq1, ‹v•ÛŒ’‘¾˜Y2, •–ö”\Œõ2 i1Œ`ŠO. 2ˆã‰qj: ‘æ47‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïEŠwpW‰ï (2004/4/9), “Œ‹ž.

723588. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹Ø”ç•Ù‚¨‚æ‚ыؕقð—p‚¢‚½œ‘‰Š‚ÌÄŒš. Žðˆä’¼•F, ”–ØT–ç, ”nêŽq, ‰““¡‚ ‚©‚Ë, –î‘òŒcŽj, ‚‹´—m•ã, ŽR“c’¼l, “àÀ‰hŽ÷ (Œ`ŠO): ‘æ47‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïEŠwpW‰ï (2004/4/9), “Œ‹ž.

723589. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒgƒŒƒ`ƒmƒCƒ“‚ƃnƒCƒhƒƒLƒmƒ“‚Ì•¹—p‚É‚æ‚éF‘f«•a•ÏŠO—pŽ¡—Ã|Šç–Ê”M, A”ç•”‚ւ̉ž—p|. —é–Ø•q•F1,2, ¼”ö‚ ‚¨‚¢2, ‘å’|®”V2,3 (1‰¡•l“실ϕa‰@. 2Œ`ŠO. 3¹˜H‰Á‘Û•a‰@j: ‘æ47‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï (2004/4/9), “Œ‹ž.

723590. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Žw“‡ó”ç•Ù‚Æ’Ü°ˆÚA‚É‚æ‚é’Ü•”Ø’f—á‚ÌÄŒš. •½£—Yˆê1, Ž™“‡’‰—Y1, •Ÿ–{ŒbŽO1, ª–{@[2, ŽRŒû—˜m3 i1é‹ÊŽè‚ÌŠO‰ÈŒ¤‹†Š. 2Œ`ŠO. 3“Œ‹žŽè‚ÌŠO‰ÈƒXƒ|[ƒcˆãŠwŒ¤‹†Šj: ‘æ47‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ïŠwpW‰ï (2004/4/22), ‘åãŽs. “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 21 (1): 46, 2004.

723591. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Ž¡—Âɓïa‚µ‚½œ‘‰Š‚𔺂Á‚½‹¹•”•úŽËü”畆’×ᇂÌ1—á. ”nêŽq1, ŽÄ“c—T’B2, –Ñ—˜–ƒ—¢1, “àÀ‰hŽ÷1 (1Œ`ŠO. 2‰¡•lŽs–¯•a‰@j: ‘æ52‰ñ“ú–{E‹ÆEЊQˆãŠw‰ï (2004/4), ‰ªŽR.

723592. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’†Šç–Ê•”‚Ì—ò¬’·‚𔺂¤—¼‘¤OŠ{ŒûŠW—ôÇ—á‚ɑ΂·‚éLe Fort‡TŒ^œ‰„’·p‚ÌŒoŒ±. •{ìr•F1, ’¹Ž”Ÿs2, ¬—Ñ^Ži3, ‘呺@i2, •ŸŽR‰pŽ¡4, ‚‹´‘ì–ç2, Š}ˆä‹v”üŽq1, ŽRŽRšòˆÀ°5 (1‚Ó‚©‚틸³Ž•‰È. 2‰¡•lŽs‘åƒZƒ“ƒ^[•a‰@. 3‰¡•lŽs‘å. 44“ŒˆãŽ•‘å. 5Œ`ŠO): ‘æ14‰ñ“ú–{Š{•ÏŒ`ÇŠw‰ï (2004/5/25), •Ÿ‰ª. —\eW, p.117, 2004.

723593. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œã•@‹¾‚ð—p‚¢‚½•@ˆôo•Â½‹@”\‚Ì•]‰¿. ‹|í–¾Žq1, —é–ØŒbŽq1, ‰ª•”‘•c1, £ŽRšòWˆê˜Y2, ŽRŽRšòˆÀ°2, ’†–kMº2 (1ˆã‰q. 2Œ`ŠO): ‘æ28‰ñ“ú–{ŒûŠW—ôŠw‰ï‘‰ïEŠwpW‰ï (2004/5/28), Ž­Ž™“‡. “ú–{ŒûŠW—ôŠw‰ïŽGŽ, 29 (2): 220, 2004.

723594. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚¨‚¯‚é—¼eŒü‚¯uÀ‚ÌŒ»ó‚Ɖۑè. ŒÃ•½Œb”üŽq1, ´‹{”ü‰r1, ¼–{çŽj1, “c•Ó—Œb1, ²“¡^‹IŽq1, —é–ØŒbŽq2, ‹|í–¾Žq2, ŽRŽRšòˆÀ°3, £ŽRšòWˆê˜Y3, ’†–kMº3 (1ŠÅŒì•”. 2ˆã‰q. 3Œ`ŠO): ‘æ28‰ñ“ú–{ŒûŠW—ôŠw‰ï‘‰ïEŠwpW‰ï (2004/5/28), Ž­Ž™“‡. “ú–{ŒûŠW—ôŠw‰ïŽGŽ, 29 (2): 227, 2004.

723595. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘Šú“ñŽŸœˆÚAÇ—á‚É‚¨‚¯‚錢Ž•‚Ì–Go‚ÉŠÖ‚µ‚Ä. Γn–õ•v1, ‚‹´Ž Ž÷2, ŽRŽRšòˆÀ°3, £ŽRšòWˆê˜Y3, ’†–kMº3 (1‚¢‚µ‚킽‹¸³Ž•‰È. 2‚½‚©‚Í‚µ‹¸³Ž•‰È. 3Œ`ŠO): ‘æ28‰ñ“ú–{ŒûŠW—ôŠw‰ï‘‰ïEŠwpW‰ï (2004/5/28), Ž­Ž™“‡. “ú–{ŒûŠW—ôŠw‰ïŽGŽ, 29(2): 243, 2004.

723596. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘Šú“ñŽŸœˆÚAÇ—á‚ɑ΂·‚鋸³Ž¡—Õûj. Γn–õ•v1, ŽRŽRšòˆÀ°2, ‚‹´Ž Ž÷3, ˆÉ“¡‘å•ã4, ’¹Ž”Ÿs5, £ŽRšòWˆê˜Y2, ’†–kMº2, “àÀ‰hŽ÷2 (1‚¢‚µ‚킽‹¸³Ž•‰È. 2Œ`ŠO. 3‚½‚©‚Í‚µ‹¸³Ž•‰È. 4‚¢‚Æ‚¤‹¸³Ž•‰È. 5‰¡•lŽs‘åƒZƒ“ƒ^[•a‰@): ‘æ28‰ñ“ú–{ŒûŠW—ôŠw‰ï‘‰ïEŠwpW‰ï (2004/5/28), Ž­Ž™“‡. “ú–{ŒûŠW—ôŠw‰ïŽGŽ, 29 (2): 244, 2004.

723597. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –Å‹ÛŽ†‚¨‚ނ‚ð‚ð—p‚¢‚½”MŽèpŽž‚̑̉tEôò‰t‚̈—–@. Vˆä”üŒbŽq1, ’†‘º@Œ’2, ‘å’J’˱”V2, ¡ˆäGˆê1 (1JA’·–ìŒú¶˜A²‹v‘‡•a‰@. 2Œ`ŠO): ‘æ30‰ñ“ú–{”MŠw‰ï (2004/6/11), “Œ‹ž.

723598. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’ቷ”M‚ð–h‚®‰·ãª–@‚ÌŒŸ“¢. Šâˆä”üç1, ‘å’J’˱”V2, ’†‘º@Œ’2, ‰ª“c–M•F1 (1JA’·–ìŒú¶˜A²‹v‘‡•a‰@. 2Œ`ŠOj: ‘æ30‰ñ“ú–{”MŠw‰ï (2004/6/11), “Œ‹ž.

723599. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒIƒLƒVƒ~ƒXƒg‚ðŽg—p‚µ‚½åñጎ¡—ÉÊ. ‚–ì’mŽq1, —é–Ø•q•F1,2, ¼”ö‚ ‚¨‚¢1 (1Œ`ŠO. 2‰¡•l“실ϕa‰@): ‘æ6‰ñ“ú–{åñጊw‰ïŠwpW‰ï (2004/9/3), ŽD–y.

723600. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚éåñ጑ÎôˆÏˆõ‰ï‚ƃXƒLƒ“ƒPƒAˆÏˆõ‰ï‚ÌŽæ‚è‘g‚Ý. ”Ñ“‡—ÇŽq1, ¯–ì–¾Žq1, ‘å’J’˱”V2 (1JA’·–ìŒú¶˜A²‹v‘‡•a‰@. 2Œ`ŠO): ‘æ6‰ñ“ú–{åñጊw‰ïŠwpW‰ï (2004/9/3-4), ŽD–y.

723601. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) •G‹ü‹Ø”ç•Ù‚É‚æ‚éÄ”­«¿œ•”åñጂ̎¡—ÃŒoŒ±. •“c@Œ[1, “c’†—Ç’m2, ¼‹{@I2, Žç’Jº•F2, “àÀ‰hŽ÷1 (1Œ`ŠO. 2‰¡•lŽs—§`˜p•a‰@): ‘æ6‰ñ“ú–{åñጊw‰ïŠwpW‰ï (2004/9/3-4), ŽD–y.

723602. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰Eæù’ê•”‚ÉåñጂðŒJ‚è•Ô‚µ, æùœœ‘‰Š‚𕹔­‚µ‚½“ñ•ªÒ’ÅÇ—á‚ɑ΂·‚郊ƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒAƒvƒ[ƒ`. ¼‹{@I1, •“c@Œ[2, “c’†—Ç’m1 (1‰¡•lŽs—§`˜p•a‰@. 2Œ`ŠO): ‘æ‚U‰ñ“ú–{åñጊw‰ïŠwpW‰ï (2004/9/3-4), ŽD–y.

723603. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’E_Œo—̈æ•À‚Ñ‚ÉŒ’í_ŒoŽx”zˆæ‚É‚¨‚¯‚é”畆‘S‘wŒ‡‘¹Ž¡–ü‰ß’ö‚Ì”äŠr•]‰¿. [ˆäF˜Y1,2, •“c@Œ[2 (1é‹ÊŒ§‰›•a‰@. 2Œ`ŠO): ‘æ6‰ñ“ú–{åñጊw‰ïŠwpW‰ï (2004/9/3-4), ŽD–y.

723604. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) V‚µ‚¢ÃŽ~Œ^ƒGƒAƒ}ƒbƒgƒŒƒX iƒuƒŒƒXƒGƒA[j ‚É‚¨‚¯‚é—Õ°ŽÀŒ±“I•]‰¿. [ˆäF˜Y1, ŽRŽRšò’mŽq2, ‚‹´GK2, ¬ìˆÓ–[3 (1Œ`ŠO. 2é‹ÊŒ§‰›•a‰@EŠÅŒì•”. 3(—L) ƒnƒbƒs[¬ìj: ‘æ6‰ñ“ú–{åñጊw‰ïŠwpW‰ï (2004/9/3-4), ŽD–y.

723605. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –֌Ãqƒ_Œ`¬p|“àŠáŠpŒ`¬pŒã‚ÌC•œ‚ɂ‚¢‚Ä|. ‘å’|®”V1,2, ¼ˆäŽq1, “‡‘qNl2, •½ŽR@s1 (1¹˜H‰Á‘Û•a‰@. 2Œ`ŠOj: ‘æ27‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2004/10/10), ’·è.

723606. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Naso-Labial AngleŠg‘å‚ð–Ú“I‚Æ‚µ‚½•@’ŒAugmentasion. ‘å’|®”V1,2, ¼ˆäŽq1, “‡‘qNl2, •½ŽR@s1, ²“¡–¾’j3, ÎìCˆê4 (1¹˜H‰Á‘Û•a‰@. 2Œ`ŠO. 3“Œ‹žƒƒ‚ƒŠƒAƒ‹ƒNƒŠƒjƒbƒN. 4‰¡•lƒxƒCƒNƒŠƒjƒbƒNj: ‘æ27‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2004/10/10), ’·è.

723607. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒŒ[ƒU[•ƒtƒHƒg‚¨‚æ‚уŒ[ƒU[•‚q‚e‚É‚æ‚érejuvenationŽ¡—Ã. ŽR‰º—ŠG1,2, ˆêŽr¢2, ‰““¡‚ ‚©‚Ë2, ¼––•—Y1, ™–{‰À1, Žðˆä@‹K1, “àÀ‰hŽ÷2 (1Ó슙‘q‘‡•a‰@. 2Œ`ŠO): “ú–{”ü—eŠO‰ÈŠw‰ï (2004/10/11), Œyˆä‘ò.

723608. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‚cavidoson–@‚É€‚¶‚½ØŠJü‚ð—p‚¢‚½“û–[’“üˆÙ•¨“EoÇ—á‚ÌŒŸ“¢. —Ñ@˜aO, ’†–kMº, –ö˜a–ç, —L”n—TŽq, “¿“c^‹IŽq, ‹´–{MŽq, “àÀ‰hŽ÷ (Œ`ŠO): ‘æ27‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï i‘æ91‰ñŠwpW‰ïj (2004/10/11), ’·–ì. ƒvƒƒOƒ‰ƒ€¥´˜^W, p.179, 2004.

723609. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) lŠÔƒhƒbƒN‚Ì”ü—e”Åg”ü—eƒhƒbƒNh‚Ì–Ú“I‚ƈӋ`. “c’†‘•c1, ‰F’Öؗ´ˆê2, ²“¡‰p–¾2, ŽRŒû–ƒŽq2, ’·¼—TŽ÷2, “àÀ‰hŽ÷1 (1Œ`ŠO. 2–k—¢Œ¤‹†Š•a‰@): ‘æ27‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2004/10/11), Œyˆä‘ò.

723610. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‚æ‚èŒø‰Ê“I‚ÈForehead Lift‚ÌŒŸ“¢. ²“¡‰p–¾1, ‰F’Öؗ´ˆê1, “c’†‘•c2, ’·¼—TŽ÷1, “àÀ‰hŽ÷2 (1–k—¢Œ¤‹†Š•a‰@. 2Œ`ŠO): ‘æ27‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2004/10/11), Œyˆä‘ò.

723611. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”ü—eƒhƒbƒN‚ÌŽÀÛ‚Æ—Õ°ã‚̈Ӌ`. ŽRŒû–ƒŽq1, ‰F’Öؗ´ˆê1, ²“¡‰p–¾1, “c’†‘•c2, ’·¼—TŽ÷1, “àÀ‰hŽ÷2 (1–k—¢Œ¤‹†Š•a‰@. 2Œ`ŠO): ‘æ27‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2004/10/11), Œyˆä‘ò.

723612. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–ƒZƒ“ƒ^[‚Ö‚Ì“d˜b–⇂¹12000Œ‚©‚ç‚Ý‚½”ü—eˆã—Âɑ΂·‚éŽÐ‰ï“I“®Œü‚ÌŒŸ“¢. âV“¡ŽO‘ã1, ‰F’Öؗ´ˆê1, ²“¡‰p–¾1, “c’†‘•c2, ŽRŒû–ƒŽq1, ’·¼—TŽ÷1, ‰–’JMK1, “àÀ‰hŽ÷2 (1–k—¢Œ¤‹†Š•a‰@. 2Œ`ŠO): ‘æ27‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2004/10/11), Œyˆä‘ò.

723613. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠO«ŽèŽwØ’fŒã‚̃XƒgƒŒƒXáŠQ‚Æ‚»‚Ì‘Îô. ª–{@[, ”–ØT–ç, ŒFàVŒ›ˆê, H–{•ôŽ, “àÀ‰hŽ÷ (Œ`ŠO): ‘æ31‰ñ“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ïŠwpW‰ï (2004/10/14), ŒF–{Žs. —\eW, p.114, 2004.

723614. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŽèŽwæ“V«Œ`‘ÔˆÙ펾Š³‚É‚¨‚¯‚éHOXD13ˆâ“`Žq‚̉ðÍ. Žðˆä’¼•F1, ’†–ì‘ãŽq1, ŽRŽRšòˆÀ°1, “nç²GˆÉ2, {²”ü—²Žj2, “¿‰iŸŽm2, “àÀ‰hŽ÷1, ‚ŒË@‹B2 (1Œ`ŠO. 2“Œ‹ž‘åj: ‘æ13‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2004/10/21), ‰YˆÀ.

723615. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “ú–{lŒûOŒûŠW—ôŠ³ŽÒ‚ÆŒó•âˆâ“`Žq@MSX1, DLX1, DLX2‚Æ‚ÌŠÖ˜AŒ¤‹†. “nç²GˆÉ1, Žðˆä’¼•F2, ’†–ì‘ãŽq2, ŽRŽRšòˆÀ°2, {²”ü—²Žj1, “¿‰iŸŽm1, “àÀ‰hŽ÷2, ‚ŒË@‹B1 (1“Œ‹ž‘å. 2Œ`ŠOj: ‘æ13‰ï“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2004/10/21), ‰YˆÀ.

723616. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘«æäæ“V«Œ`‘ÔˆÙ펾Š³‚É‚¨‚¯‚éHOXD13ˆâ“`Žq‚̉ðÍ. ’†–ì‘ãŽq1, Žðˆä’¼•F1, ŽRŽRšòˆÀ°1, “nç²GˆÉ2, {²”ü—²Žj2, ‚ŒË@‹B2, “¿‰iŸŽm, “àÀ‰hŽ÷1 (1Œ`ŠO. 2“Œ‹ž‘åj: ‘æ13‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2004/10/21), ‰YˆÀ.

723617. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘Ù¶Šúƒ}ƒEƒX–j•EŠíŠ¯”­¶‚É‚¨‚¯‚éVEGF‚̉e‹¿. •Ÿ“c—ŠGŽq, —Ñ@˜aO, “àÀ‰hŽ÷ (Œ`ŠO): ‘æ13‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2004/10/21), ç—t. ƒvƒƒOƒ‰ƒ€¥´˜^W, p.89, 2004.

723618. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “îœ×–E‚Ì‘BE•ª‰»‚ð—U“±‚·‚é‰t«ˆöŽq‚Ì‘g‚݇‚킹‚ÌÅ“K‰». ‚‹´Žk–¾1, ¬Š}Œ´@“O2, “A@—Yˆê3, ìŒû@_3, ’†‘ºkŽO3, “àÀ‰hŽ÷1, ‚ŒË@‹B3, ¯@˜al2 i1Œ`ŠO. 2“Œ‹ž‘åE‰@. 3“Œ‹ž‘å•a‰@j: ‘æ13‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2004/10/21), ‰YˆÀ.

723619. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒŒ[ƒU[•‚q‚e‚É‚æ‚é rejuvenationŽ¡—Ã. ŽR‰º—ŠG1,2, ˆêŽr¢1, ‰““¡‚ ‚©‚Ë1, ¼––•—Y2, ™–{‰À2, Žðˆä@‹K2, “àÀ‰hŽ÷1 (1Œ`ŠO. 2Ó슙‘q‘‡•a‰@: “ú–{ƒŒ[ƒU[ˆãŠw‘å‰ï (2004/11/11), “Œ‹ž.

723620. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰t‘Ì’‚‘f‚É‚æ‚éŽèŽw“€‚Ì1—á. ¼”ö‚ ‚¨‚¢1, —é–Ø•q•F2, ‚–ì’mŽq1, “àÀ‰hŽ÷1 (1Œ`ŠO. 2‰¡•l“실ϕa‰@): ‘æ52‰ñ“ú–{E‹ÆEЊQˆãŠw‰ïŠwp‘å‰ï (2004/11/11), ‰ªŽR.

723621. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‚¢‚í‚ä‚éwŽ‚¿ž‚ÝåñáŒx‚ɑ΂·‚éWŠw“IŽ¡—Â̎Ž‚Ý. [ˆäF˜Y, •“c@Œ[ (Œ`ŠO): ‘æ34‰ñ“ú–{‘nŽ¡–üŠw‰ï (2004/11/29), ‹à‘ò.

723622. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒqƒg“îœ×–E‚Ì‘B‘£i‚¨‚æ‚Ñ’E•ª‰»—}§‚ðŽÀŒ»‚·‚é”|—{•û–@‚ÌŒŸ“¢. ‚‹´Žk–¾1, ¬Š}Œ´@“O2, —«@Œõ—s2, ŽR‰ª®¢2, “A@—Yˆê3, ’©ŒË—T‹M3, ìŒû@_3, ’†‘ºkŽO3, “àÀ‰hŽ÷1, ‚ŒË@‹B3, ¯@˜al2 i1Œ`ŠO. 2“Œ‹ž‘åE‰@. 3“Œ‹ž‘å•a‰@j: ‘æ4‰ñ“ú–{Ķˆã—Êw‰ï (2005/3/1), ‘åãŽs.

732043. [Œ¤‹†‰ï] (µ‘Òu‰‰) ”ü—eŠO‰È‚Å‚Ìanti-agingŽ¡—Ã. ŽR‰º—ŠG (Ó슙‘q‘‡•a‰@, Œ`¬): ‘æ3‰ñ‚È‚È‚­‚ܔ畆”ü—eƒtƒH[ƒ‰ƒ€ (2004/6/26), •Ÿ‰ª.

732044. [Œ¤‹†‰ï] (µ‘Òu‰‰) acial rejuvenation: ”ü—eŠO‰È‚Å‚Ìanti-agingŽ¡—Ã. ŽR‰º—ŠG (Ó슙‘q‘‡•a‰@, Œ`¬): ‘æ19‰ñŒÕƒm–å”畆ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2004/7/23), “Œ‹ž.

732045, [Œ¤‹†‰ï] (µ‘Òu‰‰) “ú푘‹ö‚·‚鬊O‰È“IŽ¾Š³‚Æåñጎ¡—ÃÅ‹ß‚Ì’mŒ©. [ˆäF˜Y (Œ`ŠO): –k‘«—§ŒSŽsˆãŽt‰ï (2004/11/19), ‰±ì.

732046. [Œ¤‹†‰ï] (µ‘Òu‰‰) ŠO‰ÈƒTƒCƒh‚©‚猩‚½‹¸³Ž•‰Èˆã‚Ƃ̘AŒg. ŽRŽRšòˆÀ° (Œ`ŠO): “Œ‹žˆã‰ÈŽ•‰È‘åŠwŠ{Šç–Ê‹¸³Šw•ª–쓯–å‰ïŽåÃ@‘æ“ñ‰ñŠ{Šç–Ê‹¸³Šw•ª–ì•“¯–å‰ï‡“¯ƒZƒ~ƒi[ (2005/2/17), “Œ‹ž.

733253. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒIƒLƒVƒ~ƒXƒg‚ðŽg—p‚µ‚½åñጎ¡—ÃŒø‰Ê. ‚–ì’mŽq1, —é–Ø•q•F2. ¼”ö‚ ‚¨‚¢1 (1Œ`ŠO. 2‰¡•l“실ϕa‰@j: ‘æ5‰ñ‰¡•lŒ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2004/5/12), ‰¡•l.

733254. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ”w•”‚Æ• •”‚ɓ«’×ᇂ𶂶‚½1—á. –î‘òŒcŽj, ‘å’J’˱”V, ’†‘º@Œ’ (Œ`ŠO): “ú–{Œ`¬ŠO‰ÈŠw‰ï’†•”Žx•”MB’n•û‰ï48‰ñ—á‰ï (2004/6/5), ¼–{Žs.

733255. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘Sg«‰ŠÇ”½‰ž«ÇŒóŒQ‚É”º‚¤‹}«”xáŠQ‚ð”­Ç‚µ‚½dÇ”M‚Ì2—á. ’†‘º@Œ’1, ‘å’J’˱”V1, ŽÄ“c’m‹`1, —L”n—TŽq, –î‘òŒcŽj1, ‰ª“c–M•F2 (1Œ`ŠO. 2JA’·–ìŒú¶˜A²‹v‘‡•a‰@j: ‘æ17‰ñ“ú–{”MŠw‰ïbM’n•û‰ï (2004/7/10), b•{Žs.

733256. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‰–Ž_‚É‚æ‚éL”͈͉»Šw”M‚ÌŽ¡—ÃŒoŒ±. âV“¡’qq1, “c’†³‰p2, ‚ŽR“ÖŽq1, “àÀ‰hŽ÷1 (1Œ`ŠO. 2–kM‘‡•a‰@): ‘æ17‰ñ“ú–{”MŠw‰ïbM’n•û‰ïŠwpW‰ï (2004/7/10), ¼–{Žs.

733257. [ŒöŠJuÀ] (ˆê”Êu‰‰) ‚ ‚´E‚µ‚ÝE‚Ù‚­‚ë‚Å‚¨”Y‚Ý‚Ì•û‚Ö. ŽOD@G (Œ`ŠO): ¬“c‹}•S‰Ý“X—F‚̉NuÀ (2004/7/20), “Œ‹ž.

733258. [ŒöŠJuÀ] (ˆê”Êu‰‰) Œ`¬ŠO‰È‚ÌŽæ‚舵‚¢Ž¾Š³‚ɂ‚¢‚Ä. ‚£@Å (Œ`ŠO): ŒöŠJuÀ (2004/7/23), ‰¡•l.

733259. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒTƒEƒi‚É‚æ‚é”M‚Ì1—á. ŒFàVŒ›ˆê1, H–{•ôŽ1, ”–ØT–ç1, ª–{@[1, “àÀ‰hŽ÷1, ‘Š”nˆêˆå2 (1Œ`ŠO. 2‹~–½j: ‘æ12‰ñVh”MƒtƒH[ƒ‰ƒ€(2004/9/10), Vh.

733260. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒgƒŒƒ`ƒmƒCƒ“EƒnƒCƒhƒƒLƒmƒ“‚Ì•¹—pŠO—p—Ö@‚̉ž—p|”ìŒú«á­EŠOŒãF‘f’¾’…‚ɑ΂·‚éŒø‰Ê|. —é–Ø•q•F1, ‚–ì’mŽq2, ¼”ö‚ ‚¨‚¢2 (1‰¡•l“실ϕa‰@. 2Œ`ŠO): ‘æ5‰ñ‰¡•lŒ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2004/9/25), ‰¡•l.

733261. [ŒöŠJuÀ] (ˆê”Êu‰‰) ‚ ‚´E‚µ‚ÝE‚Ù‚­‚ë‚Å‚¨”Y‚Ý‚Ì•û‚Ö. ŽOD@G (Œ`ŠO): ¬“c‹}•S‰Ý“X—F‚̉NuÀ (2004/10/19), “Œ‹ž.

733262. [Œ¤‹†‰ï] (ˆê”Êu‰‰) —cŽ™Šú‚Ì‹¹•”ŒŒŠÇŽîØœŒã‚ɶ‚¶‚½“û–[•ÏŒ`‚ÌŽ¡—Ã. Ε‹§Žj1, ŠâéŒ[C2, –î‘òŒcŽj2, ‘“c—³Ž™2, “àÀ‰hŽ÷2 (1ã”ö’†‰›‘‡•a‰@. 2Œ`ŠO): _“ÞìǗጟ“¢‰ï (2004/11/10), ìè.

733263. [§˜b‰ï] (ˆê”Êu‰‰) “ÁŽê‚ÈŒ`‘Ô‚ð’æ‚·‚éΊD‰»ã”çŽî‚ɂ‚¢‚Ä. ’†‘º@Œ’1, ‘å’J’˱”V1, –î‘òŒcŽj1, ÂŽRO“¹2 (1Œ`ŠO. 2JA’·–ìŒú¶˜A²‹v‘‡•a‰@j: ‘æ6‰ñ“Œ–kMŒ`¬ŠO‰È§˜b‰ï (2004/11/12), ’·–ìŽs.

733264. [ŒöŠJuÀ] (ˆê”Êu‰‰) Šª‚«’Ü‚ÌV‚µ‚¢Ž¡—Ã. ŽOD@G (Œ`ŠO): ¬“c‹}•S‰Ý“X—F‚̉NuÀ (2004/11/16), “Œ‹ž.

733265. [Œ¤‹†‰ï] (ˆê”Êu‰‰) dÇ”M‚ɑ΂·‚éƒGƒ‰ƒXƒ|[ƒ‹‚ÌŽg—pŒoŒ±. ‰““¡‚ ‚©‚Ë1, ŽR‰º—ŠG2, ˆêŽr¢1, ¼––•—Y2, ™–{‰À1, Žðˆä@‹K2 (1Œ`ŠO. 2Ó슙‘q‘‡•a‰@. j: ‘æ7‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2004/11/20), ‰¡•l.

733266. [Œ¤‹†‰ï] (ˆê”Êu‰‰) •¡”‚Ì”ç•Ù‚ð—p‚¢‚½‘S‹¹ŠsŒ`¬p‚Ì1—á. ”nêŽq1, ŽÄ“c—T’B2, –Ñ—˜–ƒ—¢1, “àÀ‰hŽ÷1 (1Œ`ŠO. 2‰¡•lŽs–¯•a‰@j: ‘æ7‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2004/11/20), ‰¡•l.

733267. [Œ¤‹†‰ï] (ˆê”Êu‰‰) dÇ”xáŠQ‚ɊׂÁ‚½‘Sg”M‚Ì3—á. –î‘òŒcŽj1, ‘å’J’˱”V1, ’†‘º@Œ’1, ÂŽRO“¹2 (1Œ`ŠO. 2JA’·–ìŒú¶˜A²‹v‘‡•a‰@j: ‘æ7‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2004/11/20), ‰¡•l.

733268. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŠO‰A•”‘BŠà‚Ì1—á. ²“¡Žj˜Y1, ª–{@[2, ‚貋v1 (1϶‰ï‰ºŠÖ‘‡•a‰@. 2Œ`ŠOj: ‘æ7‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2004/11/20), ‰¡•l.

733269. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Wound healing process of full-thickness skin wound model by rat. ’¹‹”ŽŽq, •“c@Œ[, ‘]ª—R”üŽq, “àÀ‰hŽ÷ (Œ`ŠO): ‘æ7‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2004/11/20), ‰¡•l.

733270. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Ž¨‰º‘B“àŠç–Ê_ŒoâŽî‚Ì1—á. ‚–ì’mŽq1, —é–Ø•q•F2, ¼”ö‚ ‚¨‚¢1 (1Œ`ŠO. 2‰¡•l“실ϕa‰@j: ‘æ7‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2004/11/20), ‰¡•l.

733271. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Œy”÷‚ÈŠOŒãÄ”­‚ðŒJ‚è•Ô‚·ãŽi“«”畆’×ᇂÌ1—á. Š–ì^Žq1, £ŽRšòWˆê˜Y1, —L”n—TŽq1, –ö˜a–ç1, H–{•ôŽ1, ŽÄ“c’m‹`1, “àÀ‰hŽ÷1, ‚{@”Ž2 (1Œ`ŠO. 2”ç): _“ÞìǗጟ“¢‰ï (2004/11/27), ìè.

733272. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚éŽè•”™ù‚ÌŒŸ“¢. ÂŽRO“¹1, ‘å’J’˱”V2, ’†‘º@Œ’2, –î‘òŒcŽj2 (1JA’·–ìŒú¶˜A²‹v‘‡•a‰@. 2Œ`ŠO): “ú–{Œ`¬ŠO‰ÈŠw‰ï’†•”Žx•”MB’n•û‰ï‘æ49‰ñ—á‰ï (2004/12/4), z–KŒS•xŽmŒ©’¬.

733273. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒWƒFƒbƒg•¬ŽËŽ®ôòŠí‚ɂĎ󂵂½Šáâ|“àˆÙ•¨‚Ì1—á. ‹ž’JŽ÷Žq1, “c’†³‰p2, ‚ŽR“ÖŽq1, âV“¡’qq1, “àÀ‰hŽ÷1 (1Œ`ŠO. 2–kM‘‡•a‰@): ‘æ44‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï’†•”Žx•”MB’n•û‰ï (2004/12/4), z–KŒS•xŽmŒ©’¬.

733274. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) F‘f«Š£”çÇ‚Ì1–UŒŸ—á. “c’†³‰p1, ‚ŽR“ÖŽq2, âV“¡’qq2, ‹ž’JŽ÷Žq, “àÀ‰hŽ÷2 (1–kM‘‡•a‰@. 2Œ`ŠO): ‘æ44‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï’†•”Žx•”MB’n•û‰ï (2004/12/4), z–KŒS•xŽmŒ©’¬.

733275. [ŒöŠJuÀ] (ˆê”Êu‰‰) ‚ ‚´E‚µ‚ÝE‚Ù‚­‚ë‚Å‚¨”Y‚Ý‚Ì•û‚Ö. ŽOD@G (Œ`ŠO): ¬“c‹}•S‰Ý“X—F‚̉NuÀ (2005/1/18), “Œ‹ž.

733276. [‚»‚Ì‘¼] (ˆê”Êu‰‰) Œ`¬ŠO‰È‚Á‚Ä‚È‚ ‚É. ’¹‹”ŽŽq (Œ`ŠO): ’nˆæŽx‰‡•×‹­‰ï (2005/2/8), ‘Š–ÍŒ´.

733277. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ˆãŒ´«•úŽËü’×ᇂÆl‚¦‚ç‚ꂽ‰E•I“«’×ᇂÌ1—á. ’†‘º@Œ’, ‘å’J’˱”V, –î‘òŒcŽj (Œ`ŠO): ‘æ1‰ñ i“Œ–kMj ”畆’×á‡Ç—ጟ“¢‰ï (2005/2/10), ’·–ìŽs.

733278. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ’YŽ_ƒKƒXƒŒ[ƒU[‚ð—p‚¢‚½Š×“ü’Ü‚ÌŽ¡—Ã. Ε‹§Žj1, –î‘òŒcŽj2, ŠâéŒ[C2, ‘“c—³Ž™2, “àÀ‰hŽ÷2, ã–쑈ê˜Y1 (1ã”ö’†‰›‘‡•a‰@. 2Œ`ŠOj: ‘æ42‰ñé‹ÊŒ§ˆãŠw‰ï‘‰ï (2005/2/27), ìè.

733279. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) V‚µ‚¢åñ጗\–hƒ}ƒbƒgƒŒƒXu‚»‚æ‚©‚ºv‚É‚¨‚¯‚é—Õ°ŽÀŒ±“I•]‰¿. [ˆäF˜Y (Œ`ŠO): ‘æ42‰ñé‹ÊŒ§ˆãŠw‰ï‘‰ï (2005/2/27), ‚³‚¢‚½‚ÜŽs.

733280. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “û—cŽ™Šú‚É”­Ç‚µ‚½Œûo“àŽîᇂÌ2—á. ’†‹v–ØNˆê1, Žðˆä’¼•F1, ŽRŽRšòˆÀ°1, ’†–kMº1, Š–ì^Žq1, “¿“c^‹IŽq, —L”n—TŽq, ‰““¡‚ ‚©‚Ë1, ŽÄ“c’m‹`1, “àÀ‰hŽ÷1 (1Œ`ŠO): ‘æ241‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠÖ“ŒŽx•”“Œ‹ž’n•û‰ï (2005/3/5), “Œ‹ž.

733281. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ŠááÙ‰º‚‚ð’悵‚½ãŠááÙƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á. –ö˜a–ç, —Ñ@˜aO, ”–ØT–ç, ”nêŽq, ‹ž’JŽ÷Žq, “àÀ‰hŽ÷ (Œ`ŠO): ‘æ241‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠÖ“ŒŽx•”“Œ‹ž’n•û‰ï (2005/3/5), “Œ‹ž. “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 24 (6): 399, 2004.

733282. [ŒöŠJuÀ] (ˆê”Êu‰‰) ‚Ü‚Ô‚½‚Ì‚½‚é‚݂ɂ‚¢‚Ä. ŽOD@G (Œ`ŠO): ¬“c‹}•S‰Ý“X—F‚̉NuÀ (2005/3/10), “Œ‹ž.

733283. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒPƒƒCƒhE”ìŒú«á­‚Ì‘gD“à‚É‚¨‚¯‚é‘BˆöŽq”­Œ»‚̉ðÍ. –Ñ—˜–ƒ—¢1, Žðˆä’¼•F1, “àÀ‰hŽ÷1, ²“¡—Yˆê2 (1Œ`ŠO. 2ˆã‰qj: ‘æ11‰ñƒPƒƒCƒhE”ìŒú«á­Œ¤‹†‰ï (2005/3/12), “Œ‹ž. ƒvƒƒOƒ‰ƒ€—\eW, p.7, 2005.

733284. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŠO—ˆf—Âɂ¨‚¯‚é‘nˆ’u‚ɂ‚¢‚Ä. ’¹‹”ŽŽq (Œ`ŠO): ‘Š–ÍŒ´ˆãŽt‰ïŠO‰Èˆã‰ï (2005/3/25), ‘Š–ÍŒ´.


<<”畆‰ÈŠw>>

mŠwp˜_•¶n

110155. [Œ´’˜] Eosinophilic pustular folliculitis (Ofuju disease) manifested as pustules on the palms and soles. ’؈äœA”ü, VŽRŽj˜N, Ÿ‰ªŒ›¶ (”ç): Cutis, 74 (8): 107-110, 2004.

110156. [Œ´’˜] Acquired reactive perforating collagenosis in a patient with lung fibrosis. ’؈äœA”ü1, Œü–ì@“N1, ²“¡’¼Æ1, Ÿ‰ªŒ›¶1, Yanase N (1”ç): Journal of Dermatol, 31 (11): 916-919, 2004.

110157. [Œ´’˜] Nascent blood vessels in the skin arise from nestin-expressing hair-follicle cells. “V‰HN”V1, Lingna Li2, Meng Yang2, AR Moossa2, Ÿ‰ªŒ›¶1, Sheldon Penman3, Robert M Hoffman2 (1”ç. 2AntiCancer, Inc., San Diego, CA; Department of Surgery, University of California San Diego, CA. 3Department of Biology, Massachusetts Institute of Technology, Cambridge, MA): Proceedings of the National Academy of Sciences of the USA, 101: 13291-13295, 2004.

110158. [Œ´’˜] Hair follicle-derived blood vessels vascularize tumors in skin and are inhibited by doxorubicin. “V‰HN”V1, Lingna Li2, Meng Yang2, Ping Jiang2, AR Moossa2, Ÿ‰ªŒ›¶1, Robert M Hoffman2 (1”ç. 2AntiCancer, Inc., San Diego, CA; Department of Surgery, University of California San Diego, CA): Cancer Research, 65: 2337-2343, 2005.

110159. [Œ´’˜] Dual-color fluorescence imaging of tumor-host interaction with green and red fluorescent proteins. Meng Yang1, “V‰HN”V1,2, Lingna Li1, Eugene Baranov1, Jinwei Wang1, Ping Jiang1, AR Moossa2, Robert M Hoffman1,2 (1AntiCancer, Inc., San Diego, CA. 2Department of Surgery, University of California San Diego, CA.): Proceedings of the SPIE, 5329: 54-60, 2004.

120055. [Œ´’˜] Livedo reticularis with summer ulceration‚̉ċG’×ᇂɑ΂·‚é‚©‚ñ‚Û‚¤’ƒ‚Ì—\–hŒø‰Ê. ‘àVŠ²’j, ‘àV^ŽÀŽq, ‘O“cˆŸŠóŽq, ‹{“c‘Žq, Ÿ‰ªŒ›¶ (”ç): “ú–{”畆‰ÈŠw‰ïŽGŽ, 115 (1): 7-13, 2005.

120056. [Œ´’˜] R^‹ÛÜ (terbinafine hydrochloridej ‚̬lŒ^ƒAƒgƒs[«”畆‰ŠŠ³ŽÒ‚ÌŠç–Ê•a•Ï‚ɑ΂·‚é—L—p«‚ÌŒŸ“¢|Mallassezia furfur“ÁˆÙIgER‘̉¿‚¨‚æ‚уqƒXƒ^ƒ~ƒ“—V—£ŽŽŒ±‚Ì„ˆÚ‚É‚æ‚錟“¢|. ‘O“‡‰pŽ÷1, “¿‰içt2, ‹àŽq@‘2, ŒüˆäGŽ÷2, ˆ¢•”–¾•v3 (1”ç. 2‰¡•l˜JЕa‰@”畆‰È. 3(Š”) SBS): ƒAƒŒƒ‹ƒM[, 53 (5): 515`521, 2004.

120057. [Œ´’˜] •\‘è:ƒKƒ“ƒ}ƒOƒƒuƒŠƒ“‚Ì‘å—Ê“Š—^‚ðŽŽ‚Ý‚½‹}‘¬is«ŠÔŽ¿«”x‰Š‚Ì•¹”­‚ª‚Ý‚ç‚ꂽ”畆‹Ø‰Š. ‘O“‡‰pŽ÷1, “ˆ‘º—S”ü2, ꎓ¡˜a”ü2, Œ´“c°”ü2, ‰q“¡@Œõ2 i1”ç. 2¹˜H‰Á‘Û•a‰@j: ¼“ú–{”畆‰È, 66 (3): 226-231, 2004.

210024. [€Œ´’˜] Observations on angiopoietin-2 in patients with angiosarcoma. “V‰HN”V, ‘àVŠ²’j, •l“c—SŽq, Ÿ‰ªŒ›¶ (”ç): :British Journal of Dermatology, 150: 1028-1029, 2004.

220050. [€Œ´’˜] ¶Œã‚Tƒ–ŒŽ’jŽ™‚ɶ‚¶‚½’P”­«‚ÌŠ¾EŠp‰»Ç. ’؈äœA”ü, Ÿ‰ªŒ›¶ (”ç): ”畆‰È‚Ì—Õ°, 47 (3): 492-493, 2004.

220051. [€Œ´’˜] “–‰È‚É‚¨‚¯‚éŠÖßÇ«Š£á. ‘O“‡‰pŽ÷, ‘hŒ´‚µ‚Ì‚Ô, ²“¡Š¨Ž¡, êŽâÙ“T[, Ÿ‰ªŒ›¶ (”ç): ‘æ19‰ñ“ú–{Š£áŠw‰ï‹L˜^W, 113-114, 2004.

220052. [’Z•ñ] ŠÂóg”Á@SjoegrenÇŒóŒQ. “c•Ó‚Ý‚Ç‚è (”ç): ”畆•af—Ã, 26: 47, 2004.

220053. [’Z•ñ] V¶Ž™ƒGƒŠƒeƒ}ƒg[ƒfƒX. “í@@•‘ (”ç): ”畆•af—Ã, 26 (‘): 50, 2004.

310016. [Ç—á•ñ] Microscopic Polyangiitis Presenting Urticarial Erythema and Henoch-Schnolein Purpura, Two cases report. ‘O“‡‰pŽ÷1, ”’ˆä‹ž”ü1, Yumi Shimamura2, Harumi Harada2, Hikaru Eto2 i1”ç. 2Department of Dermatology, St' Luke's International Hospitalj: Journal of Dermatology, 31 (8): 655-660, 2004.

310017. [Ç—á•ñ] A case of intractable ulcer in the lower leg that began with congestive dermatitis. ꎓ¡“T[1, ]ŠÔ@‘1, ‘àV^ŽÀŽq1, Ÿ‰ªŒ›¶1, Masayoshi Kinjyo2 (1”ç. 2Ó쓌•”•a‰@): Breakthrough in The Treatment for Critical Limb Ischemia in Japan, p.73-78, 2004.

310018. [Ç—á•ñ] Angiotropic B-cell lymphoma with telangiectasia,accompanied by panniculitic formation. ¼ŽR_”ü1,2, Tanei Ryoji2, Motegi Takashi2, Ohta Masatsugu2, Sawabe Motoji2 (1”ç. 2Tokyo Metropolitan Geriatric Hospital): Journal of Dermatology, 31 (12): 1032-1035, 2004.

320055. [Ç—á•ñ] Ž„‚ÌŒoŒ±‚µ‚½ƒjƒAƒ~ƒXEƒsƒbƒgƒtƒH[ƒ‹Ç—áu”Ä”­«”S‰t…Žîv. Ÿ‰ªŒ›¶ (”ç): Allergy & Clinical Conference, 24: 2, 2005.

320056. [Ç—á•ñ] ƒCƒvƒVƒƒ“ƒAƒ~ƒmƒJƒvƒƒ“Ž_‚É‚æ‚éÚG”畆‰Š‚Ì1—á. ‹{“c‘Žq1, ’†‘º”ü‰Ä1, ‘àVŠ²’j1, Ÿ‰ªŒ›¶1, ‘ë@‰ÀŽq2 (1”ç. 2‚³‚ª‚ݶ‹¦Šá‰È): ”畆‰È‚Ì—Õ°, 47 (2): 270-271, 2004.

320057. [Ç—á•ñ] ƒÀƒJƒƒ`ƒ“‚É‚æ‚銹”çÇ. Vˆä@’B1, ŒüˆäGŽ÷2 (1”ç. 2‰¡•l˜JЕa‰@j: ”畆•af—Ã, 26 (8): 1015-1018, 2004.

320058. [Ç—á•ñ] Microvenular hemangioma. ꎓ¡“T[, VŽR“ÞXŽq, Ÿ‰ªŒ›¶ (”ç): ”畆•af—Ã, 27 (2): 151-154, 2005.

320059. [Ç—á•ñ] “ª•”lHA–Ñ”^”çÇ. ꎓ¡“T[, Œü–ì@“N, Ÿ‰ªŒ›¶ (”ç): ”畆•af—Ã, 27 (3): 245-248, 2005.

320060. [Ç—á•ñ] pseudopelade. ꎓ¡“T[, ’؈äœA”ü, Ÿ‰ªŒ›¶ (”ç): ”畆•af—Ã, 27 (3): 269-272, 2005.

320061. [Ç—á•ñ] ÂFƒSƒ€‚Ü‚è—l•ê”ÁÇŒóŒQ. VŽRŽj˜N1, ¼–{‹žŽq2, ‰Á“¡ˆê˜Y2, ŒüˆäGŽ÷2 i1”ç. 2‰¡•l˜JЕa‰@j: ”畆•af—Ã, 26: 341-344, 2004.

320062. [Ç—á•ñ] Buerger•a. VŽRŽj˜N1, ŒüˆäGŽ÷2, Š‹¼–M”Ž3 i1”ç. 2‰¡•l˜JЕa‰@. 3çΔ畆‰È): ”畆•af—Ã, 26: 1403-1406, 2004.

320063. [Ç—á•ñ] uŠÂó‚ð’æ‚·‚é”畆•a•Ïv–Ô–Úó•a•Ï livedo vasculitis. ‘O“‡‰pŽ÷, Ÿ‰ªŒ›¶ (”ç): Visual Dermatology, 4 (2): 174-175, 2005.

320064. [Ç—á•ñ] Keratotic basal cell carcinoma‚𔺂Á‚½ŠO–Ѫ⫔XŽî‚̈ê—á. “V‰H N”V1, ì–ìMŽq2, ‚{@”Ž1 (1”ç. 2ˆî“c“oŒË•a‰@): ”畆‰È‚Ì—Õ°, 44 (4): 465-468, 2004.

320065. [Ç—á•ñ] Ž•‰ÈÞ—¿’†‚̃†[ƒWƒm[ƒ‹‚É‚æ‚鑽Œ^Ÿøo«g”ÁŒ^ÚG”畆‰Š. “í@•‘, ‚{@”Ž, Ÿ‰ªŒ›¶ (”ç): ”畆•af—Ã, 26 (7): 825-828, 2004.

320066. [Ç—á•ñ] ”S•\”çŠà imucoepidermoid carcinomaj. ’·‹´˜a–î, •y“c¹G, ꎓ¡“T[, ‚{@”Ž, Ÿ‰ªŒ›¶ (”ç): ”畆•af—Ã, 26 (4): 431`434, 2004.

320067. [Ç—á•ñ] Stevens-JhonsonÇŒóŒQ. ’·‹´˜a–î (”ç): ”畆•af—Ã, 26 (‘): 37, 2004.

320068. [Ç—á•ñ] •ÂÇ«“®–¬d‰»Ç. ˆÀåY—Ljê1,2, óˆäŽõŽq2, VˆätŽ}3 i1”ç. 2¹˜H‰Á‘Û•a‰@. 3‘å˜aŽs—§•a‰@j: ”畆•af—Ã, 27 (1): 47-50, 2005.

320069. [Ç—á•ñ] ŠÖ߃ŠƒEƒ}ƒ`‚É”º‚Á‚½’×á‡. ]“¡GŒõ, Vˆä@’B, Ÿ‰ªŒ›¶ (”ç): ”畆•af—Ã, 27 (1): 59-62, 2005.

320070. [Ç—á•ñ] œ‘«ƒvƒƒgƒ|ƒ‹ƒtƒBƒŠƒ“Ç. —é–Ø—‰Ø1, Vˆä@’B1, ŠÃ—˜@~, Ÿ‰ªŒ›¶1 (1”ç): ”畆•af—Ã, 26 (10): 1257-1260, 2004.

320071. [Ç—á•ñ] HIV—z«Š³ŽÒ‚Ì‘æ‡UŠúŒ°«”~“Å. —é–Ø—‰Ø, ’؈äœA”ü, Ÿ‰ªŒ›¶ (”ç): ”畆•af—Ã, 26 (11): 1379-1382, 2004.

520189. [‰ðà] ƒŠƒxƒh. Ÿ‰ªŒ›¶ (”ç): ŠÖ“Œ”畆–¬ŠÇ§˜b‰ï ‹L˜^W1, 1: 30-31, 2004.

520190. [uÀ] Livedo. Ÿ‰ªŒ›¶ (”ç): ”畆‰È‚Ì—Õ°, 47 (1): 5-6, 2005.

520191. [‘à] erythema papulatum centrifugum. ‘àVŠ²’j (”ç): ”畆•af—à g”Á‚Ì‚Ý‚ç‚ê‚é”畆Ž¾Š³, (‘): 56, 2004.

520192. [‘à] ”²–ÑÇ. ’؈äœA”ü (”ç): –Ñ”¯Ž¾Š³‚ÌÅVŽ¡—Ã@Šî‘b‚Æ—Õ° (A–Ñ), p.60-61, 2004.

520193. [‘à] ”²–ÑÇ ƒJƒ‰[ƒOƒ‰ƒt. ’؈äœA”ü (”ç): “ú–{ˆãŽ–V•ñ, 4203: 33-36, 2004.

520194. [‘à] –Ñ”¯Ž¾Š³. V¶Ž™E¬Ž™”畆Ž¾Š³ƒ}ƒjƒ…ƒAƒ‹. ‘æ4•”@”äŠr“I‹H‚ÈŽ¾Š³. ’؈äœA”ü (”ç): MB derma, 93: 225-230, 2004.

520195. [‘à] ƒJƒ‰[ƒAƒgƒ‰ƒXg”Á‚Ì‚Ý‚ç‚ê‚é”畆Ž¾Š³. ‚{@”Ž (”ç): ”畆•af—Ã, 26 (‘): 87, 2004.

520196. [‘à] Gottron’¥Œó. Vˆä@’B (”ç): ”畆•af—Ã, 26 (11): 1369-1374, 2004.

520197. [‘à] Churg-StraussÇŒóŒQ. Vˆä@’B, Ÿ‰ªŒ›¶ (”ç): ”畆‰È‚Ì—Õ°, 46 (10): 1454-1459, 2004.

520198. [‘à] ‚·‚ׂĂ̬Ž™”畆‹Ø‰Š‚ɑ΂µ‚ÄÏ‹É“I‚ÈŽ¡—Ã‚ð‚·‚×‚«‚Å‚Í‚È‚¢. Vˆä@’B1, ‰q“¡@Œõ2 (1”ç. 2¹˜H‰Á‘Û•a‰@j: Visual dermatology, 3 (11): 1220-222, 2004.

520199. [‘à] “§ÍŠ³ŽÒ‚É‚Ý‚ç‚ê‚é’E–Ñ. ꎓ¡“T[, Ÿ‰ªŒ›¶ (”ç): Visual Dermatology, 3 (5): 485-487, 2005.

520200. [‰ðà] f’f‚ÌŽwjEŽ¡—Â̎wjg“à‘Ÿˆ««Žîᇂ̔畆Çóh. ‘O“‡‰pŽ÷, Ÿ‰ªŒ›¶ (”ç): ‘‡—Õà¬, 53 (10): 2747-2749, 2004.

520201. [‘à] g”Á‚Ì‚Ý‚ç‚ê‚é”畆Ž¾Š³@“€áŒ. ‘àV^ŽÀŽq (”ç): ”畆•af—Ã, 26 (‘): 24, 2004.

520202. [‘à] g”Á‚Ì‚Ý‚ç‚ê‚é”畆Ž¾Š³ƒAƒgƒ‰ƒX@’O“Å. à_¼“ÞXŽq (”ç): ”畆•af—Ã, 26 (‘): 14, 2004.

m’˜@‘n

620123. [Šwp‘] (‹¤’˜) ”畆Ž¾Š³ÅV‚ÌŽ¡—Ã2005-2006; ‰óŽ€«‹Ø–Œ‰ŠCƒKƒX‰óás, p.145. Ÿ‰ªŒ›¶ (”ç), •ÒW ‘ëì‰ë_ i•l¼ˆã‘åj, “n•ÓWˆê i’é‹ž‘åj, “ì]“°, “Œ‹ž, 2004”­s.

620124. [‚»‚Ì‘¼ iƒz[ƒ€ƒy[ƒWj] (’P’˜) Œ’Nî•ñŽ¢self doctor£; ¢ƒŠƒAƒbƒv”­–у}ƒ‰ƒ\ƒ“£. Ÿ‰ªŒ›¶ (”ç), •ÒW ƒWƒƒƒpƒ“ƒ‰ƒCƒtƒfƒUƒCƒ“ƒVƒXƒeƒ€ƒYƒZƒ‹ƒtƒhƒNƒ^[•ÒWŽº, ‘å³»–ò, “Œ‹ž, 2004/9-2005/5.

620125. [Œ[–Ö‘] (’P’˜) –¯•ñ, —¤‰œV•ñ, ‹ú˜HV•·, —®‹…V•ñ; –û’f‚Å‚«‚È‚¢‚ ‚¹‚à. Ÿ‰ªŒ›¶ (”ç), •ÒW ƒƒfƒBƒJƒ‹ƒgƒŠƒrƒ…[ƒ“Eƒjƒ…[ƒX•ÒW•”, ƒƒfƒBƒJƒ‹ƒgƒŠƒrƒ…[ƒ“, “Œ‹ž, 2004/6”­s.

620126. [Ž‹’®Šoo”Å•¨] (’P’˜) ƒwƒ‹ƒV[ƒƒ‚¢‚µ‚ÝE‚»‚΂©‚·‘Îô£, p.1-10. Ÿ‰ªŒ›¶ (”ç), •ÒW NHKƒT[ƒrƒXƒZƒ“ƒ^[, “Œ‹ž, 2004/7”­s.

620127. [‚»‚Ì‘¼‚Ì’˜‘] (‹¤’˜) Derma Hotline –Ñ”¯‰ÈŠwÅ‘Oü@‘nŠ§†; ’E–ÑÇ‚ÌŽ¡—Â̌»ó‚Æ«—ˆ, p.2-11. Ÿ‰ªŒ›¶ (”ç), •ÒW ¬ìG‹» i‡“V“°‘åj, Ÿ‰ªŒ›¶, r£½Ž¡ i“¿“‡‘åj, 쓇@áÁ i“Œ‹ž—ˆã‘åj, ’؈ä—ÇŽ¡ i“Œ‹žˆã‘åj, (Š”) ƒeƒBƒGƒ‹ƒGƒ€ƒWƒƒƒpƒ“, “Œ‹ž, 2005/1”­s.

620128. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M3•Å•ª) ŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; ‡]‡V 9. ”畆‰È—p܉ðà. ‚{@”Ž (”ç), •ÒW ΋´@W i‹~¢ŒRƒu[ƒX‹L”O•a‰@j, “¡“cŒbŽq iŠÅŒì•”j ‚Ù‚©, ’†‰›–@‹K, 2005/3/10”­s.

620129. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M3•Å•ªj “œ”A•aÅV‚ÌŽ¡—Ã2004-2006•ª; ‡]‡V‚»‚Ì‘¼‚̇•¹Ç 5. ”畆•a•Ï. Vˆä@’B, Ÿ‰ªŒ›¶ (”ç), •ÒW ‰Í·—²‘¢ i‡“V“°‘åj, Šâ–{ˆÀ•F i“Œ‹ž—ˆã‘åj, “ì]“°, “Œ‹ž, 2004/2/15”­s.

620130. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M2•Å•ªj ÅV”畆‰ÈŠw‘ÌŒn@“Á•ÊŠª2 ”畆‰ÈÇŒóŒQ; Wissler FanconiÇŒóŒQ. Vˆä@’B, Ÿ‰ªŒ›¶ (”ç), •ÒW ‹Ê’u–M•F, ’†ŽR‘“X, 2004/6/10”­s.

620131. [Šwp‘] (‹¤ŽÒ) “«”畆Ž¾Š³‚Ì•a‘Ô‚ÆŽ¡—Ã; ’j«Œ^’E–Ñ‚Æ‚»‚Ì‘¼‚Ì’E–ÑÇ. Ÿ‰ªŒ›¶ (”ç), •ÒW ‡“V“°‘åŠwˆãŠw•””畆‰ÈŠw‹³Žº, ‘æ102‰ñ“ú–{”畆‰ÈŠw‰ï‘‰ï‹L”Oo”Å”­sŠ, “Œ‹ž, 2005 iˆóü’†j.

mŠw‰ïEŒ¤‹†‰ï“™n

713135. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Localization of MYC/MAD1 protein in the hair follicle during hair cycle. ꎓ¡“T[, •l“c—SŽq, Ÿ‰ªŒ›¶ (”ç): 4th Intercontinental Meeting of Hair Research Societies (2004/6/18), Berlin.

713136. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Potential of nestin-expressing hair follicle cells to form neurons and blood vessels. Robert M Hoffman1,2, Lingna Li1, “V‰HN”V1,2,3, Meng Yang1 (1AntiCancer, Inc., San Diego, CA. 2”ç. 3Department of Surgery, University of California San Diego, CA): The Fourth Intercontinental Meeting of Hair Research Societies (2004/6/17-19), Berlin.

713137. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Multi-color in vivo imaging with fluorescent proteins. Robert M Hoffman1,2, Meng Yang1, Ping Jiang1, “V‰HN”V1,2,3, J Wang1 (1AntiCancer, Inc., San Diego, CA. 2”ç. 3Department of Surgery, University of California San Diego, CA): The 32nd Annual Meeting American Society for Photobiology (2004/7/10-14), Seattle.

713138. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Hair follicle nestin-expressing stem cells give rise to nascent blood vessels in the skin. “V‰H N”V1,2,3, Lingna Li1, Meng Yang1, AR Moossa3, Ÿ‰ªŒ›¶2, Sheldon Penman1, Robert M Hoffman1 (1AntiCancer, Inc., San Diego, CA. 2Department of Dermatology, Kitasato University School of Medicine,Sagamihara, Japan. 3Department of Surgery, University of California San Diego, CA): 34th Annual European Society for Dermatological Research (ESDR) Meeting (2004/9/9-11), Vienna.

722073. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‰~Œ`’E–ÑÇ‚ÌÅ‘Oü. Ÿ‰ªŒ›¶ (”ç): ‘æ68‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”Šwp‘å‰ï (2005/2/20), “Œ‹ž.

723623. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Nestin is a marker for nascent tumor angiogenesis. “V‰HN”V1,2,3, Lingna Li1, Meng Yang1, Ping Jiang1, Ÿ‰ªŒ›¶2, AR Moossa3, Robert M Hoffman1,3 (1AntiCancer, Inc., San Diego, CA. 2”ç. 3Department of Surgery, University of California San Diego, CA): ‘æ29‰ñ“ú–{Œ¤‹†”畆‰ÈŠw‰ï (2004/4/14-16), ‹ž“s.

723624. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Nestin-expressing hair follicle stem cells contribute to wound healing. Robert M Hoffman1,3, “V‰H N”V1,2,3, Lingna Li1, Meng Yang1, AR Moossa3, Ÿ‰ªŒ›¶2 (1AntiCancer, Inc., San Diego, CA. 2”ç. 3Department of Surgery, University of California San Diego, CA): ‘æ29‰ñ“ú–{Œ¤‹†”畆‰ÈŠw‰ï (2004/4/14-16), ‹ž“s.

723625. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ‚ç‚¢‹Ûmce1A‘g‚ÝŠ·‚¦’`”’‚̃qƒg”畆\¬×–E‹y‚уqƒg•@”S–Œã”ç×–E‚ɑ΂·‚éN“ü”\‚ÌŒŸ“¢. ²“¡’¼Æ1, “¡‘º‹¿’j1, Žë–ì^”¿2, ‘àVŠ²’j1, Ÿ‰ªŒ›¶1 (1”ç. 2ˆã—ÃŒn‘åŠw‰@): ‘æ29‰ñ“ú–{Œ¤‹†”畆‰ÈŠw‰ï”NŽŸŠwp‘å‰ï (2004/4/14-16), ‹ž“s.

723626. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) Œ´”­«œ‘üˆÛÇ‚ÌŠ³ŽÒ‚É‚Ý‚ç‚ꂽ”畆œ‘ŠO‘¢ŒŒ‚Ì1—á. ‹{“c‘Žq1, “c•Ó‚Ý‚Ç‚è1, ‘àVŠ²’j1, Ÿ‰ªŒ›¶1, “ŒŒ´³–¾2 (1”ç. 2“à‡Wj: ‘æ103‰ñ“ú–{”畆‰ÈŠw‰ï‘‰ï (2004/4.16-18), ‹ž“s. “ú–{”畆‰ÈŠw‰ïŽGŽ, 114 (3 —Õ‘): 576, 2004.

723627. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‚ç‚¢‹Ûmce1A’`”’‚ÌŠeŽí×–E‚ɑ΂·‚éN“ü”\‚ÌŒŸ“¢. ²“¡’¼Æ, “¡‘º‹¿’j, ‘àVŠ²’j, Ÿ‰ªŒ›¶ (”ç): ‘æ103‰ñ“ú–{”畆‰ÈŠw‰ï‘‰ï (2004/4.16-18), ‹ž“s. “ú–{”畆‰ÈŠw‰ïŽGŽ, 114 (2): 194, 2004.

723628. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”ç]‚ðŒ_‹@‚Éf’f‚ÉŽŠ‚Á‚½Churg-StraussÇŒóŒQ‚Ì2—á. ]“¡GŒõ1, ŽOˆäƒá1, ’·‹´˜a–î1, “í@@•‘1, •y“c¹G1, Vˆä@’B1, Ÿ‰ªŒ›¶1, z–K•”ŽõŽq2, •ÄŒ³N‘ 2 (1”ç. 2ŠC˜V–¼‘‡•a‰@j: ‘æ103‰ñ“ú–{”畆‰ÈŠw‰ï‘‰ï (2004/4/17), ‹ž“s.

723629. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) LRSU‚̉ċG’×ᇂɑ΂·‚ég‚©‚ñ‚Û‚¤’ƒh‚Ì—\–hŒø‰Ê|4”NŠÔ’²¸Œ‹‰Ê‚Ì‘‡•]‰¿|. ‘àVŠ²’j1, ‘O“cˆŸŠóŽq1, ‘àV^ŽÀŽq1, ‹{“c‘Žq1, Ÿ‰ªŒ›¶1, ÷ˆä”ü“T2 (1”ç. 2•‘ –ì–ƉuŒ¤‹†Šj: ‘æ103‰ñ“ú–{”畆‰ÈŠw‰ï‘‰ï (2004/4/18), ‹ž“s. “ú–{”畆‰ÈŠw‰ïŽGŽ, 114 (3 —Õ‘): 630, 2004.

723630. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) CD4+ƒLƒ‰[T×–E‚̉~Œ`’E–ÑÇ”­Ç‚Ö‚ÌŠÖ—^. Œü–ì@“N, ’؈äœA”ü, “¡‘º‹¿’j, Ÿ‰ªŒ›¶ (”ç): ‘æ103‰ñ“ú–{”畆‰ÈŠw‰ï‘‰ï (2004/4.16-18), ‹ž“s. “ú–{”畆‰ÈŠw‰ïŽGŽ, 114 (10): 1682, 2004.

723631. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) mce1A’`”’‚É‚æ‚é‚ç‚¢‹Û‚Ìã”ç×–E‚Ö‚ÌN“ü. “¡‘º‹¿’j1, ²“¡’¼Æ1, Žë–ì^”¿1, ‹{“c‘Žq1, ‘àV^ŽÀŽq1, ‘àVŠ²’j1, Ÿ‰ªŒ›¶1, —^‹Vƒ„ƒXŽq2, ¼‰ª³“T3 (1”ç. 2Š´õÇŒ¤. 3ƒnƒ“ƒZƒ“•aŒ¤ƒZ): ‘æ77‰ñ“ú–{ƒnƒ“ƒZƒ“•aŠw‰ï‘‰ïEŠwp‘å‰ï (2004/5/20-22), ‘å‹{. Jpn J Lepr, 73 (2): 148, 2004.

723632. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒvƒƒuƒR[ƒ‹‚É‚æ‚èŒy‰õ‚µ‚½[Ý«ƒGƒŠƒgƒ}ƒg[ƒfƒX. “¿‰içt, •S£—tŽq, VˆätŽ} (‘å˜aŽs—§•a‰@): ‘æ20‰ñ“ú–{—Õ°”畆‰ÈŠw‰ïŠwp‘å‰ï (2004/5/22-23), “Œ‹ž.

723633. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “®Ã–¬ŠïŒ`‚̇•¹‚ªl‚¦‚ç‚ꂽ“ûŽ™Šç–Êä•óŒŒŠÇŽî. ‘àV^ŽÀŽq, “í@@•‘, Vˆä@’B, ‘àVŠ²’j, Ÿ‰ªŒ›¶ (”ç): ‘æ28‰ñ“ú–{¬Ž™”畆‰ÈŠw‰ï (2004/5), ŒSŽR.

723634. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰È‚É‚¨‚¯‚éŠÖßÇ«Š£á. ‘O“‡‰pŽ÷, ‘hŒ´‚µ‚Ì‚Ô, ²“¡Š¨Ž¡, ꎓ¡“T[, Ÿ‰ªŒ›¶ (”ç): ‘æ19‰ñ“ú–{Š£áŠwp‘å‰ï (2004/9/4), ŽRŒ`. ‹L˜^W, p.113-114, 2004.

723635. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠO—ˆ’ʉ@Š£áŠ³ŽÒ47—á‚É‚¨‚¯‚énarrow band UVB—Ö@‚ÌŒŸ“¢. ˆÀåY—Ljê1, Â’n¹Žq2, óˆäŽõŽq2, ˜e“c‰ÁŒb2, Œ´“c°”ü2, ‰q“¡@Œõ2 (1”ç. 2¹˜H‰Á•a‰@): ‘æ19‰ñ“ú–{Š£áŠw‰ï (2004/9/4-5), ŽRŒ`.

723636. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Visualization of nascent tumor angiogenesis by differential dual-color fluorescence imaging in nestin-linked-GFP mice. “V‰HN”V1,2,3, Lingna Li1, Meng Yang1, Ping Jiang1, Ÿ‰ªŒ›¶2, Satoshi Hasegawa1, AR Moossa3, Robert M Hoffman1,3 (1AntiCancer, Inc., San Diego, CA. 2”ç. 3Department of Surgery, University of California San Diego, CA): ‘æ63‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2004/9/29-10/1), •Ÿ‰ª.

723637. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) Œ‹Šj‹Ûmce1—̈æInv-3ƒyƒvƒ`ƒh‚ÌŽ‘±”­Œ»‚É‚æ‚é”ñ•aŒ´«‘å’°‹Û‚̃}ƒNƒƒtƒ@[ƒW“එ¶E‘B. Žë–ì^”¿1, “¡‘º‹¿’j2, ‘àVŠ²’j2, Ÿ‰ªŒ›¶2 (1ˆã—ÃŒn‘åŠw‰@. 2”ç): ‘æ34‰ñ“ú–{–ƉuŠw‰ï‘‰ï (2004/12/1-3), ŽD–y. “ú–{–ƉuŠw‰ï‘‰ï¥ŠwpW‰ï‹L˜^, 34: 292, 2004.

723638. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ã”çŒn×–E‚Ö‚ÌN“ü‚ÉŠÖ‚í‚é, ‚ç‚¢‹Ûmce1A’`”’‚Ìactive peptide‚ÌŒŸõ. ŽR–{•‡Šó1, “¡‘º‹¿’j2, ²“¡’¼Æ2, Žë–ì^”¿1, ‘àVŠ²’j2, Ÿ‰ªŒ›¶2, —^‹Vƒ„ƒXŽq3 (1ˆã—ÃŒn‘åŠw‰@. 2”ç. 3Š´õÇŒ¤): “ú–{–ƉuŠw‰ï‘‰ï¥ŠwpW‰ï (2004/12/1-3), ŽD–y. W‰ï‹L˜^, 34: 292, 2004.

723639. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) DNFB—U“±ƒ}ƒEƒXÚG”畆‰Š‚¨‚æ‚уqƒg‹à‘®ƒAƒŒƒ‹ƒM[‚ɑ΂·‚é“ûŽ_‹Û‰Á”Mˆ—‹Û–– (EC-12) ‚ÌR‰ŠÇŒø‰Ê‚ÌŒŸ“¢. ’†–ì•q–¾1, “¡‘º‹¿’j1, Ÿ‰ªŒ›¶1, •ì˜a‹Õ2 (1”ç. 2ƒRƒ“ƒr): ‘æ34‰ñ“ú–{”畆ƒAƒŒƒ‹ƒM[Šw‰ï‘‰ï¥Šwp‘å‰ï (2004/7/17-18), •xŽRŽs. ƒvƒƒOƒ‰ƒ€¥´˜^W, Vol.34th: 119, 2004.

731089. [Œ¤‹†‰ï] (“Á•Êu‰‰) ŒŒŠÇ‰Š‚ÆzŠÂáŠQ‚Ì‹«ŠE. Ÿ‰ªŒ›¶ (”ç): é‹Ê”畆‰Èˆã‰ï40Žü”NŠwp‘å‰ï (2004/5/9), ‚³‚¢‚½‚ÜŽs.

731090. [Œ¤‹†‰ï] (“Á•Êu‰‰) ŒŒŠÇ‰Š‚ÆŒŒsáŠQ. Ÿ‰ªŒ›¶ (”ç): “ú–{ˆãŽt‰ï¶ŠU‹³ˆçuÀ, Šwpu‰‰‰ï (2004/7/12), ‹ú˜HŽs.

731091. [Œ¤‹†‰ï] (“Á•Êu‰‰) –Ôó”ç”Á ilivedo) ‚̈Ӌ`. Ÿ‰ªŒ›¶ (”ç): ‘æ5‰ñ‚µ‚܂Ȃݔ畆ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/9/18), ¼ŽRŽs.

731092. [§˜b‰ï] (“Á•Êu‰‰) ŒŒŠÇ‰Š‚ÆzŠÂáŠQ‚Ì‹«ŠE. Ÿ‰ªŒ›¶ (”ç): ‘æ34‰ñŽO‰Y”¼“‡”畆‰È§˜b‰ï (2005/2/5), ‰¡{‰êŽs.

731093. [Œ¤‹†‰ï] (“Á•Êu‰‰) ŒŒŠÇ‰Š‚ÆzŠÂáŠQ‚Ì‹«ŠE|Livedo|. Ÿ‰ªŒ›¶ (”ç): ‘æ26‰ñŠÖ“ŒEbM‰zMMCŒ¤‹†‰ï (2005/2/26), “Œ‹ž.

731094. [Œ¤‹†‰ï] (“Á•Êu‰‰) ŒŒŠÇ‰Š‚ÆzŠÂáŠQ‚Ì‹«ŠE|Livedo|. Ÿ‰ªŒ›¶ (”ç): ‘æ1‰ñŽR‰A”畆Ž¾Š³Œ¤‹†‰ï (2005/3/3), ¼]Žs.

732047. [Œ¤‹†‰ï] (µ‘Ò‚³‚ꂽu‰‰) ‘Sg‚Ɣ畆|áy‚݂𔺂¤Ž¾Š³|. Ÿ‰ªŒ›¶ (”ç): —Õ°ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/4/28), Ž­“‡Žs.

732048. [Œ¤‹†‰ï] (µ‘Òu‰‰) –k—¢‘åŠw•a‰@‚É‚¨‚¯‚é”畆ŠO‰È‚ÌŽÀÛ. ꎓ¡“T[ (”ç): ‘æ16‰ñŒú–ØŽs”畆‰Èˆã‰ï (2004/11/11), Œú–Ø.

733285. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒlƒp[ƒ‹ƒgƒŒƒbƒLƒ“ƒO‹A‘Œã”­Ç‚µ‚½‚‚‚ª’Ž•a‚Ì1—á. ˆÀåY—Ljê1, Â’n¹Žq2, óˆäŽõŽq2, Œ´“c°”ü2, ‰q“¡@Œõ2, ‰¡“c‹±Žq2, ŒÃì@Œb2 (1”ç. 2¹˜H‰Á•a‰@j: ‘æ790‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/5/15), ìè.

733286. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) —²‹N«Œ‹ß‚𔺂Á‚½ƒ{[ƒGƒ“•a‚Ì1—á. ‘O“cˆŸŠóŽq, •y“c¹G, ꎓ¡“T[, Vˆä@’B, ‚{@”Ž, Ÿ‰ªŒ›¶ (”ç): ‘æ790‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/5/15), ìè.

733287. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Basal cell nevus syndrome‚Ì1—á. ‘hŒ´‚µ‚Ì‚Ô1, ꎓ¡“T[1, •y“c¹G1, Vˆä@’B1, ‚{@”Ž1, Ÿ‰ªŒ›¶1, ‰F’ÖØ@‘2 (1”ç. 2”]ŠOj: ‘æ790‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/5/15), ìè.

733288. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Superficial granulomatous pyoderma‚Ì1—á. —é–Ø—‰Ø, •y“c¹G, ’·‹´˜a–î, “í@@•‘, Vˆä@’B, Ÿ‰ªŒ›¶ (”ç): ‘æ790‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/5/15), ìè.

733289. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Eosinophilic cellulitis‚Ì1—á. ŽR–{“s”ü, •y“c¹G, Vˆä@’B, Ÿ‰ªŒ›¶ (”ç): ‘æ797‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/5/15), ìè.

733290. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒÃ-ƒAƒ~ƒmƒJƒvƒƒ“Ž_‚É‚æ‚éÚG”畆‰Š‚Ì1—á. ‹{“c‘Žq1, ’†‘º”ü‰Ä1, ‘àVŠ²’j1, Ÿ‰ªŒ›¶1, ‘ë@‰ÀŽq2 (1”ç. 2‚³‚ª‚ݶ‹¦Šá‰Èj: ‘æ791‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/6/19), ‰¡•l.

733291. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ’¼’°ŠàpŒã‚ÌŒ‹’°ƒXƒg[ƒ}ŽüˆÍ‚ɶ‚¶‚½“÷‰èŽî. “¿‰içt1, “c•Ó‚Ý‚Ç‚è1, VˆätŽ}2, ‹´–{@C2, •Ÿ“c”ü•ä2 i1”ç. 2‘å˜aŽs—§•a‰@): ‘æ791‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/6/19), _“Þì.

733292. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Acquired reactive perforating collagenosis iARPCj ‚Ì1—á. ‘O“‡‰pŽ÷1, ꎓ¡“T[1, Ÿ‰ªŒ›¶1, V’Ã@–]2 (1”ç. 2“à‡Wj: ‘æ791‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/6/19), _“Þì.

733293. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ŒÅ’è–ò]‚ÆŽv‚í‚ꂽ—Ž—tó“VávጂÌ1—á. ²“¡Š¨Ž¡, •y“c¹G, Vˆä@’B, ‚{@”Ž, Ÿ‰ªŒ›¶ (”ç): ‘æ791‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/6/19), _“Þì. —\eWEƒvƒƒOƒ‰ƒ€, p.17, 2004.

733294. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) g”Á‹Ç–Êã‚É–³”‚Ì“_óoŒŒ‚𔺂Á‚½hypereosinophilic syndrome (HES) ‚Ì1—á. “c•Ó‚Ý‚Ç‚è1, “¿‰içt1, VˆätŽ}2 (1”ç. 2‘å˜aŽs—§•a‰@): ‘æ791‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/6/19), _“Þì.

733295. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Mycobacterium abscessus‚É‚æ‚é”ñ’èŒ^RŽ_‹ÛÇ‚Ì1—á. ‚{@”Ž, VŽR“ÞXŽq, ‘hŒ´‚µ‚Ì‚Ô, ꎓ¡“T[, ‹{“c‘Žq, Vˆä@’B, “¡‘º‹¿’j, Ÿ‰ªŒ›¶ (”ç): ‘æ792‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (‡“¯—Õ°) (2004/7/17), “Œ‹ž. —\eWEƒvƒƒOƒ‰ƒ€, p.14, 2004.

733296. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ¶‘å‘ڂɶ‚¶‚½ Reticulohistiocytic Glanuloma‚Ì1—á. ’·‹´˜a–î1, VŽRŽj˜N1, ‹àŽq@‘1, ‹ÀêLì1, ŒüˆäGŽ÷2, “¡‰ª@²3, ŽR–{–¾Žj4 (1”ç. 2‰¡•l˜JЕa‰@. 3‘å“c‹æ. 4‘—§‚ª‚ñƒZƒ“ƒ^[’†‰›j: ‘æ792‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/7/17), “Œ‹ž.

733297. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘½Ê‚È”ç]‚𶂶Ž¡—ÂɒïR«‚ÌLupus erythematosus profundus (LE profundus). —é–Ø—‰Ø, Vˆä@’B, Ÿ‰ªŒ›¶ (”ç): ‘æ55‰ñ“ú–{”畆‰ÈŠw‰ï’†•”Žx•”‘‰ï (2004/9/11), ‹à‘ò.

733298. [Šw‰ï (’n•û) (ˆê”Êu‰‰) ‚»‚¤áy‚𔺂¢‹}‘¬‚Éis‚·‚é‰~Œ`’E–ÑÇ‚Ì3—á. ꎓ¡“T[, ‘O“‡‰pŽ÷, Œü–ì@“N, Ÿ‰ªŒ›¶ (”ç): ‘æ55‰ñ“ú–{”畆‰ÈŠw‰ï’†•”Žx•”Šwp‘å‰ï (2004/9/12), ‹à‘ò.

733299. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ŒûO‚ÌSCC. ‚{@”Ž, Vˆä@’B, Ÿ‰ªŒ›¶ (”ç): ‘æ793‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/9/18), ‰¡•l. —\eWEƒvƒƒOƒ‰ƒ€, p.14, 2004.

733300. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒŒƒNƒ`ƒ][ƒ‹‚ª‘tŒø‚µ‚½SLE‚É”º‚¤[Ý«ƒGƒŠƒeƒ}ƒg[ƒfƒX. Vˆä@’B1, “í@@•‘1, ´–ì‚Ý‚«1, Ÿ‰ªŒ›¶1, Ô¯@“§2 (1”ç. 2—ÕŒŸŠw): ‘æ793‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/9/18), ‰¡•l. —\eWEƒvƒƒOƒ‰ƒ€, p.14, 2004.

733301. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Mycobacterium chelonaeŠ´õÇ‚Ì1—á. “c•Ó‚Ý‚Ç‚è1, “¿‰içt1, VˆätŽ}2, Ž­Z—SŽq3, ŒäŽèô@‘3, –î–ìˆè–ç4 i1”ç. 2‘å˜aŽs—§•a‰@. 3Œ‹ŠjŒ¤‹†Š. 4“ú–{BCG’†‰›Œ¤‹†Šj: ‘æ793‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/9/18), ‰¡•l.

733302. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Churg-StraussÇŒóŒQ‚Ì1—á. ]“¡GŒõ, ŽOˆäƒá, Vˆä@’B, Ÿ‰ªŒ›¶ (”ç): ‘æ793‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/9/18), ‰¡•l

733303. [§˜b‰ï] (ˆê”Êu‰‰) IgA’¾’…‚ð”F‚ß‚È‚¢ƒAƒiƒtƒBƒ‰ƒNƒgƒCƒhŽ‡”Á•a. ‹{“c‘Žq (”ç): ‘æ3‰ñŠÖ“Œ”畆–¬ŠÇ§˜b‰ï (2004/9/26), “Œ‹ž.

733304. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ’·ŠúŒo‰ß’†‚ÉŠÔŽ¿«”x‰Š‚ð‡•¹‚µ‚½‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX. •S£—tŽq1, —é–Ø—‰Ø1, ŽOˆäƒá1, ”’ˆä‹ž”ü1, Vˆä@’B1, Ÿ‰ªŒ›¶1, ‰q“¡@Œõ2, VˆätŽ}3 (1”ç. 2¹˜H‰Á‘Û•a‰@. 3‘å˜aŽs—§•a‰@j: ‘æ68‰ñ“ú–{”畆‰ÈŠw‰ï“Œ•”Žx•”‘‰ï (2004/10/2), VŠƒ.

733305. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) G““Eo‚ª‘tŒ÷‚µ‚½“HóŠ£á‚ÆŒ‹ß«g”Á‚̇•¹—á. ‘àV^ŽÀŽq, ŽOˆäƒá, ꎓ¡“T[, Vˆä@’B, Ÿ‰ªŒ›¶ (”ç): ‘æ794‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/10/16), ‰¡•l.

733306. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒGƒNƒŠƒ“Š¾ŠíŠ¯Šà‚Ì1—á. •y“c¹G, ‚{@”Ž, Ÿ‰ªŒ›¶ (”ç): ‘æ794‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/10/16), ‰¡•l.

733307. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒ{[ƒGƒ“Šà‚Ì1—á. ŽOˆäƒá, VŽRŽj˜N, ’؈äœA”ü, ‚{@”Ž, Ÿ‰ªŒ›¶ (”ç): ‘æ56‰ñ“ú–{”畆‰ÈŠw‰ï¼•”Žx•”‘‰ï (2004/11/6-7), ‹v—¯•Ä.

733308. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒqƒgƒpƒ‹ƒ{ƒEƒCƒ‹ƒXB19Š´õÇ‚É‚æ‚éPapular-Purpuric Gloves and Socks Syndrome‚Ì1—á. ’·‹´˜a–î1, VŽRŽj˜N1, ‹àŽq@‘1, ‹ÀêLì2, ŒüˆäGŽ÷2 (1”ç. 2‰¡•l˜JЕa‰@): ‘æ56‰ñ“ú–{”畆‰ÈŠw‰ï¼•”Žx•”Šwp‘å‰ï (2004/11/6-7), ‹v—¯•Ä.

733309. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Ø’f‚ÉŽŠ‚Á‚½“œ”A•a«’×ᇂÌ1—á|“–‰È‚É‚¨‚¯‚é“œ”A•a«’×ᇂ̂܂Ƃß|. ]“¡GŒõ1, ‘àV^ŽÀŽq1, Vˆä@’B1, Ÿ‰ªŒ›¶1, ‹àX@W2 (1”ç. 2ŠC˜V–¼‘‡•a‰@): ‘æ795‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/11/20), ˆÉ¨Œ´.

733310. [Šw‰ï (’n•û)] (ˆê”ʉ‰‘è) ƒVƒƒXƒ^ƒ][ƒ‹‚ª‘tŒø‚µ‚½ŠO‰A•”ƒŠƒ“ƒp˜R. ‘àVŠ²’j, ‘O“cˆŸŠóŽq, ‘àV^ŽÀŽq, ‹{“c‘Žq, Ÿ‰ªŒ›¶ (”ç): ‘æ795‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/11/20), ˆÉ¨Œ´.

733311. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “úŒõ–\˜IŒã‚É”^áv‚ª—U”­‚µ‚½ƒuƒtƒFƒLƒTƒ}ƒN‚É‚æ‚éÚG«”畆‰Š. ”’ˆä‹ž”ü, Vˆä@’B, ’·£GŽq, ’؈äœA”ü, Ÿ‰ªŒ›¶ (”ç): ‘æ795‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/11/20), ˆÉ¨Œ´.

733312. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) AIDSŠ³ŽÒ‚É”­Ç‚µ‚½B cell lymphoma‚Ì1—á. ˆÀåY—Ljê1, Â’n¹Žq2, óˆäŽõŽq2, Œ´“c°”ü2, ‰q“¡@Œõ2 (1”ç. 2¹˜H‰Á•a‰@): ‘æ795‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/11/20), ˆÉ¨Œ´.

733313. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) tufted angioma‚Ì1—á. “c•Ó‚Ý‚Ç‚è1, “¿‰içt1, VˆätŽ}2 (1”ç. 2‘å˜aŽs—§•a‰@): ‘æ795‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/11/20), ˆÉ¨Œ´.

733314. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‰–Ž_ƒ~ƒmƒTƒCƒNƒŠƒ“‚ª’˜Œø‚µ‚½Acquired reactive perforating collagenosis‚Ì1—á. “c•ÓŒ’ˆê1, ŽR–{“s”ü1, ’؈äœA”ü1,2 i1‰¡•lˆã—ÃZƒ“ƒ^[. 2”çj: ‘æ795‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/11/20), ˆÉ¨Œ´.

733315. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ”x“]ˆÚ‚ð‚«‚½‚µ‚½Šî’ê×–EŠà‚Ì1—á. ‘hŒ´‚µ‚Ì‚Ô, Vˆä@’B, ‚{@”Ž, Ÿ‰ªŒ›¶ (”ç): ‘æ795‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/11/20), ˆÉ¨Œ´.

733316. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ä\•”‚Ì–«”^”çÇ‚æ‚趂¶‚½—Lž™×–EŠà‚Ì1—á. ´–ì‚Ý‚« (Ž­“‡˜JÐ, ”ç): ‚³‚´‚ñ‚©”畆‰È‚̉ï (’¶Žq, ˆ®, ”gè”畆‰Èˆã‰ï) (2004/12/2), ç—t.

733317. [Šw‰ï (’n•û)] (ˆê”ʉ‰‘è) ’á‘B«“à”çŒn×–E‚Ì”|—{. ‘àVŠ²’j, ‘àV^ŽÀŽq, •l“c—SŽq, “¡‘º‹¿’j, Ÿ‰ªŒ›¶ (”ç): ‘æ796‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/12/18), “Œ‹ž.

733318. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Œã“V«–Ɖu•s‘SÇŒóŒQ‚ÌŠ³ŽÒ‚ɶ‚¶‚½‘æ2Šú”~“Å]. ‹{“c‘Žq1, “¡‘º‹¿’j1, ‘àVŠ²’j1, Ÿ‰ªŒ›¶1, ‚ŽR—zŽq2 (1”ç. 2“à‡W): ‘æ797‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2005/1/15), ‰¡•l.

733319. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒAƒiƒtƒBƒ‰ƒNƒgƒCƒhŽ‡”Á•a‚ÌŒo‰ß’†‚É‚Ý‚ç‚ꂽ”sŒŒ]. ꎓ¡“T[, ‚{@”Ž, ‘àVŠ²’j, Ÿ‰ªŒ›¶ (”ç): ‘æ797‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2005/1/15), ‰¡•l.

733320. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) •½ŠŠ‹Ø“÷Žî‚Ì1—á. ŽOˆäƒá1, “í@@•‘1, Vˆä@’B1, ‚{@”Ž1, Ÿ‰ªŒ›¶1, Žðˆä’¼•F2 (1”ç. 2Œ`ŠOj: ‘æ797‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2005/1/15), ‰¡•l.

733321. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒwƒ‹ƒyƒX”]‰Š‚̇•¹‚ð‹^‚Á‚½ƒJƒ|ƒW…“——l”­]Ç‚Ì1—á. ²“¡Š¨Ž¡1, ŽOˆäƒá1, Vˆä@’B1, Ÿ‰ªŒ›¶1, —Rˆäi‘¾˜Y2, ¬”¦Gˆê3 (1”ç. 2“à‡V. 3Œú–ØŽsj: ‘æ797‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï(2005/1/15), ‰¡•l.

733322. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) SLE‚ÌŒZ’í—á. ˆÀåY—Ljê1, Â’n¹Žq2, —´–ì²’mŽq2, óˆäŽõŽq2, ˜e“c‰ÁŒb2, Œ´“c°”ü2, ‰q“¡@Œõ2 (1”ç. 2¹˜H‰Á•a‰@): ‘æ797‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2005/1/15), ‰¡•l.

733323. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Gordona blonchialis”畆Š´õÇ‚Ì1—á. “c•Ó‚Ý‚Ç‚è1, “¿‰içt1, VˆätŽ}2, “¡‘º‹¿’j1, Ž­Z—SŽq3, –î–ìˆè–ç4 (1”ç. 2‘å˜aŽs—§•a‰@. 3Œ‹ŠjŒ¤‹†Š. 4“ú–{BCGŒ¤j: ‘æ797‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2005/1/15), ‰¡•l.

733324. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ’mŠo_ŒoáŠQ‚𶂶‚½ƒTƒ‹ƒRƒCƒh[ƒVƒX. “c•ÓŒ’ˆê1, ŽR–{“s”ü1, ’؈äœA”ü1,2 (1‰¡•lˆã—ÃZƒ“ƒ^[. 2”ç): ‘æ797‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2005/1/15), ‰¡•l.

733325. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒlƒR‚ЂÁ‚©‚«•a‚Ì1—á. ŽR–{“s”ü1, “c•ÓŒ’ˆê1, ’؈äœA”ü1,2 (1‰¡•lˆã—ÃZƒ“ƒ^[. 2”ç): ‘æ797‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2005/1/15), ‰¡•l.

733326. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚É”º‚¤’E–Ñ‚Ì—Õ°“IŒŸ“¢. Vˆä@’B1, ”’ˆä‹ž”ü1, “í@@•‘1, •S£—tŽq1, ]“¡GŒõ1, Ÿ‰ªŒ›¶1, ‰q“¡@Œõ2, VˆätŽ}3 (1”ç. 2¹˜H‰Á•a‰@. 3‘å˜aŽs—§•a‰@j: ‘æ28‰ñ”畆–¬ŠÇEäPŒ´•aŒ¤‹†‰ï (2005/1/28-29), “Œ‹ž. —\eWEƒvƒƒOƒ‰ƒ€, p.15, 2005.

733327. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‘¤“ª“®–¬‰Š‚Ì1—á. ˆÀåY—Ljê1, Â’n¹Žq2, óˆäŽõŽq2, ˜e“c‰ÁŒb2, Œ´“c°”ü2, ‰q“¡@Œõ2 (1”ç. 2¹˜H‰Á•a‰@): ‘æ28‰ñ”畆–¬ŠÇEäPŒ´•aŒ¤‹†‰ï (2005/1/28-29), “Œ‹ž.

733328. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ”牺Œ^ˆ««ŒŒŠÇ“à”ç×–EŽî‚Ì1—á. ]“¡GŒõ1, ŽOˆäƒá1, ‘àVŠ²’j1, ]“¡—²Žj2 (1”ç. 2“Œ‹ž’üM•a‰@j: ‘æ28‰ñ”畆–¬ŠÇEäPŒ´•aŒ¤‹†‰ï (2005/1.27), “Œ‹ž.

733329. [§˜b‰ï] (ˆê”Êu‰‰) “ÁˆÙ‚ȃAƒiƒtƒBƒ‰ƒNƒgƒCƒhŽ‡”Á•a‚Ì2—á. ꎓ¡“T[ (”ç): ‘æ4‰ñŠÖ“Œ”畆–¬ŠÇ§˜b‰ï (2005/2/6), “Œ‹ž.

733330. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) g”Á‚ªæs‚µ‚½Angioedema with eosinophilia. ‘O“‡‰pŽ÷, ꎓ¡“T[, Ÿ‰ªŒ›¶ (”ç): ‘æ295‰ñ“ú–{”畆‰ÈŠw‰ï’·è’n•û‰ï—á‰ï (2005/2/13), ’·è.

733331. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) –«áå‘f’†“Å‚É‚æ‚鑽”­«ƒ{[ƒGƒ“•a. •S£—tŽq, ‘hŒ´‚µ‚Ì‚Ô, ŽOˆäƒá, Vˆä@’B, ‚{@”Ž, Ÿ‰ªŒ›¶ (”ç): ‘æ68‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”‘‰ï (2005/2/19), “Œ‹ž.

733332. [Šw‰ï (’n•û)] (ˆê”ʉ‰‘è) ã”çŒn×–E‚ÌN“ü‚ÉŠÖ‚í‚é, ‚ç‚¢‹Ûmce1A’`”’‚Ìactive pepetide‚ÌŒŸõ. ŽR–{•‡Šó1, “¡‘º‹¿’j2, ²“¡’¼Æ2, Žë–ì^”¿1, ‘àVŠ²’j2, Ÿ‰ªŒ›¶2 (1ˆã—ÃŒn‘åŠw‰@. 2”ç): ‘æ798‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2005/3/19), “Œ‹ž.


<<”å”AŠí‰ÈŠw>>

mŠwp˜_•¶n

110160. [Œ´’˜] Laparoscopic pyeloplasty for ureteropelvic junction obatruction: Outcome of initial 12 procedures. Šâ‘º³Žk1, ‘v@¬_1, “ü]@Œ[1, –å˜e˜ab2, ¼‰º@–õ3, “¡‰ª’mº3, ”nêŽu˜Y1 (1”å. 2–kŒ¤. 3ŠâŽè‘å): International Journal of Urology, 11: 449-455, 2004.

110161. [Œ´’˜] Route of administration Influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model. ŽG‰ê—²Žu1, ²“¡ˆÐ•¶2, “ú‰ºMs1, ]Œ´@L1, Vladimir B Mouraviev1, Terry L Timme1, Timothy C Thompson1 (1ƒxƒCƒ‰|ˆã‘å. 2”å): Cancer Gene Therapy, 11: 317-324, 2004.

110162. [Œ´’˜] Impact of biochemical failure on long-term clinical outcome after radical prostatectomy for prostate cancer in Japan. ‰oì@W1, ¼ˆäŠì”V2, ¼–{˜a«1, {ŽRˆê•ä1, rˆä—zˆê2, ŒK”ö’èm3, ”nêŽu˜Y1 (1”å. 2‘q•~’†‰›. 3•a—): Prostate Cancer and Prostatic Diseases, 7: 152-157, 2004D

110163. [Œ´’˜] Kidney Disease Quality of Life of Japanese Dialysis Patients Who Desire Administration of Sildenafil and the Treatment of Erectile Dysfunction Using Sildenafil. •º“¡@“§1, Γc—T‘¥2, ‘ˆä‘¥º2, •½—Ç—²•Û1, ŽR–{ƒXƒ~Žq1, ‰ª@”ü’q‘ã3, “à“c–Lº4, ‰““¡’‰—Y5, Žðˆä@‹Š6, ‹g“cˆê¬7, ”nêŽu˜Y7 (1‰¡•l‘æˆê. 2Γc•a‰@. 3Œú–؃NƒŠ. 4“ŒŠC‘唪‰¤Žq. 5é‹ÊŒ§‰›. 6¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š. 7”å): Therapeutic Apheresis and Dialysis, 8 (4): 340-346, 2004D

110164. [Œ´’˜] An Application of the Fluorescence Differential Display Method to Clone Genes Related to Prostate Cancer. ˆÉ“Œˆê˜Y1, ’Â@ˆÌ‹­2, ¼–{˜a«2, “ü]@Œ[2, “à“c–Lº3, ‰oì@W2, ”nêŽu˜Y2 (1—\–hˆãŠwŒn. 2”å. 3“ŒŠC‘唪‰¤Žq): –k—¢ˆãŠw, 33 (5): 311-319, 2004.

110165. [Œ´’˜] ENHACED SYSTEMIC T-CELL ACTIVATION AFTER IN SITU GENE THERAPY WITH RADIOTHERAPY IN PROSTATE CANCER PATIENTS. ²“¡ˆÐ•¶1, Bin S The2, Terry L Timme2, Wei-Yuan Mai2, Yehoshua Gdor2, “ú‰ºMs2, “¡“c“N•v1, Christina K Pramudji2, Maria T Vlachaki2, Gustavo Ayala2, Thomas Wheeler2, Robert Amato2, Brian J Miles2, Dov Kadman2, E Braian Butler2, Timothy C Thompson2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): Int J Radiation Biol Phys, 59 (2): 562-571, 2004.

110166. [Œ´’˜] Quality of life after laparoscopic or open radical prostatectomy : interim report on mulyi-institution-al longitudinal study in japan. Shunichi Namiki1, ‰oì@W2, ”nêŽu˜Y2, Yukio Usui3, Toshiro Teracti3, Koji Yoshimura4, Akito Terai4, Tatsuo Tochigi5, Sadafumi Kawamura5, Masaaki Kuwahara5, Masataka Aizawa6, Naomasa Ioritani6, Seiichi Saito7, Yoichi Arai7 (1“Œ–k‘å. 2”å. 3“ŒŠC‘å. 4‘q•~. 5‹{錧—§‚ª‚ñƒZƒ“ƒ^[. 6å‘äŽÐ‰ï•ÛŒ¯. 7“Œ–k‘å): Jpn J Endourol ESWL, 17: 211-215, 2004.

110167. [Œ´’˜] Clonality analysis of T cells mediating acute and chronic rejection in kidney allografts. ¬”¦•¶–í1, ‹g“cˆê¬2, Y Ikeda1, ‘å‹v•Û‚Ý‚Ç‚è3, Ö“¡@‹B2, ’|“àN—Y4, ŽÂŒ´MŒ«3, ‰““¡’‰—Y5, ”nêŽu˜Y2 (1ˆã‰q. 2”å. 3–Ɖu. 4“à‡W. 5é‹ÊŒ§‰›): Transplant Immunology, 13: 233-237, 2004.

110168. [Œ´’˜] High molecular mass proteome of androgen-independent prostate cancer. ŽÔ@‰pr1, ‰oì@W1, Masamichi Oh-Ishi2, Yoshio kodera2, Mamoru Satoh2, Weigiang Chenw2, ‘å‘@—m1, ¼–{˜a«1, Tadakazu Maeda2, ”nêŽu˜Y1 (1”å. 2—Šw•”): Proteomics, 4: 1097-1112, 2005.

110169. [Œ´’˜] Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. ‘å–x@—1, Kattan MW2, ‰©@‰p–Î1, ŠÛ@“T•v1, Slawin KM2, Shariat S2, ‘º–{«r1, Reuter VE2, Wheeler TM2, Scardino PT2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): J Urol, 5; 171 (5): 1844-1849, 2004.

110170. [Œ´’˜] RECOVERY OF QUALITY OF LIFE IN YEAR AFTER LAPAROSCOPIC OR RETROPUBIC RADICAL PROSTATECTOMY: A MULTI-INSTITUTIONAL LONGITUDINAL STUDY. •À–Ørˆê1, ‰oì@W2, ”nêŽu˜Y2, Ž›’n•q˜Y3, ‰PˆäK’j3, Ž›ˆäÍl4, “È–Ø’B•v5, ŒKŒ´³–¾5, ˆÁ’J®³6, rˆä—zˆê1 (1“Œ–k‘å. 2”å. 3“ŒŠC‘å. 4‘q•~’†‰›. 5‹{錧—§‚ª‚ñƒZƒ“ƒ^[. 6å‘äŽÐ‰ï•ÛŒ¯): UROLOGY, 65 (3): 517-523, 2005D

110171. [Œ´’˜] Proteome analysis of prostate cancer. ŽÔ@‰pr1, ‰oì@W1, ‘åγ“¹2, ¬Ž›‹`’j2, ‘O“c’‰Œv2 (1”å. 2—Šw•”): Prostate Cancer and Prostatic Diseases, 8: 14-21, 2005.

120058. [Œ´’˜] ƒ}ƒCƒNƒ”g‹[ŒÅ‘•’u iƒ}ƒCƒNƒƒ^[ƒ[R j ‚ð—p‚¢‚½• o‹¾‰ºt•”•ªØœp‚Ì—L—p«‚Æ“K‰ž. Šâ‘º³Žk, ”nêŽu˜Y (”å): J Microwave Surgery, 22: 137-140, 2004.

120059. [Œ´’˜] ”å”AŠí‰ÈŽüpŠú‚É‚¨‚¯‚éR‹Û–ò‚ÌŽg—p•û–@‚ɂ‚¢‚ẴAƒ“ƒP[ƒg•ñ. ŽR–{VŒá1, ‹àŠÛãà~1, ¬ì@C1, ‘¼2, Šâ‘º³Žk3, ²“¡ˆÐ•¶3, ”nêŽu˜Y3, ‘¼4 (1‹ž“s‘å. 2‰ªŽR‘å, “¡“c•ÛŒ’‰q¶‘å, ‹ãB‘å. 3”å. 4_ŒË‘å, ŽD–yˆã‘å, Šò•Œ‘å, “Œ‹žŽœŒbˆã‘å, ŽY‹Æˆã‘å): ”å”A‹I—v, 50 (11): 779-786, 2004D

120060. [Œ´’˜] ŒÀ‹Ç«‘O—§‘BŠà‚ɑ΂·‚éŒo’¼’°“I‚–§“xÅ“_Ž®’´‰¹”g (high-intensity focused ultrasound:HIFU) —Ö@‚Ì—Õ°¬Ñ. “à“c–Lº1, ŽR‰º‰p”V2, ‘å‘@—m2, ’·“cŒbO1, —äˆä’è‹I2, ²“¡ˆÐ•¶2, “ü]@Œ[2, •º“¡@“§3 (1“ŒŠC‘唪‰¤Žq. 2”å. 3‰¡•l‘æˆê): Japanese Journal of Endourology and ESWL, 17 (2): 235-241, 2004D

120061. [Œ´’˜] …tǂ𔺂¤–Ttá±”X–E‚ɑ΂·‚é‘Ìo‹¾‰º”X–E•ÇØœp. •âáÁ“ñ, Šâ‘º³Žk, ¼“c‘å‰î, “ü]@Œ[, ”nêŽu˜Y (”å): ”å”A‹I—v, 51 (1): 1-4, 2005D

120062. [Œ´’˜] —Õ°Œ¤‹†|‰–Ž_ƒZƒxƒ‰ƒ}[‚Ì“Š—^ŒoŒ±(1)F•›ì—p‚Æ‚µ‚Ä‚Ì•Ö”é‚ÌŽ•ž. •º“¡@“§1, •½—Ç—²•Û1, ŽR–{ƒXƒ~Žq2, Žáˆä—zŠó1, ’|‘º@“O1, “y“c–š”ü3, ŽÔ@‰pr3, ‹g“cˆê¬3, Žðˆä@‹Š4, “ú‘ä‰p—Y1, ”nêŽu˜Y3 (1‰¡•l‘æˆê. 2Œú–؃N. 3”å. 4¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š): ”å”AŠíŠO‰È, 18 (3): 239-247, 2005.

120063. [Œ´’˜] BCGäNã÷“à’“ü—Ö@Œã‚É”­Ç‚µ‚½ŠÖ߉Š‚ÌŒŸ“¢. —äˆä’è‹I, “ü]@Œ[, ’Â@ˆÌ‹­, •âáÁ“ñ, “c”¨Œ’ˆê, ‰©@‰p–Î, Έä‘å•ã, Šâ‘º³Žk, “à“c–Lº, Žu‘º@“N, ”nêŽu˜Y (”å): “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (4): 657-662, 2004.

220054. [€Œ´’˜] ’·Šú“§ÍŠ³ŽÒ‚Ö‚ÌtˆÚA|‚»‚Ì–â‘è“_‚Æ‰ðŒˆ•û–@|. ‹g“cˆê¬1, “c‰ª‰ÀŒ›1, Ö“¡@‹B1, Šâ‘º³Žk1, ”nêŽu˜Y1, ‰““¡’‰—Y2 (1”å. 2é‹ÊŒ§‰›j: ”å”AŠíŠO‰È, 17 (—Õ‘): 523-528, 2004.

220055. [€Œ´’˜] tŠà|ÅV‚Ìf’f‚ÆŽ¡—Ö@|. Ž·ˆó‘¾˜Y1, Šâ‘º³Žk2, ‰¡ŽR‰ëD3 (1‚’m‘å. 2”å. 3ˆ¤•Q‘å): BSƒ‰ƒWƒINIKKEIˆãŠw“Á•Ê”Ô‘g <–¾“ú‚ÌŽ¡—ÃŽwj>, p.1-14, 2004.

220056. [€Œ´’˜] ƒŒƒVƒsƒGƒ“ƒg‚ÌMarginalÇ—á‚ÌtˆÚA‚ ‚È‚½‚È‚ç‚Ç‚¤‚·‚é?@’·Šú“§ÍŠ³ŽÒ‚Ö‚ÌtˆÚA@‚»‚Ì–â‘è“_‚Æ‰ðŒˆ•û–@. ‹g“cˆê¬, “c‰ª‰ÀŒ›, Ö“¡@‹B, Šâ‘º³Žk, ”nêŽu˜Y, ‰““¡’‰—Y (”å): ”å”AŠíŠO‰È, 17 (‘): 523-528, 2004/6D

220057. [€Œ´’˜] <ƒVƒƒƒ“ƒg‚Ì”–â‘è> ŒŒ‰t“§Í“®Ã–¬ƒVƒƒƒ“ƒg‚̃gƒ‰ƒuƒ‹•]‰¿–@@DUS, DSA, MRA, 3DCTA‚Ì”äŠr. ¼Šª@”Ž1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, –î“àŒ´@‹v1, ŽR–{aˆê˜Y2, ‘ëì­˜a1, ¼‰iŒh“ñ1, “c‰ª‰ÀŒ›3, ‹g“cˆê¬3, ‘ì˜ad1 (1•ú. 2–@ˆã. 3”å): tˆÚAEŒŒŠÇŠO‰È, 15 (2): 119-132, 2004.

320072. [Ç—á•ñ] ”A˜HG•½ã”牻¶‚Ì1—á. “à“c–Lº1, ‘å‘@—m2, ŽR‰º‰p”V2, ’·“cŒbO1 (1“ŒŠC‘唪‰¤Žq. 2”å): ”å”A‹I—v, 50: 207-209, 2004.

320073. [Ç—á•ñ] äNã÷á‘‚ðŒ`¬‚µ‚½—‘‘ƒ—Þ”ç”XŽî‚Ì1—á. “c”¨Œ’ˆê1, ’·‘q˜a•F2, •½–ì@Œ÷3, ”nêŽu˜Y1 (1”å. 2¼ŒE. 3•½–ìƒNƒŠ): ”å”A‹I—v, 50: 219-221, 2004.

320074. [Ç—á•ñ] ’×ᇫ‘å’°‰Š (UC) ‚ÌpŒã‚É”­Ç‚µ‚½”í”X«• –Œd‰»Ç (EPS) ‚̈ê—á. ‰H‘º‘fŽq1, Žç‰®—˜‰À1, ‹´–{ƒqƒƒR1, –q–ì•Žu1, ²–ì@—²1, ’|“àN—Y1, â–{®“o1, Š™“cvšæ1, “y“c–šŽq2, ‹g“cˆê¬2 (1“à‡W. 2”åj: ‘æ18‰ñ_“Þ쌧CAPDŒ¤‹†‰ïŽ, p.5-9, 2005D

510012. [‘à] Where we stand with gene therapy for bladder cancer. Zhiping Wang1, ¼–{˜a«2, Seth Lerner3, Ronald Rodriguez1 (1Johns Hopkins‘å. 2”å. 3ƒxƒCƒ‰|ˆã‘å): Contemporary Urology, 16: 28-33, 2004.

510013. [‘à] Current advances in gene therapy for kidney cancer. ¼–{˜a«, “ü]@Œ[, ²“¡ˆÐ•¶, Šâ‘º³Žk, ‰oì@W, ”nêŽu˜Y (”å): Res Adv in Cancer, 4: 39-51, 2004D

510014. [‘à] In Situ Gene Therapy for Prostate Cancer. ²“¡ˆÐ•¶, “ü]@Œ[, ‰oì@W, ”nêŽu˜Y (”å): Current gene therapy, 5 (1): 111-119, 2005D

520203. [‘à] “à•ª”å—Ö@‚É‚æ‚駊àŒã‚Ì’†Ž~Šî€|2. ‘O—§‘BŠà‚É‚¨‚¯‚é“à•ª”å—Ö@’†Ž~Œã‚̃zƒ‹ƒ‚ƒ“ƒŒƒxƒ‹C‚¨‚æ‚ÑPSA’l‚̕ω»|. ²“¡ˆÐ•¶, ¼–{˜a«, ‰oì@W (”å): ”å”AŠíŠO‰È, 17 (8): 921-925, 2004.

520204. [‘à] tŽîᇂ̉摜f’f. ¼–{˜a«, Šâ‘º³Žk, ”nêŽu˜Y (”å): t‚Æ“§Í, 57: 159-163, 2004.

520205. [‰ðà] tˆÚA‚ÉŠÖ‚·‚é’²¸ (•½¬15”N“x) ‚Ì•ªÍŒ‹‰Ê‚ɂ‚¢‚Ä. ‹g“cˆê¬ (”å): _“Þ쌧“§ÍŽ{ݘA—‹¦‹c‰ï•ñ, 19: 16-18, 2004.

520206. [‘à] ’j«X”NŠúáŠQ‚É“Á‚É‹C‚ð‚‚¯‚½‚¢”å”AŠíŽ¾Š³|‘O—§‘B”ì‘åÇ‚Æ‚»‚ÌŽ¡—Âɔº‚¤’j«‹@”\áŠQ|. ŽÔ@‰pr, ”nêŽu˜Y (”å): Modern Physician, 24 (3): 319-322, 2004.

520207. [‘à] “ÁW: ƒKƒCƒhƒ‰ƒCƒ“‚ÉŠî‚­t”A˜HŽ¾Š³f—Ã|f’fE—\–hEŽ¡—à [”å”AŠí‰ÈŽ¾Š³] ”A˜HŒ‹ÎÇ‚Ìf’fE—\–hEŽ¡—Ã|. rì@F (”å): t‚Æ“§Í, 56 (5): 726-732, 2004.

520208. [‘à] “ÁW: <”A˜HŒ‹ÎÇ‚Ìf’fEŽ¡—Â̗¬‚ê> ESWL, TUL, PNL‚ÌŽÀÛ‚ÆŠÅŒì‚̃|ƒCƒ“ƒg. rì@F1, ‘异ЂƂÝ2, ‰¡“cçŒb2, ’†‘º‚½‚¢Žq3 (1”å. 2ŠÅŒì•”. 3‘Š–Í‘ä•a‰@): Urological Nursing, 9 (2): 27-34, 2004.

520209. [‘à] “ÁW: Endourology‚Ææ’[Technology |‚ƒGƒlƒ‹ƒM[Å“_Ž®’´‰¹”g (HIFU) ‚ð—p‚¢‚½• o‹¾‰ºt•”•ª‹[ŒÅp‚ÌŠî‘bŽÀŒ±|. Šâ‘º³Žk , ¼‰ºˆêm, “c”¨Œ’ˆê, ‰œ–ì‹I•F, ”nêŽu˜Y (”å): Jpn J Endourol ESWL, 17: 134-139, 2004.

520210. [‘à] “ÁW: “§ÍŠ³ŽÒ‚̉h—{•]‰¿‚É‚¨‚¯‚éV—˜_‚ÆV‹Zp. ‡Z Subjective global assessment‚É‚æ‚铧͊³ŽÒ‚̉h—{•]‰¿. •º“¡@“§1, ‹ïŽuŒ˜‰ÄŽq1, ŽR–{ƒXƒ~Žq2, ‹g“cˆê¬3, ”nêŽu˜Y3 (1‰¡•l‘æˆê. 2Œú–؃NƒŠ. 3”å): —Õଓ§Í, 20 (12): 49-58, 2004.

520211. [‘à] “ÁW: ĶˆãŠw@ƒNƒ[ƒ“EŠ²×–E‚©‚çˆã—ÂÖ@f’f‚ÌŽwjEŽ¡—Â̎wju‘O—§‘BŠà‚ɑ΂·‚éV‚µ‚¢•úŽËüŽ¡—Ãv. ²“¡ˆÐ•¶1, –k–ì‰ëŽj2, ÎŽR”ŽžŠ2, ’Â@ˆÌ‹­1, ‘ì˜ad2, ”nêŽu˜Y1 (1”å. 2•ú): ‘‡—Õà¬, 54 (1): 187-189, 2004.

520212. [‘à] ”A˜HŒ‹Î”jÓŽ¡—Ã. rì@F1, ‹v•Û¯ˆê2, ”nêŽu˜Y1 (1”å. 2‘Š–Í‘ä): u“ú–{çÎŽ–V•ñv•Êü, 4206: 25-32, 2004.

520213. [‘à] ƒoƒCƒAƒOƒ‰Šó–]ŒŒ‰t“§ÍŠ³ŽÒ‚ÌQOL, «‹@”\‚¨‚æ‚Ñ‚»‚Ì“Š—^Ž¡—ÃŒoŒ±‚ÆŒ»Žž“_‚É‚¨‚¯‚é–{–M‚¨‚æ‚ÑŠCŠO‚É‚¨‚¯‚é“Š—^ó‹µ. •º“¡@“§1, ŽR–{ƒXƒ~Žq2, ”nêŽu˜Y3 (1‰¡•l‘æˆê. 2Œú–؃NƒŠ. 3”å): “§Í‰ïŽ, 37 (7): 1475-1478, 2004.

520214. [‘à] sƒŠƒ“‹z’…–òt‰–Ž_ƒZƒxƒ‰ƒ}|. •º“¡@“§1, •½—Ç—²•Û1, Žáˆä—zŠó1, ’|‘º@“O1, ŽR–{ƒXƒ~Žq2, ‹g“cˆê¬3, ”nêŽu˜Y3 (1‰¡•l‘æˆê. 2Œú–؃NƒŠ. 3”å): CLINICAL CALCIUM, 15 (1): 61-70, 2004.

m’˜@‘n

610003. [‹³‰È‘] (•ª’SŽ·•M) Recent Advances in Endourology 5 uNew Challenges in Laparoscopic Urologic Surgeryv; Laparoscopic Partial Nephrectomy for Renal Cell Carcinoma: Japanese Experience, p.55-67. Hayakazu Nakazawa1, Hiroshi Toma1, Tadashi Matsuda2, Šâ‘º³Žk3, ”nêŽu˜Y3, Eiji Higashihara4 (1“Œ‹ž—ˆã‘å. 2ŠÖ¼ˆã‘å. 3”å. 4ˆÇ—Ñ‘å), •ÒW E Higashihara, S Naito, T Matuda, Springer, “Œ‹ž, 2004”­s.

610004. [Šwp‘] (•ª’SŽ·•M) Recent Research Developments In. Cancer; Immunomodulatory in situ gene therapy for prostate cancer: 6, p.179-190. ²“¡ˆÐ•¶, ‰oì@W, ¼–{˜a«, “¡“c“N•v, “c”¨Œ’ˆê, ‘å‘@—m, “ü]@Œ[, Šâ‘º³Žk, ”nêŽu˜Y (”å), •ÒW SG Pandalai, ŠÄC A Gayathri, Transworld Research network, India, 2004”­s.

610005. [‹³‰È‘] (•ª’SŽ·•M) Recent Advances in Endourology 6: uEndourooncologyvNew Horizons in Endourology; High-Intensity Focused Ultrasound(HIFU) for the Treatment of Localized Prostate Cancer Recent Advances in Endourology, p.99-113. “à“c–Lº1, ‘å‘@—m2, ŽR‰º‰p”V2, ’·“cŒbO1 (1“ŒŠC‘唪‰¤Žq. 2”å), •ÒW H Kumon, M Murai, ”nêŽu˜Y1 (1”å), Springer, “Œ‹ž, 2005”­s.

620132. [Šwp‘] (•ª’SŽ·•M) —Õ°”å”AŠí‰È “ÁW: ƒCƒ‰ƒXƒgƒŒƒCƒeƒbƒh ”å”AŠí‰ÈŽèp 58‘Š§† (4); • o‹¾‰ºt᱌`¬p, p.317-326. Šâ‘º³Žk (”å), •ÒW ‘ºˆä@Ÿ, ŒS@Œ’“ñ˜Y, “¡‰ª’mº, ˆãŠw‘‰@, “Œ‹ž, 2004/4/5”­s.

620133. [Šwp‘] (•ª’SŽ·•M) ”å”AŠí‰ÈŽüpŠúŠÇ—‚Ì‚·‚ׂÄ; • o‹¾Žèp|• o‹¾‰ºt᱌`¬p|, ‚.134-140. Šâ‘º³Žk, ”nêŽu˜Y (”å), •ÒW rˆä—zˆê, ¼“cŒöŽu, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004.

620134. [‚»‚Ì‘¼‚Ì’˜‘ (ŠTà‘)] (•ª’SŽ·•M) Urology View, “ÁW: ”å”AŠí‰ÈŠ´õÇ‘Îô; ”å”AŠí‰È—̈æ‚É‚¨‚¯‚épŒãŠ´õÇ–hŽ~‘Îô: • o‹¾‰ºŽèp, Urology View 3 (1): 62-66. Šâ‘º³Žk, ²“¡ˆÐ•¶, ”nêŽu˜Y (”å), ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

712031. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) ENHANCED SYSTEMIC T-CELL RESPONSES FOLLOWING COMBINATION IN SITU GENE THERAPY + RADIOTHERAPY OR HORMONAL THERAPY FOR PROSTATE CANCER. –Ø‘º«‹M1, ²“¡ˆÐ•¶1, The BS2, Timme TL2, Mai WY2, Vlachaki MT2, Nobuyuki Kusaka2, “¡“c“N•v1, Abd El2, Fattah EM2, Gdor Y2, Kadmon D2, Butler EB2, Thompson TC2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 10th international charles Heidelbeger Symposium (2004/11/4-7), Óì.

<Šw‰ïi‘Ûj•½¬15”N“x–¢ŒfÚ•ª>
713139. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Effective suicide gene transfer strategy by a chimeric adenovirus vector to bladder cancer. ¼–{˜a«1, Jian W2, Yotnda P2, Freund CT2, Olmsted-Davis EA2, Davis AR2, Lerner SP2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 98th Annual Meeting American Urological Association (2003/4/25-5/1), Chicago, IL, USA.

713140. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Loss of coxsackie adenovirus receptor expression is associated with bladder cancer grade, stage and survival. ¼–{˜a«1, Ayala GE2, Shariat SF2, Rauen KA2, Li R2, Vazina A2, Lerner SP2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 98th Annual Meeting American Urological Association (2003/4/25-5/1), Chicago, IL, USA.

713141. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Preoperative plasma soluble E-cadherin predicts lymph nodes metastases and disease progression in patients undergoing radical cystectomy. ¼–{˜a«1, Shariat SF2, Casella R2, Freund CT2, Wheeler TM2, Slawin KM2, Lerner SP2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 98th Annual Meeting American Urological Association (2003/4/25-5/1), Chicago, IL, USA.

713142. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) FK228 increases adenovirus transgene expression and enhances adenovirus mediated suicide gene therapy in human bladder cancer cells. Jian W1, Li L1, ¼–{˜a«2, Jiang Yu1, Davis AR1, Lerner SP1 (1ƒxƒCƒ‰|ˆã‘å. 2”å): 6th Annual Meeting American Society of Gene Therapy (2003/6/4-8), Washington DC, USA.

713143. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Combination therapy of radiation and cytotoxic gene transfer using chimeric adenovirus vector for bladder cancer. ¼–{˜a«1, Freund CT2, Jian W2, Yotnda P2, Olmsted-Davis EA2, Davis AR2, Lerner SP2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 6th Annual Meeting American Society of Gene Therapy (2003/6/4-8), Washington DC, USA.

713144. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Cell cycle effects of combination adenovirus-mediated suicide gene therapy and chemotherapy in bladder cancer. Freund CT1, ¼–{˜a«2, Jian W1, Yu J1, Davis AR1, Lerner SP1 (1ƒxƒCƒ‰|ˆã‘å. 2”å): 94th Annual Meeting American Association for Cancer Research (2003/6/11-15), Washington DC, USA.

713145. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) A novel chimeric adenovirus vector enhances suicide gene therapy for bladder cancer. ¼–{˜a«1, Jian W2, Yotnda P2, Freund CT2, Olmsted-Davis EA2, Davis AR2, Lerner SP2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 94th Annual Meeting American Association for Cancer Research (2003/6/11-15), Washington DC, USA.

713146. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Combination of adenovirus mediated suicide gene therapy with the histone deacetylase inhibitors butyrate, phenylbutyrate and electroporation in bladder cancer in vitro and in vivo. Jian W1, Li L1, ¼–{˜a«2, Freund CT1, Chen SY1, Davis AR1, Lerner SP1 (1ƒxƒCƒ‰|ˆã‘å. 2”å): 94th Annual Meeting American Association for Cancer Research (2003/6/11-15), Washington DC, USA.

713147. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Urinary levels of soluble E-cadherin in the detection of transitional cell carcinoma of the bladder cancer. ¼–{˜a«1, Shariat SF2, Casella R2, Jian W2, Ayala GE2, Lerner SP2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 82nd Annual Meeting the South Central Section of the American Urological Association (2003/9/6-10), Boston, MA.

713148. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Gene therapy for bladder cancer using a chimeric adenovirus vector. ¼–{˜a« (”å): Wolf Visiting Professor 2003 Research Conference (2003/10/29), Houston, TX.

713149. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Urinary levels of soluble E-cadherin in the detection of transitional cell carcinoma of the bladder cancer. ¼–{˜a«1, Shariat SF2, Casella R2, Jian W2, Ayala GE2, Lerner SP2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 1st Cancer Center Retreat & Symposium (2003/11/7), Houston, TX.

713150. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Loss of coxsackie adenovirus receptor expression is associated with bladder cancer grade, stage and survival. ¼–{˜a«1, Shariat SF2, Ayala GE2, Vazina A2, Rauen KA2, Li R2, Lerner SP2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 1st Cancer Center Retreat & Symposium (2003/11/7), Houston, TX.

713151. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Effictive of the histone deacetylase inhibitor FK228 in improving adenoviral mediated gene expression and suicide gene therapy in TCC-SUP cell. Jian W1, ¼–{˜a«2, Yu J1, Davis A1, Lerner SP1 (1ƒxƒCƒ‰|ˆã‘å. 2”å): 1st Cancer Center Retreat & Symposium (2003/11/7), Houston, TX.

713152. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Combination therapy of radiation and cytotoxic gene transfer using chimeric adenovirus vector for bladder cancer. ¼–{˜a«1, Freund CT2, Jian W2, Yotnda P2, Olmsted-Davis EA2, Davis AR2, Lerner SP2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 1st Cancer Center Retreat & Symposium (2003/11/7), Houston, TX.

713153. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Raloxifene in combination with cytotoxic chemotherapy in bladder cancer in vitro. Yu J1, Kim M1, ¼–{˜a«2, Kim YI1, Smith CL1, Lerner SP1 (1ƒxƒCƒ‰|ˆã‘å. 2”å): 1st Cancer Center Retreat & Symposium (2003/11/7), Houston, TX.

713154. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Effictive of the histone deacetylase inhibitor FK228 in improving adenoviral mediated gene expression and suicide gene therapy in TCC-SUP bladder cancer. Jian W1, Li Ling1, ¼–{˜a«2, Yu J1, Freund CTF1, Lerner SP1 (1ƒxƒCƒ‰|ˆã‘å. 2”å): 5th Annual Retreat of Cell and Gene Therapy (2003/11/20-21), Galveston TX.

713155. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Combination therapy of radiation and cytotoxic gene transfer using chimeric adenovirus vector for bladder cancer in vitro. ¼–{˜a«1, Freund CT2, Jian W2, Yu Jiang2, Yotnda P2, Olmsted-Davis EA2, Davis AR2, Lerner SP2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 5th Annual Retreat of Cell and Gene Therapy (2003/11/20-21), Galveston TX.

713156. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) RACIAL DIFFERENCES IN ZONAL DISTRIBUTION OF PROSTATE CANCER IN RADICAL PROSTATECTOMY SPECIMENS. Έä~ˆê˜Y1, ‘å–x@—1, Gustavo E Ayala2, Thomas M Wheeler2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): ‘æ93‰ñ•Ä‘ƒJƒiƒ_•a—Šw‰ï (2004/3/9), ƒoƒ“ƒN[ƒo[, ƒJƒiƒ_.

713157. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Raloxifen in combination with cytotoxic chemotherapy in bladder cancer in vitro. Yu J1, Kim M1, ¼–{˜a«2, Kim IY1, Shen S1, Smith CL1, Lerner SP1 (1ƒxƒCƒ‰|ˆã‘å. 2”å): 95th Annual Meeting American Association for Cancer Research (2004/3/27-31), Orlando, FL, USA.

713158. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Effects of the histone deacetylase inhibitor FK228 in improving adenoviral mediated gene expression and suicide gene therapy in human TCC-sup bladder cancer. Jian W1, Li L1, ¼–{˜a«2, Yu J1, Shen S1, Freund CTF1, Lerner SP1 (1ƒxƒCƒ‰|ˆã‘å. 2”å): 95th Annual Meeting American Association for Cancer Research (2004/3/27-31), Orlando, FL, USA.

<Šw‰ïi‘Ûj•½¬16”N“x•ª>
713159. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Differential expression of estrogen receptor ƒ¿ and ƒÀin bladder cancer cell lines and human bladder tumor tissue. Shen SS1, Yu J KimIY1, Jian W1, ¼–{˜a«2, Kim MM1, Sonpavde G1, Smith C1, Ayala GE1, Younes M1, Lerner SP1 (1ƒxƒCƒ‰|ˆã‘å. 2”å): 99th Annual Meeting American Urological Association (2004/5/8-13), San Francisco.

713160. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) A chimeric adenovirus vector enhances suicide gene therapy forbladder cancer. ¼–{˜a«1, Freund CT2, Jian W2, Yu J2, Richardson BE2, Davis A2, Lerner SP2 (1”å. 2ƒxƒCƒ‰[ˆã‘å): 99th Annual Meeting American Urological Association (2004/5/8-13), San Francisco.

713161. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) ENHANCED SYSTEMIC T-CELL RESPONSES FOLLOWING COMBINATION IN SITU GENE THERAPY + RADIOTHERAPY OR HORMONAL THERAPY FOR PROSTATE CANCER. ²“¡ˆÐ•¶1, Bin S Teh2, Terry L Timme2, Wei-Yuan Mai2, Maria T Vlachaki2, Nobuyuki Kusaka2, “¡“c“N•v1, El Moataz Abd2, El Fattah2, Yehoshua Gdor2, Dov Kadmon2, E Brian Butler2, Timothy C Thompson2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): ‘æ99‰ñAUA 2004 Annual Meeting (2004/5/10), ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR. The Journal of Urology, 171 (4): 283-284, 2004.

713162. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) ROUTE OF ADMINISTRATION INFLUENCES THE ANTI-TUMOR EFFECT OF BONE MARROW DERIVED DENDRITIC CELLS ENGINEERED TO PRODUCE INTERLEUKIN-12 IN A METASTATIC MOUSE PROSTATE CANCER MODEL. ŽG‰ê—²Žu1, ²“¡ˆÐ•¶2, “ú‰ºMs1, ]Œ´@L1, Vladimir B Mouraviev3, Hiromi Kumon1, Terry L Timme, Timothy C Thompson3 (1‰ªŽR‘å. 2”å. 3ƒxƒCƒ‰|ˆã‘å): AUA 2004 Annual Meeting (2004/5/10), ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR. The Journal of Urology, 171 (4): 283-284, 2004.

713163. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) PRSENCE OF PERIPHERAL ZONE CANCER AT APICAL SHAVE IS IMPORTANT PROGNOSTIC FACTOR. Έä~ˆê˜Y1, ‘å–x@—1, Michael W Kattan2, Peter T Scardino2, Toshiki Tsuboi2, Kevin M Slawin3, Thomas M Wheeler3 (1”å. 2MSKCC. 3ƒxƒCƒ‰[ˆã‘å): ‘æ99‰ñ•Ä‘”å”AŠí‰ÈŠw‰ï‘‰ï (2004/5/10), ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR.

713164. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) IL-12 Transduced Bone Marrow Cells Home to Bone and Generate Anti-Metastatic Activities in a Mouse Prostate Cancer Model. Hongyu Wang1, Guang Yang1, Terry L Timme1, “¡“c“N•v2, Koji Naruishi1, Xiaorong Ji1, Malcolm K Brenner1, Dov Kadmon1, Timothy C Thompson1 (1ƒxƒCƒ‰|ˆã‘å. 2”å): 7th Annual Meeting of the American Society of Gene Therapy (2004/6), Minneapolis.

713165. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Synergism of combined radiation and suicide gene therapy using a chimeric adenovirus vector for bladder cancer. ¼–{˜a«1, Freund CT2, Jian W2, Yu J2, Yotnda P2, Davis AR2, Lerner SP2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 7th Annual Meeting American Society of Gene Therapy (2004/6/2-6), Mineapollis, USA.

713166. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Enhanced Therapeutic Effect of Adenoviral Vector-Mediated RTVP-1 Gene Therapy in Combination with Irradiation for Prostate Cancer. “¡“c“N•v1, Koji Naruishi2, Nobuyuki Kusaka2, ²“¡ˆÐ•¶1, Xiaorong Ji2, Jianxiang Wang2, Xiaohong Zhu2, Guang Yang2, Alexei A Goltsov2, Terry T Timme2, Maria T Vlachaki2, Bin S Teh2, E Brian Butler2, Timothy C Thompson2 (1”å. 2ƒxƒCƒ‰[ˆã‘å): 7th Annual Meeting of the American Society of Gene Therapy (2004/6/2-6), Minneapolis.

713167. [Šw‰ï (‘Û)] (ƒ[ƒNƒVƒ‡ƒbƒv) Combination Adenoviral Vector-Mediated Interleukin 12 Gene Therapy Plus Radiotherapy for Prostate Cancer. Bin Sing Teh1, Robert J Amato1, “¡“c“N•v2, Terry L Timme1, Brian J Miles1, Gustavo Ayala1, Thomas M Wheeler1, Dov Kadmon1, E Brian Butler1, Timothy C Thompson1 (1ƒxƒCƒ‰|ˆã‘å. 2”å): 12th SPORE Investigators' Workship (2004/8), Baltimore.

713168. [Šw‰ï (‘Û)] (ƒ[ƒNƒVƒ‡ƒbƒv) IL-12 Transduced Bone Marrow Cells Home to Bone and Generate Anti-Metastatic Activities in a Mouse Prostate Cancer Model. Hongyu Wang1, Guang Yang1, Terry L Timme1, “¡“c“N•v2, Koji Naruishi1, Xiaorong Ji1, Malcolm K Brenner1, Dov Kadmon1, Timothy C Thompson1 (1ƒxƒCƒ‰|ˆã‘å. 2”å): 12th SPORE Investigators' Workship (2004/8), Baltimore.

713169. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Analysis of Cytokines and Anti-HLA Antibodies in Kidney Transplantation: Transforming Growth Factor-Betal Exhibitis a Protective Effect on Chronic Rejection. ¬”¦•¶–í1, ‹g“cˆê¬2, ‘å‹v•Û‚Ý‚Ç‚è3, ’|“àN—Y4, “c‰ª‰ÀŒ›2, ŽÂŒ´MŒ«5, ‰““¡’‰—Y6, ”nêŽu˜Y2 (1ˆã‰q. 2”å. 3—\–hˆãŠwŒn. 4“à‡W. 5–Ɖu. 6é‹ÊŒ§‰›): ‘æ20‰ñ‘ÛˆÚAŠw‰ï (2004/9/5-10), ƒEƒB[ƒ“.

713170. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Cooperative Effects of Adenoviral Vector-Mediated Interleukin 12 Gene Therapy and Radiotherapy in a Preclinical Model of Metastatic Prostate Cancer. “¡“c“N•v1, Terry L Timme2, Koji Naruishi2, Nobuyuki Kusaka2, Julie X Zhu2, Guang Yang2, Alexei Goltsov2, Maria T Vlachaki2, Bin S Teh2, E Brian Butler2, Timothy C Thompson2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 2nd Annual Cancer Center Symposium (2004/10), Houston.

713171. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) IL-12 Gene Modified Bone Marrow Stem Cell Therapy in a Mouse Model of Metastatic Prostate Cancer. Hongyu Wang1, Guang Yang1, Terry L Timme1, “¡“c“N•v2, Koji Naruishi1, Xiaorong Ji1, Malcolm K Brenner1, Dov Kadmon1, Timothy C Thompson1 (1ƒxƒCƒ‰|ˆã‘å. 2”å): 2nd Annual Cancer Center Symposium (2004/10), Houston.

713172. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Combinatorial Effect of Adenoviral Vector Mediated Interleukin 12 Gene Therapy with Radiotherapy in a Preclinical Model of Metastatic Prostate Cancer. “¡“c“N•v1, Bin S Teh2, Koji Naruishi2, Nobuyuki Kusaka2, ²“¡ˆÐ•¶1, Xiaohong Zhu2, Xiaorong Ji2, Guang Yang2, Terry L Timme2, Maria T Vlachaki2, E Brian Butler2, Timothy C Thompson2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (2004/10), Atlanta.

713173. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Novel therapeutic approach for bladder cancer: synergistic effects with combined radiation and suicide gene therapy using a chimeric adenovirus vector. ¼–{˜a«1, Freund CTF2, Teh BS2, Yu J2, Jian W2, Vlachaki MT2, Davis AR2, Butler EB2, Lerner SP2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 46th Annual Meeting American Society for Therapeutic Radiology and Oncology (2004/10/3-7), Atlanta, GA, USA.

713174. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) The Combination Therapy With Oxacalcitriol and Menatetrenone(Vitamin K2) Greatly Enhances ƒÁ-carboxylation in the Normo-High Turnover Bone. •º“¡@“§1, ‹g“cˆê¬2, “c”¨Œ’ˆê2, •½—Ç—²•Û1, ”nêŽu˜Y2 (1‰¡•l‘æˆê. 2”å): ASN 37th Annual Meeting & Scientific Exposition (2004/10/27), ƒZƒ“ƒgƒ‹ƒCƒX.

713175. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Combination radio-suicide gene therapy using a chimeric adenovirus for treatment of bladder cancer. ‰œ–ì‹I•F1, ¼–{˜a«1, Bin STeh2, Weigo Jian2, Maria T Vlachaki2, Aran R Davis2, Seth P Lerner2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): 2nd cancer center symposium (2004/10), Houston USA.

713176. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Preoperative soluble E-cadherin predicts lymph nodes metastases and disease progression in patients undergoing radical cystectomy. ¼–{˜a«, “ü]@Œ[, ²“¡ˆÐ•¶, ¼“c‘å‰î, ‘v@¬_, Šâ‘º³Žk, ”nêŽu˜Y (”å): 7th Annual Meeting the international urological conference of the republic of China (2004/11/6), Taipei, Taiwan, ROC.

713177. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Combined effects with combined radiation and suicide gene therapy using a chimeric adenovirus for bladder cancer in animal model. ‰œ–ì‹I•F1, ¼–{˜a«1, Julie X Zhu2, Bin STeh2, Weigo Jian2, Maria T Vlachaki2, Aran R Davis2, Seth P Lerner2 (1”å. 2ƒxƒCƒ‰|ˆã‘åj: Cell and Gene Therapy association (2004/11/19), Galveston USA.

713178. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Computer simulated additionally deep apical biopsy enhances cancer detection in non-palpable prostate gland. Yamada H1, Shimomura T1, Miki K1, Koide H1, Yusu H1, Numazaki S1, ¼–{˜a«2, ‰oì@W2, ”nêŽu˜Y2 (1ƒxƒCƒ‰[ˆã‘å. v”å): 5 th Urological Research Forum Okinawa (2005/1/28-29), “ß”e.

722074. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) TUR-P‚Ì’·Šú¬Ñ. ‰oì@W, ŽÔ@‰pr, “c‰ª‰ÀŒ›, ²“¡ˆÐ•¶, ¬ŽÄ@Œ’, ”nêŽu˜Y (”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/11), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 138, 2004.

722075. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€/Ži‰ï‚Ì‚±‚Æ‚Î) uNew technology‚ª‘n‘¢‚·‚é”å”AŠí‰È‚Ì‹ß–¢—ˆv. ¼“cŒöŽu1, ”nêŽu˜Y2 (1ŠÖ¼ˆã‘å. 2”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 155, 2004.

722076. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) 3ŽŸŒ³‰æ‘œ‰ðÍ‚Ì“±“ü‚Æ—Õ°‰ž—p. Šâ‘º³Žk1, ’I‹´‘PŽ2, ”nêŽu˜Y1 (1”å. 2‚XƒNƒŠ): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 157, 2004.

722077. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”å”AŠí‰È‚É‚¨‚¯‚é• o‹¾‰º•›t“Eœp‚Ì‹³ˆçEƒgƒŒ[ƒjƒ“ƒO. Šâ‘º³Žk, ”nêŽu˜Y (”å): ‘æ16‰ñ“ú–{“à•ª”åŠO‰ÈŠw‰ï‘‰ï (2004/5/18), “Œ‹ž.

723640. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒv) Proteome Analysis of Androgen independent Prostate Cancer. ŽÔ@‰pr (”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/10), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 292, 2004.

723641. [Šw‰ï (‘S‘)] (ƒrƒfƒIj ‘Ìo‹¾‰º‘O—§‘B‘S“Eœp‚É‚¨‚¯‚éDVC–³Œ‹ãF–@‚É‚æ‚é‘O—§‘Bë•”ˆ—‚ÆäNã÷”A“¹•«‡. Ž›’n•q˜Y1, ‰PˆäK’j1, “‡@³‘¥1, “¿‰i³r1, ¬—ёהV1, ²X–Ø@—T1, ŽR‰º‰p”V2, ¯@º•v1, ‹{–k‰pŽi1, ¬•ûN¶3, ‰¶“c@ˆê3, ˆî“y”Ž‰E3, –ؖƒ“Þ3 (1“ŒŠC‘å. 2”å. 3ɪŽs—§´…): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/11), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 311, 2004.

723642. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œn““I‘½Š«¶ŒŸ‚ÅŠù‚Éf’f‚ðŽó‚¯‚½‘O—§‘BŠàŠ³ŽÒ‚ɑ΂·‚鎡—ÑO‚ÌĶŒŸ‚Í•a—•aŠú‚ð³Šm‚É—\‘ª‚Å‚«‚é‚©? ‘å–x@—1, ƒVƒ‹ƒJ[ ƒJƒjƒVƒJ2, ‰©@‰p–Î1, ƒXƒJƒ‹ƒfƒB[ƒm ƒs[ƒ^[2, ƒƒCƒ^[ ƒrƒNƒ^[2 (1”å. 2ƒƒ‚ƒŠƒAƒ‹ƒXƒƒ“ƒPƒ^ƒŠƒ“ƒOŠàƒZƒ“ƒ^[): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/11), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 358, 2004.

723643. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œo”A“¹“I‘O—§‘BƒGƒ^ƒm[ƒ‹’“üp‚ÌŒø‰Ê”­Œ», ƒƒJƒjƒYƒ€‚ÌŒŸ“¢. ŒÃ‰êËŽk1, `–ì@’¼1, â–{@¸1, –ö’åˆê˜Y1, ‹g‰ª–M•F1, •À–؈ê“T1, ‘å–ì–F³1, ‰©@‰p–Î2, ”©ŽR’¼Ž÷3, ¼ˆä‘Pˆê1, ¼–{ˆêG1, ’†_‹`O1, ‹k@­º1 (1“Œ‹žˆã‘å. 2”å. 3‘—§é‹Ê): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/11), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 368, 2004.

723644. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j “ú–{l‘O—§‘BŠà‚É‚¨‚¯‚éCaveoiin-1”­Œ»‚ÌŒŸ“¢. ²“¡ˆÐ•¶1, ƒ„ƒ“ ƒOƒAƒ“2, ‰oì@W1, ƒAƒ_ƒC ƒWƒ‡ƒZƒtƒBƒ“2, ƒtƒƒƒu ƒAƒ“ƒi2, ŒK”ö’èm3, ƒeƒBƒ~[ ƒeƒŠ[2, ƒgƒ“ƒvƒ\ƒ“ ƒeƒBƒ‚ƒV[2, ”nêŽu˜Y1 (1”å. 2ƒxƒCƒ‰[ˆã‘å. 3•a—): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/11), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 329, 2004.

723645. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j ‘O—§‘B‚É‚¨‚¯‚éRLYVE-1R‘Ì—z«–¬ŠÇ‚Ì•ª•z. ²“¡ŠG—¢“Þ1, ‘v@¬_1, H“ˆ—R—¢2, ˆÉ“¡‹àŽŸ2, Έäšæ°2, ”nêŽu˜Y1 (1”å. 2“Œ–M‘å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/11), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 330, 2004.

723646. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j • o‹¾‰º‘O—§‘B‘S“Ep‚Æ’pœŒãŽ®‘O—§‘B‘S“Ep‚É‚¨‚¯QOL‚̉ñ•œ‰ß’ö: ‘¼Ž{Ý‹¤“¯‘OŒü‚«Œ¤‹†. •À–Ørˆê1, ˆÉ“¡–¾G1, Ö“¡½ˆê1, rˆä—zˆê1, ‰oì@W2, ”nêŽu˜Y2, ‰PˆäK’j3, Ž›’n•q˜Y3, “È–Ø’B•v4, ŒKŒ´³–¾4, ˆÁ’J®³5 (1“Œ–k‘å. 2”å. 3“ŒŠC‘å. 4‹{錧—§‚ª‚ñƒZƒ“ƒ^[. 5å‘äŽÐ‰ï•ÛŒ¯): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/11), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 334, 2004.

723647. [Šw‰ï (‘S‘)] (ƒrƒfƒIj Vascular Sealing System‚É‚æ‚ét‚Ì”¼Øœp. `–ì@’¼1, –ö’åˆê˜Y1, ‹g‰ª–M•F1, •À–؈ê“T1, ŒÃ‰êËŽk1, ‘å–ì–F³1, ‰©@‰p–Î2, ¼ˆä‘Pˆê1, â–{@¸1, ‹k@­º1, ŽR쌒ˆê1, ‘O“c_”V1, ¬ì—R‰p3 (1“Œ‹žˆã‘å. 2”å. 3—®‹…‘å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/11), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 440, 2004.

723648. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j “–‰@‚É‚¨‚¯‚é‘O—§‘B¶ŒŸ‚ÌŒŸ“¢. â–{@¸1, ŒÃ‰êËŽk1, `–ì@’¼1, –ö’åˆê˜Y1, ‹g‰ª–M•F1, •À–؈ê“T1, ‘å–ì–F³1, ‰©@‰p–Î2, ¼ˆä‘Pˆê1, ¼–{ˆêG1, ’†_‹`O1, ‹ÚàV”Ž”ü1, ‹k@­º1 (1“Œ‹žˆã‘å. 2”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/11), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 462, 2004.

723649. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) tŽXŒèóŒ‹Î‚ɑ΂·‚錋ΔjÓŽ¡—ÃŒã‚Ì’·Šú¬Ñ|Š³‘¤t‹@”\‚ɂ‚¢‚Ä‚ÌŒŸ“¢|. rì@F1, ’ѺGN1, ²“¡ˆÐ•¶1, ”nêŽu˜Y1, •½ˆäËŽi1, ŠÛ@“T•v2, ‘å–x@—2, ‹v•Û¯ˆê2, {ŽRˆê•ä3 (1”å. 2‘Š–Í‘ä. 3ˆßŠ}): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 377, 2004.

723650. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹t—¬«tÇ‚É‚¨‚¯‚éGF-1 (lnsulin 1ike growth factor-1) ‚ÌŠÖ—^. ‹{–k‰pŽi1, ¯@º•v1, ŽR‰º‰p”V2, ²X–Ø@—T1, “‡@³‘¥1, ¬—ёהV1, “¿‰i³r1, ‰PˆäK’j1, Ž›’n•q˜Y1 (1“ŒŠC‘å. 2”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 380, 2004.

723651. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘O—§‘BŠà‚Ì lymphangiogenesis‚ÌŒŸ“¢‚Ö. ‘v@¬_1, ²“¡ŠG—¢“Þ1, H“ˆ—R—¢2, ˆÉ“¡‹àŽŸ2, Έäšæ°2, ”nêŽu˜Y1 (1”å. 2“Œ–M‘å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 389, 2004.

723652. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘Šú‘O—§‘BŠà‚ɑ΂·‚éŒo”A“¹“Iƒ}ƒCƒNŒû”g‚‰·“xŽ¡—ÂÆR’j«ƒzƒ‹ƒ‚ƒ“—Ö@‚Æ‚Ì•¹—pŒø‰Ê. dé@—T1, ¬ŽÄ@Œ’1, —é–Ø—²‘å2, ¯‡@Ž¡1, ‰““¡’‰—Y1, ‘ŠŒ´³O3, ’†žŠO—²3, Ÿ“c^s2 (1é‹ÊŒ§‰›. 2”å. 3’·’Óc): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 391, 2004.

723653. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒÀ‹Ç«‘O—§‘B‚ª‚ñ‚ɑ΂·‚é‚–§“xÅ“_Ž®’´‰¹”g (HIFU) —Ö@‚Ì—Õ°¬Ñ. “à“c–Lº1, ‘å‘@—m2, ’·“cŒbO1, ²“¡ˆÐ•¶2, “ü]@Œ[2, •º“¡@“§2, ¬–““ñ–ç2, a’J@‘¥2, ”nêŽu˜Y2, ‰PˆäK’j3, Ž›’n•q˜Y3 (1“ŒŠC‘唪‰¤Žq. 2”å. 3“ŒŠC‘å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 392, 2004.

723654. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒAƒKƒ[ƒXTwo Dimensional Differential Gel Electrophoresis (2D DIGE) –@‚É‚æ‚éƒzƒ‹ƒ‚ƒ“”ñˆË‘¶«‘O—§‘BŠà‚Ì‚•ªŽq—ʃvƒƒeƒI[ƒ€‰ðÍ. ŽÔ@‰pr1, ‰oì@W1, ‘åγ“¹2, ¬Ž›‹`’j2, ’Â@ˆÌ‹­1, ‘O“c’‰Œv2, ”nêŽu˜Y1 (1”å. 2—Šw•”): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 395, 2004.

723655. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j ”å”AŠíˆ««Žîᇂɂ¨‚¯‚élactoferrinŠÖ˜Aˆâ“`ŽqECAPL/mts1”­Œ»‚ÉŠÖ‚·‚錟“¢. ’Â@ˆÌ‹­1, “ü]@Œ[1, ˆÉ“Œˆê˜Y2, Šâ‘º³Žk1, ‰oì@W1, ”nêŽu˜Y1 (1”å. 2—\–hˆãŠwŒn): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 479, 2004.

723656. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j t×–EŠà‚É‚¨‚¯‚éCaveolin-1‚Ì”­Œ»‚Æ‚»‚̈Ӌ`. Šâ‘º³Žk, ’Â@ˆÌ‹­, ²“¡ŠG—¢“Þ, ²“¡ˆÐ•¶, “ü]@Œ[, ”nêŽu˜Y (”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 480, 2004.

723657. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j Rough neural network‚ð—p‚¢‚½‘O—§‘B¶ŒŸŒ‹‰Ê—\‘ªƒ‚ƒfƒ‹‚Ìì¬ (PSA2.0 ng/ml-10.O ng/ml‚ÌÇ—á‚ɂ‚¢‚Ä). {ŽRˆê•ä1, ‰oì@W2, “cè‰hˆê˜Y3, ƒnƒbƒTƒ“ ƒ„ƒZ[ƒ‹3, ŒK”ö’èm4 (1ˆßŠ}. 2”å. 3‹Ëˆü‰¡•l‘å. 4“Œ‘å˜a): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 501, 2004.

723658. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j Œo’¼’°“I‘O—§‘B’´‰¹”g‚É‚æ‚é14ƒ–ŠŒn““I‘½Š¶ŒŸ‚ÌŒŸ“¢. ¼“c‘å‰î1, ‘º–{«r1, Έä‘å•ã1, ‚“ˆ—Í–í1, ‰©@‰p–Î1, –å˜e˜ab2, ”nêŽu˜Y1 (1”å. 2–kŒ¤): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 502, 2004.

723659. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j ‘O—§‘B‘S“EœpŒã‚ÌPSAÄ”­‚ɑ΂·‚é•úŽËüŽ¡—Â̌Ÿ“¢. “¿‰i³r1, ¯@º•v1, ŽR‰º‰p”V2, ²X–Ø@—T1, ¬—ёהV1, “‡@­‘¥1, ‰PˆäK’j1, ‹{–k‰pŽi1, Ž›’n•q˜Y1 (1“ŒŠC‘å. 2”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 511, 2004.

723660. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j Z«äNã÷Šà‚Ìf’f‚Ì‚à‚Æ, äNã÷‘S“EopŒã‚É”­Œ©‚³‚ꂽ‘O—§‘BŠà‚ÌŒŸ“¢. aŒûG”V1, {“¡—˜—Y1, Â@‹Pº2 (1”å. 2–kŒ¤): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 512, 2004.

723661. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j “–‰È‚É‚¨‚¯‚鋾Ž‹‰ºtŽèp‚ÌŒŸ“¢. •À–؈ê“T1, ŒÃ‰êËŽk1, –ö’åˆê˜Y1, ‹g‰ª–M•F1, Œ “¡—§’j1, ’†_‹`O1, â–{@¸1, ¼–{ˆêG1, ¼ˆä‘Pˆê1, ‰©@‰p–Î2, ‘å–ì–F³1, `–ì@’¼1, ‹k@­º1 (1“Œ‹žˆã‘å. 2”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 522, 2004.

723662. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j tŠà‚ɑ΂·‚é• o‹¾‰ºªŽ¡“It“Eœp‚¨‚æ‚Ñt•”•ªØœp‚Ì—Õ°“IŒŸ“¢. Έä‘å•ã1, Šâ‘º³Žk1, “ì“c@—@, Îì@–í1, ‰œ–ì‹I•F1, •½ˆäËŽi1, “ü]@Œ[1, ‰oì@W1, ”nêŽu˜Y1 (1”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 524, 2004.

723663. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j “–‰@‚É‚¨‚¯‚é• o‹¾‰ºt᱌`¬p‚ÌŽ¡—ìÑ. “c”¨Œ’ˆê1, Šâ‘º³Žk1, ‘v@–Î_1, “¡é‹M‹³1, ‰œ–ì‹I•F1, “c‰ª‰ÀŒ›1, ’r“cŸb1, ’؈ärŽ÷, ”nêŽu˜Y1 (1”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 525, 2004.

723664. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j “–‰@‚Å‚Ì”å”AŠí‰È‚Ì‘Ìo‹¾‰ºŽèp‚ÌŽüpŠú‡•¹Ç, pŒã‡•¹Ç‚ÌŒŸ“¢. ‰œ–ì‹I•F, Šâ‘º³Žk, •½ŽR‹M”Ž, ¼“c‘å‰î, “¡é‹M‹³, “ü]@Œ[, ‰oì@W, ”nêŽu˜Y (”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/12), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 528, 2004.

723665. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j ”A˜H“à”½«Žîᇂ̶•¨Šw“IŠˆ«‚ÉŠÖ‚·‚錟“¢. ¼‰ºˆêm, “ü]@Œ[, Îì@–í, ²“¡ŠG—¢“Þ, ŠÛ@“T•v, ÝŠy•q–ç, ”nêŽu˜Y (”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 542, 2004.

723666. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[j “–‰@‚É‚¨‚¯‚é”n’ût‚É”º‚¤”A˜HŒ‹Îǂɑ΂·‚鎡—Õñ. •½ˆäËŽi, ‹v•Û¯ˆê, ŠÛ@“T•v, ‰¡“c^“ñ, ‘å–x@—, rì@F, ”nêŽu˜Y (”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 575, 2004.

723667. [Šw‰ï i‘S‘j] (ˆê”Êu‰‰) tˆÚAŒã‚“x‚̈ÚA”AŠÇ‹·ó‚ɑ΂µ‚ĈÚAt–Ð|Ž©ŒÈ”AŠÇ (t–Ð) •«‡p‚É‚æ‚é”A˜HÄŒš‚ðs‚Á‚½3—á. “c‰ª‰ÀŒ›, ‹g“cˆê¬, “¡é‹M‹³, “c”¨Œ’ˆê, aŒûG”V, ‰œ–ì‹I•F, ‰““¡’‰—Y, ”nêŽu˜Y (”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 409, 2004.

723668. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠO—ˆ’ʉ@ˆÛŽŒŒ‰t“§ÍŠ³ŽÒ‚ɑ΂·‚éƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒƒNƒ`ƒ“ÚŽí‚ÌŒø‰Ê: R‘̉¿‚¨‚æ‚Ñ—Õ°Çó‚ɂ‚¢‚Ä. •º“¡@“§1, ‹g“cˆê¬1, “¡é‹M‹³1, ŽÔ@‰pr1, “c‰ª‰ÀŒ›1, “à“c–Lº2, ‰““¡’‰—Y, Žðˆä@‹Š3, “ú‘ä‰p—Y4, ”nêŽu˜Y1 (1”å. 2“ŒŠC‘唪‰¤Žq. 3¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š. 4‰¡•l‘æˆê): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 414, 2004.

723669. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒÀ‹Ç«t×–EŠà‚ÌpŒãÄ”­—\Œ©ˆöŽq‚ÌŒŸ“¢ªŽ¡“I‘O—§‘B‘S“Ep: ”í–ŒŠOZ (ECE) ‚ð”F‚ß‚È‚¢Øœ‰—z« (+SM) ‚Ì—\Œã‚É‚¨‚¯‚éˆÓ‹`. Έä~ˆê˜Y1, ‘å–x@—1, ŠÛ@“T•v1, ‘º–{«r1, ƒXƒŒƒCƒ”ƒ@ƒ“ ƒPƒ”ƒBƒ“2, ƒXƒJƒ‹ƒfƒB[ƒm ƒs[ƒ^[2, ”nêŽu˜Y1, ƒEƒB[ƒ‰[ ƒg[ƒ}ƒX2 (1”å. 2ƒxƒCƒ‰|ˆã‘å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã.

723670. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) BCG‚ÌäNã÷Šà×–E“ài“ü‚É‚¨‚¯‚émce 1‚Ìì—p‚ÉŠÖ‚·‚錟“¢. “ü]@Œ[1, “¡‘º‹¿’j2, —äˆä’è‹I1, Œ´–ì—TŽi1, ˜ZŠp@Žü1, ”nêŽu˜Y1 (1”å. 2”ç): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 416, 2004.

723671. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œã• –Œ‹¾‰ºt“EœpŒã‚Éport-site recurrence‚𗈂½‚µ‚½t×–EŠà‚Ì1—á. Îì@–í, Šâ‘º³Žk, “¡é‹M‹³, aŒûG”V, ‰œ–ì‹I•F, ”nêŽu˜Y (”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 425, 2004.

723672. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘Ìo‹¾‰º‘O—§‘B‘S“EœpŠJŽn‘OŒã‚É‚¨‚¯‚é’pœŒãŽ®pŽ®‚̕ω»‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ²X–Ø@—T1, ¯@º•v1, ŽR‰º‰p”V2, ¬—ёהV1, “‡@³‘¥1, “¿‰i³r1, ‰PˆäK’j1, ‹{–k‰pŽi1, ‰Í‘ºM•v, Ž›’n•q˜Y1 (1“ŒŠC‘å. 2”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 430, 2004.

723673. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ªŽ¡“I‘O—§‘B“EœpŒã‚Ì’·Šú¬ÑPSA failure‚Æoverall survival. ‰oì@W1, ¼ˆäŠì”V2, rˆä—zˆê2, {ŽRˆê•ä1, ”nêŽu˜Y1, ŒK”ö’èm3 (1”å. 2‘q•~. 3•a—): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 431, 2004.

723674. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ªŽ¡“I’pœŒãŽ®‘O—§‘B“Eœp‚É‚¨‚¯‚épŒã‘Šú”AŽ¸‹Ö‰ñ•œ‚ÌŽŽ‚Ý. ‹g‰ª–M•F1, ŒÃ‰êË“ñ1, •À–؈ê“T1, ‘å–ì–F³1, –ö’åˆê˜Y1, `–ì@’¼1, ‰©@‰p–Î2, â–{@¸1, ¼–{ˆêG1, ’†_‹`O1, Œ “¡—§’j1, ¼ˆä‘Pˆê1, ‹k@­º1 (1“Œ‹žˆã‘å. 2”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 432, 2004.

723675. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘O—§‘BŠàªŽ¡pŒã‚Ì–u‹NáŠQ‚ɑ΂·‚éPGE1‰AŒs“àŽ©ŒÈ’ŽË‚ÌŒoŒ±. Žu‘º@“N, —äˆä’è‹I, Šâ‘º³Žk, ‰oì@W, ”nêŽu˜Y (”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 433, 2004.

723676. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘O—§‘B‘S“EŽž‚É‚¨‚¯‚év‘¬•a—‚ÍØœ‰—z« (+SM) ‚ðŒ¸‚ç‚¹‚é‚©? ’؈ärŽ÷, ‘å–x@—1, •ŠâŒ°‘¾˜Y, ƒƒCƒ^|ƒrƒNƒ^|2, ”nêŽu˜Y1, ƒXƒJƒ‹ƒfƒB|ƒm ƒs|ƒ^|2 (1”å. 2ƒƒ‚ƒŠƒAƒ‹ƒXƒƒ“ƒPƒ^ƒŠƒ“ƒOŠàƒZƒ“ƒ^[): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 434, 2004.

723677. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒv) • o‹¾‰ºªŽ¡“I‘O—§‘B“Eœp‚̃|ƒCƒ“ƒg‚ƃRƒc|“Á‚É•Žè‚Ì–ðŠ„‚ð’†S‚É|. Šâ‘º³Žk, ‰oì@W, ”nêŽu˜Y (”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 259, 2004.

723678. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒv) ŒÀ‹Ç«‘O—§‘BŠà‚É‚¨‚¯‚骎¡“I‘O—§‘B“Eœp‚Ì•a—Šw“I•aŠú—\‘ª|“ú–{”Ńmƒ‚ƒOƒ‰ƒ€‚Ìì¬ (ŒÀ‹Ç«‘O—§‘BŠà‚Ì—Õ°•a—Œ¤‹†‰ï). Œã“¡@Œ’1, ŸŒ³—³—Y1, ŒÃ‰êŠ°Žj1, ÔÀ‰p”V2, rˆä—zˆê3, ‰F²”ü“¹”V4, ‘哇Lˆê5, ¬ì@C6, ‰œŽR–¾•F7, ì@ª8, ‹à•@—m9, ”’Α׎O10, ’Ë–{‘׎i11, –죑P–¾1, ”nêŽu˜Y12, •½”ö‰À•F13, ‘ºˆä@Ÿ14, ŽR’†‰pšæ15, “à“¡½“ñ1 (1‹ãB‘å. 2’}”g‘å. 3“Œ–k‘å. 4‘åã•{—§¬l•aƒZƒ“ƒ^[. 5–¼ŒÃ‰®‘å. 6‹ž“s‘å. 7‘åã‘å. 8“¿“‡‘å. 9’·è‘å. 10ŽOd‘å. 11ŽD–yˆã‘å. 12”å. 13“Þ—ÇŒ§—§ˆã‘å. 14Œc‰ž‘å. 15ŒQ”n‘å): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï (2004/10/29), ‹ž“s.

723679. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ªŽ¡“I‘O—§‘B‘S“Eœp: ”í–ŒŠOZ (ECE) ‚ð”F‚ß‚È‚¢Øœ‰—z« (+SM) ‚Ì—\Œã‚É‚¨‚¯‚éˆÓ‹`. Έä~ˆê˜Y1, ‘å–x@—1, ŠÛ@“T•v1, ‘º–{«r1, ƒXƒŒƒCƒƒ“ ƒPƒrƒ“2, ƒXƒJƒ‹ƒfƒB[ƒm ƒs[ƒ^[2, ”nêŽu˜Y1, ƒEƒBƒ‰[ƒg[ƒ}ƒY3 (1”å. 2ƒxƒCƒ‰[ˆã‘å. 3ƒƒ‚ƒŠƒAƒ‹ƒXƒƒ“ƒPƒ^ƒŠƒ“ƒOŠàƒZƒ“ƒ^[): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 434, 2004.

723680. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘O—§‘B”ì‘åÇŽ¡—ÂðŒŸØ‚·‚éTUR-P‚Ì’·Šú¬Ñ. ‰oì@W1, ŽÔ@‰pr1, “c‰ª‰ÀŒ›1, ²“¡ˆÐ•¶1, ¬ŽÄ@Œ’, ”nêŽu˜Y1 (1”å): ‘æ92‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2004/4/13), ‘åã. “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 95 (2): 138, 2004.

723681. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) HD“±“üŽžŠú‚©‚瓧͗ʂª­‚È‚­‘‰‚¹‚½ó‘Ô‚ÌŠ³ŽÒ‚Ì‘Ìd‚Í‚»‚ÌŒã‚Ì“§Í—Ê‚Ì‘‰Á‚ʼnü‘P‰Â”\‚©. ²“¡Œb”üŽq1, •º“¡@“§1, ‹ïŽuŒ˜‰ÄŽq1, —Lˆä’B˜Y1, ŽR–{ƒXƒ~Žq2, “n•Ó‹žŽq2, •½—Ç—²•Û1, ç—t“N’j1, ‹g“cˆê¬3, Žðˆä@‹Š4, “ú‘ä‰p—Y2, ”nêŽu˜Y3 (1‰¡•l‘æˆê. 2Œú–؃NƒŠ. 3”å. 4¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï (2004/6/18), _ŒË.

723682. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Urea Kinetics“™‚ð—p‚¢‚½ŒŒ‰t“§ÍŠ³ŽÒ‚̉h—{ó‘Ô‚É‚¨‚¯‚é‹Gß“I•Ï“®‚ÌŒŸ“¢. ²“¡Œb”üŽq1, •º“¡@“§1, ‹ïŽuŒ˜‰ÄŽq1, ŽR–{ƒXƒ~Žq2, •½—Ç—²•Û1, ‹g“cˆê¬3, ç—t“N’j1, “ú‘ä‰p—Y2, ”nêŽu˜Y3 (1‰¡•l‘æˆê. 2Œú–؃NƒŠ. 3”å): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï (200/6/18), _ŒË.

723683. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘½–Ú“I‘Ìo‹¾‚É‚æ‚éSMAP‚ÌŒoŒ±. Έä‘å•ã1, ‹g“cˆê¬1, ù–{Ž¡Žq1, “y“c–š”ü1, ¼‰ºˆêm1, “c”¨Œ’ˆê1, “¡é‹M‹³1, “c‰ª‰ÀŒ›1, ’|“àN—Y2, ”nêŽu˜Y1 (1”å. 2“à‡W): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï (2004/6/18), _ŒË. “ú–{“§ÍˆãŠw‰ïŽGŽ, 37 (S.1): 753, 2004.

723684. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰–Ž_ƒZƒxƒ‰ƒ}[“Š—^‚É‚æ‚é‰h—{ó‘Ԃ̕ω». ‹ïŽuŒ˜‰ÄŽq1, •º“¡@“§1, ²“¡Œb”üŽq1, •½—Ç—²•Û1, ç—t“N’j1, ù–{Ž¡Žq2, ‹g“cˆê¬2, “ú‘ä‰p—Y1, Žðˆä@‹Š3, ”nêŽu˜Y2 (1‰¡•l‘æˆê. 2”å. 3¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï (2004/6/18), _ŒË.

723685. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) áy‚݂ɑ΂·‚é“ú“à•Ï“®‚ÆQOL‚Ì•]‰¿. ’·’Jì—¢“Þ1, •x’˺Žq1, ‚‹´—Tˆê˜Y1, ‹g“cˆê¬2, Έä‘å•ã2, ”nêŽu˜Y2, –å˜e˜ab3 (1tŒ’ƒNƒŠ. 2”å. 3–kŒ¤): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï (2004/6/19), _ŒË.

723686. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒIƒLƒTƒ[ƒ‹‚ƃOƒ‰ƒP[‚Ì•¹—p—Ö@`”ñƒJƒ‹ƒ{ƒLƒVƒ‹‰»ƒIƒXƒeƒIƒJƒ‹ƒVƒ“‚Å‚ÌŒŸ“¢. •º“¡@“§1, ‹g“cˆê¬2, “y“c–š”ü2, Έä‘å•ã2, •½—Ç—²•Û1, “à“c–Lº3, ‰““¡’‰—Y2, “ú‘ä‰p—Y1, Žðˆä@‹Š4, ”nêŽu˜Y2 (1‰¡•l‘æˆê. 2”å. 3“ŒŠC‘唪‰¤Žq. 4¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï (2004/6/19), _ŒË.

723687. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) HPV–Œ‚̶‘Ì“K‡«‚ɂ‚¢‚Ä‚ÌŒŸ“¢`PVP‚͈«‰e‹¿H`. ‚”¨•‡”ü1, “y‰®’mŽq1, ‹ààV”üŽ}1, •ž•”ˆêŠó1, Ö“¡@‹B1, ÷ˆäŒ’Ž¡1, Žá—Ñ–õ‹v2, ŽR‰º–¾‘×3, ²“¡ˆÐ•¶4, ‹g“cˆê¬4, ”nêŽu˜Y4 (1‹´–{ƒNƒŠ. 2–kŒ¤. 3ÓìH‰È‘å. 4”å): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï (2004/6/19), _ŒË.

723688. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰–Ž_ƒZƒxƒ‰ƒ}[“Š—^‚É‚æ‚é•Ö”éó‘Ô‚ÍŽ•ž‚Å‚«‚é‚©H ‹ïŽuŒ˜‰ÄŽq1, •º“¡@“§1, •½—Ç—²•Û1, “c”¨Œ’ˆê2, ²“¡Œb”üŽq1, ‹g“cˆê¬2, ‰““¡’‰—Y2, Žðˆä@‹Š3, ”nêŽu˜Y2, “ú‘ä‰p—Y1 (1‰¡•l‘æˆê. 2”å. 3¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï (2004/6/19), _ŒË.

723689. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žct‹@”\•ÛŽ–Ú“I‚Ì–³œ…ŒŒ‰t“§Í‚ÌŒŸ“¢. “›–{N‘ã1, ‹ß“¡Œõ—m1, •º“¡@“§2, ˆ¢•”ˆèŽq1, •x–ž]—œŽq1, Šp“c”ü—R‹M1, ”ª–ؘaŽq1, ”nêŽu˜Y3, “ú‘ä‰p—Y2 (1Œú–؃NƒŠ. 2‰¡•l‘æˆê. 3”å): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï (2004/6/19), _ŒË.

723690. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒŠƒNƒZƒ‹‚ÌÄzŠÂŽg—p‚É‚¨‚¯‚éƒÀ2-mg‹z’…—Ê‚ÌŒŸ“¢. ‹ß“¡Œõ—m1, •º“¡@“§2, ˆ¢•”ˆèŽq1, “n•Ó‹žŽq1, ŽR–{ƒXƒ~Žq1, ‰““¡••v3, –{ŠÔ@’2, •½—Ç—²•Û2, ç—t“N’j2, ‹g“cˆê¬4, ”nêŽu˜Y4, Žðˆä@‹Š5, “ú‘ä‰p—Y2 (1Œú–؃NƒŠ. 2‰¡•l‘æˆê. 3‘å˜aƒNƒŠ. 4”å. 5¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï (2004/6/20), _ŒË.

723691. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒŒ‰t“§Í’†‚ÌŒŒŠÇ’ɂɑ΂·‚é41Ž‚Å‚ÌlH’YŽ_ò—Ö@ iASƒPƒAj —L—p«‚ÌŒŸ“¢. ŽR–{ƒXƒ~Žq1, ‹ß“¡Œõ—m1, •º“¡@“§2, ‘åŽRƒgƒˆŽq1, ‰œ“c°Žq1, ŠFìˆê”ü1, ¼‰i”£Žq1, ”nêŽu˜Y3, Žðˆä@‹Š4, “ú‘ä‰p—Y2 (1Œú–؃NƒŠ. 2‰¡•l‘æˆê. 3”å. 4¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï (2004/6/20), _ŒË.

723692. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰–Ž_ƒZƒxƒ‰ƒ}[‚É‚æ‚é–³Œ`¬œ‚ÌŽ¡—Ã. Žáˆä—zŠó1, •º“¡@“§1, Žu‘º@“N2, ’|쟎¡2, ’|‘º@“O1, •½—Ç—²•Û1, ‹g“cˆê¬2, ‰““¡’‰—Y2, Žðˆä@‹Š3, “ú‘ä‰p—Y1, ”nêŽu˜Y2 (1‰¡•l‘æˆê. 2”å. 3¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï (2004/6/20), _ŒË.

723693. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) HDŠ³ŽÒ‚ɑ΂·‚éƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒƒNƒ`ƒ“ÚŽí‚̉ñ”•Ê‚ÌŒø‰Ê@SARS—¬s‚É”õ‚¦‚Ä. •º“¡@“§1, •½—Ç—²•Û1, ç—t“N’j1, “ú‘ä‰p—Y1, “n•Ó‹žŽq2, ŽR–{ƒXƒ~Žq2, Žðˆä@‹Š3, ‹g“cˆê¬4, ”nêŽu˜Y4 (1‰¡•l‘æˆê. 2Œú–؃NƒŠ. 3¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š. 4”å): “ú–{t‘ŸŠw‰ï (2004/6/23), ‰F“s‹{.

723694. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¢‚ÄŽ{s‚µ‚½ˆÚAt¶ŒŸ‚É‚¨‚¯‚éƒVƒNƒƒXƒ|ƒŠƒ“ŒŒŠÇÇ‚ÌŒŸ“¢. Έä‘å•ã1, “c粈ê¬2, V‘º_–¾2, Îì’¨•v2, Γc‰pŽ÷2, ŽRŒû@—T3, “ŒŠÔ@h2 (1”å. 2“Œ‹ž—ˆã‘å. 3Žœˆã‘åE”): ‘æ40‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2004/9/16-18), ‰ªŽR.

723695. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) tˆÚA‚É‚¨‚¯‚éPSL, CNI, MMF‚ÉBasiliximab‚𕹗p‚µ‚½–Ɖu—}§—Ö@. “c”¨Œ’ˆê1, ‹g“cˆê¬1, ¼‰ºˆêm1, “c‰ª‰ÀŒ›1, “y“c–š”ü1, Έä‘å•ã1, ‰““¡’‰—Y2, ”nêŽu˜Y1 (1”å. 2é‹ÊŒ§‰›): ‘æ40‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2004/9/17), ‰ªŽR. “ú–{ˆÚAŠw‰ïŽ, 39 (—Õ): 338, 2004.

723696. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰–Ž_ƒZƒxƒ‰ƒ}| (Sevelamer) ‚É‚æ‚èƒVƒNƒƒXƒ|ƒŠƒ“ (CsA) ‚Ì‹zŽûáŠQ‚ð‚«‚½‚µ‚½Œ£tˆÚA—á. “y“c–š”ü1, ‹g“cˆê¬1, ¬—ѹG2, “c”¨Œ’ˆê1, ¼‰ºˆêm1, ‘•ªG–ç3, –Ø‘º—˜”ü3, ”nêŽu˜Y1 (1”å. 2–òŠw. 3–òÜ•”): ‘æ40‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2004/9/17), ‰ªŽR.

723697. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘O—§‘BŠà‚Ì Iymphangiogenesis‚ÆIymphtic vessel invasion‚ɂ‚¢‚Ä‚Ì•a—Šw“IŒŸ“¢. ‘v@¬_, “ü]@Œ[, ¼–{˜a«, Šâ‘º³Žk, ”nêŽu˜Y (”å): ‘æ63‰ñ“ú–{ŠàŠw‰ï‘‰ï (2004/9/30), •Ÿ‰ª.

723698. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) äNã÷Šà‚ɑ΂·‚éƒLƒƒ‰ƒEƒCƒ‹ƒX‚ð—p‚¢‚½HSV-tk/GCVˆâ“`ŽqŽ¡—Â̌Ÿ“¢. ¼–{˜a«1, Christian Freund2, “ü]@Œ[1, Έä~ˆê˜Y1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, Patricia Ytonda2, Alan Davis2, Seth Lerner2, ”nêŽu˜Y1 (1”å. 2ƒxƒCƒ‰|ˆã‘å): ‘æ63‰ñ“ú–{ŠàŠw‰ï‘‰ï (2004/9/30), •Ÿ‰ª.

723699. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) äNã÷Šà×–E‚Ö‚ÌÚ’…Ei“ü‚É‚¨‚¯‚éBCG-mce1‚Ìì—p‚ÉŠÖ‚·‚錟“¢. “ü]@Œ[1, ¼–{˜a«1, “¡‘º‹¿’j2, ŽÔ@‰pr1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å. 2”ç): ‘æ63‰ñ“ú–{ŠàŠw‰ï‘‰ï (2004/9/30), •Ÿ‰ª.

723700. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Two Dimensional Differential Gel Electrophoresis (2D DIGE) –@‚ð—p‚¢‚½‘O—§‘BŠàŒŒ´ƒ}[ƒJ[‚Ì’Tõ. ŽÔ@‰pr1, ‰oì@W2, ‘åγ“¹3, ¬Ž›‹`’j3, ‘å‘@—m1, ”nêŽu˜Y1, ‘O“c’‰Œv3 (1”å. 2“Œ‹žŽœˆã‘å. 3—Šw•”): ‘æ63‰ñ“ú–{ŠàŠw‰ï‘‰ï (2004/10/1), •Ÿ‰ª.

723701. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰ßŠˆ“®äNã÷‚ɑ΂·‚銱’áŽü”g‚ÌŽg—pŒoŒ±. ‘åì–ƒŽq, Έä~ˆê˜Y, •âáÁ“ñ, –å˜e˜ab, ìã’B‰›, ‰©@‰p–Î, “¡é‹M‹³, ¼–{˜a«, ‹y”\‹v—², ”nêŽu˜Y (”å): ‘æ11‰ñ“ú–{”r”A‹@”\Šw‰ï (2004/10/15), “Œ‹ž.

723702. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) SELDI-TOF MS‚ð—p‚¢‚½‘O—§‘BŠàŒŒ´f’f. ŽÔ@‰pr1, ‘å‘@—m1, ‰oì@W2, ‘]ìˆêK3, ’©’·@‹B3, –쑺•¶•v3, ”nêŽu˜Y1 (1”å. 2“Œ‹žŽœˆã‘å. 3ç—t‘å): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/27), ‹ž“s. “ú–{ŠàŽ¡—Êw‰ïŽ, 39 (2): 584, 2004.

723703. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 2002”N“x‚Ì‘O—§‘BŠàŒŸfLˆæŒ¤‹†E‘ÎÆŒ¤‹†‚ÌŒŸfŒ‹‰Ê. ˆÉ“¡ˆêl1, Ô‘qŒ÷ˆê˜Y2, ŽR–{@I1, “c’†Œ[Š²3, ’Ë–{‘׎i4, ’†“c‰l_5, ÔÀ‰p”V6, ‘ºˆä@Ÿ7, ”nêŽu˜Y8, •½”ö‰À•F9, •zŽ{GŽ÷10, ¼“cŒöŽu11, Ž·ˆó‘¾˜Y12, ‰Oˆä@˜±13, “à“¡½“ñ14, ‹à•@—m15, ‘å‹´–õ—Y16, “‡è@~17, ŽR’†‰pšæ1 (1ŒQ”n‘å. 2Œú¶”N‹à. 3ìèˆã‘å. 4ŽD–yˆã‘å. 5Ö“¡˜JÐ. 6’}”g‘å. 7Œc‰ž‘å. 8”å. 9“Þ—ÇŒ§—§ˆã‘å. 10•xŽRˆã–ò‘å. 11ŠÖ¼ˆã‘å. 12‚’mˆã‘å. 13L“‡‘å. 14‹ãB‘å. 15’·è‘å. 16“Œ‹ž‘å. 17ç—t‘å): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/27), ‹ž“s. “ú–{ŠàŽ¡—Êw‰ïŽ, 39 (2): 603, 2004.

723704. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘O—§‘BŠà‚Ì Iymphangiogenesis‚ÆIymphtic vessel invasion‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‘v@¬_1, “ü]@Œ[1, Šâ‘º³Žk1, ²“¡ˆÐ•¶1, H“ˆ—R—¢2, ˆÉ“¡‹àŽŸ2, Έäšæ°2, ”nêŽu˜Y1 (1”å. 2“Œ–M‘å): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/29), ‹ž“s. “ú–{ŠàŽ¡—Êw‰ïŽ, 39 (2): 838, 2004.

723705. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) äNã÷“EœpÇ—á‚É‚¨‚¯‚ép‘OŒŒŸ÷—n‰ðŒ^E-ƒJƒhƒwƒŠƒ“‚ð—p‚¢‚½—\Œã—\‘ª‚ÉŠÖ‚·‚錟“¢. ¼–{˜a«1, Shariat Shahrokh2, ²“¡ˆÐ•¶1, “ü]@Œ[1, Slawin Kevin2, Lerner Seth2, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å. 2ƒxƒCƒ‰|ˆã‘å): ‘æ63‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/29), ‹ž“s. “ú–{ŠàŽ¡—Êw‰ïŽ, 39 (2): 918, 2004.

723706. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) BCG‚ÌäNã÷Šà×–E‚Ö‚ÌÚ’…Ei“ü‚É‚¨‚¯‚éMCE1‚Ìì—p‚ÉŠÖ‚·‚錟“¢. “ü]@Œ[1, “¡‘º‹¿’j2, ¼–{˜a«1, ‘v@¬_1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å. 2”ç): ‘æ63‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/29), ‹ž“s. “ú–{ŠàŽ¡—Êw‰ïŽ, 39 (2): 933, 2004.

723707. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘O—§‘BŠà‚ɑ΂·‚éHDRihigh-dose-ratej Ir-192 brachytherapy‚Æexternal beam radiation therapy•¹—p‚É‚æ‚鎡—ÃŒø‰Ê‚ÌŒŸ“¢. ²“¡ˆÐ•¶1, –k–ì‰ëŽj2, ‰oì@W1, ‘å‘@—m1, ¼–{˜a«1, –Ø‘º«‹M1, “ü]@Œ[1, rì@F1, ‘ì˜ad2, ”nêŽu˜Y1 (1”å. 2•ú): ‘æ18‰ñ“ú–{EndourologyEESWLŠw‰ï‘‰ï (2004/11/18), ‰ªŽR.

723708. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒÀ‹Ç«‘O—§‘BŠà‚ɑ΂·‚é‚–§“xÅ“_Ž®’´‰¹”g—Ö@ (high-intensity focused ultrasound: HIFU) Œã‚ÌQOL•Ï‰». ŽR‰º‰p”V1, ‘å‘@—m1, ’·“cŒbO2, “à“c–Lº2 (1”å. 2“ŒŠC‘唪‰¤Žq): ‘æ18‰ñ“ú–{EndourologyEESWLŠw‰ï‘‰ï (2004/11/18), ‰ªŽR.

723709. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) tŽXŒèóŒ‹Î‚É‚¨‚¯‚錋ΔjÓŽ¡—ÃŒã‚Ì’·ŠúŒo‰ßŠÏŽ@|”ÓŠú‡•¹Ç‚Æ‚µ‚Ä‚ÌŠ³‘¤t‹@”\’ቺ‚ɂ‚¢‚Ä‚ÌŒŸ“¢. rì@F, ²“¡ˆÐ•¶, Îì@–í, ‹v•Û¯ˆê, “¡é‹M‹³, •½ˆäËŽi, ŠÛ@“T•v, {ŽRˆê•ä, ”nêŽu˜Y (”å): ‘æ18‰ñ“ú–{EndourologyEESWLŠw‰ï‘‰ï (2004/11/18), ‰ªŽR.

723710. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘O—§‘BŠà‚ɑ΂·‚é‚ü—Ê—¦Ir-192‘gD“àÆŽË (HDR brachytherapy) ‚¨‚æ‚ÑI-125–§••¬üŒ¹—Ö@Œã‚Ìtoxicity, QOL”äŠrŒŸ“¢. ²“¡ˆÐ•¶1, ’Â@ˆÌ‹­, ‘å‘@—m1, Šâ‘º³Žk1, rì@F1, ‰oì@W1, ”nêŽu˜Y1, –k–ì‰ëŽj2, ÎŽR”ŽžŠ2, ‘ì˜ad2 (1”å. 2•ú): ‘æ18‰ñ“ú–{EndourologyEESWLŠw‰ï‘‰ï (2004/11/18), ‰ªŽR.

723711. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) • o‹¾‰ºäNã÷‘S“Eœp‚ÌpŽ®‚ÉŠÖ‚·‚錟“¢. “ü]@Œ[, ¼–{˜a«, “c”¨Œ’ˆê, Έä‘å•ã, ŠÛ@“T•v, ‹g“cˆê¬, Šâ‘º³Žk, ”nêŽu˜Y (”å): ‘æ18‰ñ“ú–{EndourologyEESWLŠw‰ï‘‰ï (2004/11/18), ‰ªŽR.

723712. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ureakinetics“™‚ð—p‚¢‚½ŒŒ‰t“§ÍŠ³ŽÒ‚̉h—{ó‘Ô‚É‚¨‚¯‚é‹Gß“I•Ï“®‚ÌŒŸ“¢. ²“¡Œb”üŽq1, ‹ïŽuŒ˜‰ÄŽq1, “n•Ó‹žŽq2, ŽR–{ƒXƒ~Žq2, •º“¡@“§1, •½—Ç—²•Û1, ‹g“cˆê¬3, ”nêŽu˜Y3 (1‰¡•l‘æˆê. 2Œú–؃NƒŠ. 3”å): “ú–{•a‘Ô‰h—{Šw‰ï (2005/1/8), ‹ž“s.

723713. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚ł̌㕠–Œ‹¾‰ºƒhƒi[t“Ep‚É‚¨‚¯‚éƒsƒbƒgƒtƒH[ƒ‹. ‹{–{’¼Žu1, “c粈ê¬1, Γc‰pŽ÷1, “¿–{’¼•F1, Îì’¨•v1, ´…•üˆê1, V‘º_–¾1, £ŒËŒû@½1, ”’ì_Šó1, Έä‘å•ã2, ”Ñ“cˈê1, “ŒŠÔ@h1 (1“Œ‹ž—ˆã‘å. 2”å): ‘æ38‰ñ“ú–{—Õ°tˆÚAŠw‰ï (2005/1/27), ”ú”iŒÎ.

723714. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¶‘ÌtˆÚAŒã‚Ì”A˜Hã”çŽîᇂɑ΂µ‚ÄäNã÷‘S“Eœp‚¨‚æ‚щñ’°VäNã÷‘¢Ýp‚ðŽ{s‚µ‚½1—á. ”’ì_Šó1, “c粈ê¬1, Γc‰pŽ÷1, Îì’¨•v1, ‹´–{‹±L1, –ìè‘åŽi1, Έä‘å•ã2, “ŒŠÔ@h1 (1“Œ‹ž—ˆã‘å. 2”å): ‘æ38‰ñ“ú–{—Õ°tˆÚAŠw‰ï (2005/1/27), ”ú”iŒÎ.

723715. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œ£tˆÚAŒã5”N‚ðŒo‚Ă悤‚â‚­ŒŒ‰t“§Í‚ðŠ®‘S—£’E‚µ‚½1—á. “c‰ª‰ÀŒ›1, ‹g“cˆê¬1, “y“c–š”ü1, “c”¨Œ’ˆê1, Έä‘å•ã1, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å): ‘æ38‰ñ“ú–{—Õ°tˆÚAŠw‰ï (2005/1/27), ”ú”iŒÎ.

723716. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œ£tˆÚA’†‚É‘½”­«”X–Et‚ɇ•¹‚µ‚½t×–EŠà‚ª”­Œ©‚³‚ê, Œ£tˆÚA‚ð’†’f‚µ‚½ˆê—á. “y“c–š”ü, ‹g“cˆê¬, “c”¨Œ’ˆê, Έä‘å•ã, ¼–{˜a«, “¡“c“N•v, “ü]@Œ[, Šâ‘º³Žk, ”nêŽu˜Y (”å): ‘æ38‰ñ“ú–{—Õ°tˆÚAŠw‰ï (2005/1/27), ”ú”iŒÎ.

723717. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) tˆÚAŒãƒAƒfƒmƒEƒBƒ‹ƒXŠ´õÇ‚É‚æ‚éoŒŒ«äNã÷‰Š‚ɑ΂µ‚ăKƒ“ƒVƒNƒƒrƒ‹“Š—^‚ª—LŒø‚Å‚ ‚Á‚½ˆê—á. Έä‘å•ã1, “c粈ê¬2, •Ÿ“c••F2, “yŠò‘å‰î2, –ìè‘åŽm2, “ì—¢³”V2, £ŒËŒû@½2, V‘º_–¾2, ”’ì_Šó2, ‹{–{’¼Žu2, ‹ß“¡P“¿2, Γc‰pŽ÷2, ‡’JMs2, “ŒŠÔ@h2 (1”å. 2“Œ‹ž—ˆã‘å): ‘æ38‰ñ“ú–{—Õ°tˆÚAŠw‰ï (2005/1/27), ”ú”iŒÎ.

723718. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Baciliximab“±“ü‚É‚æ‚étˆÚAŒãƒXƒeƒƒCƒh‘ŠúŒ¸—ʖƉu—}§—Ö@‚ÌŒŸ“¢. ’†ì@Œ’1, ‘ºˆä@Ÿ1, ‘Šì@Œú2, ¬Œ´•”Ž2, ’·’Jì@º2, Ž³ŒË´ˆê˜Y3, ‹g“cˆê¬4, ”nêŽu˜Y4, ¯’·´—²5 (1Œc‰ž‘å. 2“Œ–M‘å. 3“s—§´£¬Ž™. 4”å. 5“¡“c•ÛŒ’‰q¶‘å): ‘æ38‰ñ“ú–{—Õ°tˆÚAŠw‰ï (2005/1/28): ”ú”iŒÎ. “ú–{—Õ°tˆÚAŠw‰ïŽ, 46 (6): 640, 2004.

723719. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) tˆÚAp‘OŒã‚ÌŒø‰Ê“I‚Èî•ñ’ñ‹Ÿ‚ð–ÚŽw‚µ‚Ä|tˆÚAŽÒ‚̃Aƒ“ƒP[ƒg’²¸Œ‹‰Ê‚ð‚à‚Æ‚É|. “cŒûˆ»Žq1, “c’†”üç‘ã1, “¡–Ø‚­‚ÉŽq1, ’r“c¬]2, ’|“àN—Y3, ‹g“cˆê¬2 (1ŠÅŒì•”. 2”å. 3“à‡W): ‘æ38‰ñ“ú–{—Õ°tˆÚAŠw‰ï (2005/1/28), ”ú”iŒÎ.

723720. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) SF-36‚ð—p‚¢‚½tˆÚAŠ³ŽÒ‚Æ“§ÍŠ³ŽÒ‚Æ‚ÌQOL‚Ì”äŠrŒŸ“¢. ’r“c¬]1, ‹g“cˆê¬1, •º“¡@“§2, ’|“àN—Y3, ¼‰i“Ä•F4, Ö“¡³˜a4, â–{ƒŽq4, ‘“c@‘ì4, –––Ø^“Þ”ü5, ”nêŽu˜Y1 (1”å. 2‰¡•l‘æˆê. 3“à‡W. 4ˆã‰q. 5ŠÅŒì•”): ‘æ38‰ñ“ú–{—Õ°tˆÚAŠw‰ï (2005/1/28), ”ú”iŒÎ.

731095. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‘O—§‘BŠà‚ɑ΂·‚é‘Šúf’f‚Æ—\Œã‚Ì’T‹|T1c‚Ì“Á«‚¨‚æ‚ÑV‚½‚Èmoleular marker‚̉”\«|. ²“¡ˆÐ•¶ (”å): ˆ¤“†”å”AŠí‰Èˆã‰ï (2004/5/27), V‹´.

731096. [Œ¤‹†‰ï] (“Á•Êu‰‰) ƒJƒe[ƒeƒ‹—¯’upE‡•¹Ç‚ÌŠÇ—. ‹g“cˆê¬ (”å): _“ÞìCAPDuÀ (2004/7/17), ‰¡•l.

731097. [u‰‰‰ï] (“Á•Êu‰‰) ’YŽ_ƒJƒ‹ƒVƒEƒ€Žž‘ã‚©‚çRenagelŽž‘ã‚ւ̈ÚsŠú‚É‚¨‚¯‚ét«œÇ‚ɑ΂·‚éƒIƒLƒTƒ[ƒ‹‚ÌŽg—pŒoŒ±. •º“¡@“§1, •½—Ç—²•Û1, ç—t“N’j1, “ú‘ä‰p—Y1, Žðˆä@‹Š2, ‹g“cˆê¬3, ”nêŽu˜Y3 (1‰¡•l‘æˆê. 2¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š. 3”å): ’†ŠO»–òƒ}ƒLƒTƒJƒ‹ƒVƒg[ƒ‹”­”„3Žü”N‹L”Ou‰‰‰ï (2004/8), Œú–ØŽs.

731098. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‘O—§‘B‚ª‚ñŒ¤‹†‚ւ̃vƒƒeƒIƒ~ƒNƒX‚̉ž—p. ŽÔ@‰pr (”å): Ž¾Š³ƒvƒƒeƒI[ƒ€Œ¤‹†‰ï (2004/10/25), –k—¢.

731099. [Œ¤‹†‰ï] (“Á•Êu‰‰) ”å”AŠí‰È‚É‚¨‚¯‚é• o‹¾Žèp‚ÌŒ»ó‚Æ–â‘è“_. Šâ‘º³Žk (”å): ¼]’n‹æ”å”AŠí‰ÈŒ¤‹†‰ï (2004/10/25), ¼].

731100. [Œ¤‹†‰ï] (“Á•Êu‰‰) ”å”AŠí‰È—̈æ‚ÌNomogram‚ÌŒ»ó. ”nêŽu˜Y (”å): ’}Œã”å”AŠí‰Èˆã‰ï‘æ45‰ñŒ¤C‰ï (2004/10/30), ‹v—¯•Ä.

731101. [Šw‰ï (’n•û)] (“Á•Êu‰‰) ”å”AŠí‰È• o‹¾Žèp‚̇•¹Ç‚Æ‘Îô. Šâ‘º³Žk (”å): ‘æ1‰ñˆ¤“†”å”AŠíˆã‰ï (2005/1/20), V‹´.

732049. [Šw‰ï (’n•û)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”å”AŠí• o‹¾Žèp‚̃gƒŒ[ƒjƒ“ƒO|“ú–{‚ÌŒ»ó‚ƃtƒ‰ƒ“ƒX‚Ì‹³ˆçƒVƒXƒeƒ€|. Šâ‘º³Žk, ”nêŽu˜Y (”å): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/24), •iì.

732050. [Œ¤‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€) [•”Ö¬ƒVƒƒƒ“ƒg‚Ì•\݉» (lHŒŒŠÇ‚Æ‚Ç‚¿‚炪—Ç‚¢‚Ì‚©H). ‹g“cˆê¬ (”å): _“Þìƒuƒ‰ƒbƒhƒAƒNƒZƒXŒ¤‹†‰ï (2004/12/2), ‰¡•l.

733333. [Œ¤‹†‰ï] (ƒrƒfƒIj uHow to manage complications during laparoscopic renal surgeryvGunter Janetschek. Šâ‘º³Žk (”å): ”å”AŠí‰È• o‹¾‰ºŽèpŒ¤‹†‰ï (2004/4/3), –¼ŒÃ‰®.

733334. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒoƒVƒŠƒLƒ“ƒ}ƒu‚ð—p‚¢‚½tˆÚAÇ—á. ‹g“cˆê¬ (”å): ‘æ2‰ñ‚¤‚낤‚ëˆÚAŒðŠ½‰ï (2004/4/24), “Œ‹ž.

733335. [Œ¤‹†‰ï] (ˆê”Êu‰‰) u•p”A‚Æ‚»‚ÌŠÇ—væ“V«…tÇŽ™‚É‚¨‚¯‚éƒoƒ‹[ƒ“—¯’uã‚Ì–â‘è“_. “y“c–š”ü1, ‘v@¬_1, ‘å‘@—m1, Îì@–í1, “ì“c@—@, …–ì‰À“s”ü, “n•Ó‚«‚ÊŽq, –––Ø^“Þ”ü2, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å. 2ŠÅŒì•”): ‘æ10‰ñ”r”AáŠQŒ¤‹†‰ïE_“ÞìƒtƒH[ƒ‰ƒ€ (2004/5/22), ‰¡•l.

733336. [Œ¤‹†‰ï] (ˆê”Êu‰‰) u•p”A‚Æ‚»‚ÌŠÇ—vParkinson•a‚É‚¨‚¯‚é”A—¬“®‘Ô‚ÌŒŸ“¢. ¼@·G1, “c”¨Œ’ˆê1, {“¡—˜—Y1, ’؈ärŽ÷, “¡é‹M‹³1, ‘åì–ƒŽq1, ‘v@¬_1, “ü]@Œ[1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å): ‘æ10‰ñ”r”AáŠQŒ¤‹†‰ïE_“ÞìƒtƒH[ƒ‰ƒ€ (2004/5/22), ‰¡•l.

733337. [Œ¤‹†‰ï] (ˆê”Êu‰‰) PMIT, PEIT‚¨‚æ‚Ñ|Ž_ƒJƒ‹ƒVƒEƒ€, ƒRƒŒƒXƒ`ƒ~ƒh, ƒjƒZƒŠƒgƒ[ƒ‹, ‰–Ž_ƒZƒxƒ‰ƒ}[‚ÌŽg—p‚É‚æ‚è’·Šú‚ɂ킽‚èMaxacalcitolÃ’—Ö@‚ðˆÛŽ‚µ“¾‚Ä‚¢‚é1—á. •º“¡@“§1, Šp“c—²r2, ‹g“cˆê¬3, ‰““¡’‰—Y, ”nêŽu˜Y3 (1‰¡•l‘æˆê. 2“ŒŠC‘å. 3”å): •›bó‘BƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“Œ¤‹†‰ï (2004/5), “Œ‹ž.

733338. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Basiliximab‚𕹗p‚µ‚½–Ɖu—}§—Ö@‚É‚æ‚étˆÚA‚ÌŒoŒ±. “c”¨Œ’ˆê, ‹g“cˆê¬, “c‰ª‰ÀŒ›, ¼‰ºˆêm, “y“c–š”ü, ”nêŽu˜Y (”å): ‘æ16‰ñ_“ÞìˆÚAˆãŠw‰ï (2004/6/5), ‰¡•l.

733339. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ˆÚAtƒhƒi[‚É‚¨‚¯‚é‚l‚q‚`ngiography‚Ì—L—p«‚ÌŒŸ“¢. Έä‘å•ã1, ‹g“cˆê¬1, ù–{Ž¡Žq1, “y“c–š”ü1, “c”¨Œ’ˆê1, ¼‰iŒh“ñ2, ƒEƒbƒhƒnƒ€ƒX—æŽq2, ’r“crº2, ”nêŽu˜Y1 (1”å. 2•ú): ‘æ20‰ñtˆÚAEŒŒŠÇŠO‰ÈŒ¤‹†‰ïE“ú–{”å”AŠí‰ÈŠw‰ïbM‰z‡“¯’n•û‰ï (‘æ150‰ñMB’n•û‰ïE‘æ56‰ñŽR—œ’n•û‰ïE‘æ330‰ñVŠƒ’n•û‰ï) (2004/6/11), ²“n.

733340. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ’´’áo¶‘ÌdŽ™‚ɑ΂·‚é‘ÌŠOÕŒ‚”gŒ‹Î”jÓp iESWLj ‚ÌŒoŒ±. ’r“cŸb, rì@F, ‘v@¬_, “c”¨Œ’ˆê, ’ѺGN, Îì@–í, ”nêŽu˜Y (”å): ‘æ66‰ñ_“Þ쌧”å”AŠí‰Èˆã‰ï (2004/6/12), ‰¡•l.

733341. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ”A–ŒŠÇŽîᇂÆf’f‚³‚ꂽäNã÷’¸•”ŒeŽº“àŽîᇂÌ1—á. ¼“c‘å‰î, “ü]@Œ[, ‘º–{«r, –å˜e˜ab, ”nêŽu˜Y (”å): ‘æ568‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/6/17), “Œ‹ž.

733342. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘O—§‘BŠàªŽ¡pŒã‚Ì–u‹NáŠQ‚ɑ΂·‚éPGE1‰AŒs“àŽ©ŒÈ’ŽË‚ÌŒoŒ±. Žu‘º@“N, —äˆä’è‹I, Šâ‘º³Žk, ‰oì@W, ”nêŽu˜Y (”å): ‘æ14‰ñ“ú–{«‹@”\Šw‰ï“Œ•”‘‰ï (2004/6), “Œ‹ž.

733343. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “§ÍŠ³ŽÒ‚ɑ΂·‚éƒNƒGƒ“Ž_ƒVƒ‹ƒfƒiƒtƒBƒ‹‚Ì“Š—^ŒoŒ±. •º“¡@“§1, Γc—T‘¥2, ‘ˆä‘¥º2, “¡é‹M‹³3, Έä‘å•ã3, Žu‘º@“N3, ‹g“cˆê¬3, ”nêŽu˜Y3 (1‰¡•l‘æˆê. 2Γc•a‰@. 3”å): “ú–{«‹@”\Šw‰ï“Œ•”‘‰ï (2004/6), “Œ‹ž.

733344. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒlƒIƒAƒWƒ…ƒoƒ“ƒg—Ö@‚Æ‚µ‚Ă̈â“`ŽqŽ¡—Â̌Ÿ“¢. ²“¡ˆÐ•¶1, ¼–{˜a«1, “¡“c“N•v1, Έä~ˆê˜Y1, ‰œ–ì‹I•F1, “c”¨Œ’ˆê1, ‘å‘@—m1, “ü]@Œ[1, Šâ‘º³Žk1, Dov Kadmon2, Thomas M Wheeler2, Timothy C Thompson2, ”nêŽu˜Y1 (1”å. 2ƒxƒCƒ‰[‘å): ‘æ21‰ñ_“Þì‘O—§‘BŽîᇌ¤‹†‰ï (2004/7/3), ‰¡•l.

733345. [Œ¤‹†‰ï] (ˆê”Êu‰‰) High-risk‘O—§‘BŠà‚ɑ΂·‚ép‘O8ƒ–ŒŽneoadjuvant hormonal thrapy‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢. “c”¨Œ’ˆê, ²“¡ˆÐ•¶, ‰oì@W, ¼–{˜a«, Šâ‘º³Žk, ¼“c‘å‰î, ‘º–{«r, –å˜e˜ab, {ŽRˆê•ä, ¯Ži´Žu, ‘åì–ƒŽq, ìã’B‰›, ”nêŽu˜Y (”å): ‘æ21‰ñ_“Þì‘O—§‘BŽîᇌ¤‹†‰ï (2004/7/3), ‰¡•l.

733346. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‰Et”AŠÇäNã÷‘S“EpŒã13”N–Ú‚ÉÄ”­‚ð‚«‚½‚µ‚½”A˜Hã”çŠà‚Ì1—á. •Ÿ“c••F1, ‹´–{‹±L1, ‰œ“c”䲎u1, Έä‘å•ã2, –ìè‘åŽi1, “ì—¢³”V1, ”’ì_Šó1, ‹ß“¡P“¿1, ˆÉ“¡•¶•v1, ‹S’ËŽj˜Y1, ‡’JM”V1, ’†àV‘¬˜a1, “ŒŠÔ@h1 (1“Œ‹ž—ˆã‘å. 2”å): ‘æ569‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/7/8), “Œ‹ž.

733347. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ã˜r‚Ì[•”Ö¬‚ð—p‚¢‚½“®Ã–¬“àƒVƒƒƒ“ƒgp. “c”¨Œ’ˆê1, ‹g“cˆê¬1, ¼‰ºˆêm1, “y“c–š”ü1, Έä‘å•ã1, “c‰ª‰ÀŒ›1, ’ѺGN1, Â@‹Pº2, ”nêŽu˜Y1 (1”å. 2–kŒ¤): ‘æ13‰ñt•s‘SŠO‰ÈŒ¤‹†‰ï (2004/7/10), ˜a‰ÌŽR.

733348. [Œ¤‹†‰ï] (ˆê”Êu‰‰) tˆÚAŒã”AŠÇ‹·ó‚ɑ΂·‚éŠO‰È“IC•œp (ˆÚAtá±|Ž©ŒÈ”AŠÇ [tá±] •«‡p‚É‚æ‚é”A˜HÄŒš•û–@). “c‰ª‰ÀŒ›1, ‹g“cˆê¬1, “c”¨Œ’ˆê1, ¼‰ºˆêm1, Έä‘å•ã1, “y“c–š”ü1, ‰““¡’‰—Y2, ”nêŽu˜Y1 (1”å. 2é‹ÊŒ§‰›): ‘æ13‰ñt•s‘SŠO‰ÈŒ¤‹†‰ï (2004/7/10), ˜a‰ÌŽR.

733349. [Œ¤‹†‰ï] (ƒRƒƒ“ƒe[ƒ^[) • o‹¾‚ÌŽèpŽè‹Z. Šâ‘º³Žk (”å): ‘æ6‰ñ_“Þì”å”AŠí‰ÈŠî–{ŽèpŽè‹Z•×‹­‰ï (2004/7/17), ‰¡•l.

733350. [Œ¤‹†‰ï] (ˆê”Êu‰‰) äNã÷Šà‚ɑ΂·‚éƒLƒƒ‰ƒAƒfƒmƒEƒCƒ‹ƒX‚ð—p‚¢‚½HSV-tkˆâ“`ŽqŽ¡—Â̌Ÿ“¢. ¼–{˜a«1, Christian T Freun2, “ü]@Œ[1, ²“¡ˆÐ•¶1, ‘å‘@—m1, “c”¨Œ’ˆê1, Patricia Yotnda2, Alan R Davis2, Seth P Lerner2, ”nêŽu˜Y1 (1”å. 2ƒxƒCƒ‰|ˆã‘å): ‘æ17‰ñuˆâ“`Žq‚Æ‚»‚ÌŽü•ÓvŒ¤‹†‰ï (2004/8/3-4), –k—¢.

733351. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ³Š«ƒ}ƒEƒX‘O—§‘BŠàƒ‚ƒfƒ‹‚ð—p‚¢‚½ IL-12ˆâ“`Žq‘g‚Ýž‚݃}ƒNƒƒtƒ@[ƒW (IL-12 gene-modified macrophages) ‚É‚æ‚éRŽîᇌø‰Ê‚ÌŒŸ“¢. ²“¡ˆÐ•¶1, ŽG‰ê—²Žj2, ]Œ´@L2, ¼–{˜a«1, “¡“c“N•v1, “c”¨Œ’ˆê1, ‘å‘@—m1, “ü]@Œ[1, Šâ‘º³Žk1, Guang Yang3, Terry L Timme3, Timothy C Thompson3, ”nêŽu˜Y1 (1”å. 2‰ªŽR‘å. 3ƒxƒCƒ‰|ˆã‘å): ‘æ17‰ñuˆâ“`Žq‚Æ‚»‚ÌŽü•ÓvŒ¤‹†‰ï (2004/8/3-4), –k—¢.

733352. [ŒöŠJuÀ] (ˆê”Êu‰‰) ‘O—§‘BŠà‚ɑ΂·‚éŽèp—Ö@E•úŽËü—Ö@Žs–¯ŒöŠJuÀ. ²“¡ˆÐ•¶ (”å): ‘O—§‘BŠàƒZƒ~ƒi[ (2004/8/28), ’Ëvˆä.

733353. [Œ¤‹†‰ï] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“/À’·) QOL(ƒNƒIƒŠƒeƒBƒIƒuƒ‰ƒCƒt)Œüã‚ÅD—I ”nêŽu˜Y (”å): –ˆ“úŒ’NƒtƒH[ƒ‰ƒ€21 `CARE‚ÅŒ’NECURE‚ʼnñ•œ` (2004/9/2), ‰¡•l.

733354. [Œ¤‹†‰ï] (‹³ˆçu‰‰) –§••¬üŒ¹—Ö@‚É‚¨‚¯‚郊ƒXƒN•ª—Þ‚©‚ç‚̃Aƒvƒ[ƒ`: T1c‚ð”@‰½‚ÉŽ•ž‚·‚é‚©H ²“¡ˆÐ•¶ (”å): ‘æ1‰ñ¬üŒ¹‰i‹vŽh“ü‹ZpŒ¤‹†‰ï (2004/9/4), “Œ‹ž.

733355. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘½–[«”X–Eót×–EŠà‚Ì1—á. •âáÁ“ñ1, ¼“c‹vŒö2, ‘º–{«r1, Έä~ˆê˜Y1, ‚“ˆ—Í–í1, ‚‹´—Tˆê˜Y, –å˜e˜ab2, ”nêŽu˜Y1 (1”å. 2–kŒ¤): ‘æ570‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/9/9), “Œ‹ž.

733356. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‰Et[Ç‚Ì1—á. ŒÜ\—’’q”Ž1, ‹ß“¡‘¾ˆê1, ’·ª—S‰î1, —äˆä’è‹I2, ŽRŒûŒ’Æ1, ‹gì“N•v1, •½–ì‘åì1, ‹g“c—˜•v1, ‘ê–{ŽŠ“¾1 (1“ú–{‘å. 2”å): ‘æ570‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2004/9/9), “Œ‹ž.

733357. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ˆÚsã”çŠà‚ðŠù‰‚É‚à‚ÂäNã÷_Œo“à•ª”åŽîᇂÌ1—á. •½ŽR‹M”Ž, ¼–{˜a«, “y“c–š”ü, “ì“c@—@, ’؈ärŽ÷, “ü]@Œ[, ‹g“cˆê¬, rì@F, ”nêŽu˜Y (”å): ‘æ30‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï (2004/9/9), V‰¡•l.

733358. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘O—§‘BŠà‚Ì“ªŠW’êŽÎ‘ä•”œ“]ˆÚ‚É‚æ‚è”]_ŒoÇó‚ð’悵‚½2—á. –Ø‘º«‹M, ²“¡ˆÐ•¶, {“¡—˜—Y, ‘å‘@—m, ¼@·G, “c”¨Œ’ˆê, ‘v@¬_, Šâ‘º³Žk, ”nêŽu˜Y (”å): ‘æ30‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï (2004/9/9), V‰¡•l.

733359. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘åŒûŒa‘½–Ú“I‘Ìo‹¾‚ðŽg—p‚µ‚½• –Œ“§Í—p—pƒJƒe[ƒeƒ‹—¯’u–@. Έä‘å•ã, ‹g“cˆê¬, ù–{Ž¡Žq, “y“c–š”ü, ¼‰ºˆêm, {“¡—˜—Y, “c”¨Œ’ˆê, “¡é‹M‹³, “c‰ª‰ÀŒ›, “ü]@Œ[, ”nêŽu˜Y (”å): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/23), •iì.

733360. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) ”]ŽîᇂðŒ_‹@‚É”­Œ©‚³‚ꂽ•›t¬×–EŠà‚̈ê—á. ¼‰ºˆêm, Šâ‘º³Žk, Îì@–í, “c”¨Œ’ˆê, Έä‘å•ã, ”nêŽu˜Y (”å): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/23), •iì.

733361. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) ƒrƒ‹ƒnƒCƒcZŒŒ‹z’ŽÇ‚̈ê—á. ’؈ärŽ÷1, “ü]@Œ[1, ‚ŽR—zŽq2, ¼@·G1, ¼‰ºˆêm1, ”nêŽu˜Y1 (1”å. 2“à‡W): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/23), •iì.

733362. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) “§ÍŠ³ŽÒ‚É‚¨‚¯‚éZ«äNã÷Šà‚ɑ΂·‚é• o‹¾‰ºäNã÷‘S“Ep‚ÌŒoŒ±. Έä‘å•ã, “ü]@Œ[, ù–{Ž¡Žq, “ì“c@—@, ¼@·G, “c”¨Œ’ˆê, ‰œ–ì‹I•F, “c‰ª‰ÀŒ›, Šâ‘º³Žk, ‹g“cˆê¬, ”nêŽu˜Y (”å): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/23), •iì.

733363. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) —«–T”A“¹”X–E‚Ì1—á. •âáÁ“ñ1, –{“c’¼N2, ”nêŽu˜Y1 (1”å. 2‘—§‰¡•l): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/24), •iì.

733364. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) äNã÷“EœpÇ—á‚É‚¨‚¯‚ép‘OŒŒŸ÷—n‰ðŒ^E-ƒJƒhƒwƒŠƒ“‚ð—p‚¢‚½ƒŠƒ“ƒpß“]ˆÚ‹y‚Ñ—\Œã—\‘ª‚ÉŠÖ‚·‚錟“¢. ¼–{˜a«1, Shariat S2, Wheeler TM2, Slawin KM, Lerner SP, ”nêŽu˜Y1 (1”å. 2ƒxƒCƒ‰[‘å): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/24), •iì.

733365. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) ĶŒŸ‚Æ‚µ‚Ä‚ÌŒo‰ï‰A“Iƒeƒ“ƒvƒŒ[ƒgƒKƒCƒh‚É‚æ‚é‘O—§‘B22ƒ–Š¶ŒŸ‚̈Ӌ`. “c”¨Œ’ˆê, ²“¡ˆÐ•¶, ¼–{˜a«, Îì@–í, ¼“c‘å‰î, ‘º–{«r, rì@F, ‰oì@W, ”nêŽu˜Y (”å): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/24), •iì.

733366. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) ‘O—§‘BŠà‚ɑ΂µHDR brachytherapy‚Æexternal beam radiotherapy‚ðŽ{s‚µ‚½Ç—á‚̇•¹Ç‚ÆŠ³ŽÒ‚ÌQOL‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‘å‘@—m1, ‰oì@W1, ²“¡ˆÐ•¶1, ŽÔ@‰pr1, ”nêŽu˜Y1, –k–ì‰ëŽj2, ‘ì˜ad2 (1”å. 2•ú): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/24), •iì.

733367. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) indinavir iHIVŽ¡—Öòj ‚É‚æ‚錋΂ɑ΂·‚鎡—ÃŒoŒ±. “y“c–š”ü, rì@F, “c”¨Œ’ˆê, “ì“c@—@, ¼@·G, {“¡—˜—Y, ‹g“cˆê¬, ”nêŽu˜Y (”å): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/24), •iì.

733368. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) ’´’á‘ÌdIo¶Ž™‚ɑ΂·‚é‘ÌŠOÕŒ‚”gŒ‹Î”jÓp iESWLj ‚ÌŒoŒ±. ’r“cŸb, rì@F, ‘v@¬_, “c”¨Œ’ˆê, ’ѺGN, Îì@–í, ”nêŽu˜Y (”å): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/24), •iì.

733369. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) BCGäNã÷“à’“ü—Ö@31ƒ–ŒŽ‚É”A’†BCG”r‹Û‚ÌŒp‘±‚ð”F‚ß‚é1Ç—á. “c”¨Œ’ˆê1, “ü]@Œ[1, {“¡—˜—Y1, ÝŠy•q–ç2, Œ´–ì—TŽi1, ˜ZŠp@Žü1, ”nêŽu˜Y1 (1”å. 2•£–ì•Ó‘‡): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/24), •iì.

733370. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) ˆóŠÂ×–EŠà‚𔺂Á‚½”A–ŒŠÇŽîᇂ̈ê—á. ¼“c‘å‰î1, ‘º–{«r1, •âáÁ“ñ1, ‚“ˆ—Í–í1, Έä~ˆê˜Y1, ‚‹´—Tˆê˜Y2, X‰i³“ñ˜Y3, –å˜e˜ab2, ”nêŽu˜Y1 (1”å. 2–kŒ¤. 3•a—): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/24), •iì.

733371. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚¯‚éŒn““I‘O—§‘Bj¶ŒŸ‚Ì—Õ°“IŒŸ“¢. ’ѺGN1, “c‰ª‰ÀŒ›1, aŒûG”V1, Â@‹Pº2, “c”¨Œ’ˆê1 (1”å. 2–kŒ¤ƒƒfƒBƒJƒ‹): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/24), •iì.

733372. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) Purple Urine Bag Syndrome‚Ì—Õ°‘œ‚ÉŠÖ‚·‚錟“¢. ’ѺGN1, ²“¡ˆÐ•¶1, ‘å‘@—m1, “¡é‹M‹³1, rì@F1, ŒÃ‘ò‰p–¾2, ”nêŽu˜Y1 (1”å. 2•ú): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/24), •iì.

733373. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) äNã÷Šà‚ɑ΂·‚éBCGäNã÷“à’“ü—Ö@‚Ì3”NŒã‚Ü‚Å”A’†BCG”rŸ•‚ªŽ‘±‚µ‚½Ç—á. “c”¨Œ’ˆê, “ü]@Œ[, ¼–{˜a«, {“¡—˜—Y, ’؈ärŽ÷, “y“c–š”ü, ‹g“cˆê¬, ”nêŽu˜Y (”å): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/24), •iì.

733374. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ĶŒŸ‚É‚¨‚¯‚é22ƒ–ŠŒo‰ï‰A“I‘O—§‘B¶ŒŸ‚Ì—Õ°“IŒŸ“¢. “c”¨Œ’ˆê, ²“¡ˆÐ•¶, “y“c–š”ü, ‹g“cˆê¬, ”nêŽu˜Y (”å): ‘æ69‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2004/9/24), •iì.

733375. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‰–Ž_ƒZƒxƒ‰ƒ}[‚É‚æ‚é–³Œ`¬œ‚ÌŽ¡—Ã. Žáˆä—zŠó1, •º“¡@“§1, ’|쟎¡2, ’|‘º@“O1, •½—Ç—²•Û1, ‹g“cˆê¬2, ‰““¡’‰—Y2, Žðˆä@‹Š3, “ú‘ä‰p—Y1, ”nêŽu˜Y2 (1‰¡•l‘æˆê. 2”å. 3¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š): t‚Æœ‘ãŽÓŒ¤‹†‰ï (2004/9), “Œ‹ž.

733376. [§˜b‰ï] (ˆê”Êu‰‰) ‰–Ž_ƒZƒxƒ‰ƒ}[’P“Æ“Š—^‚Æ•›ì—p‚ÌŽ•ž: •Ö”éó‘Ô‚ÍŽ•ž‚Å‚«‚é‚©? •º“¡@“§1, “ú‘ä‰p—Y1, ŽR–{ƒXƒ~Žq2, ‹ïŽuŒ˜‰ÄŽq1, “y“c–š”ü3, “c”¨Œ’ˆê3, ‹g“cˆê¬3, ”nêŽu˜Y3, Žðˆä@‹Š4 (1‰¡•l‘æˆê. 2Œú–؃NƒŠ. 3”å. 4¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š): ‘æ12‰ñ‘Š–ÍŒ´’n‹æ“§Í§˜b‰ï (2004/9), ‘Š–ÍŒ´Žs.

733377. [Œ¤‹†‰ï] (ƒ|ƒXƒ^[) “§ÍŠ³ŽÒ‚Ì–u‹N•s‘S iEDj ‘΂·‚éƒoƒCƒAƒOƒ‰‚ÌŒø‰Ê. •º“¡@“§1, •½—Ç—²•Û1, ç—t“N’j1, “ú‘ä‰p—Y1, Έä‘å•ã2, ‹g“cˆê¬2, ”nêŽu˜Y2, ŽR–{ƒXƒ~Žq3, Γc—T‘¥4, Žðˆä@‹Š5 (1‰¡•l‘æˆê. 2”å. 3Œú–؃NƒŠ. 4Γc•a‰@. 5¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š): _“ÞìtŒ¤‹†‰ï (2004/10), ‰¡•l.

733378. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Basiliximab‚𕹗p‚µ‚½–Ɖu—}§—Ö@‚É‚æ‚étˆÚAÇ—á‚ÌŒŸ“¢. ‹g“cˆê¬1, “c”¨Œ’ˆê1, ¼‰ºˆêm1, Έä‘å•ã1, “c‰ª‰ÀŒ›1, ’|“àN—Y2, ‰““¡’‰—Y3, ”nêŽu˜Y1 (1”å. 2“à‡W. 3é‹ÊŒ§‰›): ‘æ34‰ñ“ú–{t‘ŸŠw‰ï“Œ•”‘‰ï (2004/11/5), Î’È. “ú–{t‘ŸŠw‰ïŽ, 46 (6): 640, 2004.

733379. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Œn““I‘O—§‘B‘½Š¶ŒŸi12-14ƒ–Šj ‚É‚¨‚¯‚é‘O—§‘BŠàŒŸo‚Ì—Õ°•a—Šw“IˆÓ‹`. ‘º–{«r1, ¼“c‘å‰î1, ‰©@‰p–Î1, Έä~ˆê˜Y1, Έä‘å•ã1, ‚“ˆ—Í–í1, ‘åì–ƒŽq1, “ü]@Œ[1, –å˜e˜ab2, X‰i³“ñ˜Y3, ìã’B‰›4, ŒK”ö’èm4, ”nêŽu˜Y1 (1”å. 2–kŒ¤. 3•a—. 4“Œ‘å˜a): ‘æ56‰ñ“ú–{”å”AŠí‰ÈŠw‰ï¼“ú–{‘‰ï (2004/11/11), ‘啪.

733380. [Œ¤‹†‰ï] (ˆê”Êu‰‰) High-risk‘O—§‘BŠà‚ɑ΂·‚ép‘O8ƒ–ŒŽneoadjuvant hormonal thrapy‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢|”å”AŠí‰È—Õ°ƒJƒ“ƒtƒ@ƒŒƒ“ƒX—Õ°‰Û‘è@’†ŠÔŒ‹‰Ê•ñ|. ²“¡ˆÐ•¶ (”å): ‘æ5‰ñ”å”AŠí‰È—Õ°ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/11/12), ‰¡•l.

733381. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Œã• –ŒŽîᇂð’悵‚½ Castleman's desease‚Ì1—á. ¼“c‘å‰î, Šâ‘º³Žk, “y“c–š”ü, –Ø‘º«‹M, •½ŽR‹M”Ž, ¼@·G, ‘å‘@—m, ”nêŽu˜Y (”å): ‘æ67‰ñ_“Þ쌧”å”AŠí‰Èˆã‰ï (2004/11/27), ‰¡•l.

733382. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŠeŽ{Ý‚É‚¨‚¯‚é‘O—§‘B¶ŒŸ‚ÌŒ»ó‚ɂ‚¢‚Ä|ĶŒŸ‚Æ‚µ‚Ä‚ÌŒo‰ï‰A“I‘O—§‘B22ƒ–Š¶ŒŸ|. rì@F (”å): ‘æ67‰ñ_“Þ쌧”å”AŠí‰Èˆã‰ï (2004/11/27), ‰¡•l.

733383. [Œ¤‹†‰ï] (ƒ|ƒXƒ^[) 2‰ñ–ڂ̶‘ÌtˆÚAŒã8”N–ڂł̈ÚAt•a—‘œ. “y“c–š”ü, ‹g“cˆê¬ (”å): ‘æ7‰ñ_“ÞìEˆÚAt•a—‚ð•×‹­‚·‚é‰ï (2004/11/27), ‰¡•l.

733384. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŒÀ‹Ç«‘O—§‘BŠà‚ɑ΂·‚éHSV-tkˆâ“`ŽqŽ¡—ÂƕúŽËüŽ¡—Ëy‚уzƒ‹ƒ‚ƒ“—Ö@‚Æ‚Ì•¹—p—Ö@‚É‚¨‚¯‚é–ƉuŠw“I•Ï‰»‚ÌŒŸ“¢. “¡“c“N•v1, ²“¡ˆÐ•¶1, “c”¨Œ’ˆê1, “ú‰ºMs2, ¬Î_Ži2, Bin S Teh3, Terry L Timme3, E Brian Butler3, Timothy C Thompson3 (1”å. 2‰ªŽR‘å. 3ƒxƒCƒ‰|ˆã‘å): ‘æ6‰ñ”å”AŠíˆâ“`ŽqE×–EŽ¡—ÃŒ¤‹†‰ï (2004/11), ‰ªŽR.

733385. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Œ‹ß«d‰»Ç‚𔺂Á‚½—¼‘¤‘½”­«tŒŒŠÇ‹ØüˆÛ‰è×–EŽî‚̈ê—á. “yŠò‘å‰î1, ‹´–{‹±L1, ”’ì_Šó1, –ìè‘åŽi1, “n•Ó‰hŽq1, ”Ñ“cˈê1, Έä‘å•ã2, •Ÿ“c••F1, ‹ß“¡P“¿1, ‰œ“c”䲎1, ‹S’ËŽj˜N1, ˆÉ“¡•¶•v1, “c粈ê¬1, “ŒŠÔ@h1 (1“Œ‹ž—ˆã‘å. 2”å): ‘æ571‰ñ“ú–{”å”AŠíŠw‰ï“Œ‹ž’n•û‰ï (2004/12/2), “Œ‹ž.

733386. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) • o‹¾‰º”X–E•ÇŠJ‘‹p‚ðŽ{s‚µ‚½–Ttá±”X–E‚Ì2—á. •âáÁ“ñ1, Έä~ˆê˜Y1, ‘åì–ƒŽq1, ‚“ˆ—Í–í1, –å˜e˜ab2, ”nêŽu˜Y1, ‘º–{«r1, Šâ‘º³Žk1, “ü]@Œ[1 (1”å. 2–kŒ¤): ‘æ571‰ñ“ú–{”å”AŠíŠw‰ï“Œ‹ž’n•û‰ï (2004/12/2), “Œ‹ž.

733387. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) äNã÷Paraganglioma ‚Ì2—á. ¼‰ºˆêm1, ‘å–ì–F³2, Œ “¡—§’j2, ’†_‹`O2, â–{@¸2, ¼–{^—RŽq2, ŒÃ‰êËŽi2, ‹g‰ª–M•F2, •À–؈ê“T2, –ö’åˆê˜Y2, ‘å–x@—1, `–ì@’¼2, ‹k@­º2 (1”å. 2“Œ‹žˆã‘å): ‘æ571‰ñ“ú–{”å”AŠíŠw‰ï“Œ‹ž’n•û (2004/12/2), “Œ‹ž.

733388. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “ú–{‘åŠwˆãŠw•”•‘®”‹´•a‰@”å”AŠí‰È‚É‚¨‚¯‚é10”NŠÔ (1995`2004”N) ‚ÌÏ‹É“IŽ¡—ÂɊւ·‚é“®Œü. ‹gì“N•v1, ‹ß“¡‘¾ˆê1, ¼ˆä@‹­1, ŒÜ\—’’q”Ž1, çŠÔ—²—T1, ’·ª—T‰î1, ²“¡Ž•F1, ŒÜ\—’@—m1, —äˆä’è‹I2, ™–{Žü˜H1, ŽRŒûŒ’Æ1, •½–ì‘åì1, ‹g“c—˜•v1, ‘ê–{ŽŠ“¾1, ‰ª“c´ŒÈ3 (1“ú–{‘å. 2”å. 3Œö—§ˆ¢Šê—¯): ‘æ571‰ñ“ú–{”å”AŠíŠw‰ï“Œ‹ž’n•û‰ï (2004/12/2), “Œ‹ž.

733389. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Œã• –Œ’E•ª‰»Œ^Ž‰–b“÷Žî‚Ì1—á. Œ “¡—§’j1, ‘å–x@—2, ’†_‹`O1, ¼‰ºˆêm2, â–{@¸1, ¼–{^—RŽq1, ‘å–ì–F³1, ŒÃ‰êËŽk1, ‹g‰ª–M•F1, •À–؈ê“T1, –ö’åˆê˜Y1, `–ì@’¼1, ‹k@­º1 (1“Œ‹žˆã‘å. 2”å): ‘æ572‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2005/1/27), “Œ‹ž.

733390. [Œ¤‹†‰ï] (ˆê”Êu‰‰) is«tŠà‚ɑ΂·‚éIL-2, IFN, 5-FU•¹—p–Ɖu‰»Šw—Ö@‚Ì—L—p«. ‘º–{«r, Šâ‘º³Žk, ¼–{˜a«, ²“¡ˆÐ•¶, “ü]@Œ[, ”nêŽu˜Y (”å): ‘æ8‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€ (2005/1/28), ‘Š–ÍŒ´.

733391. [Œ¤‹†‰ï] (ˆê”Êu‰‰) High risk‘O—§‘BŠàÇ—á‚ɑ΂·‚é, ƒlƒIƒAƒWƒ…ƒoƒ“ƒh—Ö@‚Æ‚µ‚Ă̈â“`ŽqŽ¡—Â̌Ÿ“¢. ²“¡ˆÐ•¶1, “¡“c“N•v1, ¼–{˜a«1, “c”¨Œ’ˆê1, ‘å‘@—m1, “ü]@Œ[1, Šâ‘º³Žk1, “ß{•Û—F2, Œö•¶”ô—T–¤2, Dov Kadmon3, Terry L Timme3, Brian J Miles3, Bin S Teh3, Brian E Butler3, Thomas M Wheeler4, Timothy C Thompson3, ”nêŽu˜Y1 (1”å. 2‰ªŽR‘å. 3ƒXƒRƒbƒg‘å. 4ƒxƒCƒ‰|ˆã‘å): ‘æ8‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€ (2005/1/28), ‘Š–ÍŒ´.

733392. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‘O—§‘BŠà‚Ì–§••¬üŒ¹—Ö@‚É‚¨‚¯‚郊ƒXƒN•ª—Þ‚©‚ç‚̃Aƒvƒ|ƒ`: HDR‚È‚ç‚Ñ‚ÉLDR‚ÌŒŸ“¢. ²“¡ˆÐ•¶1, –k–ì‰ëŽj2, ÎŽR”ŽžŠ2, ’Â@ˆÌ‹­1, V•”@÷2, ‘å‘@—m1, ¼–{˜a«1, “¡“c“N•v1, “ü]@Œ[1, ‘ì˜ad2, ”nêŽu˜Y1 (1”å. 2•ú): ‘æ13‰ñƒNƒŠƒjƒJƒ‹EƒrƒfƒIƒtƒH[ƒ‰ƒ€ (2005/2/5), “Œ‹ž.

733393. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) S–[“àŽîá‡Çð‚ð”F‚ß‚½‰EtŠà‚̈ê—á. –Ø‘º«‹M, Šâ‘º³Žk, ¼–{˜a«, “ì“c@—@, ’؈ärŽ÷, ¼“c‘å‰î, ‘å‘@—m, ²“¡ˆÐ•¶, ‘v@¬_, rì@F, ”nêŽu˜Y (”å): ‘æ31‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï (2005/2/10), V‰¡•l.

733394. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) —‘‘ƒÃ–¬‚ÉŽr‘ÌtÖ¬‚𕫇‚µ, —ÇD‚ȈÚAt‹@”\‚ð‚¦‚½Ç—á. “y“c–š”ü, ‹g“cˆê¬, “¡“c“N•v, •½ŽR‹M”Ž, ¼@·G, ¼“c‘å‰î, ‘º–{«r, ŽÔ@‰pr, “ü]@Œ[, ”nêŽu˜Y (”å): ‘æ31‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï (2005/2/10), V‰¡•l.

733395. [Œ¤‹†‰ï] (ˆê”Êu‰‰) On-line HDFŽ{sŽž‚É‚¨‚¯‚éƒAƒ‹ƒuƒ~ƒ“˜Ro‚ªƒOƒŠƒRƒAƒ‹ƒuƒ~ƒ“ (GAj ’l‚É—^‚¦‚é‰e‹¿. ‹ß“¡Œõ—m1, •º“¡@“§2, ˆ¢•”ˆèŽq1, ÔÎ@m3, ‰ª–{’q”V2, –{ŠÔ@’2, Žðˆä@‹Š4, “ú‘ä‰p—Y2, ‹g“cˆê¬5, ‰““¡’‰—Y5, ”nêŽu˜Y5 (1Œú–؃NƒŠ. 2‰¡•l‘æˆê. 3‹gËŽ›‚ ‚³‚Ð. 4¬Ž™tŽ¾Š³‘Ž‡ŠÇ—Œ¤‹†Š. 5”å): HDFŒ¤‹†‰ï (2005/2/18-19), VŠƒ.

733396. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒŠƒNƒZƒ‹R‚ÌÄzŠÂŽg—p‚É‚¨‚¯‚éƒÀ2-mg‹z’…—Ê‚ÌŒŸ“¢. ‹ß“¡Œõ—m1, •º“¡@“§2, ˆ¢•”ˆèŽq1, ÔÎ@m3, ‰ª–{’q”V1, –{ŠÔ@’1, Žðˆä@‹Š4, “ú‘ä‰p—Y1, ‹g“cˆê¬5, ‰““¡’‰—Y5, ”nêŽu˜Y5 (1Œú–؃NƒŠ. 2‰¡•l‘æˆê. 3‹gËŽ›‚ ‚³‚Ð. 4¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š. 5”å): HDFŒ¤‹†‰ï (2005/2/18-19), VŠƒ.

733397. [Œ¤‹†‰ï] (ˆê”Êu‰‰) On-line HDFŽ{sŽž‚É‚¨‚¯‚éwhole-PTH˜Ro—Ê‚ÌŒŸ“¢. •º“¡@“§1, ‹ß“¡Œõ—m2, ˆ¢•”ˆèŽq2, ÔÎ@m3, ‰ª–{’q”V1, –{ŠÔ@’1, Žðˆä@‹Š4, “ú‘ä‰p—Y1, ‹g“cˆê¬5, ‰““¡’‰—Y5, ”nêŽu˜Y5 (1‰¡•l‘æˆê. 2Œú–؃NƒŠ. 3‹gËŽ›‚ ‚³‚Ð. 4¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š. 5”å): HDFŒ¤‹†‰ï (2005/2/18-19), VŠƒ.

733398. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ”A˜Hinverted papilloma‚Ì2—á. •âáÁ“ñ1, Έä~ˆê˜Y1, ‘åì–ƒŽq1, ‚“ˆ—Í–í1, –å˜e˜ab2, X‰i³“ñ˜Y2, “ü]@Œ[1, ”nêŽu˜Y1 (1”å. 2–kŒ¤): ‘æ573‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2005/2/24), “Œ‹ž.

733399. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) äNã÷Œ´”­ˆ««ƒŠƒ“ƒpŽî‚Ì1—á. —é–Ø—TŽq1, ‹´–{‹±L1, “yŠò‘å‰î1, Έä‘å•ã2, ”Ñ“cˈê1, ”’ì_Šó1, ‹ß“¡P“¿1, ‰œ“c”䲎1, ˆÉ“¡•¶•v1, “c粈ê¬1, ‡’JMs1, “ŒŠÔ@h1 (1“Œ‹ž—ˆã‘å. 2”å): ‘æ573‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2005/2/24), “Œ‹ž.

733400. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) G-CSFŽY¶äNã÷ŽîᇂÌ1—á. ’†_‹`O1, ‘å–ì–F³1, Œ “¡—§’j1, ¼‰ºˆêm2, â–{@¸1, X@@‚, ŒÃ‰êËŽk1, •À–؈ê“T1, ‹g‰ª–M•F1, –ö’åˆê˜Y1, ‘å–x@—2, `–ì@’¼1, ‹k@­º1 (1“Œ‹žˆã‘å. 2”å): ‘æ573‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2005/2/24), “Œ‹ž.

733401. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ’YŽ_ƒJƒ‹ƒVƒEƒ€‚©‚牖Ž_ƒZƒxƒ‰ƒ}[‚Ö‚ÌŠ®‘S’uŠ·‚É‚æ‚é–³Œ`¬œ‚ÌŽ¡—Ã. •º“¡@“§1, ‹g“cˆê¬2, Žáˆä—zŠó1, •½—Ç—²•Û1, “y“c–š”ü2, “¡“c“N•v2, Žðˆä@‹Š3, “ú‘ä‰p—Y1, ”nêŽu˜Y2 (1‰¡•l‘æˆê. 2”å. 3¬Ž™tŽ¾Š³‘‡ŠÇ—Œ¤‹†Š): t‚ƃrƒ^ƒ~ƒ“DŒ¤‹†‰ï (2005/2/26), “Œ‹ž.

733402. [Œ¤‹†‰ï] (ˆê”Êu‰‰) 2‰ñ–ڂ̶‘ÌtˆÚAŒã8”N–ڂł̈ÚAt•a—‘œ. ‹g“cˆê¬ (”å): ‘æ8‰ñ_“ÞìEˆÚAt•a—‚ð•×‹­‚·‚é‰ï (2005/3/12), ‰¡•l.

733403. [Œ¤‹†‰ï] (ˆê”Êu‰‰) HTLV-1—z«¨—z«‚ÌABO•s“K‡“ñŽŸˆÚA. –Ø‘º«‹M, ‹g“cˆê¬ (”å): ‘æ8‰ñ_“ÞìEˆÚAt•a—‚ð•×‹­‚·‚é‰ï (2005/3/12), ‰¡•l.

733404. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) •›tœ‘Ž‰–bŽî‚Ì1—á. •âáÁ“ñ1, Έä~ˆê˜Y1, ‘åì–ƒŽq1, ‚“ˆ—Í–í1, –å˜e˜ab2, X‰i³“ñ˜Y2 Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å. 2–kŒ¤): ‘æ574‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2005/3/17), “Œ‹ž.

733405. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ˆÚAŒãCAPD‚ÉÄ“±“ü‚µ, Extraneal‚É‚æ‚èŽct‹@”\‚ª‰ü‘P‚µ‚½1—á. –Ø‘º«‹M1, “y“c–š”ü1, ‹g“cˆê¬1, ’|“àN—Y2, ‰H‘º‘fŽq2, “¡“c“N•v1, Š™“cvšæ2, ”nêŽu˜Y1 (1”å. 2“à‡W): ‘æ19‰ñ_“Þ쌧CAPDŒ¤‹†‰ï (2005/3/19), ‰¡•l.

733406. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŒŒ”A‚ð‰”­Çó‚Æ‚µ‚Ä”­Ç‚µ‚½ƒrƒ‹ƒnƒ‹ƒcZŒŒ‹z’ŽÇ‚Ì1—á. ’؈ärŽ÷1, “ü]@Œ[1, ¼–{˜a«1, ‚ŽR—zŽq2, ’ѺGN1, ‘å‘@—m1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å. 2“à‡W): ‘æ57‰ñ_“Þ쌧Š´õˆãŠw‰ïŒ¤‹†‰ïE‘æ5‰ñ_“Þ쌧STDŒ¤‹†‰ï (2005/3/26), ‰¡•l.

733407. [uK‰ï] (‹³ˆçu‰‰) –§••¬üŒ¹—Ö@Œã‚Ì‘ŠúŽ€–SÇ—á‚ɑ΂·‚é‘Έ. ²“¡ˆÐ•¶ (”å): ‘æ6‰ñƒˆƒE‘f125ƒV[ƒhüŒ¹‚É‚æ‚é‘O—§‘B‰i‹v‘}“ü–§••¬üŒ¹Ž¡—Â̈À‘SŽæ‚舵‚¢uK‰ï (2005/3/26), •iì.


<<Šá‰ÈŠw>>

mŠwp˜_•¶n

110172. [Œ´’˜] Ocular dominance and patient satisfaction after monovision induced by intraocular lens implantation. ”¼“c’m–ç1, Œü–ì˜a—Y2, ‹›—¢@”Ž2, Vˆä“cF—T3,4, ¯ŽiMs2, —äˆä—˜¹Žq4, V“c”C—]4, ´…Œö–ç4 (1ˆã—ÃŒn‘åŠw‰@. 2ˆã‰q. 3‘Ûˆã—ÕŸŽƒ‘å. 4Šá): Journal of Cataract & Refractive Surgery, 30 (4): 769-774, 2004.

110173. [Œ´’˜] Pharmacological vascular reactivity in isolated hypercholesterolemic rabbit ciliary artery. Îì@‹Ï1,2, ‰F‰ê–ÎŽO1,2, ^‰º‹I”ü‘ã1, ‹g•xŒšŽu3, Masahiko Kusanagi4. ´…Œö–ç1 (1Šá. 2‘Ûˆã—ÕŸŽƒ‘å. 3H“c‘å. 4Japan Laboratory Animals Inc): Experimental Eye Research, 78 (4): 805-813, 2004.

110174. [Œ´’˜] Vasodilatory mechanism of unoprostone isopropyl on isolated rabbit ciliary artery. ‹g•xŒšŽu1, ŽR’nˆê’õ2, Îì@‹Ï3, Yoshitaka Ohnishi1 (1˜a‰ÌŽRŒ§—§ˆã‘å. 2—‰»ŠwŒ¤. 3‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@, Šá): Current Eye Research, 28 (3): 167-174, 2004.

110175. [Œ´’˜] Effects of Dominant and Nondominant Eyes in Binocular Rivalry. ”¼“c’m–ç1, Œü–ì˜a—Y2, ‹›—¢@”Ž2, Vˆä“cF—T3,4, ¯ŽiMs2, ´…Œö–ç4 (1ˆã—ÃŒn‘åŠw‰@. 2ˆã‰q. 3‘Ûˆã—ÕŸŽƒ‘å. 4Šá): Optometry and Vision Science, 81 (5): 377-382, 2004.

110176. [Œ´’˜] OFDR with an SSG-DBR laser. “V–ì‘쎡1, H Hiro-Oka1, D Choi1, H Furukawa1, F Kano2, M Takeda3, ’†¼@Šî4, ´…Œö–ç4, K Obayashi1 i1ˆê”Ê‹³ˆç. 2NTT. 3Department of Information and Communication Engineering, University Electro-Communications. 4Šá): SPIE, 5531: 375-382, 2004.

110177. [Œ´’˜] Antimuscarinic Action of Oxymetazoline on Human Intraocular Muscles. Popat N Patil1, Îì@‹Ï2 (1Division of Pharmacology, College of Pharmacy. 2Šá): Journal of Ocular Pharmacology and Therapeutics, 20 (4): 328-332, 2004.

110178. [Œ´’˜] Dynamic Measurement of the Implanted Intraocular Lens Position with M-mode Ultrasound Biometry. ‹›—¢@”Ž, ìŽç“c‘ñŽu (ˆã‰q, Šá): Invest Ophthalmol Vis Sci, 45 (4): 1730, 2004.

110179. [Œ´’˜] Correlation between allergen-specific IgE serum levels in patients with allergic conjunctivitis in spring. Tatsuya Mimura1, Shiro Amano1, Hideharu Funatsu2, Satoru Yamagami1, Makoto Araie1, Yuichi Kaji3,4, —L–{‚ ‚±1,4,5, Yoshiko Ishida4, Tomohiko Usui1, Shinseiro Okamoto4 (1“Œ‹ž‘å. 2“Œ‹ž—ˆã‘å. 3‚‚­‚Αå. 4Okamoto Eye Clinic. 5Šá): Ocular Immunology and Inflammation, 12 (1): 45-51, 2004.

110180. [Œ´’˜] Eleven-year follow-up of photorefractive keratectomy for myopia. ’†¼@Šî, —é–؉ëM, ´…Œö–ç (Šá): The Kitasato Medical Journal, 34 (1): 9-12, 2004.

110181. [Œ´’˜] Optical frequency-domain reflectometry with a rapid wavelength-scanning superstructure-grating distributed Bragg reflector laser. “V–ì‘쎡1, Hideaki Hiro-Oka1, Donghak Choi1, Hiroyuki Furukawa1, Fumiyoshi Kano2, Mituo Takeda3, ’†¼@Šî4, ´…Œö–ç4, Kohji Ohbayashi5 (1ˆê”Ê‹³ˆç. 2NTT. 3Department of Information and Communication Engineering, University of Electro-Communications. 4Šá. 5ˆã—ÃŒn‘åŠw‰@): Applied Optics, 44 (5): 808-816, 2004.

110182. [Œ´’˜] Evaluation of apparent ectasia of the posterior surface of the cornea after keratorefractive surgery. Yoshiaki Nawa1, Kozo Masuda1, Tetsuo Ueda1, Yoshiai Hara1, ‹›—¢@”Ž2 (1“Þ—ÇŒ§ˆã‘å. 2ˆã‰q, Šá): Journal of Cataract & Refractive Surgery, 31 (3): 571-573, 2004.

120064. [Œ´’˜] ˜VŽ‹‚ÌŽ¡—Ã. ´…Œö–ç (Šá): _ŒoŠá‰È, 21 (1): 29-36, 2005.

120065. [Œ´’˜] Šá“àƒŒƒ“ƒY‚É‚æ‚郂ƒmƒrƒWƒ‡ƒ“–@‚ÌŽ‹‹@”\•]‰¿. —äˆä—˜¹Žq1, ´…Œö–ç1, V“c”C—¢]1, ‹›—¢@”Ž2, Vˆä“cF—T3, ˆäãr—m4 (1Šá. 2ˆã‰q. 3‘Ûˆã—ÕŸŽƒ‘å. 4ŒF–{‘å): Šá‰ÈŽèp, 17 (2): 223-228, 2004.

120066. [Œ´’˜] Šp–Œ“à”ç×–EŒ¸­Ç—á‚ɑ΂·‚éDouble Circular Capsulotomy & Endocapsular Phacoemulsification. _ŽR‚Æ‚æ‚Ý, ´…Œö–ç, —äˆä—˜¹Žq, “¡àV–Mr, •D“c•üŽq, ŒãŠÖ—˜–¾ (Šá): Šá‰ÈŽèp, 17 (2): 241-244, 2004.

120067. [Œ´’˜] GDx-‚m‚ÆGDx Access‚Ì‘ª’莞ŠÔ‚Æ‘ª’è’l‚Ì”äŠr. X“c“N–ç1, ¯ŽiMs2, ”d–—D‹MŽq1, ¼@‘׎}, ‚‹´ŒcŽq1, ´…Œö–ç1 (1Šá. 2ˆã‰q): ‚ ‚½‚炵‚¢Šá‰È, 21 (3): 409-414, 2004.

120068. [Œ´’˜] ‰Ë‹´ƒqƒAƒ‹ƒƒ“Ž_ƒQƒ‹‚Ì‘@ˆÛ’Œ‘ÑØœp‚ւ̉ž—p. ¯ŽiMs1, ´…Œö–ç2, ‚‹´ŸÆ3, ª–{—4, ‰Í‡—T”ü2, •y‰ª•q–ç5 (1ˆã‰q. 2Šá. 3¶‰»ŠwH‹Æ (Š”) ’†‰›Œ¤. 4“ŒŽÅ—ÑŠÔ•a‰@. 5•‘ –ìÔ\Žš•a‰@): “ú–{Šá‰ÈŠw‰ïŽGŽ, 108 (5): 277-282, 2004.

120069. [Œ´’˜] LASIKpŒã‚Ì”–•éŽ‹‚ÌŒŸ“¢. ¬Žèì‘׎}1, ‹›—¢@”Ž1, Œü–ì˜a—Y1, ´…Œö–ç1,2, ‰Á“¡”üŽ}3, ‘å–ìWŽi3 (1ˆã—ÃŒn‘åŠw‰@. 2Šá. 3_“Þ쎕‘剡•lƒNƒŠƒjƒbƒN): ‚ ‚½‚炵‚¢Šá‰È, 21 (4): 519-522, 2004.

120070. [Œ´’˜] —ΓàኳŽÒ‚Ì—¼Šá‰ð•úŽ‹–ì‚É‚¨‚¯‚é—݉Á. ŽRì–í¶1, ¯ŽiMs2, ‰Í‡—T”ü1, “›ˆäŒ’‘¾1, ´…Œö–ç1 (1Šá. 2ˆã‰q): —Õ°Šá‰È, 58 (7): 1193-1198, 2004.

120071. [Œ´’˜] “µE‚ÉŠÖ‚·‚éÅ‹ß‚Ì’mŒ©. ‹g•yŒšŽu1, ŽR’nˆê’õ2, Îì@‹Ï3 (1H“c‘å. 2—‰»ŠwŒ¤. 3‘Ûˆã—ÕŸŽƒ‘å, Šá): _ŒoŠá‰È, 21 (2): 116-120, 2004.

120072. [Œ´’˜] ‰Šú”’“àá‚É‚¨‚¯‚éD‘i‚Æ‚ŽŸ”g–ÊŽû·. ‚èŒb—Žq1, ˆÉ“¡”ü¹ŠG1, ‘ŠàV‘å•ã1, “¡àV–Mr1, —é–؉ëM1, ‹›—¢@”Ž2, ´…Œö–ç1 (1Šá. 2ˆã‰q): —Õ°Šá‰È, 58 (8): 1543-1547, 2004.

120073. [Œ´’˜] ƒgƒ‰ƒCƒCƒŠƒX‚ð—p‚¢‚½’²ßŽhŒƒ‚ɑ΂·‚铵EŒaEçt–©‚̉Á—î•Ï‰». ‚‹´ŒcŽq1, Îì@‹Ï1, V“c”C—¢]1, –x•”@‰~1, ¯ŽiMs2, ´…Œö–ç1 (1Šá. 2ˆã‰q): Ž©—¥_Œo, 41 (3): 361-364, 2004.

120074. [Œ´’˜] ‰“Ž‹LASIK‚É‚¨‚¯‚é‚ŽŸŽû·•Ï‰». –‘“c_ŽO1, –¼˜a—ÇW1, ã“c“N¶1, Œ´@‰Ãº1, ‹›—¢@”Ž2 (1“Þ—ÇŒ§ˆã‘å. 2ˆã‰q, Šá): ‚ ‚½‚炵‚¢Šá‰È, 21 (9): 1237-1240, 2004.

120075. [Œ´’˜] ”’“àáŽèpŒã‚̉©”Á–Ô–ŒŒú‚ÌŒoŽž“I•Ï‰» |“œ”A•aŠ³ŽÒ‚ÆŒ’íŽÒ‚Ì”äŠr|. ’†ŽR@K1, Œb”ü˜aK2 (1ˆã‰q, Šá. 2‘åã˜JЕa‰@): “ú–{Šá‰ÈŠw‰ïŽGŽ, 108 (6): 347-354, 2004.

120076. [Œ´’˜] ’†”]E‹´”w‘¤‚Ñ‚Ü‚ñ«‹•ŒŒ•a•Ï‚É‚Ý‚ç‚ꂽŠá‹…‰^“®áŠQ|•ª…—äÇŒóŒQ|. ¼èœA‰h1, ¼Œ³‹v°2, ¬£—ÁŽq2, ´…Œö–ç2, Œü–ì˜a—Y3 (1“Œ•a‰@Šá‰È. 2Šá. 3ˆã‰q): “ú–{Šá‰È‹I—v, 55 (11): 902-907, 2004.

120077. [Œ´’˜] ¬Ž™‚É‚¨‚¯‚钲ߖƒáƒ–ò“_Šá‘OŒã‚Å‚Ì‚ŽŸŽû·‚̕ω». –î–ì@—²1, ‹›—¢@”Ž2, —é–؉ëM1, ˆÉ“¡”ü¹ŠG1, ´…Œö–ç1 (1Šá. 2ˆã‰q): ‚ ‚½‚炵‚¢Šá‰È, 21 (10): 1379-1382, 2004.

120078. [Œ´’˜] ’PW“_‚Æ‘½W“_IOL‚É‚¨‚¯‚é‹óŠÔŽü”g”“Á«‚Ì”äŠr. ìŽç“c‘ñŽu, ‹›—¢ ”Ž (ˆã‰q, Šá): Šá‰ÈŽèp, 18 (1): 77-81, 2004.

120079. [Œ´’˜] —¼ŠáŽ‹‚Æ’PŠáŽ‹‰º‚ÌŽ‹‹@”\‚É‹y‚Ú‚·“µEŒa‚ÆŽû·‚̉e‹¿. ‹›—¢ ”Ž, ìŽç“c‘ñŽu (ˆã‰q. Šá): ‚ ‚½‚炵‚¢Šá‰È, 22 (1): 93-95, 2005.

120080. [Œ´’˜] Laser in situ keratomileusispŒã2”N‚ÌŒo‰ß. ‘ŠàV‘å•ã1, ´…Œö–ç1, ’†¼@Šî1, —é–؉ëM1, ‘å–ìWŽi2, ¬¼^—3 (1Šá. 2_“Þ쎕‘剡•lƒNƒŠƒjƒbƒN. 3ŽR‰¤•a‰@): “ú–{Šá‰ÈŠw‰ïŽGŽ, 109 (2): 88-92, 2005.

120081. [Œ´’˜] –k—¢‘åŠw•a‰@‚É‚¨‚¯‚é•ÐŠá‹­“x‹ßŽ‹«ŽãŽ‹‚ÌŒŸ“¢. ¼—ÑCŽq1, ‚èŒb—Žq1, ¼èœA‰h2, X“c“N–ç1, V“c”C—¢]1, –x•”@‰~1, Œü–ì˜a—Y3, ´…Œö–ç1 (1Šá. 2“Œ•a‰@Šá‰È. 3ˆã‰q): Šá‰È—Õ°ˆã•ñ, 99 (2): 50-53, 2005.

120082. [Œ´’˜] —܉t‚ªŠp–ŒŽû·‚ÌŽžŠÔ“I•Ï‰»‚É—^‚¦‚é‰e‹¿^‘æ28‰ñŠp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX. ìŽç“c‘ñŽu, ‹›—¢@”Ž (ˆã‰q, Šá): “ú–{Šá‰È‹I—v, 56 (1): 3-6, 2005.

120083. [Œ´’˜] ”½•œ‚·‚é“Ý“I‹@ŠBŽhŒƒ‚É‚æ‚éŽÀŒ±“I”’“àჂƒfƒ‹‚ÌŠm—§‚Æ”­Ç‹@˜‚̉ð–¾. ‘剺‰ë¢1, Œã“¡@_1, ŽRì’¼”V1, ‰Pˆä³•F1, ‰F‰ê–ÎŽO2 (1“Œ‹žˆã‘å. 2‘Ûˆã—ÕŸŽƒ‘å, Šá): “ú–{Šá‰ÈŠw‰ïŽGŽ, 109 (4): 197-204, 2005.

120084. [Œ´’˜] ˜VŽ‹‚̉ü‘PE•âž‚ɑ΂·‚é‹ßŒ©”½‰ž‚©‚ç‚ÌŽŽ‚Ý. Œ´@’¼l (_“Þ쎕‘剡•lƒNƒŠƒjƒbƒN, Šá): Ž©—¥_Œo, 41 (3): 249-254, 2004.

120085. [Œ´’˜] “œ”A•a‰©”Á•‚Žî‚Æ“§Í—Ö@. Žsìˆê•v1,2, ŠI]‰À•äŽq2, ‹g“c‘¥•F2, ‰Á‰ê’BŽu2, ‰i“c@“Ä3 (1Šá. 2ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@. 3Šò•ŒŽÐ‰ï•ÛŒ¯•a‰@): “ú–{Šá‰È‹I—v, 55: 258-264, 2004.

120086. [Œ´’˜] –Ô–ŒÃ–¬•ÂÇǂɑ΂·‚铮Ö¬Œð³•”Œ¸ˆ³p. ’†ŽR@K1, ”ó“c“N•v2, ŽR‰ªÂ—2, ‰Í–ìŽm3, ”Ñ“c‹Ži3, ‰F‘½dˆõ3 (1ˆã‰q, Šá. 2ˆÇ—уAƒCƒZƒ“ƒ^[. 3“ñ–{¼Šá‰È): Šá‰È—Õ°ˆã•ñ, 98 (4): 287-291, 2004.

210025. [€Œ´’˜] Quantitative measurement of ocular dominance as clinical application in monovision. ”¼“c’m–ç1, ‹›—¢@”Ž2, Œü–ì˜a—Y2, —äˆä—˜¹Žq3, V“c”C—¢]3, ´…Œö–ç3 (1ˆã—ÃŒn‘åŠw‰@. 2ˆã‰q. 3Šá): Invest Ophthalmol Vision and Science, 42 (4): E-313, 2004.

210026. [€Œ´’˜] The Effect of Pupil Size on Binocular Summation. ìŽç“c‘ñŽu, ‹›—¢@”Ž (ˆã‰q, Šá): Invest Ophthalmol Vision and Science, E-4322, 2004.

220058. [€Œ´’˜] ƒ‚ƒmƒrƒWƒ‡ƒ“Ç—á‚É‚¨‚¯‚鎋‹@”\‚ƊḔæ˜J‚ÌŠÖ˜A‚ɂ‚¢‚Ä. Vˆä“cF—T1,2, ´…Œö–ç1, ”ä‰Ã—˜¹Žq1, V“c”C—¢]1 (1Šá. 2‘Ûˆã—ÕŸŽƒ‘å): “ú–{Šá‰Èˆã‰ï@ITŠáǂƊ‹«ˆöŽqŒ¤‹†”Ç‹ÆÑW, p.153-158, 2004.

320075. [Ç—á•ñ] ’ᒲ߫çt–©‰ßè“àŽÎŽ‹‚ª‹^‚í‚ê‚é1Ç—á. “¡‘º•‡²Žq1, V“c”C—¢]2, ‚‹´ŒcŽq3, ¼—ÑCŽq4, Œü–ì˜a—Y1, ´…Œö–ç2 (1ˆã‰q. 2Šá. 3‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@. 4“Œ•a‰@Šá‰È): Šá‰È—Õ°ˆã•ñ, 98 (4): 66-69, 2004.

320076. [Ç—á•ñ] ‹üÜ‹¸³Žèp3”NŒã‚ÌŽ‹_Œo“û“ªŒ`ó‚Ì”äŠr. ‹à@¬ˆ¤1, ¯ŽiMs2, —L–{‚ ‚±1, ´…Œö–ç1 (1Šá. 2ˆã‰q): —Õ°Šá‰È, 58 (13): 2281-2284, 2004.

510015. [‰ðà] Refractive surgical problem edited by Kohnen T. —é–؉ëM (Šá): Journal of Cataract & Refractive Surgery, 30 (1): 12, 2004.

520215. [uÀ] ƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“ƒR[ƒi[EƒGƒLƒXƒp[ƒg‚É•·‚­. ‘ŠàV‘å•ã, ´…Œö–ç (Šá): IOL & RS, 17(4): 470-471, 2004.

520216. [uÀ] ŠwZ•ÛŒ’–@. ‰F’ÃŒ©‹`ˆê (‰F’ÃŒ©Šá‰È, Šá): Šá‰È, 46 (4): 399-405, 2004.

520217. [‘à] ‰»Šw•¨Ž¿‰ß•qÇ‚ÌŒ©•ûEl‚¦•û (3)|SgˆãŠw‚©‚ç‚Ý‚½‰»Šw•¨Ž¿‰ß•qÇ|. â•”@v, ‹{“cŠ²•v, Îì@“N (–kŒ¤•a‰@ŠÂ‹«ˆãŠwƒZƒ“ƒ^[): _ŒoŠá‰È, 21 (1): 59-62, 2004.

520218. [‘à] ƒvƒŠƒZƒbƒgIOLƒCƒ“ƒWƒFƒNƒ^[. —äˆä—˜¹Žq, ´…Œö–ç (Šá): Šá‰ÈŽèp, 17 (2): 189-191, 2004.

520219. [‰ðà] ‰»Šw•¨Ž¿‰ß•qÇ‚ÉŒg‚í‚Á‚Ä|‚»‚ÌŒã‚Ì”­“W‚È‚Ç|. Îì@“N (–kŒ¤•a‰@—Õ°ŠÂ‹«ˆãŠwƒZƒ“ƒ^[): Ž©—¥_Œo, 41 (1): 7-10, 2004.

520220. [‘à] ˜V”N–Ô–Œ‚É‚¨‚¯‚éBDNF‚ÌĶì—p. ‚–ì‰ë•F (Šá): Clinical Neuroscience, 22 (3): 320-322, 2004.

520221. [‘à] ŠÔŸ[«ŠOŽÎŽ‹@‚»‚Ì•aˆö˜_|_ŒoŠá‰ÈŠw“I—§ê‚©‚ç|. Œü–ì˜a—Y (ˆã‰q): “ú–{‚ÌŠá‰È, 75 (7): 821-826, 2004.

520222. [‰ðà] ŠwZŒ»ê‚É‚¨‚¯‚éƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚Æ‚»‚Ì–â‘è“_. ‰F’ÃŒ©‹`ˆê (‰F’ÃŒ©Šá‰È, Šáj: ‚ ‚½‚炵‚¢Šá‰È, 21 (6): 723-729, 2004.

520223. [‘à] ”’“àápŒã‚É‚¨‚¯‚é˜VŽ‹‚ÌŽ•ž. ´…Œö–ç (Šá): IOL & RS, 18 (1): 30-35, 2004.

520224. [uÀ] ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠááŠQ‚ÌŽÀÛ. ‰F’ÃŒ©‹`ˆê (‰F’ÃŒ©Šá‰È, Šá): “ú–{‚ÌŠá‰È, 75 (8): 971-977, 2004.

520225. [‘à] ‹üÜ‹¸³Žèp‚Æ’²ß«“àŽÎŽ‹. ´…Œö–ç (Šá): ‚ ‚½‚炵‚¢Šá‰È, 21 (9): 1167-1171, 2004.

520226. [uÀ] ƒŒƒ“ƒYƒPƒA‚ƃhƒ‰ƒCƒAƒC. ‰F’ÃŒ©‹`ˆê (‰F’ÃŒ©Šá‰È, Šá): “ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ïŽ, 46 (3): 164-167, 2004.

520227. [‘à] Å‹ß‚Ì”’“àᎡ—Ã. ´…Œö–ç (Šá): ‘Ž‡—Õà¬, 53 (10): 2668-2672, 2004.

520228. [uÀ] Monovision‚ð—‰ð‚·‚邽‚ß‚É•K—v‚È_ŒoŠá‰È. Vˆä“cF—T (‘Ûˆã—ÕŸŽƒ‘å, Šá): IOL & RS, 18 (2): 105-109, 2004.

520229. [uÀ] ”ñ‹…–ʃŒƒ“ƒY‚ɂ‚¢‚Ä. Žsìˆê•v (ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, Šá): IOL & RS, 18 (2): 132-133, 2004.

520230. [‘à] “µE”½‰ž. Îì@‹Ï1, óì@Œ«2, ‹g•yŒ’Žu3 (1Šá. 2‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@. 3H“c‘å): _ŒoŠá‰È, 21 (3): 280-285, 2004.

520231. [‘à] ‘ª’è•û–@‚Æ‹@Ší. óì@Œ«1, Îì@‹Ï2, ‹g•yŒ’Žu3 (1‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@. 2Šá. 3H“c‘å): _ŒoŠá‰È, 21 (3): 286-292, 2004.

520232. [‘à] ‹ßŒ©”½‰ž‚Ì—Õ°‰ž—p|˜VŽ‹‚̋ߌ©”½‰ž|. Œ´@’¼l (_“Þ쎕‘剡•lƒNƒŠƒjƒbƒN, Šá): _ŒoŠá‰È, 21 (3): 293-300, 2004.

520233. [‘à] Šp–Œ¬‘÷Šá‚Ì”’“àá. “¡àV–Mr, ´…Œö–ç (Šá): —Õ°Šá‰È (‘), 58 (11): 191-195, 2004.

520234. [‘à] _ŒoŠá‰È‚ÉŒg‚í‚Á‚Ä40”N (‹•ŒŒ«Šá‹…‰^“®áŠQ, “œ”A•a«Ž‹_ŒoÇ, ƒ‚ƒmƒrƒWƒ‡ƒ“–@‚ÆŠá—DˆÊ«, “µEU“®‚̉ðÍ, ˜VŽ‹)|Thinking Neuro-Ophthalmology‚ÌŽÀ‘H|. Œü–ì˜a—Y (ˆã‰q): ü‚ÌŠá‰È, 9 (11): 19-29, 2004.

520235. [‘à] —L…»‘ÌŠá“àƒŒƒ“ƒY|Œã–[Œ^ƒŒƒ“ƒY(ICL) ‚ÌŽ¡Œ±¬Ñ@Phakic IOL. —é–؉ëM, ´…Œö–ç (Šá): ˆãŠw‚Ì‚ ‚ä‚Ý (‘æ1“y—j“ÁW), 211 (10): 943-948, 2004.

520236. [‘à] ˜VŽ‹‚ƃX[ƒp[ƒrƒWƒ‡ƒ“. ‘ŠàV‘å•ã, ´…Œö–ç (Šá): –k—¢ˆãŠw, 33 (6): 362-368, 2003.

520237. [‰ðà] Ž‹Ž²‚ÆÆ€ü. ‹›—¢@”Ž (ˆã‰q): Tomey Ophthalmology News, 35: 19, 2004.

520238. [‘à] ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚É‚¨‚¯‚éŠáŒõŠw. ‹›—¢@”Ž (ˆã‰q): —Õ°Šá‰È, 58 (13): 2211-2220, 2004.

520239. [uÀ] ŒõŒ¹‚ɂ‚¢‚Ä. Žsìˆê•v1,2, ’†‘º‰pŽ÷1 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@. 2Šá): IOL & RS, 18 (4): 400-402, 2004.

520240. [uÀ] ƒ‚ƒmƒrƒWƒ‡ƒ“LASIK. ´…Œö–ç (Šá): ‚ ‚½‚炵‚¢Šá‰È, 22 (1): 51-52, 2005.

520241. [‘à] Šá‚Ì–ò•¨’†“Å‚Ìf’f. Œü–ì˜a—Y1, Žs糋`Í2 (1ˆã‰q. 2Šá): Šá‰È, 47 (2): 125-139, 2005.

520242. [‘à] —L‹@ƒŠƒ“’†“Å. ‹{“cŠ²•v, Îì@“N, â•”@v (–kŒ¤•a‰@ŠÂ‹«ˆãŠwƒZƒ“ƒ^[): Šá‰È, 47 (2): 141-148, 2005.

520243. [‘à] ƒVƒbƒNƒnƒEƒXÇŒóŒQE‰»Šw•¨Ž¿‰ß•qÇ. Îì@“N1, â•”@v1, ‹{“cŠ²•v1, ‹g–ì@”Ž2, Šp“c˜a•F3, –kžŠËŽq4 (1–kŒ¤•a‰@ŠÂ‹«ˆãŠwƒZƒ“ƒ^[. 2“Œ–k‘å. 3⑇•a‰@. 4®ãDŠw‰@‘å): Šá‰È, 47 (2): 149-160, 2005.

520244. [‘à] ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYf—Â̌»ó. ‰F’ÃŒ©‹`ˆê (‰F’ÃŒ©Šá‰È, Šá): Šá‰È, 47 (2): 175-187, 2005.

520245. [‘à] ˜VŽ‹‚Æ‚»‚Ì‘Îô. ´…Œö–ç (Šá): ‘Ž‡—Õà¬, 54 (3): 627-628, 2005.

520246. [‘à] Wavefront-Guided LASIK. ‘ŠàV‘å•ã, ´…Œö–ç (Šá): ‚ ‚½‚炵‚¢Šá‰È, 22 (2): 177-180, 2005.

520247. [‘à] VDT‹Æ–±‚ƃVƒbƒNƒnƒEƒXÇŒóŒQ‚ÉŠÖ‚·‚é—\•ñ“IŒ¤‹†. Îì@“N1, “c’†ŠÚ–¾”Ž2, Šp“c˜a•F3, ‹{“cŠ²•v1, Îì@‹Ï4, •½‰ª^—5, —é–Ø••q6, ŒÑ“c’¼r7 (1–kŒ¤•a‰@—Õ°ŠÂ‹«ˆãŠwƒZƒ“ƒ^[. 2ˆã‰q. 3⑇•a‰@. 4‘Ûˆã—ÕŸŽƒ‘å, Šá. 5•½‰ªŠá‰È. 6—é–ØŠá‰È. 7•l¼ƒzƒgƒjƒNƒX): “ú–{Šá‰Èˆã‰ï@ITŠáǂƊ‹«ˆöŽqŒ¤‹†”Ç‹ÆÑW, p.83-87, 2005.

520248. [‘à] Žº“à‹ó‹C‰˜õ‚ÆŠÖ˜A‚·‚é‚Æ‚³‚ê‚é—L‹@ƒŠƒ“‰»‡•¨. Îì@“N, â•”@v, ‹{“cŠ²•v (–kŒ¤•a‰@—Õ°ŠÂ‹«ˆãŠwƒZƒ“ƒ^[): “ú–{Šá‰Èˆã‰ï@ITŠáǂƊ‹«ˆöŽqŒ¤‹†”Ç‹ÆÑW, p.88-93, 2005.

520249. [‘à] ƒgƒ‰ƒCƒCƒŠƒX‚ð—p‚¢‚½ITŠáÇ‚Ì•]‰¿. Îì@‹Ï1, ´…Œö–ç1, –x•”@‰~1, óì@Œ«2, “©ŽRG•v2, Îì@“N3 (1Šá. 2‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@. 3–kŒ¤•a‰@ŠÂ‹«ˆãŠwƒZƒ“ƒ^[): “ú–{Šá‰Èˆã‰ï@ITŠáǂƊ‹«ˆöŽqŒ¤‹†”Ç‹ÆÑW, p.129-134, 2005.

520250. [‘à] Œg‘Ñ“d˜bƒ[ƒ‹Žg—p‘OŒã‚Ì“µE”½‰ž. Œ´@’¼l1,3, ‘å–ìWŽi1,3,, “àŽRmŽu2, “c’†ŠÚ–¾”Ž2, “¡ŽR—R‹IŽq2, Œü–ì˜a—Y2, ´…Œö–ç3 (1_“Þ쎕‘åŠw. 2ˆã‰q. 3Šá): “ú–{Šá‰Èˆã‰ï@ITŠáǂƊ‹«ˆöŽqŒ¤‹†”Ç‹ÆÑW, p.147-152, 2005.

520251. [‘à] ’²ßŠá“àƒŒƒ“ƒY. Žsìˆê•v (ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, Šá): IOL & RS, 18 (4): 386-389, 2004.

520252. [uÀ] Wavefront-guided ablation. ´…Œö–ç, ‘ŠàV‘å•ã (Šá): Ocular Surgery News, Japan Edition, (5): 3, 2004.

520253. [‘à] “µEŠÖ˜AŽ¾Š³‚Ìf’fEŽ¡—Âɂ¨‚¯‚éPitfall. Îì ‹Ï1,2, ´…Œö–ç2, ‹g•yŒ’Žu3 (1ˆã‰q. 2Šá. 3H“c‘åj: _ŒoŠá‰È, 22 (1): 4-13, 2005.

520254. [‰ðà] ”’“àáŽèp‚É‚¨‚¯‚郂ƒmƒrƒWƒ‡ƒ“. ”ä‰Ã—˜¹Žq (Šá): IOL & RS, 18 (2): 123-127, 2004.

520255. [‰ðà] ƒVƒbƒNƒnƒEƒXÇŒóŒQE‰»Šw•¨Ž¿‰ß•qÇ‚ÆŒ’N‰e‹¿@‚Æ‚­‚É—L‹@ƒŠƒ“Ü‚Ì_ŒoŒn‚ւ̉e‹¿@|’á—p—ÊE˜A‘±”˜˜I‚¨‚æ‚Ñ”½•œ”˜˜I‚̊댯«‚ÌÄ•]‰¿‚ÉŒü‚¯‚Ä|. Îì@“N (–k—¢Œ¤‹†Š•a‰@—Õ°ŠÂ‹«ˆãŠwƒZƒ“ƒ^[): Ž©—¥_Œo, 41 (5): 485-489, 2004.

m’˜@‘n

620135. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) Šá‰Èƒx[ƒVƒbƒNƒ|ƒCƒ“ƒg; Šî‘b’mŽ¯@\‘¢‚ƶ—/‹üÜ‚Æ’²ß. ’†ŽR@K (“ñ–{¼Šá‰È•a‰@, Šá): ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, 2004/3”­s.

620136. [‚»‚Ì‘¼‚Ì’˜‘] (•ÒW) Šá‰È—Õ°Œ¤CƒZƒŒƒNƒg@‚Æ‚Á‚Ä‚¨‚«¬u‹`W. •ÒW ˆ»–؉ë•F (º˜a‘å“¡‚ª‹u•a‰@), ´…Œö–ç (Šá), ‹àŒ´o”Å, “Œ‹ž, 2004/8”­s.

620137. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) Šá‰È—Õ°Œ¤CƒZƒŒƒNƒg@‚Æ‚Á‚Ä‚¨‚«¬u‹`W; ‚â‚Á‚Ä‚Í‚¢‚¯‚È‚¢! 16‚©ð|Šá‰Èf—Âׂ©‚炸W|, p.27-33. Žs糋`Í (Šá), •ÒW ˆ»–؉ë•F (º˜a‘å“¡‚ª‹u•a‰@), ´…Œö–ç (Šá), ‹àŒ´o”Å, “Œ‹ž, 2004/8”­s.

620138. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) Šá‰È—Õ°Œ¤CƒZƒŒƒNƒg@‚Æ‚Á‚Ä‚¨‚«¬u‹`W; ‚Í‚¶‚ß‚Ä‚ÌŠá’ꌟ¸, p.40-46. Žs糋`Í (Šá), •ÒW ˆ»–؉ë•F (º˜a‘å“¡‚ª‹u•a‰@), ´…Œö–ç (Šá), ‹àŒ´o”Å, “Œ‹ž, 2004/8”­s.

620139. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) Šá‰È—Õ°Œ¤CƒZƒŒƒNƒg@‚Æ‚Á‚Ä‚¨‚«¬u‹`W; ‚Í‚¶‚߂Ă̗Γàá, p.61-71. ¯ŽiMs (ˆã‰q, Šá): ˆ»–؉ë•F (º˜a‘å“¡‚ª‹u•a‰@), ´…Œö–ç (Šá), ‹àŒ´o”Å, “Œ‹ž, 2004/8”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

712032. [Šw‰ï (‘Û)] (µ‘Ò‚³‚ꂽu‰‰) The Quantitative Comparison of the Higher-order Aberrations between Conventional, Wavefront-guided LASIK, and Phakic Refractive Lens. ´…Œö–ç (Šá): 5th International Meeting on Advanced Cataract and Refractive Surgery (KSCRS) (2004/6/13), ŠØ‘.

712033. [Šw‰ï (‘Û)] (µ‘Ò‚³‚ꂽu‰‰) A New Preloaded Injector System -Three Piece Aspheric Silicone IOL with Square Edge-. ´…Œö–ç (Šá): 5th International Meeting on Advanced Cataract and Refractive Surgery (KSCRS) (2004/6/13), ŠØ‘.

713179. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Quantitative measurement of ocular dominance as clinical application in monovision. ”¼“c’m–ç1, ‹›—¢@”Ž1, Œü–ì˜a—Y1, —äˆä—˜¹Žq2, V“c”C—¢]2, ´…Œö–ç2 (1ˆã‰q. 2Šá): 2004 Annual Meeting of ARVO (The Association for Research in Vision and Ophthalmology) (2004/4/25), Fort Lauderdale, FL.

713180. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Dynamic Measurement of the Implanted Intraocular Lens Position with M-mode Ultrasound Biometry. ‹›—¢@”Ž, ìŽç“c‘ñŽu (ˆã‰q): 2004 Annual Meeting of ARVO (The Association for Research in Vision and Ophthalmology) (2004/4/26), Fort Lauderdale, FL.

713181. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) The Effect of Pupil Size on Binocular Summation. ìŽç“c‘ñŽu, ‹›—¢@”Ž (ˆã‰q): 2004 Annual Meeting of ARVO (The Association for Research in Vision and Ophthalmology)(2004/4/28), Fort Lauderdale, FL.

713182. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Refractive Phakic IOLs. David Allen, David Jory, ´…Œö–ç1 (1Šá): ASCRS (•Ä‘”’“àáE‹üÜŽèp‰ï‹c) (2004/5/1), ƒTƒ“ƒfƒBƒGƒS.

713183. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) International Video Symposium of Challenging Cases. Robert H Osher, Graham D Barrett, Kensaku Miyake, ´…Œö–ç1, Dennis Lam, Jaime Zacharias, Carlos J Aregento, Fernando C Trinidade, Abhay R Vasavada, Howard V Gimbel, Albert Galand, Camille Budo, Lucio Buratto, Phillipe Sourdille, Spyros Georagaras, Thomas F Neuhann, Ronald Yeoh, Virgilio Centurion, Richard B Packard, Jorg yae L Alio (1Šáj: ASCRS (•Ä‘”’“àáE‹üÜŽèp‰ï‹c) (2004/5/1), ƒTƒ“ƒfƒBƒGƒS.

713184. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Treatment of irregular Astigmatism with Wavefront-Guided Ablation. ¬¼^—1, ´…Œö–ç2, ”Ñ“c‰Ã•F2, ‘ŠàV‘å•ã2, —é–؉ëM2 (1ŽR‰¤•a‰@. 2Šá): ASCRS (•Ä‘”’“àáE‹üÜŽèp‰ï‹c)(2004/5/3), ƒTƒ“ƒfƒBƒGƒS.

713185. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Vertical Strabismus Treatment by Decentered IOL Implantation. ¼Œ³‹v°1,2, ´…Œö–ç2, —äˆä—˜¹Žq2, ¼èœA‰h2, “¡àV–Mr2, –î–ì@—²3, ‹›—¢@”Ž3, Œü–ì˜a—Y3 (1•‘ –ìÔ\Žš•a‰@. 2Šá. 3ˆã‰q): ASCRS (•Ä‘”’“àáE‹üÜŽèp‰ï‹c) (2004/5/3), ƒTƒ“ƒfƒBƒGƒS.

713186. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Wavefront-Guided LASIK for Myopia:2-Year Results. ”Ñ“c‰Ã•F1, ´…Œö–ç1, ¬¼^—2, ‘ŠàV‘å•ã1, —é–؉ëM1, ‹›—¢@”Ž3 (1Šá. 2ŽR‰¤•a‰@. 3ˆã‰q): ASCRS (•Ä‘”’“àáE‹üÜŽèp‰ï‹c)(2004/5/3), ƒTƒ“ƒfƒBƒGƒS.

713187. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) NEW FLICKER PERIMETRY VERSUS FREQUENCY DOUBLING TECHNOLOGY. ¯ŽiMs1, ¬£—ÁŽq2, —é–ØG¹2, X“c“N–ç2, ª–{—2, ´…Œö–ç2 (1ˆã‰q. 2Šá): EGS (‰¢B—ΓàáŠw‰ï) (2004/5/30-6/4), ƒtƒ[ƒŒƒ“ƒX (ƒCƒ^ƒŠƒA).

713188. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) The quantitative comparison of the higher-order abrrations between (conventional, wavefront-guided) LASIK, and phakic refractive lens. ´…Œö–ç1, ”Ñ“c‰Ã•F2, ‘ŠàV‘å•ã1, “¡àV–Mr1 (1Šá. 2ŽR‰¤•a‰@j: ESCRS (Europian Society Cataract and Refractive Surgeons) (2004/9/20), ƒpƒŠ.

713189. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Nipradilol enhances neurite regeneration from adult rat retinal exlant. ‚–ì‰ë•F1, _ŽR‚Æ‚æ‚Ý1, ’£@¬–Ò2, X Zhang2, ’†¼@Šî1, ^‰º‹I”ü‘ã1, Îì@‹Ï1, ¯ŽiMs1, ´…Œö–ç1 (1Šá. 2‹g—Ñ‘å): Neuroscience 2004 Society for Neurooscience 34th Annual Meeting (2004/10/25), ƒTƒ“ƒfƒBƒGƒS.

713190. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) A Clinical Quantitative Measurement of Ocular Dominance. ”¼“c’m–ç1, ‹›—¢@”Ž1, Œü–ì˜a—Y1, Vˆä“cF_2, ¯ŽiMs1, ”ä‰Ã—˜¹Žq3, V“c”C—¢]3, ´…Œö–ç3 (1ˆã‰q. 2‘Ûˆã—ÕŸŽƒ‘å. 3Šá): ‡]th International Orthoptic Congress (2004/11/14-17), ƒƒ‹ƒ{ƒ‹ƒ“ (ƒI[ƒXƒgƒ‰ƒŠƒA).

713191. [Šw‰ï (‘Û)] (Šwp“WŽ¦) Tissue imaging by OFDR-OCT using an SSG-DBR laser. D Choi1, ‚s Amano1, H Hiro]Oka1, H Furukawa1, T Miyazawa2, R Yoshimura2, ’†¼@Šî3, ´…Œö–ç3, K Ohbayashi4(1Center for Natural Science, Kitasato University. 2NTT Photonics Laboratories, NTT Corporation. 3Šá. 4ˆã—ÃŒn‘åŠw‰@): Coherence Domain Optical Methods ‚‚Ž‚„ Optical Coherence Tomography in Biomedicine ‡\ (2005/1/23-26), San Jose, California, USA.

713192. [Šw‰ï (‘Û)] (Šwp“WŽ¦) A Relatonship in Higher-Order Aberrations Between Pre-and Pstoperative Wavefrot Gueded LASIK. ‘ŠàV‘å•ã1, ´…Œö–ç1, ”Ñ“c‰Ã•F1, ¬¼^—2, —é–؉ëM1 i1Šá. 2ŽR‰¤•a‰@): 20th Asia Pacfic Academy of Ophthalmology Congress (2005/3/31), Kuala Lumpur, Malaysia.

721012. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) Ž‹—Í‚ÌŒõŠw“I‘¤–Ê. ‹›—¢@”Ž (ˆã‰q): “ú–{Ž‹”\ŒP—ûŽm‹¦‰ï‘æ17‰ñ‘‰ïE‘æ20‰ñu‰‰‰ïE‘æ3‰ñŒ¤C‰ï (2004/6/6), “Œ‹ž.

721013. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) “ïÇ—á‚ÌŠjˆ—@ˆŸ’E‰P‚Ƭ“µE i–¼lƒrƒfƒIj. ´…Œö–ç (Šá): ‘æ28‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2005/1/28-30), ‘åã.

722078. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) ’²ß‹@”\‚ðl—¶‚µ‚½pŽ®. ´…Œö–ç (Šá): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/25), •Ÿ‰ª.

722079. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) Phakic IOL. ´…Œö–ç (Šá): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/26), •Ÿ‰ª.

722080. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) ‹üÜ‹¸³ŽèpŒã‚̗Γàá‚Ìf’f‚ÆŽ¡—Ã. ¯ŽiMs (Šá): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/26), •Ÿ‰ª.

722081. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) Wavefront-guided LASIK. —é–؉ëM (Šá): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/27), •Ÿ‰ª.

722082. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) ”’“àáŽèp‚É‚¨‚¯‚éŠë‹@ŠÇ—. ”ä‰Ã—˜¹Žq (Šá): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/27), •Ÿ‰ª.

722083. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) “ú‹A‚è”’“àáE‹üÜŽèp‚̃ŠƒXƒNƒ}ƒl[ƒWƒƒ“ƒg. Žsìˆê•v (ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, Šá): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï(2004/6/27), •Ÿ‰ª.

722084. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) ”’“àáŽèp‚É‚¨‚¯‚郊ƒXƒNƒ}ƒl[ƒWƒƒ“ƒg. ¬¼^— (ŽR‰¤•a‰@, Šá): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/27), •Ÿ‰ª.

722085. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) AK, LASIK. ´…Œö–ç (Šá): ‘æ47‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï(2004/7/10), ŽD–y.

722086. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) ’´‚Š´“x‚¸×ƒJƒƒ‰‚̃[ƒrƒWƒ‡ƒ“ƒPƒA‚ւ̉ž—p. “›ˆäŒ’‘¾ (Šá): ‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ï(2004/9/11), ‰¡•l.

722087. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) ’´‚Š´“x‚¸×ƒJƒƒ‰‚Ì—Õ°‰ž—p. –ö“c’q•F (Šá): ‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ï (2004/9/11), ‰¡•l.

722088. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) ”’“àápŒã‚Ì Quality of Vision|Šá“àƒŒƒ“ƒY‚É‚æ‚郂ƒmƒrƒWƒ‡ƒ“–@|. V“c”C—¢] (Šá): ‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ï (2004/9/11), ‰¡•l.

722089. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) ’²ßŠá“àƒŒƒ“ƒY‚̬Ñ. Žsìˆê•v (ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, Šá): ‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ï (2004/9/11), ‰¡•l.

722090. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) IOLƒ}ƒXƒ^[‚Æ’²ß. ”ä‰Ã—˜¹Žq (Šá): ‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ï (2004/9/11), ‰¡•l.

722091. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) “µEˆÙí‚Ì”­Œ©‚Æf’f‚Ìd—v«. Îì@‹Ï (Šá): ‘æ42‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (2004/10/16), –¼ŒÃ‰®.

722092. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) FŠoŒŸ¸‰ü³‚ÌŒoˆÜ iê–å•ÊŒ¤‹†‰ïFFŠoˆÙíj. ‰F’ÃŒ©‹`ˆê (‰F’ÃŒ©Šá‰Èˆã‰@, Šá): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11), “Œ‹ž.

722093. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŠO«”’“àá‚ÌŽèp. ”ä‰Ã—˜¹Žq (Šá): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11), “Œ‹ž.

722094. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‹÷Šp‚ÌŒ©•û‚ð•×‹­‚µ‚悤|“ú–{—ΓàáŠw‰ïŒ¤CˆÏˆõ‰ïŠé‰æ|ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX. ¯ŽiMs (ˆã‰q. Šá): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/12), “Œ‹ž.

722095. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘iׂɎŠ‚ç‚È‚¢Žèp‚ð–ÚŽw‚µ‚Ä. ´…Œö–ç (Šá): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï(2004/11/14), “Œ‹ž.

722096. [Šw‰ï (‘S‘)] (µ‘Òu‰‰) ƒJƒXƒ^ƒ€ƒŒ[ƒVƒbƒN3”N‚Ì¬Ñ iƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[@‹üÜ‹¸³Žèp‚ÌŒ»ó‚Æ–¢—ˆ`ƒJƒXƒ^ƒ€ƒŒ[ƒVƒbƒN‚̉”\«`. ´…Œö–ç (Šá): ‘æ28‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2005/1/28), ‘åã.

722097. [Šw‰ï (‘S‘)] (µ‘Òu‰‰) Phakic IOL-Œã–[Œ^—L…»‘ÌŠá“àƒŒƒ“ƒY iICLTMj. ´…Œö–ç (Šá): ‘æ28‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2005/1/29), ‘åã.

722098. [Šw‰ï (‘S‘)] (µ‘Òu‰‰) Šá—Ö‹Ø‚ð•W“I‚Æ‚µ‚½‰ºŠááÙ“à”½ÇŽèp (‰ï’·Šé‰æƒVƒ“ƒ|ƒWƒEƒ€2@ŠááÙ‰º‚, “à”½ÇŽèp‚Ì•W“I‚ÆpŽ®). ¼–{_”V (‘Š–ÍŒ´‹¦“¯•a‰@, Šá): ‘æ28‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2005/1/30), ‘åã.

722099. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) Šá–ò—Šw“IŒ©’n‚©‚猩‚½‹ß–¢—ˆ‚̗ΓàᎡ—Öò|ŠázŠÂ‚ð’†S‚É|. Îì@‹Ï1, ´…Œö–ç1, ‹g•yŒ’Žu2 (1Šá. 2H“c‘åj: ‘æ109‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2005/3/24), ‹ž“s.

723721. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒtƒŠƒbƒJ[Ž‹–ìŒv‚Æ Frequency Doubling Technology‚Ì”äŠr. ¬£—ÁŽq1, ¯ŽiMs2, ª–{—1, X“c“N–ç1, ‚‹´ŒcŽq3, ´…Œö–ç1 (1Šá. 2ˆã‰q. 3‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@): ‘æ108‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2004/4/15), “Œ‹ž.

723722. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Šá“àƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY(ICLTM) ‘}“ü“ØŠá‚É‚¨‚¯‚é…»‘̕ω». “¡àV–Mr1, ¼Œ³‹v°1, ’£@¬–Ò1, ‰i–ìKˆê1, —é–؉ëM1, ´…Œö–ç1, ‰F‰ê–ÎŽO1,2, ˆÀ’B‚ä‚©‚è3, “¡Œ´Š°Žq3 (1Šá. 2‘Ûˆã—ÕŸŽƒ‘å. 3ƒLƒƒƒmƒ“ƒXƒ^[j: ‘æ108‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï(2004/4/16), “Œ‹ž.

723723. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) —¼ŠáŠJ•ú‚¨‚æ‚ѕЊáŽÕ‰º‚ÌŽ‹‹@”\ŒŸ¸‚É‹y‚Ú‚·“µEŒa‚̉e‹¿. ‹›—¢@”Ž1,2, ìŽç“c‘ñŽu3, –‘“c_ŽO4 (1Šá. 2ˆã‰q. 3ˆã—ÃŒn‘åŠw‰@. 4“Þ—ÇŒ§ˆã‘åj: ‘æ108‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2004/4/16), “Œ‹ž.

723724. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰“Ž‹LASIKŒã‚̃Rƒ“ƒgƒ‰ƒXƒgŠ´“x‚ÆŠp–Œ‚ŽŸŽû·‚ÌŠÖŒW. ã“c“N¶1, –¼˜a—ÇW1, –‘“c_ŽO1, Œ´@‰Ãº1, ‹›—¢@”Ž2,3 (1“Þ—ÇŒ§ˆã‘å. 2Šá. 3ˆã‰q): ‘æ108‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2004/4/16), “Œ‹ž.

723725. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “Eo‰Æ“e–Ñ—l“®–¬, ƒ‰ƒbƒg’°ŠÔ–Œ“®–¬‚É‚¨‚¯‚éƒJƒŠƒWƒmƒQƒi[ƒ[‚Ì–ò—Šw“Iì—p. Îì@‹Ï1,2, —Ñ@ò3, ‹g•yŒ’Žu4, ´…Œö–ç1, ^‰º‹I”ü‘ã1 (1Šá. 2‘Ûˆã—ÕŸŽƒ‘å. 3–ò—. 4H“c‘å): ‘æ108‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2004/4/17), “Œ‹ž.

723726. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šp–Œ‹üÜ‹¸³ŽèpŒã‚Ì Orbscan‚É‚æ‚éu‚Ý‚©‚¯‚ÌŒã–Ê“Ëov‚ÌŒŸ“¢. –¼˜a—ÇW1, –‘“c_ŽO1, ã“c“N¶1, ΋´Gr1, Œ´@‰Ãº1, ‹›—¢@”Ž2,3 (1“Þ—ÇŒ§ˆã‘å. 2ˆã‰q. 3Šá): ‘æ108‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï(2004/4/16), “Œ‹ž.

723727. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šá—DˆÊ«‚Ì”ñ—DˆÊŠá defocus‚É‚¨‚¯‚é“K‰ž‹@”\. ”¼“c’m–ç1, Œü–ì˜a—Y1, ìŽç“c‘ñŽu2, ´…Œö–ç3, ‹›—¢@”Ž1 (1ˆã‰q. 2ˆã—ÃŒn‘åŠw‰@. 3Šá): ‘æ108‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2004/4/16), “Œ‹ž.

723728. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚ŽŸ”g–ÊŽû·‚Ì”N—î•Ï‰». ˆÉ“¡”ü¹ŠG1, ´…Œö–ç2, ‹›—¢@”Ž1, –î–ì@—²2, ŠÖŒû¹’mŽq2, “c‘ºçt2, “¡àV–Mr2, ‘ŠàV‘å•ã2 (1ˆã‰q. 2Šá): ‘æ108‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2004/4/16), “Œ‹ž.

723729. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠáŽ²’·‘ª’èŒë·‚ɉe‹¿‚³‚ê‚È‚¢, IOLŒðŠ·‚Ì‚½‚ß‚Ì“x”Œˆ’莮. ¼@@’q1, –¼˜a—ÇW1, ’Ò@‰p”V2, Œ´@‰Ãº1, ‹›—¢@”Ž3,4 (1“Þ—ÇŒ§ˆã‘å. 2’¬—§YŒ´‘‡•a‰@. 3Šá. 4ˆã‰q): ‘æ108‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2004/4/17), “Œ‹ž.

723730. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’´‚Š´“x‚¸×ƒJƒƒ‰‚É‚æ‚é–Ô–Œ_ŒoüˆÛ‘w‚ÌŠÏŽ@. ¯ŽiMs1, ‰i–ìKˆê2, X“c“N–ç2, Žs糋`Í2, ´…Œö–ç2, ’J‰ªŒ’‹g3 (1ˆã‰q. 2Šá. 3NHK•ú‘—‹ZpŒ¤‹†Šj: ‘æ108‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï(2004/4/17), “Œ‹ž.

723731. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’´‚Š´“x‚¸×ƒJƒƒ‰‚̃[ƒrƒWƒ‡ƒ“ƒPƒA‚ւ̉ž—p. “›ˆäŒ’‘¾1, ‰i–ìKˆê1, –ö“c’q•F1, Žs糋`Í1, ´…Œö–ç1, ’J‰ªŒ’‹g2 (1Šá. 2NHK•ú‘—‹ZpŒ¤‹†Šj: ‘æ108‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2004/4/17), “Œ‹ž.

723732. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Nipradilol‚Ì–Ô–Œ_Œoß×–E‚ɑ΂·‚é_ŒoĶ‘£iŒø‰Ê‚ÌŒŸ“¢. _ŽR‚Æ‚æ‚Ý1, ‚–ì‰ë•F1, ’£@¬–Ò1, ’†¼@Šî1, ^‰º‹I”ü‘ã1, Îì@‹Ï2, ¯ŽiMs3, ´…Œö–ç1 (1Šá. 2‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@. 3ˆã‰q): ‘æ108‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2004/4/17), “Œ‹ž.

723733. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) SRK/TŽ®‚ÌÅ“K‰»‚`’蔌vŽZ•û–@‚ÌŒŸ“¢. ’Ò@‰p”V1, ‰€“c—ljp1, –¼˜a—ÇW2, Œ´@‰Ãº2, ‹›—¢@”Ž3,4 (1’¬—§YŒ´‘‡•a‰@. 2“Þ—ÇŒ§ˆã‘å. 3Šá. 4ˆã‰q): ‘æ108‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2004/4/17), “Œ‹ž.

723734. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –k—¢‘åŠw•a‰@‚É‚¨‚¯‚é•ÐŠá‹­“x‹ßŽ‹«ŽãŽ‹‚ÌŒŸ“¢. ¼—ÑCŽq1, ‚èŒb—Žq2, ¼èœA‰h1, V“c”C—¢]2, –x•”@‰~2, Œü–ì˜a—Y3, ´…Œö–ç2 (1“Œ•a‰@Šá‰È. 2Šá. 3ˆã‰q): ‘æ60‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ï(2004/6/18), ‰«“ê.

723735. [Šw‰ï (‘S‘)] (Šwp“WŽ¦) Ž¡—Âɋꗶ‚µ‚Ä‚¢‚éŽüŠú«Œð‘ã«ŠáU‚Ì1—á. ’†“c‚©‚«1, ŽR“c“Ol2, Žl”V‹{—C”n2, “¡“cƒŽq2, Vˆä“cF—T2,3, ‚‹´˜aW1 (1‘Ûˆã—ÕŸŽƒ•a‰@. 2‘Ûˆã—ÕŸŽƒ‘å. 3Šá): ‘æ60‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ï (2004/6/18), ‰«“ê.

723736. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Wavefront-guided LASIK‚É‚¨‚¯‚é—Ž‹Ž¡—ÃŒø‰Ê. ”Ñ“c‰Ã•F1,2, ´…Œö–ç1, ¬¼^—1,2, ‘ŠàV‘å•ã1, —é–؉ëM1, ‹›—¢@”Ž3 (1Šá. 2ŽR‰¤•a‰@. 3ˆã‰q): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/25), •Ÿ‰ª.

723737. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Å‹­“x‹ßŽ‹‚ɑ΂·‚é wavefront-guided LASIK‚¨‚æ‚Ñ—L…»‘ÌŠá“àƒŒƒ“ƒY‚Ì”äŠr. “¡àV–Mr, ‘ŠàV‘å•ã, —é–؉ëM, ´…Œö–ç (Šá): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/25), •Ÿ‰ª.

723738. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’†‹žŽ®Rescue Lens ‚ð—p‚¢‚½…»‘ÌŠj, ”玿—Ž‰ºŽž‚̈—‚Ì•û–@. ‰Á‰ê’BŽu1, Žsìˆê•v1,2, “n•ÓŽOŒP1, ¬“‡—²Ži1, “à“¡®‹v3, Žsì—æŽq3, Γc»Žq4, ŒË“c—Tl4, –ö£O”ü4, ŠC˜V–¼ƒ5, ‘å‹´³Žu5, ‹gŒ´‹Óãà5, •ì’qŽq1 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@. 2Šá. 3’†‹žŠá‰È. 4’†‹žƒƒfƒBƒJƒ‹. 5ƒTƒ“ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYj: ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/26), •Ÿ‰ª.

723739. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒXƒŠƒbƒgÆ–¾‘•’uVISULUX‚ð—p‚¢‚½‘O”XØŠJ. “n•ÓŽOŒP1, Žsìˆê•v1,2, ‰Á‰ê’BŽu1 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@. 2Šá): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/26), •Ÿ‰ª.

723740. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’²ß«Šá“àƒŒƒ“ƒY‘}“üŠá‚Ì—Õ°Œo‰ß. ”ä‰Ã—˜¹Žq1, ´…Œö–ç1, “¡àV–Mr1, V“c”C—¢]1, ‹›—¢@”Ž2 (1Šá. 2ˆã‰q): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/26), •Ÿ‰ª.

723741. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”ñ‹…–ÊŠá“àƒŒƒ“ƒY‚ÌpŒã‘Šú¬Ñ. ’†‘º‰pŽ÷1, Žsìˆê•v1,2, ‰Á“¡Žu•ä1, “à“¡®‹v3, ŽðˆäKO3 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@. 2Šá. 3’†‹žŠá‰È): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/26), •Ÿ‰ª.

723742. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”ñ—DˆÊŠádefocus‚É‚¨‚¯‚ébinocular summation. ”¼“c’m–ç1, ´…Œö–ç1, Œü–ì˜a—Y2, ìŽç“c‘ñŽu2, ‹›—¢@”Ž2 (1Šá. 2ˆã‰q): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/26), •Ÿ‰ª.

723743. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) —¼ŠáŠJ•ú‚¨‚æ‚ѕЊáŽÕ•Á‰º‚ÌŽ‹‹@”\‚É‹y‚Ú‚·“µEŒa‚ÆŽû·‚̉e‹¿. ‹›—¢@”Ž1, ìŽç“c‘ñŽu1, –‘“c_ŽO2,3 (1ˆã‰q. 2Šá. 3“Þ—ÇŒ§ˆã‘å): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/26), •Ÿ‰ª.

723744. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒAƒgƒs[”’“àápŒã‚Ì’²ßŽhŒƒ‚ɑ΂·‚铵E”½‰ž. ŒãŠÖ—˜–¾1, “¡àV–Mr1, ”ä‰Ã—˜¹Žq1, ´…Œö–ç1, Îì@‹Ï2 (1Šá. 2‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/26), •Ÿ‰ª.

723745. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) LASEKpŒã‚ÌŽc‘¶Šp–ŒŒú‚ÉŠÖ‚·‚錟“¢. ’†‘º—Fº1, “´ˆä—¢ŠG1, ¬“‡—²Ži2, Œ´@CÆ2, Žsìˆê•v2,3 (1REC. 2ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@. 3Šá): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/26), •Ÿ‰ª.

723746. [Šw‰ï (‘S‘)] (Šwp“WŽ¦) —LŒÀ—v‘f–@‚ð—p‚¢‚½PRKŒã‚ÌŠp–Œ“Ëo‚̉ðÍ. –¼˜a—ÇW1, ’|’J@‘¾1, ã“c“N¶1, Œ´@‰Ãº1, ¼–{r˜Y2, Šâ•”W“¿2, ‹›—¢@”Ž3,4 (1“Þ—ÇŒ§ˆã‘å. 2‹ß‹E‘å. 3ˆã‰q. 4Šá): ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/26), •Ÿ‰ª.

723747. [Šw‰ï (‘S‘)] (Šwp“WŽ¦) ŒÊóƒuƒŒƒCƒh‚É‚æ‚éŠp–Œ¬ØŠJ—pƒ}[ƒJ[‚ÌŽŽì. ‚¼@‘¾1, ¯–ì²G2, Žsìˆê•v2,3, “f‡Cˆê4 (1“ñ–{¼Šá‰È. 2ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@. 3Šá. 4(Š”) ƒŠƒBƒcƒƒfƒBƒJƒ‹j: ‘æ19‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2004/6/26), •Ÿ‰ª.

723748. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) •½¬15”N“xŠwZŒ»ê‚ł̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—pó‹µ’²¸. ‰F’ÃŒ©‹`ˆê1,2, ‹g“c@”Ž2, ŽO‘ì2, —é–Ø@–«2, ²–쎵˜Y2 (1Šá. 2“ú–{Šá‰Èˆã‰ïj: ‘æ47‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï (2004/7/10), ŽD–y.

723749. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –k—¢‘åŠw‚É‚¨‚¯‚é‰~Šp–Œ—pƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚Ì‘•—pó‹µ. ‘å’Î’qG1, ‰F’ÃŒ©‹`ˆê1,2, ŒF”WŒä“°—²1, ‘ŠàV‘å•ã1, —é–؉ëM1, ´…Œö–ç1 (1Šá. 2‰F’ÃŒ©Šá‰Èˆã‰@): ‘æ47‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï (2004/7/10), ŽD–y.

723750. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œc‰ž‹`m‘åŠw•a‰@‚É‚¨‚¯‚éƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‘•—pŽÒ‚ւ̃Aƒ“ƒP[ƒg’²¸. “cç²²’qŽq1, ŒF”WŒä“°—²2, ‰F’ÃŒ©‹`ˆê2,3, ^“‡s•F1 (1Œc‰ž‘å. 2Šá. 3‰F’ÃŒ©Šá‰Èˆã‰@j: ‘æ47‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï (2004/7/10), ŽD–y.

723751. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ICL‘}“üp‘OŒã‚̃Rƒ“ƒgƒ‰ƒXƒgŠ´“x. “c‘ºçt1, –x•”@‰~1, ‚èŒb—Žq1, ‘ŠàV‘å•ã1, “¡àV–Mr1, —é–؉ëM1, ´…Œö–ç1, ‹›—¢@”Ž2 (1Šá. 2ˆã‰qj: ‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ï (2004/9/11), ‰¡•l.

723752. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒ‚ƒmƒrƒWƒ‡ƒ“‚Ì—¼Šá‰ÁŽZ‚É‚¨‚¯‚éŠá—DˆÊ«‚̉e‹¿. ”¼“c’m–ç1, ‹›—¢@”Ž1, ”ä‰Ã—˜¹Žq2, V“c”C—¢]2, ´…Œö–ç2 (1ˆã‰q. 2Šá): ‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ï (2004/9/11), ‰¡•l.

723753. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’²ß‚É”º‚¤Šp–Œ‚ÌŒ`ó•Ï‰»‚ɂ‚¢‚Ä. –‘“c_ŽO1, ã“c“N¶1, –¼˜a—ÇW1, Œ´@‰Ãº1, ‹›—¢@”Ž2 (1“Þ—ÇŒ§ˆã‘å. 2ˆã‰q, Šá): ‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ï (2004/9/11), ‰¡•l.

723754. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) OFDR-OCT‚É‚æ‚鶑̌°”÷‹¾. ’†¼@Šî1, “V–ì‘쎡2, œA‰ªG–¾2, ŒÃì—T”V2, ›Á@“ŒŠw2, ‘å—ÑN“ñ2, ¯ŽiMs1, ´…Œö–ç1 (1Šá. 2ˆê”Ê‹³ˆç): ‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ï (2004/9/11), ‰¡•l.

723755. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È‚É‚¨‚¯‚é“dŽqƒJƒ‹ƒe‰^—p‚ÌŒ»ó. ”–ØLÆ1,2, “©ŽRG•v1,3, ´…Œö–ç1 (1Šá. 2Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[. 3‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@): ‘æ2‰ñ“dŽqƒJƒ‹ƒeƒ~[ƒeƒBƒ“ƒO i‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ïj (2004/9/11), ‰¡•l.

723756. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Ž©Šo‹üÜŒŸ¸‘æ“ñ–@‚ðŽÀŒ»‚·‚邽‚ß‚ÌV‚µ‚¢Ž‹—Í•W. ’†ìá©•v1, –¼˜a—ÇW1, “nç³ç”Ž1, ŠÝ–{¸ˆê1, ’†”öŽåˆê1, ‹›—¢@”Ž2, —é–Ø••q3 (1“Þ—ÇŒ§ˆã‘å. 2ˆã‰q, Šá. 3—é–ØŠá‰È): ‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ï (2004/9/12), ‰¡•l.

723757. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ³Ž‹Šá‚Ƌߎ‹Šá‚É‚¨‚¯‚钲ߔ÷“®‰ðÍ. ìŽç“c‘ñŽu, ‹›—¢@”Ž (ˆã—ÃŒn‘åŠw‰@, Šá): ‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ï (2004/9/12), ‰¡•l.

723758. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “µE‚̋ߌ©”½‰ž‘ª’è‘•’u, ƒgƒ‰ƒCƒCƒŠƒXC9000‚É‚æ‚éŠá¸”æ˜JŠá‚Ì•]‰¿. ’†ìá©•v1, –¼˜a—ÇW1, “nç³ç”Ž1, ŠÝ–{¸ˆê1, ‹›—¢@”Ž2, —é–Ø••q3 (1“Þ—ÇŒ§ˆã‘å. 2ˆã‰q, Šá. 3—é–ØŠá‰È): ‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ï (2004/9/12), ‰¡•l.

723759. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’²ß‚ÆŽû·. ‘å–ìWŽi (_“Þ쎕‘剡•lƒNƒŠƒjƒbƒN, Šá): ‘æ8‰ñISRS JAPAN Meeting i‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ïj (2004/9/12), ‰¡•l.

723760. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) —L…»‘ÌŠá“àƒŒƒ“ƒYiICLTMj ‚Ì—Õ°¬Ñ‚Æ”g–ÊŽû·. “¡àV–Mr (Šá): ‘æ8‰ñISRS JAPAN Meeting i‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ïj (2004/9/12), ‰¡•l.

723761. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Wavefront-guided refractive surgery. ¬¼^— (ŽR‰¤•a‰@, Šá): ‘æ8‰ñ ISRS JAPAN Meeting i‘æ40‰ñ“ú–{ŠáŒõŠwŠw‰ïE‘æ19‰ñŠá‰ÈMEŠw‰ï‡“¯Šw‰ï‘‰ïj (2004/9/12), ‰¡•l.

723762. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) üˆÛ’Œ‘ÑØœŒã‚Ì–Ô–Œ_ŒoüˆÛ‘wŒú‚Ì•]‰¿. X“c“N–ç1, ¯ŽiMs2, —`…@Šw1, ™–{˜a‹v1, ŽRŒû—t“ÞŽq1, ”ä—¯ŠÔ”ü•ä1, ‚‹´ŒcŽq1, ´…Œö–ç1 (1Šá. 2ˆã‰q): ‘æ15‰ñ“ú–{—ΓàáŠw‰ï (2004/9/24), VŠƒ.

723763. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¬‘̃‰ƒbƒg–Ô–Œ‚ɑ΂·‚éNipradilol‚Ì_Œo“Ë‹NĶ‘£iŒø‰Ê. _ŽR‚Æ‚æ‚Ý1, ‚–ì‰ë•F, ’£@¬–Ò, ’†¼@Šî, ^‰º‹I”ü‘ã, Îì@‹Ï, ¯ŽiMs, ´…Œö–ç (Šá): ‘æ15‰ñ“ú–{—ΓàáŠw‰ï (2004/9/24-25), VŠƒ.

723764. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 2Ží—ނ̃vƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“ŠÖ˜A–ò‚ÌŽ‹–ìˆÛŽŒø‰Ê‚Ì”äŠr. ŽRì–í¶1,2, ¯ŽiMs3, ª–{—2, X“c“N–ç2, —é–ØG¹2, ´…Œö–ç2 (1“ŒŽÅ—ÑŠÔ•a‰@. 2Šá. 3ˆã‰q): ‘æ15‰ñ“ú–{—ΓàáŠw‰ï (2004/9/24-25), VŠƒ.

723765. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒAƒƒLƒTƒ““Š—^‚É‚æ‚éŽÀŒ±“I‚ŒŒ“œ‰Æ“e‚Ì“Eo–Ñ—l“®–¬‚Ì–ò—Šw“I, ‘gDŠw“I«Ž¿. ŒãŠÖ—˜–¾1,2, Îì@‹Ï1, ^‰º‹I”ü‘ã1, ´…Œö–ç11, ‹g•yŒ’Žu3 (1Šá. 2ŠC˜V–¼‘‡•a‰@. 3H“c‘å): ‘æ24‰ñ“ú–{Šá–ò—Šw‰ï (2004/10/9), ”ª‰¤Žq.

723766. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) 3D‰f‘œƒgƒŒ[ƒjƒ“ƒOƒ\ƒtƒgŽ‹’®‚É‚æ‚鎋Šo‹@”\‚ւ̉e‹¿‚ÆŒø‰Ê@’²ß‚ÆŠáˆÊ‚ÌŒŸ“¢. 匴Žµd1, Œ´@’¼l1,2, ‘å–ìWŽi1,2, Ž}ì@G3, ¼Œ´³’j4 (1_“Þ쎕‘剡•lƒNƒŠƒjƒbƒN. 2Šá. 3Ž}ìŠá‰ÈƒNƒŠƒjƒbƒN. 4“Œ‹ž—ˆã‘å‘æ2•a‰@): ‘æ42‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2004/10/15), –¼ŒÃ‰®.

723767. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Žá”NŒQE˜VŽ‹ŒQ‚̋ߌ©Žž“µE”½‰žEŠá‹…‰^“®‚ɑ΂·‚é•ÐŠáŽÕ•Â‚̉e‹¿. óì@Œ«1, Îì@‹Ï2, ‹›—¢@”Ž3, ´…Œö–ç2 (1‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@. 2Šá. 3ˆã‰q): ‘æ42‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2004/10/15), –¼ŒÃ‰®.

723768. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Behcet•a‚É‚æ‚鎋_ŒoÇ‚ª‹^‚í‚ꂽ1Ç—á. ŒÜ\—’ÍŽj, —é–ØG¹, Žs糋`Í, ´…Œö–ç (Šá): ‘æ42‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2004/10/15), –¼ŒÃ‰®.

723769. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –³‹Û«‘–Œ‰ŠŒã‚ÉoŒ»‚µ‚½—¼‘¤Ž‹_Œo‰Š‚Ì1—á. —`…@Šw1, Žs糋`Í1, Œü–ì˜a—Y2 (1Šá. 2ˆã‰q): ‘æ42‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2004/10/15), –¼ŒÃ‰®.

723770. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Ž‹°oŒŒ‚É”º‚¤Šá‹…‰^“®áŠQ‚Ì’·Šú—\Œã‚ÌŒŸ“¢. Œ´@’¼l1, ”¨@—²Žu3, Œü–ì˜a—Y4, ‘å–ìWŽi1, ´…Œö–ç2 (1_“Þ쎕‘剡•lƒNƒŠƒjƒbƒN. 2Šá. 3‰¡•lŽs—§”]ŒŒŠÇˆã—ÃZƒ“ƒ^[. 4ˆã‰q): ‘æ42‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2004/10/16), –¼ŒÃ‰®.

723771. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒjƒvƒ‰ƒWƒ[ƒ‹‚É‚æ‚é–Ô–Œ‚Ì_ŒoĶ‘£i. ‚–ì‰ë•F (Šá): ‘æ42‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï@ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[‚Q@ƒnƒCƒpƒW[ƒ‹ƒR[ƒ“_Šá‰t5Žü”N‹L”OƒZƒ~ƒi[ (2004/10/16), –¼ŒÃ‰®.

723772. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Žá”NŽÒ‚É‚¨‚¯‚é‚ŽŸŽû·‚ÌŒŸ“¢. ŠÖŒû¹’mŽq1, ˆÉ“¡”ü¹ŠG2, –î–ì@—²3, ‘ŠàV‘å•ã4, —é–؉ëM4, ‹›—¢@”Ž2, ´…Œö–ç4 (1‘Š–ÍŒ´‹¦“¯•a‰@. 2ˆã‰q. 3‘Ûˆã—ÕŸŽƒ‘å. 4Šá): ‘æ45‰ñ“ú–{Ž‹”\‹¸³Šw‰ï(2004/10/23), ·‰ª.

723773. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹ßŒ©ì‹Æ‚É”º‚¤ŠáŽ²’·, ‘O–[[“x‚̕ω». ŽRŒû‰Ø“ÞŽq1, –x•”@‰~1, “›ˆäŒ’‘¾1, ‚‹´–í¶1, –]ŒŽ_Žu1, ´…Œö–ç1, ‹›—¢@”Ž2 (1Šá. 2ˆã‰q): ‘æ45‰ñ“ú–{Ž‹”\‹¸³Šw‰ï (2004/10/23), ·‰ª.

723774. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 3D‰f‘œŽ‹’®‚ªŽ‹Šo‹@”\‚É—^‚¦‚é‰e‹¿‚ɂ‚¢‚Ä. 匴Žµd1, Œ´@’¼l1,2, ‘å–ìWŽi1,2, ¼ˆäFŽq3, Ž}ì@G4, ¼Œ´³’j5 i1_“Þ쎕‘剡•lƒNƒŠƒjƒbƒN. 2Šá. 3–kŒ¤•a‰@. 4Ž}ìŠá‰ÈƒNƒŠƒjƒbƒN. 5“Œ‹ž—ˆã‘å‘æ2•a‰@j: ‘æ45‰ñ“ú–{Ž‹”\‹¸³Šw‰ï (2004/10/23-24), ·‰ª.

723775. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”]Ž¾Š³‚É‚¨‚¯‚鎋—Í, Ž‹–ìáŠQ‚ÌŽ©Šo. –x•”@‰~1, Œü–ì˜a—Y2, ¼èœA‰h1, “ï”g‹M‘ã1, ¼—ÑCŽq1, “c‘ºçt1, ´…Œö–ç1 (1Šá. 2ˆã‰q): ‘æ45‰ñ“ú–{Ž‹”\‹¸³Šw‰ï (2004/10/23-24), ·‰ª.

723776. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚’¼‰^“®áŠQ‚𔺂Á‚½“ÁˆÙ‚ÈDuaneÇŒóŒQ‚ÌÇ—á. Žl”V‹{—C”n1,2, ŽR“c“Ol1,2, “ú‚ÊŽq2, Vˆä“cF—T1,2,3, ‚‹´˜aW2 i1‘Ûˆã—ÕŸŽƒ‘å. 2‘Ûˆã—ÕŸŽƒ•a‰@. 3Šá): ‘æ45‰ñ“ú–{Ž‹”\‹¸³Šw‰ï(2004/10/23-24), ·‰ª.

723777. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) phoria adaptation‚Ìg˜VŽ‹ŒQh‚Æg”ñ˜VŽ‹ŒQh‚Å‚ÌŒŸ“¢. “n糋v”üŽq1, ¯ŽiMs2, ´…Œö–ç3, ¬Žèì‘×]4, Œ´@’¼l3,4 (1ˆã—ÃŒn‘åŠw‰@. 2ˆã‰q. 3Šá. 4_“Þ쎕‘剡•lƒNƒŠƒjƒbƒN): ‘æ45‰ñ“ú–{Ž‹”\‹¸³Šw‰ï (2004/10/23-24), ·‰ª.

723778. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰Á—î‚É”º‚¤‹ßŒ©”½‰ž‚̕ω»‚ÌŒŸ“¢|“µE‚Ì–ðŠ„‚É‚Â‚¢‚Ä|. ¬Žèì‘׎}1, Œ´@’¼l1,2, ‘å–ìWŽi1,2, Œü–ì˜a—Y3, ´…Œö–ç2 (1_“Þ쎕‘剡•lƒNƒŠƒjƒbƒN. 2Šá. 3ˆã‰q): ‘æ57‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï (2004/10/28), ’·è.

723779. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Žá”NŒQE˜VŽ‹ŒQ‚̃XƒeƒbƒvŽhŒƒ‚É‚æ‚é‹ßŒ©Žž“µE”½‰žEŠá‹…‰^“®‚ɑ΂·‚é•ÐŠáŽÕ•Â‚̉e‹¿. óì@Œ«1, Îì@‹Ï2, ‹›—¢@”Ž3, ´…Œö–ç2 (1‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@. 2Šá. 3ˆã‰q): ‘æ57‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï (2004/10/28), ’·è.

723780. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’´‰¹”gA-mode‚ð‰ž—p‚µ‚½ˆÚAŠá“àƒŒƒ“ƒY‚Ì“®“I‹““®‘ª’è. ‹›—¢@”Ž, ìŽç“c‘ñŽu (ˆã‰q): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/ 11/ 11), “Œ‹ž.

723781. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –k—¢‘åŠw•a‰@‚É‚¨‚¯‚鬎™”’“àáŽèp‚ÌŒŸ“¢. ”’’J@“O1, ”ä‰Ã—˜¹Žq1, ŒãŠÖ—˜–¾1, •D“c•üŽq1, Îì@‹Ï1,2, ´…Œö–ç1 (1Šá. 2‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï”­ (2004/11/11), “Œ‹ž.

723782. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) —Γàá«Ž‹–ìˆÙí‚É”º‚¤Šá—DˆÊ«‚Ì“K‰ž•Ï‰». ”¼“c’m–ç1, ¯ŽiMs1, ŽRì–í¶2, ‰Í‡—T”ü2, V“c”C—¢]2, ‹›—¢@”Ž1, ´…Œö–ç2 (1ˆã‰q. 2Šá): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11), “Œ‹ž.

723783. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”’“àáŽèpŽž‚̃gƒŠƒAƒ€ƒVƒmƒƒ“‘O–[“à’“ü‚ÌŒŸ“¢. ‹ß“¡—T”ü1,2, ”ä‰Ã—˜¹Žq1, ‹v•Û—S•ã1, “¡àV–Mr1, ´…Œö–ç1 (1Šá. 2ŽR‰¤•a‰@): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11), “Œ‹ž.

723784. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –Ô–Œ’†SÖ¬•ªŽ}•ÂÇÇ‚É‚æ‚鉩”Á•‚Žî‚ɑ΂·‚éƒgƒŠƒAƒ€ƒVƒmƒƒ“ÉŽq‘Ì’“ü‚ÌŒø‰Ê. ¬ì”üK, ‚–ì‰ë•F, ’†¼@Šî, –ö“c’q•F, ´…Œö–ç (Šá): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11), “Œ‹ž.

723785. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰©”Á•”–Ô–Œ”—£pŒã‚ÌŠáâ|ƒJƒ‰[ƒhƒvƒ‰ŒŒ—¬ŒŸ¸. ˆÉ“¡—TŽq1,2, ‹g“c^l3, ’†ì‰ÄŽi2, ŠÖ@@•Û2, …’J³ˆê2, ¬àV’‰•F2 (1Šá. 2¬‘òŠá‰È“à‰È•a‰@. 3º˜a‘å): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11), “Œ‹ž.

723786. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@ʼn‚Ì—zŽqüŽ¡—ÂƂȂÁ‚½, —Ü”X•”G•½ã”çŠà‚Ì1—á. ”–ØLÆ1,2, ‹S’Ë“N˜Y2, ŠC˜VŒ´@[2, ‰L‹vX@“O2, ‘ºŽRds2, “¡@_2, ×콓ñ3, ™‰Y@‹B4, ´…Œö–ç1 (1Šá. 2Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[. 3À’ÃŽs—§•a‰@. 4•xŽmŽs™‰YŠá‰È): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11), “Œ‹ž.

723787. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Phakic IOL‘}“üŠá‚¨‚æ‚ÑLASIK‚Ì‚ŽŸ”g–ÊŽû·‚Ì”äŠr. ‘ŠàV‘å•ã, ”Ñ“c‰Ã•F, —é–؉ëM, ´…Œö–ç (Šá): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/12), “Œ‹ž.

723788. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –k—¢‘åŠw•a‰@‚É‚¨‚¯‚é–¢nŽ™–Ô–ŒÇŠëŒ¯ˆöŽq‚ÌŒŸ“¢. ŒÜ\—’ÍŽj, ’†¼@Šî, •D“c•üŽq, ‚–ì‰ë•F, ´…Œö–ç (Šá): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/12), “Œ‹ž.

723789. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’PŠáŽ‹‚Æ—¼ŠáŽ‹‰º‚É‚¨‚¯‚铵EŒa‚Æ‚ŽŸŽû·. ìŽç“c‘ñŽu, ”¼“c’m–ç, ‹›—¢@”Ž (ˆã‰q): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11-13), “Œ‹ž.

723790. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’²ß•t‰Á‚É”º‚¤Šá‹…‚ŽŸŽû·‚̕ω». –‘“c_ŽO1, Œ´@‰Ãº1, ‹›—¢@”Ž2 (1“Þ—ÇŒ§ˆã‘å. 2ˆã‰q): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11-13), “Œ‹ž.

723791. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚ŽŸ”g–ÊŽû·‚ð—p‚¢‚½ƒn[ƒhƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‘•—p‚Ì—Õ°“I•]‰¿. ‚èŒb—Žq1, ŒF”WŒä“°—²1, ‰F’ÃŒ©‹`ˆê1, ”Ñ“c‰Ã•F1, ‘ŠàV‘å•ã1, —é–؉ëM1, ‹›—¢@”Ž2, ´…Œö–ç1 (1Šá. 2ˆã‰q): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11-13), “Œ‹ž.

723792. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”ñ‹…–Ê‚¨‚æ‚Ñ‹…–ÊIOL‘}“üŠá‚Ì‚ŽŸ”g–ÊŽû·‚Ì”äŠr. ”ä‰Ã—˜¹Žq, ´…Œö–ç, ”Ñ“c‰Ã•F, ŒÜ\—’ÍŽj (Šá): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11-13), “Œ‹ž.

723793. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 25GŒoŒ‹–ŒÉŽq‘ÌŽèpƒVƒXƒeƒ€‚ÌŽg—pŒoŒ±. –ö“c’q•F, ‚–ì‰ë•F, ¬ì”üK, ’†¼@Šî, ´…Œö–ç (Šá): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11-13), “Œ‹ž.

723794. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “µEŽ‹–ìŒv‚É‚æ‚铯–¼”¼–ÓŠ³ŽÒ‚ÌŽ‹–쑪’è‚ÌŽŽ‚Ý. ‘å’J’©Žq1, ‹g•yŒ’Žu1, Îì@‹Ï2 (1H“c‘å. 2Šá): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11-13), “Œ‹ž.

723795. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ³íŠáˆ³—Γàá‚É‚¨‚¯‚郉ƒ^ƒmƒvƒƒXƒg’PÜ•ÏX1”NŒã‚ÌŒŸ“¢. •û”ŽŽq1,2, ¯ŽiMs3, •y‰ª•q–ç1,2, —L–{‚ ‚±1,4, —é–ØG¹1, ‚£³˜Y5, ’†àVLŽq6, ´…Œö–ç1 (1Šá. 2•‘ –ìÔ\Žš•a‰@. 3ˆã‰q. 4_“Þ쎕‘剡•lƒNƒŠƒjƒbƒN. 5é‹Êˆã‘呇ˆã—ÃZƒ“ƒ^[. 6“¯ˆ¤‹L”O•a‰@): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11-13), “Œ‹ž.

723796. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) VŒ^ƒfƒBƒXƒvƒŒƒCŽ‹’®‚É‚æ‚鎋‹@”\EŽ©—¥_Œo‹@”\‚ð’†S‚Æ‚µ‚½ƒqƒg‚ւ̉e‹¿•]‰¿. ¼ˆäFŽq1, ‹{“cŠ²•v1, ¬ŽR“c_2, Îì@“N1 i1–kŒ¤•a‰@—Õ°ŠÂ‹«ˆãŠwƒZƒ“ƒ^[. 2ƒ\ƒj[j: ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11-13), “Œ‹ž.

723797. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹Â‰çˆÊ‚É‚¨‚¯‚éŠp–ŒŒ`ó‚̕ω». ìŽç“c‘ñŽu, ”¼“c’m–ç, ‹›—¢@”Ž (ˆã‰qj: ‘æ28‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2005/1/28), ‘åã.

723798. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Šp–Œ‹üÜ‹¸³Žèp‚ªŠá“àƒŒƒ“ƒY‚Ì—LŒøŒõŠwŒa‚É‹y‚Ú‚·‰e‹¿. ‹›—¢@”Ž1, ìŽç“c‘ñŽu1, –‘“c_ŽO2, ´…Œö–ç3 (1ˆã‰q. 2“Þ—ÇŒ§ˆã‘å. 3Šá): ‘æ109‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2005/3/24), ‹ž“s.

723799. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’²ß•‰‰×‚É”º‚¤‚ŽŸ”g–ÊŽû·‚Ì’è—ʉðÍ. ”Ñ“c‰Ã•F1, ´…Œö–ç1, —é–؉ëM1, ‘ŠàV‘å•ã1, ˆÉ“¡”ü¹ŠG2, “ï”g‹M‘ã1, ‹›—¢@”Ž2 (1Šá. 2ˆã‰qj: ‘æ109‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2005/3/24), ‹ž“s.

723800. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) OFDR-OCT‚É‚æ‚é‹÷Šp‚ÌŠÏŽ@. ’†¼@Šî1, “V–ì‘쎡2, œA‰ªG–¾2, ŒÃì—T”V2, ›Á@“ŒŠw2, ‘å—ÑN“ñ2, —é–ØG¹1, ¯ŽiMs3, ´…Œö–ç1 (1Šá. 2ˆê”Ê‹³ˆç. 3ˆã‰qj: ‘æ109‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2005/3/24), ‹ž“s.

723801. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒ{ƒPŽhŒƒ•‰‰×Žž‚Ì’²ß”½‰ž‚Æ“µE”½‰ž‚ÌŒo”N“I•Ï‰»‚ÌŒŸ“¢. Œ´@’¼l1,2, ¬Žèì‘׎}2, Œü–ì˜a—Y2, ‰Á“¡”üŽ}2, ‘å–ìWŽi2, ´…Œö–ç1 (1Šá. 2_“Þ쎕‘å): ‘æ109‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2005/3/24), ‹ž“s.

723802. [Šw‰ï (‘S‘)] (ˆê”Êu) “_ó–¬—–Œ“à‘wÇ‚Ì3—á‚Ì’·ŠúŒo‰ß. –öì‰p—¢Žq1, –öì—²Žu1, Žá‘q‰ël1, ˆä㎡˜Y1, ª–{—2 (1ˆäãŠá‰È•a‰@. 2Šá): ‘æ109‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2005/3/24), ‹ž“s.

723803. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŽÀŒ±“I‚ŒŒ“œ‰Æ“e“Eo–Ñ—l“®–¬‚Ì–ò—Šw“I, ‘gDŠw“I«Ž¿. ŒãŠÖ—˜–¾1, Îì@‹Ï1, ^‰º‹I”ü‘ã1, ´…Œö–ç1, ‹g•yŒ’Žu2 i1Šá. 2H“c‘åj: ‘æ109‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2005/3/25), ‹ž“s.

723804. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”’“àáŽèp”j”X—á‚ɑ΂·‚éƒgƒŠƒAƒ€ƒVƒmƒƒ“‚Ì—L—p«. “¡àV–Mr, ¬ì”üK, ‹ß“¡—T”ü, •D“c•üŽq, ´…Œö–ç (Šá): ‘æ109‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2005/3/25), ‹ž“s.

723805. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) •ÐŠá«‹…ŒãŽ‹_Œo‰Š‚É‚¨‚¯‚鎋_Œo“û“ªE_ŒoüˆÛ‘wŒú‚Ì•]‰¿. X“c“N–ç1, ¯ŽiMs2, ´…Œö–ç1 (1Šá. 2ˆã‰q): ‘æ109‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2005/3/25), ‹ž“s.

723806. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒŒƒ`ƒmƒ[ƒ^[‚ð—p‚¢‚½Šá—DˆÊ«’è—Ê–@E‘•’u‚ÌŽŽì. ”¼“c’m–ç1, ‹›—¢@”Ž1, ´…Œö–ç2 (1ˆã‰q. 2Šá): ‘æ109‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2005/3/26), ‹ž“s.

723807. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —¼ŠáŠJ•ú‰º‚É‚¨‚¯‚钲ߋ@”\‚Ö‚ÌŠá—DˆÊ«‚̉e‹¿. “¡‘º•‡²Žq1, ”¼“c’m–ç1, ‹›—¢@”Ž1, ´…Œö–ç2 (1ˆã‰q. 2Šá): ‘æ109‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2005/3/26), ‹ž“s.

723808. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’´‰¹”gA-mode‚ð‰ž—p‚µ‚½ˆÚAŠá“àƒŒƒ“ƒY‚Ì“®“I‹““®‘ª’è. ‹›—¢@”Ž, ìŽç“c‘ñŽu (ˆã‰q): ‘æ58‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (2004/11/11), “Œ‹ž.

731102. [Œ¤‹†‰ï] (“Á•Êu‰‰) ˜VŽ‹‚̉𖾂Ǝ•ž. ´…Œö–ç (Šá): ‘æ106‰ñÂXŠá‰ÈW’k‰ï (2004/5/7), ÂX.

731103. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‹üÜ‹¸³Žèp‚Ìŋ߂̘b‘è. —é–؉ëM (Šá): ‘æ4‰ñ‹îê“Œ–MŠá‰Èˆã‰ï (2004/5/15), “Œ‹ž.

731104. [Œ¤‹†‰ï] (“Á•Êu‰‰) ê–åˆãŽŽŒ±‚̃|ƒCƒ“ƒg|‘OŠá•”•Ò|. —é–؉ëM (Šá): ‘æ9‰ñTokyo Ocular Surface Forum (2004/6/5), “Œ‹ž.

731105. [Œ¤‹†‰ï] (“Á•Êu‰‰) _ŒoŠá‰È‚ÉŒg‚í‚Á‚Ä40”N(‹•ŒŒ«Šá‹…‰^“®áŠQ, “œ”A•a«Ž‹_ŒoÇ, ƒ‚ƒmƒrƒWƒ‡ƒ“–@‚ÆŠá—DˆÊ«, “µEU“®‚̉ðÍ, ˜VŽ‹)|Thinking Neuro-ophthalmology ‚ÌŽÀ‘H|. Œü–ì˜a—Y (ˆã‰q): ‘æ15‰ñüŠá‰È—Õ°ƒtƒH[ƒ‰ƒ€ (2004/7/1), ‘Š–Í‘å–ì.

731106. [Œ¤‹†‰ï] (“Á•Êu‰‰) HRT‚ð—p‚¢‚½PPA i“û“ªŽüˆÍ–Ô–¬—–ŒˆÞkj ‚ÌŒŸ“¢. X“c“N–ç (Šá): ‘æ40‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX(2004/10/7), ‘Š–ÍŒ´.

731107. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‚Ü‚Ô‚½‚ÌŽèp. ¼–{_”V (‘Š–ÍŒ´‹¦“¯•a‰@, Šá): ‘æ33‰ñ_“Þ쌧Šá‰Èˆã‰ï•a‰@Œ©Šw‰ïEuK‰ï (2004/11/27), ‹´–{.

731108. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‚Ü‚Ô‚½‚Ì‚Ý‚©‚½. Œü–ì˜a—Y (–k—¢‘å–¼—_‹³Žö): ‘æ33‰ñ_“Þ쌧Šá‰Èˆã‰ï•a‰@Œ©Šw‰ïEuK‰ï (2004/11/27), ‹´–{.

731109. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‰ü³–òŽ––@‚ƃRƒ“ƒ^ƒNƒgƒŒƒ“ƒY”Ì”„. ‰F’ÃŒ©‹`ˆê (‰F’ÃŒ©Šá‰Èˆã‰@, Šá): ‘æ16‰ñÓìŠá‰È—Õ°ƒtƒH[ƒ‰ƒ€ (2004/12/9), Œú–Ø.

731110. [Œ¤‹†‰ï] (“Á•Êu‰‰) Šá‰ÈŽèp‚̃ŠƒXƒNƒ}ƒl[ƒWƒƒ“ƒg. ´…Œö–ç (Šá): Šá‰ÈŽèpŠJ‹Æˆã‚̉ï i‘æ28‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ïj (2005/1/29), ‘åã.

731111. [Œ¤‹†‰ï] (“Á•Êu‰‰) ÅV‚Ì”’“àᎡ—Ã. ´…Œö–ç (Šá): ‘æ7‰ñ–k—¢ƒƒfƒBƒJƒ‹ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2005/2/23), ‘Š–Í‘å–ì.

732051. [uK‰ï] (µ‘Ò‚³‚ꂽu‰‰) ƒhƒ‰ƒCƒAƒC‚ƃRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚̃GƒbƒZƒ“ƒX. ‰F’ÃŒ©‹`ˆê (‰F’ÃŒ©Šá‰Èˆã‰@, Šá): Šá‰Èˆã—Ã]Ž–ŽÒuK‰ï (2004/6/20), ‰¡•l.

732052. [u‰‰‰ï] (µ‘Ò‚³‚ꂽu‰‰) ”’“àá‚ÆŒ¾‚í‚ꂽ‚ç. ´…Œö–ç (Šá): u–Ú‚ÌŒ’NuÀvu‰‰‰ï (2004/6/20), ‰¡•l.

732053. [Œ¤‹†‰ï] (µ‘Ò‚³‚ꂽu‰‰) Å‹ß‚Ì”’“àáŽèp. ´…Œö–ç (Šá): ŽI]\“ú‰ï (2004/10/14), ŽI].

733408. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Ž¡—ÃŒã5”NŒo‚Á‚½Šáâ|‰¡–ä‹Ø“÷Žî‚Ì1—á. ”–ØLÆ1,5, Γc—T“ñ1, Žá‘q‰ë“o2, ‘啽–r˜Y3, ’†ŠÙ®–ç4, ´…Œö–ç5 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[. 2ˆäãŠá‰È•a‰@. 3‘—§‚ª‚ñƒZƒ“ƒ^[’†‰›•a‰@. 4Ž™. 5Šá): ‘æ18‰ñ_“Þ쌧Eº˜a‘åŠw“¡‚ª‹u‡“¯ƒI[ƒvƒ“ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/4/10), _“Þì.

733409. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ITŠáǂƊ‹«ˆöŽq|‘Û“IŒ©’n‚ðŠÜ‚ß‚Ä|. Îì@“N1, â•”@v1, ‹{“cŠ²•v1, Šp“c˜a•F2, ‹g–ì@”Ž3 (1–kŒ¤•a‰@—Õ°ŠÂ‹«ˆãŠwƒZƒ“ƒ^[. 2âŒû‘‡•a‰@. 3“Œ–k‘å): ITŠáǂƊ‹«ˆöŽqŒ¤‹†”Ç@‘æ3‰ñŒ¤‹†‰ï (2004/4/15), “Œ‹ž.

733410. [Œ¤‹†‰ï] (ˆê”Êu‰‰) STEPŽhŒƒ‚É‚¨‚¯‚铵E”½‰ž‚ð—p‚¢‚½Šá¸”æ˜J‚Ì•]‰¿. –x•”@‰~1,2, Îì@‹Ï1,2, óì@Œ«1,2, “©ŽRG•v1,2, ´…Œö–ç1 (1Šá. 2‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@): ITŠáǂƊ‹«ˆöŽqŒ¤‹†”Ç@‘æ3‰ñŒ¤‹†‰ï(2004/4/15), “Œ‹ž.

733411. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Œg‘Ñ“d˜bƒ[ƒ‹Žg—p‘OŒã‚Ì“µE”½‰ž|“µEU“®‚É‚æ‚錟“¢|. Œ´@’¼l1,2, ‘å–ìWŽi1,2, “àŽRmŽu2, “c’†ŠÚ–¾”Ž2, Œü–ì˜a—Y2, ´…Œö–ç2 (1_“Þ쎕‘å”MŠC•a‰@. 2Šá): ITŠáǂƊ‹«ˆöŽqŒ¤‹†”Ç@‘æ3‰ñŒ¤‹†‰ï (2004/4/15), “Œ‹ž.

733412. [Œ¤‹†‰ï] (ˆê”Êu‰‰) —§‘̉摜ŠÏŽ‹Žž‚ÌŽ‹Šo”æ˜J‚Æ‚»‚Ì•]‰¿. Vˆä“cF—T1,2, ]–{³Šì3, –ìK—TŽi3 (1‘Ûˆã—ÕŸŽƒ‘å. 2Šá. 3NHK•ú‘—‹ZpŒ¤‹†Š): ITŠáǂƊ‹«ˆöŽqŒ¤‹†”Ç@‘æ3‰ñŒ¤‹†‰ï (2004/4/15), “Œ‹ž.

733413. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒ‰ƒ^ƒmƒvƒƒXƒg’PÜŽg—p—á‚ւ̃uƒŠƒ“ƒ]ƒ‰ƒ~ƒh’ljÁ‚É‚æ‚éŠáˆ³‰º~Œø‰Ê. •û”ŽŽq1,2, •ô‘ºŒšŽi2, •y‰ª•q–ç1,2, “©ŽRG•v1,3, Îì@‹Ï1,3, ª–{@“O4, ŠÝŒ´hŽq5, ¼–{_”V5, ‰Í‡—T”ü1, ¯ŽiMs1, ´…Œö–ç1 (1Šá. 2•‘ –ìÔ\Žš•a‰@. 3‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@. 4ŠC˜V–¼‘‡•a‰@. 5‘Š–ÍŒ´‹¦“¯•a‰@): ‘æ21‰ñŠÖ“ŒŠá‰ÈŠw‰ï (2004/5/15), “Œ‹ž.

733414. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒhƒ‹ƒ]ƒ‰ƒ~ƒh“_Šá–ò‚©‚çƒuƒŠƒ“ƒ]ƒ‰ƒ~ƒh“_Šá–ò‚Ö‚Ì•ÏX‚É‚æ‚éŠáˆ³‰º~Œø‰Ê. ŠÝŒ´hŽq1,2, ’ç‰l—1,2, ¼–{_”V1,2, Îì@‹Ï1,3, “©ŽRG•v1,3, ª–{@“O4, •y‰ª•q–ç1,5, ¼Œ³‹v°1, ‰Í‡—T”ü1, ¯ŽiMs1, ´…Œö–ç1 (1Šá. 2‘Š–ÍŒ´‹¦“¯•a‰@. 3‘Ûˆã—ÕŸŽƒ‘å”MŠC•a‰@. 4ŠC˜V–¼‘‡•a‰@. 5•‘ –ìÔ\Žš•a‰@): ‘æ21‰ñŠÖ“ŒŠá‰ÈŠw‰ï (2004/5/15), “Œ‹ž.

733415. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) 33Î’j«‚É”­Ç‚µ‚½‹…Œ‹–ŒG•½ã”çŠà‚Ì1—á. “©ŽRG•v1,2, Îì@‹Ï1,2, –k‘º@‘n2 (1Šá. 2ˆã—ÕŸŽƒ‘å”MŠC•a‰@): ‘æ21‰ñŠÖ“ŒŠá‰ÈŠw‰ï(2004/5/15), “Œ‹ž.

733416. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “dŽqƒJƒ‹ƒe‚Æ‚Ì2”NŠÔ. ”–ØLÆ1,2, “©ŽRG•v1,3, Îì@‹Ï1,3, ´…Œö–ç1 (1Šá. 2Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[. 3‘Û•ŸŽƒˆã—Ñå”MŠC•a‰@): ‘æ21‰ñŠÖ“ŒŠá‰ÈŠw‰ï (2004/5/15), “Œ‹ž.

733417. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) —§‘̉f‘œ‚̃fƒWƒ^ƒ‹•\Ž¦‚ÌŽŽ‚Ý. ‹àã’å•v1,2, ‰F‘½dˆõ3, ¬“c“‡LŽõ4 (1Šá. 2Ž©Ž¡ˆã‘å. 3“ñ–{¼Šá‰È•a‰@. 4(Š”) ƒtƒ[ƒxƒ‹): ‘æ21‰ñŠÖ“ŒŠá‰ÈŠw‰ï (2004/5/15), “Œ‹ž.

733418. [Œ¤‹†‰ï] (ˆê”Êu‰‰) –k—¢‘åŠwCLŠO—ˆ‚É‚¨‚¯‚é, ‰~Šp–Œ—pƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚Ì‘•—pó‹µ. ‘å’Î’qG1, ‰F’ÃŒ©‹`ˆê1,2, ŒF”WŒä“°—²1, ‘ŠàV‘å•ã1, —é–؉ëM1, ´…Œö–ç1 (1Šá. 2‰F’ÃŒ©Šá‰Èˆã‰@): ‘æ102‰ñ_“Þ쌧Šá‰ÈW’k‰ï(2004/6/3), _“Þì.

733419. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ãŠááÙ‚É”­¶‚µ‚½ƒƒ‹ƒPƒ‹×–EŠá‚Ì1—á. ”–ØLÆ1,2, ´Œ´Ë•v2, ‹gìŽü²2, ’†ì‰ë—T2, ˆäãŒ[‘¾2, Γc@Ê2, ¼‘º“N•v2, ˆÉ“¡ˆÈ’m˜Y2, ŠHì‘׶3 (1Šá. 2.Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[. 3ŠHìŠá‰Èj: ‘æ22‰ñ“ú–{ŠáŽîᇌ¤‹†‰ï (2004/7/17), ‚’m.

733420. [Œ¤‹†‰ï] (‹³ˆçu‰‰) ‹³‰È‘—v‚炸‚̬Ž™Šá‰È. Îì@‹Ï (‘Ûˆã—ÕŸŽƒ‘åŠw”MŠC•a‰@, Šá): ‘æ3‰ñBey Ocular Culb (2004/7/31), Óì.

733421. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‘@ˆÛ’Œ‘ÑØœp‚É‚¨‚¯‚é‹­–Œ•Ù‚Ì”äŠr. —`…@Šw, ¬—Ñ“Žq, ™–{˜a‹v, —é–ØG¹, X“c“N–ç, ¯ŽiMs, ´…Œö–ç (Šá): ‘æ40‰ñ–k—¢‘åŠw¥_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/10/7), ‘Š–ÍŒ´.

733422. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Žá”NŒQE‰Šú˜VŽ‹ŒQ‚̋ߌ©Žž“µE”½‰žEŠá‹…‰^“®‚ɑ΂·‚é•ÐŠáŽÕ•Â‚̉e‹¿. ŒãŠÖ—˜–¾1,2, ¼èœA]1, Îì@‹Ï1, ‹›—¢@”Ž1, ´…Œö–ç1, óì@Œ«3 (1Šá. 2ŠC˜V–¼‘‡•a‰@. 3‘Ûˆã—ÕŸŽƒ‘åj: ‘æ40‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/10/7), ‘Š–ÍŒ´.

733423. [Œ¤‹†‰ï] (ˆê”Êu‰‰) –k—¢‘åŠw•a‰@‚É‚¨‚¯‚鬎™”’“àáŽèp‚ÌŒŸ“¢. ”’’J@“O, ”ä‰Ã—˜¹Žq, •D“c•üŽq, Îì@‹Ï, ´…Œö–ç (Šá): ‘æ40‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/10/7), ‘Š–ÍŒ´.

733424. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Žá”N‘wITŠáÇ‚Ì“úí‹üÜ‹¸³ó‹µ‚Æ’²ß”½‰ž. ‰Á“¡”üŽ}1, ¬Žèì‘׎}1, 匴Žµd1, ‘å–ìWŽi1,2, Œ´@’¼l1,2, Œü–ì˜a—Y1, ´…Œö–ç2 (1_“Þ쎕‘剡•lƒNƒŠƒjƒbƒN. 2Šá): ‘æ40‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/10/7), ‘Š–ÍŒ´.

733425. [Œ¤‹†‰ï] (ˆê”Êu‰‰) –k—¢‘åŠw•a‰@‚É‚¨‚¯‚鉩”Áã–Œ, ‰©”Á‰~E‚ÌŽèp¬Ñ. –ö“c’q•F, ‚–ì‰ë•F, ´…Œö–ç (Šá): ‘æ40‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/10/7), ‘Š–ÍŒ´.

733426. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Ǘጟ“¢. •D“c•üŽq (Šá): ‘æ2‰ñPfizer Ophthalmology Seminar (2004/11/20), ‰¡•l.

733427. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ICL (phakic IOL) ‚Ì—Õ°¬Ñ. “¡àV–Mr (Šá): ‘æ2‰ñPfizer Ophthalmology Seminar (2004/11/20), ‰¡•l.

733428. [Œ¤‹†‰ï] (ˆê”Êu‰‰) d—±ŽqüŽ¡—ÃŒãŠá‹…“Eo‚ÉŽŠ‚Á‚½, –Ñ—l‘̈««•FŽî‚Ì1—á. ”–ØLÆ (Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[, Šá): ‘æ39‰ñŠá‰È—Õ°•a—‘gDŒ¤‹†‰ï (2004/11/26), ‘åã.

733429. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘½W“_Šá“àƒŒƒ“ƒY‚É‚¨‚¢‚Ä“µEŒa‚ª‹óŠÔŽü”g”“Á« (MTF) ‚É—^‚¦‚é‰e‹¿. ìŽç“c‘ñŽu, ‹›—¢@”Ž (ˆã‰q, Šáj: ‘æ70‰ñ“ú–{’†•”Šá‰ÈŠw‰ï (2004/11/27), ‘åã.

733430. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‰©”ÁŽ¾Š³‚Ìf’f. –ö“c’q•F (Šá): ‘æ2‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2005/2/10), ‘Š–Í‘å–ì.

733431. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‰©”ÁŽ¾Š³‚ÌŽ¡—à (PDT‚ð’†S‚É). Žs糋`Í (Šá): ‘æ2‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2005/2/10), ‘Š–Í‘å–ì.


<<Ž¨•@ˆôA‰ÈŠw>>

mŠwp˜_•¶n

110183. [Œ´’˜] Increased expression of Laminin-5 and prognostic sign ificance in hypopharyngeal Cancer. ’†ŽR–¾m1, Y Sato2, ‰ª–{–ql1, S Hirohashi3 (1Ž¨•@. 2ˆã‰q. 3‘—§‚ª‚ñƒZƒ“ƒ^[): Laryngoscope, 114: 1259-1263, 2004.

120087. [Œ´’˜] “Ë”­«“ï’®‚̑Α¤’®—Í‚ÉŠÖ‚·‚錟“¢. ²–ì@”£1, V“cŒõ–M2, ¬–ì—Yˆê3, ‹´–{‘å–å1, ‰ª–{–ql1 (1Ž¨•@. 2‘å˜aŽs—§•a‰@. 3’Ëvˆä“úÔ•a‰@): Audiology Japan, 47: 92-100, 2004.

120088. [Œ´’˜] ãŠ{“´Šà‚ÌŽ¡—à (–k—¢•ûŽ®) ‚É—p‚¢‚½p‘O8 GyÆŽË‚É‚æ‚éŠÔŽ¿”½‰ž‚̕ω»‚Æ—\Œã. ”ª”ö˜a—Y, ‰ª–{–ql, ’†ŽR–¾m, ’|“c¹•F, ³—ˆ@—², ‹´–{‘å–å, 㞊‹M—T (Ž¨•@): “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñ, 107: 139-144, 2004.

120089. [Œ´’˜] ‹}«A“ªŠW‰Š237—á‚Ì—Õ°“IŒŸ“¢. ‹´–{‘å–å1, ”ª”ö˜a—Y1, ¼ŽRkˆê˜Y1, ˆäŒû–F–¾1, ³—ˆ@—²1, ˜a“c¹‹»1, –q@“ÖŽq1, –xŒû—˜”V2, ‰ª–{–ql1 (1Ž¨•@. 2ˆã‰q): “ú–{‹CŠÇH“¹‰ÈŠw‰ï‰ï•ñ, 55 (3): 245-252, 2004.

120090. [Œ´’˜] œ“±Œê‰¹’®ŠoŒŸ¸‚̊Œƒxƒ‹‚ÌŒŸ“¢. ¼•½“oŽu³1, ˆÉ•Û´Žq, ó–ì˜a], ‰ª–{–ql2 (1ˆã‰q. 2Ž¨•@): Audiology Japan, 47: 228-233, 2004.

120091. [Œ´’˜] ‹}«’ቹáŠQŒ^Š´‰¹“ï’®“TŒ^—á‚Æ”ñ“TŒ^—á‚Ì”äŠr. ²“¡Gº1, ‘ºˆä˜a•v2, ‰ª–{–ql3, Šì‘½‘º@Œ’4 (1ŠâŽèˆã‘å. 2ŠâŽè˜JЕa‰@. 3Ž¨•@. 4“Œ‹žˆãŽ•‘å): Audiology Japan, 47: 258-262, 2004.

120092. [Œ´’˜] ‡–°Žž–³ŒÄ‹zÇŒóŒQ‚É‚¨‚¯‚é•@o’ïR’l‚̑̈ʕω». ’†“c½ˆê1, ì–ì˜aO2, ‘å–ØŠ²•¶2, ‹{葈ê˜Y3, ‰ª–{–ql4, “à“¡Œ’°5, –ì’†@‘6, ”óã@–Î7, ’|“à—T”ü7, ç—tL‘¾˜Y8, ’|“à–œ•F9, ŠÔ“‡—Yˆê9 (1–¼ŒÃ‰®‘å. 2“Œ–M‘åŠw. 3Ž ‰êˆã‘å. 4Ž¨•@. 5“¡“c•ÛŒ’‰q¶‘å. 6ˆ®ìˆã‘å. 7’¹Žæ‘å. 8‘¾“c‘‡•a‰@. 9ŽOd‘å): “ú–{•@‰ÈŠw‰ï‰ïŽ, 43 (4): 391-395, 2004.

120093. [Œ´’˜] KTPƒŒ[ƒU[‚É‚æ‚éƒ|ƒŠ[ƒv—lº‘Ñ‚ÌŽ¡—Ã. ŽR–{ˆê”Ž1, ¬ìŽ“ñ2, ˆäŒû–F–¾1,2, (1Ž¨•@. 2‰¡{‰êŽs–¯•a‰@): Ž¨•@—Õ°, 97 (4): 337-342, 2004.

320077. [Ç—á•ñ] “–‰È‚ÅŒoŒ±‚µ‚½‘O“ª“´Šà‚Ì1—á. ˜a“c¹‹», ”ª”ö˜a—Y, ’†ŽR–¾m, ŽR–{ˆê”Ž, ’†“‡³ŒÈ, ‰ª–{–ql (Ž¨•@): Ž¨•@ˆôA‰ÈE“ªèò•”ŠO‰È, 77 (3): 231-234, 2005.

320078. [Ç—á•ñ] A“ª‚É”­¶‚µ‚½éÒŒ´«”X–E‚Ì1—á. ‹´–{‘å–å, ”ª”ö˜a—Y, ¼ŽRkˆê˜Y, ‰iˆä_–¤, ²“¡Œ«‘¾˜Y, ‰ª–{–ql (Ž¨•@): Ž¨•@ˆôA‰ÈE“ªèò•”ŠO‰È, 76 (8): 561-564, 2004.

320079. [Ç—á•ñ] ƒƒjƒG[ƒ‹•a‚ð‹^‚Á‚½¬”]‹´Šp•””X–EÇ—á. ‹´–{‘å–å, “¿‘Œú“ñ, ’·À‰p–¾, ‹´–{Wˆê˜Y, ˆÉ“¡º•F, ˜a“c¹‹», ‰ª–{–ql (Ž¨•@): Equilibrium Res, 63 (2): 110-116, 2004.

320080. [Ç—á•ñ] ”í–Œ‰º‚É“Eo‚µ‚½˜r_Œo‘p_ŒoâŽî2—á. ³—ˆ@—², ¼ŽRkˆê˜Y, ‰iˆä_–¤, ”ª”ö˜a—Y, ‰ª–{–ql (Ž¨•@): Ž¨•@ˆôA‰È—Õ°, 7 i6j: 543-548, 2004.

520256. [‘à] •ÂÇ«‡–°Žž–³ŒÄ‹zÇŒóŒQ‚Ì•a‘Ô. ‰ª–{–ql1, ç—tL‘¾˜Y2, ‹{葈ê˜Y3, —é–ØŒ«“ñ4, ¼‘º’‰˜Y4 (1Ž¨•@. 2‘¾“c‘‡•a‰@. 3Ž ‰êˆã‘å. 4“¡“c•ÛŒ’‰q¶‘å): “ú–{ŒûoEˆô“ª‰ÈŠw‰ïŽGŽ, 17 (2): 159-164, 2005.

520257. [‘à] ¬l‚̇–°ŒÄ‹záŠQ: f’f‚ɂ‚¢‚Ä. —é–ØŒ«“ñ1, ¼‘º’‰˜Y1, ‰ª–{–ql2, ç—tL‘¾˜Y3, ‹{葈ê˜Y4 (1“¡“c•ÛŒ’‰q¶‘å. 2Ž¨•@. 3‘¾“c‘‡•a‰@. 4Ž ‰êˆã‘å): “ú–{ŒûoEˆô“ª‰ÈŠw‰ïŽGŽ, 17 (2): 165-168, 2005.

520258. [‘à] ¬Ž™‚̇–°ŒÄ‹záŠQ: ‚¢‚Ñ‚«E–³ŒÄ‹z. ‹{葈ê˜Y1, —é–ØŒ«“ñ2, ¼‘º’‰˜Y2, ‰ª–{–ql3, ç—tL‘¾˜Y4 (1Ž ‰êˆã‘å. 2“¡“c•ÛŒ’‰q¶‘å. 3Ž¨•@. 4‘¾“c‘‡•a‰@j: “ú–{ŒûoEˆô“ª‰ÈŠw‰ïŽGŽ, 17 (2): 169-176, 2005.

520259. [‘à] ¬l‚̇–°ŒÄ‹záŠQ: Ž¡—Âɂ‚¢‚Ä. ç—tL‘¾˜Y1, ‹{葈ê˜Y2, —é–ØŒ«“ñ3, ¼‘º’‰˜Y3, ‰ª–{–ql4 (1‘¾“c‘‡•a‰@. 2Ž ‰êˆã‘å. 3“¡“c•ÛŒ’‰q¶‘å. 4Ž¨•@): “ú–{ŒûoEˆô“ª‰ÈŠw‰ïŽGŽ, 17 (2): 177-185, 2005.

520260. [‘à] •@•Â. ˆäŒû–F–¾1,2, ”ª”ö˜a—Y2 (1‰¡{‰êŽs–¯•a‰@. 2Ž¨•@): ƒAƒŒƒ‹ƒM[E–Ɖu, 12 (1): 114-118, 2004.

520261. [‘à] —‘z“I‚ȃ`[ƒ€ˆã—Âðs‚¤‚½‚ß‚É|–k—¢‘åŠw•a‰@‚É‚¨‚¯‚éƒ`[ƒ€ˆã—Â̎ÀÛ‚Æ“W–]|. ’†ŽR–¾m1, ŒIŒ´—¢‰À1, ‹{–{r•ã1, ’|“c¹•F1, ‰¡–x@Šw1, —é–Ø—§r1, ”ª”ö˜a—Y1, ‰ª–{–ql1, V•”@÷2, –k–ì‰ëŽj2, ‘ì˜ad2, ¬—ÑLs3, Žðˆä’¼•F4 (1Ž¨•@. 2•ú. 3ŠO. 4Œ`ŠO): “ªèò•”Šà, 30 (3): 385-390, 2004.

520262. [‘à] º‘Ñ“àŽ©‰Æ‘¤“ª‹Ø–ŒˆÚAp‚̌뚋–hŽ~Œø‰Ê‚ÌŒŸ“¢. ¼ŽRkˆê˜Y1, –xŒû—˜”V2, ³—ˆ@—²1, 㞊‹M—T1, ‹´–{‘å–å1, ‰Pˆä‘å—S1, –q@“ÖŽq1, ”ª”ö˜a—Y1, œA£@”£2, ‰ª–{–ql1 (1Ž¨•@. 2ˆã‰q): “ú–{‹CŠÇH“¹‰ÈŠw‰ï‰ï•ñ, 55 (2): 157, 2004.

520263. [‘à] ƒ|ƒŠ[ƒv—lº‘тɑ΂·‚éYAGƒŒ[ƒU[E”S–Œ–D‡Žèp‚ÌŒŸ“¢|]—ˆ–@‚Ƃ̉¹‹¿•ªÍ‚Ì”äŠr|. ¼ŽRkˆê˜Y1, œA£@”£2, ˆäŒû–F–¾1, ŽR–{ˆê”Ž1, ³—ˆ@—²1, ˜a“c¹‹»1, –xŒû—˜”V2, ”ª”ö˜a—Y1, ‰ª–{–ql1 (1Ž¨•@. 2ˆã‰q): “ú–{‹CŠÇH“¹‰ÈŠw‰ï‰ï•ñ, 55 (2): 134, 2004.

521046. [Œ¤‹†•ñ] (Œú˜JÈ) 1. “Ë”­«“ï’®‚̎Љï“I–â‘è|V‚½‚È“ï’®‚Ì”­¶Œ¹|. ‰ª–{–ql, ²–ì@”£, ‹´–{‘å–å, 㞊‹M—T, –q@“ÖŽq, ¬–ì—Yˆê (Ž¨•@): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à, “«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ, ‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²¸Œ¤‹†, •½¬15”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.21-23, 2004.

521047. [Œ¤‹†•ñ] (Œú˜JÈ) “Ë”­«“Ǘá‚ɑ΂·‚éƒGƒ_ƒ‰ƒ{ƒ“‚ÌŽg—pŒoŒ±. ‰ª–{–ql, ²–ì@”£, ‹´–{‘å–å, ¬–ì—Yˆê, V“cŒõ–M (Ž¨•@): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à, “«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ, ‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²¸Œ¤‹†, •½¬15”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.24-26, 2004.

521048. [Œ¤‹†•ñ] (Œú˜JÈ) _“Þ쌧‚ÆŠâŽèŒ§‚É‚¨‚¯‚é‹}«’ቹáŠQŒ^Š´‰¹“ï’®‚̉uŠw’²¸. Šì‘½‘º@Œ’1, ˆäŒ´ˆê¬2, ²“¡Gº3, ‰ª–{–ql4, ’†“‡@–±5, 쓇Œc”V1 (1“Œ‹žˆãŽ•‘å. 2“Œ–M‘å. 3ŠâŽèˆã‘å. 4Ž¨•@. 5–¼ŒÃ‰®‘å): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à, “«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ, ‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²¸Œ¤‹†, •½¬15”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.31-32, 2004.

521049. [Œ¤‹†•ñ] (Œú˜JÈ) ‹}«’ቹáŠQŒ^Š´‰¹“ï’®‚ÌŽ¡—Óà—e‚Æ—\Œã‚ÉŠÖ‚·‚錟“¢. ²“¡Gº1, Šì‘½‘º@Œ’2, ‘ºˆä˜a•v3, ‰ª–{–ql4, Š™“c‘P”Ž1, …ì“Ö—T1 (1ŠâŽèˆã‘å. 2“Œ‹žˆãŽ•‘å. 3ŠâŽè˜JЕa‰@. 4Ž¨•@): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à, “«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ, ‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²¸Œ¤‹†, •½¬15”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.35-36, 2004.

521050. [Œ¤‹†•ñ] (Œú˜JÈ) Vasopressin“Š—^“®•¨ƒ‚ƒfƒ‹‚Ìå—‹Œ`‘Ô. ’·À‰p–¾1, ‰ÍŒ´Ž‰ë2, ŽR‰È³•½3, ‰ª–{–ql1 (1Ž¨•@. 2¶—. 3‰ð–U): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à, “«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ, ‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²¸Œ¤‹†, •½¬15”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.62-63, 2004.

521051. [Œ¤‹†•ñ] (Œú˜JÈ) ƒQƒ“ƒ^ƒ}ƒCƒVƒ“‚É‚æ‚éŠO—L–Ñ×–EáŠQ‚ɑ΂·‚éƒeƒvƒŒƒmƒ“‚ÌŒø‰Ê. ²–ì@”£, •Ä“c@•q, ˆÉ“¡º•F, ‰ª–{–ql (Ž¨•@): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à, “«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ, ‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²¸Œ¤‹†, •½¬15”N“x‘Š‡E•ª’SŒ¤‹†•ñ‘, p.74-75, 2004.

521052. [Œ¤‹†•ñ] (Œú˜JÈ) “àƒŠƒ“ƒp…Žî”­¶‰ß’ö‚É‚¨‚¯‚é’®Šo’ቺƒƒJƒjƒYƒ€‚ÉŠÖ‚·‚錤‹†. ’·À‰p–¾1, ŽR‰È³•½2, ‰ÍŒ´Ž‰ë3 (1Ž¨•@. 2‰ð–U. 3¶—): •½¬16”N“x‰ÈŠwŒ¤‹†”ï•â•‹àŽÀÑ•ñ‘.

m’˜@‘n

620140. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ENTONI; ŒÛŽºŒ`¬p|Ž„‚̃RƒcEŽ„‚ÌH•v- pŽ®‚Ì‘I‘ðE‚»‚Ì3Ž¨“à–@|. ‰ª–{–ql (Ž¨•@), •ÒW –{¯@ŠÞ1, Žsì‹âˆê˜Y2 (1‹ž“s‘å–¼—_‹³Žö. 2‡“V“°‘å–¼—_‹³Žö), ‘S“ú–{•a‰@o”ÅŽÐ, “Œ‹ž, 2004”­s.

620141. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ENTONI; ˆ««ƒŠƒ“ƒpŽîŠ³ŽÒ‚ɑ΂·‚éƒCƒ“ƒtƒH[ƒ€ƒhEƒRƒ“ƒZƒ“ƒg. ’†ŽR–¾m1, ”n‰z’q_2, ‰ª–{–ql1 (1Ž¨•@. 2ɪŽs), •ÒW –{¯@ŠÞ1, Žsì‹âˆê˜Y2 (1‹ž“s‘å–¼—_‹³Žö. 2‡“V“°‘å–¼—_‹³Žö), ‘S“ú–{•a‰@o”ÅŽÐ, “Œ‹ž, 2004/9/15”­s.

620142. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ‚±‚ꂾ‚¯‚Í’m‚Á‚Ä‚¨‚«‚½‚¢ƒhƒ“ƒ^ƒhƒD[; Ž¨–Â. ²–ì@”£ (Ž¨•@), •ÒW ¼“cdŽO, V‹»ˆãŠwo”ÅŽÐ, “Œ‹ž, 2004”­s.

620143. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ‚±‚ꂾ‚¯‚Í’m‚Á‚Ä‚¨‚«‚½‚¢ƒhƒ“ƒ^ƒhƒD[; •@oŒŒ. ”ª”ö˜a—Y (Ž¨•@), •ÒW ¼“cdŽO, V‹»ˆãŠwo”ÅŽÐ, “Œ‹ž, 2004”­s.

620144. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ‚±‚ꂾ‚¯‚Í’m‚Á‚Ä‚¨‚«‚½‚¢ƒhƒ“ƒ^ƒhƒD[; Œëˆù. ‰¡–x@Šw (Ž¨•@), •ÒW ¼“cdŽO, V‹»ˆãŠwo”ÅŽÐ, “Œ‹ž, 2004”­s.

620145. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ƒCƒ‰ƒXƒgŽèpŽè‹Z‚̃Rƒc; º‘ÑaÇ‚ÌŠO‰È“IŽ¡—Ã|º‘Ñ“àŽ©‰ÆŽ‰–bE‹Ø–ŒˆÚAp‚Ì“K‰ž‚Æ—¯ˆÓ“_|. ¼ŽRkˆê˜Y (Ž¨•@), •ÒW ”ÑÀšæF, –Ø“c—º‹I, ¬—ÑrŒõ, ‹v@ˆç’j, XŽR@Š°, ‘ºã@‘×, “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2004”­s.

620146. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) JOHNS: º‘Ñ“à‹Ø–ŒŽ©‰ÆˆÚAp‚̃Rƒc‚Í? ¼ŽRkˆê˜Y, ³—ˆ@—², ‰Pˆä‘å—S (Ž¨•@), “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2004”­s.

620147. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) JOHNS; ‰¹ºŒŸ¸, ¼ŽRkˆê˜Y1, –xŒû—˜”V2 (1Ž¨•@. 2ˆã‰q). “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2004”­s.

620148. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ENTONI; ‹}«A“ªŠW‰Š‚Ìf—Ã. ¼ŽRkˆê˜Y (Ž¨•@), ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 2004”­s.

620149. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) JOHNS; šmº‚ÌŽ¡—Ã. ¼ŽRkˆê˜Y (Ž¨•@), “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2004”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

713193. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Three-Dimension reconstruction and of the human semicircular canal and measurement of each membranous canal plane defind by reid's stereotaxic coordinates. ‹´–{Wˆê˜Y, ’·À‰p–¾, “¿‘Œú“ñ, ˆÉ“¡º•F, ˜a“c¹‹», ‰ª–{–ql (Ž¨•@): Barany Society (2004/7/7-9), ƒpƒŠ.

713194. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) New methods for stimulating otolith organs by linear acceleration. ’·À‰p–¾1, “¿‘Œú“ñ1, ‰ÍŒ´‰ëŽ2, ‹´–{Wˆê˜Y1, ˆÉ“¡º•F1, ˜a“c¹‹»1, ˆÉ•Û´Žq, ‰ª–{–ql1 (1Ž¨•@. 2¶—): Barany Society (2004/7/7-9), ƒpƒŠ.

713195. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Retrospective study on long=term prognosis of cases mostly conservatively treated in meniere's disease. ˜a“c¹‹», “¿‘Œú“ñ, ’·À‰p–¾, ‹´–{Wˆê˜Y, ˆÉ“¡º•F, ‰ª–{–ql (Ž¨•@): Barany Society (2004/7/7-9), ƒpƒŠ.

713196. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) A case of primitive neuroectodermal tumor (PNET) of the larynx. ‹{–{r•ã, ’†ŽR–¾m, ”ª”ö˜a—Y, ‰ª–{–ql (Ž¨•@): ƒAƒƒŠƒJŽ¨•@ˆôA‰ÈŠw‰ï (2004/9/19-22), ƒAƒƒŠƒJ.

713197. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Increased Expression of Laminin-5:Its Prognostic Significance in Hypopharyngeal Cancer. ’†ŽR–¾m, ²“¡—Yˆê, ‰ª–{–ql (Ž¨•@): ƒAƒƒŠƒJŽ¨•@ˆôA‰ÈŠw‰ï (2004/9/19-22), ƒAƒƒŠƒJ.

713198. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) The Recovery Progress in Peritonsillar Abscess by Incision and Drainage Treatment. —é–Ø—§r, ‰Pˆä‘å—S, V“cŒõ–M, ‰¡–x@Šw, ˆî–ØŸ‰p, ‰ª–{–ql (Ž¨•@): ƒAƒƒŠƒJŽ¨•@ˆôA‰ÈŠw‰ï (2004/9/19-22), ƒAƒƒŠƒJ.

713199. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) A Case of Radiation-Induced Sarcoma of Tongue. ’|“c¹•F, ’†ŽR–¾m, ”ª”ö˜a—Y, ‰ª–{–ql (Ž¨•@): ƒAƒƒŠƒJŽ¨•@ˆôA‰ÈŠw‰ï (2004/9/19-22), ƒAƒƒŠƒJ.

713200. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) DNA-Not I and EBER1-RNA Immunohistochemical Stains of EB Virus-Induced Tonsillar Lesions. ŒIŒ´—¢‰À, ²“¡—Yˆê, ’†ŽR–¾m, ”ª”ö˜a—Y, ‰ª–{–ql (Ž¨•@): ƒAƒƒŠƒJŽ¨•@ˆôA‰ÈŠw‰ï (2004/9/19-22), ƒAƒƒŠƒJ.

722100. [Šw‰ï (‘S‘)] (—Õ°ƒZƒ~ƒi[) •â’®Ší“K‡‚Ì‚½‚ß‚Ìí—ª. ‰ª–{–ql (Ž¨•@): ‘æ105‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï (2004/5/14), L“‡. —\eW, p.339, 2004.

722101. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) –k—¢‘åŠw•a‰@‚É‚¨‚¯‚éƒ`[ƒ€ˆã—Â̎ÀÛ‚Æ“W–]. ’†ŽR–¾m, ŒIŒ´—¢‰À, ‹{–{r•ã, ’|“c¹•F, ‰¡–x@Šw, ”ª”ö˜a—Y, ‰ª–{–ql (Ž¨•@): ‘æ28‰ñ“ú–{“ªèò•”•”Žîᇊw‰ï (2004/6/17), •Ÿ‰ª. —\eW, p.154, 2004.

722102. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) u‚¢‚Ñ‚«E‡–°Žž–³ŒÄ‹zÇŒóŒQ‚Ìf—ÃKƒCƒhƒ‰ƒCƒ“‚ð‚ß‚®‚Á‚Äv ¬l‚̇–°ŒÄ‹záŠQ|•a‘Ԃɂ‚¢‚Ä|. ‰ª–{–ql (Ž¨•@): ‘æ17‰ñ“ú–{ŒûoEˆô“ª‰ÈŠw‰ï (2004/9/10), _ŒË. —\eW, p.4, 2004.

722103. [Šw‰ï (‘S‘)] (ƒ~ƒjƒVƒ“ƒ|ƒWƒEƒ€) ”â—ô“à“]p‚ÆA“ª’¼’B‹¾‰ºº‘Ñ“à•ûˆÚ“®p‚Ì”äŠrŒŸ“¢. ¼ŽRkˆê˜Y1, ³—ˆ@—²1, ‰Pˆä‘å—S1, Šp“cWˆê2, –xŒû—˜”V3, ”ª”ö˜a—Y1, œA£ ”£3, ‰ª–{–ql1 (1Ž¨•@. 2‘—§Š´ŠoŠíƒZƒ“ƒ^[. 3ˆã‰q): ‘æ49‰ñ“ú–{‰¹ºŒ¾ŒêˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2004/11/11), ŒF–{. —\eW p.53.

722104. [Šw‰ï (‘S‘)] (ƒrƒfƒIƒVƒ“ƒ|ƒWƒEƒ€) A“ª’¼’B‹¾‰ºº‘Ñ“à•ûˆÚ“®p. ¼ŽRkˆê˜Y (Ž¨•@): ‘æ56‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2004/11/25), “Œ‹ž. —\eW, p.53, 2004.

722105. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) A“ªˆŸ‘S“EpSCL-CHEP‚ÌŽÀÛ‚Æ“W–]. ’†ŽR–¾m (Ž¨•@): “ú–{‹CŠÇH“¹‰ÈŠw‰ï (2005/2/19), “Œ‹ž.

723809. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ³Œ·”g’¼ü‰Á‘¬“xŽhŒƒ‚É‚æ‚éˆê‘¤‚Ì—‘Œ`”X‹@”\‚Ì‘ª’è‚ÌŽŽ‚Ý. ’·À‰p–¾1, “¿‘Œú“ñ, ‰ÍŒ´Ž‰ë2, ‹´–{Wˆê˜Y1, ˆÉ“¡º•F1, ˆÉ•Û´Žq, ‰º‰ÍƒiƒIƒ~, ‰ª–{–ql1 (1Ž¨•@. 2¶—j: ‘æ105‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï (2004/5/14), L“‡. —\eW, p.421, 2004.

723810. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) IgAtÇŠ³ŽÒG“IgA‚ÌŒŸ“¢. ˆÉ“¡º•F1, ‰ª–{–ql1, Šâ£m—E2 (1Ž¨•@. 2‘ãŽÓ’`”’): ‘æ105‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï (2004/5/15), L“‡. —\eW, p.454, 2004.

723811. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘åŠw•a‰@‚ªs‚¤Ý‘îŠÉ˜aˆã—Â̎ÀÛ: ƒ`[ƒ€ˆã—Ẩ”\«‚ÆŒÀŠE. ŒIŒ´—¢‰À, ’†ŽR–¾m, ”ª”ö˜a—Y, ’|“c¹•F, ‹{–{r•ã, ‰ª–{–ql (Ž¨•@): ‘æ28‰ñ“ú–{“ªèò•”Žîᇊw‰ï (2004/6/17), •Ÿ‰ª. —\eW, p.215, 2004.

723812. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) A“ªˆŸ‘S“EpSCL-CHEP, CHPpŒã‚Ìš‹‰ºƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚ÌŒŸ“¢|“–‰È‚É‚¨‚¯‚éƒ`[ƒ€ˆã—Âł̎æ‚è‘g‚Ý|. ‰¡–x@Šw, ’†ŽR–¾m, ”ª”ö˜a—Y, —é–Ø—§r, ’|“c¹•F, ‹{–{r•ã, ‰ª–{–ql (Ž¨•@): ‘æ28‰ñ“ªèò•”Žîᇊw‰ï (2004/6/17), •Ÿ‰ª. —\eW, p.215, 2004.

723813. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) A“ªˆŸ‘S“Ep iCHEPj‚É‚¨‚¯‚ép’†‹Ø“d}‚ð—p‚¢‚½CRicoartytenoid Unit‚̉ðÍ. ‹{–{r•ã1, ’†ŽR–¾m1, ’|“c¹•F1, ”ª”ö˜a—Y1, ‰ª–{–ql1, œA£@”£2 (1Ž¨•@. 2ˆã‰q): ‘æ28‰ñ“ªèò•”Žîᇊw‰ï(2004/6/17), •Ÿ‰ª. —\eW, p.272, 2004.

723814. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –j”S–Œˆ««•FŽî‚Ì1Ç—á. ’|“c¹•F, ’†ŽR–¾m, ‹{–{r•ã, ”ª”ö˜a—Y, ‰ª–{–ql (Ž¨•@): ‘æ28‰ñ“ªèò•”Žîᇊw‰ï (2004/6/17), •Ÿ‰ª. —\eW, p.319, 2004.

723815. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’†ˆô“ªG•½”çŠà‚ÌŽ¡—ìÑ. ˆî–ØŸ‰p, ‰iˆä_–¤, ’†ŽR–¾m, ”ª”ö˜a—Y, ‰ª–{–ql (Ž¨•@): ‘æ28‰ñ“ªèò•”Žîᇊw‰ï (2004/6/17), •Ÿ‰ª. —\eW, p.239, 2004.

723816. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒAƒŒƒ‹ƒM[«•@‰Š‚ւ̃gƒŠƒNƒ[ƒ‹|Ž_‰ºb‰î‰»ŠwÜŽèp|Ž¡—ÃŒã‚Ì•@`Çó‚ɑ΂·‚é•a—‘gDŠw“IŒŸ“¢|. ”ª”ö˜a—Y, ²“¡Œ«‘¾˜Y, ‰Pˆä‘å—S, ŒIŒ´—¢‰À, ˆäŒû–F–¾, ¼ŽRkˆê˜Y, ‰ª–{–ql (Ž¨•@): ‘æ43‰ñ“ú–{•@‰ÈŠw‰ï (2004/9/24), “Œ‹ž. —\eW, p.82, 2004.

723817. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒXƒM‰Ô•²Ç‚É‚¨‚¯‚鉺b‰î”S–Œ‚ÌFʕω» (‘æ4•ñ). ²“¡Œ«‘¾˜Y, ”ª”ö˜a—Y, ˆäŒû–F–¾, ¼ŽRkˆê˜Y, ‰Pˆä‘å—S, ‰ª–{–ql (Ž¨•@): ‘æ43‰ñ“ú–{•@‰ÈŠw‰ï (2004/9/24), “Œ‹ž. —\eW, p.104, 2004.

723818. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹}«’ቹáŠQŒ^Š´‰¹“ï’®‚ÌŽ¡—Óà—e‚Æ—\Œã‚ÉŠÖ‚·‚錟“¢. Š™“c‘P”Ž1, …ì“Ö—T1, ²“¡Gº1, ‘ºˆä˜a•v2, ‰ª–{–ql3, Šì‘½‘º@Œ’4 i1ŠâŽèˆã‘å. 2ŠâŽè˜JЕa‰@. 3Ž¨•@. 4“Œ‹žˆãŽ•‘åj: ‘æ49‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2004/10/14), •Ÿ‰ª. Audiology Japan, 47 (5): 331-332, 2004.

723819. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹}«’ቹáŠQŒ^Š´‰¹“ï’®‚Ì’·Šú—\Œã‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²¸. ²“¡Gº1, ‘ºˆä˜a•v1, ‰ª–{–ql2, Šì‘½‘º@Œ’1 (1Šâ“cˆã‘å. 2Ž¨•@): ‘æ49‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2004/10/14), •Ÿ‰ª. Audiology Japan, 47 (5): 333-334, 2004.

723820. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “Ë”­«“ï’® islow typej ‚Ì—Õ°“IŒŸ“¢. ‹´–{‘å–å, ²–ì@”£, V“cŒõ–M, ¬–ì—Yˆê, ‰ª–{–ql (Ž¨•@): ‘æ49‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2004/10/14), •Ÿ‰ª. Audiology Japan, 47 (5): 347-348, 2004.

723821. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) MCL, UCL‚É‚æ‚é•â’®Ší‘•—pŒø‰Ê‚Ì•]‰¿. ²–ì@”£1, ¼•½“oŽu³2, —é–Ø—§ŒbŽq, Œ´@—R‹I2, ‹´–{‘å–å1, 㞊‹M—T1, ˆäãŠG—¢1, ‰Í£“ÖŽq, ‰ª–{–ql1 (1Ž¨•@. 2ˆã‰q): ‘æ49‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2004/10/14), •Ÿ‰ª. Audiology Japan, 47 (5): 451-452, 2004.

723822. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’PŒê‚ð—p‚¢‚½ŽG‰¹‰º‚̌ꉹ—¹‰ðˆæ’lŒŸ¸. ¼•½“oŽu³1, Œ´@—R‹I1, —é–ØŒbŽq1, ˆäã—ŠG2, ‘åÀKŒb2, ‰ª–{“ÖŽq, 㞊‹M—T2, ‹´–{‘å–å2, ²–ì@”£2, ‰ª–{–ql2 (1ˆã‰q. 2Ž¨•@): ‘æ49‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2004/10/14), •Ÿ‰ª. Audiology Japan, 47 (5): 589-590, 2004.

723823. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒ‰ƒbƒgå—‹‚É‚¨‚¯‚éHSP70‚Ì”­Œ». ²–ì@”£, •Ä“c@•q, ˆÉ“¡º•F, ‹´–{‘å–å, ‰ª–{–ql (Ž¨•@): ‘æ14‰ñ“ú–{Ž¨‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï(2004/10/21), ‹ž“s. Otology Japan, 47 (5): 398, 2004.

723824. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “Ë”­«“ï’®‚Ì’·ŠúŠÏŽ@. 㞊‹M—T, ²–ì@”£, ¬–ì—Yˆê, ‹´–{‘å–å, ‰ª–{–ql (Ž¨•@): ‘æ14‰ñ“ú–{Ž¨‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2004/10/21), ‹ž“s. Otology Japan, 47 (5): 493, 2004.

723825. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚鎨d‰»Ç‚ÌŽèp¬Ñ‚Æ’®—Í‘œ‚̂‚¢‚Ä. ’– Œ’Žu, ²–ì@”£1, ’·À‰p–¾1, V“cŒõ–M1, 㞊‹M—T1, ‹´–{‘å–å1, ‰ª–{–ql1 (1Ž¨•@): ‘æ14‰ñ“ú–{Ž¨‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2004/10/21), ‹ž“s. Otology Japan, 47 (5): 493, 2004.

723826. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒƒjƒG[ƒ‹•a‚ÌV‹KŽ¡—Ö@‚ÌŠJ”­‚Æ”­ì‚Ì—\–h‚ɂ‚¢‚Ä. ’·À‰p–¾1, ‰ÍŒ´Ž‰ë2, “¿‘Œú“ñ1, ‹´–{Wˆê˜Y1, ˆÉ“¡º•F1, ˜a“c¹‹»1, ‰ª–{–ql1 (1Ž¨•@. 2¶—): ‘æ63‰ñ“ú–{‚ß‚Ü‚¢•½tˆãŠw‰ï (2004/10/21), ‚è. Equilibrium Res, 63 (5): 440, 2004.

723827. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”½•œ«‚Ì•½tŠoáŠQŠ³ŽÒ‚Ì’·ŠúŒo‰ß‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ˆÉ“¡º•F, ’·À‰p–¾, ‹´–{Wˆê˜Y, ˜a“c¹‹», “¿‘Œú“ñ, ‰ª–{–ql (Ž¨•@): ‘æ63‰ñ“ú–{‚ß‚Ü‚¢•½tˆãŠw‰ï (2004/10/21), ‚è. Equilibrium Res, 63 (5): 445, 2004.

723828. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) BPPV‚Ì”¼‹KŠÇ‹@”\‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ˜a“c¹‹», ’·À‰p–¾, “¿‘Œú“ñ, ‹´–{Wˆê˜Y, ˆÉ“¡º•F, ‰ª–{–ql (Ž¨•@): ‘æ63‰ñ“ú–{‚ß‚Ü‚¢•½tˆãŠw‰ï (2004/10/21), ‚è. Equilibrium Res, 63 (5): 469, 2004.

723829. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) …•½«Ž©”­ŠáU‚Ì•a‘ƒ. “¿‘Œú“ñ, ’·À‰p–¾, ‹´–{Wˆê˜Y, ˆÉ“¡º•F, ˜a“c¹‹», ‰ª–{–ql (Ž¨•@): ‘æ63‰ñ“ú–{‚ß‚Ü‚¢•½tˆãŠw‰ï (2004/10/21), ‚è. Equilibrium Res, 63 (5): 501, 2004.

723830. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) CCDŠá’êƒJƒƒ‰‚É‚æ‚éOcular Torsion‚ÆOcular Counter Reflex‚Ì‘ª’è. ‹´–{Wˆê˜Y, “¿‘Œú“ñ, ’·À‰p–¾, ˆÉ“¡º•F, ˜a“c¹‹», ‰ª–{–ql (Ž¨•@): ‘æ63‰ñ“ú–{‚ß‚Ü‚¢•½tˆãŠw‰ï (2004/10/21), ‚è. Equilibrium Res, 63 (5): 501, 2004.

723831. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹C“¹ˆÙ•¨‚Ì—Õ°“IŒŸ“¢. ³—ˆ@—²1, ”ª”ö˜a—Y1, ¼ŽRkˆê˜Y1, ‰Pˆä‘å—S1, –xŒû—˜”V2, ‰ª–{–ql1 (1Ž¨•@. 2ˆã‰q): ‘æ56‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2004/11/25), “Œ‹ž. —\eW, p.84, 2004.

723832. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰ÈA“ª‰¹ºŠO—ˆ‚É‚¨‚¯‚麑ь‹ß‚Ì—Õ°“Œv. ‰Pˆä‘å—S1, ³—ˆ@—²1, ¼ŽRkˆê˜Y1, –xŒû—˜”V2, ”ª”ö˜a—Y1, œA£@”£2, ‰ª–{–ql1 (1Ž¨•@. 2ˆã‰q): ‘æ56‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2004/11/25), “Œ‹ž. —\eW, p.126, 2004.

723833. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒ|ƒŠ[ƒv—lº‘Ñ‚É‚¨‚¯‚éYAGƒŒ[ƒU[”S–Œ–D‡Žèp–@‚̬Ñ. ¼ŽRkˆê˜Y1, ³—ˆ@—²1, ‰Pˆä‘å—S1, œA£@”£2, ‰ª–{–ql1 (1Ž¨•@. 2ˆã‰q): ‘æ15‰ñ“ú–{“ªèò•”ŠO‰ÈŠw‰ï (2005/1/21), VŠƒ.

723834. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹}«A“ªŠW‰Š‚Ì‹C“¹Šm•Û‚ÌŠÖ‚·‚錟“¢. ‹´–{‘å–å1, ”ª”ö˜a—Y1, ¼ŽRkˆê˜Y1, ³—ˆ@—²1, ‰Pˆä‘å—S1, –xŒû—˜”V2, ‰ª–{–ql1 (1Ž¨•@. 2ˆã‰q): ‘æ17‰ñ“ú–{A“ª‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2005/3/18), –¼ŒÃ‰®. —\eW, p.56, 2005.

731112. [Œ¤‹†‰ï] (“Á•Êu‰‰) Ž¨•@ˆôA‰È‚©‚ç‚Ý‚½‡–°Žž–³ŒÄ‹zÇŒóŒQ. ‰ª–{–ql (Ž¨•@): ‘æ18‰ñ“ŒãŽ¨•@ˆôA‰È—Õ°Œ¤‹†‰ï (2004/8/20), é‹Ê.

731113. [Œ¤‹†‰ï] (“Á•Êu‰‰) “àŽ¨‘O’ëŠí‚Ì3ŽŸŒ³Œ`‘Ô‚ÆŽ¨ÎŠí‹@”\ŒŸ¸. ’·À‰p–¾ (Ž¨•@): ‘æ64‰ñ‘Š•Ž¨•@‰ÈŒ¤‹†‰ï (2004/10/9), ‘Š–ÍŒ´.

732054. [Œ¤‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€) u•@‚͇–°ŒÄ‹záŠQ‚Ƃǂ̂悤‚ÉŠÖ‚í‚Á‚Ä‚¢‚é‚Ì‚©v OSAHS‚Æ•@Ž¾Š³‚ɂ‚¢‚Ä. ’|“c¹•F (Ž¨•@): ‘æ11‰ñ‡–°ŒÄ‹záŠQŒ¤‹†‰ïŽ¨•@ˆôA‰È•”‰ï (2004/7/9), “Œ‹ž.

732055. [Œ¤‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€) “àƒŠƒ“ƒp…Žî‚ÆADH. ’·À‰p–¾ (Ž¨•@): ‘æ13‰ñ–k—¢‘åŠwŽ¨•@ˆôA‰ÈŒ¤‹†‰ï(2004/10/30), ‘Š–ÍŒ´.

733432. [Œ¤‹†‰ï] (ˆê”Êu‰‰) º‘Ñ“àŽ©‰Æ‘¤“ª‹Ø–ŒˆÚA‚É‚æ‚é”â—ô“à•ûˆÚ“®‚ÌŒŸ“¢ i‘æ2•ñj. ¼ŽRkˆê˜Y1, œA£@”£2, ³—ˆ@—²3, 㞊‹M—T3, ‹´–{‘å–å3, ‰Pˆä‘å—S3, ”ª”ö˜a—Y3, ‰ª–{–ql3 (1‰¡•lŽs–¯•a‰@. 2‘å˜a“¿B‰ï•a‰@. 3Ž¨•@): ‘æ27‰ñ“Œ“ú–{‰¹ºŠO‰ÈŒ¤‹†‰ï (2004/4/10), “Œ‹ž.

733433. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) GradenigoÇŒóŒQ‚̈ê—á. –q@“ÖŽq, ²–ì@”£, ‹{–{r•ã, ”ª”ö˜a—Y, ‰ª–{–ql (Ž¨•@): “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ128‰ñŽ¨•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2004/6/24), ‰¡•l.

733434. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “–‰È‚É‚¨‚¯‚é‚¢‚Ñ‚«ŠO—ˆ‚ÌŒ»‹µ. ‘å‹´Œ’‘¾˜Y, ’|“c¹•F, ‹{–{r•ã, ”ª”ö˜a—Y, ‰ª–{–ql (Ž¨•@): “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ128‰ñŽ¨•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2004/6/26), ‰¡•l.

733435. [Œ¤‹†] (ˆê”Êu‰‰) ’±Œ`œ“´^‹ÛÇ‚Ì2Ç—á. ´–ì—R”y, —é–Ø—§r, ‹´–{Wˆê˜Y, ‰¡–x@Šw, ”ª”ö˜a—Y, ‰ª–{–ql (Ž¨•@): ‘æ34‰ñ“ú–{Ž¨•@ˆôA‰ÈŠ´õÇŒ¤‹†‰ï (2004/9/3), ŽOd.

733436. [Œ¤‹†] (ˆê”Êu‰‰) ¬Ž™Šáâ|œ–Œ‰º”^ᇂÌ1—á. —é–Ø—§r, ´–ì—R”y, ‰¡–x@Šw, ”ª”ö˜a—Y, ‰ª–{–ql (Ž¨•@): ‘æ34‰ñ“ú–{Ž¨•@ˆôA‰ÈŠ´õÇŒ¤‹†‰ï (2004/9/3), ŽOd. Œ¤‹†‰ï‰ïŽ, 23 (1): 56-60, 2004.

733437. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) pŒã”xÇðǂ̈ê—á. ˜a“c¹‹», ‹´–{‘å–å, ‰Pˆä‘å—S, ‹{–{r•ã, ‰ª–{–ql (Ž¨•@): “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ129‰ñŽ¨•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2004/9/11), ‰¡•l.

733438. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) A“ªè÷—±×–EŽî‚̈ê—á. “sì’m”V, ‹{–{r•ã, ‰ª–{–ql, Έä–L‘¾, ŽR–{ˆê”Ž (Ž¨•@): “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ129‰ñŽ¨•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2004/9/11), ‰¡•l.

733439. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) º‘Ñ“àŽ©‰Æ‘¤“ª‹Ø–ŒˆÚAp‚Æ”â—ô“à“]pEbó“`¬p‚Æ‚Ì”äŠrŒŸ“¢. ¼ŽRkˆê˜Y1, –xŒû—˜”V2, ³—ˆ@—²1, ‰Pˆä‘å—S1, ‹{–{r•ã1, ‰ª–{–ql1 (1Ž¨•@. 2ˆã‰q): “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ129‰ñŽ¨•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2004/9/11), ‰¡•l.

733440. [Œ¤‹†‰ï] (ˆê”Êu‰‰) pŒã”xÇðǂɂ‚¢‚Ä. ˜a“c³‹» (Ž¨•@): ‘æ64‰ñ‘Š•Ž¨•@‰ÈŒ¤‹†‰ï (2004/10/9), ‘Š–ÍŒ´.

733441. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “ûŽ™ŠO«Šç–Ê_Œo–ƒáƒ‚̈ê—á. ‰¡ŠÖ—Sˆê˜Y, ‰Pˆä‘å—S, ˆÉ“¡º•F, ‰ª–{–ql (Ž¨•@): “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ130‰ñŽ¨•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2004/12/11), ‰¡•l.

733442. [Œ¤‹†•ñ‰ï] (ˆê”Êu‰‰) Vasopressin“Š—^Œã‚ÌEP‚̕ω»@ŽÀŒ±“I“àƒŠƒ“ƒp…Žîƒ‚ƒfƒ‹. ’·À‰p–¾1, ‰ÍŒ´Ž‰ë2, ‰ª–{–ql1 (1Ž¨•@. 2¶—): Œú¶˜J“­‰ÈŠwŒ¤‹†”ïi“«Ž¾Š³Ž•žŽ–‹Æj ‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²¸Œ¤‹†•½¬16”N“xŒ¤‹†•ñ‰ï (2005/2/9), “Œ‹ž.

733443. [Œ¤‹†•ñ‰ï] (ˆê”Êu‰‰) “Ë”­«“ï’®‚ɑ΂·‚鎡Œ±‚Ì“r’†Œo‰ß. ²–ì@”£, ‹´–{‘å–å, 㞊‹M—T, ¬–ì—Yˆê, ‰ª–{–ql (Ž¨•@): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï i“«Ž¾Š³Ž•žŽ–‹Æj ‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²¸Œ¤‹†•½¬16”N“xŒ¤‹†•ñ‰ï (2005/2/19), “Œ‹ž.

733444. [Œ¤‹†•ñ‰ï] (ˆê”Êu) ‹}«’ቹáŠQŠ´‰¹“ï’®_“Þ쌧’²¸ i‘æ1•ñj. 㞊‹M—T, ²–ì@”£, ‹´–{‘å–å, ¬–ì—Yˆê, ‰ª–{–ql (Ž¨•@): Œú¶˜J“­‰ÈŠwŒ¤‹†”ï i“«Ž¾Š³Ž•žŽ–‹Æj ‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²¸Œ¤‹†•½¬16”N“xŒ¤‹†•ñ‰ï (2005/2/19), “Œ‹ž.

733445. [Œ¤‹†•ñ‰ï] (ˆê”Êu‰‰) ‹}«’ቹáŠQŒ^Š´‰¹“ï’®‚Ì’·Šú—\Œã‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²¸. ²“¡Gº1, ‘ºˆä˜a•v2, ‰ª–{–ql3, Šì‘½‘º@Œ’4 (1ŠâŽèˆã‘å. 2ŠâŽè˜JЕa‰@. 3Ž¨•@. 4“Œ‹žˆãŽ•‘åj: Œú¶˜J“­‰ÈŠwŒ¤‹†”ï i“«Ž¾Š³Ž•žŽ–‹Æj ‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²¸Œ¤‹†•½¬16”N“xŒ¤‹†•ñ‰ï (2005/2/19), “Œ‹ž.

733446. [Œ¤‹†‰ï] (ˆê”Êu‰‰) dÇSgáŠQŽÒ iŽ™j ‚ɑ΂·‚éŒëš‹–hŽ~ŽèpÇ—á. ³—ˆ@—²1, –xŒû—˜”V2, ¼ŽRkˆê˜Y3, ‰Pˆä‘å—S1, ”ª”ö˜a—Y1, ‰ª–{–ql1 (1Ž¨•@. 2ˆã‰q. 3‰¡•lŽs–¯•a‰@): “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ4‰ñš‹‰ºŒ¤‹†‰ï (2005/3/12), ‰¡•l.

733447. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‰fŽž“Ë”­«“ï’®‚ª‹^‚í‚ꂽ¬”]”]Š²[Ç‚Ì1—á. “sì’m”V, ²–ì@”£, 㞊‹M—T, ‰Pˆä‘å—S, ‰ª–{–ql (Ž¨•@): “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ131‰ñŽ¨•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2005/3/26), ‰¡•l.


<<¸_‰ÈŠw>>

mŠwp˜_•¶n

110184. [Œ´’˜] Massive Pulmonary Thromboembolism Demonstrated at Necropsy in japanese psychiatric patients Treated with Neuroleptics lncluding Atypical Antipsychoics. •l’†‘Žq1, 㞊‹gl2, ‰iˆä’q‹I3, ŒIŒ´Ž—R3, K Tanaka4, ‘Š”nˆêˆå2, ‹{‰ª@“™1 (1¸. 2‹~–½. 3–@ˆã. 4ˆã—ÃŒn‘åŠw‰@): Circulation Journal, 68: 850-852, 2004.

110185. [Œ´’˜] Daily omega-3 fatty acid intake and depression in japanese patiennts with newly diagosed lung cancer. —é–ØŽu–ƒŽq1,2, T Akechi3, ¬—ÑŽÀ‰Ä, ’JŒûKŽi2, Œã“¡Œ÷ˆê2, S Sasaki, ’Ë่ê˜Y2, ¼˜e@—T3, ‹{‰ª@“™1, “à•x—f‰î2 (1¸. 2‘—§‚ª‚ñƒZƒ“ƒ^[Œ¤‹†ŠŽxŠ. 3‘—§‚ª‚ñƒZƒ“ƒ^[“Œ•a‰@): British Journal of Cancer, 90: 787-793, 2004.

110186. [Œ´’˜] Effects of intraperitoneal administration of interferon- alpha for one, four and fourteen days on amino acid levels in various rat brain regions. ‰¡ŽR³@1, —é–؉f“ñ1, ²“¡@‘ñ1, ŠÛ“cCŽj1, ˆî“c@Œ’1, “n•Ó@Ž 2, ‹{‰ª@“™1 (1¸. 2¶•¨•¨—Œn): J Inte‚†eron Cytokine Res, 25: 187-191, 2005.

110187. [Œ´’˜] Aconiti tuber increases plasma nitrite and nitrate levels in humans. K Yamada1, —é–؉f“ñ2, T Nakaki3, “n•Ó@Ž 4, S Kanda1 (1ŽR—œ‘å. 2¸. 3’é‹ž‘å. 4¶•¨•¨—Œn): Journal of Ethnopharmacology, 96: 165-169, 2005.

110188. [Œ´’˜] Amygdalic levels of dopamine and serotonin rise upon exposure to conditioned fear stress without elevation of glutamate. ‰¡ŽR³@1, —é–؉f“ñ1, ²“¡@‘ñ1, ŠÛ“cCŽj1, “n•Ó@Ž 2, ‹{‰ª@“™1 (1¸. 2¶•¨•¨—Œn): Neurosci Lett, 379: 37-41, 2005.

120094. [Œ´’˜] ‘åŠw•a‰@‚É‚¨‚¯‚é¸_‰È‹}«Šú“ü‰@ˆã—ẪNƒŠƒjƒJƒ‹ƒpƒX‚ÌŒ»ó. ‚‹´@Œb, •Ÿ“c^“¹, ‹{‰ª@“™ (¸): ¸_ˆãŠw, 46 (11): 1169-1176, 2004.

120095. [Œ´’˜] V‹KR¸_•a–ò“±“ü‘OŒã‚Ì‹}«Šú“ü‰@Ž¡—ËZ–@‚̕ω». ‹{’nLŒá1, “¡ˆäN’j2 (1¸. 2ŽR—œŒ§—§–k•a‰@): —Õ°¸_–ò—, 7: 1501-1505, 2004.

220059. [€Œ´’˜] ”F’ms“®—Ö@‚ð’†S‚Æ‚µ‚½ƒAƒ‹ƒR[ƒ‹ˆË‘¶Ç‚ÌV“ü‰@Ž¡—ÃvƒƒOƒ‰ƒ€. àVŽR@“§1, •Ä“cƒˆê2, ”’싳l2, ‰Y–ì—mŽq3, ˆÉ“¡ŒjŽq3, ”óŒû@i2, ‹{‰ª@“™1, ”’‘qŽ”V2 (1¸. 2‹v—¢•l•a‰@¸_‰È. 3‹v—¢•l•a‰@ŠÅŒì•”): ¸__ŒoŠwŽGŽ, 106: 161-174, 2004.

520264. [‘à] ¸_Ž¾Š³Š³ŽÒ‚É‚¨‚¯‚éƒTƒCƒRƒIƒ“ƒRƒƒW[‚ÌŽÀ‘H. Œ@ŒcŽq1,2, ‰„“¡–ƒŽq2, Œ@ƒˆê1,2, ‹g“c–FŽq1, ‹{‰ª@“™1 (1¸. 2“Ö‰ê•a‰@): —Õ°¸_ˆãŠw, 33: 591-596, 2004.

520265. [‘à] ƒTƒCƒRƒIƒ“ƒRƒƒW[‚É‚¨‚¯‚錤‹†‚ÆŽÀ‘H‚̘AŒg. ‹{‰ª@“™, ‹g絑PF (¸): —Õ°¸_ˆãŠw, 33: 495-498, 2004.

520266. [‘à] S‹CÇó‚ɑ΂·‚é–ò•¨—Ö@. ‹{‰ª@“™ (¸): ¡ŒŽ‚ÌŽ¡—Ã, 12: 51-54, 2004.

520267. [‘à] ‚¤‚•a‚Ì“]‹A‚ÉŠÖ‚·‚éƒGƒrƒfƒ“ƒX. –؉º—æŽq, ‹{‰ª@“™ (¸): EBMƒWƒƒ[ƒiƒ‹, 15: 62-65, 2004.

520268. [‘à] ˆê”ÊŽ¡—Öò‚É‚æ‚é¸_áŠQ. –؉º—æŽq, ‹{‰ª@“™ (¸): ¸_‰ÈŽ¡—Êw, 19 (‘): 127-130, 2004.

520269. [‘à] S‹CÇ‚Æ‚»‚ÌŽü•Ó. –Ø™Ç@‚©‚¨‚è, ‹{’n‰p—Y, ‹{‰ª@“™ (¸): ’É‚Ý‚Æ—Õ°, 4: 17-23, 2004.

520270. [‘à] ‚ª‚ñŠ³ŽÒ‚Ì—}‚¤‚‚ɑ΂·‚é–ò•¨—Ö@‚̃Gƒrƒfƒ“ƒX. —é–ØŽu–ƒŽq, ‹{‰ª@“™ (¸): EBMƒWƒƒ[ƒiƒ‹ 5: 547-552, 2004.

520271. [‘à] ”F’ms“®—Ö@‚ð’†S‚Æ‚µ‚½ƒAƒ‹ƒR[ƒ‹ˆË‘¶Ç‚ÌV“ü‰@Ž¡—ÃvƒƒOƒ‰ƒ€. àVŽR@“§ (¸): ¸__ŒoŠwŽGŽ, 160: 161-174, 2004.

520272. [‘à] –¡ŠoEškŠo‚̈Ùí‚ÆŒûo“à‚Ì‘ÌŠ´ˆÙí. ‹{’n‰p—Y, ‹{‰ª@“™ (¸): ˜V”N¸_ˆãŠwŽGŽ, 15: 299-305, 2004.

520273. [‘à] ˆã—ÖÊڂƸ_ˆãŠw. ‹{‰ª@“™ (¸): ¸__ŒoŠwŽGŽ, 106: 512-514, 2004.

520274. [‘à] V‹KR‚¤‚–ò‚Í‚¤‚•a—Õ°‚ð•Ï‚¦‚½‚©. ‹{‰ª@“™ (¸): ¸__ŒoŠwŽGŽ, 106: 933-935, 2004.

520275. [‘à] f—ÕñV‚ªŽ¡—Ö@‚É‚Ç‚¤‰e‹¿‚·‚é‚©. ‹g絋`F (¸): ‚±‚±‚ë‚̉Ȋw, 116: 28-33, 2004.

520276. [‘à] Õ“®‚Ì_Œo¶•¨Šw. ‰¡ŽR³@, —é–؉f“ñ (¸): —Õ°¸_ˆãŠw, 34 (2): 203-211, 2004.

520277. [‘à] ¶•¨Šw“I¸_ˆãŠwŒ¤‹†‚ÌŒ»ó‚Æ“W–]@–k—¢‘åŠw‚É‚¨‚¯‚鶕¨Šw“I¸_ˆãŠwŒ¤‹†‚Ö‚ÌŽæ‚è‘g‚Ý. —é–؉f“ñ1, ‚‹´@Œb1, âV“¡³”Í1, ‰¡ŽR³@1, ˆî“c@Œ’1, ‹{‰ª@“™1, “n•Ó@Ž 2 (1¸. 2¶•¨•¨—Œn): ”]‚Ƹ_‚̈ãŠw, 15: 8-14, 2004.

520278. [‘à] SSRI‚ÆSNRI‚Ì”äŠr; ŠCŠO‚É‚¨‚¯‚é–³ìˆ×2d–ÓŒŸŽŽŒ±‚̃Œƒrƒ…[. —é–؉f“ñ, ŠÛ“cCŽj (¸): ¸__ŒoŠwŽGŽ, 160 (10): 1203-1217, 2004.

520279. [‘à] “K‰žáŠQ‚Æ‚Í‚Ç‚ñ‚È•a‹C‚©. ‹{‰ª@“™ (¸): –ˆ“úƒ‰ƒCƒt3ŒŽ†: 12-17, 2005.

520280. [‘à] ‚¤‚•a‚É‚¨‚¯‚éƒvƒ‰ƒCƒ}ƒŠƒPƒAˆã‚Ƹ_‰Èˆã‚̘AŒg. ‹{‰ª@“™ (¸): ƒNƒŠƒjƒJƒ‹ƒvƒ‰ƒNƒeƒBƒX, 24: 40-43, 2005.

520281. [‘à] ’èŒ^R¸_•a–ò‚Å‚È‚­, clozapine‚ª“‡Ž¸’²ÇŠ³ŽÒ‚ÌP50—}§‚ÌŒ‡”@‚𥳂·‚é. –؉º—æŽq, âV“¡³”Í (¸): Schizoph Front, 5 (3): 201, 2004.

520282. [‘à] “‡Ž¸’²Ç”­•aŒã10”NŠÔ‚Ì”]Žº•Ï‰». HàVç°, âV“¡³”Í (¸): Schizoph Front, 5 (3): 201-202, 2004.

520283. [‘à] “‡Ž¸’²Ç‚É‚¨‚¯‚écatechol-O-methyltransferase Val158Met‘½Œ^. Ž›–{Œb”g, âV“¡³”Í (¸): Schizoph Front, 5 (3): 202, 2004.

m’˜@‘n

620150. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ‹H‚Å“ÁˆÙ‚ȸ_ÇŒóŒQ‚È‚¢‚µó‘ÔÛ; Œûo“àƒZƒlƒXƒgƒpƒ`[, p.100-108. ‹{‰ª@“™, “c–ìKr˜Y (¸), •ÒW ’†ˆÀM•v (“Œ‹ž‘å), ¯˜a‘“X, “Œ‹ž, 2004/4/21”­s.

620151. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ƒ`ƒƒ[ƒgŽ®: ‚±‚ñ‚ÈŠ³ŽÒ‚ª—ˆ‰@‚µ‚½‚ç Ž•‰ÈŽ¡—ÂƑSgŽ¾Š³; ¸_Ž¾Š³, p.118-121. ˜a‹C—T”V1, ‹{‰ª@“™2 (1‚݂ǂ謎™Ž•‰È. 2¸), •ÒW ˜a“ˆ_ˆê1, ˆäã@F2, ˜a‹C—T”V3 (1Œc‰ž‘å. 2“Œ‹žŽ•‘å. 3‚݂ǂ謎™Ž•‰È), ƒfƒ“ƒ^ƒ‹ƒ_ƒCƒ„ƒ‚ƒ“ƒhŽÐ, “Œ‹ž, 2004/4/1”­s.

620152. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ˜’Å•Ï«Ž¾Š³@Šî–{’mŽ¯‚ƃ`ƒFƒbƒNƒ|ƒCƒ“ƒg; SgˆãŠw‚©‚ç‚Ý‚½˜’É, p.149-152. ‹{‰ª@“™ (¸), •ÒW —é–ØM³, ’†Œ´i”V‰î, –쌴@—T, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/6/1”­s.

620153. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) V—Õ°Œ¤C‚Ì‚½‚ß‚Ì‹~‹}f—ÃKƒCƒhƒ‰ƒCƒ“; ‚¹‚ñ–Ï, p.232-233. ‹{‰ª@“™ (¸), •ÒW ‰ª–{˜a•¶1, ‘Š”nˆêˆå2, ŽR‰È@Í3, ŽR“cŽŠN4, s‰ª“N’j3 (1MB‘å. 2‹~–½. 3“Œ‹ž‰È‘å. 4˜ZbƒAƒCƒ‰ƒ“ƒh•a‰@), ‘‡ˆãŠwŽÐ, “Œ‹ž, 2004/7/28”­s.

620154. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ³‚µ‚¢f—Ø^‚Ì‘‚«•û: ¸_‰È, p.125-140. ‹{‰ª@“™, ‚‹´@Œb, ‹g絑PF (¸), •ÒW ˆ¢•”D•¶1, ‹´–{—z•½2 (1“c–¼•a‰@. 2ŽRŒû‘å), ’©‘q‘“X, “Œ‹ž, 2004/6/30”­s.

620155. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ƒXƒgƒŒƒXŽ¾Š³ƒiƒrƒQ[ƒ^[; •sˆÀáŠQ‚Ìf’fŠî€[‹C•ª•Ï’²ÇE‹C•ªzŠÂÇ, p.60-61. ²“¡@‘ñ, ‹{‰ª@“™ (¸), •ÒW ‹v•Û–Ø•x–[1, ’†‘º@ƒ2, ŽR˜e¬l3 (1“Œ‹ž‘å. 2ŽY‹Æˆã‘å. 3L“‡‘å), ƒƒfƒBƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/6/25”­s.

620156. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ƒXƒgƒŒƒXŽ¾Š³ƒiƒrƒQ[À°•ª; •sˆÀáŠQ‚ÌŽ¡—ÃŽwj|‹C•ª•Ï’²ÇE‹C•ªzŠÂÇ, p.92-93. ²“¡@‘ñ, ‹{‰ª@“™ (¸), •ÒW ‹v•Û–Ø•x–[1, ’†‘º@ƒ2, ŽR˜e¬l3 (1“Œ‹ž‘å. 2ŽY‹Æˆã‘å. 3L“‡‘å), ƒƒfƒBƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/6/25”­s.

620157. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ”õ‚¦‚ĈÀS: ƒ`ƒFƒA[ƒTƒCƒh‚ÌŽå‘i‘Ήžƒ}ƒjƒ…ƒAƒ‹; ã‚Ì’É‚Ý‚ð‘i‚¦‚Ä‚¢‚é (ã’ÉÇ), p.46-50. ŒN“‡ËŽq1, ˜a‹C—T”V1, “n•Ó—TŽq1, “VŠ}Œõ—Y1, ‹{’n‰p—Y2, ‹{‰ª@“™2 (1“Œ‹žˆãŽ•‘åE‰@D2¸): •ÒW ˜a‹C—T”V1, ŠO–ØŽç—Y2, ‹Ê’uŸŽi3 (1‚݂ǂ謎™Ž•‰È. 2“Œ‹žŽ•‘å. 3_“Þ쎕‘å), ƒfƒ“ƒ^ƒ‹ƒ_ƒCƒ„ƒ‚ƒ“ƒhŽÐ, “Œ‹ž, 2004/7/1”­s.

620158. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ¡“ú‚ÌŽ¡—ÂƊŌì; g‘Ì•\Œ»«áŠQ, p.837-840. ‹v‘º³Ž÷, ‹{‰ª@“™ (¸), ŠÄC …“‡@—T, •ì@´, “ì]“°, “Œ‹ž, 2004/5/10”­s.

620159. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ¸_áŠQ‚Ì—Õ°; SgÇ‚ÆŠe‰È—Õ°‚É‚¨‚¯‚éSgˆãŠw, p.274-277. ‹{‰ª@“™ (¸), •ÒWEŠÄC 㓇‘—˜, ‹“‡’èM, •“c‰ër, ’O‰H^ˆê, ‹{‰ª@“™, “ú–{ˆãŽt‰ï, “Œ‹ž, 2004/6/15”­s.

620160. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ¸_áŠQ‚Ì—Õ°; ¸_áŠQ‚©‚çf’fEŽ¡—ÂÖ, p.48-50. ‹{‰ª@“™ (¸), •ÒWEŠÄC 㓇‘—˜, ‹“‡’èM, •“c‰ër, ’O‰H^ˆê, ‹{‰ª@“™, “ú–{ˆãŽt‰ï, “Œ‹ž, 2004/6/15”­s.

620161. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ¸_áŠQ‚Ì—Õ°; Œ´ˆö•s–¾‚Ìg‘ÌD‘i (’É‚Ý‚ðŠÜ‚Þ) ‚ð‘i‚¦‚é, p.124-125. ‹{‰ª@“™ (¸), •ÒWEŠÄC 㓇‘—˜, ‹“‡’èM, •“c‰ër, ’O‰H^ˆê, ‹{‰ª@“™, “ú–{ˆãŽt‰ï, “Œ‹ž, 2004/6/15”­s.

620162. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ¸_áŠQ‚Ì—Õ°; Ž©ŒÈ‹L“üŽ®S—ƒeƒXƒg, p.62-63. ‹{‰ª@“™ (¸), •ÒWEŠÄC 㓇‘—˜, ‹“‡’èM, •“c‰ër, ’O‰H^ˆê, ‹{‰ª@“™, “ú–{ˆãŽt‰ï, “Œ‹ž, 2004/6/15”­s.

620163. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) Š{ŠÖßÇf’fEŽ¡—Ã}ƒjƒ…ƒAƒ‹; Š{ŠÖßÇVŒ^‚Ìf’f, p.34-37. ˜a‹C—T”V1, ‹{‰ª@“™2 (1‚݂ǂ謎™Ž•‰È. 2¸), ŠÄC ”Ñ’Ë’‰•F, ‰i––‘“X, ‹ž“s, 2004/8/31”­s.

620164. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ¸_áŠQ‚Ì—Õ°; ¸_Ž¾Š³f’f‚É•K—v‚Èg‘Ì–Ê‚ÌŒŸ¸, p.68-71. ‚‹´@Œb (¸), •ÒWEŠÄC 㓇‘—˜, ‹“‡’èM, •“c‰ër, ’O‰H^ˆê, ‹{‰ª@“™1 (1¸), “ú–{ˆãŽt‰ï, “Œ‹ž, 2004/6/15”­s.

620165. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•ME•ÒW) ¸_‰È@•K{–ò‚ð’T‚é; VˆãŽt—Õ°Œ¤C§“x‚Æ•K{Œü¸_–ò, p.215-225. ‹{‰ª@“™, âV“¡³”Í (¸), •ÒW ‹{‰ª@“™, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2004/11/20”­s.

620166. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ”]_ŒoŠO‰È‹~‹}; ¸_Çó, p.111-117. ‚‹´Œb—, ‹{‰ª@“™ (¸), •ÒW ŽR‰Y@» (‘•ÒW), —L‰ê@“O (ê–å•ÒW), ’†ŽR‘“X, “Œ‹ž, 2005/3/31”­s.

620167. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ¸_‰ÈE_Œo‰Èƒi[ƒX‚ÌŽ¾Š³•ÊƒPƒAƒnƒ“ƒhƒuƒbƒN; SgÇ, p.129-133. HàVç°, ‹{‰ª@“™ (¸), •ÒW ˆäãW•½, ƒƒfƒBƒJƒ‹o”Å, ‘åã, 2005/3/10”­s.

620168. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ‚ЂƂƓ®•¨‚Ì‚©‚©‚í‚è; ¸_‰Èˆã‚©‚猩‚½l‚ƃyƒbƒg‚Ì‚©‚©‚í‚è, p.49-58, ‹g“c–FŽq (¸), •ÒW —{˜V–ÐŽi (‘åŠw‰@‹³Žö), ‰Ío‘–[VŽÐ, “Œ‹ž, 2005/2/28”­s.

620169. [‹³‰È‘] (•ª’SŽ·•M) ‹~‹}f—ÃKƒCƒhƒ‰ƒCƒ“; ¬l‹~‹}•Ò@Ž©ŽEŠé‰æ p.234-235. ‚¤‚•a, p.352-353. ‹g“c–FŽq (¸), •ÒW ‰ª–{˜a•¶1, ‘Š”nˆêˆå2, ŽR‰È@Í3, ŽR“cŽŠN4, s‰ª“N’j3 (1MB‘å. 2‹~–½. 3“Œ‹žˆã‘å. 4˜ZbƒAƒCƒ‰ƒ“ƒh•a‰@), ‘‡ˆãŠwŽÐ, “Œ‹ž, 2004/7/28”­s.

620170. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ¸_‰È•K{–ò‚ð’T‚é; ¸_Ž¾Š³Ž¡—Öò@‘o‹É«áŠQ, p.21-35. —é–؉f“ñ, ‘”n@r (¸), •ÒW ‹{‰ª@“™ (¸), ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2004/11/20”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

713201. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer. —é–ØŽu–ƒŽq1,2, Tatsuo Akechi3, ¬—ÑŽÀ‰Ä1, ’JŒûKŽi1, Œã“¡Œ÷ˆê1, ²X–Ø@•q4, ’Ë่ê˜Y1, ¼˜e@—T3, ‹{‰ª@“™2, “à•x—f‰î1 (1‘—§‚ª‚ñƒZƒ“ƒ^[Œ¤‹†ŠŽxŠ. 2¸. 3‘—§‚ª‚ñƒZƒ“ƒ^[“Œ•a‰@. 4‘—§Œ’NE‰h—{Œ¤‹†Š): 7th World Congress of Psycho-oncology (2004/8/25-28), Copenhagen, Denmark.

713202. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Conditioned Stimulus and Amygdalic Amino Acids. ‰¡ŽR³@1, —é–؉f“ñ1, ²“¡@‘ñ1, ŠÛ“cCŽj1, ˆî“c@Œ’1, “n•Ó@Ž 2, ‹{‰ª@“™1 (1¸. 2¶•¨•¨—Œn): 7th International Congress of Biological Psychiatry (2005/2/9-12), Sydney, Australia.

713203. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Effects of Fear Conditioned Stress on Nitrate Levels in Amygdala. ²“¡@‘ñ1, —é–؉f“ñ1, ‰¡ŽR³@1, ˆî“c@Œ’1, ŠÛ“cCŽj1, “n•Ó@Ž 2, ‹{‰ª@“™1 (1¸. 2¶•¨•¨—Œn): 7th International Congress of Biological Psychiatry (2005/2/9-12), Sydney, Australia.

713204. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Effect of interferon-alpha on monoamines and amino acids in the central nervous system. ‰¡ŽR³@1, —é–؉f“ñ1, ²“¡@‘ñ1, ˆî“c@Œ’1, ŠÛ“cCŽj1, “n•Ó@Ž 2, ‹{‰ª@“™1 (1¸. 2¶•¨•¨—Œn): The CINP (Collegium Internationale Neuro-Psychopharmacologicum) Congress (2004/6), Paris, France.

713205. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Dopamine-related gene polymorphisms and Autism. ŽR–{Œ«Ži1, Sato-Koishi S, Koishi S, Natsume N, Yamazaki K, Nanba E, Sasaki T, Kato N, Matsumoto H (1¸): The 16th International Congress of the International Association for Child and Adolescent Psychiatry and Allied Professions (IACAPAP) (2004/8/24), Berline, Germany.

713206. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) The relationship among anxiety, emotional suppression, and psychological distress before and after breast cancer diagnosis. Iwamitsu Y1, Shimoda K2, Abe H3, Tani T3, Okawa M3, ‹{‰ª@“™4, Ross Buck5 (1ˆã—ÃŒn‘åŠw‰@. 2àÕ‹¦ˆã‘å. 3Ž ‰êˆã‘å 4¸. 5Department of Communication Sciences, University of Connecticut): International Symposium New Perspectives in Affective Science (2005/1/29), ‹ž“s. Program & Abstracts, p.36, 2005.

713207. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Correlation among depression, care burden and QOL of caregivers of dementia patients (’s•ðŠ³ŽÒ‰îŒìŽÒ‚Ì—}‚¤‚Â, ‰îŒì•‰’S‚ÆQOL‚ÌŠÖ˜A). ‚‹´@Œb, ’†“‡Œ[‰î, “c’†Žr, ‹{‰ª@“™ (¸): ‘ÛƒAƒ‹ƒcƒnƒCƒ}[•a‹¦‰ï‘æ20‰ñ‘Û‰ï‹c (2004/10/16), ‹ž“s.

721014. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) Ž•‰ÈSgˆãŠw‚Ö‚ÌŠú‘Ò. ‹{‰ª@“™ (¸): ‘æ19‰ñ“ú–{Ž•‰ÈSgˆãŠw‰ï‘‰ï (2004/7/17-18), “Œ‹ž.

722106. [Šw‰ï (‘S‘)] (µ‘Òu‰‰) “ª”çã”]”g‚Å‘ÌŒ±‚Í‚í‚©‚é‚©. âV“¡³”Í (¸): ‘æ34‰ñ“ú–{—Õ°_Œo¶—Šw‰ïŠwp‘å‰ï (2004), “Œ‹ž.

723835. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Interferon–«“Š—^‚É‚æ‚éserotonin transporter ‚RNA‚Ì”­Œ». ²“¡@‘ñ1, å”gƒˆê2, —é–؉f“ñ1, ‰¡ŽR³@1, “n•Ó@Ž 3, ŠÛ“cCŽj1, ˆî“c@Œ’1, ‹{‰ª@“™1 (1¸. 2•ú‘—‘å. 3¶•¨•¨—Œn): ‘æ26‰ñ“ú–{¶•¨Šw“I¸_ˆãŠw‰ï ‘æ34‰ñ“ú–{_Œo¸_–ò—Šw‰ï‡“¯‘å‰ï (2004/4), “Œ‹ž.

723836. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) V‹KR¸_•a–ò“±“ü‘OŒã‚Ì‹}«Šú“ü‰@Ž¡—ËZ–@‚̕ω». ‹{’nLŒá1, “¡ˆäN’j2 (1¸. 2ŽR—œŒ§—§–k•a‰@): ‘æ100‰ñ“ú–{¸__ŒoŠw‰ï‘‰ï (2004/5/21), ŽD–y. ¸__ŒoŠwŽGŽ, 106 (11): 1433-1434, 2004.

723837. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ˆãŽt‚ÍS—Žm‚ɉ½‚ð‹‚ß‚é‚©|ˆãŽt‘¤‚Ì’mŽ¯‚Æ‚ÌŠÖŒW|. ‹{‰ª@“™ (¸): ‘æ45‰ñ“ú–{SgˆãŠw‰ï (2004/6/4), –k‹ãB.

723838. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒAƒ‹ƒcƒnƒCƒ}[Œ^’s•ðŠ³ŽÒ‚̸_Çó. ‚‹´@Œb, “c㊰Žq, •½”ö‘׎q, ’†“‡Œ[‰î, ‘åÎ@’q, ]‘º@‘å, ‹{‰ª@“™ (¸): ‘æ19‰ñ“ú–{˜V”N¸_ˆãŠw‰ï (2004/6/26), ¼–{.

723839. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘åŠw•a‰@‚̸_‰ÈƒŠƒGƒ]ƒ“‚Éè‚ß‚é‚—îŽÒ‚Ì“Á’¥. ’†“‡Œ[‰î, ‚‹´@Œb, ‰Ã”[–¾Žq, ]‘º@‘å, ‘åÎ@’q, ‹{‰ª@“™ (¸): ‘æ19‰ñ“ú–{˜V”N¸_ˆãŠw‰ï (2004/6/26), ¼–{.

723840. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ¸_‰È‹~‹}ˆã—Â̌»ó‚Æ–â‘è“_|_“Þ쌧‚ÌŒ»ó‚Æ‘åŠw•a‰@‚Æ‚µ‚Ä‚ÌŠÖ‚í‚è|. ‹{‰ª@“™ (¸): ‘æ32‰ñ“ú–{¸_‰È•a‰@‹¦‰ï¸_ˆãŠw‰ï (2004/7/15-16), _ŒË. ´˜^W, p.50, 2004.

723841. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒCƒ“ƒ^[ƒtƒFƒƒ“EƒAƒ‹ƒtƒ@ˆŸ‹}«“Š—^‚É‚æ‚郉ƒbƒg”]“à‚ÌŠeŽíƒAƒ~ƒmŽ_”Z“x‚̕ω». ‰¡ŽR³@1, —é–؉f“ñ1, ²“¡@‘ñ1, “n•Ó@Ž 2, ŠÛ“cCŽj1, ˆî“c@Œ’1, ‹{‰ª@“™1 (1¸. 2¶•¨•¨—Œn): ‘æ26‰ñ“ú–{¶•¨Šw“I¸_ˆãŠw‰ï ‘æ34‰ñ“ú–{_Œo¸_–ò—Šw‰ï‡“¯‘å‰ï (2004/7), “Œ‹ž.

723842. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) V‹KŒ´”­«”x‚ª‚ñŠ³ŽÒ‚Ì—}‚¤‚‚ƃÖ-3ŒnŽ‰–bŽ_ÛŽæ—Ê‚ÌŠÖ˜A. —é–ØŽu–ƒŽq1,2, ’JŒûKŽi1, ¬—ÑŽÀ‰Ä1, Œã“¡Œ÷ˆê3, ²X–Ø@•q4, ’Ë่ê˜Y1, ¼˜e@—T3, ‹{‰ª@“™2, “à•x—f‰î1 (1‘—§‚ª‚ñƒZƒ“ƒ^[Œ¤‹†ŠŽxŠ. 2¸. 3‘—§‚ª‚ñƒZƒ“ƒ^[“Œ•a‰@. 4‘—§Œ’NE‰h—{Œ¤‹†Š): ‘æ63‰ñ“ú–{‚ª‚ñŠw‰ïŠwp‘‰ï (2004/9/24-10/1), •Ÿ‰ªŽs.

723843. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹°•|ðŒ•t‚¯ƒ‚ƒfƒ‹‚É‚¨‚¯‚éG“‘̂̃Aƒ~ƒmŽ_Eƒh[ƒpƒ~ƒ“‚̕ω» (Conditioned stimulus and amygdalic amino acids and dopamine). ‰¡ŽR³@1, ²“¡@‘ñ1, —é–؉f“ñ1, “n•Ó@Ž 2, ŠÛ“cCŽj1, ˆî“c@Œ’1, ‹{‰ª@“™1 (1¸. 2¶•¨•¨—Œn): Neuro 2004 i‘æ47‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ïE‘æ27‰ñ“ú–{_Œo‰ÈŠw‘å‰ï ‡“¯‘å‰ïj (2004/9), ‘åã.

723844. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “ú–{lŽ©•ÂÇ‚É‚¨‚¯‚éFMR1‚¨‚æ‚ÑHOXA1ˆâ“`Žq‚̉ðÍ. ‰„@³g1, â–{—T”üŽq1, “ï”g‰h“ñ1, ŽR–{Œ«Ži2,3, ¼–{‰p•v3, ²X–Ø@Ži4, ‰Á“¡i¹4 i1’¹Žæ‘å. 2¸. 3“ŒŠC‘å. 4“Œ‹ž‘åj: ‘æ12‰ñ“ú–{¸_Es“®ˆâ“`ˆãŠw‰ï (2004/10/16), “Œ‹ž.

723845. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¸_‰È‹~‹}Š³ŽÒ‚ւ̈•û‚ƈ‹ö‚ðŒˆ’è‚·‚é—vˆö. ]‘º@‘å, ‚‹´@Œb, ‘åÎ@’q, “c’†Žr, “’ì‘׈ê, ŽR–{Œ«Ži, Έä˜a‹v, ‹g‰Y‰Â—e, ‹{‰ª@“™ (¸): ‘æ12‰ñ“ú–{¸_‰È‹~‹}Šw‰ï (2004/10/8), ‰ªŽR.

723846. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Š´î—}§ŒXŒü‚É‚ ‚é“û‚ª‚ñŠ³ŽÒ‚ɑ΂·‚éS—“I‰î“ü‚ÌŽŽ‚Ý. Šâ–ž—D”ü1, ‰º“c˜aF2, ‘å싧Žq3, ‹{‰ª@“™4 (1ˆã—ÃS—Šw. 2àÕ‹¦ˆã‘å. 3Ž ‰êˆã‘å. 4¸): ‘æ17‰ñ“ú–{‘‡•a‰@¸_ˆãŠw‰ï‘‰ï (2004/11/26), “Œ‹ž. ‘‰ïƒvƒƒOƒ‰ƒ€E´˜^, p.s-94, 2004.

723847. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŠÈˆÕ‚ȃRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“ƒXƒLƒ‹‚Ì•]‰¿–@. ‚‹´@Œb, ˆäã@Ê, ŽO‰Y—Y‘¾, –Lò‹M–ç, ²“¡’qŽq, “c’†Žr, ‹{‰ª@“™ (¸): ‘æ9‰ñSSTŠwpW‰ï (2004/12/4), ‰F“s‹{.

723848. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Impact of bilateral putaminal lesions on sleep macrostructure. âV“¡³”Í1, —é–Ø~Žq2, •P“c‹v”ü2, ‰Ÿ“c—Ç”ü2, ‚‹´Œb—1, ŽR–{Œ«Ži1, ‹{‰ª@“™1 (1¸. 2“Œ•a‰@—Õ°ŒŸ¸•”): ‘æ34‰ñ“ú–{—Õ°_Œo¶—Šw‰ïŠwp‘å‰ï (2004), “Œ‹ž.

731114. [uK‰ï] (“Á•Êu‰‰) ¸_‰Èf’fEŽ¡—ÂÌi‚ß•û. ‹{‰ª@“™ (¸): ‘æ48‰ñŽÐ‰ï•ÛŒ¯Žw“±ŽÒuK‰ï (2004/8/25-26), “Œ‹ž.

731115. [‚»‚Ì‘¼] (“Á•Êu‰‰) w’s•ðx‚ɂ‚¢‚ÄŠw‚Ô. ‚‹´@Œb (¸): Ý‘î‰îŒìŽx‰‡ƒZƒ“ƒ^[K‰€@‰îŒì—\–h‹³Žº (2004/9/4), ‘Š–ÍŒ´.

731116. [Œ¤‹†‰ï] (“Á•Êu‰‰) ¸_‰Èˆã‚Æ’s•ð‚Ì‚©‚©‚í‚è |ŋ߂̘b‘è‚Æ‚a‚o‚r‚c‚ւ̑Έ|. ‚‹´@Œb (¸): ‘å˜aˆãŽt‰ï¸_‰Èˆã‰ï (2004/10/27), ‘å˜aŽs.

731117. [u‰‰‰ï] (“Á•Êu‰‰) ƒvƒ‰ƒCƒ}ƒŠ[ƒPƒA‚É‚¨‚¯‚邤‚•a‚Ìf’f‚ÆŽ¡—Ã. ŽR–{Œ«Ži (¸): `–ìEˆÉ¨Œ´ˆãŽt‰ïŠwpu‰‰‰ï (2004/10), `–ìŽs.

731118. [u‰‰‰ï] (“Á•Êu‰‰) “‡Ž¸’²Ç‚Ìŋ߂̘b‘è|•ªŽqˆâ“`Šw“I’mŒ©‚Ì’†S‚É|. ŽR–{Œ«Ži (¸): ‘æ11‰ñ‘Š–ÍŒ´ˆãŽt‰ï¸_‰Èˆã‰ïu‰‰‰ï (2004/11/10), ‘Š–ÍŒ´Žs.

731119. [Šw‰ï (’n•û)] (“Á•Êu‰‰) ƒvƒ‰ƒCƒ}ƒŠƒPƒA‚É‚¨‚¯‚邤‚‚Ìf’f‚ÆŽ¡—Ã. ‹{‰ª@“™ (¸): _“Þ쌧“à‰ÈˆãŠw‰ï‘æ67‰ñŠwpW‰ï (2004/11/13), ‰¡•l.

731120. [Œ¤‹†‰ï] (“Á•Êu‰‰) ’s•ð«˜Vl‹y‚јV”N¸_áŠQŽÒ‚̉‡•‚ƉîŒì. ‚‹´@Œb (¸): _“Þ쌧‚—îŽÒ•ŸŽƒŽ{Ý‹¦‹c‰ï (2004/12/9), ‰¡•l.

731121. [Œ¤C‰ï] (“Á•Êu‰‰) ’s•ðŠ³ŽÒ‰îŒìŽÒ‚Ì—}‚¤‚‚ÆQOL. ‚‹´@Œb (¸): ˜Vl«’s•ðŽ¾Š³Œ¤C‰ï (2005/1/14), ‘Š–ÍŒ´.

731122. [Œ¤‹†‰ï] (“Á•Êu‰‰) S—Óà‰È‚Í•K—v‚©. ‹{‰ª@“™ (¸): ‘æ15‰ñ‰¡•lS—Óà‰ÈŒ¤‹†‰ï (2005/1/21), ‰¡•l.

731123. [Œ¤C‰ï] (“Á•Êu‰‰) Ž•‰Èf—Â̂½‚ß‚ÌSgˆãŠwE¸_ˆãŠw. ‹{‰ª@“™ (¸): •½¬16”N“x_“Þ쌧’nˆæŽ•‰Èˆã—ÃŒ¤C‰ï (2005/2/20), ‰¡•l.

731124. [u‰‰‰ï] (“Á•Êu‰‰) Ž•‰Èˆã‚Ì‚½‚ß‚ÌSgˆãŠw. ‹{‰ª@“™ (¸): ¢“c’J‹æŽ•‰ÈˆãŽt‰ï‘æ3‰ñŠwpu‰‰‰ï (2005/2/23), “Œ‹ž.

731125. [Œ¤‹†‰ï] (“Á•Êu‰‰) ¸_Çó”cˆ¬‚Ì‚½‚ß‚Ì–ÊÚ. ‹{‰ª@“™ (¸): •Ÿ“‡Œ§V‚µ‚¢¸_ˆãŠw•‹y‚ðl‚¦‚é‰ï (2005/3/5), •Ÿ“‡.

732056. [Œ¤‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€) u”ñŽ•Œ´«Ž•’Év‚ð‚ǂ̂悤‚Ɉµ‚¤‚ׂ«‚©|¸_‰Èˆã‚©‚ç‚Ý‚½Ž•’ɂ̉ðŽß‚ƑΉž|. ‹{‰ª@“™ (¸): ‘æ5‰ñŒûoŠç–ʒɧ’k‰ïŠwpW‰ï (2004/6/12-13), VŠƒ.

733448. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ’x”­«‘ÌŠO˜HÇó‚ÆŽv‚í‚ê‚éŒûŠWƒ~ƒIƒNƒ[ƒkƒX‚ð’悵‚½Ç—á. ¼Œ´’¼”ü, “’ì‘׈ê, ˆ¢•”Lˆê, Έä˜a‹v, ‘åÎ@’q, ‚‹´@Œb, âV“¡³”Í, ‹{‰ª@“™ (¸): _“Þ쌧¸_ˆãŠw‰ï‘æ144‰ñ—á‰ï (2004/7/3), ‰¡•l.

733449. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŽvtŠúOCD‚Ì”F’ms“®—Ö@. –Ø™Ç@‚©‚¨‚è (¸): OCDŒ¤‹†‰ï (2004/11/27), å‘ä.

733450. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) –«Œo‰ß’†‚ɃpƒLƒVƒ‹’PÜŽ¡—ÂɂČy‰õ‚µ‚½’x”­«‹Ù’£•a‚̈êÇ—á. ˆ¢•”Lˆê, Vˆä‹v–«, ²X–Ø“¹•v, ‘åÎ@’q, “’ì‘׈ê, —é–؉f“ñ, ‹{‰ª@“™ (¸): ‘æ145‰ñ_“Þ쌧¸_ˆãŠw‰ï (2004/11), ‰¡•l.


<<•úŽËü‰ÈŠw>>

mŠwp˜_•¶n

110189. [Œ´’˜] Hyperfractionated radiation therapy for oropharyngeal carcinoma in a Japanease population. V•”@÷1, Katsuyuki Karasawa2, Toshio Mitsuhashi2, Hisao Miyashita2, Yoshiaki Tanaka3 (1•ú. 2“s—§‹îž•a‰@. 3“ú–{‘å): Jpnapanese Journal of Clinical Oncology, 34: 312-315, 2004.

110190. [Œ´’˜] Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanease multiinstitutional study. Hiroshi Onishi1, Tsutomu Araki1, Hiroki Shirato2, Yasushi Nagata3, Masahiro Hiraoka3, Koutarou Gomi4, Takashi Yamashita4, V•”@÷5, Katsuyuki Karasawa6, Kazushige Hayakawa5, Yoshihiro Takai7, Tomoki Kimura8, Yutaka Hirokawa8, Atsuya Takeda9, Atsushi Ouchi10, Masato Hareyama10, Masashi kokubo11, Ryusuke Hara12, Jun Itami12, Kazunari Yamada13 (1ŽR—œ‘å. 2–kŠC“¹‘å. 3‹ž“s‘åE‰@. 4Department of Radiation Oncology, Cancer Institute Hospital, JFCR. 5•ú. 6“s—§‹îž•a‰@. 7“Œ–k‘å. 8L“‡‘å. 9“s—§L”ö•a‰@. 10ŽD–yˆã‘å. 11Departement of Image-based Medicine, Institute of Biomedical Research and Innovation. 12Department of Radiation Oncology, International Medical Center of Japan. 13“V—•a‰@): Cancer, 101: 1623-1631, 2004.

110191. [Œ´’˜] Intrathoracic thermoradiotherapy for the treatment of locally-advanced malingnant pleural mesothelioma. Tomoko Itazawa1, Katsuyuki Karasawa1, Hidemasa Kawamura1, Naokok Hanyu1, V•”@÷2, Yoshiaki Tanaka3 (1“s—§‹îž•a‰@. 2•ú. 3“ú–{‘å): Japanese Journal of Hyperhermic Oncology, 20: 171-178, 2004.

110192. [Œ´’˜] Impact of pretreatment cholinesterase level on survival of inoperable intrahepatic or hepatic-hilar carcinomas treated with three-dimensional conformal radiotherapy. Hamamoto Y, Niino K, ÎŽR”ŽžŠ1, Hosoya T (1•ú): Radiation Medicine, 22 (5): 316-23, 2004.

110193. [Œ´’˜] Geometrical Verification System Using Adobe Photoshop in Radiotherapy. ÎŽR”ŽžŠ1, Koji Suzuki, Kenji Niino, ×–î‹M—º2, ‘ì˜ad1 (1•ú. 2ŽRŒ`‘å): Radiation Medicine, 23 (1): 80-83, 2005.

110194. [Œ´’˜] Assessment of therapeutic tumor response using 99mTc-ethylenedicysteine-glucosamine. Yang D, sœA‰ëŽm1, Yu D F, Ito M, Oh C S, Kohanim S, Azhdarinia A, Kim C G, Bryant J, Kim E E, Podoloff D (1•ú): Cancer Biother Radiopharm, 19: 443-56, 2004.

120096. [Œ´’˜] ˆÙ‚È‚éŽ{ÝŠÔ‚Å‚Ì”x¬ŽîáŽGTV‚̉ðÍ. ŠÖ@’qŽj1, Hossain M Deloar1, ‘Ž}‰x•v1, ŠÚ‰ª–M•F2, °ŽR‰ël2, ‚ŽRŒ«“ñ3, –Ø‘º’qŽ÷4, ¬‹{ŽR‹MŽj5, V•”@÷6, “‚àVŽ”V7, ‹v•Û“ÖŽi1 (1Œc‰ž‘å. 2ŽD–yˆã‘å. 3‹ž“s‘å. 4L“‡‘å. 5ŽR—œ‘å. 6•ú. 7“Œ‹ž“s—§‹îž•a‰@): “ú–{•úŽËüŽîᇊw‰ïŽ, 17: 25-30, 2005.

120097. [Œ´’˜] RIS‹@”\‚̈ꕔ‚ðŠÜ‚ÞƒŒƒ|[ƒeƒBƒ“ƒOƒVƒXƒeƒ€‚Ì\’z. ¼‰iŒh“ñ1, –k–ì‰ëŽj1, ‘ëì­˜a1, Ί_—¤‘¾, ó–ì—Y“ñ1, ‘åX’qŽq1, ›@Mˆê1, ‘ì˜ad1 (1•ú): —Õ°•úŽËü, 49 (6): 812-816, 2004.

120098. [Œ´’˜] ŒÒŠÖß‹ü‹ÈL“W‚É”º‚¤’°œ“®–¬•ÏŒ`‚Ì’è—Ê“I•]‰¿–@@MDCT‚ð—p‚¢‚½3ŽŸŒ³À•W‚É‚æ‚é•]‰¿. ¼‰iŒh“ñ, ‚‰®–ƒ”üŽq1, ¼Šª@”Ž1, ‘åÀ—Yˆê˜Y1, ¬’J³Žq1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ²X–Ø^‹|1, `@”Ž•¶1, “c‘ºK•ä2, •½“cŒõ”Ž2, ‘ì˜ad1 (1•ú. 2ŠO): “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 64 (5): 307-309, 2004.

120099. [Œ´’˜] ”ñ‘¢‰eMRI‚É‚æ‚éˆÚAt“®Ã–¬‚¨‚æ‚Ñ”AŠÇ‚Ì•`o: ’èíó‘ÔƒRƒq[ƒŒƒ“ƒgƒV[ƒPƒ“ƒX iFIESTAj‚ð—p‚¢‚Ä. ¼‰iŒh“ñ1, ‘åÀ—Yˆê˜Y1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ‘ì˜ad1, ‹g“cˆê¬2, Έä‘å•ã2, “c”¨Œ’ˆê2, “y“c–š”ü2, Šâ‘º³Žk2, ‰““¡’‰—Y, ”nêŽu˜Y2 (1•ú. 2”å): tˆÚAEŒŒŠÇŠO‰È, 16 (1): 15-19, 2004.

120100. [Œ´’˜] ŽOŽŸŒ³Œ´‘ÌÆŽË‚É‚æ‚é•úŽËü”’Ž¿áŠQŒyŒ¸‚̉”\«. à_–{@‘×, V–ìŒbŽi, ÎŽR”ŽžŠ1, ˆÀ’B^l, ×–î‹M—º2, •Ð‰ª³–¾ (1•ú. 2ŽRŒ`‘å): “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 64 (3): 132-138, 2004.

210027. [€Œ´’˜] Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma: clinical outcomes in 273 cases of a Japanese multiinstitutional study. Onishi H, Nagata Y, Shirato H, Gomi K, Karasawa K, Arimoto T, ‘ì˜ad1, Takai Y, Kimura T, Takeda A (1•ú): J Clin Oncol (2004 ASCO annual meeting proceedings (post-meeting edition)), 22 (14S): 617s, 2004.

210028. [€Œ´’˜] 3D Conformal Single High-Dose Boost Radiosurgery for Peripheral Stage I Non-small Cell Lung Cancer Using C-Arm Linear Accelerator and A Spiro-Analyzer. ‘ì˜ad1, ¼Œû@ˆè1, –k–ì‰ëŽj1, V•”@÷1, ÎŽR”ŽžŠ1, ¼‰iŒh“ñ1, M Uemae, N Masuda, H Yoshimura (1•ú): 13th World Congress for Bronchoesophagology, 2004.

210029. [€Œ´’˜] Relationship between morphine and radiotherapy for management of symptomatic bone metastases from lung cancer. ÎŽR”ŽžŠ1, Akiko Shibata, Keiji Niino, ×–î‹M—º2 (1•ú. 2ŽRŒ`‘å): Supportive Care in Cancer, 12 (10): 743-745, 2004.

310019. [Ç—á•ñ] Ten-year disease-free survival of a small cell lung cancer patient with brain Metastasis. V•”@÷1, Katsuyuki Karasawa2, ‘ì˜ad1 (1•ú. 2“s—§‹îž•a‰@): Anticancer Research, 24: 2097-2100, 2004.

320081. [Ç—á•ñ] ã’°ŠÔ–Œ“®–¬Çðǂ̈ê—á. ‘ëì­˜a1, ²X–Ø^‹|2, ˆé•”‹`Œ›2 (1‘Š–ÍŒ´•a‰@. 2•ú): Á‰»Ší‚Ì—Õ°, 7 (3): 291-293, 2004.

320082. [Ç—á•ñ] FDG‚ª‚WÏ‚ðŽ¦‚µ‚½ŠÌ‚Ìhyper-vascular tumor‚̈ê—á. sœA‰ëŽm1, ŒE“c˜a—Y (1•ú): ŒQ”nŒ§ŠjˆãŠwŒ¤‹†‰ï‰ïŽ, 19: 21-23, 2004.

320083. [Ç—á•ñ] ˆŸ‹}«˜A‡«Ò‘•Ï«Ç‚Ì2—á. ‚‰®–ƒ”üŽq, ›@Mˆê, ó–ì—Y“ñ, Š`“c‘Žq, ƒEƒbƒhƒnƒ€ƒX—æŽq, ¼‰iŒh“ñ, ’r“crº, ‘ì˜ad (•ú): —Õ°•úŽËü, 49 (13): 1844-1847, 2004.

510016. [‘à] Imaging the vulnerable plaque: a scintillating light at the end of the tunnel? Strauss HW, Dunphy M, “¼“c®Ž÷ (Nuclear Medicine Laboratory, Memorial Sloan-Kettering Cancer Center): J Nucl Med, 45 (7): 1106-1107, 2004.

520284. [‘à] ŒÄ‹z¢“ï‚ÌŒ´ˆö‚ð‚Ç‚±‚Ü‚ÅŽ¡—·‚é‚©|ã‘å֬njóŒQ|. ‘ì˜ad, ¼Šª@”Ž (•ú): ƒ^[ƒ~ƒiƒ‹ƒPƒA, 14: 283-286, 2004.

520285. [‘à] ”xŠà•úŽËüŽ¡—Â̓W–]. ‘ì˜ad, –k–ì‰ëŽj, V•”@÷ (•ú): “úàÕˆã•ñ, 49 (2): 223-233, 2004.

520286. [‘à] ”xŠà‚ɑ΂µ‚Ä•úŽËü—Ö@‚ð‚¢‚©‚É—p‚¢‚é‚©. ‘ì˜ad (•ú): ¬l•a‚ƶŠˆKŠµ•a, 35 (3): 341-348, 2005.

520287. [‘à] ”xŠà‚Ì•úŽËü—Ö@. ‘ì˜ad (•ú): “à‰È, 95 (1): 65-70, 2005.

520288. [‘à] ”xŠàf—ÃKƒCƒhƒ‰ƒCƒ“‚ÆŽ¡—Â̌•ʉ». ‘ì˜ad (•ú): —Õ°•úŽËü, 50 (2): 249-257, 2005.

520289. [‘à] Žèp“K‰žŠOÇ—á‚ÌŽ¡—Õûj@•úŽËü—Ö@. ‘ì˜ad (•ú): “ú–{‹¹•”—Õ°, 63 (8): 741-750, 2004.

520290. [‘à] ‘O—§‘BŠà‚ɑ΂·‚éV‚µ‚¢•úŽËüŽ¡—Ã. ²“¡ˆÐ•¶1, –k–ì‰ëŽj2, ÎŽR”ŽžŠ2, ’Â@ˆÌ‹­, ‘ì˜ad2, ”nêŽu˜Y1 (1”å. 2•ú): ‘‡—Õ°, 54 (1): 187-189, 2005.

520291. [uÀ] _Œo•úŽËü. ›@Mˆê (•ú): ‰æ‘œf’f, 24 (6): 766-767, 2004.

520292. [uÀ] _Œo•úŽËü. ›@Mˆê (•ú): ‰æ‘œf’f, 24 (12): 1498-1499, 2004.

520293. [‰ðà] –å–¬ŒŒðÇ. ˆé•”‹`Œ› (•ú): ‹~‹}ˆãŠw, 28 (12): 1333-1336, 2004.

520294. [‰ðà] CTƒXƒLƒƒƒ“. ˆé•”‹`Œ› (•ú): ‘‡—Õ°, 53 (suppl): 828-834, 2004.

520295. [‘à] ‘å—e—ʉ摜ƒf[ƒ^‚Ö‚Ì’§í. ‘º“cWˆê˜Y (•ú): ‰f‘œî•ñƒƒfƒBƒJƒ‹, 36 (9): 927, 2004.

520296. [‘à] IVR: “Ý“IäB‘¹‚Æt‘¹. ¼Šª@”Ž1, ŽR–{aˆê˜Y2 (1•ú. 2‹~–½j: ‹~‹}ˆãŠw, 28: 1354-1360, 2004.

520297. [‘à] œ”ÕÖ¬‘¹‚ɑ΂·‚éIVR. ¼Šª@”Ž1, •Ð‰ª—Sˆê2 (1•ú. 2‹~–½j: ‹~‹}ˆãŠw, 28: 1365-1367, 2004.

520298. [‘à] ¬×–E”xŠà‚ÌŽ¡—Ã|•úŽËüŽ¡—Ã|. V•”@÷, ‘ì˜ad (•ú): —Õ°‚ÆŒ¤‹†, 82: 257-269, 2005.

520299. [‘à] IŠú”ñ¬×–E”x‚ª‚ñ‚ɑ΂·‚é’èˆÊ•úŽËüÆŽË. V•”@÷, ‘ì˜ad (•ú): ŒÄ‹zŠí‰È, 7: 119-125, 2005.

520300. [‘à] ‘O—§‘BŠà‚Ì‚ü—Ê—¦¬üŒ¹Ž¡—Â̸“xŒüã‚ÉŠÖ‚·‚錤‹†. –k–ì‰ëŽj, ÎŽR”ŽžŠ, V•”@÷, ‘ì˜ad (•ú): INNERVISION, 19 (7): 37, 2004.

520301. [‘à] ŒŒ‰t“§Í“®Ã–¬ƒVƒƒƒ“ƒg‚̃gƒ‰ƒuƒ‹•]‰¿–@@DUS, DSA, MRA, 3DCTA‚Ì”äŠr. ‹g“cˆê¬1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, “¡“c“N•v1, “c‰ª‰ÀŒ›1, ¼‰iŒh“ñ2, ‰FŽ¡‹´‘PŸ, `@”Ž•¶2, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å. 2•ú): tˆÚAEŒŒŠÇŠO‰È, 15 (2): 119-132, 2004.

520302. [‘à] Ö¬ŒŒðÇðÇ. ‘ëì­˜a, ‘åX’qŽq, ²X–Ø^‹|, ˆé•”‹`Œ›, –î“àŒ´@‹v, ¼Šª@”Ž, ‘ì˜ad (•ú): ‹~‹}ŠO‰È, 28 (12): 1330-1332, 2004.

520303. [‘à] ‘¢‰eÜ iSPIOj ‚ÌÅV“®Œü. 1) ŠÌ‘Ÿ‚ւ̉ž—p 2j SPIO‚ð—p‚¢‚½ŠÌ‚ÌMRA. ²X–Ø^‹|, ˆé•”‹`Œ›, ‘ëì­˜a, –î“àŒ´@‹v, ‹v•Û“cŸ–¤ (•ú): INNERVISON, 19 (9): 28-30, 2004.

520304. [‘à] dÇ‹}«äX‰Š‚ÆŒãŠú‡•¹Ç iäX”^Žî, ‰¼«”X–E“àoŒŒj. ²X–Ø^‹|, ˆé•”‹`Œ›, ¼Šª@”Ž, ‘ëì­˜a, –î“àŒ´@‹v (•ú): ‹~‹}ŠO‰È, 28 (12): 297-1300, 2004.

520305. [‘à] ŠjˆãŠw iPETj. ŒE“c˜a—Y, sœA‰ëŽm1 (1•ú): “ú–{‹¹•”—Õ°, 63: 570-580, 2004.

520306. [‘à] PET‚É‚æ‚é”xŠàf’f‚̃Gƒrƒfƒ“ƒX. ŒE“c˜a—Y, sœA‰ëŽm1 (1•ú): Ž¡—Êw, 38: 619-622, 2004.

520307. [‘à] ‡W•”@‹Ù‹}ŒŸ¸‚Æ‹~‹}ˆã—Ë@ŠíEÝ”õ@5 ‹¹E• •”’PƒXüŒŸ¸. ¬’J³Žq1, ¼Šª@”Ž1, ‘Š”nˆêˆå2 (1•ú. 2‹~–½): ‘‡—Õ°, 53 (S.): 814-817, 2004.

520308. [‘à] ”xŠà•úŽËüŽ¡—ẪKƒCƒhƒ‰ƒCƒ“. ¼‘º‹±¹1, ‘ì˜ad2, Ä“¡@”Ž3, —L‹g@Š°4 (1‹ß‹E‘å. 2•ú. 3Œ§—§ˆ¤’m•a‰@. 4‘OŒ§—§ˆ¤’m•a‰@’·): Medico, 35 (5): 2004.

m’˜@‘n

620171. [Šwp‘] (•ª’SŽ·•M) •úŽËüŽ¡—Ã|ê–åˆã‚É‚«‚­ÅV‚Ì—Õ°|; ”xŠàªŽ¡Ž¡—ÂÆÅV‚ÌŽ¡—ÃŒ‹‰Ê‚ð‹³‚¦‚Ä‚­‚¾‚³‚¢, p.128-131. ‘ì˜ad (•ú), •ÒW àF’J@‹Ï, ùˆäŒ[Ž‘, ¬‹v•Û‰ëŽ÷, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2004”­s.

620172. [Šwp‘] (•ª’SŽ·•M) •úŽËüŽ¡—Ã|ê–åˆã‚É‚«‚­ÅV‚Ì—Õ°|; ”ñ¬×–E”xŠàªŽ¡ÆŽË‚Ì“K‰ž‚ÆƎ˖쌈’è‚Å’ˆÓ‚·‚ׂ«“_‚Í‚Ç‚±‚Å‚·‚©, p.132-134. ‘ì˜ad (•ú), •ÒW àF’J@‹Ï, ùˆäŒ[Ž‘, ¬‹v•Û‰ëŽ÷, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2004”­s.

620173. [Šwp‘] (•ª’SŽ·•M) •úŽËüŽ¡—Ã|ê–åˆã‚É‚«‚­ÅV‚Ì—Õ°|; ”ñ¬×–E”xŠà‚ÌpŒãÆŽË‚Ì“K‰ž‚ƈӖ¡‚ð‹³‚¦‚Ä‚­‚¾‚³‚¢, p.135-137. ‘ì˜ad (•ú), •ÒW àF’J@‹Ï, ùˆäŒ[Ž‘, ¬‹v•Û‰ëŽ÷, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2004”­s.

620174. [Šwp‘] (•ª’SŽ·•M) •úŽËüŽ¡—ÃKƒCƒhƒ‰ƒCƒ“2004; ‹¹•”F”ñ¬×–E”xŠà, p.67-71. ‘ì˜ad (•ú), •ÒW “ú–{•úŽËüê–åˆã‰ïE“ú–{•úŽËüŽîᇊw‰ïE“ú–{ˆãŠw•úŽËüŠw‰ï, “ú–{•úŽËü‰Èê–åˆã‰ï, é‹Ê, 2004/7/1”­s.

620175. [Šwp‘] (•ª’SŽ·•M) ”xŠàf—Óñ•Å‚Ì”éŒ; Superior sulcus tumor iPancoastŽîá‡j ‚Ì•úŽËüŽ¡—Ã, p.200-201. ‘ì˜ad (•ú), •ÒW “¡‘ºd•¶, ‹àŒ´o”Å, “Œ‹ž, 2004”­s.

620176. [Šwp‘] (•ª’SŽ·•M) Á‰»Ší“àŽ‹‹¾Ž~ŒŒp; ˆÝÖ¬áŽoŒŒ iLg-c‚ÆLg-cfj ‚ɑ΂·‚éBRTO, p.198-199. ‘ëì­˜a1, ˆé•”‹`Œ›2 i1‘Š–ÍŒ´•a‰@. 2•új, ƒƒfƒBƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2004/4/1”­s.

620177. [‚»‚Ì‘¼’˜‘] (•ª’SŽ·•M) ‚ª‚ñáu’Ɋɘa@ƒ|ƒPƒbƒgƒŠƒtƒ@ƒŒƒ“ƒX vol.2; Šà«áu’ɂɑ΂·‚é•úŽËüŽ¡—Ã, p.2-4. V•”@÷, ‘ì˜ad (•ú), •ÒW —L‰ê‰xŽq (‘—§‘Ûˆã—ÃZƒ“ƒ^[j, “ú–{•úŽËü‹ZŽt‰ïo”ʼnï, “Œ‹ž, 2004/7/15”­s.

620178. [‹³‰È‘] (•ª’SŽ·•M) ŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; ‘¢‰eÜ, p.657-659. ›@Mˆê (•ú), •ÒW ΋´@W, Ž›è–¾”ü, “¡“cŒbŽq, •ŽR­ˆê, ’†‰›–@‹Ko”Å (Š”), “Œ‹ž, 2005/3/10”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

711009. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Clinical Trials for Cancer Therapy in Japan. ‘ì˜ad (•ú): ‘ÛŒ´Žq—Í‹@ŠÖ (IAEA) ƒAƒWƒA’nˆæ‹¦—̓gƒŒ[ƒjƒ“ƒOƒR[ƒX (2004/7/12-16), ŒQ”n.

713208. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Demonstration of mostly thrombosed large PICA aneusyms with CT angiography and MR angiography. ›@Mˆê (•ú): ‘æ5‰ñƒAƒWƒAEƒIƒZƒAƒjƒA_Œo•úŽËüE“ªèò•”•úŽËüŠw‰ï (2004/10/8-11), ’†‘.

713209. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Mid-term results of endovascular aortic stent-grafts placement in treating aortic dissection. ¼Šª@”Ž1, ’¬ˆä³l2, —Ñ@@”Ž2, ˆé•”‹`Œ›1, –î“àŒ´@‹v1, ‘ëì­˜a1, ‘Š”nˆêˆå3, ¬Œ´–M‹`2, ‘ì˜ad1 (1•ú. 2‹¹ŠO. 3‹~–½j: CIRSE (2004/4/25-29), Barcelona, Spain. Cardiovascular & Interventional Radiology Proceeding, p.180, 2004.

713210. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Phase II trial of three-dimensional conformal radiation therapy for stage I non-small cell lung cancer (NSCLC) in elderly patients. V•”@÷1, Katsuyuki Karasawa2, Ryuji Ieki2, Masahiko Shibuya2, Hiromasa Kawamura2, Tomoko Umezawa2, Naoko Hanyu2, ‘ì˜ad1 (1•ú. 2“s—§‹îž•a‰@): 40th Annuan Meeting of American Society of Clinical Oncology (ASCO) (2004/6), New Orleans, USA. Journal of Clinical Oncology, 22: 673s, 2004. : Proceeding of American Society of Clinical Oncology, 23: 670, 2004.

713211. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Hyperfractionated radiation therapy for the treatment of squamous cell carcinoma of the head and neck. Katsuyuki karasawa1, Tomoko Umezawa1, Naoko Hanyu1, Hiromasa Kawamura1, Yurie Kiguchi1, Toshio Mitsuhashi1, V•”@÷2 (1“s—§‹îž•a‰@. 2•ú): 40th Annuan Meeting of American Society of Clinical Oncology (ASCO) (2004/6), New Orleans. Journal of Clinical Oncology, 22: 501s, 2004. : Proceeding of American Society of Clinical Oncology, 23: 499, 2004.

713212. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) A prospective study of non-coplanar conformal radiotherapy for stage I non-small cell lung cancer using middle-sized fractions. Katsuyuki Karasawa1, Naoko Hanyu1, Hiromasa Kawamura1, Tomoko Itazawa1, Yurie Kiguchi1, kousaku Harada1, V•”@÷2 (1“s—§‹îž•a‰@. 1•ú): 46th ASTRO (American Society of Therapeutic Radiology and Oncology)'s Annual Meeting (2004/10), Atlanta, USA. International Journal of Radiation Oncology Biology Physics, 60: s534. 2004.

713213. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Does C-11 choline-PET improve diagnostic accuracy of pulmonary nodule compaired with FDG-PET? sœA‰ëŽm1, Kubota K, Kosaka N, Hara T (1•ú): Society of nuclear medicine 51st annual meeting (2004), Philadelphia. J Nucl Med, 45: 380, 2004.

713214. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Repeated transarterial chemoembolization for treatment of advanced pancreatic cancer with superselective catheterzation of the pancreas. ‰Í‘º»D1, T Okuno, F Ganaha, ‘ì˜ad1 (1•ú): European Congress of Radiology (2004/12/1), Austria.

713215. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Pharmacologic and Metabolic Substrate Suppression of Myocardial FDG Uptake. “¼“c®Ž÷, Zanzonico P, Dunphy M, Forster G, Santos E, Smith-Jones P, Larson S, Strauss HW (Nuclear Medicine Laboratory, Memorial Sloan-Kettering Cancer Center): 51st Annual Meeting of the Society of Nuclear Medicine (2004/6/20), Philadelphia, USA.

713216. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) FDG-PET Detected Infiltration of Inflammatory Cells around Coronary Arteries as a Marker for Atherosclerosis. “¼“c®Ž÷, Zanzonico P, Dunphy M, Jhanwar Y, Forster G, Santos E, Smith-Jones P, Larson S, Strauss HW. (Nuclear Medicine Laboratory, Memorial Sloan-Kettering Cancer Center): Annual Congress of the European Association of Nuclear Medicine (2004/9/5), Helsinki, Finland.

721015. [Šw‰ï (‘S‘)] (“Á•Êu‰‰/ŠwpÜŽóÜu‰‰) Prognostic significance of c-erb B-2/HER2 expression in advanced uterine cervical carcinoma with para-aoritc lymph node metastasis treated with radiation therapy. V•”@÷ (•ú): “ú–{•úŽËüŽîᇊw‰ï‘æ17‰ñŠwp‘å‰ï (2004/11), ç—t. “ú–{•úŽËüŽîᇊw‰ïŽ, 16 (Suppl): 67, 2004.

721016. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) Ò‘‚Ì”ñŽîᇫŽ¾Š³‚̉摜f’f. ›@Mˆê (•ú): ‘æ9‰ñDiagnostic Imaging Conference (2004/11/21), ’¹Žæ.

721017. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) “ª•”ŠO. ›@Mˆê (•ú): ‘æ40‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Õ°‘å‰ï (2004/10/29), “Œ‹ž. ‘å‰ï´˜^W, p.s380, 2004.

722107. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) •úŽËüŽîᇊw. ‘ì˜ad (•ú): “ú–{—Õ°Žîᇊw‰ï‘æ4‰ñ‹³ˆçƒZƒ~ƒi[ (2005/3/6), ‰¡•l.

722108. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) Š´õÇ. ›@Mˆê (•ú): ‘æ63‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2004/4/8), ‰¡•l. “ú–{ˆã•ú‰ïŽ, 64 (2 —Õ‘): s23, 2004.

722109. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ã•”‹¹’ÅE‹¹‘•a•Ï‚̉摜f’f. ›@Mˆê (•ú): ‘æ39‰ñ“ú–{Ò‘áŠQˆãŠw‰ï (2004/11/5-6), “Œ‹ž.

722110. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ‹Zp‹³ˆçƒZƒ~ƒi[ V. ‹~‹}‚ÌIVR ƒXƒeƒ“ƒgEƒXƒeƒ“ƒgƒOƒ‰ƒtƒg‚ÌŽÀÛ. ¼Šª@”Ž (•ú): ‘æ33‰ñ“ú–{ŒŒŠÇ‘¢‰eEIVRŠw‰ï‘‰ï (2004/5/7-8), “Œ‹ž. IVRŽ, 19: 2004.

722111. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) –k—¢‘åŠw•a‰@‚É‚¨‚¯‚éƒ`[ƒ€ˆã—Â̎ÀÛ‚Æ“W–]. ’†ŽR–¾m1, ŒIŒ´—¢‰À1, ‹{–{r•ã1, ’|“c¹•F1, ‰¡–x@Šw1, ”ª”ö˜a—Y1, ‰ª–{–ql1, V•”@÷2, –k–ì‰ëŽj2, ‘ì˜ad2 (1Ž¨•@. 2•ú): ‘æ28‰ñ“ú–{“ªèò•”Žîᇊw‰ï (2004/6), •Ÿ‰ª. “ªèò•”Žîá‡, 30: 153, 2004.

722112. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”xŠàf—ÃKƒCƒhƒ‰ƒCƒ“‚ÆŽ¡—Â̌•ʉ». ‘ì˜ad (•ú): ‘æ63‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2004/4/10), ‰¡•l. “ú–{ˆã•ú‰ïŽ, 64 (2 —Õ‘): s22, 2004.

722113. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) •úŽËüŽ¡—Ã‚Ì Quality Assuarance (QAj. ‘ì˜ad (•ú): ‘æ63‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2004/9/29-10/1), •Ÿ‰ª.

723849. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “ûüŽ¾Š³‚É‚¨‚¯‚éŠgŽU‹­’²‰æ‘œ‚ÌŒŸ“¢. ƒEƒbƒhƒnƒ€ƒX—æŽq1, ›@Mˆê1, ’r“crº1, ¼‰iŒh“ñ1, ŒŠ‘º@‘1, ‘ì˜ad1, Šâ•£Œ[ˆê2, `@”Ž•¶1, ”ö賑¥ (1•ú. 2•a—): ‘æ63‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2004/4/8-10), ‰¡•l. “ú–{ˆã•ú‰ïŽ, 64 (2 —Õ‘): s92, 2004.

723850. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹¹• •”CTAŽž‚ÌŽŠ“K‘¢‰eÜ”Z“x‚Æ’“ü‘¬“x‚ÌŒŸ“¢. ŒŠ‘º@‘, ’r“crº, ‘åÀ—Yˆê˜Y, ¬’J³Žq, ƒEƒbƒhƒnƒ€ƒX—æŽq, ó–ì—Y“ñ, ¼‰iŒh“ñ, ›@Mˆê, ‘ì˜ad (•ú): ‘æ63‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2004/4/8-10), ‰¡•l. “ú–{ˆã•ú‰ïŽ, 64 (2 —Õ‘): s85, 2004.

723851. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) SƒTƒ‹ƒRƒCƒh[ƒVƒX‚ª‹^‚í‚ꂽƒKƒŠƒEƒ€ƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚ðs‚Á‚½20Ç—á‚ÌŒŸ“¢. ó–ì—Y“ñ1, Έ䟌È1, ŒŠ‘º@‘1, Š`“c‘Žq1, ‚‰®–ƒ”üŽq1, ‘ì˜ad1, ‹e’r@Œh, _‹{ŽiŒö“ñ, ‘¾“cK—˜1 (1•ú): ‘æ63‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2004/4/8-10), ‰¡•l. “ú–{ˆã•ú‰ïŽ, 64 (2 —Õ‘): s80, 2004.

723852. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒtƒFƒ‹ƒJƒ‹ƒ{ƒgƒ‰ƒ“‚ð—p‚¢‚½MRA‚É‚¨‚¯‚鎊“KŽB‘œðŒ‚ÌŒŸ“¢. ²X–Ø^‹|, ˆé•”‹`Œ›, –î“àŒ´@‹v, ‘ëì­˜a, ‹v•Û“cŸ–¤ (•ú): ‘æ63‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2004/4/8-10), ‰¡•l. “ú–{ˆã•ú‰ïŽ, 64 (2 —Õ‘): s85, 2004.

723853. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒÒŠÖß‹ü‹Èi“W‚É”º‚¤’°œ“®–¬•ÏŒ`‚Ì•]‰¿|MDCT‚É‚æ‚é3ŽŸŒ³“I•]‰¿|. ¼‰iŒh“ñ1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ‚‰®–ƒ”üŽq1, ¼Šª@”Ž1, ‘ì˜ad1, “c‘ºK•ä2, •½“cŒõ”Ž2 (1•ú. 2ŠOj: ‘æ63‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2004/4/8-10), ‰¡•l. “ú–{ˆã•ú‰ïŽ, 64 (2 —Õ‘): s84, 2004.

723854. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) œ”Õ“àˆ««Žîᇂɔº‚¤Ã–¬ŒŒðǂɑ΂·‚錌ð‹zˆø–@‚Ì—L—p«‚ÌŒŸ“¢. ‘ëì­˜a, ˆé•”‹`Œ›, ‘åX’qŽq, –î“àŒ´@‹v, ²X–Ø^‹|, ¼Šª@”Ž, ‘ì˜ad (•ú): ‘æ63‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2004/4/8-10), ‰¡•l. “ú–{ˆã•ú‰ïŽ, 64 (2 —Õ‘): s77, 2004.

723855. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’†ˆô“ªŠà‰ß•ªŠ„ÆŽËŽ¡—ìÑ|‘OŒü‚«Œ¤‹†‚Å‚Ì‘e¶‘¶—¦‚ւ̉e‹¿|. V•”@÷1, “‚àVŽ”V2, ”~‘ò•üŽq2, “c’†—Ç–¾3 (1•ú. 2“s—§‹îž•a‰@. 3“ú–{‘å): ‘æ63‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠwpW‰ï (2004/4), ‰¡•l. “ú–{ˆãŠw•úŽËüŠw‰ïŽ, 64 (2 —Õ‘): s149, 2004.

723856. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) IŠú”ñ¬×–E”xŠà‚ɑ΂·‚éŽOŽŸŒ³•úŽËüŽ¡—ìÑ. ‰Í‘º‰p«1, “‚àVŽ”V1, ”~‘ò•üŽq1, ‰H¶Ø•äŽq1, V•”@÷2, “c’†—Ç–¾3 (1“s—§‹îž•a‰@. 2•ú. 3“ú–{‘å): ‘æ63‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠwpW‰ï (2004/4), ‰¡•l. “ú–{ˆãŠw•úŽËüŠw‰ïŽ, 64 (2 —Õ‘): s153, 2004.

723857. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒJƒbƒeƒBƒ“ƒOƒoƒ‹[ƒ“‚ðŽg—p‚µ‚½“§ÍƒVƒƒƒ“ƒgPTA‚Ì’ZŠú¬Ñ. ¼‰iŒh“ñ1, ¼Šª@”Ž1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, –î“àŒ´@‹v1, ŽR–{aˆê˜Y2, ‘ëì­˜a1, ù–{_Žq2, Έä‘å•ã3, ‹g“cˆê¬3, ˆé•”‹`Œ›1, ‘ì˜ad1 (1•ú. 2‹~–½. 3”å): ‘æ33‰ñ“ú–{ŒŒŠÇ‘¢‰eEIVRŠw‰ï‘‰ï (2004/5/7-8), “Œ‹ž.

723858. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒŒŠÇ“àŽ¡—Âɂ¨‚¯‚éƒKƒCƒhƒƒCƒ„[‚Ì‘Ï‹v«‚ÌŒŸ“¢ iŽ©Œ±—á‚ðŠî‚Éj. –î“àŒ´@‹v, ˆé•”‹`Œ›, ²X–Ø^‹|, ¼Šª@”Ž, ‘ëì­˜a, ‘ì˜ad (•ú): ‘æ33‰ñ“ú–{ŒŒŠÇ‘¢‰eEƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒiƒ‹ƒ‰ƒWƒIƒƒW[Šw‰ï (2004/5/7-8), “Œ‹ž.

723859. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘å“®–¬‰ð—£‚ɑ΂·‚錌ŠÇ“àStentgrafts—¯’up‚Ì’†Šú¬Ñ. –î“àŒ´@‹v1, ¼Šª@”Ž1, ŽR–{aˆê˜Y2, ²X–Ø^‹|1, ‘ëì­˜a1, —Ñ@@”Ž3, ’¬ˆä³l3, ˆé•”‹`Œ›1, ‘ì˜ad1 (1•ú. 2‹~–½. 3‹¹ŠO): ‘æ33‰ñ“ú–{ŒŒŠÇ‘¢‰eEƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒiƒ‹ƒ‰ƒWƒIƒƒW[Šw‰ï‘‰ï (2004/5/7-8), “Œ‹ž.

723860. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “ûüŽ¾Š³‚É‚¨‚¯‚éŠgŽU‹­’²‰æ‘œ‚ÌŠŒ©‚Æ—L—p«‚ÌŒŸ“¢. ƒEƒbƒhƒnƒ€ƒX—æŽq1, ‘ •À@Ÿ2, Šâ•£Œ[ˆê3, ‘ì˜ad1, “cã_ˆê1, Îì—R”üŽq (1•ú. 2ŠO. 3•a—): ‘æ12‰ñ“ú–{“ûŠàŠw‰ï‘‰ï (2004/6/11-12), ¬‘q.

723861. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) •@o‰”­‡TE‡UŠúNK/T×–EƒŠƒ“ƒpŽî‚ɑ΂·‚éTHP-CVP—Ö@“¯Žž•¹—p•úŽËüŽ¡—Ã. V•”@÷1, –k–ì‰ëŽj1, ’†ŽR–¾m2, ”ª”ö˜a—Y2, ‰ª–{–ql2, ‘ì˜ad1 (1•ú. 2Ž¨•@): ‘æ28‰ñ“ú–{“ªèò•”Žîᇊw‰ï (2004/6/17), •Ÿ‰ª. ƒvƒƒOƒ‰ƒ€—\eW, p.318, 2004.

723862. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒyƒŠƒtƒFƒ‰ƒ‹ƒJƒbƒeƒBƒ“ƒOƒoƒ‹[ƒ“‚É‚æ‚éPTA‚Ì’ZŠú¬Ñ. ¼‰iŒh“ñ1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, “c”¨Œ’ˆê2, ‹g“cˆê¬2, Έä‘å•ã2, ù–{Ž¡Žq2, “y“c–š”ü2, ¼‰ºˆêm2, ”nêŽu˜Y2 (1•ú. 2”å): ‘æ49‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2004/6/18-20), _ŒË.

723863. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) •›tÖ¬ƒTƒ“ƒvƒŠƒ“ƒO‚Ì–â‘è“_@’Êí–@‚ƃ}ƒCƒNƒƒJƒe[ƒeƒ‹Žg—p–@‚Æ‚Ì”äŠr. ˆé•”‹`Œ› (•ú): ‘æ77‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï (2004/6/24), ‹ž“s. “ú–{“à•ª”åŠw‰ïŽGŽ, 80 (1): 67, 2004.

723864. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Single ShotŽ‰–b—}§ FIESTA‚ÌŠî‘b“IŒŸ“¢ iScroll linear view order‚É‚æ‚錟“¢j. ”ö賑¥, `@”Ž•¶1, ‚‹´ŒõK, •Û“c‰pŽu, ›@Mˆê1, ¼‰iŒh“ñ1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, •½–쟖ç, –ìè@“Ö (1•ú): ‘æ32‰ñ“ú–{Ž¥‹C‹¤–ˆãŠw‰ï‘å‰ï (2004/9/16-18), Ž ‰ê.

723865. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Single ShotŽ‰–b—}§ FIESTA ‚É‚¨‚¯‚éScroll linear view order‚ÆCentric view order‚Ì”äŠr. ”ö賑¥, `@”Ž•¶1, ‚‹´ŒõK, •Û“c‰pŽu, ›@Mˆê1, ¼‰iŒh“ñ1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, •½–쟖ç, –ìè@“Ö (1•ú): ‘æ32‰ñ“ú–{Ž¥‹C‹¤–ˆãŠw‰ï‘å‰ï (2004/9/16-18), Ž ‰ê.

723866. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Single ShotŽ‰–b—}§FIESTA‚É‚¨‚¯‚éŠeŽíŽ‰–b—}§‚Ì”äŠr. ”ö賑¥, `@”Ž•¶1, ‚‹´ŒõK, •Û“c‰pŽu, ›@Mˆê1, ¼‰iŒh“ñ1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, •½–쟖ç, –ìè@“Ö (1•ú): ‘æ32‰ñ“ú–{Ž¥‹C‹¤–ˆãŠw‰ï‘å‰ï (2004/9/16-18), Ž ‰ê.

723867. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) SpeclR pulse‚ð—p‚¢‚½MultiShotŽ‰–b—}§FIESTA‚ÌŠî‘b“IŒŸ“¢ iLinear view order‚É‚æ‚錟“¢j. `@”Ž•¶1, ”ö賑¥, ‚‹´ŒõK, •Û“c‰pŽu, ›@Mˆê1, ¼‰iŒh“ñ1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, •½–쟖ç, –ìè@“Ö (1•ú): ‘æ32‰ñ“ú–{Ž¥‹C‹¤–ˆãŠw‰ï‘å‰ï (2004/9/16-18), Ž ‰ê.

723868. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒÄ‹z•â³–@‚𕹗p‚µ‚½2DTOF‰ºŽˆMRV enography‚Ì—L—p«‚Æ, ŽB‘œ‘̈ʂ̈Ⴂ‚É‚æ‚鉺‘Ú•”[•”Ö¬•`o”\‚ÌŒŸ“¢. `@”Ž•¶1, ”ö賑¥, ‰L’r[G, ”·@G“T1, ‘ŠàV@^1, —é–Ø’¼“ñ1, ²“¡^—R”ü, ›@Mˆê1, ¼‰iŒh“ñ1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, •½–쟖ç, –ìè@“Ö (1•ú): ‘æ32‰ñ“ú–{Ž¥‹C‹¤–ˆãŠw‰ï‘å‰ï (2004/9/16-18), Ž ‰ê.

723869. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”ñ‘¢‰eMRI‚É‚æ‚鉺Žˆ[•”Ö¬ŒŒðÇ‚Ì•]‰¿. ‘åÀ—Yˆê˜Y1, ¼‰iŒh“ñ1, ›@Mˆê1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ŒŠ‘º@‘1, ¬’J³Žq1, ‰Í‘º»D1, ‚‰®–ƒ”üŽq1, Š`“c‘Žq1, `@”Ž•¶1, ”ö賑¥, ‘ì˜ad1 (1•ú): ‘æ32‰ñ“ú–{Ž¥‹C‹¤–ˆãŠw‰ï‘å‰ï (2004/9/16-18), Ž ‰ê.

723870. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “û‘BŠgŽU‹­’²‰æ‘œ‚Ì—L—p«‚ÌŒŸ“¢. ƒEƒbƒhƒnƒ€ƒX—æŽq1, ›@Mˆê1, ¼‰iŒh“ñ1, `@”Ž•¶1, ”ö賑¥, ŒŠ‘º@‘1, Š`“c‘Žq1, ‘ì˜ad1 (1•ú): ‘æ32‰ñ“ú–{Ž¥‹C‹¤–ˆãŠw‰ï‘å‰ï (2004/9/16-18), Ž ‰ê.

723871. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒtƒFƒ‹ƒJƒ‹ƒ{ƒgƒ‰ƒ“‚ð—p‚¢‚½Fluoro triggered MRA‚É‚æ‚錌ŠÇ•`o”\‚ÌŒŸ“¢. ²X–Ø^‹|1, ˆé•”‹`Œ›1, ‹v•Û“cŸ–¤, •õ@Œ’ŽŸ, “c’†’õl, ‘ëì­˜a1, –î“àŒ´@‹v1 (1•ú): ‘æ32‰ñ“ú–{Ž¥‹C‹¤–ˆãŠw‰ï‘å‰ï (2004/9/16-18), Ž ‰ê.

723872. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‡TŠú”ñ¬×–E”xŠà‚ɑ΂·‚é’èˆÊ•úŽËüŽ¡—Ã: “ú–{‘½Ž{Ý‹¤“¯Œ¤‹†ƒOƒ‹[ƒv‚Ì14Ž{ÝE281Ç—á‚̬Ñ. ‘å¼@—m, ‰i“c@–õ, •½‰ªáÁŠ°, ”’“y”ŽŽ÷, ŒÜ–¡Œõ‘¾˜Y, —L–{‘ì˜Y, “‚àVŽ”V, ‘ì˜ad1, ‚ˆä—Çq, –Ø‘º’qŽ÷, •“c“Ä–ç (1•ú): ‘æ45‰ñ“ú–{”xŠàŠw‰ï‘‰ï (2004/10/25-26), ‰¡•l.

723873. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) •úŽËüŽ¡—ÂðŽ{s‚µ‚½‡UŠú”ñ¬×–E”xŠà’·Šú¶‘¶—á‚ÌŒŸ“¢. ‰Á“¡O”V, ’†ŽR—DŽq1, –k–{‰ÀZ1, Îì@m, ‰Í‘º‰p«, ’·’Jì³r1, ’†–ì—²Žj, V•”‰p’j1, ‘ì˜ad1 (1•ú): ‘æ45‰ñ“ú–{”xŠàŠw‰ï‘‰ï (2004/10/25-26), ‰¡•l.

723874. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ––½Œ^‚hŠú”ñ¬×–E”xŠà‚ɑ΂·‚é1‰ñ‘åü—ÊŽOŽŸŒ³’èˆÊ•úŽËüŽ¡—Ã|BoostÆŽË‚Æ‚µ‚Ä‚Ì–ðŠ„. V•”@÷1, ‘ì˜ad1, –k–ì‰ëŽj1, ‰v“c“TK2, ‹g‘º”Ž–M3 (1•ú. 2“à‡X. 3‹¹ŠOj: ‘æ45‰ñ“ú–{”xŠàŠw‰ï‘‰ï (2004/10/25-26), ‰¡•l.

723875. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‡VBŠúŽq‹{èò•”‘BŠà‚ɑ΂·‚骎¡“I•úŽËüŽ¡—ìÑ@Biological Effective Dose‚ð—p‚¢‚½ŒŸ“¢. V•”@÷1, –k–ì‰ëŽj1, ÎŽR”ŽžŠ1, ‘ì˜ad1, ‹àˆä“”V2, ¡ˆä@ˆ¤2, “c‘ºr’j2, Šp“cV•½2, ã–V•qŽq2, Vˆä@“w3, ìŒû”ü˜a3, ‘ –{”Žs3 (1•ú. 2ŽY•w. 3ˆã—ÃŒn‘åŠw‰@j: ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/27-29), ‹ž“s. “ú–{ŠàŽ¡—Êw‰ïŽ, 39 (2): 629, 2004.

723876. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[u‰‰) “û–[‰·‘¶—Ö@Œã‚̔ӊú—LŠQŽ–Û‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²¸Œ‹‰Ê. ÎŽR”ŽžŠ1, –k–ì‰ëŽj1, V•”@÷1, ‘ì˜ad1, V–ìŒbŽi2, ×–î‹M—º2 i1•ú. 2ŽRŒ`‘åj: ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10/27-29), ‹ž“s. “ú–{ŠàŽ¡—Êw‰ïŽ, 39 (2): 629, 2004.

723877. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ŠíÞ‚Æ‚»‚ÌŽg‚¢•ûvascular IVR. ˆé•”‹`Œ› (•ú): ‘æ40‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Õ°‘å‰ï (2004/10/28-30), “Œ‹ž. “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 64 (6): s421, 2004.

723878. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŠO«‰º‘åÖ¬E‘’°œÃ–¬‘¹‚ɑ΂·‚éƒXƒeƒ“ƒg—¯’up‚Ì—L—p«. ¼Šª@”Ž1, ²X–Ø^‹|1, ˆé•”‹`Œ›1, ‘ì˜ad1, •Ð‰ª—Sˆê2, ŽR–{aˆê˜Y2, —é–Ø@‘ì2, “c‘ºK•ä3, ‘ëì­˜a1 (1•ú. 2‹~–½. 3ŠO): ‘æ40‰ñ“ú–{•úŽËüŠw‰ïH‹G—Õ°‘å‰ï (2004/10/28-30), “Œ‹ž. “ú–{ˆãŠw•úŽËüŠw‰ïŽ, 64 (6): s421, 2004.

723879. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ––½Œ^IŠú”ñ¬×–E”xŠà‚ɑ΂·‚é1‰ñ‘åü—ÊŽOŽŸŒ³’èˆÊ•úŽËüŽ¡—Ã|BoostÆŽË‚Æ‚µ‚Ä‚Ì–ðŠ„|. V•”@÷1, ‘ì˜ad1, –k–ì‰ëŽj1, ‰v“c“TK2, ‹g‘º”Ž–M3 (1•ú. 2“à‡X. 3‹¹ŠO): ‘æ45‰ñ“ú–{”xŠàŠw‰ï‘‰ï (2004/10), ‰¡•l. ”xŠà, 44: 57, 2004.

723880. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‡VBŠúŽq‹{èò•”‘BŠà‚ɑ΂·‚骎¡“I•úŽËüŽ¡—ìÑ|Biological Effective Dose‚ð—p‚¢‚½ŒŸ“¢|. V•”@÷1, –k–ì‰ëŽj1, ÎŽR”ŽžŠ1, ‘ì˜ad1, ‹àˆä“”V2, ¡ˆä@ˆ¤2, “c‘ºr’j2, Vˆä@“w3, ìŒû”ü˜a3, Šp“cV•½2, ã–V•qŽq2, ‘ –{”Žs3 (1•ú. 2ŽY•w. 3ˆã—ÃŒn‘åŠw‰@): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (2004/10), ‹ž“s. “ú–{ŠàŽ¡—Êw‰ïŽ, 39: 819, 2004.

723881. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‚­‚à–Œ‰ºoŒŒ”­ÇŒã,S‹@”\ˆÙí‚ð’悵‚½5Ç—á‚ÌS‘ŸŠjˆãŠwŒŸ¸‚Å‚ÌŒŸ“¢. ó–ì—Y“ñ1, Έ䟌È1, ë“à—²—Y2, ‰““¡¹F2, Š`“c‘Žq1, ‚‰®–ƒ”üŽq1, ŒŠ‘º@‘1, ‹e’r@Œh, _‹{ŽiŒö“ñ, “¡ˆä´F2, ‘ì˜ad1 (1•ú. 2”]ŠO): ‘æ44‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (2004/11/4-6), ‹ž“s.

723882. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) S‹ØŒŒ—¬SPECT‚É‚¨‚¯‚éS”ŒÄ‹zEŒÄ‹z“¯ŽžGated SPECT‚ÌŒŸ“¢. ‹e’r@Œh, _‹{ŽiŒö“ñ, ó–ì—Y“ñ1, Έ䟌È1, ‘ì˜ad1 (1•ú): ‘æ44‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (2004/11/4-6), ‹ž“s.

723883. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) FDG-PET‚ªŠÓ•Ê‚É—LŒø‚Å‚ ‚Á‚½gastrointestinal stromal tumor (GIST) ‚ÌŠÌ“]ˆÚ‚̈ê—á. sœA‰ëŽm1, ŒE“c˜a—Y (1•ú): ‘æ44‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (2004/11/4-6), ‹ž“s. ŠjˆãŠw, 41: 345, 2004.

723884. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‡TŠú”ñ¬×–E”xŠà‚ɑ΂·‚é’èˆÊ•úŽËüŽ¡—Ã|‘½Ž{Ý‹¤“¯Œ¤‹†ƒOƒ‹[ƒv281Ç—á‚̬Ñ|D ‘å¼@—m, ‰i“c@–õ, •½‰ªáÁŠ°, ”’“y”ŽŽ÷, ŒÜ–¡Œõ‘¾˜Y, —L–{‘ì˜Y, “‚àVŽ”V, ‘ì˜ad1, ‚ˆä—Çq (1•ú): “ú–{•úŽËüŽîᇊw‰ï‘æ17‰ñŠwp‘å‰ï (2004/11/18-20), ç—t. ‘å‰ï•ñ•¶W, p.76, 2004.

723885. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹ÇŠ‘O—§‘BŠà‚ÌŠOÆŽË•¹—p‚ü—Ê—¦¬üŒ¹Ž¡—Ã. –k–ì‰ëŽj1, ÎŽR”ŽžŠ1, V•”@÷1, ²“¡ˆÐ•¶2, “ü]@Œ[2, ‰oì@W2, ã‘O•ôŽq, ‘ì˜ad1 (1•ú. 2”å): “ú–{•úŽËüŽîᇊw‰ï‘æ17‰ñŠwp‘å‰ï (2004/11/18-20), ç—t. ‘å‰ï•ñ•¶W, p.88, 2004.

723886. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒ‰ƒ“ƒ_ƒ€ƒZƒbƒgƒAƒbƒvƒGƒ‰[‚𔽉f‚µ‚½ü—Ê•ª•z}‚Ìì¬. ÎŽR”ŽžŠ1, –k–ì‰ëŽj1, V•”@÷1, ]ìrK, Žñ“¡éº, A‘º‚è‚イ, ã‘O•ôŽq, ‘ì˜ad1 (1•ú): “ú–{•úŽËüŽîᇊw‰ï‘æ17‰ñŠwp‘å‰ï (2004/11/18-20), ç—t. ‘å‰ï•ñ•¶W, p.119, 2004.

723887. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) •@o‰”­ŒÀ‹ÇŠúNK/T×–EƒŠƒ“ƒpŽî‚ɑ΂·‚éTHP-CVP—Ö@“¯Žž•¹—p•úŽËüŽ¡—Ã. V•”@÷1, –k–ì‰ëŽj1, ÎŽR”ŽžŠ1, ‘ì˜ad1, ’†ŽR–¾m2, ”ª”ö˜a—Y2, ‰ª–{–ql2 (1•ú, 2Ž¨•@): “ú–{•úŽËüŽîᇊw‰ï‘æ17‰ñŠwp‘å‰ï (2004/11), ç—t. “ú–{•úŽËüŽîᇊw‰ïŽ, 16: 152, 2004.

723888. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŽO³_Œo—̈æ‘Ñóáv]Œã_Œo’É‚É”F‚ß‚ç‚ꂽŽO³_Œo‰·’ÉŠo˜H‚ÌMRIŠŒ©. ‰Í‘º»D, ›@Mˆê, ƒEƒbƒhƒnƒ€ƒX—æŽq, ¼‰iŒh“ñ, ‘ì˜ad (•ú): ‘æ34‰ñ“ú–{_Œo•úŽËüŠw‰ï (2005/2/11), –¼ŒÃ‰®.

731126. [§˜b‰ï] (“Á•Êu‰‰) •úŽËüŽ¡—ËZp‚Ìi•à‚Æ•iŽ¿ŠÇ—. ‘ì˜ad (•ú): ‘æ20‰ñ‰¡•l•úŽËüŽ¡—ç˜b‰ï (2004/9/27), ‰¡•l.

731127. [Œ¤‹†‰ï] (“Á•Êu‰‰) ƒOƒŠƒI[ƒ}‚̉摜f’f. ›@Mˆê (•ú): ‘æ9‰ñ‹ãBEŽRŒû‚ª‚ñf’fŽ¡—ÃŒ¤‹†‰ï (2005/3/12), •Ÿ‰ª.

733451. [‚»‚Ì‘¼] (ˆê”Êu‰‰) PIXE‚É‚æ‚é‚Q-ƒuƒƒ‚ƒGƒ^ƒm[ƒ‹“Š—^ƒ‰ƒbƒgŒŒ´’†‚̃NƒŠƒAƒ‰ƒ“ƒX‘ª’è. ‘¾“cŒ°¬1, –m@Œj—–1, ‘ì˜ad1, ‘]ª—R”üŽq2, ’†ŽR–ÎM3 (1•ú. 2¶‰»ŠwŒn. 3ŽÀ“®ƒZj: ‘æ11‰ñm‰È‹L”OƒTƒCƒNƒƒgƒƒ“ƒZƒ“ƒ^[‹¤“¯—˜—pŒ¤‹†¬‰Ê”­•\‰ï (200‚S/5/22), ·‰ª. —vŽ|W, p.3, 2004.

733452. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ’_ŠÇ“ài“W‚𔺂¤Žîᎌ`¬Œ^’_ŠÇ×–EŠà‚̈ê—á. ²X–Ø^‹|, ˆé•”‹`Œ›, ‘ëì­˜a, –î“àŒ´@‹v (•ú): ‘æ18‰ñ• •”•úŽËüŒ¤‹†‰ï (2004/5/28-29), ¼–{.

733453. [Œ¤‹†‰ï] (ƒ|ƒXƒ^[) ”ñ“TŒ^“IŠŒ©‚ð’悵‚½ŠÌŒŒŠÇŽî‚̈ê—á. ‘åX’qŽq1, ‘ëì­˜a1, –î“àŒ´@‹v1, ²X–Ø^‹|1, ¼‰iŒh“ñ1, ¼Šª@”Ž1, ŽO•xO”V, –Ø‘º@“O2, ‹à“cŒå˜Y2, ˆé•”‹`Œ›1, ‘ì˜ad1 (1•ú. 2ŠO): ‘æ18‰ñ• •”•úŽËüŒ¤‹†‰ï (2004/5/28-29), ¼–{. ƒvƒƒOƒ‰ƒ€, p.46, 2004.

733454. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ”ñ‘¢‰eMRI‚É‚æ‚éˆÚAt“®Ã–¬‚¨‚æ‚Ñ”AŠÇ‚Ì•]‰¿. ¼‰iŒh“ñ1, ‘åÀ—Yˆê˜Y1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ‹g“cˆê¬2, Έä‘å•ã2, “c”¨Œ’ˆê2, ù–{Ž¡Žq2, “y“c–š”ü2, Šâ‘º³Žk2, ”nêŽu˜Y2 (1•ú. 2”å): ‘æ20‰ñtˆÚAEŒŒŠÇŠO‰ÈŒ¤‹†‰ï (2004/6/11-12), VŠƒ.

733455. [Šw‰ï i’n•ûj] (ˆê”Êu‰‰) Žîᇫ•a•Ï‚Æ‚ÌŠÓ•Ê‚ª¢“ï‚ŶŒŸ‚ðŽ{s‚µ‚½‘½”­«d‰»Ç‚Ì3—á. ‚‰®–ƒ”üŽq, ›@Mˆê, ó–ì—Y“ñ, Š`“c‘Žq, ƒEƒbƒhƒnƒ€ƒX—æŽq, ¼‰iŒh“ñ, ’r“crº, ‘ì˜ad (•ú): ‘æ425‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠÖ“Œ’n•û‰ï (2004/6/19), “Œ‹ž.

733456. [Œ¤‹†‰ï] (ˆê”Êu‰‰) –¬ŠÇZ‚𔺂¤ŠÌ×–EŠà‚Ì•úŽËüŽ¡—ẨŠú¬Ñ. –k–ì‰ëŽj1, V•”@÷1, ²X–Ø^‹|1, ˆé•”‹`Œ›1, a’J–¾—²2, š •ª–ΔŽ2, ‘ì˜ad1 (1•ú. 2“à‡T): ‘æ40‰ñ“ú–{ŠÌŠàŒ¤‹†‰ï (2004/6/24-25), ‚‚­‚Î. ´˜^W, p.185, 2004.

733457. [Šw‰ï i’n•ûj] (ˆê”Êu‰‰) Protein iC,S) Œ‡‘¹Ç‚É”º‚¤‘Sg«ŒŒðÇ‚Ìf’f‚ÆŽ¡—ÃŒø‰Ê”»’è‚É—L—p‚Å‚ ‚Á‚½ŒŒ¬”ƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚Ì1—á. ó–ì—Y“ñ1, Έ䟌È1, Š`“c‘Žq1, ‚‰®–ƒ”üŽq1, ŒŠ‘º@‘1, ‘ì˜ad1, ë“à—²—Y2, “¡ˆä´F2, ‹e’r@Œh, _‹{ŽiŒö“ñ, “¿d‘¸é, ŠÛ”öGŽ÷, ˆÉ“¡ŠìO, “cã‘”ü, ’†“‡‹K—e, ‘¾“cK—˜1 (1•ú. 2”]ŠO): ‘æ61‰ñ“ú–{ŠjˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2004/7/3), “Œ‹ž.

733458. [Œ¤‹†‰ï] (ˆê”Êu‰‰) • …úŽh‚É‚æ‚éó• •Ç“®–¬‘¹‚ɑ΂µ‚ÄTAE‚ðŽ{s‚µ‚½1—á. ‘åX’qŽq1, ‘ëì­˜a1, Έ䌒ˆê˜Y2, •Ê‹{ŠG”ü^2, ˜m’J”ü“Þ2, ’¬“c_Žu3, Š™“cOŽ÷2, ŠÝ–{ˆê˜Y2, ‹ààVG‹I2, ˆä㔹l4, –Ø‘º@“O2, ¼ŽR•Û”äŒÃ2, ‹à“cŒå˜Y2, HŽRŒ›‹`2, “n•”K•v, ˆÀ’B@Œ£, ’†‘º—zŽq, ‹Ê^r•½ (1•ú. 2ŠO. 3“à‡X. 4‹¹ŠO): ‘æ22‰ñ–k—¢ŠÌE’_EäXŽ¾Š³ŒŸ“¢‰ï (2004/7/7), ‘Š–ÍŒ´.

733459. [Œ¤‹†‰ï] (ˆê”Êu‰‰) äX”X–E«Ž¾Š³‚ɑ΂·‚éCTƒKƒCƒh‰ºŒo”ç“I“àá‘p‚ÌŒoŒ±. Έ䌒ˆê˜Y1, •Ê‹{ŠG”ü^1, ˜m’J”ü“Þ1, ’¬“c_Žu2, Š™“cOŽ÷1, ŠÝ–{ˆê˜Y1, ‹ààVG‹I1, ˆä㔹l3, –Ø‘º@“O1, ¼ŽR•Û”äŒÃ1, ‹à“cŒå˜Y1, HŽRŒ›‹`1, ‘åX’qŽq4, ‘ëì­˜a4, “n•”K•v, ˆÀ’B@Œ£, ’†‘º—zŽq, ‹Ê^r•½ (1ŠO. 2“à‡X. 3‹¹ŠO. 4•ú): ‘æ22‰ñ–k—¢ŠÌE’_EäXŽ¾Š³ŒŸ“¢‰ï (2004/7/7), ‘Š–ÍŒ´.

733460. [Œ¤‹†‰ï] (ˆê”Êu‰‰) “àŽ‹‹¾“IŽ¡—â“ï‚ȈÝH“¹Ã–¬áŽ‚ɑ΂·‚éPTS‚ÌŒŸ“¢. ²X–Ø^‹|, ˆé•”‹`Œ›, ‘ëì­˜a, –î“àŒ´@‹v (•ú): ‘æ16‰ñŠÖ“ŒIVRŒ¤‹†‰ï (2004/7/17), “Œ‹ž.

733461. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Œo”ç“Iƒgƒƒ“ƒrƒ“’“ü‚ª—LŒø‚Å‚ ‚Á‚½•Gâ|“®–¬‰¼«áŽ‚ÌÇ—á. ƒEƒbƒhƒnƒ€ƒX—æŽq1, ¼Šª@”Ž1, ¼‰iŒh“ñ1, ‘ì˜ad1, •½“cŒõ”Ž2, “c‘ºK•ä2, ”ü“‡—˜º2, ŽR–{aˆê˜Y3, Š~Œ©•¶Ž}3 (1•ú. 2ŠO. 3‹~–½j: ‘æ16‰ñŠÖ“ŒIVRŒ¤‹†‰ï (2004/7/17), “Œ‹ž.

733462. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Çðp‚ª—LŒø‚Å‚ ‚Á‚½œ”Õ“à‚¤‚ÁŒŒÇŒóŒQ‚Ì1—á. ‘åX’qŽq1, ‘ëì­˜a1, ‹Ê^r•½, –î“àŒ´@‹v1, ²X–Ø^‹|1, ˆé•”‹`Œ›1, ¼‰iŒh“ñ1, ¼Šª@”Ž1, ‘ì˜ad1 (1•ú): ‘æ16‰ñŠÖ“ŒIVRŒ¤‹†‰ï (2004/7/17), “Œ‹ž. ƒvƒƒOƒ‰ƒ€, p.19, 2004.

733463. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒŒƒ|[ƒgƒf[ƒ^ƒx[ƒX‚ð—˜—p‚µ‚½ƒŒƒWƒfƒ“ƒg‚ÌK”M“x•]‰¿‚ÌŽŽ‚Ý. ¼‰iŒh“ñ, ›@Mˆê, ó–ì—Y“ñ, ƒEƒbƒhƒnƒ€ƒX—æŽq, ‘åÀ—Yˆê˜Y, ¬’J³Žq, ‰Í‘º»D, ŒŠ‘º@‘, ‚‰®–ƒ”üŽq, Š`“c‘Žq, ‘ì˜ad (•ú): ‘æ6‰ñˆã—p‰æ‘œ”F’mŒ¤‹†‰ï, ‘æ6‰ñ‰“Šu‰æ‘œf’f•”‰ï, ‘æ4‰ñ‰æ‘œf’f•ñ‘Œ¤‹†‰ï, ‘æ23‰ñˆã—p‰æ‘œ“dŽq‰»Œ¤‹†‰ï‡“¯Œ¤‹†‰ï (2004/8/21-22), “¿“‡.

733464. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ”xŠà‚ɑ΂·‚é“®‘Ì’ÇÕ‘•’u‚Ì“±“ü. V•”@÷ (•ú): ‘æ9‰ñ–kŠC“¹’èˆÊ•úŽËüÆŽËŒ¤‹†‰ï (2004/8/3), ŽD–y.

733465. [Šw‰ï i’n•ûj] (ˆê”Êu‰‰) èò•”•›_ŒoâŽî‚Ì1—á. ‚‰®–ƒ”üŽq, ›@Mˆê, Š`“c‘Žq, ŒŠ‘º@‘, ‘åÀ—Yˆê˜Y, ¬’J³Žq, ‰Í‘º»D, ƒEƒbƒhƒnƒ€ƒX—æŽq, ¼‰iŒh“ñ, ‘ì˜ad (•ú): _“Þ쌧•úŽËüˆã‰ïŠwp‘‰ï (2004/9/4), ‰¡•l.

733466. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ƒyƒŠƒtƒFƒ‰ƒ‹ƒJƒbƒeƒBƒ“ƒOƒoƒ‹[ƒ“ iPCBj ‚ð—p‚¢‚½“§ÍƒVƒƒƒ“ƒg‚ɑ΂·‚éPTA‚ÌŽ¡—ìÑ. ¼‰iŒh“ñ1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ‘åÀ—Yˆê˜Y1, ‚‰®–ƒ”üŽq1, –î“àŒ´@‹v1, ‘ëì­˜a1, ‘ì˜ad1, “c”¨Œ’ˆê2, “y“c–š”ü2, “¡“c“N•v2, “c‰ª‰ÀŒ›2, ‹g“cˆê¬2, ”nêŽu˜Y2 (1•ú. 2”å): ‘æ8‰ñƒAƒNƒZƒXŒ¤‹†‰ï (2004/10/2), ‘åã.

733467. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ˆã—ÂÌIT‰»‚ÆŒo‰c‚ÌŒø—¦‰» |‚»‚Ì—Ž‚µŒŠ‚Æ—¯ˆÓ“_|. ‘º“cWˆê˜Y (•ú): ‘æ14‰ñƒ\ƒjƒbƒNCTƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004/11/22), ‘å‹{.

733468. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ˆã—ÂÌIT‰»‚ÆŒo‰c‚ÌŒø—¦‰». ‘º“cWˆê˜Y (•ú): ƒp[ƒXƒWƒƒƒpƒ“ˆã—ÃZƒ~ƒi[ (2004/11/22), “Œ‹ž.

733469. [Šw‰ï i’n•ûj] (ˆê”Êu‰‰) ‹ÇŠÄ”­ high-risk ŒQ‚ÌŽq‹{‘ÌŠà‚ɑ΂·‚épŒãÆŽË‚ÌŒŸ“¢. ¬’J ³Žq1, V•”@÷1, –k–ì‰ëŽj1, ÎŽR”ŽžŠ1, ‘ì˜ad1, ‹àˆä“”V2, ã–V•qŽq2, ‘ –{”Žs3 (1•ú. 2ŽY•w. 3ˆã‰q): ‘æ426‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠÖ“Œ’n•û‰ï (2004/12/11), “Œ‹ž.

733470. [Šw‰ï i’n•ûj] (ˆê”Êu‰‰) ˆ³”—«•a•Ï‚𔺂Á‚½Ò‘ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á. ‚‰®–ƒ”üŽq, ›@Mˆê, ó–ì—Y“ñ, Š`“c‘Žq, ‰Í‘º»D, ‘åÀ—Yˆê˜Y, ƒEƒbƒhƒnƒ€ƒX—æŽq, ¼‰iŒh“ñ, ‘ì˜ad (•ú): ‘æ426‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠÖ“Œ’n•û‰ï (2004/12/11), “Œ‹ž. ƒvƒƒOƒ‰ƒ€, p.10, 2004.

733471. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŠgŽU‹­’²‰æ‘œ‚É‚æ‚é“ûŠàãüâ|ƒŠƒ“ƒpß“]ˆÚ•]‰¿‚ÌŽŽ‚Ý. ƒEƒbƒhƒnƒ€ƒX—æŽq1, ‘ì˜ad1, ‘ •À@Ÿ2, Šâ•£Œ[ˆê3, `@”Ž•¶1, ”ö賑¥ (1•ú. 2ŠO. 3•a—): ‘æ14‰ñ“ú–{“ûŠà‰æ‘œŒ¤‹†‰ï (2005/2/11-12), ‰¡•l.

733472. [Œ¤‹†‰ï] (ˆê”Êu‰‰) •a‰@‚̃~ƒbƒVƒ‡ƒ“‚Æ‚»‚ê‚ðŽx‚¦‚éHIS|‰æ‘œf’fˆã‚Ì—§ê‚©‚ç|. ‘º“cWˆê˜Y (•ú): NECˆã—ÃZƒ~ƒi[2005“Œ‹ž (2005/2/18), “Œ‹ž.

733473. [Œ¤‹†‰ï] (ˆê”Êu‰‰) f—Âɂ¨‚¯‚éƒvƒƒWƒFƒNƒgƒ}ƒlƒWƒƒ“ƒgƒTƒCƒNƒ‹. ‘º“cWˆê˜Y1, ‹g“cG”ü, ŽR蔎Žu (1•ú): ‘æ10‰ñƒvƒƒWƒFƒNƒgƒ}ƒlƒWƒƒ“ƒgŠw‰ï2005”N“xt‹GŒ¤‹†”­•\‘å‰ï (2005/3/17-19), ç—t. ‘å‰ï—\eW, p.241-243, 2005.

733474. [Œ¤‹†‰ï] (‹³ˆçu‰‰) ŠÌ×–EŠà‚ɑ΂·‚éRFA. ²X–Ø^‹|1, ˆé•”‹`Œ›1, š •ª–ΔŽ2 (1•ú. 2“à‡Tj: _“ÞìIVRƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2004), ‘Š–ÍŒ´.


<<–ƒŒ‰ÈŠw>>

mŠwp˜_•¶n

110195. [Œ´’˜] Painful neuropathy alters the effect of gabapentin on sensory neuron excitability in rats. ‹àˆäº•¶1, Costantinos Sarantopoulos2, J Bruce McCallum2, Quinn Hogan2 (1–ƒ. 2Department of Anesthesiology, Medical College of Wisconsin): Acta Anaesthesiol Scand, 48: 507-512, 2004.

110196. [Œ´’˜] Efficacy of oral pranlukast hydrate, a leukotriene receptor antagonist, in the treatment of postherpetic neuralgia. ‹àˆäº•¶, X@¹–é”T, ‘åàV@—¹, —é–Ø–ƒ—t, ŠO@{”ü•v (–ƒ): The Pain Clinic, 16: 389-392, 2004.

110197. [Œ´’˜] Rapid injection of epidural mepivacaine speeds the onset of nerve blockade. ‹àˆäº•¶, —é–Ø–ƒ—t, ŠO@{”ü•v (–ƒ): Can J Anaesth, 52: 281-284, 2005.

110198. [Œ´’˜] The effect of dexmedetomidine on transient focal cerebral ischemia in rats. ŠÌ•t@—m, ‰ª–{_Žk, ¬àVÍŽq, ŠO@{”ü•v (–ƒ): Circulation Control, 25: 50-55, 2004.

110199. [Œ´’˜] Migration of neutrophils elicited by leukotoriene B4 is inhibited by fasudil, a Rho-kinase inhibitor, in the microvasculature of hamster cheek pouch. ¬àVÍŽq1, “ޗljÀ—m2, ŠÌ•t@—m1, ’†Œ´ŠG—¢1, ‰ª–{_Žk1, ŠO@{”ü•v1 (1–ƒ. 2¶•¨•¨—Œn): Circulation Control, 25: 267-271, 2004.

110200. [Œ´’˜] Intrathecal mepivacaine and prilocaine are less neurotoxic than lidocaine in a rat intrathecal model. ’|˜Q–¯]1, Saburo Yagishita, “ޗljÀ—m2, ŠO@{”ü•v1 (1–ƒ. 2¶•¨•¨—Œn): Regional Anesthesia and Pain Medicine, 29: 446-453, 2004.

110201. [Œ´’˜] Magnesium and bupivacaine-induced convulsions in awake pregnant rats. ‰œ•xr”V1, Yi Zhang2, Hisayo O Morishima2, Thomas B Cooper2 i1–ƒ. 2ƒRƒƒ“ƒrƒA‘åj: Int J Obstet Anesth, 14 (1): 32-36, 2005.

120101. [Œ´’˜] –«áu’ɂɑ΂·‚éƒvƒƒXƒ^ƒ“ƒWƒ“E1‚Ì“Š—^‘¬“x‚ÌŒŸ“¢. ‹àˆäº•¶, ¬ˆéi‘¾˜Y, ‘åàV@—¹, ŠO@{”ü•v (–ƒ): ƒyƒCƒ“ƒNƒŠƒjƒbƒN, 25: 1201-1205, 2004.

120102. [Œ´’˜] ®Œ`ŠO‰È‰ºŽˆŽèp‚ð‘ÎÛ‚Æ‚µ‚½pŒã˜•”d–ŒŠO’Á’É‚É‚¨‚¯‚郃sƒoƒJƒCƒ“‚Ì—LŒø«‚ÌŒŸ“¢. ‹àˆäº•¶, –؉º@L, —é–Ø–ƒ—t, ‰ª–{_Žk, ŠO@{”ü•v (–ƒ): –ƒŒ, 54: 8-13, 2004.

120103. [Œ´’˜] ƒƒsƒoƒJƒCƒ“‚ƃtƒFƒ“ƒ^ƒjƒ‹‚ð—p‚¢‚½PCEA•t‚«pŒãŽ‘±‹¹•”d–ŒŠO’Á’É‚É‚¨‚¯‚é’Á’ÉŒø‰Ê‚ÌŒŸ“¢. —é–Ø–ƒ—t, ‘åàV@—¹, ‹àˆäº•¶, ¬àVÍŽq, ‰ª–{_Žk, ŠO@{”ü•v (–ƒ): –ƒŒ, 54: 2-7, 2005.

120104. [Œ´’˜] ƒuƒsƒoƒJƒCƒ“‚ƃƒsƒoƒJƒCƒ“‚ð—p‚¢‚½d–ŒŠO•¹—pÒ‘‚­‚à–Œ‰º–ƒŒŒã‚ÌTNS (Transient Neurologic Symptoms) ”­Ç—¦‚ÌŒŸ“¢. HŽR–ƒ‹I, Vˆä–¯], Ž…–žD, ˆé–ì‰ëŽq, ‘åàV@—¹, ŠO@{”ü•v (–ƒ): —Õ°–ƒŒ, 28: 1797-1801, 2004.

120105. [Œ´’˜] ’´‘Šú”²ŠÇ‚ðs‚¤fast track pediatric cardiac surgery‚É‚¨‚¯‚ébispectral index (BIS) monitor‚Ì—L—p«. ŠÛŽR”ü—R‹I1, ‰ª–{_Žk1, z–KŽq1, –ƒ¶r‰p2, ŠO@{”ü•v1 (1–ƒ. 2‹¹ŠO): –ƒŒ, 53: 629-633, 2004.

120106. [Œ´’˜] æ“V«SŽ¾Š³‚ɑ΂·‚éfast track cardiac surgery‚É‚¨‚¯‚éƒIƒ‹ƒvƒŠƒmƒ“‚ÌŒø‰Ê@ŒŒs“®‘Ô‚Æ”²ŠÇŽžŠÔ‚ɑ΂·‚éƒNƒƒ‹ƒvƒƒ}ƒWƒ“‚Æ‚Ì”äŠr. ˆÉ“¡”ü—R‹I, ‰ª–{_Žk, z–KŽq (–ƒ): –ƒŒ, 53: 258-263, 2005.

120107. [Œ´’˜] PCEA (Patient-controlled analgesia) –@‚ð—p‚¢‚½•ª•ØŽžd–ŒŠO–ƒŒ|]—ˆ‚ÌŽ‘±d–ŒŠO–ƒŒ–@‚Æ‚Ì”äŠrŒŸ“¢|. Ö“¡”ü˜aŽq1, ‰œ•xr”V1, ‹g‘ºç2, ‹àˆä—Y“ñ2, –]ŒŽƒŽq2, “V–ì@Š®2 (1–ƒ. 2ŽY•w): •ª•Ø‚Æ–ƒŒ, 85: 6-10, 2004.

120108. [Œ´’˜] ƒAƒ“ƒP[ƒg‚©‚猩‚½ˆãŠw¶‚Ì–³’É•ª•Ø‚ɑ΂·‚é”FŽ¯“x. ‰œ•xr”V, Ö“¡”ü˜aŽq (–ƒ): •ª•Ø‚Æ–ƒŒ, 86: 44-47, 2004.

220060. [€Œ´’˜] ŠO«‘å—ÊoŒŒ‚É‚æ‚éŽüpŠúS’âŽ~Š³ŽÒ‚̶‘¶—¦‚Æ’j—·. ¬àVÍŽq, ŠO@{”ü•v (–ƒ): zŠÂ§Œä, 25: 246-249, 2004.

220061. [’Z•ñ] –{–M‚É‚¨‚¯‚éŽüpŠú”xŒŒðÇðÇ‚Ì“Á’¥. •Šâ­”V1, ŒÃ‰Æ@m2, ŠÞ@NG3, ²X–؇Ži4, ˆÉ“¡@½5, ŽÓ@@ˆÀ6, X“c@Œ‰7 (1‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@, –ƒ. 2“Þ—ÇŒ§—§‰È‘å. 3ˆÇ—Ñ‘å. 4“Œ–M‘å‘åX•a‰@. 5Šâ‘ˆã—ÃZƒ“ƒ^[. 6’é‹ž‘åaŒû•a‰@. 7‰ªŽR‘åj: Therapeutic Research, 25 (5): 2004.

220062. [’Z•ñ] ŽüpŠú‚É‚¨‚¯‚éˆêŽžŒ^‰º‘åÖ¬ƒtƒBƒ‹ƒ^Žg—pÇ—á‚ÌŒŸ“¢. ’†Œ´ŠG—¢1, •Šâ­”V1,2, ŠO@{”ü•v1 (1–ƒ. 2‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@j: Therapeutic Research, 25 (5): 2004.

320084. [Ç—á•ñ] “§ÍƒAƒ~ƒƒCƒhÇ‚É‚¨‚¯‚é“«ŠÖߒɂɑ΂·‚éƒLƒZƒmƒ“ŒõÆŽË‚Ì’Á’ÉŒø‰Ê‚ÌŒŸ“¢. ´…@—v, ‹àˆäº•¶, ŠO@{”ü•v (–ƒ): ƒyƒCƒ“ƒNƒŠƒjƒbƒN, 26: 67-69, 2005.

320085. [Ç—á•ñ] ‹CŠÇƒ`ƒ…-ƒuŒðŠ·‚Ì‚½‚ß2–{‚̃`ƒ…[ƒu‚ð‘}“ü‚µ‚½‡–°Žž–³ŒÄ‹zÇŒóŒQ‚Ì1Ç—á. ¬—щÀ, Vˆä–¯], ˆî‘º”ü•äŽq, ´…@—v, ŠÛŽR”ü—R‹I, ŠO@{”ü•v (–ƒ): –ƒŒ, 53: 1414-1417, 2004.

320086. [Ç—á•ñ] ŠÔŽ¿«äNã÷‰Š‚ɑ΂·‚郌ƒWƒjƒtƒFƒ‰ƒgƒLƒVƒ“äNã÷“à’“ü—Ö@‚Ì–ƒŒŒoŒ±. ¬‘ºŒ«Ë1, •Šâ­”V1,2, ÀàV‰ØØŽq, ŽR“c“N•v, ŠO@{”ü•v1 (1–ƒ. 2‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@): –ƒŒ, 54: 149-152, 2005.

320087. [Ç—á•ñ] d–ŒŠO–ƒŒŒã‚ɶ‚¶‚½“ªŠW“àd–Œ‰ºoŒŒ‚Ì1Ç—á. X@¹–é”T, •º“ªˆŸ‹IŽq, HŽR–ƒ‹I, ‚—Ç–ƒ‹IŽq, ‹àˆäº•¶, ŠO@{”ü•v (–ƒ): –ƒŒ, 53: 1075, 2004.

320088. [Ç—á•ñ] ƒXƒLƒTƒƒgƒjƒEƒ€“Š—^Œã‚É™ù‹Ød’¼‚ð‹N‚±‚µpŒã‚ɈŸŒ^ˆ««‚”MÇ‚ð”­Ç‚µ‚½¬lH“¹ƒAƒJƒ‰ƒVƒAªŽ¡p‚Ì1—á. rì—L—Žq1, •Šâ­”V2, ˆÀÄ@Œ’3, ‹àˆäº•¶1, ‰ª–{_Žk1, ŠO@{”ü•v1 (1–ƒ. 2‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@. 3ŽÐ‰ï•ÛŒ¯•a‰@‚³‚ª‚Ý–ì•a‰@j: –ƒŒ, 53 (3): 287-90, 2004.

520309. [‰ðà] ƒnƒCƒŠƒXƒNŠ³ŽÒ‚ÌŽüŽèpŠúŠÅŒì@Ž¾Š³•ÊŠ³ŽÒ‚Ì“Á’¥‚ƃPƒA‚̃|ƒCƒ“ƒg|šb‘§Š³ŽÒ‚ÌŽüŽèpŠúŠÇ—. ‰ª–{_Žk (–ƒ): ƒi[ƒVƒ“ƒO, 24: 30-36, 2004.

520310. [‰ðà] “à‰È‚ÆŠO‰È‚ÌŠÏ“_‚©‚ç@CABG‚É‚¨‚¯‚éTEE‚ÌŽå‚È–ðŠ„. ‰ª–{_Žk (–ƒ): LISA, 11: 768-780, 2004.

520311. [‰ðà] ’m‚ç‚È‚«‚á‚Å‚«‚È‚¢I ƒ‚ƒjƒ^S“d}Q&A@S“d}‚Ì‚±‚±‚ª’m‚肽‚¢I “ÇŽÒ‚©‚ç‚Ì‚p•A. ‰ª–{_Žk (–ƒ): ƒi[ƒVƒ“ƒO, 24: 58-61, 2004.

520312. [‰ðà] ’m‚ç‚È‚«‚á‚Å‚«‚È‚¢I ƒ‚ƒjƒ^S“d}Q&A@•s®–¬Žž‚̜ד®‚Æ–ò•¨—Ö@Q&A. ‰ª–{_Žk (–ƒ): ƒi[ƒVƒ“ƒO, 24: 48-57, 2004.

520313. [‘à] “àˆö«ƒJƒ“ƒiƒrƒmƒCƒh‚Ì–ðŠ„. ŠO@{”ü•v (–ƒ): —Õ°–ƒŒ, 29: 159-165, 2005.

520314. [‰ðà] ‰õ“Kˆã—ÃVƒXƒeƒ€‚Ì‘n¬@ŠÉ˜aˆã—Ã. ŠO@{”ü•v (–ƒ): –k—¢ˆãŠw, 33: 358-361, 2003.

520315. [‰ðà] ƒXƒeƒbƒv•ûŽ®‚ÅŠw‚Ô—A‰t—Ö@@dÇŠ³ŽÒ‚ւ̑Ήž@‹}«S•s‘S. ’†Œ´ŠG—, ŠO@{”ü•v (–ƒ): ‹~‹}EW’†Ž¡—Ã, 16: 1375-1381, 2004.

520316. [‰ðà] ŽüpŠú‚É‚¨‚¯‚éƒjƒgƒƒOƒŠƒZƒŠƒ“‚Ì–ðŠ„‚Æ‰Â”\«. ŠO@{”ü•v (–ƒ): ˆãŠw‚Æ–òŠw, 52: 663-682, 2004.

520317. [‘à] u—Õ°–ƒŒŽãƒZƒ~ƒi['04vƒ–ƒŒ–@„‡DÅ‹ß‚Ì”DP’†“ÅÇ‚Ìl‚¦•û‚Æ–ƒŒ–@. ‰œ•xr”V (–ƒ): —Õ°–ƒŒ, 28 (‘): 367-381, 2004.

520318. [‘à] –³’É•ª•ØE˜a’É•ª•ØƒKƒCƒ_ƒ“ƒX1. ”ŠO‘, –{–M‚É‚¨‚¯‚é–³’É•ª•Ø‚ÌŒ»ó‚ɂ‚¢‚Ä‹³‚¦‚ĉº‚³‚¢. ‰œ•xr”V (–ƒ): —Õ°•wl‰ÈŽY‰È, 58 (4): 358-359, 2004.

520319. [‘à] –³’É•ª•ØE˜a’É•ª•ØƒKƒCƒ_ƒ“ƒX2. ‚È‚º“ú–{‚Å‚Í–³’É•ª•Ø‚ª‚ ‚Ü‚ès‚í‚ê‚È‚¢‚Ì‚Å‚·‚©. ‰œ•xr”V (–ƒ): —Õ°•wl‰ÈŽY‰È, 58 (4): 361-363, 2004.

520320. [‘à] –³’É•ª•ØE˜a’É•ª•ØƒKƒCƒ_ƒ“ƒX3. –³’É•ª•Ø‚Ì–Ú“I‚ɂ‚¢‚Ä‹³‚¦‚ĉº‚³‚¢. ‰œ•xr”V (–ƒ): —Õ°•wl‰ÈŽY‰È, 58 (4): 365-367, 2004.

520321. [‘à] –³’É•ª•ØE˜a’É•ª•ØƒKƒCƒ_ƒ“ƒX4. –³’É•ª•Ø‚ÌŒø—p‚ɂ‚¢‚Ä‹³‚¦‚ĉº‚³‚¢. ‰œ•xr”V (–ƒ): —Õ°•wl‰ÈŽY‰È, 58 (4): 368-369, 2004.

520322. [‘à] Ǘጟ“¢uŽY‰ÈƒVƒ‡ƒbƒNŠ³ŽÒ‚Ì–ƒŒv”DP’†“ÅLJ•¹‘Šú”—£|•ê‘Ì‚Ìó‘Ô‚ð‚·‚Î‚â‚­”»’f‚µ, ‹ÖŠõ‚ª‚È‚¯‚ê‚΋æˆæ–ƒŒ‚Å. Ö“¡”ü˜aŽq, ‰œ•xr”V (–ƒ): LiSA, 11 (11): 1140-1146, 2004.

520323. [‘à] Ò‘‚­‚à–Œ‰º–ƒŒ i’Á’Éj –@‚ÌŽY‰È–ƒŒ‚ւ̉ž—p i“Á‚ÉÒd–ƒCSEA‚ɂ‚¢‚Äj. ‰œ•xr”V (–ƒ): •ª•Ø‚Æ–ƒŒ, 86: 6-13, 2004.

520324. [‘à] “ÁW: ’鉤؊J‚ð„‚éV‚½‚È“WŠJ, 2. Å‹ß‚Ì•ª•ØŽž–ƒŒ/’鉤؊JŽž–ƒŒ‚Ì“®Œü. ‰œ•xr”V (–ƒ): ŽY•wl‰È‚ÌŽÀÛ, 58 (13): 1969-1978, 2004.

520325. [‰ðà] –{–M‚É‚¨‚¯‚éŽüpŠú”xÇðÇ‚Ì”­Ç•p“x‚Æ‚»‚Ì“Á’¥|2002”N“xŽüpŠú”xŒŒðÇðÇ”­Ç’²¸•ñ|. iŽÐj “ú–{–ƒŒ‰ÈŠw‰ï@”xŒŒðÇðÇ—\–hƒKƒCƒhƒ‰ƒCƒ“ì¬ì‹Æ•”‰ï, •Šâ­”V1, ŒÃ‰Æ@m2, ŠÞ@NG3, ²X–؇Ži4, ˆÉ“¡@½5, ŽÓ@@ˆÀ6, X“c@Œ‰7 (1‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@, –ƒ. 2“Þ—ÇŒ§—§ˆã‘å. 3ˆÇ—Ñ‘å. 4“Œ–M‘å‘åX•a‰@. 5Šâ‘ˆã—ÃZƒ“ƒ^[. 6’é‹ž‘åaŒû•a‰@. 7‰ªŽR‘åj: –ƒŒ, 53 (4): 454-63, 2004.

520326. [‘à] ƒIƒLƒVƒRƒhƒ“™•úù (ƒIƒLƒVƒRƒ“ƒ`ƒ“) ‚̃S[ƒXƒgƒsƒ‹‚É‚¨‚¯‚éƒIƒLƒVƒRƒhƒ“ŠÜ—Ê. ‘•ªG–ç1, ‘ºã•qŽj2, “IꌳO2, ˆÉ“Œr‰ë1, Žu^‘וv3, ŠO@{”ü•v2, –îŒã˜a•v1 (1–òÜ. 2–ƒ. 3‘—§‚ª‚ñƒZƒ“ƒ^[“Œ•a‰@): “ú–{•a‰@–òÜŽt‰ïŽGŽ, 40 (8): 1011-1013, 2004.

520327. [‘à] ‚ª‚ñ‚Ì’É‚Ý‚ð‚Æ‚é|ƒ‚ƒ‹ƒqƒl‚ðˆù‚Þ‚Ì‚Í‹°‚¢‚Å‚·‚©H “IꌳO (–ƒ): •wl”V—F10ŒŽ† p.131-135, 2004.

520328. [‘à] ƒIƒsƒIƒCƒhƒ[ƒe[ƒVƒ‡ƒ“‚ÌŽÀÛ. “IꌳO (–ƒ): ƒƒfƒBƒJƒ‹’©“ú12ŒŽ† p.70-71, 2004.

520329. [‘à] •¡•ûƒIƒLƒVƒRƒhƒ“’ŽË‰t‚É‚æ‚邪‚ñáu’ÉŽ¡—Ã. “IꌳO1, ΊۗŒb1, ¬‘ºŒ«Ë, ˆÉ“¡L‘å1, ŠÛŽR”ü—R‹I1, ˆÉ“Œr‰ë2, ‘•ªG–ç2, ŠO@{”ü•v1 (1–ƒ. 2–òÜ): ŠÉ˜aˆã—Êw, 7 (1): 53-58, 2005.

520330. [‘à] ‚ª‚ñáu’ÉŽ¡—Âɂ¨‚¯‚éƒIƒLƒVƒRƒhƒ“™•úù‚©‚牖Ž_ƒIƒLƒVƒRƒhƒ“E‰–Ž_ƒqƒhƒƒRƒ^ƒ‹ƒjƒ“•¡•û’ŽË‰t‚Ö‚Ì•ÏŠ·‚Ì—L—p«. ŠÛŽR”ü—R‹I1, “IꌳO1, ˆÉ“¡L‘å1, ˆé–ì‰ëŽq1, ‘ºã•qŽj1, ‘•ªG–ç2, ˆÉ“Œr‰ë2, ŠO@{”ü•v1 (1–ƒ. 2–òÜ): ŠÉ˜aˆã—Êw, 7 (1): 65-69, 2005.

m’˜@‘n

620179. [‹³‰È‘] (•ª’SŽ·•M) ŽY‰È–ƒŒ; ‹ÇŠ–ƒŒ–ò|‚»‚ÌŠî‘b‚Æ—Õ°|, p.215-232. ‰œ•xr”V (–ƒ), •ÒW ó“c@Í (‘åãŽs‘å), Ž½“°o”Å, “Œ‹ž, 2004/5/20”­s.

620180. [Šwp‘] (•ª’SŽ·•M) —Õ°–ƒŒŠwuÀIV; –ƒŒƒKƒXƒ‚ƒjƒ^[. ‰œ•xr”V1, “n•Ó@•q2 (1–ƒ. 2ˆã‰qj, •ÒW —Õ°–ƒŒŽ•ÒW•”, ^‹»ŒðˆÕˆãŠwo”Å•”, 2004/4/15”­s.

620181. [‰ðà‘] (•ª’SŽ·•M) ŽüŽYŠúƒPƒAuƒGƒrƒfƒ“ƒX‚ð‹‚ß‚Äv; –³’É•ª•Ø‚̃ƒŠƒbƒg‚ƃfƒƒŠƒbƒg‚͉½‚©H p.346-348. ‰œ•xr”V (–ƒ), •ÒW ŽüŽYŠúˆãŠw•ÒWˆÏˆõ‰ï, “Œ‹žˆãŠwŽÐ, 2004/11/30”­s.

620182. [Œ[–Ö‘] (’P’˜) –³’É•ª•Ø‚ÌH‚É“š‚¦‚Ü‚·, ’É‚­‚È‚¢‚¨ŽYu–ƒŒ•ª•Ø‚ª‚æ[‚­•ª‚©‚é–{v. ‰œ•xr”V (–ƒ), ŠÄC “‡“cMG (ŽR‰¤•a‰@), ƒƒfƒBƒJo”Å, 2005/1/1”­s.

620183. [Šwp‘] (•ª’SŽ·•M) “úíf—Âɖ𗧂ŒŒ¬”ÂEŒŒ‰t‹ÃŒÅü—n‚ÆŽüpŠúŠÇ—; ŽüpŠú”xŒŒðÇðÇ‚ÌŒ»ó. •Šâ­”V (‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@, –ƒ), •ÒW •À–غ‹`, ŽR‰A“¹–¾ (ŽD–yˆã‰È‘å), ^‹»ŒðˆÕˆãŠwo”Å•”, “Œ‹ž, 2004/9/25”­s.

620184. [Šwp‘] (•ª’SŽ·•M) “úíf—Âɖ𗧂ŒŒ¬”ÂEŒŒ‰t‹ÃŒÅü—n‚ÆŽüpŠúŠÇ—; ŽüpŠú”xŒŒðÇðÇ‚ÌŽ¡—Ã. •Šâ­”V (‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@, –ƒ), •ÒW •À–غ‹`, ŽR‰A“¹–¾ (ŽD–yˆã‘å), ^‹»ŒðˆÕˆãŠwo”Å•”, “Œ‹ž, 2004/9/25”­s.

620185. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ŒŽŠ§ƒi[ƒVƒ“ƒO@ƒnƒCƒŠƒXƒNŠ³ŽÒ‚ÌŽüŽèpŠúŠÅŒì; “œ”A•aŠ³ŽÒ‚ÌŽüŽèpŠúŠÇ—. •Šâ­”V (‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@, –ƒ), •ÒW —é–Ø•qs (ŠwŒ¤), ŠwKŒ¤‹†ŽÐ, “Œ‹ž, 2004/12/20”­s.

620186. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) —§ê‚©‚猩‚éˆã–ò•i•ï‘•E•\Ž¦‚É‚¨‚¯‚錻ê‚Å‚ÌŽÀ‘Ԃƃj[ƒY; ˆãŽt‚©‚ç‚Ý‚½•ï‘•E•\Ž¦‚Ö‚Ì—v–], ˆã–ò•i‚Ì•ï‘•E•\Ž¦EÜŒ`‚É‚¨‚¯‚éˆã—ÃŒ»êƒgƒ‰ƒuƒ‹E‘ÎôŽ–—áW, ‘æ1”Å•ª p.5-10. ¬àVÍŽq, ŠO@{”ü•v (–ƒ), •ÒW ‚”–ˆêO, ‹Zpî•ñ‹¦‰ï, “Œ‹ž, 2004”­s.

620187. [‰ðà‘] (•ª’SŽ·•M) ˆã–ò•i“™“K«Žg—p„iŽ{sŽ–‹Æ|–ƒŒ–ò‚¨‚æ‚Ñ–ƒŒŠÖ˜A–òŽg—pƒKƒCƒhƒ‰ƒCƒ“|‰ü’ù‘æ2”Å: ‰–Ž_ƒIƒLƒVƒRƒhƒ“, p.10-13. “IꌳO (–ƒ), ŽÐ’c–@l“ú–{–ƒŒ‰ÈŠw‰ï, “Œ‹ž, 2004/5”­s.

620188. [‰ðà‘] (ŠÄC) ŠÉ˜aƒPƒA‚É‚¨‚¯‚é•Ö”é‚Ì—‰ð‚ƃPƒA. ‰Á‰ê’J”£1, ˆ¢•”Œb]2 (1϶‰ï‰¡•lŽs“ì•”•a‰@. 2ŠÅŒì•”). “IꌳO (–ƒ), ƒCƒ“ƒ^[ƒTƒCƒGƒ“ƒXŽÐ, “Œ‹ž, 2004/7/1”­s.

620189. [‰ðà‘] (‹¤’˜/ŠÄCj Œ©‚‚¯‚悤I ‚ª‚ñ‚Ì’É‚Ý‚ÆŠÖ˜A’É. “IꌳO1, •yˆÀŽu˜Y2 (1–ƒ. 2’·è‘åj, ŠÄC “IꌳO, tHŽÐ, “Œ‹ž, 2004/7/15”­s.

620190. [“ü–å‘](’P’˜/ŠÄC) Ž„‚Ì’É‚Ý‚ÆŽ¡—Â̓ú‹L, “IꌳO (–ƒ). ŠÄC “IꌳO, tHŽÐ, “Œ‹ž, 2005/1/20”­s.

620191. [“ü–å‘] (’P’˜/ŠÄC) ‚ª‚ñáu’ÉŽ¡—ẪŒƒVƒs. “IꌳO (–ƒ), ŠÄC “IꌳO, tHŽÐ, “Œ‹ž, 2005/2/1”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

713217. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Changes in platelet aggregation during off-pump and on-pump coronary artery bypass surgery measured by a whole blood aggregometer. •Šâ­”V, Osamu Ito, ŠO@{”ü•v, ‰ª–{_Žk, Ž…–žD (–ƒ): 2004 Society of Cardiovascular Anesthesiologists Annual Meeting (2004/4/2), Honolulu, USA.

713218. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Effects of Left Heart Bypass on Arterial Oxygenation During One-Lung Ventilation in Patients Undergoing Descending Thoracic Aortic Surgery. ŽL“‡çŒbŽq1, Yoshinari Niimi2, Shin Yamamoto3, Mariko Hoshino4, Chieko Sakuramoto4, ŠO@{”ü•v1 (1–ƒ. 2’é‹ž‘å. 3Kawasaki Saiwai Hospital Aortic Center. 4Machida municipal Hospital): The Meeting of the Society of Cardiovascular Anesthesiologists (2004/4/26), Honolulu.

713219. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) The speed in epidural infusion mepivacaine affects the degree of nerve blockade. —é–Ø–ƒ—t, ‹àˆäº•¶, ŠO@{”ü•v (–ƒ): Canadian Anesthesiologists'Society 60th Annual Meeting (2004/6/21), Quebec.

713220. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Sumatriptan alleviates the pain in patients with trigeminal neuralgia. ‹àˆäº•¶, ‘åàV@—¹, —é–Ø–ƒ—t, ΊۗŒb, ŠO@{”ü•v (–ƒ): American Society of Anesthesiologist (2004/10/25), Las Vegas.

713221. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Effectiveness of prostaglandin E1 for the treatment of patients with neuropathic pain following herpes zoster. ‹àˆäº•¶, ‘åàV@—¹, —é–Ø–ƒ—t, ΊۗŒb, ŠO@{”ü•v (–ƒ): American Society of Anesthesiologist (2004/10/25), Las Vegas.

713222. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Efficacy of oral pranlukast hydrate, a leukotriene receptor antagonist, in the treatment of postherpetic neuralgia. ‹àˆäº•¶, ‘åàV@—¹, —é–Ø–ƒ—t, ΊۗŒb, ŠO@{”ü•v (–ƒ): American Society of Anesthesiologist (2004/10/25), Las Vegas.

713223. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Sensory and motor blockade during postoperative continuous epidural infusion of ropivacaine and fentanyl. ‘åàV@—¹, —é–Ø–ƒ—t, ‹àˆäº•¶, ‰ª–{_Žk, ŠO@{”ü•v (–ƒ): American Society of Anesthesiologist (2004/10/25), Las Vegas.

713224. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) The Effect of Timing in the Initiation of Epidural Infusion at Combined Spinal-Epidural Analgesia for Labor on the Total Dose of Local Anesthetic. ‰œ•xr”V1, –]ŒŽƒŽq2, “V–ì@Š®2, Ö“¡”ü˜aŽq1, ŠO@{”ü•v1 (1–ƒ. 2ŽY•w): Annual Meeting of American Society of Anesthesiology (2004/10/26), Las Vegas.

713225. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Dilution of local anesthetic with saline affects epidural analgesic property. ‹àˆäº•¶, —é–Ø–ƒ—t, ‘åàV@—¹, ‰ª–{_Žk, ŠO@{”ü•v (–ƒ): American Society of Anesthesiologist (2004/10/27), Las Vegas.

713226. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Changes in platelet aggregation after cardiopulmonary bypass measured by a new aggregometor using whole blood. •Šâ­”V, Osamu Ito, ŠO@{”ü•v, ‰ª–{_Žk, Ž…–žD (–ƒ): American Society of Anesthesiologists, annual meeting 2004 (2004/10/28), Las Vegas.

713227. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Migration of Neutrophil s Evoked by Leukotriene B4 Is Inhibited by Olprinone, a PDE-3 Inhibitor, in the Microvasculature of Hamster Cheek pouch. ¬àVÍŽq1, “ޗljÀ—m2, ŠÌ•t@—m1, ‰ª–{_Žk1, ŠO@{”ü•v1 (1–ƒ. 2¶•¨•¨—Œn): ASA 2004 Annual Meeting (2004/10), Las Vegas, Nevada. Program, A-725, 2004.

713228. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Intraocular Pressure Changes During Laparoscopic Radical Prostatectomy. ¬àVÍŽq1, ‘“c‰p—Žq1, ‰ª–{_Žk1, ŠO@{”ü•v1, ‰oì@W2 (1–ƒ. 2”å): ASA 2004 Annual Meeting (2004/10), Las Vegas, Nevada. Program, A-1271, 2004.

713229. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Incidence of transient neurologic symptoms after combined spinal and epidural nesthesia. ’|˜Q–¯] (–ƒ): American Society of Anesthesiologists (2004/10), Las Vegas.

713230. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Neurotoxic change caused by intrathecal lidocaine via catheter implanted in cauda equina commences from the posterior root in rats. ’|˜Q–¯] (–ƒ): American Society of Anesthesiologists (2004/10), Las Vegas.

713231. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Membrane mechanisms of lodocaine induced inhibition of axonal transport. ’|˜Q–¯] (–ƒ): Neuroscience (2004/10), San Diego.

713232. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Combined spinal-epidural versus epidural analgesia: The initial analgesic methods may affect the subsequent anesthetic requirements during labor analgesia using patient-controlled infusion pump. ‰œ•xr”V1, Ö“¡”ü˜aŽq1, –]ŒŽƒŽq2, “V–ì@Š®2, ŠO@{”ü•v1 (1–ƒ. 2ŽY•w): 79th International Anesthesia Research Society (2005/3/13), Honolulu.

721018. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‚ª‚ñáu’ÉŽ¡—ẪIƒsƒIƒCƒh@‚Ç‚¤l‚¦‚Ä‘I‘ð‚·‚é‚©. “IꌳO (–ƒ): ‘æ66‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï (2004/10/13), ·‰ª.

722114. [Šw‰ï (‘S‘)] (µ‘Ò‚³‚ꂽu‰‰) –«áu’ɂ̃`[ƒ€ˆã—Ã? ‚»‚ÌŽÀŒ»«‚ɂ‚¢‚Ä. ‹àˆäº•¶, ŠO@{”ü•v (–ƒ): ‘æ34‰ñ“ú–{–«áu’ÉŠw‰ï (2004/2/26), “Œ‹ž.

722115. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’j—·‚ðl—¶‚µ‚½–ƒŒEŽüpŠúŠÇ—, ŠO«‘å—ÊoŒŒ‚É‚æ‚éŽüpŠúS’âŽ~Š³ŽÒ‚̶‘¶—¦‚Æ’j—·. ¬àVÍŽq (–ƒ): ‘æ25‰ñ“ú–{zŠÂ§ŒäˆãŠw‰ï‘‰ï (2004/6), ”ŸŠÙ.

722116. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒtƒFƒ“ƒ^ƒjƒ‹ƒpƒbƒ`‚ÌŽg‚¢•û‚̃Rƒc‚Æ–â‘è“_. “IꌳO (–ƒ): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—Êw‰ï (2004/6/17), ŽD–y. ƒvƒƒOƒ‰ƒ€E´˜^W, p.54, 2004.

722117. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŠÉ˜aƒPƒAˆã‚ÆÇóŠÉ˜aŽ¡—Ã@‚Ç‚±‚Ü‚ÅŽ¡—ÂɊւí‚é‚Ì‚©. “IꌳO (–ƒ): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—Êw‰ï (2004/6/18), ŽD–y. ƒvƒƒOƒ‰ƒ€E´˜^W, p.59, 2004.

722118. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒ‚ƒ‹ƒqƒl‚ƃIƒLƒVƒRƒhƒ“‚̃[ƒe[ƒVƒ‡ƒ“. “IꌳO (–ƒ): “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ38‰ñ‘å‰ï (2004/7/16), “Œ‹ž. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ‘æ38‰ñ‘å‰ï†, 11 (3): 231, 2004.

723889. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’·ŽžŠÔ head down position‚Ì• o‹¾‰ºŽèp‚̊ሳ•Ï‰». ¬àVÍŽq, ‘“c‰p—Žq, ã–ì“N¶, ‰ª–{_Žk, ŠO@{”ü•v (–ƒ): ‘æ15‰ñ—Õ°ƒ‚ƒjƒ^[Šw‰ï‘‰ï (2004/4), “Œ‹ž.

723890. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ú–{l”D•w‚Ì¿ˆÊ‚É‚¨‚¯‚éd–ŒŠOo‚Ü‚Å‚Ì‹——£. ‰œ•xr”V, Ö“¡”ü˜aŽq, ŠO@{”ü•v (–ƒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ51‰ñ‘å‰ï (2004/5/27), –¼ŒÃ‰®.

723891. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ƒCƒIƒ“‰»ƒ}ƒOƒlƒVƒEƒ€ŠÜ—L1%ƒuƒhƒE“œ‰Á|Ž_ƒŠƒ“ƒQƒ‹‚Ì”]ŠO‰ÈŽèp‚É‚¨‚¯‚錟“¢. ¬âN°1, ‰ª–{_Žk1, •Šâ­”V1,2, ã–ì“N¶1, ΊۗŒb1, ŠO@{”ü•v1 (1–ƒ. 2‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@): ‘æ51‰ñ“ú–{–ƒŒ‰ÈŠw‰ï‘‰ï (2004/5/27), –¼ŒÃ‰®.

723892. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒƒsƒoƒJƒCƒ“‚ƃtƒFƒ“ƒ^ƒjƒ‹‚ð—p‚¢‚½PCEA•t‚«pŒã‹¹•”Ž‘±d–ŒŠO’Á’É‚É‚¨‚¯‚é’Á’ÉŒø‰Ê‚ÌŒŸ“¢. •º“ªˆŸ‹IŽq, —é–Ø–ƒ—t, ¬ˆéi‘¾˜Y, ‹àˆäº•¶, ‰ª–{_Žk, ŠO@{”ü•v (–ƒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ51‰ñŠwpW‰ï (2004/5/27), –¼ŒÃ‰®.

723893. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒƒsƒoƒJƒCƒ“‚ƃtƒFƒ“ƒ^ƒjƒ‹‚ð—p‚¢‚½PCEA•t‚«pŒã˜•”Ž‘±d–ŒŠO’Á’É‚É‚¨‚¯‚é‚­‚à–Œ‰ºÒ‘–ƒŒ‚Æd–ŒŠO–ƒŒ‚Ì”äŠr. ¬ˆéi‘¾˜Y, ‘åàV@—¹, ´…@—v, ‹àˆäº•¶, ‰ª–{_Žk, ŠO@{”ü•v (–ƒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ51‰ñŠwpW‰ï (2004/5/27), –¼ŒÃ‰®.

723894. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) d–ŒŠO–ƒŒ‚É‚¨‚¯‚郃sƒoƒJƒCƒ“‚Ì’“ü‘¬“x‚ª_ŒoŽÕ’fì—p‚ÆŒŒs“®‘Ô‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä‚ÌŒŸ“¢. —é–Ø–ƒ—t, ‘åàV@—¹, ´…@—v, ‹àˆäº•¶, ‰ª–{_Žk, ŠO@{”ü•v (–ƒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ51‰ñŠwpW‰ï (2004/5/28), –¼ŒÃ‰®.

723895. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) H“¹ƒAƒJƒ‰ƒVƒAŠ³ŽÒ‚Ì–ƒŒ“±“ü‚Ƈ•¹Ç‚ÌŒŸ“¢. Ö“¡—TŽq, ¬àVÍŽq, ¬ˆéi‘¾˜Y, ‰œ•xr”V, ‰ª–{_Žk, ŠO@{”ü•v (–ƒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ51‰ñŠwpW‰ï (2004/5/28), –¼ŒÃ‰®.

723896. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) • o‹¾‰º‘O—§‘B‘S“EopŽž‚̊ሳ•Ï“®. ‘“c‰p—Žq1, ¬àVÍŽq1, ˆÉ“¡‘s•½1, ‰ª–{_Žk1, ŠO@{”ü•v1, ‰oì@W2 (1–ƒ. 2”å): “ú–{–ƒŒ‰ÈŠw‰ï‘æ51‰ñŠwpW‰ï (2004/5/28), –¼ŒÃ‰®.

723897. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒIƒ‹ƒvƒŠƒmƒ“‚É‚æ‚é”÷¬zŠÂ‚Å‚Ì”’ŒŒ‹…‰ž“š (ƒrƒfƒIƒZƒbƒVƒ‡ƒ“). ¬àVÍŽq1, “ޗljÀ—m2, ŠÌ•t@—m1, ‰ª–{_Žk1, ŠO@{”ü•v1 (1–ƒ. 2¶•¨•¨—Œn): “ú–{–ƒŒ‰ÈŠw‰ï‘æ51‰ñŠwpW‰ï (2004/5/28), –¼ŒÃ‰®. ‘æ25‰ñ“ú–{zŠÂ§ŒäˆãŠw‰ï‘‰ï (2004/6/11), ”ŸŠÙ.

723898. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒtƒFƒ“ƒ^ƒjƒ‹ƒpƒbƒ`‚Ɖ–Ž_ƒIƒLƒVƒRƒhƒ“™•úù‚̃IƒsƒIƒCƒhƒ[ƒe[ƒVƒ‡ƒ“‚ÌŒŸ“¢. ¬ˆéi‘¾˜Y1, ‘•ªG–ç2, ˆÉ“Œr‰ë2, ˆÉ“¡L‘å1, “IꌳO1, ŠO@{”ü•v1 (1–ƒ. 2–òÜ): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—Êw‰ï (2004/6/17), ŽD–y. ƒvƒƒOƒ‰ƒ€E´˜^W, p.83, 2004.

723899. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‚ª‚ñ«áu’ÉŠ³ŽÒ‚É‚¨‚¯‚éƒIƒLƒVƒRƒhƒ“»Ü‚Ì‘Ì“à–ò•¨“®‘Ô. ‘•ªG–ç1, ‘å–Ø–ƒŒÈŽq1, “IꌳO2, ‘º£¨’ÃŽq1, ²ìŒ«ˆê1, –îŒã˜a•v1, ŠO@{”ü•v2 (1–òÜ. 2–ƒ): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—Êw‰ï (2004/6/18), ŽD–y. ƒvƒƒOƒ‰ƒ€E´˜^W, p.141, 2004.

723900. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) t‹@”\áŠQ‚Ì‚ ‚銳ŽÒ‚ł̉–Ž_ƒIƒLƒVƒRƒ“ƒ`ƒ“™•úù‚ÌŽg—p‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ˆé–ì‰ëŽq1, ˆÉ“Œr‰ë2, ‘•ªG–ç2, ˆÉ“¡L‘å1, “IꌳO1, ŠO@{”ü•v1 (1–ƒ. 2–òÜ): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—Êw‰ï (2004/6/18), ŽD–y. ƒvƒƒOƒ‰ƒ€E´˜^W, p.142, 2004.

723901. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒŠƒ“Ž_ƒRƒfƒCƒ“‚©‚牖Ž_ƒIƒLƒVƒRƒhƒ“™•úù‚Ö‚Ì•ÏX. ˆÉ“¡L‘å1, ˆé–ì‰ëŽq1, ‘•ªG–ç2, ˆÉ“Œr‰ë2, “IꌳO1, ŠO@{”ü•v1 (1–ƒ. 2–òÜ): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—Êw‰ï (2004/6/18), ŽD–y. ƒvƒƒOƒ‰ƒ€E´˜^W, p.143, 2004.

723902. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “§Í“±“ü’†‚Ìt•s‘SŠ³ŽÒ‚ɑ΂·‚éƒIƒLƒVƒRƒhƒ“‚ÌŽg—pŒoŒ±. ‘åàV@—¹1, “IꌳO1, ‘•ªG–ç2, ˆÉ“Œr‰ë2, ŠO@{”ü•v1 (1–ƒ. 2–òÜ): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—Êw‰ï (2004/6/18), ŽD–y. ƒvƒƒOƒ‰ƒ€E´˜^W, p.143, 2004.

723903. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‚ª‚ñŠ³ŽÒ‚̃Šƒ“ƒp•‚Žî‚Ö‚ÌŽæ‚è‘g‚Ý1|ƒŠƒ“ƒpƒ}ƒbƒT[ƒW‚ð’†S‚Æ‚µ‚½Šˆ“®‚ÌL‚ª‚è|. ŒI“c‚©‚Ù‚é, –،ªŽ¡, –ûìŒb”üŽq, ˆ¢•”Œb], ìˆä’qŒb, Ž›àV’¼Žq1, “IꌳO2 (1ŠÅŒì•”. 2–ƒ): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—Êw‰ï (2004/6/18), ŽD–y. ƒvƒƒOƒ‰ƒ€E´˜^W, p.160, 2004.

723904. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‚ª‚ñŠ³ŽÒ‚̃Šƒ“ƒp•‚Žî‚Ö‚ÌŽæ‚è‘g‚Ý2|ƒIƒŠƒWƒiƒ‹ƒAƒZƒXƒƒ“ƒgƒV[ƒg‚Ì쬂̎Ž‚Ý|. –،ªŽ¡, ìˆä’qŒb, Ž›àV’¼Žq, –ûìŒb”üŽq, ˆ¢•”Œb], ŒI“c‚©‚Ù‚é1, “IꌳO2 (1ŠÅŒì•”. 2–ƒ): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—Êw‰ï (2004/6/18), ŽD–y. ƒvƒƒOƒ‰ƒ€E´˜^W, p.175, 2004.

723905. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒƒgƒƒjƒ_ƒ][ƒ‹‰@“à»Ü‚ð—p‚¢‚½‚ª‚ñ«ˆ«LƒPƒA‚Æ–òÜŽt‚ÌŠÖ‚í‚è. ˆÉ“Œr‰ë1, ‘•ªG–ç1, ²ìŒ«ˆê1, –îŒã˜a•v1, “IꌳO2, ŠO@{”ü•v2 (1–òÜ. 2–ƒ): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—Êw‰ï (2004/6/18), ŽD–y. ƒvƒƒOƒ‰ƒ€E´˜^W, p.191, 2004.

723906. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒŠƒhƒJƒCƒ“‚ÌŽ²õ—A‘——}§ì—p‚Ì×–E–ŒƒƒJƒjƒYƒ€. Vˆä–¯] (–ƒ): ‘æ81‰ñ“ú–{¶—Šw‰ï (2004/6/3-5), ŽD–y.

723907. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”n”ö_Œo—̈æ‚É“Š—^‚µ‚½ƒŠƒhƒJƒCƒ“‚Ì_Œo“Å«‚ÌŒŸ“¢. Vˆä–¯] (–ƒ): ‘æ15‰ñ‹ÇŠ–ƒŒŠw‰ï (2004/6), “Œ‹ž.

723908. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹}«‘Ñóáv]’ɂɑ΂·‚éƒAƒ~ƒgƒŠƒvƒ`ƒŠƒ“‚Ì’Á’ÉŒø‰Ê‚ÌŒŸ“¢. —é–Ø–ƒ—t, ‹àˆäº•¶, ŠO@{”ü•v (–ƒ): ‘æ38‰ñ“ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï (2004/7/15-17), “Œ‹ž.

723909. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘Ñóáv]Œã_Œo’ɂɑ΂·‚éƒIƒLƒVƒRƒhƒ“‚ƃNƒƒ‹ƒtƒFƒjƒ‰ƒ~ƒ“‚Ì’Á’ÉŒø‰Ê‚ÌŒŸ“¢. m–Ø—L—Žq, ΊۗŒb, ‹àˆäº•¶, ŠO@{”ü•v (–ƒ): ‘æ38‰ñ“ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï (2004/7/15-17), “Œ‹ž.

723910. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Œü¸_–ò‚Ì’†Ž~‚É‚æ‚è‰ü‘P‚µ‚½“«–«áu’É‚Ì1—á. —é–Ø–ƒ—t, ‹àˆäº•¶, ŠO@{”ü•v (–ƒ): ‘æ38‰ñ“ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï (2004/7/15-17), “Œ‹ž.

723911. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Ž‘±d–ŒŠO’Á’É‚É‚¨‚¯‚é‹ÇŠ–ƒŒ–ò‚ÌŠóŽß‚̉e‹¿. ¬ˆéi‘¾˜Y, ΊۗŒb, ‹àˆäº•¶, ŠO@{”ü•v (–ƒ): ‘æ38‰ñ“ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï (2004/7/15-17), “Œ‹ž.

723912. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒƒsƒoƒJƒCƒ“‚É‚æ‚鎑±d–ŒŠO’Á’É‚É‚¨‚¯‚銴ŠoŽÕ’fˆæ‚Ì„ˆÚ‚ÌŒŸ“¢. ‘åàV@—¹, ΊۗŒb, ‹àˆäº•¶, ŠO@{”ü•v (–ƒ): ‘æ38‰ñ“ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï (2004/7/15-17), “Œ‹ž.

723913. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘Ñóáv]”­Ç•”ˆÊ‚É‘¼Ž¾Š³‚É‚æ‚éáu’É‚ª‡•¹‚µ‚½2Ç—á. m–Ø—L—Žq, ‹àˆäº•¶, ŠO@{”ü•v (–ƒ): ‘æ38‰ñ“ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï(2004/7/15-17), “Œ‹ž.

723914. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒpƒƒLƒZƒ`ƒ“‚É‚æ‚è‰ü‘P‚µ‚½“«–«áu’ÉŠ³ŽÒ‚ÌŒŸ“¢. —é–Ø–ƒ—t, ‹àˆäº•¶, ŠO@{”ü•v (–ƒ): ‘æ38‰ñ“ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï(2004/7/15-17), “Œ‹ž.

723915. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –«áu’ɂɑ΂·‚éƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“E1‚Ì“Š—^‘¬“x‚ÌŒŸ“¢. ¬ˆéi‘¾˜Y, ΊۗŒb, ‹àˆäº•¶, ŠO@{”ü•v (–ƒ): ‘æ38‰ñ“ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï (2004/7/15-17), “Œ‹ž.

723916. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) •Û‘¶Ü‚ªƒ~ƒ_ƒ]ƒ‰ƒ€‚Ì_Œo“Å«‚É—^‚¦‚é‰e‹¿. Vˆä–¯] (–ƒ): ‘æ31‰ñƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï (2004/7/15-17), “Œ‹ž.

723917. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ú–{l”D•w‚Ì¿ˆÊ‚É‚¨‚¯‚éd–ŒŠOo? Ò‘‚­‚à–Œ‰ºoŠÔ‹——£. ‰œ•xr”V, Ö“¡”ü˜aŽq, ŠO@{”ü•v (–ƒ): “ú–{—Õ°–ƒŒŠw‰ï‘æ24‰ñ‘å‰ï (2004/10/14), ‘åã.

723918. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹~‹}‹~–½Žm‹CŠÇ‘}ŠÇŽÀK‘æ1—á–Ú‚ÌŒo‰ß‚ɂ‚¢‚Ä. ¬àVÍŽq, Vˆä³N, Vˆä–¯], ‹àˆäº•¶, ‰œ•xr”V, ‰ª–{_Žk, ŠO@{”ü•v, –쌩ŽR@‰„ (–ƒ): “ú–{—Õ°–ƒŒŠw‰ï‘æ24‰ñ‘å‰ï (2004/10/14-16), ‘åã.

723919. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 2Ží—ނ̃vƒƒ|ƒtƒH[ƒ‹»Ü‚É‚æ‚铱“üŽž‚ÌBIS’l‚̕ω». ˆé–ì‰ëŽq, ¬àVÍŽq, ã–ì“N¶, ¬âN°, ‰œ•xr”V, ‰ª–{_Žk, ŠO@{”ü•v, —é–Ø—Œb (–ƒ): “ú–{—Õ°–ƒŒŠw‰ï‘æ24‰ñ‘å‰ï (2004/10/14-16), ‘åã.

723920. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) TUR-P‚É‚¨‚¯‚éƒtƒŠ[ƒX‚ÌŒø‰Ê‚ɂ‚¢‚Ä. —é–Ø—Œb, ¬àVÍŽq, ŠÌ•t@—m, ‰ª–{_Žk, ŠO@{”ü•v (–ƒ): “ú–{—Õ°–ƒŒŠw‰ï‘æ24‰ñ‘å‰ï (2004/10/14-16), ‘åã.

731128. [Œ¤‹†‰ï] i“Á•Êu‰‰) ‚ª‚ñáu’ÉŽ¡—ẪŒƒVƒs. “IꌳO (–ƒ): Cancer Pain Management Symposium in˜a‰ÌŽR (2004/1/9), ˜a‰ÌŽR. ‘æ1‰ñ‹{èŠàáu’ÉŽ¡—ç˜b‰ïŠwpu‰‰‰ï (2004/4/17), ‹{è. ¼Ã’n‹æ‚ª‚ñáu’ÉŽ¡—ÃŒ¤‹†‰ï (2004/6/4), ¬“cŒ´. ’¹ŽæŒ§ŠÉ˜aˆã—ÃŒ¤‹†‰ï (2004/6/20), ’¹Žæ.

731129. [§˜b‰ï] (“Á•Êu‰‰) ƒ‚ƒ‹ƒqƒlEƒIƒLƒVƒRƒhƒ“EƒtƒFƒ“ƒ^ƒjƒ‹. “IꌳO (–ƒ): ˜a‰ÌŽR‚ª‚ñáu’ÉŽ¡—ç˜b‰ï (2004/4/10), ˜a‰ÌŽR.

731130. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‚ª‚ñáu’ÉŽ¡—Âɂ¨‚¯‚郂ƒ‹ƒqƒlEƒIƒLƒVƒRƒhƒ“EƒtƒFƒ“ƒ^ƒjƒ‹. “IꌳO (–ƒ): ŒQ”nCancer Pain Forum (2004/5/15), ŒQ”n.

731131. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‚ª‚ñ‚̒ɂ݂ƃIƒsƒIƒCƒh»Ü‚ÌŽg‚¢•ª‚¯. “IꌳO (–ƒ): Šàáu’ÉŠÇ—Œ¤‹†‰ï (2004/6/25), ‹ž“s.

731132. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‚ª‚ñáu’ÉŽ¡—Âɂ¨‚¯‚é’Á’É•â•–ò‚ÌŽg‚¢•û. “IꌳO (–ƒ): ‘æ6‰ñ²‹v•½ŠÉ˜aˆã—ÃŒ¤‹†‰ï (2004/7/9), ’·–쌧E²‹v.

731133. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‚ª‚ñ‚̒ɂ݂ƃ‚ƒ‹ƒqƒlEƒIƒLƒVƒRƒhƒ“EƒtƒFƒ“ƒ^ƒjƒ‹. “IꌳO (–ƒ): ‘æ19‰ñ_“Þì“û‘BŽ¾Š³Ç—ጟ“¢‰ï (2004/7/24), ‰¡•l.

731134. [Œ¤‹†‰ï] (“Á•Êu‰‰) ƒIƒsƒIƒCƒhƒ[ƒe[ƒVƒ‡ƒ“. “IꌳO (–ƒ): ‘æ2‰ñ–¼ŒÃ‰®‚ª‚ñáu’ɊɘaƒtƒH[ƒ‰ƒ€ (2004/7/31), –¼ŒÃ‰®.

731135. [Œ¤‹†‰ï] (“Á•Êu‰‰) ƒ‚ƒ‹ƒqƒlEƒIƒLƒVƒRƒhƒ“EƒtƒFƒ“ƒ^ƒjƒ‹, ‚Ç‚¤Žg‚¢•ª‚¯‚é‚©? “IꌳO (–ƒ): ‘æ18‰ñ”ђˊɘaˆã—Õ׋­‰ï (2004/8/4), •Ÿ‰ª. `ƒyƒCƒ“ƒRƒ“ƒgƒ[ƒ‹ƒvƒ‰ƒNƒeƒBƒXŒ¤‹†‰ï@‘æ2‰ñ“Á•Êu‰‰‰ï (2004/8/11), “Œ‹ž.

731136. [‚»‚Ì‘¼] (“Á•Êu‰‰) ÇóŠÉ˜a‚Ɖ‡•‹Zp. “IꌳO (–ƒ): •½¬16”N“xƒzƒXƒsƒXƒPƒA”F’èŠÅŒìŽt‹³ˆç‰Û’ö (2004/8/21), “Œ‹ž.

731137. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‚ª‚ñáu’ÉŽ¡—Âɂ¨‚¯‚éƒIƒsƒIƒCƒh‚ÆÜŒ`‚Ì‘I‘ð. “IꌳO (–ƒ): ‘æ4‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[‚ðŠw‚Ô‰ï (2004/8/25), ŽD–y.

731138. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‚ª‚ñáu’ÉŽ¡—ÂÌl‚¦•û‚ƃIƒsƒIƒCƒh‚Ì‘I‘ð. “IꌳO (–ƒ): ‘æ4‰ñÂXŠÉ˜aƒPƒA§˜b‰ï (2004/9/11), ÂX. ‚ª‚ñáu’Ɋɘa‚ƈã—×p–ƒ–ò‚Ì“K³Žg—p„i‚Ì‚½‚ß‚ÌuK‰ï (2004/10/9), ’·–ì. ‘æ3‰ñTFCìŠwpu‰‰‰ï (2004/11/13), ‚¼. ‘æ‚S‰ñŠÉ˜aˆã—Êwpu‰‰‰ï (2004/12/3), ¼–{. ‘æ2‰ñ²‰êŠà«áu’ɧ˜b‰ï (2005/1/28), ²‰ê. Cancer Pain Control u‰‰‰ï (2005/2/4), “Œ‹ž. ‚ª‚ñáu’ÉŽ¡—Õ׋­‰ï (2005/3/25), ŽD–y.

731139. [Œ¤C‰ï] (“Á•Êu‰‰) ŠÉ˜aƒPƒA. “IꌳO (–ƒ): ‘æ25‰ñ“ú–{•a‰@–òÜŽt‰ïŽÀ–±Œ¤C‰ï (2004/9/17), “Œ‹ž.

731140. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‚ª‚ñáu’ɂ̃Rƒ“ƒgƒ[ƒ‹. “IꌳO (–ƒ): ‘æ70‰ñ‘åã‚©‚ç”x‚ª‚ñ‚ð‚È‚­‚·‰ïƒVƒ“ƒ|ƒWƒEƒ€•‘æ‚Q‰ñ–k–ìŠÉ˜aˆã—ÃŒ¤‹†‰ï (2004/10/16), ‘åã.

731141. [u‰‰‰ï] (“Á•Êu‰‰) ‚ª‚ñ‚Ì’É‚Ý‚É‚Ç‚¤‘Έ‚·‚é‚©`“KØ‚È–òÜ‚Ì‘I‘ð‚Æ•›ì—p‘Îô. “IꌳO (–ƒ): “¡‘òŽs—Õ°ŠO‰Èˆã‰ïŠwpu‰‰‰ï (2004/11/10), “¡‘ò. ŠÉ˜aˆã—Õ׋­‰ï (2005/2/19), ˆ®ì.

731142. [Šw‰ï (’n•û)] (“Á•Êu‰‰) ÇóŠÉ˜a‘Îô‚Ìi•à|‚ª‚ñ«áu’É‚È‚Ç|. “IꌳO (–ƒ): ‘æ46‰ñ_“ÞìˆãŠw‰ï‘‰ïEŠwp‘å‰ïƒVƒ“ƒ|ƒWƒEƒ€ (2004/11/23), ‰¡•l.

731143. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‚ª‚ñáu’ÉŽ¡—Âƃ`[ƒ€ˆã—Ã. “IꌳO (–ƒ): ‘æ4‰ñŠÉ˜aƒPƒA—̈æ–òÜŽtŒ¤‹†‰ï (2005/1/8), “Œ‹ž.

731144. [Œ¤‹†‰ï] (“Á•Êu‰‰) Å‹ß‚Ìáu’Ɋɘa‚Ìi•à. “IꌳO (–ƒ): ‘æ13‰ñŠÉ˜aˆã—ÃŒ¤‹†‰ï (2005/2/5), ‰ªŽR.

731145. [u‰‰‰ï] (“Á•Êu‰‰) ‚ª‚ñáu’ÉŽ¡—ÂƃtƒFƒ“ƒ^ƒjƒ‹»Ü‚̈ʒu‚¯. “IꌳO (–ƒ): Šwpu‰‰‰ï`‚ª‚ñáu’ÉŽ¡—Âðl‚¦‚é (2005/2/18), ˆ®ì.

731146. [Œ¤‹†‰ï] (“Á•Êu‰‰) ƒIƒLƒVƒRƒhƒ“‚̻܂ð’†S‚É‚µ‚½ƒIƒsƒIƒCƒh‚ÌŽg‚¢•û‚Æ•›ì—p‘Îô. “IꌳO (–ƒ): ‚ª‚ñŽ¡—ÂÆÇóŠÉ˜aŒ¤‹†‰ï in ¬“cŒ´ (2005/2/24), ¬“cŒ´.

731147. [Œ¤‹†‰ï] (“Á•Êu‰‰) ‚ª‚ñáu’É‚Ìl‚¦•û|ƒIƒsƒIƒCƒh. “IꌳO (–ƒ): ‘æ7‰ñ“ì‘åãŠÉ˜aˆã—ÃŒ¤‹†‰ï (2005/3/5), ‘åã.

731148. [Œ¤‹†‰ï] (“Á•Êu‰‰) ƒtƒFƒ“ƒ^ƒjƒ‹‚É‚æ‚邪‚ñáu’ÉŽ¡—Â̬‰Ê‚Æ¡Œã‚Ì“W–]. “IꌳO (–ƒ): Cancer Pain Management Symposium 2005 (2005/3/12), “Œ‹ž.

733475. [Œ¤‹†‰ï] (ˆê”ʉ‰‘è) ŽüpŠú”xŒŒðÇðÇ”­Ç󋵂Ƃ»‚̕ω». •Šâ­”V1, ŒÃ‰Æ@m2, £”öŒ›³3, “ü“c˜a’j4, ˆÉ“¡@½5, ²X–؇“ñ6, àV@’q”Ž7 (1‘—§•a‰@‹@\‘Š–ÍŒ´•a‰@, –ƒ. 2“Þ—ÇŒ§—§ˆã‘å. 3Ž©Ž¡ˆã‘å. 4‹ãB‘å. 5Šâ‘ˆã—ÃZƒ“ƒ^[. 6“Œ‹ž—ÕŠC•a‰@. 7’é‹ž‘å): ‘æ11‰ñ”xÇðÇŒ¤‹†‰ïŠwpW‰ï (2004/11/21), “Œ‹ž.

733476. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) ƒvƒƒ|ƒtƒH[ƒ‹‚Ì’“üŽž’É‚Ì”äŠr|»Ü‚¨‚æ‚Ñ’“üŽž•”ˆÊ‚É‚æ‚éˆá‚¢|. ˆé–ì‰ëŽq, ¬àVÍŽq, ‰œ•xr”V, ‰ª–{_Žk, ŠO@{”ü•v (–ƒ): “ú–{–ƒŒ‰ÈŠw‰ï“Œ‹žEŠÖ“ŒbM‰zŽx•”‘æ44‰ñ‡“¯ŠwpW‰ï (2004), ’}”g.


<<—Õ°ŒŸ¸f’fŠw>>

mŠwp˜_•¶n

110202. [Œ´’˜] Analysis of the oligosaccharide chain of human serum immunoglobulin G in patients with localized or metastatic cancer. Žë–ì—Lì1, Mashiko T, ’hŒ´Š²¶1, ‚ŽR‹g‰i1, ‘å’JTˆê1, ¡è‹M¶2, ˆ¢•”@’¼3, Ô¯@“§1 (1—ÕŒŸŠw. 2“à‡X. 3ˆãŠw‹³ˆçŒ¤‹†•”–å): Oncology, 66: 365-370, 2004.

110203. [Œ´’˜] Change of the serum IgG oligosaccharide chains with prostate canser progression. Žë–ì—Lì1, ’hŒ´Š²¶1, ‚ŽR‹g‰i1, ‘å’JTˆê1, ‰oì@W2, ”nêŽu˜Y2, Ô¯@“§1 (1—ÕŒŸŠw. 2”å): Anticancer research, 24: 3135-3140, 2004.

110204. [Œ´’˜] Regular hemodialysis reverses Gastric mucosal atrophy of patients with chronic renal failure. ‘匴³Žu1, —é–ØG˜a2, Žë–ì—Lì3, Žç‰®—˜‰À4, ‰ªˆÀ@ŒM5 (1“Œ‹žˆãŽ•‘å. 2Œc‰ž‘å. 3—ÕŒŸŠw. 4ˆãŠw‹³ˆç. 5•a—): :Hepato-gastroenterology, 51 (57): 679-683, 2004.

120109. [Œ´’˜] 16‰ñ˜A‘±ŽhŒƒ‚É‚æ‚éF”gƒpƒ‰ƒ[ƒ^[‚ÌŒŸ“¢. Ä“¡]”üŽq, Îìm”ü, ‰Í“‡]”ü, “n•Ó’¼Žq, Ô¯@“§1 (1—ÕŒŸŠw): ˆãŠwŒŸ¸, 53: 927-932, 2004.

120110. [Œ´’˜] ˜V”NŽÒ‚É‚¨‚¯‚鎋Šo—U”­“dˆÊ iVECPj ‚Ì—Õ°‰ž—p. ‹g–{gŽq, “•ûLˆê, ó–ì˜a], ‰Í“‡]”ü, ‹“‡@m, Ä“¡]”üŽq, ¬–ì‘ò—T–ç, Ô¯@“§1, ”Ñ’Ë‚_2, ”¨@—²Žu (1—ÕŒŸŠw. 2“à‡V): —Õ°”]”g, 46: 715-722, 2004.

120111. [Œ´’˜] Œãèòœ_ŒoŽhŒƒ‚É‚æ‚é’ZöŽžSEP‚̊d‹É‚ÌŒŸ“¢. ¬–ì‘ò—T–ç, ‰Í“‡]”ü, ‹“‡@m, Ä“¡]”üŽq, ó–ì˜a], ‹g–{gŽq, “•ûLˆê, Žë–ì—Lì1, Ô¯@“§1 (1—ÕŒŸŠw): _“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 39: 6-8, 2004.

520331, [‘à] •ªŽqƒŠƒEƒ}ƒ`. Ô¯@“§ (—ÕŒŸŠw): Journal Club, 1 (1): 65, 2004.

520332. [‘à] ŠÖ߃ŠƒEƒ}ƒ`‚ÆRCCPR‘Ì. Ô¯@“§ (—ÕŒŸŠw): Medical Practice, 21: 1756, 2004.

520333. [‘à] äPŒ´•a iRAˆÈŠOj. Ô¯@“§ (—ÕŒŸŠw): —Õ°•a—, 52: 743-750, 2004.

520334. [‘à] —Õ°ŒŸ¸‚ЂƂ­‚¿ƒƒ‚. ‘å’JTˆê (—ÕŒŸŠw): ƒ‚ƒ_ƒ“ƒƒfƒBƒA, 50 (11): 265-268, 2004.

mŠw‰ïEŒ¤‹†‰ï“™n

712034. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Novel autoantibodies against 7SL RNA in patients with polymyositis/dermatomyositis (PM/DM). Satoh T, Okano T, Matsui T, Watabe H, Ogasawara T, Kubo K, Kuwana M, N Fertig, CV Oddis, Kondo H, Ô¯ “§1 (1—ÕŒŸŠw): American College of Rheumatology 68th National Scientific Meeting (2004), San Antonio. Arthritis Rheum, 50 (S.9): S103, 2004.

712035. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Liver X receptorƒ¿(LXRƒ¿) induced in monocytes by monosodium urate monohydrate (MSU) crystals negatively regulates the crystalinduced acute inflammation. Ô¯@“§1, Matsui H, Murakami Y, ‚ŽR‹g‰i1, Watabe H (1—ÕŒŸŠw): American College of Rheumatology 68th National Scientific Meeting (2004), San Antonio. Arthritis Rheum, 50 (S.9): S103, 2004.

723921. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “–‰@‚É‚¨‚¯‚é—AŒŒ‹Æ–±“ú“–’¼‘̧‚Ì•à‚Ý‚Æ¡Œã‚Ì“W–]. ”ª–ؘa¢, ¬–{”ü“Þ, ‚–ì”g—¯”ü, •—ŠÔ‚ ‚«‚Ý, •½“c‘×—Ç, ‘å’JTˆê1, ¬Œ´–M‹`2 (1—ÕŒŸŠw. 2‹¹ŠO): ‘æ52‰ñ“ú–{—AŒŒŠw‰ï (2004/6/23-25), ŽD–y. “ú–{—AŒŒŠw‰ïŽGŽ, 50 (2): 313. 2004.

723922. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) –k—¢‘åŠw•a‰@‚É‚¨‚¯‚é”ñ—nŒŒ«—AŒŒ•›ì—p. Ô¯@“§ (—ÕŒŸŠw): ‘æ52‰ñ“ú–{—AŒŒŠw‰ï (2004/6/23-25), ŽD–y. “ú–{—AŒŒŠw‰ïŽGŽ, 50 (2): 339, 2004.

723923. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘Šú“®–¬d‰»•a•ÏŒŸo‚É‚¨‚¯‚é”ñNP«“®–¬d‰»f’f–@‚Ì—L—p«. Ô¯@“§ (—ÕŒŸŠw): ‘æ51‰ñ“ú–{—Õ°ŒŸ¸ˆãŠw‰ï‘‰ï (2004/9/5), “Œ‹ž. —Õ°•a—, 52 (•â): 195, 2004.

723924. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘O—§‘BŠà‚Ìi“W‚É‚¨‚¯‚錌´IgG“œ½\‘¢‚̕ω». Ô¯@“§ (—ÕŒŸŠw): ‘æ51‰ñ“ú–{—Õ°ŒŸ¸ˆãŠw‰ï‘‰ï (2004.9.5), “Œ‹ž. —Õ°•a—, 52 (•â): 158, 2004.

723925. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) RSRPR‘Ì—z«‹Ø‰ŠŠ³ŽÒ‚É‚¨‚¯‚éR7SL-RNAR‘̂̉ðÍ. ²“¡—²Ži, ’hŒ´Š²¶1, ‘å’JTˆê1, Žë–ì—Lì1, Ô¯@“§1 (1—ÕŒŸŠw): ‘æ51‰ñ“ú–{—Õ°ŒŸ¸ˆãŠw‰ï‘‰ï (2004/9/5), “Œ‹ž. —Õ°•a—, 52 (•â): 107, 2004.

732057. [Šw‰ï (’n•û‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) äPŒ´•a, ŠÖ߃ŠƒEƒ}ƒ`‚ÌŒŸ¸‚ÌŒ©•û‚ɂ‚¢‚Ä. Ô¯@“§ (—ÕŒŸŠw): ‘æ3‰ñMBäPŒ´•aƒZƒ~ƒi[ (2004/2), ’·–ì.

733477. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ŠàŽî‚Ìi“W‚É‚¨‚¯‚éN-Œ‹‡Œ^ƒIƒŠƒS“œ½‚̕ω». Žë–ì—Lì, ’hŒ´Š²¶, ‚ŽR‹g‰i, ‘å’JTˆê, Ô¯@“§ (—ÕŒŸŠw): ‘æ15‰ñ_“Þ쌧—Õ°ŒŸ¸ˆãŠw‰ï (2004/7/10), ‰¡•l.

733478. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒtƒ[ƒTƒCƒgƒƒgƒŠ[‚ð—p‚¢‚½”x¬×–EŠàœ“]ˆÚ—á‚Ìf’f‚ÉŠÖ‚·‚éŠî‘b“IŒŸ“¢. –F“c@v, ’hŒ´Š²¶1, Žë–ì—Lì1, ‚ŽR‹g‰i1, ‘å’JTˆê1, Ô¯@“§1 (1—ÕŒŸŠw): ‘æ15‰ñ_“Þ쌧—Õ°ŒŸ¸ˆãŠw‰ï (2004/7/10), ‰¡•l.


<<‹~–½‹~‹}ˆãŠw>>

mŠwp˜_•¶n

110205. [Œ´’˜] Miniprobe ultrasonography for determining prognosis in corrosive esophagitis.: Miniprobe ultrasonography for determining prognosis in corrosive esophagitis. 㞊‹gl1, ‹ß“¡ˆê‰p2, ‘“ŒŠ²•v2, •Ð‰ª—Sˆê1, ‘Š”nˆêˆå1 (1‹~–½. 2“à‡T): American Journal of Gastroenterology, 99 (5): 851-854, 2004.

110206, [Œ´’˜] Iliac vein injuries in hemodynamically unstable patients with pelvic fracture due to blunt trauma. •Ð‰ª—Sˆê1, Kazuhiko Maekawa2, ¼Šª@”Ž1, ŽR–{aˆê˜Y1, ‘Š”nˆêˆå1 (1‹~–½. 2Kanto Central Hospital): The Journal of Trauma, 58 (4): 704-710, 2005.

120112. [Œ´’˜] S–[ד®‚ÌhybridŽ¡—Âɂ¨‚¯‚éEŒQR•s®–¬–ò‚ƃxƒvƒŠƒWƒ‹‚Ì—L—p«‚Ì”äŠrŒŸ“¢. ‹g“c@“O1, ’ë–ìTˆê2, ‹|í@‘å2, •½àV³ŽŸ2, ¡–Ø—²‘¾2, ²“¡‘å•ã2, ²X–Ø@‹B2, ˜eâ—TŽq2, “’–{‰ÀG2, Œ´@‰pK2, XŒû¹•F2, ’ë–ì—TŒb2, ˜aò@“O2 (1‹~–½. 2“à‡U): S‘Ÿ, 36: 235-238, 2004.

210030. [€Œ´’˜] Ventilator-associated pneumonia. ‘Š”nˆêˆå (‹~–½): APSR (Respirology), 9: S30-S34, 2004.

310020. [Ç—á•ñ] Pharmacokinetics of the active metabolites of ethyl loflazepate in elderly patients who died of asphyxia associated with benzodiazepine-related toxicity. 㞊‹gl1, —Ñ@ò2, Takashi Nishikawa3, ‹g‘º‹vmŽq4, ‘Š”nˆêˆå1 (1‹~–½. 2–ò—. 3‹¤—§–ò‘å. 4¶•¨‰»ŠwŒn): Journal of Analytical Toxicology, 29: 140-144, 2005.

310021. [Ç—á•ñ] Acute Respiratory Distress Syndrome Following Asthma-Like Symptoms from Massive Ingestion of a Monoethanolamine-Containing Detergent. 㞊‹gl1, ‘Š”nˆêˆå1, Ayako Inoue, ‰iˆä’q‹I2, ŒIŒ´Ž—R2 i1‹~–½. 2–@ˆãŠwj: Veterinary and Human Toxicology, 46 (2): 79-80, 2004.

310022. [Ç—á•ñ] Emergent endovascular stent-graft placement to treat ruptured Stanford type B acute aortic dissection. ‰Í‘º»D1, ¼Šª@”Ž1, Zong-Bo Lin, ’¬ˆä³l2, ˆé•”‹`Œ›1, ‘ì˜ad1, ‘Š”nˆêˆå3 (1•ú. 2‹¹ŠO. 3‹~–½): Journal of vascular Surgery, 39 (3): 668-671, 2004.

320089. [Ç—á•ñ] Œo•@o“Iú’Ê«”]‘¹‚É‚æ‚è‘–Œ‰Š, ”]•‚Žî‚ð‚«‚½‚µ‚½1—á. ‹v{”ü^—1, –kŒ´F—Y2, ‰““¡¹F2, ‘Š”nˆêˆå2 (1”]ŠO. 2‹~–½): “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 25: 62-63, 2004.

320090. [Ç—á•ñ] –@ˆã‰ð–U‚É‚æ‚Á‚Äf’f‚³‚ꂽ3ΗŽ™iN«ƒCƒŒƒEƒX‚Ì1—á. ¼‰Y—RŠóŽq1, •Ð‰ª—Sˆê2, ‘Š”nˆêˆå2 (1¬Ž™. 2‹~–½): “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 25: 126-127, 2004.

510017. [‘à] Diffuse axonal injury (DAI). –kŒ´F—Y (‹~–½): Clinical Neuroscience, 22: 588-589, 2004.

520335. [uÀ] ‹~‹}ƒ}ƒjƒ…ƒAƒ‹2004: ‹¹E‹¹•”’PƒXüŒŸ¸. ¬’J³Žq1, ¼Šª@”Ž1, ‘Š”nˆêˆå2 (1•ú. 2‹~–½): ‘‡—Õ°, 53: 194-197, 2004.

520336. [uÀ] lHŒÄ‹zŠíŠÖ˜A”x‰Š. ‘Š”nˆêˆå (‹~–½): ŒÄ‹z, 23 (4): 284-287, 2004.

520337. [uÀ] Žs’†”x‰Š‚Ɖ@“à”x‰Š‚ÌlHŒÄ‹zŠíŠÖ˜A”x‰Š. ‘Š”nˆêˆå (‹~–½): Emergency Nursing, 17 (9): 36-44, 2004.

520338. [uÀ] lHŒÄ‹zŠíŠÖ˜A”x‰Š iVAPj. ‘Š”nˆêˆå (‹~–½): —Õ°ŠÅŒì, 30 (10): 1513-1517, 2004.

520339. [uÀ] ŒÄ‹zŠíŠ´õ‘Îô. ‘Š”nˆêˆå, ¡ˆä@Š°, Vˆä³N (‹~–½): “ú–{ŠO‰ÈŠw‰ïŽGŽ, 105 (11): 716-719, 2004.

520340. [uÀ] lHŒÄ‹zŠíŠÖ˜A”x‰Š‚Ìf’f‚ÆŽ¡—Ã. ‘Š”nˆêˆå (‹~–½): Clinical Engineering, 15 (12): 1172-1177, 2004.

520341. [uÀ] ALI/ARDS‚Æ‚Í|•a‘Ô‚Æf’f -”­¶•p“x‚Æ—\Œã|. ‘Š”nˆêˆå (‹~–½): ŒÄ‹zŠíƒPƒA, 3 (1): 66-71, 2004.

520342. [uÀ] ‹}«”xÇðÇ. ‘Š”nˆêˆå (‹~–½): ‹~‹}EW’†Ž¡—Ã, 16 (—Õ‘): 67-70, 2004.

520343. [uÀ] lHŒÄ‹zŠíŠÖ˜A”x‰Š. ‘Š”nˆêˆå (‹~–½): ICU‚ÆCCU, 28 (12): 977-984, 2004.

520342. [uÀ] COPD‚Ì‹}«‘ˆ«‚ɑ΂·‚éNPPV. ‘Š”nˆêˆå (‹~–½): ‹~‹}EW’†Ž¡—Ã, 17 (1): 31-36, 2005.

520343. [uÀ] dÇ”x‰Š|‘Ήž‚ÌŽÀÛ|. ‘Š”nˆêˆå (‹~–½): ‚—îŽÒf—Ẫcƒ{@”x‰Š, p.220-224, 2004.

520344. [‘à] œ”ÕÖ¬‘¹‚ɑ΂·‚éIVR. ¼Šª@”Ž1, •Ð‰ª—Sˆê2 (1•ú. 2‹~–½): ‹~‹}ˆãŠw, 28 (12): 1365-1367, 2004.

520345. [uÀ] ”]“®–¬áŽ‚ÍŒŒŠÇ“àŽ¡—©H ŠO‰ÈŽ¡—©H|ŠO‰ÈŽ¡—Â̗§ê‚©‚ç|. –kŒ´F—Y (‹~–½): ‹~‹}EW’†Ž¡—Ã, 16 (4): 487-490, 2004.

520346. [uÀ] Blood access interventional radiology‚Ì”–â‘è. ¼Šª@”Ž1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, –î“àŒ´@‹v1, ŽR–{aˆê˜Y2, ‘ë쳘a1, ¼‰iŒh“ñ1, “c‰ª‰ÀŒ›3, ‹g“cˆê¬3, ‘ì˜ad1 (1•ú. 2‹~–½. 3”å): tˆÚAEŒŒŠÇŠO‰È, 15 (2): 107-113, 2004.

520347. [‘à] “Ý“IäB‘¹‚Æt‘¹. ¼Šª@”Ž1, ŽR–{aˆê˜Y2 (1•ú. 2‹~–½): ‹~‹}ˆãŠw, 28 (12): 1354-1360, 2004.

520348. [‘à] ‚±‚ñ‚ÈÇ—á, ‚±‚ñ‚ȉ摜. ŽR–{aˆê˜Y1, ˆø“crˆê, ‘Š”nˆêˆå1, ¼Šª@”Ž2 (1‹~–½. 2•ú): ‹~‹}EW’†Ž¡—Ã, 16 i2j: 137, 2004.

521053. [Œ¤‹†•ñ] iŒú˜JÈj ‘ŸŠí’ñ‹Ÿ•a‰@‚É‚¨‚¯‚éˆãŽt‚Ì–ðŠ„‚Æ–â‘è“_. –kŒ´F—Y1, —L‰ê@“O, ‰¡“c—Ts, “‚àVGŽ¡, ŽR“c@Ÿ, ¯@‚ä‚©‚è (1‹~–½): •½¬15”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à iƒqƒgƒQƒmƒ€EĶˆã—Ó™Œ¤‹†Ž–‹Æj ”]Ž€‰º‚Å‚Ì‘ŸŠíˆÚA‚̎ЉïŠî”Õ‚É‚Þ‚¯‚Ä‚ÌŒ¤‹†, p.49-58, 2004.

m’˜@‘n

620192. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ¸_‰È •K{–ò‚ð’T‚é ‘æ1”Å; D. •a“, •a‰@•Ê‚É‚Ý‚½•K{–ò 9.‹~‹}ƒZƒ“ƒ^[, p.206-214. 㞊‹gl (‹~–½), •ÒW ‹{‰ª@“™ (¸), ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2004/11/1”­s.

620193. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ‹~–½‹~‹}ƒGƒLƒXƒp[ƒgƒi[ƒVƒ“ƒO ‘æ1”Å; ‘æ‡V.Žå‚ÈÇóEÇŒó‚ւ̑Ήž 20.¸_‰È‹~‹}, p.300-311. 㞊‹gl (‹~–½), •ÒW ‘å‹´‹³—Ç, a’J³“¿, â–{“N–ç, “ìŒõ“°, “Œ‹ž, 2005/3/10”­s.

620194. [Šwp‘] (‹¤’˜) ‹¹’É. Clinicianfs Journal (CD-ROM); Autumn. ‹g“c@“O, ‘Š”nˆêˆå (‹~–½), MediArt, 2004”­s.

620195. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) –ð‚É—§‚ŒċzŠÇ—‚ÌŽÀÛ@ƒvƒŒƒzƒXƒsƒ^ƒ‹‚©‚çÝ‘î‚Ü‚Å; lHŒÄ‹z’†‚ÌŠ´õ‘Îô, p.163-170. ‘Š”nˆêˆå (‹~–½), •ÒW –ìŒû@G1, ˆÀ–{˜a³2 (1ˆ¤’mˆã‘å. 2º˜a‘å), ^‹»ŒðˆÕˆãŠwo”Å•”, “Œ‹ž, 2004/5/20”­s.

620196. [Šwp‘] (•ª’SŽ·•M) æ’[ˆã—ÃVƒŠ[ƒY27 ‹~‹}ˆã—Ãu‹~‹}ˆã—ÂÌÅæ’[v; ‘æ8ÍŠ´õÇ‚ÌŽ¡—ÂƊǗ 4.ŒÄ‹zŠíŠ´õÇ, p.186-191. ‘Š”nˆêˆå (‹~–½), •ÒWŽåŠ² “‡èCŽŸ, ŽR–{•Û”Ž, ‘Šì’¼Ž÷, •ÒWˆÏˆõ ’–Œû’åŽ÷, ŠÛ“¡@“N, ‘ë@Œ’Ž¡, ’JìŒ÷ˆê, ’ç@°•F, (Š”) Ž›“c‘ÛŽ––±Š/æ’[ˆã—ËZpŒ¤‹†Š, “Œ‹ž, 2004/5/19”­s.

620197. [Šwp‘] (•ª’SŽ·•M) ŒÄ‹zŠíƒPƒA@Ç—áƒVƒ…ƒ~ƒŒ[ƒVƒ‡ƒ“@ŒÄ‹zŠíŽ¾Š³‚ÌŽ¡—ÂƊǗ; š\ŒŒ, p.25-29. ‘Š”nˆêˆå (‹~–½), ŠÄC ‹ß“¡“N— (“ŒŠC‘å‘åˆé•a‰@), ƒƒfƒBƒJo”Å, ‘åã, 2004/5/25”­s.

620198. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ŒÄ‹zŠíŽ¾Š³‚ÌŽ¡—ÂƊŌì; ‹C“¹”M, p.162-165. ‘Š”nˆêˆå (‹~–½), •ÒW H“¡ãÄ“ñ (“ú–{ˆã‘å), “ì]“°, “Œ‹ž, 2004/6/30”­s.

620199. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ‹~‹}f—ÃKƒCƒhƒ‰ƒCƒ“ ŠO—ˆ‚ł̃gƒŠƒA[ƒW‚ƈ•û; ‹}«ŒÄ‹z•s‘S, e84-85. ‘Š”nˆêˆå (‹~–½), •ÒW ‰ªŒ³˜a•¶, ‘Š”nˆêˆå, ŽR‰È@Í, s‰ª“N’j, ‘‡ˆãŠwŽÐ, “Œ‹ž, 2004”­s.

620200. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ICU‚É‚¨‚¯‚銴õ‘Îô; Œ‹Šj, SARS‘Îô, p.144-158, ‘Š”nˆêˆå1, •Ð‹Ë^l2 (1‹~–½. 2ˆã‰q). •ÒW s‰ªG˜a (‘åãŽs‘åE‰@), ^‹»ŒðˆÕˆãŠwo”Å•”, “Œ‹ž, 2005/2/25”­s.

620201. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) —Õ°ˆã 30‘Š§†;˜2. ‹~–½‹~‹}f—Â̊î–{ 16. “dŒ‚, p.785-789. “‡‘qNl1, ‘Š”nˆêˆå2 (1Œ`ŠO. 2‹~–½), ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2004/6/5”­s.

620202. [Šwp‘] (•ª’SŽ·•M) æ’[ˆã—ÃVƒŠ[ƒY27 ‹~‹}ˆã—Ãu‹~‹}ˆã—ÂÌÅæ’[v, ”][Ç, p.122-126. –kŒ´F—Y (‹~–½), •ÒWŽåŠ² “‡èCŽŸ, ŽR–{•Û”Ž, ‘Šì’¼Ž÷, •ÒWˆÏˆõ ’–Œû’åŽ÷, ŠÛ“¡@“N, ‘ë@Œ’Ž¡, ’JìŒ÷ˆê, ’ç@°•F, (Š”) Ž›“c‘ÛŽ––±Š/æ’[ˆã—ËZpŒ¤‹†Š, “Œ‹ž, 2004/5/19”­s.

620203. [Šwp‘] (•ª’SŽ·•M) ”]_ŒoŠO‰ÈŠw‘åŒn5 ”]_ŒoŠO‰È‹~‹}; ‹~–½‹~‹}ƒZƒ“ƒ^[‚¨‚æ‚Ñ‚“x‹~–½‹~‹}ƒZƒ“ƒ^[, p.12-14. –kŒ´F—Y (‹~–½), •ÒW —L‰ê@“O, ’†ŽR‘“X, “Œ‹ž, 2005/3/31”­s.

620204. [‚»‚Ì‘¼ (Œú˜JȔnj¤‹†ƒeƒLƒXƒg)] (•ª’SŽ·•M) ”]‘²’†‚ðŒ©“¦‚³‚È‚¢‚½‚ß‚É; ê–åŽ{Ý‚Ö‚Ì”À‘—, p.25-29. –kŒ´F—Y (‹~–½), •ÒW ‹g•ôrŽ÷, ŠÄC “‡èCŽŸ, 2004/3/1”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

711010. [Šw‰ï (‘Û)] (“Á•Êu‰‰) VAP. ‘Š”nˆêˆå (‹~–½): ŠØ‘‹~‹}Šw‰ï (2004/4/29-30), ƒ\ƒEƒ‹.

713233. [Šw‰ï (‘Û)] (ˆê”ʉ‰‘è) Iliac vein injuries in hemodynamically unstable patients with pelvic fracture due to blunt trauma. •Ð‰ª—Sˆê1, ¼Šª@”Ž1, –kŒ´F—Y1, ‘Š”nˆêˆå1, Kazuhiko Maekawa2 (1‹~–½. 2Kanto Central Hospital): American Association for the Surgery of Trauma 63 Meeting and Japanese Association for Acute Medicine (2004/10/1), Maui, USA.

722119. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) •sˆÀ’èŒ^œ”՗֜܊³ŽÒ‚Ì’·Šú‹@”\—\Œã‚ÌŒŸ“¢. —é–Ø@‘ì1, V“¡³‹P2, •Ð‰ª—Sˆê1, ¬—Ñ@ŒM1, “à–ì³—²3, ‰¡ŽRˆê•F3, Ž…–ž·Œ›3, ‘Š”nˆêˆå1 (1‹~–½. 2º˜a‘å. 3®ŠOj: ‘æ18‰ñ“ú–{ŠOŠw‰ï (2004/5/20-21), ŽD–y. “ú–{ŠOŠw‰ïŽGŽ, 18 (2): 198, 2004.

722120. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) œ”՜܃Vƒ‡ƒbƒNÇ—á‚ɑ΂·‚é‹}«ŠúŽ¡—Ãí—ª‚ÌŒŸ“¢. •Ð‰ª—Sˆê1, —é–Ø@‘ì1, ¼Šª@”Ž2, “à–ì³—²3, ŽR–{aˆê˜Y1, ¬—Ñ@ŒM1, “‡“c@Œª1, Vˆä³N1, ¡ˆä@Š°1, –kŒ´F—Y1, ‘Š”nˆêˆå1 (1‹~–½. 2•ú. 3®ŠO): ‘æ18‰ñ“ú–{ŠOŠw‰ï (2004/5/20-21), ŽD–y. “ú–{ŠOŠw‰ïŽGŽ, 18 (2): 198, 2004.

722121. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’†SÖ¬ƒJƒe[ƒeƒ‹—¯’u‚É‚¨‚¯‚釕¹Ç|–k—¢‘åŠw•a‰@‹~–½‹~‹}ƒZƒ“ƒ^[‚Å‚ÌŽæ‚è‘g‚Ý|. ˆä㕶Žq, ¡ˆä@Š°, ã–{“Þ”üŽq, ²“¡çŒb, ¬—Ñ@ŒM, –kŒ´F—Y, ‘Š”nˆêˆå (‹~–½): ‘æ7‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï (2004/5/14-15), ‰¡•l. “ú–{—Õ°‹~‹}ˆãŠw‰ïŽGŽ, 7 (2): 120, 2004.

722122. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) dÇŠ³ŽÒ‚̌ċzŠíEŠ´õÇ‚Ìf’fŽ¡—Ã|VAP‚ð’†S‚É|. ‘Š”nˆêˆå (‹~–½): ‘æ19‰ñ“ú–{‹~–½ˆã—Êw‰ï‘‰ï (2004/9/17-18), “Œ‹ž.

723926. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) Š¥“®–¬‘¢‰e‚Å‘S‚­•`o‚³‚ê‚È‚©‚Á‚½‚Ñ‚Ü‚ñ«‹·ó‚ª–UŒŸŽž‚É”»–¾‚µ, ŠŒ©‚ª‘å‚«‚­˜¨—£‚µ‚½S‘Ÿ“Ë‘RŽ€—á. ‹g“c@“O1, ¡ˆä@Š°1, ’¬ˆä³l1, ŽR–{Ms1, ó—˜@–õ1, ‘Š”nˆêˆå1, ˜aò@“O2, ‰iˆä’q‹I3, ŒIŒ´Ž—R3 (1‹~–½. 2“à‡U. 3–@ˆãj: ‘æ7‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï (2004/5/14-15), ‰¡•l. “ú–{—Õ°‹~‹}ˆãŠw‰ïŽGŽ, 7 (2): 192, 2004.

723927. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) S‹Ø‰Š‚É‚¨‚¯‚鶎º‚Ì\‘¢“IE“d‹C“IƒŠƒ‚ƒfƒŠƒ“ƒO‚ÌŒaŽž“I•]‰¿. ˜eâ—TŽq1, ’ë–ìTˆê1, ’ë–ì—TŒb1, Ä“¡~Žq1, ‹g“c@“O2, •½àV³ŽŸ1, ˜aò@“O1 (1“à‡U. 2‹~–½): ‘æ21‰ñ“ú–{S“dŠw‰ïŠwpW‰ï (2004/9/13-14), ‹ž“s. S“d}, 24 (5): 355, 2004.

723928. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ƒqƒgS–[—˜”Aƒyƒvƒ^ƒCƒh (hANP) ‘ãŽÓ‘jŠQ–ò‚Í’ZŠú“I“d‹C“IƒŠƒ‚ƒfƒŠƒ“ƒO‚ð—}§‚·‚é. ¡–Ø—²‘¾1, ’ë–ìTˆê1, ²“¡‘å•ã1, ‹g“c@“O2, ’ë–ì—TŒb1, ˜aò@“O1 (1“à‡U. 2‹~–½): ‘æ21‰ñ“ú–{S“dŠw‰ïŠwpW‰ï (2004/9/13-14), ‹ž“s. S“d}, 24 (5): 355, 2004.

723929. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) “–‰@‹~–½‹~‹}ƒZƒ“ƒ^[‚É”À‘—‚³‚ꂽSŽ¾Š³Š³ŽÒ”‚Ì‹Gß•Ï“®|ƒXƒgƒŒƒX‚Æ‚ÌŠÖ˜A‚©‚ç|. ‹g“c@“O, •Ð‰ª—Sˆê, ¡ˆä@Š°, ²“¡çŒb, ¬—Ñ@ŒM, –k–ì‹`˜a, 㞊‹gl, –kŒ´F—Y, ‘Š”nˆêˆå (‹~–½): ‘æ32‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2004/10/27-29), ç—t. “ú‹~‹}ˆã‰ïŽ, 15: 404, 2004.

723930. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) Neutralendopepidase Inhibitor (NEPI) Suppresses Early Phase of Atrial Electricalremodeling in Canine Rapid Atrial Stimulation Model. ¡–Ø—²‘¾1, ’ë–ìTˆê1, ²“¡‘å•ã1, ‹g“c@“O2, ’ë–ì—TŒb1, ˜aò@“O1 (1“à‡U. 2‹~–½): The 69th Annual Scientific Meeting of the Japanese Circulation Society (2005/3/19-21), Yokohama. Circulation Journal, 69 (S.1): 367, 2005.

723931. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ‹Ù‹}Žèp‚ð—v‚·‚édÇŠO‚ɑ΂·‚ép’†IVR‚ÌŽŽ‚Ý. •Ð‰ª—Sˆê, ¼Šª@”Ž, ŽR–{aˆê˜Y, “‡“c@Œª, ¬—Ñ@ŒM, ã–{“Þ”üŽq, —é–Ø@‘ì, “à–ì³—², –kŒ´F—Y, ‘Š”nˆêˆå (‹~–½): ‘æ7‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï (2004/5/14-15), ‰¡•l. “ú–{—Õ°‹~‹}ˆãŠw‰ïŽGŽ, 7 (2): 173, 2004.

723932. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ‘å“®–¬ŽÕ’fƒoƒ‹[ƒ“ƒJƒe[ƒeƒ‹ iIABOj ‚É‚Ä‹~–½‚µ“¾‚½ŠO«CPAÇ—á‚ÌŒŸ“¢. ¬—Ñ@ŒM, •Ð‰ª—Sˆê, ã–{“Þ”üŽq, “‡“c@Œª, —é–Ø@‘ì, “à–ì³—², Vˆä³N, ¡ˆä@Š°, –kŒ´F—Y, ‘Š”nˆêˆå (‹~–½): ‘æ7‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï (2004/5/14-15), ‰¡•l. ƒvƒƒOƒ‰ƒ€E´˜^W, p.177, 2004.

723933. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) Œy”÷‚È“Ý“IŠO‚É‚à‚©‚©‚í‚炸’°œ“®–¬‰ð—£‚ð”F‚ß‚½1Ç—á. _œä’m“¹1, ¼Šª@”Ž1, m–Ø@~2, ¬—Ñ@ŒM1, •Ð‰ª—Sˆê1, ŽR–{aˆê˜Y1, “‡“c@Œª1, ‘Š”nˆêˆå1 (1‹~–½. 2”]ŠO): ‘æ7‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï (2004/5/14-15), ‰¡•l. ƒvƒƒOƒ‰ƒ€E´˜^W, p.178, 2004.

723934. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ¬Ž™Ò‘‘¹‚Ì1—á. –ìX“c@–L1, “à–ì³—²2, ë“à—²—Y3, ¼Šª@”Ž4, —é–Ø@‘ì4, ’†‘ºŒõL2, Ž…–ž·Œ›2, ‘Š”nˆêˆå4 (1¬Ž™. 2®ŠO. 3”]ŠO. 4‹~–½j: ‘æ7‰ñ“ú–{—Õ°‹~‹}ˆãŠw‰ï‘‰ï (2004/5/14-15), ‰¡•l. “ú–{—Õ°‹~‹}ˆãŠw‰ïŽGŽ, 7 (2): 192, 2004.

723935. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“’†“Å‚É‚¨‚¯‚é‰ð“Å–òŽ¡—Âɋy‚Ú‚·Šˆ«’Y‚̉e‹¿. •Ÿ–{^—Žq1, ŽRŒË˜a‹M1, •Ÿ“‡‚ê‚¢1, 㞊‹gl2, ‘Š”nˆêˆå2 (1—Õ°–òŠwŒ¤‹†ƒZƒ“ƒ^[’†“Å•”–å. 2‹~–½j: ‘æ26‰ñ“ú–{’†“ÅŠw‰ï‘‰ï (2004/7/9-10), L“‡. ƒvƒƒOƒ‰ƒ€E´˜^W, p.59, 2004.

723936. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ƒGƒ^ƒm[ƒ‹ƒAƒ~ƒ“ŠÜ—L‹Æ–±—pôò܂̌뚋‚É‚æ‚é”xáŠQ‚̃ƒJƒjƒYƒ€‚ÉŠÖ‚·‚錤‹†. ˆø’n@•¶1, 㞊‹gl2, ‹g‘º‹vmŽq3, ²“¡çŒb2, ˆä㕶Žq2, ‹ß“¡—¯”üŽq1, ‘Š”nˆêˆå2 (1–òÜ•”. 2‹~–½. 3¶•¨‰»ŠwŒnj: ‘æ26‰ñ“ú–{’†“ÅŠw‰ï‘‰ï (2004/7/9-10), L“‡. ƒvƒƒOƒ‰ƒ€E´˜^W, p.72, 2004.

723937. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) “–‰@‚É‚¨‚¯‚éŠOÇ—á‚Ì•ªÍ|ŠÈ—ª‰»‚µ‚½trauma registry‚Ì—L—p«|. _œä’m“¹, Vˆä³N, ¡ˆä@Š°, ¬âN°, •Ð‰ª—Sˆê, ²“¡çŒb, ¬—Ñ@ŒM, ŽR–{aˆê˜Y, –kŒ´F—Y, ‘Š”nˆêˆå (‹~–½): ‘æ32‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (2004/10/27-29), –‹’£. “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 15 (9): 440, 2004.

723938. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ƒNƒ‚–Œ‰ºoŒŒ‹}«Šú‚É”F‚ß‚ç‚ê‚éS‹ØáŠQ‚ÆŒðŠ´_ŒoŒnŠˆ“®‚¨‚æ‚ÑŒŒŠÇ“à”çáŠQ, ŒŒ‰t‹ÃŒÅü—nŒnáŠQ‚Æ‚ÌŠÖŒW. ŽR–{aˆê˜Y1, ‘“c@‘ì2, ¼ŽRÄ‹v3, ˆø“crˆê1, –kŒ´F—Y1, ‘Š”nˆêˆå1 (1‹~–½. 2ˆã‰q. 3‘å˜aŽs—§•a‰@j: ‘æ32‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (2004/10/27-29), –‹’£. “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 15 (9): 497, 2004.

723939. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) “–ƒZƒ“ƒ^[‚É‚¨‚¢‚ĉÁ—³‚ꂽspontaneous extraperitoneal hemorrhage (SHE) ‚ÌŒŸ“¢. Š~Œ©•¶Ž}, ¼Šª@”Ž, •ž•”@, ²“¡çŒb, ŽR–{aˆê˜Y, •Ð‰ª—Sˆê, –k–ì‹`˜a, ‘Š”nˆêˆå (‹~–½): ‘æ32‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (2004/10/27-29), –‹’£. “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 15 (9): 501, 2004.

723940. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) dÇŠ´õÇŽ¡—Âɂ¨‚¯‚é‹}«Šú‰h—{ŠÇ—‚Ì—L—p«. •Ð‰ª—Sˆê, _œä’m“¹, ²“¡çŒb, ˆø“crˆê, Vˆä³N, ¡ˆä@Š°, –kŒ´F—Y, ‘Š”nˆêˆå (‹~–½): ‘æ32‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2005/2/24-26), “Œ‹ž. “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, 12: 243, 2005.

723941. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ¶‘Ìî•ñƒ‚ƒjƒ^ƒŠƒ“ƒOƒVƒXƒeƒ€“±“ü‚É‚¨‚¯‚é—Õ°HŠw‹ZŽm‚Ì–ðŠ„. “¡ˆä³ŽÀ1, “ŒžŠŒ\ˆê1, –؉ºt“Þ1, ãŽRˆŸ‹I2, –¾_“N–ç2, Vˆä³N3, ‘Š”nˆêˆå3 (1MEƒZƒ“ƒ^[•”. 2ŠÅŒì•”W’†Ž¡—ÃŽº. 3‹~–½): ‘æ32‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2005/2/24-26), “Œ‹ž. “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, 12: 313: 2005.

723942. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ‘ŸŠíˆÚA‚É‚¨‚¯‚é‘ŸŠí’ñ‹Ÿ•a‰@ˆãŽt‚Ì–ðŠ„‚Æ–â‘è“_|‚í‚ê‚í‚ê‚Ì’ñŒ¾‚ɑ΂·‚éƒAƒ“ƒP[ƒg’²¸‚©‚ç‚ÌŒŸ“¢|. –kŒ´F—Y1, —L‰ê@“O2, ‰¡“c—Ts3, ŽR“c@Ÿ4, ¯‚ä‚©‚è1, ‘Š”nˆêˆå1 (1‹~–½. 2º˜a‘å. 3“ú–{ˆã‘å. 4”]ŠO)F‘æ17‰ñ“ú–{”]Ž€”]‘h¶Šw‰ï (2004/6/5), “Œ‹ž.

733479. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŽYåñŠú‚É’°œÃ–¬ˆ³”—ÇŒóŒQ‚ð”­Ç‚µ, ƒXƒeƒ“ƒg—¯’up‚ª—LŒø‚Å‚ ‚Á‚½1—á. “c‘ºK•ä1, Ä“¡Œöˆê˜Y1, •½“cŒõ”Ž1, ¼Šª@”Ž2, ƒEƒbƒhƒnƒ€ƒX—æŽq2, ¼‰iŒh“ñ2, ŽR–{aˆê˜Y3 (1ŠO. 2•ú. 3‹~–½): ‘æ16‰ñŠÖ“ŒIVRŒ¤‹†‰ï (2004/7/17), “Œ‹ž.

733480. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‰¡Šu–Œƒwƒ‹ƒjƒA‚Æ‚ÌŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚½”xŽîᇂɂæ‚é‹Ù’£«ŒŒ‹C‹¹‚Ì1—á. •ž•”@, “‡“c@Œª, ²“¡çŒb, ¬—Ñ@ŒM, •Ð‰ª—Sˆê, ¡ˆä@Š°, ‘Š”nˆêˆå (‹~–½): ‘æ13‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2004/8/28), ‰¡•l. ƒvƒƒOƒ‰ƒ€E´˜^W, p.71, 2004.

733481. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‚ƒ}ƒOƒlƒVƒEƒ€ŒŒÇ‚É‚æ‚èˆÓŽ¯áŠQ‚Æ‹Ø’oŠÉ‚𔺂Á‚½”DP’†“Åǂ̈ê—á. Š~Œ©•¶Ž}, Vˆä³N, ²“¡çŒb, ¡ˆä@Š°, –å‘O’BÆ, 㞊‹gl, –kŒ´F—Y, ‘Š”nˆêˆå (‹~–½): ‘æ13‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2004/8/28), ‰¡•l. ƒvƒƒOƒ‰ƒ€E´˜^W, p.85, 2004.

733482. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘½”­«’°ŠÇúE‚ð’悵‚½Œ€ÇŒ^ƒAƒ[ƒoŠ´õÇ‚Ì1—á. •ž•”@1, “‡“c@Œª1, ²“¡çŒb1, ¬—Ñ@ŒM1, ‘Š”nˆêˆå1, ˆø“crˆê1, »ìŒc‰î2, –ìXŽRŸl2 (1‹~–½. 2Š´õÇj: ‘æ56‰ñ_“Þ쌧Š´õLjãŠw‰ï (2004/9/18), ‰¡•l. ƒvƒƒOƒ‰ƒ€E´˜^W, p.10, 2004.

733483. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‹~–½‹~‹}NST‚Ì—L—p«‚Æ–â‘è“_. _œä’m“¹, •Ð‰ª—Sˆê, ‘Š”nˆêˆå (‹~–½): ‘æ3‰ñ_“ÞìNSTƒtƒH[ƒ‰ƒ€ (2004/12/18), ‰¡•l.

733484. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‹~‹}‘à‚É‚æ‚é’¼—¬œ×“®‚É‚Ä‹~–½‚ɬŒ÷‚µ‚½”ñ“ÁˆÙ“IS“d}‚ÌBrugadaÇŒóŒQ‚̈ê—á. ‘OìŒb”ü1, XŒû¹•F2, •iì–íl, ‹|í@‘å2, ¼ˆäŠîŒp2, –k–ì‹`˜a3, ‹g“c@“O3, •Ÿ“c’¼l2, ’ë–ìTˆê2, ˜aò@“O2 (1®ŠO. 2“à‡U. 3‹~–½): ‘æ194‰ñ“ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2004), “Œ‹ž.

733485. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Œ¸ˆ³Ç‚Æf’f‚³‚ꂽ‹}«‘å“®–¬‰ð—£‚̈ê—á. ‹g“c@“O, •ž•”@, ¬—Ñ@ŒM, “‡“c@Œª, •Ð‰ª—Sˆê, ¼Šª@”Ž, ŽR–{aˆê˜Y, ²“¡çŒb, ˆø“crˆê, ¡ˆä@Š°, –kŒ´F—Y, ‘Š”nˆêˆå (‹~–½): ‘æ4‰ñ“ú–{‚‹Cˆ³ŠÂ‹«ˆãŠw‰ïŠÖ“Œ’n•û‰ïE‘æ6‰ñö…ˆãŠwuÀ¬“cŒ´ƒZƒ~ƒi[‡“¯ŠwpW‰ï (2005/1/22), ¬“cŒ´. “ú–{‚‹Cˆ³ŠÂ‹«ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽ, 3 (3): 35, 2005.

733486. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “–‰, Œ¸ˆ³Ç‚Æ‚Ì”»•Ê‚ª¢“ï‚Å‚ ‚Á‚½‹}«‘å“®–¬‰ð—£‚̈ê—á. •ž•”@, ‹g“c@“O, ¬—Ñ@ŒM, “‡“c@Œª, •Ð‰ª—Sˆê, ¼Šª@”Ž, ŽR–{aˆê˜Y, ²“¡çŒb, ˆø“crˆê, ¡ˆä@Š°, –kŒ´F—Y, ‘Š”nˆêˆå (‹~–½): ‘æ55‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2005/2/19), –‹’£. ƒvƒƒOƒ‰ƒ€E´˜^W, p.55, 2005.

733487. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ®Œ`ŠO‰È‰ŠúŽ¡—Â̔½È‚ð—v‚µ‚½‘½”­œÜŒã‚É”º‚Á‚½Ž‰–bÇðÇŒóŒQ‚Ì1—á. X’JŒõr1, “à–ì³—²2, •Ð‰ª—Sˆê1, ¬‹{Gˆê˜Y2, ¬—Ñ@ŒM1, Vˆä³N1, ¼Šª@”Ž1, ŽR–{aˆê˜Y1, Ž…–ž·Œ›2, ‘Š”nˆêˆå1 (1‹~–½. 2®ŠOj: ‘æ55‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2005/2/19), –‹’£. ƒvƒƒOƒ‰ƒ€E´˜^W, p.44, 2005.

733488. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) —ˆ‰@Žž‚Éd“x‚Ì‚Ñ‚Ü‚ñ«”]•‚Žî‚ð‚«‚½‚µ‚Ä‚¢3Ç—á. –å‘O’BÆ, ²“¡çŒb, Š~Œ©•¶Ž}, 㞊‹gl, ‰Í“‡‰ë“ž, ‰““¡¹F, –kŒ´F—Y, ‘Š”nˆêˆå (‹~–½)F‘æ55‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2005/2/19), –‹’£. ƒvƒƒOƒ‰ƒ€E´˜^W, p.53, 2005.

733489. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘å’°úE‚Æ‚ÌŠÓ•Ê‚É‹ê—¶‚µ‚½tŽüˆÍ”^á‡. Š`“c‘Žq, ŽR–{aˆê˜Y, ¼Šª@”Ž, Š~Œ©•¶Ž}, ˆø“crˆê, ”Ñ’Ë”ü, ¬—Ñ@ŒM, “‡“c@Œª, •Ð‰ª—Sˆê, ‘Š”nˆêˆå (‹~–½): ‘æ55‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2005/2/19), –‹’£. ƒvƒƒOƒ‰ƒ€E´˜^W, p.63, 2005.

733490. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Œü¸_–ò•ž—p‚É‚æ‚è‘O˜rƒRƒ“ƒp[ƒgƒƒ“ƒgÇŒóŒQ‚𗈂½‚µ‚½2—á. ˆø“crˆê1, •Ð‰ª—Sˆê1, ¡ˆä@Š°1, ¬‹{Gˆê˜Y2, “à–ì³—²2, 㞊‹gl1, –kŒ´F—Y1, ‘Š”nˆêˆå1 (1‹~–½. 2®ŠO): ‘æ55‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2005/2/19), –‹’£. ƒvƒƒOƒ‰ƒ€E´˜^W, p.74, 2005.


<<Š´õÇŠw>>

mŠwp˜_•¶n

110207. [Œ´’˜] Population Pharmacokinetics of Arbekacin,Vancomycin and Panipenem in Neonates. –Ø‘º—˜”ü1, »ìŒc‰î2, ¼‰YM•v3, Hiroaki Kubo, “‡“cŽ •F1, –îŒã˜a•v1 (1–òÜ•”. 2Š´õÇ. 3¬Ž™): Antimicrobial Agents and Chemotherapy, 48 (4): 1159-1167, 2004.

110208. [Œ´’˜] Rapid detection and differentiation method of VanA, VanB and VanC phenotypes in vancomycin-resistant enterococci. ‰Ô–ØG–¾1, Yamaguchi Y, Nomura S, Nagayama A, »ìŒc‰î1 (1Š´õÇ): Int J Antimicrob Agents, 23 (5): 502-505, 2004.

110209. [Œ´’˜] Characterization of HMRZ86; novel chemical compound for detecting extended spectrum beta-lactamases. ‰Ô–ØG–¾1, Kubo R, Nakano R, Kurihara M, »ìŒc‰î1 (1Š´õÇ): J Antimicrob Chemother, 53 (5): 888-889, 2004.

110210. [Œ´’˜] Antibiotic Susceptibility in Relation to Penicillin-Binding Protein Genes and Serotype Distribution of Streptococcus pneumoniae Strains Responsible for Meningitis in Japan, 1999 to 2002. ¶•ûŒöŽq1, ç—tØ•äŽq2, ’·’JìŒbŽq, ¬—Ñ—æŽq, Šâ“c@•q, »ìŒc‰î3 (1–k—¢¶–½‰ÈŠwŒ¤. 2‘åŠw‰@Š´õ§Œä‰È. 3Š´õÇ): Antimicrobial Agents And Chemotherapy, 48 (5): 1488-1494, 2004.

110211. [Œ´’˜] Rapidly Increasing Prevalence of ƒÀ-Lactamase-Nonproducing, Ampicillin Resistant Haemophilus inflenzae Type b in Patients with meningitis. ’·’JìŒbŽq, ç—tØ•äŽq1, ¬—Ñ—æŽq, Šâ“c@•q, »ìŒc‰î2, ¶•ûŒöŽq3 (1‘åŠw‰@Š´õ§Œä‰È. 2Š´õÇ. 3–k—¢¶–½‰ÈŠwŒ¤): Antimicrobial Agents And Chemotherapy, 48 (5): 1509-1514, 2004.

110212. [Œ´’˜] Double-blinded comparative study on the care of the neonatal umbilical cord using 80% ethanol with or without chlorhexidine. ‘åÎ’q—m1, S Iwata, –ìXŽRŸl1, A Tsuji, »ìŒc‰î1 (1Š´õÇ): J Hospital Infection, 58: 34-37, 2004.

110213. [Œ´’˜] In vitro protein binding of teicoplanin to neonatal serum. M Sando, Y Sato, Šâ“c@•q, H“c”ŽL, »ìŒc‰î1 (1Š´õÇ): J Infect Chemother, 10 (5): 257-306, 2004.@

110214. [Œ´’˜] ƒÀ-lactam antibiotic induced vancomycin-resistant MRSA (BIVR) ‚ɑ΂·‚épazufloxacin ‚ÆRMRSA–ò•¹—pŒø‰Ê. –ö‘òçŒb, ‰Ô–ØG–¾1, ‘åÎ’q—m1, ㌴ˆêW, ŽRŒûKŒb, ¼ˆäGm, »ìŒc‰î1 (1Š´õÇ): Jpn J Antibiotic, 58 (1): 11-15, 2005.

110215. [Œ´’˜]@In vitro Activity of Tebipenem, a New Oral Carbapenem Antibiotic, against Penicillin-Nonsusceptible Streptococcus pneumoniae. ¬—Ñ—æŽq, Mami Konomi, ’·’JìŒbŽq1, ”Šp”ü—R‹I, »ìŒc‰î2, ¶•ûŒöŽq3 (1‘åŠw‰@Š´õ§Œä‰È. 2Š´õÇ. 3–k—¢¶–½‰ÈŠwŒ¤): Antimicobial Agents and Chemotherapy, 49 (3): 889-894, 2005.

120113. [Œ´’˜] —Õ°ˆã‚Ì‚½‚ß‚ÌV–ò‚Ì’mŽ¯@ƒeƒCƒRƒvƒ‰ƒjƒ“. »ìŒc‰î (Š´õÇ): —Õ°‚Æ–ò•¨Ž¡—Ã, 23 (4): 388-389, 2004.

120114. [Œ´’˜] ‘–Œ‰Š‹ÛŠ´õÇ. »ìŒc‰î (Š´õÇ): ‚©‚炾‚̉Ȋwu‘Š§v, ‰ª•”M•F•Ò, 201-203, 2004.

120115. [Œ´’˜] Methicillin-resistant Staphylococcus aureus (MRSA) ‚ªŽY¶‚·‚éhemolysin‚ɑ΂·‚éƒqƒg–ƉuƒOƒƒuƒŠƒ“»Ü‚ÌŒø‰Ê. “c’†D, ‰Ô–ØG–¾1, –ö‘òçŒb, ㌴ˆêW, ŽRŒûKŒb, ×â‘׎q, ˆï“cˆê¬, Žðˆä•‡ŽÀŽq, ’r“ci•ã, Ž½Œ´•q”V, “c’†°—Y, »ìŒc‰î1 (1Š´õÇ): Medical Postgraduates, 42 (4): 140-144, 2004.

120116. [Œ´’˜] MRSA‚¨‚æ‚ÑVRE‚ɑ΂·‚镹—p—Ö@. ‘åÎ’q—m, ‰Ô–ØG–¾, »ìŒc‰î (Š´õÇ): ‰»Šw—Ö@‚̗̈æ, 20 (8): 59-64, 2004.

120117. [Œ´’˜] •S“úŠPƒT[ƒxƒ‰ƒ“ƒXŒ¤‹†‰ï: 2001”N‚©‚ç2002”N‚É•ª—£‚³‚ꂽBordetella pertussis‚Ì–òÜŠ´Žó«¬Ñ‚Æ•ªŽq‰uŠw“IŒŸ“¢. ‘å’˳”V, ‹e’r@Œ«, ‰ª“cŒ«Ži, “Œo³l, t“¡˜aÆ, »ìŒc‰î1 (1Š´õÇ): Š´õÇŠwŽGŽ, 78 (5): 420-427, 2004.

120118. [Œ´’˜] ƒÀ-lactam antibiotic induced vancomycin-resistant MRSA (BIVR) ‚̉uŠw’²¸. ×â‘׎q1, ‰Ô–ØG–¾2,3, —Ñ@ò2, ã•Ê•{Œ\Žq1, »ìŒc‰î3 (1“Œ‹ž‘å. 2–kŒ¤RŠ´õÇ–òŒ¤‹†ƒZƒ“ƒ^[. 3Š´õÇ): Š´õÇŠwŽGŽ, 78 (8): 717-721, 2004.

120119. [Œ´’˜] ‰»”^«‘–Œ‰Š—á‚©‚çHaemophilus influenzae‚̉uŠw‰ðÍ|1999”N‚©‚ç2003”N•ª—£Š”‚ɂ‚¢‚Ä. ’·’JìŒbŽq1, ç—tØ•äŽq1, ¬—Ñ—æŽq, ”Šp”ü—R‹I, Šâ“c@•q2, »ìŒc‰î3, ¶•ûŒöŽq4 (1‘åŠw‰@Š´õ§Œä‰È. 2‘—§•a‰@“Œ‹žˆã—ÃZƒ“ƒ^[. 3Š´õÇ. 4–k—¢¶–½‰ÈŠwŒ¤): Š´õÇŠwŽGŽ, 78 (9): 835-845, 2004.

120120. [Œ´’˜] –{–M‚É‚¨‚¯‚鬎™‰»”^«‘–Œ‰Š‚Ì“®Œü(2000`2002). »ìŒc‰î1, –ìXŽRŸl1, ‘åÎ’q—m1, Šâ“c@•q2, H“c”ŽL3, ²“¡‹g‘s4, ¶•ûŒöŽq5, ç—tØ•äŽq6, ’·’JìŒbŽq6 (1Š´õÇ. 2‘—§•a‰@“Œ‹žˆã—ÃZƒ“ƒ^[. 3¹ƒ}ƒŠƒAƒ“ƒiˆã‘剡•l¼•”•a‰@. 4•xŽmdHŒ’•Û‘‡‘¾“c•a‰@. 5–k—¢¶–½‰ÈŠwŒ¤. 6‘åŠw‰@Š´õ§Œä‰È): Š´õÇŠwŽGŽ, 78 (10): 879-890, 2004.

520349. [uÀ] 4.: ƒVƒ“ƒ|ƒWƒEƒ€@R‹Û–ò‚Ì“K³Žg—p‚Æ‚»‚̃KƒCƒhƒ‰ƒCƒ“@2)“ú–{ƒKƒCƒhƒ‰ƒCƒ“‚Ì“ÁŽê«. »ìŒc‰î (Š´õÇ): “ú–{“à‰ÈŠw‰ïŽGŽ, 93 (9): 112-115, 2004.

520350. [uÀ] ¬Ž™‚É‚¨‚¯‚é‘Ï«‹Û‚ÌŒ»ó. ‘åÎ’q—m, »ìŒc‰î (Š´õÇ): Š´õÇ‚ÆR‹Û–ò, 8 (1): 32-35, 2005.

520351. [‘à] V¶Ž™‚É‚¨‚¯‚éŠeŽíR‹Û–ò‚Ì’`”’Œ‹‡—¦. ŽR“¡@–ž1, ²“¡‹g‘s1, Šâ“c@•q2, H“c”ŽL3, »ìŒc‰î4 (1•xŽmdHŒ’•Û‘‡‘¾“c•a‰@. 2‘—§•a‰@“Œ‹žˆã—ÃZƒ“ƒ^[. 3¹ƒ}ƒŠƒAƒ“ƒiˆã‘剡•l¼•”•a‰@. 4Š´õÇ): “ú‰»—ÉïŽ, 52 (10): 556-567, 2004.

520352. [‘à] V¶Ž™‚É‚¨‚¯‚é—V—£ƒrƒŠƒ‹ƒrƒ“”Z“x‚É—^‚¦‚éR‹Û–ò‚̉e‹¿. ŽR“¡@–ž1, ²“¡‹g‘s1, Šâ“c@•q2, H“c”ŽL3, »ìŒc‰î4 (1•xŽmdHŒ’•Û‘‡‘¾“c•a‰@. 2‘—§•a‰@“Œ‹žˆã—ÃZƒ“ƒ^[. 3¹ƒ}ƒŠƒAƒ“ƒiˆã‘剡•l¼•”•a‰@. 4Š´õÇ): “ú‰»—ÉïŽ, 52 (10): 574-582, 2004.

520353. [•ñ] (ŽÐ’c–@l “ú–{‰»Šw—Ö@Šw‰ïR‹Û–ò”ç“à”½‰žŒŸ“¢“Á•Ê•”‰ï•ñ) R‹Û–ò“Š—^‚ÉŠÖ˜A‚·‚éƒAƒiƒtƒBƒ‰ƒLƒV[‘Îô‚̃KƒCƒhƒ‰ƒCƒ“ i2004”N”Åj. âV“¡@Œú, »ìŒc‰î1, ’†“‡ŒõD, ’YŽR‰ÃL, ’ràV‰Ã˜Y, ”ä‰Ã@‘¾, ²X–Ø@‹Ù, –î–ì—T“ñ (1Š´õÇ): “ú‰»—ÉïŽ, 52 (10): 583-593, 2004.

520354. [‘à] Ž¨•@‰È‚Å’m‚Á‚Ä‚¨‚«‚½‚¢¬Ž™‚ÌŠ´õÇ. »ìŒc‰î (Š´õÇ): “sŽ¨•@‰ï•ñ, (115): 57-61, 2004.

520355. [‘à] •\‘è:R‹Û–ò‚̬Ž™—Õ°–ò—. –Ø‘º—˜”ü1, –îŒã˜a•v1, »ìŒc‰î2 (1–òÜ•”. 2Š´õÇ): —Õ°–ò—, 35 (6): 280-284, 2004.

m’˜@‘n

620205. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ÅVEŠ´õÇŽ¡—ÃŽwj2004”N‰ü’ù”Å; ¬Ž™‰È@‰»”^«‘–Œ‰Š, p.184-188. »ìŒc‰î1, Šâ“c@•q2 (1Š´õÇ. 2‘—§•a‰@“Œ‹žˆã—ÃZƒ“ƒ^[), ŠÄC “‡“c@Š], ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, “Œ‹ž, 2004/8/1”­s.

620206. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) Š´õÇ‚Ìf’fEŽ¡—ÃKƒCƒhƒ‰ƒCƒ“2004; ŠeR‹Û–ò‚ÌŠTà, p.353-359. »ìŒc‰î (Š´õÇ), ŠÄC “ú–{ˆãŽt‰ïŠ´õÇŠë‹@ŠÇ—‘ÎôŽº, Œú¶˜J“­ÈŒ’N‹ÇŒ‹ŠjŠ´õljÛ, “ú–{ˆãŽt‰ï, “Œ‹ž, 2004/12/5”­s.

620207. [Šwp‘] (•ª’SŽ·•M) ¬Ž™‚Ì”x‰Š; ¬Ž™”x‰Š‚ðŽæ‚芪‚­–â‘è“_, p.16-23. »ìŒc‰î, –ìXŽRŸl, ‘åÎ’q—m, ‰Ô–ØG–¾ (Š´õÇ), •ÒW »ìŒc‰î1, ”ö“àˆêM (1Š´õÇ), ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, “Œ‹ž, 2004/12/15”­s.

620208. [Šwp‘] (•ª’SŽ·•M) ¬Ž™‚Ì”x‰Š; ƒJƒŠƒj”x‰Š, p.270-275. –ìXŽRŸl, »ìŒc‰î (Š´õÇ), •ÒW »ìŒc‰î1, ”ö“àˆêM (1Š´õÇ), ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, “Œ‹ž, 2004/12/15”­s.

620209. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ¡“ú‚ÌŽ¡—ÃŽwj 2005”N”Å; ¬Ž™‚É‚¨‚¯‚éR‹Û–ò‚ÌŽg—p–@, p.924. »ìŒc‰î (Š´õÇ), •ÒW ŽRŒû@“O, –kŒ´Œõ•v, ˆãŠw‘‰@, “Œ‹ž, 2005/1/1”­s.

620210. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) Š´õÇ‚Ìf’fEŽ¡—ÃKƒCƒhƒ‰ƒCƒ“2004; R‹Û–òŠTà, p.353-359. »ìŒc‰î (Š´õÇ), •ÒW “ú–{ˆãŽt‰ï, ˆãŠw‘‰@, “Œ‹ž, 2005/1/1”­s.

620211. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ŽÀ‘HR¶•¨Ž¿ER‹Û–ò—Ö@ƒKƒCƒh; R¶•¨Ž¿ER‹Û–ò‚Ì“Š—^ƒ‹[ƒg, “Š—^–@, “Š—^—Ê, “Š—^ŠúŠÔ‚¨‚æ‚Ñ–ò‚Ì•ÏX‚Ì–ÚˆÀ‚ƃ|ƒCƒ“ƒg, p.20-29. »ìŒc‰î (Š´õÇ), •ÒW Medical Practice•ÒWˆÏˆõ‰ï, •¶Œõ“°, “Œ‹ž, 2005/3/25”­s.

620212. [‚»‚Ì‘¼‚Ì’˜‘] (•ª’SŽ·•M) ƒXƒ^ƒ“ƒ_[ƒh”÷¶•¨Šw; 2) ’†•_ŒoŒnŠ´õÇ, p.225-228. »ìŒc‰î (Š´õÇ), •ÒW “y”ì‹`ˆû, ŽR–{—e³, ‰F‰êº“ñ, •¶Œõ“°, “Œ‹ž, 2004”­s.

mŠw‰ïEŒ¤‹†‰ïn

713234. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Prevalence of antimicrobial resistance and activity of the Ketolide Telithromycin against Haemophilus influenzae isolated from Japanese Children. »ìŒc‰î1, Farrell DJ (1Š´õÇ): 14th European Congress of Clinical Microbiology and Infectious Diseases (2004/5/1-4), Prague, Czech Republic.

713235. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Designing Antibiotics Dosage Regimens in Neonates Based on Population Pharmacokinetics (PPK): Comparative Study of Arbekacin (ABK), Vancomycin (VCM) and Panipenem (PAPM). World Conference on Dosing of Antiinfectives. –Ø‘º—˜”ü1, –îŒã˜a•v1, »ìŒc‰î2 (1–òÜ•”. 2Š´õÇ): Celebrating Paul Ehrlich'S 150th Birthday (2004/9/9-11), Nurnburg, Germany.

713236. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Emergence and Method of Detecting ƒÀ-lactam Antibiotic-Induced Vancomycin-Resistant MRSA (BIVR) in Japan. C Yanagisawa, ‰Ô–ØG–¾1, T Inamatsu, K Hatano, »ìŒc‰î1 (1Š´õÇ): 4th Interscience Conference on Antimicrobial Agents and Chemotherapy (2004/10/30-11/2), Washington, DC. USA.

713237. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Penicillin and Macrolide Resistance Identified by PCR in Streptococcus pneumoniae Isolates from Pediatric Outpatients with Community-Acquired Pneumonia (CAP). ¬—Ñ—æŽq, ç—tØ•äŽq1, ’·’JìŒbŽq1, ”Šp”ü—R‹I1, Šâ“c@•q, »ìŒc‰î2, ¶•ûŒöŽq3 (1‘åŠw‰@Š´õ§Œä‰È. 2Š´õÇ. 3–k—¢¶–½‰ÈŠwŒ¤): 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (2004/10/30-11/2), Washington, DC. USA.

713238. [Šw‰ï (‘Û)] (ˆê”Êu‰‰) Prevalence of Antibacterial Resistance among Pediatric Isolates of Haemophilus influenzae (HI) and Activity of Telithromycin (TEL) in Japan. »ìŒc‰î1, D Farrell (1Š´õÇ): 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (2004/10/30-11/2), Washington, DC. USA.

723943. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒÀ-lactam antibiotic induced VCM-resistant MRSA (BIVR) ‚Ì‘Ï«ƒƒJƒjƒYƒ€‚ÌŒŸ“¢. Žðˆä•‡ŽÀŽq, ‰Ô–ØG–¾1, ˆï“cˆê¬, –ö‘òçŒb, ×â‘׎q, »ìŒc‰î1 (1Š´õÇ): ‘æ78‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (2004/4/6-7), “Œ‹ž.

723944. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™dÇŠ´õǂɑ΂·‚é‘I‘ð–òÜ‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²¸. ²“¡‹g‘s, »ìŒc‰î1, –L‰i‹`´ (1Š´õÇ): ‘æ78‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (2004/4/6-7), “Œ‹ž.

723945. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™“`õ«”^áo]‚æ‚蕪—£‚³‚ꂽS.aureus‚ÌŒŸ“¢. ‘åÎ’q—m, –ìXŽRŸl, »ìŒc‰î (Š´õÇ): ‘æ78‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (2004/4/6-7), “Œ‹ž.

723946. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒÀ-lactam antibiotic induced VCM-resistant MRSA (BIVR) ‚É‚æ‚éƒ}ƒEƒX‘SgŠ´õ‚ɑ΂·‚éƒoƒ“ƒRƒ}ƒCƒVƒ“‚ƃeƒCƒvƒ‰ƒjƒ“’P܂ƃÀ-ƒ‰ƒNƒ^ƒ€–ò•¹—pŽž‚ÌŽ¡—ÃŒø‰Ê. ‰Ô–ØG–¾1, ”g‘½–ì˜a’j, ‰¡“c–­Žq, »ìŒc‰î1 (1Š´õÇ): ‘æ78‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (2004/4/6-7), “Œ‹ž.

723947. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Chlamydia trachomatisŽq‹{ŒzŠÇ‰ŠŠ³ŽÒŒŒ´‚ÉŒ©‚éR‘Ì‹Èü. ŒÔ“cÆŽq, â“à‹vˆê, ‘哇r•¶, ”Ñ’Ë@ˆ¤, –{‘º—´‘¾˜Y, H“c”ŽL, Šâ“c@•q, ²“¡‹g‘s, »ìŒc‰î1 (1Š´õÇ): ‘æ78‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (2004/4/6-7), “Œ‹ž.

723948. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) 2001”N‚©‚ç2003”N‚É•ª—£‚³‚ꂽ•S“úŠP‹Û‚Ì—Õ°‹y‚щuŠw“IŒŸ“¢. ‘å’˳”V, t“¡˜aÆ, “Œo³l, ‰ª“cŒ«Ži, »ìŒc‰î1 (1Š´õÇ): ‘æ78‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (2004/4/6-7), “Œ‹ž.

723949. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒÀ-lactam antibiotic induced VCM-resistant MRSA (BIVR) ‚ÌŒŸo󋵂ƶ•¨Šw“I’²¸. ×â‘׎q, ‰Ô–ØG–¾1, –ö‘òçŒb, ˆï“cˆê¬, Žðˆä•‡ŽÀŽq, —Ñ@ò1, ã•Ê•{Œ\Žq, »ìŒc‰î2 (1–ò—. 2Š´õÇ): ‘æ78‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (2004/4/6-7), “Œ‹ž.

723950. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) MRSA‚ɑ΂·‚épazufloxacin‚ÆRMRSA–ò‚Æ‚Ì•¹—pŒø‰Ê‹y‚Ñ P.aeruginosa‚ɑ΂·‚épazufloxacin ‚Æarbekacin‚Ì•¹—pŒø‰Ê. –ö‘òçŒb, ‰Ô–ØG–¾1, ˆï“cˆê¬, Žðˆä•‡ŽÀŽq, ×â‘׎q, »ìŒc‰î2 (2Š´õÇ): ‘æ78‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (2004/4/6-7), “Œ‹ž.

723951. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ABK‚ɑ΂·‚éMRSA‚Ì’iŠK“I‘Ï«Šl“¾‚ÌŒŸ“¢. ˆï“cˆê¬, ‰Ô–ØG–¾1, –ö‘òçŒb, Žðˆä•‡ŽÀŽq, ×â‘׎q, »ìŒc‰î1 (1Š´õÇ): ‘æ78‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (2004/4/6-7), “Œ‹ž.

723952. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ”sŒŒÇ‚É‚¨‚¯‚év‘¬f’f–@‚̉ž—p. ‚ŽR—zŽq1, “c’†Z–¾2, Îì@Í2, ‰““¡•½m2, –k—¢‰p˜Y3, Ô¯@“§4, »ìŒc‰î1, ‹ß“¡Œ[•¶2 (1Š´õÇ. 2“à‡X. 3ˆã‰q. 4—ÕŒŸŠw): ‘æ78‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (2004/4/6-7), “Œ‹ž.

723953. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) “ú–{‚̃KƒCƒhƒ‰ƒCƒ“‚Ì“ÁŽê«. »ìŒc‰î (Š´õÇ): ‘æ101‰ñ“ú–{“à‰ÈŠw‰ïu‰‰‰ï (2004/4/9), “Œ‹ž.

723954. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒÀ-lactam antibiotic induced VCM-resistant MRSA (BIVR) ‚¨‚æ‚Ò MRSA, MSSA‚ɑ΂·‚éƒÀ-lactam–ò‚ÆVCM‚Ì•¹—pŒø‰Ê. ×â‘׎q, ‰Ô–ØG–¾1, –ö‘òçŒb, ˆï“cˆê¬, Žðˆä•‡ŽÀŽq, —Ñ@ò2, »ìŒc‰î1 (1Š´õÇ. 2–ò—): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723955. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™‰»”^«‘–Œ‰Š‚ɑ΂·‚éƒJƒ‹ƒoƒyƒlƒ€Œn–ò‚ÌŽŠ“K—p—ʂɂ‚¢‚Ä. ²“¡~Žq, »ìŒc‰î1, ¶•ûŒöŽq2, –ìXŽRŸl1, Šâ“c@•q (1Š´õÇ. 2–k—¢¶–½‰ÈŠwŒ¤): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723956. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‰»”^«‘–Œ‰Š‚©‚番—£‚³‚ꂽ”x‰Š‹…‹Û‚ÌPBPsˆâ“`Žq‰ðÍ|ƒZƒtƒFƒ€Œn–ò‚É‚‚¢‘Ï«‚ðŽ¦‚·Š”‚ð’†S‚É|. ç—tØ•äŽq, ’·’JìŒbŽq, ¬—Ñ—æŽq, —é–؉xŽq, Šâ“c@•q, »ìŒc‰î1, ¶•ûŒöŽq2 (1Š´õÇ. 2–k—¢¶–½‰ÈŠwŒ¤): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723957. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) AGsŠO—p–ò‚ÌŽg—p§ŒÀ‚ðs‚Á‚½•a‰@‚ÅŒŸo‚³‚ꂽMRSA‚ÌGM‚¨‚æ‚ÑABK‚ÌŒo”N“I–òÜŠ´Žó«‚ÆAGsCüy‘fŽY¶ˆâ“`Žq‚ÌŠÖ˜A«‚ÌŒŸ“¢. ˆï“cˆê¬, ‰Ô–ØG–¾1, –ö‘òçŒb, Žðˆä•‡ŽÀŽq, ˆî¼FŽv, »ìŒc‰î1 (1Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï(2004/6/3-4), ‰«“ê.

723958. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™‚̔畆“î•”‘gDŠ´õÇ‚É‚¨‚¯‚éMRSA‚ÌŠÖ—^. Šâ“c@•q, –ؑ׎q, ²“¡‹g‘s, H“c”ŽL, »ìŒc‰î1 (1Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723959. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒLƒmƒƒ“‘Ï«”x‰Š‹…‹Û‚Ì–òÜŠ´Žó«‚ƈâ“`Žq•ÏˆÙ‚ÌŠÖ˜A. ‚ŽR—zŽq1, –k—¢‰p˜Y2, ùŒ´•Žu3, »ìŒc‰î1, ‰«’îO, ‹ß“¡Œ[•¶4 (1Š´õÇ. 2ˆã‰q. 3”÷EŠñ. 4“à‡X): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723960. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒÀ-lactam antibiotic induced VCM-resistant MRSA (BIVR) ‚Ì‘Ï«ƒƒJƒjƒYƒ€‚ÌŒŸ“¢. Žðˆä•‡ŽÀŽq, ‰Ô–ØG–¾1, ˆï“cˆê¬, –ö‘òçŒb, ×â‘׎q, ㌴ˆêW, ŽRŒûKŒb, »ìŒc‰î1 (1Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723961. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒÀ-lactam antibiotic induced VCM-resistant MRSA (BIVR) ‚ÌVCM‘Ï«‚É—^‚¦‚é”|—{ŽžŠÔ‚ƃÀ-ƒ‰ƒNƒ^ƒ€–ò‚̉e‹¿. –ö‘òçŒb, ×â‘׎q, Žðˆä•‡ŽÀŽq, ˆï“cˆê¬, ‰Ô–ØG–¾1, —Ñ@ò2, »ìŒc‰î1 (1Š´õÇ. 2–ò—): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723962. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹ß”N•ª—£‚³‚ꂽ•S“úŠP‹Û‚Ì–òÜŠ´Žó«¬Ñ. ‹e’r@Œ«, –p@t¬, ŒË’Ë‹±ˆê, “¡@ƒˆê˜Y, ˆÀ•À@‹B, ŽR‰Y@í, ‘å’˳”V, “Œo³l, t“¡˜aÆ, ‰ª“cŒ«Ži, »ìŒc‰î1 (1Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723963. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™‰»”^«‘–Œ‰Š‚ÌŽ¡—ÂɊւ·‚éƒAƒ“ƒP[ƒg’²¸. –ìXŽRŸl1, Šâ“c@•q, ‘åÎ’q—m1, »ìŒc‰î1 (1Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723964. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™‚É‚¨‚¯‚éR‹Û–ò‚ɑ΂·‚éƒAƒ“ƒP[ƒg’²¸. ‘åÎ’q—m, –ìXŽRŸl, »ìŒc‰î (Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723965. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒÀ-lactam antibiotic induced VCM-resistant MRSA (BIVR) ‚̃}ƒEƒX‘SgŠ´õ‚ɑ΂·‚鎡—ÃŒø‰Ê. ‰Ô–ØG–¾1, ”g‘½–ì˜a’j, ‰¡“cDŽq, »ìŒc‰î1 (1Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723966. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) HSR-903‚̌ċzŠíŠ´õǂɑ΂·‚é—LŒø«‹y‚шÀ‘S«‚ÌŒŸ“¢ i‘OŠú‹y‚ÑŒãŠú‘æ‡U‘Š—Õ°ŽŽŒ±j. —Ñ@ò1, ¼–{•¶•v, “n•Ó@², ˜a“cŒõˆê, ¬“cؔɎ÷, “ñ–Ø–Fl, ‰Í–ì@–Î, »ìŒc‰î2 (1–ò—. 2Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723967. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ׋۫”x‰Š‚ɑ΂·‚éHSR-903‚ÌLevofloxacin‚ð‘ÎÆ‚Æ‚µ‚½‘æ‡V‘Š”äŠrŽŽŒ±. —Ñ@ò1, ¼–{•¶•v, “n•Ó@², –ØMŽ÷, ˜a“cŒõˆê, ¬“cؔɎ÷, “ñ–Ø–Fl, ‰Í–ì@–Î, âV“¡@Œú, »ìŒc‰î2, ŽÄ@F–ç, ‘ŠàV—Ç•v, ŽRŒûœ¨ŽO, ’†“‡ŒõD (1–ò—. 2Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723968. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ŒÄ‹zŠíŠ´õÇŽ¡—Âɂ¨‚¯‚éƒpƒjƒyƒlƒ€/ƒxƒ^ƒ~ƒvƒƒ“‚¨‚æ‚щ–Ž_ƒZƒtƒHƒ]ƒvƒ‰ƒ“‚É‚æ‚鎡—Óú”‚ÌŒŸ“¢. »ìŒc‰î1, Œã“¡@Œ³, ˜a“cŒõˆê (1Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723969. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‘“àŠO‚É‚¨‚¯‚éR‹Û–òpŒãŠ´õ—\–h“I“Š—^‚ɂ‚¢‚Ä. ²“¡~Žq, ’|–––F¶, ‘’nM–ç, »ìŒc‰î1, ’YŽR‰ÃL (1Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2004/6/3-4), ‰«“ê.

723970. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) Nested PCR‚É‚æ‚é•S“úŠP‹Û‚Ìv‘¬f’f–@. ‹e’r@Œ«, –p@t¬, ŒË’Ë‹±ˆê, “¡@ƒˆê˜Y, ˆÀ•À@‹B, ŽR‰Y@í, ‘å’˳”V, “Œo³l, t“¡˜aÆ, ‰ª“cŒ«Ži, »ìŒc‰î1 (1Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï(2004/6/3-4), ‰«“ê.

723971. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ‹³ˆçu‰‰‡E@¬Ž™ŒÄ‹zŠíŠ´õÇ‚ÆR‹Û–ò‚ÌŽg‚¢•û. »ìŒc‰î (Š´õÇ): ‘æ15‰ñ“ú–{¬Ž™‰Èˆã‰ïƒZƒ~ƒi[ (2004/6/19-20), –¼ŒÃ‰®.

723972. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™ŒÄ‹zŠíŠ´õÇ‚ÆR‹Û–ò‚ÌŽg‚¢•û. »ìŒc‰î (Š´õÇ): ‘æ15‰ñ“ú–{¬Ž™‰Èˆã‰ïƒZƒ~ƒi[ (2004/6/19-20), –¼ŒÃ‰®.

723973. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ¬Ž™“`õ«”^áo]‚æ‚蕪—£‚³‚ꂽS, aureus‚Ì, ŠeŽíŒoŒûE’ŽË—pR‹Û–ò‚ÌMIC‚ÌŒŸ“¢. ‘åÎ’q—m1, ‰Ô–ØG–¾1, “àŽR@¹, »ìŒc‰î1 (1Š´õÇ): ‘æ36‰ñ“ú–{¬Ž™Š´õÇŠw‰ï‘‰ï (2004/11/12-13), “Œ‹ž.

723974. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ã‹C“¹‚ÆŒŒ‰t‚©‚瓯ˆê‚Ì׋ۂª•ª—£‚³‚ꂽŽs’†Š´õÇ9—á‚ÌŒŸ“¢. ¼Œ´Œ[‘¾, Šâ“c@•q, ²“¡‹g‘s, H“c”ŽL, ‘åÎ’q—m1, –ìXŽRŸl1, »ìŒc‰î1, ¶•ûŒöŽq2 (1Š´õÇ. 2–k—¢¶–½‰ÈŠwŒ¤): ‘æ36‰ñ“ú–{¬Ž™Š´õÇŠw‰ï‘‰ï (2004/11/12-13), “Œ‹ž.

723975. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ’n•û‚̈ê”Ê•a‰@¬Ž™‰È‚É‚¨‚¯‚é”x‰Š‹…‹Û‚¨‚æ‚уCƒ“ƒtƒ‹ƒGƒ“ƒU‹Û‚Ì–òÜŠ´Žó«‚Ì“®Œü|“Á‚ÉBLNAR‚Ì‘‰Á‚ɂ‚¢‚Ä|. ‘åÎ’q—m1, –ö‘òçŒb, ‰Ô–ØG–¾1, »ìŒc‰î1 (1Š´õÇ): ‘æ20‰ñ“ú–{ŠÂ‹«Š´õŠw‰ï‘‰ï (2005/2/24-26), _ŒË.

723976. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒÀ-lactam antibiotic induced VCM-resistant MRSA (BIVR) ‚ÌŒŸo‚É‹y‚Ú‚·NaCl‚̉e‹¿. Ž›“c‚Žq, ‰Ô–ØG–¾1, –ö‘òçŒb, ×â‘׎q, ˆï“cˆê¬, V“¡ˆèŽq, »ìŒc‰î1 (1Š´õÇ): ‘æ20‰ñ“ú–{ŠÂ‹«Š´õŠw‰ï‘‰ï (2005/2/24-26), _ŒË.

723977. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒÀ-lactam antibiotic induced VCM-resistant MRSA (BIVR) ‚Ì‘Ï«‹@\‚ÌŒŸ“¢. V“¡ˆèŽq, ‰Ô–ØG–¾1, ˆï“cˆê¬, »ìŒc‰î1 (1Š´õÇ): ‘æ20‰ñ“ú–{ŠÂ‹«Š´õŠw‰ï‘‰ï (2005/2/24-26), _ŒË.

723978. [Šw‰ï (‘S‘)] (ˆê”Êu‰‰) ƒÀ-lactam antibiotic induced VCM-resistant MRSA (BIVR) ‚ɑ΂·‚éVCM‚ÌR‹Û—Í‚É‹y‚Ú‚·”ˆöŽq‚ÌŒŸ“¢. –ö‘òçŒb, ‰Ô–ØG–¾1, Ž›“c‚Žq, ×â‘׎q, ‘åÎ’q—m1, »ìŒc‰î1 (1Š´õÇ): ‘æ20‰ñ“ú–{ŠÂ‹«Š´õŠw‰ï‘‰ï (2005/2/24-26), _ŒË.

733491. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒeƒCƒvƒ‰ƒjƒ“‚ª’˜Œø‚µ‚½‰»”^«Š{‰º‘B‰Š‚Ì1Î’jŽ™—á. –{ŠÔ‰p˜a, “ˆ@°Žq, ‚è@“w, –ƒ¶‘דñ, ”Ôê³”Ž, »ìŒc‰î1 (1Š´õÇ): ‘æ56‰ñ_“Þ슴õLjãŠw‰ï (2004/9/18), ‰¡•l.

733492. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) uR‹Û–òŽg—p‚ÌŽèˆø‚«v쬂Ɠú–{‚Ì“ÁŽê«@ƒ[ƒNƒVƒ‡ƒbƒv|uR‹Û–òŽg—p‚ÌŽèˆø‚«‚©‚çƒKƒCƒhƒ‰ƒCƒ“‚Öv. »ìŒc‰î (Š´õÇ): ‘æ53‰ñ“ú–{Š´õÇŠw‰ï“Œ“ú–{’n•û‰ï‘‰ï@‘æ51‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï‡“¯Šw‰ï (2004/10/21-22), VŠƒ.

733493. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ¬Ž™‰È—̈æ‚Ì‹}«ã‹C“¹Š´õǂɑ΂·‚éƒZƒtƒWƒjƒ‹‚ƃZƒtƒJƒyƒ“‚Ì—L—p«‚ÌŒŸ“¢. ²“¡‹g‘s, ŽR“¡@–ž, Šâ“c@•q, H“c”ŽL, »ìŒc‰î1 (1Š´õÇ): ‘æ53‰ñ“ú–{Š´õÇŠw‰ï“Œ“ú–{’n•û‰ï‘‰ï@‘æ51‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï‡“¯Šw‰ï (2004/10/21-22), VŠƒ.

733494. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ‘–Œ‰Š—R—ˆƒCƒ“ƒtƒ‹ƒGƒ“ƒU‹Û‚ÌMBC‚ÌŒŸ“¢. –ìXŽRŸl, ‘åÎ’q—m, »ìŒc‰î (Š´õÇ): ‘æ53‰ñ“ú–{Š´õÇŠw‰ï“Œ“ú–{’n•û‰ï‘‰ï@‘æ51‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï‡“¯Šw‰ï (2004/10/21-22), VŠƒ.

733495. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) “`õ«”^áo]‚̬Ž™‚æ‚蕪—£‚³‚ꂽS.aureus‚̃pƒ‹ƒXƒtƒB[ƒ‹ƒhƒQƒ‹“d‹C‰j“®–@‚ÆŠ´Žó«ƒpƒ^[ƒ“‚ð—p‚¢‚½‰uŠw’²¸. ‘åÎ’q—m1, ˆï“cˆê¬, ㌴ˆêW, ×â‘׎q, ‰Ô–ØG–¾1, »ìŒc‰î1 (1Š´õÇ): ‘æ53‰ñ“ú–{Š´õÇŠw‰ï“Œ“ú–{’n•û‰ï‘‰ï@‘æ51‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï‡“¯Šw‰ï (2004/10/21-22), VŠƒ.

733496. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ƒ}ƒNƒƒ‰ƒCƒh‘Ï«Mycoplasma pneumoniae‚ª•ª—£‚³‚ꂽ¬Ž™ŒÄ‹zŠíŠ´õÇ‚Ì—Õ°“IŒŸ“¢. ¼Œ´Œ[‘¾, Šâ“c@•q, “y‹´m•ÛŽq, ²“¡‹g‘s, H“c”ŽL, ‘åÎ’q—m1, –ìXŽRŸl1, »ìŒc‰î1, ”Šp”ü—R‹I, ¬—Ñ—æŽq, ¶•ûŒöŽq2 (1Š´õÇ. 2–k—¢¶–½‰ÈŠwŒ¤): ‘æ53‰ñ“ú–{Š´õÇŠw‰ï“Œ“ú–{’n•û‰ï‘‰ï@‘æ51‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï‡“¯Šw‰ï (2004/10/21-22), VŠƒ.

733497. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Chlamydia pneumoniae PCR–@‚ÌŠ´“x”äŠr. ŒÔ“cÆŽq, ˆ¢•”GŽÀ, â“à‹vˆê, H“c”ŽL, Šâ“c@•q, ²“¡‹g‘s, »ìŒc‰î1 (1Š´õÇ): ‘æ53‰ñ“ú–{Š´õÇŠw‰ï“Œ“ú–{’n•û‰ï‘‰ï@‘æ51‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï‡“¯Šw‰ï (2004/10/21-22), VŠƒ.

733498. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) MRSAƒ}ƒEƒX‘SgŠ´õ‚ɑ΂·‚évancomycin‚Ü‚½‚Íteicoplanin‚Æimipenem•¹—pŽž‚ÌŽ¡—ÃŒø‰Ê. Žáˆä–F”ü, ‰¡“cDŽq, ‰Ô–ØG–¾1, »ìŒc‰î1 (1Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï¼“ú–{Žx•”‘‰ï (2004/12/2-3), _ŒË.

733499. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ¬Ž™ŠO—ˆŠ³ŽÒ‚É‚¨‚¯‚é, Š´õÇŠ³ŽÒ‚Ì•p“x’²¸‹y‚ьċzŠíŠ´õÇ—R—ˆ‚Ì‘Ï«‹Û”­Œ»ó‹µ’²¸. »ìŒc‰î (Š´õÇ): ‘æ52‰ñ“ú–{‰»Šw—Ö@Šw‰ï¼“ú–{Žx•”‘‰ï (2004/12/2-3), _ŒË.@@@@@@@@
733500. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) Œ€ÇŒ^—nŒŒƒŒƒ“ƒT‹…‹ÛŠ´õÇ‚Ì1—á. ‘º–쇖ç, ‰Ž“c‹M”V1, ˆø“crˆê2, ²“¡çŒb2, “à–ì³—²2, ¡ˆä@Š°2, ‘Š”nˆêˆå2, »ìŒc‰î3 (1“à‡W. 2‹~–½. 3Š´õÇ): ‘æ57‰ñ_“Þ슴õLjãŠw‰ï (2005/3/26), ‰¡•l.


ˆãŠw‹³ˆçŒ¤‹†•”–å

mŠwp˜_•¶n

110216. [Œ´’˜] Interactive real time simulation system for artificial ventilation on the internet. Takeuchi A1, ˆ¢•”@’¼2, M Hirose1, Y Tsuboi1, A Hamada1, N Ikeda1 (1ˆã‰q. 2ˆãŠw‹³ˆç): J Clinical Monitoring and Computing, 18: 353-363, 2004.

m’˜@‘n

620213. [Šwp‘] (•ª’SŽ·•M) ‰ü’ù”ÅŠÅŒì‚Ì‚½‚ß‚Ì–òŽ«“T; ŒÄ‹zŠíŒnì—p–ò, p.205-207. ˆ¢•”@’¼ (ˆãŠw‹³ˆç), •ÒW ΋´@W, ‘¼•Ò, ŠÄC ‹~¢ŒRƒu[ƒX‹L”O•a‰@, ’†‰›–@‹Ko”Å, 2005/3/10”­s.

620214. [Šwp‘] (•ª’SŽ·•M) —Õ°„˜_|EBM‚Æ•a‘Ô¶—‚©‚çÇ—á‚ðl‚¦‚é; ŠP, á‚, p.238-244. ¬—Ñç—¢1, ˆ¢•” ’¼2 (1“à‡X. 2ˆãŠw‹³ˆç), •ÒW Œã“¡‰pŽi (‰¡•lŽs‘å), ƒƒWƒJƒ‹ƒrƒ…|ŽÐ, “Œ‹ž, 2004/8/10”­s.

620215. [Šwp‘] (•ª’SŽ·•M) —Õ°„˜_|EBM‚Æ•a‘Ô¶—‚©‚çÇ—á‚ðl‚¦‚é; ŒÄ‹z¢“ï, p.230-237. ‰¡ê³“T1, ˆ¢•” ’¼2 (1“à‡X. 2ˆãŠw‹³ˆç), •ÒW Œã“¡‰pŽi (‰¡•lŽs‘å), ƒƒWƒJƒ‹ƒrƒ…|ŽÐ, “Œ‹ž, 2004/8/10”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

722123. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒXƒ^[ƒg‚µ‚½V—Õ°Œ¤CƒVƒXƒeƒ€‚ðl‚¦‚é. ˆ¢•”@’¼ (ˆãŠw‹³ˆç): ‘æ29‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ïŠwpW‰ï (2004/7/3), “Œ‹ž.

722124. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŒÄ‹zŠíŽ¾Š³‚ƌċz‹Ø. ‰¡ê³“T1, ˆ¢•”@’¼2 (1“à‡X. 2ˆãŠw‹³ˆç): ‘æ14‰ñ“ú–{ŒÄ‹zŠÇ—Šw‰ïŠwpW‰ï (2004/8/7), ‘å‹{. “ú–{ŒÄ‹zŠÇ—Šw‰ïŽ, 14 (1): 73, 2004.


–òÜ•”

mŠwp˜_•¶n

120121. [Œ´’˜] HMG-Co‚`ŠÒŒ³y‘f‘jŠQ–òƒvƒ‰ƒoƒXƒ^ƒ`ƒ“ƒiƒgƒŠƒEƒ€Œã”­ˆã–ò•i‚Ì•iŽ¿‚ÉŠÖ‚·‚錤‹†|ŠÜ—ʋψ꫋y‚Ñ•sƒ•¨ŠÜ—Ê‚ÌŒŸ“¢|. •½ŽR•Ži1, •ŽR­ˆê1, ‰Á‰ê’J”£2 (1“Œ–òÜ. 2϶‰ï‰¡•lŽs“ì•”•a‰@): V–ò‚Æ—Õ°, 53: 796-804, 2004D

120122. [Œ´’˜] HMG-Co‚`ŠÒŒ³y‘f‘jŠQ–òpravastatin sodiumŒã”­ˆã–ò•i‚̈ã–ò•i“Y•t•¶‘‚É‚¨‚¯‚é–ò•¨“®‘Ôî•ñ‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錤‹†. •½ŽR•Ži1, í“cˆ¤Žq1, •ŽR­ˆê1, –îŒã˜a•v2 (1“Œ–òÜ. 2–òÜ): ˆã—ÖòŠw, 30: 770-776, 2004D

220063. [€Œ´’˜] ƒNƒŒƒAƒ`ƒjƒ“ƒNƒŠƒAƒ‰ƒ“ƒX—\‘ªŽ®‚Ì–â‘è“_. àV“cŽÀ‰Ô1, ŒF’J—YŽ¡3, ‰¡“cTˆê1, •ŽR­ˆê1, –îŒã˜a•v2, ‘å’J‹`•v3, ”Ñ“‡@”£4 (1“Œ–òÜ. 2–òÜ. 3Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[. 4–k—¢Œ¤‹†Š): TDMŒ¤‹†, 21: 157-158, 2004.

320091. [Ç—á•ñ] “d˜b‚É‚æ‚é–ò‘Š’k‚ÌŒ»ó (2003”N“x) ŽR“c‰p‹I1, ‘Š‘ò­–¾2, Šâ“c—zŽq1, •ŽR­ˆê3, ‰Í–씎[1, ÷ˆä–¯—Y1, ²“¡NM1, ŽOa˜a’j1, “Y“c^Ži1, —é–Ø^Ži1, “c’†P–¾1, ª’×ÇK1, “nç²”ü’q—¯1, ‹e’n—L“¹1 (1_“Þ쌧•a‰@–òÜŽt‰ï. 2–òÜ. 3“Œ–òÜ): _“Þ쌧•a‰@–òÜŽt‰ï‰ïŽ, 106: 20-21, 2004.

320092. [Ç—á•ñ] 16”N“xu‚­‚·‚èGet the Answers‚©‚È‚ª‚í„iˆÏˆõ‰ïvŠˆ“®—\’è. •ŽR­ˆê (“Œ–òÜ): _“Þ쌧•a‰@–òÜŽt‰ïŽGŽ, 106: 13-14, 2004.

320093. [Ç—á•ñ] “’‰ÍŒ´’¬‚É‚¨‚¯‚é’¬–¯‘ÎÛ‚Ì‚­‚·‚è‘Š’kŠˆ“®. ÷ˆä–¯—Y1, •ŽR­ˆê2, ›’J ‹B1, “Y“c^Ži1, “nç²”ü’q—¯1, Šâ“c—zŽq1, ŽOa˜a’j1, ‘Š‘ò­–¾3, ˆ¢•”³Ž‹1, —é–Ø^Ži1, ª’×ÇK1, ŽR“c‰p‹I1 (1_“Þ쌧•a‰@–òÜŽt‰ï. 2“Œ–òÜ. 3–òÜ): _“Þ쌧•a‰@–òÜŽt‰ïŽGŽ, 107: 29-30, 2004.

320094. [Ç—á•ñ] _“Þ쌧•a‰@–òÜŽt‰ïŽåÑæ9‰ñˆê”ÊŽs–¯‚Ì‚½‚ß‚Ì‚­‚·‚èuÀ. •ŽR­ˆê (“Œ–òÜ): _“Þ쌧•a‰@–òÜŽt‰ïŽGŽ, 107: 34-37, 2004.

320095. [Ç—á•ñ] •a‰@–òÜŽt‚ÌgŠÅŒì‚Ì“ú‚¨‚æ‚ÑŠÅŒìTŠÔ‚̵h‚Ö‚ÌŽQ‰Á‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²¸Œ‹‰Ê. •ŽR­ˆê1, ‘Š‘ò­–¾2, ˆ¢•”³Ž‹3, Šâ“c—zŽq3, ÷ˆä–¯—Y3, ›’J@‹B3, ŽOa˜a’j3, “Y“c^Ži3, —é–Ø^Ži3, ª’×ÇK3, ŽR“c‰p‹I3, “nç²”ü’q—¯3 (1“Œ–òÜ. 2–òÜ. 3_“Þ쌧•a‰@–òÜŽt‰ï): _“Þ쌧•a‰@–òÜŽt‰ïŽGŽ, 107: 31-33, 2004.

320096. [Ç—á•ñ] g–ò‚ÆŒ’N‚·‚±‚â‚©ƒtƒFƒAh‚ÌŠJ¨‚æ‚Ñg‚­‚·‚è‘Š’kh‚ÌŽÀŽ{. •ŽR­ˆê1, ŽOa˜a’j2, ‘Š‘ò­–¾3, —é–Ø^Ži2, ŽR“c‰p‹I2, ˆ¢•”³Ž‹2, Šâ“c—zŽq2, ÷ˆä–¯—Y2, ›’J@‹B2, “Y“c^Ži2, ª’×ÇK2, “nç²”ü’q—¯2 (1“Œ–òÜ. 2_“Þ쌧•a‰@–òÜŽt‰ï. 3–òÜ): _“Þ쌧•a‰@–òÜŽt‰ïŽGŽ, 108: 27-28, 2005.

520356. [‘à] ‚ª‚ñ‰»Šw—Ö@‚É‚¨‚¯‚é•a‰@–òÜŽt‚Ì–ðŠ„. •½ŽR•Ži, •ŽR­ˆê (“Œ–òÜ): “ú–{–òÜŽt‰ïŽGŽ, 56: 1437-1443, 2004.

520357. [‘à] ƒIƒsƒIƒCƒh»Ü‚Ì“Á’¥‚ÆŒø‰Ê“I‚ÈŽg—p•û–@. •½ŽR•Ži, •ŽR­ˆê (“Œ–òÜ): ŒŽŠ§–òŽ–, 47: 209-217, 2005.

520358. [‘à] Ž¾Š³•Ê–òŠw“I‰î“üƒ}ƒjƒ…ƒAƒ‹|‡–°áŠQ•Ò|. ‚‹´Œ«¬, •ŽR­ˆê (“Œ–òÜ): “ú–{•a‰@–òÜŽt‰ïŽGŽ, 41: 273-277, 2005.

520359. [‘à] –òÜŽt‚É‚æ‚é’ŽËÜ’²Ü‚̈Ӌ`. •ŽR­ˆê (“Œ–òÜ): ŒŽŠ§–òŽ–, 47: 357-540, 2005.

520360. [‘à] ’ŽËÜ‚É‚©‚©‚í‚銳ŽÒ‚Ö‚Ìî•ñ’ñ‹Ÿ. ‚‹´Œ«¬, •ŽR­ˆê (“Œ–òÜ): ŒŽŠ§–òŽ–, 47: 663-670, 2005.

520361. [‘à] ƒŒƒWƒƒ““o˜^‚É‚æ‚鈕ûŽx‰‡‚ƈ•ûŠÓ¸. Žu“cŽ}, ‰¡“cTˆê, •½ŽR•Ži, •ŽR­ˆê (“Œ–òÜ): ŒŽŠ§–òŽ–, 47: 703-709, 2005.

m’˜@‘n

620216. [‰ðà‘] (•ª’SŽ·•M) •a‰@–òÜŽt‹Æ–±ƒ}ƒjƒ…ƒAƒ‹ |•a‰@–òÜŽt‹Æ–±‚Ì•W€‰»‚ÉŒü‚¯‚Ä|; –ò•¨Ž¡—Â̎Às |ˆ•û‚¹‚ñŠÓ¸‚©‚ç–òÜ’²», —^–ò‚Ü‚Å‚Ì—¬‚ê|, p.45-51. •½ŽR•Ži, •ŽR­ˆê (“Œ–òÜ), ŠÄC “ú–{•a‰@–òÜŽt‰ï, ƒGƒ‹ƒ[ƒrƒAEƒWƒƒƒpƒ“, “Œ‹ž, 2004”­s.

620217. [‰ðà‘] (•ª’SŽ·•M) •a‰@–òÜŽt‹Æ–±ƒ}ƒjƒ…ƒAƒ‹ |•a‰@–òÜŽt‹Æ–±‚Ì•W€‰»‚ÉŒü‚¯‚Ä|; –ò•¨Ž¡—Â̎Às |’ŽË–ò’²Ü|, p.52-61. •½ŽR•Ži, •ŽR­ˆê (“Œ–òÜ), ŠÄC “ú–{•a‰@–òÜŽt‰ï, ƒGƒ‹ƒ[ƒrƒAEƒWƒƒƒpƒ“, “Œ‹ž, 2004”­s.

620218. [‰ðà‘] (•ª’SŽ·•M) •a‰@–òÜŽt‹Æ–±ƒ}ƒjƒ…ƒAƒ‹ |•a‰@–òÜŽt‹Æ–±‚Ì•W€‰»‚ÉŒü‚¯‚Ä|; –ò•¨Ž¡—Â̎Às |Š³ŽÒ‚Ö‚Ìî•ñ’ñ‹Ÿ|, p.62-70. •½ŽR•Ži, •ŽR­ˆê (“Œ–òÜ), ŠÄC “ú–{•a‰@–òÜŽt‰ï, ƒGƒ‹ƒ[ƒrƒAEƒWƒƒƒpƒ“, “Œ‹ž, 2004”­s.

620219. [‰ðà‘] (•ª’SŽ·•M) ƒvƒŒƒtƒBƒ‹ƒhƒVƒŠƒ“ƒWEƒLƒbƒg|ˆã—ÃŒ»ê‚©‚ç‚Ì—v‹E³”F\¿E‘“àŠO‚Ì“®Œü|; ˆã—ÃŒ»ê‚ª•K—v‚Æ‚·‚éƒvƒŒƒtƒBƒ‹ƒhƒVƒŠƒ“ƒWƒLƒbƒg»•i|ƒŒƒtƒBƒ‹ƒhƒVƒŠƒ“ƒWƒLƒbƒg»Ü‚ÌŽg—p•]‰¿|, p.163-174. •½ŽR•Ži, •ŽR­ˆê (“Œ–òÜ), î•ñ‹@\, “Œ‹ž, 2005”­s.

620220. [‰ðà‘] (•ª’SŽ·•M) ƒvƒŒƒtƒBƒ‹ƒhƒVƒŠƒ“ƒWEƒLƒbƒg|ˆã—ÃŒ»ê‚©‚ç‚Ì—v‹E³”F\¿E‘“àŠO‚Ì“®Œü|; ˆã—ÃŒ»ê‚ª•K—v‚Æ‚·‚éƒvƒŒƒtƒBƒ‹ƒhƒVƒŠƒ“ƒWƒLƒbƒg»•i|•K—v‚Æ‚³‚ê‚é–òÜ‚Í|, p.175-182. •½ŽR•Ži, •ŽR­ˆê (“Œ–òÜ), î•ñ‹@\, “Œ‹ž, 2005”­s.

620221. [‰ðà‘] (•ª’SŽ·•M) ƒvƒŒƒtƒBƒ‹ƒhƒVƒŠƒ“ƒWEƒLƒbƒg|ˆã—ÃŒ»ê‚©‚ç‚Ì—v‹E³”F\¿E‘“àŠO‚Ì“®Œü|; ˆã—ÃŒ»ê‚ª•K—v‚Æ‚·‚éƒvƒŒƒtƒBƒ‹ƒhƒVƒŠƒ“ƒWƒLƒbƒg»•i|–òÜŽt‚É‚æ‚é’ŽË–ò’²Ü‚ÌŒ»ó|, p.183-193. •½ŽR•Ži, •ŽR­ˆê (“Œ–òÜ), î•ñ‹@\, “Œ‹ž, 2005”­s.

620222. [‰ðà‘] (•ª’SŽ·•M) ‰ü’ù”ÅŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; Še•i–Ú‚Ì–òÜŠT—v, p.27-732. •ŽR­ˆê (“Œ–òÜ), •ÒW ΋´@W1, Ž›è–¾”ü2, “¡“cŒbŽq3, •ŽR­ˆê4 (1‹~¢ŒRƒu[ƒX‹L”O•a‰@. 2’·è‘å. 3ŠÅŒì•”. 4“Œ–òÜ), ’†‰›–@‹Ko”Å, “Œ‹ž, 2005/3/10”­s.

620223. [‰ðà‘] (•ª’SŽ·•M) ‰ü’ù”ÅŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; ‘˜_, p.1-14. •ŽR­ˆê (“Œ–òÜ), •ÒW ΋´@W1, Ž›è–¾”ü2, “¡“cŒbŽq3, •ŽR­ˆê4 (1‹~¢ŒRƒu[ƒX‹L”O•a‰@. 2’·è‘å. 3ŠÅŒì•”. 4“Œ–òÜ), ’†‰›–@‹Ko”Å, “Œ‹ž, 2005/3/10”­s.

620224. [‰ðà‘] (•ª’SŽ·•M) ‰ü’ù”ÅŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; ¸__Œoì—p–ò‰ðà, p.15-27. •ŽR­ˆê (“Œ–òÜ), •ÒW Î@‹´W1, Ž›è–¾”ü2, “¡“cŒbŽq3, •ŽR­ˆê4 (1‹~¢ŒRƒu[ƒX‹L”O•a‰@. 2’·è‘å. 3ŠÅŒì•”. 4“Œ–òÜ), ’†‰›–@‹Ko”Å, “Œ‹ž, 2005/3/10”­s.

620225. [‰ðà‘] (•ª’SŽ·•M) ‰ü’ù”ÅŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; Ž•‰ÈEŒûo—p–ò‰ðà, p.297. •ŽR­ˆê (“Œ–òÜ), •ÒW ΋´@W1, Ž›è–¾”ü2, “¡“cŒbŽq3, •ŽR­ˆê4 (1‹~¢ŒRƒu[ƒX‹L”O•a‰@. 2’·è‘å. 3ŠÅŒì•”. 4“Œ–òÜ), ’†‰›–@‹Ko”Å, “Œ‹ž, 2005/3/10”­s.

620226. [‰ðà‘] (•ª’SŽ·•M) ‰ü’ù”ÅŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; Ž¨•@ˆôA‰È—p–ò, p.301-302. •ŽR­ˆê (“Œ–òÜ), •ÒW Î@‹´W1, Ž›è–¾”ü2, “¡“cŒbŽq3, •ŽR­ˆê4 (1‹~¢ŒRƒu[ƒX‹L”O•a‰@. 2’·è‘å. 3ŠÅŒì•”. 4“Œ–òÜ), ’†‰›–@‹Ko”Å, “Œ‹ž, 2005/3/10”­s.

620227. [‰ðà‘] (•ª’SŽ·•M) ‰ü’ù”ÅŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; ŒŒ‰t—p–ò, p.331-332. •ŽR­ˆê (“Œ–òÜ), •ÒW ΋´@W1, Ž›è–¾”ü2, “¡“cŒbŽq3, •ŽR­ˆê4 (1‹~¢ŒRƒu[ƒX‹L”O•a‰@. 2’·è‘å. 3ŠÅŒì•”. 4“Œ–òÜ), ’†‰›–@‹Ko”Å, “Œ‹ž, 2005/3/10”­s.

620228. [‰ðà‘] (•ª’SŽ·•M) ‰ü’ù”ÅŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; ‘ãŽÓ«ˆã–ò•i, p.391-393. •ŽR­ˆê (“Œ–òÜ), •ÒW ΋´@W1, Ž›è–¾”ü2, “¡“cŒbŽq3, •ŽR­ˆê4 (1‹~¢ŒRƒu[ƒX‹L”O•a‰@. 2’·è‘å. 3ŠÅŒì•”. 4“Œ–òÜ), ’†‰›–@‹Ko”Å, “Œ‹ž, 2005/3/10”­s.

620229. [‰ðà‘] (•ª’SŽ·•M) ‰ü’ù”ÅŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; ƒrƒ^ƒ~ƒ“Ü, p.459-460. •ŽR­ˆê (“Œ–òÜ), •ÒW ΋´@W1, Ž›è–¾”ü2, “¡“cŒbŽq3, •ŽR­ˆê4 (1‹~¢ŒRƒu[ƒX‹L”O•a‰@. 2’·è‘å. 3ŠÅŒì•”. 4“Œ–òÜ), ’†‰›–@‹Ko”Å, “Œ‹ž, 2005/3/10”­s.

620230. [‰ðà‘] (•ª’SŽ·•M) ‰ü’ù”ÅŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; R¶•¨Ž¿ ‰»Šw—Ö@Ü, p.471-483. •ŽR­ˆê (“Œ–òÜ), •ÒW ΋´@W1, Ž›è–¾”ü2, “¡“cŒbŽq3, •ŽR­ˆê4 (1‹~¢ŒRƒu[ƒX‹L”O•a‰@. 2’·è‘å. 3ŠÅŒì•”. 4“Œ–òÜ), ’†‰›–@‹Ko”Å, “Œ‹ž, 2005/3/10”­s.

620231. [‰ðà‘] (•ª’SŽ·•M) ‰ü’ù”ÅŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; ¶•¨Šw“I»Ü, p.565-566. •ŽR­ˆê (“Œ–òÜ), •ÒW ΋´@W1, Ž›è–¾”ü2, “¡“cŒbŽq3, •ŽR­ˆê4 (1‹~¢ŒRƒu[ƒX‹L”O•a‰@. 2’·è‘å. 3ŠÅŒì•”. 4“Œ–òÜ), ’†‰›–@‹Ko”Å, “Œ‹ž, 2005/3/10”­s.

620232. [‰ðà‘] (•ª’SŽ·•M) ‰ü’ù”ÅŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; f’f—pŒŸ¸–ò, p.669. •ŽR­ˆê (“Œ–òÜ), •ÒW ΋´@W1, Ž›è–¾”ü2, “¡“cŒbŽq3, •ŽR­ˆê4 (1‹~¢ŒRƒu[ƒX‹L”O•a‰@. 2’·è‘å. 3ŠÅŒì•”. 4“Œ–òÜ), ’†‰›–@‹Ko”Å, “Œ‹ž, 2005/3/10”­s.

620233. [‰ðà‘] (•ª’SŽ·•M) ‰ü’ù”ÅŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; Á“Å–ò, p.677-682. •ŽR­ˆê (“Œ–òÜ), •ÒW ΋´@W1, Ž›è–¾”ü2, “¡“cŒbŽq3, •ŽR­ˆê4 (1‹~¢ŒRƒu[ƒX‹L”O•a‰@. 2’·è‘å. 3ŠÅŒì•”. 4“Œ–òÜ), ’†‰›–@‹Ko”Å, “Œ‹ž, 2005/3/10”­s.

620234. [‰ðà‘] (•ª’SŽ·•M) ‰ü’ù”ÅŠÅŒì‚Ì‚½‚ß‚Ì–òŽ–“T; •â‰tE•â³—p»Ü Œo’°‰h—{Ü, p.359-363. •ŽR­ˆê (“Œ–òÜ), •ÒW ΋´@W1, Ž›è–¾”ü2, “¡“cŒbŽq3, •ŽR­ˆê4 (1‹~¢ŒRƒu[ƒX‹L”O•a‰@. 2’·è‘å. 3ŠÅŒì•”. 4“Œ–òÜ), ’†‰›–@‹Ko”Å, “Œ‹ž, 2005/3/10”­s.

620235. [‰ðà‘] (•ª’SŽ·•M) ƒvƒƒuƒŒƒ€ƒŠƒXƒg쬂̎èˆø‚«; ‡–°áŠQ, p.26-31. ‚‹´Œ«¬ (“Œ–òÜ), •ÒW ŠwpˆÏˆõ‰ï‘æŽOˆÏˆõ‰ï, ‚¶‚Ù‚¤, “Œ‹ž, 2004”­s.

620236. [‰ðà‘] (•ª’SŽ·•M) ƒvƒƒuƒŒƒ€ƒŠƒXƒg쬂̎èˆø‚«; ‚Ž‰ŒŒÇ, p.137-141. ‚‹´Œ«¬ (“Œ–òÜ), •ÒW ŠwpˆÏˆõ‰ï‘æŽOˆÏˆõ‰ï, ‚¶‚Ù‚¤, “Œ‹ž, 2004”­s.

620237. [‰ðà‘] (•ª’SŽ·•M) ƒvƒƒuƒŒƒ€ƒŠƒXƒg쬂̎èˆø‚«; ‚”AŽ_ŒŒÇ, p.148-151. ‚‹´Œ«¬ (“Œ–òÜ), •ÒW ŠwpˆÏˆõ‰ï‘æŽOˆÏˆõ‰ï, ‚¶‚Ù‚¤, “Œ‹ž, 2004”­s.

620238. [‰ðà‘] (•ª’SŽ·•M) ƒvƒƒuƒŒƒ€ƒŠƒXƒg쬂̎èˆø‚«; ƒAƒgƒs[«”畆‰Š, p.180-183. ‚‹´Œ«¬ (“Œ–òÜ), •ÒW ŠwpˆÏˆõ‰ï‘æŽOˆÏˆõ‰ï, ‚¶‚Ù‚¤, “Œ‹ž, 2004”­s.

620239. [‰ðà‘] (•ª’SŽ·•M) ƒvƒƒuƒŒƒ€ƒŠƒXƒg쬂̎èˆø‚«; —Γàá, p.192-197. ‚‹´Œ«¬ (“Œ–òÜ), •ÒW ŠwpˆÏˆõ‰ï‘æŽOˆÏˆõ‰ï, ‚¶‚Ù‚¤, “Œ‹ž, 2004”­s.

mŠw‰ïEŒ¤‹†‰ï“™n

723979. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) I––ŠúÁ‰»ŠíŠàŠ³ŽÒ‚É‚¨‚¯‚éƒNƒŒƒAƒ`ƒjƒ“ƒNƒŠƒAƒ‰ƒ“ƒX—\‘ªŽ®‚̑Ó–«. •½ŽR•Ži1, ˆÉ“¡’¼Žq1, •ŽR­ˆê1, –îŒã˜a•v2 (1“Œ–òÜ. 2–òÜ): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—Êw‰ï‘‰ï (2004/6/17-18), ŽD–y.

723980. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) HMG-Co‚`ŠÒŒ³y‘f‘jŠQ–òpravastatin sodium‚̈ã–ò•i“Y•t•¶‘‚É‚¨‚¯‚é–ò•¨“®‘Ôî•ñ‚ÉŠÖ‚·‚錤‹†. •½ŽR•Ži1, í“cˆ¤Žq1, •ŽR­ˆê1, –îŒã˜a•v2, ŒF’J—YŽ¡3 (1“Œ–òÜ. 2–òÜ. 3Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[j: ‘æ54‰ñ“ú–{•a‰@Šw‰ï (2004/7/2), ‰¡•l.

723981. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠO—ˆ‰»Šw—Ö@‚É‚¨‚¯‚é–òÜŽt‹Æ–±‚ÌŒ»ó. ¬Œ´”ü], •½ŽR•Ži, –{ŠÔ‰ëŽm, Ä“¡—R”üŽq, ˆÉ“¡’¼Žq, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2004 (2004/7/17), ŽD–y.

723982. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆ•ûƒI[ƒ_ƒŠƒ“ƒOƒVƒXƒeƒ€‚É‚¨‚¯‚鈕û–òÜ“ü—̓~ƒX–hŽ~‚ÉŠÖ‚·‚錤‹†|“ü—Í•¶Žš”‚ÌŒŸ“¢|. ’Å@’, í“cˆ¤Žq, óˆä”ü—R‹I, •½ŽR•Ži, •ŽR­ˆê (“Œ–òÜ): ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2004 (2004/7/17), ŽD–y.

723983. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€ (‹ŒƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€) ‚É‚¨‚¯‚éˆê”ʉ‰‘è”­•\‚Ì„ˆÚ. “ï”gº—Y, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2004 (2004/7/17), ŽD–y.

723984. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žs”̃‚ƒ‹ƒqƒl…—n‰t‚Ì—L—p«‚ÉŠÖ‚·‚錤‹†|’²Ü¥–ƒ–òŠÇ—‚Ìì‹ÆŒø—¦‚ɂ‚¢‚Ä|. í“cˆ¤Žq, •½ŽR•Ži, óˆä”ü—R‹I, ’Å@’, “ï”gº—Y, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2004 (2004/7/17), ŽD–y.

723985. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘æ‡T‘ŠŽŽŒ±ŽŽŒ±‚É‚¨‚¯‚鉉ñ“Š—^—Ê‚Ìݒ誋’‚Æ‚µ‚Ä‚ÌÅ‘å–³“Å«—Ê‚Ì‘Ì•\–ÊϕⳂ̑Ó–«‚ÌŒŸ“¢. “¡“c•üŒb1, ”öè^’qŽq1, ‰¡“cTˆê2, àV“cŽÀ‰Ô2, ’†‘º’q”ü2, “¡“c’‰˜a1, ’†Œ´‚¢‚¿‚Ý1, –쑺¡“úŽq1, ”n“ˆ³—²3, •ŽR­ˆê2, ‘å’J‹`•v1, ŒF’J—YŽ¡1 (1Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[. 2“Œ–òÜ. 3–ò—): ‘æ25‰ñ“ú–{—Õ°–ò—Šw‰ï”N‰ï (2004/9/17), ɪ.

723986. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰‰ñ“Š—^—ÊÝ’è‚ÉŠÖ‚·‚郌ƒgƒƒXƒyƒNƒeƒBƒu‚ÈŒŸ“¢. ”öè^’qŽq1, “¡“c•üŒb1, ‰¡“cTˆê2, àV“cŽÀ‰Ô2, ‰i¼‹IŽq1, ²‹´–M•F1, ¬—Ñ^”ü2, ŽµžŠ‹v”üŽq1, “üŒË–ì˜a‘ã1, •ŽR­ˆê2, ŒF’J—YŽ¡1, ‘å’J‹`•v1 (1Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[. 2“Œ–òÜj: ‘æ25‰ñ“ú–{—Õ°–ò—Šw‰ï”N‰ï (2004/9/18), ɪ.

723987. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) S“d}QTŠÔŠu‚̌ő̓àEŒÂ‘ÌŠÔ‹y‚Ñ“ú“à•Ï“®‚ÉŠÖ‚·‚錟“¢|Œ’N¬l’jŽq‚ð‘ÎÛ‚Æ‚µ‚½—\”õ“IŒŸ“¢|. àV“cŽÀ‰Ô1, ŒF’J—YŽ¡2, ²‹´–M•F2, –쑺¡“úŽq2, ’†‘º’q”ü1, ‰¡“cTˆê1, ‰i¼‹IŽq2, ”öè^’qŽq2, “¡“c•üŒb2, •ŽR­ˆê1, ‘å’J‹`•v2 (1“Œ–òÜ. 2Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[): ‘æ25‰ñ“ú–{—Õ°–ò—Šw‰ï”N‰ï (2004/9/18), ɪ.

723988. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒqƒAƒŠƒ“ƒO, Ž–‘OŒŸ“¢‰ï‹^‹`Ž–—á‚ÌŒŸ“¢. ‘å‰Í“à‹v”üŽq1, Žu“cŽ}1, ‰¡“cTˆê1, •ŽR­ˆê1, ŒF’J—YŽ¡2 (1“Œ–òÜ. 2Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[): ‘æ4‰ñCRC‚Æ—Õ°ŽŽŒ±‚ÌÝ‚è•û‚ðl‚¦‚é‰ï‹c2004 (2004/10/9-10), ‰F•”.

723989. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –k—¢‘åŠw“Œ•a‰@‚É‚¨‚¯‚鎡Œ±ƒR[ƒfƒBƒl[ƒ^[‹Æ–±|ŠO‰È—̈æ‚ÌŽ¡Œ±‚É‚¨‚¯‚éƒCƒ“ƒtƒH[ƒ€ƒhEƒRƒ“ƒZƒ“ƒg‚ð’†S‚É|. àV“cŽÀ‰Ô1, ‰i¼‹IŽq2, ‘å‰Í“à‹v”üŽq1, Žu“cŽ}1, ’†‘º’q”ü1, ]“cD1, ’¹àV”ü¢2, ŽµžŠ‹v”üŽq2, ²ìŒ‰”T2, ‰¡“cTˆê1, •ŽR­ˆê1, ŒF’J—YŽ¡2, ‘å’J‹`•v2, ÷–{Mˆê3, ‘å’J„³3, “nç²¹•F3 (1“Œ–òÜ. 2Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[. 3ŠO): ‘æ4‰ñCRC‚Æ—Õ°ŽŽŒ±‚ÌÝ‚è•û‚ðl‚¦‚é‰ï‹c2004 (2004/10/9-10), ‰F•”.

723990. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) HMG-Co‚`ŠÒŒ³y‘f‘jŠQ–òƒvƒ‰ƒoƒXƒ^ƒ`ƒ“ƒiƒgƒŠƒEƒ€Œã”­ˆã–ò•i‚Ì•iŽ¿‚ÉŠÖ‚·‚錤‹†. •½ŽR•Ži, •ŽR­ˆê (“Œ–òÜ): ‘æ14‰ñ“ú–{ˆã—ÖòŠw‰ï (2004/10/16), ç—t.

723991. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠO—ˆ‰»Šw—Ö@ƒZƒ“ƒ^[‚É‚¨‚¯‚é–òÜŽt‚Ì–ðŠ„. ‚‹´Œ«¬1, ²‹vŠÔ­•F1, ²ìŒ«ˆê1, ”Ô ÍŽq2, ã–V•qŽq3, ‘ •À@Ÿ4, –îŒã˜a•v1 (1–òÜ. 2ŠÅŒì•”. 3ŽY•w. 4ŠO): ‘æ14‰ñ“ú–{ˆã—ÖòŠw‰ï (2004/10/16), ç—t.

723992. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’·Šú“Š–ò§ŒÀ‚ÌŒ´‘¥”pŽ~‚É”º‚¤ŠO—ˆˆ•û‚¹‚ñˆ•û“ú”‚Ì•Ï‘J. ™—Ñ’q”ü, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): ‘æ14‰ñ“ú–{ˆã—ÖòŠw‰ï (2004/10/16), ç—t.

723993. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Rƒp[ƒLƒ“ƒ\ƒ“•a–òƒƒVƒ‹Ž_ƒuƒƒ‚ƒNƒŠƒvƒ`ƒ“‚̈ã–ò•i“Y•t•¶‘‚É‚¨‚¯‚é–ò•¨“®‘Ôî•ñ‚ÉŠÖ‚·‚錤‹†|æ”­ˆã–ò•i‚ƌ㔭ˆã–ò•i‚Ì”äŠr|. óˆä”ü—R‹I, •½ŽR•Ži, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): ‘æ14‰ñ“ú–{ˆã—ÖòŠw‰ï (2004/10/17), ç—t.

723994. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”ñƒXƒeƒƒCƒh«R‰ŠÇ–òƒƒLƒ\ƒvƒƒtƒFƒ“‚̈ã–ò•i“Y•t•¶‘‚É‚¨‚¯‚é–ò•¨“®‘Ôî•ñ‚ÉŠÖ‚·‚錤‹†|æ”­ˆã–ò•i‚ƌ㔭ˆã–ò•i‚Ì”äŠr|. ¬Œ´”ü], •½ŽR•Ži, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): ‘æ14‰ñ“ú–{ˆã—ÖòŠw‰ï (2004/10/17), ç—t.

723995. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ‹ƒVƒEƒ€hR–òƒjƒtƒFƒWƒsƒ“‚̈ã–ò•i“Y•t•¶‘‚É‚¨‚¯‚é–ò•¨“®‘Ôî•ñ‚ÉŠÖ‚·‚錤‹†|æ”­ˆã–ò•i‚ƌ㔭ˆã–ò•i‚Ì”äŠr|. –{ŠÔ‰ëŽm, •½ŽR•Ži, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): ‘æ14‰ñ“ú–{ˆã—ÖòŠw‰ï (2004/10/17), ç—t.

723996. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) HMG-Co‚`ŠÒŒ³y‘f‘jŠQ–òƒVƒ“ƒoƒXƒ^ƒ`ƒ“ƒiƒgƒŠƒEƒ€‚̈ã–ò•i“Y•t•¶‘‚É‚¨‚¯‚é–ò•¨“®‘Ôî•ñ‚ÉŠÖ‚·‚錤‹†|æ”­ˆã–ò•i‚ƌ㔭ˆã–ò•i‚Ì”äŠr|. •½ŽR•Ži, í“cˆ¤Žq, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): ‘æ14‰ñ“ú–{ˆã—ÖòŠw‰ï (2004/10/17), ç—t.

723997. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ú–{ˆã—ÖòŠw‰ï (‹Œ“ú–{•a‰@–òŠw‰ï) ‚É‚¨‚¯‚éˆê”ʉ‰‘è”­•\‚Ì„ˆÚ. “ï”gº—Y, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): ‘æ14‰ñ“ú–{ˆã—ÖòŠw‰ï (2004/10/17), ç—t.

723998. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šà‰»Šw—Ö@ƒŠƒXƒNƒ}ƒl[ƒWƒƒ“ƒg‚Ö‚ÌŽæ‚è‘g‚Ý (‘æ2•ñ). Žu“cŽ}1, ‰¡“cTˆê1, •½ŽR•Ži1, •ŽR­ˆê1, ²X–Ø@“O2, ”óŒûŸ•F2, “c•Ó@‘2, ¬ò˜aŽO˜Y2, ^–ì“oŠìŽq3 (1“Œ–òÜ. 2“à‡T. 3ŠÅŒì•”): ‘æ42‰ñ“ú–{ŠàŽ¡—Êw‰ï (2004/10/27-10/28), ‹ž“s.

723999. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒKƒ‰ƒX—eŠí‚ðŽg—p‚µ‚½—A‰t’†‚̃Aƒ‹ƒ~ƒjƒEƒ€”Z“x‚ÉŠÖ‚·‚錤‹†. •½ŽR•Ži1, •ŽR­ˆê1, –x“à”ü•ä2 (1“Œ–òÜ. 2ƒVƒmƒeƒXƒg): ‘æ20‰ñ“ú–{ŠÂ‹«Š´õŠw‰ï‘‰ï (2005/2/25), _ŒË.

7231000. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œ’N¬l‚É‚¨‚¯‚é‚’`”’, L-ƒtƒFƒjƒ‹ƒAƒ‰ƒjƒ“•‰‰×Œã‚̬’°ƒyƒvƒ`ƒhƒgƒ‰ƒ“ƒXƒ|[ƒ^ŠîŽ¿–ò•¨ƒZƒtƒFƒ€ŒnR¶•¨Ž¿‚Ì‹zŽû‚ւ̉e‹¿‚ÌŒŸ“¢. “¡“c•üŒb1, ‰¬–ìŽO’qŽq2, ŽRè@W2, ”öè^’qŽq2, àV“cŽÀ‰Ô1, ’†‘º’q”ü1, ²‹´–M•F1, ŽµžŠ‹v”üŽq1, –쑺¡“úŽq1, ‰¡“cTˆê1, “¡“c’‰˜a2, • ŽR­ˆê1, ‘å’J‹`•v2, ”n“ˆ³—²3, ŒF’J—YŽ¡2 (1“Œ–òÜ. 2Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[. 3–ò—): ‘æ125‰ñ“ú–{–òŠw‰ï (2005/3/29), “Œ‹ž.

7231001. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –k—¢‘åŠw“Œ•a‰@‚É‚¨‚¯‚éƒIƒsƒIƒCƒh»Ü‚ÌŽg—pó‹µ. í“cˆ¤Žq, •½ŽR•Ži, óˆä”ü—R‹I, ’Å@’, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): ‘æ125‰ñ“ú–{–òŠw‰ï (2005/3/29), “Œ‹ž.

7231002. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒvƒƒgƒ“ƒ|ƒ“ƒv‘jŠQ–òƒIƒƒvƒ‰ƒ][ƒ‹‚̈ã–ò•i“Y•t•¶‘‚É‚¨‚¯‚é–ò•¨“®‘Ôî•ñ‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錤‹†|æ”­ˆã–ò•i‚ƌ㔭ˆã–ò•i‚ÌŒŸ“¢|. •½ŽR•Ži, ¬Œ´”ü], ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): ‘æ125‰ñ“ú–{–òŠw‰ï (2005/3/29), “Œ‹ž.

732058. [Šw‰ï (’n•û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šç‚ÌŒ©‚¦‚é–òÜŽt |_“Þ쌧•a‰@–òÜŽt‰ï‚ÌŠˆ“®‚ð’†S‚É|. •ŽR­ˆê (“Œ–òÜ): “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒNŠwp‘å‰ï (2004/8/29), ‚‚­‚Î.

733501. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ŠO—ˆ‰»Šw—Ö@ƒZƒ“ƒ^[‚É‚¨‚¯‚é–òÜŽt‚Ì–ðŠ„. ‚‹´Œ«¬ (–òÜ): ‘æ3‰ñ–³‹Û»Ü, —A‰t‹Æ–±Œ¤‹†‰ï (2004/8/7), –¼ŒÃ‰®.

733502. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) –k—¢‘åŠw“Œ•a‰@‚É‚¨‚¯‚éˆã–ò•i‚ÌÌ—pE휎臂ÆÌ—p•i–Ú”‚Ì„ˆÚ. óˆä”ü—R‹I, í“cˆ¤Žq, ’Å@’, •½ŽR•Ži, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒNŠwp‘å‰ï (2004/8/29), ‚‚­‚Î.

733503. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) RŒŒ¬”–ò‰–Ž_ƒ`ƒNƒƒsƒWƒ“‚̈ã–ò•i“Y•t•¶‘‚É‚¨‚¯‚é–ò•¨“®‘Ôî•ñ‚ÉŠÖ‚·‚錤‹†. ‰F–ì^—Žq, •½ŽR•Ži, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒNŠwp‘å‰ï (2004/8/28), ‚‚­‚Î.

733504. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) ‡–°“±“ü–òƒuƒƒ`ƒ]ƒ‰ƒ€‚̈ã–ò•i“Y•t•¶‘‚É‚¨‚¯‚é–ò•¨“®‘Ôî•ñ‚ÉŠÖ‚·‚錤‹† |æ”­ˆã–ò•i‚ƌ㔭ˆã–ò•i‚Ì”äŠr|. •“c‚¿‚©], •½ŽR•Ži, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒNŠwp‘å‰ï (2004/8/29), ‚‚­‚Î.

733505. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) ŒoŒûŒŒ“œ~‰º–òƒOƒŠƒyƒ“ƒNƒ‰ƒ~ƒg‚̈ã–ò•i“Y•t•¶‘‚É‚¨‚¯‚é–ò•¨“®‘Ôî•ñ‚ÉŠÖ‚·‚錤‹†|æ”­ˆã–ò•i‚ƌ㔭ˆã–ò•i‚Ì”äŠr|. –{ŠÔ‰ëŽm, •½ŽR•Ži, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒNŠwp‘å‰ï (2004/8/29), ‚‚­‚Î.

733506. [Šw‰ï (’n•û)] (ƒ|ƒXƒ^[) “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒNŠwp‘å‰ï‚É‚¨‚¯‚éˆê”ʉ‰‘è‚Ì„ˆÚ. “ï”gº—Y, ¬ìK—Y, •ŽR­ˆê (“Œ–òÜ): “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒNŠwp‘å‰ï (2004/8/29), ‚‚­‚Î.

733507. [Œ¤‹†‰ï] (ˆê”Êu‰‰) –ò•¨‹zŽû‚Ì“ú“à•Ï“®‚ÉŠÖ‚·‚錤‹†|ˆÝ“d}‚¨‚æ‚уAƒZƒgƒAƒ~ƒmƒtƒFƒ“–@‚ð—p‚¢‚½ŒŸ“¢|. àV“cŽÀ‰Ô1, ŒF’J—YŽ¡2, ‘å“à_Žq2, “¡“c•üŒb2, ”öè^’qŽq2, ‰¡“cTˆê1, •ŽR­ˆê1, ‹gŽR—F“ñ3, “c•Ó@‘4, ¬ò˜aŽO˜Y4, ¼Œ³Ž›ŽâX4 (1“Œ–òÜ. 2Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[. 3‹¤—§–ò‘å. 4“à‡T): ‘æ4‰ñŽžŠÔ–ò—EŽ¡—Âðl‚¦‚é‰ï (2004/9/19), ɪ.

733508. [Šw‰ï (’n•û)] (ˆê”Êu‰‰) ®Œ`ŠO‰È•a“‚É‚¨‚¯‚é–òÜŠÇ—Žw“±‹Æ–±‚ÌŒ»ó|“ü‰@ŽžŠ³ŽÒŽŽQ–ò‚ÉŠÖ‚·‚郊ƒXƒNƒ}ƒlƒWƒƒ“ƒg|. Ä“¡—R”üŽq1, ‰¡ˆäMŽq1, •½ŽR•Ži1, •ŽR­ˆê1, ¬—Ñ–¾³2, “ñŒ©r˜Y2 (1“Œ–òÜ. 2®ŠO): ‘æ53‰ñ“Œ“ú–{®Œ`ЊQŠO‰ÈŠw‰ï (2004/9/24), ŽRŒ`.

733509. [Œ¤‹†‰ï] (ˆê”Êu‰‰) •é‚炵‚ɖ𗧂ˆã—Â̒mŽ¯: ‚à‚Á‚Æ’m‚肽‚¢–ò‚̘bI •ŽR­ˆê (“Œ–òÜ): ‘Š–ÍŒ´Žs‹³ˆçˆÏˆõ‰ïEÀŠÔŽs‹³ˆçˆÏˆõ‰ï•½¬16”N“xŽs–¯‘åŠw–k—¢‘åŠwƒR[ƒX (2005/9/25), ‘Š–ÍŒ´.

733510. [Œ¤‹†‰ï] (ˆê”Êu‰‰) ‚ª‚ñ‰»Šw—Ö@‚É‚¨‚¯‚郊ƒXƒNƒ}ƒl[ƒWƒƒ“ƒg‚Ö‚ÌŽæ‚è‘g‚Ý|RŠàÜŽ¡—ÂðˆÀ‘SE‰~ŠŠ‚És‚¤‚½‚߂̘AŒgƒVƒXƒeƒ€‚Ì\’z|. ^–ì“oŠìŽq1, “ï”g—Œb1, Žu“cŽ}2, •ŽR­ˆê2, ¬ò˜aŽO˜Y3, ²X–Ø@“O3 (1ŠÅŒì•”. 2–òÜ. 3“à‡T): ‘æ4‰ñ–k—¢‘åŠwŠÅŒìŒ¤‹†‰ï (2004/12/18), ‘Š–ÍŒ´.

733511. [Œ¤‹†‰ï] (ˆê”Êu‰‰) Ž¡Œ±‹y‚ÑŽs”ÌŒã—Õ°ŽŽŒ±‚ÌŽó‘õ‚ɂ‚¢‚Ä. •ŽR­ˆê (“Œ–òÜ): _“Þ쌧–òŽ–ŠÄŽ‹ˆõê–帎@Œ¤C (2005/1/19), ‰¡•l.